<SEC-DOCUMENT>0000885725-21-000008.txt : 20210223
<SEC-HEADER>0000885725-21-000008.hdr.sgml : 20210223
<ACCEPTANCE-DATETIME>20210223162150
ACCESSION NUMBER:		0000885725-21-000008
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		96
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210223
DATE AS OF CHANGE:		20210223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		21665776

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>bsx-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:b8cf84dc-d42e-4cf7-a067-5352d2212acb,g:c4fd43c3-3c28-47b7-bdfe-13ef2366d2d6,d:5c3e8d69fcc1460baddde62cfa022487--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:bsx="http://www.bostonscientific.com/20201231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:srt="http://fasb.org/srt/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl8zLTEtMS0xLTA_a683da8b-ec84-428e-b58c-33c5672e2f7d">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl80LTEtMS0xLTA_ba296e2d-1937-4a09-9aad-360b4b5b648b">12/31</ix:nonNumeric><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl81LTEtMS0xLTA_181ebe90-72f6-4616-8427-ae0fe3177f03">2020</ix:nonNumeric><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl82LTEtMS0xLTA_ff7d67ef-4144-4470-a6b0-868f89e3ec2a">FY</ix:nonNumeric><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl83LTEtMS0xLTA_07c9d87d-a16e-441d-96d9-f6fc91ff8a1c">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a988978970e4005a89f2558e11bca85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb79373de9f42768da8b4de1b4c6eeb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95364ec24cbb4b618f4ac38a93e0259a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i924ec29d9a304f4882d75905eb802224_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ie7e548e9c0454041b4a4f4d799765eaa_I20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2522ce480044b738970a71b97a2834e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3a4c1a262e0442388a415c87e27e889_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2a00e6f06c444a9952e4b94b0d4e6e_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i416c4bf3762343af99956df0491cda23_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic86a24afa1544f379e9453f8559daca7_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a0e4d8d1464b8e96a0b3b99c3831e6_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6edad1230384f4ea726dde74e58b266_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97947ef16fd64573b576ede19f2d29ea_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i486c2b6f6b1147f0b09d948b6ad1b5ce_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf28bd85296f42f49e4da5f20d423b67_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82aeda8856fa47ed8b39207375fa1aa8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d1f315a766c43b1aa5940ff8e160594_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae1d8357f67849468d20db2d30de5e55_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bbe2d5f3afb49b99ec4c9803ecee919_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i815f4d787d1e4a26a2e65fce1b26129c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i978ec64dad704d138144a11d4f20a868_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7354567f0bca438fa78f4baeeceed35c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5f0b56fe933409badece00bf9ab8f17_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id118699e701242f1879566050e0064d6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7af855385df42d583c24a02df379ca7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66c17b892a204bb2b1c1aa8cd1051251_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9eec6cd5c3d47bd8cc9fa8a26bae2d0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf8a046f49ba4e7bbeb5595372a466f6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic48f447708b74f77a26a4f0286cc2a15_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b040eb90cef4343a857fe2e7740195e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib22777e33f4f476c95138787b75b0db3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i369a19338d4645fcaff218f3e0180a0a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28940fe126704087ba8a61832f5de550_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e988814a30145f686582891ff75a88e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f4c7888c677425da7039956930978ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i069e7ea9c6764fb5ab7629ac3e1b1f7d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fb62c7fcc6748a29d33c15fc1a6e4ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i214a62bd8ef9406db278c8d1a09ffa31_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf7408d8c0ac4baa9b95744bb4a1416f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf999a62069f494daaa8b34dd39eb888_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e7c6f8f9b84193a176a221054afca4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c25b897fb8e4965a95e19981c5c8a85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30f6d299f51d4710906bfb8afd9fa959_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2189acf6800a485eac08cc940a299be8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd122064a7e945ed9ca826ffcb42ab6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8e21581818b44be817499b63aaaddd8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a695a97d72f47aaae3df04c71e8be50_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11643c9862df4baea0dccd9d1fe58c3b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab42b8f2e9794e569ed587870fb84d60_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56411282f0574a36b407828ddce5e536_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i64a8d1206e3449f0ae7a7ece1b89fb96_I20210121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a34bf00cea546488f2484aedb64dcf4_D20210121-20210121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-21</xbrli:startDate><xbrli:endDate>2021-01-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic719d29f043447d9a84bc5924b1baf78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i299c7ae54a0247c3ba17d84adb96d2dc_D20190819-20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-19</xbrli:startDate><xbrli:endDate>2019-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbpPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ibbb0c3a277f94a73ada943c59b4bac0e_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f7af4ce5e334ad6a48a0c025a8c309e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35075d47b59a45d1a6bea3504735e270_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a3d5f3065944d128f235b2e66762039_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2774a1a2bba4fa7853774c9595dcb11_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibed9848d49334621abbf06402ae43b03_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68e95752e11f41c8bf7a29dafc64ed6a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a8ea6e29224419867de6bc25119d5a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58f51b9be0cb448cb46a40c48600ea96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d29dc73a76c4cf595703ac8e73f20c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie90da432f6df49e48679d93f666461e4_D20190821-20190821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:DivestedBusinessDueToBTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-21</xbrli:startDate><xbrli:endDate>2019-08-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b1cd7f1f0194f3aa27fd23d352988c0_I20190821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:DivestedBusinessDueToBTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i029e2805f8d2493c952047d8981ed692_D20190611-20190611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-11</xbrli:startDate><xbrli:endDate>2019-06-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28538f28a987480db2349df82889a791_I20190611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0659d4a09c104d69a40367c98f578cba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1be67d7dc4894d3d9ac61ec671d1f66c_D20190129-20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-29</xbrli:startDate><xbrli:endDate>2019-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506a6ba7c7f04e2fbbbc72dd6a366a00_I20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i571b355da3e14c4088b68574662a2240_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2a5ec16eee547859b062e1a0491d616_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if04f535d42894b13baf5c1bf29abbdfa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac2d0307d9d04ae1a423eaf989020c84_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c0fc8eddb08406ea3d86b0a6e07223d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idae083babc2c41c6920c5a332adfac61_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2317bba8b93a4381b47fcbb9f84a225a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d7e6ed023a74081b6372d23bc145ba3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i496c2de855594c64bc941488053cc536_D20181016-20181016"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AugmenixInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-16</xbrli:startDate><xbrli:endDate>2018-10-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i904147befc444b9bbdc64d9876b10897_I20181016"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AugmenixInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i884efc79fc7e4752a4aa11bebd3bbcf3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AugmenixInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31712f6779184ad8bf710b35128f9962_D20180802-20180802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:ClaretMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-02</xbrli:startDate><xbrli:endDate>2018-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83308e067e9f492fbd4a9d89b3ef8503_I20180802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:ClaretMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e1286aef3b14fbbbc9b05febb4fb2e0_I20180705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:CryterionMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7a425fa4f004c2eaea7363a2060f19e_D20180705-20180705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:CryterionMedicalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-05</xbrli:startDate><xbrli:endDate>2018-07-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc07fbb23104ef5b60a1a0aac61b408_D20180430-20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NxTheraIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-30</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad9c6a324c6441d1b8f2cfc19eb1608e_I20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NxTheraIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5478b53eb62b479dae6f8838d73e6197_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NxTheraIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6555d4428a7140748bd802e9a768fd8e_D20180416-20180416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NVisionMedicalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-16</xbrli:startDate><xbrli:endDate>2018-04-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9fe0db816347ab9940c21c9b0d768e_I20180416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NVisionMedicalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808cb5579b214ed483e0c55813432263_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:Other2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9d42aa1c99141d9a7c12881fbf9ad48_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:Other2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf000a38a8df435292fe43a04c563e76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c966453e2a342b3a3f4d64f2c1428d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie298bcc204ee4eb6b430de4388bf4f81_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i761fd86626924956bb4384aaa7769a24_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cf378e387584a16a29c91ef5252aa72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01e3c724a40741a28dbc546b88724c67_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5bf5b7491cc40229dcf4fc38c3ff0db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c571473f99c4f8ead199ef961c9e48e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i172db034d54f4af59ea3ef913e7f74b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic81e0a9293d34d779237110332e1ab2f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa490a08b9e140b4b87e705cf3401a77_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i225a40fb505b4a9ea385c6900535fdf6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a7f90c9cea4edc82150a9d77fd688d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85248c1e3e8d4e798e32297ec2f4a394_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21f76d998b4a431984b2deeb969e9e85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib29c8720d4e5458c8a5b0b896a9227d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib31907c21c804935b3eabe4556382002_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c0d71a4a1294e5a9aaa4452bcfcc83d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5da8394a7b3140a8b169f5c7d428772b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifab990ff13f04a489cc2ddc900075cbb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e34e4fce414bad91b9758bf3c925fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6d6a824461a469cb0d94f10e9342c7f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26e8cfad4e524c8bbce668b54331c93b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53e75f811f294c61b8be35eaba703298_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1de9a90b228e4b489fceda143c56c8cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ad66c6f19564d8281c1fa550e0e9503_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15ebe498a99547009a19b14541a8843b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d6909276f2047e6aacb514e5552c63a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f1841703d848508d023ea0e135c3ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia322e236c1ba4565bcbe28841e306760_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic32470da1e8e4392b88a0f486f43a9c1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d70084f4dd7415eabb7a85e24d97a2a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604905e66a504173a840028f3327dd56_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7793c5feec074fb6a77322031639508b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i441d6c224b974fa083f08dc17135353f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i793d999a9b624f70a0df23be83f63129_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4452aaad562b4bb899286f3797d9eb2d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e86856187e44c808f6433015dceb738_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74c2fb79c41b4be6bf7aa2326d6b1cae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd58d69b28dd40519b4334498825790f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36f17ca4d9f544e3b7cb7e5c6f72280c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i593eb42527b540c88a5921faa53b3629_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d99afc9e3b24ff09921674dea102a4b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7768e07d07cb437d89233e0f9387ac2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2019AggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80031cfd406b4f6593c9c5e695b180e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2be247223ce41e9a14396e0b34bf4d2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i363dc865fad3412d89a91d89a180cd1b_D20190819-20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-19</xbrli:startDate><xbrli:endDate>2019-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia635740e76374063a92852a9184832c4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cfe49b594e3475db1d49e7d28359214_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i465006924e984ad48ab06e31300af791_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3071c36afac844cb8c57202c79fd7e82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb470d28f5b6409baadf2c224feb3e23_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05947140c3ba40e2aedcd05c7acf1a22_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3868068050b406f9f740e75ff11f2de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab5863a52ecf47d2b29b015beb18341d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia52ebd7217064b1ebf72672758698988_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa9b86111b3449e7a2b76a24eeffe984_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="units"><xbrli:measure>bsx:units</xbrli:measure></xbrli:unit><xbrli:context id="i248f8c480024432dac8c9a0ddc15c07d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8545367409b943308f16f9d561a3c06f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21309996213144d8a28d7561f412fa26_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaad7391e2aa54540b42638571113812c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie88422a1b3d241dc8f3bc3352cdf31a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4564e07d2f464045890d0a82a7f30f1b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cef46aa868a4404ad3def8d54a0fa7c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8adfba5c23d24bc7b650917ab0f27ebe_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15892080636d4d31ae5423c34889e21a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eb9d0a4cfa94defa4a9c54410555954_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48fa4493001d449ba145886a80478889_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i905b6a41d15a4b2088787d8381188854_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e7225eec3d5430180f5e3302849762c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fcbf0b422564ac6ad7c97196af88615_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f7f17dea41f463eb86f00e0bd3fd2f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i928052d310a84aef81dc5679f247ce6c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4efb48e17cbd415e8d90d23bb91fbf35_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic80933ec2cc54616bb475d09124b5eb5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd4142356f2c47c3b2a80ca179a5478e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i008481e22f624470b6a792954311af1e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93cb97c15d414cb69088b89bb3fca575_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49e7446a63114d61a987f7353caaa479_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i722eb9acea26411b9150036527416c41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59a8047f3879432c83f1a1b97f95fb61_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf6e3376ee884eb8984657ddcb97aa63_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc3b62df941c48789aff4200f8e67d59_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06cc0641dd65461ca4819856ac55e362_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3407186c51da4b5bae15fe9b0b42918f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib860e3dce61e49049931073399687742_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i142c7d472a8344ce85925c067fa91fe9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f306bf2384c441f92d64b73af5de0d2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53b6f52da8df4fa7bf11e1a08d9ccb70_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie413d40c497c4213aed17626e6327e26_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee1e91c186b4f699e1d1d29e37ff24f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb70a5191e964f5bbfc7cab5cbae8163_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eab187810704dcaa8f9fa4fcfefcdc6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ead7f5a424543edbf6a6280a486e80e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e14f3f587f24448a4c91bf888b8b399_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice90f802b2894cb798cf1495f7ea9a11_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib421eaab309941719fac63dbb93ed872_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4504c169cc844d2ea5b6d6a2e3e9d654_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3caf59a26546f0adfd22adbf367b9f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4307d6f3a38471491744ddae330f127_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i542629f9607d42d396e07c03c41fc785_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9521f08f13f849d78d220e43a83413e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddfccdc34ae347398e8196005b47ad2d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaecb6ba3d8414b658b7074879ac58a42_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if784bc40961d41ea86115e7819324fc8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EuroDenominatedOutstandingDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id18b0f22f1a54a529beaf27a2d386682_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EuroDenominatedOutstandingDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f3624e58548487f8fe6f34329a5815d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie94729ec536f4bc8bcc1206a1a2d33b7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iace5b35349bc466aa9490fe1abc44349_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i470cf9477e25450cb165bec6ddf55cc4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93322dab74aa4ef38da4b44eda101b38_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb0ee9631c3d49d395dad185461e903d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2f5bb8d642f42c1af20b67911d62368_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3baeff6199d34f65b27933b63ede7d47_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b663172db024a7292246bcb9060972f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75fd0298f42f480aa7c38b110f45a007_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1ccd83cecce48e7a280b063a5658b6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea6c3f5fe650404b94ed7a33ebfa2cca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c13725730644fb4b3b71a64ec29e691_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d0cd11a8104fe8a096c54c797dbb77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06838a9c5668409daceef0d66f6e0b09_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9e45057621d4a2194b3b7c5a4d322e1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf15031c1e264e419f6387d7bb871a3f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82968b403f0e490b9ff37937effad01d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d9f8e01c368432c8b949ad0e9f7804a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5278deff95bf40dab3597ddea1f112c1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i881baa0d70eb4bed8a4f7c036159289e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie943736485e84ce7beed9099a5c89fc9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e7a0b5494fe433698454f3d4be42317_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i072d21384351482298b1bf90b42befe3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2765cf8e499b472db95894650fbbc9b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65aa69df316c4459b610a9a758daeb5b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2022TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2317e9eeb3514b0ebfa77fad060f3b78_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2022TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86e54183bfbf4dcea32db5920645d4c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0490e70b8eb4adaadfc6f7e99f1c154_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dfa649ec60b4e6fb3977d40dd636c0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i713d6358ca344f6b85182e9f67f64ba9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6f07d9d29b542aba0b5805828ee1cec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8e5ca3e12946a3acf25b897e7d182b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15fb9c7f5da74f4a84401aa8f7ee2b2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a3a53a9ff3742c0bb73f4f43804fb5a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cbd6ca2b191422bbed4a7a82030eee4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i809d5c20fa804d2fbb986afa7dc387e8_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a055566dd0a42d0b5247b6ea377c972_D20200518-20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-18</xbrli:startDate><xbrli:endDate>2020-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5653e63d9d764f71b37cce04c14e9918_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i934e92bb8af546eb9e57ac456dd0619a_I20200227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56087e653b324fa994949b7d0c138ef8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1160215621b243f6b393f001c1aac0d7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3916b9b9bec94f6c874dd26e645205c5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc311bfbe55c4b7bab87b29a5c5ad4af_I20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if810421b7a7142d88feb52f9a24f6b2f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bccb221eb7049dfa837d52812ecf319_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b7bd05ff52a4f2ca45526a4f36f0fa7_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:AggregateSeniorUnsecuredDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b1253b180a24f5184077538b81d86ea_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5058ef5b1744c99af286b6f6888dea9_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f029b30f006439581bf8725281e3599_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i498d29e5a70e4570a7844cf14bd02f63_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic35171b8628c4dd5ad036a63a32bfb1f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie03682fd1dea4c5b853350dd17ab556a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48219e6ea65a46868b8d56d6f5e591e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b0451592eb8487e9970e7bc57c226fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementExtensionThroughTheRemainderOf2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fd8889518a24b01acba9958549fd5e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementthirdquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92925008ccf94edb8a9a6fa812cfe728_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfourthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8273828bead4a54bad459aceb05abe5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ac5b05e233743a0918574aa15d416bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a94b491b12e42c693b11e87706c05ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7219d097f654ed583a1166ed6e2afeb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047968109f334e72b9394ec59f28e192_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1622c8dc4c6c4bf6984d78e57376b51d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb077471a35463b9f660b39ea4f3612_D20201229-20201229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-29</xbrli:startDate><xbrli:endDate>2020-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1816c871d3e444bb94fda8950db49fd_I20201229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b04a2ce24234007830997dd2dcf322c_I20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020SNAggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50f95eeb41c34ca090d9eb073b22e649_D20200518-20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-18</xbrli:startDate><xbrli:endDate>2020-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c38c44c917644b098c633ab638428cf_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d6a17efae344d4c9df3b7fb951f8515_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b96a4fc501142cf8461498cce84408b_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98969d1f5aa24ac4b7604cd2111634df_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50adfc63c2df4dea89170b844a26339c_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98b32703709b4b0aa69f93f2f184b39e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96cc1043cd04c2c983e15e941b3816f_I20190225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:February2019AggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1b49800ef2c4501b27527c8995dbbc4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i455c8d39af974255a980e1e70f644bf2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i925f70236c2e410e80b575f9f56d03c6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8101096131dd4084b7d522af75cf5248_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id186cacae9da4651be0c28bb43b1ded4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib48697a0624648d89ec42eafa9342b77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dc7bcdaccd44f068db68bbbd79a3e75_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bbc6a0e526d42a79ee7960aeca28186_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6870f9bf392f498a941330451198f38c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i929c861096094117809bff5aea456e34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i279145e1ed5d4579b641b7df4d63ddf1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i839275644c56406890c934fd58bed027_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id225a6ef1501499aba377c394f95fe05_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4576480dfa8445591015c36a302939d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44368aec498f423db8c0bf4520a896a7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id58a89551ad04c37b39770710490ccd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfcc194efc364801bd80478df09f2935_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebdf6472601d4e179cdc65a60d86275d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29926e2a05fc47c9a3dcfbe25ce22aff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f274031addf44889a33eb68c3ed4dfc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieceadf1a7f8e4fad892abbcf9491307e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60558a28aa7c4d63a693910b749950a6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e9f419b17a442ea339ee0791cb497b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7778b7f1e6944fd934bfedde17079ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb71293750e8491687172e77edc978a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17d165f894a04832a1fa68a0e736d01c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60553db20b814c02b1d910e227adc3fc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringRelatedToPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b0af9974fe547798f675a2412349d03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringRelatedToPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3f9837c2b254cdcbb2ed38175b6637d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad4e9ac9719e43a1b6053144c13aafaf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia070298726984423957d186ea4cbee58_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9dc1ef08b814cda860643ddf852fff5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b9961b90ffa46eaa0ecfefd2145c16b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bdc512ea545452b8a307ed56cefa316_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib00c2166428146c59f1dbc9ed80238de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7f722e04aec431e92c5dab638517e6c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d0fc03416e74cf7b79748dfc5fec108_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i169c8823728f4c56bf82523f72a013d7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea3689dbf1264c80b2fc2369ebb72975_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib138f03d5a5c411aa8254cb667a37e63_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1133c37811e34ad8a94424eab435b18c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i101e2c90421b466f8a45ce41d9f8dd58_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie04e61dc46ef4691b3b50088e8133d64_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8703d1164954705a5b4395347a35ba5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1888e3e03a40bf807e229e44b6ff2b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibae917fc49bf4be6a5712c59d3887549_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8e1fcec7c545189678173243202880_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb31286a42734b9eb48b8f675cd3027c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437f306d342d401085bd4bc596e6f2a3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9d0c00ba23a4901a24791aa8b568055_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieef5ec3f5c6e45c3b89e5abaaf847a2a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149a77f1ef8b4e1aa76950f7516e8136_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb54673ea5524ce182360792b2c9655d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a96b3c0c7d4f2b81bce69840269e54_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05cd1788c0054ebaa6c7c34fd116c721_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3930ab450cbc485eb4182fa96c8c03c0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id98f6675244c47d784ea3093b78e1e84_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacfedd935c9342268439fe7cbeae60e7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18140364ac7a4d3699b0c8e6c02ca49a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i080263b4497f43dd86b878ee1c6339bf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff943bdcb694439986636ed65f75c91_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2270b92546484cbf82fd0280322db3ed_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31cc871da3dc48c7a5f796348d8817ae_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia33eedfc21a14d7984d9f03c953ab5f4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c6df5a32d14725adccb334ebaac480_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaca3955aa3774955b74141f0b7742835_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5426d5162838458f96e5bd31e0cac4eb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c55f725ad2b4e03bb8b3aa0fdf79f67_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8819d44961a414f9358a2742a3ca164_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92351a2745854052bb947f9c73f7b6ce_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78f6d9f528bf4e5b810d4a2a45a83e7a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c6c1520344544848558a04190ef9084_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea799c3840b4e17bb183186348f29aa_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf19c236e1224a3e9207882bafa38c2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fc68305d0ea4e12951bcc4b90225f04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id66a034296ae4bb1a925a5b9c0323174_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13e5df102a644d64adfa3a33ffdcdfd9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ddab50db36b43dd9f17c341352773f6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie43de06282cc43d6808a84e7f69288d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e8f687653b84e89ba20c0702c69ec9f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2eef7931a47424aadfa33ed87c13bef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69acc2e1fe284629bd66ab64abb82dfe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c007a8c0e54e8f8dbfbd4c1b84ae74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d4deec479e42b4921ca3c0c19c6196_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i425c4f006d69412d874f531954a840d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0de6be7750b84ba2becd8b78d3760d22_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2af5f8f85cb4333aba96313b76a69ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida81f67779e44ee99c0f4576accd6b66_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9c026cbdf6644bdb88b307eed56919f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifad23126719c4bb4bf9ce037ea077942_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i067d126bfe71406d9637e9e0321f9dba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:AssetsHeldForSaleDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a7f21deae51477e88e1f5da1df0f205_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:AssetsHeldForSaleDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df411a051af4374b3df655f51893efc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxAssetsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e27faab8a7c4a88b4496e70958eb027_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxAssetsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38649fda4692447aa9a51f8b4b69b77a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxLiabilitiesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c0c0db4113b41ac8f0a3925494b51f7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxLiabilitiesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95932fa13d754cceaf54655a7e81a6dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b3d68a05c444d0dacb5095f51e80130_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51d17bc802334ee58e6912543c9a9101_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca84bcda655492cb7c95b91c9cc7c27_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75283a86da274266950b25d74cea7669_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83276247c7f842c9ae8442b64070ca41_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i798449bc56004b03983ad8201e6fc19d_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i847cba4eb27247b1ad73919d3359fdec_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73b83671a10a405a8f270b82a83376c5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if91e0eeaf600499ebaebbee149714e4c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7854a894ad99488694325a46151ebc34_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d753b38040d479e8b54faae20faaad1_I20190115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-01-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claims"><xbrli:measure>bsx:claims</xbrli:measure></xbrli:unit><xbrli:context id="i2f7956c04d234376aa4eecea14242910_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id75fe6d2063c4f75b07316a97a020d9a_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i409422251b4e4e6fa90403e9dba4dda7_I20210127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bsx:AssignedToOneJudgeInMAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39fb2d8200504ca99f2588af122ccb46_D20171110-20171110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-10</xbrli:startDate><xbrli:endDate>2017-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7798f7ba3d954caf8a24d240d313af4b_I20180912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:UpfrontCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94b1febde39c4df9b5982d8d880defc2_I20180912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MaximumContingentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e9be71c38ac4607af95364edaf5c01b_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26c1603e14d9490f8e287a7453ef6ad2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if76aa1de0a364b9b88b9a216851425ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i364b4c76e483475fb4929cbd7234002a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d247529a1c463fa7773c98fb47c5b4_D20200901-20200901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fa9aed9709041149e54010a083bfe82_D20201201-20201201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80fea81c0f1641e2ac476c397df768a5_D20210201-20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia14713cda1cf4913ba849fbbc13bf46f_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87014aa1c11a45678ccb64e8fe4dd544_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie17653a14c754c2ab47d617c083c0151_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i497fdd9e22bb40c9b7d641cbb2f5890b_I20130125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic981515a7d5b42c29018a2a5a0ae37fa_I20201214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i778f0f816cf84a6d802f3c954762bc96_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bsx:A2011LtipPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48dc48db06f64857b9f8f2175ed065c8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ce12987f1214f89a3dfa34f916446fb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e617b0c52e4f2f9d64b27e15217b69_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a97c4c9280f468985dbf91165af9ea0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i744cf371d9c64de7bdda73270e33e44a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib583bf860ca3439f8e8edbcc584563e9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1abb0720ff4407591ec3bb6cfe6e577_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dd3d62482574f8abab9be37411135a7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dbc60762f9246c08c22c8690df360f5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b53681c5973450a9bf67b79aa206f65_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d62047b22344b799f16b3cb7ff597c8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib22247f67db94421b34a23ad85639077_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5927d31a28d44ea785098e97b5f79f96_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i587d1e2ddfb14a2eac94b281ca12ec47_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e16f20577a495e80af1b6afc207f5f_I20200218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id21557fe18514f5291709c9c7a7b4c9c_I20190221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i778b96505b084096ac50ff6a8617ea48_I20180215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-02-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6c97b04efa749baa9a5a7d0f8ea8b37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i072f9c9e6d52435999f54ed61545ec04_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fda8d4a6d204d5592671e4160ebb649_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc16585c6e1d4e3b933534e09af497dc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2bfcb1707824651a50fb653ad5409d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportablesegments"><xbrli:measure>bsx:reportablesegments</xbrli:measure></xbrli:unit><xbrli:context id="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e266465c9541e5884b034945a9b78f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06a7f1a1b2624255b5691acb8602e67d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0820a199efab4817bdf4131117959b05_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9db1cbfd5784602a23dc09b4c7da6d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2775314c99b49018b5b755c1d609493_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74ec03875dad48559735244193b46b9c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c01e96e0cd14429b992b394174f5e9e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8fe71b06ce344c281e40bdc083e4ba9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a71de8475b842919cc1f06ff9e779cf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7255855cd0894949a78ea4a0040d8c62_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e2cbc9edb4549aebf26bdc7e9f10bc4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i438f3d71334f422fadced3dba2c1990a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63903523afd04122bb1a4624c0770c00_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9ef720185f044b09fc4ef729f49cebb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie07c1550f2534b128a6b7a2e8d0dcacb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i511243d7d4314bcfa6398e281d8d6532_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ae346373047401887060e128b7fa20e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7b8ce837b245dbb215df8479dd5f96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad363ee5163542b083904b4076004ef1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:ConsolidatedBSXDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bd94549f8c44f9d8d06813718b34318_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:ConsolidatedBSXDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5dd6328991b46b09bcc31f021284ca1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b784e91a1d84b03a340b395d9f1d9b8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c8ed886eb0f41d797c16440876e2205_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i858f772c802b438680691d7c7cb9c6e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc1298766fb4dc6afdb793f6e79a93b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b32c44341dc4909bcb9d9a63624fe3b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieec0796ecad949ba819d979b8949b690_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id00a014d50414ad386436abb58f55a11_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a659e306f1b44828d0574858121b0aa_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4ae8f5f4fc54e469b52b21b2e600588_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63189412661642f5a8f2b9aeb53a83a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3310fa9b62c34616bca02c7c2f6b9784_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f4de09d08c4833944a68b36c8d10e2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71c0aab91d34037ad9af6a815712b06_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e68166b1ff440a4bc5ba6146bce9e0c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2791d1ca0354ea3b2122b428aa941e8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied722aad4edc4278a94ca946a6b06e8c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8328c5ebea2e4fd6bc961bba6dfac1ba_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bd85cb4fae54571b1035e5edca0b5f0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f3a0f25c82248db8fd9752a33e01ca9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bf1776f98e64055a1740c5f1d4c3626_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i513e81ea5c054bb7ab98f1c6f1a9367c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87e138a0321a4237aaee54dac3eecbef_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfdceca128a8467f86bcca14efd7146b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if875c662a7874536afea940416d0a63e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefd0c81147da4757acf01048244a29a2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id75ab8e1ae0d49cbb8ac4badf8c334e3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i123d2d96cb4f4625a7ca2e22d7052b07_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96570d8f60ec4c059059878654d4e978_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iede0d66fbb154f07be0f0e39b74e8884_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06f5a94b8a8145529296757ce57b7f5a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i937aa716b0d844a989c27397f8bc1d9d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44f315c2d53749c4a98caeb0c46bf4b8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1502d18d7bc74acbb3d8ab048488f756_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b5fd5fd89d4d2e87a701257a100916_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71ff3b6b5ecd4ff78aefd5a1081e8c46_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98775703e0eb4e92aeb652fb7cd61026_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if74c3140243949a6826d8ed9cdee8a17_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3406940f365a46eb906ded17bdbd850c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9539e6fa5dcb48d8b5039083c5f40bd7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48892e98c56344a79b645469f44e7ffb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70c1a11844804faea3d997d119344357_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f5f28e5853409e93d21092b327e718_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i173fb5f80de24dc6b549cf699860ff93_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if596783ed28540409dc77820cae22014_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a0cf3f990cf48038aaa263848720334_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35965682e6934441a09c4499546789a5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac0bbd18a4ac488ab44f83280dffe8d9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5909476c857442b993ed5506e3cef59_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id91bf069a1224ec7b78acb9fbcea277b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if995755c1c9b49b4a9e75000536e2348_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdcde2cecf294a648e81bb1b6a520713_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba33321f14c4426c8f27ec58c8dd157d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d2be57e89ab4990afaf54dfd21a1651_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6206baa0607e4447a0e903f42c1ed97c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd07f73493ec4ed7a9c7b93a28fa803f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecec850c0f8c45579de9fd9d3cc81e56_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbf55f8a4d8043ddb1050e3255fcca0f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i815d46a2e6f141779fd9a976198fcb59_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08fbe1280d8c444c9dfd654d9d62ffba_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4183c9b4fb7440c8791c7d281bfec1c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c4dadc18e044be9fbc4bee8e5e1ae0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8a6c9c90a3f416e91e71e65395c477a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i528032fe7c344add96992fc9c9effe78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8e797bf1ad64edfa7c96ff371ef9a6b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8348c7076ad34dc19caa20d96d3a35a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7734b29eb824bbe92e4b31e6104b9eb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0690fd3bd0414ed3803fa0ec3f99dc1a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f26189e8ec34d198388550160abbe6f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538b7bb9612a453f9a69c50b4385870a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aa704e50bc84e7c8687de09cd75e04c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c9683dda944147b057902c94179e93_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b5cf3a4bec4cd88d7475be9f91daca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e4ccc5194b647ebae6e86a553e04f39_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a2689337c343a29b2517e48e80f21f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3027462747254c22a27e928fc0e7507b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44683e8679ca4adeab31422336b6d2b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e3f1f1a5e54483791680e1f47026b93_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i477d03746ef641e79d498573339aa789_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeb9b19833ec4b32a7043c93f3837778_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9077857b3e78429184a7980d2c9e9bd7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4029bfd2d2d45b88bbd190a55c10e4f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7416538a3917499a98dd18bd9a43544f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfaf003122284a1caf5f04531f97da3e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i247718be21934f158bd504dc0a59d0d8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96d22c0398784970921b6ca16cac29df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eae2a8bac3a45d0a646a1ba30307bb1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6304d11e4ac4f2bb33c3f2f876312d5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03b4b47b48264834a5b805b565fc497a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e9eb5b00d6e4f2e8af5e92882f84e42_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a94eb1a155c44089342c4fce8a0a175_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia44651ee68c84efd8c565cd8ede42050_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b029b8db40e4478bd41a37cbbf5ba8a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eea159e14624a668c6b1853597a984f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fc3285e99ec41baad3226a8fbb980ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37289b8d4ace48da862e203e9243e7ff_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fde0d89a66a4c76a36d9b5839bd1351_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="countries"><xbrli:measure>bsx:countries</xbrli:measure></xbrli:unit><xbrli:context id="i0ea851bcbdee439aaad834b99357bd76_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c091552d1914709958aece5ac3ec298_D20190819-20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-19</xbrli:startDate><xbrli:endDate>2019-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4abcf037f5374f05ba7fe5982239ea34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:ExecutiveRetirementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i707eebe909d64c8ca658b4340f67d9de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id161c1507c9c4caf9953e4e59e994d83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:InternationalRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9302f589d2a941e4a602a1c2a2ab8233_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:ExecutiveRetirementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0b571ab922c429c9d165e755ab1c084_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91d6efe660df47d2bdc670d53b98a6ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:InternationalRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i468ac5844c254d30825e2c4ab7683ecc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5a830b33ced43cbb812205e0f5ee769_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20811b5cbd4444aa969fc5a82825adaf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:OtherInternationalPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic11f0737ab4b4295aad087680e91578f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a90b04fd34e4f338907045e7245b889_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d72be05fbe64ee489d3b9d9a331d3d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:OtherInternationalPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i476309e0b0a84d4088d447ff4ea0c043_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8150f8dd78cd4380a0b054b41ac3d226_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia98c9174caac457e90096de44db28035_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i806afaf84c134ea09c7780052e42855b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d5d4f9059648dfbe129e24d2e5e76b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f43fb9793c542b6a313df6b768e9fd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7307f52ceeb4874b34c64b3b408a83d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45ca6f37d044456b8c5479fac92d63ad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df988ad339147759cbbf0249f88b40d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if469866c31ea46fd8b925ca78ec9465e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80602948166348f69cd4d27b5dabf946_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84d6571646ba45d1a7095a0b4e8e4915_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3134c9b872744c01ab4bf5c21d4aad7a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dd96fb2f5114cd4a6958cc13c50db13_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c25a08438574b52a9f59623d149abc5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie05f8aa1e800416d9668e75d159576ed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic36697475b27449e8bf5b48595d9608d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f02b4becdb447a6a98b17845a2f0831_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5c3e8d69fcc1460baddde62cfa022487_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjkz_6da80cfe-8f0c-4493-8241-2af2e07418e3">10-K</ix:nonNumeric></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:3.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ODRhMjRlZjQxOWJmNDQ3MjllNDg5ZDc1ZTUwYmFhMWMvdGFibGVyYW5nZTo4NGEyNGVmNDE5YmY0NDcyOWU0ODlkNzVlNTBiYWExY18wLTAtMS0xLTA_cdc039f8-6131-415e-a158-cbb8001df3e7">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, or</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18xMTY_01053003-cfca-4d96-bdd2-a7cdf8950393">December&#160;31, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:3.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6YTIzYjA3MmNjMzA4NDM2ZjkxMjQxZjE0ZTNjMjIxYjEvdGFibGVyYW5nZTphMjNiMDcyY2MzMDg0MzZmOTEyNDFmMTRlM2MyMjFiMV8wLTAtMS0xLTA_82080038-c767-44f5-abb6-d49b43208f71">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File No.&#160;<ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk0_2b7700bf-b6a0-4c1b-9ee1-f638ba6670b9">1-11083</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMzAx_08eac104-3611-4c12-aeb3-d187f76cc6c7">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"><tr><td style="width:1.0%"></td><td style="width:42.959%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ODEyM2RiNDIwNjExNDY4NDlmYmZmYTM1YTAzODM3YTUvdGFibGVyYW5nZTo4MTIzZGI0MjA2MTE0Njg0OWZiZmZhMzVhMDM4MzdhNV8wLTAtMS0xLTA_78e92b7d-b94c-470b-86b4-dcb96d012f06">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ODEyM2RiNDIwNjExNDY4NDlmYmZmYTM1YTAzODM3YTUvdGFibGVyYW5nZTo4MTIzZGI0MjA2MTE0Njg0OWZiZmZhMzVhMDM4MzdhNV8wLTItMS0xLTA_cb98c41f-1e70-4b79-9e5f-15c6c78151ea">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMzAw_fed60d7a-1da0-4da8-be9c-9fc50896da86">300 Boston Scientific Way</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk1_436bd3a0-5cfa-4728-8f4c-edae59038a70">Marlborough</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMzAy_74552753-20b6-4ee4-8886-adfdecfedfc4">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk2_1d7429c1-cda9-436d-93a5-9af2e02c5384">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMzAz_5025c1af-dc94-4eeb-a5a3-ca15d7ad38a9">508</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjg5_e626b8cd-a8d8-4b5d-b584-60a1322e33f6">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:34.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.341%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0a988978970e4005a89f2558e11bca85_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18xLTAtMS0xLTA_a2436952-906a-43fe-a049-ef76839c30e1">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0a988978970e4005a89f2558e11bca85_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18xLTItMS0xLTA_fb567bcf-f587-4376-b1c3-8706d1b4fe0a">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0a988978970e4005a89f2558e11bca85_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18xLTQtMS0xLTA_423b4ba2-265c-4145-98b7-df89b506bb4c">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eb79373de9f42768da8b4de1b4c6eeb_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18yLTAtMS0xLTA_1cc4301a-5dcc-4958-9a82-dbf7c560c2dd">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eb79373de9f42768da8b4de1b4c6eeb_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18yLTItMS0xLTA_b41690a5-92ae-4bf3-a7de-3c9085567c77">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eb79373de9f42768da8b4de1b4c6eeb_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18yLTQtMS0xLTA_33ae17c0-7a44-444d-aed4-5f2735b3f295">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i95364ec24cbb4b618f4ac38a93e0259a_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18zLTAtMS0xLTEyMg_3a0431a6-0c45-4c56-81ea-907d79a60b16">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i95364ec24cbb4b618f4ac38a93e0259a_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18zLTItMS0xLTEyMg_f7c4e284-8fe1-4809-943c-8277754c31eb">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i95364ec24cbb4b618f4ac38a93e0259a_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18zLTQtMS0xLTEyMg_d2bd6e1f-e3c6-4615-84c1-3bba072a4177">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NONE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk3_56e4ef3f-9076-41d3-8ae6-fff20c2e9610">Yes</ix:nonNumeric>: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section 15(d) of the Act. Yes: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjkw_8e45f92c-3e3b-4d52-805b-84f2bf316e26">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports) and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk4_b385f9f8-1166-4cb9-a6ad-0ade48298474">Yes</ix:nonNumeric>: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorted period that the registrant was required to submit such files). <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjkx_47100d37-413a-4064-a5e8-78338d06196f">Yes</ix:nonNumeric>: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6YTE2NmVkOGJmNDcxNDk5M2I4MmVhODFmZjk1ODg4N2MvdGFibGVyYW5nZTphMTY2ZWQ4YmY0NzE0OTkzYjgyZWE4MWZmOTU4ODg3Y18wLTAtMS0xLTA_65bb0936-7ebb-45e5-876b-99cfc3b51625">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6YTE2NmVkOGJmNDcxNDk5M2I4MmVhODFmZjk1ODg4N2MvdGFibGVyYW5nZTphMTY2ZWQ4YmY0NzE0OTkzYjgyZWE4MWZmOTU4ODg3Y18xLTMtMS0xLTA_398205e7-4522-4fe6-85b3-b7a206d84bed">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6YTE2NmVkOGJmNDcxNDk5M2I4MmVhODFmZjk1ODg4N2MvdGFibGVyYW5nZTphMTY2ZWQ4YmY0NzE0OTkzYjgyZWE4MWZmOTU4ODg3Y18yLTMtMS0xLTA_847caed1-ff00-40d6-a6f9-7bc024a94b7f">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18yNzQ4Nzc5MDczODQ0_a736520f-98f9-4ff0-8f4b-20a4ff66e10e">&#9745;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act). Yes: </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjky_950b6319-680d-4c9f-8d51-e0f13f8afc46">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates was approximately $<ix:nonFraction unitRef="usd" contextRef="i924ec29d9a304f4882d75905eb802224_I20200630" decimals="-6" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18yMzM2_4e7daa20-af37-472f-be74-d6a168b22b3e">50.0</ix:nonFraction> billion based on the last reported sale price of $35.11 of the registrant&#8217;s common stock on the New York Stock Exchange on June&#160;30, 2020, the last business day of the registrant&#8217;s most recently completed second fiscal quarter. (For this computation, the registrant has excluded the market value of all shares of common stock of the registrant reported as beneficially owned by executive officers, and directors of the registrant; such exclusion shall not be deemed to constitute an admission that any such person is an affiliate of the registrant.)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares outstanding of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, $<ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" name="dei:EntityListingParValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18yOTMw_cbaed650-b985-43b5-aef9-25619d1e6465">0.01</ix:nonFraction> par value per share,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> as of January&#160;29, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> was <ix:nonFraction unitRef="shares" contextRef="ie7e548e9c0454041b4a4f4d799765eaa_I20210129" decimals="0" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18yOTgx_f6c5ef17-722d-4b71-8a2a-7045cdbcd2c0">1,417,165,707</ix:nonFraction>.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Documents Incorporated by Reference</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s definitive proxy statement to be filed within 120 days of December&#160;31, 2020 with the Securities and Exchange Commission in connection with its 2021 Annual Meeting of Stockholders are incorporated by reference into Part&#160;III of this Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_16">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_16">BUSINESS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_19">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_19">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_19">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_22">ITEM 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_22">UNRESOLVED STAFF COMMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_22">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_25">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_25">PROPERTIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_25">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_28">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_28">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_28">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_31">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_31">MINE SAFETY DISCLOSURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_31">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_34">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_34">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_37">ITEM 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_37">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_37">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_40">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_40">SELECTED FINANCIAL DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_40">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_43">ITEM 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_43">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_43">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_67">ITEM 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_67">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_67">68</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_73">ITEM 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_73">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_73">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_163">ITEM 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_163">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_163">137</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_166">ITEM 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_166">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_166">137</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_169">ITEM 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_169">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_169">137</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_172">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_172">138</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_175">ITEM 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_175">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_175">138</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_178">ITEM 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_178">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_178">138</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_181">ITEM 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_181">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_181">138</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_184">ITEM 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_184">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_184">138</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_187">ITEM 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_187">PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_187">138</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_190">PART IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_190">139</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_193">ITEM 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_193">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_193">139</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_1976">&#160;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_1976">ITEM 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_1976">FORM 10-K SUMMARY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_1976">151</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_196">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5c3e8d69fcc1460baddde62cfa022487_196">152</a></span></div></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_16"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for more than 40 years, we have advanced the practice of less-invasive medicine by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions and improve patients&#8217; quality of life by providing alternatives to surgery and other medical procedures that are typically traumatic to the body. Our net sales have increased substantially since our formation, fueled in part by strategic acquisitions designed to improve our ability to take advantage of growth opportunities in the medical device industry and to build diversified portfolios within our core businesses. We advance science for life by providing a broad range of high performance solutions to address unmet patient needs and reduce the cost of healthcare. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate pursuant to five strategic imperatives: Strengthen Category Leadership, Expand into High Growth Adjacencies, Drive Global Expansion, Fund the Journey to Fuel Growth and Develop Key Capabilities. We believe that our execution of these strategic imperatives will drive innovation, profitable revenue growth and increase stockholder value while strengthening our leadership position in the medical device industry. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to invest in our core franchises and pursue opportunities to diversify and further expand our presence in strategic, high-growth adjacencies and new global markets, including growth within the countries we define as emerging markets. Our approach to innovation combines internally-developed products and technologies with those we may obtain externally through strategic acquisitions, alliances and other investments. Our research and development efforts are focused largely on the development of next-generation and novel technology offerings across multiple programs and all divisions. In the past several years, we have completed numerous acquisitions in support of our growth strategy, both strengthening our core franchises and expanding into high growth adjacent markets. We have also accelerated the development of our digital capabilities in multiple key areas, which helps enable us to compete more effectively in the current healthcare environment where our customers are looking for ways to improve outcomes and lower costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Enterprise Risk Management program analyzes the key risks inherent to achieving our strategic and organizational imperatives. Our ongoing risk assessment helps us to anticipate and adapt to potential challenges to preserve and grow stockholder value. Our Board of Directors oversees our risk management program and focuses on monitoring, and together with management, mitigating the most significant risks facing the Company, including strategic, operational, financial, legal and compliance risks. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a firm commitment to corporate social responsibility and living our values as a global business and global corporate citizen. This includes taking actions to combat discrimination and advancing equality and diversity, including through financial support of racial equity initiatives in the communities where we live and work, supporting COVID-19 relief efforts, protecting the environment, investing in our employees' health and well-being, and many other initiatives that ultimately help us create value responsibly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Offerings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our seven core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The following describes our key product offerings and new product innovations by reportable segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MedSurg</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endoscopy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gastroenterology and Pulmonary</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with innovative, less invasive technologies. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Resolution 360&#8482; Clip, a hemostatic clipping technology designed to stop and help prevent bleeding during endoscopic procedures, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our WallFlex&#8482; Biliary Stent System, used for relieving biliary obstruction by providing bile drainage in both malignant and benign strictures,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our AXIOS&#8482; Stent and Electrocautery Enhanced Delivery System, the first, and currently only stent in the U.S. indicated for endoscopic drainage of pancreatic pseudocysts,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our SpyGlass&#8482; DS II Direct Visualization System, which brings digital imaging, a wider field of view and a simpler set-up (compared to our legacy SpyGlass System), thus enabling cholangioscopy to play a greater role in the diagnosis and treatment of pancreatico-biliary diseases,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our SpyGlass&#8482; Discover Digital Catheter, the first single-use scope to enable physicians to take a single-stage approach to diagnostic and therapeutic procedures in the pancreaticobiliary system, including treating patients with bile duct stones,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our EXALT&#8482; Model D Single-Use Duodenoscope for use in endoscopic retrograde cholangiopancreatography (ERCP) procedures, the first and only U.S. Food and Drug Administration (FDA)-cleared single-use (disposable) duodenoscope on the market,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Acquire&#8482; Endoscopic Ultrasound Fine Needle Biopsy Device, which is designed to obtain larger tissue specimens for histological assessment and is useful when diagnosing diseases such as pancreatic cancer, liver cancer and stomach lesions,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our endoluminal surgery portfolio with ORISE&#8482; Gel, designed to be used for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions prior to excision with a snare or other endoscopic device, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our infection prevention portfolio, which includes a customizable Compliance EndoKit&#8482; and single-use Orca&#8482; Valves, designed to minimize the risk of infection transmission and improve operational efficiencies by streamlining manual cleaning or eliminating the need for cleaning and tracking.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urology and Pelvic Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia (BPH), prostate cancer, erectile dysfunction, incontinence and pelvic floor disorders. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our comprehensive line of stone management products, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons and stone laser devices,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our LithoVue&#8482; Single-Use Digital Flexible Ureteroscope, which delivers detailed high-resolution digital images for high-quality visualization and seamless navigation, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Prosthetic Urology portfolio, which includes our penile implants to treat erectile dysfunction and urinary control systems to treat male urinary incontinence,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our BPH therapies portfolio, which includes our GreenLight XPS&#8482; Laser System, MoXy&#8482; Fiber, and Rez&#363;m&#8482; System, purchased as part of the NxThera, Inc. (NxThera) acquisition in the second quarter of 2018, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our SpaceOAR&#8482; Hydrogel System, purchased as part of the Augmenix, Inc. (Augmenix) acquisition in the fourth quarter of 2018, to help reduce side effects that men may experience after receiving radiotherapy to treat prostate cancer, and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.53pt">our Pelvic Floor portfolio, which includes a comprehensive offering of female stress urinary incontinence solutions, including our innovative Solyx&#8482; Single-Incision Sling System.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, we initiated the U.S. launch of the&#160;next-generation SpaceOAR Vue&#8482; Hydrogel, providing clinicians with the added ability to view the spacer using computerized tomography (CT) scans instead of magnetic resonance imaging (MRI).</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rhythm and Neuro</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cardiac Rhythm Management</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cardiac Rhythm Management (CRM) business develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our implantable cardioverter defibrillators (ICD) and implantable cardiac resynchronization therapy defibrillators (CRT-D) as well as the world's first, and currently only, commercially available subcutaneous implantable cardiac defibrillators (S-ICD),</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our pacemakers and implantable cardiac resynchronization therapy pacemakers (CRT-P), and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our LATITUDE&#8482; Remote Patient Management System, which allows for more frequent monitoring and better guided treatment decisions by enabling physicians to monitor implantable system performance remotely in most geographies.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we announced U.S. 510(k) clearance for the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, a new, long-term diagnostic device implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope. We began U.S. commercialization of this device in the third quarter of 2020. In addition, in January 2021, we announced entry into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company that offers a full portfolio of mobile health solutions and remote monitoring services for patients with cardiac arrhythmias. Preventice offers a full portfolio ranging from ambulatory cardiac monitors &#8211; including short and long-term holter monitors &#8211; to cardiac event monitors and mobile cardiac telemetry, complementing our existing ICM offering. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current generation of defibrillators, the RESONATE&#8482; family of devices, include our proprietary HeartLogic&#8482; Heart Failure (HF) Diagnostic and SmartCRT&#8482; Technology with Multisite pacing in CRT-D. Our entire transvenous defibrillator portfolio leverages our EnduraLife&#8482; Battery Technology, including our extended longevity (EL) ICD, our CRT-D&#8217;s and our MINI (smallest and thinnest) ICD. We have magnetic resonance imaging (MRI) conditional labeling across our defibrillator portfolio in nearly all markets around the world when used with our current generation of leads, including our current generation devices as well as our prior generation of DYNAGEN&#8482; and INOGEN&#8482; devices. Our implantable defibrillator portfolio is complemented by our suite of ACUITY&#8482; X4 Quadripolar LV Leads, RELIANCE&#8482; family of ICD Leads and our INGEVITY&#8482; Pacing Lead.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our transvenous defibrillator portfolio, we offer our EMBLEM&#8482; MRI S-ICD System, which provides physicians the ability to treat patients who are at risk for sudden cardiac arrest without touching the heart or invading the vasculature. Our EMBLEM S-ICD devices have MRI conditional labeling and LATITUDE Remote Patient Management in most major markets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our ACCOLADE&#8482; family of pacemaker systems in nearly all major markets around the world. Approval of our ACCOLADE Pacemaker family in the U.S., Europe and Japan also included approval for use of these products in patients undergoing MRI scans. Much like our defibrillator portfolio, our pacemakers leverage our INGEVITY Pacing Leads and LATITUDE&#8482; Remote Patient Management in nearly all major markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Electrophysiology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Electrophysiology business develops and manufactures less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, including a broad portfolio of therapeutic and diagnostic catheters and a variety of equipment used in the Electrophysiology lab. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Rhythmia&#8482; Mapping System, a catheter-based, 3-D cardiac mapping and navigation solution designed to help diagnose and guide treatment of a variety of arrhythmias, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Blazer&#8482; Therapeutic Ablation Catheter line, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our broad portfolio of diagnostic catheters including Blazer&#8482; Dx-20, Dynamic Tip&#8482; and Viking&#8482; Catheters,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our IntellaMap Orion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Mapping Catheter, for use with our Rhythmia Mapping System to provide high-density, high-resolution maps of the heart, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our intracardiac ultrasound catheters, delivery sheaths and other accessories.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we announced the U.S. launch of the DIRECTSENSE&#8482; Technology, for which we received CE Mark and launched in Europe in 2018, a tool for monitoring radiofrequency (RF) energy delivery during cardiac ablation procedures available on the Rhythmia&#8482; Mapping System. Additionally, in the second quarter of 2020 we received CE mark approval for the INTELLANAV STABLEPOINT&#8482; Ablation Catheter enabled with DIRECTSENSE Technology and contact force </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assessment. This technology, along with our 2020 CE mark approval for the POLARx&#8482; Cryoablation System, began European commercialization in the third quarter of 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cooled ablation catheter portfolio includes our U.S. and CE Mark approved Blazer&#8482; Open-Irrigated, IntellaNav&#8482; Open-Irrigated, and IntellaNav MiFi&#8482; Open-Irrigated ablation catheters with a unique Total Tip Cooling&#8482; Design. We also offer our IntellaNav XP and IntellaNav MiFi XP solid tip catheters. Our IntellaTip&#8482; MiFi XP, IntellaNav MiFi XP and IntellaNav MiFi Open-Irrigated Catheters include MicroFidelity (MiFi) sensor technology in the catheter tip. All of our IntellaNav Catheters are designed to allow magnetic tracking when used with our Rhythmia Mapping System. Additionally, the European and Japan markets have access to our DIRECTSENSE&#8482; Software which captures and presents local impedance. DIRECTSENSE Software provides meaningful information on tissue to catheter tip proximity, catheter stability, and other local tissue characteristics. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also received CE Mark in early 2020 for our POLARx Cryoablation Single-shot Pulmonary Vein Isolation Technology, purchased as part of our acquisition of Cryterion in the third quarter of 2018. In 2020, we began our European launch and we commenced enrollment of the FROZEN-AF investigational device exemption (IDE) in the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuromodulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Our product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Precision&#8482;, Precision Spectra&#8482;, Precision Montage&#8482;, Precision Novi&#8482; and Spectra WaveWriter&#8482; Spinal Cord Stimulator (SCS)&#160;Systems, designed to provide improved pain relief to a wide range of patients who suffer from chronic pain,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Superion&#8482; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS) purchased as part of the acquisition of Vertiflex, Inc. in the second quarter of 2019,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our G4&#8482; Generator and consumable portfolio in Radiofrequency Ablation (RFA) for pain management used by physicians to treat patients with chronic back and neck pain purchased as part of the acquisition of Cosman Medical, Inc. in the third quarter of 2016, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Vercise&#8482;, Vercise&#8482; PC and Vercise Gevia&#8482; Deep Brain Stimulation (DBS) Systems for the treatment of Parkinson's disease, tremor, and intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Spectra WaveWriter&#8482; SCS System is the first and only system approved by the FDA to simultaneously provide paresthesia-based and sub-perception therapy. The Precision Spectra SCS System is the world's first and only SCS system with 32 contacts and 32 dedicated power sources. We believe that we continue to have a technological advantage due to our proprietary features such as Multiple Independent Current Control and our Illumina 3D&#8482; Proprietary Programming Software, which together are intended to allow the physician to target specific areas of pain and customize stimulation of nerve fibers more precisely. We announced the European launch of the WaveWriter Alpha&#8482; Spinal Cord Stimulator (SCS) System in the third quarter of 2020 and FDA approval in the fourth quarter of 2020, indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with failed back surgery syndrome.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Vercise&#8482; DBS System is approved in the U.S. as an adjunctive therapy that aids in reducing some of the symptoms of moderate to advanced Parkinson&#8217;s disease. Our Vercise Gevia&#8482; DBS System with the Cartesia&#8482; Directional Lead is the first and only MRI conditional, rechargeable and directional system, using multi-directional stimulation designed for greater precision, intended to minimize side effects for patients, having ImageReady&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MRI labeling to be used in a full-body magnetic resonance imaging environment. In Europe, we also market the GUIDE&#8482; XT System, the first DBS visualization system built for directionality that utilizes patient specific anatomy and stimulation field modeling. This technology provides physicians with 3-D image planning capability and when used in conjunction with the Vercise DBS Systems, enables physicians to personalize and optimize DBS treatment. In the third quarter of 2020, we received CE Mark and initiated a limited market release of the fourth generation Vercise Genus&#8482; DBS System in Europe. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Cardiology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Interventional Cardiology business develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Our broad, innovative product offerings have led to our leadership in the global interventional cardiology market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Drug-Eluting Coronary Stent Systems </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our drug-eluting coronary stent product offerings are an important element of our global Interventional Cardiology market leadership. We believe we have enhanced the outcomes associated with the use of coronary stents, particularly the processes that lead to restenosis (the growth of neointimal tissue within an artery after angioplasty and stenting), through our scientific research and product development of drug-eluting stent systems. Our coronary stent offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our SYNERGY&#8482; Everolimus-Eluting Platinum Chromium Coronary Stent System, featuring an ultra-thin abluminal (outer) bioabsorbable polymer coating,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Promus ELITE&#8482; Everolimus-Eluting Stent,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Promus PREMIER&#8482; Everolimus-Eluting family of stents, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our SYNERGY MEGATRON&#8482; Bioabsorbable Polymer Stent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complex PCI</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product offerings to perform complex percutaneous coronary interventions (PCI) include a broad line of products used to treat patients with atherosclerosis, a principal cause of coronary artery obstructive disease. These include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, crossing and re-entry devices for the treatment of chronically occluded coronary vessels and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PCI Guidance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PCI Guidance offerings include a family of intravascular catheter-directed ultrasound imaging catheters, complemented by our intravascular ultrasound (IVUS) imaging system and our fractional flow reserve (FFR) devices and systems for use in coronary arteries and heart chambers as well as certain peripheral vessels to assist in the diagnosis of coronary artery disease. Our PCI Guidance product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our OptiCross&#8482; IVUS Imaging catheter,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our COMET&#8482; FFR Pressure Guidewire, and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our iLab&#8482; Ultrasound Imaging System with Polaris Software, designed to enhance the diagnosis and treatment of blocked vessels and other heart disorders, which is compatible with our full line of imaging catheters and coronary physiology devices and continues to be our flagship console. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The iLab Ultrasound Imaging System has been placed in cardiology labs worldwide and provides an installed base through which we expect to continue to sell associated single-use products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Structural Heart Therapies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Structural heart therapies are one of the fastest growing areas of the medical technology market and are highly synergistic with our Interventional Cardiology and Rhythm Management businesses. Our current structural heart product offerings include the following: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our WATCHMAN Left Atrial Appendage Closure (LAAC) Technology, and next-generation WATCHMAN FLX&#8482; Devices, designed to close the left atrial appendage in patients with non-valvular atrial fibrillation who are at risk for ischemic stroke,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ACURATE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">neo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482; and ACURATE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">neo2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482; Aortic Valve Systems, which are based on a self-expanding architecture, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Safari2&#8482; Pre-Shaped Guidewire, intended to facilitate the introduction and placement of interventional devices within the heart, including those used with transcatheter aortic valve implantation or replacement procedures, and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our SENTINEL&#8482; Cerebral Embolic Protection System, purchased as part of our acquisition of Claret Medical, Inc. (Claret) in the third quarter of 2018. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">WATCHMAN&#8482; LAAC Device is the first device to offer a non-pharmacologic alternative to oral anti-coagulants that has been studied in a randomized clinical trial and is the leading device in percutaneous LAAC globally. In the first quarter of 2019, we received CE Mark and initiated a limited market release of the next generation WATCHMAN FLX&#8482;&#160;LAAC Device in&#160;Europe and in June 2020, we received FDA approval for and launched WATCHMAN FLX LAAC Device in the U.S. Throughout 2020, the WATCHMAN Device was the only LAAC technology commercially available in the U.S. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Transcatheter Aortic Valve Replacement (TAVR) portfolio is comprised of the ACURATE neo Valve based on self-expanding architecture for supra-annular cases. In the third quarter of 2020, we initiated a controlled launch of the ACURATE neo2 Aortic Valve System in Europe, built on a new platform designed with a number of features to improve upon the clinical performance of the original ACURATE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">neo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Valve platform. In addition, our SENTINEL&#8482; Cerebral Protection System is used to reduce the risk of stroke in TAVR procedures and is clinically proven to decrease cerebral embolization and its associated neurological effects. In the fourth quarter of 2020, we announced a voluntary recall of our LOTUS Edge&#8482; Aortic Value System and the discontinuation of our LOTUS program due to complexities associated with the product delivery system, and the time and investment required to reintroduce an enhanced delivery system, as well as slower than anticipated market adoption. We will instead focus our resources and efforts on the remainder of the portfolio and are encouraged by the successful launch of ACURATE neo2 Valve in Europe.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, through our acquisition of Millipede, Inc. in the first quarter of 2019, we are developing the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation (MR). The Millipede IRIS annuloplasty ring, delivered via a transcatheter-transseptal delivery system, follows the standard surgical approach to repair and reduce the size of a dilated mitral annulus. The IRIS device is a complete ring designed to be used as a stand-alone device, or in combination with other technologies in patients with severe MR. The device is designed to be highly customizable to a specific patient's anatomy and disease state, and is repositionable and retrievable to promote a high-quality outcome.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peripheral Interventions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Peripheral Interventions business develops and manufactures products to diagnose and treat peripheral arterial and venous diseases, as well as products to diagnose, treat and ease various forms of cancer. In the third quarter of 2019, we completed the acquisition of BTG plc (BTG). We integrated BTG's Interventional Medicine (IM) portfolio into our Peripheral Interventions division, adding complementary technologies in the areas of venous disease and interventional oncology. Our combined broad peripheral portfolio includes products to treat arterial diseases (stents, balloon catheters, wires and atherectomy) and venous diseases (thrombectomy, acoustic pulse thrombolysis, wires and stents) and for use in interventional oncology techniques to treat various cancers (peripheral embolization devices, radioactive microspheres, radiofrequency and cryotherapy ablation systems, microcatheters and drainage catheters). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our peripheral arterial technologies include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our EPIC&#8482; Vascular Self-Expanding Stent System, a nitinol stent designed to sustain vessel patency while providing enhanced visibility and accuracy during placement,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Innova&#8482; Self-Expanding Stent System, a laser-cut nitinol stent built for the superficial femoral artery (SFA, a large artery in the thigh) with flexibility, strength and fracture resistance,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Eluvia&#8482; Drug Eluting Vascular Stent System, an innovative stent built on the Innova stent platform, designed to deliver a sustained dosage of paclitaxel during the time when restenosis is most likely to occur,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our next-generation Mustang&#8482; PTA Balloon Catheter, a 0.035" balloon with superior crossing and tracking, powerful dilatation, longer lengths and smaller sheath sizes,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Coyote&#8482; Balloon Catheter, a highly deliverable and ultra-low profile balloon dilatation catheter designed for a wide range of peripheral angioplasty procedures,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Sterling&#8482; Balloon Catheter, a 0.018" PTA balloon catheter designed for post-stent dilatation as well as conventional balloon angioplasty to open blocked peripheral arteries, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Ranger&#8482; Drug-Coated Balloon, an innovative balloon built on the Sterling balloon platform, featuring a low-dose of paclitaxel. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2020, we received FDA approval for the Ranger&#8482; Drug-Coated Balloon and started U.S. commercialization of this device, making us the first company to provide physicians with both a drug-eluting stent and drug-coated balloon for the treatment of patients with peripheral artery disease.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our venous disease technologies include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our AngioJet&#8482; Thrombectomy System, used in endovascular procedures to remove blood clots from blocked arteries and veins,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our AngioJet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zelante DVT&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thrombectomy Catheter to treat deep vein thrombosis (DVT) in large-diameter upper and lower limb peripheral veins, in the U.S. and Europe,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our VICI VENOUS STENT&#8482; System to treat venous obstructive disease, purchased as part of the VENITI, Inc. acquisition in the third quarter of 2018,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our EKOS&#8482; Ultrasound Assisted Thrombolysis system used to treat pulmonary embolism, purchased as part of the BTG acquisition, which closed during the third quarter of 2019, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Varithena&#8482; Polidocanol Injectable Foam used to improve the symptoms of superficial venous incompetence and the appearance of visible varicosities, also purchased as part of the BTG acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interventional oncology product offerings include the following:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Therasphere&#8482; Y-90 radioactive glass microspheres used in the treatment of hepatocellular carcinoma (HCC or the most common type of liver cancer) purchased as part of the BTG acquisition,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our line of interventional oncology solutions, including the Renegade&#8482; HI-FLO&#8482; Fathom&#8482; Microcatheter and Guidewire System and Interlock&#8482; - 35 Fibered IDC&#8482; and 18 Fibered IDC&#8482; Occlusion System for peripheral embolization, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Cryoablation image-guided needles used to enable cryoablation visualization for optimal tumor coverage, purchased as part of the BTG acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Pharmaceuticals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of our BTG acquisition, we have presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments. Our Specialty Pharmaceuticals business develops and manufactures acute care antidotes to treat overexposure to certain medications and toxins. These products are sold primarily in the U.S. through small, specialist sales teams and through commercial partners elsewhere, where approved or permitted. Our Specialty Pharmaceuticals product offerings include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our CroFab&#8482; Antidote Product, the only FDA-approved product derived exclusively from U.S. snakes and approved to treat all North American pit viper envenomations in adult and pediatric patients,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our DigiFab&#8482; Digoxin Immune Fab (Ovine) antidote product, a treatment for patients with life-threatening or potentially life-threatening digoxin toxicity or overdose that is clinically proven to effectively clear digoxin from the body, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Voraxaze&#8482; Antidote Product, a carboxypeptidase indicated to reduce toxic plasma methotrexate concentration (greater than one micromole per liter) in adult and pediatric patients with delayed methotrexate clearance (plasma methotrexate concentrations greater than two standard deviations of the mean methotrexate excretion curve specific for the dose of methotrexate administered) due to impaired renal function.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business for a purchase price of $800 million, subject to certain adjustments, including cash on hand at the closing date of the transaction. The transaction is expected to close during the first half of 2021, subject to customary closing conditions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment in research and development is critical to driving our future growth. Our investment in research and development supports the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">internal research and development programs, regulatory design and clinical science, as well as other programs obtained through our strategic acquisitions and alliances, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engineering efforts that incorporate customer feedback into continuous improvement efforts for currently marketed and next-generation products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have directed our development efforts toward innovative technologies designed to expand current markets or enter adjacent markets. We are transforming how we conduct research and development by identifying best practices, driving efficiencies and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">optimizing our cost structure, which we believe will enable increased development activity and faster concept-to-market timelines. Focused, cross-functional teams take a formal approach to new product design and development, helping us to manufacture and offer innovative products consistently and efficiently. Involving cross-functional teams early in the process is the cornerstone of our product development cycle. We believe this collaboration allows our teams to concentrate resources on the most viable and clinically relevant new products and technologies and maximize cost and time savings as we bring them to market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to internal development, we work with hundreds of leading research institutions, universities and clinicians around the world to develop, evaluate and clinically test our products. We are expanding our collaborations to include research and development teams in our emerging market countries; these teams will focus on both global and local market requirements at a lower cost of development. We believe that these efforts will play a significant role in our future success.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing and Sales</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we marketed our products and solutions to approximately 35,000 hospitals, clinics, outpatient facilities and medical offices in more than 120 countries worldwide. Large group purchasing organizations, hospital networks and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. We have a dedicated corporate accounts organization in the United States (U.S.) and Europe, Middle East and Africa (EMEA) focused principally on selling to major buying groups and integrated healthcare networks. We consistently strive to understand and exceed the expectations of our customers. Each of our businesses maintains dedicated sales forces and marketing teams focused on physicians who specialize in the diagnosis and treatment of different medical conditions, as well as on key hospital service line administrators. We believe that this dual focus on disease state management and hospital administrators enables us to develop highly knowledgeable and dedicated sales representatives and to foster collaborative relationships with both physicians and key service line administrators. We believe that our strong working relationships with physicians, service line administrators and others in the medical industry enable us to gain a detailed understanding of new therapeutic and diagnostic alternatives and to respond quickly to our customers' changing needs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our net sales are derived from countries in which we have direct sales organizations. We also have a network of distributors and dealers who offer our products in certain countries and markets. We expect to continue to leverage our infrastructure in markets where commercially appropriate and use third party distributors in those markets where it is not economical or strategic to establish or maintain a direct presence. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International net sales accounted for 42 percent of our net sales in 2020 and 2019 and 44 percent of our net sales in 2018. Maintaining and expanding our international presence is an important component of our long-term growth strategy. Through our international presence, we seek to increase net sales and market share, leverage our relationships with leading physicians and their clinical research programs, accelerate the time to bring new products to market and gain access to worldwide technological developments that we can implement across our product lines. In addition, we continue to invest in infrastructure in emerging markets to strengthen our sales and service capabilities and maximize our opportunities in these countries. We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. We have increased our investment in infrastructure in these countries in order to maximize opportunities. Periodically, we assess our list of Emerging Markets which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam. Our Emerging Markets net sales represented 11 percent of our consolidated net sales in 2020 and 12 percent in 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had 11 principal international manufacturing facilities, in addition to our U.S. facilities, including three in Ireland, two in Costa Rica, one in Brazil, one in Malaysia, one in Israel, one in the U.K. and one in Switzerland. Our international manufacturing facilities includes our Puerto Rico facility. Approximately 52&#160;percent of our products manufactured in 2020 were produced at these international facilities. We also maintain research and development capabilities in China, Costa Rica, India, Ireland and Puerto Rico. We continue to provide localized training programs through our 15 Institutes for Advancing Science (IAS) facilities around the world.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing and Raw Materials</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on continuously improving our supply chain effectiveness, strengthening our manufacturing processes and increasing operational efficiencies within our organization. We strive to improve the efficiency of our sourcing operations and to leverage the technical expertise of the broader market by partnering with strategic suppliers. In doing so, we seek to focus </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our internal resources on the development and commercial launch of new products and the enhancement of existing products. We continue to implement new systems designed to provide improved quality, reliability, service, greater efficiency and lower supply chain costs. We also drive continuous improvement in product quality through process controls and validations, supplier and distribution controls and then necessary training and tools for our operations team. In addition, we remain focused on examining our operations and general business activities to enhance our operational effectiveness by identifying cost-improvement opportunities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to maintaining appropriate investments in supply chain resiliency on an ongoing basis. Our products are designed and manufactured in technology centers around the world, either by us or third parties. We consistently monitor our inventory levels, manufacturing and distribution capabilities and maintain recovery plans to address potential disruptions that we may encounter. Supply chain resiliency also includes sterilization, which is performed and optimized through a combination of internal and third party locations and may also be subject to potential interruptions. Many components used in the manufacturing of our products are readily fabricated from commonly available raw materials or off-the-shelf items available from multiple supply sources; however, certain items are custom made to meet our specifications. We believe that in most cases, redundant capacity exists at our suppliers and that alternative sources of supply are available or could be developed within a reasonable period of time. We have an ongoing supplier resiliency program which identifies and mitigates risk. We are also striving to build diversity and inclusion into every aspect of our company, including our supply chain. We are committed to the increased and sustained support of diverse businesses that share our dedication to improving the quality of patient care.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality Assurance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to providing high quality products to our customers. Our quality system starts with the initial product specification and continues through the design of the product, component specification process and the manufacturing, sale and servicing of the product. Our quality system is intended to build in quality and process control and to utilize continuous improvement concepts throughout the product life. Our quality system is also designed to enable us to satisfy various international quality system regulations, including those of the U.S. Food and Drug Administration (FDA) with respect to products sold in the U.S. All of our medical device manufacturing facilities and distribution centers are certified under the ISO 13485 quality system standard, established by the International Standards Organization (ISO) for medical devices, which includes requirements for an implemented quality system that applies to component quality, supplier control, product design and manufacturing operations. This certification can be obtained only after a complete audit of a company&#8217;s quality system by an independent outside auditor, and maintenance of the certification requires that these facilities undergo periodic re-examination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation and Management</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various environmental laws, directives and regulations both in the U.S. and abroad. Our operations involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. We believe that strong performance across relevant environmental, health and safety metrics enhances our competitive strength while benefiting our patients, customers, stockholders and employees. We are focused on continuous improvement in these areas by reducing pollution, minimizing depletion of natural resources and reducing our overall environmental footprint. Specifically, we are working to optimize energy and resource usage, ultimately reducing greenhouse gas emissions and waste. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Social Responsibility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for additional information regarding sustainability measures we are undertaking.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We encounter significant competition across our product lines and in each market in which we sell our products and solutions, some from companies that may have greater financial, sales and marketing resources than we do. Our primary competitors include Abbott Laboratories and Medtronic plc, as well as a wide range of medical device companies that sell a single or limited number of competitive products or participate in only a specific market segment. In certain countries, we face competition from domestic medical device companies that may benefit from their status as local suppliers. We also face competition from non-medical device companies, which may offer alternative therapies for disease states that could also be treated using our products, or from companies offering technologies that could augment or replace procedures using our products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our products and solutions compete primarily on their ability to deliver both clinical and economic outcomes for our customers by enabling physicians to perform diagnostic and therapeutic procedures safely and effectively often in a less-invasive manner. We also compete on ease of use, comparative effectiveness, reliability and physician familiarity. In the current environment of managed care, with economically-motivated buyers, consolidation among healthcare providers, increasing prevalence and importance of regional and national tenders, increased competition and declining reimbursement rates, we have </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">been increasingly required to compete on the basis of price, value, reliability and efficiency. We believe the current global economic conditions and healthcare reform measures could continue to put additional competitive pressure on us, including on our average selling prices, overall procedure rates and addressable market sizes. We recognize that our continued competitive success will depend upon our ability to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">offer products and solutions that provide differentiated clinical and economic outcomes,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create or acquire innovative, scientifically advanced technologies,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">apply our technology and solutions cost-effectively and with superior quality across product lines and markets,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">develop or acquire proprietary products and solutions,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract and retain skilled personnel, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain patent or other protection for our products,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain required regulatory and reimbursement approvals,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compete in regional and national tenders for our products,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continually enhance our quality systems, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacture and market our products and solutions either directly or through third parties, and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supply sufficient inventory to meet customer demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Device Regulatory Approvals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical devices that we manufacture and market are subject to regulation by numerous worldwide regulatory bodies, including the FDA and comparable international regulatory agencies. These agencies require manufacturers of medical devices to comply with applicable laws and regulations governing development, testing, manufacturing, labeling, marketing and distribution. Medical devices are also generally subject to varying levels of regulatory control based on risk level of the device. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., authorization to distribute a new device can generally be met in one of three ways. The first process requires that a premarket notification (510(k)) be made to the FDA to demonstrate that the device is as safe and effective as, or substantially equivalent to, a legally marketed device (the &#8220;predicate&#8221; device). Applicants must submit performance data to establish substantial equivalence. In some instances, data from human clinical trials must also be submitted in support of a 510(k) premarket notification. If so, these data must be collected in a manner that conforms to the applicable Investigational Device Exemption (IDE)&#160;regulations. The FDA must issue a decision finding substantial equivalence before commercial distribution can occur. Changes to cleared devices that could not significantly affect the safety or effectiveness of the device can generally be made without additional 510(k) premarket notifications; otherwise, a new 510(k) is required.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second process requires the submission of a premarket approval (PMA) application to the FDA to demonstrate that the device is safe and effective for its intended use. This approval process applies to most Class&#160;III devices and generally requires clinical data to support the safety and effectiveness of the device, obtained in adherence with IDE requirements. The FDA will approve the PMA application if it finds that there is a reasonable assurance that the device is safe and effective for its intended purpose and that the proposed manufacturing is in compliance with the Quality System Regulation (QSR). For novel technologies, the FDA may seek input from an advisory panel of medical experts and seek their views on the safety, effectiveness and benefit-risk of the device. The PMA process is generally more detailed, lengthier and more expensive than the 510(k) process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The third process requires that an application for a Humanitarian Device Exemption (HDE)&#160;be made to the FDA for the use of a Humanitarian Use Device (HUD). A HUD is intended to benefit patients by treating or diagnosing a disease or condition that affects, or is manifested in, not more than 8,000 individuals in the U.S. per year. The application submitted to the FDA for an HDE must demonstrate that the device does not expose the patient to unreasonable risk and that the benefit of device use outweighs the risk. The HUD provision of the regulation provides an incentive for the development of devices for use in the treatment or diagnosis of diseases affecting smaller patient populations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union (EU), we will be required to comply with the Medical Device Regulation (MDR or EU MDR) effective May 2021 (previously May 2020) which will supersede the current Medical Device Directives. Medical devices which have a valid CE Certificate to the current Directives (issued before May 2021) can continue to be sold until May 2024 or until the CE Certificate expires, whichever comes first, providing there are no significant changes to the design or intended use. The CE Mark, which is required to sell medical devices in the EU is affixed following a Conformity Assessment and either approval from the appointed independent Notified Body or through self-certification by the manufacturer. The selected pathway to CE marking is based on device risk classification. CE marking indicates conformity to the applicable Essential Requirements (ERs) of the relevant Medical Devices Directive and, in the future, to the General Safety and Performance Requirements (GSPRs) for the MDR. The MDR will change multiple aspects of the existing regulatory framework for CE marking, such as increased clinical evidence requirements, changes to labelling, and new requirements, including Unique Device Identification (UDI), and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">many new post-market reporting obligations. MDR modifies and increases the compliance requirements for the medical device industry and will require significant investment over the next few years to implement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to comply with the regulations of every other country where we commercialize products before we can launch or maintain new products on the market, such as the requirements that we obtain approval from the Japanese Ministry of Health, Labor and Welfare (MHLW), through the review at Japanese Pharmaceutical &amp; Medical Device Agency (PMDA)&#160;and the China National Medical Product Administration (NMPA). Many countries that previously did not have medical device regulations, or had minimal regulations, are now introducing them. For example, India is in the process of expanding its current regulations to include all medical device categories while many countries in the Middle East and Southeast Asia are introducing new regulations as well.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and other worldwide regulatory agencies and competent authorities actively monitor compliance to local laws and regulations through review and inspection of design and manufacturing practices, record-keeping, reporting of adverse events, labeling and promotional practices. The FDA can ban certain medical devices, detain or seize adulterated or misbranded medical devices, order recall or market withdrawal of these devices and require notification of health professionals and others with regard to medical devices that present unreasonable risks of substantial harm to the public health. The FDA may also enjoin and restrain a company for certain violations of the Food, Drug and Cosmetic Act and the Safe Medical Devices Act pertaining to medical devices or initiate action for criminal prosecution of such violations. Regulatory agencies and authorities in the countries where we do business can halt production in or distribution within their respective country or otherwise take action in accordance with local laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales of medical devices manufactured in the U.S. that are not approved by the FDA for use in the U.S., or that are banned or deviate from lawful performance standards, are subject to FDA export requirements. Additionally, exported devices are subject to the regulatory requirements of each country to which the device is exported. Some countries do not have medical device regulations, but in most foreign countries, medical devices are regulated. Frequently, regulatory approval may first be obtained in a foreign country prior to application in the U.S. due to differing regulatory requirements; however, other countries, such as China, for example, require approval in the country of origin first. Most countries outside of the U.S. require that product approvals be recertified on a regular basis. The recertification process requires that we evaluate any device changes and any new regulations or standards relevant to the device and, where needed, conduct appropriate testing to document continued compliance. Where recertification applications are required, they must be approved in order to continue selling our products in those countries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Affairs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a global Government Affairs presence, headquartered in Washington, D.C., to actively monitor and advocate on myriad legislation and policies that may potentially impact the Company, both on a domestic and an international front. The Government Affairs office works closely with members of Congress and committee staff, the White House and Administration offices, state Governors, legislatures and regulatory agencies, embassies and global governments on issues affecting our business. Our proactive approach and depth of political and policy expertise are aimed at having our positions heard by federal, state and global decision-makers to improve patient care and to advance our business objectives by educating policymakers on our positions, key priorities and the value of our technologies. The Government Affairs office manages our political action committee and works closely with trade groups on issues affecting our industry and healthcare in general. The Government Affairs office also advocates for public policy that benefits our employees, and the patients we serve and supports the communities in which we live. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthcare Policies and Reimbursement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Political, economic and regulatory influences around the world continue to subject the healthcare industry to potential fundamental changes that could substantially affect our results of operations. Government and private sector initiatives related to limiting the growth of healthcare costs (including price regulation), coverage and payment policies, comparative effectiveness reviews of therapies, technology assessments and healthcare delivery structure reforms, are continuing in many countries where we do business. We believe that these changes are causing the marketplace to put increased emphasis on the delivery of treatments that can reduce costs, improve efficiencies and/or increase patient access. Although we believe our less-invasive products and technologies generate favorable clinical outcomes, value and cost efficiency, the resources necessary to demonstrate value to our customers, patients, payers and other stakeholders are significant and new therapies may now take longer periods of time to gain widespread adoption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Federal government and certain state governments have enacted laws aimed at increasing transparency, or "sunshine," in relationships between medical device, biologics and pharmaceutical companies and healthcare professionals (HCPs). As a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">result, we are required by law to report many types of payments and transfers of value provided to HCPs. Certain foreign jurisdictions have similar laws or are currently acting to implement similar laws. Failure to comply with sunshine laws and/or implement and adhere to adequate policies and practices to address changes to legal and regulatory requirements could have a negative impact on our results of operations. Additional legislation at the state and federal levels may result in further changes to these laws.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that pricing of medical devices will remain under pressure as price transparency, expansion of site neutrality, or consistent reimbursement regardless of treatment location, alternative payment reform, value-based purchasing, and accountable care organizations (ACOs), continue to take shape in the U.S. and abroad. We also expect marketplace changes to place pressure on medical device pricing as hospitals consolidate and large group purchasing organizations, hospital networks and other groups continue to seek to aggregate purchasing power. Similarly, governments are increasing the use of tenders, placing pressure on medical device pricing. Some governments also seek to limit the growth of healthcare costs through price regulation. Implementation of cost containment initiatives and healthcare reforms in significant markets such as the U.S., China, Australia, and other markets may limit the price of, or the level at which reimbursement is provided for, our products, which in turn may influence a hospital&#8217;s or physician's selection of products used to treat patients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are purchased principally by hospitals, physicians and other healthcare providers around the world that typically bill various third-party payers, including government programs (e.g., Medicare and Medicaid in the U.S.) and private insurance payers, for the services provided to their patients. Third-party payers and governments may approve or deny coverage for certain technologies and associated procedures based on independently determined assessment criteria. Coverage decisions by payers for these technologies and associated procedures are based on a wide range of methodologies that may reflect the assessed resource costs, clinical outcomes and economic value of the technologies and associated procedures. The new U.S. Administration may attempt to reverse some of the previous Administration&#8217;s changes to the Affordable Care Act (ACA), particularly related to healthcare coverage for the uninsured, and is further expected to introduce more ambitious healthcare legislation, which could include what is commonly referred to as a &#8220;public option&#8221; or changes to Medicare age requirements. If passed, this legislation would lead to increased coverage levels and utilization of services; however, at this point, the impact of any such changes is unclear because specific changes have not been enacted or implemented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proprietary Rights and Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of patents, trademarks, trade secrets and other forms of intellectual property to protect our proprietary rights. We generally file patent applications in the U.S. and foreign countries where patent protection for our technology is appropriate and available. As of December&#160;31, 2020, we held more than 18,000 patents and had approximately 6,000 patent applications pending worldwide that cover various aspects of our technology. In addition, we hold exclusive and non-exclusive licenses to a variety of third-party technologies covered by patents and patent applications. In the aggregate, these intellectual property assets and licenses are of material importance to our business; however, we believe that no single patent, technology, trademark, intellectual property asset or license is material in relation to our business as a whole.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on non-disclosure and non-competition agreements with employees, consultants and other parties to protect, in part, trade secrets and other proprietary technology. There has been substantial litigation regarding patent and other intellectual property rights in the medical device industry, particularly in the areas in which we compete. We continue to defend ourselves against claims and legal actions alleging infringement of the patent rights of others. Additionally, we may find it necessary to initiate litigation to enforce our patent rights, to protect our trade secrets or know-how and to determine the scope and validity of the proprietary rights of others. Accordingly, we may seek to settle some or all of our pending litigation, particularly to manage risk over time. Settlement may include cross licensing of the patents that are the subject of the litigation as well as our other intellectual property and may involve monetary payments to or from third parties. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain insurance policies providing limited coverage against securities claims. We are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our 2020 consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for a discussion of intellectual property, product liability and other litigation and proceedings in which we are involved. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Boston Scientific, our work is guided by core values that define our culture and empower our employees, including Caring, Diversity, Global Collaboration, High Performance, Meaningful Innovation and Winning Spirit. As of December 31, 2020, we had approximately 38,000 employees, including approximately 16,000 in operations, 18,000 in selling, marketing, distribution and administration, and 4,000 in clinical, regulatory and research and development. Of these employees, we employed approximately 21,000 outside the U.S., approximately 10,000 of whom are in the manufacturing operations function. We believe the collective talent of our employees and our shared corporate culture and values give us a competitive advantage.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our industry, there is substantial competition for key personnel in the regions in which we operate. Hiring, developing and retaining talented employees are key parts of our strategy and are critical to our success. We strive to do this by fostering a diverse and inclusive workplace, providing competitive pay and benefits, offering ongoing employee growth and development opportunities and cultivating a culture that prioritizes employee health, safety and wellness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity Equity and Inclusion </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do our best work to advance health care when we have a diverse range of perspectives and experience on our team. Innovation thrives in a culture of engagement and inclusion. The society in which we live and the customers and patients we serve are diverse and our employees must reflect this. In recent years, we have made steady progress to increase the overall representation of employees who identify as women and as African American/Black, Asian, Hispanic/Latino, American Indian/Alaska Native, Native Hawaiian/Other Pacific Islander, and two or more races (together, multicultural talent). As of December 31, 2020, women represented 30 percent of our Board of Directors, and 47 percent of our employees. In addition, 34 percent of employees in the U.S. and Puerto Rico identified as multicultural. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are committed to our goal of making further progress toward expanding our workforce diversity. We have set measurable Diversity, Equity &amp; Inclusion (DE&amp;I) goals with our &#8220;3UP by 2023&#8221; initiative, including a three percent increase in representation of both women and multicultural talent at the supervisor and manager level to 43 percent and 23 percent, respectively by December 31, 2022. As of December 31, 2020, 40 percent of employees in management roles are women and 21 percent are multicultural. We were proud to be a globally recognized leader for workplace inclusion, named a Top 10% Inclusion Index Company by Diversity Best Practices in 2020. Our Executive Committee and our Board of Directors have oversight over employee diversity metrics and hiring trends. As evidence of our commitment to expand diversity, equity and inclusion, we have introduced a human capital performance metric to our 2021 Annual Bonus Plan. Our Executive Committee will be measured against global gender and U.S. (inclusive of Puerto Rico) multicultural goals, leadership bench retention goals and performance against annual renewable energy and recycling index goals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our Employee Resource Groups (ERGs) are at the heart of our DE&amp;I strategy. ERGs are voluntary, company-sponsored employee groups that foster and celebrate our diverse work environment. They provide forums for us to learn from one another, celebrate our differences and develop inclusive leadership skills. We support each ERG by designating global and local executive sponsors and providing financial resources. Our ERG chapters around the world collaborate across the business at all levels and are powerful voices for change in the company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitive compensation and benefits programs are essential for a productive and thriving workforce. As part of our broader rewards portfolio, we offer competitive pay and benefits that are flexible and affordable in order to meet the individual needs of our employees. Our benefits include cash bonus programs, incentive stock awards, health insurance, paid time off and family leave, retirement savings plans, childcare and Employee Assistance Programs that encourage overall well-being, including help with finances, family planning and support, elder/childcare and mental health.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global compensation practices are rooted in our values and the high priority we place on paying people equally for equal work. We regularly benchmark salaries, conduct annual internal and external parity audits and review pay recommendations company wide. In addition, we periodically contract with an independent, third party to assess pay equity across all positions. Our most recent analysis showed that our global workforce had a less than one percent statistical difference in pay along gender lines. Similarly, a less than one percent statistical difference in pay was noted for multicultural talent in the U.S. and Puerto Rico.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Health and Safety</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take a global approach to prioritizing and monitoring employee safety and we strive to foster a safety-oriented culture in all of our offices and facilities. We set health and safety goals which measure the number of injuries per 100 employees for every manufacturing and distribution site. Our Employee Health &amp; Safety Operations Council reviews performance monthly to discuss trends and risks, as well as opportunities for improvement. We have established a company-wide safety goal of 0.25 or fewer injuries per 100 employees by 2030, cutting our 2019 incident rate by 50 percent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Growth and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing our people professionally is one of the most important things we do. We have a robust succession planning program to ensure our future leaders are ready to assume roles as they become available. At every level of the company, employees have access to training and tools they can use to advance their skills and expertise and create greater possibilities for their careers. We offer professional and technical courses, including on-the-job training, skills-based learning, mentoring opportunities and leadership development programs for high-potential employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Engagement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek ongoing feedback from our employees to better understand what we are doing well and, conversely, how we can improve their experience. In addition to encouraging ongoing communication and feedback between employees and their managers, we conduct periodic employee engagement surveys to ensure all employees have an opportunity to share their insights and we take appropriate action in response. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Social Responsibility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within many of the communities in which we operate, we have launched and funded a multi-year program to combat racism, inequity and injustice focused on five pillars: community, economic empowerment, education, healthcare disparities and government/legislative change. We also continue our long-term Close the Gap initiative, which focuses on raising awareness and empowering healthcare providers to reach more patients of color, fight longstanding inequities, and address barriers to care. Through Close the Gap, hospitals and health systems are provided with zip code level data that highlight the disparities in treatment between white and non-white patients in their communities. The information allows health care administrators and providers to focus on improving care to underserved populations within their communities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As evidence of our progress, we were named among the Top 50 of America&#8217;s Most Just Companies by Forbes/Just Capital, ranking #38 overall and also tied #1 for diversity, equity and inclusion. We were also named to the 2020 Dow Jones Sustainability Index North America, one of the most prestigious global benchmarks for corporate responsibility, as well as Newsweek's America's Most Responsible Company 2021 list. We are also listed on the FTSE4Good Corporate Social Responsibility Index, managed by the Financial Times and the London Stock Exchange, which measures the performance of companies that meet globally recognized standards of corporate responsibility. These listings and awards recognize our dedication to those standards and it places us in a select group of companies with a demonstrated commitment to responsible business practices and sound environmental policies. These honors are a testament to our company-wide focus on corporate social responsibility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sustainability</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A critical priority for us as a global medical device manufacturer is to deliver on our promise to customers and patients while caring for the planet. The way we do our jobs each day contributes to reducing our environmental impacts, achieving carbon neutrality and improving supply chain sustainability. We are making measurable progress toward shaping a better future for our planet by proactively addressing energy consumption, carbon emissions, waste management and water use. We have committed to a goal of carbon neutrality in our manufacturing and key distribution sites by 2030. Our Environment, Health &amp; Safety (EH&amp;S) Center of Excellence is responsible for rigorously measuring, assessing and reporting progress toward these goals globally. We are focused on a &#8220;C3&#8221; strategy: Cutting energy use, Converting to renewable energy sources and Compensating with carbon offset projects where needed. Certain of our manufacturing sites use high-efficiency technologies such as combined heat and power to generate energy that is cleaner than conventional gas, oil or coal-fired power and our Corporate Headquarters and U.S. distribution center both utilize solar energy. We are on target to source or generate 100 percent of electricity from renewable sources by 2024. By 2027, we expect that 90 percent of all energy used across our facilities, including electricity and natural gas, will be renewable representing an important milestone toward our 2030 carbon neutrality commitment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have obtained ISO 50001:2018 - Energy Management Systems certification for our three manufacturing plants in Ireland and our Tier I Distribution Center in Kerkrade, the Netherlands. We have also obtained ISO 14001:2015 - Environment Management Systems certification at our major manufacturing plants and Tier 1 distribution centers around the world, as well as our Corporate headquarters in Marlborough, Massachusetts. ISO 50001:2018 and ISO 14001:2015 are globally recognized standards for Environmental and Energy Management Systems, established by the International Standards Organization, which provide a voluntary framework to identify key environmental and energy aspects associated with our business. Using these management systems and the specific attributes of our certified locations in the U.S., Ireland, Costa Rica and the Netherlands, we continue to improve our environmental performance and reduce our environmental footprint. We also have 15 LEED-certified buildings on campuses in the U.S., Central America, Europe and Asia. Leadership in Energy and Environmental Design (LEED) is an internationally recognized certification program for the environmental performance and sustainable design of buildings. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Community Outreach</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are united by a goal to make a difference in the lives of the approximately 30 million patients we serve annually. We seek to give our time and resources to make positive impacts upon those communities where we live, work, and serve. Guided by our core values, we seek to improve access to healthcare, to invest in educational programming for students with limited means and access to opportunities, and to support and embrace the spirit of volunteerism within our global workforce, while adhering to strong ethical standards. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some parts of the world, access to health information, screening, care and services can be limited. Our collaborations with non-profit community organizations raise awareness of chronic disease and decrease these health disparities by improving health outcomes for underserved populations. We accomplish this through our focus on 3 P&#8217;s - Prevent, Provide and Prepare. We work to prevent chronic disease through education and awareness, provide access to healthcare through increasing the quantity and quality of healthcare workers and screenings, and preparing and empowering children at high risk of or who already have a chronic disease to successfully navigate their health journey. Since 2018, we have partnered with Children&#8217;s HeartLink, a US-based global health organization, with a mission of saving the lives of children with heart disease. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also passionate about inspiring young learners to see themselves in a Science, Technology, Engineering and Math (STEM) role in the future. Our employees work with underrepresented K-12 students around the world and share their passion for STEM by providing interactive product demos, development programs, and hands-on activities for young learners in their communities. Through our outreach efforts, we are helping to develop the diverse future talent that will enable Boston Scientific to create innovative health solutions for generations to come. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beyond the classroom, we empower our employees to participate in and influence the way we care for people in their local communities. Through a number of global activities, employees helped pack over 34,000 kits from their homes that provided STEM activities, health and wellness supplies, snacks and other essentials to populations in need. We are proud of these efforts and the collective impact we have on advancing possibilities across the globe. In 2020 our employees volunteered to make a positive impact in community activities in more than 50 countries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also support the U.S. communities where we have significant business presences through the Boston Scientific Foundation. The mission of the Foundation is simple: to help expand access to quality healthcare and educational opportunities for underserved populations. The Boston Scientific Foundation awarded scholarships to children of employees and grant awards across the U.S. in 2020. The process involved more than 65 employee volunteers who evaluated proposals for the Boston Scientific Foundation Board review and approval, upon which the Boston Scientific Foundation was able to help fuel grassroots innovative solutions to improve access to quality healthcare and create new opportunities for students to learn and achieve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2020, we found new and creative ways to help our communities navigate the challenges of the COVID-19 pandemic. We contributed more than $18 million to aid relief efforts globally through monetary and supply donations and by providing engineering and manufacturing expertise and resources. This included donations of personal protective equipment (PPE) and medical equipment to local hospitals and government agencies. Through collaboration with the University of Minnesota Bakken Medical Device Center and industry peers, we brought an emergency resuscitator to market, which can be used as an alternative when traditional ventilators are not available. We also provided support to children, families and the most vulnerable through direct financial contributions to local community and global non-profit organizations, including Project HOPE and International Federation of Red Cross and Red Crescent Societies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales are influenced by many factors, including product launches, acquisitions, regulatory and reimbursement approvals, patient, physician and employee holiday schedules and other macro-economic conditions. While our consolidated net sales do not reflect any significant degree of seasonality, customer purchases of our medical devices have historically been lower in the first and third quarters of the year. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Copies of our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act), are available free of charge on our website (www.bostonscientific.com) as soon as reasonably practicable after we electronically file the material with or furnish it to the U.S. Securities and Exchange Commission (SEC). Additionally, the SEC maintains an internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Printed copies of these posted materials are also available free of charge to stockholders who request them in writing from Investor Relations, 300 Boston Scientific Way, Marlborough, MA 01752-1234. Information on our website or linked to our website is not incorporated by reference into this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safe Harbor for Forward-Looking Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements that we may make from time to time, including statements contained in this Annual Report and information incorporated by reference into this Annual Report, constitute &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;aim&#8221; and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The forward-looking statements in this Annual Report are based on certain risks and uncertainties, including the risk factors described in Item&#160;1A under the heading &#8220;Risk Factors&#8221; and the specific risk factors discussed below and in connection with forward-looking statements throughout this Annual Report, which could cause actual results to vary materially from the expectations and projections expressed or implied by our forward-looking statements. These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this Annual Report.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. Risks and uncertainties that may cause such differences include, among other things: the impact of the ongoing COVID-19 pandemic on our operations and financial results, future U.S. and global economic, political, competitive, reimbursement and regulatory conditions, new product introductions and the market acceptance of those products, markets for our products, expected pricing environment, expected procedural volumes, the closing and integration of acquisitions, clinical trial results, demographic trends, intellectual property rights, litigation, financial market conditions, the execution and effect of our restructuring program, the execution and effect of our business strategy, including our cost-savings and growth initiatives and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict, including those that have emerged or have increased in significance or likelihood as a result of the COVID-19 pandemic.&#160;All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Item 1A. Risk Factors&#160;contained within this Annual Report on Form 10-K filed with the SEC, which we may update in Part II, Item 1A.&#160;Risk Factors&#160;in subsequent Quarterly Reports on Form 10-Q that we will file hereafter.&#160;We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.&#160;This cautionary statement is applicable to all forward-looking statements contained in this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some of the important risk factors that could cause our actual results to differ materially from our expectations in any forward-looking statements. For further discussion of these and other risk factors, see Item 1A. Risk Factors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Businesses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic on the worldwide economy and financial markets, and developments related to the disease, including the time it will take for vaccines to be broadly distributed and accepted in the U.S. and the rest of the world, and the effectiveness of such vaccines in slowing or stopping the spread of COVID-19 and mitigating the economic effects of the pandemic,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic upon the scheduling of elective and semi-emergent procedures,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of COVID-19 on our global manufacturing and distribution system including the quality of our products,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Our ability to recover from the impact of the COVID-19 pandemic on our business and increase net sales, expand the markets in which we participate, capture market share and adapt to market volatility,</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of natural disasters, additional future public health crises and other catastrophic events,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive offerings and related declines in average selling prices for our products,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ongoing impact on our business of physician alignment to hospitals, governmental investigations and audits of hospitals and other market and economic conditions on the overall number of procedures performed,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The performance of, and physician and patient confidence in, our products and technologies or those of our competitors,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact and outcome of ongoing and future clinical trials and market studies undertaken by us, our competitors or other third parties or perceived product performance of our or our competitors' products,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variations in clinical results, reliability or product performance of our and our competitors' products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to acquire or develop, launch and supply new or next-generation products and technologies worldwide and in line with our commercialization strategies in a timely and successful manner and with respect to our recent acquisitions,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of consolidation and competition in the markets in which we do business or plan to do business,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption in the manufacture or supply of certain components, materials or products, or the failure to secure in a timely manner alternative manufacturing or additional or replacement components, materials or products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as some of our products are more profitable than others,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to attract and retain key personnel, including those associated with recent acquisitions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The inability of certain of our employees to return to work full time following reduced work schedules associated with the COVID-19 pandemic, or our inability to recruit personnel into direct labor roles for the duration of the pandemic,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of enhanced requirements to obtain regulatory approval in the U.S. and around the world, including EU MDR and the associated timing and cost of product approval, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased pressure on the availability and rate of third-party reimbursement for our products and procedures in the U.S. and around the world, including with respect to the timing and costs of creating and expanding markets for new products and technologies, </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The issuance of new or revised accounting standards by the Financial Accounting Standards Board or the Securities and Exchange Commission, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of potential goodwill and intangible asset impairment charges on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Compliance, Litigation and Data Protection</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of healthcare policy changes and legislative or regulatory efforts in the U.S., the EU and around the world to modify product approval or reimbursement processes, including a trend toward demonstrating clinical outcomes, comparative effectiveness and cost efficiency, as well as the impact of other healthcare reform legislation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with our regulatory compliance and quality systems and activities in the U.S., the EU and around the world, including meeting regulatory standards applicable to manufacturing and quality processes,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to minimize or avoid future field actions or FDA warning letters relating to our products and processes and the ongoing inherent risk of potential physician advisories related to our or our competitors' products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased scrutiny of and heightened global regulatory enforcement facing the medical device industry arising from political and regulatory changes, economic pressures or otherwise, including under U.S. Anti-Kickback Statute, U.S. False Claims Act and similar laws in other jurisdictions, U.S. Foreign Corrupt Practices Act (FCPA) and similar laws in other jurisdictions, and U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs and risks associated with current and future asserted litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of our litigation and risk management practices, including self-insurance and compliance activities on our loss contingencies, legal provision and cash flows,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of, diversion of management attention as a result of, and costs to cooperate with, litigate and/or resolve governmental investigations and our class action, product liability, contract and other legal proceedings,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of failure to protect our intellectual property rights and the outcome of patent litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to operate properly our information systems that support our business operations and protect our data integrity and products from a cyber-attack or other breach that has a material adverse effect on our business, reputation or results of operations, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact to internal control over financial reporting relating to potential restrictions to access to consigned inventory at customer locations for our inventory count procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Innovation and Certain Growth Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing, size and nature of our strategic growth initiatives and market opportunities, including with respect to our internal research and development platforms and externally available research and development platforms and technologies and the ultimate cost and success of those initiatives and opportunities,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to complete planned clinical trials successfully, obtain regulatory approvals and launch new and next generation products in a timely manner consistent with cost estimates, including the successful completion of projects from in-process research and development,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to identify and prioritize our internal research and development project portfolio and our external investment portfolio on profitable net sales growth opportunities as well as to maintain the estimated timing and costs of such projects and expected revenue levels for the resulting products and technologies,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to develop, manufacture and market new products and technologies successfully and in a timely manner and the ability of our competitors and other third parties to develop products or technologies that render our products or technologies noncompetitive or obsolete, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute appropriate decisions to discontinue, write-down or reduce the funding of any of our research and development projects, including projects from in-process research and development from our acquisitions, in our growth adjacencies or otherwise,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on acquisitions, alliances or investments to introduce new products or technologies and to enter new or adjacent growth markets and our ability to fund them or to fund contingent payments with respect to those acquisitions, alliances and investments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential failure to successfully integrate and realize the expected benefits, including cost synergies, from the strategic acquisitions, alliances and investments we have consummated or may consummate in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependency on international net sales to achieve growth, including in emerging markets,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing and collectability of customer payments, as well as our ability to continue factoring customer receivables where we have factoring arrangements, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact on pricing due to national tenders,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geopolitical and economic conditions, including civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">The impact of the United Kingdom&#8217;s departure from the European Union,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Protection of our intellectual property, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with established and developing U.S. and foreign legal and regulatory requirements, including FCPA, EU MDR and similar laws in other jurisdictions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in reimbursement practices and policies,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of significant developments or uncertainties stemming from changes in the U.S. administration following the 2020 presidential and congressional elections, including changes in U.S. trade policies, tariffs and the reaction of other countries thereto, particularly China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to maintain or expand our worldwide market positions in the various markets in which we compete or seek to compete, including through investments in product diversification and emerging markets such as Brazil, Russia, India and China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute and realize anticipated benefits from our investments in emerging markets, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential effect of foreign currency fluctuations and interest rate fluctuations on our net sales, expenses and resulting margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to generate sufficient cash flow to fund operations, capital expenditures, global expansion initiatives, any litigation settlements and judgments, share repurchases and strategic investments and acquisitions as well as maintaining our investment grade ratings and managing our debt levels and financial covenant compliance, particularly in light of the COVID-19 pandemic and lower demand for our products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to access the public and private capital markets when desired and to issue debt or equity securities on terms reasonably acceptable to us,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open tax matters, exposure to additional tax liabilities and the impact of changes in U.S. and international tax laws,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open litigation matters, exposure to additional loss contingencies and legal provisions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of examinations and assessments by domestic and international taxing authorities on our tax provision, financial condition or results of operations,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of counterparty default on our derivative financial instruments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to collect outstanding and future receivables and/or sell receivables under our factoring programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost Reduction and Optimization Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with changes made or expected to be made to our organizational and operational structure, pursuant to our restructuring plans as well as any further restructuring or optimization plans we may undertake in the future and our ability to recognize benefits and cost reductions from such programs and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Business disruption and employee distraction as we execute our global compliance program, restructuring and optimization plans and divestitures of assets or businesses and implement our other strategic and cost reduction initiatives.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the other information contained in this Annual Report and the exhibits hereto, the following risk factors should be considered carefully in evaluating our business. Our business, financial condition, cash flows or results of operations could be materially adversely affected by any of these risks. This section contains forward-looking statements. You should refer to the explanation of the qualifications and limitations on forward-looking statements set forth at the end of Item 1. Business of this Annual Report. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business, financial condition, cash flows or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing global COVID-19 pandemic and related impacts are having a material adverse effect on our operations, financial performance and cash flows. We are unable to predict the extent to which the pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position and the achievement of our strategic objectives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our operations, financial performance and cash flows have been negatively impacted by the ongoing COVID-19 pandemic that has caused, and is expected to continue to cause, the global slowdown of economic activity (including the decrease in demand for a broad variety of goods and services), disruptions in global supply chains and significant volatility, disruption of financial markets, a U.S. economic recession and, potentially, a global economic recession. Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing, and difficult to predict, the pandemic&#8217;s impact on our operations and financial performance, as well as its impact on our ability to execute our business strategies and initiatives successfully, remains uncertain and difficult to predict. Further, the ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited, to: governmental, business and individuals&#8217; actions that have been and continue to be taken in response to the pandemic (including restrictions on travel, transport and workforce pressures, and voluntary or mandated deferrals or postponements of elective procedures); the impact of the pandemic and actions taken in response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels of economic growth; and the timing and pace of recovery when the COVID-19 pandemic subsides, which could be impacted by a number of factors, including limited provider capacity to perform procedures using our products that were deferred as a result of the pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has subjected, and may continue to subject, our operations, financial performance and financial condition to a number of risks, including, but not limited to those discussed below:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Operations-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Across all of our businesses, we have faced increased operational challenges from the need to protect employee health and safety. Some of these challenges include site shutdowns, workplace disruptions and restrictions on the movement of people, raw materials and goods, both at our own facilities and at customers and suppliers. We also experienced, and may continue experiencing, lower demand and volume for certain products and services, customer requests for potential payment deferrals or other contract modifications, delays of deliveries and other factors related directly and indirectly to the COVID-19 pandemic that adversely impact our businesses. We expect that the longer the period of economic and global supply chain disruption continues, the more material the cumulative adverse impact will be on our business operations, financial performance and results of operations. Our ability to manufacture our products is highly dependent on our ability to maintain the safety and health of our employees. The ability of our employees to work may be significantly impacted by one or more employees contracting or being exposed to COVID-19. Additionally, when the economic recovery following the COVID-19 pandemic occurs, we may experience unpredictable increases in demand for certain of our products, which could exceed our capacity to meet such demand on a timely basis or at all, which could have a material adverse impact on our business operations, financial performance and results of operations. Further, the prioritization of vaccine distribution could affect the availability of transportation for our supply chain needs. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Customer-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In particular, as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken to quell the spread of COVID-19 and protect our customers, employees, and the patients receiving our products, we have experienced significant and unpredictable reductions in demand for certain of our products as health care customers re-prioritize the treatment of patients. In certain jurisdictions in the United States, governmental authorities have recommended, and in certain cases required, that elective procedures be suspended or canceled to avoid non-essential patient exposure to medical environments and potential infection with COVID-19 and to focus limited resources and personnel capacity toward the treatment of COVID-19. These measures and challenges significantly reduced our net sales and the situation remains challenging. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain jurisdictions, however, the timing of the pandemic and public health measures have resulted in lower levels of COVID-19 cases and some hospitals have developed protocols such that elective procedures may be conducted safely and are approaching pre-COVID-19 pandemic levels. Further, once the pandemic subsides, we anticipate there may be some continued reluctance upon the part of some patients to seek medical attention in a hospital setting.&#160;In addition, for the majority of patients who do seek appointments with physicians and surgeries to be performed at hospitals and ambulatory surgery centers relating to a variety of medical conditions, we anticipate there may be a substantial backlog. As a result, patients seeking to schedule or reschedule elective or deferrable procedures utilizing our products may have to navigate potentially limited healthcare provider capacity. We believe this likely patient reluctance and potential healthcare provider capacity could have an adverse effect on our sales following the end of the pandemic. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Employee-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In an attempt to proactively address the changed business environment caused by COVID-19, in order to preserve employees&#8217; jobs and ensure we are able to quickly respond to increased customer demand, when deferrable procedures resume as permitted by development or conclusion of the pandemic, we made temporary work hour reductions, and corresponding salary reductions, where appropriate, for many of our employees. However, because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing, and difficult to predict, we may, in the future, have to consider taking additional actions including further reductions to salary and work hours, furloughs, restructuring, layoffs or extensions of remote work arrangements, which may negatively impact our workforce and our business. These negative impacts could include inhibiting our ability to quickly respond to increased customer demand and to take advantage of more favorable economic and market conditions after the pandemic subsides as well as lower productivity and higher employee attrition.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting-related risks: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally accepted accounting principles and the related authoritative guidance are complex and involve subjective judgments.&#160;In particular, the accounting for revenue, inventory, goodwill, intangible assets, income taxes and other assets and liabilities requires reliance on forward looking estimates of sales and/or earnings.&#160;Due to the uncertainty surrounding the COVID-19 pandemic, estimating the future performance of our business is extremely challenging and the range of deviation from internal estimates could be more significant in this environment. Changes in the underlying estimates, assumptions or judgments could have a material adverse impact on our future results of operations, financial position and cash flows.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Leverage- and market-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The current financial market dynamics and volatility pose heightened risks to our previously announced timelines for decreasing our leverage, which we expect to be delayed as we seek to maintain appropriate liquidity to compensate for lower cash flows from operations or as variables impacting our leverage ratios fluctuate with extreme market volatility. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Liquidity- and funding-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: While we have significant sources of cash and liquidity and access to committed credit lines, a prolonged period of generating lower cash from operations could adversely affect our financial condition and the achievement of our strategic objectives. Additionally, there can also be no assurance that we will not face credit rating downgrades as a result of weaker than anticipated performance of our businesses, slower progress in decreasing our leverage or other factors. Future downgrades could further adversely affect our cost of funds and related margins, liquidity, competitive position and access to capital markets, and a significant downgrade could have an adverse commercial impact on our business. Conditions in the financial and credit markets may also limit the availability of funding or increase the cost of funding (including for receivables monetization or supply chain finance programs, as well as increased borrowing costs and higher interest rates), which could adversely affect our business, financial position and results of operations. Although the U.S. federal and other governments have instituted and/or announced a number of funding programs to support businesses, our ability or willingness to access funding under such programs may be limited by regulations or other guidance, or by further change or uncertainty related to the terms of these programs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic continues to adversely affect our operating and financial results, it may also have the effect of heightening many of the other risks described in the risk factors in this Annual Report on Form 10-K. Further, the COVID-19 pandemic may also affect our operating and financial results in a manner that is not presently known to us or that we currently do not expect to present significant risks to our operations or financial results, particularly if the COVID-19 pandemic and its associated impacts reoccur in successive waves in the coming months.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face intense competition and may not be able to keep pace with the rapid technological changes in the medical devices industry, which could have an adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device markets in which we participate are highly competitive. We encounter significant competition across our product lines and in each market in which our products are sold from various medical device companies. Some of our competitors may have greater financial and marketing resources than we do, including as a result of consolidation among companies in our industry. Our primary competitors include Abbott Laboratories and Medtronic plc, as well as a wide range of medical device companies that sell a single or limited number of competitive products or which participate in only a specific market segment or segments. We also face competition from non-medical device companies, including pharmaceutical companies, which may offer alternative therapies for disease states also amenable to treatment using our products. New competitors may emerge in the future, potentially including companies introducing new sales or distribution models to our industry or leveraging robotic, navigation, and/or other automation technologies. Digital technologies have and may continue to increase in their applicability and importance to various aspects of our business, operating and competitive environments, R&amp;D pipeline and product portfolio. We believe we will need to develop new and enhanced digital capabilities and competences in order to remain competitive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the medical device markets in which we participate are characterized by extensive research and development and rapid technological change. Developments by other companies of products and/or services, processes or technologies may make our products or proposed products obsolete or less competitive and may negatively impact our net sales. It is necessary for us to devote continued efforts and financial resources to the development or acquisition of scientifically advanced technologies and products. In addition, we will need to apply our technologies cost-effectively across product lines and markets, obtain patent and other protection for our technologies and products, obtain required regulatory and reimbursement approvals and successfully manufacture and market our products consistent with our quality standards. If we fail to develop or acquire new products or enhance existing products, such failure could have a material adverse effect on our business, financial condition or results of operations. In addition, a delay in the timing of the launch of next-generation products and the overall performance of, and continued physician confidence in, those products may result in declines in our market share and have an adverse impact on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience declines in market size, average selling prices for our products, medical procedure volumes and our share of the markets in which we compete, which may materially adversely affect our results of operations and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to experience pressures across many of our businesses due to competitive activity, increased market power of our customers as the healthcare industry consolidates, national and regional government tenders, economic pressures experienced by our customers, public perception of our products, and the impact of managed care organizations and other third-party payers. These and other factors may adversely impact market sizes, as well as our share of the markets in which we compete, the average selling prices for our products or medical procedure volumes. There can be no assurance that the size of the markets in which we compete will increase above existing levels, that we will be able to regain or gain market share or compete effectively on the basis of price or that the number of procedures in which our products are used will increase above existing levels. Decreases in market sizes or our market share and declines in average selling prices or procedural volumes could materially adversely affect our results of operations or financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continued consolidation in the healthcare industry or additional governmental controls exerted over pricing in key markets could lead to increased demands for price concessions or limit or eliminate our ability to sell to certain of our significant market segments, which could have an adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous initiatives and reforms by legislators, regulators and third-party payers to curb the rising cost of healthcare, and to increase access to care, have catalyzed a consolidation of aggregate purchasing power within the markets in which we sell our products. Additionally, a growing number of countries have instituted or are contemplating introducing regional or national tender processes driven primarily by price. In some cases, such processes may favor local companies to multinational companies like Boston Scientific. As the healthcare industry consolidates, competition to provide products and services is expected to continue to intensify, resulting in pricing pressures, decreased average selling prices and the exclusion of certain suppliers from important market segments. We expect that market demand, government regulation, third-party coverage and reimbursement policies, government contracting requirements and societal pressures will continue to change the worldwide healthcare industry, resulting in further business consolidations and alliances among our customers, which may increase competition, exert further downward pressure on the prices of our products and services and may adversely impact our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare cost containment pressures, government payment and delivery system reforms, changes in private payer policies, and marketplace consolidations could decrease the demand for our products, the prices which customers are willing to pay for those products and/or the number of procedures performed using our devices, which could have an adverse effect on our business, financial condition or results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are purchased principally by hospitals, physicians and other healthcare providers around the world that typically bill various third-party payers, including government programs, authorities or agencies (e.g., Medicare and Medicaid in the U.S.) and private health plans, for the healthcare services provided to their patients. Governments and payers may also institute changes in healthcare delivery systems that may reduce funding for services or encourage greater scrutiny of healthcare costs. The ability of customers to obtain appropriate reimbursement for their products and services is critical to the success of medical technology companies because it affects which products customers purchase and the prices they are willing to pay. Reimbursement and funding vary by country and can significantly impact the acceptance of new products and technologies and the use of established products and technologies. We may find limited demand for promising new products unless reimbursement approval is obtained from private and governmental third-party payers. Further legislative or administrative reforms to the reimbursement systems in the U.S., Japan, or other countries in a manner that significantly reduce or eliminate reimbursement for procedures using our medical devices, including price regulation, site of service requirements, competitive bidding and tendering, coverage and payment policies, comparative effectiveness of therapies, heightened clinical data requirements, technology assessments and managed-care arrangements, could have a material adverse effect on our business, financial condition or results of operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geopolitical Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to a number of market, business, financial, legal and regulatory risks and uncertainties with respect to our international operations that could have a material impact on our business, financial condition or results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International net sales accounted for 42 percent of our global net sales in 2020. An important part of our strategy is to continue pursuing growth opportunities in net sales and market share outside of the U.S. by expanding global presence, including in Emerging Markets. Our international operations are subject to a number of market, business and financial risks and uncertainties, including those related to our use of channel partners, geopolitical and economic instability, foreign currency exchange and interest rate fluctuations, competitive product offerings, local changes in healthcare financing and payment systems and healthcare delivery systems, local product preferences and requirements, including preferences for local manufacturers, workforce instability, weaker intellectual property protection in certain countries than exists in the U.S. and longer accounts receivable cycles. Such risks and uncertainties may adversely impact our ability to implement our growth strategy in these markets and, as a result, our sales growth, market share and operating profits from our international operations may be adversely affected. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations are subject to established and developing legal and regulatory requirements for medical devices in each country in which our products are marketed and sold. Most foreign countries have medical device regulations. Further, most countries outside of the U.S. require product approvals be renewed or recertified on a regular basis in order to continue to be marketed and sold there. In addition, several countries that previously did not have regulatory requirements for medical devices have established such requirements in recent years and other countries have expanded, or plan to expand, existing regulations, including requiring local clinical data in addition to global clinical data. These factors have caused or may cause us to experience more uncertainty, risk, expense and delay in obtaining approvals and commercializing products in certain jurisdictions, which could adversely impact our net sales, market share and operating profits from our international operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, international markets are affected by economic pressure to contain healthcare costs, which can lead to more rigorous evidence requirements and lower reimbursement rates for either our products directly or procedures in which our products are used. Governments and payers may also institute changes in healthcare delivery systems that may reduce funding for services or encourage greater scrutiny of healthcare costs. In addition, certain international markets may also be affected by foreign government efforts to reference reimbursement rates in other countries. All of these types of changes may ultimately reduce selling prices of our products and/or reduce the number of procedures in which our products are used, which may adversely impact our net sales, market share and operating profits from our international operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our international operations are subject to other established and developing U.S. and foreign legal and regulatory requirements, including FCPA and/or similar laws in other countries and U.S. and foreign import and export controls and licensing requirements, trade protection and embargo measures and customs laws. Global businesses, including those in the medical device industry, are facing increasing scrutiny of, and heightened enforcement efforts with respect to, their international operations. Any alleged or actual failure to comply with legal and regulatory requirements may subject us to government scrutiny, civil and/or criminal proceedings, sanctions and other liabilities, which may have a material adverse effect on our international operations, financial condition, results of operations and/or liquidity. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, the United Kingdom (UK) formally exited the European Union (EU), and a transition period began, during which time the U.K. and the EU negotiated a trade agreement and other terms associated with their future relationship. The transition period ended on December 31, 2020. The short- and long-term impact of the U.K.&#8217;s exit from the EU on European and global macroeconomic conditions, our business operations and results of operations remain unknown. Changes in industry regulations could have an effect on existing CE certificates being renewed and new certificates being issued which would impact the ability to trade; however, it is impossible to assess the full impact at this stage. We have implemented a Brexit Response Team and have put in place mitigation procedures intended to reduce any significant operational risks that have been identified to date. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any significant changes in the political, economic, financial, competitive, legal and regulatory or reimbursement conditions where we conduct, or plan to expand, our international operations may have a material impact on our business, financial condition or results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit and Financial Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to manage our debt levels, maintain investment grade credit ratings at the three ratings agencies, or experience a disruption in our cash flows it could have an adverse effect on our cost of borrowing, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategy to maximize stockholder value, we use financial leverage to manage our cost of capital. Our outstanding debt balance was $9.143 billion as of December&#160;31, 2020 and $10.008 billion as of December&#160;31, 2019. Although we currently have investment grade ratings at Moody's Investor Service, Standard &amp; Poor's Rating Service and Fitch Ratings, our inability to maintain investment grade credit ratings could increase our cost of borrowing funds in the future and reduce our access to liquidity. Delays in our product development and new product launches could result in disruption in our cash flow or our ability to continue to effectively manage our debt levels could have an adverse effect on our cost of borrowing, financial condition or results of operations. In addition, our credit agreements contain a financial covenant that require us to maintain a minimum specified leverage ratio and place other limits on our business. If we are unable to satisfy this covenant, we may be required to obtain waivers from our lenders and no assurance can be made that our lenders would grant such waivers on favorable terms or at all and we could be required to repay any borrowings on demand. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may record future intangible asset impairment charges related to one or more of our global reporting units, which could materially adversely impact our results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. We assess goodwill for impairment at the reporting unit level and, in evaluating the potential for impairment of goodwill, we make assumptions regarding estimated revenue projections, growth rates, cash flows and discount rates. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, we monitor the key drivers of fair value to detect events or other changes that would warrant an interim impairment test of our goodwill and other intangible assets. Relatively small declines in the future performance and cash flows of a reporting unit or asset group, changes in our reporting units or in the structure of our business as a result of future reorganizations, acquisitions or divestitures of assets or businesses, or small changes in other key assumptions, may result in the recognition of significant asset impairment charges, which could have a material adverse impact on our results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current domestic and international economic conditions could adversely affect our cash flows and results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertainty about global economic conditions, including those resulting from credit and sovereign debt issues, has caused and may continue to cause disruption in the financial markets, including diminished liquidity and credit availability. These conditions may adversely affect our suppliers, leading them to experience financial difficulties or be unable to borrow money to fund their operations, which could cause disruptions in our ability to produce our products. Our customers may experience financial difficulties or be unable to borrow money to fund their operations, which may adversely impact their ability or decision to purchase our products, particularly capital equipment, or to pay for our products that they purchase on a timely basis, if at all. In addition, we have accounts receivable factoring programs in certain European and Asian countries. Deterioration of the global economy or increase in sovereign debt issues may impact our ability to transfer receivables to third parties in certain of those countries. Third parties such as banks offering factoring programs in these countries are looking to reduce their exposure levels to government owned or supported debt. This could result in terminations of, or changes to the costs or credit limits of our existing factoring programs. Such terminations or changes could have a negative impact on our cash flow and days sales outstanding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strength and timing of economic recovery remains uncertain and there can be no assurance that there will not be further deterioration in the global economy. Accordingly, we cannot predict to what extent global economic conditions, including sovereign debt issues and increased focus on healthcare systems and costs in the U.S. and abroad, may continue to impact negatively our average selling prices, net sales and profit margins, procedural volumes and reimbursement rates from third party payers. In addition, conditions in the financial markets and other factors beyond our control may adversely affect our ability to borrow money in the credit markets, access the capital markets and to obtain financing for acquisitions or other general corporate and commercial purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business and Operational Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to integrate acquired businesses into our operations successfully could adversely affect our business, financial condition and operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategy to realign our business portfolio, we have completed multiple acquisitions in recent years and may pursue additional acquisitions in the future. Our integration of acquired businesses requires significant efforts, including corporate restructuring and the coordination of information technologies, research and development, sales and marketing, operations, regulatory, supply chain, manufacturing, quality systems and finance. These efforts result in additional expenses and involve significant management time. Some of the factors that could affect the success of our acquisitions include, among others, the effectiveness of our due diligence process, our ability to execute our business plan for the acquired companies, the strength of the acquired technology, results of clinical trials, regulatory approvals and reimbursement levels of the acquired products and related procedures, the continued performance of critical transition services, our ability to adequately fund acquired in-process research and development projects and retain key employees and our ability to achieve synergies with our acquired companies, such as increasing sales of our products, achieving cost savings and effectively combining technologies to develop new products. In addition, foreign acquisitions involve unique risks, including those related to integration of operations across different geographies, cultures and languages, currency risks and risks associated with the economic, political, legal and regulatory environment in specific countries. Our failure to manage successfully and coordinate the growth of the acquired companies could have an adverse impact on our business and our future growth. In addition, we cannot be certain that the businesses we acquire will become profitable or remain so, and if our acquisitions are not successful, we may record related asset impairment charges in the future or experience other negative consequences on our results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in our strategy relating to future strategic acquisitions of, investments in, or alliances with, other companies and businesses, which have been a significant source of historical growth for us, and will be key to our diversification into new markets and technologies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategic acquisitions, investments and alliances are intended to further expand our ability to offer customers effective, high quality medical devices that satisfy their interventional needs. These acquisitions, investments and alliances have been a significant source of our growth. We face competition for acquisitions from other healthcare and non-healthcare acquirers, financial sponsors, and from the market for Initial Public Offerings (IPOs). Strength in the market for IPOs may reduce the set of opportunities available to us for M&amp;A and/or cause us to need to pay higher prices. If we are unsuccessful in our acquisitions, investments and alliances, we may be unable to grow our business. The success of our strategy relating to future acquisitions, investments or alliances will depend on a number of factors, including our ability to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify suitable opportunities for acquisition, investment or alliance, if at all,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manage acquisition, investment or alliance opportunities within our capital capacity and prioritize those investments to execute on our strategy, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manage our due diligence process to uncover potential issues with targets,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">finance any future acquisition, investment or alliance on terms acceptable to us, if at all,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complete acquisitions, investments or alliances in a timely manner on terms that are satisfactory to us, if at all, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully integrate and operate acquired businesses,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully identify and retain key target employees,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comply with applicable laws and regulations, including foreign laws and regulations, and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">protect intellectual property and to prevail in litigation related to newly acquired technologies.&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any potential future acquisitions we consummate may be dilutive to our earnings and may require additional debt or equity financing, depending on their size or nature. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize the expected benefits from our restructuring and optimization initiatives, our long-term expense reduction programs may result in an increase in short-term expenses and our efforts may lead to unintended consequences. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the dynamics of the economy, the healthcare industry and the markets in which we compete and assess opportunities for improved operational effectiveness and efficiency and to better align expenses with revenues, while preserving our ability to make investments in research and development projects, capital and our people that we believe are important to our long-term success. As a result of these assessments, we have undertaken restructuring and optimization initiatives in order to enhance our growth potential and position us for long-term success. In November 2018, we announced a restructuring initiative (the 2019 Restructuring Plan) intended to support our effort to improve operating performance and meet anticipated market demands by ensuring that we are appropriately structured and resourced to deliver sustainable value to patients and customers. Key activities under the 2019 Restructuring Plan include supply chain network optimization intended to maximize our global manufacturing and distribution network capacity and building functional capabilities that support business growth. These activities were initiated in 2019, with the majority of activity expected to be complete by the end of 2022, following a one-year extension approved by our Board of Directors on February 22, 2021. The 2019 Restructuring Plan is expected to result in total pre-tax charges of approximately $375 million to $475 million and reduce gross annual pre-tax operating expenses by approximately $200 million to $250 million by the end of 2023 as program benefits are realized. We expect a substantial portion of the savings to be reinvested in strategic growth initiatives. These measures could yield unintended consequences, such as distraction of our management and employees, business disruption, inability to attract or retain key personnel and reduced employee productivity, which could negatively affect our business, sales, financial condition and results of operations. Moreover, our restructuring and optimization initiatives result in charges and expenses some of which impact our operating results. We cannot guarantee that the activities under our restructuring plans or other optimization initiatives will result in the desired efficiencies and estimated cost savings.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth is dependent upon the development of new products and enhancement of existing products, which requires significant research and development, clinical trials and regulatory approvals, all of which may be very expensive and time-consuming and may not result in commercially viable products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to develop new products and enhance existing products, we focus our research and development programs largely on the development of next-generation and novel technology offerings across multiple programs and businesses. The development of new products and enhancement of existing products requires significant investment in research and development, clinical trials and regulatory approvals. The results of our product development efforts may be affected by a number of factors, including our ability to anticipate customer needs, innovate and develop new products, complete clinical trials, obtain regulatory approvals and reimbursement in the United States and abroad, manufacture products in a cost-effective manner, obtain appropriate intellectual property protection for our products and gain and maintain market approval of our products. There can be no assurance that any products now in development or that we may seek to develop in the future will achieve technological feasibility, obtain regulatory approval or gain market acceptance. If we are unable to develop and launch new products and enhanced products, our ability to maintain or expand our market position in the markets in which we participate may be materially adversely impacted. Further, we are continuing to investigate and have completed several acquisitions that involve opportunities to further expand our presence in and diversify into, priority growth areas by accessing new products and technologies. There can be no assurance that our investments will be successful or that we will be able to access new products and technologies on terms favorable to us, or that these products and technologies will achieve commercial feasibility, obtain regulatory approval or gain market acceptance. A delay in the development or approval of new products and technologies or our decision to reduce our investments may adversely impact the contribution of these technologies to our future growth.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain products or groups of products, in particular new products or enhancements of existing products, may have a disproportionate impact on our business, financial condition and results of operations. Failure to meet growth projections, poor clinical outcomes, increasing regulatory requirements, launch delays and inability to effectively scale manufacturing and achieve targeted margins with respect to any of these products or groups of products in particular may materially adversely impact on our business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interruption of our supply chain or manufacturing operations, including resulting from natural disasters, further public heath crises and other catastrophic events or other events outside of our control could adversely affect our results of operations and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are designed and manufactured in technology centers around the world, either by us or third parties. In most cases, the manufacturing of any specific product is concentrated in one or a few locations. Factors such as a failure to follow specific internal protocols and procedures, equipment malfunction, environmental factors or damage to one or more of our facilities could adversely affect our ability to manufacture our products. In the event of an interruption in manufacturing, we may be unable to quickly move to alternate means of producing affected products or to meet customer demand. In the event of a significant interruption, for example, as a result of a failure to follow regulatory protocols and procedures, we may experience </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lengthy delays in resuming production of affected products due primarily to needs for regulatory approvals. As a result, we may experience loss of market share, which we may be unable to recapture and harm to our reputation, which could adversely affect our results of operations and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions in the supply of the materials and components used in manufacturing our products or the sterilization of our products by third-party vendors could adversely affect our results of operations and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase the majority of the materials and components used in manufacturing our products from third-party vendors. Certain of these materials and components are purchased from single sources due to quality considerations, expertise, costs or constraints resulting from regulatory requirements. In certain cases, we may not be able to establish additional or replacement vendors for such materials or components in a timely or cost effective manner, largely as a result of FDA regulations that require validation of materials and components prior to their use in our products and the complex nature of our and many of our vendors' manufacturing processes. A reduction or interruption in the supply of materials and components used in manufacturing our products, an inability to timely develop and validate alternative sources if required or a significant increase in the price of such materials or components could adversely affect our results of operations and financial condition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many of our products require sterilization prior to sale and we utilize a mix of internal resources and contract sterilizers to perform this service. To the extent we or our contract sterilizers are unable to sterilize our products, whether due to capacity, availability of materials for sterilization, regulatory or other constraints, including federal and state regulations on the use of ethylene oxide, we may be unable to transition to other internal resources, contract sterilizers, sterilizer locations or sterilization methods in a timely or cost effective manner or at all, which could have a material impact on our results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal and Regulatory Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare policy changes, including healthcare reform legislation, may have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Political, economic and policy influences are leading the healthcare industry to make substantial structural and financial changes that will continue affecting our results of operations. Government and private sector initiatives limiting the growth of healthcare costs (including price regulation), coverage and payment policies, comparative effectiveness of therapies, technology assessments and healthcare delivery structure reforms, are continuing in many countries where we do business. We believe that these changes are causing the marketplace to put increased emphasis on the delivery of more treatments that can reduce costs, improve efficiencies and/or increase patient access. Although we believe our less-invasive products and technologies generate favorable clinical outcomes, value and cost efficiency, the resources and evidence necessary to demonstrate value to our customers, patients, payers and other stakeholders may be significant, and it may take a longer period of time to gain widespread adoption. Moreover, there can be no assurance that our strategies will succeed for every product.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act (ACA) and Health Care and Education Affordability Reconciliation Act of 2010 were enacted into law in the U.S. in March 2010. Certain provisions of this law, including comparative effectiveness research, pilot programs to evaluate alternative payment methodologies and other changes to the payment systems, have started changing the way healthcare is delivered, reimbursed and funded. While the extent to which it has affected our business is not clear, these changes, over the long-term, may adversely affect our business and results of operations. The new U.S. Administration may attempt to reverse some of the previous Administration&#8217;s changes to the ACA, particularly related to healthcare coverage for the uninsured, and is further expected to introduce more ambitious healthcare legislation, which could include what is commonly referred to as a &#8220;public option&#8221; or changes to Medicare age requirements. If passed, this legislation would lead to increased coverage levels and utilization of services; however, at this point, the impact of any such changes is unclear because specific changes have not been enacted or implemented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the specific healthcare programs and regulations that will be ultimately implemented by regional and national governments globally. However, any changes that lower reimbursements for either our products and/or procedures using our products reduce medical procedure volumes and/or increase cost containment pressures on us or others in the healthcare sector could adversely affect our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive and dynamic medical device regulation, which may impede or hinder the approval or sale of our products and, in some cases, may ultimately result in an inability to obtain approval of certain products or may result in the recall or seizure of previously approved products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products, marketing, sales and development activities and manufacturing processes are subject to extensive and rigorous regulation by the FDA pursuant to the Federal Food, Drug and Cosmetic Act (FDC Act), by comparable agencies in foreign countries and by other regulatory agencies and governing bodies. Under the FDC Act, medical devices must receive FDA clearance or approval or an exemption from such clearance or approval before they can be commercially marketed in the U.S. In the EU, we will be required to comply with the new Medical Device Regulation (MDR or EU MDR) effective May 2021 (extended from May 2020) which will supersede the current Medical Device Directives. Medical devices which have a valid CE Certificate to the current Directives (issued before May 2021) can continue to be sold until May 2024 or until the CE Certificate expires, whichever comes first, providing there are no significant changes to the design or intended use. The CE Mark is applied following approval from an independent notified body or declaration of conformity. The process of obtaining marketing approval or clearance from the FDA or by comparable agencies in foreign countries for new products, or with respect to enhancements or modifications to existing products, could:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">take a significant period of time,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require the expenditure of substantial resources,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">involve rigorous pre-clinical and clinical testing, as well as increased post-market surveillance,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require changes to products and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">result in limitations on the indicated uses of products.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, exported devices are subject to the regulatory requirements of each country to which the device is exported. Some countries do not have medical device regulations, but in most foreign countries, medical devices are regulated. Frequently, regulatory approval may first be obtained in a foreign country prior to application in the U.S. due to differing regulatory requirements; however, other countries, such as China for example, require approval in the country of origin or legal manufacturer first. Most countries outside of the U.S. require that product approvals be renewed or recertified on a regular basis, generally every four to five years. The renewal or recertification process requires that we evaluate any device changes and any new regulations or standards relevant to the device and conduct appropriate testing to document continued compliance. Where renewal or recertification applications are required, they may need to be renewed and/or approved in order to continue selling our products in those countries. There can be no assurance that we will receive the required approvals for new products or modifications to existing products on a timely basis or that any approval will not be subsequently withdrawn or conditioned upon extensive post-market study requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global regulatory environment is becoming increasingly stringent and unpredictable, which could increase the time, cost and complexity of obtaining regulatory approvals for our products, as well as the clinical and regulatory costs of supporting those approvals. Several countries that did not have regulatory requirements for medical devices have established such requirements in recent years and other countries have expanded on existing regulations. Certain regulators are exhibiting less flexibility and are requiring local preclinical and clinical data in addition to global data. While harmonization of global regulations has been pursued, requirements continue to differ significantly among countries. We expect this global regulatory environment will continue to evolve, which could impact our ability to obtain future approvals for our products or could increase the cost and time to obtain such approvals in the future. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and other worldwide regulatory agencies actively monitor compliance with local laws and regulations through review and inspection of design and manufacturing practices, recordkeeping, reporting of adverse events, labeling and promotional practices. The FDA can ban certain medical devices, detain or seize adulterated or misbranded medical devices, order repair, replacement or refund of these devices and require notification of health professionals and others with regard to medical devices that present unreasonable risks of substantial harm to the public health. The FDA can take action against a company that promotes "off-label" uses. The FDA may also enjoin and restrain a company for certain violations of the FDC Act and other amending Acts pertaining to medical devices, or initiate action for criminal prosecution of such violations. Any adverse regulatory action, depending on its magnitude, may restrict a company from effectively marketing and selling its products, may limit a company's ability to obtain future premarket clearances or approvals and could result in a substantial modification to our business practices and operations. International sales of medical devices manufactured in the U.S. that are not approved by the FDA for use in the U.S., or that are banned or deviate from lawful performance standards, are subject to FDA export requirements. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulations regarding the development, manufacture and sale of medical devices are evolving and subject to future change. We cannot predict what impact, if any, those changes might have on our business. Failure to comply with regulatory requirements could have a material adverse effect on our business, financial condition and results of operations. Later discovery of previously unknown problems with a product or manufacturer could result in fines, delays or suspensions of regulatory clearances or approvals, seizures or recalls of products, physician advisories or other field actions, operating restrictions and/or criminal prosecution. We may also initiate field actions as a result of a failure to strictly comply with our internal quality policies. The failure to receive product approval clearance on a timely basis, suspensions of regulatory clearances, seizures or recalls of products, physician advisories or other field actions, or the withdrawal of product approval by the FDA or by comparable agencies in foreign countries could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products are continually subject to clinical trials and other analyses conducted by us, our competitors or other third parties, the results of which may be unexpected, or perceived as unfavorable by the market, and could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a part of the regulatory process of obtaining marketing clearance for new products and new indications for existing products, we conduct and participate in numerous clinical trials with a variety of study designs, patient populations and trial endpoints. Unexpected or inconsistent clinical data from existing or future clinical trials or other analyses conducted by us, by our competitors or by third parties, including acquired businesses prior to acquisition by us, or the FDA's or the market's perception of this clinical data, may adversely impact our ability to obtain product approvals, our position in, and share of, the markets in which we participate and our business, financial condition, results of operations or future prospects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The medical device industry and its customers continue to face scrutiny and regulation by governmental authorities and are often the subject of numerous investigations, often involving marketing and other business practices or product quality issues including device recalls or advisories. These investigations could result in the commencement of civil and criminal proceedings; imposition of substantial fines, penalties and administrative remedies, including corporate integrity agreements, stipulated judgments or exclusion; diversion of our employees' and management's attention; imposition of administrative costs and have an adverse effect on our financial condition, results of operations and liquidity; and may lead to greater governmental regulation in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical devices we design, develop, manufacture and market are subject to rigorous regulation by the FDA and numerous other federal, state and foreign governmental authorities. These authorities continue to closely scrutinize our industry. We have received and in the future may receive, subpoenas and other requests for information from Congress and state and federal governmental agencies, including, among others, the U.S. Department of Justice (DOJ), the Office of Inspector General of the Department of Health and Human Services (HHS) and the Department of Defense, as well as from foreign governments and agencies. The requests and/or subpoenas we have received relate primarily to financial arrangements with healthcare providers, regulatory compliance and sale and/or product promotional practices. We have cooperated with these subpoenas and other requests for information and expect to continue to do so in the future. We cannot predict when a matter will be resolved, the outcome of the matter or its impact on us and cooperation may involve significant costs, including document production costs. An adverse outcome in any matter could include the commencement of an investigation, civil and criminal proceedings, substantial fines, penalties and administrative remedies, including exclusion from government reimbursement programs, entry into Corporate Integrity Agreements (CIAs) with governmental agencies and amendments to any existing CIAs. In addition, resolution of any matter could involve the imposition of additional and costly compliance obligations. Cooperation with requests and investigations from external agencies result in employee resource costs and diversion of employee focus. If any requests or investigations continue over a long period of time, they could divert the attention of management from the day-to-day operations of our business and impose significant additional administrative burdens on us. These potential consequences, as well as any adverse outcome from these requests or investigations, could have a material adverse effect on our financial condition, results of operations and liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain foreign governments, state governments (including that of Massachusetts, where we are headquartered) and the U.S. federal government have enacted legislation aimed at increasing transparency of our interactions with healthcare providers. As an example, compliance with the U.S. Physician Payment Sunshine Act requires us by law to disclose payments and other transfers of value to all U.S. physicians and U.S. teaching hospitals at the U.S. federal level made after August 1, 2013. Any failure to comply with these legal and regulatory requirements could impact our business. In addition, we have and may continue to devote substantial additional time and financial resources to further develop and implement enhanced structure, policies, systems and processes to comply with enhanced legal and regulatory requirements, which may also impact our business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that governmental authorities will continue to scrutinize our industry closely and that additional regulation may increase compliance and legal cost and exposure to litigation and have additional adverse effects on our operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws, unfavorable resolution of tax contingencies, or exposure to additional income tax liabilities could have a material impact on our financial condition, results of operations and/or liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes as well as non-income based taxes and tariffs, in both the U.S. and various foreign jurisdictions. We are subject to ongoing tax audits in various jurisdictions. Tax authorities may disagree with certain positions we have taken and assess additional taxes. We regularly assess the likely outcomes of these audits to determine the appropriateness of our tax provision, and we have established contingency reserves for material, known tax exposures. However, the calculation of such tax exposures involves the application of complex tax laws and regulations in many jurisdictions, as well as interpretations as to the legality under European Union state aid rules of tax advantages granted in certain jurisdictions. Therefore, there can be no assurance that we will accurately predict the outcomes of these disputes or other tax audits or that issues raised by tax authorities will be resolved at a financial cost that does not exceed our related reserves and the actual outcomes of these disputes and other tax audits could have a material impact on our results of operations or financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws and regulations, or their interpretation and application, in the jurisdictions where we are subject to tax could materially impact our effective tax rate. The U.S. enacted the Tax Cuts and Jobs Act (TCJA) on December 22, 2017 and we expect the U.S. Treasury to issue future notices and regulations under the TCJA. Certain provisions of the TCJA and the regulations issued thereunder could have a significant impact on our future results of operations as could interpretations made by the Company in the absence of regulatory guidance and judicial interpretations. The change in administration and control of Congress in the U.S. may result in additional U.S. tax law changes that could have a material impact on our future effective tax rate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Organization for Economic Co-operation and Development (OECD), the European Commission (EC) and individual taxing jurisdictions where we and our affiliates do business have recently focused on issues related to the taxation of multinational corporations. The OECD has released its comprehensive plan to create an agreed set of international rules for fighting base erosion and profit shifting. In addition, the OECD, the EC and individual countries are examining changes to how taxing rights should be allocated among countries considering the digital economy. As a result, the tax laws in the U.S. and other countries in which we and our affiliates do business could change on a prospective or retroactive basis and any such changes could materially adversely affect our business. Furthermore, changes in customs laws and regulations in the U.S. and various foreign jurisdictions could have a material impact on our results of operations or financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in Puerto Rico and Costa Rica presently benefit from various tax incentives and grants. Unless these incentives and grants are extended, they will expire between 2027 and 2035. If we are unable to renew, extend, or obtain new incentive and grants, the expiration of the existing incentives and grants could have a material impact on our financial results in future periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not effectively be able to protect our intellectual property or other sensitive data, which could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. Physician customers have historically moved quickly to new products and new technologies. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. However, intellectual property litigation is inherently complex and unpredictable and appellate courts can overturn lower court decisions. Furthermore, as our business increasingly relies on technology systems and infrastructure, our intellectual property, other proprietary technology and other sensitive data are potentially vulnerable to loss, damage or misappropriation. Finally, our ability to protect novel business models is uncertain. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competing parties in our industry frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These forces frequently drive settlement not only of individual cases, but also of a series of pending and potentially related and unrelated cases. In addition, although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of third parties have asserted that our current and former product offerings infringe patents owned or licensed by them. We have similarly asserted that products sold by our competitors infringe patents owned or licensed by us. Adverse outcomes in one or more of the proceedings against us could limit our ability to sell certain products in certain jurisdictions, or reduce our operating margin on the sale of these products and could have a material adverse effect on our financial condition, results of operations or liquidity.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents and other proprietary rights are and will continue to be essential to our business and our ability to compete effectively with other companies will be dependent upon the proprietary nature of our technologies. We rely upon trade secrets, know-how, continuing technological innovations, strategic alliances and licensing opportunities to develop, maintain and strengthen our competitive position. We pursue a policy of generally obtaining patent protection in both the U.S. and abroad for patentable subject matter in our proprietary devices and attempt to review third-party patents and patent applications to the extent publicly available in order to develop an effective patent strategy, avoid infringement of third-party patents, identify licensing opportunities and monitor the patent claims of others. We own numerous U.S. and foreign patents and have numerous patent applications pending. We also are party to license agreements pursuant to which patent rights have been obtained or granted in consideration for cash, cross-licensing rights or royalty payments. No assurance can be made that any pending or future patent applications will result in the issuance of patents, that any current or future patents issued to, or licensed by, us will not be challenged or circumvented by our competitors, or that our patents will not be found invalid. In addition, we may have to take legal action in the future to protect our patents, trade secrets or know-how or to assert them against claimed infringement by others. Any legal action of that type could be costly and time consuming and no assurances can be made that any lawsuit will be successful. We are generally involved as both a plaintiff and a defendant in a number of patent infringement and other intellectual property-related actions. The invalidation of key patents or proprietary rights that we own, or an unsuccessful outcome in lawsuits to protect our intellectual property, could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the laws of certain countries in which we market and plan on manufacturing some of our products in the near future, do not protect our intellectual property rights to the same extent as the laws of the U.S. If we are unable to protect our intellectual property in these countries, it could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our intellectual property, other proprietary technology and other sensitive data are potentially vulnerable to loss, damage or misappropriation from system malfunction, computer viruses and unauthorized access to our data or misappropriation or misuse thereof by those with permitted access and other events. While we have invested to protect our intellectual property, products and other data and continue to work diligently in this area, there can be no assurance that our precautionary measures will prevent breakdowns, breaches, cyber-attacks or other events. Such events could have a material adverse effect on our reputation, business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on the proper function, availability and security of information technology systems to operate our business and a cyber-attack or other breach of these systems could have a material adverse effect on our business, financial condition or results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology systems, including technology from third party vendors, to process, transmit and store electronic information in our day-to-day operations. Similar to other large multi-national companies, the size and complexity of our information technology systems makes them vulnerable to a cyber-attack, malicious intrusion, breakdown, destruction, loss of data privacy, or other significant disruption. Our information systems require an ongoing commitment of significant resources to maintain, protect and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards, the increasing need to protect patient and customer information and changing customer patterns. In addition, third parties may attempt to hack into our products to obtain data relating to patients or disrupt performance of our products or to access our proprietary information and the technology from third party vendors that we rely upon may have defects or vulnerabilities which, in turn, create vulnerabilities or disruptions in our system. Any failure by us to maintain or protect our information technology systems, products and data integrity, including from cyber-attacks, intrusions or other breaches, could result in the unauthorized access to patient data and personally identifiable information, theft of intellectual property or other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations, or, in the worst case, could result in harm to patients. Such failure, or demonstration of vulnerability to such failure, may also result in additional regulatory scrutiny. We also grow our company through acquisitions and may face risks associated with defects and vulnerabilities in their systems as we work to integrate the acquisitions into our information technology system. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., federal and state privacy and security laws require certain of our operations to protect the confidentiality of personal information including patient medical records and other health information, and to comply with other requirements with respect to personal data. In Europe, the Data Protection Directive requires us to manage individually identifiable information in the EU and, the new General Data Protection Regulation (GDPR) may impose fines of up to four percent of our global revenue. Internationally, some countries have also passed laws that require individually identifiable data on their citizens to be maintained on local servers and that may restrict transfer or processing of that data. We believe that we meet the expectations of applicable regulations and that the ongoing costs and impacts of ensuring compliance with such rules are not material to our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business. However, there is no guarantee that we will avoid enforcement actions by governmental bodies or civil actions based on this growing body of regulations. Enforcement actions could be costly and interrupt regular operations of our business. Any of these events, in turn, may cause us to lose existing customers, have difficulty preventing, detecting and controlling fraud, have disputes with customers, physicians and other healthcare professionals, be subject to legal claims and liability, have regulatory sanctions or penalties imposed, have increases in operating expenses, incur expenses or lose revenues as a result of a data privacy breach or theft of intellectual property, or suffer other adverse consequences, any of which could have a material adverse effect on our business, financial condition or results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending and future intellectual property litigation could be costly and disruptive to us.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in an industry that is susceptible to significant intellectual property litigation and, in recent years, it has been common for companies in the medical device field to aggressively challenge the patent rights of other companies. We are currently the subject of various patent litigation proceedings and other proceedings described in more detail under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Intellectual property litigation is expensive, complex and lengthy and its outcome is difficult to predict. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial condition, results of operation or liquidity. Pending or future patent litigation may result in significant royalty or other payments or injunctions that can prevent the sale of products and may significantly divert the attention of our technical and management personnel. In the event that our right to market any of our products is successfully challenged, we may be required to obtain a license on terms which may not be favorable to us, if at all. If we fail to obtain a required license or are unable to design around a patent, our business, financial condition or results of operations could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending and future product liability claims and other litigation, including private securities litigation, stockholder derivative suits and contract litigation, may adversely affect our financial condition and results of operations or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design, manufacturing and marketing of medical devices of the types that we produce entail an inherent risk of product liability claims. Many of the medical devices that we manufacture and market are designed to be implanted in the human body for long periods of time or indefinitely. A number of factors could result in an unsafe condition or injury to, or death of, a patient with respect to these or other products that we manufacture or sell, including physician technique and experience in performing the surgical procedure, component failures, manufacturing flaws, design defects, off-label use or inadequate disclosure of product-related risks or product-related information. These factors could result in product liability claims, a recall of one or more of our products or a safety alert relating to one or more of our products. Product liability claims may be brought by individuals or by groups seeking to represent a class.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently the subject of product liability litigation proceedings and other proceedings described in more detail under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The outcome of litigation, particularly class action lawsuits, is difficult to assess or quantify. Plaintiffs in these types of lawsuits often seek recovery of very large or indeterminate amounts, including not only actual damages, but also punitive damages. The magnitude of the potential losses relating to these lawsuits may remain unknown for substantial periods of time. In addition, the cost to defend against any future litigation may be significant. Product liability claims, securities and commercial litigation and other litigation in the future, regardless of the outcome, could have a material adverse effect on our financial condition, results of operations or liquidity. Additionally, we maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The fact that we do not maintain third-party insurance coverage for all categories of losses increases our exposure to unanticipated claims and adverse decisions and these losses could have a material adverse effect on our financial condition, results of operations or liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure to meet regulatory quality standards applicable to our manufacturing and quality processes could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device manufacturer, we are required to register our establishments and list our devices with the FDA and are subject to periodic inspection by the FDA for compliance with its Quality System Regulation requirements, which require manufacturers of medical devices to adhere to certain regulations, including testing, quality control and documentation procedures. In addition, the Federal Medical Device Reporting regulations require us to provide information to the FDA whenever there is evidence that reasonably suggests that a device may have caused or contributed to a death or serious injury or, if a malfunction were to occur, could cause or contribute to a death or serious injury. Compliance with applicable regulatory requirements is subject to continual review and is monitored rigorously through periodic inspections by the FDA which may result in observations on Form&#160;483 and in some cases warning letters that require corrective action. In the European </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Community, we are required to maintain certain International Standards Organization (ISO)&#160;certifications in order to sell our products and must undergo periodic inspections by notified bodies to obtain and maintain these certifications. Many other countries in which we do business have requirements similar to those of the U.S. or the EU and other foreign governments or agencies may subject us to periodic inspections as well.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we, or our manufacturers, fail to adhere to quality system regulations or ISO requirements, this could delay production of our products and lead to fines, difficulties in obtaining regulatory clearances, recalls, enforcement actions, including injunctive relief or consent decrees, or other consequences, which could, in turn, have a material adverse effect on our financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be negatively impacted by corporate social responsibility and sustainability matters.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, there has been an increased focus from certain investors, customers, employees, and other stakeholders concerning corporate social responsibility and sustainability matters. From time to time, we announce certain initiatives, including goals, regarding our focus areas, which include environmental matters, responsible sourcing, social investments and diversity, equity and inclusion. We could fail, or be perceived to fail, in our achievement of such initiatives or goals, or we could fail in accurately reporting our progress on such initiatives and goals. Such failures could be due to changes in our business. Moreover, the standards by which corporate social responsibility and sustainability efforts and related matters are measured are developing and evolving, and certain areas are subject to assumptions that could change over time. In addition, we could be criticized for the scope of such initiatives or goals or perceived as not acting responsibly in connection with these matters. Any such matters, or related corporate social responsibility and sustainability matters, could have a material adverse impact on our future results of operations, financial position and cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_25"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our world headquarters is located in Marlborough, Massachusetts, with principal regional headquarters located in Singapore and Voisins-le-Bretonneux, France. As of December&#160;31, 2020, our principal manufacturing and technology centers were located in Minnesota, California and Indiana within the U.S., as well as internationally in Ireland, Costa Rica, Puerto Rico, Malaysia, Brazil and Switzerland. Our products are distributed worldwide from primary customer fulfillment centers in Massachusetts, the Netherlands, and Japan. As of December&#160;31, 2020, we maintained 16 principal manufacturing facilities, including seven in the U.S., three in Ireland, two in Costa Rica, one in Puerto Rico, one in Malaysia, one in Brazil and one in Switzerland, as well as various distribution and technology centers around the world. Many of these facilities produce and manufacture products for more than one of our divisions, and also perform research activities. The following is a summary of our facilities as of December&#160;31, 2020 (in approximate square feet):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,043,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,363,001&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200,044&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653,732&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,853,776&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,243,085</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,973,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,216,777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Includes our principal manufacturing facilities in Minnesota, Ireland, Puerto Rico and one facility in Costa Rica, our manufacturing facility in Malaysia, our primary customer fulfillment centers in Massachusetts, the Netherlands and Japan, and our global headquarters location in Marlborough, Massachusetts.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Includes our principal manufacturing facilities in California, Indiana, Brazil, Switzerland and one in Costa Rica, and our regional headquarters located in Singapore and Voisins-le-Bretonneux, France.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;International facilities includes Puerto Rico.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_28"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report and incorporated herein by reference.</span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_31"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Market Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal market on which our common stock is traded is the New York Stock Exchange (NYSE)&#160;under the symbol &#8220;BSX.&#8221; </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Holders of Record</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January&#160;29, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there were 6,943 holders of record of our common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividends</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not pay a cash dividend in 2020, 2019 or 2018 on our common stock and currently we do not intend to pay cash dividends on our common stock. We may consider declaring and paying a cash dividend in the future; however, there can be no assurance that we will do so.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see Item 12. "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters" under Part III of this Annual Report for information on where to find information required by Item 201(d) of Regulation S-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Purchases of Equity Securities by the Issuer and Affiliated Purchases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2020, we repurchased approximately 15.7 million shares of our common stock pursuant to our share repurchase authorization for a total of approximately $535 million in cash. We made no share repurchases in 2019 or 2018. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information with respect to purchases by Boston Scientific Corporation of equity securities that are registered by us pursuant to Section 12 of the Exchange Act, during the fourth quarter of 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/20 - 10/31/20</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,535,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/20 - 11/30/20</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,535,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/20 - 12/31/20</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,723,578</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,723,578</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,723,578</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33.98</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,723,578</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,000,000,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;Excludes any fees, commissions or other expenses related to such repurchases.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(2)&#160;&#160;&#160;&#160;On December 14, 2020, our Board of Directors approved, and we announced, a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock (2020 share repurchase program). As of December&#160;31, 2020, we had $1.000 billion remaining available under the 2020 share repurchase program. On January 25, 2013, our Board of Directors approved, and on January 29, 2013, we announced, a program authorizing the repurchase of up to $1.000 billion of our common stock (2013 share repurchase program). During the fourth quarter of 2020, we repurchased approximately $535 million of our common stock under the 2013 share repurchase program, which represented the full amount remaining under that authorization.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares the five-year total return to stockholders on our common stock with the return of the Standard &amp; Poor&#8217;s (S&amp;P) 500 Stock Index and the S&amp;P Healthcare Equipment Index. The graph assumes $100 was invested in our common stock and in each of the named indices on December&#160;31, 2015 and that any dividends were reinvested.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><img src="bsx-20201231_g1.jpg" alt="bsx-20201231_g1.jpg" style="height:575px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note: The stock price performance shown on the graph above is not indicative of future price performance. This graph shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filing. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. SELECTED FINANCIAL DATA</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FIVE-YEAR SELECTED FINANCIAL DATA</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions, except per share data)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Data</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) available to common stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Balance Sheet Data</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings (short-term)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings (long-term)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The data above should be read in conjunction with our consolidated financial statements, including the notes thereto, included in Item 8. Financial Statements and Supplementary Data of our Annual Report on Form&#160;10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis provides information management believes to be relevant to understanding the financial condition and results of operations of Boston Scientific Corporation and its subsidiaries for the years ended December 31, 2020 and 2019. For a full understanding of our financial condition and results of operations, this discussion should be read in conjunction with our consolidated financial statements and accompanying notes included in Item 8. Financial Statements and Supplementary Data of this Annual Report.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our financial condition and results of operations for the year ended December 31, 2018, refer to our previously filed Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the novel strain of coronavirus (SARS-Cov-2), and its disease commonly known as COVID-19 (COVID-19), was reported in China and has since widely impacted the global public health and economic environment. In March 2020, the World Health Organization (WHO) declared COVID-19, including all additional variations and strains thereof, a global pandemic (COVID-19 pandemic). While the majority of procedures using our products are deferrable, most of the conditions that we treat are generally fairly acute and cannot be deferred for extended periods. As the pandemic spread worldwide and with COVID-19 cases confirmed in all major geographies, many elective and semi-emergent procedures were postponed, enabling hospital staff to focus critical resources on caring for COVID-19 patients. Some jurisdictions mandated elective procedure bans that included financial penalties for non-compliance, certain of which continued to be in effect throughout the year, or evolved to reduce capacity available for elective procedures, including in some cases restricting elective procedures to those that are outpatient procedures only. In other jurisdictions, the timing of the pandemic and public health measures resulted in lower levels of COVID-19 cases, while hospitals developed protocols such that elective procedures could be conducted safely. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing pandemic and accompanying restrictions negatively impacted our net sales and our results of operations in 2020. We experienced some improvement in our global sales trends in the second half of 2020 as previously deferred procedures resumed and referral rates improved. However, as COVID-19 cases re-surged in many locations around the world and new, more contagious variant strains of COVID-19 emerged in late 2020, renewed restrictions were implemented in areas that had previously reopened, including in parts of Europe and the U.S. In the fourth quarter of 2020, the U.S. Food and Drug Administration (FDA) issued emergency use authorizations for two COVID-19 vaccines and regulatory bodies in other geographies around the world have also authorized COVID-19 vaccines for use. The timing and success of efforts to distribute and administer these vaccines to broad portions of the population, enabling widespread immunity to COVID-19, will impact the duration and extent of the pandemic and its effect on demand for our products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, we implemented cost reduction initiatives, including decreases in travel, meetings and customer events, hiring, clinical programs and certain research and development projects. We also implemented a temporary four-day work week for many employees globally and reduced employee compensation, including temporary significant cuts in the salaries of our executive officers and the cash retainer paid to our Board of Directors. In addition, we temporarily closed and/or reduced production levels at certain of our manufacturing sites in an effort to align our build plans to the current and expected demand environment. As COVID-19 cases began to decrease in certain geographies mid-year, we implemented a careful and tiered approach for employees to return to our sites following state and local ordinances, and continue to adjust for the recent resurgence in COVID-19 cases, including outbreaks of new variants of the disease. Employees with the greatest need to access onsite resources to perform their roles have returned first, while those who can effectively work remotely will continue to do so in order to facilitate maximum social distancing in our sites and within our communities. For non-executive officer employees, in those jurisdictions where temporary four-day work weeks and reductions in employee compensation were in effect, those measures concluded at the beginning of the third quarter. We also announced the end of the aforementioned reductions in executive officer pay and further announced that a portion of the annual cash retainer for our Board of Directors would be restored, beginning with a payment made during the fourth quarter of 2020. While we have implemented measures to reduce costs, our operating expenses as a percentage of net sales increased during 2020, as compared to the prior year, as approximately 70 percent of our operating expenses are fixed in nature. Our gross profit margin was also unfavorably impacted by the COVID-19 pandemic, due primarily to manufacturing costs associated with abnormally low production levels in our plants. All of our plants have now resumed manufacturing and have returned to more normalized production levels exiting 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain and rapidly changing, the pandemic&#8217;s impact on our operations and financial performance, as well as its impact on our ability to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">execute our business strategies and initiatives successfully, remains uncertain and difficult to predict. Procedural delays from the further resurgence of COVID-19 infections and the emergence of new, more contagious variant strains of COVID-19 may continue to negatively impact demand for our products, net sales, gross profit margin and operating expenses as a percentage of net sales in 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the recoverability of the assets in our consolidated balance sheet in accordance with relevant authoritative accounting literature. We considered the disruptions caused by COVID-19, including revised forecasted sales and customer demand, a decline in the price of our common stock and macroeconomic factors potentially impacting accounts receivable, inventory, investments, intangible assets, goodwill and other assets and liabilities. Where forward-looking estimates are required, we made a good-faith estimate based on information available as of the balance sheet date. We have continued to monitor for indicators of impairment through the date of this Annual Report filed on Form 10-K, and reflected accordingly in the accompanying consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to focus our efforts on the health and safety of patients, healthcare providers and employees, while executing our mission of transforming lives through innovative medical solutions to improve the health of patients around the world. Since the onset of COVID-19, our global crisis management team has focused on protecting our employees and customers, optimizing our operations and securing our supply chain. We have successfully implemented business continuity plans including establishing a medical advisory group for employees, leveraging work from home infrastructure to facilitate social distancing, limiting sales visits to critical cases and accelerating capabilities to provide remote physician support. While we expect the COVID-19 pandemic will continue to negatively impact our 2021 performance, we continue to believe our long-term fundamentals remain strong and we will manage through these challenges with strategic focus and the winning spirit of our global team. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Highlights and Trends</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we generated net sales of $9.913 billion, as compared to $10.735 billion&#160;in 2019. This decrease of $823 million, or 7.7 percent, included operational declines of 7.8 percent and the positive impact of 10 basis points from foreign currency fluctuations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operational net sales included $413 million in 2020 associated with our acquisition of Vertiflex, Inc. (Vertiflex) for the period prior to June 2020 and our acquisition of BTG plc (BTG) for the period prior to mid-August 2020, for both of which there were no prior period net sales. Operational net sales also included $41&#160;million in 2019 associated with our global embolic microspheres portfolio, for which there were no comparable period sales in 2020 following our divestiture in the third quarter of 2019, and our intra-uterine health business, for which there were no comparable period sales in 2020 following our divestiture in the second quarter of 2020. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business and Market Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section for further discussion of our net sales by global business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net loss available to common stockholders in 2020 was $115 million, or $0.08 per diluted share. Our reported results for 2020 included certain charges and/or credits totaling $1.492 billion (after-tax), or $1.04 per diluted share. Excluding these items, adjusted net income available to common stockholders for 2020 was $1.378 billion, or $0.96 per diluted share. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income in 2019 was $4.700 billion, or $3.33 per diluted share. Our reported results for 2019 included certain charges and/or credits totaling $2.466 billion (after-tax), or $1.75 per diluted share. Excluding these items, adjusted net income for 2019 was $2.234 billion, or $1.58 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operational net sales growth rates, which exclude the impact of foreign currency fluctuations and adjusted measures, which exclude certain items required by generally accepted accounting principles in the United States (U.S. GAAP), are not prepared in accordance with U.S. GAAP and should not be considered in isolation from, or as a replacement for, the most directly comparable GAAP measure. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for a discussion of management&#8217;s use of these non-GAAP financial measures. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In May 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) at a price to the public and liquidation preference of $100 per share. Refer to the reconciliations below for the impact of the MCPS cumulative preferred stock dividends on our calculations of earnings per share (EPS).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of each reconciling item:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(82)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(115)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU MDR implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(3) For 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our consolidated statements of operations, for purposes of calculating GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">. We have assumed dilution of 13.8 million common stock equivalents related to employee stock options for all or a portion of the non-GAAP adjustments, which were anti-dilutive for GAAP purposes due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> position.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU MDR implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,234</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash provided by operating activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $1.508 billion in 2020. As of December&#160;31, 2020, we had total debt of $9.143 billion, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $1.734 billion and working capital of $3.013 billion. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business and Market Overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following section describes our results of operations by reportable segment and business unit. For additional information on our businesses and their product offerings, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MedSurg</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endoscopy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with innovative, less invasive technologies. Our net sales of Endoscopy products of $1.780 billion represented 18 percent of our consolidated net sales in 2020. Our Endoscopy net sales decreased&#160;$114 million, or 6.0 percent, in 2020, as compared to 2019. This decrease included operational net sales declines of 6.3 percent and the positive impact of 30 basis points from foreign currency fluctuations, as compared to 2019. These year-over-year changes were primarily driven by declines in elective or semi-emergent upper endoscopy and colonoscopy procedures due to the COVID-19 pandemic environment, partially offset by growth in our infection prevention franchise. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urology and Pelvic Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions for both male and female anatomies. Our net sales of Urology and Pelvic Health products of $1.286 billion represented 13 percent of our consolidated net sales in 2020. Urology and Pelvic Health net sales decreased $127 million, or 9.0 percent on an as reported and operational basis in 2020, as compared to 2019. These year-over-year changes were due primarily to a reduction in sales of our prosthetic urology and pelvic floor franchises which were negatively impacted by the COVID -19 pandemic given their elective or semi-emergent nature and the divestiture of our Intrauterine Health business in the second quarter of 2020. These decreases were partially offset by growth in our prostate health franchise. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rhythm and Neuro</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cardiac Rhythm Management</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cardiac Rhythm Management (CRM) business develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. Our net sales of CRM products of $1.704 billion represented 17 percent of our consolidated net sales in 2020. Our net sales of CRM products decreased $235 million, or 12.1 percent, in 2020, as compared to 2019. This decrease included operational net sales declines of 12.4 percent and the positive impact of 20 basis points from foreign currency fluctuations, as compared to 2019. These year-over-year changes were driven by a decline in both defibrillator and pacemaker procedures due to the deferral of semi-emergent and emergent procedures in the COVID-19 pandemic environment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Electrophysiology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Electrophysiology business develops and manufactures less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Our net sales of Electrophysiology products of $287 million represented three percent of our consolidated net sales in 2020. Our Electrophysiology net sales decreased $42 million, or 12.8 percent, in 2020, as compared to 2019. This decrease included operational net sales declines of 13.5 percent and the positive impact of 80 basis points from foreign currency fluctuations, as compared to 2019. Sales of our mapping and navigation products and our core diagnostic and therapeutic devices declined year over year due to the impact of COVID-19 and deferral of elective Electrophysiology procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuromodulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Our net sales of Neuromodulation products of $761 million represented 8 percent of our consolidated net sales in 2020. Neuromodulation net sales decreased $112 million, or 12.8 percent, in 2020, as compared to 2019. This decrease included operational net sales declines of 13.0 percent and the positive impact of 10 basis points from foreign currency fluctuations, as compared to 2019. These year-over-year changes were primarily due to sales declines in our spinal cord stimulation (SCS) systems due to deferral of elective procedures in the COVID-19 pandemic environment. The unfavorable </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact was partially offset by higher Superion&#8482; Indirect Decompression System sales, which was purchased as part of our Vertiflex acquisition in the second quarter of 2019, and deep brain stimulation (DBS) system sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Cardiology</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Interventional Cardiology business develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Our net sales of Interventional Cardiology products of $2.299 billion represented 23 percent of our consolidated net sales in 2020. Our Interventional Cardiology net sales decreased $517 million, or 18.4 percent, in 2020, as compared to 2019. This decrease included operational net sales declines of 18.2 percent and the negative impact of 10 basis points from foreign currency fluctuations, as compared to 2019. These year-over-year changes were primarily driven by our coronary stent and other complex percutaneous coronary intervention (PCI) franchises, with a significant slowdown in procedural volumes in the COVID-19 pandemic environment. Within our structural heart business, sales of our WATCHMAN&#8482; Left Atrial Appendage Closure (LAAC) Device were also negatively impacted by the COVID-19 pandemic, particularly during the first half of 2020. They were further negatively impacted by $179 million in revenue reserves primarily related to our conversion to a consignment inventory model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device in the U.S. This program to shift to a consignment model, whereby revenue will be recognized in the future as units are consumed by the customer, has now concluded. In the fourth quarter of 2020, we announced a voluntary recall of our LOTUS Edge&#8482; Aortic Value System and the discontinuation of our LOTUS program due to complexities associated with the product delivery system and given the additional time and investment required to develop and reintroduce an enhanced delivery system. We will instead focus our resources and efforts on the remainder of the portfolio and are encouraged by the successful launch of our ACURATE neo2 Aortic Valve System in Europe, initiated in the third quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peripheral Interventions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Peripheral Interventions business develops and manufactures products to diagnose and treat peripheral arterial and venous diseases, as well as products to diagnose, treat and ease various forms of cancer. In the third quarter of 2019, we completed the acquisition of BTG plc (BTG). We integrated BTG's Interventional Medicine (IM) portfolio into our Peripheral Interventions division, adding complementary technologies in the areas of venous disease and interventional oncology. Our net sales of Peripheral Interventions products of $1.577 billion represented 16 percent of our consolidated net sales in 2020. Our Peripheral Interventions net sales increased $185 million, or 13.3 percent, in 2020, as compared to 2019. This increase included operational net sales growth of 13.1 percent and the positive impact of 20 basis points from foreign currency fluctuations, as compared to 2019. These year-over-year changes were primarily driven by the Interventional Oncology franchise, including our TheraSphere&#8482; Y-90 radioactive glass microspheres acquired with BTG, as well as growth in our drug-eluting portfolio, including the Eluvia&#8482; Drug-Eluting Stent and Ranger&#8482; Drug-Coated Balloon. Excluding BTG for the period prior to mid-August 2020, for which there were no prior year net sales and the related divestiture of our drug-eluting and bland embolic microsphere portfolio, our Peripheral Interventions net sales decreased $35 million, or 2.5 percent, in 2020, compared to 2019, primarily due to the deferral of semi-emergent and elective procedures in the COVID-19 pandemic environment, notably impacting core peripheral technologies and stents. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Pharmaceuticals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of our BTG acquisition, we have presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments. Our Specialty Pharmaceuticals business develops and manufactures acute care antidotes to treat overexposure to certain medications and toxins. These products are sold primarily in the U.S. through small, specialist sales teams and through commercial partners elsewhere, where approved or permitted. Our net sales of Specialty Pharmaceuticals products of $219 million represented 2 percent of our consolidated net sales in 2020. On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business for a purchase price of $800 million, subject to certain adjustments, including cash on hand at the closing date of the transaction. The transaction is expected to close during the first half of 2021, subject to customary closing conditions. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of our strategic imperatives to drive global expansion, described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Item 1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Annual Report, we are seeking to grow net sales and market share by expanding our global presence, including in Emerging Markets. We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. We have increased our investment in infrastructure in these countries in order to maximize opportunities. Periodically, we assess our list of Emerging Markets which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam. Our Emerging Markets net sales represented 11 percent of our consolidated net sales in 2020 and 12 percent in 2019. In 2020, our Emerging Markets net sales declined 12.7 percent on a reported basis including operational net sales declines of 9.2 percent and the negative impact of 350 basis points from foreign currency fluctuations, as compared to 2019. The decline in 2020 was largely driven by the impact of the COVID-19 pandemic on our sales in Brazil, India and China. In addition, during 2020, our net sales in China were negatively impacted by recent national tenders driving down prices for drug-eluting stent products, including the impact of customer price concessions and inventory repurchases associated with business model changes. Our future net sales in Emerging Markets may continue to be negatively impacted by the COVID-19 pandemic, as well as geopolitical and economic instability and a number of other factors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Sales</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides our net sales by business and the relative change in growth on a reported basis: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 versus 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 versus 2018</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,208&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7.7)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.3%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:27pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Summary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further discussion of our net sales and a comparison of our 2020 and 2019 net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we generated net sales of $10.735 billion, as compared to $9.823 billion in 2018. This increase of $912 million, or 9.3 percent, included operational growth of 11.1 percent and the negative impact of 180 basis points from foreign currency fluctuations. Operational net sales included approximately $378 million in 2019 associated with the acquisitions of NxThera, Inc. (NxThera) in the second quarter of 2018, Claret Medical, Inc. (Claret) in the third quarter of 2018, Augmenix, Inc. (Augmenix) in the fourth quarter of 2018, Vertiflex in the second quarter of 2019, and BTG in the third quarter of 2019, each with less than a full year of prior period related net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit was $6.448 billion in 2020 and $7.620 billion in 2019. As a percentage of net sales, our gross profit decreased to 65.0 percent in 2020, as compared to 71.0 percent in 2019. The following is a rollforward of our gross profit margins and a description of the drivers of the change from period to period:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Profit Margin</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing cost reductions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales pricing and mix</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory step-up amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of foreign currency fluctuations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, including other period expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing cost reductions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales pricing and mix</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abnormal production variances</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WATCHMAN FLX&#8482; transition</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOTUS Edge&#8482; discontinuation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory step-up amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of foreign currency fluctuations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, including other period expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.0%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant factor contributing to the decrease in our gross profit margin for 2020 as compared to 2019 was manufacturing costs of $149 million associated with abnormally low production levels resulting from plant shutdowns and reduced operations. In addition, we recorded $119 million of inventory charges associated with the global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System and discontinuation of the LOTUS platform. Our gross margin was further negatively impacted in 2020 due to our conversion to a consignment inventory model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device. In addition, the unfavorable product mix due to the deferral of procedures using higher-margin products, price declines related primarily to sales of our coronary drug-eluting stent products, excess and obsolete inventory charges due to lower forecasted demand for certain of our products as well as the amortization of the inventory fair value step up recorded in connection with our acquisition of BTG contributed to a decrease in gross margin. These decreases were partially offset by manufacturing cost reductions driven by our process improvement programs in each period as well as favorable foreign currency fluctuations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary factors contributing to the decrease in our gross profit margin for 2019 as compared to 2018 were the negative impacts of pricing declines related primarily to sales of our coronary drug-eluting stent products, as well as increased levels of scrap associated with recently launched products and excess and obsolete inventory. In addition, in connection with our recent acquisitions, we adjusted acquired inventory from manufacturing cost to fair value. The step-up in value is amortized through gross profit over an average estimated inventory turnover period. In 2019, we recorded increased cost of $46 million associated with these step-ups. This was partially offset by manufacturing cost reductions driven by our process improvement programs as well as favorable foreign currency fluctuations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EU MDR Implementation Costs </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Union Medical Device Regulation (EU MDR) is a replacement of the existing European Medical Devices Directive (MDD) regulatory framework, and manufacturers of medical devices are required to comply with EU MDR beginning in May 2021 (previously May 2020) for new product registrations and by May 2024 for medical devices which have a valid CE Certificate to the current Directives (issued before May 2021).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the adoption of EU MDR to be a significant change to a regulatory framework, and therefore, certain incremental costs specific to complying with EU MDR for previously registered products are not considered to be ordinary course expenditures in connection with regulatory matters. As such, certain of these costs are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assessing performance. We began our implementation efforts in late-2019 and incurred associated expenses of $51 million in 2020. We expect to incur total expenses of approximately $150 million to $200 million over the four year implementation period, which will be recorded primarily within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our operating expenses:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:35.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.173%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative (SG&amp;A) Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $154 million, or 4 percent, as compared to 2019 and were 150 basis points higher as a percentage of net sales. The decrease in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was due primarily to our efforts to reduce expenditures to minimize the impact of the COVID-19 pandemic on our results of operations. We implemented several cost reduction initiatives, including decreases in travel, meetings and customer events, hiring and other variable spending. We also implemented a temporary four-day work week for many employees globally and reduced employee compensation, including temporary significant cuts in the salaries of our executive officers and the cash retainer paid to our Board of Directors. For non-executive officer employees, in those jurisdictions where temporary four-day work weeks and reductions in employee compensation were in effect, those measures concluded at the beginning of the third quarter. We also announced the end of the aforementioned reductions in executive officer pay and further announced that a portion of the annual cash retainer for our Board of Directors would be restored, beginning with a payment made during the fourth quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $371 million, or 10 percent, as compared to 2018 and were 40 basis points higher as a percentage of net sales. This increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a percentage of net sales was primarily due to acquisition-related charges primarily associated with our acquisition and integration of BTG, partially offset by savings from ongoing cost optimization initiatives. These increased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were also partially offset by a $25 million net gain recorded in the first quarter primarily associated with a portion of a litigation settlement with Edwards Lifesciences Corporation (Edwards). For further details regarding the presentation of the Edwards litigation settlement see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development (R&amp;D) Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to advancing medical technologies and investing in meaningful research and development projects across our businesses. In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $31 million, or 3 percent, as compared to 2019, and were 60 basis points higher as a percentage of net sales. We expect to continue to make investments across our businesses in order to maintain a pipeline of new products that we believe will contribute to profitable sales growth. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2019, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased $61 million, or 6 percent, as compared to 2018, and were 40 basis points lower as a percentage of sales as a result of investments across our businesses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $20 million, or 31 percent, as compared to 2019 and was 10 basis points lower as a percentage of net sales and relates primarily to the expiration of certain royalty agreements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $5 million, or 7 percent, as compared to 2018 and was 10 basis points lower as a percentage of net sales. The decrease in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2019, as compared to 2018, relates primarily to contractual reductions in royalty rates associated with certain products. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our other operating expenses, which are excluded by management for purposes of evaluating operating performance, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a further description of certain operating expenses:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:56.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $90 million, or 13 percent, as compared to 2019. In 2019, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $101 million, or 17 percent, as compared to 2018. The increases in each period were driven by an increase in the balance of amortizable intangible assets due to recent acquisitions, including BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $73 million related to the execution of a definitive agreement to sell our Specialty Pharmaceuticals business. We did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2019 or 2018. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional information and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of key assumptions used in our goodwill impairment testing and future events that could have a negative impact on the recoverability of our goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Asset Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $460 million, primarily associated with our acquisitions of Apama Medical Inc. and nVision Medical Corporation (nVision) following management&#8217;s decision to cancel the programs due to cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2020 also included charges related to our acquisition of Sadra Medical, Inc. (Sadra Medical) as a result of lower sales forecasts, as well as the cost of quality remediation efforts following the voluntary recall of our LOTUS Edge&#8482; Aortic Valve System and subsequent discontinuation of the LOTUS platform. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of key assumptions used in our intangible asset impairment testing and future events that could have a negative impact on the recoverability of our intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Net Expense (Benefit)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $100 million benefit recorded in 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or in the case of nVision, for milestones that would not be achieved due to discontinuation of the R&amp;D program. In 2019 and 2018, we recorded net benefits related to the change in fair value of our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional details related to our contingent consideration arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Net Charges (Credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, our Board of Directors approved, and we committed to a restructuring initiative (the 2016 Restructuring Plan), which was initiated in the second quarter of 2016 and substantially completed in 2019. The 2016 Restructuring Plan resulted in total pre-tax charges of $271 million and approximately $255 million in cash outlays. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2018, our Board of Directors approved, and we committed to, a new global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan, for which our Board of Directors approved an expansion in February 2021, is expected to result in total pre-tax charges of approximately $375 million to $475 million and approximately $340 million to $440 million of these charges are expected to result in cash outlays. A substantial portion of the savings are being reinvested in strategic growth initiatives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total restructuring and restructuring-related net charges pursuant to these programs were $116 million in 2020, $82 million in 2019 and $96 million in 2018. In addition, on November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System, and our decision to retire the entire LOTUS platform. We estimate the decision will result in total pre-tax restructuring and restructuring-related net charges of approximately $80 million to $90 million, which includes $30 million to $40 million of estimated charges expected to result in future cash outlays. We recorded $55 million of restructuring and restructuring-related net charges associated with the product discontinuation in 2020, and expect the remaining activity to be substantially complete during early 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional details on our restructuring plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related Net Charges (Credits) </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $278 million in 2020, primarily related to transvaginal mesh products, inclusive of a reserve related to claims made by a coalition of state attorneys general.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $115 million in 2019, which included a net charge of $223 million in the fourth quarter of 2019, primarily related to litigation with Channel Medsystems, Inc. (Channel), net charges of $25 million in the third quarter of 2019 and $15 million in the second quarter of 2019, primarily related to transvaginal surgical mesh product liability litigation, and a gain of $148 million recorded in the first quarter of 2019, which represents a portion of the total $180 million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our&#160;consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As such, a portion of the related gain from the Edwards settlement was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation, and therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with the financial covenant required by our credit agreements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional discussion of our material legal proceedings.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and average borrowing rate:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average borrowing rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our average borrowing rate decreased in 2020, as compared to 2019, primarily due to our euro-denominated senior notes offering in November 2019, which carry lower interest rates than the senior notes we partially repaid with proceeds from the offering. In 2019, we incurred debt extinguishment charges of $86 million presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations associated with repayments of debt using proceeds from our November 2019 offering.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in this Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note E &#8211; Hedging Activities and Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report for information regarding our debt obligations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other, net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign currency gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains (losses) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">362</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we recorded a $363 million gain on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to remeasure to fair value based on observable market prices. Certain gains and losses associated with our investment portfolio are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment portfolio net losses (gains)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> presented in the reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the reconciliation and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of management's use of non-GAAP financial measures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we settled all outstanding non-designated forward currency contracts that we entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. We recognized a $323 million loss in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to changes in fair value of the contracts. These amounts are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition/divestiture-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> presented in the reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the reconciliation and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of management's use of non-GAAP financial measures.</span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_52"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Rate</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our reported tax rate:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(584.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of certain receipts/charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;These receipts/charges are taxed at different rates than our effective tax rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rate for 2020, as compared to 2019, relates primarily to the deferred tax benefit of intra-entity transfers of intellectual property rights realized in 2019, as well as a shift in geographical mix of earnings to higher-tax jurisdictions. This is partially offset by the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include goodwill and intangible asset impairment charges, acquisition/divestiture-related net charges, restructuring and restructuring-related net charges, litigation-related net charges, as well as certain discrete tax items primarily related to the resolution of an Internal Revenue Service (IRS) audit, as explained below, tax windfall benefits associated with share-based payments, and impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act, enacted on March 27, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rate for 2019, as compared to 2018, relates primarily to the deferred tax benefit of intra-entity transfers of intellectual property rights partially offset by increased current tax expense related to the U.S. taxation of current foreign earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2018, a decision was entered by the U.S. Tax Court resolving all disputes for Guidant Corporation for its 2001 through 2006 tax years and our 2006 and 2007 tax years as well as the tax issues related to our 2006 transaction with Abbott Laboratories. Additionally, we resolved all issues with the IRS Office of Appeals for our 2008 through 2010 tax years. The final settlement calculation resulted in a final net tax payment of $303 million plus $307 million of estimated interest, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which was remitted in the second quarter of 2018. Due to the final settlement of these disputes, we recorded a net tax benefit of $250 million in 2018 to remove a reserve related to these years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2018, we received a Revenue Agent Report (RAR) from the IRS for our 2011 through 2013 tax years. We remitted $93 million to the IRS in the fourth quarter of 2018 reflecting the net balance of tax and interest due for these years after consideration of amounts owed to us by the IRS. Due to the resolution of these tax years, we recorded a net tax benefit of $90 million to remove a reserve related to these years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter of 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years stating that the Joint Committee on Taxation completed its review on July 21, 2020, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91&#160;million in the third quarter of 2020 to release the reserves related to these years. We received a refund of $62&#160;million from the IRS in the fourth quarter of 2020 reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional details on our tax rate.</span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_55"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current business plan, we believe our existing balance of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, future cash generated from operations, access to capital markets and existing credit facilities will be sufficient to fund our operations, invest in our infrastructure, pay our legal-related liabilities, pay taxes due and service and repay our existing debt for at least the next 12 months. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for additional details on our future payment obligations and commitments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty of the impact of the COVID-19 pandemic on our business, we took proactive steps to reduce costs and ensure we are in a strong position to support customers and patients as healthcare systems recover and elective and semi-emergent procedures resume. These actions included taking steps to manage outstanding borrowings and increase available liquidity, preemptively amending our financial covenant requirement for our outstanding credit arrangements, implementing significant cost reductions as described above in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and slowing planned capital expenditures. We also created a cross-functional strategic cash management team to take appropriate actions to ensure we continue to optimize funds to execute our core mission. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $1.700 billion in aggregate principal amount of senior notes and used the net proceeds to prepay $1.250 billion of amounts outstanding under our February 2021 and April 2021 Term Loan and pay related fees, expenses and premiums, as well as to refinance $450 million of amounts outstanding under our Revolving Credit Facility. We now have full access to the $2.750 billion of available liquidity under our Revolving Credit Facility. In May 2020, we also completed public equity offerings of our preferred stock and common stock, as discussed below, and used a portion of the combined net proceeds to repay in full the remaining amounts outstanding under the April 2021 Term Loan. During the third quarter of 2020, we made a further prepayment of the remaining $250 million outstanding under our February 2021 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2020, we redeemed $250 million of our $500 million 3.375% senior notes due 2022 (May 2022 Notes) at a redemption price calculated in accordance with the terms of the May 2022 Notes and its indenture, plus accrued and unpaid interest through, but excluding, the date of redemption. Also in the fourth quarter of 2020, we repurchased approximately 15.7 million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $535 million in cash, which represented the full amount remaining under that authorization. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had $1.734 billion of unrestricted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on hand, comprised of $1.584 billion invested in money market funds and time deposits and $150 million in interest bearing and non-interest-bearing bank accounts. We invest excess cash on hand in short-term financial instruments that earn at market interest rates while mitigating principal risk through instrument and counterparty diversification, as well as what we believe to be prudent instrument selection. We limit our direct exposure to securities in any one industry or issuer. As of&#160;December&#160;31, 2020, we had no commercial paper debt outstanding, resulting in an additional $2.750 billion of available liquidity.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional details related to our debt obligations, including our financial covenant requirement, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report on Form 10-K, which is incorporated herein by reference.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides a summary and description of our net cash inflows (outflows):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, cash provided by operating activities decreased $328 million, as compared to 2019. This decrease was primarily due to revenue declines resulting from the COVID-19 pandemic, partially offset by implementation of spend controls. In addition, included in 2020 was a settlement payment related to litigation with Channel, whereas 2019 included a litigation-related receipt of $180 million from Edwards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, cash used for investing activities primarily included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchases of property, plant and equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $376 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for investments and acquisitions of certain technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $146 million, partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $87 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, cash used for investing activities primarily included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for acquisitions of businesses, net of cash acquired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $4.382 billion relating to our acquisitions of BTG, Vertiflex and Millipede, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchases of property, plant and equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $461 million, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for investments and acquisitions of certain technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $149 million, partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from divestiture of certain businesses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $90 million relating to the sale of our drug-eluting and bland embolic microsphere portfolio to Varian Medical Systems, Inc. (Varian) in connection with our acquisition of BTG. Cash used for investing activities also included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for settlements of hedge contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $199 million, of which $95 million relates to the termination and settlement of our outstanding forward currency contracts designated as net investment hedges in our Euro-denominated entities and $294 million relates to the settlement of our non-designated forward currency contracts entered into for the purpose of managing our exposure to currency exchange rate risk related to the British-pound sterling (GBP) denominated purchase price of BTG. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows provided by financing activities reflect issuances and repayments of debt, including our senior notes, term loans, commercial paper program and Revolving Credit Facility as well as net proceeds from issuances of our common stock and preferred stock in connection with public offerings, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for repurchase of common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our financing activities included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payment of contingent consideration previously established in purchase accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $49 million in 2020, $66 million in 2019 and $19 million in 2018 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $97 million in 2020 and $69 million in 2019. In 2019, we also sold our rights to future royalties associated with the Zytiga&#8482; Drug for $256 million in cash presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity plans are subject to a number of risks and uncertainties, including those described in Item 1A. Risk Factors of this Annual Report, some of which are outside our control. Macroeconomic conditions, adverse tax and litigation matter outcomes and other risks and uncertainties could limit our ability to successfully execute our business plans and adversely affect our liquidity plans.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the current and long-term portions of our total debt:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:61.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the portions of our total debt that are comprised of fixed and variable rate debt instruments, which are presented on an amortized cost basis:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:61.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate debt instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable rate debt instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through December&#160;31, 2020, we were in compliance with the financial covenant required by our credit facilities described above. For additional details related to our debt obligations, including our financial covenant requirements, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. On May 27, 2020, we also completed an offering of 29,382,500 shares of our common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, during 2020 we received $111 million in proceeds from stock issuances related to our stock option and employee stock purchase plans, as compared to $123 million in 2019. Proceeds from the exercise of employee stock options and employee stock purchases vary from period to period based upon, among other factors, fluctuations in the trading price of our common stock and in the exercise and stock purchase patterns of employees. Stock-based compensation expense related to our stock ownership plans was $170 million in 2020 and $157 million in 2019. Stock-based compensation expense varies from period to period based upon, among other factors, the timing, number and fair value of awards granted during the period, forfeiture levels related to unvested awards and employee contributions to our employee stock purchase plan, as well as the retirement eligibility of stock award recipients. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2013, our Board of Directors approved and on January 29, 2013, we announced a program authorizing the repurchase of up to $1.000 billion of our common stock (2013 share repurchase program). In the fourth quarter of 2020, we repurchased approximately 15.7 million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $535 million in cash, which represented the full amount remaining under that authorization. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock (2020 share repurchase program). As of December&#160;31, 2020, we had the full amount remaining available under the 2020 share repurchase program. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock during 2019. There were approximately 263 million shares in treasury as of December&#160;31, 2020 and 248 million shares in treasury as of December&#160;31, 2019.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain information concerning our obligations and commitments to make future payments and is based on conditions in existence as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:27.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum royalty obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License and software commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One-time transition tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,369</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">748</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">745</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,472</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,525</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,181</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Debt obligations are comprised of our senior notes outstanding as of December&#160;31, 2020. This does not include unamortized debt issuance discounts, deferred financing costs and gain on fair value hedges or capital lease obligations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional information.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;In accordance with U.S. GAAP, these obligations relate to expenses associated with future periods and are not reflected in our consolidated balance sheets. Interest payments included above are calculated based on rates and required fees applicable to our outstanding debt obligations as of December&#160;31, 2020 described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report. Interest payments above do not include interest on variable rate debt instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts in the table above with respect to purchase obligations relate primarily to non-cancellable inventory commitments and capital expenditures entered in the normal course of business. Royalty obligations reported above represent minimum contractual obligations under our current royalty agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above does not include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our long-term liability for legal matters that are probable and estimable of $64 million due to the timing of payment being uncertain. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for more information,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Any future obligations to make payments of contingent consideration pursuant to certain of our acquisition agreements, due to the exact amount and timing of payments being uncertain. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for more information,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Adjustments to increase our estimated one-time transition tax totaling $97 million, which are pending review by the U.S. Internal Revenue Service (IRS), and unrecognized tax benefits, accrued interest and penalties and other related items totaling $159 million because the timing of their future cash settlement is uncertain. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for more information,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With certain of our acquisitions, we acquired IPR&amp;D projects that require future funding to complete. We estimate that the total remaining cost to complete acquired IPR&amp;D projects is between $130 million and $140 million. Net cash inflows from the projects currently in development are expected to continue through 2038, following the respective launches of these technologies in the U.S., Europe and Japan. Certain of our acquisitions also involve the potential payment of contingent consideration, but the timing and amounts are uncertain. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for more information,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Holders of our MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 21, 2021, we announced our entrance into a definitive agreement to acquire Preventice Solutions, Inc. (Preventice). We have been an investor in Preventice since 2015 and currently hold an equity stake of approximately 22 percent. The transaction price to acquire the remaining stake is expected to result in a net cash payment of approximately $720 million upon closing and up to an additional $230 million payment upon achievement of a commercial milestone. The acquisition is expected to close during the first half of 2021, subject to customary closing conditions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our material legal proceedings see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report.</span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_58"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results are affected by the selection and application of accounting policies and methods. We have adopted accounting policies to prepare our consolidated financial statements in conformity with U.S. GAAP. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, including our contingent liabilities, as of the date of our financial statements and the reported amounts of our revenues and expenses during the reporting periods. Our actual results may differ from these estimates. We consider estimates to be critical (i)&#160;if we are required to make assumptions about material matters that are uncertain at the time of estimation or (ii) if materially different estimates could have been made or it is reasonably likely that the accounting estimate will change from period to period. The following are areas considered to be critical and require management&#8217;s judgment: Revenue Recognition, Bad Debt Reserves, Inventory Provisions, Valuation of Intangible Assets and Contingent Consideration Liability, Goodwill Valuation, Legal and Product Liability Accruals and Income Taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional information related to our accounting policies and our consideration of these critical accounting areas. In addition, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of the valuation of goodwill and intangible assets and contingent consideration, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of income tax related matters, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of legal and product liability matters and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note P &#8211; Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of revenue recognition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System, within our Cardiac Rhythm Management (CRM) business. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. The use of alternative assumptions could impact the period over which revenue is recognized.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers and record these as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Implant Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide non-contractual services to customers to ensure the safe and effective use of certain implanted devices. We forward accrue the costs to provide these services at the time the devices are sold by estimating the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note P &#8211; Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for further information on our revenue recognition accounting policies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventory Provisions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Valuation of Intangible Assets and Contingent Consideration Liability</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimates of inputs and assumptions that a market participant would use. Further, for those arrangements that involve potential future contingent consideration, we record on the date of acquisition a liability equal to the fair value of the estimated additional consideration we may be obligated to pay in the future. We re-measure this liability each reporting period and record changes in the fair value through a separate line item within our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, cash flows, discount rates, useful life or probability of achieving clinical, regulatory or revenue-based milestones could result in different purchase price allocations and recognized amortization expense and contingent consideration expense or benefit in current and future periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or adjustment to the remaining useful life. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. If the carrying value of the intangible asset is determined not recoverable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we will write the carrying value down to fair value in the period identified. We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset using a risk-adjusted discount rate. The use of alternative assumptions, including estimated cash flows, discount rates and alternative estimated remaining useful lives could result in different calculations of impairment.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we test our indefinite-lived intangible assets at least annually for impairment and reassess their classification as indefinite-lived assets, or more frequently if indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 350)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to fair value. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, cash flows and discount rates could result in different fair value estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill Valuation</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. We identified the following reporting units in our 2020 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we utilized the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, when performing our annual goodwill impairment test, we determined that it was more likely than not that the fair value of each of our reporting units had sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $800 million, subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. We acquired our Specialty Pharmaceuticals business in conjunction with the BTG acquisition on August 19, 2019. In connection with the execution of a definitive agreement to sell the disposal group for a specified amount, we performed an impairment assessment of our goodwill and intangible assets, which resulted in a goodwill impairment of $73 million. As of December 31, 2020, we classified the remaining assets and liabilities of the disposal group as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less cost to sell. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional details related to our annual goodwill impairment assessments performed in 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although it was not applicable to our annual impairment test performed in 2020, if it is determined that impairment is more likely than not, then we perform the quantitative impairment test. When allocating goodwill from business combinations to our reporting units, we assign goodwill to the reporting units that we expect to benefit from the respective business combination at the time of acquisition. In addition, for purposes of performing our goodwill impairment tests, assets and liabilities, including corporate assets, which relate to a reporting unit&#8217;s operations, and would be considered in determining its fair value, are allocated to the individual reporting units. We allocate assets and liabilities not directly related to a specific reporting unit, but from which the reporting unit benefits, based primarily on the respective revenue contribution of each reporting unit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing annual impairment assessments, for those reporting units for which a quantitative test is performed, we typically use only the income approach, specifically the Discounted Cash Flow method, to derive the fair value of each of our reporting units in preparing our goodwill impairment assessments. We historically selected this method as being the most meaningful in preparing our goodwill assessments because we believe the income approach most appropriately measures our income producing assets. We have considered using the market approach and cost approach but concluded they are not appropriate in valuing our reporting units given the lack of relevant market comparisons available for application of the market approach and the inability to replicate the value of the specific technology-based assets within our reporting units for application of the cost approach. Therefore, we believe that the income approach represents the most appropriate valuation technique for which sufficient data are available to determine the fair value of our reporting units.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In applying the income approach to our accounting for goodwill, we make assumptions about the amount and timing of future expected cash flows, terminal value growth rates and appropriate discount rates. The amount and timing of future cash flows within our Discounted Cash Flow analysis is based on our most recent operational budgets, long range strategic plans and other estimates. The terminal value growth rate reflects our best estimates for stable, perpetual growth of our reporting units. We use estimates of market-participant risk-adjusted weighted average cost of capital as a basis for determining the discount rates to apply to our reporting units&#8217; future expected cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we use consistent methodologies in developing the assumptions and estimates underlying the fair value calculations used in our impairment tests, these estimates are uncertain by nature and can vary from actual results. The use of alternative valuation assumptions, including estimated revenue projections, growth rates, cash flows and discount rates could result in different fair value estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future events that could have a negative impact on the levels of excess fair value over carrying value of our reporting units include, but are not limited to, the following: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in estimated market sizes or market growth rates due to greater-than-expected declines in procedural volumes inclusive of those resulting from the ongoing COVID-19 pandemic, pricing pressures, reductions in reimbursement levels, product actions and/or competitive technology developments, </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">declines in our market share and penetration assumptions due to increased competition, an inability to develop or launch new and next-generation products and technology features in line with our commercialization strategies and market and/or regulatory conditions that may cause significant launch delays or product recalls, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in our forecasted profitability due to an inability to implement successfully and achieve timely and sustainable cost improvement measures consistent with our expectations, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative developments in intellectual property litigation that may impact our ability to market certain products or increase our costs to sell certain products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of success of ongoing and future research and development efforts, including those related to recent acquisitions and increases in the research and development costs necessary to obtain regulatory approvals and launch new products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of success in managing the growth of acquired companies, achieving sustained profitability consistent with our expectations, establishing government and third-party payer reimbursement, supplying the market and increases in the costs and time necessary to integrate acquired businesses into our operations successfully, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our reporting units or in the structure of our business as a result of future reorganizations, acquisitions or divestitures of assets or businesses and </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in our market-participant risk-adjusted weighted average cost of capital (WACC) and increases in our market-participant tax rate and/or changes in tax laws or macroeconomic conditions.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negative changes in one or more of these factors, among others, could result in future impairment charges.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional details related to our annual goodwill balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal and Product Liability Accruals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities litigation and product liability suits. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range. Litigation and product liability matters are inherently uncertain, and the outcomes of individual matters are difficult to predict and quantify. As such, significant judgment is required in determining our legal and product liability accruals. Our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates related to our legal and product liability accruals may change as additional information becomes available to us, including information related to the nature or existence of claims against us, trial court or appellate proceedings, and mediation, arbitration or settlement proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We establish reserves when we believe that certain positions are likely to be challenged despite our belief that our tax return positions are fully supportable. The calculation of our tax liabilities involves significant judgment based on individual facts, circumstances and information available in addition to applying complex tax regulations in various jurisdictions across our global operations. Under U.S. GAAP, in order to recognize an uncertain tax benefit, the taxpayer must determine it is more likely than not the position will be sustained, and the measurement of the benefit is calculated as the largest amount that is more than 50 percent likely to be realized upon resolution of the benefit. Although we believe that we have adequately provided for liabilities resulting from tax assessments by taxing authorities, positions taken by these tax authorities could have a material impact on our effective tax rate, results of operations, financial position and/or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Tax Cut and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as a part of continuing operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note R &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements included in Item 8. Financial Statements and Supplementary Data of this Annual Report for additional information on standards implemented since December&#160;31, 2019 and standards to be implemented.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established controls and procedures to escalate enterprise level issues, including cybersecurity matters, to the appropriate management levels within our organization and our Board of Directors, or members or committees thereof, as appropriate. Under our framework, cybersecurity issues are analyzed by subject matter experts and a crisis committee for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact. Matters determined to present potential material impacts to the Company&#8217;s financial results, operations, and/or reputation are immediately reported by management to the Board of Directors, or individual members or committees thereof, as appropriate, in accordance with our escalation framework. In addition, we have established procedures to ensure that members of management responsible for overseeing the effectiveness of disclosure controls are informed in a timely manner of known cybersecurity risks and incidents that may materially impact our operations and that timely public disclosure is made, as appropriate.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share that exclude certain amounts, and operational net sales, which exclude the impact of foreign currency fluctuations. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share we exclude certain charges (credits) from GAAP net income and GAAP net income available to common stockholders as detailed below. Amounts are presented after-tax using our effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with FASB ASC section 740-270-30, "General Methodology and Use of Estimated Annual Effective Tax Rate." </span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GAAP financial measure most directly comparable to adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) available to common stockholders and GAAP net income (loss) per common share - assuming dilution, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior periods. The GAAP financial measure most directly comparable to operational net sales and operational net sales growth is net sales and net sales growth on a GAAP basis. </span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the relevant sections of this Annual Report.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) available to common stockholders adjusted net income (loss) per share that exclude certain amounts, and operational net sales growth rates that exclude the impact of changes in foreign currency exchange rates, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an explanation of each of the adjustments that management excluded as part of these non-GAAP financial measures as well as reasons for excluding each of these individual items. In each case, management has excluded the item for purposes of calculating the relevant non-GAAP financial measure to facilitate an evaluation of our current operating performance and a comparison to our past operating performance:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted Net Income (loss), Adjusted Net Income (loss) Available to Common Stockholders and Adjusted Net Income (loss) per Share</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Amortization expense&#160;- We record intangible assets at historical cost and amortize them over their estimated useful lives. Amortization expense is excluded from management's assessment of operating performance and is also excluded from our operating segments' measures of profit and loss used for making operating decisions and assessing performance. </span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Goodwill and other intangible asset impairment charges&#160;- These amounts represent write-downs of certain goodwill and/or other intangible asset balances. We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment and test our goodwill and other indefinite-lived intangible assets at least annually for impairment. If we determine the carrying value of the amortizable intangible asset is not recoverable, goodwill of a reporting unit is impaired or it is more likely than not that the indefinite-lived asset is impaired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we will write the carrying value down to fair value in the period identified. Impairment charges are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Acquisition/divestiture-related net charges (credits) - These adjustments may consist of (a) contingent consideration fair value adjustments; (b) gains on previously held investments; (c) due diligence, deal fees and other fees and costs related to our acquisition and divestiture transactions; (d) inventory step-up amortization and accelerated compensation expense; (e) integration and exit costs; and (f) separation costs and gains primarily associated with the sale of a business or portion of a business. The contingent consideration fair value adjustments represent accounting adjustments to state contingent consideration liabilities at their estimated fair value. These adjustments can be highly variable depending on the assessed likelihood and amount of future contingent consideration. Gains on previously held investments, due diligence, deal fees and other fees and costs, inventory step-up amortization, accelerated compensation expense, and other expenses and gains associated with prior and potential future acquisitions and divestitures can be highly variable and not representative of ongoing operations. Integration and exit costs, include </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contract cancellations, severance and other compensation-related charges and costs, project management fees and costs, and other direct costs associated with the integration of our acquisitions. These integration and exit activities take place over a defined timeframe and have distinct project timelines, are incremental to activities and costs that arise in the ordinary course of our business and are not considered part of our core, ongoing operations. These acquisition/divestiture-related net charges (credits) are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Restructuring and restructuring-related net charges (credits)&#160;- These adjustments primarily represent compensation-related charges, fixed asset write-offs, contract cancellations, project management fees and other direct costs associated with our restructuring plans. These restructuring plans each consist of distinct initiatives that are fundamentally different from our ongoing, core cost reduction initiatives in terms of, among other things, the frequency with which each action is performed and the required planning, resourcing, cost and timing. Examples of such initiatives include the movement of business activities, facility consolidations and closures and the transfer of product lines between manufacturing facilities, which, due to the highly regulated nature of our industry, requires a significant investment in time and cost to create duplicate manufacturing lines, run product validations and seek regulatory approvals. Restructuring initiatives take place over a defined timeframe and have a distinct project timeline that begins subsequent to approval by our Board of Directors. In contrast to our ongoing cost reduction initiatives, restructuring initiatives typically result in duplicative cost and exit costs over the defined timeframe and are not considered part of our core, ongoing operations. In addition, during the fourth quarter of 2020, we incurred restructuring and restructuring-related net charges associated with management&#8217;s decision to retire the LOTUS platform. These restructuring plans are incremental to the core activities that arise in the ordinary course of our business. Restructuring and restructuring-related net charges (credits) are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Litigation-related net charges (credits) - These adjustments include certain significant product liability and other litigation-related charges and credits. We record these charges and credits, which we consider to be unusual or infrequent and significant, within the litigation-related charges line in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within selling general and administrative expenses. Certain litigation-related net charges (credits) are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">EU MDR implementation costs - These adjustments represent certain incremental costs specific to complying with new regulatory requirements in the EU. EU MDR is a replacement of the existing European Medical Devices Directive (MDD) regulatory framework, and manufacturers of medical devices are required to comply with EU MDR beginning in May 2021 (previously May 2020) for new product registrations and by May 2024 for medical devices which have a valid CE Certificate to the current Directives (issued before May 2021). We expect to incur significant expenditures in connection with the adoption of the EU MDR requirements and we consider the adoption of EU MDR to be a significant change to a regulatory framework, and therefore, these expenditures are not considered to be ordinary course expenditures in connection with regulatory matters. As such, certain of these costs are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.15pt">Debt extinguishment net charges (credits) - These amounts relate to the early extinguishment of certain outstanding principal amounts of our senior notes. Certain debt extinguishment net charges (credits) are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Investment portfolio net losses (gains) - These amounts represent certain write-downs or fair value remeasurement gains and losses related to our investment portfolio. Each reporting period, we evaluate our investments without a readily determinable fair value to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value and determine if the impairment is other-than-temporary, and recognize an impairment loss. In addition, for those investments accounted for under the measurement alternative method of accounting, we record gains and losses to remeasure the carrying value of the investments to their fair values based on observable market prices or implied market values. Investment impairment </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charges and fair value remeasurements can be highly variable dependent on external market factors and conditions relative to the underlying investee, which are generally outside of the control of management, as such certain of these amounts are excluded from management's assessment of performance.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:22.02pt">Deferred tax expenses (benefits) - This adjustment relates to a significant non-cash tax benefit arising from an intra-entity asset transfer of intellectual property completed in the fourth quarter of 2019 which resulted in our recording a $4.102 billion net deferred tax asset. The deferred tax benefit associated with the establishment of the net deferred tax asset as well as any deferred tax expense resulting from the reversal of the deferred tax asset are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Discrete tax items - These items represent adjustments of certain tax positions including those which a) are related to the finalization of the enactment date impact of the TCJA, or b) are related to the tax consequences of a non-GAAP adjustment item booked in a prior period. These discrete tax items are excluded from management's assessment of operating performance and from our operating segments' measures of profit and loss used for making operating decisions and assessing performance. </span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operational Net Sales Excluding the Impact of Foreign Currency Fluctuations</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">The impact of foreign currency fluctuations is highly variable and difficult to predict. Accordingly, management excludes the impact of foreign currency fluctuations for purposes of reviewing net sales and growth rates to facilitate an evaluation of our current operating performance and a comparison to our past operating performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rule&#160;10b5-1 Trading Plans by Executive Officers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, certain of our executive officers adopt written stock trading plans in accordance with Rule 10b5-1 under the Exchange Act and our own Stock Trading Policy. A Rule 10b5-1 Trading Plan is a written document that pre-establishes the amount, prices and dates (or formulas for determining the amounts, prices and dates) of future purchases or sales of our stock, including shares issued upon exercise of stock options or vesting of deferred stock units. These plans are entered into at a time when the person is not in possession of material non-public information about our company. We disclose details regarding individual Rule 10b5-1 Trading Plans on the Investor Relations section of our website.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the management of Boston Scientific Corporation, we are responsible for establishing and maintaining adequate internal control over financial reporting. We designed our internal control process to provide reasonable assurance to management and the Board of Directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2020. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control&#8211;Integrated Framework (2013 framework). Based on our assessment, we believe that, as of December&#160;31, 2020, our internal control over financial reporting is effective at a reasonable assurance level based on these criteria.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &amp; Young LLP, an independent registered public accounting firm, has issued an audit report on the effectiveness of our internal control over financial reporting. This report, in which they expressed an unqualified opinion, is included below.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.784%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael F. Mahoney</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel J. Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief<br/>Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_64"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Boston Scientific Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Boston Scientific Corporation&#8217;s internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission 2013 framework) (the COSO criteria). In our opinion, Boston Scientific Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2020 consolidated financial statements of the Company and our report dated February 23, 2021 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2021 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and sell medical devices globally and our earnings and cash flows are exposed to market risk from changes in currency exchange rates and interest rates. We address these risks through a risk management program that includes the use of derivative financial instruments. We operate the program pursuant to documented corporate risk management policies. We do not enter derivative transactions for speculative purposes. Gains and losses on derivative financial instruments substantially offset losses and gains on underlying hedged exposures. Furthermore, we manage our exposure to counterparty risk on derivative instruments by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our currency risk consists primarily of foreign currency denominated firm commitments, forecasted foreign currency denominated intercompany and third-party transactions and net investments in certain subsidiaries. We use both nonderivative (primarily manufacturing operations outside the U.S.) and derivative instruments to manage our earnings and cash flow exposure to changes in currency exchange rates. We had currency derivative instruments outstanding in the contract amount of $10.481 billion as of December&#160;31, 2020 and $9.221 billion as of December&#160;31, 2019. A ten percent appreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would increase the derivative instruments&#8217; fair value by $333 million as of December&#160;31, 2020 as compared to $337&#160;million as of December&#160;31, 2019. A ten percent depreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would decrease the derivative instruments&#8217; fair value by $407&#160;million as of December&#160;31, 2020 as compared to $412&#160;million as of December&#160;31, 2019. Any increase or decrease in the fair value of our currency exchange rate sensitive derivative instruments would be substantially offset by a corresponding decrease or increase in the fair value of the hedged underlying asset, liability or forecasted transaction, resulting in minimal impact on our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We have historically used interest rate derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. We had no interest rate derivative instruments outstanding as of December&#160;31, 2020 and December&#160;31, 2019. As of December&#160;31, 2020, $9.205 billion in aggregate principal amount of our outstanding debt obligations were at fixed interest rates, representing approximately 100 percent of our total debt, on an amortized cost basis. As of December&#160;31, 2020, our outstanding debt obligations at fixed interest rates were comprised of senior notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data of this Annual Report for further information regarding our derivative financial instruments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_70"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Corporation </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Boston Scientific Corporation (the Company) as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 23, 2021 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.257%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contingent Consideration</span></div></td></tr><tr style="height:207pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Note B to the consolidated financial statements, the Company has recognized a liability for acquisition consideration that is contingent upon achieving either research and development and commercialization milestones, or sales-based milestones. The Company determines the fair value of these arrangements, both as part of the initial purchase price allocation, and on an ongoing basis each reporting period until the arrangements are settled. Subsequent changes to the fair value of the contingent consideration liabilities are recorded within the consolidated statement of earnings in the period of change. As of December 31, 2020, the amount accrued for future estimated contingent consideration is $196 million which represents a Level 3 estimate in the fair value hierarchy due to the significant unobservable inputs used in determining the fair value and the use of management judgment about the assumptions market participants would use in pricing the liabilities.<br/><br/>The significance of the estimations used by management to determine the fair value of contingent consideration was primarily due to the sensitivity of the respective fair values to the significant underlying assumptions. The significant assumptions include estimation of the probability and timing of payment, future sales forecasts, as well as the appropriate discount rate based on the estimated timing of payments. These significant assumptions are forward looking and could be affected by future economic and market conditions. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of the controls over the Company&#8217;s accounting for the valuation of the contingent consideration liabilities, including the valuation models and underlying assumptions used to develop such estimates.<br/><br/>In testing the valuation of contingent consideration, we assessed, among other things, the terms of the arrangements and the conditions that must be met for the arrangements to become payable. We evaluated the completeness and accuracy of the underlying data used in the analyses. For example, we compared the significant assumptions such as revenue growth rates to current industry, market and economic trends, to the assumptions used to value similar assets in other acquisitions when relevant, and to the historical results of the acquired business where available. We involved our valuation professionals to assist with our evaluation of the methodology used by the Company and significant assumptions included in the fair value estimates.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1992.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2021 </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:56.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMy0xLTEtMS0w_d59d0b44-5971-4f54-8029-477f6a5a762c">9,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMy0zLTEtMS0w_87a85e99-5ca0-4334-beb6-670e5b3684af">10,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMy01LTEtMS0w_b396fd5d-358d-4ae6-9d57-a3952a714efb">9,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNC0xLTEtMS0w_b8a9f635-3747-451a-9b62-2eaab52be34b">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNC0zLTEtMS0w_df426cb5-3237-4bea-accb-c99353cf2772">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNC01LTEtMS0w_b51b71e2-0629-4371-b8a0-8246eb265405">2,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNS0xLTEtMS0w_c1d231f4-de59-4140-aa73-736b8b1f22f4">6,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNS0zLTEtMS0w_ddec54d0-8392-4627-a608-0a57b77eb247">7,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNS01LTEtMS0w_82c0fb34-5aef-4e72-bc64-7bcc4476265e">7,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOC0xLTEtMS0w_7d6ea58a-f006-48de-a341-e5afc310d720">3,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOC0zLTEtMS0w_4ea99e5c-a9f6-4b09-92f4-dfd067587519">3,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOC01LTEtMS0w_f3d4d1b2-e91c-4dec-ade6-2cbcda2477ef">3,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOS0xLTEtMS0w_c9a2be28-4bef-4e61-abb2-a7a4c8e44538">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOS0zLTEtMS0w_afd203b4-c3fb-4dd8-a042-b08d0da3b0d3">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOS01LTEtMS0w_d8e8767c-ca86-4407-82ac-2d4568f0fea0">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTAtMS0xLTEtMA_39926f97-de91-4259-8b68-216471764f5d">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTAtMy0xLTEtMA_024c93ce-d1eb-4718-830c-2b1fac3052cf">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTAtNS0xLTEtMA_ae504d74-4f58-4813-b73b-58ccb5354f06">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTEtMS0xLTEtMA_147741e0-f354-4ef7-b48d-d42580ded6e7">789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTEtMy0xLTEtMA_9910ff45-9ca0-449a-9c8e-700c2f60b819">699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTEtNS0xLTEtMA_a1af6ecf-16f5-4da8-8a59-3d7104f839ea">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTItMS0xLTEtMA_957e7ce5-fcc0-4f10-bfe5-f5f042cd7971">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTItMy0xLTEtMA_3769e534-f17b-4553-8d48-349d3006c093">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTItNS0xLTEtMA_ec919cc9-86bb-48f9-a080-dff607743365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTMtMS0xLTEtMA_5c538a4c-8f90-4a07-9673-349dd2aca177">460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTMtMy0xLTEtMA_c4af45c3-6ab9-4f9b-be36-4d46386eaaef">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTMtNS0xLTEtMA_01ec64d0-8883-413a-acaf-50e65b8df617">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTQtMS0xLTEtMA_3cd1823f-d395-4bc0-b650-628050648a1d">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTQtMy0xLTEtMA_b7cd3cea-b3f4-4df4-bd9d-9289a3e0756f">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTQtNS0xLTEtMA_da548212-e048-4b67-8984-8962888ed9ce">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTUtMS0xLTEtMA_179e6d6f-2e34-4d69-85e3-e1fdfd1c6dea">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTUtMy0xLTEtMA_6aa91924-c318-410d-ab4e-6e8ce400457e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTUtNS0xLTEtMA_19797d07-feac-4ac0-ab74-2fbe20efa9c6">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTYtMS0xLTEtMA_bc1639c8-5f89-4847-a230-960efc8b0cd3">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTYtMy0xLTEtMA_f47f54df-0f13-4b8b-8e9e-66810416f76c">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTYtNS0xLTEtMA_c9f03e7e-2771-430a-8f02-f514c69f44e7">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTgtMS0xLTEtMA_7082f71e-94be-4884-82ca-c832c5861b9b">6,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTgtMy0xLTEtMA_ea0aa13f-611a-4a54-be50-8e2a93fd9b5d">6,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTgtNS0xLTEtMA_1f79f5c3-1aa1-4f39-ad50-38fb34f4103e">5,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTktMS0xLTEtMA_82cc1223-f344-4aa6-8add-dbecfb24b246">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTktMy0xLTEtMA_a1fc9871-937f-4f6e-bcc1-dc2fa0b94557">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTktNS0xLTEtMA_c2a6d108-d500-488f-9dcb-f67017e57dfa">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjItMS0xLTEtMA_59b0eb0b-e257-4bf8-ada9-3ad1241ce52a">361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjItMy0xLTEtMA_4601563e-7e2e-4661-a97c-30f7ad65d1c8">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjItNS0xLTEtMA_33ce04e0-6a9a-465b-ab49-e9bfdf750f3b">241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjMtMS0xLTEtMA_0749fedf-d759-41bb-9475-68c40f1ce1d0">362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjMtMy0xLTEtMA_7cb625bd-4ff5-4615-9151-ad2363775f1b">358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjMtNS0xLTEtMA_ddb8b692-c75e-4b58-8908-f37a5c96ecd5">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjQtMS0xLTEtMA_f0203817-3d89-482a-a0b8-ae9e1bf64e57">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjQtMy0xLTEtMA_7a3f6f2a-f55f-4101-b1b1-da3b72f21ac1">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjQtNS0xLTEtMA_14be8704-fc3f-4600-a27a-bb1e569c19c7">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjUtMS0xLTEtMA_37ebadfa-4c7a-4502-b5aa-82e7b6a0279f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjUtMy0xLTEtMA_c5829d58-538b-4d3e-a230-f3db9544c8da">4,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjUtNS0xLTEtMA_29222d7d-1faf-453f-b2b2-fef2c98fba6f">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjYtMS0xLTEtMA_33de8a62-17a5-4851-bb44-b98c80b37eab">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjYtMy0xLTEtMA_5f815bd1-4a16-43b6-9071-2e4ba8622a84">4,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjYtNS0xLTEtMA_2016c394-041f-4b18-b429-df830ad7985d">1,671</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjctMS0xLTEtMTM0ODQ_38c0b270-ad29-4127-a7bf-cc6de8706fab">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjctMy0xLTEtMTM0OTQ_97df1b9a-700e-4c78-9187-f24a767f3dde">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjctNS0xLTEtMTM1MDc_c65a872e-a812-4e3f-9d82-a3d409aa7e43">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtMS0xLTEtMTM0ODk_ba1fcd05-3d81-43f4-bb40-1ea03777aeba">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtMy0xLTEtMTU2_8ae41da3-c0af-4acf-a968-72275cc92800">4,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtNS0xLTEtMTU5_454991ec-a3c9-4c7b-917a-0cbf32990389">1,671</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share &#8212; basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtMS0xLTEtMA_c07227e5-be7a-47aa-b151-6a01de132553">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtMy0xLTEtMA_e288098f-df95-4913-bfdc-b04b1af4b8b6">3.38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtNS0xLTEtMA_5efb2f57-d9dd-4125-9fef-d1900911704e">1.21</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per common share &#8212; assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjktMS0xLTEtMA_b30953f9-66e9-4ed5-ba01-0fc29beec324">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjktMy0xLTEtMA_54edeec6-57f0-426d-bef8-64e330ad2f10">3.33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjktNS0xLTEtMA_90612444-f1f9-4d9e-abf0-4c77c06f5b2b">1.19</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzItMS0xLTEtMA_85e99615-b442-4fdb-a174-c7ef33d5a261">1,416.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzItMy0xLTEtMA_4c873d9a-e8a6-44fd-8053-ff7e1c7dc5d8">1,391.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzItNS0xLTEtMA_afe35cdc-7ae6-446d-8367-235bdffd2cf2">1,381.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzMtMS0xLTEtMA_3f866433-bf0d-4b39-af84-f8e43061b3cb">1,416.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzMtMy0xLTEtMA_ea9ab042-f3da-47c1-9983-addf27c8257e">1,410.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzMtNS0xLTEtMA_0336d56f-1e8b-4ecf-a08c-1eaa2ff958a5">1,401.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMi0xLTEtMS0w_33de8a62-17a5-4851-bb44-b98c80b37eab">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMi0zLTEtMS0w_5f815bd1-4a16-43b6-9071-2e4ba8622a84">4,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMi01LTEtMS0w_2016c394-041f-4b18-b429-df830ad7985d">1,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNS0xLTEtMS0w_73143eea-9189-4b5a-a676-f83c8785d484">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNS0zLTEtMS0w_6f572db0-a7fc-4932-abed-d3857266a752">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNS01LTEtMS0w_d334adb4-dafc-49ed-a3ad-0500206a2617">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNi0xLTEtMS0w_37f825fe-1c9c-471d-b3dd-71472546ea24">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNi0zLTEtMS0w_1cc44725-1ed0-4352-81d0-54aa0521f517">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNi01LTEtMS0w_b64221f5-7c2d-4d8c-b490-9258350faa9d">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOC0xLTEtMS0w_5ca32564-295f-40d6-b2c3-1d8a57558a5b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOC0zLTEtMS0w_fe429fae-ff8e-4520-ae85-54f55793d428">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOC01LTEtMS0w_02f29ad1-7399-49fe-be2d-2898aa35623a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOS0xLTEtMS0w_70c23445-5e9d-465f-91a4-51c7362f5a8a">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOS0zLTEtMS0w_be13617d-769a-4030-adc3-5aa1c565449b">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOS01LTEtMS0w_4549ca5e-b943-49cd-8eb1-36acaa58f4e2">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMTAtMS0xLTEtMA_5c032791-4860-4ee8-8931-7b3244ef8f67">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMTAtMy0xLTEtMA_fc78832b-eb82-4fe2-8cc5-742e77b5c485">4,937</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMTAtNS0xLTEtMA_14c8f9c4-c295-417e-b7e2-d01b24b85102">1,761</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNC0xLTEtMS0w_40cabaa5-3d82-41d5-a50f-2aacc0162656">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNC0zLTEtMS0w_93ff828b-42c4-4665-8b7d-e784a91c66dd">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNS0xLTEtMS0w_3a5dc780-3a00-44c0-9ad2-b71b1ce2c214">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNS0zLTEtMS0w_f9182a2d-8556-4414-92ab-8903c0fb1745">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNi0xLTEtMS0w_c958436e-ab32-4386-918a-3bf73533ab98">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNi0zLTEtMS0w_8bc94cdd-0f88-4c1e-b1f6-c68a0d7d4bf3">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNy0xLTEtMS0w_745e1510-09d5-4069-b950-af9bb5f4bf84">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNy0zLTEtMS0w_053c3460-c180-44ce-98b5-71fd51ea1deb">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOC0xLTEtMS0xMzUxNg_2d94f1f3-e605-416d-8edb-69f623462c6e">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOC0zLTEtMS0xMzUxNg_f23e3dc7-3601-4cbc-99a7-7e9a9aa7abec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOC0xLTEtMS0w_a588ddcf-dd90-472b-a054-560d369ed9f6">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOC0zLTEtMS0w_7c51e4b4-c870-485b-82af-4018e9f3e19b">880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOS0xLTEtMS0w_93374b0d-3445-44a1-a0b6-8d677695a1d7">6,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOS0zLTEtMS0w_f36a58bd-80b0-4e39-8308-13db4ee31844">4,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTAtMS0xLTEtMA_c4e5f18f-e27b-4b69-bb29-49ba668ab464">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTAtMy0xLTEtMA_abf1a96d-bf97-4e03-aad1-e6bc13b03748">2,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTEtMS0xLTEtMA_f82bd445-2c9f-425e-be29-bbb5c5e1b01b">9,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTEtMy0xLTEtMA_b817d6b3-a149-4a2e-b402-808e19d12406">10,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTItMS0xLTEtMA_da5540d4-f986-4814-a832-85e5ff9a1ace">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTItMy0xLTEtMA_36e9fd94-a267-4ed6-82c1-75eb4768f031">7,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTMtMS0xLTEtMA_215d374b-db66-4ca8-80b5-0ccb8a68eb36">4,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTMtMy0xLTEtMA_dcc3d53a-eee2-430f-a32f-f7c4edfffd84">4,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTQtMS0xLTEtMA_274f691e-e507-4716-a53c-7e5ca2de7290">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTQtMy0xLTEtMA_822a21a4-e23b-4d8c-b592-4a9fa3505d42">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTUtMS0xLTEtMA_cb9ca439-aab0-4ff6-9e31-cfc4949716af">30,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTUtMy0xLTEtMA_fb1d1caa-65ce-41f7-8b4a-07dbecf1b515">30,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTktMS0xLTEtMA_c60cc048-6879-4379-bc41-8fffe3e8a332">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTktMy0xLTEtMA_77bbd495-a6c9-4759-90e4-7bd391c51ffc">1,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjAtMS0xLTEtMA_3508b802-59c2-42ba-ae3c-f2126b3066fd">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjAtMy0xLTEtMA_e9b67b04-9946-48c2-bc99-42b7baf35e96">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjEtMS0xLTEtMA_61749cc2-a84a-4a6a-968d-df7b5d3a62e8">2,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjEtMy0xLTEtMA_1bda3810-e56c-47cd-b385-3560a5d701f0">2,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjItMS0xLTEtMA_546d9322-09e5-437a-a2d3-70fa6b44ab8a">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjItMy0xLTEtMA_85068faf-0497-4917-9b7b-fece12b16b76">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjMtMS0xLTEtMA_121e9d33-9b7a-4449-8d77-20c03970a4b9">3,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjMtMy0xLTEtMA_4a3e63d5-e3a9-4639-8ad2-303c6d34351d">4,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjQtMS0xLTEtMA_3a5f06c8-6643-471b-a415-e43f2a9651bf">9,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjQtMy0xLTEtMA_23a8b886-a73d-4d44-98e0-db441c069f73">8,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjUtMS0xLTEtMA_8bbfa60a-d2fe-45cf-b583-df0604ec6548">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjUtMy0xLTEtMA_c82c00c1-3b9d-445f-bb2a-4b41572b7dbb">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjYtMS0xLTEtMA_ea96f366-10ff-49b1-a9e1-87592b1e67f9">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjYtMy0xLTEtMA_3a94fefb-e677-4e57-bf80-da2ebeccc303">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjgtMS0xLTEtMA_64531727-972a-4f23-8715-651069a732a9"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjgtMy0xLTEtMA_8767e9db-342b-4f57-b989-b07e5c516ee1"></ix:nonFraction></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk1OTc_67478fb7-7a94-47b9-9cce-ee16e1f29933"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk1OTc_826db844-4c43-4fcd-b039-6575add45a2f">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk2MTA_b3dfaf66-ca6d-4015-8d6c-30546785de48"><ix:nonFraction unitRef="shares" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk2MTA_e22029f4-b7d8-4753-933b-02ae71324c17">50,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk2MjM_e85bb555-16bd-40c3-a366-2799e05aadfd">10,062,500</ix:nonFraction> shares as of December 31, 2020 and none as of December 31, 2019 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMS0xLTEtMA_ee8be5e5-3db1-4c03-966b-84a0c56f1d1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMy0xLTEtMA_c8b7f82c-5ed0-4da2-8b69-4a4b1a70eb78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MDI_1cbba0b1-133f-4728-a93d-3e7a8081d582"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MDI_fca2681e-8ff6-4439-a1a1-027a12bbd243">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MTg_6a4241f8-7a39-4a52-8aba-8af761b82d59"><ix:nonFraction unitRef="shares" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MTg_80d3ac50-c4d3-4229-a843-ecbf4e4e9932">2,000,000,000</ix:nonFraction></ix:nonFraction> shares; issued <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MjI_4bfdc087-329b-43ba-ba42-9ac3db6be188">1,679,911,918</ix:nonFraction> shares as of December 31, 2020 and <ix:nonFraction unitRef="shares" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2Mzg_52dc6f28-d466-4844-a1c3-61d80cc0134a">1,642,488,911</ix:nonFraction> shares as of December 31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMS0xLTEtMA_e774e0e2-2b04-45c1-8109-05e9cc19f031">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMy0xLTEtMA_fb36a408-d7e3-4a69-a89e-329feec4b45b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost - <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjVjYmY5MzYwZjVkOTRiZGY5ZTYxMDBlMTFiMzlhMjgwXzI3NDg3NzkwNjk1NjQ_036cc46e-bbe6-4b78-b1ff-fc9027602a98">263,289,848</ix:nonFraction> shares as of December 31, 2020 and <ix:nonFraction unitRef="shares" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjVjYmY5MzYwZjVkOTRiZGY5ZTYxMDBlMTFiMzlhMjgwXzI3NDg3NzkwNjk1NjA_645b9ea2-6776-47a2-8ddc-c83f6b523131">247,566,270</ix:nonFraction> shares as of December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzMtMS0xLTEtMA_0893a379-9740-4114-b4f2-2e3d87238b8c">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzMtMy0xLTEtMA_c68c8595-f106-4fcc-8aef-7d996448e8a8">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzQtMS0xLTEtMA_fc61f2c2-e2d3-47bc-8920-34d02d7f0066">19,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzQtMy0xLTEtMA_aa9f65a2-f7a9-4623-8af1-d8fcc438b07f">17,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzUtMS0xLTEtMA_cc4386ca-7921-4ab8-b29b-32b251111238">2,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzUtMy0xLTEtMA_68ddd045-b7ea-4bd7-9c96-b48c240db383">2,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzctMS0xLTEtMA_e4f3efd7-61a2-42f4-8faa-2752540b51c0">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzctMy0xLTEtMA_2d66d092-58ab-4936-92f1-8a4f9a5987bf">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzgtMS0xLTEtMA_d8cedf9b-3fde-4889-b8d0-c5265e53c048">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzgtMy0xLTEtMA_07d81233-9118-4410-8fb2-fdbb285f7537">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized costs associated with defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDAtMS0xLTEtMA_85698734-21f8-4157-96f9-5cb9d3fa8eb7">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDAtMy0xLTEtMA_9e41eecb-9b45-4253-8de9-120c2bc86a01">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDEtMS0xLTEtMA_4935541b-1327-4d18-8372-9fe66fbe93ae">15,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDEtMy0xLTEtMA_f0e5e54f-9849-41e3-8361-44d4365cd6f9">13,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDItMS0xLTEtMA_e6cb6b61-a148-49d4-b9f8-adeddc34c4fb">30,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDItMy0xLTEtMA_82d27da8-a171-404a-803f-d29ff2505bb2">30,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.629%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss), Net of Tax</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec2a00e6f06c444a9952e4b94b0d4e6e_I20171231" decimals="-3" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMS0xLTEtMTM1Njk_5811d3f0-8278-4139-93d5-ef948b179465">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2a00e6f06c444a9952e4b94b0d4e6e_I20171231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMy0xLTEtMTM1Njk_20e546a4-e095-4edd-b1c0-2e159ef6074f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i416c4bf3762343af99956df0491cda23_I20171231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMS0xLTEtMA_395d71a2-b03e-4afa-bfee-9f54ac1d3808">1,621,062,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i416c4bf3762343af99956df0491cda23_I20171231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMy0xLTEtMA_3b353616-4433-4842-9bbf-e18fd389ce66">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic86a24afa1544f379e9453f8559daca7_I20171231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItNS0xLTEtMA_4e82a2e9-f787-4ba3-8d81-cb6c8c949e7b">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a0e4d8d1464b8e96a0b3b99c3831e6_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItNy0xLTEtMA_886db32c-71d4-44ad-83bb-08f45fc068a6">17,161</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6edad1230384f4ea726dde74e58b266_I20171231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMTAtMS0xLTA_a1f92e72-04bb-435f-9caa-65b1d67e9727">8,390</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97947ef16fd64573b576ede19f2d29ea_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMTItMS0xLTA_72e1fdb0-09c7-4251-aaeb-5803a97597c2">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486c2b6f6b1147f0b09d948b6ad1b5ce_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTMtMTAtMS0xLTA_f906c068-0dc6-4221-82f5-2638d1772fbf">1,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect adjustments for ASC Update Adoptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i486c2b6f6b1147f0b09d948b6ad1b5ce_D20180101-20181231" decimals="-6" sign="-" name="bsx:CumulativeEffectOfNewAccountingPrinciples" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTQtMTAtMS0xLTA_45f386cd-a247-431b-b5e6-7d8b56d7c66b">233</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf28bd85296f42f49e4da5f20d423b67_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTYtMTItMS0xLTA_2d2b13ab-3ee1-4a71-951f-49a883d2fd43">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf28bd85296f42f49e4da5f20d423b67_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTctMTItMS0xLTA_b3ce1cc1-1c4b-4619-a8ed-69b5cf2fdbd1">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pensions and other items</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf28bd85296f42f49e4da5f20d423b67_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTgtMTItMS0xLTA_7df2602c-2901-4a88-8599-fdf85cb0d76a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82aeda8856fa47ed8b39207375fa1aa8_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTktMS0xLTEtMA_87e6be78-608a-41db-9bf5-d062daccaf27">11,085,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d1f315a766c43b1aa5940ff8e160594_D20180101-20181231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTktNy0xLTEtMA_79a3c01f-d4ed-45c8-8c4f-fffbacfd26a4">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae1d8357f67849468d20db2d30de5e55_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMS0xLTEtMTM1NjU_c55d2755-4d71-4493-a001-35297df1f916">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1d8357f67849468d20db2d30de5e55_I20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMy0xLTEtMTM1NjU_b6331b13-73f1-4ac2-95ad-c5616b46d806">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6bbe2d5f3afb49b99ec4c9803ecee919_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMS0xLTEtMA_75cb40c3-3369-4a5c-bbad-bc8ce2760ded">1,632,148,030</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bbe2d5f3afb49b99ec4c9803ecee919_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMy0xLTEtMA_c44a227c-9dec-4770-8cdd-c6147d13e86f">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i815f4d787d1e4a26a2e65fce1b26129c_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtNS0xLTEtMA_21a18fbc-c911-46fc-a22f-3cea518b2d43">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i978ec64dad704d138144a11d4f20a868_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtNy0xLTEtMA_b8a2fb24-e177-4893-8095-f3b16e4ada95">17,346</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7354567f0bca438fa78f4baeeceed35c_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMTAtMS0xLTA_82f3d669-91bd-4daa-9008-31a60d71a027">6,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f0b56fe933409badece00bf9ab8f17_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMTItMS0xLTA_babde80a-4fcd-42d4-a350-7dc7d41be405">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id118699e701242f1879566050e0064d6_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjItMTAtMS0xLTA_dba6e02c-46ee-46f2-9ea1-97391e15f53b">4,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7af855385df42d583c24a02df379ca7_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjUtMTItMS0xLTA_3b6dd0d2-6d6a-4dd8-b463-42ef259b4a67">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7af855385df42d583c24a02df379ca7_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjYtMTItMS0xLTA_f7ca8132-a8e3-415e-aa11-f072ad651c7f">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pensions and other items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7af855385df42d583c24a02df379ca7_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjgtMTItMS0xLTA_cab6d046-fcb3-4cad-a064-209cf5e8f410">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66c17b892a204bb2b1c1aa8cd1051251_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjktMS0xLTEtMA_d23de662-a31f-441b-bf18-e3f2fe0d22f6">10,340,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9eec6cd5c3d47bd8cc9fa8a26bae2d0_D20190101-20191231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjktNy0xLTEtMA_f2ab33c3-57b4-4542-9d3d-239f965ed8d4">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf8a046f49ba4e7bbeb5595372a466f6_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMS0xLTEtMTM1NjA_d959a7c9-9034-494b-aad7-7837c8cdf995">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8a046f49ba4e7bbeb5595372a466f6_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMy0xLTEtMTM1NjA_5821b9ef-bc84-4ad8-a9c7-9ebf6a0f4aab">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic48f447708b74f77a26a4f0286cc2a15_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMS0xLTEtMA_17730aff-0d3f-4c3d-b728-1da437d01d49">1,642,488,911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48f447708b74f77a26a4f0286cc2a15_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMy0xLTEtMA_24764a7d-add2-4485-930f-2992be300b72">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b040eb90cef4343a857fe2e7740195e_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtNS0xLTEtMA_9ec96f94-c829-4924-9d38-f0b6f4140fc7">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22777e33f4f476c95138787b75b0db3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtNy0xLTEtMA_0215db04-d6e9-4be2-9cb0-6e1d7ca0eb7c">17,561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i369a19338d4645fcaff218f3e0180a0a_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMTAtMS0xLTA_18bf620e-6164-4edd-8e29-a293d9294583">2,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28940fe126704087ba8a61832f5de550_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMTItMS0xLTA_7021b035-4479-4488-aef0-1dad2f1a15c0">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e988814a30145f686582891ff75a88e_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzEtMTAtMS0xLTcyNzc_63f64f4d-1784-4ce8-9d37-edde5ecc2733">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect adjustments for adoption of ASC 2016-13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e988814a30145f686582891ff75a88e_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzItMTQtMS0xLTE4MjM4_b4f4482e-10d7-40eb-800d-aea059470af8">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f4c7888c677425da7039956930978ba_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzMtMTItMS0xLTcyODM_ffa2829e-5ca3-4568-892b-9c5491ff1856">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f4c7888c677425da7039956930978ba_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzQtMTItMS0xLTcyODk_daf463ab-30f8-4d29-9588-2b594c18c2be">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pensions and other items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f4c7888c677425da7039956930978ba_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzUtMTItMS0xLTcyOTM_4d6fafb6-3c25-41cf-bc75-f86689110bda">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i069e7ea9c6764fb5ab7629ac3e1b1f7d_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzYtMS0xLTEtNzQ1Mg_10ef139c-cf0d-4050-b59b-cb65a6502c17">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i069e7ea9c6764fb5ab7629ac3e1b1f7d_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzYtMy0xLTEtNzQ1Nw_f19f0a45-e21b-462e-8cfb-cbb3c69ba036">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb62c7fcc6748a29d33c15fc1a6e4ee_D20200101-20201231" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzYtMTEtMS0xLTc0NzQ_ac2758aa-a326-492b-9d0f-22bc27c9fe45">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i214a62bd8ef9406db278c8d1a09ffa31_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzctNS0xLTEtNzQ2Mw_5f727683-a640-467f-9810-29cdef484f3e">29,382,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i214a62bd8ef9406db278c8d1a09ffa31_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzctNy0xLTEtNzQ2OA_a5500b02-ff4f-4c19-af9d-2557d880607f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb62c7fcc6748a29d33c15fc1a6e4ee_D20200101-20201231" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzctMTEtMS0xLTc0NzQ_b3f6fdad-716d-42d0-be2c-416c315e24ac">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e988814a30145f686582891ff75a88e_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzktMTQtMS0xLTE4MjU3_9fb68e7c-09d0-4b7a-aa3c-e229e25fc5cc">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf7408d8c0ac4baa9b95744bb4a1416f_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtOS0xLTEtMTgyODY_c6c917e6-5f70-40ef-ab36-d1dab4eadd30">535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock-based compensation plans, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i214a62bd8ef9406db278c8d1a09ffa31_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzktNS0xLTEtNzM2Ng_d34f67de-c567-4a5d-b6cd-fd122a9916a3">8,040,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb62c7fcc6748a29d33c15fc1a6e4ee_D20200101-20201231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzktMTEtMS0xLTczNjk_536801ba-cc6b-4777-9f2f-2381d292790e">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf999a62069f494daaa8b34dd39eb888_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMS0xLTEtNzM2Mg_5a6268ca-9781-4be0-8aad-ce0fd878aa44">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf999a62069f494daaa8b34dd39eb888_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMy0xLTEtNzQ0OA_371c6bfb-1d43-460d-bc99-d0ef47062554">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89e7c6f8f9b84193a176a221054afca4_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtNS0xLTEtNzM4Mg_bc13dc3c-6e8b-4da0-9c65-b535d4e9d25f">1,679,911,918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e7c6f8f9b84193a176a221054afca4_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtNy0xLTEtNzM4OA_154e567f-71b9-4b61-8304-4d95d4441798">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c25b897fb8e4965a95e19981c5c8a85_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtOS0xLTEtNzM5NA_6f50e17d-21b1-4866-baf6-57780c1e38b4">2,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30f6d299f51d4710906bfb8afd9fa959_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMTEtMS0xLTc0MDI_e9baea6c-f26c-4ef6-b08d-ed27a7fa1f7e">19,732</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2189acf6800a485eac08cc940a299be8_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMTQtMS0xLTc0MDY_1be07fc6-0d8a-4b47-bad1-63d8a20e9937">2,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd122064a7e945ed9ca826ffcb42ab6f_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMTYtMS0xLTc0MTA_3eab0e10-56a1-462a-8d6f-4d88ee6cfd14">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) In 2018, we recorded cumulative effect adjustments to retained earnings to reflect the adoption of Accounting Standards Codification&#160;(ASC) Update No. 2014-09, Update No. 2016-16 and Update No. 2016-01. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2019 for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.067%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMy0xLTEtMS0w_0f127d33-94d4-4c1f-99f7-6c51d174ea95">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMy0zLTEtMS0w_71d6d480-7046-4a61-9560-442a2214c1f9">4,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMy01LTEtMS0w_dad1af46-bcdb-4d9d-a755-6645c580d282">1,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNS0xLTEtMS0w_4355a7b8-0c93-4e1d-b33d-8c4db89dd1d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNS0zLTEtMS0w_53c609af-a31b-45a8-a07b-d4642dbd1f50">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNS01LTEtMS0w_f6e318ff-c662-440d-ac51-28eef35a3a31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNy0xLTEtMS0w_aaf13309-74e9-4e3d-acca-707ca93956ad">1,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNy0zLTEtMS0w_ad59eae7-a610-40d7-80be-8c34ed59d656">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNy01LTEtMS0w_4daf10d2-08ba-453d-a0d8-22ce78dade46">894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred and prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOC0xLTEtMS0w_127ffd73-4155-4269-b0b5-518f63ccbfaa">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOC0zLTEtMS0w_e262d354-e63a-4ea0-867b-91bc2438f819">4,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOC01LTEtMS0w_cd8ea081-f59d-47a8-aa31-d40ae7021855">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOS0xLTEtMS0w_1a6dce89-ac9f-436c-8682-b4265031ac25">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOS0zLTEtMS0w_fbfe8e48-9b2d-49a2-8f56-e949798402c8">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOS01LTEtMS0w_9bc7f6c7-68ac-4787-8bce-3d729e0f7e9b">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTEtMS0xLTEtMA_c341d889-94f7-4d05-87e7-35425a662ee4">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTEtMy0xLTEtMA_db140bf7-c911-423a-89fa-ceb7a9c5a3a4">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTEtNS0xLTEtMA_debbe669-8e9e-463a-92d5-2a14545453c2">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss (gain) on investments and notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTItMS0xLTEtMA_7175f700-f2f6-4dd4-84ef-1f721d5fbf7e">398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTItMy0xLTEtMA_e3d3298b-4155-4d54-9c77-f46596bfbfb5">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTItNS0xLTEtMA_15148215-42c8-44b7-9ee7-581d3f2d8190">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTMtMS0xLTEtMA_d6d0a5a3-eb93-4ad9-898a-6f88f73b5158">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTMtMy0xLTEtMA_34e874c6-bd71-40a0-a19f-1a45180a0f84">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTMtNS0xLTEtMA_14dc7f22-6777-4e75-81b4-a649b59bb5b6">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory step-up amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTYtMS0xLTEtMA_e64674ad-0c80-49ef-a385-a925fcf4c320">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTYtMy0xLTEtMA_b6a899ff-e6ea-49cd-879d-316372d677e0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTYtNS0xLTEtMA_90ed8c5a-9cb1-4af6-b379-502dd0562f9b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTctMS0xLTEtMA_c1856edd-228d-4ae3-902e-75eeee2919ce">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTctMy0xLTEtMA_e8e62a90-3060-402b-9d42-2f9cc70ae5ee">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTctNS0xLTEtMA_d5c788e1-eb8d-490d-bd7e-c58b73577100">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTgtMS0xLTEtMA_dfbf7d23-c6f0-4d51-80cc-794ada5b8f81">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTgtMy0xLTEtMA_5d295a28-8c2e-464b-aac3-97d3f6cf1f07">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTgtNS0xLTEtMA_a5241113-1dc6-46da-8a8c-089dc1e6b55a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjAtMS0xLTEtMA_557256c6-df65-4ce5-9f54-6b57224421b0">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjAtMy0xLTEtMA_19a2a9f3-b2aa-401c-85e8-1f22e248e10a">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjAtNS0xLTEtMA_88956284-b4c3-4a17-a6fa-aa72ca054897">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjEtMS0xLTEtMA_2f50f81e-f1d2-4535-bb20-8502e877cc66">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjEtMy0xLTEtMA_eaa619a7-3d69-4d63-83e4-b8875f2414c8">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjEtNS0xLTEtMA_a3bb49dd-530c-405c-8baa-a4ba651c9e93">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjItMS0xLTEtMA_6ebc1f90-7684-4028-bff5-85f6a342aaac">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjItMy0xLTEtMA_76c2673e-c9c4-4182-803f-4a1d470d6f04">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjItNS0xLTEtMA_9049894f-84e8-4e62-aa56-e1ccffe6c1df">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjMtMS0xLTEtMA_c2e4453e-0696-473e-a2eb-284054ed9517">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjMtMy0xLTEtMA_7e6b4b0a-c8f9-41e2-bf26-deff83b47e0e">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjMtNS0xLTEtMA_fa3f0d7b-9f65-42c0-bd41-2c88db60bcca">640</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjQtMS0xLTEtMA_13443da1-8e2e-41d6-85fb-d7ccd7b2d880">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjQtMy0xLTEtMA_f289cf5a-c1af-430f-9709-bf0c6850ac60">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjQtNS0xLTEtMA_ddf08f2e-14ba-4302-a88d-9350cd2bfecc">1,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjUtMS0xLTEtMA_a863415a-7ae6-4db6-8327-a6252efc6c30">1,508</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjUtMy0xLTEtMA_731f2221-6be9-4561-866d-de4737e0a482">1,836</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjUtNS0xLTEtMA_7f0edbef-3786-4e10-8d99-89a91eca5b88">310</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjctMS0xLTEtMA_cef2a711-ccf9-430f-83e9-bd850f487072">376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjctMy0xLTEtMA_ca3ecc3c-f000-486f-9d4b-58cb6bbdf08a">461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjctNS0xLTEtMA_56f5bfa4-2aca-4fec-9105-6cbf39b5fcd2">316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds on disposals of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjgtMS0xLTEtMA_dc14f986-c0aa-48bf-8732-ffd852ae8edf">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjgtMy0xLTEtMA_2554b6a5-8797-44b0-8709-95cc46ff7846">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjgtNS0xLTEtMA_f60dcabe-629f-45e4-a4fc-5ce2fc71e2cc">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for acquisitions of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjktMS0xLTEtMA_81a3d64c-09ba-4297-af67-c20b03f59005">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjktMy0xLTEtMA_b787a543-9278-4ecd-ac74-eec816278dfc">4,382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjktNS0xLTEtMA_da6edf89-9170-4ced-b3a6-263bcc38759a">1,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from divestiture of certain businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzAtMS0xLTEtMA_a2de0226-2d1d-4cda-a23d-822d0f86476c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzAtMy0xLTEtMA_9b999b63-3ba5-47ee-b52b-f8c1eda3a176">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzAtNS0xLTEtMA_3e9b4331-344e-4b13-af70-40d4c732c624">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzEtMS0xLTEtMA_07f94993-f3eb-408a-a5ae-42a68ef1c4c6">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzEtMy0xLTEtMA_9d084eae-6147-4cf9-99a3-548e5de6773f">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzEtNS0xLTEtMA_107b9531-0837-4541-a4a2-25cf7cc947e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for settlements of hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzItMS0xLTEtMA_ade4357a-ed55-442d-ba9a-136b8b18e180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzItMy0xLTEtMA_f6173221-2998-423f-821c-024a33dcbc1e">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzItNS0xLTEtMA_10cb51ad-4be4-43b8-9b38-b701a0a939ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for investments and acquisitions of certain technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzMtMS0xLTEtMA_5c934295-f8f5-4100-a11c-c3b08f7fa798">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzMtMy0xLTEtMA_ac72c640-ef07-48d7-8a43-8977933167b1">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzMtNS0xLTEtMA_be0f1c56-ec2f-429b-b496-6395c5c3b5b0">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzUtMS0xLTEtMA_e4180483-7f6c-4667-a656-6c08949405b1">411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzUtMy0xLTEtMA_65124af0-fd76-409a-8491-196df1287e9b">5,041</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzUtNS0xLTEtMA_fcd5580a-f783-402a-a357-ec31a75c2f22">1,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of contingent consideration previously established in purchase accounting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctMS0xLTEtMA_014d7ed8-5eda-4282-abf5-ca814268ecba">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctMy0xLTEtMA_a1acc0e9-ccd8-40de-a8b8-1fa9638499ff">66</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctNS0xLTEtMA_ac2984c5-32f0-42f4-8a5b-4a3a546d8df2">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctMS0xLTEtMjI5MDM_4e30ee71-df1b-4fda-acab-383b07ffa92b">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctMy0xLTEtMjI5MDc_9a52040e-fa9b-4fda-afbb-659ffaa9fd59">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctNS0xLTEtMjI5MTE_d2a2cd99-326d-4b1e-a9cf-b068484062fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from royalty rights transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzgtMS0xLTEtMA_03808543-ef7c-4256-b6d2-57c70bcd92d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzgtMy0xLTEtMA_79496b1c-0c93-451f-83b8-bc8f0e8dd6f1">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzgtNS0xLTEtMA_a510f324-dfa5-44bf-9b69-aa78dfe63438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktMS0xLTEtMTM2MDY_32c07ea0-c6b5-44b6-8b9d-c608bbd4bfc0">2,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktMy0xLTEtMTM2MDY_0063d402-2d4d-4d2d-9211-55e407119aaf">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktNS0xLTEtMTM2MDY_bd3c701b-fd6c-481b-bce8-053fd38724f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktMS0xLTEtMA_fab174f3-b559-40b4-bda5-fbbfad33c2e3">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktMy0xLTEtMA_d3af5edc-70c6-4b1c-8e37-09a658a2639f">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktNS0xLTEtMA_f3e03eb8-6ad6-47af-81e7-ef494c99fe24">999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDAtMS0xLTEtMA_57820039-97a1-484a-85bf-2c5590f6d3af">714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDAtMy0xLTEtMA_ec10bc83-4ce8-4a7c-8167-8b3cbe48a820">575</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDAtNS0xLTEtMA_32714261-4a15-4ccd-9ca1-1d7a49b341b8">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on borrowings from credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDItMS0xLTEtMA_d0ea5de3-1845-45b5-8025-9b265358bc89">1,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDItMy0xLTEtMA_2517fa63-be69-4db6-8cab-d9e63ce7c39d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDItNS0xLTEtMA_5d578378-78b1-46cd-8165-e5f72d78a247">569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from borrowings on credit facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDMtMS0xLTEtMA_85f14dbd-5a27-48fb-9a30-1d203234ec0a">1,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDMtMy0xLTEtMA_3c1888ba-ba1c-4e99-993e-5dfc6b42755a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDMtNS0xLTEtMA_8b41e535-4db1-4588-99fa-d21b88f15caa">569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on long-term borrowings and debt extinguishment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDQtMS0xLTEtMA_557b7c7c-d74f-4bb3-ae3b-af9f8cbd2c45">1,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDQtMy0xLTEtMA_45b0adc8-6a25-4d59-887f-54846f36c2c2">3,560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDQtNS0xLTEtMA_4c800c02-da33-4ca0-bcd2-1504a0c89b88">602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from long-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDUtMS0xLTEtMA_867e225f-8410-4e1c-988e-cd6834767645">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDUtMy0xLTEtMA_816dd4a2-e30d-450a-83a5-d4cb62e0eed3">7,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDUtNS0xLTEtMA_343b0283-6033-414b-9fe9-c1a032d83d42">987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtMS0xLTEtMTg3NjQ_103edd03-5493-4d5c-a500-209db7317a50">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtMy0xLTEtMTg3Njg_15ff0277-f20f-4fde-9154-afc0b683c3dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtNS0xLTEtMTg3NzI_0fa82bc2-c358-4bfb-9e45-713287219171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuance of preferred stock in connection with public offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctMS0xLTEtMTg3NjQ_84e31dff-822c-4816-a0b1-2ec6994a1f40">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctMy0xLTEtMTg3Njg_c4a26e20-eb3f-4361-bf0d-15459cd0c527">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctNS0xLTEtMTg3NzI_b9882e50-6e69-49b8-8196-8ac77a063c85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock in connection with public offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtMS0xLTEtMTg3NjQ_df99e7a1-032a-4d20-a45f-bb1560eb1acb">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtMy0xLTEtMTg3Njg_44e521e1-bdb4-488f-9dcc-c210aadc493c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtNS0xLTEtMTg3NzI_10329588-e2f0-406a-bec5-454c2680c9c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtMS0xLTEtMA_4bdfebda-af52-4851-a837-93463e82d770">535</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtMy0xLTEtMA_0bd8c729-d562-4f7d-b4e1-ad6096a6d072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtNS0xLTEtMA_98119dd7-2431-4195-a9aa-2cb1db29c75b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash used to net share settle employee equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctMS0xLTEtMA_03e64a12-ce16-4c96-b75a-1acca262b3ff">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctMy0xLTEtMA_ae1acf33-676e-4df4-b58d-4303dd425468">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctNS0xLTEtMA_c4fccb18-db4c-4998-a434-ce456a2d99fc">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtMS0xLTEtMA_ce346553-75af-4687-ae2b-f0bc086acb9e">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtMy0xLTEtMA_6e262e90-af01-4f51-8ee8-cdcd316c22e9">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtNS0xLTEtMA_61d79e97-ef59-463f-94f8-c1b712851811">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDktMS0xLTEtMA_ceba6afa-ee32-4c04-9cf7-8b4a5155b07b">293</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDktMy0xLTEtMA_b7a391e8-da73-42cf-84e1-b0de9bac077e">2,973</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDktNS0xLTEtMA_9f288cb2-fcbd-4f2b-932f-66a0249a4a01">1,432</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTAtMS0xLTEtMA_52b74e74-f38a-456f-ab04-8490a1271493">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTAtMy0xLTEtMA_4e4dd1ff-8ebe-4ee9-897f-6d75e4b70fe9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTAtNS0xLTEtMA_17429a39-f933-4a6f-8295-41c044de871c">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTEtMS0xLTEtMA_80be32d3-dfca-4983-9b68-8703a044d0eb">1,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTEtMy0xLTEtMA_53ac8377-9add-430c-aec0-c7a9da6f4c3c">222</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTEtNS0xLTEtMA_66f00a26-b6ac-47ef-9230-8c54131257d2">188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTItMS0xLTEtMA_51d321d9-b8ab-4b18-b31c-62021cabeb76">607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTItMy0xLTEtMA_d3f30bab-4e25-485c-9063-d025a5de019b">829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTItNS0xLTEtMA_1c786e16-e4ea-4cd2-9fa3-ae78fabedd80">1,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTMtMS0xLTEtMA_aac796be-ce15-49f9-bff7-b6fbd146f80d">1,995</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTMtMy0xLTEtMA_7e2db1d4-c8c8-4794-80eb-404b83e44afb">607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTMtNS0xLTEtMA_664ff9e2-ecaf-4dfe-9f9c-6867503475fa">829</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (SUPPLEMENTAL INFORMATION)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.067%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Supplemental Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash (received) paid for income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMy0xLTEtMS0xOTU3OQ_a76fed1d-b1ec-4e52-9331-5e74865bb80f">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMy0zLTEtMS0xOTU3OQ_63949007-ff3c-4463-9c66-6446cf4f8309">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMy01LTEtMS0xOTU3OQ_72510af8-bdb7-40f7-8737-c6ccb7fdc2ad">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNC0xLTEtMS0xOTU3OQ_f88600c4-26a4-4415-b543-44e6ed0d405c">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNC0zLTEtMS0xOTU3OQ_05fe541d-ce32-4472-99a4-0468173a5b19">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNC01LTEtMS0xOTU3OQ_ef180a0b-f541-40ca-bd25-3b35a4fc5d78">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of contingent consideration recorded in purchase accounting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNS0xLTEtMS0xOTU3OQ_3d6153ad-47e5-410c-bcb8-08054a607aa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNS0zLTEtMS0xOTU3OQ_e04611cf-912c-4728-8319-a3caceeda214">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNS01LTEtMS0xOTU3OQ_2709775e-e25a-4aa8-a23e-f1b242efccd2">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" sign="-" name="bsx:NonCashImpactOfTransferredRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNi0xLTEtMS0xOTU3OQ_86c30206-4299-489e-a395-4de09f20f481">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:NonCashImpactOfTransferredRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNi0zLTEtMS0xOTU3OQ_a424c108-2231-4697-a104-898f6b6914ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:zerodash" name="bsx:NonCashImpactOfTransferredRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNi01LTEtMS0xOTU3OQ_69b32207-75c3-48fd-aff9-b9856cb69f10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation to amounts within the consolidated balance sheets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfOS0xLTEtMS0xOTU3OQ_3b151575-73d1-4d19-aac7-28bb0f3da5c0">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfOS0zLTEtMS0xOTU3OQ_f32851b2-047f-41d4-8831-147df037da5c">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfOS01LTEtMS0xOTU3OQ_bee9567c-8022-4a8a-9794-bbf04c0189a3">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTAtMS0xLTEtMTk1Nzk_56810aae-b577-4965-a6cf-8fa74a0cb7d5">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTAtMy0xLTEtMTk1Nzk_886cfada-378f-4af0-a11a-492f6db733dd">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTAtNS0xLTEtMTk1Nzk_81c208df-3c4c-47db-b508-19548d8dc6f2">655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTEtMS0xLTEtMTk1Nzk_722d4650-ea73-435b-8f12-c30f2f8793e9">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTEtMy0xLTEtMTk1Nzk_8c5800a9-9f77-436b-b863-4d315da13253">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTEtNS0xLTEtMTk1Nzk_f5720a1c-97a4-4235-b616-a3e56ca2afe7">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTItMS0xLTEtMTk1Nzk_bc985bfa-1c03-497d-8b4e-a98f45a67024">1,995</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTItMy0xLTEtMTk1Nzk_c3653837-2a6a-4f3f-9adc-e271362b337e">607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTItNS0xLTEtMTk1Nzk_96fa9f68-57c7-4e9d-9824-3e2b83efb243">829</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_97"></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNjA_1a4aa5e0-dbac-47c6-9d40-5d3aca9153a3" continuedAt="ia234866e01dc477c94a986c16bad2139" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; SIGNIFICANT ACCOUNTING POLICIES</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMjI_b99b9813-bdf5-4739-bf7b-0ed3445c78c5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#8217;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2020, 2019 or 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczNjc_c7d15dd1-12fc-4bf0-ae4c-4cb9b1fb7619" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyNjU_de60c874-4d2e-4032-a27a-321f2f437ca2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report for further discussion.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNDk_2d141865-9564-4451-89e2-f5b16c6f14de" continuedAt="ibe2faabde1ab48549e75063cb167d5f8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia234866e01dc477c94a986c16bad2139" continuedAt="i0fbeed9d3148402a80fd891ae08e4838"><ix:continuation id="ibe2faabde1ab48549e75063cb167d5f8" continuedAt="i16b0d5fa5bb644c0bfa0105ba31df833"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash Equivalents</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i16b0d5fa5bb644c0bfa0105ba31df833" continuedAt="i2e20cd2200d64e9caeaab50a680ca3b4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2e20cd2200d64e9caeaab50a680ca3b4">caption within our consolidated balance sheets are related to deferred compensation plans.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNzc_e917632b-79e7-469d-b5ff-65f876005f60" continuedAt="id29bb48547c5484b97f08d9fbfade19b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We write-off amounts determined to be uncollectible against this reserve. Write-offs of uncollectible accounts receivable were immaterial in 2020, 2019 and 2018. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2020, 2019 and 2018; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="id29bb48547c5484b97f08d9fbfade19b" continuedAt="ic5adcb0fe1cb44d49dbc97d2439ce373"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes toward non-hospital settings, particularly ambulatory surgery centers, driven by considerations surrounding costs, reimbursement policies, advances in minimally invasive treatments and remote patient monitoring. We have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers. Many of these customers are smaller than those we have historically done business with and may have limited liquidity. While certain ambulatory surgery centers are performing an increasing number of procedures in response to the COVID-19 pandemic, others have been negatively impacted by COVID-19 restrictions and mitigation measures. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic5adcb0fe1cb44d49dbc97d2439ce373"> is adequate as of December&#160;31, 2020 and 2019; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase.</ix:continuation> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0fbeed9d3148402a80fd891ae08e4838" continuedAt="i73c7f59620244264887af77ffeaabc7a"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNDA_b3eb3a4c-fec8-4e6f-ac78-4b2989e7c9e0" continuedAt="i90b0bab268854343acc340d31cc53fc7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a contract with a customer that creates enforceable rights and obligations,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Promised products or services are identified,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The transaction price, or the amount we expect to receive, is determinable and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have transferred control of the promised items to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management product offerings combine the sale of a device with our LATITUDE&#8482; Patient Management System, within our Cardiac Rhythm Management (CRM) business, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Implant Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide non-contractual services to customers to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i73c7f59620244264887af77ffeaabc7a" continuedAt="i9c6647cb537d4847a02e47a3cd5ebb9e"><div style="text-align:justify"><ix:continuation id="i90b0bab268854343acc340d31cc53fc7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services at the time the devices are sold. We record these costs to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNjg_6f43422c-f1ec-4af6-ad49-36316ff09862" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczMjg_11f7c785-7447-4eb4-a281-f141c644b434" continuedAt="ie5b27e946bbb454dba559a16aba33f22" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During the year ended December 31, 2020, we recorded $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProductionRelatedImpairmentsOrCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfMjc0ODc3OTIyNjc5Mw_98f012de-3293-4b62-b340-47ba8a8d9b2a">149</ix:nonFraction>&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2019 or 2018.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie5b27e946bbb454dba559a16aba33f22">We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMTM_1cbdf9ae-857a-4554-8bc5-ed5888de4dfd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczMzM_23eb7a70-e130-4e95-a84e-76c78275e8a7" continuedAt="i8235ae787a2347af8c0e70b62917c92f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Business Combinations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In those circumstances where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration net expense (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9c6647cb537d4847a02e47a3cd5ebb9e" continuedAt="i05e9f346b39f465d967b9808fbc53e40"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8235ae787a2347af8c0e70b62917c92f">levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:InProcessResearchAndDevelopmentPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMjg_6d225683-7da5-4f3b-9a99-d51069379a99" continuedAt="i3afd97ef7ca84f73bae4c545c9e90830" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived Intangibles and IPR&amp;D </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which is foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, and IPR&amp;D intangible assets acquired in a business combination. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;D intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the income approach to determine the fair values of our IPR&amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#8217; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to indefinite-lived intangibles, including IPR&amp;D.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3afd97ef7ca84f73bae4c545c9e90830">For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNDI_f87fc2aa-29d3-41d9-8a77-fde2c616a9b8" continuedAt="i8c71ed0b925b4e5f95c8da81fa42cc8c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization and Impairment of Intangible Assets </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to impairments of intangible assets.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i05e9f346b39f465d967b9808fbc53e40" continuedAt="i3ea2236662e5414ca24c6155e2614dbb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8c71ed0b925b4e5f95c8da81fa42cc8c">For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczMjU_56c3c6c0-d242-40c8-8c60-7488d651139d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Valuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2020 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the second quarter of&#160;2020, we performed our annual goodwill impairment test utilizing the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $800 million, subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. We acquired our Specialty Pharmaceuticals business in conjunction with the BTG acquisition on August 19, 2019. In connection with the execution of a definitive agreement to sell the disposal group for a specified amount, we performed an impairment assessment of our goodwill and intangible assets, which resulted in a goodwill impairment of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNTQ5NzU1ODI5MDUyMw_957e7ce5-fcc0-4f10-bfe5-f5f042cd7971">73</ix:nonFraction> million. As of December 31, 2020, we classified the remaining assets and liabilities of the disposal group as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less cost to sell. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements for additional details related to our goodwill balances.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMzQ_04ff5973-39ea-40f5-91aa-f2b9d5241ccb" continuedAt="i68184d6ce34341fc97494739c31f6d82" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Publicly Traded and Privately Held Entities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any, observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities over which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investments - Equity Method and Joint Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">, Investments - Debt and Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for additional details on our investment balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#8217;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3ea2236662e5414ca24c6155e2614dbb" continuedAt="idc02621b5ce3444b8130755c54c99813"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i68184d6ce34341fc97494739c31f6d82" continuedAt="i71f51104bb404984b20a03e3cb87f34b">is impaired and we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. </ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i71f51104bb404984b20a03e3cb87f34b" continuedAt="i7ca40bc01ade46cdb72ec4a1c600feba"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses and impairments associated with our investment portfolio are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ca40bc01ade46cdb72ec4a1c600feba">in our consolidated statements of operations.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNjU_1e1cba56-dc9b-48fe-884d-37e85dd7aff2" continuedAt="i06f17788000f48ecb4e864b4933bf90c" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i06f17788000f48ecb4e864b4933bf90c" continuedAt="i4bfc26ed845543098dc0057c461ae90f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4bfc26ed845543098dc0057c461ae90f"> for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA</ix:continuation>.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyNTk_775b6526-b736-478a-b10e-abe50da07f02" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Product Liability Costs </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities litigation and product liability suits. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue our best estimate of the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of our individual material legal proceedings.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyNTM_1f28bec7-66f8-4cbc-9d51-8d1265dcf4e1" continuedAt="ica7db63fbc7d43b8884abe2190d9f71a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record employee termination costs in accordance with FASB ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. We record such costs into expense over the employee&#8217;s future service period, if any. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idc02621b5ce3444b8130755c54c99813"><div style="text-align:justify"><ix:continuation id="ica7db63fbc7d43b8884abe2190d9f71a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information and discussion of our restructuring plans.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxODU_65434d9a-ac68-4fbf-91f0-4f3d3571a909" continuedAt="i1a37bb20a8764554bfc00b34de583509" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currency</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i1a37bb20a8764554bfc00b34de583509" continuedAt="i1442320e58ed4fe5850771a16329b7f2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency transaction gains and losses are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1442320e58ed4fe5850771a16329b7f2">in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNDg_b7a18a69-33de-4a60-820c-efe0193124dc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments<ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" xsi:nil="true" name="bsx:ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNTU_fc852768-870b-42bf-a4b6-c630280251c6" escape="true"></ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on our hedging instruments.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMDE_a34660eb-6705-4bed-ae5d-e7380936c2f9" continuedAt="if56a4b8b46654bec8459fddbe5fbed14" escape="true">Shipping and Handling Costs</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="if56a4b8b46654bec8459fddbe5fbed14" continuedAt="ic6a09c7f809949f396d343239eca95dc"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not bill customers for shipping and handling of our products. We treat shipping and handling costs incurred after a customer obtains control of the good as a fulfillment cost and record in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic6a09c7f809949f396d343239eca95dc">within our consolidated statements of operations. Shipping and handling costs were $<ix:nonFraction unitRef="usd" contextRef="i11643c9862df4baea0dccd9d1fe58c3b_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDYzNjE_a23d3b21-37bf-4525-89fb-d603ed4cc371">146</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="iab42b8f2e9794e569ed587870fb84d60_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDYzNzE_29ebd9d3-8b6f-41f6-850a-1874c6308bdd">144</ix:nonFraction> million in 2019 and $<ix:nonFraction unitRef="usd" contextRef="i56411282f0574a36b407828ddce5e536_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDYzODQ_7a19225f-d4fe-480f-9bea-8bd1407a548a">124</ix:nonFraction> million in 2018</ix:continuation>.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczNjE_edbfc4fe-45cd-4a55-a4e8-d59fcff38ad9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development (R&amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Indefinite-lived Intangibles and IPR&amp;D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for our policy regarding R&amp;D projects acquired in connection with our business combinations and asset purchases.</span></div></ix:nonNumeric></ix:continuation><div id="i5c3e8d69fcc1460baddde62cfa022487_103"></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjMw_01947733-c3f0-46b0-b302-dc3020a72e6f" continuedAt="icc3d695c668c4bfc9ffb01d6e76682be" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS AND STRATEGIC INVESTMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We did not complete any material acquisitions during 2020. We have not presented supplemental pro forma financial information for prior acquisitions given their results are not material to our consolidated financial statements. Transaction costs for all acquisitions completed during 2020, 2019 and 2018 were immaterial to our consolidated financial statements and were expensed as incurred. In 2020, we recorded immaterial purchase price adjustments during the measurement period for the preliminary purchase price allocations associated with prior acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 21, 2021, we announced our entrance into a definitive agreement to acquire Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. We have been an investor in Preventice since 2015 and currently hold an equity stake of approximately <ix:nonFraction unitRef="number" contextRef="i64a8d1206e3449f0ae7a7ece1b89fb96_I20210121" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxODcxMTQ_305b6388-62ea-429d-ae97-f9190ead8a8b">22</ix:nonFraction> percent. The transaction price to acquire the remaining stake is expected to result in a net cash payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i5a34bf00cea546488f2484aedb64dcf4_D20210121-20210121" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxODcwODY_2694608a-21e5-4dc4-9c8a-9fa6bf6c6791">720</ix:nonFraction> million upon closing and up to an additional $<ix:nonFraction unitRef="usd" contextRef="i64a8d1206e3449f0ae7a7ece1b89fb96_I20210121" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxODcxMDE_b3003767-52d8-4603-844a-53ebe302247f">230</ix:nonFraction> million payment upon achievement of a commercial milestone. The acquisition is expected to close during the first half of 2021, subject to customary </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icc3d695c668c4bfc9ffb01d6e76682be" continuedAt="i7b4d06a642c443f79c23bc530e96333a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">closing conditions. Following the closing of the acquisition, the Preventice business will be managed by our Cardiac Rhythm Management division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">BTG plc</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;19, 2019, we announced the closing of our acquisition of BTG plc (BTG), a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we integrated BTG's Interventional Medicine business into our Peripheral Interventions division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Interventional Medicine product lines, the BTG portfolio also included a specialty pharmaceutical business (Specialty Pharmaceuticals) comprised of acute care antidotes to treat overexposure to certain medications and toxins. On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxODk5NjI_ae7fb70f-bb50-4324-97a6-efa611c19699">800</ix:nonFraction> million , subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BTG portfolio further included a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. In connection with the acquisition, we acquired rights to future royalties associated with the Zytiga&#8482; Drug used to treat certain forms of prostate cancer. In the fourth quarter of 2019, we sold our rights to these royalties for $<ix:nonFraction unitRef="usd" contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTAyNzI_bda3f833-47fd-4481-84d9-7462f0a0655c">256</ix:nonFraction> million in cash, included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of cash flows. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price for the acquisition of BTG consisted of upfront cash in the aggregate amount of &#163;<ix:nonFraction unitRef="gbp" contextRef="i299c7ae54a0247c3ba17d84adb96d2dc_D20190819-20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE5OTE_a82ffc27-bf10-4bc6-94e0-39ee29cb4c8b">3.312</ix:nonFraction> billion (or $<ix:nonFraction unitRef="usd" contextRef="i299c7ae54a0247c3ba17d84adb96d2dc_D20190819-20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE5OTg_109e0dd4-2e74-41b8-aabe-e359cef29651">4.023</ix:nonFraction> billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received <ix:nonFraction unitRef="gbpPerShare" contextRef="ibbb0c3a277f94a73ada943c59b4bac0e_I20190819" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIxNDY_f020c04d-8d80-461e-9eb1-a39527b6063c">840</ix:nonFraction> pence (or $<ix:nonFraction unitRef="usdPerShare" contextRef="ibbb0c3a277f94a73ada943c59b4bac0e_I20190819" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIxNTM_101679dc-08e9-423a-a867-0a46909aac69">10.20</ix:nonFraction> based on the exchange rate at closing) in cash for each BTG share. The transaction price included $<ix:nonFraction unitRef="usd" contextRef="i299c7ae54a0247c3ba17d84adb96d2dc_D20190819-20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIyNTQ_540156bd-717e-4a43-83a2-52d070372492">404</ix:nonFraction> million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,&#160;Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NTE_a269ddc7-162e-4795-bad6-a28cc3e80ab8" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4MDE0NGIwMjZjMDU0NTBiYWFmNDUyNTRkZTdhMWIzNC90YWJsZXJhbmdlOjgwMTQ0YjAyNmMwNTQ1MGJhYWY0NTI1NGRlN2ExYjM0XzEtMS0xLTEtMA_ae95c9fa-e133-45b9-903d-6f04cfbfe938">3,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><ix:continuation id="i7b4d06a642c443f79c23bc530e96333a" continuedAt="ib2df95943daa4a90a6f2478260200bb9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NTQ_f4ca2391-32af-4bf3-9f0f-123528666eb0" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzEtMS0xLTEtMA_4ec12b6d-4c6e-457a-97bb-a8161864dfa2">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzMtMS0xLTEtMA_8d161dd1-9edc-4111-b921-4d4abf41f0f8">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzQtMS0xLTEtMA_12078a57-b3d0-48fa-9b0d-2851ae2821ce">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzUtMS0xLTEtMA_f42bee97-aa22-4d7d-a2aa-fe13325bbd0f">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzYtMS0xLTEtMA_7228612b-2129-4a73-9151-4e30474da25f">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzctMS0xLTEtMA_23439585-5f27-41bc-8585-449e8aa4be15">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzgtMS0xLTEtMA_22c94636-125e-46e8-9fd0-582cc16a8f3d">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzktMS0xLTEtMA_fd8ac99e-bafb-4f50-a927-4438f65607e2">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzEwLTEtMS0xLTA_07ee9a85-a731-4aa8-a007-5224397db5db">349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzExLTEtMS0xLTA_7c6dd23c-fa84-4616-85dc-b79234ad025c">3,619</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NTU_b8a59fda-124a-41f5-a3f5-c5a1089c668c" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f7af4ce5e334ad6a48a0c025a8c309e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItMS0xLTEtMA_1799aebc-0093-40ba-af83-4c90e7708767">1,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i35075d47b59a45d1a6bea3504735e270_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItMy0xLTEtMA_435fe2e1-f3df-4559-83a0-072086f8a3e9">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2a3d5f3065944d128f235b2e66762039_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItNS0xLTEtMA_00ccdce2-714f-41b3-b8ff-d5dda9d03acc">18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35075d47b59a45d1a6bea3504735e270_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItNy0xLTEtMA_9e14c70b-b4e8-4913-8198-be779d0002ce">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a3d5f3065944d128f235b2e66762039_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItOS0xLTEtMA_3113870d-4f09-4909-bc94-fbc0aa06a66c">12</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2774a1a2bba4fa7853774c9595dcb11_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzUtMS0xLTEtMA_8596aa7d-de21-4bd2-949c-9085a5121e24">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibed9848d49334621abbf06402ae43b03_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzUtMy0xLTEtMA_e14278df-e233-4ad7-8cdf-401e45476178">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i68e95752e11f41c8bf7a29dafc64ed6a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzUtNS0xLTEtMA_1fae820e-dc6d-4424-8f91-dfc311e60386">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27a8ea6e29224419867de6bc25119d5a_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzUtNy0xLTEtMA_6d1d876d-c819-46cb-b960-d2a09c3726ad">11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzgtMS0xLTEtMA_bf376486-c046-474a-933e-225546cfa412">1,785</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized goodwill of $<ix:nonFraction unitRef="usd" contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkwOTU1NjA_4ec12b6d-4c6e-457a-97bb-a8161864dfa2">1.635</ix:nonFraction> billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. We allocated $<ix:nonFraction unitRef="usd" contextRef="i58f51b9be0cb448cb46a40c48600ea96_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkwOTU3OTY_c97e5c7e-14e7-43d5-beb7-96d14af0fa52">1.399</ix:nonFraction> billion to our Peripheral Interventions reporting unit and $<ix:nonFraction unitRef="usd" contextRef="i3d29dc73a76c4cf595703ac8e73f20c3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkwOTYzNTI_e5aad4b9-4171-4806-b7ed-ae988eaadb03">236</ix:nonFraction> million to the Specialty Pharmaceuticals reporting unit. In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTY0OTk_957e7ce5-fcc0-4f10-bfe5-f5f042cd7971">73</ix:nonFraction> million related to our Specialty Pharmaceuticals business. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction with Varian Medical Systems, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2019, we completed the sale of our drug-eluting and bland embolic microsphere portfolio to Varian Medical Systems, Inc. (Varian) in connection with our acquisition of BTG. The transaction price consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="ie90da432f6df49e48679d93f666461e4_D20190821-20190821" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzY5Nzk_7bc66144-95f0-48b6-9635-96284e479f7f">90</ix:nonFraction> million, a portion of which is allocated to the fair value of the services to be rendered under the Transition Services Agreement and Transition Manufacturing Agreement entered into with Varian as part of this transaction. Additionally, we transferred certain contingent consideration arrangements arising from our initial acquisition of the portfolio to Varian and agreed to indemnify Varian for any payments ultimately arising under the terms of the contingent consideration arrangement. Accordingly, as part of the disposal, we recorded a liability of $<ix:nonFraction unitRef="usd" contextRef="i7b1cd7f1f0194f3aa27fd23d352988c0_I20190821" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GuaranteesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzc1Mjk_394627d9-cd94-4782-9e1b-3cfe541d8ac6">16</ix:nonFraction> million to recognize the fair value of this guarantee based on our potential obligation resulting from the indemnifications. The maximum amount payable under this guarantee is $<ix:nonFraction unitRef="usd" contextRef="i7b1cd7f1f0194f3aa27fd23d352988c0_I20190821" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GuaranteeObligationsMaximumExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzc3MDA_f57807cc-6d1e-45d7-8a79-1f5ddf184c9c">200</ix:nonFraction> million in accordance with FASB ASC Topic 460, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is consistent with the contingent consideration arrangement executed with our initial acquisition of the portfolio in accordance with FASB ASC Topic 805.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib2df95943daa4a90a6f2478260200bb9" continuedAt="i54ede861ec794d64a98b3bd428e2c223"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vertiflex, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2019, we announced the closing of our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#8482; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i029e2805f8d2493c952047d8981ed692_D20190611-20190611" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzgyNzg_35b7981f-18e0-432f-b1a2-24c62a6d2b0e">465</ix:nonFraction> million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of <ix:nonFraction unitRef="usd" contextRef="i28538f28a987480db2349df82889a791_I20190611" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzg0ODg_f4230bc1-8a02-4c16-8aa7-9172dad65abd">zero</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i28538f28a987480db2349df82889a791_I20190611" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzg0OTQ_d7406bf7-98a4-40ef-b05e-0eadd950bb4e">100</ix:nonFraction> million; however, the payments are uncapped over the three year earn-out period. Through December&#160;31, 2020, we have made incremental payments of $<ix:nonFraction unitRef="usd" contextRef="i0659d4a09c104d69a40367c98f578cba_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTE3OTE_977cb711-d4bd-45fe-98b1-b80907fa7e21">20</ix:nonFraction> million to the prior shareholders of Vertiflex in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Millipede, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we announced the closing of our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i1be67d7dc4894d3d9ac61ec671d1f66c_D20190129-20190129" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzkyMzQ_585f0629-bb84-4b1b-9937-42db59acbdca">90</ix:nonFraction> million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately <ix:nonFraction unitRef="number" contextRef="i506a6ba7c7f04e2fbbbc72dd6a366a00_I20190129" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzk0NDM_a3ba5427-bc13-4b91-9e3a-6fc1de09d586">20</ix:nonFraction> percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i1be67d7dc4894d3d9ac61ec671d1f66c_D20190129-20190129" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzk3NjY_4d4065ba-46d3-4996-b65b-db4f4d9bc186">325</ix:nonFraction> million and up to an additional $<ix:nonFraction unitRef="usd" contextRef="i506a6ba7c7f04e2fbbbc72dd6a366a00_I20190129" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzk3OTM_3611dab6-e6c4-4469-8d9e-4fdaaebab05a">125</ix:nonFraction> million payment upon achievement of a commercial milestone. Through December&#160;31, 2020, we have not made any incremental payments to the prior shareholders of Millipede, as the commercial milestone has not yet been achieved. Following the closing of the acquisition, we integrated the Millipede business into our Interventional Cardiology division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NTk_c38654e7-c9c3-43d1-bb3d-98f563e0807a" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4N2YyOTFiNDEyMWY0MWM1YmY4OTNjNzYzYjI2NWIyZi90YWJsZXJhbmdlOjg3ZjI5MWI0MTIxZjQxYzViZjg5M2M3NjNiMjY1YjJmXzEtMS0xLTEtMA_0096038a-5684-4379-937d-363b70f6a4d7">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4N2YyOTFiNDEyMWY0MWM1YmY4OTNjNzYzYjI2NWIyZi90YWJsZXJhbmdlOjg3ZjI5MWI0MTIxZjQxYzViZjg5M2M3NjNiMjY1YjJmXzItMS0xLTEtMA_6b6103e1-c5d4-43a8-b807-56661cbefafb">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4N2YyOTFiNDEyMWY0MWM1YmY4OTNjNzYzYjI2NWIyZi90YWJsZXJhbmdlOjg3ZjI5MWI0MTIxZjQxYzViZjg5M2M3NjNiMjY1YjJmXzMtMS0xLTEtMA_de610e67-d87a-4177-b749-a054b5e0877f">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4N2YyOTFiNDEyMWY0MWM1YmY4OTNjNzYzYjI2NWIyZi90YWJsZXJhbmdlOjg3ZjI5MWI0MTIxZjQxYzViZjg5M2M3NjNiMjY1YjJmXzQtMS0xLTEtMA_ca246030-eb08-4a81-92f3-131a4688c917">992</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NjE_1238934c-84f1-489f-8091-932973d90cbd" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzEtMS0xLTEtMA_f789011b-20b5-4bc3-85d5-a1026b314ff1">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzItMS0xLTEtMA_6fd2501b-1e4c-4bca-954b-ee4617ccc57d">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzMtMS0xLTEtMA_c5da6fa3-e733-4d3c-9000-25abfad85f3c">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzQtMS0xLTEtMA_b8ac8f12-8360-42d2-bf02-21f2a2d2d7c7">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzUtMS0xLTEtMA_af6b10e5-1027-4950-b1cd-cc7a8f015af8">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzYtMS0xLTEtMA_26f1388a-c9b4-43e1-abff-6b7289789fda">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzctMS0xLTEtMA_96ea76fc-9c6c-47fc-bdd9-03e7a927338a">992</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i54ede861ec794d64a98b3bd428e2c223" continuedAt="idb49cc97998644f0934eff0ecdb00e6f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NjI_281246f6-1914-46b8-b169-52f6d1c6fbf2" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04f535d42894b13baf5c1bf29abbdfa_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzItMS0xLTEtMA_596a9bec-ff87-4b8e-9cdb-c3e237266345">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac2d0307d9d04ae1a423eaf989020c84_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzItMy0xLTEtMA_94c5ec9f-3b7d-456d-89e2-760f4e228371">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac2d0307d9d04ae1a423eaf989020c84_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzItNy0xLTEtMA_8c42b17b-503a-4fee-9412-9a3cd9019fc1">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c0fc8eddb08406ea3d86b0a6e07223d_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzQtMS0xLTEtMA_ce291dfa-a484-4f5c-878b-bbe51c06f5af">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idae083babc2c41c6920c5a332adfac61_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzQtMy0xLTEtMA_a33c2a06-a40a-4f99-8a57-7b3992be01c7">12</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idae083babc2c41c6920c5a332adfac61_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzQtNy0xLTEtMA_44796ffd-58ac-487c-8536-d2fe90bc1c6b">15</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2317bba8b93a4381b47fcbb9f84a225a_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzYtMS0xLTEtMA_32294ab2-c686-48ee-9b28-300247c94f0e">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d7e6ed023a74081b6372d23bc145ba3_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzYtNy0xLTEtMA_14781e1b-a596-4902-bf3a-4e7096f885f4">19</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzctMS0xLTEtMA_5dedc0fb-e370-451e-a005-ab13deebba8e">461</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Augmenix, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 16, 2018, we announced the closing of our acquisition of Augmenix, Inc. (Augmenix), a privately-held company that developed and commercialized the SpaceOAR&#8482; Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer. The transaction price consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i496c2de855594c64bc941488053cc536_D20181016-20181016" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzExMTg0_694d6f6e-07a2-44c6-88a6-36936a81b625">500</ix:nonFraction> million and up to $<ix:nonFraction unitRef="usd" contextRef="i904147befc444b9bbdc64d9876b10897_I20181016" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzExMTk3_5beb4ae1-6319-4958-920b-6c6d339bbec8">100</ix:nonFraction> million in payments contingent upon achieving certain revenue-based milestones. Through December&#160;31, 2020, we made incremental payments of $<ix:nonFraction unitRef="usd" contextRef="i884efc79fc7e4752a4aa11bebd3bbcf3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTE4MjQ_6aff175e-76fb-48b8-ae65-f5c0fdebbdec">24</ix:nonFraction> million to the prior shareholders of Augmenix in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Augmenix business into our Urology and Pelvic Health division.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Claret Medical, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2018, we announced the closing of our acquisition of Claret Medical, Inc. (Claret), a privately-held company that has developed and commercialized the Sentinel&#8482; Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter aortic valve replacement (TAVR). The transaction price consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i31712f6779184ad8bf710b35128f9962_D20180802-20180802" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzExODYx_bb93a638-6226-4cec-a4be-00c49635f988">220</ix:nonFraction> million and an additional $<ix:nonFraction unitRef="usd" contextRef="i83308e067e9f492fbd4a9d89b3ef8503_I20180802" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzExODgy_af913a63-0080-4994-a736-256fea111dff">50</ix:nonFraction> million payment for achieving a reimbursement-based milestone that was achieved in the third quarter of 2018. Following the closing of the acquisition, we integrated the Claret business into our Interventional Cardiology division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cryterion Medical, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2018, we announced the closing of our acquisition of Cryterion Medical, Inc. (Cryterion), a privately-held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation. We had been an investor in Cryterion since 2016 and held an interest of approximately <ix:nonFraction unitRef="number" contextRef="i1e1286aef3b14fbbbc9b05febb4fb2e0_I20180705" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEyNDQw_f76a0f87-de9b-4aa7-b900-d03f04f3fb3d">35</ix:nonFraction> percent immediately prior to the acquisition date. The transaction price to acquire the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="ia7a425fa4f004c2eaea7363a2060f19e_D20180705-20180705" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEyNTc5_675c4869-26d7-4e89-a0ce-355db6ee3317">202</ix:nonFraction> million. Following the closing of the acquisition, we integrated the Cryterion business into our Electrophysiology division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NxThera, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2018, we announced the closing of our acquisition of NxThera, Inc. (NxThera), a privately-held company that developed the Rez&#363;m&#8482; System, a minimally invasive therapy in a growing category of treatment options for patients with benign prostatic hyperplasia (BPH). We held a minority interest immediately prior to the acquisition date. The transaction price to acquire the remaining stake consisted of an upfront cash payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i3cc07fbb23104ef5b60a1a0aac61b408_D20180430-20180430" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEzMTc0_12d79ded-f69c-40a3-981f-c222a7fa7e3d">240</ix:nonFraction> million and up to approximately $<ix:nonFraction unitRef="usd" contextRef="iad9c6a324c6441d1b8f2cfc19eb1608e_I20180430" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEzMjAx_1a538ead-22d4-45b9-913d-ded5aabc6dbd">85</ix:nonFraction> million in future potential payments contingent upon achieving commercial milestones over the four years following the date of acquisition. Through December&#160;31, 2020, we have made incremental payments of $<ix:nonFraction unitRef="usd" contextRef="i5478b53eb62b479dae6f8838d73e6197_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTE4Mzk_44baefde-3aad-466e-bbd3-034e5acf4f74">12</ix:nonFraction> million to the prior shareholders of NxThera in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the NxThera business into our Urology and Pelvic Health division.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idb49cc97998644f0934eff0ecdb00e6f" continuedAt="i4897f7b113564cd2b7a286776ee18392"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">nVision Medical Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2018, we announced the closing of our acquisition of nVision Medical Corporation (nVision), a privately-held company focused on women&#8217;s health. nVision developed the first and only device cleared by the U.S. Food and Drug Administration (FDA) to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer. The transaction price consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i6555d4428a7140748bd802e9a768fd8e_D20180416-20180416" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEzOTI1_9bf47792-e07c-4336-afa6-fe0330292f1a">150</ix:nonFraction> million and up to an additional $<ix:nonFraction unitRef="usd" contextRef="i3b9fe0db816347ab9940c21c9b0d768e_I20180416" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEzOTUy_153bd0e9-a926-4619-9ec4-08623680f46d">125</ix:nonFraction> million in future potential payments contingent upon achieving certain clinical and commercial milestones over the four years following the date of acquisition. Following the closing of the acquisition, we integrated the nVision business into our Urology and Pelvic Health division. We discontinued the nVision R&amp;D program during 2020 and do not expect to make any incremental payments to the prior shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we completed other individually immaterial acquisitions in 2018 for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i808cb5579b214ed483e0c55813432263_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE0MzYw_e09e31ad-9a31-45fa-a796-16f64da9a4e1">158</ix:nonFraction> million in cash at closing plus aggregate future potential contingent consideration of up to $<ix:nonFraction unitRef="usd" contextRef="ie9d42aa1c99141d9a7c12881fbf9ad48_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE0NDQ4_b28034a4-cc4d-43c1-8482-e5685c5431e0">62</ix:nonFraction> million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded gains of $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE0NDc1_4584732e-0fdb-4650-a856-5062540909b6">184</ix:nonFraction> million in 2018 within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated statements of operations based on the difference between the book values and the fair values of our previously-held investments immediately prior to the acquisition dates. The aggregate fair value of our previously-held investments immediately prior to the acquisition dates was $<ix:nonFraction unitRef="usd" contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE0NzY4_a078e880-a79a-4ef9-a3ba-4943965caac6">251</ix:nonFraction> million. We remeasured the fair value of each previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for our 2018 acquisitions as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. <ix:nonNumeric contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjIw_c14a7dd6-18bf-4e07-ab84-d36eb2ffc5eb" continuedAt="i3423ebcc3b014ff99ceec3da786c8c45" escape="true">The final purchase prices were comprised of the following components:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="i3423ebcc3b014ff99ceec3da786c8c45"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTplZTc3NjM0YmNlNTE0ZTAzYmQxODJjNGY3YTU5NDJlZS90YWJsZXJhbmdlOmVlNzc2MzRiY2U1MTRlMDNiZDE4MmM0ZjdhNTk0MmVlXzEtMS0xLTEtMA_3e21dfdb-4546-44e6-bf7e-b8cb68d71fed">1,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf000a38a8df435292fe43a04c563e76_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTplZTc3NjM0YmNlNTE0ZTAzYmQxODJjNGY3YTU5NDJlZS90YWJsZXJhbmdlOmVlNzc2MzRiY2U1MTRlMDNiZDE4MmM0ZjdhNTk0MmVlXzItMS0xLTEtMA_74d484f3-4fd5-4f02-8cf5-6e6d5a0fad7d">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTplZTc3NjM0YmNlNTE0ZTAzYmQxODJjNGY3YTU5NDJlZS90YWJsZXJhbmdlOmVlNzc2MzRiY2U1MTRlMDNiZDE4MmM0ZjdhNTk0MmVlXzMtMS0xLTEtMA_a078e880-a79a-4ef9-a3ba-4943965caac6">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTplZTc3NjM0YmNlNTE0ZTAzYmQxODJjNGY3YTU5NDJlZS90YWJsZXJhbmdlOmVlNzc2MzRiY2U1MTRlMDNiZDE4MmM0ZjdhNTk0MmVlXzQtMS0xLTEtMA_776d7325-6f8b-48a7-ad6d-97accc1e2e58">1,948</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjUz_72dbea65-05ad-4f15-8e81-d61deafd5621" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf000a38a8df435292fe43a04c563e76_I20201231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzEtMS0xLTEtMA_80132c26-c418-4acf-a917-2356c0e41ff5">939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf000a38a8df435292fe43a04c563e76_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzItMS0xLTEtMA_7644d4c1-48c8-4d70-8d29-fc6f75453b29">939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf000a38a8df435292fe43a04c563e76_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzMtMS0xLTEtMA_9d44ec65-ed37-4ef0-8aad-5cdce0b2f01c">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf000a38a8df435292fe43a04c563e76_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzQtMS0xLTEtMA_99d895a6-132a-4471-ae4c-113c6a88eb2e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf000a38a8df435292fe43a04c563e76_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzUtMS0xLTEtMA_adfb949d-5856-446e-8f71-821cb352ee90">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf000a38a8df435292fe43a04c563e76_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzYtMS0xLTEtMA_6699817a-00fa-430b-9d27-f4ddb4341d4c">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzctMS0xLTEtMA_1be5916f-89ae-4225-8a91-3b0165ebacaa">1,948</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4897f7b113564cd2b7a286776ee18392" continuedAt="i9f81907dec7d405a8376b47d549e1433"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjUy_38f6fc13-a126-4b75-aae4-ce0896bf34d9" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c966453e2a342b3a3f4d64f2c1428d0_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItMS0xLTEtMA_194b83a3-2437-4eb5-ac03-d0b62382134d">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie298bcc204ee4eb6b430de4388bf4f81_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItMy0xLTEtMA_dbb6c6aa-3ef0-4a85-8750-daec6b8d8d13">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i761fd86626924956bb4384aaa7769a24_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItNS0xLTEtMA_7b0c0fef-f2dc-41ec-be3e-39031f491aac">14</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie298bcc204ee4eb6b430de4388bf4f81_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItNy0xLTEtMA_a5c98cf0-349c-4dfd-a1e3-9146b7380b71">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i761fd86626924956bb4384aaa7769a24_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItOS0xLTEtMA_a3c3b3dc-b902-4f0c-995e-a04a1200672e">23</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf378e387584a16a29c91ef5252aa72_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtMS0xLTEtMA_bbd5a089-9222-42ba-ada7-dfb31d23c136">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01e3c724a40741a28dbc546b88724c67_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtMy0xLTEtMA_32491e25-518e-4442-adf1-0564af5c53f4">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia5bf5b7491cc40229dcf4fc38c3ff0db_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtNS0xLTEtMA_7170223f-614f-4502-bc3b-f95c788e37f0">13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01e3c724a40741a28dbc546b88724c67_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtNy0xLTEtMA_c46f90a7-61ec-477b-9c56-77033950d3d0">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5bf5b7491cc40229dcf4fc38c3ff0db_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtOS0xLTEtMA_baccc4e8-4169-49fc-8103-4c20887ec0c2">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c571473f99c4f8ead199ef961c9e48e_I20201231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzYtMS0xLTEtMA_88d8a0f6-c6af-4a89-b21e-899d02240e1f">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i172db034d54f4af59ea3ef913e7f74b6_D20200101-20201231" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzYtNy0xLTEtMA_0897ffd4-68b0-40dd-a408-8651afeb5073">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf000a38a8df435292fe43a04c563e76_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzctMS0xLTEtMA_26c8b533-145e-4273-88e0-d40f6f0d4554">1,153</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies. The goodwill recorded relating to our acquisitions is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjU3_5a312fed-8c8a-4d5b-a428-f95e12fa8f6d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzEtMS0xLTEtMA_6e06355d-8263-4b60-88c3-d95dd12451c7">347</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzItMS0xLTEtMA_0c4c502c-ef28-413b-bde3-562b7a8ca6c6">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzQtMS0xLTEtODU1NA_b90893d5-cc09-4ff6-8e6a-88fb1585e5c4">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzQtMS0xLTEtMA_e7d7d8fe-65d4-48da-8bc3-33a9c6ed62e2">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzUtMS0xLTEtMA_b16cd8b6-0dfe-46d5-a501-0f3213746e39">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzYtMS0xLTEtMA_1a16af1a-03b9-4f8b-b045-53c600b2de80">354</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzEwLTEtMS0xLTA_69f16185-a21f-4e6c-8b87-5fcdd9871174">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzExLTEtMS0xLTA_d1aaf4e3-5fbe-4a04-b03b-50436284de34">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzEyLTEtMS0xLTA_f714630e-e682-464a-aed1-21677b677624">196</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE4Mjg4_88c2bbd6-7ce4-4888-9760-6f4261f0e43a">532</ix:nonFraction> million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxNzg4ODE_3cd1823f-d395-4bc0-b650-628050648a1d">100</ix:nonFraction> million benefit recorded in 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or in the case of nVision, for milestones that would not be achieved due to discontinuation of the R&amp;D program.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9f81907dec7d405a8376b47d549e1433" continuedAt="i7aaf6565e8a444e1ba39571fc8269442"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjkyNzM_4a90a924-4bc4-4917-a164-223e908aaf9e" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic81e0a9293d34d779237110332e1ab2f_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzEtMS0xLTEtMA_67fd80c3-b9f9-47d1-8f4a-39d94b32c96d">104</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa490a08b9e140b4b87e705cf3401a77_D20200101-20201231" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzEtNC0xLTEtMA_da046651-fa79-48f1-a80d-64de11d93c45">2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i225a40fb505b4a9ea385c6900535fdf6_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzEtNy0xLTEtMA_f6153892-2ebd-4a92-8d14-10dd172da5eb">2</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic81e0a9293d34d779237110332e1ab2f_I20201231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzItNC0xLTEtMA_25f71c91-23df-4955-ae8a-cdc483f69a09">90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id3a7f90c9cea4edc82150a9d77fd688d_I20201231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzItNy0xLTEtMA_f5f3f89d-c1db-4121-a767-c1fbfa6cb13c">90</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i85248c1e3e8d4e798e32297ec2f4a394_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzQtMS0xLTEtMA_3533138e-242b-450b-8edc-0867f79c9873">93</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21f76d998b4a431984b2deeb969e9e85_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzQtNC0xLTEtMA_b0fab79e-09ff-4d76-a2ae-ff55ad01cb41">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib29c8720d4e5458c8a5b0b896a9227d5_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzQtNi0xLTEtMA_1dac3d12-ac46-4bfa-a985-7513d8d9d148">14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib31907c21c804935b3eabe4556382002_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzQtNy0xLTEtMA_8d815b86-fc7e-430b-97ab-5301ce18f8b9">13</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0d71a4a1294e5a9aaa4452bcfcc83d_I20201231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzUtNC0xLTEtMA_6d7f6c93-9d35-48e5-a877-ec0fa76d649f">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5da8394a7b3140a8b169f5c7d428772b_I20201231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzUtNi0xLTEtMA_35dfcdb0-cad6-4074-ba6f-f55f2ac5db5c">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifab990ff13f04a489cc2ddc900075cbb_I20201231" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzUtNy0xLTEtMA_a03eb26c-90be-4581-97af-c60e8f5266bf">100</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to our R&amp;D, commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzMyOTg1MzQ5MTM4MjA_132b9ddc-7016-4979-8497-6ce645f11688" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzItMS0xLTEtMA_3caa92be-ed1b-4794-8f6d-710cddcf4de3">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzItMy0xLTEtMA_e0fa71c2-c90d-46aa-9920-cfae5bd5a97c">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzMtMS0xLTEtMA_0c5b88bf-4ceb-4e69-8f1c-f814e0f594a6">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzMtMy0xLTEtMA_f4fff1f9-0587-4dc0-8b5c-24204d1c8ba0">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzQtMS0xLTEtMA_7fa941e5-0d3c-4c61-b59f-c25bd850e2a5">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzQtMy0xLTEtMA_e48194a6-c850-41db-94d0-aceac6294c51">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzUtMS0xLTEtMA_1fd859ca-0b89-4a66-8bb0-c51c30000849">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzUtMy0xLTEtMA_c815f300-cba7-4098-98b5-9c97e48b5e1b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzYtMS0xLTEtMA_94be00c3-4ecd-4b61-ad48-1f55d67db54e">918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzYtMy0xLTEtMA_d56865e9-91f8-4723-b574-5103baff1239">458</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated statements of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i7aaf6565e8a444e1ba39571fc8269442" continuedAt="i6489e69e349b49c4b0b6f285357cda40"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we recorded a $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTc5NzM_7e29be69-1c14-4151-8518-75ce3f327ef4">363</ix:nonFraction> million gain on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6489e69e349b49c4b0b6f285357cda40"> to remeasure to fair value based on observable market prices. As of December&#160;31, 2020, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTc0Mjc_d032d0fe-81f1-488d-9987-ed7a6cc2cf9b">272</ix:nonFraction> million, which represents amortizable intangible assets, IPR&amp;D, goodwill and deferred tax liabilities.</ix:continuation> </span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_1934"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGV4dHJlZ2lvbjphNzFkYTNhNzc4MDI0YjhmYTcwMzEyMzNjM2NiZGRmZV81NDk3NTU4MTYxMzU2_f93efd86-dc26-456a-8d05-e786ad5cc356" continuedAt="i568be1d808ba4b8aa70e3243cc00211f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; ASSETS AND LIABILITIES HELD FOR SALE</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGV4dHJlZ2lvbjphNzFkYTNhNzc4MDI0YjhmYTcwMzEyMzNjM2NiZGRmZV8yNzQ4Nzc5MDg4MDQ0_ae7fb70f-bb50-4324-97a6-efa611c19699">800</ix:nonFraction> million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement includes the transfer of five facilities and approximately 280 employees globally. The transaction is expected to close during the first half of 2021, subject to customary closing conditions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we have classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less costs to sell. Assets within the disposal group are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated balance sheets. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i568be1d808ba4b8aa70e3243cc00211f" continuedAt="icfd0fdc345294c228af9c856aec500f0"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGV4dHJlZ2lvbjphNzFkYTNhNzc4MDI0YjhmYTcwMzEyMzNjM2NiZGRmZV81NDk3NTU4MTYxMzU3_c8af59c7-ad6f-47db-bcd7-7e621f439b7f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xLTEtMS0xLTEzODU2_89948fac-ffe8-445c-b70d-75287221b80a">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xLTEtMS0xLTgzNzE_d091a40c-e76f-432f-b568-3050b0825bb1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8yLTEtMS0xLTgzNzE_7fed4567-a1cd-43d9-98aa-3374d7f49c37">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8zLTEtMS0xLTgzNzE_49305cf8-5f23-45bb-8aa0-6c5b1fa65f71">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV80LTEtMS0xLTgzNzE_c92beb0a-b938-4f7f-a819-83ec5584b87e">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV81LTEtMS0xLTgzNzE_acffb073-f1cd-4c2d-bff8-6c10c9936b12">758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="bsx:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV82LTEtMS0xLTgzNzE_6ff0e721-66bc-46bd-98e8-a4247476b1d9">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV83LTEtMS0xLTgzNzE_1d16b292-6675-4bdf-a1fc-0eb91d9d3ca9">1,133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV85LTEtMS0xLTgzNzk_74eb3d8c-765b-4c3f-b080-5b92fcbdf2ce">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xMC0xLTEtMS04Mzc5_127b0b35-51f1-4581-be9b-b75b31e52bda">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xMS0xLTEtMS04Mzc5_e734bcdb-4bc9-4e03-b25a-d2b5a2c3efcc">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other current liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xMi0xLTEtMS04Mzc5_52d02795-9d2d-4e31-9d9c-fcf08f893f32">200</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="icfd0fdc345294c228af9c856aec500f0" continuedAt="i65d4c5e016d043da961fe364769a7914"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of December 31, 2020, we had foreign currency translation adjustments of $<ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGV4dHJlZ2lvbjphNzFkYTNhNzc4MDI0YjhmYTcwMzEyMzNjM2NiZGRmZV81NDk3NTU4MTYxMzU5_3eaee706-bdfc-42a1-9de5-8d00d53c42b8">107</ix:nonFraction> million contained within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i65d4c5e016d043da961fe364769a7914"> attributable to the Specialty Pharmaceuticals business to be released upon the closing of the transaction.</ix:continuation> </span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_106"></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzEzODQ_aa01f9ad-c22f-4d77-b610-df76d9c9c0d6" continuedAt="i30b7674dd23d4a578f6bc9c018ef8761" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows: </span></div><div style="margin-bottom:6pt;text-align:justify"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzE0MTY_4abac3d1-d991-4d1b-91da-6f1534f4edf7" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Goodwill Impairment Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Goodwill Impairment Charges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e34e4fce414bad91b9758bf3c925fb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzMtMS0xLTEtMA_1045a15c-9f95-4b63-ae8e-a27adb78f81f">11,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e34e4fce414bad91b9758bf3c925fb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzMtMy0xLTEtMA_b807c09b-55c1-4746-b37c-3f6914973270">6,179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d6a824461a469cb0d94f10e9342c7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzMtNS0xLTEtMA_b01513ed-0c75-4090-b041-93ecfcad4bf8">12,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6d6a824461a469cb0d94f10e9342c7f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzMtNy0xLTEtMA_d1af0435-4d2d-4a72-a4c5-80e65186102a">5,706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26e8cfad4e524c8bbce668b54331c93b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzQtMS0xLTEtMA_350566cb-9e51-4579-a330-675b87d78f97">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26e8cfad4e524c8bbce668b54331c93b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzQtMy0xLTEtMA_6595e391-7129-49c5-9a25-ba6361bbf953">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53e75f811f294c61b8be35eaba703298_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzQtNS0xLTEtMA_c86b11ab-c662-470e-93b4-73613e16acf0">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53e75f811f294c61b8be35eaba703298_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzQtNy0xLTEtMA_b06124a3-da40-4b58-85af-a6bccd49cf0b">408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1de9a90b228e4b489fceda143c56c8cf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzUtMS0xLTEtMA_c27d0518-6e36-4e93-807d-7536347d6bf9">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1de9a90b228e4b489fceda143c56c8cf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzUtMy0xLTEtMA_045c0245-3d9f-447d-91e4-2e67e5c68211">1,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad66c6f19564d8281c1fa550e0e9503_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzUtNS0xLTEtMA_d11590a1-8ebb-4684-9017-17c0ffd4849e">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ad66c6f19564d8281c1fa550e0e9503_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzUtNy0xLTEtMA_47545c49-600d-443d-a08b-77dc799cfcfc">1,081</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzYtMS0xLTEtMA_8b3b6190-9857-4c1e-8ed3-14a2fdfecdf7">13,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzYtMy0xLTEtMA_86df6118-2076-49e0-8d77-f7336d3d6cc4">7,806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzYtNS0xLTEtMA_79db63e0-fe04-481e-add8-a7fd5dfde3b5">14,299</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzYtNy0xLTEtMA_59cd29a8-e847-4432-beda-54aea60001be">7,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzctMS0xLTEtNjMx_d16f0cfc-94df-43f7-aff6-b9a9ce2809f3">19,924</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzctMy0xLTEtNjMx_d0c17ecc-6a9b-4655-b9e7-ac97c85e8706">9,973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzctNS0xLTEtNjMx_05e06944-9808-4b6e-acb8-a7241b4e4ee2">20,076</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzctNy0xLTEtNjMx_c7778227-b84e-4d9a-84b5-244a9536cf4b">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ebe498a99547009a19b14541a8843b_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzktMS0xLTEtMA_273955c3-3591-47d9-a276-be524881ef37">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6909276f2047e6aacb514e5552c63a_I20191231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzktNS0xLTEtMA_cf1eb68d-d165-472f-9ea2-6638a09db7d4">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41f1841703d848508d023ea0e135c3ca_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzEwLTEtMS0xLTA_852ec45c-abac-4e90-81d8-82c0c155d2f4">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia322e236c1ba4565bcbe28841e306760_I20191231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzEwLTUtMS0xLTA_03eda13e-7936-4ea3-a21f-34b90d51e411">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzExLTEtMS0xLTA_dbad1cc0-14c4-4df1-baa1-1395c3b286c8">377</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzExLTUtMS0xLTA_5da9d0cf-1a33-441c-9e9c-4329f848b2bb">782</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, following receipt of regulatory approvals, we reclassified certain of our IPR&amp;D intangible assets to amortizable technology-related assets and began amortization to reflect their use over their remaining lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzU1Mw_5c538a4c-8f90-4a07-9673-349dd2aca177">460</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzU2Mw_c4af45c3-6ab9-4f9b-be36-4d46386eaaef">105</ix:nonFraction> million in 2019 and $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzU3Ng_01ec64d0-8883-413a-acaf-50e65b8df617">35</ix:nonFraction> million in 2018. The impairment charges recorded in 2020 were primarily associated with our acquisitions of Apama Medical Inc. and nVision Medical Corporation (nVision) following management&#8217;s decision to cancel the programs due to cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2020 also included charges related to our acquisition of Sadra Medical, Inc. (Sadra Medical) as a result of lower sales forecasts, as well as the cost of quality remediation efforts following the voluntary recall of our LOTUS Edge&#8482; Aortic Valve System and subsequent discontinuation of the LOTUS platform. </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i30b7674dd23d4a578f6bc9c018ef8761"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzEzODE_93b6bdd2-9432-4842-8613-ddd3bb563716" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.550%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32470da1e8e4392b88a0f486f43a9c1_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtMS0xLTEtMA_bd28c3bd-c021-407c-8eb8-53e8dd9fd058">2,063</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d70084f4dd7415eabb7a85e24d97a2a_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtMy0xLTEtMA_d7ee7ca9-58a7-4f03-81ab-66194e799eca">1,924</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604905e66a504173a840028f3327dd56_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtNS0xLTEtMA_edde02a9-b82d-4003-bc51-61a592ff4bc1">3,925</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7793c5feec074fb6a77322031639508b_I20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtNy0xLTEtMA_ec31db2e-0e83-4469-b431-0054cae304ac">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtOS0xLTEtMA_80fd4626-b4d4-4373-b6e5-edb0a8981084">7,911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtMS0xLTEtMA_71eaaf7b-15a1-48ce-a1a0-7c0ddf0398bc">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtMy0xLTEtMA_e0f7960d-07e7-4bd4-a722-4b1bc1b67489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtNS0xLTEtMA_778cb794-5683-4d42-98c7-f648470a062b">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtNy0xLTEtMA_b6ce2f4a-b46e-4cde-bb0f-118d2caa8bcb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtOS0xLTEtMA_af6a2443-c760-4fe8-832e-960323a97ca1">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtMS0xLTEtMA_80e67f85-0116-42fa-9412-ff7f446af285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtMy0xLTEtMA_fbde0985-fb97-4e7b-a341-fb7e47186cc1">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtNS0xLTEtMA_c423465d-239f-42df-a73f-e0dadd28f375">1,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtNy0xLTEtMA_48366408-eef8-4c3e-9044-f6f86d178e75">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtOS0xLTEtMA_973c06e6-2b65-466d-8953-9f5cccf1c960">2,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill divested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtMS0xLTEtMA_d2476021-cace-4d42-afac-224d66b9ffa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtMy0xLTEtMA_5ccdcc74-6785-47aa-bf7d-a218b4940bd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtNS0xLTEtMA_9ff81f03-a60e-43fb-9912-6ed9e2b3cecc">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtNy0xLTEtMA_6b4d3658-d552-402c-b1c1-cdc008f172e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtOS0xLTEtMA_603c9930-fba3-44d1-91fc-c5477a7acc3d">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4452aaad562b4bb899286f3797d9eb2d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtMS0xLTEtMA_9716d85e-4f8e-4b8f-8c1f-a88f8b5f5814">2,061</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e86856187e44c808f6433015dceb738_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtMy0xLTEtMA_d90f1441-eff3-4008-b5ae-da9050f927d3">2,192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c2fb79c41b4be6bf7aa2326d6b1cae_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtNS0xLTEtMA_e898e000-baf0-4ed6-8a27-ff971ef551be">5,676</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd58d69b28dd40519b4334498825790f_I20191231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtNy0xLTEtMA_51e66d50-1061-4803-b452-83410dea29ef">247</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtOS0xLTEtMA_1f0f819a-f7dc-4063-8695-b905cfcc4c05">10,176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtMS0xLTEtMA_7c1f071c-0037-41b3-b863-a09df7bfbfb5">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtMy0xLTEtMA_cfa94fbb-04f2-46b1-8a07-66b0e1491c1b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtNS0xLTEtMA_1c7a3d20-5392-41dd-a0d5-58f1ec304176">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtNy0xLTEtMA_d7d758d5-10b5-4e29-980c-ce2cb233d3d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtOS0xLTEtMA_3b5fa9ea-884d-4dd2-b6e3-0ef71bc03f3e">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTEtMS0xLTUwMzU_14be819b-2930-439b-aa5c-560016af6ada">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTMtMS0xLTUwMzU_2845b794-2686-461f-8b93-f01d7f569479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTUtMS0xLTUwMzU_a15ee14a-aa40-4eb0-b8e8-da3571d7e98a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTctMS0xLTUwMzU_cb85a980-be69-4178-83f4-a7edf13e5733">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTktMS0xLTUwMzU_dea5b7a8-c750-4d73-b759-1c9ead4d6c68">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill reclassified to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current assets held for sale</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTctMS0xLTUwMzU_d6a24dd3-4908-44e0-be6f-2a4acd458b4e">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTktMS0xLTUwMzU_9887e531-f26c-4c8c-96b1-ca7685e817ca">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f17ca4d9f544e3b7cb7e5c6f72280c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTEtMS0xLTA_4fccd5ae-3cf7-4409-8599-f1df2bc0b9bd">2,059</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593eb42527b540c88a5921faa53b3629_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTMtMS0xLTA_6443d117-2035-45ae-8e75-c3fb717886c8">2,194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d99afc9e3b24ff09921674dea102a4b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTUtMS0xLTA_008c53e2-763d-42a2-a632-c0164c9ad2f7">5,697</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7768e07d07cb437d89233e0f9387ac2e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTctMS0xLTA_0ff8b339-2427-4b00-8f8a-0c86540e7d47">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTktMS0xLTA_ad04277e-f0f6-4c0a-9c0e-4030bcc1240c">9,951</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzY1OTcwNjk3ODY4ODI_957e7ce5-fcc0-4f10-bfe5-f5f042cd7971">73</ix:nonFraction> million related to our Specialty Pharmaceuticals business. We did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2019 or 2018. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of our goodwill and intangible asset impairment testing.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzE0MDY_bfe21adf-c642-4c12-8e8c-be1866a4d34a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2020 is as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:83.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzItMS0xLTEtMA_ef300c30-4875-464c-8fef-b1f0c1c2754a">689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzMtMS0xLTEtMA_3f251035-88ec-4f87-a73e-b92039bd97f5">664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzQtMS0xLTEtMA_b1755369-b4c9-465a-beea-70477d426942">651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzUtMS0xLTEtMA_0d9244ea-1890-4587-95a1-616ee8e71e52">613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzYtMS0xLTEtMA_f4ae4ff2-fbc4-420f-942a-9d8806879fc7">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_109"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwMzM1_2fe8f260-933c-4c94-9c8c-f989880e9bb4" continuedAt="i5a117fe3c7e94811bcb112fc8b671101" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i5a117fe3c7e94811bcb112fc8b671101" continuedAt="ia40a87824caa4f73956e0697224af227"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Euro, Japanese yen, Chinese renminbi, Australian dollar and British pound sterling. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast, particularly resulting from the impact of COVID-19 on transaction volumes. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro, Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. We elected to use the spot method to assess effectiveness for our derivatives that are designated as net investment hedges. Under the spot method, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have elected to exclude the spot-forward difference from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. Amortization of the spot-forward difference is then reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to current period earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;<ix:nonFraction unitRef="eur" contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzQ3MzY_ac05efa7-de8c-4aa6-aca2-663c5e930ce8">900</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzQ3NTQ_5f177565-b444-4ef5-9f6f-c3adfa17c8dc">1.000</ix:nonFraction> billion) in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i80031cfd406b4f6593c9c5e695b180e8_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzQ3NTk_ad02b3e5-73a4-45a5-81b9-d7a7021fa3f9">0.625</ix:nonFraction>% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. We dedesignated a portion of the net investment hedge in 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In 2019, we settled all outstanding contracts, for $<ix:nonFraction unitRef="usd" contextRef="ic2be247223ce41e9a14396e0b34bf4d2_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzU3ODg_50b80874-e549-48b9-a136-04b00ee53a37">294</ix:nonFraction> million, which is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for settlements of hedge contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of cash flows. Upon settlement in 2019, we received &#163;<ix:nonFraction unitRef="gbp" contextRef="i363dc865fad3412d89a91d89a180cd1b_D20190819-20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeCashReceivedOnHedge" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzYwODU_7c2cde82-576a-44dd-bd3e-d92328e1e81b">3.312</ix:nonFraction> billion of cash to fund our acquisition of BTG, which translated into $<ix:nonFraction unitRef="usd" contextRef="i363dc865fad3412d89a91d89a180cd1b_D20190819-20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeCashReceivedOnHedge" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzYxNTA_bd99cbd7-7ede-40bb-8d60-4200e69b1443">4.303</ix:nonFraction> billion based on hedged currency exchange rates. We recognized a $<ix:nonFraction unitRef="usd" contextRef="ia635740e76374063a92852a9184832c4_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzYyMTA_4d2ac00c-f538-4b81-ae20-14945d86e890">323</ix:nonFraction> million loss in 2019 and a $<ix:nonFraction unitRef="usd" contextRef="i2cfe49b594e3475db1d49e7d28359214_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzYyMzI_51883272-acf4-41a7-9dd3-cbc840389373">29</ix:nonFraction> million gain in 2018 in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to changes in fair value of the contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia40a87824caa4f73956e0697224af227" continuedAt="id55eb7ea549543c58c5fb2684b0f601d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of December&#160;31, 2020 and December&#160;31, 2019. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we designate outstanding interest rate derivative instruments as cash flow hedges we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1Xzg3NjY_908b1227-e435-4e6f-bfc8-865eb5a55dc3">29</ix:nonFraction> million loss as of December&#160;31, 2020 and a $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1Xzg3ODk_4b814c49-fae2-4663-a26a-b6c77843deb2">34</ix:nonFraction> million loss as of December&#160;31, 2019. We recognized immaterial gains and losses in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of our terminated cash flow hedges in the current and prior periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as fair value hedges outstanding as of December&#160;31, 2020 and December&#160;31, 2019. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets into earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which generally offset. The balance of the deferred gains on our terminated fair value hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was immaterial as of December&#160;31, 2020 and December&#160;31, 2019. We recognized immaterial gains in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of the terminated fair value hedges in the current and prior periods. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDI2_6695df72-6f0c-4813-93b4-ff5872bb104d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.213%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i465006924e984ad48ab06e31300af791_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzItNC0xLTEtMA_168c0b96-ca16-45d4-981e-787a8ca141b7">4,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3071c36afac844cb8c57202c79fd7e82_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzItNi0xLTEtMA_80cc1666-486f-4ad6-89a0-0931777ccb68">3,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb470d28f5b6409baadf2c224feb3e23_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzMtNC0xLTEtMA_bb307240-f35c-435c-aaca-5253a10a2973">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05947140c3ba40e2aedcd05c7acf1a22_I20191231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzMtNi0xLTEtMA_57053f71-7b97-4b1a-8c16-d8a60d649937">953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3868068050b406f9f740e75ff11f2de_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzQtNC0xLTEtMA_bc050266-75aa-42dd-b075-c945cf75d560">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab5863a52ecf47d2b29b015beb18341d_I20191231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzQtNi0xLTEtMA_998fc9fd-3754-442c-b864-4623a44b6c02">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52ebd7217064b1ebf72672758698988_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzUtNC0xLTEtMA_2b3878cf-68b9-4622-91e7-eec7918f1d92">4,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9b86111b3449e7a2b76a24eeffe984_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzUtNi0xLTEtMA_e248497a-2cea-4034-a902-e028d6ebbf7e">4,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzctNC0xLTEtMA_9376235b-41b7-48b4-a629-fafdbcbb0b67">11,349</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzctNi0xLTEtMA_8486d497-c2f6-4a4e-997e-380db09b4d48">10,218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8364;<ix:nonFraction unitRef="eur" contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzEwMTM4_ac05efa7-de8c-4aa6-aca2-663c5e930ce8">900</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzEwMTU2_5f177565-b444-4ef5-9f6f-c3adfa17c8dc">1.000</ix:nonFraction> billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of December&#160;31, 2020 is within <ix:nonFraction unitRef="units" contextRef="i248f8c480024432dac8c9a0ddc15c07d_I20201231" decimals="INF" name="bsx:ForwardCurrencyContractsTimetoMaturity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzEwMzY0_72072e57-2faf-4995-94a5-e9e5e40dbb84">60</ix:nonFraction>&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next two years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id55eb7ea549543c58c5fb2684b0f601d" continuedAt="i2852b7c3a294417d84715af56a0c799e"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwMzU2_87f97e5f-41b1-4f08-b3d7-a731a2ff15f3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note Q &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtMS0xLTEtMA_1742764a-0bd8-496b-9f7a-c0e73abb476b">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtMi0xLTEtMA_bc25e688-0cae-46d1-a091-52a479ff0423">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtMy0xLTEtMA_79163a7c-b53a-4935-b9cd-bfde6428d9a7">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtNi0xLTEtMA_b8a9f635-3747-451a-9b62-2eaab52be34b">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtOC0xLTEtMA_588dfaee-f3fa-4985-bb53-d41a3a8a988a">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtOS0xLTEtMA_b858e33a-1382-41fa-bc5e-293a4c3c8f71">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtMTAtMS0xLTA_17aa83f7-c6af-4b09-8e37-e62065d9e689">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtMS0xLTEtMA_5a735f86-2899-47ed-b2b6-0332ab551dca">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtMi0xLTEtMA_8fb245bb-8ee3-4366-bf01-7a6a246bf56c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtMy0xLTEtMA_c669a1b5-c690-4b20-b4ae-1d0a9f84a3b1">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtNi0xLTEtMA_3df5f582-a36e-4b76-be63-5f8b4037578c">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtOC0xLTEtMA_6e73e76e-721e-40c7-bc06-370344e6fed6">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtOS0xLTEtMA_fdf34ab1-fa8c-4cab-a334-11cee568c862">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtMTAtMS0xLTA_3415646e-df54-4365-93e7-131025118d61">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtMS0xLTEtMA_882adacd-b826-4274-a124-10b4614884f9">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtMi0xLTEtMA_7dce6506-31ca-40b9-996c-6d34335d4773">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtMy0xLTEtMA_0d968885-da70-417b-8ea9-8bcfb80659db">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtNi0xLTEtMA_2beee99c-34db-4442-8666-42e2b0914202">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtOC0xLTEtMA_3fa1eb6f-249a-4db3-b9f7-28699a6c9360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtOS0xLTEtMA_0621d4c6-0ad8-4486-9dd2-9e47c7292ff8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtMTAtMS0xLTA_adef48ec-3aed-4dc3-bbf5-1943d8664daf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTEtMS0xLTA_be398625-250c-4411-8480-830ce2a33971">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTItMS0xLTA_79dc644b-4aca-4269-806b-51b9f438ea2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTMtMS0xLTA_95052fe0-8ed6-4ad7-8810-b1c522e17bd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTYtMS0xLTA_3df5f582-a36e-4b76-be63-5f8b4037578c">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTgtMS0xLTA_95bbc4b4-01c5-4c92-8d99-be85f939c63d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTktMS0xLTA_cc0c2133-e62a-4919-98aa-9ff312be9bea">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTEwLTEtMS0w_43b69fee-d856-4856-a9db-e79db95fde95">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTEtMS0xLTA_05e4f214-2895-4f5e-b21e-368f68a96d4f">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTItMS0xLTA_d4dfcefe-c71a-4af1-98fd-4fb6754f3c28">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTMtMS0xLTA_487a7375-af60-41c7-902a-47890dbb9f4d">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTYtMS0xLTA_df426cb5-3237-4bea-accb-c99353cf2772">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTgtMS0xLTA_56d0dcd5-928a-4071-b193-b80b967f4bae">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTktMS0xLTA_da9776bb-773a-48f9-8aa2-3bd96cc63bca">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTEwLTEtMS0w_30915b8b-fed8-4c4d-8e16-b4776ba79f8d">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTEtMS0xLTA_3e1500f0-1df5-46ff-83ae-f68c9688f96d">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTItMS0xLTA_23a87387-6df7-4ef0-b835-59e472b536c4">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTMtMS0xLTA_93cc6c4e-faa1-40db-b46f-805c9ee94ae8">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTYtMS0xLTA_177cfe74-7add-43df-ab0b-05e513f23beb">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTgtMS0xLTA_43d3c0f3-a5db-46ce-aa77-221f0707ff65">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTktMS0xLTA_b862e17b-59ab-479b-ada5-8090830b3d16">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTEwLTEtMS0w_eef7b1b9-e95c-4067-b3b3-f3b213272fbd">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTEtMS0xLTEwODEw_713a5206-e02c-4432-b89e-b98de9554169">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTItMS0xLTEwODEw_adb6f52d-f869-4324-b356-6b388ca7bfd9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTMtMS0xLTEwODEw_bc73d832-ba21-4bf4-b635-746ce6361344">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTYtMS0xLTEwODI0_9f575652-868b-40ab-a852-5464cb2e7f23">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTgtMS0xLTEwODE5_d9e392ad-d2db-4631-92f6-c6626e388e5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTktMS0xLTEwODE5_09e1e3b0-c6da-4532-a07e-f542be9bfd4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTEwLTEtMS0xMDgxOQ_9a047b68-f847-4739-9657-87684029f472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTEtMS0xLTA_cc425355-3ea9-4014-bfa3-c7f1e719368e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTItMS0xLTA_32c7739d-4939-468b-9c81-40b441ace379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTMtMS0xLTA_36af2d83-bd10-4695-947e-e689d28f4a9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTYtMS0xLTA_177cfe74-7add-43df-ab0b-05e513f23beb">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTgtMS0xLTA_1a26183d-583d-43ba-bca4-58c67a284d9b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTktMS0xLTA_b090d014-fcef-4fb2-a5be-12dcd9ba3e3b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTEwLTEtMS0w_f3d36b0c-f495-4ea5-bc55-bf5c87b00c15">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTEtMS0xLTA_6ce285f2-1368-4d3d-ab4e-4cc0eb43219d">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTItMS0xLTA_351e8c6e-fbf2-4226-8394-363d4031da68">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTMtMS0xLTA_130ad6dd-582a-4196-9137-124020477e76">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTYtMS0xLTA_b51b71e2-0629-4371-b8a0-8246eb265405">2,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTgtMS0xLTA_51db832b-bea2-4ded-9c60-2a2d526d9dcd">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTktMS0xLTA_3732a033-303a-41d3-a8c9-20b116fc71e7">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTEwLTEtMS0w_154abda0-e229-4b27-8440-6abc9d301849">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTEtMS0xLTEwNzY5_8809742c-6a4b-4801-b36e-15d05a07fff0">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTItMS0xLTEwNzY5_3d3d03ab-c106-4d1d-813f-3592ea5e5300">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTMtMS0xLTEwNzY5_870f328f-94a2-404f-932c-a085f2c7587f">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTYtMS0xLTEwNzc2_e8c8b388-362e-494a-bd2d-9a90f15f662d">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTgtMS0xLTEwNzcy_b7bfc0e4-df9d-4327-aa11-a1a4915abd67">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTktMS0xLTEwNzcy_b6c2142e-fd6e-4a55-8ba2-bd5fbda4b77f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTEwLTEtMS0xMDc3Mg_88e369fc-5134-4573-abe0-141a066964f1">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTEtMS0xLTA_4eeaf38c-c842-4d07-abe4-53f27e043dc1">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTItMS0xLTA_cef00114-7289-42df-9293-9c38e9ca238f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTMtMS0xLTA_0f23e764-e0bf-4bfc-8208-b7911fd45da3">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTYtMS0xLTA_e8c8b388-362e-494a-bd2d-9a90f15f662d">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTgtMS0xLTA_80e70cd0-747f-44c3-949e-823faf47f659">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTktMS0xLTA_4be4d33f-7825-48b1-8682-546134fcbed2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTEwLTEtMS0w_e8c6f3de-7c10-4609-a67c-b25d28ba12fe">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2852b7c3a294417d84715af56a0c799e" continuedAt="i2d4e177bac224cec8e0363ba3c165505"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDIz_f3d5ebe1-a159-4532-9d40-7457290f1ffc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.564%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21309996213144d8a28d7561f412fa26_I20201231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4ZWEwM2Y1YWQ1ZDA0OWM0OTZmZDg0ZDBiYTVkMDYyNy90YWJsZXJhbmdlOjhlYTAzZjVhZDVkMDQ5YzQ5NmZkODRkMGJhNWQwNjI3XzEtNi0xLTEtMA_dd514c5b-4119-49c1-b6a9-6045de3d0daa">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad7391e2aa54540b42638571113812c_I20201231" decimals="-6" name="bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4ZWEwM2Y1YWQ1ZDA0OWM0OTZmZDg0ZDBiYTVkMDYyNy90YWJsZXJhbmdlOjhlYTAzZjVhZDVkMDQ5YzQ5NmZkODRkMGJhNWQwNjI3XzItNi0xLTEtMA_76d6210d-879c-4000-8b5b-27897f8954c3">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie88422a1b3d241dc8f3bc3352cdf31a0_I20201231" decimals="-6" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4ZWEwM2Y1YWQ1ZDA0OWM0OTZmZDg0ZDBiYTVkMDYyNy90YWJsZXJhbmdlOjhlYTAzZjVhZDVkMDQ5YzQ5NmZkODRkMGJhNWQwNjI3XzMtNi0xLTEtMA_699e8490-2219-4316-a020-61c6cb817db0">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwMzM0_83db553a-8bab-4752-a270-e2e325771246" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:41.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.035%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4564e07d2f464045890d0a82a7f30f1b_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzItNC0xLTEtMA_2a389ae1-bc81-4fea-bfa1-9443b7e539fe">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cef46aa868a4404ad3def8d54a0fa7c_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzItNi0xLTEtMA_f5ae51e8-26fe-4608-90c0-1d3c95581152">343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adfba5c23d24bc7b650917ab0f27ebe_D20180101-20181231" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzItOC0xLTEtMA_847a155a-f537-4aea-91bb-bf5fea9c23a3">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4564e07d2f464045890d0a82a7f30f1b_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzMtNC0xLTEtMA_971d2ca4-22c8-495d-98d3-0c1ff9a86d39">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cef46aa868a4404ad3def8d54a0fa7c_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzMtNi0xLTEtMA_7dafd3d3-f52f-41eb-804f-418a52c1fbc9">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8adfba5c23d24bc7b650917ab0f27ebe_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzMtOC0xLTEtMA_a8b79bf4-45b3-4a5f-814d-516dd53be9ce">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4564e07d2f464045890d0a82a7f30f1b_D20200101-20201231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzQtNC0xLTEtMA_44748ae0-99f1-4bcb-a70b-a519e0e2d946">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cef46aa868a4404ad3def8d54a0fa7c_D20190101-20191231" decimals="-6" sign="-" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzQtNi0xLTEtMA_b3d862d9-f0d1-4e8c-8fa1-685766619042">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adfba5c23d24bc7b650917ab0f27ebe_D20180101-20181231" decimals="-6" name="bsx:NetCurrencyExchangeGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzQtOC0xLTEtMA_64887ee8-b8dd-4325-b61d-57e3896ce732">11</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2d4e177bac224cec8e0363ba3c165505" continuedAt="ibb1ebdbac42f4a03b1661acf2cfec850"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDE1_72e70d77-f2fb-40a8-bc69-322bf788797f" continuedAt="if5e9bad17648411e888672518ad61ca3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if5e9bad17648411e888672518ad61ca3">, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means.</ix:continuation> <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDAz_90218bba-2b69-4764-a95f-76a703e18975" continuedAt="id9a92c467731410cb0e6c9f03ab8b523" escape="true">The following are the balances of our derivative and nonderivative assets and liabilities:</ix:nonNumeric></span></div><ix:continuation id="id9a92c467731410cb0e6c9f03ab8b523"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.559%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15892080636d4d31ae5423c34889e21a_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzQtNC0xLTEtMA_e96a9d46-295b-42d5-974d-9c954f8d9d48">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eb9d0a4cfa94defa4a9c54410555954_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzQtNi0xLTEtMA_29add0dd-d0ce-4162-bd55-9abf13488fd9">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48fa4493001d449ba145886a80478889_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzUtNC0xLTEtMA_7f18ecc1-7240-4234-9874-872066962b4e">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i905b6a41d15a4b2088787d8381188854_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzUtNi0xLTEtMA_cef5fedf-e30f-4682-80dd-f4458bfc3304">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7225eec3d5430180f5e3302849762c_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzYtNC0xLTEtMA_f9f61a18-b71a-47db-8503-2d40e85a0107">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fcbf0b422564ac6ad7c97196af88615_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzYtNi0xLTEtMA_fc5d3cb3-c336-4e5f-ad11-d56e94825f1e">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f7f17dea41f463eb86f00e0bd3fd2f0_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzgtNC0xLTEtMA_d2b8f5aa-80c0-46c2-8300-c0260ea7c216">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i928052d310a84aef81dc5679f247ce6c_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzgtNi0xLTEtMA_8dced763-c8c9-4de6-b119-408a6e5a695a">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzktNC0xLTEtMA_e1214ea5-14b0-4ce0-8e49-5453e2453697">242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzktNi0xLTEtMA_61ad5a7c-099a-4785-a98e-f984a81e7ee9">321</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4efb48e17cbd415e8d90d23bb91fbf35_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzEzLTQtMS0xLTA_834e8944-faef-46f9-bff0-fd9c9113f4a7">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80933ec2cc54616bb475d09124b5eb5_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzEzLTYtMS0xLTA_4dd8f481-e9e2-4aab-ba53-1157278a227d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4142356f2c47c3b2a80ca179a5478e_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE0LTQtMS0xLTA_429ba127-1f7c-474b-87e9-25fdedca7300">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008481e22f624470b6a792954311af1e_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE0LTYtMS0xLTA_2340e7af-928c-451f-81ec-d797ca7fd642">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cb97c15d414cb69088b89bb3fca575_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE1LTQtMS0xLTA_f89bb84e-93af-446f-b23a-e6bc0b0ccc0e">1,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49e7446a63114d61a987f7353caaa479_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE1LTYtMS0xLTA_aca5680b-95ff-496e-a1fc-ec7924050b12">998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7225eec3d5430180f5e3302849762c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE3LTQtMS0xLTA_6d60dd64-5d24-45aa-8c14-954d03a71fa5">1,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fcbf0b422564ac6ad7c97196af88615_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE3LTYtMS0xLTA_ee7cf7e2-1d05-44ca-9782-8ae281175b00">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i722eb9acea26411b9150036527416c41_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE5LTQtMS0xLTA_ff52172d-a5d4-4849-8da9-2cac09508303">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59a8047f3879432c83f1a1b97f95fb61_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE5LTYtMS0xLTA_9223ca24-b507-4578-9e1d-146baaee1e5c">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzIwLTQtMS0xLTA_f2392de6-e9c5-40a3-a094-44421aa4b7d5">1,262</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzIwLTYtMS0xLTA_0b4b2be0-1fd9-492e-b4e3-442862538691">1,037</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The &#8364;<ix:nonFraction unitRef="eur" contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzU0OTc1NTgxNzM3MjA_ac05efa7-de8c-4aa6-aca2-663c5e930ce8">900</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzU0OTc1NTgxNzM3Mzk_5f177565-b444-4ef5-9f6f-c3adfa17c8dc">1.000</ix:nonFraction> billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibb1ebdbac42f4a03b1661acf2cfec850" continuedAt="icada37379056487eb93599332d68c930"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDEw_3f20157d-1657-41ba-ac90-451806ccb244" continuedAt="i82638160859a401ab6dd2a24ab5959c4" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:31.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMS0xLTEtMA_230453e8-2079-416a-b74a-26c4828211a0">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMy0xLTEtMA_1b038707-ad88-4b1a-ab77-b41b969a2158">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtNS0xLTEtMA_a267a323-f17d-40f2-8508-650b6c6d6b86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtNy0xLTEtMA_341fd6f5-e498-453d-a3f6-f67a025e530b">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtOS0xLTEtMA_80a3e131-8012-4fe3-87b6-414d6225b689">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMTEtMS0xLTA_e948a87b-d376-42dc-8ce0-c92216df3c82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMTMtMS0xLTA_29b408f5-600b-495c-9a2f-dfd8bcc8b7a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMTUtMS0xLTA_41b600fa-254c-494d-bc44-fcb020fd241e">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMS0xLTEtMA_b444d906-fbeb-4c68-9945-31b5c7144d80">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMy0xLTEtMA_70cc1527-ac4d-4137-ae0b-5406aaa6185e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtNS0xLTEtMA_a5e53783-201e-4ee1-916c-9a35bd896998">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtNy0xLTEtMA_7c2f1cd7-129d-4c2a-8a0c-1b78b9075cc7">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtOS0xLTEtMA_be353c07-fe21-4ac5-8dc2-5ed49026275a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMTEtMS0xLTA_124c297a-22b6-411b-af83-9593f3a78376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMTMtMS0xLTA_da1ae609-5bfd-4d14-8b07-8a29f972ade0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMTUtMS0xLTA_e48083c7-eb7d-44aa-b7c2-cdcfc4f7c23c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMS0xLTEtMA_4092d81a-22d0-4b2b-8228-b23eaf334d45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMy0xLTEtMA_924e7e48-d9e5-467c-9769-ce1f8c0e9483">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtNS0xLTEtMA_2a17637b-2bd1-4319-a5cd-93db2dc3d843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtNy0xLTEtMA_70aaf307-dce6-49df-a449-b35af91ac727">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtOS0xLTEtMA_452aa28e-a40f-4f5c-9eac-8140d8f4a40a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMTEtMS0xLTA_7da40e5c-fcb6-4020-9648-5d31e2b6f1d7">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMTMtMS0xLTA_bb812cb6-ad80-4de4-bbf2-1ad61ee2a39d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMTUtMS0xLTA_85b895df-99a3-4954-a1c5-d3805a82a909">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMS0xLTEtMA_eb373f58-5e6b-4f3f-bfd4-1e0b5fbf748d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMy0xLTEtMA_7b6c5ed0-3e4f-43dc-a03c-58d9d800b3c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctNS0xLTEtMA_0010bce4-9fd0-458d-9964-99df56f13cfa">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctNy0xLTEtMA_82768f3b-5afc-4efd-81d8-2c67f336b8d6">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctOS0xLTEtMA_186a920f-169d-41c3-897d-b0b9363bf0a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMTEtMS0xLTA_89a02310-7ea9-4b4d-a246-41e249ed8523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMTMtMS0xLTA_0412eb68-603e-4c40-bea6-7547c7b3e4c8">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMTUtMS0xLTA_18fac086-e182-4bc0-9a36-aed9df40d6a6">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMS0xLTEtMA_570ef5b9-a66f-4cb3-b124-e83d21e869d9">1,998</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMy0xLTEtMA_7c9113c2-940e-40eb-a8da-15883162fe6b">242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtNS0xLTEtMA_5a7ac7c6-2874-4498-8b08-b0321e6bf02a">365</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtNy0xLTEtMA_47277b45-1734-4f0b-a241-89d28f5fe303">2,605</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtOS0xLTEtMA_07e174c7-5d51-443a-9f56-2b06bd39360b">51</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMTEtMS0xLTA_25164119-fceb-48ff-a022-487279cadd52">321</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMTMtMS0xLTA_59024fe7-5733-40d9-9f04-dcfbab969234">518</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMTUtMS0xLTA_582e3171-5b83-4ba5-a6ee-139dbe14d7c9">890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTEtMS0xLTA_8febd73a-0c38-46c6-9103-c1b49a42636f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTMtMS0xLTA_a9720a11-d5ca-413f-878f-87065b35a3f1">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTUtMS0xLTA_7ddbbe93-60fc-47da-a09f-ce755dea209b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTctMS0xLTA_d4e14535-a4ad-4571-8b7b-a03b9fa35ab3">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTktMS0xLTA_0fd590a9-bccf-41fe-9dd3-3169b71d650a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTExLTEtMS0w_77977a78-e4fb-445c-8135-51ae69822402">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTEzLTEtMS0w_1ffd092f-67b4-4293-9d75-b6b9b5aa666f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTE1LTEtMS0w_1253c5eb-cdbb-4795-80ac-c80fa9321122">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTEtMS0xLTA_e0a3f065-b4cb-4d98-abcb-5c11d8cb7fbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTMtMS0xLTA_c24bd9a0-25ad-4603-8f3d-d40f1ca9877c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTUtMS0xLTA_9b7d8b33-0f46-46eb-b0b5-be405a9546d7">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTctMS0xLTA_eeac6db6-ef98-4d36-81bd-1a8066d004e8">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTktMS0xLTA_42cd0124-262a-47cf-b381-813308270822">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTExLTEtMS0w_8074c36e-6e43-43c2-9d9b-b1f052752645">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTEzLTEtMS0w_d4d4892a-ee71-4d28-994c-150dcc989f80">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTE1LTEtMS0w_3d4519f8-3743-45b0-9b1f-d9e08ab833e8">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTEtMS0xLTA_cf85fd50-8788-4191-bad7-d51de3850f78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTMtMS0xLTA_ec4c8995-c7cb-467e-b29a-855c155f2c18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTUtMS0xLTA_48e0b731-9a7d-4b83-8bce-c21d0b5d57eb">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTctMS0xLTA_69553c2c-25ee-41b5-8047-3a7eb943f531">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTktMS0xLTA_b7eeaad5-e1a3-4341-b977-09dc67257d2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTExLTEtMS0w_b71625b8-2a9d-4160-b01e-0c0345fb43e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTEzLTEtMS0w_22b8c310-ece7-4612-a2fc-0ee0be6501b1">571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTE1LTEtMS0w_c17be766-204c-4d73-a869-ef05b5ca6fb5">571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTEtMS0xLTA_ebfbd874-b168-4ccb-b9d3-1b371034bc68">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTMtMS0xLTA_ec76cff9-9a7c-4a2b-8c33-a192a4627866">1,262</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTUtMS0xLTA_b7f2b6f6-b838-49fd-b0a8-3a4f2d75b9d5">603</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTctMS0xLTA_fc202305-eafb-440f-896d-092f1fa0535b">1,865</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTktMS0xLTA_bb4a83e2-9a9d-4f54-9930-8d947167bfe0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTExLTEtMS0w_c0302620-5070-4946-b04d-3948acdb519e">1,037</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTEzLTEtMS0w_ffc44840-8dc3-4179-806c-2b15c2378069">925</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTE1LTEtMS0w_97548f8c-0a6f-4854-a257-5e41c2bbff8c">1,963</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $<ix:nonFraction unitRef="usd" contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE1MTM1_230453e8-2079-416a-b74a-26c4828211a0">1.584</ix:nonFraction> billion invested in money market funds and time deposits as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ib860e3dce61e49049931073399687742_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzI3NDg3NzkwOTMwMzQ_80a3e131-8012-4fe3-87b6-414d6225b689">50</ix:nonFraction> million as of December&#160;31, 2019, we held $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE1MjAx_0904d41c-7520-49c9-9b97-b156e84faeda">150</ix:nonFraction> million in interest-bearing and non-interest-bearing bank accounts as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE1MzQ1_ee6e115a-c72f-4720-859e-fb4b1e996e3f">165</ix:nonFraction> million as of December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, principally the contractual right to receive future royalty payments related to Zytiga&#8482; Drug acquired with BTG. Prior to our acquisition of BTG, BTG agreed to pay 50 percent of the Zytiga royalty stream, net of certain offsets, to the inventors associated with the intellectual property. In the fourth quarter of 2019, we sold the remaining 50 percent we acquired through our acquisition with BTG of the future Zytiga royalty stream for an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzI3NDg3NzkwOTQxMjA_bda3f833-47fd-4481-84d9-7462f0a0655c">256</ix:nonFraction> million to the Ontario Municipal Employees Retirement System (OMERS). In accordance with FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we are accounting for the transfer of the royalty stream to OMERS as a secured borrowing, continue to recognize the financial asset and associated liability in our consolidated balance sheets and do not expect to receive any future cash benefit from Zytiga royalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected the fair value option to account for our licensing arrangements' financial asset and financial liability in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have recorded the fair values using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. </span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i82638160859a401ab6dd2a24ab5959c4" continuedAt="i67a861bb4458474e83e5396b2bf86afa"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2020 include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i53b6f52da8df4fa7bf11e1a08d9ccb70_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzEtMS0xLTEtMA_3561902a-f218-41f8-87a4-98ddb48a42c3">365</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie413d40c497c4213aed17626e6327e26_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzEtNC0xLTEtMA_9c6d186c-0cc4-4684-9968-ead0ce599625">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ee1e91c186b4f699e1d1d29e37ff24f_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzEtNy0xLTEtMA_ed404b6b-0020-4ed5-b7e7-f8106143c1e6">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i53b6f52da8df4fa7bf11e1a08d9ccb70_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzQtMS0xLTEtMA_b1e94cde-bb52-4d5c-b064-afbff0162b2d">407</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb70a5191e964f5bbfc7cab5cbae8163_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzQtNC0xLTEtMA_b9485e88-95ba-4963-addf-3cf61e5385b3">12</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0eab187810704dcaa8f9fa4fcfefcdc6_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzQtNi0xLTEtMTM5MTk_2569e5b9-e4b3-4362-b369-a5c92d0714f2">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ead7f5a424543edbf6a6280a486e80e_D20200101-20201231" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzQtNy0xLTEtMA_849be89e-295f-475a-ab48-5cff194e0b5a">13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="icada37379056487eb93599332d68c930"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of December&#160;31, 2020. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains or losses from the licensing arrangement.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i67a861bb4458474e83e5396b2bf86afa"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e14f3f587f24448a4c91bf888b8b399_I20181231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzEtMS0xLTEtMTA2OTg_a2a83c7c-3dc8-4249-b96f-bbaef3027fd5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice90f802b2894cb798cf1495f7ea9a11_D20190101-20191231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzItMS0xLTEtMTA2OTg_4772049a-d866-483e-96d1-907a6d6593a7">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice90f802b2894cb798cf1495f7ea9a11_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzMtMS0xLTEtMTA2OTg_20c5067a-19d1-496d-acb9-e34dc8ff6d3d">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice90f802b2894cb798cf1495f7ea9a11_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzQtMS0xLTEtMTA2OTg_49e35797-0008-4ed3-aa70-57ebfcd7407b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib421eaab309941719fac63dbb93ed872_I20191231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzEtMS0xLTEtMA_9db98ea1-2da7-4203-8325-cd12e3873d7b">518</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4504c169cc844d2ea5b6d6a2e3e9d654_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzMtMS0xLTEtMA_cb5eae26-eb0e-40ee-b6cf-250f050b82a2">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4504c169cc844d2ea5b6d6a2e3e9d654_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzUtMS0xLTEtMA_70d8dff1-8f90-4ce6-b060-b4e7f78f1739">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3caf59a26546f0adfd22adbf367b9f_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzYtMS0xLTEtMA_3cceb703-89fb-42b5-adf1-f3df5de12b63">365</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4307d6f3a38471491744ddae330f127_I20181231" decimals="-6" format="ixt:zerodash" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzEtMS0xLTEtMTA3MjI_c163c30a-4f21-4536-a77e-03073c1a6af0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i542629f9607d42d396e07c03c41fc785_D20190101-20191231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzItMS0xLTEtMTA3MjI_0bf7c9d9-77c8-4b46-a5fc-ec1d862ebbcc">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i542629f9607d42d396e07c03c41fc785_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzMtMS0xLTEtMTA3MjI_ec4d058b-f2f2-4d05-b9c7-8714f4182a59">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9521f08f13f849d78d220e43a83413e7_I20191231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzEtMS0xLTEtMA_8bf814d7-dd50-48e2-b1e9-cc2ebdcce7ab">571</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddfccdc34ae347398e8196005b47ad2d_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzMtMS0xLTEtMA_49a06f5b-96f3-4d09-8063-700f557679ae">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfccdc34ae347398e8196005b47ad2d_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzYtMS0xLTEtMTA3MzU_58ba0dcf-523e-4c55-bac6-94a02ed565f9">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaecb6ba3d8414b658b7074879ac58a42_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzYtMS0xLTEtMA_22cc153c-5c22-4be8-9ff7-3e2e23e385df">407</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE5OTY1_8098346c-2820-4fcb-9b6d-75329d4f445d">10.774</ix:nonFraction> billion as of December&#160;31, 2020, including $<ix:nonFraction unitRef="usd" contextRef="if784bc40961d41ea86115e7819324fc8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE5OTc4_3003b3c2-cf27-4f36-b6e2-fa23b1c9468a">1.118</ix:nonFraction> billion relating to the euro-denominated December 2027 Notes, and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwMDM0_f1ea39fa-3879-40f7-b632-b8f1871af16c">11.020</ix:nonFraction> billion as of December&#160;31, 2019, including $<ix:nonFraction unitRef="usd" contextRef="id18b0f22f1a54a529beaf27a2d386682_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzI3NDg3NzkwOTU3ODQ_834a8c8c-ef1a-4460-afd5-e1b1d88741ca">1.004</ix:nonFraction> billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDc4_ed8063e8-bb49-4d6a-b58e-912f1758984b" continuedAt="i7f359c044d074c3baded506b9454fe9b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzY4_b9a010ae-3087-4581-a12b-59706d450655">9.143</ix:nonFraction> billion as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg0_19301b47-213a-4161-9db7-64b1941a51b4">10.008</ix:nonFraction> billion as of December&#160;31, 2019, with current maturities of $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzYwNDczMTM5OTUxNTg_c60cc048-6879-4379-bc41-8fffe3e8a332">13</ix:nonFraction> million as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzYwNDczMTM5OTUxNzc_77bbd495-a6c9-4759-90e4-7bd391c51ffc">1.416</ix:nonFraction> billion as of December&#160;31, 2019. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDc0_b404f99f-ab57-4a93-aa6a-e56fe854be7c" escape="true"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3624e58548487f8fe6f34329a5815d_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzQtNi0xLTEtMA_b94dc5dc-91a2-45b3-aa5e-baf87f4cf18f">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie94729ec536f4bc8bcc1206a1a2d33b7_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzQtOC0xLTEtMA_1c6289d4-e96a-4cac-bf0b-a21ea417d89c">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4f3624e58548487f8fe6f34329a5815d_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzQtMTAtMS0xLTA_bf5f9305-2af7-4b78-8580-fc8d0c6082a4">3.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace5b35349bc466aa9490fe1abc44349_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtNi0xLTEtMA_2bbb4d09-e100-49c9-aa50-5b3867309cf7">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i470cf9477e25450cb165bec6ddf55cc4_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtOC0xLTEtMA_caae28d9-1aec-4811-ad70-426f4ee782ea">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iace5b35349bc466aa9490fe1abc44349_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtMTAtMS0xLTA_0ec3be5a-bc79-42bd-8de9-900810906b92">4.125</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93322dab74aa4ef38da4b44eda101b38_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzctNi0xLTEtMA_f118289a-c137-4811-a6b3-d13d92ac1eab">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0ee9631c3d49d395dad185461e903d_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzctOC0xLTEtMA_145689c7-ac4e-4077-b959-be6a254c110e">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i93322dab74aa4ef38da4b44eda101b38_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzctMTAtMS0xLTA_dbd71569-5942-4807-b8bc-00f04baaa0d9">3.450</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2f5bb8d642f42c1af20b67911d62368_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzgtNi0xLTEtMA_4784dfb3-298a-467e-8962-cec0d3f62702">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3baeff6199d34f65b27933b63ede7d47_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzgtOC0xLTEtMA_0fd5fb84-fa62-4b2b-b072-69b23d8de8fe">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2f5bb8d642f42c1af20b67911d62368_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzgtMTAtMS0xLTA_4ceda274-b66b-4b73-ad11-d75d708702d5">3.850</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b663172db024a7292246bcb9060972f_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtNi0xLTEtMjA2NQ_ed3ae441-4943-42d5-8945-3170c0fd0c1c">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75fd0298f42f480aa7c38b110f45a007_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtOC0xLTEtMjA2NQ_70f86a74-08e1-4443-a248-d1087ab1a144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b663172db024a7292246bcb9060972f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtMTAtMS0xLTIwNjk_8a155073-c4ed-442f-a29c-b67c8037fed1">1.900</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1ccd83cecce48e7a280b063a5658b6a_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzktNi0xLTEtMA_f18bb80c-ae64-47dd-abdd-17fec6b640a5">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6c3f5fe650404b94ed7a33ebfa2cca_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzktOC0xLTEtMA_1fdacc0f-86b8-4199-b780-a29c7073667f">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1ccd83cecce48e7a280b063a5658b6a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzktMTAtMS0xLTA_4788c4a0-1852-4de6-8005-0477f7553909">3.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80031cfd406b4f6593c9c5e695b180e8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEwLTYtMS0xLTA_c96cf811-c8b2-4478-bf3e-161f2eadf4bc">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c13725730644fb4b3b71a64ec29e691_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEwLTgtMS0xLTA_4e0dbd40-b31a-4f48-9aaa-034c9031c3bf">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80031cfd406b4f6593c9c5e695b180e8_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEwLTEwLTEtMS0w_ad02b3e5-73a4-45a5-81b9-d7a7021fa3f9">0.625</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d0cd11a8104fe8a096c54c797dbb77_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTYtMS0xLTA_6e33019e-17eb-484a-b061-86a96db0bdf0">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06838a9c5668409daceef0d66f6e0b09_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTgtMS0xLTA_35dcdce4-e3af-43ef-b081-eb9c9b13b4ae">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28d0cd11a8104fe8a096c54c797dbb77_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTEwLTEtMS0w_20105cf7-3dff-48f3-a885-9a02356b98c1">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEyLTYtMS0xLTA_f06b0e05-1078-499a-b3bd-5ff12733b491">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e45057621d4a2194b3b7c5a4d322e1_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEyLTgtMS0xLTA_af838b2d-0dd3-4214-84df-d35daa111043">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEyLTEwLTEtMS0w_c69a0d7c-55d1-4896-8405-a534c785bdea">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf15031c1e264e419f6387d7bb871a3f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTYtMS0xLTIwODI_f216f8ad-1e55-4c28-973f-59fcb83e9a8b">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82968b403f0e490b9ff37937effad01d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTgtMS0xLTIwODI_f60cca88-51ac-478d-bbff-1b3454ab3511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf15031c1e264e419f6387d7bb871a3f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTEwLTEtMS0yMDg2_0a2900ea-430b-4d76-98d4-68811e01e00a">2.650</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9f8e01c368432c8b949ad0e9f7804a_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEzLTYtMS0xLTA_6ffbc48f-41bb-4b98-9a22-3a1eee6095f7">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5278deff95bf40dab3597ddea1f112c1_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEzLTgtMS0xLTA_aeb4198c-4305-4679-ab6b-91a719ae0b51">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d9f8e01c368432c8b949ad0e9f7804a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEzLTEwLTEtMS0w_6b45b85a-157b-41d0-bc06-004e61dcc0d9">7.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE0LTYtMS0xLTA_52c9b30f-0f31-4002-b853-217b7468a11d">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i881baa0d70eb4bed8a4f7c036159289e_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE0LTgtMS0xLTA_bc433160-e018-4e90-bedb-ad39fa16774c">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE0LTEwLTEtMS0w_59d0a856-7c6e-4032-83f2-fd261bab74a5">4.550</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie943736485e84ce7beed9099a5c89fc9_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTYtMS0xLTA_4459c637-675d-4dcb-b2a9-7d09fb09113f">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7a0b5494fe433698454f3d4be42317_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTgtMS0xLTA_4e6bb3b3-e25e-47ad-9c30-50c07266f024">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie943736485e84ce7beed9099a5c89fc9_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTEwLTEtMS0w_f4c5689d-69c3-4e5b-90ee-0f104c607bd2">7.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072d21384351482298b1bf90b42befe3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE2LTYtMS0xLTA_0987ef84-9341-4d67-8e26-10328c65064f">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2765cf8e499b472db95894650fbbc9b1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE2LTgtMS0xLTA_22fd0b5a-84ee-436a-a9a8-637d002bc5b8">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i072d21384351482298b1bf90b42befe3_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE2LTEwLTEtMS0w_a17d1742-f99e-4aca-b44d-ee6de2269461">4.700</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022 Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65aa69df316c4459b610a9a758daeb5b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTYtMS0xLTIwNTA_1d9a2cd3-3249-4c19-ba3a-28622e4eca94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2317e9eeb3514b0ebfa77fad060f3b78_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTgtMS0xLTIwNTA_40470241-c743-4875-b6ca-c9b8c2062854">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86e54183bfbf4dcea32db5920645d4c1_I20201231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE3LTYtMS0xLTA_c6e6e6ef-2a2a-4d1a-bfde-74d49a51d475">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0490e70b8eb4adaadfc6f7e99f1c154_I20191231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE3LTgtMS0xLTA_849c5ab1-4b2c-4557-a15f-eefdc515bb9e">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dfa649ec60b4e6fb3977d40dd636c0d_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE4LTYtMS0xLTA_1d233a76-188e-4397-8344-e342d865c613">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713d6358ca344f6b85182e9f67f64ba9_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE4LTgtMS0xLTA_14576d39-2756-45be-a2e2-982f9542b43e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f07d9d29b542aba0b5805828ee1cec_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE5LTYtMS0xLTA_c2265601-6eaf-498f-8b0d-05026aa051cb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8e5ca3e12946a3acf25b897e7d182b_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE5LTgtMS0xLTA_4d7688e7-9cff-455f-9130-96969a738aea">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzIwLTYtMS0xLTA_c22d9b0e-735b-4698-91c6-e742893e9a67">9,130</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzIwLTgtMS0xLTA_a77a022f-b79a-4396-9434-d63677e1e3a0">8,592</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which was a variable-rate instrument based on LIBOR.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a $<ix:nonFraction unitRef="usd" contextRef="i15fb9c7f5da74f4a84401aa8f7ee2b2c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODg5OTA_9e5bc550-9649-4a6b-bb73-308f505be041">2.750</ix:nonFraction> billion revolving credit facility (Revolving Credit Facility) with a global syndicate of commercial banks that matures on December 19, 2023 with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. The credit agreement requires that we comply with certain covenants, including a financial covenant described within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. In the first quarter of 2020, we refinanced $<ix:nonFraction unitRef="usd" contextRef="i8a3a53a9ff3742c0bb73f4f43804fb5a_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODg5OTc_05f87621-cd11-499b-ba56-c9f9d89c0693">1.360</ix:nonFraction> billion of commercial paper using proceeds from the Revolving Credit Facility. In April 2020, we entered into the April 2021 Term Loan, described below, and used the proceeds to repay a portion of the amounts outstanding under the Revolving Credit Facility. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued <ix:nonFraction unitRef="number" contextRef="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODkxMjE_6d83f753-9356-4350-b183-1ebcaf1b803b">5.50</ix:nonFraction>% Mandatory Convertible Preferred Stock, Series A (MCPS) and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. In May 2020, we completed our senior notes offering described below and used a portion of the proceeds to repay $<ix:nonFraction unitRef="usd" contextRef="i6cbd6ca2b191422bbed4a7a82030eee4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODkxMTA_8f86b75b-93fa-48bb-a61b-73599b63bdd4">450</ix:nonFraction> million outstanding under the Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of December&#160;31, 2020 or December&#160;31, 2019.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7f359c044d074c3baded506b9454fe9b" continuedAt="i783c094a60124d4f820dfcae8016fcd9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i809d5c20fa804d2fbb986afa7dc387e8_I20200421" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODUxNzk_33c4b499-6d9b-4a69-b30f-2645e6ef1b0d">1.250</ix:nonFraction> billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $<ix:nonFraction unitRef="usd" contextRef="i6a055566dd0a42d0b5247b6ea377c972_D20200518-20200518" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU0NTM_53cd2afe-a186-42ce-a15c-22cac59712eb">500</ix:nonFraction> million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our MCPS and common stock offerings to repay in full the remaining $<ix:nonFraction unitRef="usd" contextRef="i5653e63d9d764f71b37cce04c14e9918_D20200527-20200527" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU0OTA_b4635809-8236-4e7d-8169-e9e8f027b41e">750</ix:nonFraction> million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i934e92bb8af546eb9e57ac456dd0619a_I20200227" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU1MTg_12ca4601-370f-4c9d-8334-dccb72a3e728">1.000</ix:nonFraction> billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding on the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of <ix:nonFraction unitRef="number" contextRef="i56087e653b324fa994949b7d0c138ef8_I20201231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU2NzM_2a0659ca-f5fe-4272-985e-8d2829376bf3">0.85</ix:nonFraction>%. The credit agreement is subject to a financial covenant described below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $<ix:nonFraction unitRef="usd" contextRef="i1160215621b243f6b393f001c1aac0d7_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU2Nzc_5a969957-6a30-4151-8c96-0d70cf048fb6">750</ix:nonFraction> million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $<ix:nonFraction unitRef="usd" contextRef="i3916b9b9bec94f6c874dd26e645205c5_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU3MDg_b48a2e0f-382b-4b40-b2dc-fe6d9ce13387">250</ix:nonFraction> million and terminated the February 2021 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, we entered into a $<ix:nonFraction unitRef="usd" contextRef="icc311bfbe55c4b7bab87b29a5c5ad4af_I20191205" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzIyOTE_aba98705-2768-4165-a3d1-4c5694432baf">700</ix:nonFraction> million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="if810421b7a7142d88feb52f9a24f6b2f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI2OTU_a2914774-f28c-4ce2-8a2d-f3a5e7d0cda2">700</ix:nonFraction> million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $<ix:nonFraction unitRef="usd" contextRef="i6bccb221eb7049dfa837d52812ecf319_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI5NzA_ddce2954-a2ad-4df3-86b4-0fb1e4a2a03e">300</ix:nonFraction> million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2018, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i3b7bd05ff52a4f2ca45526a4f36f0fa7_I20181219" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzM2MDk_c1be03ab-6f35-4ec2-a5e8-ff1f05c172eb">2.000</ix:nonFraction> billion senior unsecured delayed-draw term loan facility consisting of a $<ix:nonFraction unitRef="usd" contextRef="i7b1253b180a24f5184077538b81d86ea_I20181219" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzM2Nzc_acd3ba2a-428d-428c-93c0-3da1c69bdd48">1.000</ix:nonFraction> billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $<ix:nonFraction unitRef="usd" contextRef="if5058ef5b1744c99af286b6f6888dea9_I20181219" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzM4NDU_9e350f54-211d-44b2-97e0-0ce2d1d19a55">1.000</ix:nonFraction> billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August 19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $<ix:nonFraction unitRef="usd" contextRef="i0f029b30f006439581bf8725281e3599_I20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkxMTEyMDA_b6318119-568f-4975-ba45-615332156d34">1.000</ix:nonFraction> billion under the Two-Year Delayed Draw Term Loan and $<ix:nonFraction unitRef="usd" contextRef="i498d29e5a70e4570a7844cf14bd02f63_I20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkxMTEyMDc_283ce3ac-a92c-4810-b7f2-828f74ea8043">1.000</ix:nonFraction> billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, the December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="ic35171b8628c4dd5ad036a63a32bfb1f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzUwNTI_b9d1946e-bd4f-45ad-b3aa-b076a3a1908f">1.000</ix:nonFraction> billion outstanding under the Three-Year Delayed Draw Term Loan (also referred to as the "August 2022 Term Loan" in the debt maturity schedule above). In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of December&#160;31, 2020, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through December&#160;31, 2020, we were in compliance with the financial covenant required by our credit facilities described above. </span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDYy_6fb70a01-3db2-4062-879b-542e8f41a904" escape="true"><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.046%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.047%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement<br/>as of December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual<br/>as of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie03682fd1dea4c5b853350dd17ab556a_I20201231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTo1OGQ2NjI1OWM4Mzg0MzE0YjEwOTExMzgzZGZhMjQ3My90YWJsZXJhbmdlOjU4ZDY2MjU5YzgzODQzMTRiMTA5MTEzODNkZmEyNDczXzEtMS0xLTEtMA_c9548651-357b-495f-8894-9571c2772c32">4.75</ix:nonFraction> times</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48219e6ea65a46868b8d56d6f5e591e4_I20201231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTo1OGQ2NjI1OWM4Mzg0MzE0YjEwOTExMzgzZGZhMjQ3My90YWJsZXJhbmdlOjU4ZDY2MjU5YzgzODQzMTRiMTA5MTEzODNkZmEyNDczXzEtMy0xLTEtMA_e19ed0b5-0e5d-4bf9-9a14-730dafd04f2c">3.48</ix:nonFraction> times</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into an agreement with our banking syndicates to amend the financial covenant requirement for all of our outstanding credit arrangements as follows: (i) established a deemed Consolidated EBITDA of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:DeemedConsolidatedEBITDA" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTE5NjE_5f87126e-a30b-45d8-b126-98d4f117dfbc">671</ix:nonFraction> million for the second, third and fourth quarters of 2020, reflecting average quarterly Consolidated EBITDA, as defined in the credit agreements, for 2018 and 2019; and (ii) maintain the maximum permitted leverage ratio of <ix:nonFraction unitRef="number" contextRef="i7b0451592eb8487e9970e7bc57c226fb_I20201231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTIxOTE_d3298a5b-85c8-4e70-81f0-89fdf6d80709">4.75</ix:nonFraction> times through the remainder of 2020, with a step-down for each succeeding fiscal quarter end to <ix:nonFraction unitRef="number" contextRef="i0fd8889518a24b01acba9958549fd5e7_I20201231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU4NTA_76a9c03f-7c15-48fd-b0d0-e7ee17fb6fa4">4.50</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="i92925008ccf94edb8a9a6fa812cfe728_I20201231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU4NTQ_52f4899b-3e66-4703-b375-cf661e1af434">4.25</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="if8273828bead4a54bad459aceb05abe5_I20201231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU4NTg_5307b40f-a2f4-4984-b388-756a17e4ea61">4.00</ix:nonFraction> times and ultimately <ix:nonFraction unitRef="number" contextRef="i3ac5b05e233743a0918574aa15d416bd_I20201231" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU4Nzg_34bb17f6-e8e0-4511-86d3-4538dda9b425">3.75</ix:nonFraction> times for the fourth quarter of 2021 and through the remaining term of the facility. In addition, pursuant to the April 21, 2020 </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i783c094a60124d4f820dfcae8016fcd9" continuedAt="if5606033850e42caa6818d00b38076a6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Credit Facility and February 2021 Term Loan amendments, the definition of "Material Adverse Effect" has been amended to exclude the direct and indirect effects of the COVID-19 pandemic from what constitutes a material adverse effect through the remainder of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ExclusionFromEbitdaForRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzYyNjc_3cf363c9-ac68-48ef-8b41-87afab58fe91">500</ix:nonFraction> million in restructuring and restructuring-related net charges related to our current or future restructuring plans. As of December&#160;31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzY0MDE_13bff39a-5fbb-49cd-b9fe-b9257e19c4dd">101</ix:nonFraction> million of the restructuring net charges exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:LitigationAndDebtExclusionFromEbitda" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzY3MzU_5c7c696a-3e1a-4243-b282-7eaa755cf144">2.624</ix:nonFraction> billion in the aggregate. As of December&#160;31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzY3NzM_bc641705-36fc-426c-8035-bdb87c84d8a0">926</ix:nonFraction> million of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this amended covenant could require us to seek to further renegotiate the terms of our Revolving Credit Facility or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i8a94b491b12e42c693b11e87706c05ae_D20200101-20201231" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDU1_058ad1b5-f922-47d7-a419-2a92caadd0ff" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $<ix:nonFraction unitRef="usd" contextRef="i8a3a53a9ff3742c0bb73f4f43804fb5a_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTM4NjY_05f87621-cd11-499b-ba56-c9f9d89c0693">1.360</ix:nonFraction> billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7219d097f654ed583a1166ed6e2afeb_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzItMS0xLTEtMA_3d62e582-925e-462c-9d84-65c72a79d198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047968109f334e72b9394ec59f28e192_I20191231" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzItMy0xLTEtMA_ce8329eb-6d10-4bf6-b5a6-2bcf84fa508d">711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fb9c7f5da74f4a84401aa8f7ee2b2c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzMtMS0xLTEtMA_9e5bc550-9649-4a6b-bb73-308f505be041">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047968109f334e72b9394ec59f28e192_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:MaximumCommercialPaperOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzMtMy0xLTEtMA_5f7912de-60af-45f0-839d-023391ff123a">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7219d097f654ed583a1166ed6e2afeb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzQtMS0xLTEtMA_ef468bcc-0c5d-435b-9ba3-0e7fb4454e80">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047968109f334e72b9394ec59f28e192_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzQtMy0xLTEtMA_50756451-7e23-4399-8bb0-8210766c2d11">2,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8a94b491b12e42c693b11e87706c05ae_D20200101-20201231" name="bsx:WeightedAverageMaturityDays" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzUtMS0xLTEtMA_f4857337-665f-43ce-a96c-780f0840662b">0 days</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1622c8dc4c6c4bf6984d78e57376b51d_D20190101-20191231" name="bsx:WeightedAverageMaturityDays" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzUtMy0xLTEtMA_51890e0a-d44e-449d-a164-3eca37e8ead2">55 days</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7219d097f654ed583a1166ed6e2afeb_I20201231" decimals="4" format="ixt:zerodash" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzYtMS0xLTEtMA_9e23da38-dabe-49d9-b3a8-3603f58497b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i047968109f334e72b9394ec59f28e192_I20191231" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzYtMy0xLTEtMA_5232c001-4bd2-4652-a681-437c91653bed">2.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $<ix:nonFraction unitRef="usd" contextRef="i86e54183bfbf4dcea32db5920645d4c1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc4Mjk_f104fabc-f06b-4f9d-8964-ee0806b3bad8">9.205</ix:nonFraction> billion as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ia0490e70b8eb4adaadfc6f7e99f1c154_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc4NDU_1a11e3f5-efc6-4fdb-804c-cccd2beb7e97">7.661</ix:nonFraction> billion as of December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2020, we redeemed $<ix:nonFraction unitRef="usd" contextRef="idfb077471a35463b9f660b39ea4f3612_D20201229-20201229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU0OTc1NTgxODAxMjk_780f8af2-6ecb-4a29-912b-0275237ecac7">250</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="id1816c871d3e444bb94fda8950db49fd_I20201229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU0OTc1NTgxODAxMTI_abee1a81-08a9-4e26-98b8-f8b18568c860">500</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i4f3624e58548487f8fe6f34329a5815d_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU0OTc1NTgxNzk1NTU_bf5f9305-2af7-4b78-8580-fc8d0c6082a4">3.375</ix:nonFraction>% senior notes due 2022 (May 2022 Notes) at a redemption price calculated in accordance with the terms of the May 2022 Notes and its indenture, plus accrued and unpaid interest through, but excluding, the date of redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="i0b04a2ce24234007830997dd2dcf322c_I20200518" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTM5MTY_3ad37971-8cde-49a3-ab0e-9e7a777aec79">1.700</ix:nonFraction> billion in aggregate principal amount of senior notes comprised of $<ix:nonFraction unitRef="usd" contextRef="i3b663172db024a7292246bcb9060972f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTM5ODI_f6254bfd-5106-4115-b2d0-9ee5a2634c46">500</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i3b663172db024a7292246bcb9060972f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTM5OTI_8a155073-c4ed-442f-a29c-b67c8037fed1">1.900</ix:nonFraction>% senior notes due June 2025 and $<ix:nonFraction unitRef="usd" contextRef="icf15031c1e264e419f6387d7bb871a3f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQwMjc_c6ef1cfe-9f5b-4ec7-8c70-56e61c1b72b8">1.200</ix:nonFraction> billion of <ix:nonFraction unitRef="number" contextRef="icf15031c1e264e419f6387d7bb871a3f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQwMzc_0a2900ea-430b-4d76-98d4-68811e01e00a">2.650</ix:nonFraction>% senior notes due June 2030. We used the net proceeds from the offering to refinance $<ix:nonFraction unitRef="usd" contextRef="i6cbd6ca2b191422bbed4a7a82030eee4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQxMjU_763054dd-2a90-4d11-a015-f932d8e57f35">450</ix:nonFraction> million of amounts outstanding under the Revolving Credit Facility, prepay $<ix:nonFraction unitRef="usd" contextRef="i50f95eeb41c34ca090d9eb073b22e649_D20200518-20200518" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQxOTk_aac6019c-c575-40d1-808b-0e8a124d6f6c">750</ix:nonFraction> million of amounts outstanding under the $<ix:nonFraction unitRef="usd" contextRef="i934e92bb8af546eb9e57ac456dd0619a_I20200227" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQyMzk_12ca4601-370f-4c9d-8334-dccb72a3e728">1.000</ix:nonFraction> billion February 2021 Term Loan, prepay $<ix:nonFraction unitRef="usd" contextRef="i6a055566dd0a42d0b5247b6ea377c972_D20200518-20200518" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQyODE_f8a6ae54-5f78-4d11-9a94-1509f2950692">500</ix:nonFraction> million of amounts outstanding under the $<ix:nonFraction unitRef="usd" contextRef="i809d5c20fa804d2fbb986afa7dc387e8_I20200421" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQzMjE_33c4b499-6d9b-4a69-b30f-2645e6ef1b0d">1.250</ix:nonFraction> billion April 2021 Term Loan and pay related fees, expenses and premiums.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;<ix:nonFraction unitRef="eur" contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc5MDU_ac05efa7-de8c-4aa6-aca2-663c5e930ce8">900</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc5MjM_5f177565-b444-4ef5-9f6f-c3adfa17c8dc">1.000</ix:nonFraction> billion) in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i80031cfd406b4f6593c9c5e695b180e8_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc5NjA_ad02b3e5-73a4-45a5-81b9-d7a7021fa3f9">0.625</ix:nonFraction>% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $<ix:nonFraction unitRef="usd" contextRef="i8c38c44c917644b098c633ab638428cf_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzgzNTk_b9b693fd-e69b-4d10-b75e-7ab67ebdb691">206</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="i0d6a17efae344d4c9df3b7fb951f8515_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQzOTU_de2ddfbd-ddf3-4024-9360-a097739ee08f">450</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="iace5b35349bc466aa9490fe1abc44349_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzgzNzI_0ec3be5a-bc79-42bd-8de9-900810906b92">4.125</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i6b96a4fc501142cf8461498cce84408b_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzgzOTg_76f43d28-00c5-4bac-8434-4d5ce2af1505">566</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="i98969d1f5aa24ac4b7604cd2111634df_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQ0MDM_7569f904-b515-4047-b593-a50849c49533">1.000</ix:nonFraction> billion <ix:nonFraction unitRef="number" contextRef="i28d0cd11a8104fe8a096c54c797dbb77_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg0MTE_20105cf7-3dff-48f3-a885-9a02356b98c1">4.000</ix:nonFraction>% senior notes due 2028 and $<ix:nonFraction unitRef="usd" contextRef="i50adfc63c2df4dea89170b844a26339c_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg0NDA_1e138afa-79f8-4143-b76f-cd7ba2f05e86">227</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="i98b32703709b4b0aa69f93f2f184b39e_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQ0MTE_ee1c8fa8-a55a-408c-9b96-9d0b18be56fa">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="ib2f5bb8d642f42c1af20b67911d62368_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg0NTM_4ceda274-b66b-4b73-ad11-d75d708702d5">3.850</ix:nonFraction>% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if5606033850e42caa6818d00b38076a6" continuedAt="i99081d42094247598d90234bd20a1aa4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">connection with the transaction. In 2019, we incurred associated debt extinguishment charges of $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg2NDI_984397d9-63d8-4844-96dd-869ffad50f46">86</ix:nonFraction> million presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="if96cc1043cd04c2c983e15e941b3816f_I20190225" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg3Mjc_6f004b08-6be6-43a4-9421-88b4bc0fd51b">4.300</ix:nonFraction> billion in aggregate principal amount of senior notes comprised of $<ix:nonFraction unitRef="usd" contextRef="i93322dab74aa4ef38da4b44eda101b38_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg3ODk_f118289a-c137-4811-a6b3-d13d92ac1eab">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i93322dab74aa4ef38da4b44eda101b38_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg3OTU_dbd71569-5942-4807-b8bc-00f04baaa0d9">3.450</ix:nonFraction>% senior notes due March 2024, $<ix:nonFraction unitRef="usd" contextRef="if1ccd83cecce48e7a280b063a5658b6a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg4Mjc_f18bb80c-ae64-47dd-abdd-17fec6b640a5">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="if1ccd83cecce48e7a280b063a5658b6a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg4MzM_4788c4a0-1852-4de6-8005-0477f7553909">3.750</ix:nonFraction>% senior notes due March 2026, $<ix:nonFraction unitRef="usd" contextRef="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg4NjU_f06b0e05-1078-499a-b3bd-5ff12733b491">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg4NzE_c69a0d7c-55d1-4896-8405-a534c785bdea">4.000</ix:nonFraction>% senior notes due March 2029, $<ix:nonFraction unitRef="usd" contextRef="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg5MDQ_52c9b30f-0f31-4002-b853-217b7468a11d">750</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg5MTA_59d0a856-7c6e-4032-83f2-fd261bab74a5">4.550</ix:nonFraction>% senior notes due March 2039 and $<ix:nonFraction unitRef="usd" contextRef="i072d21384351482298b1bf90b42befe3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg5NDU_0987ef84-9341-4d67-8e26-10328c65064f">1.000</ix:nonFraction> billion of <ix:nonFraction unitRef="number" contextRef="i072d21384351482298b1bf90b42befe3_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg5NTE_a17d1742-f99e-4aca-b44d-ee6de2269461">4.700</ix:nonFraction>% senior notes due March 2049. We used a portion of the net proceeds from the offering to repay the $<ix:nonFraction unitRef="usd" contextRef="if1b49800ef2c4501b27527c8995dbbc4_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkwNTI_58c067ec-fff0-4c0a-94fc-99c206755a05">850</ix:nonFraction> million plus accrued interest and premium of our <ix:nonFraction unitRef="number" contextRef="i455c8d39af974255a980e1e70f644bf2_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkwOTY_37dc427d-e42b-41d9-b06c-5a58a033d55c">6.000</ix:nonFraction>% senior notes due in January 2020, the $<ix:nonFraction unitRef="usd" contextRef="i925f70236c2e410e80b575f9f56d03c6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkxMzc_f34c522e-3f26-411a-ab42-6c9aa5d127fc">600</ix:nonFraction> million plus accrued interest and premium of our <ix:nonFraction unitRef="number" contextRef="i8101096131dd4084b7d522af75cf5248_I20201231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkxODE_494ba4fc-25f0-4f71-bddc-ccafff77c207">2.850</ix:nonFraction>% senior notes due in May 2020 and the $<ix:nonFraction unitRef="usd" contextRef="id186cacae9da4651be0c28bb43b1ded4_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkyMjE_89cd0594-f7e5-413c-901b-1c637c5a1140">1.000</ix:nonFraction> billion plus accrued interest of our August 2019 Term Loan. In 2019, the remaining proceeds were used to finance a portion of our acquisition of BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:Seniornotesissued" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEwMTEz_977b9054-082f-42ca-bb2b-2f3dad5a03f5">8.855</ix:nonFraction> billion of senior notes issued in 2009, 2013, 2015, 2018, 2019 and 2020 contain a change-in-control provision, which provides that each holder of the senior notes may require us to repurchase all or a portion of the notes at a price equal to <ix:nonFraction unitRef="number" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="2" format="ixt:numdotdecimal" name="bsx:ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEwMzQ0_8dc0dc99-323a-45b9-85bf-49b9fa6e1630">101</ix:nonFraction> percent of the aggregate repurchased principal, plus accrued and unpaid interest, if a rating event, as defined in the indenture, occurs as a result of a change-in-control, as defined in the indenture. Any other credit rating changes may impact our borrowing cost, but do not require us to repay any borrowings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDE2_86531699-2cbb-4994-9813-4d0d13946d00" continuedAt="i17919a1e16f4499db7fd9f736127e2aa" escape="true">Amounts de-recognized for accounts and notes receivable, which are excluded from </ix:nonNumeric></span><ix:continuation id="i17919a1e16f4499db7fd9f736127e2aa" continuedAt="i15fc47ee07334714a3801ad05c5f98b2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): </span></ix:continuation></div><ix:continuation id="i15fc47ee07334714a3801ad05c5f98b2"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib48697a0624648d89ec42eafa9342b77_I20201231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzItMS0xLTEtMA_d01b52da-a38f-40a8-8629-3b9c2d7d2419">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8dc7bcdaccd44f068db68bbbd79a3e75_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzItMy0xLTEtMA_4c7730b8-1c92-4aa6-a3b2-8589f2f123cd">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bbc6a0e526d42a79ee7960aeca28186_I20191231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzItNS0xLTEtMA_8aac7e58-a01f-49b1-8f80-734f31ff48a2">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6870f9bf392f498a941330451198f38c_D20190101-20191231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzItNy0xLTEtMA_7e695f37-0819-4caf-b655-f9f86f9983b4">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i929c861096094117809bff5aea456e34_I20201231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzMtMS0xLTEtMA_1e2f6799-b68e-4e7e-b474-37ebbfe74bf9">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i279145e1ed5d4579b641b7df4d63ddf1_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzMtMy0xLTEtMA_fa56c717-90f1-437d-8c73-5026cd8ab9fb">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839275644c56406890c934fd58bed027_I20191231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzMtNS0xLTEtMA_c671e14b-af7c-4996-b8e4-baa39a40d4a6">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id225a6ef1501499aba377c394f95fe05_D20190101-20191231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzMtNy0xLTEtMA_5bad52a8-16a9-458b-aca9-392dc4ce3934">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renminbi denominated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4576480dfa8445591015c36a302939d_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzQtMS0xLTEtMjYzMg_1df5636c-4601-4e5a-9f52-914c488e75c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44368aec498f423db8c0bf4520a896a7_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzQtMy0xLTEtMjYzNg_c8567561-3a8f-4bb4-9431-7e115d5969f3">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Renminbi denominated factoring arrangement was entered into in 2020 and had remaining capacity available as of December 31, 2020. There were no amounts de-recognized for accounts receivable as of December 31, 2020 associated with this arrangement.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEyMzQx_43cd2ec2-2660-4516-91f5-6a425e68dca2">124</ix:nonFraction> million as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEyMzU3_a44ef61a-ece3-42e4-98f2-0c4bd2fe4dca">105</ix:nonFraction> million as of December&#160;31, 2019, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of December&#160;31, 2020 and December&#160;31, 2019, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our consolidated balance sheets as of December&#160;31, 2020 and December&#160;31, 2019.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i99081d42094247598d90234bd20a1aa4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum purchase obligations, relating primarily to non-cancellable inventory commitments and capital expenditures entered in the normal course of business, were as of December&#160;31, 2020 (in millions):</span></div><div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:LongTermPurchaseCommitmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkxMTEyMTU_2bb06f91-2493-45a4-b02d-b0a764652670" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.009%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecorded Purchase Obligations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzEtMS0xLTEtMA_84fde59b-1750-45eb-a794-8e22314dccd3">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:PurchaseObligationDueInSecondYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzItMS0xLTEtMA_de8487e7-9dfb-4e45-bd0e-948149935954">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:PurchaseObligationDueInThirdYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzMtMS0xLTEtMA_cb040885-1145-4221-b782-7a930141ceef">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:PurchaseObligationDueInFourthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzQtMS0xLTEtMA_ef82dfb5-b420-4db7-b982-c729f5fb7237">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:PurchaseObligationDueInFifthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzUtMS0xLTEtMA_357c7d79-159d-41c2-89f8-315cedc0dd3c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PurchaseObligationDueAfterFifthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzYtMS0xLTEtMA_6790e6b4-8588-44b9-9481-c2725be97f73">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:PurchaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzctMS0xLTEtMA_588b0d9e-914b-4d89-aa90-553b29e74e95">535</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_115"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:LeasesOfLesseeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzMyNjk_35cef36b-5795-4684-b0d9-2621d13baf20" continuedAt="i2ed686d938e442d5adbf4f37e0157609" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; LEASES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance leases for real estate including corporate offices, land, warehouse space, and vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet, unless the arrangement includes an option to purchase the underlying asset, or an option to renew the arrangement, that we are reasonably certain to exercise (short-term leases). We recognize lease expense on a straight-line basis over the lease term for short-term leases that we do not record on our balance sheet. If there is a change in our assessment of the lease term and, as a result, the remaining lease term extends more than 12 months from the end of the previously determined lease term, or we subsequently become reasonably certain that we will exercise an option to purchase the underlying asset, the lease no longer meets the definition of a short-term lease and is accounted for as either an operating or finance lease and recognized on the balance sheet. In accordance with FASB ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we account for the lease components and the non-lease components as a single lease component, with the exception of our warehouse leases. Our leases have remaining lease terms of less than <ix:nonNumeric contextRef="id58a89551ad04c37b39770710490ccd6_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzEyOTA_b72a473d-6b6f-4628-8dbf-fc256f2e3534">1</ix:nonNumeric> year to approximately <ix:nonNumeric contextRef="idfcc194efc364801bd80478df09f2935_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzEzMTA_6e2c0ce5-e3cd-4ef0-adb8-e6a5356d4251">56</ix:nonNumeric> years, some of which may include options to extend the leases for up to <ix:nonNumeric contextRef="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231" format="ixt-sec:duryear" name="bsx:LesseeOperatingAndFinanceLeasesOptionToExtend" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzEzNzk_3631c05c-2885-447c-bb26-9fb8cfae3738">10</ix:nonNumeric> years. If we are reasonably certain we will exercise an option to extend the lease, the time period covered by the extension option is included in the lease term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of the arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, we utilize the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease right-of-use assets are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and corresponding liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated balance sheets. Finance leases are immaterial to our consolidated financial statements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI3NDg3NzkwNzc2ODI_adfd34ef-562c-4b86-b096-c20ce1ec65a9" continuedAt="iba78edd3fd5342beb26d48a28ac0484a" escape="true">The following table presents supplemental balance sheet information related to our operating leases:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="iba78edd3fd5342beb26d48a28ac0484a"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:52.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzItMS0xLTEtMA_837debbd-304b-4403-8b6d-22157ad3a7cc">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzMtMy0xLTEtOTgwOA_f2cef876-6f8b-4c3c-8a8e-fb03e64d7e27">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdf6472601d4e179cdc65a60d86275d_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzQtMS0xLTEtMA_e084e218-7778-4cbf-98d5-0f7c2ae40acf">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29926e2a05fc47c9a3dcfbe25ce22aff_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzUtMy0xLTEtOTgwOA_a5e3bc28-6e83-4a0a-9907-7b84cbedf49e">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzUtMS0xLTEtMA_6e062ce2-4729-4734-8305-7a305b340dac">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzYtMy0xLTEtOTgwOA_3ace5145-0b95-44ba-8acd-21d80b2f710e">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2ed686d938e442d5adbf4f37e0157609"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI3NDg3NzkwNzc2ODM_fc37fa5e-63ba-4eec-8456-d9011052ebbb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:52.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTplNjJhOTc3ZmVkNDk0N2UyYjExODdjNDFkOTJiY2U3Yy90YWJsZXJhbmdlOmU2MmE5NzdmZWQ0OTQ3ZTJiMTE4N2M0MWQ5MmJjZTdjXzEtMS0xLTEtMA_f8f1549b-f863-439a-9bca-b4c2bfb93e58">10.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTplNjJhOTc3ZmVkNDk0N2UyYjExODdjNDFkOTJiY2U3Yy90YWJsZXJhbmdlOmU2MmE5NzdmZWQ0OTQ3ZTJiMTE4N2M0MWQ5MmJjZTdjXzItMy0xLTEtOTg1Mg_1d77eb08-4504-4843-ac8a-f1348d37f178">5.8</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTplNjJhOTc3ZmVkNDk0N2UyYjExODdjNDFkOTJiY2U3Yy90YWJsZXJhbmdlOmU2MmE5NzdmZWQ0OTQ3ZTJiMTE4N2M0MWQ5MmJjZTdjXzItMS0xLTEtMA_a567d070-9012-4035-a747-13390781cd42">2.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTplNjJhOTc3ZmVkNDk0N2UyYjExODdjNDFkOTJiY2U3Yy90YWJsZXJhbmdlOmU2MmE5NzdmZWQ0OTQ3ZTJiMTE4N2M0MWQ5MmJjZTdjXzMtMy0xLTEtOTg1Mg_dc55bb9d-f6d8-4fdb-b744-69a1643c3540">3.7</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease cost under FASB ASC Topic 842 was $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI1Njc_895d8bcf-2b01-44a3-b4a5-b5ebea63b555">92</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzU0OTc1NTgxNDM5NDA_9e216062-de55-40b6-9f2b-bc135cd0e6fe">80</ix:nonFraction>&#160;million in 2019. Rent expense under FASB ASC Topic 840 amounted to $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI2MjQ_c0ab9461-0d29-4943-b28c-61a4ffc40f04">92</ix:nonFraction> million in 2018.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI3NDg3NzkwNzc2ODQ_cc3169cf-be61-48a3-a0b1-35e260bbec9f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:52.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTpmNjNiNDlhMmQwNGU0YTUwOTE2MWFiMmJkNzZkMjVjYy90YWJsZXJhbmdlOmY2M2I0OWEyZDA0ZTRhNTA5MTYxYWIyYmQ3NmQyNWNjXzMtMS0xLTEtMA_b9ddc765-4b78-4e7c-8cd2-7235ee187ca4">91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTpmNjNiNDlhMmQwNGU0YTUwOTE2MWFiMmJkNzZkMjVjYy90YWJsZXJhbmdlOmY2M2I0OWEyZDA0ZTRhNTA5MTYxYWIyYmQ3NmQyNWNjXzMtMy0xLTEtOTg1OA_d473c5dc-4e98-406a-8a58-e53c7c06f1bd">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for operating lease obligations were $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI4MTM_414bdcb6-2377-4556-b8e2-32bca6a61e3d">202</ix:nonFraction> million as of December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzU0OTc1NTgxNDM5NDk_8eda88b6-6ad1-4961-af5c-eaba2ca3fbc2">137</ix:nonFraction> million as of December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:MaturitiesOfLeaseLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI3NDg3NzkwNzc2ODU_55c378f2-69e0-4c8c-ac74-24c74e03be03" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzEtMS0xLTEtMA_8e613e91-6bc9-46a3-aa0b-d4cd66ec20a2">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzItMS0xLTEtMA_5df8e2b6-028b-46df-b86e-af1e74b6ada9">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzMtMS0xLTEtMA_593bdb44-cc3b-4522-9b1c-989bdad99bc2">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzQtMS0xLTEtMA_b2591ed4-bf48-4927-8c29-c1f3d5d3a7ab">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzUtMS0xLTEtMA_cb4ef14c-99a3-48ed-9c5e-e3549c4ccdda">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzYtMS0xLTEtMA_94e9e753-13db-4f4d-a3de-4d6960bf4819">218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzctMS0xLTEtMA_7ef251ea-dc26-4ae8-9642-fd6e9b3c1589">530</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzgtMS0xLTEtMA_d428a377-361d-460d-8d10-d3039e93f148">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzktMS0xLTEtMA_bb7d1d8e-d071-4118-8ac7-4e357ff5a1ae">471</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have additional leases for office space and warehouse space, that have not yet commenced, of approximately $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:LesseeLeasesNotYetCommencedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzMwNjY_92e08fd4-9f35-4650-a62a-85fa6db2bfc8">25</ix:nonFraction> million. These leases will commence in 2021 and thereafter with lease terms of up to <ix:nonNumeric contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzMxMzA_6f9730da-08ea-45fa-87c7-41e41f0b920b">15</ix:nonNumeric> years.</span></div></ix:continuation><div id="i5c3e8d69fcc1460baddde62cfa022487_118"></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NjY_29306584-bc7f-47bb-9334-11a8913eaed4" continuedAt="ic4219bcdd878489ba90e19646ba5fc8e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE H &#8211; RESTRUCTURING-RELATED ACTIVITIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Restructuring Plan </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2018, our Board of Directors approved, and we committed to a global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan is intended to support our effort to improve operating performance and meet anticipated market demands by ensuring that we are appropriately structured and resourced to deliver sustainable value to patients and customers. Key activities under the 2019 Restructuring Plan include supply chain network optimization intended to maximize our global manufacturing and distribution network capacity and building functional capabilities that support business growth. These activities were initiated in 2019, with the majority of activity expected to be complete by the end of 2022, following a one-year extension approved by our Board of Directors on February 22, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, our Board of Directors approved an extension and expansion of the 2019 Restructuring Plan to include additional cost optimization activities, including the centralization of certain functional capabilities within the international regions in which we operate, and a one-year extension of the program to complete these activities along with certain other initiatives that were delayed in 2020 due to restrictions related to the COVID-19 pandemic. We expect the majority of activity associated with our 2019 Restructuring Plan, including the expansion, to be substantially complete by the end of 2022.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic4219bcdd878489ba90e19646ba5fc8e" continuedAt="id544496b823446e08d1062394ddc40de"><ix:nonNumeric contextRef="i3f274031addf44889a33eb68c3ed4dfc_D20200101-20201231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NTY_ee3dc626-6325-4b1d-a3b4-57a0cf76ee85" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, including the expansion, by major type of cost, of which approximately $<ix:nonFraction unitRef="usd" contextRef="ieceadf1a7f8e4fad892abbcf9491307e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectOnFutureCashFlowsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzYwNDczMTM5ODY0ODA_aa1e3ab6-f88d-48b6-9cb4-977dc33e3fc6">340</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i60558a28aa7c4d63a693910b749950a6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectOnFutureCashFlowsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzYwNDczMTM5ODY0ODc_492e6c11-caf1-4880-ac9a-202a1814503d">440</ix:nonFraction> million are expected to result in cash outlays:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Estimated Amount Expected to be Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if4e9f419b17a442ea339ee0791cb497b_I20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzItMS0xLTEtMA_60d4ff42-d583-4e04-bb77-ad53332359a9">75</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id7778b7f1e6944fd934bfedde17079ef_I20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzItMy0xLTEtMA_8dc0c5a8-2aab-4c4f-b8f1-a07fb76896b3">100</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb71293750e8491687172e77edc978a9_I20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzMtMS0xLTEtMA_b62d275d-815b-478d-9b25-a2eac2c018a6">25</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d165f894a04832a1fa68a0e736d01c_I20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzMtMy0xLTEtMA_25f2cf96-9214-45a4-bc81-06d53a773fa0">50</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60553db20b814c02b1d910e227adc3fc_I20201231" decimals="-6" name="bsx:RestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzUtMS0xLTEtMA_d883935d-e1b6-4c7c-a492-b4a759acb11a">275</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b0af9974fe547798f675a2412349d03_I20201231" decimals="-6" name="bsx:RestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzUtMy0xLTEtMA_cc40a707-c06b-4757-8803-c2902df1fa03">325</ix:nonFraction> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia3f9837c2b254cdcbb2ed38175b6637d_I20201231" decimals="-6" name="bsx:RestructuringandRestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzYtMS0xLTEtMA_0296d687-e76e-48b4-b792-5164560b467b">375</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iad4e9ac9719e43a1b6053144c13aafaf_I20201231" decimals="-6" name="bsx:RestructuringandRestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzYtMy0xLTEtMA_2c084736-03bb-422a-a503-01dceb5bc34b">475</ix:nonFraction> </span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Restructuring Plan </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2016, our Board of Directors approved, and we committed to a restructuring initiative (the 2016 Restructuring Plan). The 2016 Restructuring Plan was intended to&#160;develop global commercialization, technology and manufacturing capabilities in key growth markets, build on our Plant Network Optimization (PNO) strategy which is intended to simplify our manufacturing plant structure by transferring certain production lines among facilities and expand operational efficiencies in support of our operating income margin goals. Key activities under the 2016 Restructuring Plan included strengthening global infrastructure through evolving global real estate assets and workplaces, developing global commercial and technical competencies, enhancing manufacturing and distribution expertise in certain regions and continuing implementation of our PNO strategy. These activities were initiated in the second quarter of 2016 and substantially completed in 2019. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ia070298726984423957d186ea4cbee58_D20200101-20201231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2OTU_839df2ef-4a46-4f7d-9965-8c6b41937bde" continuedAt="i0dbcd11c945d41e49387fcee98a8577f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $<ix:nonFraction unitRef="usd" contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzYwNDczMTM5ODY2NDk_957cab66-975b-4ec6-9e5d-5ce528a2e78b">255</ix:nonFraction> million resulted in cash outlays:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9961b90ffa46eaa0ecfefd2145c16b_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTpiNzc5YmQ5YzA1MTQ0ZjgxOWEzZmUxMWUxODY3YWU0MC90YWJsZXJhbmdlOmI3NzliZDljMDUxNDRmODE5YTNmZTExZTE4NjdhZTQwXzItMS0xLTEtMA_919e31dc-ad9f-461d-96d0-f278cb916388">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bdc512ea545452b8a307ed56cefa316_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTpiNzc5YmQ5YzA1MTQ0ZjgxOWEzZmUxMWUxODY3YWU0MC90YWJsZXJhbmdlOmI3NzliZDljMDUxNDRmODE5YTNmZTExZTE4NjdhZTQwXzMtMS0xLTEtMA_a683f3e4-5501-4753-9968-2ef76e9f10c6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTpiNzc5YmQ5YzA1MTQ0ZjgxOWEzZmUxMWUxODY3YWU0MC90YWJsZXJhbmdlOmI3NzliZDljMDUxNDRmODE5YTNmZTExZTE4NjdhZTQwXzUtMS0xLTEtMA_5367deb0-2b3b-47ca-affa-a9da12e0045a">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTpiNzc5YmQ5YzA1MTQ0ZjgxOWEzZmUxMWUxODY3YWU0MC90YWJsZXJhbmdlOmI3NzliZDljMDUxNDRmODE5YTNmZTExZTE4NjdhZTQwXzYtMS0xLTEtMA_4ee19b2c-0638-4c8d-a158-6481f48c339a">271</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div></ix:nonNumeric><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i0dbcd11c945d41e49387fcee98a8577f">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NjU_52035752-aa86-4b2f-8c5e-d17370e1fc07" continuedAt="i2e03a2dcce584e05ba32a147e0133107" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib00c2166428146c59f1dbc9ed80238de_D20200101-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzEtMS0xLTEtMA_e6cb4394-a0ec-44d7-9f25-a5273b2673ed">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f722e04aec431e92c5dab638517e6c_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:TransferCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzEtMy0xLTEtMA_09548d92-69ad-447a-80d1-ed96a05a7b12">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0fc03416e74cf7b79748dfc5fec108_D20200101-20201231" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzEtNS0xLTEtMA_81d750a4-ed90-4b1f-bb65-a6535afe0e1b">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzEtNy0xLTEtMA_558c9a46-9ab3-4691-9eb1-33b794347d97">52</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169c8823728f4c56bf82523f72a013d7_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzMtMS0xLTEtMA_b9552217-2078-45f6-a593-6d55a4e9535a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3689dbf1264c80b2fc2369ebb72975_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzMtMy0xLTEtMA_02e37b94-efe7-4d96-9429-32b5589b463c">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib138f03d5a5c411aa8254cb667a37e63_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzMtNS0xLTEtMA_8c68c982-2f01-48e8-926e-71790dd503c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1133c37811e34ad8a94424eab435b18c_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzMtNy0xLTEtMA_2f202967-281d-4ce5-a86f-7af09d2da8fa">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101e2c90421b466f8a45ce41d9f8dd58_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzQtMS0xLTEtMA_9756afa0-855a-4569-aeac-cf2e8eab2e5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04e61dc46ef4691b3b50088e8133d64_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzQtMy0xLTEtMA_8858c142-18dd-4d06-98a6-6fe9784250da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8703d1164954705a5b4395347a35ba5_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzQtNS0xLTEtMA_b42a7595-9892-4ace-98e9-c7707ac7e574">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1888e3e03a40bf807e229e44b6ff2b_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzQtNy0xLTEtMA_3038780b-be23-4220-9154-aa6ca012b774">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae917fc49bf4be6a5712c59d3887549_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtMS0xLTEtMTkwNzA_b8013a3c-0b28-4aa2-b367-9a6338603ba2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8e1fcec7c545189678173243202880_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtMy0xLTEtMTkwNzQ_5afc924a-ef21-47d2-9c98-6d547d40a382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb31286a42734b9eb48b8f675cd3027c_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtNS0xLTEtMTg5OTc_29927c43-6eb8-4e32-b499-590866f8da84">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437f306d342d401085bd4bc596e6f2a3_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtNy0xLTEtMTg5ODk_829a9608-e7d1-48d7-a265-21cdb0a0a1aa">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib00c2166428146c59f1dbc9ed80238de_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtMS0xLTEtMA_d5c9fcad-0df6-46fa-8210-e0995eacf147">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f722e04aec431e92c5dab638517e6c_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtMy0xLTEtMA_b2c1473a-12ed-4624-a2bb-b70cdd5dff04">64</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0fc03416e74cf7b79748dfc5fec108_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtNS0xLTEtMA_c9e2294b-33f0-4673-814a-1685f6e0ab1d">55</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtNy0xLTEtMA_ea6d59b6-3b75-41ae-a714-bf4fa4d273b7">119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib00c2166428146c59f1dbc9ed80238de_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzYtMS0xLTEtMA_c999518f-33fc-46b8-8aae-18d84c85f339">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f722e04aec431e92c5dab638517e6c_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzYtMy0xLTEtMA_7b2dd8ce-9328-40f2-ad2a-a3abb746ef3b">64</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0fc03416e74cf7b79748dfc5fec108_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzYtNS0xLTEtMA_5884cef0-bf78-4383-b92b-114d2db8b031">79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzYtNy0xLTEtMA_4d784065-29c6-48e0-b4e1-7a73e0b46db9">171</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id544496b823446e08d1062394ddc40de"><ix:continuation id="i2e03a2dcce584e05ba32a147e0133107"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d0c00ba23a4901a24791aa8b568055_D20190101-20191231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzEtMS0xLTEtMA_446661be-05fe-4cf5-bc94-4b733257b66b">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef5ec3f5c6e45c3b89e5abaaf847a2a_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="bsx:TransferCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzEtMy0xLTEtMA_38780b84-4746-459e-b581-4afb70dc5332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149a77f1ef8b4e1aa76950f7516e8136_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzEtNS0xLTEtMA_d44a8a69-6082-4185-8907-c7b2dbaa0dc9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb54673ea5524ce182360792b2c9655d_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzEtNy0xLTEtMA_e2704e9f-9fb7-45c8-a013-ca6888aec4a7">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a96b3c0c7d4f2b81bce69840269e54_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzMtMS0xLTEtMA_fc839bbd-1280-49bf-934c-0b020412d15d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05cd1788c0054ebaa6c7c34fd116c721_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzMtMy0xLTEtMA_ea24b71f-db71-4f70-93df-4840f253c005">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3930ab450cbc485eb4182fa96c8c03c0_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzMtNS0xLTEtMA_629651f7-7b54-4830-aefe-e005382a6dae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98f6675244c47d784ea3093b78e1e84_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzMtNy0xLTEtMA_0f475749-10dd-44ee-80cd-4b0803abddd0">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfedd935c9342268439fe7cbeae60e7_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzQtMS0xLTEtMA_7b93bdb6-5105-4e26-85e6-32aa9d7b3b88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18140364ac7a4d3699b0c8e6c02ca49a_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzQtMy0xLTEtMA_9a5fa1fd-64a3-43f2-8f1f-8a86b22bd8a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080263b4497f43dd86b878ee1c6339bf_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzQtNS0xLTEtMA_45832b99-937a-47dc-a0b4-87c1d5014eb1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff943bdcb694439986636ed65f75c91_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzQtNy0xLTEtMA_50c07e6c-f8f0-480d-8fcb-f2cbeeddb6b3">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d0c00ba23a4901a24791aa8b568055_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzUtMS0xLTEtMA_1df92c86-d8cc-4098-b9b3-a7f86fb3415b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef5ec3f5c6e45c3b89e5abaaf847a2a_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzUtMy0xLTEtMA_ab79205e-558b-4c31-bb1c-fa6faebfa137">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149a77f1ef8b4e1aa76950f7516e8136_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzUtNS0xLTEtMA_436a1691-ab1f-4ec1-b286-58241852b02c">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb54673ea5524ce182360792b2c9655d_D20190101-20191231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzUtNy0xLTEtMA_79c2e06c-15c1-4338-bc22-71a0590bfdcc">44</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d0c00ba23a4901a24791aa8b568055_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzYtMS0xLTEtMA_51c4ff24-4fcd-4f6f-a617-e7c0533913fd">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef5ec3f5c6e45c3b89e5abaaf847a2a_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzYtMy0xLTEtMA_ae42d1c6-cc34-42a4-8a8d-72980d911406">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149a77f1ef8b4e1aa76950f7516e8136_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzYtNS0xLTEtMA_9983c2f6-fb52-407f-9740-f805cfbe0ef6">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb54673ea5524ce182360792b2c9655d_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzYtNy0xLTEtMA_57d23cd5-a721-467d-be63-d4f3f635975c">82</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270b92546484cbf82fd0280322db3ed_D20180101-20181231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzEtMS0xLTEtMA_44d2ff40-f65c-43f2-bb75-edacc2810ea0">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31cc871da3dc48c7a5f796348d8817ae_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="bsx:TransferCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzEtMy0xLTEtMA_2de97115-ad19-45e6-b182-8c1a522619a6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33eedfc21a14d7984d9f03c953ab5f4_D20180101-20181231" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzEtNS0xLTEtMA_fc475b64-5f2d-4514-bfb5-6d830ad23721">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c6df5a32d14725adccb334ebaac480_D20180101-20181231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzEtNy0xLTEtMA_9a4b7815-b132-49c1-a3b8-1065ccf2467c">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaca3955aa3774955b74141f0b7742835_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzMtMS0xLTEtMA_23bccd12-baf3-4906-a300-f4ed8ad0b102">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5426d5162838458f96e5bd31e0cac4eb_D20180101-20181231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzMtMy0xLTEtMA_904875df-fec1-4561-b2c9-25cb52663330">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c55f725ad2b4e03bb8b3aa0fdf79f67_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzMtNS0xLTEtMA_2cfc8805-3fdf-46da-acae-20c977380e8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8819d44961a414f9358a2742a3ca164_D20180101-20181231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzMtNy0xLTEtMA_17fde006-22d3-4942-9d7a-135a9fc22dbb">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92351a2745854052bb947f9c73f7b6ce_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzQtMS0xLTEtMA_88349915-7962-498c-91cd-4b14dd2495af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78f6d9f528bf4e5b810d4a2a45a83e7a_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzQtMy0xLTEtMA_c6f7f483-c18b-4add-ae04-9553e88d527e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c6c1520344544848558a04190ef9084_D20180101-20181231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzQtNS0xLTEtMA_346e3420-f5ea-48b2-9ba5-1a07fb2a7468">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea799c3840b4e17bb183186348f29aa_D20180101-20181231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzQtNy0xLTEtMA_7186b03d-220a-4f99-b2a9-8e26bed226f2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270b92546484cbf82fd0280322db3ed_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzUtMS0xLTEtMA_c5cd5bd9-6ab9-47cb-bd56-c8c107d60fe1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31cc871da3dc48c7a5f796348d8817ae_D20180101-20181231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzUtMy0xLTEtMA_7c04d90f-0cfc-4cdd-9a9c-f817bc7abeda">47</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33eedfc21a14d7984d9f03c953ab5f4_D20180101-20181231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzUtNS0xLTEtMA_35bc5482-8751-4b13-9c9e-3a69472200ae">12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c6df5a32d14725adccb334ebaac480_D20180101-20181231" decimals="-6" name="bsx:RestructuringRelatedExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzUtNy0xLTEtMA_f833c44a-decc-4230-8d96-ba0a1b91a280">59</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270b92546484cbf82fd0280322db3ed_D20180101-20181231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzYtMS0xLTEtMA_599f4013-5226-4dcf-827d-880150b8e592">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31cc871da3dc48c7a5f796348d8817ae_D20180101-20181231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzYtMy0xLTEtMA_de07c9da-852c-498e-8f22-d8dcac7a94ac">47</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33eedfc21a14d7984d9f03c953ab5f4_D20180101-20181231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzYtNS0xLTEtMA_ea82bd0b-bdab-43b6-9700-49f145d370ee">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c6df5a32d14725adccb334ebaac480_D20180101-20181231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzYtNy0xLTEtMA_4d12a649-665a-4dbd-a8ca-c8dd0534b87e">96</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LOTUS Discontinuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System, and our decision to retire the entire LOTUS platform. We estimate the decision will result in total pre-tax restructuring and restructuring-related net charges of approximately $<ix:nonFraction unitRef="usd" contextRef="icf19c236e1224a3e9207882bafa38c2e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:RestructuringandRestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5NTQ_95b3dbab-9515-41b6-a29f-028f24f0860b">80</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i4fc68305d0ea4e12951bcc4b90225f04_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:RestructuringandRestructuringrelatedCostExpectedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5NjI_df505fb7-d74c-4629-bff7-ba66a392781c">90</ix:nonFraction> million, which includes $<ix:nonFraction unitRef="usd" contextRef="id66a034296ae4bb1a925a5b9c0323174_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectOnFutureCashFlowsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5Njk_20f9d4bb-5261-4018-85aa-8816c6bde84b">30</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i13e5df102a644d64adfa3a33ffdcdfd9_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectOnFutureCashFlowsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5Nzc_19f262a0-cd85-4d40-869c-6067ad4b9ab4">40</ix:nonFraction> million of estimated charges expected to result in future cash outlays. We recorded $<ix:nonFraction unitRef="usd" contextRef="i2ddab50db36b43dd9f17c341352773f6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5ODk_95ea66e7-d0bd-4ffe-bf84-a6339e33ca6a">55</ix:nonFraction> million of restructuring and restructuring-related net charges associated with the product discontinuation in 2020, which is included in the table above for the year ended December 31, 2020, and expect the remaining activity to be substantially complete during early 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2020 we recorded $<ix:nonFraction unitRef="usd" contextRef="ie43de06282cc43d6808a84e7f69288d4_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzIwMzY_e10d1aac-e93f-440e-9d66-3584cf8c3af7">119</ix:nonFraction> million of inventory charges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and $<ix:nonFraction unitRef="usd" contextRef="i2ddab50db36b43dd9f17c341352773f6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzIwOTQ_6ea46cea-43eb-4c73-8e1e-cc05afc6bc0d">8</ix:nonFraction> million of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> associated with the product discontinuation.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:CumulativeRestructuringChargesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NTI_e63bb1bc-f6c0-4ca3-af85-c21417b38a6a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2020, related to our ongoing Restructuring Plans by major type: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:22.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9961b90ffa46eaa0ecfefd2145c16b_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzEtMS0xLTEtMA_60af89a9-8471-4d1d-ae25-c84f06793adc">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e8f687653b84e89ba20c0702c69ec9f_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzEtMy0xLTEtMA_9768bbc6-8c07-4f5d-b4b9-c99ee80cc8b1">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2eef7931a47424aadfa33ed87c13bef_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzEtNS0xLTEtMA_cfe4e2cc-f5b1-453c-aaee-a4bc8efe93c8">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bdc512ea545452b8a307ed56cefa316_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzItMS0xLTEtMA_a5fb3d0f-d25a-49d4-83c5-a00d89b2f4b6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69acc2e1fe284629bd66ab64abb82dfe_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzItMy0xLTEtMA_8fe049c5-a133-467c-acf4-947584371fa8">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c007a8c0e54e8f8dbfbd4c1b84ae74_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzItNS0xLTEtMA_23347ebe-6491-4805-9983-f0afac5995f0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzMtMS0xLTEtMA_ff3a5fae-0a42-4078-af36-27f2e0e5b39d">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d4deec479e42b4921ca3c0c19c6196_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzMtMy0xLTEtMA_23f10353-f643-41e1-ab49-45c8cf743317">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425c4f006d69412d874f531954a840d6_I20201231" decimals="-6" name="bsx:CumulativeRestructuringChargesIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzMtNS0xLTEtMA_3860db48-eade-4802-b5a9-bb5a29815617">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de6be7750b84ba2becd8b78d3760d22_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzQtMS0xLTEtMA_96c45992-bf3d-42f1-805a-4336199b81fd">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2af5f8f85cb4333aba96313b76a69ca_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzQtMy0xLTEtMA_ca5a6833-6415-4eb1-b95c-4ea942f038ad">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida81f67779e44ee99c0f4576accd6b66_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzQtNS0xLTEtMA_63eca985-6d1b-4ce4-bc4a-208224e79ea3">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bdc512ea545452b8a307ed56cefa316_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzUtMS0xLTEtMA_0a4ffb5d-9191-428e-8753-8db47d7a18d3">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69acc2e1fe284629bd66ab64abb82dfe_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzUtMy0xLTEtMA_b34c5a0f-aab8-4f17-8f95-0553c8d23b3c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c007a8c0e54e8f8dbfbd4c1b84ae74_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzUtNS0xLTEtMA_fd692c82-d78f-47a3-b984-121805c21db6">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzYtMS0xLTEtMA_6866f5be-0653-4be1-bbd0-0c7ec9f153b1">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d4deec479e42b4921ca3c0c19c6196_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzYtMy0xLTEtMA_54413585-9525-4755-b683-f76f3a98ee3b">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425c4f006d69412d874f531954a840d6_I20201231" decimals="-6" name="bsx:CumulativeRestructuringRelatedCostsIncurredToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzYtNS0xLTEtMA_59cf954c-cb1d-4fb8-80e6-4ffd0541d7e0">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzctMS0xLTEtMA_5a5d901e-c033-4030-830f-a7e4be703b56">271</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d4deec479e42b4921ca3c0c19c6196_I20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzctMy0xLTEtMA_d83d2f21-31a2-4a6c-bc53-527fcae4fd53">179</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425c4f006d69412d874f531954a840d6_I20201231" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzctNS0xLTEtMA_73c84a66-b560-40ea-b803-3317a737c07e">450</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NzE_b8a0c5cd-f3eb-46fb-a9e6-c4aafab6942d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9961b90ffa46eaa0ecfefd2145c16b_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzItMS0xLTEtMA_b0da7227-19ca-43ea-9a64-1d3e0945404c">89</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e8f687653b84e89ba20c0702c69ec9f_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzItMy0xLTEtMA_86eb8def-7183-4f97-87b9-856565182e1c">12</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2eef7931a47424aadfa33ed87c13bef_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzItNS0xLTEtMA_0fd5e2c8-653d-4db7-83ff-eafae2bab3c7">100</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de6be7750b84ba2becd8b78d3760d22_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzMtMS0xLTEtMA_baa6c689-316d-408b-ab5b-e33f46b7bf7a">125</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2af5f8f85cb4333aba96313b76a69ca_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzMtMy0xLTEtMA_130cfd2c-cb4f-4cb9-b77d-d04d8be45934">77</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida81f67779e44ee99c0f4576accd6b66_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzMtNS0xLTEtMA_be1deb70-3a61-4900-ab85-e911a44dc014">202</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bdc512ea545452b8a307ed56cefa316_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzQtMS0xLTEtMA_c08198b5-a48e-4da8-a674-b37e9701536f">41</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69acc2e1fe284629bd66ab64abb82dfe_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzQtMy0xLTEtMA_b3b186d0-d1b8-4bff-8a75-1598e0c89a4f">25</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c007a8c0e54e8f8dbfbd4c1b84ae74_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzQtNS0xLTEtMA_7983f07c-9cad-419c-a89d-2658e44fb54f">67</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzUtMS0xLTEtMA_cf640814-7d79-4134-996b-e5c834953568">255</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d4deec479e42b4921ca3c0c19c6196_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzUtMy0xLTEtMA_30890f46-c6bf-441d-a6be-b0fb1a2d9b79">114</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425c4f006d69412d874f531954a840d6_I20201231" decimals="-6" name="bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzUtNS0xLTEtMA_e97f2e14-5fcf-48dc-8368-d30465721bfc">369</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ4Ng_b51552dd-076b-43bc-826f-f0abf16a52b8" continuedAt="icc020605b94e4c0eb290a6a79a13f29d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in our accompanying consolidated balance sheets are as follows:</span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ3MA_518fb515-a019-4ab0-8a50-90b021cd621d" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzItMS0xLTEtMA_9241aabd-56c5-47d8-b0d7-4c1a62974905">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzItMy0xLTEtMA_881a2f61-9584-4ba4-ab4e-a275d3f47087">1,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzMtMS0xLTEtMA_476c6c33-2111-440d-8c1e-f094425cc381">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzMtMy0xLTEtMA_6d66cbb8-2aff-4ac3-99ad-1504cf6532d1">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzUtMS0xLTEtMA_95bc21aa-05af-4b1e-88db-970c9bb8ab9e">1,531</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzUtMy0xLTEtMA_6a18ccfe-7087-4203-bcda-9a9bbd5c9749">1,828</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzItMS0xLTEtMA_8f6a492e-e858-4275-949b-c47280a17354">74</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzItMy0xLTEtMA_064cc20f-5eb4-46ed-9070-486ef79ba1ec">68</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzItNS0xLTEtMA_f323fead-2c22-480c-bda3-d9a53165126a">68</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzMtMS0xLTEtMzMxMA_2310ac2d-db03-4931-9626-74c35c793a50">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzMtMS0xLTEtMA_2c256f9e-b035-4689-b9ce-679b2a8ecf19">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzMtMy0xLTEtMA_2f970d0c-d997-491c-8189-04b42ee8ea0f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzMtNS0xLTEtMA_e47ba6fe-940b-47ec-ad11-c1f951b0f09e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzQtMS0xLTEtMA_ae78b64c-65be-4d9d-af13-61189fd17f49">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzQtMy0xLTEtMA_873806e3-6df0-4d39-9dbf-1bcb38620814">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzQtNS0xLTEtMA_2e75757a-1e1b-454f-8fd8-492c571dc4fe">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzUtMS0xLTEtMA_02581f64-88b2-44bb-935e-5f870f08fdc9">105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzUtMy0xLTEtMA_db4bcc1e-a6da-44be-bbf8-9f102b8d985b">74</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzUtNS0xLTEtMA_ea1e9a2e-90a4-4e2f-9587-8ec5888ffbab">68</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 310</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note R &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="padding-left:18pt"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQzNg_0a94a2eb-b1c7-4058-98b0-c5ba42fbe4da" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzItMS0xLTEtMA_85efb986-ec76-401e-9d85-8f96ea0fb0a4">893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzItMy0xLTEtMA_da6f6748-c663-47bd-802a-b9eb1e115247">971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzMtMS0xLTEtMA_761b967b-ce98-4ce7-a6d4-ec7924f66206">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzMtMy0xLTEtMA_65cc18cb-1ed4-4f91-b67d-9d7a4f3063d6">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzQtMS0xLTEtMA_bb4bec94-2342-45fe-ae26-73ae232d7e10">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzQtMy0xLTEtMA_4892b5b4-cd9d-4a7f-aab1-472bfaa751d9">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzUtMS0xLTEtMA_55a5ec57-ba0d-4627-afe8-f7e9337a59e3">1,351</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzUtMy0xLTEtMA_ffc72796-507b-4521-bc57-d0c4fafb3872">1,579</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately <ix:nonFraction unitRef="number" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="2" format="ixt:numdotdecimal" name="bsx:PercentOfFinishedGoodsAtConsignment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzU0OTc1NTgxNDUwNzI_2fe2db06-88c6-48dd-9a8e-f19000b57842">33</ix:nonFraction> percent of our finished goods inventory as of December&#160;31, 2020 and approximately <ix:nonFraction unitRef="number" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="2" format="ixt:numdotdecimal" name="bsx:PercentOfFinishedGoodsAtConsignment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzU0OTc1NTgxNDUxMzY_dc56327f-51b5-49d5-9d25-d7db991b5b4c">32</ix:nonFraction> percent as of December 31, 2019 was at customer locations pursuant to consignment arrangements or held by sales representatives.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzI3NDg3NzkwNzU4Mjg_605c913b-7062-47df-ab4d-92f6804b882c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzItMS0xLTEtMA_cac28a21-e73f-460d-b4f0-d90b4f627e64">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzItMy0xLTEtMA_37d01976-d2b7-440e-9aed-a7052463d189">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzMtMS0xLTEtMA_d3858a60-65b5-40e7-9a74-9ecef35ba75c">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzMtMy0xLTEtMA_4322207c-171c-43f9-ab77-f74669f067b8">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:LicensingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzQtMS0xLTEtMA_9598a952-163b-4521-acf5-3beb30e819be">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="bsx:LicensingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzQtMy0xLTEtMA_5af4f2e4-3a93-4dc9-9061-b1d1da004f3b">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzYtMS0xLTEtMA_f22e293d-9113-4088-888d-1dbdf40a7669">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzYtMy0xLTEtMA_ae1d9565-4712-4908-be55-5673d6738c03">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzctMS0xLTEtMA_b6dd0597-0cb4-4665-b18f-9c4c0c63ccf1">751</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzctMy0xLTEtMA_274db232-80ce-4145-b46a-dd22c3beee1f">880</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icc020605b94e4c0eb290a6a79a13f29d" continuedAt="i1ea10a640b7d47b9a78b16ecb39ee58e"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ3NQ_e4315c02-e90a-446b-9504-cabb2002c4fc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzItMS0xLTEtMA_7b328a91-7cc0-4609-9c3d-bbea94eecd46">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzItMy0xLTEtMA_1d1fbf10-8b41-4a24-b2d6-9c5f73c317ef">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzMtMS0xLTEtMA_ab442ddc-4c70-4a6f-9871-2abba8ccf326">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzMtMy0xLTEtMA_8590930b-a77d-4bd0-9621-f5db00e612e9">1,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:EquipmentFurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzQtMS0xLTEtMA_c4522796-68e4-4aca-8a6c-3ce96279b3aa">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:EquipmentFurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzQtMy0xLTEtMA_c585de2d-37a1-4065-ab90-ec02733f7f50">3,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzUtMS0xLTEtMA_1b3a0ca6-e51f-473c-8aa1-e805e5db5fba">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzUtMy0xLTEtMA_f88573d6-6f10-4dd4-b274-068a9d669fdb">442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzYtMS0xLTEtMA_ee2471fb-0512-4a8f-beb9-1e0a8bf92781">5,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzYtMy0xLTEtMA_47f1f26d-b366-4398-9426-e628284144bb">5,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzctMS0xLTEtMA_517bbbb4-c073-4ac6-8e51-a7ea811d83f8">3,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzctMy0xLTEtMA_7a534488-6cbc-427b-8489-31a3cd574d12">3,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzgtMS0xLTEtMA_3f8c4bd2-9d42-43e9-b3d4-1b2a39b524b7">2,084</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzgtMy0xLTEtMA_e6a462bf-836e-48f8-992f-764af428a1ff">2,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzI5Mg_abcf7229-4bbd-4f9d-b613-27f4d03a7da2">333</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzMwMg_dcd6434d-716d-47db-808a-a96ce664a846">311</ix:nonFraction> million in 2019 and $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzMxNQ_0919107c-5261-4fc9-bd4c-28b522e76068">296</ix:nonFraction> million in 2018.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzI3NDg3NzkwNzU4Mjk_bcde5b5a-950b-4528-9c58-1d7fa97fdde3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzItMS0xLTEtMA_e113717c-5c38-4060-b071-bf5dc28f70be">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzItMy0xLTEtMA_52aa7e33-cb91-4775-bd8d-1ebfa68556cc">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzMtMS0xLTEtMA_9dc71aff-841c-487e-986d-2261f3aa3228">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzMtMy0xLTEtMA_dbaf798b-6976-4f2f-81c7-12381f868095">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzQtMS0xLTEtMA_3d3fbbdc-5a70-422b-a4ce-ef5482ee11d6">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzQtMy0xLTEtMA_3c6bbf84-4fae-432f-a0c4-cc8de54b848f">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzUtMS0xLTEtMA_e22cd7c6-a276-41a5-bce8-38a3d4cc204c">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzUtMy0xLTEtMA_ce8fb14c-3cbf-428f-9c6a-cf45b7dc3a44">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzYtMS0xLTEtMA_6b2112a4-b440-4aee-8b19-28b3d8fe2639">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="bsx:LicensingArrangementsAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzYtMy0xLTEtMA_4b231024-5529-4d04-bff4-00ac4022d95d">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:OtherOtherLongTermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzctMS0xLTEtMA_ffcf2866-7d87-45aa-a306-f5c2f531e5ec">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="bsx:OtherOtherLongTermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzctMy0xLTEtMA_0321adee-c5bc-40a7-8214-a853c7ce4b27">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzgtMS0xLTEtMA_ea5ac1c2-a495-4ee9-abb4-8a6e8b818d17">1,921</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzgtMy0xLTEtMA_7233be75-b72c-4e4e-8898-2a8a91c72d62">1,529</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ0OQ_50f856ca-7113-4fca-a7b3-2d53c2aeddd2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzItMS0xLTEtMA_407d0beb-308b-47b9-8020-d0c31c27eaa7">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzItMy0xLTEtMA_73667082-ad22-403c-afc7-c14b63086019">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzMtMS0xLTEtMA_9cbd3456-b165-4d03-bf9d-309b428335b6">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzMtMy0xLTEtMA_ac714850-3c0e-4dea-bf79-06bb706cb2e0">708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzQtMS0xLTEtODM0MA_be0b41ed-b7ef-403b-bd0e-f091a551dc60">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzQtMy0xLTEtODM0MA_e104916c-a95c-44f7-9eaa-da97cdaf763e">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzQtMS0xLTEtMA_e2e5d7d1-93c4-4b69-997a-91ffa4b7ff1c">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzQtMy0xLTEtMA_3568f161-c4b1-45d6-ab2f-f563c5bf19ee">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzYtMS0xLTEtMA_fb0e1545-b1da-4a0f-8150-656f7deb4a0d">656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzYtMy0xLTEtMA_66677a10-4669-465d-b628-5a3b24b3ac26">576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzctMS0xLTEtMA_cc23c2e9-08d7-41e3-9a82-6078679d636d">2,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzctMy0xLTEtMA_2fb24337-0414-4543-9472-dfec3fd8c8e2">2,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzI3NDg3NzkwNzU4MzA_b46309be-647d-4a29-b956-b5697077825a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzItMS0xLTEtMA_8c7ca585-a3e4-4211-bb40-f65ce8ed52a2">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzItMy0xLTEtMA_ff2a7cfb-355a-45dd-81f8-559b0c7447bd">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzMtMS0xLTEtMA_5dd92f6e-0de9-4710-ab91-40c1957dd105">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzMtMy0xLTEtMA_763946dc-aa3e-4a84-a1c3-f0194ecdb4ff">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzQtMS0xLTEtMA_84253954-6920-4e46-b855-3639e1e5cfe3">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzQtMy0xLTEtMA_80910aa2-d552-4e0c-963f-45c3471d9f5e">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzUtMS0xLTEtMTM4Mzc_7b0a0fc1-b85c-4eab-b0d6-e388c4017353">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzUtMy0xLTEtMTM4NDE_75ba376c-ef25-4374-844a-aae896e630f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzUtMS0xLTEtMA_67b47743-7d2f-4583-84eb-0f4339acf30c">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzUtMy0xLTEtMA_8e6e0d09-61b6-4d5a-9596-017aa729867c">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzYtMS0xLTEtMA_0846ff7b-63fe-4b5c-abc1-724718e9fb04">958</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzYtMy0xLTEtMA_89e7e46f-f15e-4136-8a96-62fdcae75c5d">800</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i1ea10a640b7d47b9a78b16ecb39ee58e"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ5OQ_b9a599f4-6c85-48ec-bceb-ce6ed2456ee9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzItMS0xLTEtMA_8473363d-b882-420c-98db-521fb18e6fb2">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzItMy0xLTEtMA_737458d2-3835-4f0b-a3d5-8996b97e7e9f">667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzMtMS0xLTEtMA_a601a44f-3b97-49db-9a39-ba2a2c583aea">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzMtMy0xLTEtMA_799c1e4b-9789-4530-8ecc-e376ce6240a7">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzQtMS0xLTEtMA_fab418e2-2722-492d-b0cb-4467ea986f5d">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzQtMy0xLTEtMA_6f9dd8f1-7cbb-43e5-ab5a-bb398f6a412e">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzUtMS0xLTEtMA_5908cea6-9872-44b8-868d-e286be6befd0">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231" decimals="-6" name="bsx:LicensingArrangementsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzUtMy0xLTEtMA_4e835774-bf43-49a0-a222-7771c1b58c94">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzYtMS0xLTEtMA_d3f05afd-7e07-4237-8529-fa473374be33">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzYtMy0xLTEtMA_302e64e6-44fb-43b5-b1fa-bfaf8d7e7075">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzctMS0xLTEtODM5Mg_33f05edf-ec7a-4b68-b6bc-f34d03630fd2">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzctMy0xLTEtODM4OA_e203fd33-98bb-4d23-afed-c087d1ae81e0">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzctMS0xLTEtMA_14771849-718e-4f73-ac5c-1b58ec534e32">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzctMy0xLTEtMA_3599d149-ce2a-4648-bcd4-8c0e763897e9">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzgtMS0xLTEtMA_2c5759c8-e80f-48d6-966d-0caad314472c">2,309</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzgtMy0xLTEtMA_d172f686-c417-4b15-ab0e-79e30f2be9be">2,635</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_124"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI3NDg3NzkwODg0NjA_d6cc408b-7251-41ec-ace4-a38d793fafc0" continuedAt="id1c31785e72a48ddb73a6dc7fbc11955" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyNDk_0e27c9e2-d65b-4176-b306-9849a4f1f6de" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzItMS0xLTEtMA_8bff351d-95e4-4e92-975d-fe7c3c6c5c70">660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzItMy0xLTEtMA_677142a0-db76-4dc8-a667-ab39bc8a1f74">1,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzItNS0xLTEtMA_3596c702-7bdb-4a02-a97c-2c081584a4b7">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzMtMS0xLTEtMA_b1e60fdf-32b6-4618-aad2-a8894202046b">581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzMtMy0xLTEtMA_ce2a5e80-9bec-402f-8637-1fe014318d17">1,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzMtNS0xLTEtMA_acf33ce8-4b0f-432e-8380-f9283543cfab">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzQtMS0xLTEtMA_e3cc319a-cce5-4121-a217-5cd417b057b4">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzQtMy0xLTEtMA_b83dc5ee-2cf2-440e-8087-3f50e5d92eec">687</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzQtNS0xLTEtMA_a16e4d60-369a-4d9a-bba0-917931715115">1,422</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyMTg_4d79eb62-ae58-4408-9f3f-8e5fd3a12567" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related expense (benefit) for income taxes consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzMtMS0xLTEtMA_f480b55f-e481-47a9-a9b4-b25271cef55c">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzMtMy0xLTEtMA_973d1e13-5976-48dd-b1f1-b0c807aef465">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzMtNS0xLTEtMA_7bdbf382-aa24-42e6-8e3a-eb90b203bb69">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzQtMS0xLTEtMA_79be3130-403b-483f-9944-c56cf0f89374">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzQtMy0xLTEtMA_55f8c740-1078-4184-bc03-7574f821c716">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzQtNS0xLTEtMA_5bf133ad-5370-411d-ba32-795270e5e7ed">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzUtMS0xLTEtMA_ad9fe786-3fa7-44d6-b736-b6a3a51363d9">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzUtMy0xLTEtMA_20f37522-473c-4396-94b1-26920b00c339">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzUtNS0xLTEtMA_15802d84-b190-4a61-a53e-adee367396ab">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzYtMS0xLTEtMA_2a623ea5-46e6-426d-a5fa-4dc813f9cbad">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzYtMy0xLTEtMA_16d5676d-f8ad-4392-a187-aa444775c4dd">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzYtNS0xLTEtMA_51e70ab9-f0bb-4e67-9733-d66d49b591a4">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzktMS0xLTEtMA_cfe5258e-4a09-4d00-b8d2-00ec2eacda51">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzktMy0xLTEtMA_bcf8e7e8-49aa-417b-ab5e-e29e6285f2df">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzktNS0xLTEtMA_8a4bd112-cad7-4476-93a1-24665ba6396f">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEwLTEtMS0xLTA_400ea2d7-5417-4fe9-aef9-a1e09258b4bc">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEwLTMtMS0xLTA_daab8e3e-26c8-419a-a44b-ed0038a0a9fd">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEwLTUtMS0xLTA_b7228b96-2a3e-4de0-9f42-b0b8c0ff88d5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzExLTEtMS0xLTA_2efdb0d6-576d-460f-9aa0-07254c6748ae">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzExLTMtMS0xLTA_08e013b2-8cdd-4260-8c52-1082ea4d152f">4,124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzExLTUtMS0xLTA_3b891976-1181-4b85-9432-24ddc195f290">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEyLTEtMS0xLTA_850576b2-4ded-4d98-9c31-13908a508746">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEyLTMtMS0xLTA_dfce95eb-7d7d-4700-8e2a-a20f40549cdf">4,288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEyLTUtMS0xLTA_3e29ffe4-6316-4b82-9efa-905a495f23f9">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEzLTEtMS0xLTA_52ba1cf8-b64c-4d12-b6a8-3906a28fdc39">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEzLTMtMS0xLTA_63b5abc8-3400-4a3f-a101-f82ce96c82f2">4,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEzLTUtMS0xLTA_f2d890d5-0d4b-42f2-9c18-15616a2b7d27">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id1c31785e72a48ddb73a6dc7fbc11955" continuedAt="i4adc2404cd484b4d9bb923d7d13a291d"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyNDQ_8bfafc8b-8213-4759-92a3-a20aaafe2872" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzMtMS0xLTEtMA_d3d3ffcb-17df-4ae3-970f-da8f73a09ca0">21.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzMtMy0xLTEtMA_ab566ee1-1eec-4d20-b267-c4b109272305">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzMtNS0xLTEtMA_50612e66-dcc3-44b2-a61e-5df532812d37">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzQtMS0xLTEtMA_91c32c4d-c6f3-4c00-a771-aa8d496b0b8a">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzQtMy0xLTEtMA_1058964b-a933-4ab0-ad5b-24fccd9ee8f5">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzQtNS0xLTEtMA_9644f794-6660-4b8e-aba4-759130e03fa8">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic taxes on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzYtMS0xLTEtMA_e6c817ac-f1f3-40a0-9365-beb828b94e2f">155.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzYtMy0xLTEtMA_a1b7a865-6083-4b4f-9f40-b04ca979ea1b">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzYtNS0xLTEtMA_fe2eb4ac-8f99-4384-b10f-7553e3ce7b66">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzctMS0xLTEtMA_4397601a-12ab-474b-9bd2-960f1e6f4212">40.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzctMy0xLTEtMA_42440e0a-4fdd-4409-8235-c448950faa9c">47.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzctNS0xLTEtMA_5fe104d5-9e18-4fdf-adec-d6b7624ba3e4">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzgtMS0xLTEtMA_d6433020-6821-4b00-9db1-a54c851f9410">16.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzgtMy0xLTEtMA_364475b0-b7a3-4cf6-be78-45bba042aed6">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzgtNS0xLTEtMA_6ffc282c-3179-4e52-9020-cd06d3cff904">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzktMS0xLTEtMA_eeae65e4-0505-4513-bbb7-8e30dca1efe9">43.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzktMy0xLTEtMA_c8afa197-4740-4e3d-9c32-94d3bcca69bb">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzktNS0xLTEtMA_73a51a0d-55a6-438e-b8c0-6d1dc87b1946">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEwLTEtMS0xLTA_e78351a9-f128-414a-90d6-181de353cbaf">42.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEwLTMtMS0xLTA_3c70ad8a-6ea8-409b-93bf-788cf223a2b1">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEwLTUtMS0xLTA_c5387394-af40-45ff-af29-143f36c17730">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEyLTEtMS0xLTA_321316d7-e074-427b-a1d2-e5ad6be71576">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEyLTMtMS0xLTA_73472627-029c-4566-8113-b3eec4e477a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEyLTUtMS0xLTA_45829a2d-948c-4ed0-b3a9-d319ef230e4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEzLTEtMS0xLTA_dc61c9e6-fb03-4eab-9f23-0a6345b47d10">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEzLTMtMS0xLTA_d2e4b8a2-37fb-40d4-bb33-ecdeee8cb1e9">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEzLTUtMS0xLTA_d21d6b38-8946-4b10-aaa1-36dbb5cf7e3c">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE0LTEtMS0xLTA_8dbf0134-8cea-4c79-bd35-3a6922d9d371">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE0LTMtMS0xLTA_e29b45ef-0d6b-4258-956d-9e3e1011d8c4">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE0LTUtMS0xLTA_d43765ed-e283-46e2-ab1e-2b0cd75930e4">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE1LTEtMS0xLTA_e51ea434-b4fc-4543-a105-10fb5e9907c3">96.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" name="bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE1LTMtMS0xLTA_5b7102e8-358e-4ab3-b39e-f2e2ba67cfd0">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE1LTUtMS0xLTA_adb9ca75-5076-49d8-9b3e-38e0027d113f">22.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TCJA net impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" format="ixt:zerodash" name="bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE2LTEtMS0xLTA_81d12f62-5680-49d8-bd94-89d435480d36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" format="ixt:zerodash" name="bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE2LTMtMS0xLTA_55fa523f-94f2-4158-911e-c9a36edd72cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE2LTUtMS0xLTA_a408fe23-2501-4f7e-9cd8-993b754e4a7a">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intra-entity asset transfers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE3LTEtMS0xLTA_b6d03510-f830-47ef-8fd2-016b6f2f2588">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE3LTMtMS0xLTA_20e942bd-da42-4634-9173-3f6a75f66a33">597.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" format="ixt:zerodash" name="bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE3LTUtMS0xLTA_23a73ba7-5eb2-4201-b3b0-2fd4f40f5af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTEtMS0xLTE4MTkx_d1edd87b-300c-4430-af7c-3a396d4b4130">37.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTMtMS0xLTE4MTkx_401f06e5-7bf0-4a59-9729-9a9826116896">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" sign="-" name="bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTUtMS0xLTE4MTkx_c9e7fcd8-3743-4d86-884a-0362cfcfacf9">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzIwLTEtMS0xLTE4MTkx_41f31d34-4173-4f18-b4a7-8d75c479e21a">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzIwLTMtMS0xLTE4MTkx_e65dec36-b265-46b5-9dcf-095f9ea4f9d4">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzIwLTUtMS0xLTE4MTkx_4df516ad-09ad-477e-a8e9-786ed05235ef">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE4LTEtMS0xLTA_a6908805-1199-4bee-b274-a220c7060c71">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE4LTMtMS0xLTA_80afca73-0bb2-40d6-aa01-4399cd2ddbd3">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE4LTUtMS0xLTA_93078244-cc1f-433f-8604-52a23a5d977c">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTEtMS0xLTA_c452bf5e-eb0b-4db6-8cb6-93d6b4ab089c">2.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTMtMS0xLTA_3fe51678-9fe7-46f1-bad6-decd0fa65a50">584.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTUtMS0xLTA_5ea78c42-489d-4f49-ab14-c08efbf7a050">17.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Due to the disclosure of additional rate reconciling items in 2020, we have reclassified select items in prior years to align with the new categories disclosed in the current year.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4adc2404cd484b4d9bb923d7d13a291d" continuedAt="i3460322a5bf94d3d97772df3c7fc1e44"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyNDY_3996899a-38f9-4992-a0da-70964c14ade2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzQtMS0xLTEtMA_57c1457f-fd7b-46c6-a362-fb20d74bf81f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzQtMy0xLTEtMA_071de60d-7a8c-4605-8bad-dff156fc0c5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit of net operating loss and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzUtMS0xLTEtMA_80bf7c0a-3283-4ff9-a82a-036ae38df7fe">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzUtMy0xLTEtMA_18e9889c-069b-486d-a1be-c03905e3e33a">545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves and accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzYtMS0xLTEtMA_90d97950-81d6-43f1-942f-8768a8636a47">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzYtMy0xLTEtMA_2a37251b-1f77-43ac-8d2f-ad1c21ce6277">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzctMS0xLTEtMA_d180a8dc-9e2a-487b-9b03-647489207a02">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzctMy0xLTEtMA_fd03646a-6f22-408e-8906-4671381a3a54">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and product liability reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzgtMS0xLTEtMA_c4afa166-0e6b-4b77-9db8-d6dd9f1539e8">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzgtMy0xLTEtMA_9a07006e-fcce-452a-8a4f-2f1a9ac4eeac">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEwLTEtMS0xLTA_789d4133-09c1-4f9a-a78e-f7036cd79019">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEwLTMtMS0xLTA_3b20b368-1c5f-4aa4-bc36-a8eb468a9823">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzExLTEtMS0xLTA_87696844-ed22-4313-80d1-f1007c5e777c">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzExLTMtMS0xLTA_42c34e6f-155c-4652-9c3e-27da6ebc8fa4">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal benefit of uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:FederalBenefitOfUncertainTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEyLTEtMS0xLTA_64263660-61e5-4904-92b8-16143f2b86ca">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="bsx:FederalBenefitOfUncertainTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEyLTMtMS0xLTA_65806f75-33ce-4ece-9385-b04fcdf75fe2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEzLTEtMS0xLTA_a1d0a9c7-4008-4764-b6ca-e033f8e65e9d">3,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEzLTMtMS0xLTA_5124a962-f2a2-4c64-b3e1-bf339ac5e7e8">3,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" sign="-" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE0LTEtMS0xLTA_a1ecf0ba-44fe-4244-bbd9-636426bb4b1c">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE0LTMtMS0xLTA_e90bb5c3-db38-46b4-9be4-2a20ca8627c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE1LTEtMS0xLTA_fe21e4a5-16d8-4385-bb9d-2211099cf963">4,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE1LTMtMS0xLTA_80ca23b5-f59e-42b8-a246-104b401fe7f1">4,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE2LTEtMS0xLTA_8b634947-490b-4b71-9e58-5a9c96bd049f">887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE2LTMtMS0xLTA_55aa803e-3f57-4efa-91a2-9bac4e82415c">915</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE3LTEtMS0xLTA_25cfe4eb-81e9-4559-be16-b65c0fad3a0a">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE3LTMtMS0xLTA_c844a630-150b-4512-a280-dbcaf334662c">3,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE5LTEtMS0xLTA_6b2c8e60-2845-471b-9588-f516602cb670">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE5LTMtMS0xLTA_09a9d45f-61d3-494c-9a64-cab66932fecd">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains and losses on derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIwLTEtMS0xLTA_f4622e20-22c2-4967-b87c-d2358a1db186">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIwLTMtMS0xLTA_636aa297-d39e-45bd-9982-9d69733656d9">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIxLTEtMS0xLTA_798e9e41-d553-4edb-859e-fef1ccbe93d4">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIxLTMtMS0xLTA_f433ac92-e5bb-4544-969f-c7f97eddf3b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIyLTEtMS0xLTA_b0e56971-f636-4759-a126-0cb6dece0e3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIyLTMtMS0xLTA_74eab285-6608-4e88-a983-70f980e30edf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIzLTEtMS0xLTA_8daf91a6-ed8f-46cf-ba4b-d1ea0fa83633">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIzLTMtMS0xLTA_16c32b67-2592-41e1-9264-89056df6cc4d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI0LTEtMS0xLTA_f3b4b59f-37f6-4770-8046-9dad7c5cc300">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI0LTMtMS0xLTA_ce51d5af-33ca-44ce-b350-fef18f0c3d07">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI2LTEtMS0xLTA_61e91fc8-3761-4b8f-b032-979ab7d4cb2a">3,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI2LTMtMS0xLTA_ac957d33-389a-4371-a9d4-b02eaa6685db">3,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI3LTEtMS0xLTA_2d9bd4e6-5089-4582-aae5-07af1146fced">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI3LTMtMS0xLTA_a1e6fc70-ff10-4eab-8875-328bc3385f7b">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI4LTEtMS0xLTA_7ba2afe0-7586-4f99-9e30-4f4d16815e3a">3,928</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI4LTMtMS0xLTA_2b54d739-fbb8-49db-bcc0-e4ffd751d044">3,796</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Component</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c026cbdf6644bdb88b307eed56919f_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzItMi0xLTEtMA_5841b8b1-8f4a-47af-b0fe-c0f84f9c5615">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifad23126719c4bb4bf9ce037ea077942_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzItNC0xLTEtMA_2caf5d63-19ab-4030-a005-3798b15a7f60">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i067d126bfe71406d9637e9e0321f9dba_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzMtMi0xLTEtMjAwOTk_d8e0a910-820e-449b-aa59-7b3a0f3c6b47">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7f21deae51477e88e1f5da1df0f205_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzMtNC0xLTEtMjAwOTk_d9a2104e-6359-4a2a-9d63-e770508a8720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df411a051af4374b3df655f51893efc_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzMtMi0xLTEtMA_63fd5327-68ed-44ff-ada9-45ae22f6f5e0">4,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e27faab8a7c4a88b4496e70958eb027_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzMtNC0xLTEtMA_55d7817e-94ae-4633-b4c9-498845115f9d">4,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzQtMi0xLTEtMA_be71b637-30be-49c4-b40c-9da49bf3356a">4,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzQtNC0xLTEtMA_a6620368-73e7-4ddc-b92d-d0c13a002d4f">4,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38649fda4692447aa9a51f8b4b69b77a_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzctMi0xLTEtMTgyMDA_496e37bf-411c-4e9f-81cd-21672d0f89c1">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0c0db4113b41ac8f0a3925494b51f7_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzctNC0xLTEtMTgyMDA_1177179b-d6c7-4c7a-987a-514d4ee8506c">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95932fa13d754cceaf54655a7e81a6dd_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzktMi0xLTEtMTgyMDM_040263b6-a360-4757-b4da-aefc7617e889">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b3d68a05c444d0dacb5095f51e80130_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzktNC0xLTEtMTgyMDM_035ca7c5-fb80-4913-9cf8-54d6aefd2343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzgtMi0xLTEtMA_97b414d7-4958-4e85-8cbc-75f186589774">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzgtNC0xLTEtMA_39191847-e79d-449a-b860-c11663a713c4">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzEwLTItMS0xLTA_df9566f1-37b2-4d15-ae6c-f1b469bf0bb9">3,928</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzEwLTQtMS0xLTA_afe298db-6a7e-49b0-8bb3-710dc9bb5fb2">3,796</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzkxNg_fe4153f0-b718-443b-836d-3494b29ccec7">474</ix:nonFraction> million. As of December&#160;31, 2019, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzEwNDI_54efe122-ebe6-42d0-9ec0-f2a92c01dc1a">449</ix:nonFraction> million. In addition, we had foreign tax net operating loss carryforwards and tax credits, the tax effect of which was $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzExNTY_65b068cd-03f2-4e0a-ba55-ddb54ffc2140">83</ix:nonFraction> million as of December&#160;31, 2020, as compared to $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzExODQ_75972048-7d65-480e-80bb-5c720546a7f2">105</ix:nonFraction> million as of December&#160;31, 2019. These tax attributes expire periodically beginning in 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3460322a5bf94d3d97772df3c7fc1e44" continuedAt="ice2ee16ac9d44e9c8f2b0d68605466c6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, we completed intra-entity asset transfers of certain intellectual property rights among various wholly owned subsidiaries. These transactions occurred to more closely align the global economic ownership of our intellectual property rights with our current and future business operations. These transactions did not result in a taxable gain in any jurisdiction, however, some of the transactions did create a step-up in the tax-deductible basis in the transferred intellectual property rights in certain jurisdictions. As a result, we recorded deferred tax assets in the amount of $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzE4NzM_de0ebd12-c994-4d87-b21a-97f80978c98b">4.102</ix:nonFraction> billion, which represents the book and tax basis differences measured at applicable statutory tax rates, net of a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:DeferredTaxAssetValuationAllowanceIntraEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIwMDU_60edb0e5-3071-4f22-8849-3cfe46ef6c46"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:DeferredTaxAssetValuationAllowanceIntraEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIwMDU_aee7f557-9748-4301-bb20-607c0d186755">542</ix:nonFraction></ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After consideration of all positive and negative evidence, we believe that it is more likely than not that a portion of our deferred tax assets will not be realized. As a result, we established a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIyMzE_8b634947-490b-4b71-9e58-5a9c96bd049f">887</ix:nonFraction> million as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIyNDc_55aa803e-3f57-4efa-91a2-9bac4e82415c">915</ix:nonFraction> million as of December&#160;31, 2019, representing a decrease of $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="bsx:ChangeinDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIyODI_f7728fa9-02d0-4650-8c98-000c9dae4522">28</ix:nonFraction> million. The decrease in the valuation allowance as of December&#160;31, 2020, as compared to December&#160;31, 2019, is primarily due to current year utilization of loss carryforwards and the concurrent release of the related valuation allowance. The income tax impact of the unrealized gain or loss component of other comprehensive income and stockholders' equity was a benefit of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI1NzE_81e19c65-542b-469a-ae80-cc8d3307fa03">78</ix:nonFraction> million in 2020, a charge of $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI1OTM_4e3f6e44-1b8b-4fb8-bcc5-fa9e504ac697">13</ix:nonFraction> million in 2019 and a charge of $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI2MTk_b0fc9cce-fa9c-4e3b-968c-fbc6c723d0c3">37</ix:nonFraction> million in 2018. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain tax incentives through Free Trade Zone Regime offered in Costa Rica which allows 100.0 percent exemption from income tax in the first eight years of operations and 50.0 percent exemption in the following four years. This tax incentive resulted in income tax savings of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:FreeTradeZoneRegimeTaxIncentive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI5MTA_ed84bb94-a46b-44b5-b65a-caa8f13b7bf6">64</ix:nonFraction> million for 2020, $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:FreeTradeZoneRegimeTaxIncentive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI5MjE_459ad8fe-70fe-468d-823e-332a6ad537d8">173</ix:nonFraction> million for 2019 and $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="bsx:FreeTradeZoneRegimeTaxIncentive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI5MzU_8a5a459a-f413-4986-9524-2ebf457d0650">146</ix:nonFraction> million for 2018. The tax incentive for 100.0 percent exemption from income tax was renewed during 2019 and is expected to expire in 2027. The impact on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $<ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="2" name="bsx:FreeTradeZoneTaxIncentivePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMxMDQ_af4d290c-22bf-4e2d-85e5-9b67bfb9e3eb">0.04</ix:nonFraction> for 2020, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="2" name="bsx:FreeTradeZoneTaxIncentivePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMxMTg_c4f44767-8bbb-4473-8c34-b1e180502542">0.12</ix:nonFraction> for 2019 and $<ix:nonFraction unitRef="usdPerShare" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="2" name="bsx:FreeTradeZoneTaxIncentivePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMxMzI_1206ddf7-57ef-4cb1-85c0-ff8804c7fa84">0.10</ix:nonFraction> for 2018. Additionally, we benefit from tax incentives in Puerto Rico resulting in income tax savings of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:TaxIncentivesInPuertoRico" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU0OTc1NTgxNTc5MjE_73a69042-e7e9-48a5-96f9-8bf34a740289">30</ix:nonFraction> million for 2020, and immaterial amounts for 2019 and 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMyOTg_9b094213-7d69-40a9-80bb-4f12d71b5c19">261</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMzNTI_04244edc-7571-4b36-9ee1-cb475c0b1126">183</ix:nonFraction> million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzM0MjU_6cf126d6-b30c-4f81-a656-58836a2a0d6b">455</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzM0Nzk_b59daec3-70f0-4a0d-b4cf-50e7c2475b18">355</ix:nonFraction> million, if recognized, would affect our effective tax rate. As of December&#160;31, 2018, we had $<ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzM1NTI_0a5e230d-085d-40dd-b408-2881e35820c7">427</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzM2MDY_e1ce7c00-40f4-488d-aa7b-24c7e12b903a">332</ix:nonFraction> million, if recognized, would affect our effective tax rate. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyNTI_3e029fa2-18bb-46fd-a2f6-a1f4e2938f9a" continuedAt="if13f352253f040c59300a6d357639d73" escape="true">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="if13f352253f040c59300a6d357639d73"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzItMS0xLTEtMA_b7fc6b5d-5986-49e6-8ec0-de14396b64cf">455</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzItMy0xLTEtMA_66d43876-4463-4707-a8b4-4a6fdaa6807e">427</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzItNS0xLTEtMA_3aafbeb3-4536-42ac-8d3d-9e4f60253566">1,238</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzMtMS0xLTEtMA_547a2b6c-8bd3-4b4e-82cf-7e4febd0b9bf">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzMtMy0xLTEtMA_163137e4-d441-4b2e-8736-3fe25e08d7a1">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzMtNS0xLTEtMA_07490fac-70e0-4117-9c04-dfc7cbf4a8dd">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzQtMS0xLTEtMA_72cedd42-92f2-4e66-9dbd-06d738f763b4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzQtMy0xLTEtMA_699486b0-cb89-4c94-8eb7-e68fbb3a246a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzQtNS0xLTEtMA_05a5f1d5-0972-4f6d-8b9e-0bb339ccc7b1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzUtMS0xLTEtMA_81c8e667-8513-442a-9785-b714fe1984fe">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzUtMy0xLTEtMA_e53d1cc8-f1c5-4996-a073-01f69743e0d4">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzUtNS0xLTEtMA_8ca72654-370e-4076-943d-e39fda5ed0c4">433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzYtMS0xLTEtMA_7334b168-226e-4ae1-aaaa-7b9777769db3">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzYtMy0xLTEtMA_977bea10-b60c-4c04-a2e3-6b8d71d5e5db">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzYtNS0xLTEtMA_79811488-d728-4b88-bbd8-3be885505f8c">459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation expirations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzctMS0xLTEtMA_629a29cd-249c-48c8-91a8-69323fc11fe5">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzctMy0xLTEtMA_671b2e46-929a-4459-961d-f63490611978">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzctNS0xLTEtMA_e1222012-7936-424f-9e90-434bc04bde78">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzgtMS0xLTEtMA_9b094213-7d69-40a9-80bb-4f12d71b5c19">261</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzgtMy0xLTEtMA_6cf126d6-b30c-4f81-a656-58836a2a0d6b">455</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzgtNS0xLTEtMA_0a5e230d-085d-40dd-b408-2881e35820c7">427</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. Federal income tax as well as income tax of multiple state and foreign jurisdictions. We have concluded all U.S. federal income tax matters through 2016 and substantially all material state and local income tax matters through 2010. We have concluded all foreign income tax matters through 2013, with the exception of issues for Italy, which have concluded through 2002.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2018, a decision was entered by the U.S. Tax Court resolving all disputes for Guidant Corporation for its 2001 through 2006 tax years and our 2006 and 2007 tax years as well as the tax issues related to our 2006 transaction with Abbott Laboratories. Additionally, we resolved all issues with the IRS Office of Appeals for our 2008 through 2010 tax years. The final settlement calculation resulted in a final net tax payment of $<ix:nonFraction unitRef="usd" contextRef="i51d17bc802334ee58e6912543c9a9101_D20180401-20180630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzQ2NTI_14cc67ae-0015-49f1-b209-66ab98199200">303</ix:nonFraction> million plus $<ix:nonFraction unitRef="usd" contextRef="i2ca84bcda655492cb7c95b91c9cc7c27_I20180630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzQ2NjA_45e53a32-e162-4d8c-a0f8-4571fbcd7d9b">307</ix:nonFraction> million of estimated interest, which was remitted in the second quarter of 2018. Due to the final settlement of these disputes, we recorded a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzQ4MTY_45937f62-6c12-4bb9-a27a-bc7feeb70ee0">250</ix:nonFraction> million in 2018 to remove a reserve related to these years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2018, we received a Revenue Agent Report (RAR) from the IRS for our 2011 through 2013 tax years. We remitted $<ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="bsx:NetSettlementPaymenttoIRS" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzUwMDc_7a3b94cb-9a6a-4cce-a1af-82b587afd442">93</ix:nonFraction> million to the IRS in the fourth quarter of 2018 reflecting the net balance of tax and interest due for these years after consideration of amounts owed to us by the IRS. Due to the resolution of these tax years, we recorded a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i75283a86da274266950b25d74cea7669_D20181001-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzUyNDc_3afb06dc-5bf6-4308-b674-f9d8b5e4fbcd">90</ix:nonFraction> million in 2018 to remove a reserve related to these years. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ice2ee16ac9d44e9c8f2b0d68605466c6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter of 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years stating that the Joint Committee on Taxation completed its review on July 21, 2020, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i83276247c7f842c9ae8442b64070ca41_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYwNDczMTM5NjkyNDI_7a52f650-1033-4c04-8816-7de36168b383">91</ix:nonFraction>&#160;million in the third quarter of 2020 to release the reserves related to these years. We received a refund of $<ix:nonFraction unitRef="usd" contextRef="i798449bc56004b03983ad8201e6fc19d_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYwNDczMTM5NjkyODk_a8e28555-dbd2-4864-9b1d-21a41d71b97c">62</ix:nonFraction>&#160;million from the IRS in the fourth quarter of 2020 reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to income taxes as a component of income tax expense. We had $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU0MDE_8c31db34-a903-4cdd-aee0-e6a3390c926c">41</ix:nonFraction> million accrued for gross interest and penalties as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU0NTg_6f1ae8b0-ffee-4f18-b9ed-d0d9ec253190">19</ix:nonFraction> million as of December&#160;31, 2019. We recognized net tax expense related to interest and penalties of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU2ODc_05ab6b87-7f08-4324-938e-4d010a4813ab">7</ix:nonFraction> million in 2020, as compared to a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU3MzM_0ebf0e10-fe7d-4beb-a2a9-9e62e3d77f31">1</ix:nonFraction> million in 2019 and a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU3Njc_395aaaa5-e693-40c8-9b21-4081f71023f9">498</ix:nonFraction> million in 2018. The increase in our net tax expense related to interest and penalties as of December&#160;31, 2020, as compared to December&#160;31, 2019, is related to reaching favorable settlements with the taxing authorities during 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12&#160;months we will resolve transactional- related issues with foreign and state taxing authorities, in which case we could record a reduction in our balance of unrecognized tax benefits of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYxOTY_95f3d0ab-d688-4026-ba7d-185f437ea5a9">27</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, we completed our analysis and recording of all tax effects related to the TCJA, as required under SAB 118, and recorded a net benefit of $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYzNjg_bbb81d63-28da-485f-ada4-36697ae658de">67</ix:nonFraction> million, exclusive of the one-time transition tax adjustment described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2017, we were required under the TCJA to calculate a one-time transition tax based on our total post-1986 foreign subsidiaries' earnings and profits (E&amp;P) that we previously deferred from U.S. income taxes. As a result of various audit activities, the revised amount of transition tax was approximately $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI3NDg3NzkwODgzODg_541db9ae-64ec-4513-9ddf-ab532add53b7">939</ix:nonFraction>&#160;million as of December 31, 2020 as compared to $<ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzY4MDc_195e5ddc-6aca-4d48-9a40-aa7f411a6282">856</ix:nonFraction> million as of December 31, 2018. We anticipate offsetting this liability against existing tax attributes reducing the required payment to approximately $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:Onetimetransactiontaxpost1986EPnetpayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzcwNDU_844176b6-328a-409b-ba8b-bb7e75088de2">597</ix:nonFraction> million, which will be remitted over an eight-year period. We have begun remitting the required installment payments, with a balance remaining of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:TransitionTaxPaymentRemaining" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI3NDg3NzkwODg0MDI_773a9e58-9106-441c-9da7-b79fdfe70aad">477</ix:nonFraction>&#160;million as of December&#160;31, 2020. In addition, we have provided for U.S. state income taxes of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzcyNjA_54436d44-04c7-4bdf-a082-9b598b367714">20</ix:nonFraction> million on all U.S. dollar-denominated E&amp;P accumulated through December 31, 2017, which constitutes the preponderance of our foreign subsidiaries' accumulated E&amp;P through December 31, 2017. We intend to indefinitely reinvest the unremitted foreign earnings of all other subsidiaries as of December 31, 2017, as well as all subsequent earnings generated by all of our foreign subsidiaries. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings and additional outside basis difference in these entities is not practicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a territorial tax system under the TCJA, in which we are required to provide for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have established an accounting policy election to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:TheCARESAct" scale="12" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYwNDczMTM5NjkzMDk_ad58c0ee-1e79-4ce7-b0ec-50747c95f547">2.2</ix:nonFraction> trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments.</span></div></ix:continuation><div id="i5c3e8d69fcc1460baddde62cfa022487_127"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzM1MzQz_ff4f6e4c-cfee-4c6c-8250-bbe8fdafa63c" continuedAt="id16112aae73345818cd92440a29704a6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id16112aae73345818cd92440a29704a6" continuedAt="i35c52e3373af46bb8c61b5515e749e56"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzM1MzI4_02ec0e3f-209c-40a9-8af5-eed8a1fb6fdc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzM4NTI_4b0de3cf-903f-486c-b775-e618b480fd21">569</ix:nonFraction> million as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzM4Njg_24f241c7-e819-49f6-9d2f-99c7afb13642">697</ix:nonFraction> million as of December&#160;31, 2019 and includes certain estimated costs of settlement, damages and defense. The decrease in our legal accrual was mainly due to settlement payments related to litigation with Channel Medsystems, Inc. (Channel), partially offset by charges associated with product liability cases or claims related to transvaginal surgical mesh products. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzQzMjU_c0f55534-e15f-439d-a22c-d43da7300074">208</ix:nonFraction> million as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzQzNDE_6959a7c9-59f4-4372-8515-a4361fced530">346</ix:nonFraction> million as of December&#160;31, 2019. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQyNzk_bc1639c8-5f89-4847-a230-960efc8b0cd3">278</ix:nonFraction> million in 2020, primarily related to transvaginal mesh products, inclusive of a reserve related to claims made by a coalition of state attorneys general. Those claims settled in principle in the fourth quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ0NzY_f47f54df-0f13-4b8b-8e9e-66810416f76c">115</ix:nonFraction> million in 2019, which included a net charge of $<ix:nonFraction unitRef="usd" contextRef="i847cba4eb27247b1ad73919d3359fdec_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ0ODI_59b0f9e8-0448-4898-bc01-50be29d3d287">223</ix:nonFraction> million in the fourth quarter of 2019, primarily related to litigation with Channel, net charges of $<ix:nonFraction unitRef="usd" contextRef="i73b83671a10a405a8f270b82a83376c5_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ1MjY_749a152c-f05e-4b0a-a85b-4ac6ae910617">25</ix:nonFraction> million in the third quarter of 2019 and $<ix:nonFraction unitRef="usd" contextRef="if91e0eeaf600499ebaebbee149714e4c_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ1NDE_1692b232-2dbf-4044-9a74-a7649cc4c98d">15</ix:nonFraction> million in the second quarter of 2019, primarily related to transvaginal surgical mesh product liability litigation, and a gain of $<ix:nonFraction unitRef="usd" contextRef="i7854a894ad99488694325a46151ebc34_D20190101-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ1NTc_8418644b-2d43-4220-994c-85713e7115db">148</ix:nonFraction> million recorded in the first quarter of 2019, which represents a portion of the total $<ix:nonFraction unitRef="usd" contextRef="i6d753b38040d479e8b54faae20faaad1_I20190115" decimals="-6" format="ixt:numdotdecimal" name="bsx:LitigationSettlementReceivedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ1NzM_9c11a5ec-6a52-4c9c-a496-183e7c45cf9b">180</ix:nonFraction> million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our&#160;consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As such, a portion of the related gain from this settlement was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzQ0NDU_c9f03e7e-2771-430a-8f02-f514c69f44e7">103</ix:nonFraction> million in 2018, primarily related to transvaginal surgical mesh product liability litigation. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i35c52e3373af46bb8c61b5515e749e56" continuedAt="i6b5a86d65f73471591aeed5090bc409e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, BSC filed suit against Cook Group Limited and Cook Medical LLC (collectively, &#8220;Cook&#8221;) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct Endoscopic Hemoclip. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (&#8220;IPR&#8221;) requests with the U.S. Patent and Trademark Office against the four asserted patents. All IPRs have concluded, and Cook and Boston Scientific both appealed the Patent Office&#8217;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Boston Scientific patents remain valid, remanding two of the patents for further review by the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USPTO's Patent Trial and Appeal Board. In November, the Patent Office issued remand rulings invalidating several additional claims. The district court had stayed the case pending the appeals court decision on the IPRs, which is now complete. In the first or second quarter of 2021, the case will proceed before the United States District Court for the Southern District of Indiana, with BSC asserting two patents against Cook. Trial is anticipated in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#8217;s Senza&#8482; Spinal Cord Stimulation System. On June 22, 2020, this action was consolidated with case 18-cv-664, described below. The court set trial for October 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2017, The Board of Regents, University of Texas System (UT) and TissueGen. Inc., served a lawsuit against us in the Western District of Texas. The complaint against us alleges patent infringement of two U.S. patents owned by UT, relating to &#8220;Drug Releasing Biodegradable Fiber Implant&#8221; and &#8220;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#8221; and affects the manufacture, use and sale of our Synergy&#8482; Stent System. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the University&#8217;s Petition for Certiorari. UT is proceeding with its case against BSC in Delaware.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#8217;s Senza&#8482; I and Senza&#8482; II Spinal Cord Stimulation Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our Spinal Cord Stimulation systems infringe five Nevro patents. On June 22, 2020, this action was consolidated with case 16-cv-1163. The theft of trade secrets, patent counterclaims, and patent infringement claims from case 16-cv-1163 were set for trial in October 2021. The patent infringement claims from case 18-cv-664 were stayed pending IPRs. On January 6, 2021, the court stayed one of the patent infringement claims from case 16-cv-1163, such that it will proceed with the stayed patent infringement claims from case 18-cv-664.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, Koninklijke Philips N.V. and IP2IPO Innovations, Ltd. (&#8220;Philips&#8221;) served a complaint against the Company in the United States District Court for the District of Delaware. The complaint alleges that certain BSC cardiovascular diagnostic devices infringe six Philips patents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2021, approximately <ix:nonFraction unitRef="claims" contextRef="i2f7956c04d234376aa4eecea14242910_I20210127" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzk3NTM_628cb731-8e32-427a-9707-c7ccaf37ab63">54,000</ix:nonFraction> product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of January 27, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately&#160;<ix:nonFraction unitRef="claims" contextRef="id75fe6d2063c4f75b07316a97a020d9a_I20210127" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEwMTMw_89386a43-c486-44db-b0b7-8d6db56db16f">52,000</ix:nonFraction>&#160;cases and claims, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately <ix:nonFraction unitRef="claims" contextRef="id75fe6d2063c4f75b07316a97a020d9a_I20210127" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEwNDAz_89386a43-c486-44db-b0b7-8d6db56db16f">52,000</ix:nonFraction> cases and claims, approximately <ix:nonFraction unitRef="claims" contextRef="id75fe6d2063c4f75b07316a97a020d9a_I20210127" decimals="0" format="ixt:numdotdecimal" name="bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEwNDM4_f1e25fb9-247e-4569-b25b-293d62b4b782">48,000</ix:nonFraction> have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over <ix:nonFraction unitRef="claims" contextRef="i409422251b4e4e6fa90403e9dba4dda7_I20210127" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzExNTEy_3697d487-15b9-411a-a1cb-f38c4d19cd66">3,100</ix:nonFraction> of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6b5a86d65f73471591aeed5090bc409e" continuedAt="i43b98b0682e549d0a052f868b28a9431"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general offices regarding our transvaginal surgical mesh products. We have responded to those requests. On December 12, 2019 the Mississippi Attorney General filed suit against BSC in State Court alleging violations of the Mississippi Consumer Protection Act which the Company plans to vigorously defend. There are fewer than <ix:nonFraction unitRef="claims" contextRef="i2f7956c04d234376aa4eecea14242910_I20210127" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzI3NDg3NzkxMDcyNDg_87ef03bd-3989-413e-999a-7053c16027d6">60</ix:nonFraction> claims in the United Kingdom and fewer than <ix:nonFraction unitRef="usd" contextRef="i2f7956c04d234376aa4eecea14242910_I20210127" decimals="0" name="bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzU0OTc1NTgyNzc2ODY_ec4ebe43-22e3-48de-88f0-53abd51bed50">125</ix:nonFraction> cases in Australia. There are also fewer than <ix:nonFraction unitRef="claims" contextRef="i2f7956c04d234376aa4eecea14242910_I20210127" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEyMzE2_d962b336-924a-477e-ac25-41031f023011">10</ix:nonFraction> cases in Canada, inclusive of <ix:nonFraction unitRef="claims" contextRef="i2f7956c04d234376aa4eecea14242910_I20210127" decimals="0" format="ixt-sec:numwordsen" name="bsx:CertifiedclassactionsinCanadaMesh" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEyMzQ5_40bb83c8-96a5-43de-9f51-11a4a9eb866b">one</ix:nonFraction> certified class action, which has settled and received Court approval. On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. While we believe that our accrual associated with this matter is adequate, changes to this accrual may be required in the future as additional information becomes available. We have also established an accrual related to the claims made by the coalition of state attorneys general. While we continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims and intend to vigorously contest the cases and claims asserted against us that do not settle, the final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Initial trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named a defendant in 118 filed product liability cases involving our Greenfield Vena Cava Filter, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 597 claims, none of which have been filed. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena seeks information relating to the launch of the Cognis&#8482; and Teligen&#8482; line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of the Physician Guided Learning Program. We are cooperating with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. government and the State of California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to the Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for Boston Scientific and three of its employees, as well as numerous other defendants charged in criminal proceedings.&#160;The charges arise from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials.&#160;A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Boston Scientific employee but acquitted two others and levied a fine of &#8364;<ix:nonFraction unitRef="eur" contextRef="i39fb2d8200504ca99f2588af122ccb46_D20171110-20171110" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzE1ODEy_345dd371-af59-40e0-a632-99e2c8bfa8e7">245</ix:nonFraction> thousand against us and imposed joint and several civil damages of &#8364;<ix:nonFraction unitRef="eur" contextRef="i39fb2d8200504ca99f2588af122ccb46_D20171110-20171110" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzE1ODcz_83a0b2b8-c1ea-41f5-90cb-80002fee4488">620</ix:nonFraction> thousand on all defendants. We continue to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against Boston Scientific and its employee and acquitted them of all charges.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#8220;technical note,&#8221; announced that it was launching a formal administrative proceeding against Boston Scientific&#8217;s Brazilian subsidiary, Boston Scientific do Brasil Ltda., as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i43b98b0682e549d0a052f868b28a9431" continuedAt="i4e7490389c0c4e56bb216edc5d48baa6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. We deny the allegations and intend to defend ourselves vigorously.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments are due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019, Blue Cross &amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia. The complaint alleges that the defendants violated the Sherman Act and the antitrust and consumer protections laws of several states by pursuing patent litigation relating to ZYTIGA&#8482; in order to delay generic entry. On June 21, 2019, the case was transferred to the United States District Court for the District of New Jersey and has been consolidated with similar complaints.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2017, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint filed on behalf of the United States, 28 states, and the District of Columbia. The complaint, which was filed in the United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA to the government in connection with direct government sales and government-funded drug reimbursement programs. The case has been transferred to United States District Court for the District of New Jersey. On June 20, 2019, the complaint was amended to include BTG International Limited as a defendant. In May 2020, a class action complaint was filed in New Jersey federal court against Johnson &amp; Johnson and BTG by two direct purchasers of Zytiga on behalf of similarly situated entities. The complaint alleges that BTG and J&amp;J violated antitrust laws by attempting to enforce certain patents against potential generic competitors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against Boston Scientific Corporation, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all other similarly situated, filed a second, materially similar class action complaint against Boston Scientific Corporation, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. The Company expects these cases to be superseded by a single amended and consolidated class action complaint in the first or second quarter of 2021. On December 15, 2020, the Securities and Exchange Commission&#8217;s Boston Regional Office (Boston SEC) notified the Company that it is conducting an investigation related to Boston Scientific&#8217;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company is cooperating fully with the investigation. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#8217;s Board of Directors conduct an investigation into actions by the Company&#8217;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020 Mariano Errichiello, individually and on behalf of all others similarly situated, filed a class action complaint against Boston Scientific Corporation, Michael F. Mahoney, Joseph M. Fitzgerald and Daniel J. Brennan stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System in United States District Court for the District of Massachusetts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information regarding our tax litigation.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4e7490389c0c4e56bb216edc5d48baa6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters Concluded Since December 31, 2019</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2019, Tissue Anchor Innovations filed a complaint for patent infringement in the United States District Court Central District of California against Fountain Valley Regional Hospital and Medical Center, Los Alamitos Medical Center and us. The complaint alleged that the Solyx&#8482; Sling System infringes US Patent 6,506,190. We reached a confidential settlement in this matter in July 2020, pursuant to which the action was dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, Imran Niazi filed a patent infringement action against us in the United States District Court for the Western District of Wisconsin alleging that a U.S. patent owned by him is infringed by our Acuity&#8482; Lead Delivery System. On June 30, 2017, we filed a motion to dismiss for improper venue and on November 7, 2017 the Wisconsin Court granted the motion to dismiss. On November 13, 2017 Niazi refiled the same action in the U.S. District of Minnesota. We reached a confidential settlement on this matter on February 3, 2020 pursuant to which the action was dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2017, we entered into a definitive agreement with Channel pursuant to which we could have been obligated to pay $<ix:nonFraction unitRef="usd" contextRef="i7798f7ba3d954caf8a24d240d313af4b_I20180912" decimals="-6" format="ixt:numdotdecimal" name="bsx:AllegedBreachofPurchaseAgreementAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzMzNTcy_205a1506-d250-4db1-b59f-7d0e5ec1d9fe">145</ix:nonFraction> million in cash up-front and a maximum of $<ix:nonFraction unitRef="usd" contextRef="i94b1febde39c4df9b5982d8d880defc2_I20180912" decimals="-6" format="ixt:numdotdecimal" name="bsx:AllegedBreachofPurchaseAgreementAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzMzNjA5_1c500334-d5ba-4b47-8b21-6005ac6d905d">130</ix:nonFraction> million in contingent payments to acquire Channel. The agreement contained a provision allowing Channel to sell the remaining equity interests of Channel to us upon achievement of a regulatory milestone and an option allowing us to acquire the remaining equity interests. We sent a notice of termination of that agreement to Channel in the second quarter of 2018. On September 12, 2018, Channel filed a complaint in Delaware Chancery Court against us for alleged breach of the agreement. Channel alleged that we breached the agreement by terminating it. We answered the complaint, denied the claims by Channel and counterclaimed to recover part of our investment in Channel, alleging fraud in the inducement. On April 2, 2019, Channel announced its receipt of FDA approval of the Cerene&#8482; Cryotherapy Device. Trial testimony was taken in April 2019, and the post-trial briefing and hearing were completed. During the third quarter of 2019, Channel notified us that they were exercising their option to sell the remaining equity interests in Channel to us. We responded to the notification that we did not intend to purchase Channel since the previous agreement had been terminated. On December 18, 2019, the Chancery Court ruled that Boston Scientific was in breach of the agreement and granted Channel's request for specific performance to require the Company to complete the purchase. On January 10, 2020, we filed a Notice of Appeal of the Chancery Court&#8217;s decision to the Delaware Supreme Court. On February 4, 2020, the Company settled the dispute with Channel resulting in termination of the agreement, payment by the Company of an undisclosed sum and surrender of the Company's equity interest in Channel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2016 Nevro Corp. (Nevro) filed a patent infringement action against us and one of our subsidiaries, Boston Scientific Neuromodulation Corporation, in the U.S. District Court for the Northern District of California alleging that six U.S. patents (Alataris) owned by Nevro are infringed by our spinal cord stimulation systems. On June 29, 2017, Nevro amended the complaint to add an additional patent (Fang). On July 24, 2018, summary judgment was entered in favor of the Company and on July 31, 2018, we received final judgment and dismissal of the action. On July 31, 2018, Nevro filed an appeal. On April 9, 2020, the Court of Appeals for the Federal Circuit vacated the finding of indefiniteness as to certain patents, provided claim constructions for those patents, and remanded the case. On December 16, 2020, the district court dismissed all remaining claims with prejudice, ending the case with Nevro receiving none of its requested relief.</span></div></ix:continuation><div id="i5c3e8d69fcc1460baddde62cfa022487_130"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzE2NzY_1dcc209e-ad60-4b79-8cc8-9eed88b9ddf3" continuedAt="i3a6c075fb38a40e7b3ea969dc06ae672" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; STOCKHOLDERS' EQUITY </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0_864f09b3-8e43-4298-8e2e-040f2d26f007">50</ix:nonFraction> million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. As of December 31, 2019, we had no shares of preferred stock issued or outstanding.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="i1e9be71c38ac4607af95364edaf5c01b_I20200527" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2NjM_61edbf3f-00ef-4f09-9c51-fa36e1c30ad2">10,062,500</ix:nonFraction> shares of <ix:nonFraction unitRef="number" contextRef="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2Njc_6d83f753-9356-4350-b183-1ebcaf1b803b">5.50</ix:nonFraction>% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1e9be71c38ac4607af95364edaf5c01b_I20200527" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2NzU_3edd686f-5043-4dda-ba23-d8724bffea00">100</ix:nonFraction> per share. The net proceeds from the MCPS offering were approximately $<ix:nonFraction unitRef="usd" contextRef="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3NTc_72c887eb-6249-4d71-8367-db4030381bf2">975</ix:nonFraction> million after deducting underwriting discounts and commissions and offering expenses. As of December&#160;31, 2020, our MCPS had an aggregate liquidation preference of $<ix:nonFraction unitRef="usd" contextRef="i26c1603e14d9490f8e287a7453ef6ad2_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3Njg_595be710-1ead-4be7-8a56-0a59ebbfe009">1.006</ix:nonFraction>&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of <ix:nonFraction unitRef="number" contextRef="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2NzE_6d83f753-9356-4350-b183-1ebcaf1b803b">5.50</ix:nonFraction>% of the liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i26c1603e14d9490f8e287a7453ef6ad2_I20201231" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2Nzk_00edeac7-c4a3-485d-a139-3cdb93258845">100</ix:nonFraction> per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i3a6c075fb38a40e7b3ea969dc06ae672"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="i26c1603e14d9490f8e287a7453ef6ad2_I20201231" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2ODM_00edeac7-c4a3-485d-a139-3cdb93258845">100</ix:nonFraction> per share plus accumulated and unpaid dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between <ix:nonNumeric contextRef="if76aa1de0a364b9b88b9a216851425ba_D20200101-20201231" name="us-gaap:ConvertiblePreferredStockTermsOfConversion" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3Nzc_00b2f053-df5a-448a-8a2d-a9a80047a28c">2.3834</ix:nonNumeric> and <ix:nonNumeric contextRef="i364b4c76e483475fb4929cbd7234002a_D20200101-20201231" name="us-gaap:ConvertiblePreferredStockTermsOfConversion" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3ODI_85d70463-72aa-41ea-9edb-839c5da2f66d">2.9197</ix:nonNumeric> shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2020, we paid to holders of our MCPS as of August 15, 2020 a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie7d247529a1c463fa7773c98fb47c5b4_D20200901-20200901" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwODMyNjk_3d0ef3e0-76ff-4860-b12e-b3bcf5b432cb">1.4361</ix:nonFraction> per MCPS share (or $<ix:nonFraction unitRef="usd" contextRef="ie7d247529a1c463fa7773c98fb47c5b4_D20200901-20200901" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwODMyODM_604fd913-267b-4318-b9e8-83792b3d8e72">14</ix:nonFraction> million in aggregate cash dividends), representing a dividend period beginning on the May 27, 2020 issuance date through August 31, 2020. On December 1, 2020, we paid to holders of our MCPS as of November 15, 2020 a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4fa9aed9709041149e54010a083bfe82_D20201201-20201201" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3ODY_fa77dc1f-645e-4de2-b33b-d023ff856a52">1.3750</ix:nonFraction> per MCPS share (or $<ix:nonFraction unitRef="usd" contextRef="i4fa9aed9709041149e54010a083bfe82_D20201201-20201201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3OTA_a257d563-d778-42da-a348-2a7d11fcdced">14</ix:nonFraction> million in aggregate cash dividends), representing a dividend period beginning on September 1, 2020 through November 30, 2020. On February 1, 2021, the Audit Committee of our Board of Directors, pursuant to authority delegated to such committee by our Board of Directors, declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i80fea81c0f1641e2ac476c397df768a5_D20210201-20210201" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ4MDA_0bb0ddb5-9626-4f7a-9de4-6f8ee7d942a1">1.375</ix:nonFraction> per MCPS share (or $<ix:nonFraction unitRef="usd" contextRef="i80fea81c0f1641e2ac476c397df768a5_D20210201-20210201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ4MDU_1006ea8a-75f3-4630-bf67-ca30521f5ff5">14</ix:nonFraction> million in aggregate cash dividends) to be paid on March 1, 2021 to holders of our MCPS as of February 15, 2021, representing a dividend period beginning December 1, 2020 through February 28, 2021. We have presented cumulative, unpaid dividends covering this period from December 1, 2020 through December 31, 2020 totaling $<ix:nonFraction unitRef="usd" contextRef="ia14713cda1cf4913ba849fbbc13bf46f_I20210201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ4MTY_9c5d9291-4765-4c36-b336-7c14385510c8">5</ix:nonFraction> million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets as of December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0MQ_92a1f2f5-375f-421b-b0c1-23e0cf90db4a">2.000</ix:nonFraction> billion shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU2OA_cdd8c004-f4b3-4b53-a234-0a57243f481a">0.01</ix:nonFraction> par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="i87014aa1c11a45678ccb64e8fe4dd544_D20200527-20200527" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzUwNDk_590a28b5-8aba-43c4-8021-f8ebaff68d35">29,382,500</ix:nonFraction> shares of common stock at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie17653a14c754c2ab47d617c083c0151_I20200527" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzUxMTA_c3a379f5-886e-4720-9e1c-ee13ab001e56">34.25</ix:nonFraction> per share. The net proceeds from the common stock offering were approximately $<ix:nonFraction unitRef="usd" contextRef="i87014aa1c11a45678ccb64e8fe4dd544_D20200527-20200527" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzUxOTI_ed536d62-3d85-4dcb-b3ce-8d7561463026">975</ix:nonFraction> million after deducting underwriting discounts and commissions and offering expenses. We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The remaining proceeds are being used for general corporate purposes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2013, our Board of Directors approved and on January 29, 2013, we announced a program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i497fdd9e22bb40c9b7d641cbb2f5890b_I20130125" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTIxNDk_db6691b3-d899-4b8e-90e4-510d46a566bc">1.000</ix:nonFraction> billion of our common stock (2013 share repurchase program). In the fourth quarter of 2020, we repurchased approximately <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTIxNTc_afac6079-2e7f-4eea-b426-bcaaabfb8e0d">15.7</ix:nonFraction> million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTIxNjU_ef413264-c54c-4f7f-a8fd-b60016ab2e16">535</ix:nonFraction> million in cash, which represented the full amount remaining under that authorization. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ic981515a7d5b42c29018a2a5a0ae37fa_I20201214" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTA0NzM_88757f11-6b88-4d02-9c6a-eec486fc503c">1.000</ix:nonFraction> billion of our common stock (2020 share repurchase program). As of December&#160;31, 2020, we had the full amount remaining available under the 2020 share repurchase program. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock during 2019 or 2018. There were approximately <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTA1MDk_5ef701a8-4c54-4125-b2e8-df76831f36ca">263</ix:nonFraction> million shares in treasury as of December&#160;31, 2020 and <ix:nonFraction unitRef="shares" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTA1MjU_81cc3f91-727c-4d83-845f-217c4bfbdb74">248</ix:nonFraction> million shares in treasury as of December&#160;31, 2019.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1OTI_1b6a6dd4-bf8d-478e-84c5-14848bc67057" continuedAt="ic241802141524499aa016df0999dcb24" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; STOCK INCENTIVE AND PURCHASE PLANS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee and Director Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Board of Directors and stockholders approved amendments to our 2011 Long-Term Incentive Plan effective October 1, 2020 (Amended and Restated 2011 LTIP), authorizing for issuance up to <ix:nonFraction unitRef="shares" contextRef="i778f0f816cf84a6d802f3c954762bc96_I20201001" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzE5Ng_78d4aa0b-fec0-45a2-b25f-3a8afbbe04cc">171</ix:nonFraction> million shares of our common stock. The Amended and Restated 2011 LTIP covers officers, directors, employees and consultants and provides for the grant of restricted or unrestricted common stock, restricted stock units (RSUs), options to acquire our common stock, stock appreciation rights, performance awards (market-based and performance-based RSUs) and other stock and non-stock awards. Shares reserved under our current and former stock incentive plans totaled approximately <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzY0Ng_8d36afe1-179e-4ada-aa5e-c7b94159c70b">187</ix:nonFraction> million as of December&#160;31, 2020. The Executive Compensation and Human Resources Committee (the Committee) of the Board of Directors, consisting of independent, non-employee directors may authorize the issuance of common stock and cash awards under the Amended and Restated 2011 LTIP in recognition of the achievement of long-term performance objectives established by the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-qualified options issued to employees are generally granted with an exercise price equal to the market price of our stock on the grant date, vest over a four-year service period and have a ten-year contractual life. In the case of qualified options, if the recipient owns more than <ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" format="ixt-sec:numwordsen" name="bsx:VotingPowerOfAllClassesOfStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzEyNzI_701d3d32-2922-4d96-a940-45965cd4fcac">ten</ix:nonFraction> percent of the voting power of all classes of stock, the option granted will be at an exercise price of <ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" format="ixt:numdotdecimal" name="bsx:Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzEzNzE_503acce6-1176-4ec6-b8e1-24aa3d16147d">110</ix:nonFraction> percent&#160;of the fair market value of our common stock on the date of grant and will expire over a period not to exceed five years. Non-vested stock awards, including restricted stock awards (RSAs), RSUs and deferred stock units (DSUs) issued to employees are generally granted with an exercise price of <ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" format="ixt-sec:numwordsen" name="bsx:Nonvestedstockawardsexerciseprice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzE2MzE_f49fcd6c-6bea-45e0-a9d4-62991418dd6b">zero</ix:nonFraction> and typically vest in four or five equal annual installments. These awards represent our commitment to issue shares to recipients after the vesting period. Upon each vesting date, such awards are no longer subject to risk of forfeiture and we issue shares of our common stock to the recipient.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1NTI_48c8b21c-3e00-4a2d-aa45-d855729705b5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the impact of stock-based compensation on our consolidated statements of operations:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48dc48db06f64857b9f8f2175ed065c8_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzItMS0xLTEtMA_530f92d4-dd73-4d3c-9023-aad67063f00c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce12987f1214f89a3dfa34f916446fb_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzItMy0xLTEtMA_6439fa27-7c50-4f10-8c1b-9debb22577c2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61e617b0c52e4f2f9d64b27e15217b69_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzItNS0xLTEtMA_54c7a3fd-5de4-4699-b0b1-203a59bf61a2">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a97c4c9280f468985dbf91165af9ea0_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzMtMS0xLTEtMA_c797b25f-764a-4955-9ff4-dedef46b144f">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744cf371d9c64de7bdda73270e33e44a_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzMtMy0xLTEtMA_13908a67-36bf-4824-9b58-c24e7edc57d6">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib583bf860ca3439f8e8edbcc584563e9_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzMtNS0xLTEtMA_ad045c42-b4d5-4172-b470-5f81e3bf5a46">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1abb0720ff4407591ec3bb6cfe6e577_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzQtMS0xLTEtMA_748be6f9-890b-4bd5-b319-cf11035f2590">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd3d62482574f8abab9be37411135a7_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzQtMy0xLTEtMA_a916c2ac-a0e4-4ace-906f-d5481df2f6df">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbc60762f9246c08c22c8690df360f5_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzQtNS0xLTEtMA_70208b88-f060-4dbb-8c24-c2cc04477168">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzUtMS0xLTEtMA_f68572ab-34cf-4202-986e-3319f06f2d55">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzUtMy0xLTEtMA_311bdac4-467b-4b85-b94c-9cd5c277cb97">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzUtNS0xLTEtMA_ea62305f-b479-4ee4-91e4-445d1cc8ca25">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzYtMS0xLTEtMA_d76b0a2c-c2ed-4999-8b77-e01b013db318">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzYtMy0xLTEtMA_3311ac41-394f-429d-9ccf-44eedfa2a25c">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzYtNS0xLTEtMA_b185dc65-1da9-4c3b-bb19-682467401c98">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:ShareBasedCompensationNetOfTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzctMS0xLTEtMA_4f09f825-7374-4515-a8dd-c6b3347dc786">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:ShareBasedCompensationNetOfTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzctMy0xLTEtMA_ec838662-f281-493e-9a1c-b3def3b0f13b">133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="bsx:ShareBasedCompensationNetOfTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzctNS0xLTEtMA_eb3cbd34-b61a-4b50-b9b6-229ead572d3c">119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" name="bsx:CompensationExpensePerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzgtMS0xLTEtMA_670be8bd-ed6f-485a-90ef-29b7d15b6afe">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="2" name="bsx:CompensationExpensePerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzgtMy0xLTEtMA_368ffbe9-7cb9-4dd5-a826-14379fbcd729">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="2" name="bsx:CompensationExpensePerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzgtNS0xLTEtMA_d779cd78-8528-4849-a340-096fdedc2e13">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" name="bsx:CompensationExpensePerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzktMS0xLTEtMA_1fdff9b1-ad6e-4b8d-810f-68373e82c012">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="2" name="bsx:CompensationExpensePerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzktMy0xLTEtMA_677ddc1d-5281-4dc6-9f5e-bda2c3979ab5">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="2" name="bsx:CompensationExpensePerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzktNS0xLTEtMA_8e0a0e10-06fc-4ced-970f-b840eca93b85">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1MzQ_07c22178-5ceb-4ad5-8bd7-a1c3d3331cfe" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzItMS0xLTEtMA_0edda775-d104-4f75-bc3a-4dce93713a13">3,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzItNS0xLTEtMA_2b8d1bbd-d3d1-482b-8e49-b4be338ec44e">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzItOS0xLTEtMA_6765cada-4342-4556-904c-573379a9023e">3,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzMtMS0xLTEtMA_0e028fc3-8793-40ae-9e19-7bc8bd607532">41.79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzMtNS0xLTEtMA_4f40dde9-24f7-45b8-986a-71b7834f9e86">40.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzMtOS0xLTEtMA_b4a0e9f2-45e3-44e4-bd84-a8704253cf0b">27.26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzQtMS0xLTEtMA_355b6e46-cdbd-4b12-a6f9-87e1f30085f0">10.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzQtNS0xLTEtMA_2cf74a56-55f5-4ac8-a0ac-be30a90aca4c">11.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzQtOS0xLTEtMA_e4f7b40d-d3fc-4f60-87bf-a7eabaa7a9de">8.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Black-Scholes Assumptions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzYtMS0xLTEtMA_3ecf206c-eb79-49e3-a2ee-ea92f7180d83">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzYtNS0xLTEtMA_9ca90b5b-a146-459a-9460-9c908084eb89">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzYtOS0xLTEtMA_9f36eaff-aa82-408b-baff-01ce264d0f54">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years, weighted)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzctMS0xLTEtMA_4dab56a7-7924-4a20-9662-a35297a4ac05">5.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzctNS0xLTEtMA_e64054f3-bd82-4cd0-8160-358c81144dc9">6.1</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzctOS0xLTEtMA_08908531-ffa0-4929-8718-06e14dea7c8e">6.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b53681c5973450a9bf67b79aa206f65_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtMS0xLTEtMA_3fbbf11b-fc76-4883-8fbc-937656b3b8cc">0.27</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtMy0xLTEtMA_15dc0d6f-f1b8-436e-9689-d0e5edd24387">1.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d62047b22344b799f16b3cb7ff597c8_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtNS0xLTEtMA_c9b17394-d8b0-4f65-9894-c3f63a10db4e">1.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib22247f67db94421b34a23ad85639077_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtNy0xLTEtMA_298452de-e27f-4242-be83-42f03d5f5383">2.61</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5927d31a28d44ea785098e97b5f79f96_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtOS0xLTEtMA_13a9ef8a-5bcd-4567-8318-402605e21b50">2.61</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i587d1e2ddfb14a2eac94b281ca12ec47_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtMTEtMS0xLTA_072773ea-05eb-477e-8bd1-f0b7fd8fad55">3.01</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ic241802141524499aa016df0999dcb24" continuedAt="ie88915c6b41e4734bec585eb7412d60f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Volatility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our historical volatility and implied volatility as a basis to estimate expected volatility in our valuation of stock options.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Term</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the expected term of options using historical exercise and forfeiture data. We believe that this historical data provides the best estimate of the expected term of new option grants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk-Free Interest Rate</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use yield rates on U.S. Treasury securities for a period approximating the expected term of the award to estimate the risk-free interest rate in our grant-date fair value assessment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Dividend Yield</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not historically paid cash dividends on our common stock and currently we do not intend to pay cash dividends on our common stock. Therefore, we have assumed an expected dividend yield of zero in our grant-date fair value assessment.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1NDY_e3b4a16c-b9df-4db6-8dab-2580ccfed1b3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to stock options under stock incentive plans are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:49.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzUtMS0xLTEtMA_160a0e28-a26e-4e1e-b1c8-572fcb4b8e04">26,716</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzUtMy0xLTEtMA_ecba538d-20ca-4937-adb9-718b655f4a89">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzYtMS0xLTEtMA_742b95d2-4a3d-41f5-ae7c-5bca7df33eda">3,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzYtMy0xLTEtMA_658eb4e9-fc58-44f2-bc6d-d9573470d7a6">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzctMS0xLTEtMA_66f517eb-942d-4c4c-91ba-cb669444d0b3">4,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzctMy0xLTEtMA_7606cb32-bf6a-48a8-8a0b-6eb4bcd05b1d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzgtMS0xLTEtMA_38d1e005-ac87-47e1-b8a2-4153163b6d98">519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzgtMy0xLTEtMA_1c8798d8-5884-4161-8a93-73cf71acc1c0">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzktMS0xLTEtMA_58443595-dd8a-4b3b-80ea-6a459e1b0704">25,304</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzktMy0xLTEtMA_1651519b-f0dd-48bc-82d7-5516af101f3b">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEwLTEtMS0xLTA_b1cd2510-769a-4b03-b4bc-1daa24b067ee">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEwLTMtMS0xLTA_60b81c49-c210-4d42-9112-164acd91b6b1">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzExLTEtMS0xLTA_a233d1fb-06f9-46b5-9d61-73a27ad884f5">4,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzExLTMtMS0xLTA_8319d9e5-af3c-4443-8326-ff40da3fbf86">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEyLTEtMS0xLTA_77bf109d-4991-4d14-8a13-40cb2bf4e062">359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEyLTMtMS0xLTA_21620cc0-9f8a-4a71-84e2-0559258a8e0b">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEzLTEtMS0xLTA_c5ef195e-942b-4aac-916d-0283c5eeff27">23,065</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEzLTMtMS0xLTA_c006c9b7-e3cb-413d-912f-c12ffb71abc3">19</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTEtMS0xLTMyMzM_eac7b8c3-d527-44d1-9e65-f8479cb0c406">3,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTMtMS0xLTMyMzc_84edd5ab-5251-41d9-ab1d-208ef87ba27a">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTEtMS0xLTMyMzM_090dfc8f-13f3-435b-83e2-e93503168897">3,096</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTMtMS0xLTMyMzc_85dbc499-96ba-4268-83f7-43d6cff56cc4">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTEtMS0xLTMyMzM_85043b04-4c43-4ea5-a111-b2085ec60102">666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTMtMS0xLTMyMzc_4a5d06dd-5ec7-463f-a389-a6a4669c53ac">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE3LTEtMS0xLTMyMzM_e101af2c-de1f-4965-b454-68411136c30d">23,122</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE3LTMtMS0xLTMyMzc_f982996c-5358-4ab0-b5eb-814b3f9d4e01">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE3LTUtMS0xLTMyNDI_5bea03e6-74d8-44e8-a455-d2f42d1445ac">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE3LTctMS0xLTMyNDY_d5342c79-8d37-4def-a769-3728f78280cb">312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTEtMS0xLTA_8bd14d43-4dbf-4a88-9245-c5bdd1bc8716">15,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTMtMS0xLTA_a7f5e867-368a-429b-9683-1200ebd312a4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTUtMS0xLTA_8e217a63-9017-45d7-b095-e3660b2a26e4">4.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTctMS0xLTA_517db22d-d627-4bb6-91f5-e1824e668098">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="bsx:OptionsExpectedToVest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTEtMS0xLTA_125b0d48-bc55-409a-aaba-3e5174f49170">7,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" name="bsx:OptionsExpectedToVestWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTMtMS0xLTA_0ca4394f-ed91-47c8-88ac-56d248e5d706">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:duryear" name="bsx:OptionsExpectedToVestWeightedAverageRemainingContractualLife" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTUtMS0xLTA_65ee23c3-4f3d-4454-8c53-ea6eab07d058">8.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTctMS0xLTA_da4c6b1c-5ade-4590-a15c-0c3c22d408b6">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total vested and expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTEtMS0xLTA_9a84ae90-1906-4219-9d8b-96939a51d0a6">22,787</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTMtMS0xLTA_9abfefb1-003c-4c06-b90f-a6a33135cb66">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTUtMS0xLTA_22bd4a4a-89b6-41ef-a0d7-fa6b3d637879">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTctMS0xLTA_8d906901-6520-4df9-ad05-cb14f44676d8">312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzMyNTI_069eaaa7-9cb6-47a7-b19f-ff6328b568cb">84</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzMyNjI_90453fdc-a5be-420c-b320-1ba85056a9ae">140</ix:nonFraction> million in 2019 and $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzMyNzU_fb0f9576-dabf-4c53-a2ce-99c36b4b4806">90</ix:nonFraction> million in 2018.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie88915c6b41e4734bec585eb7412d60f" continuedAt="i6af98d10758d4ea5b0a61b909fd6c595"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Vested Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value RSAs, RSUs and DSUs based on the closing trading value of our shares on the date of grant. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1MzA_05f74572-0ce2-44df-ae0b-93761f69bcd3" continuedAt="i4f9b9c50974b4f80b1362d637165cd8a" escape="true">Information related to non-vested stock awards is as follows:</ix:nonNumeric></span></div><ix:continuation id="i4f9b9c50974b4f80b1362d637165cd8a"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Award Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date <br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzUtMS0xLTEtMA_c4063085-f966-45b6-84fb-3e5e3513cb51">15,250</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzUtMy0xLTEtMA_88ae322d-63c7-402a-9428-0b881135a55d">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzYtMS0xLTEtMA_fb1bc4a5-d2c1-49d8-9144-4c0d720a4158">4,375</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzYtMy0xLTEtMA_083666af-ae3f-4fb7-8b36-a10b46606caa">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzctMS0xLTEtMA_39b133f1-f274-4d92-8270-8735a50ac7d1">6,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzctMy0xLTEtMA_88883874-a5d9-4193-9fc7-5f08b10c27b7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzgtMS0xLTEtMA_12dc4370-7aea-4c9f-b86c-1569a6b6441f">748</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzgtMy0xLTEtMA_c607cf41-88c4-476c-9292-8972e8d51536">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzktMS0xLTEtMA_96b44b70-2539-45b9-8052-2525af7da3e8">12,683</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzktMy0xLTEtMA_40005a10-0787-4395-a221-2441dfc7fea6">22</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEwLTEtMS0xLTA_2424666f-0a48-4283-9d6b-1c30041e945a">3,656</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEwLTMtMS0xLTA_04e5b40f-a822-4d9e-ac80-15b0181f7886">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzExLTEtMS0xLTA_e98b9ec6-d5ad-4f49-bb67-599a0c5ff834">4,811</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzExLTMtMS0xLTA_77fec515-7703-4604-b503-07e032aec6b7">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEyLTEtMS0xLTA_d97816e8-1483-483b-98ba-d6dc06b7032c">449</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEyLTMtMS0xLTA_83bbd6b6-cb3b-431d-9688-8bd485526452">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEzLTEtMS0xLTA_309fb92c-c2f1-4bcc-9202-164b7baf951c">11,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEzLTMtMS0xLTA_49851c2b-ac4c-479b-b4bc-233ae559edfd">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE0LTEtMS0xLTMyNjc_88c53091-6bc2-42cb-9a87-cdc6abd18f3a">3,609</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE0LTMtMS0xLTMyNzE_6781b47f-c3dc-432a-b446-84ba1b5fd876">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE1LTEtMS0xLTMyNjc_333956dd-6643-4de6-af19-e3cd6fe4bb31">4,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE1LTMtMS0xLTMyNzE_5d18b0a6-bee8-4c78-a75c-000aaec2480c">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE2LTEtMS0xLTMyNjc_6a40cbdb-790c-4bab-860c-54359b01d165">554</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE2LTMtMS0xLTMyNzE_e2445cc0-5659-46f1-a3b6-8523af6fa0ab">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE3LTEtMS0xLTMyNjc_ddc2677e-ab10-4344-b4d2-c9861dab772c">9,987</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE3LTMtMS0xLTMyNzE_f9017840-bda7-45a1-b0bd-eb63824e4512">34</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of shares that vested was approximately $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzM3MTE_a717568b-d91c-4837-a495-a9c0284fff83">172</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzM3MjE_1dbc6e2a-734a-44df-bb0a-9ee87ad5ab45">193</ix:nonFraction> million in 2019 and $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzM3MzQ_5224e8f1-92e3-464d-8341-392acefac29b">170</ix:nonFraction> million in 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market-based DSU Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, we granted market-based DSU awards to certain members of our senior management team. The number of shares ultimately issued to the recipient is based on the total stockholder return (TSR) of our common stock as compared to the TSR of the common stock of the other companies in the S&amp;P 500 Healthcare Index over a three-year performance period. The number of DSUs ultimately granted under this program range from <ix:nonFraction unitRef="number" contextRef="i7b53681c5973450a9bf67b79aa206f65_D20200101-20201231" decimals="2" format="ixt:numdotdecimal" name="bsx:RangeofthetargetnumberofmarketbasedDSUsawarded" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQyMDQ_ded1ef82-4a24-44e9-b7ed-a8e949f0479b">0</ix:nonFraction> percent to <ix:nonFraction unitRef="number" contextRef="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231" decimals="2" format="ixt:numdotdecimal" name="bsx:RangeofthetargetnumberofmarketbasedDSUsawarded" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQyMTA_8471610c-b010-4031-8330-128fee93c458">200</ix:nonFraction> percent of the target number of performance-based DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout the three-year performance period to attain the full amount of the market-based DSUs that satisfied the market performance criteria.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1Njc_c39a19a2-6bc9-4ec1-902e-c5f00a585789" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the market-based DSU awards to be approximately $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:Fairvalueofmarketbasedawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQ2NDI_0deb148b-c01c-490d-ae52-d689c55e6516">8</ix:nonFraction> million for 2020, $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:Fairvalueofmarketbasedawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQ2NTM_9890483c-9636-4a13-8a62-fdb22e5d9491">10</ix:nonFraction> million for 2019 and $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="bsx:Fairvalueofmarketbasedawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQ2Njc_96219876-6eaf-4a59-9f5c-c850e31531ad">7</ix:nonFraction> million for 2018. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price on date of grant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58e16f20577a495e80af1b6afc207f5f_I20200218" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzItMS0xLTEtMA_1890fa34-2477-46fa-9bad-2cb86c944c4f">42.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id21557fe18514f5291709c9c7a7b4c9c_I20190221" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzItMy0xLTEtMA_529758e2-bf02-4529-bc66-4a5d07f0752e">40.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i778b96505b084096ac50ff6a8617ea48_I20180215" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzItNS0xLTEtMA_90ed1217-0e8f-412e-870c-bf011d7b02f2">27.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> (in years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:duryear" name="bsx:Measurementperiodmarketbasedaward" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzMtMS0xLTEtMA_d1dd24dc-aabf-45a6-8aa5-b1f5c3964a7b">2.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" format="ixt-sec:duryear" name="bsx:Measurementperiodmarketbasedaward" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzMtMy0xLTEtMA_399cfd5b-7bde-403b-9cbb-10bf474a38af">2.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" format="ixt-sec:duryear" name="bsx:Measurementperiodmarketbasedaward" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzMtNS0xLTEtMA_344ea0d0-ce65-4d6a-af5b-8c4db0188dca">2.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzQtMS0xLTEtMA_d9cdc1ac-20da-45aa-bdb8-a73443ac92a5">1.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzQtMy0xLTEtMA_8bea7640-9522-4ac2-9e96-d203d405edf1">2.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzQtNS0xLTEtMA_69c680bb-b079-427e-aa50-3a07b313d4ba">2.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the expense on these awards in our consolidated statements of operations on a straight-line basis over the three-year measurement period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i6af98d10758d4ea5b0a61b909fd6c595" continuedAt="i1ebd1c62576b4be985a8657f7fee8871"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Free Cash Flow Performance-based DSU Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, we granted free cash flow performance-based DSU awards to certain members of our senior management team. The attainment of these performance-based DSUs is based on our adjusted free cash flow (AFCF) measured against our internal annual financial plan performance for AFCF. AFCF is measured over a one-year performance period beginning January 1st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of each year and ending December 31st. The number of DSUs ultimately granted under this program range from <ix:nonFraction unitRef="number" contextRef="i7b53681c5973450a9bf67b79aa206f65_D20200101-20201231" decimals="2" format="ixt:numdotdecimal" name="bsx:RangeofthetargetnumberofperformancebasedDSUsawarded" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzU0NDU_61efa783-3efa-42cc-b096-83f2275783ee">0</ix:nonFraction> percent to <ix:nonFraction unitRef="number" contextRef="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231" decimals="2" format="ixt:numdotdecimal" name="bsx:RangeofthetargetnumberofperformancebasedDSUsawarded" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzU0NTE_253203e6-1cfa-4817-9bcc-323e9566f94e">150</ix:nonFraction> percent of the target number of performance-based DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout a three-year service period (inclusive of the one-year performance period) to attain the full amount of the performance-based DSUs that satisfied the performance criteria. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1Mzg_e629f22b-799d-4c3c-9c7b-4bbcd3fea17d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018 AFCF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, net of forfeitures to date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:FairValueOfFreeCashFlowFcfPerformanceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzEtMS0xLTEtMA_d1db602e-390f-4175-bb7f-86e069cc3593">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:FairValueOfFreeCashFlowFcfPerformanceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzEtMy0xLTEtMA_f807379a-5c9c-494b-b8ed-bec5d9078652">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="bsx:FairValueOfFreeCashFlowFcfPerformanceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzEtNS0xLTEtMA_a770eadf-3641-40d1-93cf-ffada226172c">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achievement of target payout</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" name="bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzItMS0xLTEtMA_c70ef77a-74e0-46fe-8507-561df26f8ec3">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="2" name="bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzItMy0xLTEtMA_d1caa7bb-aded-4995-bbc8-dc235c62de8c">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="2" name="bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzItNS0xLTEtMA_fa7aa0cf-682f-4d15-8363-2cb3bd87cb03">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end stock price used in determining fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzMtMS0xLTEtMA_2a7f35a3-b8ca-4789-aca8-b8094ce87ef3">35.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzMtMy0xLTEtMA_5c72abc4-5d7d-44d4-afb6-2e9cc8283b74">45.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzMtNS0xLTEtMA_9cc519d5-bf1f-4088-a219-750f3cf61c76">35.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the expense on these awards in our consolidated statements of operations over the vesting period which is three years after the date of grant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expense Attribution</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize compensation expense for our stock incentive plan using a straight-line method over the substantive vesting period. Most of our stock awards provide for immediate vesting upon death or disability of the participant. In addition, our stock grants to employees provide for accelerated vesting of our stock-based awards, other than performance-based and market-based awards, upon retirement, if the stock award has been held for at least one year by the recipient. In accordance with the terms of our stock grants, for employees who will become retirement eligible prior to the vest date we expense stock-based awards, other than performance-based and market-based awards, over the greater of one year or the period between grant date and retirement-eligibility. The performance-based and market-based awards discussed above do not contain provisions that would accelerate the full vesting of the awards upon retirement-eligibility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation expense for the value of the portion of awards that are ultimately expected to vest. FASB ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allows forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term &#8220;forfeitures&#8221; is distinct from &#8220;cancellations&#8221; or &#8220;expirations&#8221; and represents only the unvested portion of the surrendered stock-based award. We have applied, based on an analysis of our historical forfeitures, a weighted-average annual forfeiture rate of approximately <ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" format="ixt-sec:numwordsen" name="bsx:Annualweightedaverageforfeiturerate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzc2MzA_47db5698-aa9c-46ed-b948-ff9ae2430130">five</ix:nonFraction> percent to all unvested stock-based awards as of December&#160;31, 2020, which represents the portion that we expect will be forfeited each year over the vesting period. We re-evaluate this analysis annually or more frequently if there are significant changes in circumstances and adjust the forfeiture rate as necessary. Ultimately, we will only recognize expense for those shares that vest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Compensation Cost</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1NTA_71dd80ba-e129-46e3-85a4-9b1914cef354" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Cost</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:UnrecognizedCompensationCostStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphOTg4NDM0MjQ2NzM0OTgxOWQ4N2M1YzBmNzhhMWI4Yy90YWJsZXJhbmdlOmE5ODg0MzQyNDY3MzQ5ODE5ZDg3YzVjMGY3OGExYjhjXzEtMS0xLTEtMA_4f98d008-2513-4389-a4d3-9c5f8ee55627">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:UnrecognizedCompensationCostNonVestedStockAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphOTg4NDM0MjQ2NzM0OTgxOWQ4N2M1YzBmNzhhMWI4Yy90YWJsZXJhbmdlOmE5ODg0MzQyNDY3MzQ5ODE5ZDg3YzVjMGY3OGExYjhjXzItMS0xLTEtMA_dee0232d-3ce5-4cc7-a979-2043c4633ae3">169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="bsx:UnrecognizedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphOTg4NDM0MjQ2NzM0OTgxOWQ4N2M1YzBmNzhhMWI4Yy90YWJsZXJhbmdlOmE5ODg0MzQyNDY3MzQ5ODE5ZDg3YzVjMGY3OGExYjhjXzMtMS0xLTEtMA_4e9d3b8d-1620-4eb3-9511-30e67213ec9b">204</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" format="ixt-sec:duryear" name="bsx:WeightedAverageRemainingVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphOTg4NDM0MjQ2NzM0OTgxOWQ4N2M1YzBmNzhhMWI4Yy90YWJsZXJhbmdlOmE5ODg0MzQyNDY3MzQ5ODE5ZDg3YzVjMGY3OGExYjhjXzMtMy0xLTEtMA_c3e524c9-cad7-4379-8d97-75cef99cd710">1.7</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts presented represent compensation cost, net of estimated forfeitures.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1ebd1c62576b4be985a8657f7fee8871"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global employee stock purchase plan provides for the granting of options to purchase up to <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzgzMjM_bd8cc8e7-6f18-44c3-bff9-2575110eb28d">50</ix:nonFraction> million shares of our common stock to all eligible employees. Under the global employee stock purchase plan, we grant each eligible employee, at the beginning of each six-month offering period, an option to purchase shares of our common stock equal to not more than <ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" format="ixt-sec:numwordsen" name="bsx:AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzg1ODQ_5bf9e5b2-48a4-4532-9ad8-8b61241faa96">ten</ix:nonFraction> percent of the employee&#8217;s eligible compensation or the statutory limit under the U.S. Internal Revenue Code. Such options may be exercised only to the extent of accumulated payroll deductions at the end of the offering period, at a purchase price equal to <ix:nonFraction unitRef="number" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" format="ixt:numdotdecimal" name="bsx:GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzg4MzU_2e4efc36-335c-4445-a0c5-fc067d7a20cd">85</ix:nonFraction> percent of the fair market value of our common stock at the beginning or end of each offering period, whichever is less. As of December&#160;31, 2020, there were approximately <ix:nonFraction unitRef="shares" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzg5ODY_19dcbba1-c97a-44fa-9dc0-26c2c80e056a">6</ix:nonFraction> million shares available for future issuance under the employee stock purchase plan. We temporarily suspended our global employee stock purchase plan for the offering period for the second half of 2020 due to cost-savings initiatives in response to the COVID-19 pandemic and have resumed for the offering period for the first half of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1NzU_6f3cd8c8-7285-4522-84b5-fa90e1c189a2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:51.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued or to be issued&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzItMS0xLTEtMA_a135df44-2d2b-440c-b3ac-4fb7805d0e13">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzItNS0xLTEtMA_4aab7f4a-24fc-4c66-911f-77b7bf942a42">2,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzItOS0xLTEtMA_d247fb79-10a7-4c8e-917e-f3de2ed3fd23">2,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Range of purchase prices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtMS0xLTEtMA_ae4fc590-4737-4d7e-bf97-abce6605e34d">29.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i1d62047b22344b799f16b3cb7ff597c8_D20190101-20191231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtNS0xLTEtMA_ba20ca7b-df1d-42fe-9ab6-a2547e7f0675">29.29</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib22247f67db94421b34a23ad85639077_D20190101-20191231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtNy0xLTEtMA_ad4e3bb7-98ab-47ed-afe2-88d91f07edcf">36.47</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i5927d31a28d44ea785098e97b5f79f96_D20180101-20181231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtOS0xLTEtMA_a526a905-646e-4d6b-994f-6bc2f7bb0b1d">21.49</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i587d1e2ddfb14a2eac94b281ca12ec47_D20180101-20181231" decimals="2" name="us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtMTEtMS0xLTA_dd8fd785-6308-4118-8fd3-ec970bacb7ac">27.91</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recognized&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzQtMS0xLTEtMA_d91387ec-54eb-4986-b025-2064f0db41d2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzQtNS0xLTEtMA_b19bcc49-9faa-4626-8b7b-8023cf901df5">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzQtOS0xLTEtMA_d5de06a5-7fbe-4778-bcbf-26ec24571a54">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of shares issued under the employee stock purchase plan. We recognize expense related to shares purchased through the employee stock purchase plan ratably over the offering period.</span></div></ix:continuation><div id="i5c3e8d69fcc1460baddde62cfa022487_139"></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90ZXh0cmVnaW9uOmY3MDlkM2M5Y2YwODQ2MWY5ZTdlM2M3YWYwYzczYmFhXzI3NDg3NzkwNjk2NTU_cc832a1c-0ab9-4da2-a82b-fa53e4895983" continuedAt="i281b6367764c4ecf80242d980a3c65e5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90ZXh0cmVnaW9uOmY3MDlkM2M5Y2YwODQ2MWY5ZTdlM2M3YWYwYzczYmFhXzI3NDg3NzkwNzIyNDc_0e35baf0-bc4b-45b4-9b24-1119f5acb217" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzItMS0xLTEtMA_85e99615-b442-4fdb-a174-c7ef33d5a261">1,416.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzItMy0xLTEtMA_4c873d9a-e8a6-44fd-8053-ff7e1c7dc5d8">1,391.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzItNS0xLTEtMA_afe35cdc-7ae6-446d-8367-235bdffd2cf2">1,381.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzMtMS0xLTEtMA_b96e9529-c118-4eb7-bfe6-beb7ac9b5241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzMtMy0xLTEtMA_4da2b25f-224b-4dd5-8e00-40051ddb2cfa">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzMtNS0xLTEtMA_6bd2d6f8-2e17-46cd-a463-3b58d357b263">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzQtMS0xLTEtMA_cc19eef7-e0ab-4a21-b2f2-46e7bff87483">1,416.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzQtMy0xLTEtMA_6f9f7ef9-58f2-4e3c-bfeb-b8242c2b5cd9">1,410.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzQtNS0xLTEtMA_95de2ec9-1b6d-44d4-b352-8cb2839fcb57">1,401.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90ZXh0cmVnaW9uOmY3MDlkM2M5Y2YwODQ2MWY5ZTdlM2M3YWYwYzczYmFhXzI3NDg3NzkwNzIyNDQ_105f7dd3-52de-43b0-9ee4-4f82d21ce08e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6c97b04efa749baa9a5a7d0f8ea8b37_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzItMS0xLTEtMzAzNQ_6a0467aa-3ecd-417c-bd59-f276c16c634c">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i072f9c9e6d52435999f54ed61545ec04_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzMtMS0xLTEtMzAzNQ_bb98e398-1f38-4b37-a429-5da0f4794c3e">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1fda8d4a6d204d5592671e4160ebb649_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzMtMy0xLTEtMzAzNQ_04382ab3-b9db-4356-8971-f605d5ae0f52">0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc16585c6e1d4e3b933534e09af497dc_D20180101-20181231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzMtNS0xLTEtMzAzNQ_9a3927f0-7f69-4cb3-8d6f-0294f4d97e8b">0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2bfcb1707824651a50fb653ad5409d1_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzQtMS0xLTEtMzAzNQ_b354ba35-9031-46cc-93ca-b2950861fa9e">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in this period.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the later of the May 27, 2020 issuance date or the beginning of the reporting period to the extent that the effect is dilutive. </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i281b6367764c4ecf80242d980a3c65e5" continuedAt="ib73c5a124b1a49b2912ccf885c4ee32e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as presented in our consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net loss available to common stockholders</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib73c5a124b1a49b2912ccf885c4ee32e">.</ix:continuation> </span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_142"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1Mjg_13190513-d3fb-4ea8-a2db-fe2f469051f0" continuedAt="i35370c6d68254d8d8c227e13f1626cd3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE O &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our seven core businesses are organized into <ix:nonFraction unitRef="reportablesegments" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzI3NDg3NzkwNzExNzY_2d376cf4-3616-4ded-ab85-912ce3e071ed">three</ix:nonFraction> reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), certain investment portfolio net losses (gains) and EU Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations and are included in the reconciliation below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our acquisition of BTG, we have included BTG&#8217;s Interventional Medicine business within our Peripheral Interventions operating segment, within the Cardiovascular reportable segment. We present BTG&#8217;s Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1NzY_48405f6c-a6c0-4bc0-8a86-ae8ffba038d1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzItMS0xLTEtMA_c8d4b45f-e2b5-4c9e-9b14-b5d6f2227818">3,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzItMy0xLTEtMA_7b68a007-8183-4580-ab7d-4fd80fa8d096">3,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzItNS0xLTEtMA_6d8121ae-5481-4a2b-922f-e99e292ae080">3,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzMtMS0xLTEtMA_dde7f472-eafd-42b3-a003-46125e002a56">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzMtMy0xLTEtMA_07a13da5-148b-4ada-b9ce-336de02c1836">3,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzMtNS0xLTEtMA_a2a885fd-3180-4831-a52c-7eaa28828f03">3,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzQtMS0xLTEtMA_aafe796f-fe03-4cee-988d-062c8be586eb">3,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzQtMy0xLTEtMA_01486a42-8a8b-4c0f-8378-87c3c8051ba7">4,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzQtNS0xLTEtMA_9908c037-b3df-4d17-9aac-11f719e84fa9">3,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e266465c9541e5884b034945a9b78f_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzUtMS0xLTEtMA_e97cc2c0-d0e2-416a-966b-f59f3855d572">9,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a7f1a1b2624255b5691acb8602e67d_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzUtMy0xLTEtMA_b7e0bc3b-d201-4de6-a748-8ba03840554b">10,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0820a199efab4817bdf4131117959b05_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzUtNS0xLTEtMA_ea2a92dd-0526-4ed6-8f4a-b200d69d69f8">9,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9db1cbfd5784602a23dc09b4c7da6d8_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzYtMS0xLTEtMA_ac74513c-8db3-4b94-b93c-0399a35ef664">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2775314c99b49018b5b755c1d609493_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzYtMy0xLTEtMjk5OA_f2f54435-7930-4162-b039-7c06ec101a7c">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzctMS0xLTEtMA_57acf547-8f29-4565-8c11-728d6e8c6ecb">9,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzctMy0xLTEtMA_30926c08-b004-4aa2-844e-c4bcd228fc27">10,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0820a199efab4817bdf4131117959b05_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzctNS0xLTEtMA_947cbb1c-99b5-4680-9a95-a713bed3aabe">9,823</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1MzA_e963ea59-4ff3-4cf3-bfed-7dd5886eefe6" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzItMS0xLTEtMA_4d3d085c-24a8-4236-8e37-93d92755e25b">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzItMy0xLTEtMA_ce6ad229-c207-4ad6-87a9-23f827a5adf7">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzItNS0xLTEtMA_02339a62-e6ca-4e5f-a493-20d3a9caff2a">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzMtMS0xLTEtMA_81d678b5-7d4e-42a3-b74e-c2c70e0ed7c1">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzMtMy0xLTEtMA_fe2b45cf-b2e5-4f53-a15b-1c81434e7e0d">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzMtNS0xLTEtMA_de6fb14c-4b22-4d37-bc24-081eff8b0090">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzQtMS0xLTEtMA_2778628a-7e82-4d1f-a76b-11b7013cfcee">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzQtMy0xLTEtMA_3d660ab1-c99f-496b-874a-47bc95249ada">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzQtNS0xLTEtMA_9fe3369a-ad58-4732-a6eb-0987557ca5dc">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e266465c9541e5884b034945a9b78f_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzUtMS0xLTEtMA_2392872b-4c3f-468d-bb31-0d2490148f65">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a7f1a1b2624255b5691acb8602e67d_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzUtMy0xLTEtMA_6ff61822-ac25-4a9c-ad28-fdca6aa15b7a">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0820a199efab4817bdf4131117959b05_D20180101-20181231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzUtNS0xLTEtMA_e0af7619-917d-46da-8a62-709f59981dfe">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzYtMS0xLTEtMA_8664fbcf-7c8b-43c0-b8e1-8c7726990e88">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzYtMy0xLTEtMA_2a878447-15c4-4ce7-a93e-245457b50caa">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated depreciation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzctMS0xLTEtMA_4e5c397c-555d-40af-822e-075efd51150b">333</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzctMy0xLTEtMA_9aec95c1-0b41-431e-b798-33a8ec589b42">311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzctNS0xLTEtMA_2837a109-81c9-450e-aad2-1bc168a7cb26">296</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1NjA_247ca490-eac2-46cb-9de4-925be95dd431" continuedAt="i29d45b362591495cb4a08b1ed5c84c0e" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i35370c6d68254d8d8c227e13f1626cd3" continuedAt="i072498a7c2ea4a5ba78016504395fa42"><div style="margin-bottom:6pt"><ix:continuation id="i29d45b362591495cb4a08b1ed5c84c0e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzItMS0xLTEtMA_39405314-4bc4-4cd5-a60e-fa7fbf93cec7">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzItMy0xLTEtMA_bb919527-0fb4-415f-9b6c-2b192ff9eedb">1,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzItNS0xLTEtMA_cd83650e-fb57-4403-a8f6-16d250fd06c5">1,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzMtMS0xLTEtMA_aa4c816e-7c3b-44b0-bdee-a4bddf83adf2">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzMtMy0xLTEtMA_601d636d-6685-41e5-a6af-787bddf704bf">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzMtNS0xLTEtMA_8483adc7-8d82-45b7-8d7c-cecb2a785c8f">655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231" decimals="-6" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzQtMS0xLTEtMA_7fc36121-bf65-4a28-8769-6f411018ef8d">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzQtMy0xLTEtMA_ddb1e596-cdd3-498c-98c8-754773ec0876">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="bsx:OperatingIncomeLossAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzQtNS0xLTEtMA_56372444-421e-47c1-a6c9-713ba3c8f841">1,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ec03875dad48559735244193b46b9c_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzUtMS0xLTEtMA_91a5ec89-24d0-4663-9dd0-0647676f78c0">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c01e96e0cd14429b992b394174f5e9e_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzUtMy0xLTEtMA_41d5f89b-2efc-4c26-adf9-b6584a2736d2">3,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8fe71b06ce344c281e40bdc083e4ba9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzUtNS0xLTEtMA_eb068ee4-c8b5-4ddd-add6-9836066a25fa">2,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzYtMS0xLTEtMA_6c0ba3ff-3169-4eb9-bdff-00b984c2ff59">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzYtMy0xLTEtMzAwMg_c1310150-b7e4-4aea-b975-5b113f7553d0">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a71de8475b842919cc1f06ff9e779cf_D20200101-20201231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzgtMS0xLTEtMA_8741d12f-4060-4928-90a4-99cae43841bc">405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7255855cd0894949a78ea4a0040d8c62_D20190101-20191231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzgtMy0xLTEtMA_5d2d8809-e81f-4ff6-9852-3da3b9c825ac">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e2cbc9edb4549aebf26bdc7e9f10bc4_D20180101-20181231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzgtNS0xLTEtMA_13f0ab65-1562-44d6-80b0-856ba9283ac9">372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i438f3d71334f422fadced3dba2c1990a_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzktMS0xLTEtMA_e875dcb8-0d9f-4882-a28c-cb08833e83da">1,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63903523afd04122bb1a4624c0770c00_D20190101-20191231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzktMy0xLTEtMA_3ec615f8-7770-47af-9b1b-e2d1975ef78d">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9ef720185f044b09fc4ef729f49cebb_D20180101-20181231" decimals="-6" sign="-" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzktNS0xLTEtMA_9fa06587-06c6-4895-8a00-b34e2eb5d1f2">398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEwLTEtMS0xLTA_70408aa3-b101-403b-971e-e13abc600ee6">789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEwLTMtMS0xLTA_0dcb4724-2b65-4e3f-88d6-d51cb8a7c92f">699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEwLTUtMS0xLTA_c8e3ec53-eab6-4663-bb04-800a910116cf">599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzExLTEtMS0xLTA_ba8dec01-a833-4d31-abe1-74e0f14c8a78">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzExLTMtMS0xLTA_b6d3dabc-4cc7-4fdb-8342-5a8c6ffa06e2">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzExLTUtMS0xLTA_c405e9d3-9a11-44eb-a655-af8196895517">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEyLTEtMS0xLTA_6e8d2110-a23c-4676-af39-695de26ba7d9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEyLTMtMS0xLTA_93f9678b-9ed9-47e2-950f-5c9d9d06f115">831</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEyLTUtMS0xLTA_5eb66858-03c3-4f76-95e0-26e39a46fab2">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEzLTEtMS0xLTA_f314bf20-0f8d-4699-bfbd-ee21de58e46a">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEzLTMtMS0xLTA_64124ad2-74b3-4b29-b51c-d4e5fc73d5eb">687</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEzLTUtMS0xLTA_6dd68a33-9954-48c5-852d-959d503b84d9">1,422</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1NzU_1f782114-08c8-4911-a180-6c04ce70c1f7" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzItMS0xLTEtMA_d2a870f9-5834-4ca9-98c7-de26667ddad4">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzItMy0xLTEtMA_bfe6e0d0-e41a-40df-976c-edccbc98f958">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzItNS0xLTEtMA_dcec25b3-28cd-4e96-baab-ced8b4dec961">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzMtMS0xLTEtMA_8ff01aa3-825f-44c1-907e-5447197f3622">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzMtMy0xLTEtMA_4f33f610-8330-4932-b409-cb7bce9eefff">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzMtNS0xLTEtMA_4792ac4e-abf1-4305-a1ef-ff06d169c87a">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzQtMS0xLTEtMA_2a24f2dd-ec21-4da7-846e-df640f7148e3">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzQtMy0xLTEtMA_0b3ebfa6-7ae8-40b2-a9ae-fdcb5eb5fd02">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231" decimals="3" name="bsx:Segmentoperatingincomeaspercentageofnetsales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzQtNS0xLTEtMA_1d8b45aa-dd53-4684-afc9-73549e4d9a8a">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1MzU_a677a06f-3e8e-411b-b533-f0bb1e81bdf3" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f17ca4d9f544e3b7cb7e5c6f72280c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzItMS0xLTEtMA_d00069d3-ed9b-4d36-8b02-b4f22487923e">1,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4452aaad562b4bb899286f3797d9eb2d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzItMy0xLTEtMA_925361b7-769f-4af2-aed9-b614b367f2ff">1,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593eb42527b540c88a5921faa53b3629_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzMtMS0xLTEtMA_86b4aaf2-c71e-4ded-85fa-3a325856077f">1,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e86856187e44c808f6433015dceb738_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzMtMy0xLTEtMA_223a1f3b-5ec6-4e8c-a313-e81d4575d6d8">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d99afc9e3b24ff09921674dea102a4b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzQtMS0xLTEtMA_bab336e6-4f6a-4f28-a08d-e13a4fbd8d88">2,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c2fb79c41b4be6bf7aa2326d6b1cae_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzQtMy0xLTEtMA_f95707cf-478a-4af8-84a5-fd28b1d4606b">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie07c1550f2534b128a6b7a2e8d0dcacb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzUtMS0xLTEtMA_48468a51-8f47-493f-9bee-216ffb7ab460">5,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511243d7d4314bcfa6398e281d8d6532_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzUtMy0xLTEtMA_26a7962f-50ff-4723-9e8e-4e69949a09e2">6,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzYtMS0xLTEtMA_50f01fff-7b3d-48ab-a3c9-7e39f9aa3290">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd58d69b28dd40519b4334498825790f_I20191231" decimals="-6" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzYtMy0xLTEtMA_aa85b5c5-8e27-4e74-96c0-dd8852017e51">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzctMS0xLTEtMA_f82bd445-2c9f-425e-be29-bbb5c5e1b01b">9,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzctMy0xLTEtMA_b817d6b3-a149-4a2e-b402-808e19d12406">10,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzgtMS0xLTEtMA_da5540d4-f986-4814-a832-85e5ff9a1ace">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzgtMy0xLTEtMA_36e9fd94-a267-4ed6-82c1-75eb4768f031">7,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae346373047401887060e128b7fa20e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzktMS0xLTEtMA_2aa76f13-04a4-468f-b6a6-056de242bcc1">7,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7b8ce837b245dbb215df8479dd5f96_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzktMy0xLTEtMA_8dc040ad-6ba4-4b50-a75a-ea8bbdd97dba">6,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad363ee5163542b083904b4076004ef1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzEwLTEtMS0xLTA_f85b34aa-19ae-437c-b3c6-b036e01f700c">30,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd94549f8c44f9d8d06813718b34318_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzEwLTMtMS0xLTA_243cb821-0097-4bef-a7ba-a34ea22fc29f">30,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the announcement of our plan to sell our Specialty Pharmaceuticals business, as of December 31, 2020, we have classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less costs to sell. Accordingly, the total assets of the Specialty Pharmaceuticals business as of December 31, 2020 reflected above include goodwill and intangible assets attributable to the disposal group that were not previously allocated to our reportable segments.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1NTM_f15e4734-a2bc-4527-b11b-596280d95223" continuedAt="id50deafcc078409298304e5a83d07305" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="i072498a7c2ea4a5ba78016504395fa42"><ix:continuation id="id50deafcc078409298304e5a83d07305"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5dd6328991b46b09bcc31f021284ca1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzItMS0xLTEtMA_b8bc2835-777a-46c3-80a9-c921caa604c3">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b784e91a1d84b03a340b395d9f1d9b8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzItMy0xLTEtMA_4a69657a-74c6-48ae-a16d-09c97869a16b">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c8ed886eb0f41d797c16440876e2205_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzItNS0xLTEtMA_d402ff78-dfc1-46cc-add5-cca8e512718b">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858f772c802b438680691d7c7cb9c6e4_I20201231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzMtMS0xLTEtMA_9daea2e9-3831-4d72-ab8f-47a7a9c4b8bb">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbc1298766fb4dc6afdb793f6e79a93b_I20191231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzMtMy0xLTEtMA_50b09069-0c26-4af4-bb50-254b8b674387">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b32c44341dc4909bcb9d9a63624fe3b_I20181231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzMtNS0xLTEtMA_7cb78506-1d66-4c86-81b5-b23b44502015">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec0796ecad949ba819d979b8949b690_I20201231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzQtMS0xLTEtMA_721670b4-cb91-412e-b723-64932d438293">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id00a014d50414ad386436abb58f55a11_I20191231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzQtMy0xLTEtMA_e33ae956-4ce1-4f19-9324-c193217643c1">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a659e306f1b44828d0574858121b0aa_I20181231" decimals="-6" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzQtNS0xLTEtMA_ba307e9b-87c8-4c42-8e05-a1cf5a224ed2">478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzUtMS0xLTEtMA_c4e5f18f-e27b-4b69-bb29-49ba668ab464">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzUtMy0xLTEtMA_abf1a96d-bf97-4e03-aad1-e6bc13b03748">2,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzUtNS0xLTEtMA_acd69d70-fee9-4de3-9e47-56e81d5fef51">1,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzYtMS0xLTEtMA_20ff9acb-8d42-497d-a9b7-8de058a96760">9,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzYtMy0xLTEtMA_3f49d3c5-e012-4755-aaba-55aaf01ef4d2">10,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzYtNS0xLTEtMA_77f78962-0c8a-4f34-ac3d-70a8a23692e8">7,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzctMS0xLTEtMA_aace6022-0da6-43be-8a06-2390504a7284">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzctMy0xLTEtMA_97715665-18b4-4f26-933a-0f6b92077f5c">7,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzctNS0xLTEtMA_84a70640-2f7f-483b-8ab6-3d90cd2d0104">6,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzgtMS0xLTEtMA_837debbd-304b-4403-8b6d-22157ad3a7cc">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzgtMy0xLTEtMA_464538bc-0087-4d24-98a8-ee7926006743">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzgtNS0xLTEtMA_07b404d4-ccc8-491e-8ff4-2c4e3bb3c1f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzktMS0xLTEtMA_590b16b2-8157-4592-bea8-0e4eb6ada47b">18,409</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzktMy0xLTEtMA_80d74dc4-730b-49a9-85ed-99cbfabbfd38">20,477</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzktNS0xLTEtMA_782110fc-59fb-4782-8c8f-7475625f8876">16,064</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_145"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzI3NDg3NzkwNzQ4OTU_c20ecc6c-4a59-4d2c-b3d4-6ef136e3b50d" continuedAt="i71e611eab25d4a588c07b4912556544f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE P &#8211; REVENUE </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our consolidated statements of operations. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzE0MjI_98e206f8-ba7b-4d5b-b2e7-3830e753936a" continuedAt="i14235409c6db46bda7caf6b0eaf39fc5" escape="true">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): </ix:nonNumeric></span></div><ix:continuation id="i14235409c6db46bda7caf6b0eaf39fc5" continuedAt="ib52177d0f5be4c79bbe563a1dec4b49b"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:24.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.550%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ae8f5f4fc54e469b52b21b2e600588_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMS0xLTEtMA_14149293-5567-473b-9ae8-081fcdeac0ab">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63189412661642f5a8f2b9aeb53a83a9_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMy0xLTEtMA_3d36fb04-d34d-4570-83a9-6546feb8e857">780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3310fa9b62c34616bca02c7c2f6b9784_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtNS0xLTEtMA_c4b44d31-57db-4bc2-aa4e-5c8f46510ea9">1,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f4de09d08c4833944a68b36c8d10e2_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtNy0xLTEtMA_1e73b4be-1872-4908-9da9-2ad2450ee88b">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71c0aab91d34037ad9af6a815712b06_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtOS0xLTEtMA_8125d0e5-6b74-431d-afa2-5bf5d6179729">814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e68166b1ff440a4bc5ba6146bce9e0c_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMTEtMS0xLTA_79ccd1a1-533f-4b7e-b14f-f33afd5475d3">1,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2791d1ca0354ea3b2122b428aa941e8_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMTMtMS0xLTA_d166b10a-13aa-4029-9c78-352ba6908cc3">980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied722aad4edc4278a94ca946a6b06e8c_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMTUtMS0xLTA_bbc1693a-d888-44a3-9b2a-f07f663066a7">781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8328c5ebea2e4fd6bc961bba6dfac1ba_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMTctMS0xLTA_786fa77c-55ba-4825-b771-01a7374f830c">1,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd85cb4fae54571b1035e5edca0b5f0_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMS0xLTEtMA_c09096d0-c20b-4fdb-9384-ac46e4e68aca">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3a0f25c82248db8fd9752a33e01ca9_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMy0xLTEtMA_04a79046-e727-4c53-b4f8-19ef83c59af7">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf1776f98e64055a1740c5f1d4c3626_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtNS0xLTEtMA_704eacf7-1ea5-49da-99be-546e33cef032">1,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513e81ea5c054bb7ab98f1c6f1a9367c_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtNy0xLTEtMA_9f88d22d-cf19-4d65-8ff7-e0c79edf65b3">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e138a0321a4237aaee54dac3eecbef_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtOS0xLTEtMA_b8fe0738-6173-46ab-abbc-edeb64de1b8d">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfdceca128a8467f86bcca14efd7146b_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMTEtMS0xLTA_fa4615fc-2195-4e60-a0d1-bd7e41a990a4">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if875c662a7874536afea940416d0a63e_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMTMtMS0xLTA_8cc83d7c-82f9-4b75-86e7-ea49cdea6ad2">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefd0c81147da4757acf01048244a29a2_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMTUtMS0xLTA_1d7d8427-60e4-4714-ac4a-ea6a064090ee">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id75ab8e1ae0d49cbb8ac4badf8c334e3_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMTctMS0xLTA_ab4eb4ee-7d41-4282-ae6e-d029b945ae2f">1,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123d2d96cb4f4625a7ca2e22d7052b07_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMS0xLTEtMA_99d523a9-ddab-49bd-938c-e64fb03dfa1c">992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96570d8f60ec4c059059878654d4e978_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMy0xLTEtMA_f873eed0-6412-44c1-8c89-a488453d20bf">712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede0d66fbb154f07be0f0e39b74e8884_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtNS0xLTEtMA_191e735e-214e-4ab4-ac97-f4f79a199e9b">1,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f5a94b8a8145529296757ce57b7f5a_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtNy0xLTEtMA_cce74860-7ecc-495d-b6bc-0ebb8cdf7f3b">1,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i937aa716b0d844a989c27397f8bc1d9d_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtOS0xLTEtMA_39dea69e-a42f-4e53-a698-a409af76b41f">804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44f315c2d53749c4a98caeb0c46bf4b8_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMTEtMS0xLTA_070ecf94-8446-434f-bb91-8c438b621105">1,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1502d18d7bc74acbb3d8ab048488f756_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMTMtMS0xLTA_6bd583d1-b6a6-4402-a7c3-df3b98fb3428">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b5fd5fd89d4d2e87a701257a100916_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMTUtMS0xLTA_a672483d-f463-4f77-954a-ef24a2970890">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ff3b6b5ecd4ff78aefd5a1081e8c46_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMTctMS0xLTA_6957c692-6f94-4802-97e2-19fdd88fdc81">1,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98775703e0eb4e92aeb652fb7cd61026_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMS0xLTEtMA_fdc32074-e084-4534-adbd-3bf833d93643">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if74c3140243949a6826d8ed9cdee8a17_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMy0xLTEtMA_c2758ff8-4c73-4ca3-87fe-dba6f5c6a91d">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3406940f365a46eb906ded17bdbd850c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtNS0xLTEtMA_e8678057-bd31-452e-a851-2a137b0b952a">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9539e6fa5dcb48d8b5039083c5f40bd7_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtNy0xLTEtMA_51999902-88eb-4cbf-907b-679027d88a2f">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48892e98c56344a79b645469f44e7ffb_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtOS0xLTEtMA_ba9f3a61-415a-40bc-9e9c-ad89062dda5c">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c1a11844804faea3d997d119344357_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMTEtMS0xLTA_ded5d6f1-6ed7-42a7-83ce-3724920a97c4">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f5f28e5853409e93d21092b327e718_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMTMtMS0xLTA_f4e4e66d-aa22-456e-afe8-2fea2f4d0fcf">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173fb5f80de24dc6b549cf699860ff93_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMTUtMS0xLTA_b26ed261-0920-45d6-b81b-92346a97d782">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if596783ed28540409dc77820cae22014_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMTctMS0xLTA_07cff5cf-c63d-4d01-9f09-df0c41be318d">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0cf3f990cf48038aaa263848720334_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMS0xLTEtMA_6d26aa94-ce89-4a03-a349-cedc7d419934">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35965682e6934441a09c4499546789a5_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMy0xLTEtMA_f08e31b6-941d-435c-aeb9-868154b8cb90">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0bbd18a4ac488ab44f83280dffe8d9_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctNS0xLTEtMA_82381b62-1a15-481d-949a-cb8770096c5d">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5909476c857442b993ed5506e3cef59_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctNy0xLTEtMA_8487d5ce-37f5-4084-9e76-4f6effb52f4d">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id91bf069a1224ec7b78acb9fbcea277b_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctOS0xLTEtMA_9f7ce9fa-d091-41e9-be9c-7854fe359723">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if995755c1c9b49b4a9e75000536e2348_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMTEtMS0xLTA_591e803e-49e3-43cc-ac22-c3f7cf5eae6a">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdcde2cecf294a648e81bb1b6a520713_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMTMtMS0xLTA_4c0ae3ea-2637-4224-af25-e8b9f2132fa4">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba33321f14c4426c8f27ec58c8dd157d_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMTUtMS0xLTA_3aeba8dd-8c68-48b7-a9df-dc671a88baed">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2be57e89ab4990afaf54dfd21a1651_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMTctMS0xLTA_2a1f7ecb-c09e-486a-b218-44a6dbaf2d12">779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6206baa0607e4447a0e903f42c1ed97c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMS0xLTEtMA_4e164c3e-5c47-4b0d-b2d8-11c8eb57b81b">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd07f73493ec4ed7a9c7b93a28fa803f_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMy0xLTEtMA_c2549896-afb4-4c41-9416-5ae510b069e2">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecec850c0f8c45579de9fd9d3cc81e56_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtNS0xLTEtMA_9dd619d2-a33b-4b17-a272-b313c2ecd979">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf55f8a4d8043ddb1050e3255fcca0f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtNy0xLTEtMA_1f1c1764-3f7d-408d-9565-378202c28509">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815d46a2e6f141779fd9a976198fcb59_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtOS0xLTEtMA_a0421bda-6c6f-4088-95cf-2232347b8fda">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08fbe1280d8c444c9dfd654d9d62ffba_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMTEtMS0xLTA_c0f14418-5eb8-4548-94f8-250d85c38080">2,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4183c9b4fb7440c8791c7d281bfec1c_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMTMtMS0xLTA_cb6feb8e-878c-4747-84ed-7e96776b156c">1,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c4dadc18e044be9fbc4bee8e5e1ae0_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMTUtMS0xLTA_92be78da-65b1-4d30-bad0-3be188129366">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8a6c9c90a3f416e91e71e65395c477a_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMTctMS0xLTA_ad827a6d-d3cd-4bd4-afea-7f7263df2c33">2,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i528032fe7c344add96992fc9c9effe78_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMS0xLTEtMA_6df2f1a1-6a6a-4578-aa3c-055c4475afed">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8e797bf1ad64edfa7c96ff371ef9a6b_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMy0xLTEtMA_5d4a43cf-d6a0-46d0-ada3-3c8f8a5d0dee">689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8348c7076ad34dc19caa20d96d3a35a0_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktNS0xLTEtMA_7791ee2f-b217-4a16-97ee-b9945075e96b">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7734b29eb824bbe92e4b31e6104b9eb_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktNy0xLTEtMA_0b862709-be52-4942-bd5d-2e034c55b0c1">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0690fd3bd0414ed3803fa0ec3f99dc1a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktOS0xLTEtMA_0f8155cc-db4e-40da-a8da-7f54d0d05fa7">651</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f26189e8ec34d198388550160abbe6f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMTEtMS0xLTA_2c6e7318-7c52-49ad-80fe-b0f589fac0ca">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i538b7bb9612a453f9a69c50b4385870a_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMTMtMS0xLTA_52391b14-525d-4557-8192-ff925bb36562">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aa704e50bc84e7c8687de09cd75e04c_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMTUtMS0xLTA_dd0444fb-3859-4c81-94ff-a43eabf38551">579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9c9683dda944147b057902c94179e93_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMTctMS0xLTA_b138abe0-c197-4cc1-8e56-52c508fca0f2">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b5cf3a4bec4cd88d7475be9f91daca_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTEtMS0xLTA_a6b41306-dc2e-47b9-b5ca-fb03d51a2662">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4ccc5194b647ebae6e86a553e04f39_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTMtMS0xLTA_d9829390-60ca-4f01-9fd3-bd2161ee5e1c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9db1cbfd5784602a23dc09b4c7da6d8_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTUtMS0xLTA_ac74513c-8db3-4b94-b93c-0399a35ef664">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a2689337c343a29b2517e48e80f21f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTctMS0xLTcxNA_85745cfd-b7db-4aa3-b0eb-c2da22fb2cce">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3027462747254c22a27e928fc0e7507b_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTktMS0xLTcyNg_93e0a764-037a-42da-820f-82c5d2b68fb8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2775314c99b49018b5b755c1d609493_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTExLTEtMS03MzA_f2f54435-7930-4162-b039-7c06ec101a7c">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44683e8679ca4adeab31422336b6d2b6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTEtMS0xLTA_70f50cef-efd8-4596-b6ac-18bd93303a08">5,701</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3f1f1a5e54483791680e1f47026b93_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTMtMS0xLTA_80c22cf1-6a88-4905-a477-ef9bbe618d03">4,212</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTUtMS0xLTA_8e2033c9-e6e2-4ffb-b87a-3292f8ca8754">9,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477d03746ef641e79d498573339aa789_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTctMS0xLTA_4a96bec7-b962-4773-bf96-da5aa48bb226">6,167</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb9b19833ec4b32a7043c93f3837778_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTktMS0xLTA_614c859c-0d95-49d0-9edc-df59b2f30a01">4,569</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTExLTEtMS0w_30926c08-b004-4aa2-844e-c4bcd228fc27">10,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9077857b3e78429184a7980d2c9e9bd7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTEzLTEtMS0w_9c4d4052-e5b9-43f0-947b-23ca175988f1">5,538</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4029bfd2d2d45b88bbd190a55c10e4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTE1LTEtMS0w_49195d47-8243-4469-994d-4f7a96f08542">4,286</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTE3LTEtMS0w_31188610-0539-40ab-8524-0a98431acf03">9,823</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7416538a3917499a98dd18bd9a43544f_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzItMS0xLTEtMA_12f880cb-d1a2-41b9-a1c7-0236760bcb96">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaf003122284a1caf5f04531f97da3e_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzItMy0xLTEtMA_b76f6cdf-4540-4e4d-a371-31c960a8b187">6,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i247718be21934f158bd504dc0a59d0d8_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzItNS0xLTEtMA_9e5f99f8-7db3-42fa-967c-4ef430c6ea0b">5,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d22c0398784970921b6ca16cac29df_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzMtMS0xLTEtMA_91c5ccde-fb6d-4aa0-bd98-ab37ad4bcacc">2,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eae2a8bac3a45d0a646a1ba30307bb1_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzMtMy0xLTEtMA_00870a8c-930f-4d5b-ac4d-7c80b52ac820">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6304d11e4ac4f2bb33c3f2f876312d5_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzMtNS0xLTEtMA_66ab0e56-8343-4c74-b222-9e14adecde78">2,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03b4b47b48264834a5b805b565fc497a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzQtMS0xLTEtMA_49a12d7c-f5c9-426a-b0b4-68c78be76187">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e9eb5b00d6e4f2e8af5e92882f84e42_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzQtMy0xLTEtMA_426682f1-e347-4443-ada9-d7bd0dfb4513">1,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a94eb1a155c44089342c4fce8a0a175_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzQtNS0xLTEtMA_d7aef7b7-1deb-4c3e-b9c3-0b03c8f02cf1">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44651ee68c84efd8c565cd8ede42050_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzUtMS0xLTEtMA_2f15440c-9f73-4796-abd5-23ca646a99db">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b029b8db40e4478bd41a37cbbf5ba8a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzUtMy0xLTEtMA_ac131266-d317-4771-83c5-c6ce30f13cfa">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eea159e14624a668c6b1853597a984f_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzUtNS0xLTEtMA_ab2f95d1-7bc8-472b-8178-2e31d1ec2ed5">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e266465c9541e5884b034945a9b78f_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzYtMS0xLTEtMA_69a0a105-7ec7-4821-ba6c-679357241b54">9,694</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a7f1a1b2624255b5691acb8602e67d_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzYtMy0xLTEtMA_91a45a60-61b6-4ad8-a195-6f107bf820f7">10,654</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0820a199efab4817bdf4131117959b05_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzYtNS0xLTEtMA_947cbb1c-99b5-4680-9a95-a713bed3aabe">9,823</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b5cf3a4bec4cd88d7475be9f91daca_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzctMS0xLTEtMA_a6b41306-dc2e-47b9-b5ca-fb03d51a2662">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a2689337c343a29b2517e48e80f21f_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzctMy0xLTEtNzQ5_85745cfd-b7db-4aa3-b0eb-c2da22fb2cce">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e4ccc5194b647ebae6e86a553e04f39_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzgtMS0xLTEtMA_d9829390-60ca-4f01-9fd3-bd2161ee5e1c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3027462747254c22a27e928fc0e7507b_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzgtMy0xLTEtNzUy_93e0a764-037a-42da-820f-82c5d2b68fb8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9db1cbfd5784602a23dc09b4c7da6d8_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzktMS0xLTEtMA_ac74513c-8db3-4b94-b93c-0399a35ef664">219</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2775314c99b49018b5b755c1d609493_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzktMy0xLTEtNzU1_f2f54435-7930-4162-b039-7c06ec101a7c">81</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEwLTEtMS0xLTA_42011400-cdac-453c-b9f0-9e0a008124e5">9,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEwLTMtMS0xLTA_7c4b3119-625d-4b2c-8716-fa187174b8fd">10,735</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEwLTUtMS0xLTA_31188610-0539-40ab-8524-0a98431acf03">9,823</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fc3285e99ec41baad3226a8fbb980ee_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEyLTEtMS0xLTA_05786017-8190-4ed5-8fd7-714d6decf209">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37289b8d4ace48da862e203e9243e7ff_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEyLTMtMS0xLTA_63476991-2b78-477a-8f6e-f9980eb9b8ff">1,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fde0d89a66a4c76a36d9b5839bd1351_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEyLTUtMS0xLTA_d9d4d320-2c55-405c-a512-1491e90d0739">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ib52177d0f5be4c79bbe563a1dec4b49b">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the <ix:nonFraction unitRef="countries" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="0" name="bsx:EmergingMarketsTotalNumberOfCountries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzI3NDg3NzkwNzQ4OTc_2bb470fd-7685-4400-bdfe-ede9566cca26">20</ix:nonFraction> countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying consolidated balance sheets. Our deferred revenue balance was $<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzY3OQ_9919dadc-f36d-4d21-bcbe-52a3e91e89bf">395</ix:nonFraction> million as of December&#160;31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzY5NQ_cf3bc634-56d4-419c-8bc5-fe0a15671860">400</ix:nonFraction> million as of </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i71e611eab25d4a588c07b4912556544f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2019. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzk1Nw_a8c722eb-0f09-4c54-ba7a-b6ce5d3c7aaa">135</ix:nonFraction> million in 2020 that was included in the above December&#160;31, 2019 contract liability balance. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize sales force commissions related to contracts with customers when the associated revenue is expected to be earned over a period that exceeds one year. Deferred commissions are primarily related to the sale of devices enabled with our LATITUDE&#8482; Patient Management System. We have elected to expense commission costs when incurred for contracts with an expected duration of one year or less. Capitalized commission fees are amortized over the period the associated products or services are transferred. Similarly, we capitalize certain recoverable costs related to the delivery of the LATITUDE&#8482; Remote Monitoring Service. These fulfillment costs are amortized over the average service period. Our total capitalized contract costs are immaterial to our consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received FDA approval in mid-2020 and began the U.S. launch of our next generation WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#8482; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In 2020, we recorded $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzI3NDg3NzkwNzQwNjE_a26573f3-6e7a-4779-80d5-0390b1be456e">179</ix:nonFraction> million in revenue reserves primarily related to our conversion to a consignment commercial model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device in the U.S. In connection with the conversion, we repurchased customer-owned inventory and will recognize revenue for consigned units as they are consumed by customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our accounting policies relating to revenue recognition.</span></div></ix:continuation><div id="i5c3e8d69fcc1460baddde62cfa022487_148"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90ZXh0cmVnaW9uOmE4YTIwNjY5N2M3MjQ1NDBhMWNjNmQzYWExOGZiZDQ3XzI3NDg3NzkwNzExMjU_da576c3e-3d37-454d-901f-e6153c264386" continuedAt="i408d50653da24ada914a05007f8d0ceb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE Q &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90ZXh0cmVnaW9uOmE4YTIwNjY5N2M3MjQ1NDBhMWNjNmQzYWExOGZiZDQ3XzExMzM_8ed9ae17-e223-443f-8864-1728928d6606" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzEtMS0xLTEtMA_3d76a716-f547-4245-8a00-f5466f67ea24">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzEtMy0xLTEtMA_b62e79bf-4fac-4669-aaa9-8d097300988e">173</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzEtNy0xLTEtMA_97ff826c-1203-4340-98ab-983f3eb10f51">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzEtOS0xLTEtMA_7c88d6d3-7369-4c8b-b086-274ee92f4b87">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzItMS0xLTEtMA_e1668fd2-f938-4f5a-9581-2d75baf72806">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzItMy0xLTEtMA_9ea8b722-5e0c-4f21-9178-26598b2f0258">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzItNy0xLTEtMA_f98241fd-d042-4982-9c4a-ac0b364bea3e">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzItOS0xLTEtMA_ecbe7d75-1401-4289-87f4-bc721c6e495e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzMtMS0xLTEtMA_75e2b8af-5b81-4252-92f8-86e7604b0a05">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzMtMy0xLTEtMA_fa958f08-46ff-49ad-a67d-7c35cbab0848">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzMtNy0xLTEtMA_8b8c6223-4b4c-4ccc-8433-5db1ad37cf03">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzMtOS0xLTEtMA_93d299cc-4a0b-49d2-aeff-56595bbb8de4">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzQtMS0xLTEtMA_73143eea-9189-4b5a-a676-f83c8785d484">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzQtMy0xLTEtMA_37f825fe-1c9c-471d-b3dd-71472546ea24">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzQtNy0xLTEtMA_5ca32564-295f-40d6-b2c3-1d8a57558a5b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzQtOS0xLTEtMA_6469dfbc-97b3-4788-861f-37ac6c7e3422">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzUtMS0xLTEtMA_4be61140-ab49-4263-8b40-f47d0b0a7e8b">218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzUtMy0xLTEtMA_22669e3f-0530-48a3-8598-f87981c156ca">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzUtNy0xLTEtMA_2b8cc5c3-c53f-461f-9bbd-a14fa99a67d4">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzUtOS0xLTEtMA_7a51d0e5-e0f4-4378-bdc9-c4b15ea3cb47">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzEtMS0xLTEtMA_c12802ac-c5f0-4efc-94b6-dc4e766a1c6e">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzEtMy0xLTEtMA_efc2e8c0-7bc8-4c76-83ae-1eb19ce7f0e9">111</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzEtNy0xLTEtMA_33ebf835-036b-427f-b8a3-feff529c605a">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzEtOS0xLTEtMA_1b933157-301a-4f28-82e2-0b20b26d066c">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzItMS0xLTEtMA_bae4e84f-4d03-4b31-9f0d-78c76b4060b0">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzItMy0xLTEtMA_5d588fc2-2958-4451-8443-6a0ad30e36e0">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzItNy0xLTEtMA_8d305038-5281-4c21-bf86-4247e60b3677">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzItOS0xLTEtMA_c7791975-f8a5-4f61-a063-c8bc487dcac0">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzMtMS0xLTEtMA_cb7412a0-5f93-4348-ab93-0987cdece41e">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzMtMy0xLTEtMA_09861514-ed42-4578-be74-645a86e2068e">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzMtNy0xLTEtMA_cb75b559-ce39-4233-af17-8bad0db4a378">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzMtOS0xLTEtMA_c247a5a2-f315-4ecc-a45a-84758b560135">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzQtMS0xLTEtMA_6f572db0-a7fc-4932-abed-d3857266a752">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzQtMy0xLTEtMA_1cc44725-1ed0-4352-81d0-54aa0521f517">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzQtNy0xLTEtMA_fe429fae-ff8e-4520-ae85-54f55793d428">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzQtOS0xLTEtMA_9b5d487a-84a9-45fa-8542-92589aa45042">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzUtMS0xLTEtMA_6966e522-50ef-45fc-bce8-6c8171efcd92">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzUtMy0xLTEtMA_eca75e9d-286f-46a0-a48a-dd44496e814b">173</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzUtNy0xLTEtMA_996d1ab7-5956-4ec4-9e34-37d8c0093b9a">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzUtOS0xLTEtMA_ae3caa2b-cc7c-4da9-8907-25c72cbeda3d">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="i408d50653da24ada914a05007f8d0ceb" continuedAt="ib7ba252e9b3348569e671dd6f4b142d3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib7ba252e9b3348569e671dd6f4b142d3"> were reduced by immaterial income tax impacts in 2020 and in 2019.</ix:continuation> </span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_151"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:NewAccountingPronouncementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzMxNjI_0d98b92f-5969-4398-b5c3-404629366375" continuedAt="i6cfe6792fd674b1a84da1c9ad342700a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE R &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Standards Implemented Since December 31, 2019</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODk_90ee9a96-e47d-4528-84c3-9aa76a9ff78c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2016-13</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASC Update No. 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">account. The adoption had an immaterial impact on our financial position and results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODc_a1cdb237-1bf3-443d-a71f-6f85d723e67e" escape="true"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODg_7f94e7ba-a60f-41c4-8a59-e5e9d676f2c0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-15</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODY_c1b88f49-2818-4626-87a4-66326241b90e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-18</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASC Update No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODU_405c9862-551c-478e-9fb1-158859d4be01" continuedAt="i58e24ed5be6241a2b63fb2b133c671bc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6cfe6792fd674b1a84da1c9ad342700a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i58e24ed5be6241a2b63fb2b133c671bc">after December 15, 2020, for public business entities. We plan to adopt Update No. 2020-10 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODQ_fa2f21af-2b2f-432a-9d55-9dfec8ec241c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We plan to early adopt Update No. 2020-06 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="bsx:ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODM_b2a20c4b-b3b9-4fce-9f31-2d056babe190" continuedAt="i4f1c0edc2dce41798d58ee420d1a0a05" escape="true">ASC Update No. 2019-12 </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i4f1c0edc2dce41798d58ee420d1a0a05" continuedAt="i83dd6e219c0a4316b66cf53686c5059a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Simplifying the Accounting for Income Taxes</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i83dd6e219c0a4316b66cf53686c5059a">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods. We plan to adopt Update No. 2019-12 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements, issued or effective, during the period had, or is expected to have, a material impact on our consolidated financial statements.</span></div></ix:continuation><div id="i5c3e8d69fcc1460baddde62cfa022487_157"></div><div><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzOTA_8645fae6-59fc-495c-b456-026fb292d974" continuedAt="i21f762e2df7545169c7a4e8e40c99fc9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE S &#8211; EMPLOYEE RETIREMENT PLANS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Domestic Retirement Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our 2006 acquisition of Guidant, we assumed the Guidant Supplemental Retirement Plan, a frozen, non-qualified defined benefit plan for certain former officers and employees of Guidant. The Guidant Supplemental Retirement Plan was partially funded through a Rabbi Trust that contains segregated company assets within restricted cash used to pay the benefit obligations related to the plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain an Executive Retirement Plan, a defined benefit plan covering executive officers and division presidents. Participants may retire with benefits once retirement conditions have been satisfied. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.K. Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our acquisition of BTG, we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom (U.K.) employees (U.K. Plan). The U.K. Plan was closed to new entrants as of June 1, 2004. Prior to the acquisition close date of August&#160;19, 2019, the Trustees of the U.K. Plan executed buy-in arrangements (Buy-in Contracts), which effectively, as structured under the Buy-in Contracts, are intended to provide payments designed to equal all future designated contractual benefit payments to covered participants. The benefit obligation of the pension plan is not transferred to the insurers, and we remain responsible for paying pension benefits. We do not anticipate any additional material contributions or payments to the U.K. Plan or the insurer.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i21f762e2df7545169c7a4e8e40c99fc9" continuedAt="iecfcb10b91594168845a4c8b386f79d6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the final purchase price allocation of BTG, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzMyOTg1MzQ5MDQwNzg_9a93eed5-1501-4553-99da-0a4ea81e92d2" continuedAt="ib98669af9e1e41f58579ff3b02f6880e" escape="true">The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:</ix:nonNumeric></span></div><ix:continuation id="ib98669af9e1e41f58579ff3b02f6880e" continuedAt="i3238aa09d2784922879c14cb0779d0e9"><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rate of Compensation Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo3OWZkNjdiN2NjZmU0YjkyOTZhNjkzZTBiNTQ5MTRlMi90YWJsZXJhbmdlOjc5ZmQ2N2I3Y2NmZTRiOTI5NmE2OTNlMGI1NDkxNGUyXzEtMS0xLTEtMA_c60dd44c-68a1-4ac2-9ad6-604957e3375d">0.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c091552d1914709958aece5ac3ec298_D20190819-20190819" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo3OWZkNjdiN2NjZmU0YjkyOTZhNjkzZTBiNTQ5MTRlMi90YWJsZXJhbmdlOjc5ZmQ2N2I3Y2NmZTRiOTI5NmE2OTNlMGI1NDkxNGUyXzEtMy0xLTEtMA_d6a18ae0-233c-4574-9ef6-07d60a09955e">0.4</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo3OWZkNjdiN2NjZmU0YjkyOTZhNjkzZTBiNTQ5MTRlMi90YWJsZXJhbmdlOjc5ZmQ2N2I3Y2NmZTRiOTI5NmE2OTNlMGI1NDkxNGUyXzEtNS0xLTEtMA_a6e2ec02-504b-497b-932b-e3f9eb3bb6f2">3.4</ix:nonFraction>%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the measurement date of August&#160;19, 2019, the funded status was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:84.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTowZTVhNDljOGIxMGU0MTBjYjc5MTFkMWY3ZWM2ZDFhYy90YWJsZXJhbmdlOjBlNWE0OWM4YjEwZTQxMGNiNzkxMWQxZjdlYzZkMWFjXzEtMS0xLTEtMA_06dc348c-fa13-4ebb-9e99-c74cca027ec1">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTowZTVhNDljOGIxMGU0MTBjYjc5MTFkMWY3ZWM2ZDFhYy90YWJsZXJhbmdlOjBlNWE0OWM4YjEwZTQxMGNiNzkxMWQxZjdlYzZkMWFjXzItMS0xLTEtMA_8d4220af-c8a5-425d-88a2-18ec3bd4ac11">216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTowZTVhNDljOGIxMGU0MTBjYjc5MTFkMWY3ZWM2ZDFhYy90YWJsZXJhbmdlOjBlNWE0OWM4YjEwZTQxMGNiNzkxMWQxZjdlYzZkMWFjXzMtMS0xLTEtMA_d9d66612-1891-4322-8bcd-95a935482c74">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our acquisition of BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the U.K. Plan presented below are as of the December 31, 2020 and 2019 measurement dates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other International Retirement Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we maintain retirement plans covering certain international employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzY0MTM_35947042-c976-4efd-96a9-a171027985c5" continuedAt="i0afc02be421549a89d0685f143856052" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0afc02be421549a89d0685f143856052">.</ix:continuation> As of December 31, 2020 and 2019, the funded status of our plans were unfunded or underfunded in aggregate. <ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzY0MTQ_559df2db-f42a-4bab-a531-453a5e0f54a8" continuedAt="ib9bfb637144e43d28f98b7fdd2cc5868" escape="true">The outstanding obligation is as follows:</ix:nonNumeric></span></div><ix:continuation id="ib9bfb637144e43d28f98b7fdd2cc5868"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:44.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded<br/>PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abcf037f5374f05ba7fe5982239ea34_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzItMS0xLTEtMA_f7a3ca4a-4870-4e94-ab81-1ce6a3f495f0">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abcf037f5374f05ba7fe5982239ea34_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzItMy0xLTEtMA_e5c6f43d-89f9-433b-a336-b8b8f9637a32">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abcf037f5374f05ba7fe5982239ea34_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzItNS0xLTEtMA_8916e389-7df3-4411-84f4-c4c8131d4ed7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abcf037f5374f05ba7fe5982239ea34_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzItNy0xLTEtMA_764e7eb3-135e-42a3-ac1a-9f04c73a134d">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzQtMS0xLTEtMA_c2bb4011-6231-464f-9d7d-f095e6c42b98">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzQtMy0xLTEtMA_efa96aad-4c4c-46fa-84b7-212741e7f4ca">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzQtNS0xLTEtMA_018b70d8-2313-4692-b614-eb6d1f958918">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzQtNy0xLTEtMA_36036184-a370-41d7-a643-57c63d347d2c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id161c1507c9c4caf9953e4e59e994d83_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzUtMS0xLTEtMA_8bac2404-b071-4b59-8055-d3b6334e6db9">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id161c1507c9c4caf9953e4e59e994d83_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzUtMy0xLTEtMA_5eb432f6-f337-40b3-841a-8189f5913a9a">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id161c1507c9c4caf9953e4e59e994d83_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzUtNS0xLTEtMA_a9769493-c23b-4ff4-ad2d-d6daa4b35ea7">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id161c1507c9c4caf9953e4e59e994d83_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzUtNy0xLTEtMA_08732aec-edac-4095-b3cd-2cc806806791">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzYtMS0xLTEtMA_18a18c5b-0bae-41fb-bd5a-8b4f2bcf19ee">506</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzYtMy0xLTEtMA_317b95ee-8bcb-4722-a55a-0bd6f45d190a">532</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzYtNS0xLTEtMA_7ed1f0a2-204c-439c-8d9a-153d0fa4277b">355</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzYtNy0xLTEtMA_a545c634-cdab-4352-8c67-d6e52eea92a4">177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:44.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9302f589d2a941e4a602a1c2a2ab8233_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzItMS0xLTEtMA_503f6cf3-be83-416f-b2ef-4df29ac82587">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9302f589d2a941e4a602a1c2a2ab8233_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzItMy0xLTEtMA_7203dcf3-83cd-492b-9c8e-2810937d5e0e">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9302f589d2a941e4a602a1c2a2ab8233_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzItNS0xLTEtMA_ba2f2577-0f3d-4094-a6bc-67dd57862c11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9302f589d2a941e4a602a1c2a2ab8233_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzItNy0xLTEtMA_a3517034-84cc-4874-bc18-529202a21a2d">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtMS0xLTEtMzE0Nw_2978837b-fb89-4111-a8a4-3911d6092db1">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtMy0xLTEtMzE1MQ_12441159-acb4-43a9-adcf-1a71acf32335">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtNS0xLTEtMzE1NQ_59fa0588-f912-4eda-927b-c797f0ad8f0c">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtNy0xLTEtMzE1OQ_3e2ee3b0-ae15-405f-a218-7fb6e7230aec">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6efe660df47d2bdc670d53b98a6ba_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtMS0xLTEtMA_5119c36a-ff5e-4041-934d-a279094c9d43">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6efe660df47d2bdc670d53b98a6ba_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtMy0xLTEtMA_8d2296f1-74b1-4830-8887-a003967ca3f7">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6efe660df47d2bdc670d53b98a6ba_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtNS0xLTEtMA_ba4ef40d-d2f5-4c9b-abbd-3ef6d095b317">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6efe660df47d2bdc670d53b98a6ba_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtNy0xLTEtMA_0d5a6a23-f722-4f12-a16a-b12cf7a81b8e">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzQtMS0xLTEtMA_741e54eb-23db-459d-a4f2-4b9c5ddce7f6">466</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzQtMy0xLTEtMA_78af4cea-d385-4c53-8ea3-a098da0de91c">488</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzQtNS0xLTEtMA_4f85a799-70b6-480a-b259-63cd4b8f2e9c">332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzQtNy0xLTEtMA_6e47d6fe-1e70-441d-b5ba-a577674c7079">156</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iecfcb10b91594168845a4c8b386f79d6" continuedAt="id2ca129d48204126a005a6ba5592dfe3"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzY0MDc_c316e889-531c-4184-8685-64b08d3b3dc3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the PBO for our retirement plans is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzItMS0xLTEtMA_37c37948-e0e8-40d6-af97-9ea7335debb6">488</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzItMy0xLTEtMA_5525be7d-fb62-4585-8a9f-1bf92a194e1b">232</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzMtMS0xLTEtMA_b1c87c92-b705-4109-8c11-908ec536e751">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzMtMy0xLTEtMA_afe21780-f918-4268-b76e-04480b5c5ca1">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzQtMS0xLTEtMA_47993b14-03a6-4512-8c9d-de4f0e5c5028">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzQtMy0xLTEtMA_a632d374-2a66-4a43-8ce5-b8d3e6a73d4b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzUtMS0xLTEtMA_2a5749d9-19f1-4924-9a58-8d7876cd0284">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzUtMy0xLTEtMA_aa10b5d5-3462-4f77-ae4a-29e4d8744510">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzYtMS0xLTEtMA_3b2465dc-5f84-45d4-8f10-1e03cd311142">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzYtMy0xLTEtMA_fea2891d-bbc8-4a5c-aae4-c58815003652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments and assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzctMS0xLTEtMA_edfba701-a6c6-4738-9dac-9c76e0b1e4e7">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzctMy0xLTEtMA_e212f991-342d-45c3-929d-07211634822c">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:Pensionbenefitobligationbenefitspaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzgtMS0xLTEtMA_9d9c78ba-bd4e-4dcb-a692-fb605b35b583">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:Pensionbenefitobligationbenefitspaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzgtMy0xLTEtMA_4fdcd001-2f39-4cbf-bea1-43d3f5335c27">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzktMS0xLTEtMA_db38bf8e-c8e8-4833-81a8-671cd5de2b4f">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzktMy0xLTEtMA_a1160375-4873-4278-a1af-762336479a3e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending obligation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzEwLTEtMS0xLTA_a8eef396-1223-4508-9869-539a0fd9cfbe">532</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzEwLTMtMS0xLTA_6277525e-a14b-4d8f-a263-d24a74cca8a9">488</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i3238aa09d2784922879c14cb0779d0e9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2020 are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:45.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.083%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i468ac5844c254d30825e2c4ab7683ecc_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzItMS0xLTEtMA_4cacb271-5355-4869-a74e-dfee6cdf74e4">1.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i468ac5844c254d30825e2c4ab7683ecc_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzItOS0xLTEtMA_4fac934d-6b25-4600-8671-b53c7997674d">1.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib5a830b33ced43cbb812205e0f5ee769_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzMtMS0xLTEtMA_23bfefb4-babb-4001-997f-414ca47cfc12">0.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib5a830b33ced43cbb812205e0f5ee769_I20201231" decimals="3" name="bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzMtNS0xLTEtMA_11c176a4-5a92-4fa8-a1df-7c468b7097a4">0.10</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i20811b5cbd4444aa969fc5a82825adaf_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzQtMS0xLTEtMA_ef45e1b6-70be-4de1-85eb-50898f04d924">0.67</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i20811b5cbd4444aa969fc5a82825adaf_I20201231" decimals="4" name="bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzQtNS0xLTEtMA_0c0249af-a1a3-4ab5-9eed-ae6671ecb983">1.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i20811b5cbd4444aa969fc5a82825adaf_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzQtOS0xLTEtMA_31d4f542-263a-4139-a4e8-21e7a877e653">2.40</ix:nonFraction>%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2019 are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic11f0737ab4b4295aad087680e91578f_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzEtMS0xLTEtMA_8a71818b-73ce-434c-ba29-2e3315522cd6">2.94</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic11f0737ab4b4295aad087680e91578f_I20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzEtOS0xLTEtMA_52c899b9-7e86-4709-aef6-1c89d0edd5ec">1.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a90b04fd34e4f338907045e7245b889_I20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItMS0xLTEtMzE5Ng_65825c3e-1e2d-4d22-94b5-bc7da0992aa5">0.60</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a90b04fd34e4f338907045e7245b889_I20191231" decimals="3" name="bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItMy0xLTEtMzIwMA_9ed2927e-56f2-4184-a632-1691c157d6fc">0.60</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a90b04fd34e4f338907045e7245b889_I20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItNS0xLTEtMzIwNA_4282d8ca-c590-4d00-b756-1c0bacf6d604">3.00</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d72be05fbe64ee489d3b9d9a331d3d6_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItMS0xLTEtMA_4d1e9853-7936-4b45-aa7c-895acf3684aa">0.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d72be05fbe64ee489d3b9d9a331d3d6_I20191231" decimals="4" name="bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItNS0xLTEtMA_cc21d60f-f2e2-45da-9ab5-03d85a88a52c">2.05</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7d72be05fbe64ee489d3b9d9a331d3d6_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItOS0xLTEtMA_d90de9b3-a86b-4bf8-a4c0-07a8f5187702">2.65</ix:nonFraction>%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:continuation><div style="padding-left:36pt;text-indent:-13.5pt"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzY0MTE_a3a47ffa-a989-44e7-b514-e62248508f8a" continuedAt="i2ce5acd67877429a9e287d551d078851" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzItMS0xLTEtMA_0118841b-cd8f-42cd-9605-8dfcfa212100">332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzItMy0xLTEtMA_c5da4948-8d0d-421d-8411-5729a4674b13">107</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzMtMS0xLTEtMA_ee2de3f3-41e5-467d-8689-9072bae4b490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzMtMy0xLTEtMA_210f0fd0-3fcd-4463-88c7-ae31ef8f5e21">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzQtMS0xLTEtMA_14b624fd-64b0-43fb-9a8f-c3bc17800e57">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzQtMy0xLTEtMA_93623504-c8a7-42a5-b0f9-125e1e89b322">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzUtMS0xLTEtMA_ab7fad45-f5f4-4151-8488-43a5f9c83f3c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzUtMy0xLTEtMA_118d4420-247a-464f-9dfc-7fd7feea62d8">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzYtMS0xLTEtMA_4fd57131-9bd1-4629-bc1d-1e68b5e5f751">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzYtMy0xLTEtMA_230d91cf-b45c-4538-abc1-d4739357de29">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzctMS0xLTEtMA_03817858-10ca-4115-851f-76baab73c9c8">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" sign="-" name="bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzctMy0xLTEtMA_87f16dc0-e983-4af6-bb7b-3869b200bb6f">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzgtMS0xLTEtMA_e4c4837a-d329-4bc2-bf84-be371862db6c">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzgtMy0xLTEtMA_5d617172-dd51-4ea5-93f3-75a55efeb241">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzktMS0xLTEtMA_93620d4e-a960-4e4b-898d-7aa344330c16">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzktMy0xLTEtMA_e7c57e8d-34c3-4f3b-b11b-88aed60ec3f2">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzEwLTEtMS0xLTA_d9ba9f33-8eea-434d-a83d-5b520f76d9a7">355</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzEwLTMtMS0xLTA_bdd24a1f-738a-4f33-bea4-9e4b8b5c8b35">332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our defined benefit plans excluding our U.K. Plan, we base our discount rate on the rates of return available on high-quality bonds with maturities approximating the expected period over which benefits will be paid. The rate of compensation increase is based on historical and expected rate increases. We base our rate of expected return on plan assets on historical experience, our </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id2ca129d48204126a005a6ba5592dfe3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment guidelines and expectations for long-term rates of return. Our assets are invested in a variety of securities, primarily equity securities and government bonds. These securities are considered Level 1 and Level 2 investments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our U.K. Plan, we utilize the insurance buy-in methodology and base our discount rate on a yield curve reflective of the market pricing obtained in the most recent buy-in transaction, which occurred prior to the acquisition of BTG, and movements in market-observed buy-in pricing as of December&#160;31, 2020. We believe this is a reasonable proxy for an effective settlement rate of the buy-in assets. The discount rate is calculated as the single equivalent assumption that gives the same value of the liabilities as if the figures were calculated using the full yield curve. We assume that all pension increases will continue to be linked to the Retail Price Inflation (RPI), both before and after retirement, for all members, with the exception of post-88 Guaranteed Minimum Pensions (GMP), which will be based on Consumer Price Inflation (CPI). We base our rate of expected return on plan assets as equal to the discount rate used to value the buy-in assets. The U.K. Plan assets' investment policy is to invest in fully matching assets. This has been achieved through the purchase of two buy-in policies (Buy-in contracts), which provide payments designed to equal all future benefit payments due from the fund. As of December&#160;31, 2020, the Buy-in contracts represented 100% of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. As of December 31, 2019, the Buy-in contracts represented 99 percent of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzMyOTg1MzQ5MDQwNzE_62f620cb-9a70-4a94-8b89-dc32a701cf62" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2020: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476309e0b0a84d4088d447ff4ea0c043_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzMtMS0xLTEtMA_6ee52868-e92f-4192-86b6-f72c68b276ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8150f8dd78cd4380a0b054b41ac3d226_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzMtMy0xLTEtMA_f41bff23-240c-4b7b-b685-10b32d76aea4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98c9174caac457e90096de44db28035_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzMtNS0xLTEtMA_fb1a5b8c-db98-4552-81ab-ec9098b4373e">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i806afaf84c134ea09c7780052e42855b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzMtNy0xLTEtMA_6b1fb143-ea13-48d7-a10f-97f6d3821393">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d5d4f9059648dfbe129e24d2e5e76b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzUtMS0xLTEtMA_813d98f5-c1cf-43c3-93b7-5303f6f8dd77">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f43fb9793c542b6a313df6b768e9fd4_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzUtMy0xLTEtMA_09b8d284-95b8-4bf7-aadb-1c8ecd8f0eca">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7307f52ceeb4874b34c64b3b408a83d_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzUtNS0xLTEtMA_a566c786-df11-4345-9899-d852f5fb9423">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzUtNy0xLTEtMA_f2a76635-25e2-49de-937b-dd1a5fd258f4">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2019:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ca6f37d044456b8c5479fac92d63ad_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzMtMS0xLTEtODc1MQ_b2231c9c-d2d0-4edb-bcd4-7093d7dab79e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df988ad339147759cbbf0249f88b40d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzMtMy0xLTEtODc1MQ_205647f5-11e0-42ae-b99f-59571bc4643e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if469866c31ea46fd8b925ca78ec9465e_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzMtNS0xLTEtODc1MQ_cdaefbb1-22e6-4c88-9410-a87628016896">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80602948166348f69cd4d27b5dabf946_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzMtNy0xLTEtODc1MQ_7cef9348-682e-44ef-bded-c79953addcb4">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84d6571646ba45d1a7095a0b4e8e4915_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzQtMS0xLTEtODc1MQ_db2ab550-814a-459d-9882-e007bb2f89c1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3134c9b872744c01ab4bf5c21d4aad7a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzQtMy0xLTEtODc1MQ_a28a8f73-1613-4289-8904-be7be4d1bc60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dd96fb2f5114cd4a6958cc13c50db13_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzQtNS0xLTEtODc1MQ_83f3ff6a-7a8e-4791-86ea-ad4197051da1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c25a08438574b52a9f59623d149abc5_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzQtNy0xLTEtODc1MQ_ac3dc40a-e753-48f4-be3a-ca5f94a78d8f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05f8aa1e800416d9668e75d159576ed_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzUtMS0xLTEtODc1MQ_fc5118e5-d9f2-4d8c-adea-d4968d445444">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36697475b27449e8bf5b48595d9608d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzUtMy0xLTEtODc1MQ_96bcfcf4-b06b-4ed9-8e66-6668e3fbeeeb">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f02b4becdb447a6a98b17845a2f0831_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzUtNS0xLTEtODc1MQ_744d316c-96a9-4a79-a7a1-235a40b2e0e4">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzUtNy0xLTEtODc1MQ_aa741f7b-8324-4506-9ec0-a56566dbd73e">209</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2ce5acd67877429a9e287d551d078851"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the U.K. Plan Level 3 assets were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Buy-in Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzgtMS0xLTEtMA_3aee6df9-280a-4a3d-a6c6-1e01de149e33">209</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzktMS0xLTEtMA_4dc332fe-f022-461d-84ae-2671f1fc5849">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzMtMS0xLTEtMjM3NjM_fc18adb7-9763-4619-a7d3-1305f7317851">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out for benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzExLTEtMS0xLTA_dc87b74b-a2dc-423c-a76f-0d2cc12dcfc5">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzEyLTEtMS0xLTA_1fbc2991-9807-48b6-92d2-c9f65f789319">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzEzLTEtMS0xLTA_426f5f54-774a-4b30-a7cc-1222f03986b5">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzODM_bfaa60f2-ab73-4367-ad5f-423c3bdaa087" escape="true">We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ExpenseRelatedToMatchingContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzNDk_4236c7d0-920a-4607-aee3-829d99c82bf8">102</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ExpenseRelatedToMatchingContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzNTk_73f1555b-6362-482b-8eac-1a72ad95e9bc">98</ix:nonFraction> million in 2019 and $<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="bsx:ExpenseRelatedToMatchingContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzNzI_02d97b98-40fa-4291-8c22-e40491dfb830">87</ix:nonFraction> million in 2018.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY RESULTS OF OPERATIONS </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mar 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sept 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dec 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net&#160;income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) available to common stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share - assuming dilution</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,930&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net&#160;income (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,996&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share - assuming dilution</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported results for 2020 included amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits), investment portfolio net losses (gains), EU MDR implementation costs, deferred tax expenses (benefits) and discrete tax items (after tax) of: $380 million in charges in the first quarter, $273 million in charges in the second quarter, $698 million in charges in the third quarter and $141 million of charges in the fourth quarter. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported results for 2019 included amortization expense, intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), investment portfolio net losses (gains), EU MDR implementation costs, certain debt extinguishment net charges (credits), deferred tax expenses (benefits) and discrete tax items (after tax) of: $66 million in charges in the first quarter, $396 million in charges in the second quarter, $424 million in charges in the third quarter and $3.353 billion of credits in the fourth quarter. These after-tax net credits consisted primarily of: deferred tax benefits of $4.102 billion arising from an intra-entity asset transfer of intellectual property.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_166"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer (CEO) and Executive Vice President and Chief Financial Officer (CFO), evaluated the effectiveness of our disclosure controls and procedures as of December&#160;31, 2020 pursuant to Rule&#160;13a-15(b) of the Securities Exchange Act of 1934, as amended. Disclosure controls and procedures are designed to ensure that material information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and ensure that such material information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Based on their evaluation, our CEO and CFO concluded that as of December&#160;31, 2020, our disclosure controls and procedures were effective.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s annual report on our internal control over financial reporting is contained in Item&#160;7 of this Annual Report.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The report of Ernst &amp; Young LLP on our internal control over financial reporting is contained in Item&#160;7 of this Annual Report.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended December&#160;31, 2020, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Further, while many of our employees worked remotely to adhere to COVID-19 social distancing requirements, this did not affect our ability to maintain financial reporting systems, internal controls over financial reporting or disclosure controls and procedures. Prior to the COVID-19 pandemic, we were leveraging electronic tools to facilitate our global close process and to connect our physically dispersed team of finance professionals in offices around the world. While the quarterly close cycle was performed remotely, fundamentally, the work performed, and the processes and controls executed did not change. </span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_169"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_175"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2020 and is incorporated into this Annual Report by reference.</span></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_178"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2020 and is incorporated into this Annual Report by reference.</span></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_181"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2020 and is incorporated into this Annual Report by reference.</span></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_184"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2020 and is incorporated into this Annual Report by reference.</span></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_187"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is set forth in our Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the SEC within 120&#160;days of December&#160;31, 2020 and is incorporated into this Annual Report by reference.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_193"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1) Financial Statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this portion of Item&#160;15 is set forth under Item&#160;8.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2) Financial Statement Schedules.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The response to this portion of Item&#160;15 (Schedule&#160;II) follows the signature page to this report. All other financial statement schedules are not required under the related instructions or are inapplicable and therefore have been omitted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(3) Exhibits (* documents filed or furnished with this report, ** certain schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K.&#160;We agree to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request, # compensatory plans or arrangements)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT<br/>NO.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TITLE</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000012/exhibit21-amsagreement.htm">Purchase Agreement among American Medical Systems Holdings, Inc., Endo Health Solutions Inc. and the Company, dated as of March 2, 2015 (incorporated by reference to Exhibit 2.1, Quarterly Report on Form 10-Q for the quarter ended March 30, 2015, File No. 1-11083).**</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308000584/exhibit3-2_15759.txt">Third Restated Certificate of Incorporation (incorporated herein by reference to Exhibit&#160;3.2, Annual Report on Form&#160;10-K for the year ended December&#160;31, 2007, File No.&#160;1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465919029732/a19-9977_1ex3d1.htm">Amended and Restated By-Laws of the Company (incorporated herein by reference to Exhibit 3.1, Current Report on Form 8-K dated May 15, 2019, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000519/ss174270_ex0301.htm">Certificate of Designations of the 5.50% Mandatory Convertible Preferred Stock, Series A, filed with the Secretary of State of the State of Delaware on May 26, 2020 (incorporated herein by reference to Exhibit 3.1, Current Report on Form 8-K dated May 27, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen Certificate for shares of the Company's Common Stock (incorporated herein by reference to Exhibit&#160;4.1, Registration No. 33-46980).</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit42-descriptionofthe.htm">Description of the Registrant&#8217;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095013504003276/b509658kexv4w1.txt">Indenture dated as of June&#160;25, 2004, between the Company and JPMorgan Chase Bank, as Trustee (incorporated herein by reference to Exhibit&#160;4.1, Current Report on Form&#160;8-K dated June&#160;25, 2004, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002201/exh4-1_13106.txt">Indenture dated as of November&#160;18, 2004, between the Company and J.P. Morgan Trust Company, National Association, as Trustee (incorporated herein by reference to Exhibit&#160;4.1, Current Report on Form&#160;8-K dated November&#160;18, 2004, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465906027974/a06-8189_4ex99d4.htm">First Supplemental Indenture dated as of April&#160;21, 2006 (incorporated herein by reference to Exhibit&#160;99.4, Current Report on Form 8-K dated April&#160;21, 2006, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465906027974/a06-8189_4ex99d6.htm">Second Supplemental Indenture dated as of April&#160;21, 2006 (incorporated herein by reference to Exhibit&#160;99.6, Current Report on Form&#160;8-K dated April&#160;21, 2006, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305002690/exh4-2_13988.htm">Form of Global Security for the 6.25% Notes due 2035 in the aggregate principal amount of $350,000,000, and form of Notice to holders thereof (incorporated herein by reference to Exhibit&#160;4.2, Current Report on Form&#160;8-K dated November&#160;17, 2005 and Exhibit&#160;99.7, Current Report on Form&#160;8-K dated April&#160;21, 2006, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095013506003879/b61236bsexv4w1.txt">Indenture dated as of June&#160;1, 2006, between the Company and JPMorgan Chase Bank, N.A., as Trustee (incorporated herein by reference to Exhibit&#160;4.1, Current Report on Form&#160;8-K dated June&#160;9, 2006, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095012309070623/b78468exv4w4.htm">7.375% Senior Note due January&#160;15, 2040 in the aggregate principal amount of $300,000,000 (incorporated herein by reference to Exhibit 4.4, Current Report on Form&#160;8-K dated December&#160;10, 2009, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913063328/a13-18170_1ex4d3.htm">4.125% Senior Note Due October 1, 2023 in the aggregate principle amount of $450,000,000 (incorporated herein by reference to Exhibit 4.3, Current Report on Form&#160;8-K dated August 8, 2013, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915037235/a15-11340_1ex4d3.htm">3.375% Senior Notes due 2022 (incorporated herein by reference to Exhibit 4.3, Current Report on Form 8-K dated May 12, 2015, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915037235/a15-11340_1ex4d4.htm">3.850% Senior Notes due 2025 (incorporated herein by reference to Exhibit 4.4, Current Report on Form 8-K dated May 12, 2015, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746913006559/a2215392zex-4_1.htm">Indenture dated as of May 29, 2013, between the Company and U.S. Bank Association, as Trustee (incorporated herein by reference to Exhibit 4.1, Registration Statement on Form S-3 (File No 333-188918) filed on May 29, 2013).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000015/exhibit42-xxxnotesdue2028.htm">4.000% Senior Notes Due 2028 (incorporated herein by reference to Exhibit 4.2, Current Report on Form 8-K dated February 26, 2018, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit42-3450notesdue2024.htm">3.450% Senior Note due 2024 (incorporated herein by reference to exhibit 4.2, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit43-3750notesdue2026.htm">3.750% Senior Note due 2026 (incorporated herein by reference to exhibit 4.3, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit44-4000notesdue2029.htm">4.000% Senior Note due 2029 (incorporated herein by reference to exhibit 4.4, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit45-4550notesdue2039.htm">4.550% Senior Note due 2039 (incorporated herein by reference to exhibit 4.5, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exhibit46-4700notesdue2049.htm">4.700% Senior Note Due 2049 (incorporated herein by reference to Exhibit 4.6, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787119000804/ss156905_ex0402.htm">Form of 0.625% Senior Note Due 2027 (incorporated herein by reference to Exhibit 4.2, Current Report on Form 8-K dated November 6, 2019, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000487/ss173781_ex0402.htm">Form of 1.900% Senior Note due 2025 (incorporated herein by reference to Exhibit 4.2, Current Report on Form 8-K dated May 14, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000487/ss173781_ex0403.htm">Form of 2.650% Senior Note due 2030 (incorporated herein by reference to Exhibit 4.3, Current Report on Form 8-K dated May 14, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000519/ss174270_ex0301.htm">Specimen Certificate of the Mandatory Convertible Preferred Stock (incorporated herein by reference to Exhibit 4.1, Current Report on Form 8-K dated May 27, 2020, File No. 1-11083).</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261307000570/exh10-2_14949.htm">Form of Omnibus Amendment dated as of December&#160;21, 2006, among the Company, Boston Scientific Funding Corporation, Variable Funding Capital Company LLC, Victory Receivables Corporation and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch (Amendment No.&#160;1 to Receivables Sale Agreement and Amendment No.&#160;9 to Credit and Security Agreement) (incorporated herein by reference to Exhibit&#160;10.2, Annual Report on 10-K for the year ended December&#160;31, 2006, File No.&#160;1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261307002697/exhibit10-2_15574.txt">Form of Amended and Restated Receivables Sale Agreement dated as of November&#160;7, 2007 between the Company and each of its Direct or Indirect Wholly-Owned Subsidiaries that Hereafter Becomes a Seller Hereunder, as the Sellers, and Boston Scientific Funding LLC, as the Buyer (incorporated herein by reference to Exhibit&#160;10.2, Current Report on Form&#160;8-K dated November&#160;7, 2007, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000014/creditagreement.htm">Credit Agreement dated as of April 18, 2012, by and among the Company, the several lenders parties thereto, and Bank of America, N.A., as Syndication Agent, and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 18, 2012, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915027462/a15-9108_1ex10d1.htm">Credit Agreement dated as of April 10, 2015, by and among Boston Scientific Corporation, the several lenders parties thereto, Bank of America, N.A., as Syndication Agent and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 14, 2015, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000028/ex105_bscfirstamendmenttor.htm">First Amendment, dated as of October 23, 2015, to the Credit Agreement, dated as of April 10, 2015, among Boston Scientific Corporation, the several lenders party thereto, Bank of America, N.A., as Syndication Agent, and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.5, Annual Report on Form 10-K for the year ended December 31, 2015, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095013503002096/b45658bsexv10w6.txt">License Agreement among Angiotech Pharmaceuticals, Inc., Cook Incorporated and the Company dated July 9, 1997, and related Agreement dated December&#160;13, 1999 (incorporated herein by reference to Exhibit&#160;10.6, Annual Report on Form&#160;10-K for the year ended December&#160;31, 2002, File No.&#160;1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002236/exh10-1_13122.txt">Amendment between Angiotech Pharmaceuticals, Inc. and the Company dated November&#160;23, 2004 modifying July&#160;9, 1997 License Agreement among Angiotech Pharmaceuticals, Inc., Cook Incorporated and the Company (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated November&#160;23, 2004, File No.&#160;1-11083).</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Agreement, dated as of January&#160;8, 2006, as amended, between the Company and Abbott Laboratories (incorporated herein by reference to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746906002665/a2167817zex-10_47.htm">Exhibit&#160;10.47</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746906002665/a2167817zex-10_48.htm">Exhibit&#160;10.48</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746906002665/a2167817zex-10_49.htm">Exhibit&#160;10.49</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000104746906002665/a2167817zex-10_50.htm">Exhibit&#160;10.50</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Annual Report on Form&#160;10-K for year ended December&#160;31, 2005 and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465906023741/a06-8189_2ex10d1.htm">Exhibit&#160;10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated April&#160;7, 2006, File No.&#160;1-11083).</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000012/exhibit101-jjagreement.htm">Settlement Agreement among Johnson &amp; Johnson, Guidant LLC and the Company, dated as of February 13, 2015 (incorporated by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 30, 2015, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002318/exh10-5_13134.txt">Form of Non-Qualified Stock Option Agreement (Non-Employee Directors) (incorporated herein by reference to Exhibit&#160;10.5, Current Report on Form&#160;8-K dated December&#160;10, 2004, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002318/exh10-6_13134.txt">Form of Restricted Stock Award Agreement (Non-Employee Directors) (incorporated herein by reference to Exhibit&#160;10.6, Current Report on Form&#160;8-K dated December&#160;10, 2004, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000029/exhibit101-q2201210xq.htm">Form of Restricted Stock Award Agreement (Non-Employee Directors) under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit&#160;10.1, Quarterly Report on Form&#160;10-Q for the quarter ended June 30, 2012, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Boston Scientific Corporation Excess Benefit Plan, as amended (incorporated herein by reference to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305001649/form8-k_13649.htm">Exhibit&#160;10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated June&#160;29, 2005 and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308002226/exhibit10-4_16230.htm">Exhibit&#160;10.4</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated December&#160;16, 2008, File No.&#160;1-11083).#</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305001649/exhibit10-2_13649.htm">Form of Trust under the Boston Scientific Corporation Excess Benefit Plan (incorporated herein by reference to Exhibit&#160;10.2, Current Report on Form&#160;8-K dated June&#160;29, 2005, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261310000567/exh10-1_16834.htm">Boston Scientific Corporation Deferred Bonus Plan (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated May 11, 2010, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095012311015112/b83548exv10w39.htm">Boston Scientific Corporation 401(k) Retirement Savings Plan, Amended and Restated, effective as of January&#160;1, 2011 (incorporated herein by reference to Exhibit 10.39, Annual Report on Form&#160;10-K for year ended December&#160;31, 2010, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1044-401k.htm">Amendment to Boston Scientific Corporation 401(k) Retirement Savings Plan, Amended and Restated, effective as of January&#160;1, 2011 (incorporated herein by reference to Exhibit 10.44, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000029/exhibit102-q2201210xq.htm">Form of Second Amendment of Boston Scientific Corporation 401(k) Retirement Savings Plan, Amended and Restated (incorporated herein by reference to Exhibit&#160;10.2, Quarterly Report on Form&#160;10-Q for the quarter ended June 30, 2012, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000043/exhibit101-q3201210xq.htm">Form of Third Amendment of the Boston Scientific Corporation 401(k) Retirement Savings Plan, Amended and Restated (incorporated herein by reference to Exhibit&#160;10.1, Quarterly Report on Form&#160;10-Q for the quarter ended September 30, 2012, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston Scientific Corporation 2000 Long-Term Incentive Plan, as amended (incorporated herein by reference to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095013500001894/0000950135-00-001894.txt">Exhibit&#160;10.20</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Annual Report on Form&#160;10-K for the year ended December&#160;31, 1999, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000091205702011989/a2074671zex-10_18.txt%20">Exhibit&#160;10.18</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Annual Report on Form&#160;10-K for the year ended December&#160;31, 2001, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002392/exh10-1_13161.txt">Exhibit&#160;10.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated December&#160;22, 2004, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305001188/exh10-3_13524.htm">Exhibit&#160;10.3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form&#160;8-K dated May&#160;9, 2005, and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308002226/exhibit10-3_16230.htm">Exhibit&#160;10.3</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, Current Report on Form 8-K dated December&#160;16, 2008, File No.&#160;1-11083).#</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308001138/exh10-1_15891.htm">Boston Scientific Corporation 2003 Long-Term Incentive Plan, as Amended and Restated, Effective June 1, 2008 (incorporated herein by reference to Exhibit&#160;10.1, Quarterly Report on Form&#160;10-Q for the quarter ended March&#160;31, 2008, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1049-ltip.htm">Boston Scientific Corporation 2011 Long-Term Incentive Plan, as amended (incorporated herein by reference to Exhibit 10.49, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002318/exh10-1_13134.txt">Form of Non-Qualified Stock Option Agreement (vesting over three years) (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated December&#160;10, 2004, File No.&#160;1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261304002318/exh10-2_13134.txt">Form of Non-Qualified Stock Option Agreement (vesting over four years) (incorporated herein by reference to Exhibit&#160;10.2, Current Report on Form&#160;8-K dated December&#160;10, 2004, File No.&#160;1-11083).#</a></span></div><div><span><br/></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308000584/exhibit10-20_15759.txt">Form of Non-Qualified Stock Option Agreement (vesting over two years) (incorporated herein by reference to Exhibit&#160;10.20, Annual Report on Form&#160;10-K for the year ended December&#160;31, 2007, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261305001671/exhibit10-1_13660.htm">Form of Non-Qualified Stock Option Agreement dated July&#160;1, 2005 (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form 8-K dated July&#160;1, 2005, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000095012310101570/b82677exv10w6.htm">Form of Stock Option Agreement (with one year service requirement for vesting upon Retirement) (incorporated herein by reference to Exhibit&#160;10.6, Quarterly Report on Form&#160;10-Q dated September&#160;30, 2010, File No.&#160;1-11083).#</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572511000042/exhibit104rsa.htm">Form of Restricted Stock Award Agreement (Non-Employee Directors) under the 2003 and 2011 Long-Term Incentive Plans (incorporated herein by reference to Exhibit&#160;10.4, Quarterly Report on Form&#160;10-Q for the quarter ended June 30, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572511000042/exhibit105nq.htm">Form of Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit&#160;10.5, Quarterly Report on Form&#160;10-Q for the quarter ended June 30, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1070-formoftsrpsuag.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.70, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1071-formoffcfpsuag.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.71, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit1072-execallowanced.htm">Form of Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (Special) (incorporated herein by reference to Exhibit 10.72, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000129993309005008/exhibit3.htm">Form of Change in Control Agreement between the Company and certain Executive Officers (incorporated herein by reference to Exhibit&#160;10.3, Current Report on Form&#160;8-K dated December&#160;15, 2009, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572511000046/exhibit101_michaelmahoneyo.htm">Form of Offer Letter dated September 6, 2011 between the Company and Michael F. Mahoney, as supplemented September 13, 2011 (incorporated herein by reference to Exhibit 10.1, Current Report on Form&#160;8-K dated September 19, 2011, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572512000006/exhibit10100-mahoneyofferl.htm">Form of Amendment, dated February 14, 2012, to Offer Letter dated September 6, 2011 between the Company and Michael F. Mahoney, as supplemented September 13, 2011 (incorporated herein by reference to Exhibit 10.100, Annual Report on Form 10-K for the year ended December 31, 2011, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000012/exhibit102-offerletterfitz.htm">Form of Offer Letter by and between the Company and Joseph M. Fitzgerald dated February 27, 2014 (incorporated by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 30, 2015, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000012/exhibit103-offerletterball.htm">Form of Offer Letter by and between the Company and Kevin J. Ballinger dated December 14, 2012 (incorporated by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 30, 2015, File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261302001397/exhibit4-1_11477.txt">The Boston Scientific Deferred Compensation Option Program (incorporated herein by reference to Exhibit 4.1, Registration No. 333-98755).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000007/exhibit10118domesticreloca.htm">Boston Scientific Corporation Domestic Relocation Policy Tier 5 Executive Officer Homeowner, effective January 2007 (incorporated herein by reference to Exhibit&#160;10.118, Annual Report on Form&#160;10-K for the year ended December 31, 2012, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913017992/a13-6792_1ex10d1.htm">Form of Letter to Key Management Personnel re: Change in Control Agreement (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated February 28, 2013, File No. 1-11083).</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913077459/a13-22722_1ex10d2.htm">Form of Offer Letter by and between the Company and Daniel J. Brennan, dated October 22, 2013 (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K dated October 24, 2013 File No. 1-11083). #</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913078031/a13-22722_2ex10d2.htm">Boston Scientific Corporation Total Shareholder Return Performance Share Program, Performance Period January 1, 2014 - December 31, 2016 (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K dated October 22, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465913078031/a13-22722_2ex10d3.htm">Boston Scientific Corporation Free Cash Flow Performance Share Program, Performance Period January 1, 2014 - December 31, 2014 (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K dated October 22, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000037/exhibit103-formofdeferreds.htm">Form of 2011 Long-Term Incentive Plan Global Deferred Stock Unit Award Agreement (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000037/exhibit104-formofnonxquali.htm">Form of 2011 Long-Term Incentive Plan Global Non-Qualified Stock Option Agreement (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000037/exhibit106-usseveranceplan.htm">Boston Scientific Corporation U.S. Severance Plan for Exempt Employees, as amended and restated, effective August 1, 2013 (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 File No. 1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000107261308001968/exhibit10-1_16156.htm">Boston Scientific Corporation Non-Employee Director Deferred Compensation Plan, as amended and restated, effective January&#160;1, 2009 (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated October&#160;28, 2008, File No.&#160;1-11083).#</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572513000045/exhibit106-bscnonxemployee.htm">Boston Scientific Corporation Non-Employee Director Deferred Compensation Plan, as amended and restated, effective January 1, 2014 (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000005/exhibit1099-tsrpsuagreement.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (2014 Total Shareholder Return) incorporated herein by reference to Exhibit 10.99, Annual Report on Form 10-K for the year ended December 31, 2013 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000005/exhibit10100fcfpsuagreement.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (2014 Free Cash Flow) incorporated herein by reference to Exhibit 10.100, Annual Report on Form 10-K for the year ended December 31, 2013 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000022/exhibit101-globalemployees.htm">Boston Scientific Corporation 2006 Global Employee Stock Ownership Plan, as amended and restated, effective July 1, 2014 (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465914075249/a14-23099_1ex10d1.htm">Boston Scientific Corporation 2015 Annual Bonus Plan, effective as of January&#160;1, 2015 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated October 28, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465914075249/a14-23099_1ex10d2.htm">Boston Scientific Corporation 2015 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K dated October 28, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465914075249/a14-23099_1ex10d3.htm">Boston Scientific Corporation 2015 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K dated October 28, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465916135014/a16-15337_1ex10d1.htm">Boston Scientific Corporation Executive Retirement Plan, as amended and restated effective August 1, 2016 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated July 25, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit101-formofnonxquali.htm">Form of Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (Non-Employee Directors) (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit102-formofrestricte.htm">Form of Restricted Stock Award Agreement under the 2011 Long-Term Incentive Plan (Non-Employee Directors) (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.58</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit103-formofdeferreds.htm">Form of Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (Non-Employee Directors) (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.59</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit104-formofperforman.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit105-formofperforman.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.61</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572514000030/exhibit106-firstamendmentt.htm">First Amendment to Boston Scientific Corporation Deferred Bonus Plan, effective January 1, 2015 (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915069104/a15-20070_1ex10d1.htm">Boston Scientific Corporation 2016 Annual Bonus Plan, effective as of January 1, 2016 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed October 5, 2015, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915069104/a15-20070_1ex10d2.htm">Boston Scientific Corporation 2016 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed October 5, 2015, File No. 001-11083)#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.64</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465915069104/a15-20070_1ex10d3.htm">Boston Scientific Corporation 2016 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed October 5, 2015, File No. 001-11083)#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.65</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000024/ex104-2016tsrformofawardag.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.66</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572515000024/ex105-2016fcfformofawardag.htm">Form of Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.67</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit101-emackeyofferlet.htm">Form of Offer Letter by and between the Company and Edward Mackey dated December 24, 2014 (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.68</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit102-formofnqsoagree.htm">Form of Global Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.69</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit103-formofdsuagreem.htm">Form of Global Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.70</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit104-2016_psuxtsr.htm">Form of 2016 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.71</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572516000035/exhibit105-2016_psuxfcf.htm">Form of 2016 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.72</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465916158618/a16-22008_1ex10d1.htm">Boston Scientific Corporation 2017 Annual Bonus Plan, effective as of January&#160;1, 2017 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 22, 2016, File No. 001-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.73</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465916158618/a16-22008_1ex10d2.htm">Boston Scientific Corporation 2017 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 22, 2016, File No. 001-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.74</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465916158618/a16-22008_1ex10d3.htm">Boston Scientific Corporation 2017 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 22, 2016, File No. 001-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.75</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787117000618/ss54238_ex1001.htm">Credit Agreement dated as of August 4, 2017 by and among Boston Scientific Corporation, the several lenders party thereto, Bank of America, N.A. and Wells Fargo Bank, National Association, as Syndication Agents and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed on August 7, 2017, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.76</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000040/a101-2018annualbonusplan.htm">Boston Scientific Corporation 2018 Annual Bonus Plan, effective as of January&#160;1, 2018 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 17, 2017, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.77</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000040/a102-2018tsrpsp.htm">Boston Scientific Corporation 2018 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 17, 2017 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.78</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000040/a103-2018fcfpsp.htm">Boston Scientific Corporation 2018 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 17, 2017, File No. 001-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.79</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000019/exhibit101-formofnqsoagree.htm">Form of Global Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.80</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000019/exhibit102-formofdsuagreem.htm">Form of Global Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.81</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000019/exhibit103-2017_tsrpsuxawa.htm">Form of 2017 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.82</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572517000019/exhibit104-2017_fcfpsuxawa.htm">Form of 2017 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.83</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787117000108/ss29948_ex1001.htm">Second Amended and Restated Credit and Security Agreement, dated as of February 7, 2017, by and among Boston Scientific Funding LLC, Boston Scientific Corporation, Wells Fargo Bank, National Association and Sumitomo Mitsui Banking Corporation, New York Branch, as Lenders, Wells Fargo Bank, National Association and SMBC Nikko Securities America, Inc., as Co-Agents, and Wells Fargo Bank, National Association, as Administrative Agent (incorporated herein by reference to Exhibit&#160;10.1, Current Report on Form&#160;8-K dated February 10, 2017, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.84</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787117000108/ss29948_ex1002.htm">Second Amended and Restated Receivables Sale Agreement, dated as of February 7, 2017, by and among Boston Scientific Corporation, each of its direct or indirect wholly-owned subsidiaries that become a seller thereunder and Boston Scientific Funding LLC (incorporated herein by reference to Exhibit&#160;10.2, Current Report on Form&#160;8-K dated February 10, 2017, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.85</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit101-formofnqsoagree.htm">Form of Global Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.86</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit102-formofdsuagreem.htm">Form of Global Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.87</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit103-2018_tsrpsuxawa.htm">Form of 2018 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.88</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit104-2018_fcfpsuxawa.htm">Form of 2018 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.89</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit105-acquisitionxrel.htm">Form of Acquisition-Related Non-Qualified Stock Option Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083). # </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.90</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit106-acquisitionxrel.htm">Form of Acquisition-Related Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.91</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit107-2018_rsaxawardx.htm">Form of Restricted Stock Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan incorporated herein by reference to Exhibit 10.7, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.92</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit108-2018_dsuxawardx.htm">Form of Deferred Stock Unit Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan incorporated herein by reference to Exhibit 10.8, Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.93</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000021/exhibit109-2018_nqsoxaward.htm">Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan# (incorporated herein by reference to Exhibit 10.9, Current Report on Form 10-Q quarter ended March 31, 2018, File No. 1-11083). #</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.94</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069204/a18-40434_1ex10d1.htm">Boston Scientific Corporation 2019 Annual Bonus Plan, effective as of January&#160;1, 2019 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 19, 2018, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.95</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069204/a18-40434_1ex10d2.htm">Boston Scientific Corporation 2019 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 19, 2018 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.96</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069204/a18-40434_1ex10d3.htm">Boston Scientific Corporation 2019 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 19, 2018, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.97</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572518000036/exhibit101-2018creditagree.htm">Credit Agreement dated as of August 20, 2018, by and among Boston Scientific Corporation, the several lenders parties thereto, Bank of America, N.A., MUFG Bank, LTD., and Sumitomo Mitsui Banking Corporation, as Syndication Agents, and Wells Fargo Bank, N.A., as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed August 21, 2018, File No. 1-11083.) </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.98</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex2d1.htm">BTG plc Acquisition Rule&#160;2.7 Announcement, dated November&#160;20, 2018. (incorporated herein by reference to Exhibit 2.1, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex2d2.htm">BTG plc Cooperation Agreement, dated November&#160;20, 2018. (incorporated herein by reference to Exhibit 2.2, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.100</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d1.htm">BTG plc Shareholder Undertaking of Invesco Asset Management Limited, dated November 20, 2018 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d2.htm">BTG plc Shareholder Undertaking of Novo Holdings A/S, dated November 20, 2018 (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.102</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d3.htm">BTG plc Shareholder Undertaking of Woodford Asset Management Limited, dated November 20, 2018 (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.103</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d4.htm">BTG plc Form of Director Undertaking (incorporated herein by reference to Exhibit 10.4, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_1ex10d5.htm">Bridge Credit Agreement, dated as of November&#160;20, 2018 by and among Boston Scientific Corporation, the lenders party thereto and Barclays Bank PLC, as administrative agent, bookrunner and lead arranger (incorporated herein by reference to Exhibit 10.5, Current Report on Form 8-K filed November 23, 2018, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.105</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787118000985/ss119647_ex1001.htm">Credit Agreement, dated as of December 19, 2018, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent and Bank of America, N.A. as syndication agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated December 21, 2018, File No. 1-11083)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.106</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787118000985/ss119647_ex1002.htm">First Amendment to Credit Agreement, dated as of December 19, 2018, among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K dated December 21, 2018, File No. 1-11083)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.107</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787118000985/ss119647_ex1003.htm">Term Loan Credit Agreement, dated as of December 19, 2018, among Boston Scientific Corporation, the lenders party thereto and Barclays Bank PLC, as administrative agent, Bank of America, N.A., Wells Fargo Bank, National Association and JPMorgan Chase Bank, N.A., as syndication agents (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K dated December 21, 2018, File No. 1-11083)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.108</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit101-formofnqsoagree.htm">Form of Non-Qualified Stock Option Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.1, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.109</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit102-formofdsuagreem.htm">Form of Global Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.2, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.110</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit103-2019_tsrpsuxawa.htm">Form of 2019 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Total Shareholder Return) (incorporated herein by reference to Exhibit 10.3, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.111</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit104-2019_fcfpsuxawa.htm">Form of 2019 Performance Share Unit Award Agreement under the 2011 Long-Term Incentive Plan (Free Cash Flow) (incorporated herein by reference to Exhibit 10.4, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.112</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit105-2019acquisition.htm">Form of Acquisition-Related Non-Qualified Stock Option Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.113</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit106-2019acquisition.htm">Form of Acquisition-Related Deferred Stock Unit Award Agreement under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.6, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.114</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit107-2019_rsaxawardx.htm">Form of Restricted Stock Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.7, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.115</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000024/exhibit108-2019_dsuxawardx.htm">Form of Deferred Stock Unit Award Agreement for Non-Employee Directors under the 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.8, Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.116</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000016/exbibit11-underwritingagre.htm">Underwriting Agreement, dated February 21, 2019, as supplemented by the Terms Agreement, dated February 21, 2019, among Boston Scientific Corporation and Barclays Capital Inc., Merrill Lynch, Pierce, Fenner &amp; Smith Inc. and Wells Fargo Securities, LLC, as representatives of the underwriters (incorporated herein by reference to Exhibit 1.1, Current Report on Form 8-K dated February 21, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.117</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000048/ex-101.htm">Boston Scientific Corporation 2020 Annual Bonus Plan, effective as of January&#160;1, 2020 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed November 20, 2019, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.118</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000048/ex-102.htm">Boston Scientific Corporation 2020 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 20, 2019 File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.119</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572519000048/ex-103.htm">Boston Scientific Corporation 2020 Free Cash Flow Performance Share Program (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K filed November 20, 2019, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.120</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787119000894/ss159395_ex1001.htm">Credit Agreement, dated as of December 5, 2019, by and among Boston Scientific Corporation, the several lenders parties thereto, Wells Fargo Bank, National Association, as Syndication Agent, and The Bank of Nova Scotia, as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated December 5, 2019, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.121</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000156/ss167320_ex1001.htm">Credit Agreement dated as of February 27, 2020, by and among Boston Scientific Corporation, the several lenders parties thereto, Wells Fargo Bank, National Association, as Syndication Agent, and The Bank of Nova Scotia, as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated February 27, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.122</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000397/ss171930_ex1001.htm">Credit Agreement dated as of April 21, 2020, by and among Boston Scientific Corporation, the several lenders parties thereto, Wells Fargo Bank, National Association, as Syndication Agent, and The Bank of Nova Scotia, as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 21, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.123</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000397/ss171930_ex1002.htm">First Amendment, dated as of April 21, 2020, to Term Loan Credit Agreement dated as of February 27, 2020, by and among Boston Scientific Corporation, the several lenders parties thereto, Wells Fargo Bank, National Association, as Syndication Agent, and The Bank of Nova Scotia, as Administrative Agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 21, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.124</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000397/ss171930_ex1003.htm">First Amendment, dated as of April 21, 2020, to Revolving Credit Agreement, dated as of December 19, 2018, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent and Bank of America, N.A. as syndication agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated April 21, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.125</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000024/exhibit101amendedandre.htm">Amended and Restated 2011 Long-Term Incentive Plan (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated May 7, 2020, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.126</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000487/ss173781_ex0101.htm">Underwriting Agreement, dated as of May 14, 2020, as supplemented by the Terms Agreement, dated May 14, 2020, among Boston Scientific Corporation and Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the underwriters. (incorporated herein by reference to Exhibit 1.1, Current Report on Form 8-K dated May 14, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.127</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000519/ss174270_ex0101.htm">Underwriting Agreement relating to the Common Stock, dated as of May 21, 2020, among Boston Scientific Corporation and J.P. Morgan Securities LLC and BofA Securities Inc., as representatives of the underwriters. (incorporated herein by reference to Exhibit 1.1, Current Report on Form 8-K filed May 28, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.128</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000519/ss174270_ex0102.htm">Underwriting Agreement relating to the Mandatory Convertible Preferred Stock, dated as of May 21, 2020, among Boston Scientific Corporation and J.P. Morgan Securities LLC and BofA Securities Inc., as representatives of the underwriters. (incorporated herein by reference to Exhibit 1.2, Current Report on Form 8-K filed May 28, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.129</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000527/ss174648_ex1001.htm">Second Amendment, dated as of May 28, 2020, to February Term Loan Credit Agreement, by and among Boston Scientific Corporation, the several lenders parties thereto, and The Bank of Nova Scotia, as administrative agent. (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed May 29, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.130</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000094787120000527/ss174648_ex1002.htm">Second Amendment, dated as of May 28, 2020, to Revolving Credit Agreement, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent. (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed May 29, 2020, File No. 1-11083).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.131</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1012021annualbo.htm">Boston Scientific Corporation 2021 Annual Bonus Plan, effective as of January 1, 2021 (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K filed </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1012021annualbo.htm">November 24, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1012021annualbo.htm">, File No. 001-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.132</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1022021totalsha.htm">Boston Scientific Corporation 2021 Total Shareholder Return Performance Share Program (incorporated herein by reference to Exhibit 10.2, Current Report on Form 8-K filed November 24, 2020, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.133</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1032021freecash.htm">Boston Scientific Corporation 2021 Free Cash Flow Performance Share Program</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1032021freecash.htm"> (incorporated herein by reference to Exhibit 10.3, Current Report on Form 8-K </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1032021freecash.htm">filed November </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1032021freecash.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/885725/000088572520000049/exhibit1032021freecash.htm">4, 2020, File No. 1-11083).#</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21-listofsubsidiari.htm">List of the Boston Scientific's subsidiaries as of January 31, 2021.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit23-2020eyconsent.htm">Consent of Independent Registered Public Accounting Firm, Ernst &amp; Young LLP.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-ceo302202010xk.htm">Certification of Chief Executive Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-cfo302202010xk.htm">Certification of Chief Financial Officer Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-ceo906202010xk.htm">Certification of Chief Executive Officer Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-cfo906202010xk.htm">Certification of Chief Financial Officer Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div id="i5c3e8d69fcc1460baddde62cfa022487_1976"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston Scientific Corporation</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(duly authorized officer and principal financial officer)</span></td></tr></table></div><div style="margin-top:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Daniel J. Brennan</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael F. Mahoney</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chairman of the Board, <br/>President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Jonathan R. Monson</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan R. Monson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Global Controller and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Nelda J. Connors</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nelda J. Connors</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Charles J. Dockendorff</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles J. Dockendorff</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Yoshiaki Fujimori</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yoshiaki Fujimori</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donna A. James</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donna A. James</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Edward J. Ludwig</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Edward J. Ludwig</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Stephen P. MacMillan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen P. MacMillan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David J. Roux</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 7.75pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David J. Roux</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John E. Sununu</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John E. Sununu</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February 23, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ellen M. Zane</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ellen M. Zane</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><div id="i5c3e8d69fcc1460baddde62cfa022487_199"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><ix:nonNumeric contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90ZXh0cmVnaW9uOjdjNmUwM2EyN2VmNTQwYTc5OGQ2MDI4Y2Y4MzVmNDU4XzY2NQ_c156be67-a394-4ac2-b45b-d665cc91e1b3" escape="true"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at<br/> Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13 (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Credit loss exposure (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Write-offs (c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Charges to<br/>(Deductions from)<br/>Other Accounts (d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at<br/>End of Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for credit losses (b)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItMi0xLTEtMA_a1599508-5286-46bc-9f01-abe885454433">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItNC0xLTEtODMyMQ_2310ac2d-db03-4931-9626-74c35c793a50">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItNC0xLTEtMA_2c256f9e-b035-4689-b9ce-679b2a8ecf19">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItNi0xLTEtMA_ae78b64c-65be-4d9d-af13-61189fd17f49">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItOC0xLTEtMA_fafbb40d-c8ce-4c23-8bca-2f518806c441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2522ce480044b738970a71b97a2834e_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItMTAtMS0xLTA_4f85ed9b-0554-4a93-8920-817897b11a1f">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for uncollectible accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtMi0xLTEtMA_d6a5c5a5-cf1d-4321-8757-790bf55bad9c">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtNC0xLTEtMA_1a12938a-4b5b-4b75-bb27-982c308e4d14">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtNi0xLTEtMA_2a0022ed-85c3-4d5d-8550-43ca656c9072">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtOC0xLTEtMA_68bc68c4-9335-41eb-8496-85a65169b243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtMTAtMS0xLTA_8bce5654-4cef-4742-ad3a-b92965c01591">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2018:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for uncollectible accounts (e)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtMi0xLTEtMA_121d58a0-b884-4d13-9315-e073007f1a6e">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtNC0xLTEtMA_f53142a7-f55f-40f1-8d6d-13cb1602bb89">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtNi0xLTEtMA_da8e3284-0521-42cf-a5f4-2c0b5c460d67">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtOC0xLTEtMA_a81ac5f1-4610-443f-b0c1-d2bf7397418c">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e21581818b44be817499b63aaaddd8_I20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtMTAtMS0xLTA_495df725-b24b-4c57-a87c-c3062ee9c754">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:20pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Following the adoption of FASB ASC Topic 326 as of January 1, 2020, we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> account. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Amounts shown within credit loss exposure above were established through selling, general and administrative expense. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Beginning in 2020, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for uncollectible accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are referred to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Represents actual write-offs of uncollectible accounts.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Represents net change in allowances for sales returns, recorded as contra-revenue.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;Following the adoption of FASB ASC Topic 606 as of January 1, 2018, the allowance for sales returns has been reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the consolidated balance sheets and is not included in the ending balance for 2018 above. Prior period balances remain unchanged.</span></div></ix:nonNumeric><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>exhibit42-descriptionofthe.htm
<DESCRIPTION>EXHIBIT 4.2 DESCRIPTION OF REGISTERED SECURITIES FY2020
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id2c76a474197445cbca0171ef216e671_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">REGISTERED PURSUANT TO SECTION 12 OF THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of the date of the Annual Report on Form 10-K of which this exhibit is a part, Boston Scientific Corporation (the &#8220;Company&#8221;) has three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)&#58; (1) our common stock, $.01 par value per share, (2) our 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share, and (3) our 0.625% Senior Notes due 2027. As used in this description, unless otherwise expressly stated or the context otherwise requires, all references to &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; mean Boston Scientific Corporation excluding its subsidiaries.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Description of Common Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following description of the terms of the common stock sets forth certain general provisions of the common stock as contained in our Charter and by-laws and is qualified in its entirety by reference to Delaware law and our Charter and by-laws in their entirety.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are currently authorized to issue up to 2,000,000,000 shares of common stock, par value $0.01 per share. As of January 31, 2020, there were 1,396,195,349 shares of our common stock outstanding. All outstanding shares of our common stock are fully paid and nonassessable. Our common stock is listed on the NYSE under the symbol &#8220;BSX.&#8221;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Holders of our common stock have no preemptive, subscription, redemption or conversion rights and the common stock is not subject to redemption. The rights, preferences and privileges of holders of common stock are subject to, and may&#160;be adversely affected by, the rights of holders of any series&#160;of preferred stock, whether currently outstanding or designated and issued in the future. </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the preferences of holders of preferred stock, if any, holders of common stock are entitled to dividends and other distributions when, as and if declared by our board of directors out of funds legally available therefor and shall share equally on a per share basis in all such dividends and other distributions.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Voting Rights</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise provided by law or by the designation of the preferences, limitations and relative rights of any series&#160;of preferred stock, the voting power with respect to us is held by holders of our common stock. Each holder of common stock is entitled to one vote for each share held.  </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidation and Dissolution</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise provided by the certificate of designation and limitations and relative rights of any series&#160;of preferred stock, in the event of any of our liquidation, dissolution, or winding up, whether voluntary or involuntary, after payment of all our liabilities and obligations and after payment has been made to holders of each series&#160;of preferred stock of the full amount to which they are entitled, holders of </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shares of common stock will be entitled to share, ratably according to the number of shares of common stock held by them, in all remaining assets available for distribution to holders of the common stock.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Provisions of Delaware Law, the Charter and the By-laws</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations with Interested Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. We are subject to the provisions of the Delaware General Corporate Law, or the DGCL. Section&#160;203 of the DGCL prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes mergers, consolidations, assets sales, and other transactions resulting in a financial benefit to the interested stockholder. Subject to certain exceptions, an &#8220;interested stockholder&#8221; is a person who, together with affiliates owns, or within three years did own, 15% or more of the corporation&#8217;s voting stock.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Liability of Directors and Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As permitted by the DGCL, our Charter provides that our directors will not be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except in certain circumstances involving wrongful acts, such as the breach of a director&#8217;s duty of loyalty, acts or omissions which involve intentional misconduct or a knowing violation of law or for any transaction from which the director derives an improper personal benefit. Our directors are also subject to liability under Section&#160;174 of the DGCL, which makes directors personally liable for unlawful dividends or unlawful stock repurchases or redemptions if the unlawful conduct is willful or results from negligence.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Under our Charter and by-laws (and in accordance with Section&#160;145 of the DGCL), we will indemnify to the fullest extent permitted by the DGCL any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding. These include civil, criminal, administrative, investigative or other proceedings by reason of the fact that the person is or was one of our directors, officers or employees, or is or was serving in that capacity or as an agent at our request for another entity. Our indemnity covers expenses, judgments, fines and amounts paid or to be paid in settlement actually and reasonably incurred in connection with the defense or settlement of an action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to our best interest and, with respect to any criminal action or proceeding, had no reasonable cause to believe that their conduct was unlawful. We will indemnify a person in a derivative action under the same conditions, except that no indemnification is permitted without judicial approval if the person is adjudged to be liable to us in performance of his or her duty. Derivative actions are actions by us or in our right to procure a judgment in our favor. Our agents may&#160;be similarly indemnified at the discretion of our board of directors. In addition, we have entered into indemnification agreements with each of our directors and executive officers. These agreements provide rights of indemnification substantially similar to and, in certain respects, broader than those provided by the Charter and by-laws.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Election of Directors&#59; Removal&#59; Vacancies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Our Charter and by-laws provide that the directors shall be elected at each annual meeting or at any special meeting the notice of which specified the election of directors as an item of business for such meeting.  Our by-laws provide that each nominee for director shall be elected to the board of directors by the affirmative vote of the majority of votes cast, in person or by proxy, by the holders of shares entitled to vote at a meeting at which a quorum is present&#59; provided, however, that if the number of nominees exceeds the number of directors to be elected at any such meeting, the directors shall be elected by a plurality of the votes cast, in person or by proxy. Our Charter provides that vacancies on the board of directors may&#160;only be filled by a majority of the board of directors </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">then in office and further provides that directors may&#160;only be removed by the affirmative vote of holders of at least 80% of the voting power of all the then outstanding shares of stock entitled to vote generally in the election of directors. The provisions of our Charter and by-laws that govern the number, election, and terms of the board of directors may&#160;not be amended without the affirmative vote of at least 80% of the voting power of all the then outstanding shares of stock entitled to vote generally in the election of directors.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Meetings of Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Our Charter provides that stockholder action can only be taken at an annual or special meeting of stockholders and that the business permitted to be conducted at any special meeting of stockholders is limited to the business brought before the meeting by the Chairman of the board of directors or our President or at the request of a majority of the members of the board of directors. Our Charter and by-laws provide that special meetings of stockholders can be called only by the Chairman of the board of directors, the Chief Executive Officer (or if there is no Chief Executive Officer, the President), or pursuant to a resolution approved by a majority of the total number of directors which we would have if there were no vacancies on the board of directors. Stockholders are not permitted to call a special meeting or to require that the board of directors call a special meeting of stockholders.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Advance Notice Requirements for Stockholder Proposals and Director Nominees. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our by-laws provide that stockholders seeking to make nominations of candidates for election as directors, or to bring other business before an annual or special meeting of the stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder&#8217;s notice must be delivered to and received at our principal executive offices not less than 120 days prior to the anniversary date that our proxy statement was released to shareholders in connection with the previous year's annual meeting. However, in the event that the date of the annual meeting is more than 30 days before or after the first anniversary date of the preceding year&#8217;s annual meeting, or in the event of a special meeting of stockholders called for the purpose of electing directors, then the deadline is a reasonable time before the we begin to print and mail our proxy materials. Our by-laws also specify certain requirements as to the form and content of a stockholder&#8217;s notice. These provisions may restrict the ability of our stockholders to bring business before our annual meeting of stockholders or to make nominations for directors at our annual meeting or any special meeting of stockholders.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Proxy Access.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Our by-laws permit an eligible stockholder or group of stockholders to include up to a specified number of director nominees in our proxy materials for an annual meeting of stockholders. To qualify, the stockholders (or group of up to twenty stockholders) must have continuously owned for at least three years 3% or more of our outstanding shares of common stock. The maximum number of stockholder nominees permitted under the proxy access provisions of our by-laws is the greater of (i) two or (ii) 20% of the total number of our directors in office as of the last day on which notice of a nomination may be delivered.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of a nomination under our proxy access by-law provisions must generally be submitted to our principal executive offices not less than 120 days nor more than 150 days prior to the first anniversary of the date that we first mailed our proxy statement to stockholders for the immediately preceding annual meeting of stockholders. The notice must contain certain information specified in our by-laws.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchases&#59; Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Our Charter prohibits us, with certain exceptions, from purchasing any shares of our stock from any person, entity or group that beneficially owns 5% or more of our voting stock at an above-market price, unless a majority of our disinterested stockholders approve the transaction. In addition, our Charter empowers the board of directors, when considering a tender offer or </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">merger or acquisition proposal, to take into account factors in addition to potential economic benefits to stockholders and to consider constituencies other than stockholders.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Amendment of Charter and By-Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The DGCL provides generally that the vote of a majority of shares entitled to vote is required to act on most matters and to amend a corporation&#8217;s certificate of incorporation. Our Charter and by-laws contain provisions requiring the affirmative vote of the holders of at least 80% of the voting stock, voting together as a single class, to amend certain provisions of the Charter and our by-laws, including certain of the foregoing provisions. Such a supermajority vote would be in addition to any separate class&#160;vote that might in the future be required with respect to shares of preferred stock then outstanding.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The foregoing and other provisions of Delaware law and the Charter and our by-laws could make it more difficult to acquire us by means of a tender offer, a proxy contest or otherwise. These provisions may&#160;have the effect of delaying, deferring or preventing a change in control of our company, may&#160;discourage bids for the common stock at a premium over the market price of the common stock and may&#160;adversely affect the market price of the common stock.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The transfer agent and registrar for our common stock is Computershare Shareowner Services.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Description of Mandatory Convertible Preferred Stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The following is a description of certain provisions of our 5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share, or the &#34;Mandatory Convertible Preferred Stock&#34;.  A copy of the certificate of designations setting forth the terms of the Mandatory Convertible Preferred Stock, which we refer to as the &#34;Certificate of Designations,&#34; is incorporated by reference as Exhibit 3.3 to our Annual Report on Form 10-K.  This description of the terms of the Mandatory Convertible Preferred Stock is not complete and is qualified in its entirety by reference to the provisions of our Charter and the Certificate of Designations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For purposes of this description, references to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">&#34;Business Day&#34; refer to any day other than a Saturday or Sunday or other day on which commercial banks in New York City are authorized or required by law or executive order to close or be closed&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">&#34;close of business&#34; refers to 5&#58;00 p.m., New York City time, and &#34;open of business&#34; refers to 9&#58;00 a.m., New York City time.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Under our Charter, our board of directors is authorized to provide, without further stockholder action, for the issuance of up to 50,000,000 shares of preferred stock, par value of $0.01 per share, and the designation of each series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and fix the voting power, full or limited or no voting power, the powers, </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">preferences and relative, participating, option or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of each series. We have no outstanding shares of preferred stock other than the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock is, and our common stock issued upon the conversion of the Mandatory Convertible Preferred Stock will be, fully paid and nonassessable. The holders of the Mandatory Convertible Preferred Stock have no preemptive or preferential rights to purchase or subscribe for any class of our stock, obligations, warrants or other securities. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent, Registrar and Conversion and Dividend Disbursing Agent</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Computershare Inc. is the transfer agent and registrar of our common stock and serves as transfer agent, registrar, conversion and dividend disbursing agent for the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Ranking</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock, with respect to dividend rights and&#47;or distribution rights upon our liquidation, winding-up or dissolution, as applicable, will rank&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">senior to (i) our common stock and (ii) each other class or series of our capital stock established after the first original issue date of shares of the Mandatory Convertible Preferred Stock (which we refer to as the &#34;Initial Issue Date&#34;), the terms of which do not expressly provide that such class or series ranks either (x) senior to the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our liquidation, winding-up or dissolution or (y) on parity with the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our liquidation, winding-up or dissolution (we refer to our common stock and all such other classes or series of capital stock, collectively, as &#34;Junior Stock&#34;)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">on parity with any class or series of our capital stock established after the Initial Issue Date the terms of which expressly provide that such class or series will rank on parity with the Mandatory Convertible Preferred Stock as to dividend rights and distribution rights upon our liquidation, winding-up or dissolution (which we refer to collectively as &#34;Parity Stock&#34;)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">junior to each class or series of our capital stock established after the Initial Issue Date the terms of which expressly provide that such class or series will rank senior to the Mandatory Convertible Preferred Stock as to dividend rights or distribution rights upon our liquidation, winding-up or dissolution (which we refer to collectively as &#34;Senior Stock&#34;)&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">junior to our existing and future indebtedness and other liabilities.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In addition, with respect to dividend rights and distribution rights upon our liquidation, winding-up or dissolution, the Mandatory Convertible Preferred Stock will be structurally subordinated to any existing and future indebtedness and other obligations of each of our subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Listing</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock is listed on The New York Stock Exchange (&#34;NYSE&#34;), under the symbol &#34;BSX PR A&#34;. </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dividends</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Subject to the rights of holders of any class or series of any Senior Stock, holders of the Mandatory Convertible Preferred Stock will be entitled to receive, when, as and if declared by our board of directors, or an authorized committee thereof, out of funds legally available for payment, in the case of dividends paid in cash, and shares of common stock legally permitted to be issued, in the case of dividends paid in shares of common stock, cumulative dividends at the rate per annum of 5.50% of the Liquidation Preference of $100.00 per share of the Mandatory Convertible Preferred Stock (equivalent to $5.50 per annum per share), payable in cash, by delivery of shares of our common stock or through any combination of cash and shares of our common stock, as determined by us in our sole discretion (subject to the limitations on our ability to pay cash dividends and other cash distributions on our capital stock described below with respect to our credit facilities, see &#34;&#8212;Limitation on Cash Payments under our Credit Facilities&#34;). See &#34;&#8212;Method of Payment of Dividends.&#34; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If declared, dividends on the Mandatory Convertible Preferred Stock will be payable quarterly on March 1, June 1, September 1 and December 1 of each year to, and including, June 1, 2023 commencing on September 1, 2020 (each, a &#34;Dividend Payment Date&#34;), at such annual rate, and dividends shall accumulate from the most recent date as to which dividends shall have been paid or, if no dividends have been paid, from the Initial Issue Date of the Mandatory Convertible Preferred Stock, whether or not in any dividend period or periods there have been funds legally available or shares of common stock legally permitted for the payment of such dividends.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If declared, dividends will be payable on the relevant Dividend Payment Date to holders of record of the Mandatory Convertible Preferred Stock as they appear on our stock register at the close of business on the February 15, May 15, August 15 and November 15, as the case may be, immediately preceding the relevant Dividend Payment Date (each, a &#34;Regular Record Date&#34;), whether or not such holders early convert their shares, or such shares are automatically converted, after a Regular Record Date and on or prior to the immediately succeeding Dividend Payment Date. These Regular Record Dates will apply regardless of whether a particular Regular Record Date is a Business Day. If a Dividend Payment Date is not a Business Day, payment will be made on the next succeeding Business Day, without any interest or other payment in lieu of interest accruing with respect to this delay.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        A full dividend period is the period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial dividend period commenced on, and included, the Initial Issue Date of the Mandatory Convertible Preferred Stock and ended on, and excluded, the September 1, 2020 Dividend Payment Date. The amount of dividends payable on each share of Mandatory Convertible Preferred Stock for each full dividend period (subsequent to the initial dividend period) will be computed by dividing the annual dividend rate by four. Dividends payable on the Mandatory Convertible Preferred Stock for the initial dividend period and any other partial dividend period will be computed based upon the actual number of days elapsed during such period over a 360-day year (consisting of twelve 30-day months). The dividend on the Mandatory Convertible Preferred Stock for each subsequent full dividend period, when, as and if declared, will be $1.375 per share of Mandatory Convertible Preferred Stock (based on the annual dividend rate of 5.50% and a Liquidation Preference of $100.00 per share). Accumulated dividends on shares of the Mandatory Convertible Preferred Stock will not bear interest, nor shall additional dividends be payable thereon, if they are paid subsequent to the applicable Dividend Payment Date.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        No dividend will be paid unless and until our board of directors, or an authorized committee of our board of directors, declares a dividend payable with respect to the Mandatory Convertible Preferred Stock. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No dividend will be declared or paid upon, or any sum of cash or number of shares of our common stock set apart for the payment of dividends upon, any outstanding shares of Mandatory Convertible Preferred Stock with respect to any dividend period unless all dividends for all preceding dividend periods have been declared and paid upon, or a sufficient sum of cash or number of shares of our common stock has been set apart for the payment of such dividends upon, all outstanding shares of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Except as described above, dividends on shares of Mandatory Convertible Preferred Stock converted to common stock will cease to accumulate, and all other rights of holders of Mandatory Convertible Preferred Stock will terminate, from and after the Mandatory Conversion Date, the Early Conversion Date and the Fundamental Change Conversion Date (each, as defined below), as applicable.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limitation on cash payments under our credit facilities</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Our ability to declare and pay cash dividends and to make other distributions with respect to our capital stock, including the Mandatory Convertible Preferred Stock, is limited by the terms of our term loans and our Revolving Credit Facility. In addition, the terms of our future indebtedness and our subsidiaries' existing and any future indebtedness may contain similar restrictions. In addition, our ability to declare and pay dividends may be limited by applicable Delaware law. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Method of Payment of Dividends</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Subject to the limitations described below, we may pay any declared dividend (or any portion of any declared dividend) on the shares of Mandatory Convertible Preferred Stock (whether or not for a current dividend period or any prior dividend period) determined in our sole discretion&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">in cash&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">by delivery of shares of our common stock&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">through any combination of cash and shares of our common stock.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will make each payment of a declared dividend on the shares of Mandatory Convertible Preferred Stock in cash, except to the extent we elect to make all or any portion of such payment in shares of our common stock. We will give the holders of the Mandatory Convertible Preferred Stock notice of any such election, and the portion of such payment that will be made in cash and the portion that will be made in shares of our common stock no later than 10 Scheduled Trading Days (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) prior to the Dividend Payment Date for such dividend&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if we do not provide timely notice of this election, we will be deemed to have elected to pay the relevant dividend in cash&#59; for the avoidance of doubt, however, we will pay the relevant dividend in shares of our common stock until we amend or terminate our existing credit agreements that contain a restriction on our ability to pay cash dividends on our capital stock, or such restrictions are no longer effective under the terms of such credit agreements. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        All cash payments to which a holder of the Mandatory Convertible Preferred Stock is entitled in connection with a declared dividend on the shares of Mandatory Convertible Preferred Stock will be rounded to the nearest cent. If we elect to make any such payment of a declared dividend, or any portion thereof, in shares of our common stock, such shares will be valued for such purpose, in the case of any </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">dividend payment or portion thereof, at 97% of the Average VWAP (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) per share of our common stock over the five consecutive Trading Day (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) period commencing on, and including, the seventh Scheduled Trading Day (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) prior to the applicable Dividend Payment Date (such average, the &#34;Average Price&#34;). If the five Trading Day period to determine the Average Price ends on or after the relevant Dividend Payment Date (whether because a Scheduled Trading Day is not a Trading Day due to the occurrence of a Market Disruption Event (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;) or otherwise), then the Dividend Payment Date will be postponed until the second Business Day after the final Trading Day of such five Trading Day period&#59; provided that no interest or other amounts will accrue as a result of such postponement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        No fractional shares of our common stock will be delivered to the holders of the Mandatory Convertible Preferred Stock in payment or partial payment of a dividend. We will instead, to the extent we are legally permitted to do so (including under our credit agreements), pay a cash amount (computed to the nearest cent) to each holder that would otherwise be entitled to receive a fraction of a share of our common stock based on the Average Price with respect to such dividend. In the event that we cannot pay cash in lieu of a fractional share, we will instead round up to the nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional share. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent a shelf registration statement is required in our reasonable judgment in connection with the issuance of or for resales of shares of our common stock issued as payment of a dividend on the shares of Mandatory Convertible Preferred Stock, including dividends paid in connection with a conversion, we will, to the extent such a shelf registration statement is not currently filed and effective, use our commercially reasonable efforts to file and maintain the effectiveness of such a shelf registration statement until the earlier of such time as all such shares of common stock have been resold thereunder and such time as all such shares are freely tradable without registration by holders thereof that are not, and have not been within the three months preceding, &#34;affiliates&#34; of ours for purposes of the Securities Act.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent applicable, we will use our commercially reasonable efforts to have the shares of our common stock approved for listing on NYSE (or if our common stock is not listed on NYSE, on the principal other U.S. national or regional securities exchange on which our common stock is then listed), and qualified or registered under applicable state securities laws, if required&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that we will not be required to qualify as a foreign corporation or to take any action that would subject us to general service of process in any such jurisdiction where we are not presently qualified or where we are not presently subject to taxation as a foreign corporation and such qualification or action would subject us to such taxation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Notwithstanding the foregoing, in no event will the number of shares of our common stock to be delivered in connection with any declared dividend, including any declared dividend payable in connection with a conversion, exceed a number equal to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the declared dividend, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">$11.9875, which amount represents approximately 35% of the Initial Price (as defined under &#34;&#8212;Mandatory Conversion&#8212;Certain Definitions&#34;), subject to adjustment in a manner inversely proportional to any anti-dilution adjustment to each Fixed Conversion Rate as set forth below in &#34;&#8212;Anti-Dilution Adjustments&#34; (such dollar amount, the &#34;Floor Price&#34;).</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent that the amount of any declared dividend exceeds the product of (x) the number of shares of our common stock delivered in connection with such declared dividend and (y) 97% of the Average Price, we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness, notwithstanding any notice by us to the contrary, pay such excess amount in cash (computed to the nearest cent). Any such payment in cash may not be permitted by our then existing debt instruments and is not permitted under our existing credit agreements. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34; To the extent that we are not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our common stock in respect of such amount, and such amount will not form a part of the cumulative dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dividend Stopper</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as any share of Mandatory Convertible Preferred Stock remains outstanding, no dividend or distribution shall be declared or paid on our common stock or any other class or series of Junior Stock, and no common stock or any other class or series of Junior Stock or Parity Stock shall be, directly or indirectly, purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid in full in cash, shares of our common stock or a combination thereof, or a sufficient sum of cash or number of shares of our common stock has been set apart for the payment of such dividends upon, all outstanding shares of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The foregoing limitation shall not apply to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any dividend or distribution payable in shares of common stock or other Junior Stock, together with cash in lieu of any fractional share&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">purchases, redemptions or other acquisitions of common stock, other Junior Stock or Parity Stock in connection with the administration of any benefit or other incentive plan, including any employment contract, in the ordinary course of business (including purchases to offset the Share Dilution Amount pursuant to a publicly announced repurchase plan, or acquisitions of shares of common stock surrendered, deemed surrendered or withheld in connection with the exercise of stock options or the vesting of restricted stock or restricted stock units)&#59; provided that the number of shares purchased to offset the Share Dilution Amount shall in no event exceed the Share Dilution Amount&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">purchases of common stock or other Junior Stock pursuant to a contractually binding agreement to buy such securities that existed prior to the date of this prospectus supplement&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any dividends or distributions of rights in connection with a stockholders' rights plan or any redemption or repurchase of rights pursuant to any stockholders' rights plan&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the exchange or conversion of Junior Stock for or into other Junior Stock or of Parity Stock for or into other Parity Stock (with the same or lesser aggregate liquidation preference) or Junior Stock and, in each case, the payment of cash solely in lieu of fractional shares&#59; and</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the deemed purchase or acquisition of fractional interests in shares of our common stock, other Junior Stock or Parity Stock pursuant to the conversion or exchange provisions of such shares or the security being converted or exchanged.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The phrase &#34;Share Dilution Amount&#34; means the increase in the number of diluted shares of our common stock outstanding (determined in accordance with accounting principles generally accepted in the United States of America, and as measured from the Initial Issue Date) resulting from the grant, vesting or exercise of equity-based compensation to directors, employees and agents and equitably adjusted for any stock split, stock dividend, reverse stock split, reclassification or similar transaction.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        When dividends on shares of the Mandatory Convertible Preferred Stock (i) have not been declared and paid in full on any Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from such Dividend Payment Dates, on a dividend payment date falling within a regular dividend period related to such Dividend Payment Date), or (ii) have been declared but a sum of cash or number of shares of our common stock sufficient for payment thereof has not been set aside for the benefit of the holders thereof on the applicable Regular Record Date, no dividends may be declared or paid on any shares of Parity Stock unless dividends are declared on the shares of Mandatory Convertible Preferred Stock such that the respective amounts of such dividends declared on the shares of Mandatory Convertible Preferred Stock and such shares of Parity Stock shall be allocated pro rata among the holders of the shares of Mandatory Convertible Preferred Stock and the holders of any shares of Parity Stock then outstanding. For purposes of calculating the pro rata allocation of partial dividend payments, the Company shall allocate those payments so that the respective amounts of those payments for the declared dividend bear the same ratio to each other as all accumulated and unpaid dividends per share on the shares of Mandatory Convertible Preferred Stock and all declared and unpaid dividends per share on such shares of Parity Stock bear to each other (subject to their having been declared by our board of directors, or an authorized committee thereof, out of legally available funds)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that any unpaid dividends on the Mandatory Convertible Preferred Stock will continue to accumulate except as described herein. For purposes of this calculation, with respect to non-cumulative Parity Stock, we will use the full amount of dividends that would be payable for the most recent dividend period if dividends were declared in full on such non-cumulative Parity Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Subject to the foregoing, and not otherwise, such dividends as may be determined by our board of directors, or an authorized committee thereof, may be declared and paid (payable in cash or other property or securities) on any securities, including our common stock and other Junior Stock, from time to time out of any funds legally available for such payment, and holders of the Mandatory Convertible Preferred Stock shall not be entitled to participate in any such dividends.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Redemption</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock will not be redeemable. However, at our option, we may purchase or exchange the Mandatory Convertible Preferred Stock from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidation Preference</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In the event of our voluntary or involuntary liquidation, winding-up or dissolution, each holder of the Mandatory Convertible Preferred Stock will be entitled to receive a Liquidation Preference in the amount of $100.00 per share of the Mandatory Convertible Preferred Stock (the &#34;Liquidation Preference&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> an amount (the &#34;Liquidation Dividend Amount&#34;) equal to accumulated and unpaid dividends on such shares, </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">whether or not declared, to, but excluding, the date fixed for liquidation, winding-up or dissolution to be paid out of our assets legally available for distribution to our stockholders, after satisfaction of debt and other liabilities owed to our creditors and holders of shares of any Senior Stock and before any payment or distribution is made to holders of Junior Stock (including our common stock). If, upon our voluntary or involuntary liquidation, winding-up or dissolution, the amounts payable with respect to (1) the Liquidation Preference plus the Liquidation Dividend Amount on the shares of Mandatory Convertible Preferred Stock and (2) the liquidation preference of, and the amount of accumulated and unpaid dividends (to, but excluding, the date fixed for liquidation, winding-up or dissolution) on, all Parity Stock are not paid in full, the holders of the Mandatory Convertible Preferred Stock and all holders of any such Parity Stock will share equally and ratably in any distribution of our assets in proportion to their respective liquidation preferences and amounts equal to accumulated and unpaid dividends to which they are entitled. After payment of the full amount of the Liquidation Preference and the Liquidation Dividend Amount on the shares of Mandatory Convertible Preferred Stock, the holders of the Mandatory Convertible Preferred Stock will have no right or claim to any of our remaining assets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Neither the sale, lease nor exchange of all or substantially all of our assets or business (other than in connection with our liquidation, winding-up or dissolution), nor our merger or consolidation into or with any other person, will be deemed to be our voluntary or involuntary liquidation, winding-up or dissolution.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Our Charter, including the Certificate of Designations for the Mandatory Convertible Preferred Stock, will not contain any provision requiring funds to be set aside to protect the Liquidation Preference of the Mandatory Convertible Preferred Stock even though it is substantially in excess of the par value thereof.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Voting Rights</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The holders of the Mandatory Convertible Preferred Stock will not have voting rights other than those described below, except as specifically required by Delaware law or by our Charter from time to time.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Whenever dividends on any shares of the Mandatory Convertible Preferred Stock have not been declared and paid for the equivalent of six or more dividend periods (including, for the avoidance of doubt, the dividend period commenced on, and included, the Initial Issue Date and ended on, but excluded, September 1, 2020), whether or not for consecutive dividend periods (a &#34;Nonpayment&#34;), the authorized number of directors on our board of directors will, at the next annual meeting of stockholders or at a special meeting of stockholders as provided below, automatically be increased by two and the holders of such shares of the Mandatory Convertible Preferred Stock, voting together as a single class with holders of any and all other series of Voting Preferred Stock (as defined below) then outstanding, will be entitled, at our next annual meeting of stockholders or at a special meeting of stockholders as provided below, to vote for the election of a total of two additional members of our board of directors (the &#34;Preferred Stock Directors&#34;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the election of any such Preferred Stock Directors will not cause us to violate the corporate governance requirements of NYSE (or any other exchange or automated quotation system on which our securities may be listed or quoted) that requires listed or quoted companies to have a majority of independent directors&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that our board of directors shall, at no time, include more than two Preferred Stock Directors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In the event of a Nonpayment, the holders of at least 25% of the shares of the Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock may request that a special meeting of </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">stockholders be called to elect such Preferred Stock Directors (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if our next annual or a special meeting of stockholders is scheduled to be held within 90 days of the receipt of such request, the election of such Preferred Stock Directors will be included in the agenda for, and will be held at, such scheduled annual or special meeting of stockholders). The Preferred Stock Directors will stand for reelection annually, at each subsequent annual meeting of the stockholders, so long as the holders of the Mandatory Convertible Preferred Stock continue to have such voting rights.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        At any meeting at which the holders of the Mandatory Convertible Preferred Stock are entitled to elect Preferred Stock Directors, the holders of a majority of the then outstanding shares of the Mandatory Convertible Preferred Stock and all other series of Voting Preferred Stock, present in person or represented by proxy, will constitute a quorum and the vote of the holders of a majority of such shares of the Mandatory Convertible Preferred Stock and other Voting Preferred Stock so present or represented by proxy at any such meeting at which there shall be a quorum shall be sufficient to elect the Preferred Stock Directors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        As used in this prospectus supplement, &#34;Voting Preferred Stock&#34; means any other class or series of our preferred stock, ranking equally with the Mandatory Convertible Preferred Stock as to dividends and to the distribution of assets upon liquidation, dissolution or winding-up and upon which like voting rights for the election of directors have been conferred and are exercisable. Whether a plurality, majority or other portion in voting power of the Mandatory Convertible Preferred Stock and any other Voting Preferred Stock have been voted in favor of any matter shall be determined by reference to the respective liquidation preference amounts of the Mandatory Convertible Preferred Stock and such other Voting Preferred Stock voted.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If and when all accumulated and unpaid dividends on the Mandatory Convertible Preferred Stock have been paid in full, or declared and a sum or number of shares of our common stock sufficient for such payment shall have been set aside for the benefit of the holders thereof (a &#34;Nonpayment Remedy&#34;), the holders of the Mandatory Convertible Preferred Stock shall immediately and, without any further action by us, be divested of the foregoing voting rights, subject to the revesting of such rights in the event of each subsequent Nonpayment. If such voting rights for the holders of the Mandatory Convertible Preferred Stock and all other holders of Voting Preferred Stock have terminated, the term of office of each Preferred Stock Director so elected will terminate at such time and the authorized number of directors on our board of directors shall automatically decrease by two.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any Preferred Stock Director may be removed at any time, with or without cause, by the holders of record of a majority in voting power of the outstanding shares of the Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock then outstanding (voting together as a single class) when they have the voting rights described above. In the event that a Nonpayment shall have occurred and there shall not have been a Nonpayment Remedy, any vacancy in the office of a Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment) may be filled by the written consent of the Preferred Stock Director remaining in office, except in the event that such vacancy is created as a result of such Preferred Stock Director being removed or if no Preferred Stock Director remains in office, such vacancy may be filled by a vote of the holders of record of a majority in voting power of the outstanding shares of the Mandatory Convertible Preferred Stock and any other series of Voting Preferred Stock then outstanding (voting together as a single class) when they have the voting rights described above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the election of any such Preferred Stock Directors to fill such vacancy will not cause us to violate the corporate governance requirements of NYSE (or any other exchange or automated quotation system on which our securities may be listed or quoted) that requires </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">listed or quoted companies to have a majority of independent directors. The Preferred Stock Directors will each be entitled to one vote per director on any matter that comes before our board of directors for a vote.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as any shares of Mandatory Convertible Preferred Stock remain outstanding, we will not, without the affirmative vote or consent of the holders of at least two-thirds in voting power of the outstanding shares of Mandatory Convertible Preferred Stock and all other series of Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting together as a single class, given in person or by proxy, either in writing or at an annual or special meeting of such stockholders&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">amend or alter the provisions of our Charter so as to authorize or create, or increase the authorized number of, any class or series of Senior Stock&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">amend, alter or repeal any provision of our Charter or the Certificate of Designations so as to adversely affect the special rights, preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">consummate a binding share exchange or reclassification involving the shares of the Mandatory Convertible Preferred Stock or a merger or consolidation of us with another entity, unless in each case&#58; (i) the shares of Mandatory Convertible Preferred Stock remain outstanding and are not amended in any respect or, in the case of any such merger or consolidation with respect to which we are not the surviving or resulting entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent&#59; and (ii) the shares of the Mandatory Convertible Preferred Stock that remain outstanding or such shares of preference securities, as the case may be, have such rights, preferences, privileges and voting powers that, taken as a whole, are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers of the Mandatory Convertible Preferred Stock immediately prior to the consummation of such transaction&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the event that a transaction would trigger voting rights under both the second and the third bullet point above, the third bullet point will govern&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any increase in the number of our authorized but unissued shares of preferred stock&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any increase in the number of authorized or issued shares of Mandatory Convertible Preferred Stock&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the creation and issuance, or an increase in the authorized or issued number, of any class or series of Parity Stock or Junior Stock,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">will be deemed not to adversely affect the rights, preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock and shall not require the affirmative vote or consent of holders of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Our Charter and Delaware law permit us, without the approval of any of our stockholders (including any holders of the Mandatory Convertible Preferred Stock), to establish and issue a new series of preferred stock ranking equally with or junior to the Mandatory Convertible Preferred Stock, which may dilute the voting and other interests of holders of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If any amendment, alteration, repeal, binding share exchange, reclassification, merger or consolidation described above would adversely affect the rights, preferences, privileges or voting powers of one or more but not all series of Voting Preferred Stock (including the Mandatory Convertible Preferred Stock for this purpose), then only the series of Voting Preferred Stock the rights, preferences, privileges or voting powers of which are adversely affected and entitled to vote, shall vote as a class in lieu of all other series of Voting Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Without the consent of the holders of the Mandatory Convertible Preferred Stock, so long as such action does not adversely affect the special rights, preferences, privileges or voting powers of the Mandatory Convertible Preferred Stock, we may amend, alter, supplement or repeal any terms of the Mandatory Convertible Preferred Stock for the following purposes&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">to cure any ambiguity, omission or mistake, or to correct or supplement any provision contained in the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock that may be defective or inconsistent with any other provision contained in such Certificate of Designations&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">to make any provision with respect to matters or questions relating to the Mandatory Convertible Preferred Stock that is not inconsistent with the provisions of our Charter or the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In addition, without the consent of the holders of the Mandatory Convertible Preferred Stock, we may amend, alter, supplement or repeal any terms of the Mandatory Convertible Preferred Stock in order to (i) conform the terms thereof to the description of the terms of the Mandatory Convertible Preferred Stock set forth under &#34;Description of Mandatory Convertible Preferred Stock&#34; in the preliminary prospectus supplement for the Mandatory Convertible Preferred Stock, as supplemented and&#47;or amended by any related pricing term sheet or (ii) file a certificate of correction with respect to the Certificate of Designations to the extent permitted by Section 103(f) of the Delaware General Corporation Law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Mandatory Conversion</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Each outstanding share of the Mandatory Convertible Preferred Stock, unless previously converted, will automatically convert on the Mandatory Conversion Date (as defined under &#34;&#8212;Certain Definitions&#34;), into a number of shares of our common stock equal to the conversion rate described below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The &#34;conversion rate&#34;, which is the number of shares of our common stock issuable upon conversion of each share of the Mandatory Convertible Preferred Stock on the Mandatory Conversion Date (excluding any shares of our common stock issued in respect of accrued and unpaid dividends, as described below), will be as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Applicable Market Value (as defined under &#34;&#8212;Certain Definitions&#34;) of our common stock is greater than the Threshold Appreciation Price, which is approximately $41.96, then the conversion rate will be 2.3834 shares of our common stock per share of Mandatory Convertible Preferred Stock (the &#34;Minimum Conversion Rate&#34;)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Applicable Market Value of our common stock is less than or equal to the Threshold Appreciation Price but equal to or greater than the Initial Price, then the conversion rate will be equal to $100.00 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Applicable Market Value of our common stock, rounded to the nearest ten-thousandth of a share&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Applicable Market Value of our common stock is less than the Initial Price, then the conversion rate will be 2.9197 shares of our common stock per share of Mandatory Convertible Preferred Stock (the &#34;Maximum Conversion Rate&#34;).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We refer to the Minimum Conversion Rate and the Maximum Conversion Rate collectively as the &#34;Fixed Conversion Rates&#34;. The Fixed Conversion Rates are subject to adjustment as described in &#34;&#8212;Anti-Dilution Adjustments&#34; below. The &#34;Threshold Appreciation Price&#34; is calculated by dividing $100.00 by the Minimum Conversion Rate and represents an approximately 22.50% appreciation over the Initial Price. The &#34;Initial Price&#34; is calculated by dividing $100.00 by the Maximum Conversion Rate and initially equals $34.25, which is the public offering price of our common stock in the Concurrent Offering.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If we declare a dividend on the Mandatory Convertible Preferred Stock for the dividend period ending on, but excluding, June 1, 2023, we will pay such dividend to the holders of record as of the immediately preceding Regular Record Date, as described above under &#34;&#8212;Dividends.&#34; If on or prior to June 1, 2023 we have not declared all or any portion of the accumulated and unpaid dividends on the Mandatory Convertible Preferred Stock, the conversion rate will be adjusted so that holders receive an additional number of shares of our common stock equal to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the amount of such accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock that have not been declared (the &#34;Mandatory Conversion Additional Conversion Amount&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the greater of (i) the Floor Price and (ii) 97% of the Average Price (calculated using June 1, 2023 as the applicable Dividend Payment Date).</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent that the Mandatory Conversion Additional Conversion Amount exceeds the product of such number of additional shares and 97% of the Average Price, we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness declare and pay such excess amount in cash (computed to the nearest cent) pro rata per share to the holders of the Mandatory Convertible Preferred Stock. Any such payment in cash may not be permitted by our then existing debt instruments and is not permitted under our existing credit agreements. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34; To the extent that we are not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our common stock in respect of such amount, and such amount will not form a part of the cumulative dividends that may be deemed to accumulate on the shares of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For the avoidance of doubt, the conversion rate per share of the Mandatory Convertible Preferred Stock will in no event exceed the Maximum Conversion Rate, subject to adjustment as described under &#34;&#8212;Anti-Dilution Adjustments&#34; below and exclusive of any amounts owing in respect of any Mandatory Conversion Additional Conversion Amount or any accrued and unpaid dividends paid at our election in shares of common stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Hypothetical conversion values upon mandatory conversion</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For illustrative purposes only, the following table shows the number of shares of our common stock that a holder of the Mandatory Convertible Preferred Stock would receive upon mandatory conversion of one share of Mandatory Convertible Preferred Stock at various Applicable Market Values for our common </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">stock. The table assumes that there will be no conversion adjustments as described above for any Mandatory Conversion Additional Conversion Amount or as described below in &#34;&#8212;Anti-Dilution Adjustments&#34; and that dividends on the Mandatory Convertible Preferred Stock will be declared and paid in cash (and not in additional shares of our common stock). The actual Applicable Market Value of our common stock may differ from those set forth in the table below. Given an Initial Price of $34.25 and a Threshold Appreciation Price of approximately $41.96, a holder of Mandatory Convertible Preferred Stock would receive on the Mandatory Conversion Date the number of shares of our common stock per share of Mandatory Convertible Preferred Stock set forth below, subject to the provisions described below with respect to any fractional share of our common stock&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Assumed Applicable Market Value of our common stock</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of shares of our common stock to be received upon mandatory conversion</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Assumed conversion value (calculated as Applicable Market Value multiplied by the number of shares of our common stock to be received upon mandatory conversion)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$58.39</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.00</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$72.99</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$87.59</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34.25</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8571</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$37.50</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6667</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.96</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.01</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$45.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$107.25</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.00</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$119.17</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55.00</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$131.09</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.00</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$143.00</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Accordingly, assuming that the market price of our common stock on the Mandatory Conversion Date is the same as the Applicable Market Value of our common stock, the aggregate market value of our common stock the holder receives upon mandatory conversion of a share of Mandatory Convertible Preferred Stock (excluding any shares of our common stock the holder receives in respect of accrued and unpaid dividends) will be&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">greater than the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is greater than the Threshold Appreciation Price&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">equal to the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is less than or equal to the Threshold Appreciation Price and greater than or equal to the Initial Price&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">less than the $100.00 liquidation preference of the share of Mandatory Convertible Preferred Stock, if the Applicable Market Value is less than the Initial Price.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Certain Definitions</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Applicable Market Value&#34; means the Average VWAP per share of our common stock over the Settlement Period.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Settlement Period&#34; means the 20 consecutive Trading Day period commencing on, and including, the 21st Scheduled Trading Day immediately preceding June 1, 2023.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Mandatory Conversion Date&#34; means the second Business Day immediately following the last Trading Day of the Settlement Period. The Mandatory Conversion Date is expected to be June 1, 2023. If the Mandatory Conversion Date occurs after June 1, 2023 (whether because a Scheduled Trading Day during the Settlement Period is not a Trading Day due to the occurrence of a Market Disruption Event or otherwise), no interest or other amounts will accrue as a result of such postponement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        A &#34;Trading Day&#34; means a day on which&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">there is no Market Disruption Event&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">trading in our common stock generally occurs on the Relevant Stock Exchange&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if our common stock is not listed or admitted for trading, &#34;Trading Day&#34; means any Business Day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        A &#34;Scheduled Trading Day&#34; is any day that is scheduled to be a Trading Day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Market Disruption Event&#34; means&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a failure by the Relevant Stock Exchange to open for trading during its regular trading session&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the occurrence or existence, prior to 1&#58;00 p.m., New York City time, on any Scheduled Trading Day for our common stock, for more than a one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the Relevant Stock Exchange or otherwise) in our common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;Relevant Stock Exchange&#34; means NYSE or, if our common stock is not then listed on NYSE, on the principal other U.S. national or regional securities exchange on which our common stock is then listed or, if our common stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which our common stock is then listed or admitted for trading.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;VWAP&#34; per share of our common stock on any Trading Day means the per share volume-weighted average price as displayed on Bloomberg page &#34;BSX &#60;EQUITY&#62; AQR&#34; (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such Trading Day (or, if such volume-weighted average price is not available, the market value per share of our common stock on such Trading Day as determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained by us for this purpose, which may include any of the underwriters for this offering). The &#34;Average VWAP&#34; per share over a certain period means the arithmetic average of the VWAP per share for each Trading Day in the relevant period.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Early Conversion at the Option of the Holder</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Other than during a Fundamental Change Conversion Period (as defined in &#34;&#8212;Conversion at the Option of the Holder upon Fundamental Change&#59; Fundamental Change Dividend Make-Whole Amount&#34;), holders of Mandatory Convertible Preferred Stock will have the right to convert their Mandatory Convertible Preferred Stock, in whole or in part (but in no event less than one share of Mandatory </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Convertible Preferred Stock), at any time prior to June 1, 2023 (an &#34;Early Conversion&#34;), into shares of our common stock at the Minimum Conversion Rate per share of Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If, as of the conversion date (as defined under &#34;&#8212;Conversion Procedures&#8212;Upon Early Conversion or Upon Early Fundamental Change Conversion&#34;) of any Early Conversion (the &#34;Early Conversion Date&#34;), we have not declared all or any portion of the accumulated and unpaid dividends for all full dividend periods ending on or before a Dividend Payment Date prior to such Early Conversion Date, the conversion rate for such Early Conversion will be adjusted so that holders converting their Mandatory Convertible Preferred Stock at such time receive an additional number of shares of our common stock equal to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">such amount of accumulated and unpaid dividends per share of Mandatory Convertible Preferred Stock that have not been declared for such prior full dividend periods (the &#34;Early Conversion Additional Conversion Amount&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the greater of (i) the Floor Price and (ii) the Average VWAP per share of our common stock over the 20 consecutive Trading Day period (the &#34;Early Conversion Settlement Period&#34;), commencing on, and including, the 21st Scheduled Trading Day immediately preceding the Early Conversion Date (such average VWAP, the &#34;Early Conversion Average Price&#34;).</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To the extent that the Early Conversion Additional Conversion Amount exceeds the product of such number of additional shares and the Early Conversion Average Price, we will not have any obligation to pay the shortfall in cash or deliver shares of our common stock in respect of such shortfall.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Except as described above, upon any Early Conversion of any Mandatory Convertible Preferred Stock, we will make no payment or allowance for unpaid dividends on such shares of the Mandatory Convertible Preferred Stock, unless such Early Conversion Date occurs after the Regular Record Date for a declared dividend and on or prior to the immediately succeeding Dividend Payment Date, in which case such dividend will be paid on such Dividend Payment Date to the holder of record of the converted shares of the Mandatory Convertible Preferred Stock as of such Regular Record Date, as described under &#34;&#8212;Dividends.&#34;</font></div><div><font><br></font></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conversion at the Option of the Holder upon Fundamental Change&#59; Fundamental Change Dividend Make-Whole Amount</font></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">General</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If a &#34;Fundamental Change&#34; (as defined below) occurs on or prior to June 1, 2023, holders of Mandatory Convertible Preferred Stock will have the right (the &#34;Fundamental Change Conversion Right&#34;) during the Fundamental Change Conversion Period (as defined below) to&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) convert their share of Mandatory Convertible Preferred Stock, in whole or in part (but in no event less than one share of Mandatory Convertible Preferred Stock), into a number of shares of our common stock (or Units of Exchange Property as described below) at the conversion rate specified in the table below (the &#34;Fundamental Change Conversion Rate&#34;)&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) with respect to such converted shares, receive a Fundamental Change Dividend Make-Whole Amount (as defined below) payable in cash or shares of our common stock&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii) with respect to such converted shares, receive the Accumulated Dividend Amount (as defined below) payable in cash or shares of our common stock,</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">subject, in the case of clauses (ii) and (iii), to certain limitations with respect to the number of shares of our common stock that we will be required to deliver, all as described below. Notwithstanding clauses (ii) and (iii) above, if the Fundamental Change Effective Date (as defined below) or the Fundamental Change Conversion Date (as defined below) falls after the Regular Record Date for a dividend period for which we have declared a dividend and prior to the next Dividend Payment Date, then we will pay such dividend on the relevant Dividend Payment Date to the holders of record on such Regular Record Date, as described under &#34;&#8212;Dividends,&#34; and the Accumulated Dividend Amount will not include the amount of such dividend, and the Fundamental Change Dividend Make-Whole Amount will not include the present value of the payment of such dividend.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        To exercise the Fundamental Change Conversion Right, a holder must submit its shares of Mandatory Convertible Preferred Stock for conversion at any time during the period (the &#34;Fundamental Change Conversion Period&#34;) commencing on, and including, the Fundamental Change Effective Date and ending at the close of business on the date that is 20 calendar days after the Fundamental Change Effective Date (or, if later, the date that is 20 calendar days after the date of notice of such Fundamental Change), but in no event later than June 1, 2023. Holders of the Mandatory Convertible Preferred Stock that submit the shares for conversion during the Fundamental Change Conversion Period shall be deemed to have exercised their Fundamental Change Conversion Right. Holders of the Mandatory Convertible Preferred Stock who do not submit their shares for conversion during the Fundamental Change Conversion Period will not be entitled to convert their Mandatory Convertible Preferred Stock at the relevant Fundamental Change Conversion Rate or to receive the relevant Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount. A conversion date occurring during such Fundamental Change Conversion Period is referred to herein as a &#34;Fundamental Change Conversion Date.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will notify holders of the Fundamental Change Effective Date no later than the second Business Day immediately following such Fundamental Change Effective Date. If we notify holders of a Fundamental Change later than the second Business Day following the Fundamental Change Effective Date, the Fundamental Change Conversion Period will be extended by a number of days equal to the number of days from, and including, such Fundamental Change Effective Date to, but excluding, the date of the notice&#59; provided, however, that the Fundamental Change Conversion Period will not be extended beyond June 1, 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        A &#34;Fundamental Change&#34; will be deemed to have occurred, at any time after the Initial Issue Date of the Mandatory Convertible Preferred Stock, if any of the following occurs&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) any &#34;person&#34; or &#34;group&#34; (as such terms are used for purposes of Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the &#34;Exchange Act&#34;), whether or not applicable), other than us, any of our wholly-owned subsidiaries or any of our or our wholly-owned subsidiaries' employee benefit plans, filing a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the &#34;beneficial owner&#34; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 50% of the total voting power in the aggregate of all classes of capital stock then outstanding entitled to vote generally in elections of our directors&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii) the consummation of (A) any recapitalization, reclassification or change of our common stock (other than changes resulting from a subdivision or combination or change in par value) as a result </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of which our common stock would be converted into, or exchanged for, stock, other securities, other property or assets (including cash or a combination thereof)&#59; (B) any consolidation, merger or other combination of us or binding share exchange pursuant to which our common stock will be converted into, or exchanged for, stock, other securities or other property or assets (including cash or a combination thereof)&#59; or (C) any sale, lease or other transfer or disposition in one transaction or a series of transactions of all or substantially all of the consolidated assets of ours and our subsidiaries taken as a whole, to any person other than one or more of our wholly-owned subsidiaries&#59; or</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii) our common stock (or other Exchange Property (as defined below)) ceases to be listed or quoted for trading on any of NYSE, the NASDAQ Global Select Market or the NASDAQ Global Market (or another U.S. national securities exchange or any of their respective successors).</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        However, a transaction or transactions described in clause (i) or clause (ii) above will not constitute a Fundamental Change if at least 90% of the consideration received or to be received by our common stockholders, excluding cash payments for fractional shares or pursuant to statutory appraisal rights, in connection with such transaction or transactions consists of shares of common stock that are listed or quoted on any of NYSE, the NASDAQ Global Select Market or the NASDAQ Global Market (or any of their respective successors) or will be so listed or quoted when issued or exchanged in connection with such transaction or transactions and as a result of such transaction or transactions such consideration (excluding cash payments for fractional shares or pursuant to statutory appraisal rights) becomes the Exchange Property.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fundamental Change Conversion Rate</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Fundamental Change Conversion Rate will be determined by reference to the table below and is based on the effective date of such Fundamental Change (the &#34;Fundamental Change Effective Date&#34;), and the price (the &#34;Fundamental Change Share Price&#34;) paid or deemed paid per share of our common stock in such Fundamental Change. If the holders of our common stock receive only cash in such Fundamental Change, the Fundamental Change Share Price shall be the cash amount paid per share of common stock. Otherwise, the Fundamental Change Share Price shall be the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Fundamental Change Effective Date.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Fundamental Change Share Prices set forth in the first row of the table below (i.e., the column headers) will be adjusted as of any date on which the Fixed Conversion Rates of the Mandatory Convertible Preferred Stock are adjusted. The adjusted Fundamental Change Share Prices will equal (i) the Fundamental Change Share Prices applicable immediately prior to such adjustment, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) a fraction, the numerator of which is the Minimum Conversion Rate immediately prior to the adjustment giving rise to the Fundamental Change Share Price adjustment and the denominator of which is the Minimum Conversion Rate as so adjusted. Each of the Fundamental Change Conversion Rates in the table below will be subject to adjustment in the same manner and at the same time as each Fixed Conversion Rate as set forth in &#34;&#8212;Anti-Dilution Adjustments&#34;.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The following table sets forth the Fundamental Change Conversion Rate per share of Mandatory Convertible Preferred Stock for each Fundamental Change Share Price and Fundamental Change Effective Date set forth below.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.326%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Fundamental Change Effective Date</font></div></td><td colspan="87" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Fundamental Change Share Price</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$10.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$15.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$20.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$25.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$30.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$34.25</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$37.50</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$40.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$41.96</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$45.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$50.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$55.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$60.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$75.00</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$100.00</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 27, 2020</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8542</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7933</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7095</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6255</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5532</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5037</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4729</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4529</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4394</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4214</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3988</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3828</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3715</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3544</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3477</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8856</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8539</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7863</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6998</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6145</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5520</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5122</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4863</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4687</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4455</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4169</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3973</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3842</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3660</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3601</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2022</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9050</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9007</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8724</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8033</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7052</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6193</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5610</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5225</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4965</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4633</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4248</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4014</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3878</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3739</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3716</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 1, 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9197</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6667</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3834</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The exact Fundamental Change Share Price and Fundamental Change Effective Date may not be set forth in the table, in which case&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Fundamental Change Share Price is between two Fundamental Change Share Price amounts in the table or the Fundamental Change Effective Date is between two Fundamental Change Effective Dates in the table, the Fundamental Change Conversion Rate will be determined by a straight-line interpolation between the Fundamental Change Conversion Rates set forth for the higher and lower Fundamental Change Share Price amounts and the earlier and later Fundamental Change Effective Dates, as applicable, based on a 365- or 366-day year, as applicable&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Fundamental Change Share Price is in excess of $100.00 per share (subject to adjustment in the same manner as the Fundamental Change Share Prices set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Minimum Conversion Rate&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if the Fundamental Change Share Price is less than $10.00 per share (subject to adjustment in the same manner as the Fundamental Change Share Prices set forth in the first row of the table above), then the Fundamental Change Conversion Rate will be the Maximum Conversion Rate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fundamental Change Dividend Make-Whole Amount and Accumulated Dividend Amount</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For any shares of Mandatory Convertible Preferred Stock that are converted during the Fundamental Change Conversion Period, in addition to the common stock issued upon conversion at the Fundamental Change Conversion Rate, we will, at our option (subject to satisfaction of the requirements described below)&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;pay in cash (computed to the nearest cent), to the extent we are able to do so under applicable law and in compliance with our indebtedness, an amount equal to the present value, calculated using a discount rate of 5.00% per annum, of all dividend payments (excluding any Accumulated Dividend Amount) on the Mandatory Convertible Preferred Stock for (i) the partial dividend period, if any, from, and including, the Fundamental Change Effective Date to, but excluding, the next Dividend Payment Date and (ii) all remaining full dividend periods from, and including, the Dividend Payment Date following the Fundamental Change Effective Date to, but excluding, the Mandatory Conversion Date (the &#34;Fundamental Change Dividend Make-Whole Amount&#34;)&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;increase the number of shares of our common stock (or Units of Exchange Property as described below) to be issued upon conversion by a number equal to (x) the Fundamental </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Change Dividend Make-Whole Amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (y) the greater of (i) the Floor Price and (ii) 97% of the Fundamental Change Share Price&#59; or</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;pay the Fundamental Change Dividend Make-Whole Amount through any combination of cash and shares of our common stock (or Units of Exchange Property as described below) in accordance with the provisions of clauses (a) and (b) above.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        As used herein, the term &#34;Accumulated Dividend Amount&#34; means, with respect to any Fundamental Change, the aggregate amount of accumulated and unpaid dividends, if any, that have not been declared for dividend periods prior to the relevant Fundamental Change Effective Date, including (but subject to the second sentence under &#34;&#8212;General&#34; above) for the partial dividend period, if any, from, and including, the Dividend Payment Date immediately preceding such Fundamental Change Effective Date to, but excluding, such Fundamental Change Effective Date. For the avoidance of doubt, if the Regular Record Date for a dividend period for which we have, as of the Fundamental Change Effective Date, declared a dividend occurs before or during the related Fundamental Change Conversion Period, then we will pay such dividend on the relevant Dividend Payment Date to the holders of record at the Close of Business on such Regular Record Date, as described under &#34;&#8212;Dividends,&#34; and the Accumulated Dividend Amount will not include the amount of such dividend, and the Fundamental Change Dividend Make-Whole Amount will not include the present value of such dividend.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Accumulated Dividend Amount will be payable at our option (subject to satisfaction of the requirements described below)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">in cash (computed to the nearest cent), to the extent we are able to do so under applicable law and in compliance with our indebtedness&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">in an additional number of shares of our common stock (or Units of Exchange Property as described below) equal to (x) the Accumulated Dividend Amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (y) the greater of (i) the Floor Price and (ii) 97% of the Fundamental Change Share Price&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">through any combination of cash and shares of our common stock (or Units of Exchange Property) in accordance with the provisions of the preceding two bullets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will pay the Fundamental Change Dividend Make-Whole Amount and the Accumulated Dividend Amount in cash, except to the extent we elect on or prior to the second Business Day following the Fundamental Change Effective Date to make all or any portion of such payments in shares of our common stock (or Units of Exchange Property). For the avoidance of doubt, however, our existing credit agreements currently contain a restriction on our ability to pay such amounts in cash. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If we elect to deliver common stock (or Units of Exchange Property) in respect of all or any portion of the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount, to the extent that the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount or the dollar amount of any portion thereof paid in common stock (or Units of Exchange Property) exceeds the product of (x) the number of additional shares we deliver in respect thereof and (y) 97% of the Fundamental Change Share Price, we will, to the extent we are able to do so under applicable law and in compliance with our indebtedness, pay such excess amount in cash (computed to the nearest cent). Any such payment in cash may not be permitted by our then existing debt instruments and is not permitted under our existing credit agreements. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">our Credit Facilities.&#34; To the extent that we are not able to pay such excess amount in cash under applicable law and in compliance with our indebtedness, we will not have any obligation to pay such amount in cash or deliver additional shares of our common stock in respect of such amount.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        However, if we are prohibited from paying or delivering, as the case may be, the Fundamental Change Dividend Make-Whole Amount (whether in cash or in shares of our common stock), in whole or in part, due to limitations of applicable law, then the Fundamental Change Conversion Rate will instead be increased by a number of shares of common stock equal to the cash amount of the aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the greater of (i) the Floor Price and (ii) 97% of the Fundamental Change Share Price. To the extent that the cash amount of the aggregate unpaid and undelivered Fundamental Change Dividend Make-Whole Amount exceeds the product of such number of additional shares and 97% of the Fundamental Change Share Price, we will not have any obligation to pay the shortfall in cash or deliver additional shares of our common stock in respect of such amount.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        No fractional shares of our common stock (or to the extent applicable, Units of Exchange Property) will be delivered to converting holders of the Mandatory Convertible Preferred Stock in respect of the Fundamental Change Dividend Make-Whole Amount or the Accumulated Dividend Amount. We will instead, to the extent we are able to do so under applicable law and in compliance with our indebtedness, pay a cash amount (computed to the nearest cent) to each converting holder that would otherwise be entitled to receive a fraction of a share of our common stock (or to the extent applicable, Units of Exchange Property) based on the Average VWAP per share of our common stock (or to the extent applicable, Units of Exchange Property) over the five consecutive Trading Day period commencing on, and including, the seventh Scheduled Trading Day immediately preceding the Fundamental Change Conversion Date. In the event that we cannot pay cash in lieu of a fractional share, we will instead round up to the nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional share. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34; Not later than the second Business Day following the Fundamental Change Effective Date, we will notify holders of&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Fundamental Change Conversion Rate (if we provide notice to holders prior to the anticipated Fundamental Change Effective Date, specifying how the Fundamental Change Conversion Rate will be determined)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Fundamental Change Dividend Make-Whole Amount and whether we will pay such amount in cash, shares of our common stock (or to the extent applicable, Units of Exchange Property) or a combination thereof, specifying the combination, if applicable&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Accumulated Dividend Amount as of the Fundamental Change Effective Date and whether we will pay such amount in cash, shares of our common stock (or to the extent applicable, Units of Exchange Property) or a combination thereof, specifying the combination, if applicable.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Our obligation to deliver shares at the Fundamental Change Conversion Rate in connection with a Fundamental Change and pay the Fundamental Change Dividend Make-Whole Amount (whether in cash, our common stock or any combination thereof) could be considered a penalty under state law, in which case the enforceability thereof would be subject to general principles of reasonableness of economic remedies and therefore may not be enforceable in whole or in part.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conversion Procedures</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Upon Mandatory Conversion</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any outstanding shares of Mandatory Convertible Preferred Stock will mandatorily and automatically convert into shares of common stock on the Mandatory Conversion Date.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The holders of the Mandatory Convertible Preferred Stock will not be required to pay any transfer or similar taxes or duties relating to the issuance or delivery of our common stock upon conversion, but each holder will be required to pay any tax or duty that may be payable relating to any transfer involved in the issuance or delivery of the common stock in a name other than such holder&#8217;s own.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as the shares of the Mandatory Convertible Preferred Stock being converted are in global form, the shares of common stock issuable upon conversion will be delivered to the converting holder through the facilities of DTC, in each case together with delivery by us to the converting holder of any cash to which the converting holder is entitled, only after all applicable taxes and duties, if any, payable by such holder have been paid in full, and such shares and cash will be delivered on the later of (i) the Mandatory Conversion Date and (ii) the Business Day after such holder has paid in full all applicable taxes and duties, if any.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The person or persons entitled to receive the shares of our common stock issuable upon mandatory conversion of the Mandatory Convertible Preferred Stock will be treated as the record holder(s) of such shares as of the close of business on the Mandatory Conversion Date. Prior to the close of business on the Mandatory Conversion Date, the common stock issuable upon conversion of the Mandatory Convertible Preferred Stock on the Mandatory Conversion Date will not be deemed to be outstanding for any purpose and such holder will have no rights, powers or preferences with respect to such common stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the common stock, by virtue of holding the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Upon Early Conversion or Upon Early Fundamental Change Conversion</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If a holder elects to convert the Mandatory Convertible Preferred Stock prior to the Mandatory Conversion Date, in the manner described in &#34;&#8212;Early Conversion at the Option of the Holder&#34; or &#34;&#8212;Conversion at the Option of the Holder upon Fundamental Change&#59; Fundamental Change Dividend Make-Whole Amount&#34; (an &#34;Early Fundamental Change Conversion&#34;), the holder must observe the following conversion procedures&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if such holder holds a beneficial interest in a global share of Mandatory Convertible Preferred Stock, such holder must deliver to DTC the appropriate instruction form for conversion pursuant to DTC's conversion program&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if such holder holds shares of the Mandatory Convertible Preferred Stock in certificated form, such holder must comply with certain procedures set forth in the Certificate of Designations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In either case, if required, the holder must pay all transfer or similar taxes or duties, if any.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The &#34;conversion date&#34; will be the date on which the holder has satisfied the foregoing requirements with respect to an Early Conversion or an Early Fundamental Change Conversion.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The holders will not be required to pay any transfer or similar taxes or duties relating to the issuance or delivery of our common stock upon conversion, but each holder will be required to pay any tax or duty that may be payable relating to any transfer involved in the issuance or delivery of the common stock in a name other than such holder&#8217;s own.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as the shares of the Mandatory Convertible Preferred Stock being converted are in global form, the shares of common stock will be issued and delivered to the converting holder through the facilities of DTC, together with delivery by us to the converting holder of any cash to which the converting holder is entitled, only after all applicable taxes and duties, if any, payable by the converting holder have been paid in full, and such shares and cash will be delivered on the latest of (i) the second Business Day immediately succeeding the conversion date, (ii) the second Business Day immediately succeeding the last day of the Early Conversion Settlement Period, if applicable, and (iii) the Business Day after the converting holder has paid in full all applicable taxes and duties, if any.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The person or persons entitled to receive the common stock issuable upon early conversion of the Mandatory Convertible Preferred Stock will be treated as the record holder(s) of such shares as of the close of business on the applicable Early Conversion Date or Fundamental Change Conversion Date. Prior to the close of business on the applicable Early Conversion Date or Fundamental Change Conversion Date, the common stock issuable upon conversion of the Mandatory Convertible Preferred Stock will not be deemed to be outstanding for any purpose, and the holder will have no rights, powers or preferences with respect to such common stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the common stock, by virtue of holding the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fractional Shares</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        No fractional shares of our common stock will be issued to holders of the Mandatory Convertible Preferred Stock upon conversion. In lieu of any fractional shares of our common stock otherwise issuable in respect of the aggregate number of shares of the Mandatory Convertible Preferred Stock of any holder that are converted, that holder will be entitled to receive an amount in cash (computed to the nearest cent) equal to the product of&#58; (i) that same fraction&#59; and (ii) the Average VWAP of our common stock over the five consecutive Trading Day period commencing on, and including, the seventh Scheduled Trading Day immediately preceding the relevant conversion date. In the event that we cannot pay cash in lieu of a fractional share, we will instead round up to the nearest whole share for each holder. The terms of our existing credit agreements do not permit the payment of a cash amount in lieu of a fractional share. See &#34;&#8212;Dividends&#8212;Limitation on Cash Payments under our Credit Facilities.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Subject to any applicable rules and procedures of DTC, if more than one share of the Mandatory Convertible Preferred Stock is surrendered for conversion at one time by or for the same holder, the number of shares of full shares of our common stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of the Mandatory Convertible Preferred Stock so surrendered.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Anti-Dilution Adjustments</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Each Fixed Conversion Rate will be adjusted as described below, except that we will not make any adjustments to the Fixed Conversion Rates if holders of the Mandatory Convertible Preferred Stock participate (other than in the case of a share split or share combination), at the same time and upon the same terms as holders of our common stock and solely as a result of holding the Mandatory Convertible </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Preferred Stock, in any of the transactions described below without having to convert their Mandatory Convertible Preferred Stock as if they held a number of shares of common stock equal to (i) the Maximum Conversion Rate as of the record date for such transaction, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) the number of shares of Mandatory Convertible Preferred Stock held by such holder.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we exclusively issue shares of our common stock as a dividend or distribution on shares of our common stock, or if we effect a share split or share combination, each Fixed Conversion Rate will be adjusted based on the following formula&#58;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mcps202010-k1.jpg" src="mcps202010-k1.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:256px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the record date (as defined below) of such dividend or distribution, or immediately prior to the open of business on the effective date of such share split or share combination, as applicable&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on such record date or immediately after the open of business on such effective date, as applicable&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS0 &#61; the number of shares of our common stock outstanding immediately prior to the close of business on such record date or immediately prior to the open of business on such effective date, as applicable, before giving effect to such dividend, distribution, share split or share combination&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS1 &#61; the number of shares of our common stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any adjustment made under this clause (1) shall become effective immediately after the close of business on the record date for such dividend or distribution, or immediately after the open of business on the effective date for such share split or share combination, as applicable. If any dividend or distribution of the type described in this clause (1) is declared but not so paid or made, each Fixed Conversion Rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or distribution, to such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared. For the purposes of this clause (1), the number of shares of our common stock outstanding immediately prior to the close of business on the record date and the number of shares of our common stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination shall, in each case, not include shares that we hold in treasury. We will not pay any dividend or make any distribution on shares of our common stock that we hold in treasury.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;effective date&#34; as used in this clause (1) means the first date on which the shares of our common stock trade on the Relevant Stock Exchange, regular way, reflecting the relevant share split or share combination, as applicable.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;record date&#34; means, with respect to any dividend, distribution or other transaction or event in which the holders of our common stock (or other applicable security) have the right to receive any cash, </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">securities or other property or in which our common stock (or such other security) is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of our common stock (or such other security) entitled to receive such cash, securities or other property (whether such date is fixed by our board of directors or a duly authorized committee thereof, statute, contract or otherwise).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we issue to all or substantially all holders of our common stock any rights, options or warrants entitling them, for a period of not more than 60 calendar days after the announcement date of such issuance, to subscribe for or purchase shares of our common stock at a price per share that is less than the Average VWAP per share of our common stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, each Fixed Conversion Rate will be increased based on the following formula&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:center"><img alt="mcps202010-k21.jpg" src="mcps202010-k21.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:258px"></div><div style="margin-bottom:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such issuance&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on such record date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS0 &#61; the number of shares of our common stock outstanding immediately prior to the close of business on such record date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">X &#61; the total number of shares of our common stock issuable pursuant to such rights, options or warrants&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Y &#61; the number of shares of our common stock equal to (i) the aggregate price payable to exercise such rights, options or warrants, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any increase made under this clause (2) will be made successively whenever any such rights, options or warrants are issued and shall become effective immediately after the close of business on the record date for such issuance. To the extent that such rights, options or warrants are not exercised prior to their expiration or shares of common stock are not delivered after the exercise of such rights, options or warrants, each Fixed Conversion Rate shall be decreased to such Fixed Conversion Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of common stock actually delivered, if any. If such rights, options or warrants are not so issued, each Fixed Conversion Rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or distribution, to such Fixed Conversion Rate that would then be in effect if such record date for such issuance had not occurred.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For the purpose of this clause (2), in determining whether any rights, options or warrants entitle the holders of our common stock to subscribe for or purchase shares of our common stock at less than such Average VWAP per share for the 10 consecutive trading day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, and in determining the aggregate offering price of such shares of our common stock, there shall be taken into account any consideration received by us for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by our board of directors or a committee thereof.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        (3)(A) If we distribute shares of our capital stock, evidences of our indebtedness, other assets or property of ours or rights, options or warrants to acquire our capital stock or other securities, to all or substantially all holders of our common stock, excluding&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">dividends, distributions or issuances as to which the provisions set forth in in clause (1) or (2) shall apply&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">dividends or distributions paid exclusively in cash as to which the provisions set forth in clause (4) below shall apply&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any dividends and distributions upon conversion of, or in exchange for, our common stock in connection with a recapitalization, reclassification, change, consolidation, merger or other combination, share exchange, or sale, lease or other transfer or disposition resulting in the change in the conversion consideration as described below under &#34;&#8212;Recapitalizations, Reclassifications and Changes of Our Common Stock&#34;&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">except as otherwise described below, rights issued pursuant to a shareholder rights plan adopted by us&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">spin-offs as to which the provisions set forth below in clause (3)(B) shall apply&#59; then each Fixed Conversion Rate will be increased based on the following formula&#58;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mcps202010-k31.jpg" src="mcps202010-k31.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such distribution&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on such record date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SP0 &#61; the Average VWAP per share of our common stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the ex-date (as defined below) for such distribution&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FMV &#61; the fair market value (as determined by our board of directors or a committee thereof) of the shares of capital stock, evidences of indebtedness, assets, property, rights, options or warrants so distributed, expressed as an amount per share of our common stock on the ex-date for such distribution.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        &#34;ex-date&#34; means the first date on which the shares of our common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from us or, if applicable, from the seller of our common stock on such exchange or market (in the form of due bills or otherwise) as determined by such exchange or market.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any increase made under this clause (3)(A) above will become effective immediately after the close of business on the record date for such distribution. If such distribution is not so paid or made, each fixed conversion rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or distribution, to be such fixed conversion rate that would then be in effect if such distribution had not been declared.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Notwithstanding the foregoing, if &#34;FMV&#34; (as defined above) is equal to or greater than &#34;SP0&#34; (as defined above), or if the difference is less than $1.00, in lieu of the foregoing increase, each holder shall receive, in respect of each share of Mandatory Convertible Preferred Stock, at the same time and upon the same terms as holders of our common stock, the amount and kind of our capital stock, evidences of our indebtedness, other assets or property of ours or rights, options or warrants to acquire our capital stock or other securities that such holder would have received if such holder owned a number of shares of common stock equal to the Maximum Conversion Rate in effect on the record date for the distribution.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If we issue rights, options or warrants that are only exercisable upon the occurrence of certain triggering events, then&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">we will not adjust the Fixed Conversion Rates pursuant to the foregoing in this clause (3) until the earliest of these triggering events occurs&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">we will readjust the Fixed Conversion Rates to the extent any of these rights, options or warrants are not exercised before they expire&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the rights, options or warrants trade together with our common stock and will be issued in respect of future issuances of the shares of our common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)(B) With respect to an adjustment pursuant to this clause (3) where there has been a payment of a dividend or other distribution on our common stock of shares of capital stock of any class or series, or similar equity interest, of or relating to a subsidiary or other business unit, that are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange, which we refer to as a &#34;spin-off,&#34; each Fixed Conversion Rate will be increased based on the following formula&#58;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mcps202010-k41.jpg" src="mcps202010-k41.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:189px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the open of business on the ex-date for the spin-off&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the open of business on the ex-date for the spin-off&#59;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FMV0 &#61; the Average VWAP per share of the capital stock or similar equity interest distributed to holders of our common stock applicable to one share of our common stock over the 10 consecutive Trading Day period commencing on, and including, the ex-date for the spin-off, or the &#34;valuation period&#34;&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MP0 &#61; the Average VWAP per share of our common stock over the valuation period.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The increase to each Fixed Conversion Rate under the preceding paragraph will be calculated as of the close of business on the last Trading Day of the valuation period but will be given effect as of immediately after the open of business on the ex-date of the spin-off. Because we will make the adjustment to each Fixed Conversion Rate with retroactive effect, we will delay the settlement of any conversion of Mandatory Convertible Preferred Stock where any date for determining the number of shares of our common stock issuable to a holder occurs during the valuation period until the second Business Day after the last date for determining the number of shares of our common stock issuable to a holder with respect to such conversion occurs. If such dividend or distribution is not so paid, each Fixed Conversion Rate shall be decreased, effective as of the date our board of directors or a committee thereof determines not to make or pay such dividend or distribution, to be such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (4)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any cash dividend or distribution is made to all or substantially all holders of our common stock, each Fixed Conversion Rate will be adjusted based on the following formula&#58;</font></div><div><font><br></font></div><div style="text-align:center"><img alt="mcps202010-k51.jpg" src="mcps202010-k51.jpg" style="height:43px;margin-bottom:5pt;vertical-align:text-bottom;width:156px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the record date for such dividend or distribution&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on the record date for such dividend or distribution&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SP0 &#61; the last reported sale price of our common stock on the Trading Day immediately preceding the ex-date for such dividend or distribution&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C &#61; the amount in cash per share we distribute to all or substantially all holders of our common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Any increase made under this clause (4) shall become effective immediately after the close of business on the record date for such dividend or distribution. If such dividend or distribution is not so paid, each Fixed Conversion Rate shall be decreased, effective as of the date our board of directors or a committee thereof determines not to make or pay such dividend or distribution, to be such Fixed Conversion Rate that would then be in effect if such dividend or distribution had not been declared.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The &#34;last reported sale price&#34; of our common stock on any date means&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">prices) on such date as reported in composite transactions for the relevant stock exchange (as defined below)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if our common stock is not listed for trading on a relevant stock exchange on such date, the last quoted bid price for our common stock in the over-the-counter market on such date as reported by OTC Markets Group Inc. or a similar organization&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">if our common stock is not so quoted, the average of the mid-point of the last bid and ask prices for our common stock on such date from each of at least three nationally recognized independent investment banking firms selected by us for this purpose.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Notwithstanding the foregoing, if &#34;C&#34; (as defined above) is equal to or greater than &#34;SP0&#34; (as defined above), or if the difference is less than $1.00, in lieu of the foregoing increase, each holder shall receive, for each share of Mandatory Convertible Preferred Stock, at the same time and upon the same terms as holders of shares of our common stock, the amount of cash that such holder would have received if such holder owned a number of shares of our common stock equal to the Maximum Conversion Rate on the record date for such cash dividend or distribution.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we or any of our subsidiaries make a payment in respect of a tender or exchange offer for our common stock, to the extent that the cash and value of any other consideration included in the payment per share of common stock exceeds the Average VWAP per share of our common stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer (the &#34;expiration date&#34;), each Fixed Conversion Rate will be increased based on the following formula&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mcps202010-k61.jpg" src="mcps202010-k61.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:207px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">where,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR0 &#61; such Fixed Conversion Rate in effect immediately prior to the close of business on the expiration date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CR1 &#61; such Fixed Conversion Rate in effect immediately after the close of business on the expiration date&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AC &#61; the aggregate value of all cash and any other consideration (as determined by our board of directors or a committee thereof) paid or payable for shares purchased in such tender or exchange offer&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS0 &#61; the number of shares of our common stock outstanding immediately prior to the expiration date (prior to giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer)&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OS1 &#61; the number of shares of our common stock outstanding immediately after the expiration date (after giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer)&#59; and</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SP1 &#61; the Average VWAP of our common stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the expiration date (the &#34;averaging period&#34;).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The increase to each Fixed Conversion Rate under the preceding paragraph will be calculated at the close of business on the last Trading Day of the averaging period but will be given effect as of immediately after the close of business on the expiration date. Because we will make the adjustment to each Fixed Conversion Rate with retroactive effect, we will delay the settlement of any conversion of Mandatory Convertible Preferred Stock where any date for determining the number of shares of our common stock issuable to a holder occurs during the averaging period until the second Business Day after the last date for determining the number of shares of our common stock issuable to a holder with respect to such conversion occurs. For the avoidance of doubt, no adjustment under this clause (5) will be made if such adjustment would result in a decrease in any Fixed Conversion Rate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In the event that we or one of our subsidiaries is obligated to purchase shares of common stock pursuant to any such tender offer or exchange offer, but we or such subsidiary is permanently prevented by applicable law from effecting any such purchases, or all such purchases are rescinded, then each Fixed Conversion Rate shall again be adjusted to be such Fixed Conversion Rate that would then be in effect if such tender offer or exchange offer had not been made.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For the avoidance of doubt, for purposes of this subsection (5), the term &#34;tender offer&#34; is used as such term is used in the Exchange Act and the term &#34;exchange offer&#34; means an exchange offer that constitutes a tender offer.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We may, to the extent permitted by law and the rules of NYSE or any other securities exchange on which our common stock or the Mandatory Convertible Preferred Stock is then listed, increase each Fixed Conversion Rate by any amount for a period of at least 20 Business Days if such increase is irrevocable during such 20 Business Days and our board of directors (or a committee thereof) determines that such increase would be in our best interest. In addition, we may make such increases in each Fixed Conversion Rate as we deem advisable in order to avoid or diminish any income tax to holders of our common stock resulting from any dividend or distribution of shares of our common stock (or issuance of rights or warrants to acquire shares of our common stock) or from any event treated as such for income tax purposes or for any other reason. We may only make such a discretionary adjustment if we make the same proportionate adjustment to each Fixed Conversion Rate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Holders of the Mandatory Convertible Preferred Stock may, in certain circumstances, including a distribution of cash dividends to holders of our shares of common stock, be deemed to have received a distribution subject to U.S. Federal income tax as a dividend as a result of an adjustment or the nonoccurrence of an adjustment to the Fixed Conversion Rates. See &#34;Material U.S. Federal Income Tax Considerations.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If we have a rights plan in effect upon conversion of the Mandatory Convertible Preferred Stock into common stock, each holder will receive, in addition to any shares of common stock received in connection with such conversion, the rights under the rights plan. However, if, prior to any conversion, the rights have separated from the shares of common stock in accordance with the provisions of the applicable rights plan, each Fixed Conversion Rate will be adjusted at the time of separation as if we distributed to all or substantially all holders of our common stock, shares of our capital stock, evidences of indebtedness, assets, property, rights, options or warrants as described in clause (3)(A) above, subject to readjustment in </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the event of the expiration, termination or redemption of such rights. We do not currently have a stockholder rights plan in effect.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Adjustments to the Fixed Conversion Rates will be calculated to the nearest 1&#47;10,000th of a share of our common stock. No adjustment to any Fixed Conversion Rate will be required unless the adjustment would require an increase or decrease of at least 1% of the Fixed Conversion Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that if an adjustment is not made because the adjustment does not change the Fixed Conversion Rates by at least 1%, then such adjustment will be carried forward and taken into account in any future adjustment. Notwithstanding the foregoing, on each date for determining the number of shares of our common stock issuable to a holder upon any conversion of the Mandatory Convertible Preferred Stock we will give effect to all adjustments that we have otherwise deferred pursuant to this sentence, and those adjustments will no longer be carried forward and taken into account in any future adjustment.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Fixed Conversion Rates will not be adjusted&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">upon the issuance of any shares of our common stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on our securities and the investment of additional optional amounts in common stock under any plan&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">upon the issuance of any shares of our common stock or rights or warrants to purchase those shares pursuant to any present or future benefit or other incentive plan or program of or assumed by us or any of our subsidiaries&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">upon the issuance of any shares of our common stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described in the preceding bullet and outstanding as of the Initial Issue Date&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">for a change in the par value of our common stock&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">for stock repurchases that are not tender offers referred to in clause (5) of the adjustments above, including structured or derivative transactions or pursuant to a stock repurchase program approved by our board of directors&#59; or for accumulated dividends on the Mandatory Convertible Preferred Stock, except as described above under &#34;&#8212;Mandatory Conversion,&#34; &#34;&#8212;Early Conversion at the Option of the Holder&#34; and &#34;&#8212;Conversion at the Option of the Holder upon Fundamental Change&#59; Fundamental Change Dividend Make-Whole Amount.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Except as otherwise provided above, we will be responsible for making all calculations called for under the Mandatory Convertible Preferred Stock. These calculations include, but are not limited to, determinations of the Fundamental Change Share Price, the VWAPs, the Average VWAPs, the last reported sale price and the Fixed Conversion Rates of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will be required, within 10 Business Days after the Fixed Conversion Rates are adjusted, to provide or cause to be provided written notice of the adjustment to the holders of the Mandatory Convertible Preferred Stock. We will also be required to deliver a statement setting forth in reasonable detail the method by which the adjustment to each Fixed Conversion Rate was determined and setting forth each adjusted Fixed Conversion Rate.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        For the avoidance of doubt, if an adjustment is made to the Fixed Conversion Rates, no separate inversely proportionate adjustment will be made to the Initial Price or the Threshold Appreciation Price </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">because the Initial Price is equal to $100.00 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Maximum Conversion Rate (as adjusted in the manner described herein) and the Threshold Appreciation Price is equal to $100.00 divided by the Minimum Conversion Rate (as adjusted in the manner described herein).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Whenever the terms of the Mandatory Convertible Preferred Stock require us to calculate the VWAP per share of our common stock over a span of multiple days, our board of directors or an authorized committee thereof will make appropriate adjustments (including, without limitation, to the Applicable Market Value, the Early Conversion Average Price, the Fundamental Change Share Price and the Average Price (as the case may be)) to account for any adjustments to the Fixed Conversion Rates (as the case may be) that become effective, or any event that would require such an adjustment if the ex-date, effective date, record date or expiration date (as the case may be) of such event occurs, during the relevant period used to calculate such prices or values (as the case may be).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the record date for a dividend or distribution on shares of our common stock occurs after the end of the 20 consecutive Trading Day period used for calculating the Applicable Market Value and before the Mandatory Conversion Date&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">that dividend or distribution would have resulted in an adjustment of the number of shares issuable to the holders of the Mandatory Convertible Preferred Stock had such record date occurred on or before the last Trading Day of such 20-Trading Day period,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">then we will deem the holders of the Mandatory Convertible Preferred Stock to be holders of record of our common stock for purposes of that dividend or distribution. In this case, the holders of the Mandatory</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Convertible Preferred Stock would receive the dividend or distribution on our common stock together with the number of shares of our common stock issuable upon mandatory conversion of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recapitalizations, Reclassifications and Changes of Our Common Stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        In the event of&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any consolidation or merger of us with or into another person (other than a merger or consolidation in which we are the surviving corporation and in which the shares of our common stock outstanding immediately prior to the merger or consolidation are not exchanged for cash, securities or other property of us or another person)&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any sale, transfer, lease or conveyance to another person of all or substantially all of our property and assets&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any reclassification of our common stock into securities, including securities other than our common stock&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">any statutory exchange of our securities with another person (other than in connection with a merger or acquisition),</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in each case, as a result of which our common stock would be converted into, or exchanged for, stock, other securities or other property or assets (including cash or any combination thereof) (each, a &#34;Reorganization Event&#34;), each share of the Mandatory Convertible Preferred Stock outstanding immediately prior to such Reorganization Event shall, without the consent of the holders of the Mandatory Convertible Preferred Stock, become convertible into the kind of stock, other securities or other property or assets (including cash or any combination thereof) that such holder would have been entitled to receive if such holder had converted its Mandatory Convertible Preferred Stock into common stock immediately prior to such Reorganization Event (such stock, other securities or other property or assets (including cash or any combination thereof), the &#34;Exchange Property&#34;, with each &#34;Unit of Exchange Property&#34; meaning the kind and amount of Exchange Property that a holder of one share of common stock is entitled to receive).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If the transaction causes our common stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of stockholder election), the Exchange Property into which the Mandatory Convertible Preferred Stock will be convertible will be deemed to be the weighted average of the types and amounts of consideration actually received by the holders of our common stock. We will notify holders of the Mandatory Convertible Preferred Stock of the weighted average as soon as practicable after such determination is made.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The number of Units of Exchange Property we will deliver for each share of the Mandatory Convertible Preferred Stock converted following the effective date of such Reorganization Event will be determined as if references to our common stock in the description of the conversion rate applicable upon mandatory conversion, Early Conversion and Early Fundamental Change Conversion were to Units of Exchange Property (without interest thereon and without any right to dividends or distributions thereon which have a record date prior to the date such Mandatory Convertible Preferred Stock is actually converted). For the purpose of determining which bullet of the definition of conversion rate in the second paragraph under &#34;&#8212;Mandatory Conversion&#34; will apply upon mandatory conversion, and for the purpose of calculating the conversion rate if the second bullet is applicable, the value of a Unit of Exchange Property will be determined in good faith by our board of directors or an authorized committee thereof (which determination will be final), except that if a Unit of Exchange Property includes common stock or American Depositary Receipts, or &#34;ADRs&#34;, that are traded on a U.S. national securities exchange, the value of such common stock or ADRs will be the average over the 20 consecutive Trading Day period used for calculating the Applicable Market Value of the volume-weighted average prices for such common stock or ADRs, as displayed on the applicable Bloomberg screen (as determined in good faith by our board of directors or an authorized committee thereof (which determination will be final))&#59; or, if such price is not available, the average market value per share of such common stock or ADRs over such period as determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained by us for this purpose. The provisions of this paragraph will apply to successive Reorganization Events, and the provisions summarized under &#34;&#8212;Anti-Dilution Adjustments&#34; will apply to any shares of capital stock or ADRs of us or any successor received by the holders of shares of our common stock in any such Reorganization Event.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We (or any successor to us) will, as soon as reasonably practicable (but in any event within 20 calendar days) after the occurrence of any Reorganization Event provide written notice to the holders of the Mandatory Convertible Preferred Stock of such occurrence and of the kind and amount of cash, securities or other property that constitute the Exchange Property. Failure to deliver such notice will not affect the operation of the provisions described in this section.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reservation of Shares</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We will at all times reserve and keep available out of the authorized and unissued shares of common stock, solely for issuance upon conversion of the Mandatory Convertible Preferred Stock, the maximum number of shares of our common stock as shall be issuable from time to time upon the conversion of all the shares of the Mandatory Convertible Preferred Stock then outstanding.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Book-Entry, Delivery and Form</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        The Mandatory Convertible Preferred Stock will be issued in global form. DTC or its nominee will be the sole registered holder of the Mandatory Convertible Preferred Stock. Ownership of beneficial interests in the Mandatory Convertible Preferred Stock in global form will be limited to persons who have accounts with DTC, or &#34;participants&#34;, or persons who hold interests through such participants. Ownership of beneficial interests in the Mandatory Convertible Preferred Stock in global form will be shown on, and the transfer of that ownership will be effected only through, records maintained by DTC or its nominee (with respect to interests of participants) and the records of participants (with respect to interests of persons other than participants).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        So long as DTC, or its nominee, is the registered owner or holder of a global certificate representing the shares of the Mandatory Convertible Preferred Stock, DTC or such nominee, as the case may be, will be considered the sole holder of the shares of the Mandatory Convertible Preferred Stock represented by such global certificate for all purposes under the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock. No beneficial owner of an interest in the shares of the Mandatory Convertible Preferred Stock in global form will be able to transfer that interest except in accordance with the applicable procedures of DTC in addition to those provided for under the Certificate of Designations establishing the terms of the Mandatory Convertible Preferred Stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Payments of dividends on the global certificate representing the shares of the Mandatory Convertible Preferred Stock will be made to DTC or its nominee, as the case may be, as the registered holder thereof. None of us, the transfer agent, registrar, conversion or dividend disbursing agent will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests in a global certificate representing the shares of the Mandatory Convertible Preferred Stock or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        We expect that DTC or its nominee, upon receipt of any payment of dividends in respect of a global certificate representing the shares of the Mandatory Convertible Preferred Stock, will credit participants' accounts with payments in amounts proportionate to their respective beneficial ownership interests in the aggregate Liquidation Preference of such global certificate representing the shares of the Mandatory Convertible Preferred Stock as shown on the records of DTC or its nominee, as the case may be. We also expect that payments by participants to owners of beneficial interests in such global certificate representing the shares of the Mandatory Convertible Preferred Stock held through such participants will be governed by standing instructions and customary practices, as is now the case with securities held for the accounts of customers registered in the names of nominees for such customers. Such payments will be the responsibility of such participants.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Transfers between participants in DTC will be effected in the ordinary way in accordance with DTC rules and will be settled in same-day funds. We understand that DTC is&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a limited purpose trust company organized under the laws of the State of New York&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a &#34;banking organization&#34; within the meaning of New York Banking Law&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a member of the Federal Reserve System&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a &#34;clearing corporation&#34; within the meaning of the Uniform Commercial Code&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">a &#34;Clearing Agency&#34; registered pursuant to the provisions of Section 17A of the Exchange Act.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        DTC was created to hold securities for its participants and facilitate the clearance and settlement of securities transactions between participants through electronic book-entry changes in accounts of its participants, thereby eliminating the need for physical movement of certificates. Participants include&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">securities brokers and dealers&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">banks and trust companies&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">clearing corporations and certain other organizations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Indirect access to the DTC system is available to others such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly (indirect participants).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        Although DTC is expected to follow the foregoing procedures in order to facilitate transfers of interests in a global security among its participants, it is under no obligation to perform or continue to perform such procedures, and such procedures may be discontinued at any time. None of us, the transfer agent, registrar, conversion or dividend disbursing agent will have any responsibility for the performance by DTC or its participants or indirect participants of their respective obligations under the rules and procedures governing their operations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        If DTC is at any time unwilling or unable to continue as a depositary for the shares of the Mandatory Convertible Preferred Stock in global form or DTC ceases to be registered as a clearing agency under the Exchange Act, and in either case a successor depositary is not appointed by us within 90 days, we will issue certificated shares in exchange for the global securities. Holders of an interest in the Mandatory Convertible Preferred Stock in global form may receive certificated shares, at our option, in accordance with the rules and procedures of DTC in addition to those provided for under the Certificate of Designations. Beneficial interests in Mandatory Convertible Preferred Stock in global form held by any direct or indirect participant may also be exchanged for certificated shares upon request to DTC by such direct participant (for itself or on behalf of an indirect participant), to the transfer agent in accordance with their respective customary procedures.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Description of 0.625% Senior Notes due 2027</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following description of our 0.625% Senior Notes due 2027 (the &#8220;notes&#8221;) is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to the form of the notes and the indenture, dated as of May 29, 2013 (the &#8220;Indenture&#8221;), between us and U.S. Bank National Association, as trustee (the &#8220;trustee&#8221;), which are both incorporated by reference as exhibits to the Annual Report on Form 10-K of which this exhibit is a part. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are traded on The New York Stock Exchange under the bond trading symbol of &#8220;BSX27.&#8221; Currently, U.S. Bank National Association is acting as transfer agent and registrar for the notes and Elavon Financial Services DAC (UK Branch) is acting as paying agent.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Capitalized terms that are used but not otherwise defined herein have the meanings assigned to them in the Indenture, and those definitions are incorporated herein by reference. We encourage you to read the above referenced Indenture for additional information.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes offered were initially issued in an aggregate principal amount of &#8364;900,000,000 aggregate principal amount, which is the amount outstanding as of the date of the Annual Report on Form 10-K of which this exhibit is a part. The notes will mature on December&#160;1, 2027.  The notes will not be entitled to the benefit of a sinking fund.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes will bear interest from November 12, 2019, payable annually in arrears on December&#160;1 of each year, beginning December&#160;1, 2020, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment date. Interest on the notes will be computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes (or November&#160;12, 2019, if no interest has been paid on the notes), to, but excluding, the next scheduled interest payment date. This payment convention is referred to as ACTUAL&#47;ACTUAL (ICMA) as defined in the rulebook of the International Capital Market Association. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Additional notes (the &#8220;Additional Notes&#8221;) in an unlimited amount may be issued in one or more series from time to time on the same terms and conditions, except for issue date, and in certain cases the issue price and the first interest payment, either of which may differ from the respective terms of the previously issued notes of the same series, and with the same CUSIP numbers as the notes (to the extent permissible under applicable law) without the consent of Holders of the notes.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Ranking</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are unsecured and rank on a parity with all of our other unsecured and unsubordinated indebtedness from time to time outstanding. The notes will rank senior to any existing and future unsecured and subordinated debt, effectively junior to our secured debt to the extent of the collateral securing such secured debt and effectively junior to liabilities of our subsidiaries, in each case as may be outstanding from time to time. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance in Euro</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will pay the principal of, premium, if any, and interest on each note to the registered holder in euro in immediately available funds, provided that, if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Economic and Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted by us into U.S. dollars at the rate mandated by the U.S. Federal Reserve Board as of the close of business on the second business day prior to the relevant payment date or, in the event the U.S. Federal Reserve Board has not mandated a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date. Any payment in respect of the notes so made in U.S. dollars will not constitute an event of default under the notes or the indenture governing the notes.</font></div><div style="margin-top:5pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitation on Liens</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will not, and will not permit any of our Subsidiaries (as defined in the Indenture) to, directly or indirectly, create, incur, assume or suffer to exist any Lien (as defined in the Indenture) upon any of our property, assets or revenues, whether now owned or hereafter acquired, except for&#58; (i)&#160;Liens for taxes not yet due or which are being contested in good faith by appropriate proceedings&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;that adequate reserves with respect thereto are maintained on our or our Subsidiaries&#8217; books, as the case may be, in conformity with accounting principles generally accepted in the United States&#59; (ii)&#160;carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s or other like Liens arising in the ordinary course of business that are not overdue for a period of more than 60&#160;days or which are being contested in good faith by appropriate proceedings&#59; (iii)&#160;pledges or deposits in connection with workers&#8217; compensation, unemployment insurance and other social security legislation and deposits securing liability to insurance carriers under insurance or self-insurance arrangements&#59; (iv)&#160;deposits to secure the performance of bids, trade contracts (other than for borrowed money), leases, statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business&#59; (v)&#160;easements, rights-of-way, restrictions and other similar encumbrances incurred in the ordinary course of business which, in the aggregate, are not substantial in amount and which do not in any case materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of our business or that of a Subsidiary&#59; (vi)&#160;Liens in existence on the date of the first issuance by us of Securities (as defined in the Indenture) issued pursuant to the Indenture&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;that no such Lien is spread to cover any additional property after such date and that the amount of Debt (as defined in the Indenture) secured thereby is not increased&#59; (vii)&#160;Liens securing our and our Subsidiaries&#8217; Debt incurred to finance the acquisition of fixed or capital assets&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;that (A)&#160;such Liens will be created substantially simultaneously with the acquisition of such fixed or capital assets, (B)&#160;such Liens do not at any time encumber any property other than the property financed by such Debt and (C)&#160;the amount of Debt secured thereby is not increased&#59; (viii)&#160;Liens on the property or assets of a corporation that becomes a Subsidiary after the date of the Indenture&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;that (A)&#160;such Liens existed at the time such corporation became a Subsidiary and were not created in anticipation thereof, (B)&#160;any such Lien is not spread to cover any property or assets of such corporation after the time such corporation becomes a Subsidiary, and (C)&#160;the amount of Debt secured thereby is not increased&#59; (ix)&#160;Liens pursuant to any Receivables Transaction (as </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">defined in the Indenture) in an aggregate principal amount not exceeding 20% of our Consolidated Tangible Assets (as defined in the Indenture)&#59; and (x)&#160;Liens (not otherwise permitted pursuant to the Indenture) (A)&#160;which secure obligations not exceeding (as to us and our Subsidiaries) the greater of (X)&#160;$250.0&#160;million or (Y)&#160;20% of our Consolidated Tangible Assets (as defined in the Indenture), in each case in an aggregate amount at any time outstanding, or (B)&#160;with respect to which we effectively provide that the Securities Outstanding (as defined in the Indenture) under the Indenture are secured equally and ratably with (or, at our option, prior to) the Debt secured by such Lien.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prior to the Par Call Date (as defined below), we may redeem the notes, in whole or in part, at our option, on at least 15&#160;days, but no more than 60&#160;days prior written notice mailed to the registered holders of the notes to be redeemed, at any time at a redemption price equal to the greater of&#58;</font></div><div style="padding-left:49.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">100% of the principal amount of the notes being redeemed, or</font></div><div style="padding-left:49.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">as determined by a Quotation Agent (as defined below), the sum of the present values of the remaining scheduled payments of principal and interest thereon to the applicable Par Call Date (not including any portion of such payments of interest accrued to the date of redemption) discounted to the redemption date on an annual basis (ACTUAL&#47;ACTUAL(ICMA)) at the Comparable Government Bond Rate (defined below), plus 20 basis points for the notes,</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">plus, in each case, accrued and unpaid interest on the notes to, but not including, the redemption date (subject to the right of holders as of the close of business on a regular record date to receive interest due on the related interest payment date).</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;At any time and from time to time on or after September&#160;1, 2027 (the date that is three months prior to the maturity date of the notes) (the &#8220;Par Call Date&#8221;), we may redeem the notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest to the redemption date.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Comparable Government Bond Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, for any redemption date, the rate per annum equal to the annual equivalent yield to maturity or interpolated yield to maturity (on a day count basis), computed as the third business day immediately preceding that redemption date, of the Comparable Government Issue (as defined below), assuming a price for the Comparable Government Issue (expressed as a percentage of its principal amount) equal to the Comparable Price (as defined below) for such redemption date.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Comparable Government Issue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the euro-denominated security issued by the German federal government selected by a Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the notes to be redeemed that would be utilized (assuming that the notes matured on the applicable Par Call Date), at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such notes.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Comparable Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any redemption date, (i)&#160;the average of the Reference Dealer Quotations (as defined below) for such redemption date, after excluding the highest and lowest such Reference Dealer Quotations, or (ii)&#160;if the trustee obtains fewer than three such Reference Dealer Quotations, the average of all such quotations.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Quotation Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Reference Dealer appointed by the trustee after consultation with us.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Reference Dealer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i)&#160;each of Barclays Bank&#160;PLC, Goldman Sachs&#160;&#38;&#160;Co.&#160;LLC and Merrill Lynch International and their respective successors&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, if any of the foregoing shall cease to be a broker or dealer of, and&#47;or a market maker in, German government bonds (a &#8220;Primary Bond Dealer&#8221;), we shall substitute therefor another Primary Bond Dealer, and (ii)&#160;any other Primary Bond Dealers selected by the trustee after consultation with us.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Reference Dealer Quotations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to each Reference Dealer and any redemption date, the average, as determined by the trustee, of the bid and ask prices for the Comparable Government Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the trustee by such Reference Dealer at 5&#58;00&#160;p.m. London time, on the third business day preceding such redemption date.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If we redeem only some of the notes, the trustee shall determine by lot the notes to be redeemed or, in the case of notes held in global form, pursuant to applicable procedures of the depositary. Notice by the depositary to these participants and by participants to &#8220;street name&#8221; holders of indirect interests in the notes will be made according to arrangements among them and may be subject to statutory or regulatory requirements. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the notes or portions of the notes called for redemption.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a Change of Control Repurchase Event occurs, unless we have exercised our option to redeem the notes as described under the heading &#8220;-Optional Redemption&#8221; above, each holder of the notes will have the right to require us to purchase all or a portion (equal to &#8364;100,000 and any integral multiples of &#8364;1,000 in excess thereof) of such holder&#8217;s notes pursuant to the offer described below (a &#8220;Change of Control Offer&#8221;) at a purchase price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to, but not including, the date of repurchase (the &#8220;Change of Control Payment&#8221;), subject to the rights of holders of notes on the relevant record date to receive interest due on the relevant interest payment date.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will be required to send a notice to each holder of the notes by first class mail, with a copy to the trustee, within 30&#160;days following the date upon which any Change of Control Repurchase Event occurred, or at our option, prior to any Change of Control but after the public announcement of the pending Change of Control. The notice will govern the terms of the Change of Control Offer and will describe, among other things, the transaction that constitutes or may constitute the Change of Control Repurchase Event and the purchase date. The purchase date will be at least 30&#160;days but no more than 60&#160;days from the date such notice is mailed, other than as may be required by law (a &#8220;Change of Control Payment Date&#8221;). If the notice is mailed prior to the date of consummation of the Change of Control, the notice will state that the Change of Control Offer is conditioned on the Change of Control being consummated on or prior to the Change of Control Payment Date.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On the Change of Control Payment Date, we will, to the extent lawful&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">accept for payment all properly tendered notes or portions of notes not validly withdrawn&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">deposit with the paying agent the required payment for all properly tendered notes or portions of notes not validly withdrawn&#59; and</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">deliver or cause to be delivered to the trustee the repurchased notes, accompanied by an officers&#8217; certificate stating, among other things, the aggregate principal amount of repurchased notes.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will not be required to make a Change of Control Offer with respect to the notes upon the occurrence of a Change of Control Repurchase Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for such an offer made by us and the third party purchases all of the notes properly tendered and not withdrawn under its offer. In addition, we will not repurchase any notes if there has occurred and is continuing on the Change of Control Payment Date an Event of Default under the Indenture.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will comply with the requirements of Rule&#160;14e-1 under the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable, in connection with the repurchase of notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the notes, we will comply with those securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Offer provisions of the notes by virtue of any such conflict. </font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The definition of Change of Control includes a phrase relating to the direct or indirect sale, lease, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our properties or assets and those of our subsidiaries taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, lease, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For purposes of the foregoing discussion, the following definitions apply&#58;</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited to a fixed sum or percentage with respect to the rights of the holders thereof to participate in dividends and in the distribution of assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more series of related transactions, of all or substantially all of our assets and the assets of our subsidiaries, taken as a whole, to any &#8220;person&#8221; (as that term is used in Section&#160;13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section&#160;13(d)(3) of the Exchange Act), other than us or one of our subsidiaries, becomes the &#8220;beneficial owner&#8221; (as defined in Rule&#160;13d-3 under the Exchange Act), directly or indirectly, of more than 50% of our then outstanding Voting Stock or other Voting Stock into which our Voting Stock is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares&#59; or</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">the adoption of a plan relating to our liquidation or dissolution.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a)&#160;we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(x) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (y)&#160;immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Change of Control Repurchase Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the occurrence of both a Change of Control and a Rating Event.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Fitch</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Fitch,&#160;Inc. and its successors.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Investment Grade</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s), a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) and a rating of BBB- or better by Fitch (or its equivalent under any successor rating categories of Fitch)&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that we shall not be required to maintain a rating by more than two Rating Agencies at any time and if only two Rating Agencies provide a rating with respect to the notes, then &#8220;Investment Grade&#8221; shall mean the applicable rating described above of such two Rating Agencies.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Moody&#8217;s Investors Service,&#160;Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Rating Agencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means each of Moody&#8217;s, S&#38;P and Fitch, or if any of Moody&#8217;s, S&#38;P or Fitch ceases to rate the notes or fails to make a rating of the notes publicly available, any &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Section&#160;3(a)(62) under the Exchange Act that is selected by us as a replacement agency for Moody&#8217;s, S&#38;P or Fitch, or each of them, as the case may be&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Company shall not be required to maintain a rating by more than two Rating Agencies at any time.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Rating Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to the notes, the rating of the notes shall be decreased by each of the Rating Agencies independently by one or more gradations during the Rating Period (as defined below). If the rating of the notes by each of the Rating Agencies is Investment Grade, then &#8220;Rating Event&#8221; will mean the rating of the notes shall be decreased by one or more gradations by each Rating Agency so that the ratings of the notes by all of the Rating Agencies fall below Investment Grade, on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the 30-day period following public notice of the occurrence of the Change of Control (the &#8220;Rating Period&#8221;) (which 30-day period shall be extended by no more than 60&#160;days from the date of the occurrence of the Change of Control if the rating of the notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies and each other Rating Agency has either downgraded, or publicly announced that it is considering downgrading, the notes). A Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed a Rating Event for purposes of the definition of &#8220;Change of Control Repurchase Event&#8221;) if each Rating Agency making the reduction in rating to which this definition would otherwise apply does not announce or publicly confirm or inform the trustee under the Indenture in writing at our request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the Rating Event).</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means S&#38;P Global Ratings, a division of S&#38;P Global&#160;Inc., and its successors.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Voting Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to any specified person as of any date, the Capital Stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Redemption for Tax Reasons</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subject to a period of not less than fifteen (15)&#160;nor more than sixty (60)&#160;days&#8217; prior written notice to the registered holders of the notes to be redeemed, we may redeem the notes at any time after the issue date and prior to the maturity date, in whole, but not in part, at a redemption price equal to 100% of the aggregate principal amount of notes being redeemed, plus accrued and unpaid interest, if any, to (but not including) the redemption date, on the date determined by us for early redemption, if&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) as a result of any change in, or amendment to, the laws (or any regulations or rulings promulgated thereunder) of a Relevant Taxing Jurisdiction (as defined below), or any change in, or amendment to, an official position regarding the application or interpretation of such laws, regulations or rulings, which change or amendment is announced or becomes effective on or after November 6, 2019, we have become or will become obligated to pay Additional Amounts (as defined below)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) any act is taken by a taxing authority of a Relevant Taxing Jurisdiction on or after November 6, 2019, whether or not such act is taken with respect to us or any of our affiliates, that results in a substantial probability that we will be required to pay Additional Amounts on the notes&#59; provided in each case that we determine, in our business judgment (determined in good faith), that the obligation to pay the Additional Amounts cannot be avoided by the use of reasonable measures available to us (including, for the avoidance of doubt, the appointment of a new paying agent where this would be reasonable and would not cause us to incur material additional out-of-pocket costs, but not including assignment of the obligation to make payment with respect to the notes).</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No redemption above may be made unless (i)&#160;we shall have received an opinion of independent counsel to the effect that any such change, amendment or act described in paragraphs&#160;(a) or (b)&#160;above results in our requirement to pay (in the case of paragraph&#160;(a)) or a substantial probability that we will be required to pay (in the case of paragraph(b)) the Additional Amounts described herein and (ii)&#160;we shall have delivered to the paying agent a certificate, signed by a duly authorized officer, stating that based on such opinion, we are entitled to redeem the notes pursuant to their terms.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Additional Amounts</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All payments of principal, premium, if any, and interest by or on behalf of us pursuant to the terms of the notes shall be made free and clear of, and without deduction or withholding for or on account of, any present or future taxes, duties, assessments or other governmental charges of whatsoever nature required to be deducted or withheld by the United States, any state thereof or the District of Columbia or any other jurisdiction through which payment on a note is made, or any political subdivision or taxing authority therein or thereof (a &#8220;Relevant Taxing Jurisdiction&#8221;), unless such withholding or deduction is required by law.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the event any withholding or deduction on payments in respect of the notes for or on account of any present or future tax, assessment or other governmental charge is required to be deducted or withheld by a Relevant Taxing Jurisdiction, we shall remit the full amount required to be deducted or withheld to </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the relevant authority in accordance with applicable law and pay such additional amounts (the &#8220;Additional Amounts&#8221;) so that every net payment of the principal of, premium, if any, and interest on the notes will result in receipt by each holder of a note of such amounts (after all such withholding or deduction, including on any additional amounts) as would have been received had no such withholding or deduction been required. We will not be required, however, to make any payment of Additional Amounts for or on account of certain situations, as set forth in the form of notes.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Events of Default</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture provides that the following will be &#8220;events of default&#8221; with respect to any series of debt securities&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1) default in the payment of any interest on any debt security of that series, when it becomes due and payable, and continuance of such default for a period of 30&#160;days&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2) default in the payment of, the principal of, or premium, if any, on any debt security of that series when due at its maturity or upon acceleration&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3) default in the deposit of any sinking fund payment, when and as due by the terms of the debt securities of that series and the Indenture&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4) default in the performance, or breach, of any of our covenant or agreement in the Indenture which affects or is applicable to debt securities of such series (other than a default in the performance, or breach of a covenant or agreement that is specifically dealt with elsewhere in the Indenture), and the continuation of that default or breach for a period of 90&#160;days after the trustee has given us, or after Holders of at least 25% in aggregate principal amount of all outstanding securities of that series have given us and the trustee, written notice thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5) certain events relating to our bankruptcy, insolvency or reorganization&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6) any other event of default provided with respect to debt securities of that series.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If an event of default specified in clauses (1), (2), (3), (4) or (6) therein with respect to the notes occurs and is continuing, either the trustee or the holders of at least 25% in aggregate principal amount of the outstanding notes may declare the principal amount, plus accrued interest, if any, on all the then outstanding notes to be due and payable immediately. If an event of default specified in clause (5) therein occurs and is continuing, then the principal amount, plus accrued interest, if any, of all the notes will be due and payable immediately, without any declaration or other act on the part of the trustee or any holder. In certain cases, holders of a majority in principal amount of the outstanding notes may, on behalf of holders of all the notes, rescind and annul a declaration of acceleration.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Indenture provides that the trustee will not be liable for any action taken, suffered or omitted by it in good faith and believed by it to be authorized or within the discretion or rights or powers conferred upon it by the Indenture. The Indenture provides that no Holder may institute any proceedings, judicial or otherwise, to enforce the Indenture except in the case of failure of the trustee thereunder to act for 60&#160;days after it has received a request to enforce the Indenture by Holders of at least 25% in aggregate principal amount of the then outstanding debt securities of that series (in the case of an event of default specified in clauses&#160;(1), (2), (3), (4)&#160;or (6)&#160;above) or a request to enforce the Indenture by Holders of at least 25% in aggregate principal amount of all of the debt securities then outstanding (in the case of an event of default specified in clause&#160;(5) above), and an offer of reasonable indemnity. This provision will not prevent any </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Holder from enforcing payment of principal thereof, and premium, if any, on and interest, if any, thereon at the respective due dates.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Holders of not less than a majority in aggregate principal amount of the debt securities of any series then outstanding may direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on it with respect to debt securities of that series. The trustee may, however, refuse to follow any direction that it determines may not lawfully be taken or would be illegal or in conflict with the Indenture or involve it in personal liability or which would be unjustly prejudicial to Holders not joining in that proceeding.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Indenture provides that the trustee will, within 90&#160;days after the occurrence of a default with respect to any series of debt securities, give to Holders of debt securities of that series notice of such default if that default has not been cured or waived. Except in the case of a default in the payment of principal of, or premium, if any, on or interest on, or in the payment of any sinking fund installment in respect of, any debt securities of that series, the trustee will be protected in withholding the notice if it determines in good faith that the withholding of the notice is in the interest of Holders of the debt securities of such series.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will be required to deliver an officers' certificate to the trustee annually as to our compliance with all conditions and covenants under the terms of the Indenture.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Defeasance</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are subject to our defeasance option. At our option, the notes will be discharged from any and all obligations (except for certain obligations to register the transfer or exchange of notes, replace stolen, lost or mutilated notes, maintain paying agencies, and hold money for payment in trust), if we deposit with the trustee, in trust, money or Government Obligations (as defined in the Indenture) which through the payment of interest thereon and principal thereof in accordance with their terms will provide money in an amount sufficient to pay all the principal (including any mandatory sinking fund payments) of, and interest on, the notes on the dates such payments are due in accordance with the terms of the notes.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To exercise any such option, we are required to deliver to the trustee an opinion of counsel to the effect that the deposit and related defeasance would not cause the Holders of the notes to recognize income, gain or loss for federal income tax purposes and, in the case of a discharge pursuant to (1)&#160;above, such opinion of counsel must be based upon a ruling to such effect received by us from or published by the United States Internal Revenue Service or a change in applicable federal income tax law to such effect. We are required to deliver to the trustee an officer's certificate stating that no event of default with respect to the notes has occurred and is continuing.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Satisfaction and Discharge</font></div><div style="margin-bottom:12pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As set forth in the Indenture, and upon the occurrence of certain events, the Indenture may be subject to satisfaction and discharge with respect to the notes.</font></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Modification and Waiver</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Modifications of and amendments to the Indenture may be made by us and the trustee with the consent of Holders of a majority in principal amount of the outstanding debt securities of each series issued under the Indenture that is affected by the modification or amendment&#59; provided, however, that no </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such modification or amendment may, without the consent of the Holder of each outstanding debt security affected thereby make certain changes as set forth in the Indenture.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We may, with respect to any series of debt securities, omit to comply with certain restrictive provisions of the Indenture if Holders of at least a majority in principal amount of all outstanding debt securities affected waive compliance. No such waiver will extend to or affect any term, provision or condition except to the extent so expressly waived, and, until the waiver becomes effective, our obligations and the duties of the trustee to Holders of debt securities of that series in respect of the applicable term, provision or condition will remain in full force and effect.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Holders of a majority in principal amount of the outstanding debt securities of each series (in the case of an event of default specified in clauses (1), (2), (3), (4) and (6) under &#34;Events of Default&#34; above) or the Holders of a majority in principal amount of all of the debt securities then outstanding (in the case of an event of default specified in clause (5) under &#34;Events of Default&#34; above) may, on behalf of all those Holders, waive any past default under the Indenture with respect to debt securities of that series except a default in the payment of the principal of, or premium, if any, on or interest, if any, on any such debt security and except a default in respect of a covenant or provision the modification or amendment of which would require the consent of the Holder of each outstanding debt security affected.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>3
<FILENAME>exhibit21-listofsubsidiari.htm
<DESCRIPTION>EXHIBIT 21 FY2020 LIST OF SUBSIDIARIES DATED JAN 31, 2021
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i32a7f6d56ed848738966d1f006be9e6f_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:13pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%;text-decoration:underline">EXHIBIT 21</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">List of worldwide subsidiaries of Boston Scientific as of January 31, 2021</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Structure of ownership and control&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific wholly owns or has a majority interest in all of the below mentioned entities.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acurate Industria e Comercio Ltda. (Brazil) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Medical Systems Europe B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apama Medical, Inc. (Delaware) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Augmenix, Inc. (Delaware) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biocompatibles International Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biocompatibles UK Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biocompatibles, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borneo Merger Sub, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific (Malaysia) Sdn. Bhd. (Malaysia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific (South Africa) Proprietary Limited (South Africa)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific (Thailand) Ltd. (Thailand)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific (UK) Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific AG (Switzerland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Argentina S.A. (Argentina)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Asia Pacific Pte. Ltd. (Singapore)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Benelux NV (Belgium)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Ceska republika s.r.o. (Czech Republic)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Chile SpA (Chile)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Clonmel Limited, in liquidation (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Colombia Limitada (Colombia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Comercial de Costa Rica BSCR, S.R.L. (Costa Rica)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Cork Limited, in liquidation (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific de Costa Rica S.R.L. (Costa Rica)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific de Mexico, S.A. de C.V. (Mexico)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific del Caribe, Inc. (Puerto Rico)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific do Brasil Ltda. (Brazil)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Far East B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Gesellschaft m.b.H. (Austria)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Group plc (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Hellas S.A. (Greece)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Hong Kong Limited (Hong Kong)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Iberica, S.A. (Spain)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific India Private Limited (India)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific International B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific International Finance Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific International Sdn. Bhd. (Malaysia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific International S.A. (France)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Ireland Limited, in liquidation (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Israel Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Japan K.K. (Japan)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Korea Co., Ltd. (Korea)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Lebanon SAL (Lebanon)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific LLC (Russian Federation)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Ltd.&#47;Boston Scientifique Ltee. (Canada)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Medical Device (Malaysia) Sdn. Bhd. (Malaysia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Medical Device Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Medizintechnik GmbH (Germany)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Middle East FZ-LLC (UAE)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Middle East SAL (Offshore) (Lebanon)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Nederland B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Neuromodulation Corporation (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific New Zealand Limited (New Zealand)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Nordic AB (Sweden)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Peru S.A.C. (Peru)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Philippines, Inc. (Philippines)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Polska Sp. z o.o. (Poland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Portugal - Dispositivos Medicos, Lda (Portugal)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Pty Ltd (Australia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Romania S.R.L. (Romania)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific S.A.S. (France)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific S.p.A. (Italy)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Scimed, Inc. (Minnesota)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Services Private Limited (India)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Technology &#38; Engineering Services Private Limited (India) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific TIP Gerecleri Limited Sirketi (Turkey)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Vietnam Company Limited (Vietnam)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bravo Bidco Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BSC International Medical Trading (Shanghai) Co., Ltd. (China)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BSC Medical Device Technology (Shanghai) Co., Ltd. (China)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG Australasia Pty Ltd (Australia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG IM Holdings Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International (Holdings) Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International Canada Inc. (Canada)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International Healthcare Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International Healthcare Limited (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International Healthcare LLC (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG International Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTG Management Services Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiac Pacemakers, Inc. (Minnesota)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CeloNova BioSciences Germany GmbH, in liquidation (Germany)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claret Medical, Inc. (Delaware) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cosman Medical, LLC (Massachusetts)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cryterion Medical, Inc. (Delaware) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cryterion Medical Ireland, Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EKOS LLC (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Electron Acquisition Corporation (Delaware) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice GmbH, in liquidation (Germany)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice Holdings, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice Innovation Center Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EndoChoice Israel Ltd. (Israel) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EP Technologies, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Flash Merger Sub, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Galil Medical Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Galil Medical Ltd. (Israel)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Galil Medical UK Limited (England)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guidant Delaware Holding Corporation (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guidant Europe NV (Belgium)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guidant Puerto Rico B.V. (The Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hong Kong Medtech Trading Limited (Hong Kong)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millipede, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notebook Merger Sub, Ltd. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novate Medical Limited (Ireland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nVision Medical Corporation (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NXT Merger Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NxThera, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PneumRx Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PneumRx LLC (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protherics Medicines Development B.V. (Netherlands)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protherics Medicines Development Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protherics UK Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provensis Limited (England)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PT Boston Scientific Indonesia (Indonesia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RMI Acquisition Corp. (California)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Robert S. Smith, M.D., Inc. (Georgia)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Roxwood Medical, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sadra Medical, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securus Medical Group, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNS Merger Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Special K Merger Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">StarMedTec GmbH, in liquidation (Germany)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stream Enterprises LLC (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Symetis SA (Switzerland)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Target Therapeutics, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Veniti, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vertiflex, Inc. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zuma Investment Pty Ltd (Australia) </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34 Biomedical Merger Corp. (Delaware)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9357-1867 Quebec Inc. (Canada)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>4
<FILENAME>exhibit23-2020eyconsent.htm
<DESCRIPTION>EXHIBIT 23 EY CONSENT FY2020
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i19dedc0b1e37433db1a2fdfdbf53b3ab_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:13pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%;text-decoration:underline">EXHIBIT 23</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;padding-right:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;Registration Statement (Form S-3 Nos. 333-238526, 333-76346, 333-61994, and 333-64991) of Boston Scientific Corporation,</font></div><div style="padding-left:27pt;padding-right:27pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:27pt;padding-right:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(2)&#160;&#160;&#160;&#160;Registration Statement (Form S-4 Nos. 333-131608 and 333-22581) of Boston Scientific Corporation,</font></div><div style="padding-left:27pt;padding-right:27pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:27pt;padding-right:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(3)&#160;&#160;&#160;&#160;Registration Statement (Form S-8 Nos. 333-25033, 333-25037, 333-36636, 333-61056, 333-61060, 333-76380, 333-98755, 333-111047, 333-131608, 333-133569, 333-134932, 333-151280, 333-174620, 333-174622, 333-188905, 333-196672, and 333-241022) of Boston Scientific Corporation&#59;</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">of our reports dated February&#160;23, 2021, with respect to the consolidated financial statements and schedule of Boston Scientific Corporation and the effectiveness of internal control over financial reporting of Boston Scientific Corporation included in this Annual Report (Form 10-K) of Boston Scientific Corporation for the year ended December&#160;31, 2020.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Boston, Massachusetts&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">February&#160;23, 2021</font></div><div><font><br></font></div><div style="margin-bottom:13pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exhibit311-ceo302202010xk.htm
<DESCRIPTION>EXHIBIT 31.1 CEO 302 CERT FY2020
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ief2a6fc0c99d41bdaec9e5196d0caaf1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael F. Mahoney, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form&#160;10-K of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:6.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 23, 2021</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exhibit312-cfo302202010xk.htm
<DESCRIPTION>EXHIBIT 31.2 CFO 302 CERT FY2020
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iad25c8fc92e34543aaf115953d4497a0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel J. Brennan, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form&#160;10-K of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5&#160;</font></td><td style="border-top:1pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:6.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 23, 2021</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>exhibit321-ceo906202010xk.htm
<DESCRIPTION>EXHIBIT 32.1 CEO 906 CERT FY2020
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if3df8dbcb1614bef8f9f71924e2ed43a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form&#160;10-K of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ending December&#160;31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13 (a)&#160;or 15 (d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>exhibit322-cfo906202010xk.htm
<DESCRIPTION>EXHIBIT 32.2 CFO 906 CERT FY2020
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia642bbd93b4b411f81f579c9b8dad0cf_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form&#160;10-K of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ending December&#160;31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13 (a)&#160;or 15 (d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 23, 2021</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>bsx-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b8cf84dc-d42e-4cf7-a067-5352d2212acb,g:c4fd43c3-3c28-47b7-bdfe-13ef2366d2d6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20201231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.bostonscientific.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations">
        <link:definition>1001002 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets">
        <link:definition>1003004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetParanthetical" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical">
        <link:definition>1004005 - Statement - Consolidated Balance Sheet Paranthetical</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.bostonscientific.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesSignificantAccountingPoliciesTables" roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails">
        <link:definition>2404401 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestments" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments">
        <link:definition>2105102 - Disclosure - Acquisitions and Strategic Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestmentsTables" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables">
        <link:definition>2306302 - Disclosure - Acquisitions and Strategic Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestmentsDetails" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails">
        <link:definition>2407402 - Disclosure - Acquisitions and Strategic Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationDetails" roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails">
        <link:definition>2408403 - Disclosure - Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicInvestmentsDetails" roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails">
        <link:definition>2409404 - Disclosure - Strategic Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldforSale" roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale">
        <link:definition>2110103 - Disclosure - Assets and Liabilities Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldforSaleTables" roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables">
        <link:definition>2311303 - Disclosure - Assets and Liabilities Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsandLiabilitiesHeldforSaleDetails" roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>2412405 - Disclosure - Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2113104 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables">
        <link:definition>2314304 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails">
        <link:definition>2415406 - Disclosure - Goodwill and Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurements" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements">
        <link:definition>2116105 - Disclosure - Hedging Activities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresPolicies" roleURI="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies">
        <link:definition>2217202 - Disclosure - Fair Value Measures and Disclosures (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsTables" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables">
        <link:definition>2318305 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsDetails">
        <link:definition>2419407 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitments" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments">
        <link:definition>2120106 - Disclosure - Contractual Obligations and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsTables" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables">
        <link:definition>2321306 - Disclosure - Contractual Obligations and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsDetails" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails">
        <link:definition>2422408 - Disclosure - Contractual Obligations and Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.bostonscientific.com/role/Leases">
        <link:definition>2123107 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.bostonscientific.com/role/LeasesTables">
        <link:definition>2324307 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.bostonscientific.com/role/LeasesDetails">
        <link:definition>2425409 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRelatedActivities" roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivities">
        <link:definition>2126108 - Disclosure - Restructuring Related Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRelatedActivitiesTables" roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables">
        <link:definition>2327308 - Disclosure - Restructuring Related Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringRelatedActivitiesDetails" roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails">
        <link:definition>2428410 - Disclosure - Restructuring Related Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformation" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation">
        <link:definition>2129109 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationTables" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables">
        <link:definition>2330309 - Disclosure - Supplemental Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationDetails" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails">
        <link:definition>2431411 - Disclosure - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.bostonscientific.com/role/IncomeTaxes">
        <link:definition>2132110 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables">
        <link:definition>2333310 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetailsRateTable" roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable">
        <link:definition>2434412 - Disclosure - Income Taxes (Details - Rate Table)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxesDetails" roleURI="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails">
        <link:definition>2435413 - Disclosure - Income Taxes Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies">
        <link:definition>2136111 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2437414 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.bostonscientific.com/role/StockholdersEquity">
        <link:definition>2138112 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails">
        <link:definition>2439415 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockInventiveandPurchasePlans" roleURI="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans">
        <link:definition>2140113 - Disclosure - Stock Inventive and Purchase Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentiveandPurchasePlansTables" roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables">
        <link:definition>2341311 - Disclosure - Stock Incentive and Purchase Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentiveandPurchasePlansDetails" roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails">
        <link:definition>2442416 - Disclosure - Stock Incentive and Purchase Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstanding" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding">
        <link:definition>2143114 - Disclosure - Weighted Average Shares Outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingTables" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables">
        <link:definition>2344312 - Disclosure - Weighted Average Shares Outstanding (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingDetails" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails">
        <link:definition>2445417 - Disclosure - Weighted Average Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.bostonscientific.com/role/SegmentReporting">
        <link:definition>2146115 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.bostonscientific.com/role/SegmentReportingTables">
        <link:definition>2347313 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails">
        <link:definition>2448418 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.bostonscientific.com/role/Revenue">
        <link:definition>2149116 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.bostonscientific.com/role/RevenueTables">
        <link:definition>2350314 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.bostonscientific.com/role/RevenueDetails">
        <link:definition>2451419 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncome" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome">
        <link:definition>2152117 - Disclosure - Changes in Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeTables" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables">
        <link:definition>2353315 - Disclosure - Changes in Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeDetails" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails">
        <link:definition>2454420 - Disclosure - Changes in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements">
        <link:definition>2155118 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsNewAccountingPronouncementsPolicies" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies">
        <link:definition>2256203 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansNotes" roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes">
        <link:definition>2157119 - Disclosure - Employee Retirement Plans (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansEmployeeRetirementPlansPolicies" roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies">
        <link:definition>2258204 - Disclosure - Employee Retirement Plans Employee Retirement Plans (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansTables" roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables">
        <link:definition>2359316 - Disclosure - Employee Retirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansDetails" roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails">
        <link:definition>2460421 - Disclosure - Employee Retirement Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleII" roleURI="http://www.bostonscientific.com/role/ScheduleII">
        <link:definition>2161120 - Disclosure - Schedule II</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIDetails" roleURI="http://www.bostonscientific.com/role/ScheduleIIDetails">
        <link:definition>2462422 - Disclosure - Schedule II (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_StatementOfOperationsCaptionAxis" abstract="true" name="StatementOfOperationsCaptionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TaxIncentivesInPuertoRico" abstract="false" name="TaxIncentivesInPuertoRico" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalCrmReportingUnitMember" abstract="true" name="GlobalCrmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" abstract="false" name="SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_AssetsHeldForSaleDomain" abstract="true" name="AssetsHeldForSaleDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RhythmandNeuroMember" abstract="true" name="RhythmandNeuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2029NotesMember" abstract="true" name="March2029NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" abstract="false" name="NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" abstract="false" name="DeferredTaxAssetsPrepaidonIntercompanyProfit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RestructuringrelatedCostExpectedCost" abstract="false" name="RestructuringrelatedCostExpectedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_UnrecognizedCompensationCostNonVestedStockAwards" abstract="false" name="UnrecognizedCompensationCostNonVestedStockAwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_August2022TermLoanMember" abstract="true" name="August2022TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" abstract="false" name="AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_MaximumCommercialPaperOutstanding" abstract="false" name="MaximumCommercialPaperOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CumulativeEffectOfNewAccountingPrinciples" abstract="false" name="CumulativeEffectOfNewAccountingPrinciples" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_November2035NotesMember" abstract="true" name="November2035NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OperatingIncomeUnallocatedToSegment" abstract="false" name="OperatingIncomeUnallocatedToSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" abstract="false" name="EffectiveIncomeTaxRateReconciliationReturnToProvision" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" abstract="false" name="ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StatementAxis" abstract="true" name="StatementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" abstract="true" name="RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalPeripheralInterventionsPiReportingUnitMember" abstract="true" name="GlobalPeripheralInterventionsPiReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Onetimetransactiontaxpost1986EPnetpayment" abstract="false" name="Onetimetransactiontaxpost1986EPnetpayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ExecutiveRetirementPlanMember" abstract="true" name="ExecutiveRetirementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" abstract="false" name="ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_May2025NotesMember" abstract="true" name="May2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalNeuromodulationNmReportingUnitMember" abstract="true" name="GlobalNeuromodulationNmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationLineItems" abstract="true" name="ScheduleofIncomeTaxRateReconciliationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationTextualsAbstract" abstract="true" name="SupplementalBalanceSheetInformationTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_LotusDiscontinuationMember" abstract="true" name="LotusDiscontinuationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SpecialtyPharmaceuticalsMember" abstract="true" name="SpecialtyPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_MillipedeMember" abstract="true" name="MillipedeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" abstract="false" name="DefinedBenefitPlanPlanAssetsActuarialGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Nonvestedstockawardsexerciseprice" abstract="false" name="Nonvestedstockawardsexerciseprice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="bsx_AllegedBreachofPurchaseAgreementAmount" abstract="false" name="AllegedBreachofPurchaseAgreementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_MaximumLeverageRatio" abstract="false" name="MaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_BSXReportableSegmentsMember" abstract="true" name="BSXReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_NetSettlementPaymenttoIRS" abstract="false" name="NetSettlementPaymenttoIRS" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" abstract="true" name="AggregateSeniorUnsecuredDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_May2020NotesMember" abstract="true" name="May2020NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" abstract="false" name="ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_LitigationAndDebtExclusionFromEbitda" abstract="false" name="LitigationAndDebtExclusionFromEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_The2018FacilityDomain" abstract="true" name="The2018FacilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_December2027NotesMember" abstract="true" name="December2027NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" abstract="false" name="OptionsExpectedToVestWeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" abstract="false" name="MarketBasedAwardsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_CumulativeRestructuringRelatedCostsIncurredToDate" abstract="false" name="CumulativeRestructuringRelatedCostsIncurredToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" abstract="false" name="SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" abstract="false" name="SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_March2026NotesMember" abstract="true" name="March2026NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" abstract="true" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" abstract="false" name="DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_DeferredTaxAssetsDomain" abstract="true" name="DeferredTaxAssetsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_WeightedAverageRemainingVestingPeriod" abstract="false" name="WeightedAverageRemainingVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" abstract="false" name="FairValueOfFreeCashFlowFcfPerformanceAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_March2049NotesMember" abstract="true" name="March2049NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ForeignCurrencyDenominatedInDebtMember" abstract="true" name="ForeignCurrencyDenominatedInDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_InventoryStepUpAmortization" abstract="false" name="InventoryStepUpAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_January2020NotesMember" abstract="true" name="January2020NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SpecialChargesMember" abstract="true" name="SpecialChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_PercentOfFinishedGoodsAtConsignment" abstract="false" name="PercentOfFinishedGoodsAtConsignment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" abstract="false" name="DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_NewAccountingPronouncementsPolicyTextBlock" abstract="false" name="NewAccountingPronouncementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_TheCARESAct" abstract="false" name="TheCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_TotalAllocatedToReportableSegmentsMember" abstract="true" name="TotalAllocatedToReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_AugmenixInc.Member" abstract="true" name="AugmenixInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CurrentRequirementMember" abstract="true" name="CurrentRequirementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OptionsExpectedToVest" abstract="false" name="OptionsExpectedToVest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" abstract="false" name="ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" abstract="false" name="MaturitiesOfLeaseLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_CovenantAxis" abstract="true" name="CovenantAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_TransferCosts" abstract="false" name="TransferCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LicensingArrangementLiabilitiesMember" abstract="true" name="LicensingArrangementLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OtherInternationalPlansMember" abstract="true" name="OtherInternationalPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LesseeLeasesNotYetCommencedAmount" abstract="false" name="LesseeLeasesNotYetCommencedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DeferredTaxLiabilitiesDomain" abstract="true" name="DeferredTaxLiabilitiesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" abstract="false" name="DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" abstract="false" name="CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CompensationExpensePerShareDiluted" abstract="false" name="CompensationExpensePerShareDiluted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="bsx_StockIncentiveAndPurchasePlansAbstract" abstract="true" name="StockIncentiveAndPurchasePlansAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_Other2018AcquisitionsMember" abstract="true" name="Other2018AcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementthirdquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OtherNet" abstract="false" name="OtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StatementOfOperationsCaptionDomain" abstract="true" name="StatementOfOperationsCaptionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" abstract="false" name="CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Fairvalueofmarketbasedawards" abstract="false" name="Fairvalueofmarketbasedawards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OtherOtherLongTermAssets" abstract="false" name="OtherOtherLongTermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" abstract="true" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_February2019AggregateOfferingMember" abstract="true" name="February2019AggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Segmentoperatingincomeaspercentageofnetsales" abstract="false" name="Segmentoperatingincomeaspercentageofnetsales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_TransferCostsMember" abstract="true" name="TransferCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RestructuringRelatedToPlanMember" abstract="true" name="RestructuringRelatedToPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RestructuringandRestructuringrelatedCostExpectedCost" abstract="false" name="RestructuringandRestructuringrelatedCostExpectedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalUrologyandPelvicHealthReportingUnitMember" abstract="true" name="GlobalUrologyandPelvicHealthReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_A2019RestructuringPlanMember" abstract="true" name="A2019RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LicensingArrangements" abstract="false" name="LicensingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DeferredTaxAssetValuationAllowanceIntraEntity" abstract="false" name="DeferredTaxAssetValuationAllowanceIntraEntity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" abstract="false" name="ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_TaxRateAxis" abstract="true" name="TaxRateAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RequirementExtensionThroughTheRemainderOf2020Member" abstract="true" name="RequirementExtensionThroughTheRemainderOf2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" abstract="false" name="ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_UpfrontCashMember" abstract="true" name="UpfrontCashMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationAbstract" abstract="true" name="SupplementalBalanceSheetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_Annualweightedaverageforfeiturerate" abstract="false" name="Annualweightedaverageforfeiturerate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_NVisionMedicalCorporationMember" abstract="true" name="NVisionMedicalCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DivestedBusinessDueToBTGAcquisitionMember" abstract="true" name="DivestedBusinessDueToBTGAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" abstract="false" name="ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" abstract="false" name="ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_NetCurrencyExchangeGainLoss" abstract="false" name="NetCurrencyExchangeGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" abstract="true" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_August2019TermLoanMember" abstract="true" name="August2019TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OtherCurrentAssetsAbstract" abstract="true" name="OtherCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_June2025NotesMember" abstract="true" name="June2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LatinAmericaandCanadaMember" abstract="true" name="LatinAmericaandCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_October2023NotesMember" abstract="true" name="October2023NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LitigationSettlementReceivedGain" abstract="false" name="LitigationSettlementReceivedGain" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CardiovascularMember" abstract="true" name="CardiovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalEndoscopyEndoReportingUnitMember" abstract="true" name="GlobalEndoscopyEndoReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_January2040NotesMember" abstract="true" name="January2040NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Measurementperiodmarketbasedaward" abstract="false" name="Measurementperiodmarketbasedaward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_UKPlanMember" abstract="true" name="UKPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_A2016RestructuringPlanMember" abstract="true" name="A2016RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_BTGAcquisitionMember" abstract="true" name="BTGAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SignificantAccountingPoliciesAbstract" abstract="true" name="SignificantAccountingPoliciesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_PreventiceSolutionsIncMember" abstract="true" name="PreventiceSolutionsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" abstract="false" name="RangeofthetargetnumberofmarketbasedDSUsawarded" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_February2021TermLoanMember" abstract="true" name="February2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_FreeTradeZoneRegimeTaxIncentive" abstract="false" name="FreeTradeZoneRegimeTaxIncentive" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DiscountRateFairValueInput" abstract="false" name="DiscountRateFairValueInput" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" abstract="false" name="Productliabilitycasesorclaimsrelatedtomeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" abstract="false" name="ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_CompensationExpensePerShareBasic" abstract="false" name="CompensationExpensePerShareBasic" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" abstract="false" name="EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" abstract="false" name="LesseeOperatingAndFinanceLeasesOptionToExtend" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_WeightedAverageMaturityDays" abstract="false" name="WeightedAverageMaturityDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="us-types:durationStringItemType"/>
  <xs:element id="bsx_ExpenseRelatedToMatchingContributions" abstract="false" name="ExpenseRelatedToMatchingContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OtherIntangibleAssetsTextualsAbstract" abstract="true" name="OtherIntangibleAssetsTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" abstract="false" name="ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationTable" abstract="true" name="ScheduleofIncomeTaxRateReconciliationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_EmergingMarketsTotalNumberOfCountries" abstract="false" name="EmergingMarketsTotalNumberOfCountries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" abstract="false" name="AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_RenminbiDenominatedFactoringArrangementsMember" abstract="true" name="RenminbiDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" abstract="false" name="OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_FederalBenefitOfUncertainTaxPositions" abstract="false" name="FederalBenefitOfUncertainTaxPositions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CryterionMedicalIncMember" abstract="true" name="CryterionMedicalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementfourthquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2039NotesMember" abstract="true" name="March2039NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CovenantDomain" abstract="true" name="CovenantDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ExclusionFromEbitdaForRestructuringCharges" abstract="false" name="ExclusionFromEbitdaForRestructuringCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_NonCashImpactOfTransferredRoyaltyRights" abstract="false" name="NonCashImpactOfTransferredRoyaltyRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_NxTheraIncMember" abstract="true" name="NxTheraIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" abstract="false" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_March2028NotesMember" abstract="true" name="March2028NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ShareBasedCompensationNetOfTaxBenefit" abstract="false" name="ShareBasedCompensationNetOfTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RestructuringRelatedExpenses" abstract="false" name="RestructuringRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductCanada" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_FreeTradeZoneTaxIncentivePerShare" abstract="false" name="FreeTradeZoneTaxIncentivePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" abstract="false" name="ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_March2024NotesMember" abstract="true" name="March2024NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" abstract="true" name="LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CertifiedclassactionsinCanadaMesh" abstract="false" name="CertifiedclassactionsinCanadaMesh" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_InternationalRetirementPlansMember" abstract="true" name="InternationalRetirementPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_June2030NotesMember" abstract="true" name="June2030NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Paymenttonetsharesettleemployeeequityawards" abstract="false" name="Paymenttonetsharesettleemployeeequityawards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OperatingIncomeLossAllocatedToReportableSegments" abstract="false" name="OperatingIncomeLossAllocatedToReportableSegments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ActualCovenantMember" abstract="true" name="ActualCovenantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_AssignedToOneJudgeInMAMember" abstract="true" name="AssignedToOneJudgeInMAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_A2019AcquisitionsVertiflexAndMillipedeMember" abstract="true" name="A2019AcquisitionsVertiflexAndMillipedeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_StatementDomain" abstract="true" name="StatementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CumulativeRestructuringChargesTableTextBlock" abstract="false" name="CumulativeRestructuringChargesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" abstract="false" name="DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_MedsurgMember" abstract="true" name="MedsurgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" abstract="false" name="RangeofthetargetnumberofperformancebasedDSUsawarded" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" abstract="false" name="TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LicensingArrangementsLiability" abstract="false" name="LicensingArrangementsLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ConsolidatedBalanceSheetParentheticalAbstract" abstract="true" name="ConsolidatedBalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_ConsolidatedBSXDomain" abstract="true" name="ConsolidatedBSXDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DeemedConsolidatedEBITDA" abstract="false" name="DeemedConsolidatedEBITDA" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" abstract="true" name="FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_AccruedRebatesCurrent" abstract="false" name="AccruedRebatesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Pensionbenefitobligationbenefitspaid" abstract="false" name="Pensionbenefitobligationbenefitspaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" abstract="false" name="GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_RevenueBasedPaymentsMember" abstract="true" name="RevenueBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_A2011LtipPlanMember" abstract="true" name="A2011LtipPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LicensingArrangementsAsset" abstract="false" name="LicensingArrangementsAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" abstract="false" name="ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" abstract="false" name="TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_VertiflexIncMember" abstract="true" name="VertiflexIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ContingentConsiderationLiabilityProbabilityOfPayment" abstract="false" name="ContingentConsiderationLiabilityProbabilityOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_TwoYearDelayedDrawTermLoanMember" abstract="true" name="TwoYearDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" abstract="true" name="ConsolidatedCashFlowSupplementalDisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" abstract="true" name="RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesPreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_November2019AggregateOfferingMember" abstract="true" name="November2019AggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ClaretMedicalIncMember" abstract="true" name="ClaretMedicalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact" abstract="false" name="EffectiveIncomeTaxRateReconciliationTCJAnetimpact" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_YenDenominatedFactoringArrangementsMember" abstract="true" name="YenDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TaxRateDomain" abstract="true" name="TaxRateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EquipmentFurnitureAndFixturesGross" abstract="false" name="EquipmentFurnitureAndFixturesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LicensingArrangementAssetsMember" abstract="true" name="LicensingArrangementAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_VotingPowerOfAllClassesOfStock" abstract="false" name="VotingPowerOfAllClassesOfStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_EuroDenominatedOutstandingDebtMember" abstract="true" name="EuroDenominatedOutstandingDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" abstract="false" name="DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CorporateExpensesincludinghedgingactivitiesMember" abstract="true" name="CorporateExpensesincludinghedgingactivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_MaximumContingentPaymentMember" abstract="true" name="MaximumContingentPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TransitionTaxPaymentRemaining" abstract="false" name="TransitionTaxPaymentRemaining" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_GoodwillTextualsAbstract" abstract="true" name="GoodwillTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_ChangeinDeferredTaxAssetsValuationAllowance" abstract="false" name="ChangeinDeferredTaxAssetsValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" abstract="true" name="RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RDRegulatoryandCommercializationbasedMilestoneMember" abstract="true" name="RDRegulatoryandCommercializationbasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EuroDenominatedFactoringArrangementsMember" abstract="true" name="EuroDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_May2020SNAggregateOfferingMember" abstract="true" name="May2020SNAggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OptionsExpectedToVestWeightedAverageExercisePrice" abstract="false" name="OptionsExpectedToVestWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="bsx_RestructuringPlanMember" abstract="true" name="RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_May2022NotesMember" abstract="true" name="May2022NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalElectrophysiologyEpReportingUnitMember" abstract="true" name="GlobalElectrophysiologyEpReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CumulativeRestructuringChargesIncurredToDate" abstract="false" name="CumulativeRestructuringChargesIncurredToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_PaymentsForRoyaltyRights" abstract="false" name="PaymentsForRoyaltyRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_UnrecognizedCompensationCostStockOptions" abstract="false" name="UnrecognizedCompensationCostStockOptions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_UnrecognizedCompensationCost" abstract="false" name="UnrecognizedCompensationCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" abstract="false" name="Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" abstract="true" name="RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_A2020TermLoanMember" abstract="true" name="A2020TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_IncomeTaxesAbstract" abstract="true" name="IncomeTaxesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementfifthquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_A2018AcquisitionsMember" abstract="true" name="A2018AcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_April2021TermLoanMember" abstract="true" name="April2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Seniornotesissued" abstract="false" name="Seniornotesissued" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" abstract="false" name="ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_GlobalInterventionalCardiologyIcReportingUnitMember" abstract="true" name="GlobalInterventionalCardiologyIcReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ForwardCurrencyContractsTimetoMaturity" abstract="false" name="ForwardCurrencyContractsTimetoMaturity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ThreeYearDelayedDrawTermLoanMember" abstract="true" name="ThreeYearDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" abstract="false" name="SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>bsx-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b8cf84dc-d42e-4cf7-a067-5352d2212acb,g:c4fd43c3-3c28-47b7-bdfe-13ef2366d2d6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Cover" xlink:type="simple" xlink:href="bsx-20201231.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_861defe1-fb85-4b08-83d4-63c6dbe97be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4e5b4996-9638-4a59-bc06-e0ca11343386" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_861defe1-fb85-4b08-83d4-63c6dbe97be0" xlink:to="loc_us-gaap_GrossProfit_4e5b4996-9638-4a59-bc06-e0ca11343386" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9718b7ff-7b5a-4c92-9413-ed80985c5f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_861defe1-fb85-4b08-83d4-63c6dbe97be0" xlink:to="loc_us-gaap_OperatingExpenses_9718b7ff-7b5a-4c92-9413-ed80985c5f09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c6741784-2d85-4ca2-b436-3dba8d53c1e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2dd14828-e3c0-40ab-9247-94b2e505ae07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c6741784-2d85-4ca2-b436-3dba8d53c1e7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2dd14828-e3c0-40ab-9247-94b2e505ae07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_95c7adb7-c89f-4ed3-b814-835962156c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c6741784-2d85-4ca2-b436-3dba8d53c1e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_95c7adb7-c89f-4ed3-b814-835962156c76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2f709006-81f0-4403-a2b6-da47749c560c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_584b3c42-d6ce-4c0c-9392-1e7996b62aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2f709006-81f0-4403-a2b6-da47749c560c" xlink:to="loc_us-gaap_DividendsPreferredStockStock_584b3c42-d6ce-4c0c-9392-1e7996b62aa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d3e4bcb3-cc3c-4596-a018-9b0ce3f6a911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2f709006-81f0-4403-a2b6-da47749c560c" xlink:to="loc_us-gaap_ProfitLoss_d3e4bcb3-cc3c-4596-a018-9b0ce3f6a911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cd6aa1de-950b-448a-846c-7ec42679f345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bb713df0-81b1-4f2c-8d9d-743a8e7ede99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_cd6aa1de-950b-448a-846c-7ec42679f345" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bb713df0-81b1-4f2c-8d9d-743a8e7ede99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cb57a397-fd1a-4731-9897-5293980f765b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_cd6aa1de-950b-448a-846c-7ec42679f345" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cb57a397-fd1a-4731-9897-5293980f765b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b6cf1196-30b5-481f-8b8d-ba6e5880a87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b6cf1196-30b5-481f-8b8d-ba6e5880a87d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_7b40ba6a-bb97-447c-b8e5-90b291109a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_7b40ba6a-bb97-447c-b8e5-90b291109a3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_ab894537-52f9-4925-bca5-d0ec1055f4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_RoyaltyExpense_ab894537-52f9-4925-bca5-d0ec1055f4ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e90e2b77-a115-4705-bdaf-419a8e1d34f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e90e2b77-a115-4705-bdaf-419a8e1d34f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_427784ed-91c3-44a0-b252-0a0b8eeecb95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_427784ed-91c3-44a0-b252-0a0b8eeecb95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_baaeac21-91a4-4368-966c-19117b44b076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_baaeac21-91a4-4368-966c-19117b44b076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a561c8fb-676c-4013-8694-1cf74ad20796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a561c8fb-676c-4013-8694-1cf74ad20796" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a8d2243a-3b84-467b-9936-1475777cdc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_RestructuringCharges_a8d2243a-3b84-467b-9936-1475777cdc9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_309a5be5-f193-459e-bddd-8bc87d4298cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f951b082-e716-43f8-bcd1-39594d45ee41" xlink:to="loc_us-gaap_LitigationSettlementExpense_309a5be5-f193-459e-bddd-8bc87d4298cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0090344e-e6b0-4a44-aa4d-91324e3b87a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_69e09807-4c4c-4c50-a5f9-ab9e520433d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0090344e-e6b0-4a44-aa4d-91324e3b87a3" xlink:to="loc_us-gaap_OperatingIncomeLoss_69e09807-4c4c-4c50-a5f9-ab9e520433d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_07074960-4350-4b78-bfb9-6d47cdced59b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0090344e-e6b0-4a44-aa4d-91324e3b87a3" xlink:to="loc_us-gaap_InterestExpense_07074960-4350-4b78-bfb9-6d47cdced59b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_962755b6-1a6e-4e61-b5dd-2b5c4b6fcfb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0090344e-e6b0-4a44-aa4d-91324e3b87a3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_962755b6-1a6e-4e61-b5dd-2b5c4b6fcfb8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b16a2607-34bc-4072-b2ec-fbc23ee97b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_11637941-b951-450d-9d9a-6de783a08196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b16a2607-34bc-4072-b2ec-fbc23ee97b9a" xlink:to="loc_us-gaap_ProfitLoss_11637941-b951-450d-9d9a-6de783a08196" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dbafe28d-ef6c-468b-974f-54be61364e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b16a2607-34bc-4072-b2ec-fbc23ee97b9a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dbafe28d-ef6c-468b-974f-54be61364e87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_26b352db-49b0-4cd0-9caf-9e8cd4bad384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_efc0e63c-cbe0-43f5-aa44-933494ceb9cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_26b352db-49b0-4cd0-9caf-9e8cd4bad384" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_efc0e63c-cbe0-43f5-aa44-933494ceb9cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2e262e03-173d-4912-939e-5b71cc41e992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_26b352db-49b0-4cd0-9caf-9e8cd4bad384" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2e262e03-173d-4912-939e-5b71cc41e992" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_69957846-b048-4bdf-a3b0-e85697a75c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_26b352db-49b0-4cd0-9caf-9e8cd4bad384" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_69957846-b048-4bdf-a3b0-e85697a75c0f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_03b8fe0c-d1b5-4d00-9e3f-e1cd7aa40fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c999d51-91da-4780-87e4-c2b2a833f98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_03b8fe0c-d1b5-4d00-9e3f-e1cd7aa40fcb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c999d51-91da-4780-87e4-c2b2a833f98f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_22ce7e50-f00b-4896-b057-05464f4e8daa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_03b8fe0c-d1b5-4d00-9e3f-e1cd7aa40fcb" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_22ce7e50-f00b-4896-b057-05464f4e8daa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d28d0e12-3b2f-4d50-9b36-2302c67c0b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_03b8fe0c-d1b5-4d00-9e3f-e1cd7aa40fcb" xlink:to="loc_us-gaap_InventoryNet_d28d0e12-3b2f-4d50-9b36-2302c67c0b7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_7de2e756-dc19-4349-b0ff-c714cc3f7dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_03b8fe0c-d1b5-4d00-9e3f-e1cd7aa40fcb" xlink:to="loc_us-gaap_PrepaidTaxes_7de2e756-dc19-4349-b0ff-c714cc3f7dd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_5a5c97a0-2b3a-4f94-be5c-7521c3508236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_03b8fe0c-d1b5-4d00-9e3f-e1cd7aa40fcb" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_5a5c97a0-2b3a-4f94-be5c-7521c3508236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e48a16c3-6a75-4e3a-abda-84209c4fc293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_03b8fe0c-d1b5-4d00-9e3f-e1cd7aa40fcb" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e48a16c3-6a75-4e3a-abda-84209c4fc293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f5182ea2-edd4-41e7-9042-a9c619a27946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_24a17c7a-7c08-44ac-88e1-8fb4b98ea99f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f5182ea2-edd4-41e7-9042-a9c619a27946" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_24a17c7a-7c08-44ac-88e1-8fb4b98ea99f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_06d97842-0e09-43cc-8364-72ccb59e3d27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f5182ea2-edd4-41e7-9042-a9c619a27946" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_06d97842-0e09-43cc-8364-72ccb59e3d27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7df3655d-8fbe-4ff0-bf30-778c428e2ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f5182ea2-edd4-41e7-9042-a9c619a27946" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7df3655d-8fbe-4ff0-bf30-778c428e2ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f19ee8f9-a7c5-4982-9b3a-d07b8f3856b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f5182ea2-edd4-41e7-9042-a9c619a27946" xlink:to="loc_us-gaap_LiabilitiesCurrent_f19ee8f9-a7c5-4982-9b3a-d07b8f3856b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_07955417-8f70-462f-833c-e9f3c0cd2468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f5182ea2-edd4-41e7-9042-a9c619a27946" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_07955417-8f70-462f-833c-e9f3c0cd2468" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_df3ca57d-9d30-46ab-8de3-6aefc361568b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:to="loc_us-gaap_PreferredStockValue_df3ca57d-9d30-46ab-8de3-6aefc361568b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0b25c614-9720-491b-b5a8-779425d89b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:to="loc_us-gaap_CommonStockValue_0b25c614-9720-491b-b5a8-779425d89b6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_db9d2482-f631-4c61-bfc6-25b2d44b84a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:to="loc_us-gaap_TreasuryStockValue_db9d2482-f631-4c61-bfc6-25b2d44b84a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e4eb6c19-13d8-49e2-b274-90e0dd9812db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e4eb6c19-13d8-49e2-b274-90e0dd9812db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_36769d89-a025-4132-ba2e-183385752127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_36769d89-a025-4132-ba2e-183385752127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e065885b-11d6-46a7-83ca-7000aa39b0cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e065885b-11d6-46a7-83ca-7000aa39b0cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_38fb7bd5-796d-4091-9878-28e1b3214f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_38fb7bd5-796d-4091-9878-28e1b3214f00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0196bb1b-c579-4fa9-9277-b256141565b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a21fe9c1-d047-42b0-91ef-c1bad86d3dd9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0196bb1b-c579-4fa9-9277-b256141565b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b2bfd43c-680e-4903-967c-d2b934362778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_ade83191-25d3-4347-941c-264c5a1aa29e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b2bfd43c-680e-4903-967c-d2b934362778" xlink:to="loc_us-gaap_DebtCurrent_ade83191-25d3-4347-941c-264c5a1aa29e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f890eeea-0232-4e6f-89ee-5006d35f76e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b2bfd43c-680e-4903-967c-d2b934362778" xlink:to="loc_us-gaap_AccountsPayableCurrent_f890eeea-0232-4e6f-89ee-5006d35f76e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_85b90737-445f-4d25-a59c-d4a3662fe484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b2bfd43c-680e-4903-967c-d2b934362778" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_85b90737-445f-4d25-a59c-d4a3662fe484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e31fb178-f1dd-4c54-bf14-0e47e672259b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b2bfd43c-680e-4903-967c-d2b934362778" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e31fb178-f1dd-4c54-bf14-0e47e672259b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5d4ae3c0-fc05-47ae-a81e-2a8a64834384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_591cf95e-af97-4885-8043-932db978749e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d4ae3c0-fc05-47ae-a81e-2a8a64834384" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_591cf95e-af97-4885-8043-932db978749e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f18b5c67-a582-49bd-a8fe-382962066cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d4ae3c0-fc05-47ae-a81e-2a8a64834384" xlink:to="loc_us-gaap_Goodwill_f18b5c67-a582-49bd-a8fe-382962066cdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fb4229f9-0a8b-4fb2-afc3-0824b87414fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d4ae3c0-fc05-47ae-a81e-2a8a64834384" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fb4229f9-0a8b-4fb2-afc3-0824b87414fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c98c2b52-71fb-47bd-8dc9-c2bbe92ce5e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d4ae3c0-fc05-47ae-a81e-2a8a64834384" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c98c2b52-71fb-47bd-8dc9-c2bbe92ce5e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e34050b8-bf31-4448-aa5f-3d01c2f4e2e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d4ae3c0-fc05-47ae-a81e-2a8a64834384" xlink:to="loc_us-gaap_AssetsCurrent_e34050b8-bf31-4448-aa5f-3d01c2f4e2e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd8771a2-a399-4134-a17d-a10e44c3ba6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5d4ae3c0-fc05-47ae-a81e-2a8a64834384" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd8771a2-a399-4134-a17d-a10e44c3ba6b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedBalanceSheetParanthetical"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_411c55c2-d3a9-4803-b30c-fa667e78bee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38231ca5-da42-4336-8b6e-3326f885ecae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_411c55c2-d3a9-4803-b30c-fa667e78bee1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38231ca5-da42-4336-8b6e-3326f885ecae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4710bff5-f49d-435b-8726-c94e2baca6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_411c55c2-d3a9-4803-b30c-fa667e78bee1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4710bff5-f49d-435b-8726-c94e2baca6ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3ac764e4-a702-4ee2-887b-24ad903c2d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_411c55c2-d3a9-4803-b30c-fa667e78bee1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3ac764e4-a702-4ee2-887b-24ad903c2d8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_528350c6-d4ec-4d9f-aeb6-ec7ac1cc7b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_411c55c2-d3a9-4803-b30c-fa667e78bee1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_528350c6-d4ec-4d9f-aeb6-ec7ac1cc7b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_66a53b39-1fc9-4bb3-816c-639628bfaefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_ProfitLoss_66a53b39-1fc9-4bb3-816c-639628bfaefc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_8a061a2a-3c20-4405-a3f7-809bfb74d8fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_8a061a2a-3c20-4405-a3f7-809bfb74d8fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f4c01936-85cb-40ed-a9a4-a115adb31321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f4c01936-85cb-40ed-a9a4-a115adb31321" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_03c67c44-fa51-49ab-871b-50727e372929" xlink:href="bsx-20201231.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_03c67c44-fa51-49ab-871b-50727e372929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_eabf748b-5b26-4226-9d09-5f1ac3c69d3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_ShareBasedCompensation_eabf748b-5b26-4226-9d09-5f1ac3c69d3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_0f7e516c-91ef-49eb-a159-bba6624653f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_0f7e516c-91ef-49eb-a159-bba6624653f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_f8fd96a1-8dc3-4372-bf36-2598dd5103be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_GainLossOnInvestments_f8fd96a1-8dc3-4372-bf36-2598dd5103be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_faeef394-9625-4846-8fe3-32eb96e5aab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_faeef394-9625-4846-8fe3-32eb96e5aab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_788c8085-d289-4bc0-9fc6-aa63e3278bbf" xlink:href="bsx-20201231.xsd#bsx_InventoryStepUpAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_bsx_InventoryStepUpAmortization_788c8085-d289-4bc0-9fc6-aa63e3278bbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_b3b05ffb-224f-4590-a666-bf7826ce3de5" xlink:href="bsx-20201231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_b3b05ffb-224f-4590-a666-bf7826ce3de5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_02ab3beb-8244-44ef-bd71-091804944cf1" xlink:href="bsx-20201231.xsd#bsx_OtherNet"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_bsx_OtherNet_02ab3beb-8244-44ef-bd71-091804944cf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a56fdb08-569e-48f1-a4b7-e3472f4663c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a56fdb08-569e-48f1-a4b7-e3472f4663c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_aa87e6bb-96cf-424d-baf4-993f4875b134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_aa87e6bb-96cf-424d-baf4-993f4875b134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_64e5f297-cb60-4ad2-95c7-6f90a584a816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_64e5f297-cb60-4ad2-95c7-6f90a584a816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6b2e76e7-7a83-421f-97b1-f3f6b09bf40a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6b2e76e7-7a83-421f-97b1-f3f6b09bf40a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_db3c33c8-71a0-4c47-a74a-177cbb52cd2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17a79a6c-b3ca-475f-b2eb-1a75371316fd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_db3c33c8-71a0-4c47-a74a-177cbb52cd2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ec31c909-0c77-43fb-91d9-7e9cfcdf1cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_ec31c909-0c77-43fb-91d9-7e9cfcdf1cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_f4e04b6a-8ffb-400f-a8e7-0a6ab0881a7a" xlink:href="bsx-20201231.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_bsx_PaymentsForRoyaltyRights_f4e04b6a-8ffb-400f-a8e7-0a6ab0881a7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_7e141827-8422-45a9-a404-74221fb007cc" xlink:href="bsx-20201231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_7e141827-8422-45a9-a404-74221fb007cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_fb6208b9-9496-4c14-9e2a-35553363123e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_fb6208b9-9496-4c14-9e2a-35553363123e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_eda58a62-1036-4192-b7e2-93c39b90f230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_eda58a62-1036-4192-b7e2-93c39b90f230" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_2799b842-fc2f-442a-a5a8-b7d9b69d80a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_2799b842-fc2f-442a-a5a8-b7d9b69d80a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_3770b199-bbbc-4833-9211-b8d6061051bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_3770b199-bbbc-4833-9211-b8d6061051bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_6bb8fc83-1fca-4d14-b101-38c85900bbcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_6bb8fc83-1fca-4d14-b101-38c85900bbcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_1adb1335-041b-494d-b4ab-b0419ae7e03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_1adb1335-041b-494d-b4ab-b0419ae7e03e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_90fdee89-9861-4a8b-ade0-b7cceee76342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_90fdee89-9861-4a8b-ade0-b7cceee76342" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_d1db31a5-2a49-4fb0-bb43-62a12a96e276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_PaymentsOfDividends_d1db31a5-2a49-4fb0-bb43-62a12a96e276" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_96a215cd-b3e4-4c96-b1b8-b830e6e0f6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_96a215cd-b3e4-4c96-b1b8-b830e6e0f6ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b66e6d02-d88c-4e4c-b405-8e36d4c26eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b66e6d02-d88c-4e4c-b405-8e36d4c26eb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_009b6d41-76e4-4698-ba7b-2d04b40cb57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_009b6d41-76e4-4698-ba7b-2d04b40cb57a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_2f157a1a-c03b-49f4-9f76-85c0d8147790" xlink:href="bsx-20201231.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_2f157a1a-c03b-49f4-9f76-85c0d8147790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_16247a4b-e688-44a3-bd22-75df8b32dea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eb6a07ac-b74e-435a-beb7-093160ffbe46" xlink:to="loc_us-gaap_ProceedsFromStockPlans_16247a4b-e688-44a3-bd22-75df8b32dea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e132a1bf-a31b-473c-aaee-966d921a9d31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0689d0ae-0e9b-4bcf-8669-d471cbe35a28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e132a1bf-a31b-473c-aaee-966d921a9d31" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0689d0ae-0e9b-4bcf-8669-d471cbe35a28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_5bbf37b1-3518-46e3-81a9-288cdc276ef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e132a1bf-a31b-473c-aaee-966d921a9d31" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_5bbf37b1-3518-46e3-81a9-288cdc276ef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_da3f1d96-c14d-48eb-ac7d-024068b24d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e132a1bf-a31b-473c-aaee-966d921a9d31" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_da3f1d96-c14d-48eb-ac7d-024068b24d58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_90de7c01-b5f2-4c49-8161-56747915d98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e132a1bf-a31b-473c-aaee-966d921a9d31" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_90de7c01-b5f2-4c49-8161-56747915d98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_11f52841-8c67-4c26-8801-5a4c4e382c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e132a1bf-a31b-473c-aaee-966d921a9d31" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_11f52841-8c67-4c26-8801-5a4c4e382c66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_d1550c1f-8aca-42cc-bb57-17d3b1a0902c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e132a1bf-a31b-473c-aaee-966d921a9d31" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_d1550c1f-8aca-42cc-bb57-17d3b1a0902c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_69a736e1-8e07-4c00-be62-01afd88e9ec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e132a1bf-a31b-473c-aaee-966d921a9d31" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_69a736e1-8e07-4c00-be62-01afd88e9ec1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestments"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContingentConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StrategicInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSale"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSaleTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20201231.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#FairValueMeasuresandDisclosuresPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitments"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_25d3e569-f227-4d6c-9a4f-0641e4efe327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_29a9535c-b889-4856-b59c-fda38c39c04e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_25d3e569-f227-4d6c-9a4f-0641e4efe327" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_29a9535c-b889-4856-b59c-fda38c39c04e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_6131d829-8a3a-4c8f-a2da-470cb5ce987f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_25d3e569-f227-4d6c-9a4f-0641e4efe327" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_6131d829-8a3a-4c8f-a2da-470cb5ce987f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_42ec6d25-ee27-4aa1-bcd3-53a046fd1994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_25d3e569-f227-4d6c-9a4f-0641e4efe327" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_42ec6d25-ee27-4aa1-bcd3-53a046fd1994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_4f98fdc2-2525-4759-8497-428c074296ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_25d3e569-f227-4d6c-9a4f-0641e4efe327" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_4f98fdc2-2525-4759-8497-428c074296ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_3695e2d4-85c4-488b-9fd7-162442353cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_25d3e569-f227-4d6c-9a4f-0641e4efe327" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_3695e2d4-85c4-488b-9fd7-162442353cf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_b43d7dde-cf00-42d9-8057-79eb00d8d27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_25d3e569-f227-4d6c-9a4f-0641e4efe327" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_b43d7dde-cf00-42d9-8057-79eb00d8d27f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Leases" xlink:type="simple" xlink:href="bsx-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#LeasesDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivities" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivities"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivitiesTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivitiesDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformation"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_5885c4bc-4e4b-4874-92c2-1fe6b5829a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_d5bdf9e3-0757-4f34-af46-f18f34c6f0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5885c4bc-4e4b-4874-92c2-1fe6b5829a79" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_d5bdf9e3-0757-4f34-af46-f18f34c6f0b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ccb3c4f7-22fb-4263-859b-4f1758b43d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5885c4bc-4e4b-4874-92c2-1fe6b5829a79" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_ccb3c4f7-22fb-4263-859b-4f1758b43d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangements_e6fe9963-1f86-4887-95fc-9e14610fc0e3" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5885c4bc-4e4b-4874-92c2-1fe6b5829a79" xlink:to="loc_bsx_LicensingArrangements_e6fe9963-1f86-4887-95fc-9e14610fc0e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_b401f35b-5e75-4a1a-afff-19db15121373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_5885c4bc-4e4b-4874-92c2-1fe6b5829a79" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_b401f35b-5e75-4a1a-afff-19db15121373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d884cd39-d287-4e8e-aa83-057c46abc231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_78199669-7a4c-48fa-8525-1d8f5c9bbb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d884cd39-d287-4e8e-aa83-057c46abc231" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_78199669-7a4c-48fa-8525-1d8f5c9bbb3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7e7ce6f5-2458-4f74-bed5-67527c41273b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d884cd39-d287-4e8e-aa83-057c46abc231" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7e7ce6f5-2458-4f74-bed5-67527c41273b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_dac0027e-ffff-41e3-b441-42f7147ade6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d884cd39-d287-4e8e-aa83-057c46abc231" xlink:to="loc_us-gaap_LitigationReserveCurrent_dac0027e-ffff-41e3-b441-42f7147ade6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fbee8eb9-cce2-44d6-bff4-a6030e996d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d884cd39-d287-4e8e-aa83-057c46abc231" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fbee8eb9-cce2-44d6-bff4-a6030e996d87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_9754eaf0-ed33-46c1-b36c-98afa90f5c8c" xlink:href="bsx-20201231.xsd#bsx_AccruedRebatesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d884cd39-d287-4e8e-aa83-057c46abc231" xlink:to="loc_bsx_AccruedRebatesCurrent_9754eaf0-ed33-46c1-b36c-98afa90f5c8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_18c28c43-d164-4c7b-b045-346ab6a636c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_493051ea-49d0-4191-baa9-067314bd3e80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_18c28c43-d164-4c7b-b045-346ab6a636c5" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_493051ea-49d0-4191-baa9-067314bd3e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bd3f0a73-668c-48d7-a2ad-0b2f2a41252f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_18c28c43-d164-4c7b-b045-346ab6a636c5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bd3f0a73-668c-48d7-a2ad-0b2f2a41252f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_aebd3738-130c-49ef-ba96-e27ed29f3c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_b7b43cb1-68f5-4b80-a13a-01f421c4b33a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_aebd3738-130c-49ef-ba96-e27ed29f3c66" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_b7b43cb1-68f5-4b80-a13a-01f421c4b33a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_71601e08-3a3a-4697-963f-53421c111180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_aebd3738-130c-49ef-ba96-e27ed29f3c66" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_71601e08-3a3a-4697-963f-53421c111180" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_206dd40d-4f3e-4583-8a84-cf020fd9ad8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_aebd3738-130c-49ef-ba96-e27ed29f3c66" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_206dd40d-4f3e-4583-8a84-cf020fd9ad8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_557edbfc-a410-4ad2-98e3-77eb3ec94c03" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_aebd3738-130c-49ef-ba96-e27ed29f3c66" xlink:to="loc_bsx_LicensingArrangementsLiability_557edbfc-a410-4ad2-98e3-77eb3ec94c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3a1b0d27-1147-4f11-a106-8db3de5f89f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_aebd3738-130c-49ef-ba96-e27ed29f3c66" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3a1b0d27-1147-4f11-a106-8db3de5f89f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_d9b4b95c-d1cf-4097-b5bf-a358d27c5c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_aebd3738-130c-49ef-ba96-e27ed29f3c66" xlink:to="loc_us-gaap_DeferredRevenue_d9b4b95c-d1cf-4097-b5bf-a358d27c5c19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_0bfb6030-322b-476b-99b7-01070a6203d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_aebd3738-130c-49ef-ba96-e27ed29f3c66" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_0bfb6030-322b-476b-99b7-01070a6203d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1f748ae1-9427-4c9a-8c6b-e38414524d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_28b633bc-88ce-4540-9f3a-4c2f3e89d3a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1f748ae1-9427-4c9a-8c6b-e38414524d15" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_28b633bc-88ce-4540-9f3a-4c2f3e89d3a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_83d535a3-41d0-414e-8856-0c1d13ca7952" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1f748ae1-9427-4c9a-8c6b-e38414524d15" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_83d535a3-41d0-414e-8856-0c1d13ca7952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7141b8c1-5850-459a-a66b-d4d52bc24c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_808f9e24-50e8-4a12-a089-9e586ead20d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7141b8c1-5850-459a-a66b-d4d52bc24c6e" xlink:to="loc_us-gaap_Investments_808f9e24-50e8-4a12-a089-9e586ead20d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset_41b23d08-0476-4c5a-a48c-18e50b15b983" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7141b8c1-5850-459a-a66b-d4d52bc24c6e" xlink:to="loc_bsx_LicensingArrangementsAsset_41b23d08-0476-4c5a-a48c-18e50b15b983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_1c529491-bb69-45da-bddd-4bd80ae0ed21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7141b8c1-5850-459a-a66b-d4d52bc24c6e" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_1c529491-bb69-45da-bddd-4bd80ae0ed21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3d3984da-36b5-423e-8c3f-38637c3d5ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7141b8c1-5850-459a-a66b-d4d52bc24c6e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3d3984da-36b5-423e-8c3f-38637c3d5ccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongTermAssets_8453c8fe-ee0d-43d2-a63c-954c664fe582" xlink:href="bsx-20201231.xsd#bsx_OtherOtherLongTermAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7141b8c1-5850-459a-a66b-d4d52bc24c6e" xlink:to="loc_bsx_OtherOtherLongTermAssets_8453c8fe-ee0d-43d2-a63c-954c664fe582" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c811f405-1420-4d0d-934b-a96ece9ffce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7141b8c1-5850-459a-a66b-d4d52bc24c6e" xlink:to="loc_us-gaap_DerivativeAssets_c811f405-1420-4d0d-934b-a96ece9ffce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4560230b-82f4-4f6e-a78b-4385fa4659a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_a29bc0ec-1adf-4620-8c55-6bf011370e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4560230b-82f4-4f6e-a78b-4385fa4659a2" xlink:to="loc_us-gaap_Land_a29bc0ec-1adf-4620-8c55-6bf011370e22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_e8a56783-0a24-4add-b985-08825b5e989e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4560230b-82f4-4f6e-a78b-4385fa4659a2" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_e8a56783-0a24-4add-b985-08825b5e989e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross_d33c4770-89ac-4f67-8d2f-e29e7f0198fc" xlink:href="bsx-20201231.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4560230b-82f4-4f6e-a78b-4385fa4659a2" xlink:to="loc_bsx_EquipmentFurnitureAndFixturesGross_d33c4770-89ac-4f67-8d2f-e29e7f0198fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_4ed28311-d3f0-4472-a7bb-1bdad6bf4e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4560230b-82f4-4f6e-a78b-4385fa4659a2" xlink:to="loc_us-gaap_ConstructionInProgressGross_4ed28311-d3f0-4472-a7bb-1bdad6bf4e35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesDetailsRateTable"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20201231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockholdersEquityDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockInventiveandPurchasePlans"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockIncentiveandPurchasePlansTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockIncentiveandPurchasePlansDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstanding"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c90a2e62-f8d9-47a4-9e56-85256b6e6677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a975e8b4-f213-409e-87e5-ef7a8588f452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c90a2e62-f8d9-47a4-9e56-85256b6e6677" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a975e8b4-f213-409e-87e5-ef7a8588f452" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_04a6cb3d-0403-4a8e-945a-2ee7162fb792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c90a2e62-f8d9-47a4-9e56-85256b6e6677" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_04a6cb3d-0403-4a8e-945a-2ee7162fb792" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReporting"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReportingTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a675601-bb83-4588-a9a7-e3b742af119e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e80907b2-9bab-4e07-b8fb-d585d05fc09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a675601-bb83-4588-a9a7-e3b742af119e" xlink:to="loc_us-gaap_OperatingIncomeLoss_e80907b2-9bab-4e07-b8fb-d585d05fc09f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c17f702c-a58f-41bb-b3ff-7a18254fceea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a675601-bb83-4588-a9a7-e3b742af119e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c17f702c-a58f-41bb-b3ff-7a18254fceea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20201231.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#RevenueDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20201231.xsd#NewAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#NewAccountingPronouncementsNewAccountingPronouncementsPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansNotes"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansEmployeeRetirementPlansPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ScheduleII" xlink:type="simple" xlink:href="bsx-20201231.xsd#ScheduleII"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ScheduleII" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ScheduleIIDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ScheduleIIDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ScheduleIIDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>bsx-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b8cf84dc-d42e-4cf7-a067-5352d2212acb,g:c4fd43c3-3c28-47b7-bdfe-13ef2366d2d6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Cover" xlink:type="simple" xlink:href="bsx-20201231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/Cover" xlink:type="extended" id="i25099c602dd54045b0f9ed2e48ade6b3_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2b7a9b5a-8ecb-47b9-b446-06e0418e54a9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentType_2b7a9b5a-8ecb-47b9-b446-06e0418e54a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_fe432dd6-dcf1-4fbc-91ed-bca8701a2bf7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentAnnualReport_fe432dd6-dcf1-4fbc-91ed-bca8701a2bf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_aedf336f-40e4-44db-914f-5e236fac8271" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentPeriodEndDate_aedf336f-40e4-44db-914f-5e236fac8271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d93a3d2c-563d-4e9d-9280-9a04d5d860b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentTransitionReport_d93a3d2c-563d-4e9d-9280-9a04d5d860b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_961e410d-5b8a-4495-96ea-77d0e46d2166" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityFileNumber_961e410d-5b8a-4495-96ea-77d0e46d2166" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8f865e8b-fa84-49c2-8771-36a72ab9bc6b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityRegistrantName_8f865e8b-fa84-49c2-8771-36a72ab9bc6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bab589af-b9ea-48d1-a7c1-c873476751cf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bab589af-b9ea-48d1-a7c1-c873476751cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4baca1b8-ab84-445b-8037-660ae2959765" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityTaxIdentificationNumber_4baca1b8-ab84-445b-8037-660ae2959765" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6e355a6c-2cf5-4982-af33-907a5bc2a2ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityAddressAddressLine1_6e355a6c-2cf5-4982-af33-907a5bc2a2ee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a23e963c-6dd3-4467-b645-29131b08a6dd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityAddressCityOrTown_a23e963c-6dd3-4467-b645-29131b08a6dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a76e0ba3-3022-4ace-872b-1f743df1eb8c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityAddressStateOrProvince_a76e0ba3-3022-4ace-872b-1f743df1eb8c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_27cd8449-96c8-4fd0-bca2-4a89ba9a6afb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityAddressPostalZipCode_27cd8449-96c8-4fd0-bca2-4a89ba9a6afb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_8c180485-d1a0-424a-8203-8b54590fea63" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_CityAreaCode_8c180485-d1a0-424a-8203-8b54590fea63" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_50e4799e-d414-4cba-a652-6a56904d04a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_LocalPhoneNumber_50e4799e-d414-4cba-a652-6a56904d04a0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e9c0001a-25b3-471e-b054-2863a300ce66" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_Security12bTitle_e9c0001a-25b3-471e-b054-2863a300ce66" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b02d6fdc-d336-4c8a-ac52-1830fc405003" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_TradingSymbol_b02d6fdc-d336-4c8a-ac52-1830fc405003" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_575e2da5-6eee-4043-a068-fe403e571e4d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_SecurityExchangeName_575e2da5-6eee-4043-a068-fe403e571e4d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_e9598397-f22f-42f0-bde1-c9667b994bdc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_e9598397-f22f-42f0-bde1-c9667b994bdc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_2426f0f2-1393-4545-893d-5c6d7f0e9d66" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityVoluntaryFilers_2426f0f2-1393-4545-893d-5c6d7f0e9d66" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6a859e2c-24bf-4b0b-94f1-561d63b04224" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityCurrentReportingStatus_6a859e2c-24bf-4b0b-94f1-561d63b04224" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e1958d29-9063-4cfb-b8d2-7fffae2e6b10" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityInteractiveDataCurrent_e1958d29-9063-4cfb-b8d2-7fffae2e6b10" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_08cb6260-bd01-4061-8f07-53d1ed813c7d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityFilerCategory_08cb6260-bd01-4061-8f07-53d1ed813c7d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_373080b9-42cf-4e6b-8d4b-a6d582ed6796" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntitySmallBusiness_373080b9-42cf-4e6b-8d4b-a6d582ed6796" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3667c949-ac87-4884-abbf-e01f6c47801d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityEmergingGrowthCompany_3667c949-ac87-4884-abbf-e01f6c47801d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_8e3f207a-bef3-407e-96c7-49fa417c03a2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_IcfrAuditorAttestationFlag_8e3f207a-bef3-407e-96c7-49fa417c03a2" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_42be85c5-a1db-462a-8d1e-4e84ed69ee0f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityShellCompany_42be85c5-a1db-462a-8d1e-4e84ed69ee0f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_9b1cae00-d949-4d7f-9873-fb2abe7428b3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityPublicFloat_9b1cae00-d949-4d7f-9873-fb2abe7428b3" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_e662a00d-7a17-40b3-95ce-32cea8bfa7b2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityListingParValuePerShare_e662a00d-7a17-40b3-95ce-32cea8bfa7b2" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_518de9f0-1a86-430d-85f6-cc604559763b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_518de9f0-1a86-430d-85f6-cc604559763b" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1faca8d1-6468-4deb-864c-b7754972ce77" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityCentralIndexKey_1faca8d1-6468-4deb-864c-b7754972ce77" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e60b843d-b3d6-47a2-9c2e-e8262d3aa460" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_CurrentFiscalYearEndDate_e60b843d-b3d6-47a2-9c2e-e8262d3aa460" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_74436822-61a3-45a1-9e2f-3f244d5b7708" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentFiscalYearFocus_74436822-61a3-45a1-9e2f-3f244d5b7708" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d710e6eb-bd01-473f-bc45-6a6d8d882fc4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d710e6eb-bd01-473f-bc45-6a6d8d882fc4" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ea5a185a-ee39-4cdc-b879-2f872e625fc4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_AmendmentFlag_ea5a185a-ee39-4cdc-b879-2f872e625fc4" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_661c08a2-eebb-4f6c-90f6-07a33573e4ef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntitiesTable_661c08a2-eebb-4f6c-90f6-07a33573e4ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_37a3fd9f-f5a2-4436-a9cf-b2602af98515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_661c08a2-eebb-4f6c-90f6-07a33573e4ef" xlink:to="loc_us-gaap_StatementClassOfStockAxis_37a3fd9f-f5a2-4436-a9cf-b2602af98515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_37a3fd9f-f5a2-4436-a9cf-b2602af98515_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37a3fd9f-f5a2-4436-a9cf-b2602af98515" xlink:to="loc_us-gaap_ClassOfStockDomain_37a3fd9f-f5a2-4436-a9cf-b2602af98515_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37a3fd9f-f5a2-4436-a9cf-b2602af98515" xlink:to="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2522d067-a68b-4014-95bb-1a82093fa155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:to="loc_us-gaap_CommonStockMember_2522d067-a68b-4014-95bb-1a82093fa155" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_9ffc29a2-e330-44f5-b75a-285403113c70" xlink:href="bsx-20201231.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:to="loc_bsx_SeniorNotedue2027Member_9ffc29a2-e330-44f5-b75a-285403113c70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_54896f0c-d01e-47be-b82e-34906e66e8b2" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:to="loc_bsx_A550MCPSSeriesAMember_54896f0c-d01e-47be-b82e-34906e66e8b2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="ie30a4ff5d7744db29272161f93763bcf_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43475124-3aca-403b-af1f-7cb02244ce25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43475124-3aca-403b-af1f-7cb02244ce25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d51e5849-fc7e-446d-a356-42a697bebfe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d51e5849-fc7e-446d-a356-42a697bebfe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2662056f-aeee-40fc-9a0a-9ec18039c3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_GrossProfit_2662056f-aeee-40fc-9a0a-9ec18039c3ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1f4a51e2-2863-414a-b4d2-6b985e3a266a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1f4a51e2-2863-414a-b4d2-6b985e3a266a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d42d722b-03d0-4c7c-a59c-7805d806ec2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d42d722b-03d0-4c7c-a59c-7805d806ec2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_44ebcb43-1047-49c6-8440-9f06c204e5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_RoyaltyExpense_44ebcb43-1047-49c6-8440-9f06c204e5d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e15d81cd-29f0-4e8f-9f12-4aeb2bb17f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e15d81cd-29f0-4e8f-9f12-4aeb2bb17f2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_63041448-6bc5-4732-b34a-f4c52fe0d27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_63041448-6bc5-4732-b34a-f4c52fe0d27b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e19d639c-9b3a-42fd-9b47-ba276c1a38de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e19d639c-9b3a-42fd-9b47-ba276c1a38de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_53758d05-f950-4291-bdc7-57ed36827821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_53758d05-f950-4291-bdc7-57ed36827821" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a05fadbe-e01d-42c0-8b13-9be9c3d7a1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_RestructuringCharges_a05fadbe-e01d-42c0-8b13-9be9c3d7a1b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_cda08198-6a95-4e48-9176-5f08b3f1a5da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_LitigationSettlementExpense_cda08198-6a95-4e48-9176-5f08b3f1a5da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b1b35924-ded3-4c3c-ac12-757108468ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_OperatingExpenses_b1b35924-ded3-4c3c-ac12-757108468ac6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_46c237cb-9a99-4245-bdd9-7a7ea3e9c66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_OperatingIncomeLoss_46c237cb-9a99-4245-bdd9-7a7ea3e9c66f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_70751453-d5b4-4b5c-9d97-155442647304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_70751453-d5b4-4b5c-9d97-155442647304" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b6de5bf8-8db1-4a26-a109-262a8fe2a466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_70751453-d5b4-4b5c-9d97-155442647304" xlink:to="loc_us-gaap_InterestExpense_b6de5bf8-8db1-4a26-a109-262a8fe2a466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c1075aff-ccd1-4121-918a-5099ab7d4b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_70751453-d5b4-4b5c-9d97-155442647304" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c1075aff-ccd1-4121-918a-5099ab7d4b8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_48493fbb-6388-4b35-bf5f-38279e2792f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_48493fbb-6388-4b35-bf5f-38279e2792f2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f2fa0ed3-1b96-4cea-9225-1953a2ac28c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f2fa0ed3-1b96-4cea-9225-1953a2ac28c0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d3bcfc1a-b0b5-41da-a504-490ee8aa95c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_ProfitLoss_d3bcfc1a-b0b5-41da-a504-490ee8aa95c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_4755cf5d-2f92-48fd-a4cb-0d525671b5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_DividendsPreferredStockStock_4755cf5d-2f92-48fd-a4cb-0d525671b5a5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_62553b27-c704-4de4-825d-ddd26c50a745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_62553b27-c704-4de4-825d-ddd26c50a745" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_50049ae0-4358-4b5f-9b35-ccb5a3b4a87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_EarningsPerShareBasic_50049ae0-4358-4b5f-9b35-ccb5a3b4a87e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c7490e58-d9a8-4a50-a8a0-431cb384daaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c7490e58-d9a8-4a50-a8a0-431cb384daaa" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5dd60e40-a9fc-4067-a786-1195ffd19832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5dd60e40-a9fc-4067-a786-1195ffd19832" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ab0f4b8c-3516-46a8-9145-22cf2e61f104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5dd60e40-a9fc-4067-a786-1195ffd19832" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ab0f4b8c-3516-46a8-9145-22cf2e61f104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9834d717-f768-44bd-91ff-65c1bbb45590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5dd60e40-a9fc-4067-a786-1195ffd19832" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9834d717-f768-44bd-91ff-65c1bbb45590" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9b2d91ee-f027-4d72-8fd9-a4c90bb15423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_StatementTable_9b2d91ee-f027-4d72-8fd9-a4c90bb15423" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_eb1b9387-21cb-48aa-9864-89f73092824e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9b2d91ee-f027-4d72-8fd9-a4c90bb15423" xlink:to="loc_srt_StatementScenarioAxis_eb1b9387-21cb-48aa-9864-89f73092824e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_eb1b9387-21cb-48aa-9864-89f73092824e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_eb1b9387-21cb-48aa-9864-89f73092824e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_eb1b9387-21cb-48aa-9864-89f73092824e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c6e93a9d-9f9c-4c86-838b-0fe313ab2285" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_eb1b9387-21cb-48aa-9864-89f73092824e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c6e93a9d-9f9c-4c86-838b-0fe313ab2285" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i92680677f68b4387bc2b27957a275e65_ConsolidatedStatementsofComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a568ca12-1b8c-44f8-b4e9-72d10a4238c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:to="loc_us-gaap_ProfitLoss_a568ca12-1b8c-44f8-b4e9-72d10a4238c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aa5125f-9d39-4977-ac7d-ce2c3b02a54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aa5125f-9d39-4977-ac7d-ce2c3b02a54a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fdae2e34-a27b-49c7-82a5-b126c404feec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fdae2e34-a27b-49c7-82a5-b126c404feec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0092d4f4-8130-443e-8dda-c43ca8f9bfa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0092d4f4-8130-443e-8dda-c43ca8f9bfa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5607799c-a541-4979-a188-073ce8e42714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5607799c-a541-4979-a188-073ce8e42714" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5e6ff35-fce0-4837-ad5a-32c3f12d681e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5e6ff35-fce0-4837-ad5a-32c3f12d681e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:to="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_93f33f54-bccc-4f74-a153-e7a184c7838b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:to="loc_srt_StatementScenarioAxis_93f33f54-bccc-4f74-a153-e7a184c7838b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_93f33f54-bccc-4f74-a153-e7a184c7838b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_93f33f54-bccc-4f74-a153-e7a184c7838b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_93f33f54-bccc-4f74-a153-e7a184c7838b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_96e99a17-a814-4fc9-bbf2-12629b4ac38c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_93f33f54-bccc-4f74-a153-e7a184c7838b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_96e99a17-a814-4fc9-bbf2-12629b4ac38c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60" xlink:to="loc_us-gaap_EquityComponentDomain_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f958f583-e6b9-449e-85c6-e5dabbde78a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60" xlink:to="loc_us-gaap_EquityComponentDomain_f958f583-e6b9-449e-85c6-e5dabbde78a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_be888dac-251b-48f3-8b26-52bb8980df3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f958f583-e6b9-449e-85c6-e5dabbde78a2" xlink:to="loc_us-gaap_PreferredStockMember_be888dac-251b-48f3-8b26-52bb8980df3f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i68a03ca0aba246028fd71e0cdd03d0ad_ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bb24f963-8cc9-408d-8249-f468fbe35067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb24f963-8cc9-408d-8249-f468fbe35067" xlink:to="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe895eed-930a-498d-9777-913c27c46d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe895eed-930a-498d-9777-913c27c46d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_08683603-aa0c-4075-af3f-b3b4b8ec9e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_08683603-aa0c-4075-af3f-b3b4b8ec9e7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4df91bbd-5ee6-49bb-8e47-e423ee17e412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_InventoryNet_4df91bbd-5ee6-49bb-8e47-e423ee17e412" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_7a8a032f-e8ad-47c5-805d-21bbdcaaf782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_PrepaidTaxes_7a8a032f-e8ad-47c5-805d-21bbdcaaf782" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c2019fd2-1266-4dde-9ccd-b4958b7ac0bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c2019fd2-1266-4dde-9ccd-b4958b7ac0bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fd544390-0a89-4e32-84f0-f6816fd15ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fd544390-0a89-4e32-84f0-f6816fd15ec9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_248fc4d1-2aae-43a7-a4ff-b254fb752f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_AssetsCurrent_248fc4d1-2aae-43a7-a4ff-b254fb752f1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3b2278b1-797a-4d61-af0f-fdb3873f0e50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3b2278b1-797a-4d61-af0f-fdb3873f0e50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_723b766b-94fd-45e6-ba64-38c2377968fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_Goodwill_723b766b-94fd-45e6-ba64-38c2377968fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56eb96cd-b5c6-4d11-a8a3-e86df5b4fd27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56eb96cd-b5c6-4d11-a8a3-e86df5b4fd27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c6369423-5bfd-41c5-bc43-c8eff4b18aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c6369423-5bfd-41c5-bc43-c8eff4b18aa2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_970f86e6-5a7e-4549-84a4-e2b55d08fa85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_970f86e6-5a7e-4549-84a4-e2b55d08fa85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0e077a4a-4834-48b7-84ea-875d1f2c8b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_Assets_0e077a4a-4834-48b7-84ea-875d1f2c8b58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb24f963-8cc9-408d-8249-f468fbe35067" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_ebbefd95-0fd7-424e-9ffb-56c192c0a4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_DebtCurrent_ebbefd95-0fd7-424e-9ffb-56c192c0a4c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8b55ca77-9156-435a-bb6c-0013d3740a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_AccountsPayableCurrent_8b55ca77-9156-435a-bb6c-0013d3740a68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f9264065-5d99-449c-af42-18b8abc42ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f9264065-5d99-449c-af42-18b8abc42ff2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_861b0f48-e6ae-44e1-be75-303c25a4e1dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_861b0f48-e6ae-44e1-be75-303c25a4e1dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_389d4b73-d280-4d07-8e35-37884c895fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_LiabilitiesCurrent_389d4b73-d280-4d07-8e35-37884c895fdf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f5dabbe7-960d-4b6d-aa8c-e8113e6e46dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f5dabbe7-960d-4b6d-aa8c-e8113e6e46dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f5c2837b-d37e-486f-82fa-99ec63de475d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f5c2837b-d37e-486f-82fa-99ec63de475d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_edf0be58-92b9-4790-8ff5-ff8143cc1293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_edf0be58-92b9-4790-8ff5-ff8143cc1293" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1bb9ad31-7360-4bfa-a5fd-e056339cf3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1bb9ad31-7360-4bfa-a5fd-e056339cf3d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e9b3fdd0-38f5-4323-83d0-c58380207adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_PreferredStockValue_e9b3fdd0-38f5-4323-83d0-c58380207adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_51a926f0-788a-4ef9-b6ea-84619438f649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_CommonStockValue_51a926f0-788a-4ef9-b6ea-84619438f649" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_760476c3-d7c9-43d1-bb51-b0f9071c3ea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_TreasuryStockValue_760476c3-d7c9-43d1-bb51-b0f9071c3ea4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_47177806-0ad6-427b-b4ca-c3f0933f0d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_47177806-0ad6-427b-b4ca-c3f0933f0d17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05c9bb8f-f581-456e-9a6d-d648f019d799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05c9bb8f-f581-456e-9a6d-d648f019d799" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_78011f23-5e43-4ee0-8655-4fb2ba0f2e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_78011f23-5e43-4ee0-8655-4fb2ba0f2e34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_9ce8ead3-3c01-48d5-9438-fb2b8f379805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_9ce8ead3-3c01-48d5-9438-fb2b8f379805" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_820d1eed-ab8b-47a0-97bb-71b72e21b400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_820d1eed-ab8b-47a0-97bb-71b72e21b400" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_286c9f9a-9a98-4287-afbc-43afb60b4349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_286c9f9a-9a98-4287-afbc-43afb60b4349" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e64ed9c7-8e2c-49c8-a9db-34316d25c295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e64ed9c7-8e2c-49c8-a9db-34316d25c295" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_77d7d60b-032a-453f-89e9-f63989f3534d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bb24f963-8cc9-408d-8249-f468fbe35067" xlink:to="loc_us-gaap_StatementTable_77d7d60b-032a-453f-89e9-f63989f3534d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_240bb319-4349-413c-a60b-393c3039de97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_77d7d60b-032a-453f-89e9-f63989f3534d" xlink:to="loc_srt_StatementScenarioAxis_240bb319-4349-413c-a60b-393c3039de97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_240bb319-4349-413c-a60b-393c3039de97_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_240bb319-4349-413c-a60b-393c3039de97" xlink:to="loc_srt_ScenarioUnspecifiedDomain_240bb319-4349-413c-a60b-393c3039de97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cf0ddd91-9580-4628-8d0e-a01bd2f957dd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_240bb319-4349-413c-a60b-393c3039de97" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cf0ddd91-9580-4628-8d0e-a01bd2f957dd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedBalanceSheetParanthetical"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical" xlink:type="extended" id="i76530cd649864a54826269bf38609dd5_ConsolidatedBalanceSheetParanthetical"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i9d8fa639fa584999b390791b4cbca9af_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e7b554a5-7ff2-4a45-8ebc-c0129dbbf102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e7b554a5-7ff2-4a45-8ebc-c0129dbbf102" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8f6abf5a-305e-4faf-999d-43a97367896d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8f6abf5a-305e-4faf-999d-43a97367896d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ec4bbe47-ad49-4532-9ee2-7eaf0391ef16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_SharesIssued_ec4bbe47-ad49-4532-9ee2-7eaf0391ef16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_adcc6f2d-2ec4-40a8-84c7-010f6fe4c2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_ProfitLoss_adcc6f2d-2ec4-40a8-84c7-010f6fe4c2bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeEffectOfNewAccountingPrinciples_04a0525f-cd70-4028-9779-1093f8a577cb" xlink:href="bsx-20201231.xsd#bsx_CumulativeEffectOfNewAccountingPrinciples"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_bsx_CumulativeEffectOfNewAccountingPrinciples_04a0525f-cd70-4028-9779-1093f8a577cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c923938b-c30c-40f9-bd43-d264f87a20b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c923938b-c30c-40f9-bd43-d264f87a20b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3cccf95-93a7-48e5-9115-7f04a8bb8d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3cccf95-93a7-48e5-9115-7f04a8bb8d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cd60339c-a734-4ce3-b371-1b965b27bd48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cd60339c-a734-4ce3-b371-1b965b27bd48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_addcd765-9d3b-46a7-86a5-e8df196f05eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_addcd765-9d3b-46a7-86a5-e8df196f05eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_04d2d572-4ffd-4b8d-93e2-178667ede7f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_04d2d572-4ffd-4b8d-93e2-178667ede7f5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_a36b98d0-8e13-4b5b-ba74-c606b32b83a1" xlink:href="bsx-20201231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_a36b98d0-8e13-4b5b-ba74-c606b32b83a1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_e20a0ff4-49af-4490-b1ae-c3d887e7121a" xlink:href="bsx-20201231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_e20a0ff4-49af-4490-b1ae-c3d887e7121a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dca16c0e-66b1-41d9-b343-cb4dd694ac60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dca16c0e-66b1-41d9-b343-cb4dd694ac60" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_e0210aaa-c6ad-4e83-ab92-1c4a86f3c4ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_DividendsPreferredStockCash_e0210aaa-c6ad-4e83-ab92-1c4a86f3c4ff" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b5619f9b-a4ea-4741-a8fa-4af7b607fbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b5619f9b-a4ea-4741-a8fa-4af7b607fbef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_7b6a5b0c-6991-45fc-89f2-b93563b13945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_7b6a5b0c-6991-45fc-89f2-b93563b13945" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_37705ca9-1011-46b5-9478-1e78ece05cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_37705ca9-1011-46b5-9478-1e78ece05cf9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8a3102cc-a7c3-4ae1-bec0-89c58554c239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_3bdc497f-e7bf-4543-8b87-37e113e29442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f4a93ccc-aba3-4574-842f-dd2217490f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e7b554a5-7ff2-4a45-8ebc-c0129dbbf102" xlink:to="loc_us-gaap_StatementTable_f4a93ccc-aba3-4574-842f-dd2217490f42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_56ffce0b-bbc9-4429-bbd6-aba7c3070662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f4a93ccc-aba3-4574-842f-dd2217490f42" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_56ffce0b-bbc9-4429-bbd6-aba7c3070662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_56ffce0b-bbc9-4429-bbd6-aba7c3070662_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56ffce0b-bbc9-4429-bbd6-aba7c3070662" xlink:to="loc_us-gaap_EquityComponentDomain_56ffce0b-bbc9-4429-bbd6-aba7c3070662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56ffce0b-bbc9-4429-bbd6-aba7c3070662" xlink:to="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_d35a6428-c017-4402-8c94-038e14745b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_PreferredStockMember_d35a6428-c017-4402-8c94-038e14745b42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e40660fc-79f7-4874-98b2-53b3e4301177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_CommonStockMember_e40660fc-79f7-4874-98b2-53b3e4301177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_f158f931-e473-4398-b840-c38f3ad09ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_TreasuryStockMember_f158f931-e473-4398-b840-c38f3ad09ec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8aa7c2d7-bef5-43cd-bd29-01dd7e4e22b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8aa7c2d7-bef5-43cd-bd29-01dd7e4e22b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_18de3103-639f-483d-953b-03abe42bf31c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_RetainedEarningsMember_18de3103-639f-483d-953b-03abe42bf31c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04cdd00e-899e-43a3-9f43-cbb73a056059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04cdd00e-899e-43a3-9f43-cbb73a056059" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i92261e327f8c446aa01a69ba723d71af_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8af00870-5182-42d1-9938-c07b558a64ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_ProfitLoss_8af00870-5182-42d1-9938-c07b558a64ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_86645553-b27e-4fef-be96-59dda7ea8887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_86645553-b27e-4fef-be96-59dda7ea8887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3e82a489-faab-48c6-9976-a7dfa9a1fbde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3e82a489-faab-48c6-9976-a7dfa9a1fbde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b8cd45be-9dde-4f34-b6b5-ecc9988d96ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b8cd45be-9dde-4f34-b6b5-ecc9988d96ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_9bd0ada4-9c66-4130-b9f1-cc84be2c7778" xlink:href="bsx-20201231.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_9bd0ada4-9c66-4130-b9f1-cc84be2c7778" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_778d6979-d2bd-4270-8f51-cbadba1fa24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_ShareBasedCompensation_778d6979-d2bd-4270-8f51-cbadba1fa24d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5ecab0a2-b099-4d36-a859-d6a2e5c9b7cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5ecab0a2-b099-4d36-a859-d6a2e5c9b7cc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_b9470e2a-1b3a-4571-959f-5e2d678d1a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_GainLossOnInvestments_b9470e2a-1b3a-4571-959f-5e2d678d1a4b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_abbd3ac7-3dc9-4c7e-9f0c-ecdbbc425474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_abbd3ac7-3dc9-4c7e-9f0c-ecdbbc425474" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_c3d17da7-16ff-4ea5-bf52-ef8a6eaf019b" xlink:href="bsx-20201231.xsd#bsx_InventoryStepUpAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_bsx_InventoryStepUpAmortization_c3d17da7-16ff-4ea5-bf52-ef8a6eaf019b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_07af25b0-fb4f-4275-aeea-9233e2c6a517" xlink:href="bsx-20201231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_07af25b0-fb4f-4275-aeea-9233e2c6a517" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_1aae543f-dfbc-4d08-bcb5-d3c666ad4475" xlink:href="bsx-20201231.xsd#bsx_OtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_bsx_OtherNet_1aae543f-dfbc-4d08-bcb5-d3c666ad4475" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ec48e2c4-bdea-4737-a738-683b3a730aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ec48e2c4-bdea-4737-a738-683b3a730aae" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bf87de12-27ba-4054-a19c-17d2d539bf54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bf87de12-27ba-4054-a19c-17d2d539bf54" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_807e1353-76ad-487a-afb3-76d99355307c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_807e1353-76ad-487a-afb3-76d99355307c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a3abd9cd-d35e-4ce1-8d13-2cdbc00d88c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a3abd9cd-d35e-4ce1-8d13-2cdbc00d88c0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_670152ee-2cc0-49d8-99d9-649863c574e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_670152ee-2cc0-49d8-99d9-649863c574e5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_4c9d8ce3-2698-4027-ad62-4b95a6d46e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_4c9d8ce3-2698-4027-ad62-4b95a6d46e5e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e611d1ee-6a70-4cfb-8a21-9dc657e3c65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e611d1ee-6a70-4cfb-8a21-9dc657e3c65d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a896fdc6-65b2-42ac-b934-c3860a03b7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a896fdc6-65b2-42ac-b934-c3860a03b7f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e9c2cd81-4a3a-4ae3-baaa-8f9519862108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e9c2cd81-4a3a-4ae3-baaa-8f9519862108" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2f37e025-a38a-4ff6-a2b0-fcbdb467e6d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2f37e025-a38a-4ff6-a2b0-fcbdb467e6d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8597062f-2d78-48a0-ad74-afd8bc5edc6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8597062f-2d78-48a0-ad74-afd8bc5edc6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ae2dc63d-0d45-4dcd-9094-a2a42f28dac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ae2dc63d-0d45-4dcd-9094-a2a42f28dac8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_d5eb4120-9b21-47a7-abee-a84d500d4317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_d5eb4120-9b21-47a7-abee-a84d500d4317" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_8db31c71-b6d7-490c-a70a-690a112e2d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_8db31c71-b6d7-490c-a70a-690a112e2d13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9e45327-1d28-478e-b25e-06b215bebb9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9e45327-1d28-478e-b25e-06b215bebb9c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_53e666e2-3153-46e9-aaf3-d38d3f42ab36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_53e666e2-3153-46e9-aaf3-d38d3f42ab36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_478817cc-1c23-4a13-a437-48bb690ff733" xlink:href="bsx-20201231.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_bsx_PaymentsForRoyaltyRights_478817cc-1c23-4a13-a437-48bb690ff733" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_48a0a223-aa24-4f14-b3a1-6953555d3d5a" xlink:href="bsx-20201231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_48a0a223-aa24-4f14-b3a1-6953555d3d5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_c01a2cae-a565-4ca6-8d75-62c1380b52fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_c01a2cae-a565-4ca6-8d75-62c1380b52fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_cc5eae67-39a6-40e6-8270-7a31cf1b501e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_cc5eae67-39a6-40e6-8270-7a31cf1b501e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c71a8909-db1d-49b7-acfb-05ccb60455a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c71a8909-db1d-49b7-acfb-05ccb60455a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_e109ad14-45e4-4c21-bcac-6cab44e21fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_e109ad14-45e4-4c21-bcac-6cab44e21fbf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_65c079ed-bb7c-4ca6-86d0-b9731ba5db70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_65c079ed-bb7c-4ca6-86d0-b9731ba5db70" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_2ef7974b-f6bd-43d8-9d20-0a0f3e62f89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_2ef7974b-f6bd-43d8-9d20-0a0f3e62f89b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_1399cfeb-9e55-4e4f-ab2a-57c18293dd23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_1399cfeb-9e55-4e4f-ab2a-57c18293dd23" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_749b78d5-2050-415d-b9a9-1f92cc149f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_PaymentsOfDividends_749b78d5-2050-415d-b9a9-1f92cc149f7a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_d1804934-e538-4c04-9c0d-9f06aa4d73dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_d1804934-e538-4c04-9c0d-9f06aa4d73dd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5bd8ddb4-627b-451f-9886-442c5b106bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5bd8ddb4-627b-451f-9886-442c5b106bc8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_55f4f9a7-b2b9-428b-a334-32f3a450d690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_55f4f9a7-b2b9-428b-a334-32f3a450d690" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_da7dd045-6941-4d40-99cb-cc99ee9f39fe" xlink:href="bsx-20201231.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_da7dd045-6941-4d40-99cb-cc99ee9f39fe" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_e914db6d-9371-4a68-a031-38444f49a426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromStockPlans_e914db6d-9371-4a68-a031-38444f49a426" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d132317-6e02-4a4c-8576-2bae6efbe8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d132317-6e02-4a4c-8576-2bae6efbe8c6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a4b7216-e5ae-43ba-aec2-13c75a6746d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a4b7216-e5ae-43ba-aec2-13c75a6746d2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_609a2976-58e5-46b1-b4de-35dc82da926f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_609a2976-58e5-46b1-b4de-35dc82da926f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b394d26b-c1ae-460e-8a87-6e72b7e95ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b394d26b-c1ae-460e-8a87-6e72b7e95ed6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_261bce7f-3f8f-4b94-86d9-6d98b4996fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_89432b06-905b-4740-851c-e653b789f95a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:to="loc_us-gaap_IncomeTaxesPaid_89432b06-905b-4740-851c-e653b789f95a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_33d4c49a-79e0-4944-827d-b7a4f1ae4f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:to="loc_us-gaap_InterestPaidNet_33d4c49a-79e0-4944-827d-b7a4f1ae4f1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_82dc9bc7-f669-4d04-ac98-229d85ad195b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_82dc9bc7-f669-4d04-ac98-229d85ad195b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NonCashImpactOfTransferredRoyaltyRights_d4833499-3a88-4eee-a77d-627b34db3d8f" xlink:href="bsx-20201231.xsd#bsx_NonCashImpactOfTransferredRoyaltyRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:to="loc_bsx_NonCashImpactOfTransferredRoyaltyRights_d4833499-3a88-4eee-a77d-627b34db3d8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a5ffb2be-b6fc-412f-b796-bb7c044a029d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_StatementTable_a5ffb2be-b6fc-412f-b796-bb7c044a029d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_36f88f8b-96d2-4f33-85bb-3dd8c635cd70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a5ffb2be-b6fc-412f-b796-bb7c044a029d" xlink:to="loc_srt_StatementScenarioAxis_36f88f8b-96d2-4f33-85bb-3dd8c635cd70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_36f88f8b-96d2-4f33-85bb-3dd8c635cd70_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_36f88f8b-96d2-4f33-85bb-3dd8c635cd70" xlink:to="loc_srt_ScenarioUnspecifiedDomain_36f88f8b-96d2-4f33-85bb-3dd8c635cd70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_078bd731-dc5c-40e9-b57e-aa90ce4b2a00" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_36f88f8b-96d2-4f33-85bb-3dd8c635cd70" xlink:to="loc_srt_ScenarioUnspecifiedDomain_078bd731-dc5c-40e9-b57e-aa90ce4b2a00" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="extended" id="iac37214ae05845429299116271a4ed78_ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64fb3a48-7a21-4f1f-b96d-a1a12620dbd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64fb3a48-7a21-4f1f-b96d-a1a12620dbd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_8569fa3c-9853-436a-83dd-80a9711f65be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_8569fa3c-9853-436a-83dd-80a9711f65be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f5f35400-69ef-4665-83f6-e54277cb8a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f5f35400-69ef-4665-83f6-e54277cb8a9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8218aa2-7ddc-403b-869c-aa0c4988670e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8218aa2-7ddc-403b-869c-aa0c4988670e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_24ec040b-dbea-419d-94a9-7101ac347667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_StatementTable_24ec040b-dbea-419d-94a9-7101ac347667" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8" xlink:href="bsx-20201231.xsd#bsx_StatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_24ec040b-dbea-419d-94a9-7101ac347667" xlink:to="loc_bsx_StatementAxis_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8_default" xlink:href="bsx-20201231.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_StatementAxis_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8" xlink:to="loc_bsx_StatementDomain_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_34def309-d66e-47f8-b84b-b3e1865a767b" xlink:href="bsx-20201231.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_StatementAxis_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8" xlink:to="loc_bsx_StatementDomain_34def309-d66e-47f8-b84b-b3e1865a767b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPolicies" xlink:type="extended" id="i58064c16da364c6ab9d52d7ff8d31470_SignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i18d06cbb9c42475890a088776d415e25_SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="extended" id="i68282a778b254729905824056a7e6bb2_SignificantAccountingPoliciesSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="extended" id="ibe9c35be36a441699190ab2dfa78ce05_SignificantAccountingPoliciesSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesLineItems_22de3552-995b-491f-85c1-f25a761c5c25" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a96cf18e-95af-4278-b1bc-0e64718c8d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_22de3552-995b-491f-85c1-f25a761c5c25" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a96cf18e-95af-4278-b1bc-0e64718c8d65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_2ca3b22f-08b8-4761-9efa-2fb87b56016e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_22de3552-995b-491f-85c1-f25a761c5c25" xlink:to="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_2ca3b22f-08b8-4761-9efa-2fb87b56016e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_22de3552-995b-491f-85c1-f25a761c5c25" xlink:to="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_940efab8-9af1-45fa-9722-b1b9deb0f353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_940efab8-9af1-45fa-9722-b1b9deb0f353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1c22af6c-7d16-4d0a-8590-217143de2844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1c22af6c-7d16-4d0a-8590-217143de2844" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1c22af6c-7d16-4d0a-8590-217143de2844_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1c22af6c-7d16-4d0a-8590-217143de2844" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1c22af6c-7d16-4d0a-8590-217143de2844_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bfd35375-e229-40d8-9dfc-45cfeea7a064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1c22af6c-7d16-4d0a-8590-217143de2844" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bfd35375-e229-40d8-9dfc-45cfeea7a064" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2c50938a-8db7-4195-8da5-f83f3f6cd1b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_srt_RangeAxis_2c50938a-8db7-4195-8da5-f83f3f6cd1b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c50938a-8db7-4195-8da5-f83f3f6cd1b4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2c50938a-8db7-4195-8da5-f83f3f6cd1b4" xlink:to="loc_srt_RangeMember_2c50938a-8db7-4195-8da5-f83f3f6cd1b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_438e4e78-5a68-4f0a-8ce4-4614aaa98159" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2c50938a-8db7-4195-8da5-f83f3f6cd1b4" xlink:to="loc_srt_RangeMember_438e4e78-5a68-4f0a-8ce4-4614aaa98159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4bff838a-2951-45b4-be0e-40f3abe02f62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_438e4e78-5a68-4f0a-8ce4-4614aaa98159" xlink:to="loc_srt_MinimumMember_4bff838a-2951-45b4-be0e-40f3abe02f62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a701e5b5-7bf5-4a2a-bd03-990d8726c67c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_438e4e78-5a68-4f0a-8ce4-4614aaa98159" xlink:to="loc_srt_MaximumMember_a701e5b5-7bf5-4a2a-bd03-990d8726c67c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e4c471c-9786-4b11-8301-9d225b61c6c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e4c471c-9786-4b11-8301-9d225b61c6c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1e4c471c-9786-4b11-8301-9d225b61c6c3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e4c471c-9786-4b11-8301-9d225b61c6c3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1e4c471c-9786-4b11-8301-9d225b61c6c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ef7794d-46a3-426c-a07a-87ab8bf6cc8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e4c471c-9786-4b11-8301-9d225b61c6c3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ef7794d-46a3-426c-a07a-87ab8bf6cc8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_26239cbc-402c-4ec3-96ba-e16dcf8e1225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ef7794d-46a3-426c-a07a-87ab8bf6cc8e" xlink:to="loc_us-gaap_PatentsMember_26239cbc-402c-4ec3-96ba-e16dcf8e1225" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b023eb4f-8c9f-4874-8dfa-f65993f03a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b023eb4f-8c9f-4874-8dfa-f65993f03a97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b023eb4f-8c9f-4874-8dfa-f65993f03a97_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b023eb4f-8c9f-4874-8dfa-f65993f03a97" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b023eb4f-8c9f-4874-8dfa-f65993f03a97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5a94d0f-425e-46af-b668-62103423f027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b023eb4f-8c9f-4874-8dfa-f65993f03a97" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5a94d0f-425e-46af-b668-62103423f027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b2163ec5-8a02-48a4-9d70-d32fe0a55378" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_srt_ProductOrServiceAxis_b2163ec5-8a02-48a4-9d70-d32fe0a55378" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b2163ec5-8a02-48a4-9d70-d32fe0a55378_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b2163ec5-8a02-48a4-9d70-d32fe0a55378" xlink:to="loc_srt_ProductsAndServicesDomain_b2163ec5-8a02-48a4-9d70-d32fe0a55378_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7f8ebd61-a35c-471c-9fc0-d64767c35be0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b2163ec5-8a02-48a4-9d70-d32fe0a55378" xlink:to="loc_srt_ProductsAndServicesDomain_7f8ebd61-a35c-471c-9fc0-d64767c35be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_e53ce2dc-520c-46aa-9184-860a49f55adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7f8ebd61-a35c-471c-9fc0-d64767c35be0" xlink:to="loc_us-gaap_ShippingAndHandlingMember_e53ce2dc-520c-46aa-9184-860a49f55adb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestments"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="extended" id="ic9bf7f824b154903af3c87ad2463cf07_AcquisitionsandStrategicInvestments"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended" id="ie4b6585569574c1f8340de60704f7d0c_AcquisitionsandStrategicInvestmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_cc66fcbb-7e92-4a29-8924-cfcc30bf72aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_cc66fcbb-7e92-4a29-8924-cfcc30bf72aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b372d783-55d6-437a-915a-854b055ab4af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b372d783-55d6-437a-915a-854b055ab4af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_4278d241-fda2-4d34-aef8-1ba87e871aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_4278d241-fda2-4d34-aef8-1ba87e871aa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_56d55fc8-c62e-4249-a503-ab6da54cf7ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_56d55fc8-c62e-4249-a503-ab6da54cf7ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_6cfaf05d-1279-4ad1-8efa-56916d2ac47f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_6cfaf05d-1279-4ad1-8efa-56916d2ac47f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_beb0433f-7095-4f5e-9927-fe2340aa497c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_beb0433f-7095-4f5e-9927-fe2340aa497c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_80913f95-9173-49c1-9a6c-4893c1754958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_80913f95-9173-49c1-9a6c-4893c1754958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_80913f95-9173-49c1-9a6c-4893c1754958_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_80913f95-9173-49c1-9a6c-4893c1754958" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_80913f95-9173-49c1-9a6c-4893c1754958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_80913f95-9173-49c1-9a6c-4893c1754958" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_db59472d-5da1-41c9-8f0e-04a0c39eae79" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_BTGAcquisitionMember_db59472d-5da1-41c9-8f0e-04a0c39eae79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember_f9e63b2f-bf49-4c55-90cc-71928b5f6823" xlink:href="bsx-20201231.xsd#bsx_DivestedBusinessDueToBTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember_f9e63b2f-bf49-4c55-90cc-71928b5f6823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_ed9a8e8a-c635-46cf-8e80-394c3bfccf38" xlink:href="bsx-20201231.xsd#bsx_VertiflexIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_VertiflexIncMember_ed9a8e8a-c635-46cf-8e80-394c3bfccf38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember_1d8672e9-a7c6-4fa4-8406-7b918d038af5" xlink:href="bsx-20201231.xsd#bsx_MillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_MillipedeMember_1d8672e9-a7c6-4fa4-8406-7b918d038af5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_77248956-0ba4-4d97-8f09-935d4333377c" xlink:href="bsx-20201231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_77248956-0ba4-4d97-8f09-935d4333377c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AugmenixInc.Member_6905f2c8-4285-4e8e-9e44-fd1a80631375" xlink:href="bsx-20201231.xsd#bsx_AugmenixInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_AugmenixInc.Member_6905f2c8-4285-4e8e-9e44-fd1a80631375" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ClaretMedicalIncMember_827132bf-722c-47ec-b6b5-44840236231b" xlink:href="bsx-20201231.xsd#bsx_ClaretMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_ClaretMedicalIncMember_827132bf-722c-47ec-b6b5-44840236231b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CryterionMedicalIncMember_3f5f8d38-bec2-4255-b44f-212c13cd6e95" xlink:href="bsx-20201231.xsd#bsx_CryterionMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_CryterionMedicalIncMember_3f5f8d38-bec2-4255-b44f-212c13cd6e95" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NxTheraIncMember_ccb730ec-c265-4137-92c7-0055c5509590" xlink:href="bsx-20201231.xsd#bsx_NxTheraIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_NxTheraIncMember_ccb730ec-c265-4137-92c7-0055c5509590" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NVisionMedicalCorporationMember_644dae1c-77f0-4751-8ab1-59fe89c0499a" xlink:href="bsx-20201231.xsd#bsx_NVisionMedicalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_NVisionMedicalCorporationMember_644dae1c-77f0-4751-8ab1-59fe89c0499a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Other2018AcquisitionsMember_07dcca9c-33f4-472d-ba03-a72f9ae879f9" xlink:href="bsx-20201231.xsd#bsx_Other2018AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_Other2018AcquisitionsMember_07dcca9c-33f4-472d-ba03-a72f9ae879f9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2018AcquisitionsMember_bfbd09e5-4e28-4f11-a5e0-e95cb4fcdb3b" xlink:href="bsx-20201231.xsd#bsx_A2018AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_A2018AcquisitionsMember_bfbd09e5-4e28-4f11-a5e0-e95cb4fcdb3b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_247c3b4a-f4fb-4322-beea-cd310d282e41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_247c3b4a-f4fb-4322-beea-cd310d282e41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_247c3b4a-f4fb-4322-beea-cd310d282e41_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_247c3b4a-f4fb-4322-beea-cd310d282e41" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_247c3b4a-f4fb-4322-beea-cd310d282e41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_594a6673-7174-4a94-9a45-b52105f57805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_247c3b4a-f4fb-4322-beea-cd310d282e41" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_594a6673-7174-4a94-9a45-b52105f57805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_srt_OwnershipAxis_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6" xlink:to="loc_srt_OwnershipDomain_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e626fba5-4287-4d67-9e87-576687fec585" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6" xlink:to="loc_srt_OwnershipDomain_e626fba5-4287-4d67-9e87-576687fec585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_062342ca-d3a9-4557-a870-36ad135cad28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_us-gaap_StatementClassOfStockAxis_062342ca-d3a9-4557-a870-36ad135cad28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_062342ca-d3a9-4557-a870-36ad135cad28_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_062342ca-d3a9-4557-a870-36ad135cad28" xlink:to="loc_us-gaap_ClassOfStockDomain_062342ca-d3a9-4557-a870-36ad135cad28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f0044539-7faf-4e57-afd6-57c24c5e335b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_062342ca-d3a9-4557-a870-36ad135cad28" xlink:to="loc_us-gaap_ClassOfStockDomain_f0044539-7faf-4e57-afd6-57c24c5e335b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="extended" id="ibc90a9778ed94628903f7fbdce9a9abb_AcquisitionsandStrategicInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4c7b3cff-8142-4641-a583-28fadf1f60b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4c7b3cff-8142-4641-a583-28fadf1f60b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_3d6f4ad4-ab28-420c-bd41-6ae70623118f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_3d6f4ad4-ab28-420c-bd41-6ae70623118f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_28e89fcc-f808-46aa-8691-b5fd129f6e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_28e89fcc-f808-46aa-8691-b5fd129f6e42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_fb391378-dd09-4456-a492-d8b65ae12093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_fb391378-dd09-4456-a492-d8b65ae12093" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8186c3b5-a8a6-4189-8838-f64596b45d56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8186c3b5-a8a6-4189-8838-f64596b45d56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesFairValueDisclosure_ef3485ab-13bb-403b-a3d2-024ba03486d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_GuaranteesFairValueDisclosure_ef3485ab-13bb-403b-a3d2-024ba03486d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_195a2ed7-b9b4-4aff-b628-68f48f9638d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_195a2ed7-b9b4-4aff-b628-68f48f9638d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_1c9179e7-b1fa-4b14-9c44-0fe50e1e309e" xlink:href="bsx-20201231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_1c9179e7-b1fa-4b14-9c44-0fe50e1e309e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_79ea18e8-af66-4d31-9974-4305a93e9901" xlink:href="bsx-20201231.xsd#bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_79ea18e8-af66-4d31-9974-4305a93e9901" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_856feb71-7874-476e-9a05-9f6b90c968f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_856feb71-7874-476e-9a05-9f6b90c968f3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_de3cf2b6-4dcb-46f1-bd9e-6952818e26e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_de3cf2b6-4dcb-46f1-bd9e-6952818e26e4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1bdd61e8-877d-45a2-9ee8-7ba45db0cfbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_Goodwill_1bdd61e8-877d-45a2-9ee8-7ba45db0cfbe" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_06abf528-9fc6-410c-9839-e9c72de68898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_06abf528-9fc6-410c-9839-e9c72de68898" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7c16c481-a838-42d6-8d21-02f9a5142c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7c16c481-a838-42d6-8d21-02f9a5142c7c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_733eb1c7-fe31-448a-87df-9267bc84fe23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_733eb1c7-fe31-448a-87df-9267bc84fe23" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_666b06ab-9d4c-4314-b16e-b145452b3e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_666b06ab-9d4c-4314-b16e-b145452b3e62" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_20c3b3ca-7b4b-4640-aeeb-af8f8ba8ba66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_20c3b3ca-7b4b-4640-aeeb-af8f8ba8ba66" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d3de1c61-106e-4855-aa70-47c99579cca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d3de1c61-106e-4855-aa70-47c99579cca4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_780b594e-eac8-461f-be41-9369bfe7668e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_780b594e-eac8-461f-be41-9369bfe7668e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fa8cc7f0-c71d-4249-afd1-942309fda3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fa8cc7f0-c71d-4249-afd1-942309fda3a6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_54a6550a-4486-480d-9779-a9491acb1513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_54a6550a-4486-480d-9779-a9491acb1513" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_24286ae1-2816-4290-bf35-d04f38dc9853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_24286ae1-2816-4290-bf35-d04f38dc9853" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bbb5674a-0706-4d16-9f27-b6f2ae66b376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bbb5674a-0706-4d16-9f27-b6f2ae66b376" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_7cbc64fe-5a44-42de-99b8-c1becfcb8b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_7cbc64fe-5a44-42de-99b8-c1becfcb8b6f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_8f19dfe3-50ae-4d7e-aa51-1e2283df1f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_8f19dfe3-50ae-4d7e-aa51-1e2283df1f16" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76d625dc-4725-4a56-afec-d15196d64a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76d625dc-4725-4a56-afec-d15196d64a8a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_530cfb47-0b71-4b36-8b9f-92001b569951" xlink:href="bsx-20201231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_bsx_DiscountRateFairValueInput_530cfb47-0b71-4b36-8b9f-92001b569951" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_43150151-e3cb-48e7-b6f5-4b3632fc3474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_43150151-e3cb-48e7-b6f5-4b3632fc3474" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_f116c8a6-3fb6-4bcc-87f9-e3f347e01bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_f116c8a6-3fb6-4bcc-87f9-e3f347e01bdd" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6a8ffa66-65f1-46b1-9b3e-47377ef6a822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6a8ffa66-65f1-46b1-9b3e-47377ef6a822" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_49634414-0226-4e8d-a7ee-b818936aee40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_af800158-4cd6-4917-b449-79ddbe6fb29a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_af800158-4cd6-4917-b449-79ddbe6fb29a" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_da868b30-c29b-4688-82e7-6cbf3039f611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_da868b30-c29b-4688-82e7-6cbf3039f611" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_53a57300-40c2-402a-9844-bd225d0f347e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ff92127f-1362-4ae1-bac2-f5df6f3280ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ff92127f-1362-4ae1-bac2-f5df6f3280ea" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_6970967f-ce6e-4286-b8c9-9aac592b8260" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_BTGAcquisitionMember_6970967f-ce6e-4286-b8c9-9aac592b8260" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember_f2857137-2a47-4554-9c93-ccaabe9e39c0" xlink:href="bsx-20201231.xsd#bsx_DivestedBusinessDueToBTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember_f2857137-2a47-4554-9c93-ccaabe9e39c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_1b2f2f7e-de84-433c-af1a-026ca934a3fe" xlink:href="bsx-20201231.xsd#bsx_VertiflexIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_VertiflexIncMember_1b2f2f7e-de84-433c-af1a-026ca934a3fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember_fa92780d-ef76-4d7b-868e-9c32c0eff938" xlink:href="bsx-20201231.xsd#bsx_MillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_MillipedeMember_fa92780d-ef76-4d7b-868e-9c32c0eff938" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_d3712e86-67bf-4c7b-845b-c5baa0ef403c" xlink:href="bsx-20201231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_d3712e86-67bf-4c7b-845b-c5baa0ef403c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AugmenixInc.Member_4ccc3db7-8b9a-465c-8d16-3eee8606b746" xlink:href="bsx-20201231.xsd#bsx_AugmenixInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_AugmenixInc.Member_4ccc3db7-8b9a-465c-8d16-3eee8606b746" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ClaretMedicalIncMember_5ec9d8b4-8fdb-409a-9c28-fa193cc77b66" xlink:href="bsx-20201231.xsd#bsx_ClaretMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_ClaretMedicalIncMember_5ec9d8b4-8fdb-409a-9c28-fa193cc77b66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CryterionMedicalIncMember_a9977105-2dbe-4318-b9f7-cc59038d3576" xlink:href="bsx-20201231.xsd#bsx_CryterionMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_CryterionMedicalIncMember_a9977105-2dbe-4318-b9f7-cc59038d3576" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NxTheraIncMember_96801a10-05ca-459f-9ce7-270c0dddf820" xlink:href="bsx-20201231.xsd#bsx_NxTheraIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_NxTheraIncMember_96801a10-05ca-459f-9ce7-270c0dddf820" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NVisionMedicalCorporationMember_44cb1fdc-f675-4f9e-9873-aa07209bc093" xlink:href="bsx-20201231.xsd#bsx_NVisionMedicalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_NVisionMedicalCorporationMember_44cb1fdc-f675-4f9e-9873-aa07209bc093" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Other2018AcquisitionsMember_c00b2380-8562-4df5-bdae-6fc80f096bb9" xlink:href="bsx-20201231.xsd#bsx_Other2018AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_Other2018AcquisitionsMember_c00b2380-8562-4df5-bdae-6fc80f096bb9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2018AcquisitionsMember_d3b43cdd-01e7-4337-97ab-2646bf95d76e" xlink:href="bsx-20201231.xsd#bsx_A2018AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_A2018AcquisitionsMember_d3b43cdd-01e7-4337-97ab-2646bf95d76e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_20b8f74f-b5c5-4373-8eab-729fb2a4c47a" xlink:href="bsx-20201231.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_PreventiceSolutionsIncMember_20b8f74f-b5c5-4373-8eab-729fb2a4c47a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c710bd8-b7d8-4011-af53-b18c504c9b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c710bd8-b7d8-4011-af53-b18c504c9b9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c710bd8-b7d8-4011-af53-b18c504c9b9f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c710bd8-b7d8-4011-af53-b18c504c9b9f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8c710bd8-b7d8-4011-af53-b18c504c9b9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c710bd8-b7d8-4011-af53-b18c504c9b9f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5f302f9b-c5e4-4dcb-a59f-7de0bdf06942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5f302f9b-c5e4-4dcb-a59f-7de0bdf06942" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_13d19a80-421a-46b6-ae0c-d41591693e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_13d19a80-421a-46b6-ae0c-d41591693e3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_b69ba26c-4c1c-4a25-accf-dcbd977b1dba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_b69ba26c-4c1c-4a25-accf-dcbd977b1dba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_045eb726-ceb1-4088-a65d-e3ff9d84b8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_045eb726-ceb1-4088-a65d-e3ff9d84b8cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_045eb726-ceb1-4088-a65d-e3ff9d84b8cc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_045eb726-ceb1-4088-a65d-e3ff9d84b8cc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_045eb726-ceb1-4088-a65d-e3ff9d84b8cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45605c4c-fec5-4a35-bb29-03ebde917f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_045eb726-ceb1-4088-a65d-e3ff9d84b8cc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45605c4c-fec5-4a35-bb29-03ebde917f2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_8df47af5-5f3b-4f15-8874-d6deaeb01bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45605c4c-fec5-4a35-bb29-03ebde917f2b" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_8df47af5-5f3b-4f15-8874-d6deaeb01bc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a1db248b-0c46-484f-a847-ba68a4baa392" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_srt_RangeAxis_a1db248b-0c46-484f-a847-ba68a4baa392" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a1db248b-0c46-484f-a847-ba68a4baa392_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a1db248b-0c46-484f-a847-ba68a4baa392" xlink:to="loc_srt_RangeMember_a1db248b-0c46-484f-a847-ba68a4baa392_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a1db248b-0c46-484f-a847-ba68a4baa392" xlink:to="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f645d925-081d-4f68-9478-3d6ca244621c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:to="loc_srt_MinimumMember_f645d925-081d-4f68-9478-3d6ca244621c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7af821e-3e98-421d-a7ff-55702657f6fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:to="loc_srt_MaximumMember_a7af821e-3e98-421d-a7ff-55702657f6fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_bdaf2973-2bca-48ac-9ea9-3740cdf95d97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:to="loc_srt_WeightedAverageMember_bdaf2973-2bca-48ac-9ea9-3740cdf95d97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e40099cd-8ab8-4d14-a578-eaa4ceddbe79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e40099cd-8ab8-4d14-a578-eaa4ceddbe79" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e40099cd-8ab8-4d14-a578-eaa4ceddbe79_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e40099cd-8ab8-4d14-a578-eaa4ceddbe79" xlink:to="loc_us-gaap_SegmentDomain_e40099cd-8ab8-4d14-a578-eaa4ceddbe79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eb7f08ab-d451-4489-834c-0154f4797792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e40099cd-8ab8-4d14-a578-eaa4ceddbe79" xlink:to="loc_us-gaap_SegmentDomain_eb7f08ab-d451-4489-834c-0154f4797792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_fab7d8d5-d693-40d5-b636-0c0a706de486" xlink:href="bsx-20201231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eb7f08ab-d451-4489-834c-0154f4797792" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_fab7d8d5-d693-40d5-b636-0c0a706de486" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_af8b2f41-8167-410c-bb83-bf1aae1ead4e" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eb7f08ab-d451-4489-834c-0154f4797792" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_af8b2f41-8167-410c-bb83-bf1aae1ead4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_834bb233-821e-45bd-a805-cb485f2c3c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_834bb233-821e-45bd-a805-cb485f2c3c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_77ab44d7-a41a-45b6-8c59-90fd00ae00d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_834bb233-821e-45bd-a805-cb485f2c3c73" xlink:to="loc_us-gaap_SubsequentEventMember_77ab44d7-a41a-45b6-8c59-90fd00ae00d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_fed23021-c0a8-41c7-90bc-72284fffa945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_fed23021-c0a8-41c7-90bc-72284fffa945" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fed23021-c0a8-41c7-90bc-72284fffa945_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fed23021-c0a8-41c7-90bc-72284fffa945" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fed23021-c0a8-41c7-90bc-72284fffa945_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_38839a24-6497-411e-9fed-89bbd21ce6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fed23021-c0a8-41c7-90bc-72284fffa945" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_38839a24-6497-411e-9fed-89bbd21ce6fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_fd558934-3b1b-4da9-90e7-33ae52904103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_38839a24-6497-411e-9fed-89bbd21ce6fa" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_fd558934-3b1b-4da9-90e7-33ae52904103" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5e4bd33b-438d-436f-a971-f1a5f9cae447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5e4bd33b-438d-436f-a971-f1a5f9cae447" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5e4bd33b-438d-436f-a971-f1a5f9cae447_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5e4bd33b-438d-436f-a971-f1a5f9cae447" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5e4bd33b-438d-436f-a971-f1a5f9cae447_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38ae2a23-aab4-43ab-b430-166ef873625c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5e4bd33b-438d-436f-a971-f1a5f9cae447" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38ae2a23-aab4-43ab-b430-166ef873625c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_b886794e-d59b-4e7c-9fdd-58a2d3b004aa" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38ae2a23-aab4-43ab-b430-166ef873625c" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_b886794e-d59b-4e7c-9fdd-58a2d3b004aa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended" id="i8ca60a1786734da08865a1bf10d2a794_ContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_043c781b-0c23-485d-9933-a545bd3ee059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_043c781b-0c23-485d-9933-a545bd3ee059" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_71e77b90-3e92-421f-8f59-7246d26d08f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_71e77b90-3e92-421f-8f59-7246d26d08f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_0fab1507-7811-4b40-9bc1-9000b3f8c9b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_0fab1507-7811-4b40-9bc1-9000b3f8c9b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_4100c85e-34e6-4fbc-b6e8-296e0d8b121c" xlink:href="bsx-20201231.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:to="loc_bsx_PaymentOfContingentConsideration_4100c85e-34e6-4fbc-b6e8-296e0d8b121c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_21b37c78-4f6d-4407-9419-dda793604132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_21b37c78-4f6d-4407-9419-dda793604132" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_a5030d5b-6f8c-457e-9699-1ff3e48bce5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_043c781b-0c23-485d-9933-a545bd3ee059" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_a5030d5b-6f8c-457e-9699-1ff3e48bce5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_efabe932-ab2f-44bc-a9b5-de2c604a33f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_a5030d5b-6f8c-457e-9699-1ff3e48bce5b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_efabe932-ab2f-44bc-a9b5-de2c604a33f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_a5030d5b-6f8c-457e-9699-1ff3e48bce5b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_de83ce33-76ba-45ff-82b4-1c35e4b3fb3e" xlink:href="bsx-20201231.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_de83ce33-76ba-45ff-82b4-1c35e4b3fb3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_b6f4e1f2-f6d9-431c-8a32-df27b673a6b8" xlink:href="bsx-20201231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:to="loc_bsx_DiscountRateFairValueInput_b6f4e1f2-f6d9-431c-8a32-df27b673a6b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d7c8b799-81b4-445a-9e95-a2c56f3ba78b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d7c8b799-81b4-445a-9e95-a2c56f3ba78b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_043c781b-0c23-485d-9933-a545bd3ee059" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_556917cb-edf4-49a7-bedc-507cd4162294" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_srt_RangeAxis_556917cb-edf4-49a7-bedc-507cd4162294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_556917cb-edf4-49a7-bedc-507cd4162294_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_556917cb-edf4-49a7-bedc-507cd4162294" xlink:to="loc_srt_RangeMember_556917cb-edf4-49a7-bedc-507cd4162294_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_556917cb-edf4-49a7-bedc-507cd4162294" xlink:to="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ce3cc25b-8d57-42ad-b309-ba32e9d182b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:to="loc_srt_MinimumMember_ce3cc25b-8d57-42ad-b309-ba32e9d182b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b6872ed3-d8c0-4360-9a46-7bdbfaaa5942" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:to="loc_srt_MaximumMember_b6872ed3-d8c0-4360-9a46-7bdbfaaa5942" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_cbda11df-b791-4071-821c-a227005c30fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:to="loc_srt_WeightedAverageMember_cbda11df-b791-4071-821c-a227005c30fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_f7b49624-546b-4ba5-a151-86ea21937eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_us-gaap_ValuationTechniqueAxis_f7b49624-546b-4ba5-a151-86ea21937eb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_f7b49624-546b-4ba5-a151-86ea21937eb4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_f7b49624-546b-4ba5-a151-86ea21937eb4" xlink:to="loc_us-gaap_ValuationTechniqueDomain_f7b49624-546b-4ba5-a151-86ea21937eb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_f7e7cc70-9b1d-443d-ab49-1c1fbbe6dbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_f7b49624-546b-4ba5-a151-86ea21937eb4" xlink:to="loc_us-gaap_ValuationTechniqueDomain_f7e7cc70-9b1d-443d-ab49-1c1fbbe6dbef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_e7d0b04f-8b84-4bad-8e6d-94e87b21c548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_f7e7cc70-9b1d-443d-ab49-1c1fbbe6dbef" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_e7d0b04f-8b84-4bad-8e6d-94e87b21c548" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b5234d49-a1e6-42e4-ba23-35bec5ab25a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b5234d49-a1e6-42e4-ba23-35bec5ab25a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5234d49-a1e6-42e4-ba23-35bec5ab25a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b5234d49-a1e6-42e4-ba23-35bec5ab25a6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5234d49-a1e6-42e4-ba23-35bec5ab25a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e6e1ce9-eb46-4012-afa0-b897024c951a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b5234d49-a1e6-42e4-ba23-35bec5ab25a6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e6e1ce9-eb46-4012-afa0-b897024c951a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_150c8fe4-72e2-4ab4-b040-061de48400bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_150c8fe4-72e2-4ab4-b040-061de48400bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_150c8fe4-72e2-4ab4-b040-061de48400bf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_150c8fe4-72e2-4ab4-b040-061de48400bf" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_150c8fe4-72e2-4ab4-b040-061de48400bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f103fd0e-963a-42a0-ac80-c1e9c35ebf60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_150c8fe4-72e2-4ab4-b040-061de48400bf" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f103fd0e-963a-42a0-ac80-c1e9c35ebf60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_16631bc6-5d36-454d-b65c-7ffbdd53e633" xlink:href="bsx-20201231.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f103fd0e-963a-42a0-ac80-c1e9c35ebf60" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_16631bc6-5d36-454d-b65c-7ffbdd53e633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_447582ba-1cb9-41f4-a91b-34bef38da04d" xlink:href="bsx-20201231.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f103fd0e-963a-42a0-ac80-c1e9c35ebf60" xlink:to="loc_bsx_RevenueBasedPaymentsMember_447582ba-1cb9-41f4-a91b-34bef38da04d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StrategicInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended" id="i3783360835dc45079d4562644af79b62_StrategicInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_ff76942e-8783-4bd7-8880-e3d316680a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_ff76942e-8783-4bd7-8880-e3d316680a55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_16c6bf30-c1bb-4361-a0c2-ede14b41a44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_EquityMethodInvestments_16c6bf30-c1bb-4361-a0c2-ede14b41a44d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_5d75f2ff-46ab-4fa3-b82a-c2f9d3bb5070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_5d75f2ff-46ab-4fa3-b82a-c2f9d3bb5070" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_4ba275d0-7600-4f2b-bc12-b24fcd418142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_4ba275d0-7600-4f2b-bc12-b24fcd418142" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8018b467-fd44-47cd-bf6b-b55380ad633c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8018b467-fd44-47cd-bf6b-b55380ad633c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_16785502-18b5-430e-b5cd-ffd1cec65276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_Investments_16785502-18b5-430e-b5cd-ffd1cec65276" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_94379ea5-bdae-4834-97eb-5af569f2555b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_ed82a786-1d36-4b15-8b83-cfdeb87c2e41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_ed82a786-1d36-4b15-8b83-cfdeb87c2e41" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_1ba1f2cf-6eeb-47dc-9e36-79e402c4f688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_1ba1f2cf-6eeb-47dc-9e36-79e402c4f688" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a97d930e-f79d-42f6-8c79-f9c177fe6416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1ba1f2cf-6eeb-47dc-9e36-79e402c4f688" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a97d930e-f79d-42f6-8c79-f9c177fe6416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a97d930e-f79d-42f6-8c79-f9c177fe6416_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a97d930e-f79d-42f6-8c79-f9c177fe6416" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a97d930e-f79d-42f6-8c79-f9c177fe6416_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_85d5fe2e-d9e0-40ae-9198-dc91d403dc85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a97d930e-f79d-42f6-8c79-f9c177fe6416" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_85d5fe2e-d9e0-40ae-9198-dc91d403dc85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_607a33c7-1ed2-4d31-9807-8d44afd6f4ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_85d5fe2e-d9e0-40ae-9198-dc91d403dc85" xlink:to="loc_us-gaap_SubsequentEventMember_607a33c7-1ed2-4d31-9807-8d44afd6f4ea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSale"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale" xlink:type="extended" id="i1526bc9122864dc2a529295929ad0b6b_AssetsandLiabilitiesHeldforSale"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSaleTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables" xlink:type="extended" id="i7de72bb00d4d4143a8ecf00b94a91052_AssetsandLiabilitiesHeldforSaleTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="i632d6889380747cc8389d27043d0fc5e_AssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_db2cde82-c728-4141-aac4-e5255cce346b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_db2cde82-c728-4141-aac4-e5255cce346b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_95b1189e-e107-4a39-8ce4-6d7e7f66bb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_95b1189e-e107-4a39-8ce4-6d7e7f66bb2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f66a3760-01f8-48b5-89a2-b4d22a202aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f66a3760-01f8-48b5-89a2-b4d22a202aa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9dd9264-442f-4e52-b8a3-6128a58a3ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9dd9264-442f-4e52-b8a3-6128a58a3ad0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_565a0c48-fd89-439f-8a31-9d81f87959d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_565a0c48-fd89-439f-8a31-9d81f87959d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_f0e38ea1-492d-478f-86b4-7e3ec57f8de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_f0e38ea1-492d-478f-86b4-7e3ec57f8de2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_4d50e552-b3b7-4041-8d1b-a53c987f3f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_4d50e552-b3b7-4041-8d1b-a53c987f3f99" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_2d4f184f-efc3-451e-b818-07bf15e198ae" xlink:href="bsx-20201231.xsd#bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_2d4f184f-efc3-451e-b818-07bf15e198ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_bf57cb6c-f92f-48e6-bcb7-03d145c5fe5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_bf57cb6c-f92f-48e6-bcb7-03d145c5fe5a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_f22694e4-5627-4ecb-9ceb-846f0b1de4f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_f22694e4-5627-4ecb-9ceb-846f0b1de4f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_f14b75b7-0cae-4de1-a467-a13c125351b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_f14b75b7-0cae-4de1-a467-a13c125351b0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_5315b927-3d40-4943-a049-fb63884b290b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_5315b927-3d40-4943-a049-fb63884b290b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_69e3af73-1d50-4790-a4a8-512b90675900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_69e3af73-1d50-4790-a4a8-512b90675900" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_dc091140-e6de-474e-8946-7713c4e1f596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_dc091140-e6de-474e-8946-7713c4e1f596" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_afa44d44-491c-4250-bc76-3a77fa08fa6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_afa44d44-491c-4250-bc76-3a77fa08fa6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_afa44d44-491c-4250-bc76-3a77fa08fa6e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_afa44d44-491c-4250-bc76-3a77fa08fa6e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_afa44d44-491c-4250-bc76-3a77fa08fa6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f262934-65e9-476e-acc3-5bff6155525f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_afa44d44-491c-4250-bc76-3a77fa08fa6e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f262934-65e9-476e-acc3-5bff6155525f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_5cbead3a-140e-4fe8-b850-7f27d3baaae3" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f262934-65e9-476e-acc3-5bff6155525f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_5cbead3a-140e-4fe8-b850-7f27d3baaae3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9e3f4964-3ff7-41bf-ac64-a77e57f4d5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9e3f4964-3ff7-41bf-ac64-a77e57f4d5d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a7bb0210-b2c5-4085-bae5-20f56ae721ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9e3f4964-3ff7-41bf-ac64-a77e57f4d5d0" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a7bb0210-b2c5-4085-bae5-20f56ae721ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended" id="iba3fd6488d98497190fecbd92593e9ea_GoodwillandOtherIntangibleAssets"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" xlink:type="extended" id="ic033864339504f50b5ab4c71d90d0fa2_GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="iff68bdda5bba49ccb7ddaf7bbc693f4d_GoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ad6b1434-19f4-4fbb-a97a-6a59cf24506a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ad6b1434-19f4-4fbb-a97a-6a59cf24506a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_324467ab-9f6d-4530-9a14-2bdad76669e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_324467ab-9f6d-4530-9a14-2bdad76669e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_0f3a145d-7e93-4729-bc0c-ed77140a7f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_GoodwillGross_0f3a145d-7e93-4729-bc0c-ed77140a7f63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4bff57b7-efa3-4b80-b41a-62c28e3d62d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4bff57b7-efa3-4b80-b41a-62c28e3d62d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_482a4a09-aea0-4569-a3df-737c80300d03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_482a4a09-aea0-4569-a3df-737c80300d03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e15d2961-9979-46ff-952d-21aff6f0c980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e15d2961-9979-46ff-952d-21aff6f0c980" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:href="bsx-20201231.xsd#bsx_GoodwillTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6283592b-bc42-4dd0-9bce-fad6f522c5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_Goodwill_6283592b-bc42-4dd0-9bce-fad6f522c5cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_01e3735c-cc83-486b-bd03-69eb61e9d17c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_01e3735c-cc83-486b-bd03-69eb61e9d17c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_66c362e6-d61d-4144-8542-ce991d3f558e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_66c362e6-d61d-4144-8542-ce991d3f558e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5f910595-bfd5-4835-8457-3f9de84869f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5f910595-bfd5-4835-8457-3f9de84869f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_894ee226-dff3-4aee-ab6e-2fc1cee558a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_894ee226-dff3-4aee-ab6e-2fc1cee558a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_1562e5ed-d678-4f83-8bdb-475f0de931af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillTransfers_1562e5ed-d678-4f83-8bdb-475f0de931af" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:href="bsx-20201231.xsd#bsx_OtherIntangibleAssetsTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4030a95f-b19e-4772-aa3a-1e7d17a34e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4030a95f-b19e-4772-aa3a-1e7d17a34e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cc2106d6-b936-4692-ac60-87e1093d619e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cc2106d6-b936-4692-ac60-87e1093d619e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_67792e8a-29d0-4bf8-ad4e-31a433c32955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_67792e8a-29d0-4bf8-ad4e-31a433c32955" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b192f943-8898-4c35-9e4f-314a97fbb9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b192f943-8898-4c35-9e4f-314a97fbb9b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8c1a010f-5562-4120-a1a6-88bc3ffbaadc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8c1a010f-5562-4120-a1a6-88bc3ffbaadc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f833fac3-b215-4f83-90f3-2896a2552afa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_srt_RangeAxis_f833fac3-b215-4f83-90f3-2896a2552afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f833fac3-b215-4f83-90f3-2896a2552afa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f833fac3-b215-4f83-90f3-2896a2552afa" xlink:to="loc_srt_RangeMember_f833fac3-b215-4f83-90f3-2896a2552afa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_36b720f4-106c-4976-b78d-20b0ddcc770e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f833fac3-b215-4f83-90f3-2896a2552afa" xlink:to="loc_srt_RangeMember_36b720f4-106c-4976-b78d-20b0ddcc770e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_af0b9e4e-131a-4fee-b4f5-9c55d6ae07cc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_36b720f4-106c-4976-b78d-20b0ddcc770e" xlink:to="loc_srt_MinimumMember_af0b9e4e-131a-4fee-b4f5-9c55d6ae07cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b98b78b-024c-4aad-a264-5335941c6656" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_36b720f4-106c-4976-b78d-20b0ddcc770e" xlink:to="loc_srt_MaximumMember_9b98b78b-024c-4aad-a264-5335941c6656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_714b3b24-efd7-4405-aacc-c27e48ba2833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_714b3b24-efd7-4405-aacc-c27e48ba2833" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_714b3b24-efd7-4405-aacc-c27e48ba2833_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_714b3b24-efd7-4405-aacc-c27e48ba2833" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_714b3b24-efd7-4405-aacc-c27e48ba2833_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_714b3b24-efd7-4405-aacc-c27e48ba2833" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_d8dc7dea-d528-4999-95e6-cb52f46e421b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_d8dc7dea-d528-4999-95e6-cb52f46e421b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_8ab4a0e4-95bf-488e-8905-a7f5f004037a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:to="loc_us-gaap_PatentsMember_8ab4a0e4-95bf-488e-8905-a7f5f004037a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_ea6b3a39-a91f-47b2-83f8-8880ad7cecd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_ea6b3a39-a91f-47b2-83f8-8880ad7cecd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_278e80c2-424b-43f7-b17a-14d6746aaf09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_278e80c2-424b-43f7-b17a-14d6746aaf09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_278e80c2-424b-43f7-b17a-14d6746aaf09_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_278e80c2-424b-43f7-b17a-14d6746aaf09" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_278e80c2-424b-43f7-b17a-14d6746aaf09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_13cfc88d-12f8-4c5d-98f2-f4c0583a8d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_278e80c2-424b-43f7-b17a-14d6746aaf09" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_13cfc88d-12f8-4c5d-98f2-f4c0583a8d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_534e6c1b-5636-45cb-9c36-423331e65183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_13cfc88d-12f8-4c5d-98f2-f4c0583a8d8c" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_534e6c1b-5636-45cb-9c36-423331e65183" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ac508c88-35d1-438b-a088-acd8aecca43d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_13cfc88d-12f8-4c5d-98f2-f4c0583a8d8c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ac508c88-35d1-438b-a088-acd8aecca43d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3c7bee28-246a-4df4-b5ad-12a7649e3592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3c7bee28-246a-4df4-b5ad-12a7649e3592" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3c7bee28-246a-4df4-b5ad-12a7649e3592_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3c7bee28-246a-4df4-b5ad-12a7649e3592" xlink:to="loc_us-gaap_SegmentDomain_3c7bee28-246a-4df4-b5ad-12a7649e3592_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3c7bee28-246a-4df4-b5ad-12a7649e3592" xlink:to="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_7a753c0f-a1a1-4afe-93db-e9f21444c54b" xlink:href="bsx-20201231.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:to="loc_bsx_MedsurgMember_7a753c0f-a1a1-4afe-93db-e9f21444c54b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_6223f404-a4e9-441c-8ce5-4322b7b3b5c0" xlink:href="bsx-20201231.xsd#bsx_RhythmandNeuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:to="loc_bsx_RhythmandNeuroMember_6223f404-a4e9-441c-8ce5-4322b7b3b5c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_51febb52-d4bd-4ef9-ab80-8f98cc64085d" xlink:href="bsx-20201231.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:to="loc_bsx_CardiovascularMember_51febb52-d4bd-4ef9-ab80-8f98cc64085d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_445e0c61-db03-43e5-97a7-62a6070ef997" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_445e0c61-db03-43e5-97a7-62a6070ef997" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20201231.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended" id="ie49cda001d004acca708ff59c4fd823b_HedgingActivitiesandFairValueMeasurements"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#FairValueMeasuresandDisclosuresPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="extended" id="ib2ddb1814df741ed9184b3deae4e1b0e_FairValueMeasuresandDisclosuresPolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended" id="ie234e2292ee6480fa2714e849d9251a5_HedgingActivitiesandFairValueMeasurementsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_814d9bd1-5445-4915-901a-0bbfc3a0c08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_814d9bd1-5445-4915-901a-0bbfc3a0c08d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4f0b2820-d291-4def-ac4e-88237d154cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4f0b2820-d291-4def-ac4e-88237d154cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_9b4c7db1-b83c-4038-90c0-580934ef30ef" xlink:href="bsx-20201231.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_9b4c7db1-b83c-4038-90c0-580934ef30ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ba706171-463d-4812-a06d-089bea708c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ba706171-463d-4812-a06d-089bea708c1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_da7f0d19-f48f-405e-8189-20671f09ddcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_da7f0d19-f48f-405e-8189-20671f09ddcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cfa49a57-0247-4c71-bce5-d40f334a39ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_DerivativeTable_cfa49a57-0247-4c71-bce5-d40f334a39ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_117a69d4-9837-43b4-896c-ba96609e8a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cfa49a57-0247-4c71-bce5-d40f334a39ca" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_117a69d4-9837-43b4-896c-ba96609e8a15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_117a69d4-9837-43b4-896c-ba96609e8a15_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_117a69d4-9837-43b4-896c-ba96609e8a15" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_117a69d4-9837-43b4-896c-ba96609e8a15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6c47361c-7505-44fa-b4eb-8e8ad47613c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_117a69d4-9837-43b4-896c-ba96609e8a15" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6c47361c-7505-44fa-b4eb-8e8ad47613c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_17e280de-1fa0-4f9b-8738-23afdc3df9a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0d09cd9c-f132-44d6-98a5-da5fcb9549ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_17e280de-1fa0-4f9b-8738-23afdc3df9a9" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0d09cd9c-f132-44d6-98a5-da5fcb9549ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_17e280de-1fa0-4f9b-8738-23afdc3df9a9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_407558b6-562d-4c44-8e78-7a15d9659370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_407558b6-562d-4c44-8e78-7a15d9659370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_407558b6-562d-4c44-8e78-7a15d9659370_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_407558b6-562d-4c44-8e78-7a15d9659370" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_407558b6-562d-4c44-8e78-7a15d9659370_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9580d40b-5ced-494f-a572-db3f2e2d2ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_407558b6-562d-4c44-8e78-7a15d9659370" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9580d40b-5ced-494f-a572-db3f2e2d2ce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d92a50fe-d484-4892-b539-6c5a82594152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d92a50fe-d484-4892-b539-6c5a82594152" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d92a50fe-d484-4892-b539-6c5a82594152_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d92a50fe-d484-4892-b539-6c5a82594152" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d92a50fe-d484-4892-b539-6c5a82594152_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c251f18b-f3e6-4453-9810-3b7ee00de46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d92a50fe-d484-4892-b539-6c5a82594152" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c251f18b-f3e6-4453-9810-3b7ee00de46c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i0f7177be992f4c6dbc0e7e5d288278a1_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5391a967-2ce2-4ecc-a222-9f2211dff603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_LongTermDebt_5391a967-2ce2-4ecc-a222-9f2211dff603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f905b90-6140-4e4d-b98e-967fc3a26d23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f905b90-6140-4e4d-b98e-967fc3a26d23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_e9002ce8-dfb3-4d84-ab05-f4947f79f5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_e9002ce8-dfb3-4d84-ab05-f4947f79f5ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge_306219ef-1ea1-4d94-acbf-70398ea2f85e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeCashReceivedOnHedge_306219ef-1ea1-4d94-acbf-70398ea2f85e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_8f4bc008-5c1b-4e40-9cdd-c519369ea48c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_8f4bc008-5c1b-4e40-9cdd-c519369ea48c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_839dd06a-8644-4bde-96ff-0995a870d78f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_839dd06a-8644-4bde-96ff-0995a870d78f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0b6a0503-97cb-44c3-be24-c9405dbcbcae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0b6a0503-97cb-44c3-be24-c9405dbcbcae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_4d94916d-aac3-4d25-8432-a367dac1051d" xlink:href="bsx-20201231.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_4d94916d-aac3-4d25-8432-a367dac1051d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_cea078fd-1d8b-4f3c-a8ef-dd8cd306afbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_cea078fd-1d8b-4f3c-a8ef-dd8cd306afbe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_e2cf063f-4683-4cc8-9b47-dbe7d0cca67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_e2cf063f-4683-4cc8-9b47-dbe7d0cca67b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_94314eed-487a-4d3d-817c-df0b09a3a730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_94314eed-487a-4d3d-817c-df0b09a3a730" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2666ba72-acb7-4dd6-bcee-a0af3d1584c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2666ba72-acb7-4dd6-bcee-a0af3d1584c0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1a6937fe-0d9a-4ce9-8ebd-65d600ece587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1a6937fe-0d9a-4ce9-8ebd-65d600ece587" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_53a696e5-e82a-40d6-92eb-4e2e1fd71545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_53a696e5-e82a-40d6-92eb-4e2e1fd71545" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8bee7d2d-1739-4d72-8434-56408b238e4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8bee7d2d-1739-4d72-8434-56408b238e4d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8fa5ce9b-82af-4f12-be21-72181c35cffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8fa5ce9b-82af-4f12-be21-72181c35cffb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_80179e31-3517-404f-8eee-71950d070e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_80179e31-3517-404f-8eee-71950d070e29" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_d1b5fb12-5bdb-41f0-9f54-90c3c4ca2831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_d1b5fb12-5bdb-41f0-9f54-90c3c4ca2831" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4eca6661-7940-4e5a-85bb-e4c5c6f81a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_InterestExpense_4eca6661-7940-4e5a-85bb-e4c5c6f81a0f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_8cfa8ce1-c002-4b9e-8176-c314e7e7294b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_8cfa8ce1-c002-4b9e-8176-c314e7e7294b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_ecb84673-07b5-4c26-8f27-3c3f1a69f743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_ecb84673-07b5-4c26-8f27-3c3f1a69f743" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_935d2078-95be-4734-9e0a-d4202d5ba4bd" xlink:href="bsx-20201231.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_935d2078-95be-4734-9e0a-d4202d5ba4bd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_f99aedb0-5908-435f-ace3-ddd85218879e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_f99aedb0-5908-435f-ace3-ddd85218879e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_2236e968-8692-4152-b1ea-a2317ec74bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_2236e968-8692-4152-b1ea-a2317ec74bb5" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_56fe9b02-a610-4f02-96cc-ec45387cd61c" xlink:href="bsx-20201231.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_56fe9b02-a610-4f02-96cc-ec45387cd61c" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2b6723fe-676b-4393-a878-c7de91d9ab78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2b6723fe-676b-4393-a878-c7de91d9ab78" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3c4f4eb0-69da-4ffd-8411-447bf5063a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3c4f4eb0-69da-4ffd-8411-447bf5063a2f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_f5c81cda-5116-40ee-960e-a2aef1fe1037" xlink:href="bsx-20201231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_f5c81cda-5116-40ee-960e-a2aef1fe1037" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_c2a39ace-f839-4e16-a156-4c98963e901b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_c2a39ace-f839-4e16-a156-4c98963e901b" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ee4dad91-69a6-482a-847d-8d8c426aa48c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ee4dad91-69a6-482a-847d-8d8c426aa48c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_eae076df-a5a8-4d3a-94e3-c245fc0e69d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_eae076df-a5a8-4d3a-94e3-c245fc0e69d9" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0700fed6-3ffa-4014-a724-64c9d8644361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0700fed6-3ffa-4014-a724-64c9d8644361" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_1f5cf36b-d7b0-4bea-8e02-f939977c8a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_1f5cf36b-d7b0-4bea-8e02-f939977c8a4c" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ea0ded2d-eb92-4d44-91f1-b51790dbf91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ea0ded2d-eb92-4d44-91f1-b51790dbf91b" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9e5a1083-0646-46c1-9495-0f73248542fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a440caaf-262e-4f0b-9984-6f14e266f50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a440caaf-262e-4f0b-9984-6f14e266f50f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a440caaf-262e-4f0b-9984-6f14e266f50f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a440caaf-262e-4f0b-9984-6f14e266f50f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a440caaf-262e-4f0b-9984-6f14e266f50f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_553201eb-15a8-44b3-b8af-d92c3426c0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a440caaf-262e-4f0b-9984-6f14e266f50f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_553201eb-15a8-44b3-b8af-d92c3426c0d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2167c4e7-44a6-47e8-9a31-1f06ce3ecae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_553201eb-15a8-44b3-b8af-d92c3426c0d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_2167c4e7-44a6-47e8-9a31-1f06ce3ecae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_2946e282-794d-4c56-95aa-965f9899f616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_553201eb-15a8-44b3-b8af-d92c3426c0d2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_2946e282-794d-4c56-95aa-965f9899f616" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_316cb933-1d7a-4fad-9246-accb3dc82a32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_HedgingDesignationAxis_316cb933-1d7a-4fad-9246-accb3dc82a32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_316cb933-1d7a-4fad-9246-accb3dc82a32_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_316cb933-1d7a-4fad-9246-accb3dc82a32" xlink:to="loc_us-gaap_HedgingDesignationDomain_316cb933-1d7a-4fad-9246-accb3dc82a32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8d525f3b-6413-4d16-9345-7e28e5b1c4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_316cb933-1d7a-4fad-9246-accb3dc82a32" xlink:to="loc_us-gaap_HedgingDesignationDomain_8d525f3b-6413-4d16-9345-7e28e5b1c4bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c7af3226-9ef5-4ffa-ab34-9b711d36dd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8d525f3b-6413-4d16-9345-7e28e5b1c4bc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c7af3226-9ef5-4ffa-ab34-9b711d36dd14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4a870294-e9ee-451f-9cb0-868eb1e47c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8d525f3b-6413-4d16-9345-7e28e5b1c4bc" xlink:to="loc_us-gaap_NondesignatedMember_4a870294-e9ee-451f-9cb0-868eb1e47c58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1d03feff-383f-4157-b4ce-0827f864f43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1d03feff-383f-4157-b4ce-0827f864f43f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1d03feff-383f-4157-b4ce-0827f864f43f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1d03feff-383f-4157-b4ce-0827f864f43f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1d03feff-383f-4157-b4ce-0827f864f43f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1d03feff-383f-4157-b4ce-0827f864f43f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6f6fbb9b-b520-414d-a703-9fbfe96cc568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6f6fbb9b-b520-414d-a703-9fbfe96cc568" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_286667a9-3ad0-484c-92c7-add772a528bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:to="loc_us-gaap_ForeignExchangeContractMember_286667a9-3ad0-484c-92c7-add772a528bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_e14f7b6c-794c-4846-8621-bcf3b60b68e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:to="loc_us-gaap_InterestRateContractMember_e14f7b6c-794c-4846-8621-bcf3b60b68e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeignCurrencyDenominatedInDebtMember_1dfe86b5-39bd-4ffb-84a9-19237c6eb9ec" xlink:href="bsx-20201231.xsd#bsx_ForeignCurrencyDenominatedInDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:to="loc_bsx_ForeignCurrencyDenominatedInDebtMember_1dfe86b5-39bd-4ffb-84a9-19237c6eb9ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_22ddf011-29b0-45f3-bcda-9e87f7fde922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_22ddf011-29b0-45f3-bcda-9e87f7fde922" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22ddf011-29b0-45f3-bcda-9e87f7fde922_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_22ddf011-29b0-45f3-bcda-9e87f7fde922" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22ddf011-29b0-45f3-bcda-9e87f7fde922_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5b70181-4c5d-42f9-8b1f-69cb0e8a63d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_22ddf011-29b0-45f3-bcda-9e87f7fde922" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5b70181-4c5d-42f9-8b1f-69cb0e8a63d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_70e973cb-0888-49c3-baad-0fa99b36d405" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5b70181-4c5d-42f9-8b1f-69cb0e8a63d2" xlink:to="loc_bsx_BTGAcquisitionMember_70e973cb-0888-49c3-baad-0fa99b36d405" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6bd1760b-408e-43b3-a58b-3c0ad51f215a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6bd1760b-408e-43b3-a58b-3c0ad51f215a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6bd1760b-408e-43b3-a58b-3c0ad51f215a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6bd1760b-408e-43b3-a58b-3c0ad51f215a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6bd1760b-408e-43b3-a58b-3c0ad51f215a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_65d71c73-08e3-4313-9eea-bf7857d63866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6bd1760b-408e-43b3-a58b-3c0ad51f215a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_65d71c73-08e3-4313-9eea-bf7857d63866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_78348463-acc1-41c0-bc53-11801bc6970b" xlink:href="bsx-20201231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_65d71c73-08e3-4313-9eea-bf7857d63866" xlink:to="loc_bsx_November2019AggregateOfferingMember_78348463-acc1-41c0-bc53-11801bc6970b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_b2ae0cd7-93f3-46a7-9ad9-4206397832e7" xlink:href="bsx-20201231.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_65d71c73-08e3-4313-9eea-bf7857d63866" xlink:to="loc_bsx_December2027NotesMember_b2ae0cd7-93f3-46a7-9ad9-4206397832e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_61d8f06d-aac9-43dc-b114-dbcb9e6e0956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_61d8f06d-aac9-43dc-b114-dbcb9e6e0956" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_61d8f06d-aac9-43dc-b114-dbcb9e6e0956_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_61d8f06d-aac9-43dc-b114-dbcb9e6e0956" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_61d8f06d-aac9-43dc-b114-dbcb9e6e0956_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_61d8f06d-aac9-43dc-b114-dbcb9e6e0956" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember_22d75a5d-b67f-4f3a-ae6b-ada92742b3ad" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_bsx_LicensingArrangementAssetsMember_22d75a5d-b67f-4f3a-ae6b-ada92742b3ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8985a071-f79a-4305-a963-05d55e127b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8985a071-f79a-4305-a963-05d55e127b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_f208cd49-9286-4868-a151-336faff664bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_f208cd49-9286-4868-a151-336faff664bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_10033dda-bcaa-4abe-a9b7-e5dab4586238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_10033dda-bcaa-4abe-a9b7-e5dab4586238" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bb67108b-a050-428b-8522-371df49bf860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bb67108b-a050-428b-8522-371df49bf860" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_acaa1f27-3155-4f33-80b5-1a1bccefdce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_acaa1f27-3155-4f33-80b5-1a1bccefdce1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_25176341-dfd6-4cc9-bb45-6d575e5ff020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_25176341-dfd6-4cc9-bb45-6d575e5ff020" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_25176341-dfd6-4cc9-bb45-6d575e5ff020_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25176341-dfd6-4cc9-bb45-6d575e5ff020" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_25176341-dfd6-4cc9-bb45-6d575e5ff020_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25176341-dfd6-4cc9-bb45-6d575e5ff020" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e6377e50-a407-4490-86ae-081dbfc49a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:to="loc_us-gaap_CostOfSalesMember_e6377e50-a407-4490-86ae-081dbfc49a6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_4d29bf1d-48eb-46cb-b3bc-969077385295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:to="loc_us-gaap_InterestExpenseMember_4d29bf1d-48eb-46cb-b3bc-969077385295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_65592024-ef8b-4949-80ab-c9b15e2556ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_65592024-ef8b-4949-80ab-c9b15e2556ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_5c56204a-35a2-4647-b1da-35162ff398b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_5c56204a-35a2-4647-b1da-35162ff398b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_35ebee2e-d231-45a7-b13c-9ae40623e019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_35ebee2e-d231-45a7-b13c-9ae40623e019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_17a87958-6308-4906-9287-953ce7ad566e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_DerivativeAssets_17a87958-6308-4906-9287-953ce7ad566e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset_c841203e-14df-4df4-b074-7b9dd0a1a329" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_bsx_LicensingArrangementsAsset_c841203e-14df-4df4-b074-7b9dd0a1a329" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_0828a246-45ee-47ec-a0f3-3bd4ff997123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_0828a246-45ee-47ec-a0f3-3bd4ff997123" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_e0002703-d7af-429e-abc0-8b8b96e23c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_DerivativeLiabilities_e0002703-d7af-429e-abc0-8b8b96e23c66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_115b2997-946e-4d8b-a7ea-a12bbbd51e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_115b2997-946e-4d8b-a7ea-a12bbbd51e37" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_5c2f8187-63ae-4ca9-972b-f18914142b8d" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_bsx_LicensingArrangementsLiability_5c2f8187-63ae-4ca9-972b-f18914142b8d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_44b6581e-cd8d-4703-83fe-777877ee9271" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_44b6581e-cd8d-4703-83fe-777877ee9271" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_683767da-6add-4e36-b086-530c6a8bd9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_683767da-6add-4e36-b086-530c6a8bd9f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_77fff7ef-f7f4-452e-9af3-57ad38884053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_Cash_77fff7ef-f7f4-452e-9af3-57ad38884053" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_c24c951b-42f8-424f-a0ee-5c4f85485c23" xlink:href="bsx-20201231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_c24c951b-42f8-424f-a0ee-5c4f85485c23" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_808c87f1-7249-4704-8f04-495204959614" xlink:href="bsx-20201231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_bsx_DiscountRateFairValueInput_808c87f1-7249-4704-8f04-495204959614" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_557feb16-7204-41ee-ab05-b2f1fbf60eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_557feb16-7204-41ee-ab05-b2f1fbf60eca" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_0a585cbf-849f-4195-ad42-0170fa8836d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_PaymentsForRoyalties_0a585cbf-849f-4195-ad42-0170fa8836d8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_f73b6e7e-e6ca-432e-81f8-6b0831aa1318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_f73b6e7e-e6ca-432e-81f8-6b0831aa1318" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_6806ef12-393d-4d87-87f5-a13ba7da7e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_DebtInstrumentFairValue_6806ef12-393d-4d87-87f5-a13ba7da7e14" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_eb1bae45-da1a-478e-b2ad-fed30cf48f62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_srt_RangeAxis_eb1bae45-da1a-478e-b2ad-fed30cf48f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eb1bae45-da1a-478e-b2ad-fed30cf48f62_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_eb1bae45-da1a-478e-b2ad-fed30cf48f62" xlink:to="loc_srt_RangeMember_eb1bae45-da1a-478e-b2ad-fed30cf48f62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_eb1bae45-da1a-478e-b2ad-fed30cf48f62" xlink:to="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_caf73b7d-ebf1-4489-98cb-e1d4a723fbae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:to="loc_srt_WeightedAverageMember_caf73b7d-ebf1-4489-98cb-e1d4a723fbae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a7a50a84-f169-4176-8b7e-cbe6b329dc48" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:to="loc_srt_MinimumMember_a7a50a84-f169-4176-8b7e-cbe6b329dc48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4575dd0d-17b8-44b6-a0c5-02a0c505d74b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:to="loc_srt_MaximumMember_4575dd0d-17b8-44b6-a0c5-02a0c505d74b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03e2110d-4573-4f35-b4c4-ef69fd220fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03e2110d-4573-4f35-b4c4-ef69fd220fb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_03e2110d-4573-4f35-b4c4-ef69fd220fb5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03e2110d-4573-4f35-b4c4-ef69fd220fb5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_03e2110d-4573-4f35-b4c4-ef69fd220fb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0e156233-b364-480d-b47d-b2994bc6095e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03e2110d-4573-4f35-b4c4-ef69fd220fb5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0e156233-b364-480d-b47d-b2994bc6095e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_24341172-f5a7-4122-84db-278041ccfa4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0e156233-b364-480d-b47d-b2994bc6095e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_24341172-f5a7-4122-84db-278041ccfa4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d495175-3462-4712-9892-c32f025baf7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d495175-3462-4712-9892-c32f025baf7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d495175-3462-4712-9892-c32f025baf7a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d495175-3462-4712-9892-c32f025baf7a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d495175-3462-4712-9892-c32f025baf7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d495175-3462-4712-9892-c32f025baf7a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_df5ca593-2d13-4ac6-9629-290d0cb42aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_df5ca593-2d13-4ac6-9629-290d0cb42aa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f44f8f16-e200-4db1-8837-0bf4eda75a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f44f8f16-e200-4db1-8837-0bf4eda75a67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_725b8d98-e861-4549-b8b1-6db2931bf00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_725b8d98-e861-4549-b8b1-6db2931bf00a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4c854471-9e1b-4773-ab4d-ffa5289266a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4c854471-9e1b-4773-ab4d-ffa5289266a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4c854471-9e1b-4773-ab4d-ffa5289266a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4c854471-9e1b-4773-ab4d-ffa5289266a2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4c854471-9e1b-4773-ab4d-ffa5289266a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4c854471-9e1b-4773-ab4d-ffa5289266a2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember_3ee26c98-90a4-4b9c-9f94-39523bff40d9" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:to="loc_bsx_LicensingArrangementAssetsMember_3ee26c98-90a4-4b9c-9f94-39523bff40d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementLiabilitiesMember_e09d986e-9f06-44fa-aeb4-b245d38b501c" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:to="loc_bsx_LicensingArrangementLiabilitiesMember_e09d986e-9f06-44fa-aeb4-b245d38b501c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedOutstandingDebtMember_cfd7bc85-576a-407a-bfb1-4e8df1832f3e" xlink:href="bsx-20201231.xsd#bsx_EuroDenominatedOutstandingDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:to="loc_bsx_EuroDenominatedOutstandingDebtMember_cfd7bc85-576a-407a-bfb1-4e8df1832f3e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitments"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended" id="i1d2657f6faac423cb190c86bfd948626_ContractualObligationsandCommitments"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended" id="i6a3575e46863417b94667cd7d366a69d_ContractualObligationsandCommitmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_e68ee273-9aa6-4fc5-bad6-6bc54592955a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_f623dc79-b13f-47c6-80c3-ec4332dc1404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_e68ee273-9aa6-4fc5-bad6-6bc54592955a" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_f623dc79-b13f-47c6-80c3-ec4332dc1404" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_e68ee273-9aa6-4fc5-bad6-6bc54592955a" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_854c92ec-bbe3-4597-8adb-e7c48001dc11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_854c92ec-bbe3-4597-8adb-e7c48001dc11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_854c92ec-bbe3-4597-8adb-e7c48001dc11_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_854c92ec-bbe3-4597-8adb-e7c48001dc11" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_854c92ec-bbe3-4597-8adb-e7c48001dc11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a1dce8cf-ca68-4304-9d16-0a81e685f176" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_854c92ec-bbe3-4597-8adb-e7c48001dc11" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a1dce8cf-ca68-4304-9d16-0a81e685f176" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d955eee2-fedb-40a4-8e73-09a156b18a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a1dce8cf-ca68-4304-9d16-0a81e685f176" xlink:to="loc_us-gaap_CommercialPaperMember_d955eee2-fedb-40a4-8e73-09a156b18a06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_089303a0-cfb9-4e7f-99a9-7b5551956144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:to="loc_us-gaap_DebtInstrumentAxis_089303a0-cfb9-4e7f-99a9-7b5551956144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_089303a0-cfb9-4e7f-99a9-7b5551956144_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_089303a0-cfb9-4e7f-99a9-7b5551956144" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_089303a0-cfb9-4e7f-99a9-7b5551956144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4acdc2ba-73dc-4c45-8bd9-2aefc816e7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_089303a0-cfb9-4e7f-99a9-7b5551956144" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4acdc2ba-73dc-4c45-8bd9-2aefc816e7ad" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended" id="if51bea0849dc47259a4993ae0931497c_ContractualObligationsandCommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_96d1f77c-dc27-40ac-9ec4-af39d243959a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_96d1f77c-dc27-40ac-9ec4-af39d243959a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_cefd8a18-b6ae-4355-890f-ce8194d20921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtCurrent_cefd8a18-b6ae-4355-890f-ce8194d20921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e09ae71e-76c1-478c-aed9-7eb35cac6435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e09ae71e-76c1-478c-aed9-7eb35cac6435" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_33eda191-56a0-404d-9cf9-abebfa9ecaa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_33eda191-56a0-404d-9cf9-abebfa9ecaa8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a1a31b66-227d-4675-9759-eceb0d35d9dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a1a31b66-227d-4675-9759-eceb0d35d9dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_3496f6b2-5243-425a-bd86-fafcb8f259b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_3496f6b2-5243-425a-bd86-fafcb8f259b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_e0f88a79-4653-444d-9719-a06e1ec0a06f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_e0f88a79-4653-444d-9719-a06e1ec0a06f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3f2b1982-70f3-47e5-8aaa-bd9eb3bfd025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_ShortTermBorrowings_3f2b1982-70f3-47e5-8aaa-bd9eb3bfd025" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_0e8341d2-7aa5-431a-9666-1819c7ce1ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_RepaymentsOfDebt_0e8341d2-7aa5-431a-9666-1819c7ce1ac3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_0515cb17-78ee-4dd1-ba20-6a09df839d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LineOfCredit_0515cb17-78ee-4dd1-ba20-6a09df839d2d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_636e7fb8-a066-45fa-8a8d-03e029e1846b" xlink:href="bsx-20201231.xsd#bsx_MaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_MaximumLeverageRatio_636e7fb8-a066-45fa-8a8d-03e029e1846b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA_ac150480-e3e3-4804-935f-4ce3921a4e90" xlink:href="bsx-20201231.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_DeemedConsolidatedEBITDA_ac150480-e3e3-4804-935f-4ce3921a4e90" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_444ed3d2-cc6d-45cf-9daa-f619590c2664" xlink:href="bsx-20201231.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_444ed3d2-cc6d-45cf-9daa-f619590c2664" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_22a4053d-8be7-44ed-893a-3d08f302f2cb" xlink:href="bsx-20201231.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_22a4053d-8be7-44ed-893a-3d08f302f2cb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_80240c98-5e9e-4a7c-beca-ed249afc068a" xlink:href="bsx-20201231.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_80240c98-5e9e-4a7c-beca-ed249afc068a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_ce29a9e9-aa16-43f9-9b4e-d022f7338845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_CommercialPaper_ce29a9e9-aa16-43f9-9b4e-d022f7338845" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding_bfc5bdea-9edf-4f49-ab6c-556d96d02417" xlink:href="bsx-20201231.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_MaximumCommercialPaperOutstanding_bfc5bdea-9edf-4f49-ab6c-556d96d02417" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9e542f1c-f928-4215-a75c-3f2e2b7e368f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9e542f1c-f928-4215-a75c-3f2e2b7e368f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageMaturityDays_9f92cfd9-b0e6-4a60-99da-572be10bc387" xlink:href="bsx-20201231.xsd#bsx_WeightedAverageMaturityDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_WeightedAverageMaturityDays_9f92cfd9-b0e6-4a60-99da-572be10bc387" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_a8b32709-f72b-485a-9a49-959f010b06f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_a8b32709-f72b-485a-9a49-959f010b06f5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_793f54c3-f0e4-48e8-ba3e-9146fadfcce5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_793f54c3-f0e4-48e8-ba3e-9146fadfcce5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_7a093d5f-e299-419a-9901-fe7d2fcada88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_7a093d5f-e299-419a-9901-fe7d2fcada88" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_d2413e11-a0c1-4b86-b38f-52ba7bd99f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_d2413e11-a0c1-4b86-b38f-52ba7bd99f7c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_9e781869-7680-4b62-a1c0-9431e3bafa9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_9e781869-7680-4b62-a1c0-9431e3bafa9e" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f4bad841-182d-4a53-ab0a-c6a1fe481b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LongTermDebt_f4bad841-182d-4a53-ab0a-c6a1fe481b16" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_1bef1783-002e-4ff0-b0ad-f9a7a7f04f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_1bef1783-002e-4ff0-b0ad-f9a7a7f04f2f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2c7add63-afc9-467a-87c3-2bd9897ab064" xlink:href="bsx-20201231.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2c7add63-afc9-467a-87c3-2bd9897ab064" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_aa85893f-5abe-4f33-895f-eb0ded477be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_aa85893f-5abe-4f33-895f-eb0ded477be8" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Seniornotesissued_bc5b5cab-f16b-43f4-993a-e222738827b5" xlink:href="bsx-20201231.xsd#bsx_Seniornotesissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_Seniornotesissued_bc5b5cab-f16b-43f4-993a-e222738827b5" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_814d75a7-78c2-4590-ba1b-8aedeeea1124" xlink:href="bsx-20201231.xsd#bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_814d75a7-78c2-4590-ba1b-8aedeeea1124" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d9bf2af3-7710-492a-a301-d08e11af4674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d9bf2af3-7710-492a-a301-d08e11af4674" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_b0e57602-d90d-4cb0-a7df-076d83374805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_b0e57602-d90d-4cb0-a7df-076d83374805" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_6bd40962-b80a-4bf6-bfcd-9318214234bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_6bd40962-b80a-4bf6-bfcd-9318214234bc" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_73d16a30-f052-4a54-aed2-cd77420ceb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_73d16a30-f052-4a54-aed2-cd77420ceb40" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_c7ab648b-0e5f-4ad7-b9ce-371b4ee569ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_c7ab648b-0e5f-4ad7-b9ce-371b4ee569ae" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_c80ec8af-f0c3-4dd8-b880-5c27b1a428d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_c80ec8af-f0c3-4dd8-b880-5c27b1a428d8" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_7de41c3c-57cf-4899-9880-6714d71757e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligation_7de41c3c-57cf-4899-9880-6714d71757e5" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_acb6c4bd-dc11-4f2b-818b-58d7bc38404b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_acb6c4bd-dc11-4f2b-818b-58d7bc38404b" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2" xlink:to="loc_us-gaap_ClassOfStockDomain_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9b809490-ebd1-4227-abe7-1e1f7e1c4709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2" xlink:to="loc_us-gaap_ClassOfStockDomain_9b809490-ebd1-4227-abe7-1e1f7e1c4709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_c1a27d32-774a-44ee-b91c-58583f350a45" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9b809490-ebd1-4227-abe7-1e1f7e1c4709" xlink:to="loc_bsx_A550MCPSSeriesAMember_c1a27d32-774a-44ee-b91c-58583f350a45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_DebtInstrumentAxis_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember_0c8c6ad4-f460-4804-86c7-4ab51f283f75" xlink:href="bsx-20201231.xsd#bsx_April2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_April2021TermLoanMember_0c8c6ad4-f460-4804-86c7-4ab51f283f75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember_f2d4c510-f759-4417-9c99-107ca5d0f3e8" xlink:href="bsx-20201231.xsd#bsx_A2020TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_A2020TermLoanMember_f2d4c510-f759-4417-9c99-107ca5d0f3e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember_be93e4c8-e078-44c7-ace9-5e5583eeea64" xlink:href="bsx-20201231.xsd#bsx_February2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_February2021TermLoanMember_be93e4c8-e078-44c7-ace9-5e5583eeea64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember_41d5f00f-448e-4d8a-907e-d350c52e4479" xlink:href="bsx-20201231.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_ThreeYearDelayedDrawTermLoanMember_41d5f00f-448e-4d8a-907e-d350c52e4479" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember_af17f9ea-f963-4e1e-a398-51f8f4e31fcb" xlink:href="bsx-20201231.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_TwoYearDelayedDrawTermLoanMember_af17f9ea-f963-4e1e-a398-51f8f4e31fcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_3cfd4ebf-f856-4c8f-af8f-56c8f7224e83" xlink:href="bsx-20201231.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_3cfd4ebf-f856-4c8f-af8f-56c8f7224e83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_0e0e4f5e-951e-44e6-9fe1-e3c4cc8c6c37" xlink:href="bsx-20201231.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_0e0e4f5e-951e-44e6-9fe1-e3c4cc8c6c37" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_debaa01a-cc27-40f1-bc3d-929cc586cb8e" xlink:href="bsx-20201231.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_debaa01a-cc27-40f1-bc3d-929cc586cb8e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_a8ea35db-c32c-4e32-b897-d8c2b909f83e" xlink:href="bsx-20201231.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_a8ea35db-c32c-4e32-b897-d8c2b909f83e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b2ea308a-16fc-48a2-88b2-97618b19dc29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b2ea308a-16fc-48a2-88b2-97618b19dc29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b2ea308a-16fc-48a2-88b2-97618b19dc29_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b2ea308a-16fc-48a2-88b2-97618b19dc29" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b2ea308a-16fc-48a2-88b2-97618b19dc29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b2ea308a-16fc-48a2-88b2-97618b19dc29" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember_1c0dc55b-514a-41ff-a7c9-faa03468eff8" xlink:href="bsx-20201231.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_February2019AggregateOfferingMember_1c0dc55b-514a-41ff-a7c9-faa03468eff8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember_9de9fb27-dff2-4216-9bfa-c74ce2c73001" xlink:href="bsx-20201231.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_May2020SNAggregateOfferingMember_9de9fb27-dff2-4216-9bfa-c74ce2c73001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember_76a89a27-88fc-4922-8741-668302044f71" xlink:href="bsx-20201231.xsd#bsx_January2020NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_January2020NotesMember_76a89a27-88fc-4922-8741-668302044f71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember_c3f2725a-bf73-4139-b844-20b63abc17c4" xlink:href="bsx-20201231.xsd#bsx_May2020NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_May2020NotesMember_c3f2725a-bf73-4139-b844-20b63abc17c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_a2d62c7b-de0a-45ad-bfa3-15b7e9f1ebee" xlink:href="bsx-20201231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_November2019AggregateOfferingMember_a2d62c7b-de0a-45ad-bfa3-15b7e9f1ebee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_3e58b658-7df7-4d96-b9a8-dbc905a92a56" xlink:href="bsx-20201231.xsd#bsx_May2022NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_May2022NotesMember_3e58b658-7df7-4d96-b9a8-dbc905a92a56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_5b0f2378-c9a3-40b5-bd54-235077789e73" xlink:href="bsx-20201231.xsd#bsx_October2023NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_October2023NotesMember_5b0f2378-c9a3-40b5-bd54-235077789e73" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7d04f1cf-1e8c-495f-97ec-db661063cfe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7d04f1cf-1e8c-495f-97ec-db661063cfe2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_81468895-6ffc-4972-98b7-a399f5eba74f" xlink:href="bsx-20201231.xsd#bsx_March2024NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2024NotesMember_81468895-6ffc-4972-98b7-a399f5eba74f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_48425a81-4538-4c44-9721-a2d05c11feeb" xlink:href="bsx-20201231.xsd#bsx_May2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_May2025NotesMember_48425a81-4538-4c44-9721-a2d05c11feeb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_8bf076ba-4533-426d-82cd-8abae82f5cbf" xlink:href="bsx-20201231.xsd#bsx_June2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_June2025NotesMember_8bf076ba-4533-426d-82cd-8abae82f5cbf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_f49a3d1c-e3fc-43eb-843b-b6b46e734be3" xlink:href="bsx-20201231.xsd#bsx_March2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2026NotesMember_f49a3d1c-e3fc-43eb-843b-b6b46e734be3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_37c47cf4-4bc1-4c63-be30-d7939fe238fe" xlink:href="bsx-20201231.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_December2027NotesMember_37c47cf4-4bc1-4c63-be30-d7939fe238fe" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_7a0218b9-499a-4310-acd9-c36310ac0494" xlink:href="bsx-20201231.xsd#bsx_March2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2028NotesMember_7a0218b9-499a-4310-acd9-c36310ac0494" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_30143139-7973-4a6b-b310-0605caaf696f" xlink:href="bsx-20201231.xsd#bsx_March2029NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2029NotesMember_30143139-7973-4a6b-b310-0605caaf696f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_89a08db0-dd5e-480b-8c9d-89404b45ab87" xlink:href="bsx-20201231.xsd#bsx_June2030NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_June2030NotesMember_89a08db0-dd5e-480b-8c9d-89404b45ab87" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_7f2c2729-550d-4c3d-9fa3-7447c419c192" xlink:href="bsx-20201231.xsd#bsx_November2035NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_November2035NotesMember_7f2c2729-550d-4c3d-9fa3-7447c419c192" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_fe579722-fc13-4308-80f0-dad784e71b1f" xlink:href="bsx-20201231.xsd#bsx_March2039NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2039NotesMember_fe579722-fc13-4308-80f0-dad784e71b1f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_e527284c-a79e-4d9e-9da9-452b84f4efe2" xlink:href="bsx-20201231.xsd#bsx_January2040NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_January2040NotesMember_e527284c-a79e-4d9e-9da9-452b84f4efe2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_cda4c0ad-c28f-418c-89ea-9a8e45f4f27b" xlink:href="bsx-20201231.xsd#bsx_March2049NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2049NotesMember_cda4c0ad-c28f-418c-89ea-9a8e45f4f27b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2022TermLoanMember_7fd245b1-0d10-43ad-a430-0200a194f04e" xlink:href="bsx-20201231.xsd#bsx_August2022TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_August2022TermLoanMember_7fd245b1-0d10-43ad-a430-0200a194f04e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a75f5a45-445f-49ba-8f50-f8491e31f9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_InterestRateSwapMember_a75f5a45-445f-49ba-8f50-f8491e31f9f7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_ee39cec0-62f1-432c-9367-c6962b76d56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_ee39cec0-62f1-432c-9367-c6962b76d56f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_cdd85249-cdbe-4b3d-9ecf-4317c2811dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_SeniorNotesMember_cdd85249-cdbe-4b3d-9ecf-4317c2811dd6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_3cef9876-18a3-4d0d-a483-f83c29bba2ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_UnsecuredDebtMember_3cef9876-18a3-4d0d-a483-f83c29bba2ac" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3caeb296-8d77-4104-86b2-a84b7128091a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3caeb296-8d77-4104-86b2-a84b7128091a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_6e4e1713-990b-410d-8677-6bcdf7115e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_6e4e1713-990b-410d-8677-6bcdf7115e48" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_e2dcfc8a-79e6-4565-b66c-04e99d3ac4e2" xlink:href="bsx-20201231.xsd#bsx_August2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_August2019TermLoanMember_e2dcfc8a-79e6-4565-b66c-04e99d3ac4e2" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_ddcf4a87-b8d9-4e79-885d-08aa52c7198c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_ddcf4a87-b8d9-4e79-885d-08aa52c7198c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ddcf4a87-b8d9-4e79-885d-08aa52c7198c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_ddcf4a87-b8d9-4e79-885d-08aa52c7198c" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ddcf4a87-b8d9-4e79-885d-08aa52c7198c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e73f1907-0c2e-4b1b-9ee6-4f2a9d9e779d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_ddcf4a87-b8d9-4e79-885d-08aa52c7198c" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e73f1907-0c2e-4b1b-9ee6-4f2a9d9e779d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_311ef039-dc0c-456f-9f10-e9048cfc2bfe" xlink:href="bsx-20201231.xsd#bsx_The2018FacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_e73f1907-0c2e-4b1b-9ee6-4f2a9d9e779d" xlink:to="loc_bsx_The2018FacilityDomain_311ef039-dc0c-456f-9f10-e9048cfc2bfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a4e76f23-08c3-481d-a0d6-7ae6358a153a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_CreditFacilityAxis_a4e76f23-08c3-481d-a0d6-7ae6358a153a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a4e76f23-08c3-481d-a0d6-7ae6358a153a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a4e76f23-08c3-481d-a0d6-7ae6358a153a" xlink:to="loc_us-gaap_CreditFacilityDomain_a4e76f23-08c3-481d-a0d6-7ae6358a153a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_448c3a06-d68f-4bba-96ed-548a395cccd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a4e76f23-08c3-481d-a0d6-7ae6358a153a" xlink:to="loc_us-gaap_CreditFacilityDomain_448c3a06-d68f-4bba-96ed-548a395cccd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b4ce11bf-9f38-4a39-abf9-3f772cd49a14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_448c3a06-d68f-4bba-96ed-548a395cccd2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b4ce11bf-9f38-4a39-abf9-3f772cd49a14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_f6090964-5731-475b-9e4e-9aa3068c6c46" xlink:href="bsx-20201231.xsd#bsx_CovenantAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_bsx_CovenantAxis_f6090964-5731-475b-9e4e-9aa3068c6c46" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_f6090964-5731-475b-9e4e-9aa3068c6c46_default" xlink:href="bsx-20201231.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_CovenantAxis_f6090964-5731-475b-9e4e-9aa3068c6c46" xlink:to="loc_bsx_CovenantDomain_f6090964-5731-475b-9e4e-9aa3068c6c46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:href="bsx-20201231.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_CovenantAxis_f6090964-5731-475b-9e4e-9aa3068c6c46" xlink:to="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_fd0471a9-6689-4034-a46d-4e4eeea3a39a" xlink:href="bsx-20201231.xsd#bsx_CurrentRequirementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_CurrentRequirementMember_fd0471a9-6689-4034-a46d-4e4eeea3a39a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_bb04e9f8-408a-4c12-addf-0ab4e0050d2d" xlink:href="bsx-20201231.xsd#bsx_ActualCovenantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_ActualCovenantMember_bb04e9f8-408a-4c12-addf-0ab4e0050d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_2d44669e-b0b5-4c00-9438-d820eb6a61c8" xlink:href="bsx-20201231.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_2d44669e-b0b5-4c00-9438-d820eb6a61c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_8813344b-7f4a-4062-96f8-3088482d79f6" xlink:href="bsx-20201231.xsd#bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_8813344b-7f4a-4062-96f8-3088482d79f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_49a74adc-b5fa-48ce-9c46-62e762ca04c4" xlink:href="bsx-20201231.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_49a74adc-b5fa-48ce-9c46-62e762ca04c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_fe04dfa8-f0d2-4f83-876e-db9e37f78c09" xlink:href="bsx-20201231.xsd#bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_fe04dfa8-f0d2-4f83-876e-db9e37f78c09" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementExtensionThroughTheRemainderOf2020Member_e4f99afb-da9d-49cb-8841-960e6072d0cf" xlink:href="bsx-20201231.xsd#bsx_RequirementExtensionThroughTheRemainderOf2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementExtensionThroughTheRemainderOf2020Member_e4f99afb-da9d-49cb-8841-960e6072d0cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ce6355c6-1839-4bb6-8aaf-193f9a55246f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ce6355c6-1839-4bb6-8aaf-193f9a55246f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f7a9fbf8-4dc9-434f-9ff7-f462e085aaba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ce6355c6-1839-4bb6-8aaf-193f9a55246f" xlink:to="loc_us-gaap_CommercialPaperMember_f7a9fbf8-4dc9-434f-9ff7-f462e085aaba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_a4c9fc97-fbaf-4d11-9361-bd24ca8a20b8" xlink:href="bsx-20201231.xsd#bsx_August2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ce6355c6-1839-4bb6-8aaf-193f9a55246f" xlink:to="loc_bsx_August2019TermLoanMember_a4c9fc97-fbaf-4d11-9361-bd24ca8a20b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Leases" xlink:type="simple" xlink:href="bsx-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/Leases" xlink:type="extended" id="i864713515cc84cb39af05f55bb948f71_Leases"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/LeasesTables" xlink:type="extended" id="ie6d134562f46433eb437ba3ff5e12826_LeasesTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#LeasesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="extended" id="i36bace7c5cf14f28b254a5af16d91b9a_LeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_a91c1abb-b4fd-4bb9-ba94-b23c46d350c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_a91c1abb-b4fd-4bb9-ba94-b23c46d350c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_217b3bfd-0ab4-4a04-ab7b-aa59549e315d" xlink:href="bsx-20201231.xsd#bsx_LesseeOperatingAndFinanceLeasesOptionToExtend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_217b3bfd-0ab4-4a04-ab7b-aa59549e315d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b6c6710f-0dbc-4261-ba4c-5af7bae31233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b6c6710f-0dbc-4261-ba4c-5af7bae31233" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4665efc7-6c75-4fea-906e-743f534fddf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4665efc7-6c75-4fea-906e-743f534fddf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_47c74ae3-3e94-4514-aedd-931de6d49bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_47c74ae3-3e94-4514-aedd-931de6d49bf9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d34791fb-0e40-40b5-a361-2aff45ba1543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d34791fb-0e40-40b5-a361-2aff45ba1543" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b36acc0d-da6e-4a29-a74b-35ec097787e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b36acc0d-da6e-4a29-a74b-35ec097787e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e10c00f6-42f0-4080-9832-6df5fa707c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseCost_e10c00f6-42f0-4080-9832-6df5fa707c69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_a0808572-3d14-401e-b7d0-ee1905d6fe1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_a0808572-3d14-401e-b7d0-ee1905d6fe1d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_c274948d-7014-44ca-90c8-a8d13db986ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeasePayments_c274948d-7014-44ca-90c8-a8d13db986ee" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9cdba09b-74b3-42a2-9624-b978b81458f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9cdba09b-74b3-42a2-9624-b978b81458f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_2ec9a695-52d4-41aa-864d-8e5cceb2ed0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_2ec9a695-52d4-41aa-864d-8e5cceb2ed0c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_2b138b77-de22-4007-ad54-106be091dc01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_2b138b77-de22-4007-ad54-106be091dc01" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_5e28c242-1653-4d7e-9647-f533ec8803d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_5e28c242-1653-4d7e-9647-f533ec8803d0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_8e1da4c3-05d2-41a6-bc4b-4a8e8c3b2401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_8e1da4c3-05d2-41a6-bc4b-4a8e8c3b2401" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_d14fd969-7b1c-4e2f-9c48-24d1b4ccb88b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_d14fd969-7b1c-4e2f-9c48-24d1b4ccb88b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_bf00704a-b889-49d0-81d5-99554f5fdd6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_bf00704a-b889-49d0-81d5-99554f5fdd6e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60ac84ec-2269-4eee-9c0c-6bcd5737cb0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60ac84ec-2269-4eee-9c0c-6bcd5737cb0e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_27010309-2b78-492c-885d-5ae74eff6a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_27010309-2b78-492c-885d-5ae74eff6a9c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2ec121e9-d60d-4fad-aea0-44012a858869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseLiability_2ec121e9-d60d-4fad-aea0-44012a858869" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeLeasesNotYetCommencedAmount_1f226203-6fde-4bd4-8304-b2f2f31d3824" xlink:href="bsx-20201231.xsd#bsx_LesseeLeasesNotYetCommencedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_bsx_LesseeLeasesNotYetCommencedAmount_1f226203-6fde-4bd4-8304-b2f2f31d3824" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f297255f-f13c-4f09-8028-c171db68943f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f297255f-f13c-4f09-8028-c171db68943f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6117106d-7124-401a-94aa-8a54ffb702ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:to="loc_srt_RangeAxis_6117106d-7124-401a-94aa-8a54ffb702ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6117106d-7124-401a-94aa-8a54ffb702ff_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6117106d-7124-401a-94aa-8a54ffb702ff" xlink:to="loc_srt_RangeMember_6117106d-7124-401a-94aa-8a54ffb702ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d3ed16cb-0c73-49e3-aa6e-7379f1f6431e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6117106d-7124-401a-94aa-8a54ffb702ff" xlink:to="loc_srt_RangeMember_d3ed16cb-0c73-49e3-aa6e-7379f1f6431e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a6f91068-b925-4d06-9272-e5bde9648486" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d3ed16cb-0c73-49e3-aa6e-7379f1f6431e" xlink:to="loc_srt_MinimumMember_a6f91068-b925-4d06-9272-e5bde9648486" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3f14bfc5-d6b6-4605-b580-e7a9e778ffc6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d3ed16cb-0c73-49e3-aa6e-7379f1f6431e" xlink:to="loc_srt_MaximumMember_3f14bfc5-d6b6-4605-b580-e7a9e778ffc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_24a13a01-3f39-471d-a1f3-903e1b636d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_24a13a01-3f39-471d-a1f3-903e1b636d25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_fe77a048-8b06-44be-9daa-b4cb894654d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_24a13a01-3f39-471d-a1f3-903e1b636d25" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_fe77a048-8b06-44be-9daa-b4cb894654d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8c3316d0-e543-4524-b74d-728268d83691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_24a13a01-3f39-471d-a1f3-903e1b636d25" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8c3316d0-e543-4524-b74d-728268d83691" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivities" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivities"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivities" xlink:type="extended" id="ied65c3f313db48c39d86fbad09425273_RestructuringRelatedActivities"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivitiesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="extended" id="i24e60b8ea3f44d7999e1ba9741a51b56_RestructuringRelatedActivitiesTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_44b4a09e-93ee-46db-b57b-a7b4a5ca22e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_44b4a09e-93ee-46db-b57b-a7b4a5ca22e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesTableTextBlock_a596deb4-11a8-4288-b715-548ca2b4b209" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringChargesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:to="loc_bsx_CumulativeRestructuringChargesTableTextBlock_a596deb4-11a8-4288-b715-548ca2b4b209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_7fc8211f-bf50-45d0-9f68-b3c20d260de1" xlink:href="bsx-20201231.xsd#bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:to="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_7fc8211f-bf50-45d0-9f68-b3c20d260de1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ae8d9163-4bc9-442e-8bbe-4f2f96a1cb7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ae8d9163-4bc9-442e-8bbe-4f2f96a1cb7a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_d2ebcb9a-ffd6-417f-975d-895d3974d86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ae8d9163-4bc9-442e-8bbe-4f2f96a1cb7a" xlink:to="loc_us-gaap_RestructuringPlanAxis_d2ebcb9a-ffd6-417f-975d-895d3974d86a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_d2ebcb9a-ffd6-417f-975d-895d3974d86a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_d2ebcb9a-ffd6-417f-975d-895d3974d86a" xlink:to="loc_us-gaap_RestructuringPlanDomain_d2ebcb9a-ffd6-417f-975d-895d3974d86a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_d2ebcb9a-ffd6-417f-975d-895d3974d86a" xlink:to="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember_d6fbc74f-e4b2-4dbd-aa6f-742fa0c0d544" xlink:href="bsx-20201231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:to="loc_bsx_A2019RestructuringPlanMember_d6fbc74f-e4b2-4dbd-aa6f-742fa0c0d544" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_448b8c38-0f43-4319-b611-f03ed810e357" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_448b8c38-0f43-4319-b611-f03ed810e357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_7e78b4ef-d4d3-4b12-bde4-1ca456b33b97" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:to="loc_bsx_RestructuringPlanMember_7e78b4ef-d4d3-4b12-bde4-1ca456b33b97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember_c5a6d3d6-68c6-4552-b833-b72daea8d43b" xlink:href="bsx-20201231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:to="loc_bsx_A2016RestructuringPlanMember_c5a6d3d6-68c6-4552-b833-b72daea8d43b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="extended" id="i4c15a7f923e34393a15c4c603c467257_RestructuringRelatedActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_bd0328c9-2917-4e46-95a5-efdc0c6c7d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_bd0328c9-2917-4e46-95a5-efdc0c6c7d50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringrelatedCostExpectedCost_df8a4052-3bf3-4a0f-8bbe-96e6c5cccd11" xlink:href="bsx-20201231.xsd#bsx_RestructuringrelatedCostExpectedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_RestructuringrelatedCostExpectedCost_df8a4052-3bf3-4a0f-8bbe-96e6c5cccd11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost_d89cee9c-ed92-465c-9130-4312ad0dda9d" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRestructuringrelatedCostExpectedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost_d89cee9c-ed92-465c-9130-4312ad0dda9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount_9a415274-db68-4204-9229-c8d379dcd383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_EffectOnFutureCashFlowsAmount_9a415274-db68-4204-9229-c8d379dcd383" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_7975da1a-bc0a-47bc-a18f-49f19116e7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_SeveranceCosts1_7975da1a-bc0a-47bc-a18f-49f19116e7dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCosts_e38ddb6b-3c65-4352-a0d8-ca44d35a835a" xlink:href="bsx-20201231.xsd#bsx_TransferCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_TransferCosts_e38ddb6b-3c65-4352-a0d8-ca44d35a835a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_162001e7-ce1a-4ffc-847e-9f52e950fcc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_OtherRestructuringCosts_162001e7-ce1a-4ffc-847e-9f52e950fcc8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_62dbf82a-c1cb-4186-871b-46c36606066a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_RestructuringCharges_62dbf82a-c1cb-4186-871b-46c36606066a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_15324cde-2478-4175-b2c8-8992c0afa48f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_15324cde-2478-4175-b2c8-8992c0afa48f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedExpenses_1d15c72c-19c4-4cc7-b67d-ac4bce9b8f35" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_RestructuringRelatedExpenses_1d15c72c-19c4-4cc7-b67d-ac4bce9b8f35" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_2c3054e6-7382-4954-acb1-f78d56af976d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_InventoryWriteDown_2c3054e6-7382-4954-acb1-f78d56af976d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0ff2d8df-3ac0-4c9d-a425-3cae2b94a679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0ff2d8df-3ac0-4c9d-a425-3cae2b94a679" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesIncurredToDate_c7d19676-4de2-4956-be5a-9a715d74e3a5" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringChargesIncurredToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_CumulativeRestructuringChargesIncurredToDate_c7d19676-4de2-4956-be5a-9a715d74e3a5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_6917677f-fba5-46eb-9bf2-210e7c07e879" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringRelatedCostsIncurredToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_6917677f-fba5-46eb-9bf2-210e7c07e879" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_646b1511-cb79-459b-8f3d-c91d7859a11d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_646b1511-cb79-459b-8f3d-c91d7859a11d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_e1f6a763-1eea-4f8b-82bb-f6857942573f" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_e1f6a763-1eea-4f8b-82bb-f6857942573f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c5be969b-61d0-405e-ab9e-8f4803728634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c5be969b-61d0-405e-ab9e-8f4803728634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c5be969b-61d0-405e-ab9e-8f4803728634_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5be969b-61d0-405e-ab9e-8f4803728634" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c5be969b-61d0-405e-ab9e-8f4803728634_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5be969b-61d0-405e-ab9e-8f4803728634" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a872e69e-80c5-464e-b340-db4a1ebf0f53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a872e69e-80c5-464e-b340-db4a1ebf0f53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2d35ae7e-c406-4286-92b4-81e08b0042fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:to="loc_us-gaap_CostOfSalesMember_2d35ae7e-c406-4286-92b4-81e08b0042fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_722975d2-deb6-4bfd-bdbc-c4d0f62b19b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_722975d2-deb6-4bfd-bdbc-c4d0f62b19b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_4dbc96d8-8672-4bf8-899d-ccd377ed9076" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_4dbc96d8-8672-4bf8-899d-ccd377ed9076" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_4dbc96d8-8672-4bf8-899d-ccd377ed9076_default" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_4dbc96d8-8672-4bf8-899d-ccd377ed9076" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_4dbc96d8-8672-4bf8-899d-ccd377ed9076_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_39c99dfb-7ec3-45d6-af59-c5e6be2b7745" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_4dbc96d8-8672-4bf8-899d-ccd377ed9076" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_39c99dfb-7ec3-45d6-af59-c5e6be2b7745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_2d4559fa-eac2-49f7-9a5c-1d7bbba317c3" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_39c99dfb-7ec3-45d6-af59-c5e6be2b7745" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_2d4559fa-eac2-49f7-9a5c-1d7bbba317c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_bbdea70c-b68b-4fa2-84ee-ce40b11d115d" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_39c99dfb-7ec3-45d6-af59-c5e6be2b7745" xlink:to="loc_bsx_RestructuringPlanMember_bbdea70c-b68b-4fa2-84ee-ce40b11d115d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionAxis_3bd49044-b61a-4a3f-8977-83e5c767dc19" xlink:href="bsx-20201231.xsd#bsx_StatementOfOperationsCaptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_bsx_StatementOfOperationsCaptionAxis_3bd49044-b61a-4a3f-8977-83e5c767dc19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionDomain_3bd49044-b61a-4a3f-8977-83e5c767dc19_default" xlink:href="bsx-20201231.xsd#bsx_StatementOfOperationsCaptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_StatementOfOperationsCaptionAxis_3bd49044-b61a-4a3f-8977-83e5c767dc19" xlink:to="loc_bsx_StatementOfOperationsCaptionDomain_3bd49044-b61a-4a3f-8977-83e5c767dc19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionDomain_b633f03e-6df2-4d5d-ad21-ba21d234cb01" xlink:href="bsx-20201231.xsd#bsx_StatementOfOperationsCaptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_StatementOfOperationsCaptionAxis_3bd49044-b61a-4a3f-8977-83e5c767dc19" xlink:to="loc_bsx_StatementOfOperationsCaptionDomain_b633f03e-6df2-4d5d-ad21-ba21d234cb01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_34420234-b165-4218-a8eb-ff945bca57e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain_b633f03e-6df2-4d5d-ad21-ba21d234cb01" xlink:to="loc_us-gaap_CostOfSalesMember_34420234-b165-4218-a8eb-ff945bca57e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_cb339a74-606f-4f28-a7cc-c58c27071b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain_b633f03e-6df2-4d5d-ad21-ba21d234cb01" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_cb339a74-606f-4f28-a7cc-c58c27071b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_c8100574-231d-4a22-998a-03cc160bace6" xlink:href="bsx-20201231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_c8100574-231d-4a22-998a-03cc160bace6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_c8100574-231d-4a22-998a-03cc160bace6_default" xlink:href="bsx-20201231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_c8100574-231d-4a22-998a-03cc160bace6" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_c8100574-231d-4a22-998a-03cc160bace6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_1786391c-d0dc-4a73-96a4-ebc7e67b6917" xlink:href="bsx-20201231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_c8100574-231d-4a22-998a-03cc160bace6" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_1786391c-d0dc-4a73-96a4-ebc7e67b6917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_27331b31-da67-4ddc-8fa7-192b449b1f51" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_1786391c-d0dc-4a73-96a4-ebc7e67b6917" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_27331b31-da67-4ddc-8fa7-192b449b1f51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_0e6ccdf5-3d55-44c9-859c-a296c9d90ff3" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_1786391c-d0dc-4a73-96a4-ebc7e67b6917" xlink:to="loc_bsx_RestructuringPlanMember_0e6ccdf5-3d55-44c9-859c-a296c9d90ff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_srt_RangeAxis_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a" xlink:to="loc_srt_RangeMember_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_120c0503-b33c-4d63-a8e7-bccb98f1ef1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a" xlink:to="loc_srt_RangeMember_120c0503-b33c-4d63-a8e7-bccb98f1ef1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_78bdd2b7-fb0a-4180-87cf-6cff5b579397" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_120c0503-b33c-4d63-a8e7-bccb98f1ef1f" xlink:to="loc_srt_MaximumMember_78bdd2b7-fb0a-4180-87cf-6cff5b579397" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0d778d4c-eef4-4ffe-8851-944ae248552a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_120c0503-b33c-4d63-a8e7-bccb98f1ef1f" xlink:to="loc_srt_MinimumMember_0d778d4c-eef4-4ffe-8851-944ae248552a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_fd315a86-750a-4831-b95d-f7abd165bdfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_fd315a86-750a-4831-b95d-f7abd165bdfd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_fd315a86-750a-4831-b95d-f7abd165bdfd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fd315a86-750a-4831-b95d-f7abd165bdfd" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_fd315a86-750a-4831-b95d-f7abd165bdfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fd315a86-750a-4831-b95d-f7abd165bdfd" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_5fc12dc0-f487-447f-a495-7b0f20054db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:to="loc_us-gaap_EmployeeSeveranceMember_5fc12dc0-f487-447f-a495-7b0f20054db5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_15e22e40-650b-4a76-99f8-3e049cc5e377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:to="loc_us-gaap_OtherRestructuringMember_15e22e40-650b-4a76-99f8-3e049cc5e377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCostsMember_5f41c76f-99f6-40e2-bf6b-3e05943eefa9" xlink:href="bsx-20201231.xsd#bsx_TransferCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:to="loc_bsx_TransferCostsMember_5f41c76f-99f6-40e2-bf6b-3e05943eefa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_5b4dde23-989e-4566-8f9f-14e81105094a" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_5b4dde23-989e-4566-8f9f-14e81105094a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_c27784e2-ed19-4592-b36c-324f0af1e3da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_us-gaap_RestructuringPlanAxis_c27784e2-ed19-4592-b36c-324f0af1e3da" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c27784e2-ed19-4592-b36c-324f0af1e3da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_c27784e2-ed19-4592-b36c-324f0af1e3da" xlink:to="loc_us-gaap_RestructuringPlanDomain_c27784e2-ed19-4592-b36c-324f0af1e3da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_c27784e2-ed19-4592-b36c-324f0af1e3da" xlink:to="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_032bd9c1-8800-4351-900d-c2b8f241b1d1" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:to="loc_bsx_RestructuringPlanMember_032bd9c1-8800-4351-900d-c2b8f241b1d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember_d7a9d197-81cf-4170-96ac-398d37966f24" xlink:href="bsx-20201231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:to="loc_bsx_A2019RestructuringPlanMember_d7a9d197-81cf-4170-96ac-398d37966f24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember_68c645f2-9445-41ed-9d40-1bafc530eac4" xlink:href="bsx-20201231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:to="loc_bsx_A2016RestructuringPlanMember_68c645f2-9445-41ed-9d40-1bafc530eac4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LotusDiscontinuationMember_a6f6d179-20c9-4702-991c-f13bbe9158a3" xlink:href="bsx-20201231.xsd#bsx_LotusDiscontinuationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:to="loc_bsx_LotusDiscontinuationMember_a6f6d179-20c9-4702-991c-f13bbe9158a3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformation"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended" id="i80cea9f3e43841e6995694e86aa5462e_SupplementalBalanceSheetInformation"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended" id="ie313f1ca5d96414db594591c41e50660_SupplementalBalanceSheetInformationTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended" id="id8968aee7b9e4de0b4851865a39bf476_SupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_828072cf-0895-4471-9255-dd231c93adad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_828072cf-0895-4471-9255-dd231c93adad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a0bfe6dd-8f33-474d-8708-d1ff1cd2bcf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a0bfe6dd-8f33-474d-8708-d1ff1cd2bcf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_a6352c54-0d67-4075-8379-2a287544e803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_a6352c54-0d67-4075-8379-2a287544e803" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_36293564-5683-4b5a-86a3-fd456114a9bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_36293564-5683-4b5a-86a3-fd456114a9bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_07cb9ea6-281b-406b-9301-c4f9eb8c7eaa" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_bsx_LicensingArrangementsLiability_07cb9ea6-281b-406b-9301-c4f9eb8c7eaa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_6f0ef3b3-0314-4456-9f95-1dae0361bc32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_DeferredRevenue_6f0ef3b3-0314-4456-9f95-1dae0361bc32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_dc2302fa-b3ca-47b0-aa71-05afe0345708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_dc2302fa-b3ca-47b0-aa71-05afe0345708" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a1b3adf4-3b32-4fa6-a046-61d2252a0a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_StatementTable_a1b3adf4-3b32-4fa6-a046-61d2252a0a25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a1b3adf4-3b32-4fa6-a046-61d2252a0a25" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e4b01e13-195d-4c16-9b8c-16cb8c2c2c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e4b01e13-195d-4c16-9b8c-16cb8c2c2c29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9b1d2cfa-b64d-45f7-936d-0f556110f502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e4b01e13-195d-4c16-9b8c-16cb8c2c2c29" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9b1d2cfa-b64d-45f7-936d-0f556110f502" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended" id="idc4adab264b045a5a7371518dd41c85f_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended" id="i97cb01b14e3e45d09a1b4bb9b8e49bdd_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesDetailsRateTable"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="extended" id="icc2bc364003c46c9bee80f9dfc457451_IncomeTaxesDetailsRateTable">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:href="bsx-20201231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7502af8c-d437-416e-a18a-4697805dead1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7502af8c-d437-416e-a18a-4697805dead1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a5fc5425-27f6-498a-a8e0-802a14d65e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a5fc5425-27f6-498a-a8e0-802a14d65e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_1379e376-9783-481b-b489-5b2a36603340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_1379e376-9783-481b-b489-5b2a36603340" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7de3277f-b905-4971-b927-e76fb445aa72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7de3277f-b905-4971-b927-e76fb445aa72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_9e18b962-f2fe-452f-9313-d4ee95cb4510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_9e18b962-f2fe-452f-9313-d4ee95cb4510" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_91ca630c-acfa-4c20-b705-c66268adea38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_91ca630c-acfa-4c20-b705-c66268adea38" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_af3d8780-5c84-4889-b522-f7f12dc5e1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_af3d8780-5c84-4889-b522-f7f12dc5e1f4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_5ac24a5d-b4c6-4dc3-8d0e-ea17a0024e66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_5ac24a5d-b4c6-4dc3-8d0e-ea17a0024e66" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_cd78809a-df9e-417b-8831-12f21302d041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_cd78809a-df9e-417b-8831-12f21302d041" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_c209eb25-eef0-44f3-ae65-b621b2ec3ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_c209eb25-eef0-44f3-ae65-b621b2ec3ca5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_f02deb56-299c-4ba0-9e36-6871c6832b8e" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_f02deb56-299c-4ba0-9e36-6871c6832b8e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact_39151fa6-1b67-4613-88b0-e2a3a13c826e" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact_39151fa6-1b67-4613-88b0-e2a3a13c826e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_8146c09d-f1ce-436d-94a7-5c11271ea8b2" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_8146c09d-f1ce-436d-94a7-5c11271ea8b2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_2e02254f-1b18-4c09-aabb-c2a07abbbca7" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_2e02254f-1b18-4c09-aabb-c2a07abbbca7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_5ba369e7-2265-4773-9a94-e1acdeacfc52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_5ba369e7-2265-4773-9a94-e1acdeacfc52" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_38c6168f-113f-4dcd-a9bf-48ae7d065f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_38c6168f-113f-4dcd-a9bf-48ae7d065f30" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0326595c-cf9f-46e4-861f-27e2cb1109bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0326595c-cf9f-46e4-861f-27e2cb1109bc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3af58a55-67f8-4086-9e51-e277bbe7455c" xlink:href="bsx-20201231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3af58a55-67f8-4086-9e51-e277bbe7455c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateAxis_f5478cd1-1e50-4b61-88ab-583f9eca07a0" xlink:href="bsx-20201231.xsd#bsx_TaxRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3af58a55-67f8-4086-9e51-e277bbe7455c" xlink:to="loc_bsx_TaxRateAxis_f5478cd1-1e50-4b61-88ab-583f9eca07a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateDomain_f5478cd1-1e50-4b61-88ab-583f9eca07a0_default" xlink:href="bsx-20201231.xsd#bsx_TaxRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_TaxRateAxis_f5478cd1-1e50-4b61-88ab-583f9eca07a0" xlink:to="loc_bsx_TaxRateDomain_f5478cd1-1e50-4b61-88ab-583f9eca07a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateDomain_3322ec1b-debd-4c56-b02a-efc55787c7b7" xlink:href="bsx-20201231.xsd#bsx_TaxRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_TaxRateAxis_f5478cd1-1e50-4b61-88ab-583f9eca07a0" xlink:to="loc_bsx_TaxRateDomain_3322ec1b-debd-4c56-b02a-efc55787c7b7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="extended" id="i22a4f4ecad5a4377944355e3232d9cf4_IncomeTaxesIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_be98623b-26b5-4c0d-aa81-649c21719cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_be98623b-26b5-4c0d-aa81-649c21719cb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d976a76b-0d78-4755-a8dc-cfdb6bafb0a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d976a76b-0d78-4755-a8dc-cfdb6bafb0a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9ad6d569-73f1-4c0c-80f4-8393fa12b794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9ad6d569-73f1-4c0c-80f4-8393fa12b794" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21745f7a-269d-4592-ad6b-a4feba5f899a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21745f7a-269d-4592-ad6b-a4feba5f899a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_063682bb-d969-4637-aa45-6a760a8a59bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_063682bb-d969-4637-aa45-6a760a8a59bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ffa7b799-3142-448e-89c0-69012917de21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ffa7b799-3142-448e-89c0-69012917de21" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_304613af-a1b6-4cd3-a6ba-aded90b7f65c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_304613af-a1b6-4cd3-a6ba-aded90b7f65c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_73721260-c2d5-4811-8a93-6a1d5044127e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_73721260-c2d5-4811-8a93-6a1d5044127e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_94c2a084-bc5f-4fa6-a697-0fe52763ab9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_94c2a084-bc5f-4fa6-a697-0fe52763ab9a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_27d62e90-9b6a-4add-913c-8b2776dd55a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_27d62e90-9b6a-4add-913c-8b2776dd55a8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_097eb197-e6ab-4282-88df-59d8a858b1b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_097eb197-e6ab-4282-88df-59d8a858b1b0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f097f992-7cb3-484b-b762-559e21c75820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f097f992-7cb3-484b-b762-559e21c75820" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_0215d214-a2a1-45e3-92cf-4893a3e8bfb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_0215d214-a2a1-45e3-92cf-4893a3e8bfb3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_13449dff-6b40-45f4-944d-80429830b535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_13449dff-6b40-45f4-944d-80429830b535" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_fa932528-c53c-46ca-84fb-a2ca24fa7b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_fa932528-c53c-46ca-84fb-a2ca24fa7b00" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_ea12a2cf-166d-4152-92c6-43b6d58a6a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_ea12a2cf-166d-4152-92c6-43b6d58a6a47" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_6000cc51-a7cc-429e-8e89-a9317844cd72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_6000cc51-a7cc-429e-8e89-a9317844cd72" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_c1675dc3-d29e-41a5-bb22-5030825a9fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_c1675dc3-d29e-41a5-bb22-5030825a9fc5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_61285838-94da-496d-bc5b-a480f1e626b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_61285838-94da-496d-bc5b-a480f1e626b7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FederalBenefitOfUncertainTaxPositions_ddc91458-2fad-4730-be91-767a296821a8" xlink:href="bsx-20201231.xsd#bsx_FederalBenefitOfUncertainTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_FederalBenefitOfUncertainTaxPositions_ddc91458-2fad-4730-be91-767a296821a8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fa2bec50-4301-4f5e-a2a1-e4148a35617f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fa2bec50-4301-4f5e-a2a1-e4148a35617f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_c0dc2b3f-2015-4aa3-a6af-7d3653519f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_c0dc2b3f-2015-4aa3-a6af-7d3653519f2c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_772b9aa9-fc40-42b6-abfb-4f54621432f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_772b9aa9-fc40-42b6-abfb-4f54621432f9" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a7eee7ee-0709-4d47-a60b-65f51dbcc019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a7eee7ee-0709-4d47-a60b-65f51dbcc019" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4ee4611a-9088-4f99-9b63-ed7c9f7a8274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_4ee4611a-9088-4f99-9b63-ed7c9f7a8274" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_263d0d0c-8034-459f-bf5d-69cb942edcae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_263d0d0c-8034-459f-bf5d-69cb942edcae" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_e8c1e699-2e4d-4071-abef-c4c17993aa5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_e8c1e699-2e4d-4071-abef-c4c17993aa5c" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d32e2e1e-e967-457c-b708-49fece0efe1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d32e2e1e-e967-457c-b708-49fece0efe1e" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_99efb78d-51e8-4b9d-a1c5-d1d5003b4e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_99efb78d-51e8-4b9d-a1c5-d1d5003b4e20" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_399e7b48-28d8-4b23-90dc-e8da752b80e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_399e7b48-28d8-4b23-90dc-e8da752b80e2" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5ecbaffe-3cd6-470c-982f-795d2c8250a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5ecbaffe-3cd6-470c-982f-795d2c8250a7" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_3af2ea5c-3e9c-46fc-9fa3-f8a4db1bd5a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_3af2ea5c-3e9c-46fc-9fa3-f8a4db1bd5a7" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_4610ae2b-c22a-4e70-8805-7712ddeda715" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_4610ae2b-c22a-4e70-8805-7712ddeda715" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_8c85af3a-aadb-4c0c-a6f7-d1cf5ef6481d" xlink:href="bsx-20201231.xsd#bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_8c85af3a-aadb-4c0c-a6f7-d1cf5ef6481d" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_bb2771d6-5d8a-4cf6-8a66-e145bb5cf830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_bb2771d6-5d8a-4cf6-8a66-e145bb5cf830" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_776d6cfc-31e0-4896-813a-ab513b6569cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilities_776d6cfc-31e0-4896-813a-ab513b6569cf" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_b75cbecc-bd0f-4141-afcb-955fb952a7e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_b75cbecc-bd0f-4141-afcb-955fb952a7e3" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_94164906-e581-4ada-aa1f-20cd6214d58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_94164906-e581-4ada-aa1f-20cd6214d58a" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_6fc78ea3-6a23-4296-b964-240f9c78d636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_6fc78ea3-6a23-4296-b964-240f9c78d636" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_17cbb0f3-b4b3-4cda-a26d-f01b65d65517" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetValuationAllowanceIntraEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_17cbb0f3-b4b3-4cda-a26d-f01b65d65517" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance_b69dd9a3-b27a-42f2-b4dd-ecfd2621c8d2" xlink:href="bsx-20201231.xsd#bsx_ChangeinDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance_b69dd9a3-b27a-42f2-b4dd-ecfd2621c8d2" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_816cb09f-b54b-4146-8d8f-0b2726d3d9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_816cb09f-b54b-4146-8d8f-0b2726d3d9a0" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentive_96a4193e-1ca1-401f-b851-7b81dd4af723" xlink:href="bsx-20201231.xsd#bsx_FreeTradeZoneRegimeTaxIncentive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_FreeTradeZoneRegimeTaxIncentive_96a4193e-1ca1-401f-b851-7b81dd4af723" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneTaxIncentivePerShare_7bde65b2-ae5c-48c6-911e-0e3dd21eb0dd" xlink:href="bsx-20201231.xsd#bsx_FreeTradeZoneTaxIncentivePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_FreeTradeZoneTaxIncentivePerShare_7bde65b2-ae5c-48c6-911e-0e3dd21eb0dd" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRico_c57e3ca9-3ff2-4898-9c78-4cc8cdd4c65c" xlink:href="bsx-20201231.xsd#bsx_TaxIncentivesInPuertoRico"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_TaxIncentivesInPuertoRico_c57e3ca9-3ff2-4898-9c78-4cc8cdd4c65c" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b8525305-aa8c-4917-a3d6-ed596ac62173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b8525305-aa8c-4917-a3d6-ed596ac62173" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_42f1311d-f6b9-4401-b79c-277cde1e2c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_42f1311d-f6b9-4401-b79c-277cde1e2c08" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0bda10c2-d20e-4e31-876b-66e533707a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0bda10c2-d20e-4e31-876b-66e533707a94" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_76d0f6f8-c848-43ba-ab3f-c49f3513a6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_76d0f6f8-c848-43ba-ab3f-c49f3513a6e1" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8fd62991-21b4-49c0-a676-a2b7c734cbf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8fd62991-21b4-49c0-a676-a2b7c734cbf4" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a72cbe0a-fdce-4133-9798-313157262695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a72cbe0a-fdce-4133-9798-313157262695" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5b5dade0-a290-4666-b700-c10933f1c169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5b5dade0-a290-4666-b700-c10933f1c169" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_4719ad3e-2b79-4e4e-9b37-7b8e8ca36809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_4719ad3e-2b79-4e4e-9b37-7b8e8ca36809" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1bfb0ccc-a2d5-4792-b54e-a3fca4416336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1bfb0ccc-a2d5-4792-b54e-a3fca4416336" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetSettlementPaymenttoIRS_91728f0a-f78b-4a12-ac3a-a46959bc327e" xlink:href="bsx-20201231.xsd#bsx_NetSettlementPaymenttoIRS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_NetSettlementPaymenttoIRS_91728f0a-f78b-4a12-ac3a-a46959bc327e" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_c2792b07-8464-45ee-baad-7310ec6dcb76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_c2792b07-8464-45ee-baad-7310ec6dcb76" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_559ac4d3-44a0-47ab-be8f-4e25e8c67b49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_559ac4d3-44a0-47ab-be8f-4e25e8c67b49" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_b4dd2b96-36c2-4474-9d35-f25e495ea961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_b4dd2b96-36c2-4474-9d35-f25e495ea961" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_483b34e8-9bd6-4cbe-b2a5-9a7c332b603f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_483b34e8-9bd6-4cbe-b2a5-9a7c332b603f" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_fa24ba3d-cfa1-4e71-8cb5-5508fe955719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_fa24ba3d-cfa1-4e71-8cb5-5508fe955719" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment_21334275-08a4-42bf-9d81-8b956bdf2659" xlink:href="bsx-20201231.xsd#bsx_Onetimetransactiontaxpost1986EPnetpayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment_21334275-08a4-42bf-9d81-8b956bdf2659" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransitionTaxPaymentRemaining_b35bfe9f-d024-4fcf-9eef-eb2b290a5f73" xlink:href="bsx-20201231.xsd#bsx_TransitionTaxPaymentRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_TransitionTaxPaymentRemaining_b35bfe9f-d024-4fcf-9eef-eb2b290a5f73" xlink:type="arc" order="61"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_0f721ece-4b8d-42a0-9729-8bbf707dee6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_0f721ece-4b8d-42a0-9729-8bbf707dee6d" xlink:type="arc" order="62"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct_78d5420b-45d8-408b-955a-f9405250ff97" xlink:href="bsx-20201231.xsd#bsx_TheCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_TheCARESAct_78d5420b-45d8-408b-955a-f9405250ff97" xlink:type="arc" order="63"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_a2cdd1cf-d5dd-42bb-b99d-64e27abf03eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_a2cdd1cf-d5dd-42bb-b99d-64e27abf03eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d581e340-e278-4299-a663-4bf7fe9c6a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a2cdd1cf-d5dd-42bb-b99d-64e27abf03eb" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d581e340-e278-4299-a663-4bf7fe9c6a43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d581e340-e278-4299-a663-4bf7fe9c6a43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d581e340-e278-4299-a663-4bf7fe9c6a43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d581e340-e278-4299-a663-4bf7fe9c6a43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d581e340-e278-4299-a663-4bf7fe9c6a43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_90d0fd25-a4b4-4b43-bcf1-aa031fb5d509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_90d0fd25-a4b4-4b43-bcf1-aa031fb5d509" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssetsHeldForSaleDomain_146b41cd-9cd4-47f0-8abf-22c72ced711a" xlink:href="bsx-20201231.xsd#bsx_AssetsHeldForSaleDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_bsx_AssetsHeldForSaleDomain_146b41cd-9cd4-47f0-8abf-22c72ced711a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsDomain_e3965b57-45cc-4b96-85a2-600e3ea3f74f" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_bsx_DeferredTaxAssetsDomain_e3965b57-45cc-4b96-85a2-600e3ea3f74f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesDomain_f3d694d4-0416-40f4-8846-097b29cac62b" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_bsx_DeferredTaxLiabilitiesDomain_f3d694d4-0416-40f4-8846-097b29cac62b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_4a0160e6-f817-484b-b76a-16e64bd01f87" xlink:href="bsx-20201231.xsd#bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_4a0160e6-f817-484b-b76a-16e64bd01f87" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20201231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended" id="i1468d2f8f5fd40bdb486de51720ed3de_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i56f0e9308239443e947e5f7c573f8b78_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bb268847-1cde-442d-ad15-df8f5ee45971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bb268847-1cde-442d-ad15-df8f5ee45971" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_124f39b6-40f0-42a1-b8c1-bfbca74499bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_124f39b6-40f0-42a1-b8c1-bfbca74499bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_f4c413e0-aad4-4b04-a5e8-2caf76ee8c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LitigationSettlementExpense_f4c413e0-aad4-4b04-a5e8-2caf76ee8c77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain_babeb110-e624-40b8-94ae-374bd33fd387" xlink:href="bsx-20201231.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_LitigationSettlementReceivedGain_babeb110-e624-40b8-94ae-374bd33fd387" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_0c9e9c85-7223-477f-ba89-4fa5f3382336" xlink:href="bsx-20201231.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_0c9e9c85-7223-477f-ba89-4fa5f3382336" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_b1883394-2679-40e6-a21e-20db561ca4ba" xlink:href="bsx-20201231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_b1883394-2679-40e6-a21e-20db561ca4ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_3cc7e39c-aaba-41d4-8776-a452dd2bf99e" xlink:href="bsx-20201231.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_3cc7e39c-aaba-41d4-8776-a452dd2bf99e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_6a5b15e9-7822-4e6f-8676-50dd81275503" xlink:href="bsx-20201231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_6a5b15e9-7822-4e6f-8676-50dd81275503" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh_0b6d369c-cf2d-4793-b82a-907830518bf2" xlink:href="bsx-20201231.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_CertifiedclassactionsinCanadaMesh_0b6d369c-cf2d-4793-b82a-907830518bf2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_c10509c2-44dc-4174-a4bf-bda5535467c9" xlink:href="bsx-20201231.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_c10509c2-44dc-4174-a4bf-bda5535467c9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_fb38c5cb-b888-4538-95ee-6a04794bbc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_fb38c5cb-b888-4538-95ee-6a04794bbc56" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllegedBreachofPurchaseAgreementAmount_6959e562-1273-4f0e-92ec-1605d012162d" xlink:href="bsx-20201231.xsd#bsx_AllegedBreachofPurchaseAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_AllegedBreachofPurchaseAgreementAmount_6959e562-1273-4f0e-92ec-1605d012162d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_29d0ab1c-56a0-4bf4-b1ad-78d8deb86f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_29d0ab1c-56a0-4bf4-b1ad-78d8deb86f38" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_97ffb99c-c992-44b5-ab03-6947cace3950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_97ffb99c-c992-44b5-ab03-6947cace3950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97ffb99c-c992-44b5-ab03-6947cace3950_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_97ffb99c-c992-44b5-ab03-6947cace3950" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97ffb99c-c992-44b5-ab03-6947cace3950_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69a83b4-942b-41e3-a1b5-e34a42b22840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_97ffb99c-c992-44b5-ab03-6947cace3950" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69a83b4-942b-41e3-a1b5-e34a42b22840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UpfrontCashMember_0310deaa-1165-432f-be5d-881c04a2d578" xlink:href="bsx-20201231.xsd#bsx_UpfrontCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69a83b4-942b-41e3-a1b5-e34a42b22840" xlink:to="loc_bsx_UpfrontCashMember_0310deaa-1165-432f-be5d-881c04a2d578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumContingentPaymentMember_5e9c720b-0d19-4bee-b38e-f664ae969ae8" xlink:href="bsx-20201231.xsd#bsx_MaximumContingentPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69a83b4-942b-41e3-a1b5-e34a42b22840" xlink:to="loc_bsx_MaximumContingentPaymentMember_5e9c720b-0d19-4bee-b38e-f664ae969ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_us-gaap_LitigationStatusAxis_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8" xlink:to="loc_us-gaap_LitigationStatusDomain_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_0255dc2f-bec6-437f-9bbb-ba2271e95b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8" xlink:to="loc_us-gaap_LitigationStatusDomain_0255dc2f-bec6-437f-9bbb-ba2271e95b2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_77ec5bf4-4211-49d4-8484-91ab0386105f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_0255dc2f-bec6-437f-9bbb-ba2271e95b2a" xlink:to="loc_us-gaap_SettledLitigationMember_77ec5bf4-4211-49d4-8484-91ab0386105f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_151840e2-6fd8-4cfb-89aa-0da443399c80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_srt_LitigationCaseAxis_151840e2-6fd8-4cfb-89aa-0da443399c80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_151840e2-6fd8-4cfb-89aa-0da443399c80_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_151840e2-6fd8-4cfb-89aa-0da443399c80" xlink:to="loc_srt_LitigationCaseTypeDomain_151840e2-6fd8-4cfb-89aa-0da443399c80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_14b8e718-4649-41b5-952c-0bc6d02f6976" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_151840e2-6fd8-4cfb-89aa-0da443399c80" xlink:to="loc_srt_LitigationCaseTypeDomain_14b8e718-4649-41b5-952c-0bc6d02f6976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedToOneJudgeInMAMember_0ff52f36-7229-447b-881b-ae602220316f" xlink:href="bsx-20201231.xsd#bsx_AssignedToOneJudgeInMAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_14b8e718-4649-41b5-952c-0bc6d02f6976" xlink:to="loc_bsx_AssignedToOneJudgeInMAMember_0ff52f36-7229-447b-881b-ae602220316f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b4534f00-ee49-4774-bf27-6df94e27a0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b4534f00-ee49-4774-bf27-6df94e27a0ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b4534f00-ee49-4774-bf27-6df94e27a0ef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b4534f00-ee49-4774-bf27-6df94e27a0ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b4534f00-ee49-4774-bf27-6df94e27a0ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_88c894d1-0965-4af9-9deb-f1203144f9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b4534f00-ee49-4774-bf27-6df94e27a0ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_88c894d1-0965-4af9-9deb-f1203144f9a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4f6f7d50-5367-4df4-b30d-310d20846a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_88c894d1-0965-4af9-9deb-f1203144f9a3" xlink:to="loc_us-gaap_SubsequentEventMember_4f6f7d50-5367-4df4-b30d-310d20846a67" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended" id="i8af8d6e78d0b4d7fa3a52c2d5fef282e_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended" id="i2e239a6306df4c52b1ba8a165077c8e3_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e056f68a-38c4-4960-b936-a8704a66a435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e056f68a-38c4-4960-b936-a8704a66a435" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1d5f54a2-c1a5-43b0-a6ce-d7e3f7c14f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1d5f54a2-c1a5-43b0-a6ce-d7e3f7c14f5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_c96af96d-dca0-4143-82ee-9d6d6adb24b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_c96af96d-dca0-4143-82ee-9d6d6adb24b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_8fa454f0-08e3-4047-ba3c-32ae6e4a3b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_8fa454f0-08e3-4047-ba3c-32ae6e4a3b76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1011c1b0-3788-46c8-9902-4f7efc950223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1011c1b0-3788-46c8-9902-4f7efc950223" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_ecaa0df8-18e3-43af-8c46-f1f6043abafe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_ecaa0df8-18e3-43af-8c46-f1f6043abafe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_e87e6838-ca5d-44cd-9bdc-8454b9bfb7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_e87e6838-ca5d-44cd-9bdc-8454b9bfb7d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_34ea8f3b-ad3c-4dc0-84c9-4d945b7ba020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_34ea8f3b-ad3c-4dc0-84c9-4d945b7ba020" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_fa83e084-3307-4110-903e-7e7addeaed8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PaymentsOfDividends_fa83e084-3307-4110-903e-7e7addeaed8d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_b70d8e8a-08c8-4564-b860-c223ca37d779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_b70d8e8a-08c8-4564-b860-c223ca37d779" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1aa4e992-b020-4300-a007-08d91e55f3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1aa4e992-b020-4300-a007-08d91e55f3f9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_31305a3b-bf37-4c5a-bdff-22a8191dbcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_31305a3b-bf37-4c5a-bdff-22a8191dbcf3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a98bf007-5cc4-4d4a-a52d-26032f355de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a98bf007-5cc4-4d4a-a52d-26032f355de0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_950404a0-2a57-49d1-86e8-cb3d0f3d9e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_950404a0-2a57-49d1-86e8-cb3d0f3d9e3b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_69234c39-083b-4005-90c4-835c6534c80c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_69234c39-083b-4005-90c4-835c6534c80c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_68dc530b-d8af-42fb-8a61-32604c615660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_68dc530b-d8af-42fb-8a61-32604c615660" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_2ea8dbe1-6b91-4135-b0bc-a3db5627f74d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_2ea8dbe1-6b91-4135-b0bc-a3db5627f74d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9f6f702f-e7d2-41da-b296-955672bd5b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9f6f702f-e7d2-41da-b296-955672bd5b9e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_3edff8b4-5437-474f-a2eb-62d7a19513f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_TreasuryStockShares_3edff8b4-5437-474f-a2eb-62d7a19513f5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e" xlink:to="loc_us-gaap_ClassOfStockDomain_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_05cf9583-246e-43ef-9f46-3fb5b90f0c5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e" xlink:to="loc_us-gaap_ClassOfStockDomain_05cf9583-246e-43ef-9f46-3fb5b90f0c5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_1b832f39-9118-4ff8-94a9-e99b5f002a80" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_05cf9583-246e-43ef-9f46-3fb5b90f0c5b" xlink:to="loc_bsx_A550MCPSSeriesAMember_1b832f39-9118-4ff8-94a9-e99b5f002a80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_351e9d1a-82b5-4a1f-b5a2-c7b4c54b166c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_05cf9583-246e-43ef-9f46-3fb5b90f0c5b" xlink:to="loc_us-gaap_CommonStockMember_351e9d1a-82b5-4a1f-b5a2-c7b4c54b166c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e2b4d31b-c677-4507-9ac2-51924f55a3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e2b4d31b-c677-4507-9ac2-51924f55a3f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e2b4d31b-c677-4507-9ac2-51924f55a3f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e2b4d31b-c677-4507-9ac2-51924f55a3f5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e2b4d31b-c677-4507-9ac2-51924f55a3f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c9578a15-1c0a-474c-b72f-83270896f5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e2b4d31b-c677-4507-9ac2-51924f55a3f5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c9578a15-1c0a-474c-b72f-83270896f5b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2fc930fa-297a-4631-a175-fe16f7340e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c9578a15-1c0a-474c-b72f-83270896f5b5" xlink:to="loc_us-gaap_SubsequentEventMember_2fc930fa-297a-4631-a175-fe16f7340e63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2b6ca589-07f4-410a-a043-2587bfd64a73" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:to="loc_srt_RangeAxis_2b6ca589-07f4-410a-a043-2587bfd64a73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b6ca589-07f4-410a-a043-2587bfd64a73_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2b6ca589-07f4-410a-a043-2587bfd64a73" xlink:to="loc_srt_RangeMember_2b6ca589-07f4-410a-a043-2587bfd64a73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_973bd215-1555-4243-91e1-94f905cc095f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2b6ca589-07f4-410a-a043-2587bfd64a73" xlink:to="loc_srt_RangeMember_973bd215-1555-4243-91e1-94f905cc095f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ff7aecf-8427-4443-8359-b735f5ba3579" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_973bd215-1555-4243-91e1-94f905cc095f" xlink:to="loc_srt_MinimumMember_0ff7aecf-8427-4443-8359-b735f5ba3579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ce35bdea-5573-43b5-8b8b-a96f2e1c6993" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_973bd215-1555-4243-91e1-94f905cc095f" xlink:to="loc_srt_MaximumMember_ce35bdea-5573-43b5-8b8b-a96f2e1c6993" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockInventiveandPurchasePlans"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans" xlink:type="extended" id="ic717986631484810868a2cf148a90be6_StockInventiveandPurchasePlans"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockIncentiveandPurchasePlansTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="extended" id="i4bbd68bb299e4affb2096d301718b87d_StockIncentiveandPurchasePlansTables">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_17c7940b-a581-401e-b94b-a71bc43c2554" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_a45aaaf1-4676-4b09-81e3-fca39e282259" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_17c7940b-a581-401e-b94b-a71bc43c2554" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_a45aaaf1-4676-4b09-81e3-fca39e282259" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_2b0b264a-e21e-402c-842c-8808cff83883" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_17c7940b-a581-401e-b94b-a71bc43c2554" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_2b0b264a-e21e-402c-842c-8808cff83883" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_1087c830-1741-4fbf-b1a8-cb9036a4a693" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_2b0b264a-e21e-402c-842c-8808cff83883" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_1087c830-1741-4fbf-b1a8-cb9036a4a693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_1087c830-1741-4fbf-b1a8-cb9036a4a693_default" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_1087c830-1741-4fbf-b1a8-cb9036a4a693" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_1087c830-1741-4fbf-b1a8-cb9036a4a693_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_644286b4-5de3-481a-b4ba-40d6baf8c22b" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_1087c830-1741-4fbf-b1a8-cb9036a4a693" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_644286b4-5de3-481a-b4ba-40d6baf8c22b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockIncentiveandPurchasePlansDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="extended" id="i7f15dd80cd9c43efa0671852d2c06ab7_StockIncentiveandPurchasePlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Fairvalueofmarketbasedawards_312eea77-efe3-49ea-9a49-7cbfa02a5169" xlink:href="bsx-20201231.xsd#bsx_Fairvalueofmarketbasedawards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Fairvalueofmarketbasedawards_312eea77-efe3-49ea-9a49-7cbfa02a5169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_5949e396-00cd-4f6c-9678-208de4b53dcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharePrice_5949e396-00cd-4f6c-9678-208de4b53dcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostStockOptions_428a7b4c-313f-4566-8337-233e863f4911" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCostStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_UnrecognizedCompensationCostStockOptions_428a7b4c-313f-4566-8337-233e863f4911" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_bf10d789-3bbf-4978-9800-868ea622b8c6" xlink:href="bsx-20201231.xsd#bsx_RangeofthetargetnumberofperformancebasedDSUsawarded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_bf10d789-3bbf-4978-9800-868ea622b8c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4dfe6dd9-092d-4c0f-9f45-22fcf85c5010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4dfe6dd9-092d-4c0f-9f45-22fcf85c5010" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_9a8fd432-f60f-46fb-86c0-4371fe1a760f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_9a8fd432-f60f-46fb-86c0-4371fe1a760f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ac85cd56-9fe6-411a-b84a-f5ffb8f40085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ac85cd56-9fe6-411a-b84a-f5ffb8f40085" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dab5d866-07a9-4ac1-a193-70352974a7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dab5d866-07a9-4ac1-a193-70352974a7c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_67ab3a5a-44f0-4037-b567-4db87c31a9df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_67ab3a5a-44f0-4037-b567-4db87c31a9df" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Measurementperiodmarketbasedaward_98f9ccc1-cd5a-4944-ac8d-3a64b8bce513" xlink:href="bsx-20201231.xsd#bsx_Measurementperiodmarketbasedaward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Measurementperiodmarketbasedaward_98f9ccc1-cd5a-4944-ac8d-3a64b8bce513" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ccecfac8-6b08-47a8-b57c-4cadc7d9181b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ccecfac8-6b08-47a8-b57c-4cadc7d9181b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e6dd878-e869-4069-90bf-37482be9fad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e6dd878-e869-4069-90bf-37482be9fad0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_091e3b3b-4327-431b-a817-aae470fb9361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_091e3b3b-4327-431b-a817-aae470fb9361" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d2e3658b-8704-4a5b-8cc5-2fe0b10e7805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d2e3658b-8704-4a5b-8cc5-2fe0b10e7805" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f6bc078c-a6ac-407d-8f5e-aaa409e5602d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f6bc078c-a6ac-407d-8f5e-aaa409e5602d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a57125f8-507d-46c8-bd6b-6329fa88b08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a57125f8-507d-46c8-bd6b-6329fa88b08f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_edaa75dd-e346-48f9-81ca-8909be3aca79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_edaa75dd-e346-48f9-81ca-8909be3aca79" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_bac19bf4-a0eb-4bff-b70b-2c7561eb4056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_bac19bf4-a0eb-4bff-b70b-2c7561eb4056" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4ae7528d-6930-4531-82c6-2bb20809ef13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4ae7528d-6930-4531-82c6-2bb20809ef13" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2e4060ab-2a35-43ae-8a5e-64bf75852e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2e4060ab-2a35-43ae-8a5e-64bf75852e45" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_4a880dbb-8c8b-4a7d-bb8e-967bd372a6b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_4a880dbb-8c8b-4a7d-bb8e-967bd372a6b5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1d825dd8-250a-402f-b2a5-ac1e01148249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1d825dd8-250a-402f-b2a5-ac1e01148249" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ffb71c8d-84d5-4a28-848b-99813a127db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensation_ffb71c8d-84d5-4a28-848b-99813a127db1" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_120b4c5f-420c-42d4-b0c7-79f485850bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_120b4c5f-420c-42d4-b0c7-79f485850bd3" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2724b265-c2a6-42db-b2a6-343eb76c2706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2724b265-c2a6-42db-b2a6-343eb76c2706" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b47878d4-f079-4c54-a9d8-c3d61187b296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b47878d4-f079-4c54-a9d8-c3d61187b296" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ShareBasedCompensationNetOfTaxBenefit_bc5f11e7-ef5d-49ba-8bb4-313cf60e1a8b" xlink:href="bsx-20201231.xsd#bsx_ShareBasedCompensationNetOfTaxBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_ShareBasedCompensationNetOfTaxBenefit_bc5f11e7-ef5d-49ba-8bb4-313cf60e1a8b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareBasic_5ead1df2-50af-4941-949b-49aae26e73a4" xlink:href="bsx-20201231.xsd#bsx_CompensationExpensePerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_CompensationExpensePerShareBasic_5ead1df2-50af-4941-949b-49aae26e73a4" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareDiluted_2e9d4c72-cbed-4744-89e4-05ec2eeaa8d7" xlink:href="bsx-20201231.xsd#bsx_CompensationExpensePerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_CompensationExpensePerShareDiluted_2e9d4c72-cbed-4744-89e4-05ec2eeaa8d7" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b6ddccec-cfd8-4bd5-b857-dd25a8f8bd61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b6ddccec-cfd8-4bd5-b857-dd25a8f8bd61" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26829a51-2566-4775-bc56-0dc3666333c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26829a51-2566-4775-bc56-0dc3666333c9" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_666286d4-3dad-43f6-8afb-d125c21e5bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_666286d4-3dad-43f6-8afb-d125c21e5bae" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2caa86f5-5b74-4db3-91f5-630d61078d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2caa86f5-5b74-4db3-91f5-630d61078d6e" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_92fe5ae8-754d-45c9-b95d-22909827e15b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_92fe5ae8-754d-45c9-b95d-22909827e15b" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_379a8e4b-cfd4-45a7-8f2b-0b1f67eb4363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_379a8e4b-cfd4-45a7-8f2b-0b1f67eb4363" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9485e432-f162-4937-932f-5a408c9e136f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9485e432-f162-4937-932f-5a408c9e136f" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d1d6112c-fd3a-4193-827c-b0756d2646ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d1d6112c-fd3a-4193-827c-b0756d2646ca" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_71dc33ea-4e0c-4564-ac68-fbe0d1b50e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_71dc33ea-4e0c-4564-ac68-fbe0d1b50e8f" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4b7ddd28-ce73-49cc-95b4-b490c25bd4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4b7ddd28-ce73-49cc-95b4-b490c25bd4e2" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_52508581-d19a-4659-a09e-31ee6b90b8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_52508581-d19a-4659-a09e-31ee6b90b8a4" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e1f3687b-90f2-4e56-a344-7633df3c079e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e1f3687b-90f2-4e56-a344-7633df3c079e" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVest_2185bac4-0e78-41f4-aaaf-af6e58bce99f" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_OptionsExpectedToVest_2185bac4-0e78-41f4-aaaf-af6e58bce99f" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_b86e1d55-3439-4cdc-9d0d-899c6cdbb1dd" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_b86e1d55-3439-4cdc-9d0d-899c6cdbb1dd" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_e45fed73-cacf-4855-ade6-8d9ded46a8c8" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_e45fed73-cacf-4855-ade6-8d9ded46a8c8" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_72add538-4369-4dba-8b24-ed81631f1a7d" xlink:href="bsx-20201231.xsd#bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_72add538-4369-4dba-8b24-ed81631f1a7d" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b131863c-27bc-41d7-a335-0be0652c5ced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b131863c-27bc-41d7-a335-0be0652c5ced" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7a4b8dba-57e4-4aeb-b40d-51cb1259db94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7a4b8dba-57e4-4aeb-b40d-51cb1259db94" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f49c49cd-621e-4bcd-ac2b-5cf85d459b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f49c49cd-621e-4bcd-ac2b-5cf85d459b76" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_640032a0-8048-496b-a655-1ef8fc17f7af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_640032a0-8048-496b-a655-1ef8fc17f7af" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1141a8fd-ab34-44e4-84f6-760f089e6d24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1141a8fd-ab34-44e4-84f6-760f089e6d24" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_629d0f70-8cbe-4fcc-bd8a-64711865a288" xlink:href="bsx-20201231.xsd#bsx_RangeofthetargetnumberofmarketbasedDSUsawarded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_629d0f70-8cbe-4fcc-bd8a-64711865a288" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7c3f5339-4b02-447d-8df9-0aa4f3599873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7c3f5339-4b02-447d-8df9-0aa4f3599873" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_f24a01ca-5d37-4c4b-a422-b770b5d6553f" xlink:href="bsx-20201231.xsd#bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_f24a01ca-5d37-4c4b-a422-b770b5d6553f" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b4622772-6069-45a8-9f5e-69766de771fc" xlink:href="bsx-20201231.xsd#bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b4622772-6069-45a8-9f5e-69766de771fc" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_63e1524f-9c98-4635-abd3-38cfd3b91acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_63e1524f-9c98-4635-abd3-38cfd3b91acf" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards_604691b5-9b4a-493f-96a0-b12bd675eba5" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCostNonVestedStockAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards_604691b5-9b4a-493f-96a0-b12bd675eba5" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCost_fec94a7c-b202-4083-9c1a-101becbb6f97" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_UnrecognizedCompensationCost_fec94a7c-b202-4083-9c1a-101becbb6f97" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageRemainingVestingPeriod_431e547e-418a-4ff3-84f0-a574a9fffb08" xlink:href="bsx-20201231.xsd#bsx_WeightedAverageRemainingVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_WeightedAverageRemainingVestingPeriod_431e547e-418a-4ff3-84f0-a574a9fffb08" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Annualweightedaverageforfeiturerate_b90f1d5a-1d94-4202-a945-961e02948c33" xlink:href="bsx-20201231.xsd#bsx_Annualweightedaverageforfeiturerate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Annualweightedaverageforfeiturerate_b90f1d5a-1d94-4202-a945-961e02948c33" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VotingPowerOfAllClassesOfStock_bb263c11-7b87-40ac-ad9e-1a1cdd1eb293" xlink:href="bsx-20201231.xsd#bsx_VotingPowerOfAllClassesOfStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_VotingPowerOfAllClassesOfStock_bb263c11-7b87-40ac-ad9e-1a1cdd1eb293" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_36a423ac-6df0-43fb-9314-09d27ed28d98" xlink:href="bsx-20201231.xsd#bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_36a423ac-6df0-43fb-9314-09d27ed28d98" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Nonvestedstockawardsexerciseprice_2d83a0e8-c083-4ccf-8b98-2b4a357eef01" xlink:href="bsx-20201231.xsd#bsx_Nonvestedstockawardsexerciseprice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Nonvestedstockawardsexerciseprice_2d83a0e8-c083-4ccf-8b98-2b4a357eef01" xlink:type="arc" order="61"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_563ca14b-01e5-47b6-9bb8-33c5b74f2bd4" xlink:href="bsx-20201231.xsd#bsx_FairValueOfFreeCashFlowFcfPerformanceAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_563ca14b-01e5-47b6-9bb8-33c5b74f2bd4" xlink:type="arc" order="62"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_76e637de-bc15-4edc-8c4c-35d63ae588cf" xlink:href="bsx-20201231.xsd#bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_76e637de-bc15-4edc-8c4c-35d63ae588cf" xlink:type="arc" order="63"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_a163f8b5-5576-419a-8bbc-cb60e0740e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_a163f8b5-5576-419a-8bbc-cb60e0740e28" xlink:type="arc" order="64"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b7982914-8a11-4cf6-9b92-e57069ad5053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:to="loc_us-gaap_CostOfSalesMember_b7982914-8a11-4cf6-9b92-e57069ad5053" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6cfb1a4f-a94b-467d-b7d3-13f72a5de373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6cfb1a4f-a94b-467d-b7d3-13f72a5de373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b4f182a-0e72-4357-a8ca-6bb34ab7e703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b4f182a-0e72-4357-a8ca-6bb34ab7e703" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_bab3a30f-6810-4d0a-9456-ccaf07c5bd82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:to="loc_us-gaap_PlanNameAxis_bab3a30f-6810-4d0a-9456-ccaf07c5bd82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bab3a30f-6810-4d0a-9456-ccaf07c5bd82_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_bab3a30f-6810-4d0a-9456-ccaf07c5bd82" xlink:to="loc_us-gaap_PlanNameDomain_bab3a30f-6810-4d0a-9456-ccaf07c5bd82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_34af8725-f361-45ae-ab3a-4d388e93f535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_bab3a30f-6810-4d0a-9456-ccaf07c5bd82" xlink:to="loc_us-gaap_PlanNameDomain_34af8725-f361-45ae-ab3a-4d388e93f535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2011LtipPlanMember_335905c0-ff43-45ee-bec0-9c7b25af79ce" xlink:href="bsx-20201231.xsd#bsx_A2011LtipPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_34af8725-f361-45ae-ab3a-4d388e93f535" xlink:to="loc_bsx_A2011LtipPlanMember_335905c0-ff43-45ee-bec0-9c7b25af79ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bb97ea93-c054-49ad-aee2-24fe448ae947" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:to="loc_srt_RangeAxis_bb97ea93-c054-49ad-aee2-24fe448ae947" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bb97ea93-c054-49ad-aee2-24fe448ae947_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bb97ea93-c054-49ad-aee2-24fe448ae947" xlink:to="loc_srt_RangeMember_bb97ea93-c054-49ad-aee2-24fe448ae947_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bb97ea93-c054-49ad-aee2-24fe448ae947" xlink:to="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e6fb5dc0-d1ed-4f3b-8d92-bc3d29ef6a10" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:to="loc_srt_MinimumMember_e6fb5dc0-d1ed-4f3b-8d92-bc3d29ef6a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d711989-c50f-4cf6-99f2-1f9c69e3129d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:to="loc_srt_MaximumMember_5d711989-c50f-4cf6-99f2-1f9c69e3129d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_15c2e105-9257-4cf2-8ca0-889b69bca612" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstanding"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended" id="i47bbab70bf9a45d8b211417147bbf23e_WeightedAverageSharesOutstanding"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended" id="i1945ad7285b1443b8ac48307fe7f0e46_WeightedAverageSharesOutstandingTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended" id="i10998fc307fb4bdb87b2956713a18531_WeightedAverageSharesOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_43d4b3e2-5e18-4511-abf8-2fdd38484a09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_43d4b3e2-5e18-4511-abf8-2fdd38484a09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_83ef6015-c63e-4be5-9aa0-05fdd421008c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_83ef6015-c63e-4be5-9aa0-05fdd421008c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7959197a-6a7d-433b-bdd0-71e277ef8404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7959197a-6a7d-433b-bdd0-71e277ef8404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e9cb1d84-402c-4dc3-b6fe-32692e855284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e9cb1d84-402c-4dc3-b6fe-32692e855284" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_39b9f50e-e04c-4a1e-882b-275369ef2010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_39b9f50e-e04c-4a1e-882b-275369ef2010" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9297066-4069-44c7-9c74-ed9d9d52de51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_39b9f50e-e04c-4a1e-882b-275369ef2010" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9297066-4069-44c7-9c74-ed9d9d52de51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e9297066-4069-44c7-9c74-ed9d9d52de51_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9297066-4069-44c7-9c74-ed9d9d52de51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e9297066-4069-44c7-9c74-ed9d9d52de51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9297066-4069-44c7-9c74-ed9d9d52de51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4cc6401f-8cfb-4b6a-ba13-ec7626e06519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:to="loc_us-gaap_StockCompensationPlanMember_4cc6401f-8cfb-4b6a-ba13-ec7626e06519" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f76f68e3-0dd8-45bd-9fb2-bff3aef6f7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f76f68e3-0dd8-45bd-9fb2-bff3aef6f7b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_713946bf-934e-4c87-aae3-9b358990b7f8" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:to="loc_bsx_A550MCPSSeriesAMember_713946bf-934e-4c87-aae3-9b358990b7f8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReporting"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended" id="ie554da99edbc429eae4819db43eddff7_SegmentReporting"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReportingTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended" id="i0ba1407d748d4104bd8ae1496dbadd5b_SegmentReportingTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended" id="i2a4ca2d36fff4aceb7d5a5134747a1bc_SegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_bb98b8eb-6e5d-4225-9147-ff1edc1f6413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_NumberOfReportableSegments_bb98b8eb-6e5d-4225-9147-ff1edc1f6413" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6e4be4fd-f04f-4431-998f-3cdd35aec012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6e4be4fd-f04f-4431-998f-3cdd35aec012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_0e2cb0b5-d780-4f84-a54f-4e5cb736bb07" xlink:href="bsx-20201231.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_0e2cb0b5-d780-4f84-a54f-4e5cb736bb07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_efc04055-517f-4bdb-977c-845b6f3c6e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_Depreciation_efc04055-517f-4bdb-977c-845b6f3c6e03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments_f148207e-6124-4944-8b49-b3560aba35ec" xlink:href="bsx-20201231.xsd#bsx_OperatingIncomeLossAllocatedToReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments_f148207e-6124-4944-8b49-b3560aba35ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_39a59dce-bfab-45d0-b10a-09731bd9e996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_OperatingIncomeLoss_39a59dce-bfab-45d0-b10a-09731bd9e996" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_22e70ce3-aaee-473c-9e93-d748c17679a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_22e70ce3-aaee-473c-9e93-d748c17679a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a5276019-e954-44fb-8c93-9fdbb531c373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a5276019-e954-44fb-8c93-9fdbb531c373" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1394b3a1-da1f-42e0-88c1-c9c4a490fea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1394b3a1-da1f-42e0-88c1-c9c4a490fea7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_620d6360-e7c9-4b8b-aa4b-ca582d4eed10" xlink:href="bsx-20201231.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_620d6360-e7c9-4b8b-aa4b-ca582d4eed10" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_c4e660e4-bd20-4738-8641-f9c7060c71cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_OtherAssets_c4e660e4-bd20-4738-8641-f9c7060c71cf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_540bb4b6-dba6-426c-b275-c5e3e2f7615b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_Goodwill_540bb4b6-dba6-426c-b275-c5e3e2f7615b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8fb4ae9e-e1bb-4a8d-8394-a63e7dbd3d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8fb4ae9e-e1bb-4a8d-8394-a63e7dbd3d4b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4de8a764-f12a-4a1e-8a30-8c1d2a3e4ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4de8a764-f12a-4a1e-8a30-8c1d2a3e4ea3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_0768f098-14be-4901-bd36-d4b098e918b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_NoncurrentAssets_0768f098-14be-4901-bd36-d4b098e918b3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141" xlink:to="loc_us-gaap_SegmentDomain_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141" xlink:to="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_9afb2e9c-c912-4237-a87f-8b2ae1dff732" xlink:href="bsx-20201231.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_MedsurgMember_9afb2e9c-c912-4237-a87f-8b2ae1dff732" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_fcec7720-94cd-4d51-8a27-6d094ce686c4" xlink:href="bsx-20201231.xsd#bsx_RhythmandNeuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_RhythmandNeuroMember_fcec7720-94cd-4d51-8a27-6d094ce686c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_066f34da-cadb-4f22-89f4-39ba0fe26523" xlink:href="bsx-20201231.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_CardiovascularMember_066f34da-cadb-4f22-89f4-39ba0fe26523" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_e76ea7ad-2deb-4e7b-b078-09d529fbe7e0" xlink:href="bsx-20201231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_BSXReportableSegmentsMember_e76ea7ad-2deb-4e7b-b078-09d529fbe7e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_af71eb61-9ab3-4698-8bc3-7b203786b4b1" xlink:href="bsx-20201231.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_af71eb61-9ab3-4698-8bc3-7b203786b4b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_2249d43f-05fc-4218-a7ce-52a1312d01d8" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_2249d43f-05fc-4218-a7ce-52a1312d01d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_9195acd8-7aa6-410d-95ac-c39c83e6218b" xlink:href="bsx-20201231.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_9195acd8-7aa6-410d-95ac-c39c83e6218b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_9014d99a-81fe-46aa-ba6e-0926408b628d" xlink:href="bsx-20201231.xsd#bsx_SpecialChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_SpecialChargesMember_9014d99a-81fe-46aa-ba6e-0926408b628d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_53639660-db17-4c4b-be11-18fd80778523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_us-gaap_CorporateMember_53639660-db17-4c4b-be11-18fd80778523" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBSXDomain_6547d798-aedb-489f-aafd-2c3fcef0a2b2" xlink:href="bsx-20201231.xsd#bsx_ConsolidatedBSXDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_ConsolidatedBSXDomain_6547d798-aedb-489f-aafd-2c3fcef0a2b2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f68b72f9-9604-45d6-9fbb-87e349e063d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_srt_StatementGeographicalAxis_f68b72f9-9604-45d6-9fbb-87e349e063d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f68b72f9-9604-45d6-9fbb-87e349e063d6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f68b72f9-9604-45d6-9fbb-87e349e063d6" xlink:to="loc_srt_SegmentGeographicalDomain_f68b72f9-9604-45d6-9fbb-87e349e063d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f68b72f9-9604-45d6-9fbb-87e349e063d6" xlink:to="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2015abc5-8f53-4f38-9a28-3301f75b2ca7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:to="loc_country_US_2015abc5-8f53-4f38-9a28-3301f75b2ca7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_7487224f-8fd7-45f5-b2d9-4c49bbef9a11" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:to="loc_country_IE_7487224f-8fd7-45f5-b2d9-4c49bbef9a11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCountriesMember_f65f0860-3aac-4190-94ad-0bc86fafac2a" xlink:href="bsx-20201231.xsd#bsx_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:to="loc_bsx_OtherCountriesMember_f65f0860-3aac-4190-94ad-0bc86fafac2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_84c36751-f8e4-438b-a1ad-ff20361bbdcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_84c36751-f8e4-438b-a1ad-ff20361bbdcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_84c36751-f8e4-438b-a1ad-ff20361bbdcb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_84c36751-f8e4-438b-a1ad-ff20361bbdcb" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_84c36751-f8e4-438b-a1ad-ff20361bbdcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_00437b32-7b40-4111-8388-4be06a0dab25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_84c36751-f8e4-438b-a1ad-ff20361bbdcb" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_00437b32-7b40-4111-8388-4be06a0dab25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_3e566813-8d0e-4c37-8bd2-b0d5112f6609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_00437b32-7b40-4111-8388-4be06a0dab25" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_3e566813-8d0e-4c37-8bd2-b0d5112f6609" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aab88012-7cd2-4371-a5e3-1d6f5399994e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aab88012-7cd2-4371-a5e3-1d6f5399994e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aab88012-7cd2-4371-a5e3-1d6f5399994e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aab88012-7cd2-4371-a5e3-1d6f5399994e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aab88012-7cd2-4371-a5e3-1d6f5399994e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11d7fc4d-6ae3-459d-8e8a-c3fd25d4b877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aab88012-7cd2-4371-a5e3-1d6f5399994e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11d7fc4d-6ae3-459d-8e8a-c3fd25d4b877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_6f8c07be-a8f7-4441-b0d2-4c05634feddc" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11d7fc4d-6ae3-459d-8e8a-c3fd25d4b877" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_6f8c07be-a8f7-4441-b0d2-4c05634feddc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20201231.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended" id="id602cd674b704517bba43cae181db151_Revenue"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended" id="idb98764a18bf4deeb71ce95cee367aa3_RevenueTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended" id="i75ceb64779aa4bdf950ace5748558dee_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_cbe32b5d-2f3e-438f-a71b-11aab555d569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsTotalNumberOfCountries_8ef66be7-02c2-44aa-a142-aebb71e75363" xlink:href="bsx-20201231.xsd#bsx_EmergingMarketsTotalNumberOfCountries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbe32b5d-2f3e-438f-a71b-11aab555d569" xlink:to="loc_bsx_EmergingMarketsTotalNumberOfCountries_8ef66be7-02c2-44aa-a142-aebb71e75363" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6ff3e241-66fa-46f2-b019-82ec330a6f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbe32b5d-2f3e-438f-a71b-11aab555d569" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6ff3e241-66fa-46f2-b019-82ec330a6f08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbe32b5d-2f3e-438f-a71b-11aab555d569" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7" xlink:to="loc_us-gaap_SegmentDomain_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_94057187-c5e7-44cf-b627-0bc47e1c960c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7" xlink:to="loc_us-gaap_SegmentDomain_94057187-c5e7-44cf-b627-0bc47e1c960c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_f9a3d3da-0245-440d-9a68-6b94fff5efa9" xlink:href="bsx-20201231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_94057187-c5e7-44cf-b627-0bc47e1c960c" xlink:to="loc_bsx_BSXReportableSegmentsMember_f9a3d3da-0245-440d-9a68-6b94fff5efa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_28f86fb6-6ec4-4412-812f-9fe5d42a0970" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:to="loc_srt_ProductOrServiceAxis_28f86fb6-6ec4-4412-812f-9fe5d42a0970" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_28f86fb6-6ec4-4412-812f-9fe5d42a0970_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_28f86fb6-6ec4-4412-812f-9fe5d42a0970" xlink:to="loc_srt_ProductsAndServicesDomain_28f86fb6-6ec4-4412-812f-9fe5d42a0970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_28f86fb6-6ec4-4412-812f-9fe5d42a0970" xlink:to="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_36f943ef-0501-4acf-933d-a3523917911a" xlink:href="bsx-20201231.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_36f943ef-0501-4acf-933d-a3523917911a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_900bd0c7-ddab-4428-a4ac-dac80daa09e0" xlink:href="bsx-20201231.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_900bd0c7-ddab-4428-a4ac-dac80daa09e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_a4a66745-680e-4171-8974-f477e4e13584" xlink:href="bsx-20201231.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_a4a66745-680e-4171-8974-f477e4e13584" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_72845569-6523-437e-94cc-363189293076" xlink:href="bsx-20201231.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_72845569-6523-437e-94cc-363189293076" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_55b64934-3ef4-4f21-9d9f-020b76e82ef2" xlink:href="bsx-20201231.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_55b64934-3ef4-4f21-9d9f-020b76e82ef2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_9ccb1700-b9f2-47a8-a0a7-583251f29c9f" xlink:href="bsx-20201231.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_9ccb1700-b9f2-47a8-a0a7-583251f29c9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_2a2e9229-9f66-4b9d-9246-f26ee1bfa7d6" xlink:href="bsx-20201231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_2a2e9229-9f66-4b9d-9246-f26ee1bfa7d6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_9a3cecb9-2a85-4ce2-b88d-56fe0cf5f611" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_9a3cecb9-2a85-4ce2-b88d-56fe0cf5f611" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_370d68e6-2460-4133-b786-0c5dc54bb2fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:to="loc_srt_StatementGeographicalAxis_370d68e6-2460-4133-b786-0c5dc54bb2fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_370d68e6-2460-4133-b786-0c5dc54bb2fa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_370d68e6-2460-4133-b786-0c5dc54bb2fa" xlink:to="loc_srt_SegmentGeographicalDomain_370d68e6-2460-4133-b786-0c5dc54bb2fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_370d68e6-2460-4133-b786-0c5dc54bb2fa" xlink:to="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f961631b-d158-4b5e-8e7d-e8b22a2ffa8f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_country_US_f961631b-d158-4b5e-8e7d-e8b22a2ffa8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_777e4157-0a90-4156-b2b7-03d77d644813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_us-gaap_NonUsMember_777e4157-0a90-4156-b2b7-03d77d644813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_070b7e0b-95b4-4871-86d2-b8fa43582458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_us-gaap_EMEAMember_070b7e0b-95b4-4871-86d2-b8fa43582458" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_9a7bdf30-5a09-444c-8e5a-4f3dfe8f9df4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_srt_AsiaPacificMember_9a7bdf30-5a09-444c-8e5a-4f3dfe8f9df4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_d207d5c9-fca5-4f07-935d-4da9f9ee388c" xlink:href="bsx-20201231.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_bsx_LatinAmericaandCanadaMember_d207d5c9-fca5-4f07-935d-4da9f9ee388c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_fa1d3461-d505-46d0-bcc4-2f0758280dd1" xlink:href="bsx-20201231.xsd#bsx_EmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_bsx_EmergingMarketsMember_fa1d3461-d505-46d0-bcc4-2f0758280dd1" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended" id="ife74f161814f43e68da5df2352d562de_ChangesinOtherComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended" id="i0b14345ebf1144d3812aab8dea34ab43_ChangesinOtherComprehensiveIncomeTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended" id="ia2975ef6d3df4b09af59c3dd77f43dd9_ChangesinOtherComprehensiveIncomeDetails"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20201231.xsd#NewAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended" id="i8e393fb6fcb14661bfce3e257e39e690_NewAccountingPronouncements"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#NewAccountingPronouncementsNewAccountingPronouncementsPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="extended" id="i16a5a299675542dfa2e0fe34fcda0480_NewAccountingPronouncementsNewAccountingPronouncementsPolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansNotes"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes" xlink:type="extended" id="ic1ac38e237cb4feca5eeee37a91a0723_EmployeeRetirementPlansNotes"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansEmployeeRetirementPlansPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="extended" id="ia759e8cdfa864e6182fc60bed6a83b20_EmployeeRetirementPlansEmployeeRetirementPlansPolicies">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5a95f173-996b-4332-a334-8e8b7eb02941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_01597853-a808-47f4-8f65-2dcf90477dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5a95f173-996b-4332-a334-8e8b7eb02941" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_01597853-a808-47f4-8f65-2dcf90477dc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e28134aa-cd49-48ef-a8a2-7184d1440b40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5a95f173-996b-4332-a334-8e8b7eb02941" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e28134aa-cd49-48ef-a8a2-7184d1440b40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_2c06e5e9-e745-4fdd-8d5e-5ec014e13940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e28134aa-cd49-48ef-a8a2-7184d1440b40" xlink:to="loc_us-gaap_RetirementPlanNameAxis_2c06e5e9-e745-4fdd-8d5e-5ec014e13940" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_2c06e5e9-e745-4fdd-8d5e-5ec014e13940_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_2c06e5e9-e745-4fdd-8d5e-5ec014e13940" xlink:to="loc_us-gaap_RetirementPlanNameDomain_2c06e5e9-e745-4fdd-8d5e-5ec014e13940_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_671888bd-ebde-4c81-af7f-be087e15c694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_2c06e5e9-e745-4fdd-8d5e-5ec014e13940" xlink:to="loc_us-gaap_RetirementPlanNameDomain_671888bd-ebde-4c81-af7f-be087e15c694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember_63fc74f1-5548-474a-b53d-f76c37c0fddb" xlink:href="bsx-20201231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_671888bd-ebde-4c81-af7f-be087e15c694" xlink:to="loc_bsx_ExecutiveRetirementPlanMember_63fc74f1-5548-474a-b53d-f76c37c0fddb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember_0c401c94-a899-4501-b657-4c9797022069" xlink:href="bsx-20201231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_671888bd-ebde-4c81-af7f-be087e15c694" xlink:to="loc_bsx_InternationalRetirementPlansMember_0c401c94-a899-4501-b657-4c9797022069" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables" xlink:type="extended" id="ib2225ff4601347f7bfdc9efade4d0b2a_EmployeeRetirementPlansTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="extended" id="ib3ffcc678c4e4b8ba232fa449c9df857_EmployeeRetirementPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_d51bef39-2b8d-4ec0-a315-62d3eaa76837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_d51bef39-2b8d-4ec0-a315-62d3eaa76837" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_9641e199-d502-47ca-9e3c-6304eac2f8b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_9641e199-d502-47ca-9e3c-6304eac2f8b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3a4f4886-6711-4d95-a2b5-2992674088ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3a4f4886-6711-4d95-a2b5-2992674088ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_912a9921-bbb2-467e-96f1-26599e367a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_912a9921-bbb2-467e-96f1-26599e367a15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3337912b-6810-4ac9-b004-5094df072b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3337912b-6810-4ac9-b004-5094df072b21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_beb68675-5a80-4339-82c4-f38262adbe32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_beb68675-5a80-4339-82c4-f38262adbe32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_cd3a590c-7102-4844-b283-cc4395dd6da5" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_cd3a590c-7102-4844-b283-cc4395dd6da5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_8e91f51b-3b6a-4ad3-ae3d-6fa9d8eb3de5" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_8e91f51b-3b6a-4ad3-ae3d-6fa9d8eb3de5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_114579d5-e4ea-4536-a8c9-9c07288ef946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_114579d5-e4ea-4536-a8c9-9c07288ef946" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_052dca1b-398c-45d8-b741-d7379f0c5b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_052dca1b-398c-45d8-b741-d7379f0c5b88" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_062f4345-ec06-46f9-9891-3ba024bccaed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_062f4345-ec06-46f9-9891-3ba024bccaed" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Pensionbenefitobligationbenefitspaid_6d149c57-8599-48bb-be4a-ec7eed21eb9f" xlink:href="bsx-20201231.xsd#bsx_Pensionbenefitobligationbenefitspaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_Pensionbenefitobligationbenefitspaid_6d149c57-8599-48bb-be4a-ec7eed21eb9f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_9e9b7780-b6a8-46a5-901d-0d0f15afec4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_9e9b7780-b6a8-46a5-901d-0d0f15afec4f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fa8c1501-e76a-4603-9bb1-e504d4e58baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fa8c1501-e76a-4603-9bb1-e504d4e58baf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_1b6899f1-63aa-47ed-8cde-cc2c0362df9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_1b6899f1-63aa-47ed-8cde-cc2c0362df9a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_6e38718d-5019-4a2d-b5b2-da5c9ce7ffc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_6e38718d-5019-4a2d-b5b2-da5c9ce7ffc0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_b094b66d-32cd-4c2b-9e63-2bf6f5f546b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_b094b66d-32cd-4c2b-9e63-2bf6f5f546b9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_e1e90ae5-7318-4667-8232-4af90463af9e" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_e1e90ae5-7318-4667-8232-4af90463af9e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_f3be79e9-d849-42b0-8a08-de1f4bc5f921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_f3be79e9-d849-42b0-8a08-de1f4bc5f921" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_99663a6c-6a21-4c14-a050-503a50546498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_99663a6c-6a21-4c14-a050-503a50546498" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_7246cf24-0d8e-45c1-93f5-0797212f9f60" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_7246cf24-0d8e-45c1-93f5-0797212f9f60" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExpenseRelatedToMatchingContributions_a0d1fff5-087b-4a1a-953b-9cadbbde8f97" xlink:href="bsx-20201231.xsd#bsx_ExpenseRelatedToMatchingContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_ExpenseRelatedToMatchingContributions_a0d1fff5-087b-4a1a-953b-9cadbbde8f97" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0d2c2b1a-80cc-4ccc-87f4-60a0097ca76c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0d2c2b1a-80cc-4ccc-87f4-60a0097ca76c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3b34fb19-a1ce-49d0-bf11-a78ce6e400f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3b34fb19-a1ce-49d0-bf11-a78ce6e400f8" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_1691ce24-df12-4453-8acb-704d26809355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_1691ce24-df12-4453-8acb-704d26809355" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_fb035862-3efa-453b-803a-c0a2086d0613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_RetirementPlanNameAxis_fb035862-3efa-453b-803a-c0a2086d0613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_fb035862-3efa-453b-803a-c0a2086d0613_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_fb035862-3efa-453b-803a-c0a2086d0613" xlink:to="loc_us-gaap_RetirementPlanNameDomain_fb035862-3efa-453b-803a-c0a2086d0613_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_fb035862-3efa-453b-803a-c0a2086d0613" xlink:to="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember_cd3bea82-d643-4975-b7b2-02d71bb96398" xlink:href="bsx-20201231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:to="loc_bsx_ExecutiveRetirementPlanMember_cd3bea82-d643-4975-b7b2-02d71bb96398" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember_f8f93ea1-9556-4615-803f-d46601536831" xlink:href="bsx-20201231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:to="loc_bsx_InternationalRetirementPlansMember_f8f93ea1-9556-4615-803f-d46601536831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember_1dc694f5-f9a3-43ce-813e-2021e2e81b73" xlink:href="bsx-20201231.xsd#bsx_UKPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:to="loc_bsx_UKPlanMember_1dc694f5-f9a3-43ce-813e-2021e2e81b73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b923b2de-344f-40e1-8865-9f8e288f12b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b923b2de-344f-40e1-8865-9f8e288f12b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b923b2de-344f-40e1-8865-9f8e288f12b8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b923b2de-344f-40e1-8865-9f8e288f12b8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b923b2de-344f-40e1-8865-9f8e288f12b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6121643-71e4-488a-b531-91b455e29585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b923b2de-344f-40e1-8865-9f8e288f12b8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6121643-71e4-488a-b531-91b455e29585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_3b0b4763-7c2c-4ee1-9e89-5d3e474e0c4d" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6121643-71e4-488a-b531-91b455e29585" xlink:to="loc_bsx_BTGAcquisitionMember_3b0b4763-7c2c-4ee1-9e89-5d3e474e0c4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2f0f2cda-718c-4a92-a2a1-688890b68c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2f0f2cda-718c-4a92-a2a1-688890b68c63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2f0f2cda-718c-4a92-a2a1-688890b68c63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2f0f2cda-718c-4a92-a2a1-688890b68c63" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2f0f2cda-718c-4a92-a2a1-688890b68c63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_348e45f4-08bc-40b1-bfef-be62b95e5f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2f0f2cda-718c-4a92-a2a1-688890b68c63" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_348e45f4-08bc-40b1-bfef-be62b95e5f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_c1054706-a8d5-410e-802f-a72345a89bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_348e45f4-08bc-40b1-bfef-be62b95e5f8e" xlink:to="loc_us-gaap_OtherContractMember_c1054706-a8d5-410e-802f-a72345a89bbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember_42dbc242-a27d-41ce-8394-bdba3d88302a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_348e45f4-08bc-40b1-bfef-be62b95e5f8e" xlink:to="loc_us-gaap_DefinedBenefitPlanCashMember_42dbc242-a27d-41ce-8394-bdba3d88302a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bd78d99b-9082-4388-9597-5a39cbb130f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bd78d99b-9082-4388-9597-5a39cbb130f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f35ccad4-58db-4513-a308-3174d4870796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f35ccad4-58db-4513-a308-3174d4870796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e69ae0bc-f4f4-45cd-bff1-5e3612f40abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e69ae0bc-f4f4-45cd-bff1-5e3612f40abc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f2c556aa-6216-49de-8ccd-a03875d2ee00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f2c556aa-6216-49de-8ccd-a03875d2ee00" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f2c556aa-6216-49de-8ccd-a03875d2ee00_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f2c556aa-6216-49de-8ccd-a03875d2ee00" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f2c556aa-6216-49de-8ccd-a03875d2ee00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f2c556aa-6216-49de-8ccd-a03875d2ee00" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_758a4d9d-69fb-489a-af82-56a75e855390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:to="loc_us-gaap_DomesticPlanMember_758a4d9d-69fb-489a-af82-56a75e855390" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember_eed740b1-6ae1-4fe4-a7a1-5ce85fd09e21" xlink:href="bsx-20201231.xsd#bsx_UKPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:to="loc_bsx_UKPlanMember_eed740b1-6ae1-4fe4-a7a1-5ce85fd09e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherInternationalPlansMember_4e31f5b4-3a49-4207-9b17-abe9dd87ac45" xlink:href="bsx-20201231.xsd#bsx_OtherInternationalPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:to="loc_bsx_OtherInternationalPlansMember_4e31f5b4-3a49-4207-9b17-abe9dd87ac45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7c1935b1-d16b-4f45-86ed-07e39090ef9a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_srt_RangeAxis_7c1935b1-d16b-4f45-86ed-07e39090ef9a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c1935b1-d16b-4f45-86ed-07e39090ef9a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7c1935b1-d16b-4f45-86ed-07e39090ef9a" xlink:to="loc_srt_RangeMember_7c1935b1-d16b-4f45-86ed-07e39090ef9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_188823df-c422-4a49-992f-719047f7697a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7c1935b1-d16b-4f45-86ed-07e39090ef9a" xlink:to="loc_srt_RangeMember_188823df-c422-4a49-992f-719047f7697a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f677355-739c-461e-bc23-53a20198649f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_188823df-c422-4a49-992f-719047f7697a" xlink:to="loc_srt_MaximumMember_1f677355-739c-461e-bc23-53a20198649f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f0e764ea-6e70-4f9a-a48d-463b77b97ac2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_188823df-c422-4a49-992f-719047f7697a" xlink:to="loc_srt_MinimumMember_f0e764ea-6e70-4f9a-a48d-463b77b97ac2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ScheduleII" xlink:type="simple" xlink:href="bsx-20201231.xsd#ScheduleII"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ScheduleII" xlink:type="extended" id="i3a3dc64147334cc5b0cfab90b1c8b743_ScheduleII"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ScheduleIIDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ScheduleIIDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ScheduleIIDetails" xlink:type="extended" id="i3713cffb6ac24cfe81a35b9a4787b0ee_ScheduleIIDetails"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>bsx-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b8cf84dc-d42e-4cf7-a067-5352d2212acb,g:c4fd43c3-3c28-47b7-bdfe-13ef2366d2d6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_51604774-9ceb-4dd6-875b-1d806269479c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_bfb2beca-7e3a-40f5-bdc1-8bda49e5dfaf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5d6c01f4-19c7-431c-b125-3dbca67003cf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets, Intangible Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6f0a6c0c-df9e-489e-803e-551491a98a39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ca8cb787-64f7-4fc1-9eda-f6b04a89c01c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99012528-3fb5-4089-a00a-3c3600466960_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_2e85c06d-26d5-4e51-b2eb-7be5174ea906_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_b1ac089b-7b1a-4bbf-8da9-9ffcb4ff95a1_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LesseeLeasesNotYetCommencedAmount_f90c9354-8f06-4513-84b4-7b36e3d90b48_terseLabel_en-US" xlink:label="lab_bsx_LesseeLeasesNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Not Yet Commenced, Amount</link:label>
    <link:label id="lab_bsx_LesseeLeasesNotYetCommencedAmount_label_en-US" xlink:label="lab_bsx_LesseeLeasesNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Not Yet Commenced, Amount</link:label>
    <link:label id="lab_bsx_LesseeLeasesNotYetCommencedAmount_documentation_en-US" xlink:label="lab_bsx_LesseeLeasesNotYetCommencedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Not Yet Commenced, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeLeasesNotYetCommencedAmount" xlink:href="bsx-20201231.xsd#bsx_LesseeLeasesNotYetCommencedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LesseeLeasesNotYetCommencedAmount" xlink:to="lab_bsx_LesseeLeasesNotYetCommencedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_76fc0e40-75c4-4f72-a69e-9f232847eccb_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_741bb00c-71bb-487c-93df-17852dd69dc4_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbee6c1-8dc1-477b-822b-188ebbe5ed4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_0c485c4b-4c94-4f00-9f97-9b1a2ec7d5e2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_16b976e2-045d-4c55-b67c-1b5b41058592_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_726df8d9-77bd-40c1-abf3-cc88e734a801_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_82231ae3-7df4-4ca3-8b61-90d8fe4ee40f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_071e2c2e-7d76-44e5-be48-51239dbafb05_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_60bf2f75-e21c-48bb-9d7c-85c63e7c32ba_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b416ba80-eef1-4ecc-9943-7e32a14f9045_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1961f0d8-7603-44df-ae2c-128002d9a68e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d665dc4d-8828-4614-8755-0d53bae71924_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cdd7ba40-8251-4ae4-a3cd-0daf11640502_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cab98d83-a0b9-4cf3-833c-d3146b4d0580_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e9a58316-0634-4e70-9e8e-267e32bf3253_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_433d4087-b532-434c-89b5-dcc8e8423dd9_terseLabel_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_label_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract" xlink:href="bsx-20201231.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherCurrentAssetsAbstract" xlink:to="lab_bsx_OtherCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_cf8f5810-55bd-4588-98d0-2858afdb0bfd_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_417ba1fc-0d0c-47c1-b639-e852941097d7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_40768e98-3fdb-4c8d-9efe-014c7b8ba121_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_80ca6e50-29dd-4d75-a48c-185e51a9ab00_terseLabel_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration" xlink:href="bsx-20201231.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentOfContingentConsideration" xlink:to="lab_bsx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_8b628994-57a0-4b6e-a9e8-9ddd3cddca9b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_587f800f-f5c0-4fb8-89e5-ddacfa42b4b7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_1e33593a-08fc-4d6c-b15f-104ffaa1435e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_39db6604-0019-4f8e-8c7d-e008fd475890_terseLabel_en-US" xlink:label="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</link:label>
    <link:label id="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_label_en-US" xlink:label="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current</link:label>
    <link:label id="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_documentation_en-US" xlink:label="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:href="bsx-20201231.xsd#bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:to="lab_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ActualCovenantMember_1386826f-7014-4785-a831-355a1d619fc0_terseLabel_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_label_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_documentation_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember" xlink:href="bsx-20201231.xsd#bsx_ActualCovenantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ActualCovenantMember" xlink:to="lab_bsx_ActualCovenantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_549823ad-e46c-4f6c-856b-46c23496a714_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_9254aabf-fff6-43da-ba75-5bacb927889a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeRestructuringChargesTableTextBlock_8256f940-122b-4245-b38d-d11c09a52728_terseLabel_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges [Text Block]</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringChargesTableTextBlock_label_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges [Table Text Block]</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringChargesTableTextBlock_documentation_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative restructuring charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringChargesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:to="lab_bsx_CumulativeRestructuringChargesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_73d17b0c-9853-4fb0-83c6-4d9808097d6c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_b1adcf5d-d0ae-4ad3-bd9e-9ac6a06df057_terseLabel_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_label_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_documentation_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:href="bsx-20201231.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:to="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3c7424da-c9fe-4cd7-be8c-3afa9c31b188_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6b077c6d-3703-4f11-8bf9-8ed5d3983da0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeRestructuringChargesIncurredToDate_fe34aab8-6ed1-447b-a9da-10e0eaf44814_terseLabel_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges Incurred to Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringChargesIncurredToDate_label_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges Incurred to Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringChargesIncurredToDate_documentation_en-US" xlink:label="lab_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring Charges Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringChargesIncurredToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:to="lab_bsx_CumulativeRestructuringChargesIncurredToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b41001de-2f84-4a91-97e3-7debe8fd7bbc_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_1794cb6c-fc86-446c-822e-ccdc712327f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b7cf5cbf-7e41-4cca-ac2e-611efdef4ffd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeEffectOfNewAccountingPrinciples_819a271d-84aa-42da-9627-b2c19d2ab1ae_terseLabel_en-US" xlink:label="lab_bsx_CumulativeEffectOfNewAccountingPrinciples" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect Of New Accounting Principles</link:label>
    <link:label id="lab_bsx_CumulativeEffectOfNewAccountingPrinciples_label_en-US" xlink:label="lab_bsx_CumulativeEffectOfNewAccountingPrinciples" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect Of New Accounting Principles</link:label>
    <link:label id="lab_bsx_CumulativeEffectOfNewAccountingPrinciples_documentation_en-US" xlink:label="lab_bsx_CumulativeEffectOfNewAccountingPrinciples" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect Of New Accounting Principles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeEffectOfNewAccountingPrinciples" xlink:href="bsx-20201231.xsd#bsx_CumulativeEffectOfNewAccountingPrinciples"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeEffectOfNewAccountingPrinciples" xlink:to="lab_bsx_CumulativeEffectOfNewAccountingPrinciples" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5482f850-2b3a-428c-b383-3c043483c7a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_45cb131e-ece7-4761-82ff-9648ca3d712b_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_44a05b75-4d4e-408e-a82a-98f536bfe364_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_1ce1d46a-278b-41a1-a8bd-b3f9c8830ffa_terseLabel_en-US" xlink:label="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights transfer</link:label>
    <link:label id="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_label_en-US" xlink:label="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from secured borrowings relating to royalty arrangements</link:label>
    <link:label id="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_documentation_en-US" xlink:label="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from secured borrowings relating to royalty arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:href="bsx-20201231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:to="lab_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ba2b1947-f54d-4c8a-a7ea-57dce5405493_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TaxRateAxis_4807c28e-a605-40a4-9d48-61172cf7f20a_terseLabel_en-US" xlink:label="lab_bsx_TaxRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Axis]</link:label>
    <link:label id="lab_bsx_TaxRateAxis_label_en-US" xlink:label="lab_bsx_TaxRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Axis]</link:label>
    <link:label id="lab_bsx_TaxRateAxis_documentation_en-US" xlink:label="lab_bsx_TaxRateAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateAxis" xlink:href="bsx-20201231.xsd#bsx_TaxRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TaxRateAxis" xlink:to="lab_bsx_TaxRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_d3f35ae2-5c86-4fa8-9ea1-d350c42db1fa_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_2d2a07de-473a-4f43-b48a-489ef6f2c776_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_c7b383d2-4d08-4295-b3f0-99095f3d0dcb_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of December 31, 2020 and none as of December 31, 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_fbd5fd53-4077-475e-baad-90675ab104a3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_781ea649-2e07-450f-9d69-fc1c2ab27b2a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_dba7732e-ee4e-418c-b7b6-d00f13e29c8d_terseLabel_en-US" xlink:label="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:href="bsx-20201231.xsd#bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:to="lab_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7ea21ea6-bf64-4411-9f0f-30238e07a4bf_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6dce9810-b587-4db3-b155-40a270bd2bc1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_c7b728aa-565b-45e6-91ff-fa52efa685ad_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fd6fcbc5-d86d-4386-8b0f-92d5f93a2b2e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6b3daaac-e8f5-44c1-ab57-a122b658069c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_d0f67bb5-6075-42b5-85ef-6474069eb429_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_67609e8f-0f01-43b6-afae-3d81ab063c11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_60068262-3686-42b3-92e6-0e34882569ae_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_edd25806-fc00-466a-8af6-9a28ab03fa53_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_449f2c3d-402e-407f-a904-7d35304db939_terseLabel_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_label_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_documentation_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:href="bsx-20201231.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:to="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a3350143-b02d-42d6-afc8-4f5ca94c3322_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_818f1721-dbca-4265-9dc9-52b573d0faa4_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_03c90ea3-1c6b-4d83-81be-2547a705fe2e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_602c080b-3df1-4a35-bdda-c69e81c418e7_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_2fd00704-20f6-4a0e-80c3-86aa7333b30c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_5a534770-d913-432c-8cf4-624ebd817afa_terseLabel_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:href="bsx-20201231.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_1afc2a0d-8b32-4bd9-ba76-69cb30130603_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_af371b3d-af15-4596-8b18-70555abac276_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_2d7e3614-0e37-4790-868e-ff4e788e16ea_terseLabel_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:href="bsx-20201231.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:to="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_VertiflexIncMember_5977ad9f-962e-4f45-a002-89115554e70f_terseLabel_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc. [Member]</link:label>
    <link:label id="lab_bsx_VertiflexIncMember_label_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc. [Member]</link:label>
    <link:label id="lab_bsx_VertiflexIncMember_documentation_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember" xlink:href="bsx-20201231.xsd#bsx_VertiflexIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_VertiflexIncMember" xlink:to="lab_bsx_VertiflexIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_20b3b4da-573e-40d0-abda-eaef639ce9f6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_182b5b17-00f4-475b-96dd-f9c6c085caf8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TransitionTaxPaymentRemaining_0846aca6-689e-421f-811e-4994f36305e6_terseLabel_en-US" xlink:label="lab_bsx_TransitionTaxPaymentRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">transition tax payment remaining</link:label>
    <link:label id="lab_bsx_TransitionTaxPaymentRemaining_label_en-US" xlink:label="lab_bsx_TransitionTaxPaymentRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Tax Payment Remaining</link:label>
    <link:label id="lab_bsx_TransitionTaxPaymentRemaining_documentation_en-US" xlink:label="lab_bsx_TransitionTaxPaymentRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Tax Payment Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransitionTaxPaymentRemaining" xlink:href="bsx-20201231.xsd#bsx_TransitionTaxPaymentRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TransitionTaxPaymentRemaining" xlink:to="lab_bsx_TransitionTaxPaymentRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0fe9289e-4f98-4d75-8825-4a6d77289672_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherIntangibleAssetsTextualsAbstract_b3cab01a-f422-43f5-855b-435fe3a251a6_terseLabel_en-US" xlink:label="lab_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_OtherIntangibleAssetsTextualsAbstract_label_en-US" xlink:label="lab_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_OtherIntangibleAssetsTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets (Textuals) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:href="bsx-20201231.xsd#bsx_OtherIntangibleAssetsTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:to="lab_bsx_OtherIntangibleAssetsTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_5120ce1a-46b4-4b50-b310-9215fbfb2be0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_9b81ad93-b016-4840-b064-aa0582b40fd0_terseLabel_en-US" xlink:label="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring and Restructuring-Related Payments Made To Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_label_en-US" xlink:label="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring and Restructuring-Related Payments Made To Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_documentation_en-US" xlink:label="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring and Restructuring-Related Payments Made To Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:to="lab_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d5574acb-a44b-45eb-9efc-040c684f3021_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance (Par value)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e5cc1bc9-7896-4d7a-810f-e6ff246b4ebd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7a25bba9-72ed-434c-bf2e-e1bd11828c01_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_508b740d-3214-4b90-8207-3ca3cc3c3a38_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization of allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_5612bf5f-7f8f-4a1f-83b5-915b16fbbe8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization of allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_6fc17ed8-b382-4050-9a2c-6bfd28f3909a_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_66eb594e-589f-472b-8350-a72b2db9c97a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_81bda50e-62c2-435b-b2cf-2364812ab4a9_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_c0a7b587-4395-4e21-954a-c29da5d4dd97_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_673d38d1-11b0-4579-80b6-0f06a7ccdfba_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_91fc7270-6217-4277-847a-f1288317c96c_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantAxis_785362f2-0fa5-4bcc-a3d0-a3194850c69e_terseLabel_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_label_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_documentation_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis" xlink:href="bsx-20201231.xsd#bsx_CovenantAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantAxis" xlink:to="lab_bsx_CovenantAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_4f1f4c3d-5f3f-451c-acb8-e46932e33ca5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_8fcbadd0-25f1-4d88-b0c7-a6f3ab347bc8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_26614e42-566c-4e2c-bd44-9b8fbac14eb1_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on borrowings from credit facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense_f0c704a5-893e-4cd5-b479-1e92b1a8ee1f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_bd64365d-a45f-4c6d-a22c-4e0c16df02a5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_fea68ed0-a888-4680-8090-e4eb98642b86_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average (Member)</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2028NotesMember_587506f1-adf6-4281-abd7-1bb43f224cf8_terseLabel_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_label_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_documentation_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember" xlink:href="bsx-20201231.xsd#bsx_March2028NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2028NotesMember" xlink:to="lab_bsx_March2028NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0610a903-5926-42bf-982f-f16ca8f0ade1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_0bad0ed1-f992-427e-8520-e3b5e40d58ff_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_8a2815d0-4713-4144-a184-cd99fa922348_terseLabel_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_label_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_documentation_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:to="lab_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_79a8c301-eefe-42d3-8b75-dfb12f413e8b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab288d81-7449-4f92-90ba-195803eec8c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion_c71e93a2-1d6e-4907-bbf8-a544fb2359b9_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Terms of Conversion</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Terms of Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_7543fd15-018a-4aa3-8f6f-775aeecdc067_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">effective income tax reconciliation, compensation-related</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c4e03d41-a703-4856-b29a-587bafac094e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fdcf9062-5000-47c2-8223-92dcda6ad32f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35f21bf4-9e36-4cc1-aec2-753abaf75900_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_August2019TermLoanMember_20979fbf-75b3-4ac5-9c69-38179f14fb0b_terseLabel_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2019TermLoanMember_label_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2019TermLoanMember_documentation_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember" xlink:href="bsx-20201231.xsd#bsx_August2019TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_August2019TermLoanMember" xlink:to="lab_bsx_August2019TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_fe96a4da-8887-459f-bb93-fd2d6dccc85b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_897370f2-315e-4a3b-9017-3ce59d2fe28f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_f90a9475-1c17-444a-bdb6-25ed15400175_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_87ca9ab3-cafe-4217-af86-af49f18afaac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9efd57b7-faf1-4a09-af2a-ad450b4eb11c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EuroDenominatedOutstandingDebtMember_da4de890-2204-4c85-afec-0f2c4709ddfc_terseLabel_en-US" xlink:label="lab_bsx_EuroDenominatedOutstandingDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedOutstandingDebtMember_label_en-US" xlink:label="lab_bsx_EuroDenominatedOutstandingDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedOutstandingDebtMember_documentation_en-US" xlink:label="lab_bsx_EuroDenominatedOutstandingDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedOutstandingDebtMember" xlink:href="bsx-20201231.xsd#bsx_EuroDenominatedOutstandingDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EuroDenominatedOutstandingDebtMember" xlink:to="lab_bsx_EuroDenominatedOutstandingDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1f946dc7-205a-42f6-8b80-ae5676d025e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_f93f7a15-aafe-4b93-ac37-5d3e33b1ad0b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumContingentPaymentMember_e4ac398a-ef00-4de1-815e-07be46a72f6e_terseLabel_en-US" xlink:label="lab_bsx_MaximumContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Contingent Payment [Member]</link:label>
    <link:label id="lab_bsx_MaximumContingentPaymentMember_label_en-US" xlink:label="lab_bsx_MaximumContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Contingent Payment [Member]</link:label>
    <link:label id="lab_bsx_MaximumContingentPaymentMember_documentation_en-US" xlink:label="lab_bsx_MaximumContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Contingent Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumContingentPaymentMember" xlink:href="bsx-20201231.xsd#bsx_MaximumContingentPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumContingentPaymentMember" xlink:to="lab_bsx_MaximumContingentPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_a6fd1064-ae67-4e97-a7ef-f1bcfdb2760f_negatedTerseLabel_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_label_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_documentation_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:href="bsx-20201231.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:to="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2bf09c3f-9e2d-4a5e-ba5c-9ad4cf404016_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_5eee348c-868e-4e54-9801-9aa4a3ddba3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5174eae2-8a74-44e7-a817-6143ebca4349_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_89054fa3-78cb-4b1c-b015-7bbfdc7b3f4d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash equivalents included in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_e502aa4e-0f11-4f25-a75c-c2b2702e66aa_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents included in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_3b3cf176-be1b-4fa3-b73c-f8902772e8f3_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_label_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:href="bsx-20201231.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:to="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_1a74e8f3-2ca4-4464-895e-f95a1a0442ee_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b14c14b1-30f4-4c76-807c-e73103912324_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_8c3d5b4c-8438-4d0d-ae38-24b9a70e06c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_cb7fc194-ce46-48be-b964-48a2b94bcfda_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due in Four Years</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_da4ca7fb-b788-4a51-b5d9-2ca55a0b5226_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_f86bdde4-f39a-425a-9409-77783d1ffe83_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_0549b293-b34c-44c0-8a58-bb2f81d96b0c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_a5cdc7ce-22bb-494d-a5ae-a7e4941e5fd8_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentPolicy_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantDomain_cdc91e33-1673-49b3-8fdf-44ee386109f5_terseLabel_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_label_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_documentation_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain" xlink:href="bsx-20201231.xsd#bsx_CovenantDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantDomain" xlink:to="lab_bsx_CovenantDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RhythmandNeuroMember_4748112b-e22e-470d-875a-16c34f04d4e9_terseLabel_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:label id="lab_bsx_RhythmandNeuroMember_label_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:label id="lab_bsx_RhythmandNeuroMember_documentation_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember" xlink:href="bsx-20201231.xsd#bsx_RhythmandNeuroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RhythmandNeuroMember" xlink:to="lab_bsx_RhythmandNeuroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_15a55da8-b301-4df8-9762-00a96ec58a60_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NonCashImpactOfTransferredRoyaltyRights_9f0b3c3c-9d89-4875-87ec-cd6cc96301cc_terseLabel_en-US" xlink:label="lab_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_NonCashImpactOfTransferredRoyaltyRights_label_en-US" xlink:label="lab_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_NonCashImpactOfTransferredRoyaltyRights_documentation_en-US" xlink:label="lab_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:href="bsx-20201231.xsd#bsx_NonCashImpactOfTransferredRoyaltyRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:to="lab_bsx_NonCashImpactOfTransferredRoyaltyRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c80007d2-dfae-4535-a341-e80dfdf8424f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2244b15d-4bea-497f-9980-ac94c6cc6a9c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_cdcb127e-0271-4320-a3e3-cfcc5d418466_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b85ab54f-2a38-4641-8b28-f192e5742626_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_dddbc24a-4b2d-4bcd-9a66-ede381d88aa0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Annualweightedaverageforfeiturerate_923e45ed-1f8f-4b40-ba6a-6743164e752f_terseLabel_en-US" xlink:label="lab_bsx_Annualweightedaverageforfeiturerate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">annualweightedaverageforfeiturerate</link:label>
    <link:label id="lab_bsx_Annualweightedaverageforfeiturerate_label_en-US" xlink:label="lab_bsx_Annualweightedaverageforfeiturerate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">annualweightedaverageforfeiturerate</link:label>
    <link:label id="lab_bsx_Annualweightedaverageforfeiturerate_documentation_en-US" xlink:label="lab_bsx_Annualweightedaverageforfeiturerate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Weighted Average Forfeiture Rate The weighted average of estimated forfeitures for grants based on historical trends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Annualweightedaverageforfeiturerate" xlink:href="bsx-20201231.xsd#bsx_Annualweightedaverageforfeiturerate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Annualweightedaverageforfeiturerate" xlink:to="lab_bsx_Annualweightedaverageforfeiturerate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d0765e6c-fc3d-487d-b80d-327cf25de200_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_462eec17-ba57-4482-8181-f400ec7ada0f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_10479690-3c76-4323-a5c3-266a5d27877e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_e3f57d99-f3be-45b7-be42-4b364d8583b8_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_e73b22e8-115d-49f7-88d9-93c72755a47f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract (Member)</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_82f63033-5981-4133-b711-900f6411505a_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AugmenixInc.Member_54f9551f-3589-431f-afa6-f81f676080a3_terseLabel_en-US" xlink:label="lab_bsx_AugmenixInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Augmenix, Inc. [Member]</link:label>
    <link:label id="lab_bsx_AugmenixInc.Member_label_en-US" xlink:label="lab_bsx_AugmenixInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Augmenix, Inc. [Member]</link:label>
    <link:label id="lab_bsx_AugmenixInc.Member_documentation_en-US" xlink:label="lab_bsx_AugmenixInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Augmenix, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AugmenixInc.Member" xlink:href="bsx-20201231.xsd#bsx_AugmenixInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AugmenixInc.Member" xlink:to="lab_bsx_AugmenixInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_dde7934f-e9ad-456b-9c33-fa71ed95c008_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_48bebd5d-bdee-4182-b25a-3b61ba439db6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets (total)</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Measurementperiodmarketbasedaward_6554f6a7-98dc-4c72-a7c8-4211c97326a7_terseLabel_en-US" xlink:label="lab_bsx_Measurementperiodmarketbasedaward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period - market based awards</link:label>
    <link:label id="lab_bsx_Measurementperiodmarketbasedaward_label_en-US" xlink:label="lab_bsx_Measurementperiodmarketbasedaward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period - market based award</link:label>
    <link:label id="lab_bsx_Measurementperiodmarketbasedaward_documentation_en-US" xlink:label="lab_bsx_Measurementperiodmarketbasedaward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period - market based awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Measurementperiodmarketbasedaward" xlink:href="bsx-20201231.xsd#bsx_Measurementperiodmarketbasedaward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Measurementperiodmarketbasedaward" xlink:to="lab_bsx_Measurementperiodmarketbasedaward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_0435ea1b-0157-4d65-b710-aab1bd05e160_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketsTotalNumberOfCountries_f98e08fd-2edd-4206-8f0d-acfe34b1757d_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketsTotalNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:label id="lab_bsx_EmergingMarketsTotalNumberOfCountries_label_en-US" xlink:label="lab_bsx_EmergingMarketsTotalNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:label id="lab_bsx_EmergingMarketsTotalNumberOfCountries_documentation_en-US" xlink:label="lab_bsx_EmergingMarketsTotalNumberOfCountries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsTotalNumberOfCountries" xlink:href="bsx-20201231.xsd#bsx_EmergingMarketsTotalNumberOfCountries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketsTotalNumberOfCountries" xlink:to="lab_bsx_EmergingMarketsTotalNumberOfCountries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5be1b21b-2a5a-4154-82ee-92f8bbe1441f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_58dd0afe-239c-49fc-a38f-3323ef6da066_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Pensionbenefitobligationbenefitspaid_46462187-ca41-4bf6-9c0e-32941bd6dd74_negatedTerseLabel_en-US" xlink:label="lab_bsx_Pensionbenefitobligationbenefitspaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">pension benefit obligation, benefits paid</link:label>
    <link:label id="lab_bsx_Pensionbenefitobligationbenefitspaid_label_en-US" xlink:label="lab_bsx_Pensionbenefitobligationbenefitspaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">pension benefit obligation, benefits paid</link:label>
    <link:label id="lab_bsx_Pensionbenefitobligationbenefitspaid_documentation_en-US" xlink:label="lab_bsx_Pensionbenefitobligationbenefitspaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">pension benefit obligation, benefits paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Pensionbenefitobligationbenefitspaid" xlink:href="bsx-20201231.xsd#bsx_Pensionbenefitobligationbenefitspaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Pensionbenefitobligationbenefitspaid" xlink:to="lab_bsx_Pensionbenefitobligationbenefitspaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_f5812529-3247-40ac-86e0-d812b6c4cee5_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0c2330ad-1808-47ff-be61-6b73464268ce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cc423217-61be-48b4-8c2b-5d1fc2cece40_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_0137e65c-345e-4f7d-8900-babc743fb713_terseLabel_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average exercise price</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_label_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average exercise price</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average exercise price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:to="lab_bsx_OptionsExpectedToVestWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_67c515b6-26bd-4a16-8626-f1ea242e7375_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of businesses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_19a0b28c-c67f-497b-9340-c33affe4348c_terseLabel_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_documentation_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:href="bsx-20201231.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:to="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_64d2b213-ad3a-4df3-8cb5-5ea6fc0e9d3c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_efe4b1c4-c3c4-4a6b-89c9-48a4e17e332b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_041e5be3-b004-4bc1-b5b8-84eccfbc749c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_4c585ecc-8c3d-4721-b5a2-d41742fa4498_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_7bb17c70-9b02-47a6-a82a-671fc0296581_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract_documentation_en-US" xlink:label="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Balance Sheet (Parenthetical)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:href="bsx-20201231.xsd#bsx_ConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:to="lab_bsx_ConsolidatedBalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_07a8bdec-594f-444b-921f-efe35bd2b340_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_ee810035-7165-4180-bd2b-22f15b622b59_verboseLabel_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20201231.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TransferCostsMember_ad48feb2-cac5-4c73-8cf2-eca6b456f0f9_terseLabel_en-US" xlink:label="lab_bsx_TransferCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer costs [Member]</link:label>
    <link:label id="lab_bsx_TransferCostsMember_label_en-US" xlink:label="lab_bsx_TransferCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer costs [Member]</link:label>
    <link:label id="lab_bsx_TransferCostsMember_documentation_en-US" xlink:label="lab_bsx_TransferCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer costs [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCostsMember" xlink:href="bsx-20201231.xsd#bsx_TransferCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TransferCostsMember" xlink:to="lab_bsx_TransferCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_fcf290f2-a0ab-4523-836d-91e8a00493b4_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_16289d63-1955-41ee-9d20-b23efa45f4cc_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a2c7bf34-122d-4f82-bb01-c6de306e9296_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_f5969874-20ec-49be-95a0-b311bfa5f82c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_32ca159e-e45e-4759-b6b0-8945cfa7d365_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_0cb5cb09-3cf9-4d56-86a6-1223f7b25470_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b1d80b51-675f-4ca8-9a90-633b3da4129e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_2ae4aa3a-12d0-44bb-9177-aa3ab30a6b9f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a0cadf4-a8bf-4c75-95cc-d97206f2c078_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_9974d51f-3b2c-4a70-8976-efc051712a59_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due in Five Years</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_5e0bf8bc-f522-4b10-95ab-f59a0d44601d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_e41467ef-2052-4137-be9d-85260dc21313_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_c37b5d49-96e0-4485-aebc-e5e98ac14eb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementOfOperationsCaptionDomain_7378ea1e-9103-450f-a9cf-9e34bae29cb5_terseLabel_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Domain]</link:label>
    <link:label id="lab_bsx_StatementOfOperationsCaptionDomain_label_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Domain]</link:label>
    <link:label id="lab_bsx_StatementOfOperationsCaptionDomain_documentation_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionDomain" xlink:href="bsx-20201231.xsd#bsx_StatementOfOperationsCaptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain" xlink:to="lab_bsx_StatementOfOperationsCaptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_cbeb9b0d-d296-4171-8f41-8a92047b2eed_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_da1e6ea8-8434-4077-aaf5-b50042ce81fb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets (segment reporting)</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_316e9176-5916-4601-8283-ef2dde2fbb9a_terseLabel_en-US" xlink:label="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</link:label>
    <link:label id="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_label_en-US" xlink:label="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</link:label>
    <link:label id="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_documentation_en-US" xlink:label="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:href="bsx-20201231.xsd#bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:to="lab_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4c5f75f4-cbf9-4492-bcc7-f9903f721ab8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_34912ad3-3bee-4add-98b4-53efd484ee33_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due in Two Years</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_c775c1e3-8c49-4243-b1af-9838c8622375_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_ae939e7a-e854-475c-b1fe-2b818adb351f_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_a1a42c9f-4002-416d-a0ea-950e52131df3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_54779f5d-2a83-4a1f-8817-80d8ec07da6e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_c5d040b1-4c75-4c51-8662-1f36858124cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_6554ac76-61b7-4f58-9caa-05034fc04fcb_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_27a1b215-e7c4-424c-aa43-54907803795a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_8bdb3297-d690-4a2f-8c2a-607fbdace99c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6aedc55c-ed00-4c2d-b094-03df21dbef97_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9883cb7d-7e7e-438b-b9c2-c1bc19233c71_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_b6a0c401-901b-4de7-9625-aba836d7dfac_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a368e825-5c53-421c-935e-8bcc3e60f9cf_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2d199395-bd79-4822-985d-6ffb58ce9a59_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ecb861d9-ad92-40ae-ae90-aba6f5ec9ec1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fa27f2c9-a793-4a38-8725-30a28eacfc48_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c35b9d0e-a60c-4391-ac59-7769e0209fc5_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_8dcb8f4a-857f-473b-bf82-ad77be4558ee_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_2e283620-3b35-402d-8700-8dd0a0d6e6dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_1e94639f-fc25-4ba2-84db-73f37ecce309_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExpenseRelatedToMatchingContributions_6cb04f52-22df-4f1a-8178-f05a91337a39_terseLabel_en-US" xlink:label="lab_bsx_ExpenseRelatedToMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to matching contributions</link:label>
    <link:label id="lab_bsx_ExpenseRelatedToMatchingContributions_label_en-US" xlink:label="lab_bsx_ExpenseRelatedToMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to matching contributions</link:label>
    <link:label id="lab_bsx_ExpenseRelatedToMatchingContributions_documentation_en-US" xlink:label="lab_bsx_ExpenseRelatedToMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to matching contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExpenseRelatedToMatchingContributions" xlink:href="bsx-20201231.xsd#bsx_ExpenseRelatedToMatchingContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExpenseRelatedToMatchingContributions" xlink:to="lab_bsx_ExpenseRelatedToMatchingContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_04ccc0c4-26fb-4062-b016-cf794732a358_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_ca9a8edb-8710-479f-a417-a4f930b7e677_terseLabel_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_label_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:label id="lab_bsx_Segmentoperatingincomeaspercentageofnetsales_documentation_en-US" xlink:label="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:href="bsx-20201231.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:to="lab_bsx_Segmentoperatingincomeaspercentageofnetsales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_44558d9c-e40b-43f6-b743-d84dae8561e1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_303ef666-ca08-486a-a1d0-abadc9cdc76a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DiscountRateFairValueInput_0de61ac8-a3e0-4d9a-8480-320b1484f6e3_terseLabel_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_label_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_documentation_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput" xlink:href="bsx-20201231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DiscountRateFairValueInput" xlink:to="lab_bsx_DiscountRateFairValueInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_67efe0dc-f1b7-43cc-932f-31a31089a5ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_44fafa13-0bea-4a6b-b385-e42ce47dc877_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingParValuePerShare_c8fcd5a2-2cf4-4874-8ca4-7c5f53d69f8a_terseLabel_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:label id="lab_dei_EntityListingParValuePerShare_label_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingParValuePerShare" xlink:to="lab_dei_EntityListingParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementOfOperationsCaptionAxis_502883f8-70c2-4911-8f42-02b5eeab0ac0_terseLabel_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Axis]</link:label>
    <link:label id="lab_bsx_StatementOfOperationsCaptionAxis_label_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Axis]</link:label>
    <link:label id="lab_bsx_StatementOfOperationsCaptionAxis_documentation_en-US" xlink:label="lab_bsx_StatementOfOperationsCaptionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Operations Caption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionAxis" xlink:href="bsx-20201231.xsd#bsx_StatementOfOperationsCaptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementOfOperationsCaptionAxis" xlink:to="lab_bsx_StatementOfOperationsCaptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_114db92b-f292-4b73-8fbe-ed786cd42e35_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_126f734d-d597-4c39-99c2-861ad7a4a6c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Segment Reporting Information By Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_b058deb1-6802-4396-8d29-af43774ac6ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4b037491-60e0-408c-bf59-1563996d16fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ece00133-8d16-48cb-a231-0175cc4a33f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration recorded in purchase accounting</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ebc57c2d-e272-41e1-a83f-9cb8ee2e317c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_599ff6fc-f244-483d-8fca-5f74a2079b09_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_0c29e82b-e9c7-4f9c-ac88-7b4600e18759_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_c2245e6b-4e3b-4767-85ac-3df15f1a0595_terseLabel_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_label_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_documentation_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:to="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_9c273d87-4005-4cb7-9758-6a624215eef9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_5a72848d-5114-46e9-900e-a9e39a5586dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_2e452323-7b80-4b5d-8637-af9ff11a48b8_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_2584135b-a70b-4bcc-aa8b-191913639c8b_verboseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e3c89793-93d9-4997-95c2-e74cf7e723ef_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_afac4eba-4aae-40c2-a0d2-4c4937447e35_terseLabel_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases</link:label>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_label_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases [Policy Text Block]</link:label>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:to="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxAssetsDomain_502200d6-fc83-4667-8ab4-2334541117ad_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets [Domain]</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetsDomain_label_en-US" xlink:label="lab_bsx_DeferredTaxAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets [Domain]</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetsDomain_documentation_en-US" xlink:label="lab_bsx_DeferredTaxAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsDomain" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxAssetsDomain" xlink:to="lab_bsx_DeferredTaxAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_5ac92b26-2f9f-4d43-8ee7-03ddb3c47982_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3f4aee65-f3de-4708-a641-e3232d840abb_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_25e98801-08b5-4d0d-a385-3391a95372b5_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_fa0fb4fa-e503-4641-bf19-e6312e2d1b85_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for legal matters that are probable and estimable</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_cfa9fcb6-0f81-457b-8a10-1d8cb25f955d_terseLabel_en-US" xlink:label="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:href="bsx-20201231.xsd#bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_7f412520-fb57-4088-a5e1-48b34be9b0bd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_16a045b0-90fd-4230-bf59-63aed5123920_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_7cbed7bd-b676-4518-9c19-98a2e91689b7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_cf80f765-ab1c-48a6-9a86-d2db9d0fb9ed_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_3de2c035-fd4c-40f1-8274-124b4b65d5f5_terseLabel_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20201231.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_1375ef32-9758-4092-b013-31c42490bfd9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_bb0e8dae-cf39-42aa-8264-34e507db9605_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_c48dba80-bdfa-4311-b7bc-f191c29399a2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8c9ea416-af29-4621-90a0-3b616ac86c5a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_4c3ce016-a612-4116-9af7-afce34ad68c2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_ce8e2ceb-2b27-4c1b-91e5-928236b1a5a6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_50db468f-c5e1-4fa9-bfb8-c3facdbd75b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_f2033ff0-0bef-4b03-aa81-ba203231bad0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_0850e942-1f91-4654-bdb2-841c3dd3590c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_9d977efd-e017-46ec-9ebe-acfe5d40d41a_terseLabel_en-US" xlink:label="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</link:label>
    <link:label id="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_label_en-US" xlink:label="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</link:label>
    <link:label id="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_documentation_en-US" xlink:label="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:href="bsx-20201231.xsd#bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:to="lab_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_c1a24b70-eba4-4f0c-b97d-3c9f73c699be_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_457f7d68-bd0c-46c2-b59f-d71ad5b44b0d_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_6ce79162-80fa-44b3-8548-e6492d669d0d_terseLabel_en-US" xlink:label="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of employees total compensation eligible for GESOP purchase</link:label>
    <link:label id="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_label_en-US" xlink:label="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of employees total compensation eligible for GESOP purchase</link:label>
    <link:label id="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_documentation_en-US" xlink:label="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of employees total compensation eligible for GESOP purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:href="bsx-20201231.xsd#bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:to="lab_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_3169ad41-b644-455d-a0c2-46d69c5e8a71_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_d3dc0ac6-f6bd-4e0e-a563-25953bc20d5d_terseLabel_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge [Domain]</link:label>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_label_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge [Domain]</link:label>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_documentation_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Three [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:href="bsx-20201231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:to="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_dfccb0ef-49ac-489a-b5ad-096d8ba5d36e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of restructuring costs on the accompanying financial statements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_c9c58937-b288-4328-8632-fe5aa9439ab2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesDomain_a51a2a3c-de40-4f3d-acac-14d58d2092b9_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities [Domain]</link:label>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesDomain_label_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities [Domain]</link:label>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesDomain_documentation_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesDomain" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxLiabilitiesDomain" xlink:to="lab_bsx_DeferredTaxLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_62aba045-3ccc-4831-ae43-e0bda3c28e64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments (Table Text Block)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_fc4c0ce2-b62d-4980-a1b3-ad50cc1b2540_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_4aec6f9e-2a68-4306-9058-95caef166912_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e26af85d-cc17-4289-8219-30fd18548964_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PercentOfFinishedGoodsAtConsignment_a5e77cbb-4dbd-4a16-b284-b897903cfd0e_terseLabel_en-US" xlink:label="lab_bsx_PercentOfFinishedGoodsAtConsignment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of finished goods at consignment</link:label>
    <link:label id="lab_bsx_PercentOfFinishedGoodsAtConsignment_label_en-US" xlink:label="lab_bsx_PercentOfFinishedGoodsAtConsignment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of finished goods at consignment</link:label>
    <link:label id="lab_bsx_PercentOfFinishedGoodsAtConsignment_documentation_en-US" xlink:label="lab_bsx_PercentOfFinishedGoodsAtConsignment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of finished goods at consignment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PercentOfFinishedGoodsAtConsignment" xlink:href="bsx-20201231.xsd#bsx_PercentOfFinishedGoodsAtConsignment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PercentOfFinishedGoodsAtConsignment" xlink:to="lab_bsx_PercentOfFinishedGoodsAtConsignment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_39cf0d52-6e3a-4e1f-a0fd-b6595e38cc13_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_420f13ff-c9d5-49a4-8fc4-dc2acc31f198_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_18a64fd4-ff1f-40a3-87cc-034011f214cb_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fe4b3e87-54b8-4c36-9c76-2a271fa430ef_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_6dc648bd-f27c-4a85-b6d9-18b808ad218a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1bb2f3e0-b9b6-4197-9edb-120b0e0647ea_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_bf71a561-b20b-4f98-986b-d5e2f1fa7382_terseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:href="bsx-20201231.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangements_60ed9c9a-83d6-41dd-b798-88ac6d6f5a41_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_LicensingArrangements_label_en-US" xlink:label="lab_bsx_LicensingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_LicensingArrangements_documentation_en-US" xlink:label="lab_bsx_LicensingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangements" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangements" xlink:to="lab_bsx_LicensingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f27bdfec-6c5d-4b0f-9c42-04ba0a331a51_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_354e09fa-afee-467c-9a8d-5241816b9f6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_6335a606-14ee-4af7-b8ae-7a96d5af0325_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_221bb304-d21e-4a2c-ba42-32244b00c942_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_13d6ee95-e96f-4773-bde9-355783c6765b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8f855e74-f185-4599-a09e-79d7846828b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_982e4a1a-258c-4581-8cd2-200b24e92723_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_037783a7-4f8a-4fa7-b73b-053fa2afcf15_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_074c964a-95da-4dff-8902-6e70d47c5854_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Table Text Block)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementAxis_cfe0dceb-ef57-4cfc-a050-3a7eda06789a_terseLabel_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_label_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_documentation_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis" xlink:href="bsx-20201231.xsd#bsx_StatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementAxis" xlink:to="lab_bsx_StatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d02722cf-3553-49b5-9361-8417d17a4d62_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LotusDiscontinuationMember_71d7251a-0649-4eb8-a0b1-7543d26f9c44_terseLabel_en-US" xlink:label="lab_bsx_LotusDiscontinuationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lotus Discontinuation [Member]</link:label>
    <link:label id="lab_bsx_LotusDiscontinuationMember_label_en-US" xlink:label="lab_bsx_LotusDiscontinuationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lotus Discontinuation [Member]</link:label>
    <link:label id="lab_bsx_LotusDiscontinuationMember_documentation_en-US" xlink:label="lab_bsx_LotusDiscontinuationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lotus Discontinuation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LotusDiscontinuationMember" xlink:href="bsx-20201231.xsd#bsx_LotusDiscontinuationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LotusDiscontinuationMember" xlink:to="lab_bsx_LotusDiscontinuationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_a18d08a3-e7f0-44af-adfe-a57769758976_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Gain on Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_53525b8d-2672-40e7-8729-573a8c46c478_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c6068bc2-5b29-45f4-9639-c57b6c234d40_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_534a0273-c68a-4017-80a6-a598d575553a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_1ee2cc39-271f-4f8e-b49d-d01adfbaae5f_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_d58e7c8c-f444-49ca-b307-9f7cdad8be5c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_0723b5e3-663f-49bf-bd84-886c41de5406_terseLabel_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_label_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_documentation_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:href="bsx-20201231.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:to="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_240bb07f-8975-4e8a-a9ec-9b5409f91cce_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards_17e68658-692b-426a-a2f9-e768995f948d_terseLabel_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Non-vested stock awards</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards_label_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Non-vested stock awards</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards_documentation_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Non-vested stock awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCostNonVestedStockAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:to="lab_bsx_UnrecognizedCompensationCostNonVestedStockAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4414c4ca-ae86-4f6a-90dc-05ca5e514aa9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_4692160c-181b-49d1-a1a7-ca89943cbd55_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_c7163bd2-3074-437b-a237-400969616dc6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_cea1cb2f-6165-4358-ad16-3adeb8991820_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fd93b9e3-f73d-4364-aa4c-034a39457e4e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_7ca78976-381d-4353-bcc3-24301b4f49a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_d98734f1-8773-42b0-b300-e3402912980c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_0caec715-ff47-43b7-8322-29c8afb12f98_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_WeightedAverageRemainingVestingPeriod_7005abe4-b323-495c-a432-a311fd39db32_terseLabel_en-US" xlink:label="lab_bsx_WeightedAverageRemainingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted average remaining vesting period</link:label>
    <link:label id="lab_bsx_WeightedAverageRemainingVestingPeriod_label_en-US" xlink:label="lab_bsx_WeightedAverageRemainingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted average remaining vesting period</link:label>
    <link:label id="lab_bsx_WeightedAverageRemainingVestingPeriod_documentation_en-US" xlink:label="lab_bsx_WeightedAverageRemainingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted average remaining vesting period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageRemainingVestingPeriod" xlink:href="bsx-20201231.xsd#bsx_WeightedAverageRemainingVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_WeightedAverageRemainingVestingPeriod" xlink:to="lab_bsx_WeightedAverageRemainingVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7a0845c7-af1d-464f-a442-6b2507ff554b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_2b9fc6bf-e5f6-41e9-95b9-3d13960d48c9_terseLabel_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_label_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_documentation_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity in Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:href="bsx-20201231.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:to="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_c967edb1-091f-4017-a5ab-a44032e3c01c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_ac54b96b-5bcc-4747-9cdc-77259eae4ee0_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockCash" xlink:to="lab_us-gaap_DividendsPreferredStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2049NotesMember_99dd309c-2c9a-4242-b19b-e06442801821_terseLabel_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_label_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_documentation_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember" xlink:href="bsx-20201231.xsd#bsx_March2049NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2049NotesMember" xlink:to="lab_bsx_March2049NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2039NotesMember_0ca67798-e373-46e4-98a6-419dbb905827_terseLabel_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_label_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_documentation_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember" xlink:href="bsx-20201231.xsd#bsx_March2039NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2039NotesMember" xlink:to="lab_bsx_March2039NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_41472e58-dfc7-4988-b3d3-697e68774b4f_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_680d6148-1290-4fac-b9a4-a389685e53e3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_fad0af6a-eabd-4b93-bad9-31e6f9bb3c98_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_45e38e7f-1b9d-4c03-985d-35e3bde06fdc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_a8b05b67-dda5-486a-9383-747f582cee88_terseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_label_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:href="bsx-20201231.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:to="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketsMember_08075067-24a7-4cd2-a300-1b53cfc74fc9_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_label_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_documentation_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember" xlink:href="bsx-20201231.xsd#bsx_EmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketsMember" xlink:to="lab_bsx_EmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_c2147265-d9d8-4e81-83ee-13ac118c8550_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0cdb6a9b-846e-453b-bada-af313186a57f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_0af81cd4-7b4d-4b82-9a31-b95020c3447e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_61dfa432-e17d-4364-9063-1f48002ac583_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_a70490c2-1600-4edb-88b0-960c171b4baf_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_e49498a9-6fd2-4316-b80b-a1e2ebc12b77_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_1fbcb699-6201-47bf-a5b0-d2171540fc83_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_3af46c0c-2a67-441d-99c9-e3ba6a74b5cf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_85de8c53-e858-43b8-8431-668956375884_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e7e21b3a-74d2-4531-bb71-c2ed7289aec4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_23d9849d-3877-4a22-92b5-b826e5fd600b_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:href="bsx-20201231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_5117168a-f272-4aac-9bed-890949927fd0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Non-current deferred tax liability, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_614483a1-506f-4e3e-ad91-9b2a50d3e20b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_20ea8591-9d69-4dc4-b7cc-4af3be6674eb_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_467e9892-274a-4d45-9786-d425664990c2_terseLabel_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of performance-based DSUs awarded</link:label>
    <link:label id="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_label_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of performance-based DSUs awarded</link:label>
    <link:label id="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_documentation_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of performance-based DSUs awarded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:href="bsx-20201231.xsd#bsx_RangeofthetargetnumberofperformancebasedDSUsawarded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:to="lab_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_59662868-da60-4be0-a6cf-a90c86ee5471_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_5a10c758-9a47-41d8-a925-f7b891dccb81_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_1a0a210b-207e-4977-be8b-3abac4e85093_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5f1f845b-fa58-4e2a-bd0b-78ba05da366e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_03a3bf70-31f7-49b0-84a3-1fffff8b4c9e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS AND LIABILITIES HELD FOR SALE</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_12a78764-9c0b-4ecc-b0b4-6d1107b7643d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_31d0722d-880b-4954-8524-9bf7c48f31ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_c17a7f49-ca6a-4e89-9624-927ea5266189_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_dcb14b4f-46b9-46c6-8381-e2ccfcced648_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8c93408b-f659-4093-87ec-421d163a5084_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_e750817f-29c0-42aa-8b81-1d3520e87290_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherCountriesMember_4c6fe917-3c2f-4436-a909-face7c68edff_terseLabel_en-US" xlink:label="lab_bsx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_bsx_OtherCountriesMember_label_en-US" xlink:label="lab_bsx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_bsx_OtherCountriesMember_documentation_en-US" xlink:label="lab_bsx_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCountriesMember" xlink:href="bsx-20201231.xsd#bsx_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherCountriesMember" xlink:to="lab_bsx_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_d3c76452-383b-4ef6-85a9-8ec35a9560f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_181ea94d-efb6-482f-87a0-c4e5de372830_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_360a0f13-60ae-431b-a11a-514c407f327f_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_cb92abc4-b060-40da-85dc-e506e202803e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b14aa29-9fda-4e38-b9a2-98ae28e35d6a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assuming dilution</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8cfca31b-22e6-4234-b20d-5b74184ac0c6_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CompensationExpensePerShareDiluted_be4d465b-723a-4d3f-861e-b53b386c11c0_terseLabel_en-US" xlink:label="lab_bsx_CompensationExpensePerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - diluted</link:label>
    <link:label id="lab_bsx_CompensationExpensePerShareDiluted_label_en-US" xlink:label="lab_bsx_CompensationExpensePerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - diluted</link:label>
    <link:label id="lab_bsx_CompensationExpensePerShareDiluted_documentation_en-US" xlink:label="lab_bsx_CompensationExpensePerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareDiluted" xlink:href="bsx-20201231.xsd#bsx_CompensationExpensePerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CompensationExpensePerShareDiluted" xlink:to="lab_bsx_CompensationExpensePerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_a306f730-3dbb-45f5-8276-861a9ede7971_terseLabel_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:href="bsx-20201231.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:to="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7bae4372-2352-4925-ad5a-adcefede4061_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_55ddaa81-0aa2-47d1-8861-ef0b52420059_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_203cce2a-c08a-4e27-8caa-e91ee5387336_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_95b80a15-75cf-47e9-a7b7-918fe483b1bb_terseLabel_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Expected [Axis]</link:label>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_label_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Expected [Axis]</link:label>
    <link:label id="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_documentation_en-US" xlink:label="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Three [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:href="bsx-20201231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:to="lab_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_1f585ee3-b9e7-471b-a6b9-5d3f54f11594_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_f7b0055f-7df9-4088-9ce4-409c0899ea4b_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_aaa2a811-3043-445b-adee-6ca04116c648_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3f7af7cb-e80d-41c7-9fbb-7b4957dcdedf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_523aa13e-7e1f-464d-9dbb-cc478106590e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CompensationExpensePerShareBasic_41890d2f-c11b-4888-9326-ae335e52b703_terseLabel_en-US" xlink:label="lab_bsx_CompensationExpensePerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - basic</link:label>
    <link:label id="lab_bsx_CompensationExpensePerShareBasic_label_en-US" xlink:label="lab_bsx_CompensationExpensePerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - basic</link:label>
    <link:label id="lab_bsx_CompensationExpensePerShareBasic_documentation_en-US" xlink:label="lab_bsx_CompensationExpensePerShareBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">compensation expense, per share - basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareBasic" xlink:href="bsx-20201231.xsd#bsx_CompensationExpensePerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CompensationExpensePerShareBasic" xlink:to="lab_bsx_CompensationExpensePerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_a6ccddcd-f176-459e-b54e-4ac51b280174_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_393858fa-8e57-405e-b62b-c92c06f0422e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d39cd9d3-19ab-4656-b137-776784341b08_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value - authorized 2,000,000,000 shares; issued 1,679,911,918 shares as of December 31, 2020 and 1,642,488,911 shares as of December 31, 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1d891bec-98f6-49d9-9980-721e183994ee_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3d728f15-854d-4ee9-8806-735980afc08b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UnrecognizedCompensationCostStockOptions_20fd043f-0fb2-4fa4-b910-0068e2193d7f_terseLabel_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Stock Options</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCostStockOptions_label_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Stock Options</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCostStockOptions_documentation_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCostStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost - Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostStockOptions" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCostStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UnrecognizedCompensationCostStockOptions" xlink:to="lab_bsx_UnrecognizedCompensationCostStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_86d56648-a3c6-4af1-a02c-913c2a671ad8_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_02a9b259-c60c-4de5-9f65-94d89dcbff0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_6c8be986-23f5-4d4a-b14f-2083086ae1b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_December2027NotesMember_97dea1d5-185e-4ac3-962d-3ae5001eb829_terseLabel_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_label_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_documentation_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember" xlink:href="bsx-20201231.xsd#bsx_December2027NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_December2027NotesMember" xlink:to="lab_bsx_December2027NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e5759d01-4381-4fcc-b7ca-0bea83cf108a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_df2e81e0-6c4d-4977-9648-cb38f86a6a5d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_1b603fbf-3a4e-45fc-b148-d010cb71563e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FederalBenefitOfUncertainTaxPositions_49a88bd7-7e5f-4d98-9a08-2a9272a24554_terseLabel_en-US" xlink:label="lab_bsx_FederalBenefitOfUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal benefit of uncertain tax positions</link:label>
    <link:label id="lab_bsx_FederalBenefitOfUncertainTaxPositions_label_en-US" xlink:label="lab_bsx_FederalBenefitOfUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal benefit of uncertain tax positions</link:label>
    <link:label id="lab_bsx_FederalBenefitOfUncertainTaxPositions_documentation_en-US" xlink:label="lab_bsx_FederalBenefitOfUncertainTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal benefit of uncertain tax positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FederalBenefitOfUncertainTaxPositions" xlink:href="bsx-20201231.xsd#bsx_FederalBenefitOfUncertainTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FederalBenefitOfUncertainTaxPositions" xlink:to="lab_bsx_FederalBenefitOfUncertainTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_9b68ebe3-ae13-476d-af37-eb93f9f13a63_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_3d6c3580-538c-48e6-8413-d4d44d352ba4_terseLabel_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]</link:label>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_label_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]</link:label>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_documentation_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:to="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_bf6324fd-d99a-4c46-a8af-4af018b71ede_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fcef16ef-1882-4274-9963-8fc715b59067_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_d9489af8-eba2-44ec-959c-1cdaff299da5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_1b07bc20-ebf4-4432-9d53-bb63257c2d87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_893e726d-4b1f-4f6b-bd64-3e57ed803704_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_bc5b89d0-9b4d-4b6c-bc5b-0456d0c794b1_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_902b997b-e82c-4128-9238-81d732e2e59a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_2be5dc7b-cce7-467b-b78c-9dbd89100243_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2020TermLoanMember_56e64499-d1c0-4916-8713-6d8d56ce68a6_terseLabel_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_A2020TermLoanMember_label_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_A2020TermLoanMember_documentation_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember" xlink:href="bsx-20201231.xsd#bsx_A2020TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2020TermLoanMember" xlink:to="lab_bsx_A2020TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_a9c3c3ac-d7d4-4553-9b23-f68e52a032b1_terseLabel_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen denominated factoring arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:href="bsx-20201231.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3206a9a5-ccfa-4dec-a643-2b75882a7124_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_552fd5ec-5eae-4725-9b21-83419986819b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_0d3489de-2d19-4939-bfac-98cfdef34ed0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_60de14c0-9629-40b3-bc29-fc565b4daa8c_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_57c09b8a-8a48-4252-ae12-99f2eb869869_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_4ec01bc1-40f4-43d6-9bd9-d66db5c550cc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_66db742c-2ab7-4458-9e3a-b4e4e72271c0_terseLabel_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Text Block]</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:to="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_0ff5c47f-1ee8-4fc1-8fa1-79fa2f874b66_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2025NotesMember_1b6a1502-4f3c-484d-af5c-95f162ac243d_terseLabel_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_label_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_documentation_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember" xlink:href="bsx-20201231.xsd#bsx_June2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2025NotesMember" xlink:to="lab_bsx_June2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a9ebd509-d902-401e-9e64-6e3df6fc0a38_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_f7364dd4-73c0-44d4-a73a-2399c37b96d7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_2b7ecdc9-9eb0-46c2-833f-e6971b7064b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_1a5cd8f4-e9e7-4699-b149-ae1657ba07ee_terseLabel_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_label_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_documentation_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims asserted related to mesh products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:href="bsx-20201231.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:to="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_3ba683cc-867d-4f2b-8ac3-398877c62b8e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_aa5fcaad-850a-4d87-8e60-769f78179b0b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_9e95944d-c1ea-4ebb-9da1-6ce2b2c5f857_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_b5da74f9-1f4c-4d4b-b9db-0a104cedec1b_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_b51b97e7-9ef3-4885-814d-c201eeea561d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_4921bcb0-81a3-422d-ac65-373438216cd7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_027c3a90-6799-4645-9ca8-9512af321650_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_380e8f0c-8be5-44f6-b3c8-48ee9dfaad3d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_e5ab45f2-0edf-4950-8e77-3b632cfb54e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid on preferred stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_7ab4f12b-9f39-4558-b572-f960ae14f22d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0658c153-750c-4046-a7b7-c2e09503a05e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_34447c48-898b-48d4-bdb9-5469f14a3f36_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f30027e9-f01b-4cdd-b27d-ce5cb8876d22_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year Three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_479415e4-cd9b-4758-9088-d1881b630ca2_terseLabel_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_label_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_documentation_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding" xlink:href="bsx-20201231.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumCommercialPaperOutstanding" xlink:to="lab_bsx_MaximumCommercialPaperOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_a4019365-569d-4cc0-8afe-7f4e3838f98b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions (Table Text Block)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_64ccc880-2b73-462f-a01a-9adc2eb66b7b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InternationalRetirementPlansMember_158911ed-3d49-4f2d-8200-e67842f4c1f9_terseLabel_en-US" xlink:label="lab_bsx_InternationalRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International retirement plans [Member]</link:label>
    <link:label id="lab_bsx_InternationalRetirementPlansMember_label_en-US" xlink:label="lab_bsx_InternationalRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International retirement plans [Member]</link:label>
    <link:label id="lab_bsx_InternationalRetirementPlansMember_documentation_en-US" xlink:label="lab_bsx_InternationalRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International retirement plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember" xlink:href="bsx-20201231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InternationalRetirementPlansMember" xlink:to="lab_bsx_InternationalRetirementPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f4a6398c-c3ac-45cb-b30d-532a00da4d91_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0408e8f3-0db5-4d3a-bde1-39da2f5e0996_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_cd5c29d8-8831-4a4f-887c-d16396d0ebc5_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementsLiability_a628f714-1be1-40f4-a227-cd8c965ad5cf_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_LicensingArrangementsLiability_label_en-US" xlink:label="lab_bsx_LicensingArrangementsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_LicensingArrangementsLiability_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementsLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementsLiability" xlink:to="lab_bsx_LicensingArrangementsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_14eabaa7-fffc-4f84-aa2d-b0c4cd991831_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_52c0fc92-9b1b-4205-9ceb-094d173d8523_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_aa756e67-f016-4e43-88eb-f69aa2889ee7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0fb99198-75cc-4fad-933a-6a817e3e7fa8_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TransferCosts_bd39958a-5842-4095-bce6-12b7f42cd6dd_terseLabel_en-US" xlink:label="lab_bsx_TransferCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Costs</link:label>
    <link:label id="lab_bsx_TransferCosts_label_en-US" xlink:label="lab_bsx_TransferCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Costs</link:label>
    <link:label id="lab_bsx_TransferCosts_documentation_en-US" xlink:label="lab_bsx_TransferCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCosts" xlink:href="bsx-20201231.xsd#bsx_TransferCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TransferCosts" xlink:to="lab_bsx_TransferCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementExtensionThroughTheRemainderOf2020Member_4ba9c64a-5ebb-48c5-ac5d-d89a84491f17_terseLabel_en-US" xlink:label="lab_bsx_RequirementExtensionThroughTheRemainderOf2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, extension through the remainder of 2020 [Member]</link:label>
    <link:label id="lab_bsx_RequirementExtensionThroughTheRemainderOf2020Member_label_en-US" xlink:label="lab_bsx_RequirementExtensionThroughTheRemainderOf2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, extension through the remainder of 2020 [Member]</link:label>
    <link:label id="lab_bsx_RequirementExtensionThroughTheRemainderOf2020Member_documentation_en-US" xlink:label="lab_bsx_RequirementExtensionThroughTheRemainderOf2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, extension through the remainder of 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementExtensionThroughTheRemainderOf2020Member" xlink:href="bsx-20201231.xsd#bsx_RequirementExtensionThroughTheRemainderOf2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementExtensionThroughTheRemainderOf2020Member" xlink:to="lab_bsx_RequirementExtensionThroughTheRemainderOf2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a7a90452-8894-42f7-b916-600bd0f11a13_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_34834495-ca7f-4334-ad8e-9e99d178f580_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring net charges (credits)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_aa214f48-94b6-4863-a43e-25980190b4f6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c5bfc099-70bd-45fb-908f-3d81120b5a5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ab257a12-957e-40eb-9b08-8e16a2e8e49a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7d16b043-518e-4603-a16c-85b3fd17b837_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8bb1387c-698a-4577-9f86-c7ffd2f99e08_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e432402c-1899-4939-9632-d17099867943_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_413ffb4b-fd3a-42c3-82af-1d8d3a0254d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:to="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d39a7206-50fa-4c00-a82e-e2b7c8b62d0b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4808ad63-1399-458c-ab3b-5505cbfa133f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_9b555644-aa84-431d-bb66-0ee8831ba4bb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_1756d3c2-5a7c-4723-a0f9-1f13737ab434_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2016RestructuringPlanMember_f10c0da6-21c4-4be0-9a81-555f7601f804_terseLabel_en-US" xlink:label="lab_bsx_A2016RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2016RestructuringPlanMember_label_en-US" xlink:label="lab_bsx_A2016RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2016RestructuringPlanMember_documentation_en-US" xlink:label="lab_bsx_A2016RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember" xlink:href="bsx-20201231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2016RestructuringPlanMember" xlink:to="lab_bsx_A2016RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_f3710672-c1d5-4e91-9ffc-16b16f028171_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_853febe8-acf1-4c28-ba76-b2e688249a99_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_216e4795-7cd7-4f89-82d1-777bf7702322_verboseLabel_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_label_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of term loan and revolving credit facility agreement compliance with debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:to="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7b751c77-be5d-4b92-9ef7-89181bda4c57_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_5d2f73dd-ace9-489b-af69-bbe7ed4b3930_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance_d66db590-e58c-4342-8218-278512476093_terseLabel_en-US" xlink:label="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance_documentation_en-US" xlink:label="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:href="bsx-20201231.xsd#bsx_ChangeinDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:to="lab_bsx_ChangeinDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_107802ad-d542-4315-8bc4-062bed83b46c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_4a6655e5-2486-4828-99e4-f6c89ffba8eb_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1fa5a967-7c23-417d-87eb-fba110b274a1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Seniornotesissued_d501d352-a3fb-41f9-a530-835142b18e22_terseLabel_en-US" xlink:label="lab_bsx_Seniornotesissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes issued</link:label>
    <link:label id="lab_bsx_Seniornotesissued_label_en-US" xlink:label="lab_bsx_Seniornotesissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes issued</link:label>
    <link:label id="lab_bsx_Seniornotesissued_documentation_en-US" xlink:label="lab_bsx_Seniornotesissued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Seniornotesissued" xlink:href="bsx-20201231.xsd#bsx_Seniornotesissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Seniornotesissued" xlink:to="lab_bsx_Seniornotesissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_a0650f75-5bd6-474b-a453-7021fba04ae6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_24d14a58-e40a-4bb5-bc4d-96c0f8171527_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_c57a0507-3c1b-49fb-88cd-c2e6d7210c01_terseLabel_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:href="bsx-20201231.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:to="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_fc8fff01-24e1-424a-b6a5-a6c4579190f8_terseLabel_en-US" xlink:label="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale in Other current liabilities [Domain]</link:label>
    <link:label id="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_label_en-US" xlink:label="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale in Other current liabilities [Domain]</link:label>
    <link:label id="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_documentation_en-US" xlink:label="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale in Other current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:href="bsx-20201231.xsd#bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:to="lab_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringPlanMember_6dc092a7-b865-4444-ab6a-50860ee2da74_terseLabel_en-US" xlink:label="lab_bsx_RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_RestructuringPlanMember_label_en-US" xlink:label="lab_bsx_RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_RestructuringPlanMember_documentation_en-US" xlink:label="lab_bsx_RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringPlanMember" xlink:to="lab_bsx_RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_db65fac1-c88d-48a9-b16d-f2a0d829224b_terseLabel_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA [Member]</link:label>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_label_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA</link:label>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_documentation_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA" xlink:href="bsx-20201231.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeemedConsolidatedEBITDA" xlink:to="lab_bsx_DeemedConsolidatedEBITDA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_5b5c68ee-2e36-49ed-aed8-c5434ba610e6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_f51b761d-e863-4773-8d2f-195826ab2d5a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_50620b78-2d3f-408c-8603-910989e0c7d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_9d843a90-e56a-44dc-88fb-28f56bb0ec5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_c803073b-9da5-47df-a97d-64a96fa7dad3_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_03daaeb7-5d02-42c6-af76-66df72a8661f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d9429881-c39f-4042-8a80-e998c4ecf992_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5a28974c-d05e-495c-b925-e6e05cdf5ac0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_ab93765c-17d0-4aea-bd3b-241135778b52_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2018AcquisitionsMember_ca55a64f-def6-41f4-a1a2-e7e9fd64b094_terseLabel_en-US" xlink:label="lab_bsx_A2018AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Acquisitions [Member]</link:label>
    <link:label id="lab_bsx_A2018AcquisitionsMember_label_en-US" xlink:label="lab_bsx_A2018AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Acquisitions [Member]</link:label>
    <link:label id="lab_bsx_A2018AcquisitionsMember_documentation_en-US" xlink:label="lab_bsx_A2018AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2018AcquisitionsMember" xlink:href="bsx-20201231.xsd#bsx_A2018AcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2018AcquisitionsMember" xlink:to="lab_bsx_A2018AcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_30b9041f-c0ae-4f84-ac09-895037579f53_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND STRATEGIC INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_VotingPowerOfAllClassesOfStock_ddeb4086-5c80-4191-99b1-d6ae2a71c48d_verboseLabel_en-US" xlink:label="lab_bsx_VotingPowerOfAllClassesOfStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting power of all classes of stock</link:label>
    <link:label id="lab_bsx_VotingPowerOfAllClassesOfStock_label_en-US" xlink:label="lab_bsx_VotingPowerOfAllClassesOfStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting power of all classes of stock</link:label>
    <link:label id="lab_bsx_VotingPowerOfAllClassesOfStock_documentation_en-US" xlink:label="lab_bsx_VotingPowerOfAllClassesOfStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting power of all classes of stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VotingPowerOfAllClassesOfStock" xlink:href="bsx-20201231.xsd#bsx_VotingPowerOfAllClassesOfStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_VotingPowerOfAllClassesOfStock" xlink:to="lab_bsx_VotingPowerOfAllClassesOfStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_232db5cf-034e-444b-9f66-c36aa8928a2a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ClaretMedicalIncMember_162c43ba-f4c4-4bdb-8a3a-ecd853292c12_terseLabel_en-US" xlink:label="lab_bsx_ClaretMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claret Medical, Inc. [Member]</link:label>
    <link:label id="lab_bsx_ClaretMedicalIncMember_label_en-US" xlink:label="lab_bsx_ClaretMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claret Medical, Inc. [Member]</link:label>
    <link:label id="lab_bsx_ClaretMedicalIncMember_documentation_en-US" xlink:label="lab_bsx_ClaretMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claret [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ClaretMedicalIncMember" xlink:href="bsx-20201231.xsd#bsx_ClaretMedicalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ClaretMedicalIncMember" xlink:to="lab_bsx_ClaretMedicalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_254901c9-45e8-4873-ba31-6f11d52f1ef2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_47fad91a-920e-4dc8-8a7c-57a4050f7059_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e14f9d7f-3f59-4a84-9f7f-ac8f89649fef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_cb13efa7-676c-440e-9d01-4c2a28e514b9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_d880e9e9-387d-4f19-930c-1af072048882_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_09d85647-e154-46e1-9afe-1d8c9828525d_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_fd2700c3-3bc5-4986-be4d-fa21c3228a7a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_19b6600a-7ccc-4f3c-a3d8-a7073352f8e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_a362af39-3eec-41d9-b718-57acec0c47b8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SignificantAccountingPoliciesTable_7f1853ec-2c7b-4bfd-82e4-4a0e162572da_terseLabel_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesTable" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SignificantAccountingPoliciesTable" xlink:to="lab_bsx_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_894ed732-7916-489f-b2a0-2c962406c8e0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement alternative investments (1)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a5ab6b7d-f69d-4b5c-98f0-224e591bca69_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf0724c8-82f5-49b3-9b91-4a0807dc3ed4_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6cbe50a2-ec1a-45f3-b860-690ddf8ae0dc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_05a0f327-7b09-48f3-8d4b-f83c5be0b370_terseLabel_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:href="bsx-20201231.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:to="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d16e8184-22fa-4915-b581-a5da1f1874f6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_477bb13c-a561-4b1a-9ce2-1b7b03e9f709_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year One</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_a5878d4a-4b6b-4b57-a469-31a781bb1f35_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_e0e089cc-9986-447b-a6a2-ef139dd588d4_terseLabel_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:href="bsx-20201231.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:to="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_bd55f5a8-467a-4a6f-adfd-862bc070973d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of certain businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_4a836b23-7731-470c-a00e-b69e633031fa_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRico_de3c23ac-56ef-49d2-a8cf-1e71c9c34c3d_terseLabel_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRico" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico</link:label>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRico_label_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRico" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico</link:label>
    <link:label id="lab_bsx_TaxIncentivesInPuertoRico_documentation_en-US" xlink:label="lab_bsx_TaxIncentivesInPuertoRico" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Incentives in Puerto Rico</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRico" xlink:href="bsx-20201231.xsd#bsx_TaxIncentivesInPuertoRico"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TaxIncentivesInPuertoRico" xlink:to="lab_bsx_TaxIncentivesInPuertoRico" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_5f7f9913-5cc2-4c86-a325-0b6645030169_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_f56409e9-aa61-4eb6-9f3f-37ca9351ba88_terseLabel_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of market-based DSUs awarded</link:label>
    <link:label id="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_label_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of market-based DSUs awarded</link:label>
    <link:label id="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_documentation_en-US" xlink:label="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of the target number of market-based DSUs awarded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:href="bsx-20201231.xsd#bsx_RangeofthetargetnumberofmarketbasedDSUsawarded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:to="lab_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_09b467fa-dd25-4a7e-8b2f-8d36a9995745_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_73dd14a9-2e1e-4e44-94af-ba4a40ebc4d8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_162a9eae-7d7d-47bc-86ce-561859c1dce3_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities, current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ca430718-e597-49ea-a835-70289a8db451_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share &#8212; assuming dilution</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_40a490e5-42dd-4ee4-bc9a-18d2f628db88_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_377f9c3c-9d96-492f-a46b-3a5744a67e85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_9f6b7ce8-eca9-4682-bc18-11918bca6b80_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Domain]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Domain]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_4f0d1dd6-c94b-4fa4-b558-7b5ff971c0fb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_33c85f85-7394-436f-a7ff-927dc213e64f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_0d6c7620-8e5c-43a2-a213-f312c1566c0d_terseLabel_en-US" xlink:label="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities</link:label>
    <link:label id="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities [Table Text Block]</link:label>
    <link:label id="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:to="lab_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_5035c5d4-d6f1-42eb-8522-2f90f44080b1_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_fce44597-8ce0-46f0-b4c9-0577311315ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_8ccdb667-5853-466c-b836-0109518c8d75_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a8eb5f0c-0e65-425a-9b3b-558dc2e738ff_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c0b23fb3-3d1e-450b-b927-421bd816a1a1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_168607bd-198a-4344-8147-efa378d1e901_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_329827f2-6c40-4974-9465-60de415f8c6f_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_87f0c493-a626-4854-aa42-2e394f1f3ad3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3474afd0-5c79-4f44-a809-34d149cdc92b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIncentiveAndPurchasePlansAbstract_d354ee06-dad5-413c-ad65-1a2ebd8daf51_terseLabel_en-US" xlink:label="lab_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive and Ownership Plans [Abstract]</link:label>
    <link:label id="lab_bsx_StockIncentiveAndPurchasePlansAbstract_label_en-US" xlink:label="lab_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive and Purchase Plans [Abstract]</link:label>
    <link:label id="lab_bsx_StockIncentiveAndPurchasePlansAbstract_documentation_en-US" xlink:label="lab_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive and Purchase Plans [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:href="bsx-20201231.xsd#bsx_StockIncentiveAndPurchasePlansAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:to="lab_bsx_StockIncentiveAndPurchasePlansAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_7c98cc22-0f0f-45f4-9d10-f930867e20d7_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_eefa7356-a634-4454-b353-6f25a6532f09_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High end of range [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3208746e-1d74-4b42-9810-61b2a301ec48_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_9de2c906-9cee-48b1-b2a7-2531049d14dc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForeignCurrencyDenominatedInDebtMember_1460b524-36b7-464c-8204-fdc91d8fd867_terseLabel_en-US" xlink:label="lab_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeignCurrencyDenominatedInDebtMember_label_en-US" xlink:label="lab_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeignCurrencyDenominatedInDebtMember_documentation_en-US" xlink:label="lab_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated in debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:href="bsx-20201231.xsd#bsx_ForeignCurrencyDenominatedInDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:to="lab_bsx_ForeignCurrencyDenominatedInDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ffcb9fe2-3eda-44a2-affc-39de15c7c7e0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_5bedeb3d-052d-4ead-97e9-b68acf4ef6cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) on investments and notes receivable</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9f33d12e-5c6a-4a46-82ec-6b686ad9c7e8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba3bf43a-00ff-46aa-9a12-6dd0817ca5ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_28a2cdd1-2c79-4cdc-bb0c-3230440edcaf_terseLabel_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice Solutions, Inc. [Member]</link:label>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_label_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice Solutions, Inc. [Member]</link:label>
    <link:label id="lab_bsx_PreventiceSolutionsIncMember_documentation_en-US" xlink:label="lab_bsx_PreventiceSolutionsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice Solutions, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember" xlink:href="bsx-20201231.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PreventiceSolutionsIncMember" xlink:to="lab_bsx_PreventiceSolutionsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd199eac-3c17-4efd-a004-5e616cad7ced_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_2a99f6d2-bdf7-4f94-b12f-f8cd80aac894_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss (beginning balance)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_50f4fde6-0d62-4d8c-a22d-b9d86e5e8e0f_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss (ending balance)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_d6a7e591-1526-4cfe-85a4-fdcb2525e4dd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_600ff270-67b6-4f07-bf24-07e30d49d0a6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_c211f25f-ba6c-49ae-916c-79500212753e_terseLabel_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_label_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember" xlink:href="bsx-20201231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2019AggregateOfferingMember" xlink:to="lab_bsx_November2019AggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_b09edcdd-11ea-4e06-b48f-1b9e4d9fb805_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_edbdb0ba-372d-4bf5-83a8-c23dbf64584e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AssetsHeldForSaleDomain_4734eaeb-6e05-4f63-b890-b7ed832e76a0_terseLabel_en-US" xlink:label="lab_bsx_AssetsHeldForSaleDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale [Domain]</link:label>
    <link:label id="lab_bsx_AssetsHeldForSaleDomain_label_en-US" xlink:label="lab_bsx_AssetsHeldForSaleDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale [Domain]</link:label>
    <link:label id="lab_bsx_AssetsHeldForSaleDomain_documentation_en-US" xlink:label="lab_bsx_AssetsHeldForSaleDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssetsHeldForSaleDomain" xlink:href="bsx-20201231.xsd#bsx_AssetsHeldForSaleDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AssetsHeldForSaleDomain" xlink:to="lab_bsx_AssetsHeldForSaleDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DivestedBusinessDueToBTGAcquisitionMember_4a3a6ac0-414d-4c93-a146-f9367d7c4dc7_terseLabel_en-US" xlink:label="lab_bsx_DivestedBusinessDueToBTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested Business due to BTG Acquisition [Member]</link:label>
    <link:label id="lab_bsx_DivestedBusinessDueToBTGAcquisitionMember_label_en-US" xlink:label="lab_bsx_DivestedBusinessDueToBTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested Business due to BTG Acquisition [Member]</link:label>
    <link:label id="lab_bsx_DivestedBusinessDueToBTGAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_DivestedBusinessDueToBTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested Business due to BTG Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember" xlink:href="bsx-20201231.xsd#bsx_DivestedBusinessDueToBTGAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember" xlink:to="lab_bsx_DivestedBusinessDueToBTGAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3a213f14-b23b-46c1-983a-d587e3da1857_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8843b676-3357-4088-bd32-568c48b281db_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_7352d8f7-9260-4aa5-8c35-a228dcfcb66d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_a6497c06-cd24-4c41-ba36-83ab377f4d54_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_0e82e633-6e94-4335-8920-f08f676444ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_a77d1fce-f699-4566-991e-36e6e4fc1445_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockStock" xlink:to="lab_us-gaap_DividendsPreferredStockStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_4c770e0d-a3e2-4cf7-8a16-a5fc4cee0530_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_9c248f4c-5103-4017-af79-bc24d8cfd668_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_7f1ea65f-c6b6-4e82-ac8f-27284f1b26a2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c197eefb-e4a1-46d9-9b92-68b124291509_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_5508de97-2214-488e-9f87-9c9efeeebeac_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a8d33de3-fa33-4c53-8464-0eb8f122320e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1a394627-6105-4e59-a7a5-6ad608397142_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_a4bd4a0b-6726-4ff7-b487-36b831df47d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_da052275-d35a-4cfe-a45a-5b401bcb5ff1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_7901a51c-343c-4170-8097-7d66589237ee_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_28faa81a-7775-4ec1-8c3a-2356dc3dda5a_terseLabel_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20201231.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e80a07af-855b-41ff-9704-2324a29404f7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_221cf252-74c7-4fc4-b606-8713d50f422f_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_d23bc2a7-ef49-4cd8-9006-29c0c1c6979e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6b7f85ef-6421-4108-aa89-8a0f1e57f5f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c9c8dd07-d2c4-45b2-aa26-a39e0093432c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_14c6a682-c40f-4b89-9bb2-fa31cbe29d7b_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherContractMember_b15979af-4f8a-4a27-b673-d19cf9a073a0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract</link:label>
    <link:label id="lab_us-gaap_OtherContractMember_label_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherContractMember" xlink:to="lab_us-gaap_OtherContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_59fa7155-cd27-4ff4-9e06-ba83b94eb916_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4879ec0b-cc0e-429b-8b20-54fb192f0a9c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_44b0a321-a732-42f6-80d4-46549d0b5e56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments_6995dcb8-9553-4a19-89e2-cb150fb406f4_terseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments_label_en-US" xlink:label="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Allocated to Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:href="bsx-20201231.xsd#bsx_OperatingIncomeLossAllocatedToReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:to="lab_bsx_OperatingIncomeLossAllocatedToReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOnFutureCashFlowsAmount_2b99cafc-1090-4d2b-af2e-a0dd10f9db03_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Cash Flows, Amount</link:label>
    <link:label id="lab_us-gaap_EffectOnFutureCashFlowsAmount_label_en-US" xlink:label="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect on Future Cash Flows, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOnFutureCashFlowsAmount" xlink:to="lab_us-gaap_EffectOnFutureCashFlowsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_efbc092b-1452-48d4-8957-8135a25b4fbb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_fa7d299a-c7b6-458a-9b2e-c42ba01674cb_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_c316ac9c-dbeb-4298-8fd6-6b1f35119044_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_bfe59192-d63f-4bef-b388-f8a861f9c83e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_e235c6fc-037a-4d24-9c3e-a1b2a7559d29_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d8903d88-0590-4e6c-b925-53b785af68be_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_c3b8663b-881c-40aa-b2ee-df36447467e9_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementLiabilitiesMember_537ffc75-911f-471c-878b-c7eeecea1ff7_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities (Member)</link:label>
    <link:label id="lab_bsx_LicensingArrangementLiabilitiesMember_label_en-US" xlink:label="lab_bsx_LicensingArrangementLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingArrangementLiabilitiesMember_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementLiabilitiesMember" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementLiabilitiesMember" xlink:to="lab_bsx_LicensingArrangementLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_45168564-024c-4cb1-bcd5-afd20b4c16f6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_The2018FacilityDomain_3d4ac528-4f48-4d24-be31-f61c718a7a82_terseLabel_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Domain]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_label_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Domain]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_documentation_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain" xlink:href="bsx-20201231.xsd#bsx_The2018FacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_The2018FacilityDomain" xlink:to="lab_bsx_The2018FacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_cef2b7a1-37ac-48d1-a5bd-6f8294b0f8e9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_15bf2800-4432-4df5-9bef-4bda164d9887_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income allocated to reportable segments</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_c073c815-4ac9-4cf3-b044-b6095b97eb50_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueAfterFifthYear_d4123d54-7f72-4902-ac60-f27dffc7be16_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due Thereafter</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:to="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_6d27e674-b45b-4f11-8140-f6ce2bb71d74_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_04c8dcf6-3cbf-4fac-968e-fa0acd5ca9b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_968d1652-d2b5-4cee-854f-085657484f73_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_080146d4-d350-420e-8887-fed21773bdca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_5f6d3ed2-0b72-4c49-ae68-a67b0a546360_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock_8a5dc567-37ea-4300-87bd-ac60dc9e4a6b_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-18 Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-18 Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606 [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-18 Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_d167b41a-4f62-47e2-bc09-1de9d18bab25_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7dc33f94-7b09-409f-8ebf-cd8e8556872d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_9e0c2081-ffa9-4fef-9554-6cb9668e2425_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e1aca939-5702-4bf9-b92f-dda408855dae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_fea53f7a-7cf8-4316-bca1-f2bfcc36704a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MedsurgMember_c35dccc4-f434-4423-a731-222197100bb9_terseLabel_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_label_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_documentation_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember" xlink:href="bsx-20201231.xsd#bsx_MedsurgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MedsurgMember" xlink:to="lab_bsx_MedsurgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_e5cdda48-de96-4b6a-a469-aab1aa8ba5cd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_dc43f6c0-96e9-4040-baf7-eb9f841be832_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_480dec80-a610-4c49-abc2-79609640f109_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_779d11ac-9571-4b31-8efe-f18ca9efd7a3_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6c8b8330-6476-4606-8918-10f70a68e712_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a5c275aa-54b9-4b9d-8525-637796ae53d9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_5356a185-e1f2-4b2b-8568-05fc70b3e950_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20201231.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_b2617f32-2387-4117-8f6f-4ba47b29d657_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_7126afd2-7563-4935-bb3e-f1588a1b8ca5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash (received) paid for income taxes, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringrelatedCostExpectedCost_aa2d7d0f-7cee-4942-8e2c-28575a598ae3_terseLabel_en-US" xlink:label="lab_bsx_RestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring-related Cost, Expected Cost</link:label>
    <link:label id="lab_bsx_RestructuringrelatedCostExpectedCost_label_en-US" xlink:label="lab_bsx_RestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring-related Cost, Expected Cost</link:label>
    <link:label id="lab_bsx_RestructuringrelatedCostExpectedCost_documentation_en-US" xlink:label="lab_bsx_RestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring-related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringrelatedCostExpectedCost" xlink:href="bsx-20201231.xsd#bsx_RestructuringrelatedCostExpectedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringrelatedCostExpectedCost" xlink:to="lab_bsx_RestructuringrelatedCostExpectedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UnrecognizedCompensationCost_4c087dbf-e461-43cb-8e37-4ca6348dc735_terseLabel_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCost_label_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost</link:label>
    <link:label id="lab_bsx_UnrecognizedCompensationCost_documentation_en-US" xlink:label="lab_bsx_UnrecognizedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCost" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UnrecognizedCompensationCost" xlink:to="lab_bsx_UnrecognizedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_78a4df90-b31b-45c5-9389-f02767b2609d_terseLabel_en-US" xlink:label="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of depreciation by reportable segment to total [Table Text Block]</link:label>
    <link:label id="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_label_en-US" xlink:label="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of depreciation by reportable segment to total [Table Text Block]</link:label>
    <link:label id="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_documentation_en-US" xlink:label="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of depreciation by reportable segment to total [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:to="lab_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_a21332e2-f0c4-459f-9921-b79fcdaf8ae3_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments made to prior shareholders to date</link:label>
    <link:label id="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_label_en-US" xlink:label="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments made to prior shareholders to date</link:label>
    <link:label id="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments made to prior shareholders to date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:href="bsx-20201231.xsd#bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:to="lab_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_dcd43579-4610-481c-9da3-64ac36bad6c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_ea77df4b-d70c-4476-80ad-c134c098f091_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_cbd1cdf2-7358-4ef3-b211-c53199e22d13_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_2995f267-f7f4-4151-9fe3-a4cc1d505215_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_cba207f7-1148-43fa-a2e6-c9df7dc00a72_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CardiovascularMember_755f23a3-eab2-4d3e-9d34-9d1f69757f40_terseLabel_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_label_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_documentation_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember" xlink:href="bsx-20201231.xsd#bsx_CardiovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CardiovascularMember" xlink:to="lab_bsx_CardiovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_9d2f4323-9f4c-4d6a-a71a-b2715778d0d1_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_89a66ead-a926-4e61-a909-eb52a5a5b629_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_312301a9-f26b-4885-bf15-47a3ef9f9e35_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_3c93b220-4922-4df1-a3f5-b8e79ba436a7_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</link:label>
    <link:label id="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:to="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_e2ae0ee5-8f63-4858-90cf-6b7441ac3917_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_3ff4aaa0-02e3-4e93-b249-15302cc797a4_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_52cda23c-4e71-42ea-b557-4c5d64443960_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_135632dd-8048-4efa-8f9c-71ea5fb29cb5_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_9619514a-5dfe-4f4e-a1d2-f3738b218c36_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_a4ddf5f0-66c3-4e67-9331-2bd3622df3b2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_0be3531c-6e27-49d3-a837-7549ea509563_terseLabel_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:href="bsx-20201231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:to="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_73bc1e27-128c-4ec4-943b-14a1b1a9bd90_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e091d233-9c78-40f6-8d4b-d8734717583b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_375edac5-4931-46d3-87e3-59f5597647a3_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_6fb9bd74-cd17-4281-b11b-3714b4ccb677_terseLabel_en-US" xlink:label="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales [Table Text Block]</link:label>
    <link:label id="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_label_en-US" xlink:label="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales [Table Text Block]</link:label>
    <link:label id="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income as percentage of net sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:to="lab_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_830bf8fe-37a8-4d94-93cb-466b496723e2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_c78ee566-8859-42cc-abbf-e3c754279cd6_terseLabel_en-US" xlink:label="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fourth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fourth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fourth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20201231.xsd#bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_February2021TermLoanMember_89e036e1-91a7-4d3f-8ef8-f856d1751223_terseLabel_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_February2021TermLoanMember_label_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_February2021TermLoanMember_documentation_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember" xlink:href="bsx-20201231.xsd#bsx_February2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_February2021TermLoanMember" xlink:to="lab_bsx_February2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_069b4074-6e3c-4b79-ac3f-b24c2ae60cc0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_9b383624-1ef0-4399-9920-1d3b24693a5a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeTradeZoneTaxIncentivePerShare_67b6ef4e-e2ad-437f-96cf-db4f51eeac8e_terseLabel_en-US" xlink:label="lab_bsx_FreeTradeZoneTaxIncentivePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive Per Share</link:label>
    <link:label id="lab_bsx_FreeTradeZoneTaxIncentivePerShare_label_en-US" xlink:label="lab_bsx_FreeTradeZoneTaxIncentivePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Tax Incentive, Per Share</link:label>
    <link:label id="lab_bsx_FreeTradeZoneTaxIncentivePerShare_documentation_en-US" xlink:label="lab_bsx_FreeTradeZoneTaxIncentivePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Tax Incentive, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneTaxIncentivePerShare" xlink:href="bsx-20201231.xsd#bsx_FreeTradeZoneTaxIncentivePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeTradeZoneTaxIncentivePerShare" xlink:to="lab_bsx_FreeTradeZoneTaxIncentivePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_cad47870-5759-47c4-bd69-03f59eb93fba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings on credit facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_b91a9e84-3898-432f-a583-1f3cc7b597a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_6f1b6a9e-f0da-46df-a39f-126be2a9605f_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3eebbf66-6de4-407c-a29a-ef84020da789_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_34ae6cdd-bb5e-4fd1-8ecb-6715b0bf2b17_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_300b2cd7-8b02-4570-b262-c8143bc0d396_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_de34348c-7002-4714-90f5-3daa0d1482ed_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_d36100bf-7582-49cd-9636-ee81d6f0df5e_terseLabel_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_label_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_documentation_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:href="bsx-20201231.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:to="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_428f899d-3a0e-4707-8717-7de028fd914d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GoodwillTextualsAbstract_af85db50-a490-4ea6-b5bb-6affe3c4b92a_terseLabel_en-US" xlink:label="lab_bsx_GoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Roll Forward)</link:label>
    <link:label id="lab_bsx_GoodwillTextualsAbstract_label_en-US" xlink:label="lab_bsx_GoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_GoodwillTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_GoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Textuals) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GoodwillTextualsAbstract" xlink:href="bsx-20201231.xsd#bsx_GoodwillTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GoodwillTextualsAbstract" xlink:to="lab_bsx_GoodwillTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_932ae16b-db96-4dd9-be4d-ec4c32c5caa8_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NxTheraIncMember_72b375be-94a1-447a-8eba-1ecb5512da46_terseLabel_en-US" xlink:label="lab_bsx_NxTheraIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NxThera, Inc. [Member]</link:label>
    <link:label id="lab_bsx_NxTheraIncMember_label_en-US" xlink:label="lab_bsx_NxTheraIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NxThera, Inc. [Member]</link:label>
    <link:label id="lab_bsx_NxTheraIncMember_documentation_en-US" xlink:label="lab_bsx_NxTheraIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NxThera [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NxTheraIncMember" xlink:href="bsx-20201231.xsd#bsx_NxTheraIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NxTheraIncMember" xlink:to="lab_bsx_NxTheraIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_db494c97-7991-4f81-a71c-45f32863a2ee_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_19f14f0f-9321-4ed7-8045-5a7c44390f00_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_a9c73f60-81cf-4519-af43-ebff404157ff_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_66840616-4af6-45b6-bcad-209a6c1913cd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_893bb21c-9410-43ce-843c-6e7c3b152b81_terseLabel_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuance (Value in excess of par)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_label_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Common stock)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_documentation_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Common stock)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:href="bsx-20201231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:to="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b44718c-3d20-4a52-bff2-238a76163479_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2615aab2-7a7e-4c08-aca4-7cf6542b221f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_cfd30ae1-ea4b-485e-820b-2a4712c0e828_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_963e1771-5187-4a6d-b011-54f9aa7b4291_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_04af7fca-0216-443f-968d-77813f3ed3d4_verboseLabel_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_label_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_documentation_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:href="bsx-20201231.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:to="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ShareBasedCompensationNetOfTaxBenefit_484d05f6-e2a2-4b3a-a4f1-a7afd5646d97_terseLabel_en-US" xlink:label="lab_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, net of tax benefit</link:label>
    <link:label id="lab_bsx_ShareBasedCompensationNetOfTaxBenefit_label_en-US" xlink:label="lab_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, net of tax benefit</link:label>
    <link:label id="lab_bsx_ShareBasedCompensationNetOfTaxBenefit_documentation_en-US" xlink:label="lab_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, net of tax benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:href="bsx-20201231.xsd#bsx_ShareBasedCompensationNetOfTaxBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:to="lab_bsx_ShareBasedCompensationNetOfTaxBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_b1716eb6-65f0-4c1b-b0f8-0cd7c7ea67ca_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_511f4532-7c96-4b62-aa1a-9cc1865407ae_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_a5e22df2-8d45-4efe-a558-a978e047871c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect adjustment for adoption of ASC 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:to="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_c1b6cd18-f27b-463f-ac09-c053259ee6e7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_a32211e3-b81a-4c1f-bdfb-675b11831f48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_5ff63aec-b86a-4b41-8b8b-81300bf8dea0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for settlements of hedge contracts</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_63173a47-0176-4079-88f7-b899cc03ef59_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeInvestingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_763e758a-b1b7-4b96-937a-a9e380c0e1bd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_3eb40c55-7cdf-4f66-af2f-2bbe12a36386_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_fa2a0dd7-89b9-40a9-9df9-fca24c46d37a_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2d91ebec-060a-4e6c-a076-50c7695b9460_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_80c627bf-0e6d-408d-8bfe-3107050aa224_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_533b028a-a128-462a-a144-ec3e6e7fa511_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL BALANCE SHEET INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_40f94d45-7115-42be-bc3b-26a8181d0dbe_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligation</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsMember" xlink:to="lab_us-gaap_CapitalLeaseObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InventoryStepUpAmortization_dc01c5fd-da8e-4056-b0fb-4d92692bb505_terseLabel_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step-up amortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_label_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">InventoryStepUpAmortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_documentation_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Step Up Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization" xlink:href="bsx-20201231.xsd#bsx_InventoryStepUpAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InventoryStepUpAmortization" xlink:to="lab_bsx_InventoryStepUpAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_073c83a6-92e4-48e2-8c77-408970886eed_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2019RestructuringPlanMember_e9376728-a0ca-434d-8d42-0f48b32d1ea6_terseLabel_en-US" xlink:label="lab_bsx_A2019RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2019RestructuringPlanMember_14ac7db7-6e4a-4712-8736-fda2a45a6085_verboseLabel_en-US" xlink:label="lab_bsx_A2019RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2019RestructuringPlanMember_label_en-US" xlink:label="lab_bsx_A2019RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Restructuring Plan [Member]</link:label>
    <link:label id="lab_bsx_A2019RestructuringPlanMember_documentation_en-US" xlink:label="lab_bsx_A2019RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Restructuring Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember" xlink:href="bsx-20201231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2019RestructuringPlanMember" xlink:to="lab_bsx_A2019RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_23027d0c-08d2-4663-a017-c27e269054cf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_29203b8d-67fa-4c92-b5ce-549297704b5a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_fdcb9152-05cb-4d40-9aa5-8d057c651ba3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UpfrontCashMember_5b247720-4ba5-496e-a873-883ad09d20ff_terseLabel_en-US" xlink:label="lab_bsx_UpfrontCashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Cash [Member]</link:label>
    <link:label id="lab_bsx_UpfrontCashMember_label_en-US" xlink:label="lab_bsx_UpfrontCashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Cash [Member]</link:label>
    <link:label id="lab_bsx_UpfrontCashMember_documentation_en-US" xlink:label="lab_bsx_UpfrontCashMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UpfrontCashMember" xlink:href="bsx-20201231.xsd#bsx_UpfrontCashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UpfrontCashMember" xlink:to="lab_bsx_UpfrontCashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_e6ceb6ba-7d90-448d-9ab4-738de3685d3f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related net charges (credits)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_adaf4514-8914-4ce4-8ef9-6782c2c4fc29_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_28bf1324-6c91-41bd-92b7-402825246229_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82a5287a-3e51-4a57-ad65-52bab775c6af_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef2deb00-eafd-42c6-9b79-74e3e6cd324d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_2291d836-65aa-4c87-90e0-c8c511ef79f1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_ada08bd7-6462-49f0-a431-5ececc524dbe_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MillipedeMember_8f5e5de9-9eb1-440c-863f-9be6aa5d9995_terseLabel_en-US" xlink:label="lab_bsx_MillipedeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede [Member]</link:label>
    <link:label id="lab_bsx_MillipedeMember_label_en-US" xlink:label="lab_bsx_MillipedeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede [Member]</link:label>
    <link:label id="lab_bsx_MillipedeMember_documentation_en-US" xlink:label="lab_bsx_MillipedeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember" xlink:href="bsx-20201231.xsd#bsx_MillipedeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MillipedeMember" xlink:to="lab_bsx_MillipedeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3d8d816d-5f68-44f8-9452-ddff51c64b21_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity-Wide Disclosure on Geographic Areas, Revenue from External Customers Attributed to Individual Foreign Countries [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_db7e97c0-7335-4e61-ae59-8a890606bb26_verboseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_a19f8012-157e-4541-9b69-dc2ab2b4f0fe_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d709f168-1000-4342-b4da-2e30209067f2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5df5e0e5-c124-4a59-855d-e3666642536a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_61a37d93-1b76-4e89-90b0-da216dee9167_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2020NotesMember_98a0a81f-5136-4740-b8ee-23141f0973e9_terseLabel_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2020NotesMember_label_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2020NotesMember_documentation_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember" xlink:href="bsx-20201231.xsd#bsx_May2020NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2020NotesMember" xlink:to="lab_bsx_May2020NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a3e81a3e-1549-4d57-bfa8-f2b849bf1fd8_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_e51834e4-d64a-4629-b825-8c416fe193e7_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_5feefe18-8db1-42b4-a29d-ffe7348c32a7_terseLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_4d2807f5-aca6-4d90-89d3-08e4d099e7a8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_2035f5ca-9a44-4f8c-a601-fc98552b1b40_terseLabel_en-US" xlink:label="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Liabilities and Prepaid on Intercompany Profit</link:label>
    <link:label id="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_label_en-US" xlink:label="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Assets and Prepaid on Intercompany Profit</link:label>
    <link:label id="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_documentation_en-US" xlink:label="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Assets and Prepaid on Intercompany Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:href="bsx-20201231.xsd#bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:to="lab_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_9219a81b-52c7-4045-af94-3abe98485d53_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_4a65fa4a-fc7e-41b9-97d8-c08f10ec2ec8_terseLabel_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_label_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]</link:label>
    <link:label id="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:to="lab_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_62dc4ad2-5834-4178-a602-e9c60a34854e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_2dad6edb-1784-48d4-ad0e-1687790c6564_terseLabel_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_label_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_documentation_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:to="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_fcc33ff1-3b82-4147-80b3-2848b5ab896b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8d2024ea-0655-4647-9586-e80e4989ef90_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_2d615203-a090-464f-8669-1e68eee66cb3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_38364560-0e5c-463d-aae2-7616782ddfdc_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_dea865dc-6c86-47cb-bad8-1a255879189d_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3bf93de8-4d37-4862-b0aa-d83f0a39200e_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT REPORTING</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_7c8b6640-2717-4354-8cbc-9a9ad8d9d3e2_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_b52151a0-3e49-4ac8-950a-f2adaeee58cb_verboseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ConsolidatedBSXDomain_0cffd515-ea31-4a6d-80e6-ad6332325d9d_terseLabel_en-US" xlink:label="lab_bsx_ConsolidatedBSXDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated BSX [Domain]</link:label>
    <link:label id="lab_bsx_ConsolidatedBSXDomain_label_en-US" xlink:label="lab_bsx_ConsolidatedBSXDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated BSX [Domain]</link:label>
    <link:label id="lab_bsx_ConsolidatedBSXDomain_documentation_en-US" xlink:label="lab_bsx_ConsolidatedBSXDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated BSX</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBSXDomain" xlink:href="bsx-20201231.xsd#bsx_ConsolidatedBSXDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ConsolidatedBSXDomain" xlink:to="lab_bsx_ConsolidatedBSXDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_45a27529-f7b7-4382-a701-75b44e63e9ed_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_89e4fc27-5034-4809-a81d-41c1a5f8422c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_08409a59-75d7-4a27-903a-d339aa3f438b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_630164f8-9eea-46b5-8c7c-eb3e0532fd67_terseLabel_en-US" xlink:label="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Leases, Option to Extend</link:label>
    <link:label id="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_label_en-US" xlink:label="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Leases, Option to Extend</link:label>
    <link:label id="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_documentation_en-US" xlink:label="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Leases, Option to Extend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:href="bsx-20201231.xsd#bsx_LesseeOperatingAndFinanceLeasesOptionToExtend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:to="lab_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_5121ad40-4dbd-4d45-b9af-c862991a6a22_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6ba109fb-0f0e-46f4-a628-97eb56811297_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_c00980e8-ca2d-48a0-a94d-6219988bae72_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_f17fb2d1-bdc9-428c-92c2-a4a4d3f861cb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SignificantAccountingPoliciesLineItems_b8416100-0839-4584-baed-cafd69546a96_terseLabel_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesLineItems" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems" xlink:to="lab_bsx_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2030NotesMember_fe724fb6-f9e8-405f-959e-dfa77cebfa1f_terseLabel_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_label_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_documentation_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember" xlink:href="bsx-20201231.xsd#bsx_June2030NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2030NotesMember" xlink:to="lab_bsx_June2030NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_0914997d-0832-4d39-857a-b177477d9b51_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_9f059e6a-5674-43e2-8269-544be42b4e47_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Compensation Expense</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_02cb5b94-9d8e-447d-b623-bae0ef55123b_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_a2b20b16-da70-4a14-acac-6d3041afa17c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f8f4cff0-004e-4ad1-8b57-233256ab7034_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_516515f7-0251-4e42-aa52-d9c9e7efe8b2_terseLabel_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average remaining contractual life</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average remaining contractual life</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest, weighted average remaining contractual life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:to="lab_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_8611bfc3-1be6-48b6-9ba9-4d4f9055707f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_3fdee7d9-3643-45c3-a31a-04c1305dd119_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_928c25f6-33dd-4198-9f97-156d3108b9b0_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringRelatedExpenses_c475bdc4-0a6a-4cf5-83ee-daa3f0977044_terseLabel_en-US" xlink:label="lab_bsx_RestructuringRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Expenses</link:label>
    <link:label id="lab_bsx_RestructuringRelatedExpenses_label_en-US" xlink:label="lab_bsx_RestructuringRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Expenses</link:label>
    <link:label id="lab_bsx_RestructuringRelatedExpenses_documentation_en-US" xlink:label="lab_bsx_RestructuringRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring related expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedExpenses" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringRelatedExpenses" xlink:to="lab_bsx_RestructuringRelatedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_18deac00-75c3-4566-b5c8-79b5a1fba017_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_b2e805fe-d5e9-42c0-b007-ff29870bfa1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_66e9b9da-661a-490b-b3df-2200338f1da8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_6fdafa3d-de3b-4447-901b-1cccebfdc2e9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_847aef14-46da-49db-a78c-ce85d0d531ac_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherInternationalPlansMember_dbd61f8f-2b10-4cc8-b91e-42b5ebb00ba4_terseLabel_en-US" xlink:label="lab_bsx_OtherInternationalPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International Plans</link:label>
    <link:label id="lab_bsx_OtherInternationalPlansMember_label_en-US" xlink:label="lab_bsx_OtherInternationalPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International Plans [Member]</link:label>
    <link:label id="lab_bsx_OtherInternationalPlansMember_documentation_en-US" xlink:label="lab_bsx_OtherInternationalPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other International Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherInternationalPlansMember" xlink:href="bsx-20201231.xsd#bsx_OtherInternationalPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherInternationalPlansMember" xlink:to="lab_bsx_OtherInternationalPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_00c944d3-1b9e-4d96-b79b-cb8b859437f0_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average interest rate of de-recognized receivables</link:label>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_label_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable with Imputed Interest, Effective Yield (Interest Rate)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:to="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_bbf6a641-6157-48bf-8017-329da6d6b45f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_32a9ac7c-7307-465c-aa76-91e65cfccb04_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_112f9ed0-25f5-4da4-b5af-81f7f26a7634_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_33889a51-3593-445d-bba4-e5ca0915b175_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_October2023NotesMember_86c966c0-2011-4251-ba87-77c582e989f5_terseLabel_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_label_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_documentation_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember" xlink:href="bsx-20201231.xsd#bsx_October2023NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_October2023NotesMember" xlink:to="lab_bsx_October2023NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_314fcc3b-8b15-4055-bf29-aa43534cae66_negatedTerseLabel_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_label_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_documentation_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights" xlink:href="bsx-20201231.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentsForRoyaltyRights" xlink:to="lab_bsx_PaymentsForRoyaltyRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7d3c9c13-6388-4e3c-bd9a-5768ff2f4717_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_65fc243b-37b7-47ce-9755-12bf99ede35f_terseLabel_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_label_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_documentation_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh" xlink:href="bsx-20201231.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CertifiedclassactionsinCanadaMesh" xlink:to="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost_d080290b-8303-4dc0-a713-f8e8323404cb_terseLabel_en-US" xlink:label="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring-related Cost, Expected Cost</link:label>
    <link:label id="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost_label_en-US" xlink:label="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring-related Cost, Expected Cost</link:label>
    <link:label id="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost_documentation_en-US" xlink:label="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring-related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRestructuringrelatedCostExpectedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:to="lab_bsx_RestructuringandRestructuringrelatedCostExpectedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_8070984f-a2d0-4cb6-8592-7db3ffca44e3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_b6c9080a-1f5c-4679-b126-f40bd1d955bb_terseLabel_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:href="bsx-20201231.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:to="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_41f19939-11c6-4325-bf30-bb9a4dd5daff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_7c3f21c1-2764-41f7-97fe-657ea3738c67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_ba920542-56e6-4107-8a46-62133de46edb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_dabde746-f7b2-410c-bf1e-040d1cdf228a_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims in Canada, Mesh</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:href="bsx-20201231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentive_3513ae19-df62-433d-b754-7c8a2c09ec40_terseLabel_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive</link:label>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentive_label_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive</link:label>
    <link:label id="lab_bsx_FreeTradeZoneRegimeTaxIncentive_documentation_en-US" xlink:label="lab_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Trade Zone Regime Tax Incentive</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:href="bsx-20201231.xsd#bsx_FreeTradeZoneRegimeTaxIncentive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:to="lab_bsx_FreeTradeZoneRegimeTaxIncentive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_8ae7eff8-d865-4e69-b230-a29d00b1c851_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_c308c7ac-5da8-4cbf-b107-dbefcbbc0c1f_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_755b9225-c8f6-45f6-a1f1-6baa22a7b202_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_2f029048-7db5-49a1-8860-ac6b9fa6ab23_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_64d3532f-9f38-4ddc-89db-9cb6d9b40e93_terseLabel_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return to provision</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_label_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return to provision</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_documentation_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return to provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:to="lab_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_0df88639-344b-4166-b4a5-dd177e8c045c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_62847633-94f2-4521-990d-de6ed2d79d7d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_49b1c7fd-c4b4-4ed0-919c-d056880bb914_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_edf6eb42-a420-4813-b4bc-fff6c7336aef_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SignificantAccountingPoliciesAbstract_f0f2e9ba-0853-4d7d-b806-a1b5de09f960_terseLabel_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesAbstract_label_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:label id="lab_bsx_SignificantAccountingPoliciesAbstract_documentation_en-US" xlink:label="lab_bsx_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesAbstract" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract" xlink:to="lab_bsx_SignificantAccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_2b304630-c362-493b-94ca-4802ad0b7950_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_afb0c0ec-a60b-46e4-accc-364ccce58b22_terseLabel_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_label_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, PBO</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_documentation_en-US" xlink:label="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Acquired and Established Plan Changes, PBO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:to="lab_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_4e77ee49-6bd7-4a6d-9215-bf95c90c7401_terseLabel_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember" xlink:href="bsx-20201231.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TwoYearDelayedDrawTermLoanMember" xlink:to="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_9a9628db-f389-4392-b217-3622f1668025_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_0f416322-f0a5-45eb-b9d1-25d01c6b2d3d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_ea3b0c5c-9ae2-429b-b099-bc79834f6914_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_8442a3a9-0f52-4edc-a2af-55d37b8e5a16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_cb948a4c-a9b0-40c5-b69b-97c67eff0f95_terseLabel_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:href="bsx-20201231.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock_ed801e45-85e5-485b-81f7-000806990ff0_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2016-13 Financial Instruments - Credit Losses (FASB ASC Topic 326, Financial Instruments - Credit Losses)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2016-13 Financial Instruments - Credit Losses (FASB ASC Topic 326, Financial Instruments - Credit Losses) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2016-13 Financial Instruments - Credit Losses (FASB ASC Topic 326, Financial Instruments - Credit Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_245bb3c8-f205-43df-a1a4-1ffcfbdebd3d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CryterionMedicalIncMember_977210f7-34c4-4afd-a7e2-15d7d989e7ac_terseLabel_en-US" xlink:label="lab_bsx_CryterionMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cryterion Medical, Inc. [Member]</link:label>
    <link:label id="lab_bsx_CryterionMedicalIncMember_label_en-US" xlink:label="lab_bsx_CryterionMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cryterion Medical, Inc. [Member]</link:label>
    <link:label id="lab_bsx_CryterionMedicalIncMember_documentation_en-US" xlink:label="lab_bsx_CryterionMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cryterion [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CryterionMedicalIncMember" xlink:href="bsx-20201231.xsd#bsx_CryterionMedicalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CryterionMedicalIncMember" xlink:to="lab_bsx_CryterionMedicalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact_79d5c606-bd8e-48e8-9bdb-a5ab200bd074_terseLabel_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, TCJA net impact</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact_label_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, TCJA net impact</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact_documentation_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, TCJA net impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact" xlink:to="lab_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_30ede835-3aef-40ec-bf8e-06e7cecdee4a_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_6b911c26-6330-40da-bd05-2c3d4b7429ac_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_40d6b3c5-420d-4f64-b7bb-d5fbb321653e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_2722f51f-9505-475a-bb74-890f118d5188_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_46b58b62-3740-4fe5-9d6c-132b4bcda9d8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AssignedToOneJudgeInMAMember_0298a3f5-c0c2-40a2-bce1-45df0c60ccc9_terseLabel_en-US" xlink:label="lab_bsx_AssignedToOneJudgeInMAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA [Member]</link:label>
    <link:label id="lab_bsx_AssignedToOneJudgeInMAMember_label_en-US" xlink:label="lab_bsx_AssignedToOneJudgeInMAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA [Member]</link:label>
    <link:label id="lab_bsx_AssignedToOneJudgeInMAMember_documentation_en-US" xlink:label="lab_bsx_AssignedToOneJudgeInMAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedToOneJudgeInMAMember" xlink:href="bsx-20201231.xsd#bsx_AssignedToOneJudgeInMAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AssignedToOneJudgeInMAMember" xlink:to="lab_bsx_AssignedToOneJudgeInMAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_bae0b08c-8d06-465a-a9d6-287257b9c2c9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_f5407b33-d090-4a1f-a254-8f1d32d57b7a_terseLabel_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_label_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_documentation_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain" xlink:href="bsx-20201231.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationSettlementReceivedGain" xlink:to="lab_bsx_LitigationSettlementReceivedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_a386ea10-de99-47d1-bf55-5e647b06c603_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term borrowings and debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2115ff8f-db5f-4d1a-9514-e66cb735772f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_a7de5cbf-f702-4df6-84c1-f7182d525357_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cca91b6a-9b02-44c1-8da6-83ea0e729d87_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_a595c6cb-a979-4f92-a006-6cdc72d480f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ea044703-1dc0-4f1f-aed5-f7e3b98a3d9a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f499bd56-0139-49d4-97de-e2449747ff57_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_554ebaee-38a3-4f48-a1c1-c04ddcba8a5c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_bd0e7611-e5b9-4c08-962a-698ba0e1b43d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credits, Research</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_39d73ab7-bc29-42b7-ac2a-3dfda8154f91_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Nonvestedstockawardsexerciseprice_11b69a54-0ce5-4d29-9a27-92073efc43d6_terseLabel_en-US" xlink:label="lab_bsx_Nonvestedstockawardsexerciseprice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified options exercise price</link:label>
    <link:label id="lab_bsx_Nonvestedstockawardsexerciseprice_label_en-US" xlink:label="lab_bsx_Nonvestedstockawardsexerciseprice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested stock awards exercise price</link:label>
    <link:label id="lab_bsx_Nonvestedstockawardsexerciseprice_documentation_en-US" xlink:label="lab_bsx_Nonvestedstockawardsexerciseprice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested stock awards exercise price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Nonvestedstockawardsexerciseprice" xlink:href="bsx-20201231.xsd#bsx_Nonvestedstockawardsexerciseprice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Nonvestedstockawardsexerciseprice" xlink:to="lab_bsx_Nonvestedstockawardsexerciseprice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_853dd508-b31a-40b6-a9b4-5462e3a10cbe_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_e7a0dc7e-43f5-4a51-b5e1-8d5c2a7dc8a4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Fairvalueofmarketbasedawards_fb911085-a73d-4430-b5e9-c2994f700c3a_terseLabel_en-US" xlink:label="lab_bsx_Fairvalueofmarketbasedawards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of market based awards</link:label>
    <link:label id="lab_bsx_Fairvalueofmarketbasedawards_label_en-US" xlink:label="lab_bsx_Fairvalueofmarketbasedawards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of market based awards</link:label>
    <link:label id="lab_bsx_Fairvalueofmarketbasedawards_documentation_en-US" xlink:label="lab_bsx_Fairvalueofmarketbasedawards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of market based awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Fairvalueofmarketbasedawards" xlink:href="bsx-20201231.xsd#bsx_Fairvalueofmarketbasedawards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Fairvalueofmarketbasedawards" xlink:to="lab_bsx_Fairvalueofmarketbasedawards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_38be3d57-d0b4-41ea-9d28-ea867b472bb3_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_1fb3d6a4-fdfe-47e7-8060-6d9cc9ad63b8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a1f948eb-78e2-441b-ba59-912a5ee7c110_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_bf9f5760-7c54-48b7-9830-8f9493eda4a6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Retirement Plan Rate of Compensation Increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_27df980d-f337-4b51-9c93-0710fe10cabe_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC [Member]</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d503d84c-cbb9-435d-bbf7-da9060a2878f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_590da816-83b4-41dd-82e7-cb5099c7c9b8_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Valuation Allowance, Intra-entity</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_label_en-US" xlink:label="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Valuation Allowance, Intra-entity</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_documentation_en-US" xlink:label="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Valuation Allowance, Intra-entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetValuationAllowanceIntraEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:to="lab_bsx_DeferredTaxAssetValuationAllowanceIntraEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2011LtipPlanMember_0f669a06-8dc9-4fe5-8129-f2d14387c28c_terseLabel_en-US" xlink:label="lab_bsx_A2011LtipPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP Plan [Member]</link:label>
    <link:label id="lab_bsx_A2011LtipPlanMember_label_en-US" xlink:label="lab_bsx_A2011LtipPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP Plan [Member]</link:label>
    <link:label id="lab_bsx_A2011LtipPlanMember_documentation_en-US" xlink:label="lab_bsx_A2011LtipPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 LTIP Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2011LtipPlanMember" xlink:href="bsx-20201231.xsd#bsx_A2011LtipPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2011LtipPlanMember" xlink:to="lab_bsx_A2011LtipPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_37b05aa7-90a4-470c-b719-1332f78d51e3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_b78aca95-63a6-4606-9067-2d10bd779853_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_fcf38951-ac8a-4df6-acbd-3754213f0ffb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExecutiveRetirementPlanMember_b9b19168-323b-4407-87f3-aff1fafdd875_terseLabel_en-US" xlink:label="lab_bsx_ExecutiveRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive retirement plan [Member]</link:label>
    <link:label id="lab_bsx_ExecutiveRetirementPlanMember_label_en-US" xlink:label="lab_bsx_ExecutiveRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive retirement plan [Member]</link:label>
    <link:label id="lab_bsx_ExecutiveRetirementPlanMember_documentation_en-US" xlink:label="lab_bsx_ExecutiveRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive retirement plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember" xlink:href="bsx-20201231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExecutiveRetirementPlanMember" xlink:to="lab_bsx_ExecutiveRetirementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_636287aa-10f8-4c2f-ab60-718066fa7a94_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_3535ecd3-2824-429d-b6ed-43926836e775_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_75be9568-7861-4306-b528-924e393dc0c0_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_8424f6d9-18e2-4040-98d7-6b064dc06bc1_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_99c40ec8-02a5-45a7-bfaf-6e3a5b1746fc_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e5187cc3-1b22-4b15-afbd-317edef565e0_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_708b1383-f44b-406a-9a2e-106095ee7579_terseLabel_en-US" xlink:label="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of the fair market value of our common stock on the date of grant</link:label>
    <link:label id="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_label_en-US" xlink:label="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of the fair market value of our common stock on the date of grant</link:label>
    <link:label id="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_documentation_en-US" xlink:label="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of the fair market value of our common stock on the date of grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:href="bsx-20201231.xsd#bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:to="lab_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_f4be5a21-c5e4-4847-9319-1f237012ab58_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_d151bcbf-f80c-40dc-b894-3d637a76c1c9_terseLabel_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20201231.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2020NotesMember_3b456230-72fa-4ae3-82fa-23a8e66a8b3d_terseLabel_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2020NotesMember_label_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2020NotesMember_documentation_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember" xlink:href="bsx-20201231.xsd#bsx_January2020NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2020NotesMember" xlink:to="lab_bsx_January2020NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_b18b86e9-08d5-4737-acf9-d28b362fcaa5_terseLabel_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred and prepaid income taxes</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:href="bsx-20201231.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:to="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_0de76d54-94dd-4eee-b89f-5831e178a890_terseLabel_en-US" xlink:label="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market-based awards, valuation assumptions [Table Text Block]</link:label>
    <link:label id="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market-based awards, valuation assumptions [Table Text Block]</link:label>
    <link:label id="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market-based awards, valuation assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:to="lab_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_e663ebfb-39fb-46f8-90ba-8e826ec0c136_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_00e13c26-cb3e-4cfe-bdaf-46de46290554_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_bcdb956c-2eef-4fda-bf63-3eb743b80497_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_55bd058c-bf0e-4603-b037-761888d1a856_terseLabel_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember" xlink:href="bsx-20201231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BSXReportableSegmentsMember" xlink:to="lab_bsx_BSXReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashMember_b7d033fe-161a-4ba5-930a-971932b0522e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_29067577-28f5-45b4-8452-2b883ab752ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2035NotesMember_ad5e1b0d-612c-4bb1-b438-45bd758aff62_terseLabel_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_label_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_documentation_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember" xlink:href="bsx-20201231.xsd#bsx_November2035NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2035NotesMember" xlink:to="lab_bsx_November2035NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_5dc9d246-accb-415f-9ff0-494440a9729b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_4a31c36d-9871-4e48-b096-194e7cf338fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_dae8c4d8-70ec-4872-a480-427a53bc288a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_3423a209-8064-471b-b875-26d6bbdf867e_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_825ed483-e996-4ebf-b075-3bd87f9aaa0e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_e416d282-4390-4be5-a617-8227f3ad7496_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_2dc6793b-8f66-4905-98d9-a1aaddee3477_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_90f5a9e7-e91e-4fc7-9355-7ea8e2fed714_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UKPlanMember_9d281211-7c66-4633-bc10-7c00917db877_terseLabel_en-US" xlink:label="lab_bsx_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Plan</link:label>
    <link:label id="lab_bsx_UKPlanMember_label_en-US" xlink:label="lab_bsx_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Plan [Member]</link:label>
    <link:label id="lab_bsx_UKPlanMember_documentation_en-US" xlink:label="lab_bsx_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember" xlink:href="bsx-20201231.xsd#bsx_UKPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UKPlanMember" xlink:to="lab_bsx_UKPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_20c86fa9-9bdd-4299-a216-d94013e2885f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6ab1d41e-2bff-4a91-b068-ddfec8442645_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NetCurrencyExchangeGainLoss_6eb237c7-ddfe-4c49-ab1d-8c53498215ef_negatedTerseLabel_en-US" xlink:label="lab_bsx_NetCurrencyExchangeGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gain) loss</link:label>
    <link:label id="lab_bsx_NetCurrencyExchangeGainLoss_8e85d461-46c1-48ac-85a4-67358283e020_terseLabel_en-US" xlink:label="lab_bsx_NetCurrencyExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gain) loss</link:label>
    <link:label id="lab_bsx_NetCurrencyExchangeGainLoss_label_en-US" xlink:label="lab_bsx_NetCurrencyExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_NetCurrencyExchangeGainLoss_documentation_en-US" xlink:label="lab_bsx_NetCurrencyExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss" xlink:href="bsx-20201231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NetCurrencyExchangeGainLoss" xlink:to="lab_bsx_NetCurrencyExchangeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_abc693b5-f906-4f6d-af4d-0ce5e19ac5a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_2823aba8-bd20-4390-ba1d-eb7c207d2a4b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_fbe3ecb9-03a3-49b4-957d-ffc3ac806f80_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_449766f6-0f7a-4f3f-a464-cdafce5d488d_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9789b21d-ba94-482e-ab02-680b999533ea_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherOtherLongTermAssets_aec7c77c-10e6-4911-8e2a-f0fd447ddd3c_terseLabel_en-US" xlink:label="lab_bsx_OtherOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongTermAssets_label_en-US" xlink:label="lab_bsx_OtherOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongTermAssets_documentation_en-US" xlink:label="lab_bsx_OtherOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongTermAssets" xlink:href="bsx-20201231.xsd#bsx_OtherOtherLongTermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherOtherLongTermAssets" xlink:to="lab_bsx_OtherOtherLongTermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_c23e2e8c-8155-4b5c-ab2e-d4011db845d4_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_5a4b00fa-b612-4c05-867d-1bc3e9e94335_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_19e58b68-a4ca-4bd4-bde9-c87e5e1b8ca0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_93f960aa-456b-4f13-8324-28ab0885bf03_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_793ba79a-f169-402f-b139-0e5957bb8064_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_2f6aca2f-519c-478b-9db8-92f26662c41e_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States [Member]</link:label>
    <link:label id="lab_country_US_49ed41a0-064a-4d6c-b32f-621680633080_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_7960134f-ca4d-4d2a-8512-f25ec88b8d26_verboseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals)</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:href="bsx-20201231.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_acf0defb-57cb-4331-baab-4058b497fcde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60b2e8df-967a-4179-957f-766b9d9c3e2e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b16a6495-a0aa-45d2-8316-6e82094730ba_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDER'S EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d3e1d750-3121-441e-b67e-89dc9130f751_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_40947b02-914b-44a6-8ceb-55b65d9e3e36_totalLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments Due</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NetSettlementPaymenttoIRS_1870a52d-59d0-4bc6-942c-5c67b2530e43_terseLabel_en-US" xlink:label="lab_bsx_NetSettlementPaymenttoIRS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Settlement Payment to IRS</link:label>
    <link:label id="lab_bsx_NetSettlementPaymenttoIRS_label_en-US" xlink:label="lab_bsx_NetSettlementPaymenttoIRS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Settlement Payment to IRS</link:label>
    <link:label id="lab_bsx_NetSettlementPaymenttoIRS_documentation_en-US" xlink:label="lab_bsx_NetSettlementPaymenttoIRS" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Settlement Payment to IRS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetSettlementPaymenttoIRS" xlink:href="bsx-20201231.xsd#bsx_NetSettlementPaymenttoIRS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NetSettlementPaymenttoIRS" xlink:to="lab_bsx_NetSettlementPaymenttoIRS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_88ae1918-ab30-493a-8295-e5c53306707e_verboseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_ad671577-039c-4f53-ba54-1fa7bdfb95b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_d21bc53b-32fb-46ca-a55e-0629ee14389a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_29611ac6-75c4-4e47-9f42-18e911a8f70c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_2690cae6-3646-4694-8f24-9af452670160_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments, Due in Three Years</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_369a9df6-df9a-4a3b-adc0-4524537fc85d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7c7d2e86-14a2-42ab-bda9-75163cf5a288_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_15e18a21-2c61-4102-9846-b024a7b67991_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_74cb048f-e620-42b6-bc67-2ea75798cfae_terseLabel_en-US" xlink:label="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the Free Cash Flow (FCF) performance awards</link:label>
    <link:label id="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_label_en-US" xlink:label="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the Free Cash Flow (FCF) performance awards</link:label>
    <link:label id="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_documentation_en-US" xlink:label="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the Free Cash Flow (FCF) performance awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:href="bsx-20201231.xsd#bsx_FairValueOfFreeCashFlowFcfPerformanceAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:to="lab_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_cc994ffc-2cfd-445f-b4ec-92c94d3ccd7a_terseLabel_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_label_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2019 Aggregate Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember" xlink:href="bsx-20201231.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_February2019AggregateOfferingMember" xlink:to="lab_bsx_February2019AggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b3e92a13-300b-4968-8bde-90c48b253845_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds on disposals of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_39db4e85-aeed-4eaf-87b0-0112df6dbf01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_0b5821bd-29b0-40fb-8e91-d157c860bcac_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_2f7b105b-0ad1-4819-8630-b2e4e29646a4_terseLabel_en-US" xlink:label="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Cash Flow Supplemental Disclosure [Abstract]</link:label>
    <link:label id="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_label_en-US" xlink:label="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Cash Flow Supplemental Disclosure [Abstract]</link:label>
    <link:label id="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_documentation_en-US" xlink:label="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Cash Flow Supplemental Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:href="bsx-20201231.xsd#bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:to="lab_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_900c37ff-ccd0-4f1e-b1fc-95b4ac346c9b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ff51c813-8ef7-44e0-bdea-7004cd04808c_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_60f2541a-797c-472c-8037-1f09d2e449f6_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_64300c8f-ef0b-4de5-8345-91d1bf12d3e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7deeca65-0ae3-4570-9ffe-1a9572f241ca_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_4b6a976a-6dc5-4f77-9005-f66b3be8e179_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_29a4db78-2532-4167-9db6-3e3eec9788b9_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:href="bsx-20201231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_91f0a0a1-7812-4afc-b8c3-9eeb7d5f45e3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_746e75ee-bfa1-45aa-be67-72d6cb6f50b6_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_94d5b40d-17f0-477c-af1e-ac22a9f3fd22_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_bb5db644-e823-4348-b8ea-11842dc13c82_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0ed16614-6b99-4f7f-911b-dafce549f0dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized costs associated with defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_bfd40a0c-4c40-4929-b3e8-0aa70708fa78_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a8690489-8c5f-45e6-84a0-986af1674127_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_180c4871-4d47-4c63-8256-210638e45df8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_762769c0-5ae9-45c0-912d-561f9fe2feaf_terseLabel_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_label_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_documentation_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:to="lab_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_68c3255c-4801-45ac-a9ff-aa2eb4af73ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_322845b6-9737-4ee0-84b0-db731486f68c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_224cdd4f-1c5c-44e1-a2ca-db5aee3d1966_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_080b8bbb-7c2c-454a-b89c-80bc347603ed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:to="lab_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_3fb70ba8-40e2-4ebc-8e88-751558cd40ef_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NVisionMedicalCorporationMember_c13bcc7b-19a7-4704-b831-645bc584d4ce_terseLabel_en-US" xlink:label="lab_bsx_NVisionMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">nVision Medical Corporation [Member]</link:label>
    <link:label id="lab_bsx_NVisionMedicalCorporationMember_label_en-US" xlink:label="lab_bsx_NVisionMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">nVision Medical Corporation [Member]</link:label>
    <link:label id="lab_bsx_NVisionMedicalCorporationMember_documentation_en-US" xlink:label="lab_bsx_NVisionMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">nVision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NVisionMedicalCorporationMember" xlink:href="bsx-20201231.xsd#bsx_NVisionMedicalCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NVisionMedicalCorporationMember" xlink:to="lab_bsx_NVisionMedicalCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_d5eb4fc7-f231-4f2a-9677-cf3c11a283cc_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4021b883-80a2-4b22-b85c-0ee2eb1850b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_fe1bb381-f54e-4aed-b522-8bc8ff71ec86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_457ec26f-412f-43cc-8205-6995a75d8056_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_45882e97-40bb-4241-b845-a145b4fb6d83_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_3b4939dd-809f-4300-b557-f2306c9830e3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and restricted cash equivalents included in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TheCARESAct_6733f2c6-c1bf-45fd-8c77-78e965dfab7e_terseLabel_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:label id="lab_bsx_TheCARESAct_label_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:label id="lab_bsx_TheCARESAct_documentation_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct" xlink:href="bsx-20201231.xsd#bsx_TheCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TheCARESAct" xlink:to="lab_bsx_TheCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3e2e66e9-fc11-4ed4-b4d9-97893ffca6f7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_2c58767b-37bf-41d1-9390-efe91a75b2e9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IncomeTaxesAbstract_d4215885-1a4e-4507-a4a3-6eb6f3e79832_terseLabel_en-US" xlink:label="lab_bsx_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:label id="lab_bsx_IncomeTaxesAbstract_label_en-US" xlink:label="lab_bsx_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:label id="lab_bsx_IncomeTaxesAbstract_documentation_en-US" xlink:label="lab_bsx_IncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IncomeTaxesAbstract" xlink:href="bsx-20201231.xsd#bsx_IncomeTaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IncomeTaxesAbstract" xlink:to="lab_bsx_IncomeTaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_54e2a0ea-7c76-4aaf-834d-7338b5014e9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_7d03302b-ec65-4eb1-8613-3e1240ea8a02_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_f355a05d-c0ed-4de8-85cb-b532aa2f59d3_terseLabel_en-US" xlink:label="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout of Free Cash Flows (FCF) performance awards</link:label>
    <link:label id="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_label_en-US" xlink:label="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout of Free Cash Flows (FCF) performance awards</link:label>
    <link:label id="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_documentation_en-US" xlink:label="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target payout of Free Cash Flows (FCF) performance awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:href="bsx-20201231.xsd#bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:to="lab_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_b53d049c-eb68-4710-a1b1-739349460bd1_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_31082205-af61-46ee-975b-9200758bc819_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share &#8212; basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8db366a7-7934-4ce8-a76d-33ff0446a543_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_271ba8bd-daa4-4853-a83c-bcc8279f1b03_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:href="bsx-20201231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_99af99d7-1343-47b5-9f3c-8b22fa15b5d4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_c6b0df65-f369-4dec-8db8-d17c1257855f_terseLabel_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issuance (Value in excess of par)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_label_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Preferred stock)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_documentation_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Preferred stock)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:href="bsx-20201231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:to="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b2872017-61d5-4ff1-b050-c1d5ee4eb3e8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_5d846af9-4306-4890-b750-739af1b8d566_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_95cb7960-3513-4787-8dab-99940cc67c02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_0e1349b0-4537-4355-951d-c3b13a63500c_terseLabel_en-US" xlink:label="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Text Block]</link:label>
    <link:label id="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_label_en-US" xlink:label="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Table Text Block]</link:label>
    <link:label id="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_documentation_en-US" xlink:label="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of cash paid in the period to fully or partially settle a specified type of restructuring cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:to="lab_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_907ad1fe-38b4-4090-87ee-b71757d6b1f1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2022NotesMember_322b0c86-3efe-4864-b129-31898055df38_verboseLabel_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_label_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_documentation_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember" xlink:href="bsx-20201231.xsd#bsx_May2022NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2022NotesMember" xlink:to="lab_bsx_May2022NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_b5dd65bc-52e8-4f16-a442-2be32b09658b_terseLabel_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_label_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:to="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment_dc43beb8-496f-4cc0-af88-a6333456e8c0_terseLabel_en-US" xlink:label="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time transaction tax post-1986 E&amp;P - net payment</link:label>
    <link:label id="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment_label_en-US" xlink:label="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time transaction tax post-1986 E&amp;P - net payment</link:label>
    <link:label id="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment_documentation_en-US" xlink:label="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-time transaction tax post-1986 E&amp;P - net payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:href="bsx-20201231.xsd#bsx_Onetimetransactiontaxpost1986EPnetpayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:to="lab_bsx_Onetimetransactiontaxpost1986EPnetpayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d4cd177e-73c6-48d8-af41-b78142bf3168_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_41616b88-529d-44f5-a17e-0b2b8d1318d0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Other2018AcquisitionsMember_7d2aa4d6-d07b-4686-a211-4bedbff21bb2_terseLabel_en-US" xlink:label="lab_bsx_Other2018AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other 2018 Acquisitions [Member]</link:label>
    <link:label id="lab_bsx_Other2018AcquisitionsMember_label_en-US" xlink:label="lab_bsx_Other2018AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other 2018 Acquisitions [Member]</link:label>
    <link:label id="lab_bsx_Other2018AcquisitionsMember_documentation_en-US" xlink:label="lab_bsx_Other2018AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other 2018 Acquisitions - immaterial in the aggregate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Other2018AcquisitionsMember" xlink:href="bsx-20201231.xsd#bsx_Other2018AcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Other2018AcquisitionsMember" xlink:to="lab_bsx_Other2018AcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_ec8c12e6-f5fb-41fa-9402-48bd67dea112_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bf1a7dca-5819-4ca5-99ec-4518588c30b4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f9fd3525-27ff-4d93-af3c-ae25ad9410ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_65975814-9960-4634-942a-e261de5e45ca_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_d42a4aac-82d4-4ea8-ade3-de2038df1a0c_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_656e4627-817b-4b14-bfc5-21c0a460eb9d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_159cd7a5-21cb-4d24-88ab-bf674837f2df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Tax Benefit from Compensation Expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_6ebb3f12-6be1-49b3-98ad-ad711723c471_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_3ecc66d4-af42-4291-80fd-61a240ebcd2a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_d034a7cf-fc0c-4d63-829b-0ec28ffed9f6_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_5ff08a1f-0550-42e5-9c8e-59436aec08c1_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_49c086df-8845-43c5-b0a0-b48ca8bbb76f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_760d97e2-2dea-4ecf-885e-6afb49f62429_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5695053c-4675-4af6-af43-865febae018f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_2605599e-4569-4e17-8640-8a46fb77c93d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_e03fabd3-8b28-40ae-a230-605527cc0c8e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_67028591-2819-49d6-8268-c4c194f5cc60_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_b96dda6e-bf39-4412-a4da-efda052cefca_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2c215ec4-ac73-4e83-9798-f8a67e610cb8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_fdab9ea3-0c51-4a03-97f6-735000aedcb4_terseLabel_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_label_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</link:label>
    <link:label id="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_documentation_en-US" xlink:label="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:to="lab_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TaxRateDomain_4691c89a-85e5-4802-8e27-f189780e4385_terseLabel_en-US" xlink:label="lab_bsx_TaxRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Domain]</link:label>
    <link:label id="lab_bsx_TaxRateDomain_label_en-US" xlink:label="lab_bsx_TaxRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Domain]</link:label>
    <link:label id="lab_bsx_TaxRateDomain_documentation_en-US" xlink:label="lab_bsx_TaxRateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateDomain" xlink:href="bsx-20201231.xsd#bsx_TaxRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TaxRateDomain" xlink:to="lab_bsx_TaxRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2026NotesMember_3ae18726-468b-48d9-8aa0-794c29bb271b_terseLabel_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_label_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_documentation_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember" xlink:href="bsx-20201231.xsd#bsx_March2026NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2026NotesMember" xlink:to="lab_bsx_March2026NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_f7a2ab8a-d166-4bbd-bb52-f3d44b689c14_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialChargesMember_46e5fe49-34f3-4b59-bb7e-bce74fd7f2c4_terseLabel_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_label_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges [Member]</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_documentation_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember" xlink:href="bsx-20201231.xsd#bsx_SpecialChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialChargesMember" xlink:to="lab_bsx_SpecialChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0d16e62d-d5d0-4ee0-9fe3-b5331206605f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_4eb79b52-b0f8-45c5-b12a-196770b24330_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_27e26a5b-0cab-4438-8c06-a39dcec9c6e6_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_b0b6bdff-937a-441f-9fd8-14542785b563_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_e044a452-92c9-40db-b474-57ddd8062bf5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bd8156ba-4657-4490-bde9-7d8d8ff07733_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_dbd40502-7473-45e6-be10-aec603ca7601_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_1c94d304-d823-40f7-ad39-14cdb28d4196_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Expense, Net</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_850b4ec1-1dbd-452f-99c4-68f81348b277_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_94b43ba4-2a02-4842-ab59-7cebcde913bf_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_982b371a-0f93-4512-8f73-6c9c445b9bb9_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2d1df4c5-a83f-489b-b1b7-00440f846816_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_bbd4a540-b8b6-44df-a260-4ee05b667e00_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_66738b4c-73ee-4dc7-8d58-32c60d56105c_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_b368dd09-1a6d-4e0e-b864-4775886c0a15_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_f79ff8cc-f7cc-4e3a-8f32-cd5aa7934136_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_92ef5d50-da0f-4a7f-a031-344097627b09_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_45e8abad-5720-468b-a8a9-7ed3743f9216_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_10620da4-edd3-404b-b8ca-b46a442675bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5c15335a-5017-4cfe-a37a-8f1ff2ac0ad9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_b6cc102c-499e-4e17-a27b-2d31464ca133_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2024NotesMember_3a70e29f-1be9-4a67-b784-0a963284c179_terseLabel_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_label_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_documentation_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember" xlink:href="bsx-20201231.xsd#bsx_March2024NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2024NotesMember" xlink:to="lab_bsx_March2024NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5c11a244-2bde-400e-b5f8-833fc7b0509a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dca084c9-829f-40f2-afdd-679efb0c66e2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_401dbf2a-39fa-4f98-961c-0a9273de4e4f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_ca3725c7-d1c7-480e-9dfa-43695c0f95f6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_51c36354-52c9-4e08-83cb-6ca17c1fc8c6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b1d78876-842a-4c86-b0e6-a7e96fee0a72_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock_db244c7a-cd96-49d4-b25a-e45650953f13_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_35549250-563f-4ddf-b1e0-1e57bf133c88_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b8f0d215-793b-4748-a039-a3f50e970c5c_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a5e91d10-a7f4-42de-92cc-c93267d91536_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductionRelatedImpairmentsOrCharges_0131a357-c4a4-40f3-9069-49239a7221ee_terseLabel_en-US" xlink:label="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Related Impairments or Charges</link:label>
    <link:label id="lab_us-gaap_ProductionRelatedImpairmentsOrCharges_label_en-US" xlink:label="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Related Impairments or Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:to="lab_us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f405ebe9-a88f-4c10-b518-12c409b2e1e1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_9458fdf6-16b6-450f-addc-cbd585b68a51_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_be6fd6db-103d-4e1b-9a76-b6c20af5263b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_5d7a8b36-a842-4c34-8bcf-1fe6d397dc28_terseLabel_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_label_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_documentation_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:href="bsx-20201231.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:to="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fb093d86-2483-4c4d-b795-af7d3cbcfc39_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_794e2778-bb4b-4483-b05b-d4057397090c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5283991a-f8e8-47af-b54b-25fa636b3b5e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ba2641a8-47dd-4199-a91e-fb2086b013a5_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_30851597-4ba2-47cc-aa16-0fa0edcef861_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_caac6893-b7ab-4529-8136-620e243a6cb6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringRelatedToPlanMember_f1f01aae-0825-4d48-9903-2a8798ada561_terseLabel_en-US" xlink:label="lab_bsx_RestructuringRelatedToPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related To Plan [Member]</link:label>
    <link:label id="lab_bsx_RestructuringRelatedToPlanMember_label_en-US" xlink:label="lab_bsx_RestructuringRelatedToPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related To Plan [Member]</link:label>
    <link:label id="lab_bsx_RestructuringRelatedToPlanMember_documentation_en-US" xlink:label="lab_bsx_RestructuringRelatedToPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related To Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringRelatedToPlanMember" xlink:to="lab_bsx_RestructuringRelatedToPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_3e05fb69-9549-41de-a758-52074f8ac83d_terseLabel_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_label_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember" xlink:href="bsx-20201231.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2020SNAggregateOfferingMember" xlink:to="lab_bsx_May2020SNAggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_f2cf7d3c-a09e-4864-8465-343483bb3ebb_terseLabel_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_label_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_documentation_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember" xlink:href="bsx-20201231.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LatinAmericaandCanadaMember" xlink:to="lab_bsx_LatinAmericaandCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_52315723-d973-4a41-9053-a73f8406c036_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementDomain_bd07218d-11de-482b-8b5d-1017cc63ca29_terseLabel_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_label_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_documentation_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain" xlink:href="bsx-20201231.xsd#bsx_StatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementDomain" xlink:to="lab_bsx_StatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cdc43cba-e1a1-4a0d-b8ef-09b12a9119e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_49e7fa50-9731-4bb3-8f2c-1e7c4552f3fd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_818e268b-8c93-40ae-92aa-c4a29eb466e2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_2b353159-3fc4-4eb1-994a-697d121e9aca_terseLabel_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:href="bsx-20201231.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:to="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_August2022TermLoanMember_3dd30658-2fec-4332-b173-862dfd94fbc9_terseLabel_en-US" xlink:label="lab_bsx_August2022TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2022 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2022TermLoanMember_label_en-US" xlink:label="lab_bsx_August2022TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2022 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2022TermLoanMember_documentation_en-US" xlink:label="lab_bsx_August2022TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2022 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2022TermLoanMember" xlink:href="bsx-20201231.xsd#bsx_August2022TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_August2022TermLoanMember" xlink:to="lab_bsx_August2022TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b4b370ba-2740-406a-b424-65c5fef159a7_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementAssetsMember_3e09176a-5ab7-4741-86db-ca5a97f9868b_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets (Member)</link:label>
    <link:label id="lab_bsx_LicensingArrangementAssetsMember_label_en-US" xlink:label="lab_bsx_LicensingArrangementAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingArrangementAssetsMember_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementAssetsMember" xlink:to="lab_bsx_LicensingArrangementAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_1661d6a3-9750-4755-a467-513043583536_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_ac9d0e23-77e8-4008-8d2e-5e090d77258b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_06a3763d-2464-4e68-8c8b-6c0a5014205e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_06bbc67d-a169-424a-a368-e285a9626916_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5e31e8d2-16c3-4785-9ed1-a2d3c3db12a9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_af99b19f-f8f6-468b-b6fc-e5c0f4ad5b00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumLeverageRatio_af4bf541-3caa-4c23-8407-d9bc54650aa1_terseLabel_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_label_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_documentation_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio permitted by revolving credit facility agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio" xlink:href="bsx-20201231.xsd#bsx_MaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumLeverageRatio" xlink:to="lab_bsx_MaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_5dcf12cc-d0cf-4adf-b720-394cad53e447_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_WeightedAverageMaturityDays_792c171d-f888-4cb6-bc7e-e498e378cde9_terseLabel_en-US" xlink:label="lab_bsx_WeightedAverageMaturityDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity, Days</link:label>
    <link:label id="lab_bsx_WeightedAverageMaturityDays_label_en-US" xlink:label="lab_bsx_WeightedAverageMaturityDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity, Days</link:label>
    <link:label id="lab_bsx_WeightedAverageMaturityDays_documentation_en-US" xlink:label="lab_bsx_WeightedAverageMaturityDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity, Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageMaturityDays" xlink:href="bsx-20201231.xsd#bsx_WeightedAverageMaturityDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_WeightedAverageMaturityDays" xlink:to="lab_bsx_WeightedAverageMaturityDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_7c3bbf58-4586-4aa8-a4c0-55157a357f34_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDerivatives_e34b1ae4-257f-4c0c-aec4-eeee82593346_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Derivatives</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDerivatives_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_57ad8134-0059-4c42-9648-4285db03da83_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a3bdba3a-f5cf-4458-ab9a-642a18f30105_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_50120bfe-dd9a-48fd-b912-72b9a73f3fcc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_13c05d16-0cad-4c1e-9dad-b15e48b16adf_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_633fc694-f484-49b5-a9f2-dce5eb197295_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_label_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:href="bsx-20201231.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:to="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_311c8131-dbd5-4c86-bfdc-ae37044d5860_terseLabel_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_label_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_documentation_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember" xlink:href="bsx-20201231.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevenueBasedPaymentsMember" xlink:to="lab_bsx_RevenueBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_c7b336a0-c9b0-422e-9bcb-ca722beaac0a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AllegedBreachofPurchaseAgreementAmount_20c9154f-ad35-43db-9ee2-8155a44209c1_terseLabel_en-US" xlink:label="lab_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alleged Breach of Purchase Agreement, Amount</link:label>
    <link:label id="lab_bsx_AllegedBreachofPurchaseAgreementAmount_label_en-US" xlink:label="lab_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alleged Breach of Purchase Agreement, Amount</link:label>
    <link:label id="lab_bsx_AllegedBreachofPurchaseAgreementAmount_documentation_en-US" xlink:label="lab_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alleged Breach of Purchase Agreement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:href="bsx-20201231.xsd#bsx_AllegedBreachofPurchaseAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:to="lab_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_0a210053-902f-4b5c-845c-19cc421de7fd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_April2021TermLoanMember_fcca59d4-fc3d-41a8-8895-cd9dc0480622_terseLabel_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_April2021TermLoanMember_label_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_April2021TermLoanMember_documentation_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember" xlink:href="bsx-20201231.xsd#bsx_April2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_April2021TermLoanMember" xlink:to="lab_bsx_April2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_822cf4a5-885d-44d7-a44f-7ef4dc26fbed_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (credits) charges to expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_11d5a734-a070-42c2-a5cf-5a58bd45b199_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_4f95c98e-07a0-4ba9-b74a-033c820aac2e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4499a917-3d94-45a6-a327-055c9a372ac2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0a54ae78-dbcf-428c-8fa0-6d21bdb78b52_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_5bcea522-8010-429f-be08-22cccb311665_terseLabel_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember" xlink:href="bsx-20201231.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalCrmReportingUnitMember" xlink:to="lab_bsx_GlobalCrmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_c0d29b1c-a1aa-4fdb-8c49-584c45f6b6fc_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1c503bc7-8d19-42c7-9940-d005aede4bc5_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0241c61d-5ce6-4db3-a818-b635e2521e5c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a42e2ff7-c135-4319-9213-cbec437e4dbd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_5dfe4d1f-71f8-4a31-aeab-c3483c36ca9d_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_d6dff9d6-a6bf-48e6-a8ff-2a7607643171_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_3085e4b5-ab7f-4e8d-827e-53088a8ab438_terseLabel_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_label_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_documentation_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:href="bsx-20201231.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:to="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_d47ff7c6-a23a-4fba-9ef1-a207cc01ec47_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_a13047cf-d721-4bdc-9069-7b3a24a320dc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_af1a15f2-cd90-44ac-bfb6-306b63c55f3e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_c1e45941-0cd2-467c-b0c5-0a6d0f721af4_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_0acff796-24a0-4238-a4d5-eeb832a8eb1d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_40ff6a9c-f97f-47ee-8cd2-9c434a9ebb0a_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_3c811951-3484-4719-b202-ec27e556395a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_374c2ba0-7f36-4c2d-9974-17bae4c71784_terseLabel_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:href="bsx-20201231.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:to="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1ff1e5ac-e582-47b0-becc-4256836279a1_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_73529e76-ca5e-412d-8282-daf3d4f0918d_terseLabel_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases</link:label>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_label_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases [Table Text Block]</link:label>
    <link:label id="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information Related to Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:href="bsx-20201231.xsd#bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="lab_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CurrentRequirementMember_af8628f2-09a0-44fc-a901-f3c0b9a77eb7_terseLabel_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_label_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_documentation_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember" xlink:href="bsx-20201231.xsd#bsx_CurrentRequirementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CurrentRequirementMember" xlink:to="lab_bsx_CurrentRequirementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_7f676032-683b-4e4a-8563-bf43f9c8cc8a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8d441edf-3bb3-4436-8668-231265484b16_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2a059f9a-bd5b-4ff8-8a01-ea9b6c682b37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) from foreign currency transaction exposures</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_48968531-8f28-4a9c-a9b7-719516e43a81_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCashReceivedOnHedge_782a5a27-e103-41f3-a114-676797e8b507_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cash Received on Hedge</link:label>
    <link:label id="lab_us-gaap_DerivativeCashReceivedOnHedge_label_en-US" xlink:label="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cash Received on Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCashReceivedOnHedge" xlink:to="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_ef2e4a97-e765-4279-b24f-906b38bf7a4b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_702f48d7-5d4c-48a6-b436-20ac48bf182b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_18f51d11-b817-48ba-b428-1ade7b675ae1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AccruedRebatesCurrent_b42005d3-4e04-40eb-9729-8cfd4df4e7ab_terseLabel_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_label_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_documentation_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent" xlink:href="bsx-20201231.xsd#bsx_AccruedRebatesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AccruedRebatesCurrent" xlink:to="lab_bsx_AccruedRebatesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8aec7d99-3ceb-428f-a07e-99e9844cfbbe_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_06892242-7a55-4f5f-9397-443eb28a2862_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_31889947-7b77-4182-8da9-b8b2a78290cf_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2d4cb78c-b43b-457b-ad9e-c10c08719978_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7e603df4-7c89-4ee7-8777-3db25cd4b5ee_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae75963c-bdfa-451a-8b23-02aefdbd974a_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2d5ac916-8412-4a8f-8286-31b085bfe6a5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite Lived Intangible Assets Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherNet_54df4ba4-3ea6-42ea-80bb-1fa6910c8f6a_terseLabel_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_label_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_documentation_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet" xlink:href="bsx-20201231.xsd#bsx_OtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherNet" xlink:to="lab_bsx_OtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_8cee32c0-cded-4470-8ef6-4f7148ab089b_terseLabel_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Domain]</link:label>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_label_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Domain]</link:label>
    <link:label id="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_documentation_en-US" xlink:label="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:to="lab_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2029NotesMember_ae60168c-b02f-4f36-8867-e009917dfcf4_terseLabel_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_label_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_documentation_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember" xlink:href="bsx-20201231.xsd#bsx_March2029NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2029NotesMember" xlink:to="lab_bsx_March2029NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ff99fa1a-82e0-4f52-81d5-9f625ef471b6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_6ef2c38a-117b-4b3e-be5a-754294aa5a43_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec5bbe00-fdd0-4851-a839-e18b4c9c9657_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_457d2ed0-1d38-4712-8502-27b99f1754d6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_2ca172ec-d583-4d9f-8b9c-5279ec88526e_terseLabel_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_label_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, plan assets, actuarial gain loss</link:label>
    <link:label id="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_documentation_en-US" xlink:label="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, plan assets, actuarial gain loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:to="lab_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_60d16a3b-4f5b-4f79-a38a-5a855843a13e_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6de41241-4cbe-47a7-b291-cd62e9f2176e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_ddc25232-9d50-4385-89cb-e3fa3af31a6b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_29e38ea4-9cf5-4732-9c01-0a49a27f6b11_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_aa5ec22c-343d-49a8-af65-f72b78df36bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decreases Resulting from Prior Period Tax Positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_b1ca93b7-6cff-4936-8392-e3ac4508dd2d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_685346f3-3bff-48e1-9e3a-d728c977b40a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_94499329-f113-47ac-9584-01b5d29c87b3_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BTGAcquisitionMember_03f93d7b-3a4f-4dfa-8129-e7a9979d3eda_terseLabel_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition [Member]</link:label>
    <link:label id="lab_bsx_BTGAcquisitionMember_label_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition [Member]</link:label>
    <link:label id="lab_bsx_BTGAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BTGAcquisitionMember" xlink:to="lab_bsx_BTGAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_542c6c3d-7c69-40cf-9c46-9cedfbc31a90_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_50c9d999-817a-4c6c-b631-b747cadfe687_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_9a9eeee2-d99b-4f94-a916-503bae5fa85f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_4e4842b7-98bc-4e9f-b681-2438c9038aab_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9921f430-3ad4-4005-8ada-11f762db0263_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ccb85157-ed68-4fc2-8c60-d76308cf2a0b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fb703cc6-8f49-4231-8101-c74a3f3e9cae_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_3b7fb7ef-f9f1-42c9-900e-adae7f757856_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8e998032-d966-42a1-8fd2-0c64ad20b8c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_e2185e97-0ab2-453a-8724-0fd419d36b23_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_365f39bd-9317-44c6-bf72-cc95ad05b22a_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OptionsExpectedToVest_8840dfdc-91b2-4f88-84f3-8cb05d3df96a_terseLabel_en-US" xlink:label="lab_bsx_OptionsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVest_label_en-US" xlink:label="lab_bsx_OptionsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest</link:label>
    <link:label id="lab_bsx_OptionsExpectedToVest_documentation_en-US" xlink:label="lab_bsx_OptionsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVest" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OptionsExpectedToVest" xlink:to="lab_bsx_OptionsExpectedToVest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1c330fdc-e9a3-4cd9-aaa1-fbf69cdd5e1f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_04630a79-d548-489a-8b82-d5f7560640ad_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Prepaid on Intercompany Profit</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_label_en-US" xlink:label="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Prepaid on Intercompany Profit</link:label>
    <link:label id="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_documentation_en-US" xlink:label="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Prepaid on Intercompany Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:to="lab_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_852a1ec7-bdb3-4c0c-aef7-968f43391552_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligations, Future Minimum Payments Due, Current</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_da8c908f-ed6a-499b-97e0-a51c7972f282_terseLabel_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede)</link:label>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_label_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede) [Member]</link:label>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_documentation_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:href="bsx-20201231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:to="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_b78b038e-ed30-4de1-91fa-a8f741a8434b_terseLabel_en-US" xlink:label="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring-related Costs Incurred to Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_label_en-US" xlink:label="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring-related Costs Incurred to Date</link:label>
    <link:label id="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_documentation_en-US" xlink:label="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Restructuring-related Costs Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringRelatedCostsIncurredToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:to="lab_bsx_CumulativeRestructuringRelatedCostsIncurredToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7abcb5b4-bda4-47d1-93bd-6b1c59fa7464_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a75b11b0-929f-4ef4-934f-f68facdf5543_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_1e7c43e7-eb27-4961-bd19-90fcce935b07_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9a18bd89-9d98-4af2-a823-333ceeb9ee41_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration previously established in purchase accounting</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_cd16a219-c245-4f68-85e1-29b5ed2f6968_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_a725ae43-e398-400f-9bee-129de98604d5_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6df20c9-feeb-406e-accb-f625fdcb3a47_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_372317b7-af13-4904-a02d-48d3d4c01aee_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2eee8784-de2d-4527-83da-31956fc9e6c0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2040NotesMember_1fa75b20-837f-4b28-8519-1ab93597d754_terseLabel_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_label_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_documentation_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember" xlink:href="bsx-20201231.xsd#bsx_January2040NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2040NotesMember" xlink:to="lab_bsx_January2040NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_87670327-fde8-405f-a98a-b30a498b4677_terseLabel_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_db7c8a17-71bb-4014-9217-485198340d8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4f332411-e4c3-4741-a7e1-4f6032769e04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2ba05a2f-fd44-4888-9b69-53899507a27e_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_ac4bf6f5-adeb-45b6-afe0-a5c4bc06c82e_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2025NotesMember_80f65954-086e-4e1e-94c1-57fb73b2db29_terseLabel_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_label_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_documentation_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember" xlink:href="bsx-20201231.xsd#bsx_May2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2025NotesMember" xlink:to="lab_bsx_May2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_7e06c255-ad63-4bb3-923a-998052b5540e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost - 263,289,848 shares as of December 31, 2020 and 247,566,270 shares as of December 31, 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesFairValueDisclosure_58050963-5eca-4d9c-a263-67d3d21ff0d9_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_GuaranteesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_GuaranteesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesFairValueDisclosure" xlink:to="lab_us-gaap_GuaranteesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d2037588-1908-45f3-ac2f-7f1947d64c5e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_72e2c857-4de4-4ac2-a0c6-d59438ec51d9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Retirement Plan Discount Rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3e7e4544-ad9a-4773-b4b9-a20ae5b531d7_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2fd96829-2b64-4066-830c-462d7f2a2c7a_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_bd0bed8b-9e01-421a-82a6-a24f82069cb1_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementsAsset_8051bc8c-db77-478e-bd00-af367c4d39d2_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementsAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAsset_label_en-US" xlink:label="lab_bsx_LicensingArrangementsAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAsset_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementsAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementsAsset" xlink:to="lab_bsx_LicensingArrangementsAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_23b0aac7-b514-4338-9b05-94915e0ae52b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2239a704-aacb-4334-a5a4-84613f9192d2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_3c8f42d7-6ab8-4929-a47f-b7a6bb338f06_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>bsx-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b8cf84dc-d42e-4cf7-a067-5352d2212acb,g:c4fd43c3-3c28-47b7-bdfe-13ef2366d2d6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Cover" xlink:type="simple" xlink:href="bsx-20201231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_43929df1-0030-410e-8d03-6bca08632f5f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_661c08a2-eebb-4f6c-90f6-07a33573e4ef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43929df1-0030-410e-8d03-6bca08632f5f" xlink:to="loc_dei_EntitiesTable_661c08a2-eebb-4f6c-90f6-07a33573e4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_37a3fd9f-f5a2-4436-a9cf-b2602af98515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_661c08a2-eebb-4f6c-90f6-07a33573e4ef" xlink:to="loc_us-gaap_StatementClassOfStockAxis_37a3fd9f-f5a2-4436-a9cf-b2602af98515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37a3fd9f-f5a2-4436-a9cf-b2602af98515" xlink:to="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2522d067-a68b-4014-95bb-1a82093fa155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:to="loc_us-gaap_CommonStockMember_2522d067-a68b-4014-95bb-1a82093fa155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_9ffc29a2-e330-44f5-b75a-285403113c70" xlink:href="bsx-20201231.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:to="loc_bsx_SeniorNotedue2027Member_9ffc29a2-e330-44f5-b75a-285403113c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_54896f0c-d01e-47be-b82e-34906e66e8b2" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_27b05682-8f8f-457d-a511-f9bfb0872b47" xlink:to="loc_bsx_A550MCPSSeriesAMember_54896f0c-d01e-47be-b82e-34906e66e8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_661c08a2-eebb-4f6c-90f6-07a33573e4ef" xlink:to="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2b7a9b5a-8ecb-47b9-b446-06e0418e54a9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentType_2b7a9b5a-8ecb-47b9-b446-06e0418e54a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_fe432dd6-dcf1-4fbc-91ed-bca8701a2bf7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentAnnualReport_fe432dd6-dcf1-4fbc-91ed-bca8701a2bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_aedf336f-40e4-44db-914f-5e236fac8271" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentPeriodEndDate_aedf336f-40e4-44db-914f-5e236fac8271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d93a3d2c-563d-4e9d-9280-9a04d5d860b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentTransitionReport_d93a3d2c-563d-4e9d-9280-9a04d5d860b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_961e410d-5b8a-4495-96ea-77d0e46d2166" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityFileNumber_961e410d-5b8a-4495-96ea-77d0e46d2166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8f865e8b-fa84-49c2-8771-36a72ab9bc6b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityRegistrantName_8f865e8b-fa84-49c2-8771-36a72ab9bc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bab589af-b9ea-48d1-a7c1-c873476751cf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bab589af-b9ea-48d1-a7c1-c873476751cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4baca1b8-ab84-445b-8037-660ae2959765" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityTaxIdentificationNumber_4baca1b8-ab84-445b-8037-660ae2959765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6e355a6c-2cf5-4982-af33-907a5bc2a2ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityAddressAddressLine1_6e355a6c-2cf5-4982-af33-907a5bc2a2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a23e963c-6dd3-4467-b645-29131b08a6dd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityAddressCityOrTown_a23e963c-6dd3-4467-b645-29131b08a6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a76e0ba3-3022-4ace-872b-1f743df1eb8c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityAddressStateOrProvince_a76e0ba3-3022-4ace-872b-1f743df1eb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_27cd8449-96c8-4fd0-bca2-4a89ba9a6afb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityAddressPostalZipCode_27cd8449-96c8-4fd0-bca2-4a89ba9a6afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_8c180485-d1a0-424a-8203-8b54590fea63" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_CityAreaCode_8c180485-d1a0-424a-8203-8b54590fea63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_50e4799e-d414-4cba-a652-6a56904d04a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_LocalPhoneNumber_50e4799e-d414-4cba-a652-6a56904d04a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e9c0001a-25b3-471e-b054-2863a300ce66" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_Security12bTitle_e9c0001a-25b3-471e-b054-2863a300ce66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b02d6fdc-d336-4c8a-ac52-1830fc405003" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_TradingSymbol_b02d6fdc-d336-4c8a-ac52-1830fc405003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_575e2da5-6eee-4043-a068-fe403e571e4d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_SecurityExchangeName_575e2da5-6eee-4043-a068-fe403e571e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_e9598397-f22f-42f0-bde1-c9667b994bdc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_e9598397-f22f-42f0-bde1-c9667b994bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_2426f0f2-1393-4545-893d-5c6d7f0e9d66" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityVoluntaryFilers_2426f0f2-1393-4545-893d-5c6d7f0e9d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6a859e2c-24bf-4b0b-94f1-561d63b04224" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityCurrentReportingStatus_6a859e2c-24bf-4b0b-94f1-561d63b04224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e1958d29-9063-4cfb-b8d2-7fffae2e6b10" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityInteractiveDataCurrent_e1958d29-9063-4cfb-b8d2-7fffae2e6b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_08cb6260-bd01-4061-8f07-53d1ed813c7d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityFilerCategory_08cb6260-bd01-4061-8f07-53d1ed813c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_373080b9-42cf-4e6b-8d4b-a6d582ed6796" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntitySmallBusiness_373080b9-42cf-4e6b-8d4b-a6d582ed6796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3667c949-ac87-4884-abbf-e01f6c47801d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityEmergingGrowthCompany_3667c949-ac87-4884-abbf-e01f6c47801d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_8e3f207a-bef3-407e-96c7-49fa417c03a2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_IcfrAuditorAttestationFlag_8e3f207a-bef3-407e-96c7-49fa417c03a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_42be85c5-a1db-462a-8d1e-4e84ed69ee0f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityShellCompany_42be85c5-a1db-462a-8d1e-4e84ed69ee0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_9b1cae00-d949-4d7f-9873-fb2abe7428b3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityPublicFloat_9b1cae00-d949-4d7f-9873-fb2abe7428b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_e662a00d-7a17-40b3-95ce-32cea8bfa7b2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityListingParValuePerShare_e662a00d-7a17-40b3-95ce-32cea8bfa7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_518de9f0-1a86-430d-85f6-cc604559763b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_518de9f0-1a86-430d-85f6-cc604559763b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1faca8d1-6468-4deb-864c-b7754972ce77" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_EntityCentralIndexKey_1faca8d1-6468-4deb-864c-b7754972ce77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e60b843d-b3d6-47a2-9c2e-e8262d3aa460" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_CurrentFiscalYearEndDate_e60b843d-b3d6-47a2-9c2e-e8262d3aa460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_74436822-61a3-45a1-9e2f-3f244d5b7708" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentFiscalYearFocus_74436822-61a3-45a1-9e2f-3f244d5b7708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d710e6eb-bd01-473f-bc45-6a6d8d882fc4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d710e6eb-bd01-473f-bc45-6a6d8d882fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ea5a185a-ee39-4cdc-b879-2f872e625fc4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_357fa5e9-39e6-469e-8258-f801bb8892b9" xlink:to="loc_dei_AmendmentFlag_ea5a185a-ee39-4cdc-b879-2f872e625fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_542a41b0-2ad3-49a0-9716-22b40f5a80d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9b2d91ee-f027-4d72-8fd9-a4c90bb15423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_542a41b0-2ad3-49a0-9716-22b40f5a80d0" xlink:to="loc_us-gaap_StatementTable_9b2d91ee-f027-4d72-8fd9-a4c90bb15423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_eb1b9387-21cb-48aa-9864-89f73092824e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9b2d91ee-f027-4d72-8fd9-a4c90bb15423" xlink:to="loc_srt_StatementScenarioAxis_eb1b9387-21cb-48aa-9864-89f73092824e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c6e93a9d-9f9c-4c86-838b-0fe313ab2285" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_eb1b9387-21cb-48aa-9864-89f73092824e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c6e93a9d-9f9c-4c86-838b-0fe313ab2285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9b2d91ee-f027-4d72-8fd9-a4c90bb15423" xlink:to="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43475124-3aca-403b-af1f-7cb02244ce25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43475124-3aca-403b-af1f-7cb02244ce25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d51e5849-fc7e-446d-a356-42a697bebfe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d51e5849-fc7e-446d-a356-42a697bebfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2662056f-aeee-40fc-9a0a-9ec18039c3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_GrossProfit_2662056f-aeee-40fc-9a0a-9ec18039c3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1f4a51e2-2863-414a-b4d2-6b985e3a266a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1f4a51e2-2863-414a-b4d2-6b985e3a266a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d42d722b-03d0-4c7c-a59c-7805d806ec2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d42d722b-03d0-4c7c-a59c-7805d806ec2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_44ebcb43-1047-49c6-8440-9f06c204e5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_RoyaltyExpense_44ebcb43-1047-49c6-8440-9f06c204e5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e15d81cd-29f0-4e8f-9f12-4aeb2bb17f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e15d81cd-29f0-4e8f-9f12-4aeb2bb17f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_63041448-6bc5-4732-b34a-f4c52fe0d27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_63041448-6bc5-4732-b34a-f4c52fe0d27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e19d639c-9b3a-42fd-9b47-ba276c1a38de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e19d639c-9b3a-42fd-9b47-ba276c1a38de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_53758d05-f950-4291-bdc7-57ed36827821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_53758d05-f950-4291-bdc7-57ed36827821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a05fadbe-e01d-42c0-8b13-9be9c3d7a1b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_RestructuringCharges_a05fadbe-e01d-42c0-8b13-9be9c3d7a1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_cda08198-6a95-4e48-9176-5f08b3f1a5da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_LitigationSettlementExpense_cda08198-6a95-4e48-9176-5f08b3f1a5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b1b35924-ded3-4c3c-ac12-757108468ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c442d9d5-99da-45f2-ad1c-1b0acb2ccf91" xlink:to="loc_us-gaap_OperatingExpenses_b1b35924-ded3-4c3c-ac12-757108468ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_46c237cb-9a99-4245-bdd9-7a7ea3e9c66f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_OperatingIncomeLoss_46c237cb-9a99-4245-bdd9-7a7ea3e9c66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_70751453-d5b4-4b5c-9d97-155442647304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_70751453-d5b4-4b5c-9d97-155442647304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b6de5bf8-8db1-4a26-a109-262a8fe2a466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_70751453-d5b4-4b5c-9d97-155442647304" xlink:to="loc_us-gaap_InterestExpense_b6de5bf8-8db1-4a26-a109-262a8fe2a466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c1075aff-ccd1-4121-918a-5099ab7d4b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_70751453-d5b4-4b5c-9d97-155442647304" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c1075aff-ccd1-4121-918a-5099ab7d4b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_48493fbb-6388-4b35-bf5f-38279e2792f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_48493fbb-6388-4b35-bf5f-38279e2792f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f2fa0ed3-1b96-4cea-9225-1953a2ac28c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f2fa0ed3-1b96-4cea-9225-1953a2ac28c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d3bcfc1a-b0b5-41da-a504-490ee8aa95c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_ProfitLoss_d3bcfc1a-b0b5-41da-a504-490ee8aa95c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_4755cf5d-2f92-48fd-a4cb-0d525671b5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_DividendsPreferredStockStock_4755cf5d-2f92-48fd-a4cb-0d525671b5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_62553b27-c704-4de4-825d-ddd26c50a745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_62553b27-c704-4de4-825d-ddd26c50a745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_50049ae0-4358-4b5f-9b35-ccb5a3b4a87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_EarningsPerShareBasic_50049ae0-4358-4b5f-9b35-ccb5a3b4a87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c7490e58-d9a8-4a50-a8a0-431cb384daaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c7490e58-d9a8-4a50-a8a0-431cb384daaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5dd60e40-a9fc-4067-a786-1195ffd19832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_94028730-ef62-4962-8b38-3affc8006c37" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5dd60e40-a9fc-4067-a786-1195ffd19832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ab0f4b8c-3516-46a8-9145-22cf2e61f104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5dd60e40-a9fc-4067-a786-1195ffd19832" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ab0f4b8c-3516-46a8-9145-22cf2e61f104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9834d717-f768-44bd-91ff-65c1bbb45590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5dd60e40-a9fc-4067-a786-1195ffd19832" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9834d717-f768-44bd-91ff-65c1bbb45590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dcb758ef-ca75-4557-a1ed-81fd0c9d550c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dcb758ef-ca75-4557-a1ed-81fd0c9d550c" xlink:to="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_93f33f54-bccc-4f74-a153-e7a184c7838b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:to="loc_srt_StatementScenarioAxis_93f33f54-bccc-4f74-a153-e7a184c7838b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_96e99a17-a814-4fc9-bbf2-12629b4ac38c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_93f33f54-bccc-4f74-a153-e7a184c7838b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_96e99a17-a814-4fc9-bbf2-12629b4ac38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f958f583-e6b9-449e-85c6-e5dabbde78a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_08aeaf5d-aa1e-48d1-8b18-2f1d9afa8f60" xlink:to="loc_us-gaap_EquityComponentDomain_f958f583-e6b9-449e-85c6-e5dabbde78a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_be888dac-251b-48f3-8b26-52bb8980df3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f958f583-e6b9-449e-85c6-e5dabbde78a2" xlink:to="loc_us-gaap_PreferredStockMember_be888dac-251b-48f3-8b26-52bb8980df3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bd4b1b4f-3d79-4a25-b09f-fabaa9b96eef" xlink:to="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a568ca12-1b8c-44f8-b4e9-72d10a4238c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:to="loc_us-gaap_ProfitLoss_a568ca12-1b8c-44f8-b4e9-72d10a4238c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aa5125f-9d39-4977-ac7d-ce2c3b02a54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aa5125f-9d39-4977-ac7d-ce2c3b02a54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fdae2e34-a27b-49c7-82a5-b126c404feec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fdae2e34-a27b-49c7-82a5-b126c404feec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0092d4f4-8130-443e-8dda-c43ca8f9bfa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0092d4f4-8130-443e-8dda-c43ca8f9bfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5607799c-a541-4979-a188-073ce8e42714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_47be11da-a654-4e4f-80b0-fbe164ad9f95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5607799c-a541-4979-a188-073ce8e42714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5e6ff35-fce0-4837-ad5a-32c3f12d681e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_41968c8a-acf1-43d6-b0ea-8c77ebc3b431" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5e6ff35-fce0-4837-ad5a-32c3f12d681e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1970faee-fc5c-4892-8f4f-ff7788169edc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_77d7d60b-032a-453f-89e9-f63989f3534d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1970faee-fc5c-4892-8f4f-ff7788169edc" xlink:to="loc_us-gaap_StatementTable_77d7d60b-032a-453f-89e9-f63989f3534d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_240bb319-4349-413c-a60b-393c3039de97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_77d7d60b-032a-453f-89e9-f63989f3534d" xlink:to="loc_srt_StatementScenarioAxis_240bb319-4349-413c-a60b-393c3039de97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cf0ddd91-9580-4628-8d0e-a01bd2f957dd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_240bb319-4349-413c-a60b-393c3039de97" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cf0ddd91-9580-4628-8d0e-a01bd2f957dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bb24f963-8cc9-408d-8249-f468fbe35067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_77d7d60b-032a-453f-89e9-f63989f3534d" xlink:to="loc_us-gaap_StatementLineItems_bb24f963-8cc9-408d-8249-f468fbe35067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb24f963-8cc9-408d-8249-f468fbe35067" xlink:to="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe895eed-930a-498d-9777-913c27c46d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe895eed-930a-498d-9777-913c27c46d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_08683603-aa0c-4075-af3f-b3b4b8ec9e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_08683603-aa0c-4075-af3f-b3b4b8ec9e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4df91bbd-5ee6-49bb-8e47-e423ee17e412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_InventoryNet_4df91bbd-5ee6-49bb-8e47-e423ee17e412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_7a8a032f-e8ad-47c5-805d-21bbdcaaf782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_PrepaidTaxes_7a8a032f-e8ad-47c5-805d-21bbdcaaf782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c2019fd2-1266-4dde-9ccd-b4958b7ac0bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c2019fd2-1266-4dde-9ccd-b4958b7ac0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fd544390-0a89-4e32-84f0-f6816fd15ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fd544390-0a89-4e32-84f0-f6816fd15ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_248fc4d1-2aae-43a7-a4ff-b254fb752f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_35700c4d-3c80-4a19-8348-2e125a92e506" xlink:to="loc_us-gaap_AssetsCurrent_248fc4d1-2aae-43a7-a4ff-b254fb752f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3b2278b1-797a-4d61-af0f-fdb3873f0e50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3b2278b1-797a-4d61-af0f-fdb3873f0e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_723b766b-94fd-45e6-ba64-38c2377968fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_Goodwill_723b766b-94fd-45e6-ba64-38c2377968fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56eb96cd-b5c6-4d11-a8a3-e86df5b4fd27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56eb96cd-b5c6-4d11-a8a3-e86df5b4fd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c6369423-5bfd-41c5-bc43-c8eff4b18aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c6369423-5bfd-41c5-bc43-c8eff4b18aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_970f86e6-5a7e-4549-84a4-e2b55d08fa85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_970f86e6-5a7e-4549-84a4-e2b55d08fa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0e077a4a-4834-48b7-84ea-875d1f2c8b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dc7df02-a9a3-4f9a-a322-aa644d51583d" xlink:to="loc_us-gaap_Assets_0e077a4a-4834-48b7-84ea-875d1f2c8b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb24f963-8cc9-408d-8249-f468fbe35067" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_ebbefd95-0fd7-424e-9ffb-56c192c0a4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_DebtCurrent_ebbefd95-0fd7-424e-9ffb-56c192c0a4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8b55ca77-9156-435a-bb6c-0013d3740a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_AccountsPayableCurrent_8b55ca77-9156-435a-bb6c-0013d3740a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f9264065-5d99-449c-af42-18b8abc42ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f9264065-5d99-449c-af42-18b8abc42ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_861b0f48-e6ae-44e1-be75-303c25a4e1dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_861b0f48-e6ae-44e1-be75-303c25a4e1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_389d4b73-d280-4d07-8e35-37884c895fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9a6dcd24-14a3-4e16-895c-3aeb0dc34c7c" xlink:to="loc_us-gaap_LiabilitiesCurrent_389d4b73-d280-4d07-8e35-37884c895fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f5dabbe7-960d-4b6d-aa8c-e8113e6e46dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f5dabbe7-960d-4b6d-aa8c-e8113e6e46dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f5c2837b-d37e-486f-82fa-99ec63de475d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f5c2837b-d37e-486f-82fa-99ec63de475d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_edf0be58-92b9-4790-8ff5-ff8143cc1293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_edf0be58-92b9-4790-8ff5-ff8143cc1293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1bb9ad31-7360-4bfa-a5fd-e056339cf3d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1bb9ad31-7360-4bfa-a5fd-e056339cf3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e9b3fdd0-38f5-4323-83d0-c58380207adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_PreferredStockValue_e9b3fdd0-38f5-4323-83d0-c58380207adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_51a926f0-788a-4ef9-b6ea-84619438f649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_CommonStockValue_51a926f0-788a-4ef9-b6ea-84619438f649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_760476c3-d7c9-43d1-bb51-b0f9071c3ea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_TreasuryStockValue_760476c3-d7c9-43d1-bb51-b0f9071c3ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_47177806-0ad6-427b-b4ca-c3f0933f0d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_47177806-0ad6-427b-b4ca-c3f0933f0d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05c9bb8f-f581-456e-9a6d-d648f019d799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05c9bb8f-f581-456e-9a6d-d648f019d799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_78011f23-5e43-4ee0-8655-4fb2ba0f2e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_78011f23-5e43-4ee0-8655-4fb2ba0f2e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_9ce8ead3-3c01-48d5-9438-fb2b8f379805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_9ce8ead3-3c01-48d5-9438-fb2b8f379805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_820d1eed-ab8b-47a0-97bb-71b72e21b400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_419cd704-8c86-4ab3-b1c0-90ad42963c33" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_820d1eed-ab8b-47a0-97bb-71b72e21b400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_286c9f9a-9a98-4287-afbc-43afb60b4349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e481e3e-f02a-4e5a-a5e9-d62e96c50653" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_286c9f9a-9a98-4287-afbc-43afb60b4349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e64ed9c7-8e2c-49c8-a9db-34316d25c295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c60370c9-5b43-4d9c-b27a-efddc9808a04" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e64ed9c7-8e2c-49c8-a9db-34316d25c295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedBalanceSheetParanthetical"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_c8910bbe-b8c6-4dc2-8bbe-1407072f05bb" xlink:href="bsx-20201231.xsd#bsx_ConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_67ec7fb0-145e-4573-a728-ec20a8d3d913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_c8910bbe-b8c6-4dc2-8bbe-1407072f05bb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_67ec7fb0-145e-4573-a728-ec20a8d3d913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_cb56308a-cf21-46c1-8681-be0ca5df59cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_c8910bbe-b8c6-4dc2-8bbe-1407072f05bb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_cb56308a-cf21-46c1-8681-be0ca5df59cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_7136ffa6-c795-42c4-badd-90cb86d7d251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_c8910bbe-b8c6-4dc2-8bbe-1407072f05bb" xlink:to="loc_us-gaap_PreferredStockSharesIssued_7136ffa6-c795-42c4-badd-90cb86d7d251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_886c3d03-8edd-4f46-bd98-23dff890fc8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_c8910bbe-b8c6-4dc2-8bbe-1407072f05bb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_886c3d03-8edd-4f46-bd98-23dff890fc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_99c42859-7c46-40c1-a344-daa505841f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_c8910bbe-b8c6-4dc2-8bbe-1407072f05bb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_99c42859-7c46-40c1-a344-daa505841f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_73f82512-87be-4330-8d0d-d3d3b46bdd65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_c8910bbe-b8c6-4dc2-8bbe-1407072f05bb" xlink:to="loc_us-gaap_CommonStockSharesIssued_73f82512-87be-4330-8d0d-d3d3b46bdd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_09db33bb-d9ec-4000-ad74-a5ea43b58be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedBalanceSheetParentheticalAbstract_c8910bbe-b8c6-4dc2-8bbe-1407072f05bb" xlink:to="loc_us-gaap_TreasuryStockShares_09db33bb-d9ec-4000-ad74-a5ea43b58be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6344112a-dd72-4db6-801d-2e16150daa2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f4a93ccc-aba3-4574-842f-dd2217490f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6344112a-dd72-4db6-801d-2e16150daa2e" xlink:to="loc_us-gaap_StatementTable_f4a93ccc-aba3-4574-842f-dd2217490f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_56ffce0b-bbc9-4429-bbd6-aba7c3070662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f4a93ccc-aba3-4574-842f-dd2217490f42" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_56ffce0b-bbc9-4429-bbd6-aba7c3070662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56ffce0b-bbc9-4429-bbd6-aba7c3070662" xlink:to="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_d35a6428-c017-4402-8c94-038e14745b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_PreferredStockMember_d35a6428-c017-4402-8c94-038e14745b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e40660fc-79f7-4874-98b2-53b3e4301177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_CommonStockMember_e40660fc-79f7-4874-98b2-53b3e4301177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_f158f931-e473-4398-b840-c38f3ad09ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_TreasuryStockMember_f158f931-e473-4398-b840-c38f3ad09ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8aa7c2d7-bef5-43cd-bd29-01dd7e4e22b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8aa7c2d7-bef5-43cd-bd29-01dd7e4e22b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_18de3103-639f-483d-953b-03abe42bf31c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_RetainedEarningsMember_18de3103-639f-483d-953b-03abe42bf31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04cdd00e-899e-43a3-9f43-cbb73a056059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8bf94019-7fe9-4151-969d-8e5928ce92fb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04cdd00e-899e-43a3-9f43-cbb73a056059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e7b554a5-7ff2-4a45-8ebc-c0129dbbf102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f4a93ccc-aba3-4574-842f-dd2217490f42" xlink:to="loc_us-gaap_StatementLineItems_e7b554a5-7ff2-4a45-8ebc-c0129dbbf102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e7b554a5-7ff2-4a45-8ebc-c0129dbbf102" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8f6abf5a-305e-4faf-999d-43a97367896d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8f6abf5a-305e-4faf-999d-43a97367896d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ec4bbe47-ad49-4532-9ee2-7eaf0391ef16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_SharesIssued_ec4bbe47-ad49-4532-9ee2-7eaf0391ef16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_adcc6f2d-2ec4-40a8-84c7-010f6fe4c2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_ProfitLoss_adcc6f2d-2ec4-40a8-84c7-010f6fe4c2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeEffectOfNewAccountingPrinciples_04a0525f-cd70-4028-9779-1093f8a577cb" xlink:href="bsx-20201231.xsd#bsx_CumulativeEffectOfNewAccountingPrinciples"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_bsx_CumulativeEffectOfNewAccountingPrinciples_04a0525f-cd70-4028-9779-1093f8a577cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c923938b-c30c-40f9-bd43-d264f87a20b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c923938b-c30c-40f9-bd43-d264f87a20b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3cccf95-93a7-48e5-9115-7f04a8bb8d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3cccf95-93a7-48e5-9115-7f04a8bb8d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cd60339c-a734-4ce3-b371-1b965b27bd48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cd60339c-a734-4ce3-b371-1b965b27bd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_addcd765-9d3b-46a7-86a5-e8df196f05eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_200415f4-fda1-4a2d-94a3-078d0c4e172b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_addcd765-9d3b-46a7-86a5-e8df196f05eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_04d2d572-4ffd-4b8d-93e2-178667ede7f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_04d2d572-4ffd-4b8d-93e2-178667ede7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_a36b98d0-8e13-4b5b-ba74-c606b32b83a1" xlink:href="bsx-20201231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_a36b98d0-8e13-4b5b-ba74-c606b32b83a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_e20a0ff4-49af-4490-b1ae-c3d887e7121a" xlink:href="bsx-20201231.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_e20a0ff4-49af-4490-b1ae-c3d887e7121a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dca16c0e-66b1-41d9-b343-cb4dd694ac60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dca16c0e-66b1-41d9-b343-cb4dd694ac60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_e0210aaa-c6ad-4e83-ab92-1c4a86f3c4ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_DividendsPreferredStockCash_e0210aaa-c6ad-4e83-ab92-1c4a86f3c4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b5619f9b-a4ea-4741-a8fa-4af7b607fbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b5619f9b-a4ea-4741-a8fa-4af7b607fbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_7b6a5b0c-6991-45fc-89f2-b93563b13945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_7b6a5b0c-6991-45fc-89f2-b93563b13945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_37705ca9-1011-46b5-9478-1e78ece05cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_37705ca9-1011-46b5-9478-1e78ece05cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8a3102cc-a7c3-4ae1-bec0-89c58554c239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8a3102cc-a7c3-4ae1-bec0-89c58554c239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_3bdc497f-e7bf-4543-8b87-37e113e29442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f174c0b5-002a-40af-933d-46d3a6fd04b5" xlink:to="loc_us-gaap_SharesIssued_3bdc497f-e7bf-4543-8b87-37e113e29442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ee7bb45d-0098-45d2-a3d8-3c9c00a472f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a5ffb2be-b6fc-412f-b796-bb7c044a029d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee7bb45d-0098-45d2-a3d8-3c9c00a472f4" xlink:to="loc_us-gaap_StatementTable_a5ffb2be-b6fc-412f-b796-bb7c044a029d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_36f88f8b-96d2-4f33-85bb-3dd8c635cd70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a5ffb2be-b6fc-412f-b796-bb7c044a029d" xlink:to="loc_srt_StatementScenarioAxis_36f88f8b-96d2-4f33-85bb-3dd8c635cd70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_078bd731-dc5c-40e9-b57e-aa90ce4b2a00" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_36f88f8b-96d2-4f33-85bb-3dd8c635cd70" xlink:to="loc_srt_ScenarioUnspecifiedDomain_078bd731-dc5c-40e9-b57e-aa90ce4b2a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a5ffb2be-b6fc-412f-b796-bb7c044a029d" xlink:to="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8af00870-5182-42d1-9938-c07b558a64ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_ProfitLoss_8af00870-5182-42d1-9938-c07b558a64ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_86645553-b27e-4fef-be96-59dda7ea8887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_86645553-b27e-4fef-be96-59dda7ea8887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3e82a489-faab-48c6-9976-a7dfa9a1fbde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3e82a489-faab-48c6-9976-a7dfa9a1fbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b8cd45be-9dde-4f34-b6b5-ecc9988d96ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b8cd45be-9dde-4f34-b6b5-ecc9988d96ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_9bd0ada4-9c66-4130-b9f1-cc84be2c7778" xlink:href="bsx-20201231.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_9bd0ada4-9c66-4130-b9f1-cc84be2c7778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_778d6979-d2bd-4270-8f51-cbadba1fa24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_ShareBasedCompensation_778d6979-d2bd-4270-8f51-cbadba1fa24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5ecab0a2-b099-4d36-a859-d6a2e5c9b7cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5ecab0a2-b099-4d36-a859-d6a2e5c9b7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_b9470e2a-1b3a-4571-959f-5e2d678d1a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_GainLossOnInvestments_b9470e2a-1b3a-4571-959f-5e2d678d1a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_abbd3ac7-3dc9-4c7e-9f0c-ecdbbc425474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_abbd3ac7-3dc9-4c7e-9f0c-ecdbbc425474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_c3d17da7-16ff-4ea5-bf52-ef8a6eaf019b" xlink:href="bsx-20201231.xsd#bsx_InventoryStepUpAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_bsx_InventoryStepUpAmortization_c3d17da7-16ff-4ea5-bf52-ef8a6eaf019b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_07af25b0-fb4f-4275-aeea-9233e2c6a517" xlink:href="bsx-20201231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_07af25b0-fb4f-4275-aeea-9233e2c6a517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_1aae543f-dfbc-4d08-bcb5-d3c666ad4475" xlink:href="bsx-20201231.xsd#bsx_OtherNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_bsx_OtherNet_1aae543f-dfbc-4d08-bcb5-d3c666ad4475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ec48e2c4-bdea-4737-a738-683b3a730aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ec48e2c4-bdea-4737-a738-683b3a730aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bf87de12-27ba-4054-a19c-17d2d539bf54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bf87de12-27ba-4054-a19c-17d2d539bf54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_807e1353-76ad-487a-afb3-76d99355307c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_807e1353-76ad-487a-afb3-76d99355307c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a3abd9cd-d35e-4ce1-8d13-2cdbc00d88c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a3abd9cd-d35e-4ce1-8d13-2cdbc00d88c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_670152ee-2cc0-49d8-99d9-649863c574e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_670152ee-2cc0-49d8-99d9-649863c574e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_4c9d8ce3-2698-4027-ad62-4b95a6d46e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_4c9d8ce3-2698-4027-ad62-4b95a6d46e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e611d1ee-6a70-4cfb-8a21-9dc657e3c65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e611d1ee-6a70-4cfb-8a21-9dc657e3c65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a896fdc6-65b2-42ac-b934-c3860a03b7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a896fdc6-65b2-42ac-b934-c3860a03b7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e9c2cd81-4a3a-4ae3-baaa-8f9519862108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e9c2cd81-4a3a-4ae3-baaa-8f9519862108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2f37e025-a38a-4ff6-a2b0-fcbdb467e6d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2f37e025-a38a-4ff6-a2b0-fcbdb467e6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8597062f-2d78-48a0-ad74-afd8bc5edc6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8597062f-2d78-48a0-ad74-afd8bc5edc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ae2dc63d-0d45-4dcd-9094-a2a42f28dac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ae2dc63d-0d45-4dcd-9094-a2a42f28dac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_d5eb4120-9b21-47a7-abee-a84d500d4317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_d5eb4120-9b21-47a7-abee-a84d500d4317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_8db31c71-b6d7-490c-a70a-690a112e2d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_8db31c71-b6d7-490c-a70a-690a112e2d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9e45327-1d28-478e-b25e-06b215bebb9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a7d13c5f-2aa2-455f-90d7-da458940a211" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9e45327-1d28-478e-b25e-06b215bebb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_53e666e2-3153-46e9-aaf3-d38d3f42ab36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_53e666e2-3153-46e9-aaf3-d38d3f42ab36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_478817cc-1c23-4a13-a437-48bb690ff733" xlink:href="bsx-20201231.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_bsx_PaymentsForRoyaltyRights_478817cc-1c23-4a13-a437-48bb690ff733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_48a0a223-aa24-4f14-b3a1-6953555d3d5a" xlink:href="bsx-20201231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_48a0a223-aa24-4f14-b3a1-6953555d3d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_c01a2cae-a565-4ca6-8d75-62c1380b52fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_c01a2cae-a565-4ca6-8d75-62c1380b52fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_cc5eae67-39a6-40e6-8270-7a31cf1b501e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_cc5eae67-39a6-40e6-8270-7a31cf1b501e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c71a8909-db1d-49b7-acfb-05ccb60455a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_c71a8909-db1d-49b7-acfb-05ccb60455a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_e109ad14-45e4-4c21-bcac-6cab44e21fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_e109ad14-45e4-4c21-bcac-6cab44e21fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_65c079ed-bb7c-4ca6-86d0-b9731ba5db70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_65c079ed-bb7c-4ca6-86d0-b9731ba5db70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_2ef7974b-f6bd-43d8-9d20-0a0f3e62f89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_2ef7974b-f6bd-43d8-9d20-0a0f3e62f89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_1399cfeb-9e55-4e4f-ab2a-57c18293dd23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_1399cfeb-9e55-4e4f-ab2a-57c18293dd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_749b78d5-2050-415d-b9a9-1f92cc149f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_PaymentsOfDividends_749b78d5-2050-415d-b9a9-1f92cc149f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_d1804934-e538-4c04-9c0d-9f06aa4d73dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_d1804934-e538-4c04-9c0d-9f06aa4d73dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5bd8ddb4-627b-451f-9886-442c5b106bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5bd8ddb4-627b-451f-9886-442c5b106bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_55f4f9a7-b2b9-428b-a334-32f3a450d690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_55f4f9a7-b2b9-428b-a334-32f3a450d690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_da7dd045-6941-4d40-99cb-cc99ee9f39fe" xlink:href="bsx-20201231.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_da7dd045-6941-4d40-99cb-cc99ee9f39fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_e914db6d-9371-4a68-a031-38444f49a426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_ProceedsFromStockPlans_e914db6d-9371-4a68-a031-38444f49a426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d132317-6e02-4a4c-8576-2bae6efbe8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3994c034-3142-458a-b2d3-99ca8bf1f281" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d132317-6e02-4a4c-8576-2bae6efbe8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a4b7216-e5ae-43ba-aec2-13c75a6746d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a4b7216-e5ae-43ba-aec2-13c75a6746d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_609a2976-58e5-46b1-b4de-35dc82da926f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_609a2976-58e5-46b1-b4de-35dc82da926f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b394d26b-c1ae-460e-8a87-6e72b7e95ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b394d26b-c1ae-460e-8a87-6e72b7e95ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_261bce7f-3f8f-4b94-86d9-6d98b4996fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_261bce7f-3f8f-4b94-86d9-6d98b4996fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ce6aaf92-b397-4ba3-afb7-e32d5732bcd9" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_89432b06-905b-4740-851c-e653b789f95a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:to="loc_us-gaap_IncomeTaxesPaid_89432b06-905b-4740-851c-e653b789f95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_33d4c49a-79e0-4944-827d-b7a4f1ae4f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:to="loc_us-gaap_InterestPaidNet_33d4c49a-79e0-4944-827d-b7a4f1ae4f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_82dc9bc7-f669-4d04-ac98-229d85ad195b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_82dc9bc7-f669-4d04-ac98-229d85ad195b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NonCashImpactOfTransferredRoyaltyRights_d4833499-3a88-4eee-a77d-627b34db3d8f" xlink:href="bsx-20201231.xsd#bsx_NonCashImpactOfTransferredRoyaltyRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ac3c9064-5cd3-46de-b886-2ae479b008ee" xlink:to="loc_bsx_NonCashImpactOfTransferredRoyaltyRights_d4833499-3a88-4eee-a77d-627b34db3d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20201231.xsd#ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_61364b72-9294-4195-9a50-d912b0889a43" xlink:href="bsx-20201231.xsd#bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_24ec040b-dbea-419d-94a9-7101ac347667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract_61364b72-9294-4195-9a50-d912b0889a43" xlink:to="loc_us-gaap_StatementTable_24ec040b-dbea-419d-94a9-7101ac347667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8" xlink:href="bsx-20201231.xsd#bsx_StatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24ec040b-dbea-419d-94a9-7101ac347667" xlink:to="loc_bsx_StatementAxis_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_34def309-d66e-47f8-b84b-b3e1865a767b" xlink:href="bsx-20201231.xsd#bsx_StatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementAxis_b01cd07c-a3d8-4958-ac02-7fe81c6a24a8" xlink:to="loc_bsx_StatementDomain_34def309-d66e-47f8-b84b-b3e1865a767b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24ec040b-dbea-419d-94a9-7101ac347667" xlink:to="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64fb3a48-7a21-4f1f-b96d-a1a12620dbd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64fb3a48-7a21-4f1f-b96d-a1a12620dbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_8569fa3c-9853-436a-83dd-80a9711f65be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_8569fa3c-9853-436a-83dd-80a9711f65be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f5f35400-69ef-4665-83f6-e54277cb8a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f5f35400-69ef-4665-83f6-e54277cb8a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8218aa2-7ddc-403b-869c-aa0c4988670e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0d9943a-e0a5-4dd6-ba63-6490477406cb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8218aa2-7ddc-403b-869c-aa0c4988670e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bc59ae27-e4c9-4c01-a850-0d34502b88d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e6f8c58d-44e2-4983-b22a-d708536a9eb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bc59ae27-e4c9-4c01-a850-0d34502b88d5" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e6f8c58d-44e2-4983-b22a-d708536a9eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_eae1dfd9-a3d4-4ac0-95a4-2df80e030bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_eae1dfd9-a3d4-4ac0-95a4-2df80e030bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_c5c12e66-7748-4159-9acd-def9c482b222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_c5c12e66-7748-4159-9acd-def9c482b222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_fb631955-2c77-4f04-9f1a-e6b796619ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_UseOfEstimates_fb631955-2c77-4f04-9f1a-e6b796619ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_93e36886-dbdb-45fc-bc35-13b1c2a66dbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_93e36886-dbdb-45fc-bc35-13b1c2a66dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_4fac5a6a-0116-41e5-af98-28fea77a3721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_4fac5a6a-0116-41e5-af98-28fea77a3721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_acee4b8d-e789-47ab-9209-56f39f765e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_acee4b8d-e789-47ab-9209-56f39f765e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_ab372832-e9c1-4208-9a2e-026a5bb8d4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_ab372832-e9c1-4208-9a2e-026a5bb8d4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3a8a3baa-589e-4267-9bb7-b392d58bce6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3a8a3baa-589e-4267-9bb7-b392d58bce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_f49b8aa0-3776-434a-a949-e33326f56e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_f49b8aa0-3776-434a-a949-e33326f56e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentPolicy_3db2ef8f-21dc-46be-b655-446ff120ce83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentPolicy_3db2ef8f-21dc-46be-b655-446ff120ce83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_c4c722d3-2db2-4ac4-9c22-5b707785c449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_c4c722d3-2db2-4ac4-9c22-5b707785c449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_b2c61c98-4498-47b8-8eb1-59dfcd620f76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_b2c61c98-4498-47b8-8eb1-59dfcd620f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_5f0c9d1f-c3c2-4b3b-88b0-4973e000b5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_5f0c9d1f-c3c2-4b3b-88b0-4973e000b5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_db3bba53-92de-4660-ba7a-609f4f0ae0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_db3bba53-92de-4660-ba7a-609f4f0ae0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_6d1a43f7-72c6-4808-9fbc-e3101956fe9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_6d1a43f7-72c6-4808-9fbc-e3101956fe9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1a89464a-7de8-4b6c-9e76-be94b7773c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1a89464a-7de8-4b6c-9e76-be94b7773c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_c1c38ca1-d22b-45c2-a242-08d291f875d9" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock_c1c38ca1-d22b-45c2-a242-08d291f875d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_bf7626fa-bdde-4186-8d61-d3f46734f342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_bf7626fa-bdde-4186-8d61-d3f46734f342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_99d941fb-afcc-4f06-b293-902f928a3334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_99d941fb-afcc-4f06-b293-902f928a3334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_f024cf04-1f67-4201-9b2d-9162e0453dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_f024cf04-1f67-4201-9b2d-9162e0453dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_f67775be-7e31-4413-b20c-233dcec0c112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_dba1c8eb-d97d-46b0-806a-93a3241df041" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_f67775be-7e31-4413-b20c-233dcec0c112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesAbstract_f4ebcc56-dd8f-44bb-b6d0-304c88c20e86" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesAbstract_f4ebcc56-dd8f-44bb-b6d0-304c88c20e86" xlink:to="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_940efab8-9af1-45fa-9722-b1b9deb0f353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_45b2c2a1-9566-44d4-9fbb-7a20b5a7ef6f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_940efab8-9af1-45fa-9722-b1b9deb0f353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1c22af6c-7d16-4d0a-8590-217143de2844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1c22af6c-7d16-4d0a-8590-217143de2844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bfd35375-e229-40d8-9dfc-45cfeea7a064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1c22af6c-7d16-4d0a-8590-217143de2844" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bfd35375-e229-40d8-9dfc-45cfeea7a064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2c50938a-8db7-4195-8da5-f83f3f6cd1b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_srt_RangeAxis_2c50938a-8db7-4195-8da5-f83f3f6cd1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_438e4e78-5a68-4f0a-8ce4-4614aaa98159" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2c50938a-8db7-4195-8da5-f83f3f6cd1b4" xlink:to="loc_srt_RangeMember_438e4e78-5a68-4f0a-8ce4-4614aaa98159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4bff838a-2951-45b4-be0e-40f3abe02f62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_438e4e78-5a68-4f0a-8ce4-4614aaa98159" xlink:to="loc_srt_MinimumMember_4bff838a-2951-45b4-be0e-40f3abe02f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a701e5b5-7bf5-4a2a-bd03-990d8726c67c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_438e4e78-5a68-4f0a-8ce4-4614aaa98159" xlink:to="loc_srt_MaximumMember_a701e5b5-7bf5-4a2a-bd03-990d8726c67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e4c471c-9786-4b11-8301-9d225b61c6c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e4c471c-9786-4b11-8301-9d225b61c6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ef7794d-46a3-426c-a07a-87ab8bf6cc8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e4c471c-9786-4b11-8301-9d225b61c6c3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ef7794d-46a3-426c-a07a-87ab8bf6cc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_26239cbc-402c-4ec3-96ba-e16dcf8e1225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ef7794d-46a3-426c-a07a-87ab8bf6cc8e" xlink:to="loc_us-gaap_PatentsMember_26239cbc-402c-4ec3-96ba-e16dcf8e1225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b023eb4f-8c9f-4874-8dfa-f65993f03a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b023eb4f-8c9f-4874-8dfa-f65993f03a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5a94d0f-425e-46af-b668-62103423f027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b023eb4f-8c9f-4874-8dfa-f65993f03a97" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5a94d0f-425e-46af-b668-62103423f027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b2163ec5-8a02-48a4-9d70-d32fe0a55378" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_srt_ProductOrServiceAxis_b2163ec5-8a02-48a4-9d70-d32fe0a55378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7f8ebd61-a35c-471c-9fc0-d64767c35be0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b2163ec5-8a02-48a4-9d70-d32fe0a55378" xlink:to="loc_srt_ProductsAndServicesDomain_7f8ebd61-a35c-471c-9fc0-d64767c35be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_e53ce2dc-520c-46aa-9184-860a49f55adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7f8ebd61-a35c-471c-9fc0-d64767c35be0" xlink:to="loc_us-gaap_ShippingAndHandlingMember_e53ce2dc-520c-46aa-9184-860a49f55adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SignificantAccountingPoliciesLineItems_22de3552-995b-491f-85c1-f25a761c5c25" xlink:href="bsx-20201231.xsd#bsx_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesTable_c7be20d1-d8ce-4aec-851b-4f8fce269b32" xlink:to="loc_bsx_SignificantAccountingPoliciesLineItems_22de3552-995b-491f-85c1-f25a761c5c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a96cf18e-95af-4278-b1bc-0e64718c8d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_22de3552-995b-491f-85c1-f25a761c5c25" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a96cf18e-95af-4278-b1bc-0e64718c8d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_2ca3b22f-08b8-4761-9efa-2fb87b56016e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SignificantAccountingPoliciesLineItems_22de3552-995b-491f-85c1-f25a761c5c25" xlink:to="loc_us-gaap_ProductionRelatedImpairmentsOrCharges_2ca3b22f-08b8-4761-9efa-2fb87b56016e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_2d8e2fd4-9448-4bf1-bc59-a4e3590c983e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1b890c7e-cda3-44e2-aa22-bd50108e011f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2d8e2fd4-9448-4bf1-bc59-a4e3590c983e" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1b890c7e-cda3-44e2-aa22-bd50108e011f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_87eb50b8-c977-4428-9248-ac5b1726bcaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_87eb50b8-c977-4428-9248-ac5b1726bcaa" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_80913f95-9173-49c1-9a6c-4893c1754958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_80913f95-9173-49c1-9a6c-4893c1754958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_80913f95-9173-49c1-9a6c-4893c1754958" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_db59472d-5da1-41c9-8f0e-04a0c39eae79" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_BTGAcquisitionMember_db59472d-5da1-41c9-8f0e-04a0c39eae79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember_f9e63b2f-bf49-4c55-90cc-71928b5f6823" xlink:href="bsx-20201231.xsd#bsx_DivestedBusinessDueToBTGAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember_f9e63b2f-bf49-4c55-90cc-71928b5f6823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_ed9a8e8a-c635-46cf-8e80-394c3bfccf38" xlink:href="bsx-20201231.xsd#bsx_VertiflexIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_VertiflexIncMember_ed9a8e8a-c635-46cf-8e80-394c3bfccf38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember_1d8672e9-a7c6-4fa4-8406-7b918d038af5" xlink:href="bsx-20201231.xsd#bsx_MillipedeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_MillipedeMember_1d8672e9-a7c6-4fa4-8406-7b918d038af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_77248956-0ba4-4d97-8f09-935d4333377c" xlink:href="bsx-20201231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_77248956-0ba4-4d97-8f09-935d4333377c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AugmenixInc.Member_6905f2c8-4285-4e8e-9e44-fd1a80631375" xlink:href="bsx-20201231.xsd#bsx_AugmenixInc.Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_AugmenixInc.Member_6905f2c8-4285-4e8e-9e44-fd1a80631375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ClaretMedicalIncMember_827132bf-722c-47ec-b6b5-44840236231b" xlink:href="bsx-20201231.xsd#bsx_ClaretMedicalIncMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_ClaretMedicalIncMember_827132bf-722c-47ec-b6b5-44840236231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CryterionMedicalIncMember_3f5f8d38-bec2-4255-b44f-212c13cd6e95" xlink:href="bsx-20201231.xsd#bsx_CryterionMedicalIncMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_CryterionMedicalIncMember_3f5f8d38-bec2-4255-b44f-212c13cd6e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NxTheraIncMember_ccb730ec-c265-4137-92c7-0055c5509590" xlink:href="bsx-20201231.xsd#bsx_NxTheraIncMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_NxTheraIncMember_ccb730ec-c265-4137-92c7-0055c5509590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NVisionMedicalCorporationMember_644dae1c-77f0-4751-8ab1-59fe89c0499a" xlink:href="bsx-20201231.xsd#bsx_NVisionMedicalCorporationMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_NVisionMedicalCorporationMember_644dae1c-77f0-4751-8ab1-59fe89c0499a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Other2018AcquisitionsMember_07dcca9c-33f4-472d-ba03-a72f9ae879f9" xlink:href="bsx-20201231.xsd#bsx_Other2018AcquisitionsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_Other2018AcquisitionsMember_07dcca9c-33f4-472d-ba03-a72f9ae879f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2018AcquisitionsMember_bfbd09e5-4e28-4f11-a5e0-e95cb4fcdb3b" xlink:href="bsx-20201231.xsd#bsx_A2018AcquisitionsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3a1c71ce-c54b-47e1-ae03-c908c005df69" xlink:to="loc_bsx_A2018AcquisitionsMember_bfbd09e5-4e28-4f11-a5e0-e95cb4fcdb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_247c3b4a-f4fb-4322-beea-cd310d282e41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_247c3b4a-f4fb-4322-beea-cd310d282e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_594a6673-7174-4a94-9a45-b52105f57805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_247c3b4a-f4fb-4322-beea-cd310d282e41" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_594a6673-7174-4a94-9a45-b52105f57805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_srt_OwnershipAxis_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e626fba5-4287-4d67-9e87-576687fec585" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_9ad01e6b-0ca5-41ca-a602-13921bc1d1d6" xlink:to="loc_srt_OwnershipDomain_e626fba5-4287-4d67-9e87-576687fec585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_062342ca-d3a9-4557-a870-36ad135cad28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_us-gaap_StatementClassOfStockAxis_062342ca-d3a9-4557-a870-36ad135cad28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f0044539-7faf-4e57-afd6-57c24c5e335b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_062342ca-d3a9-4557-a870-36ad135cad28" xlink:to="loc_us-gaap_ClassOfStockDomain_f0044539-7faf-4e57-afd6-57c24c5e335b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9e0d8a89-f273-4286-b106-bdf9ff249581" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_cc66fcbb-7e92-4a29-8924-cfcc30bf72aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_cc66fcbb-7e92-4a29-8924-cfcc30bf72aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b372d783-55d6-437a-915a-854b055ab4af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b372d783-55d6-437a-915a-854b055ab4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_4278d241-fda2-4d34-aef8-1ba87e871aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_4278d241-fda2-4d34-aef8-1ba87e871aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_56d55fc8-c62e-4249-a503-ab6da54cf7ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_56d55fc8-c62e-4249-a503-ab6da54cf7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_6cfaf05d-1279-4ad1-8efa-56916d2ac47f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_6cfaf05d-1279-4ad1-8efa-56916d2ac47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_beb0433f-7095-4f5e-9927-fe2340aa497c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e449305-2e7b-4317-9e2f-8cd9b091d047" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_beb0433f-7095-4f5e-9927-fe2340aa497c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#AcquisitionsandStrategicInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_2663c284-b808-4231-9118-ef2f845f360a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2663c284-b808-4231-9118-ef2f845f360a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f86c1a9a-6a53-41cd-847a-5bc5cf9b6994" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_6970967f-ce6e-4286-b8c9-9aac592b8260" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_BTGAcquisitionMember_6970967f-ce6e-4286-b8c9-9aac592b8260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember_f2857137-2a47-4554-9c93-ccaabe9e39c0" xlink:href="bsx-20201231.xsd#bsx_DivestedBusinessDueToBTGAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_DivestedBusinessDueToBTGAcquisitionMember_f2857137-2a47-4554-9c93-ccaabe9e39c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_1b2f2f7e-de84-433c-af1a-026ca934a3fe" xlink:href="bsx-20201231.xsd#bsx_VertiflexIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_VertiflexIncMember_1b2f2f7e-de84-433c-af1a-026ca934a3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeMember_fa92780d-ef76-4d7b-868e-9c32c0eff938" xlink:href="bsx-20201231.xsd#bsx_MillipedeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_MillipedeMember_fa92780d-ef76-4d7b-868e-9c32c0eff938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_d3712e86-67bf-4c7b-845b-c5baa0ef403c" xlink:href="bsx-20201231.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_d3712e86-67bf-4c7b-845b-c5baa0ef403c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AugmenixInc.Member_4ccc3db7-8b9a-465c-8d16-3eee8606b746" xlink:href="bsx-20201231.xsd#bsx_AugmenixInc.Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_AugmenixInc.Member_4ccc3db7-8b9a-465c-8d16-3eee8606b746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ClaretMedicalIncMember_5ec9d8b4-8fdb-409a-9c28-fa193cc77b66" xlink:href="bsx-20201231.xsd#bsx_ClaretMedicalIncMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_ClaretMedicalIncMember_5ec9d8b4-8fdb-409a-9c28-fa193cc77b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CryterionMedicalIncMember_a9977105-2dbe-4318-b9f7-cc59038d3576" xlink:href="bsx-20201231.xsd#bsx_CryterionMedicalIncMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_CryterionMedicalIncMember_a9977105-2dbe-4318-b9f7-cc59038d3576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NxTheraIncMember_96801a10-05ca-459f-9ce7-270c0dddf820" xlink:href="bsx-20201231.xsd#bsx_NxTheraIncMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_NxTheraIncMember_96801a10-05ca-459f-9ce7-270c0dddf820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NVisionMedicalCorporationMember_44cb1fdc-f675-4f9e-9873-aa07209bc093" xlink:href="bsx-20201231.xsd#bsx_NVisionMedicalCorporationMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_NVisionMedicalCorporationMember_44cb1fdc-f675-4f9e-9873-aa07209bc093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Other2018AcquisitionsMember_c00b2380-8562-4df5-bdae-6fc80f096bb9" xlink:href="bsx-20201231.xsd#bsx_Other2018AcquisitionsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_Other2018AcquisitionsMember_c00b2380-8562-4df5-bdae-6fc80f096bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2018AcquisitionsMember_d3b43cdd-01e7-4337-97ab-2646bf95d76e" xlink:href="bsx-20201231.xsd#bsx_A2018AcquisitionsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_A2018AcquisitionsMember_d3b43cdd-01e7-4337-97ab-2646bf95d76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceSolutionsIncMember_20b8f74f-b5c5-4373-8eab-729fb2a4c47a" xlink:href="bsx-20201231.xsd#bsx_PreventiceSolutionsIncMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ece9cc81-f030-48dc-9375-3f78463bc193" xlink:to="loc_bsx_PreventiceSolutionsIncMember_20b8f74f-b5c5-4373-8eab-729fb2a4c47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c710bd8-b7d8-4011-af53-b18c504c9b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c710bd8-b7d8-4011-af53-b18c504c9b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8c710bd8-b7d8-4011-af53-b18c504c9b9f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5f302f9b-c5e4-4dcb-a59f-7de0bdf06942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5f302f9b-c5e4-4dcb-a59f-7de0bdf06942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_13d19a80-421a-46b6-ae0c-d41591693e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_13d19a80-421a-46b6-ae0c-d41591693e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_b69ba26c-4c1c-4a25-accf-dcbd977b1dba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef40bc9-fa4e-4dd2-bff8-2456393862a2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_b69ba26c-4c1c-4a25-accf-dcbd977b1dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_045eb726-ceb1-4088-a65d-e3ff9d84b8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_045eb726-ceb1-4088-a65d-e3ff9d84b8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45605c4c-fec5-4a35-bb29-03ebde917f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_045eb726-ceb1-4088-a65d-e3ff9d84b8cc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45605c4c-fec5-4a35-bb29-03ebde917f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_8df47af5-5f3b-4f15-8874-d6deaeb01bc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_45605c4c-fec5-4a35-bb29-03ebde917f2b" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_8df47af5-5f3b-4f15-8874-d6deaeb01bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a1db248b-0c46-484f-a847-ba68a4baa392" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_srt_RangeAxis_a1db248b-0c46-484f-a847-ba68a4baa392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a1db248b-0c46-484f-a847-ba68a4baa392" xlink:to="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f645d925-081d-4f68-9478-3d6ca244621c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:to="loc_srt_MinimumMember_f645d925-081d-4f68-9478-3d6ca244621c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7af821e-3e98-421d-a7ff-55702657f6fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:to="loc_srt_MaximumMember_a7af821e-3e98-421d-a7ff-55702657f6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_bdaf2973-2bca-48ac-9ea9-3740cdf95d97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a035356c-c09d-4b1b-b77d-438d03b8381a" xlink:to="loc_srt_WeightedAverageMember_bdaf2973-2bca-48ac-9ea9-3740cdf95d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e40099cd-8ab8-4d14-a578-eaa4ceddbe79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e40099cd-8ab8-4d14-a578-eaa4ceddbe79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eb7f08ab-d451-4489-834c-0154f4797792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e40099cd-8ab8-4d14-a578-eaa4ceddbe79" xlink:to="loc_us-gaap_SegmentDomain_eb7f08ab-d451-4489-834c-0154f4797792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_fab7d8d5-d693-40d5-b636-0c0a706de486" xlink:href="bsx-20201231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eb7f08ab-d451-4489-834c-0154f4797792" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_fab7d8d5-d693-40d5-b636-0c0a706de486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_af8b2f41-8167-410c-bb83-bf1aae1ead4e" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eb7f08ab-d451-4489-834c-0154f4797792" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_af8b2f41-8167-410c-bb83-bf1aae1ead4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_834bb233-821e-45bd-a805-cb485f2c3c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e089cbbe-6bfe-44fa-b2aa-479e7ec9fb82" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_834bb233-821e-45bd-a805-cb485f2c3c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_77ab44d7-a41a-45b6-8c59-90fd00ae00d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_834bb233-821e-45bd-a805-cb485f2c3c73" xlink:to="loc_us-gaap_SubsequentEventMember_77ab44d7-a41a-45b6-8c59-90fd00ae00d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_fed23021-c0a8-41c7-90bc-72284fffa945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_fed23021-c0a8-41c7-90bc-72284fffa945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_38839a24-6497-411e-9fed-89bbd21ce6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fed23021-c0a8-41c7-90bc-72284fffa945" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_38839a24-6497-411e-9fed-89bbd21ce6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_fd558934-3b1b-4da9-90e7-33ae52904103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_38839a24-6497-411e-9fed-89bbd21ce6fa" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_fd558934-3b1b-4da9-90e7-33ae52904103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5e4bd33b-438d-436f-a971-f1a5f9cae447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5e4bd33b-438d-436f-a971-f1a5f9cae447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38ae2a23-aab4-43ab-b430-166ef873625c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5e4bd33b-438d-436f-a971-f1a5f9cae447" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38ae2a23-aab4-43ab-b430-166ef873625c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_b886794e-d59b-4e7c-9fdd-58a2d3b004aa" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_38ae2a23-aab4-43ab-b430-166ef873625c" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_b886794e-d59b-4e7c-9fdd-58a2d3b004aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0a35cd2b-a28c-4b68-b0df-e0ec1c4d6a0f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4c7b3cff-8142-4641-a583-28fadf1f60b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_4c7b3cff-8142-4641-a583-28fadf1f60b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_3d6f4ad4-ab28-420c-bd41-6ae70623118f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_3d6f4ad4-ab28-420c-bd41-6ae70623118f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_28e89fcc-f808-46aa-8691-b5fd129f6e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_28e89fcc-f808-46aa-8691-b5fd129f6e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_fb391378-dd09-4456-a492-d8b65ae12093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_fb391378-dd09-4456-a492-d8b65ae12093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8186c3b5-a8a6-4189-8838-f64596b45d56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8186c3b5-a8a6-4189-8838-f64596b45d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesFairValueDisclosure_ef3485ab-13bb-403b-a3d2-024ba03486d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_GuaranteesFairValueDisclosure_ef3485ab-13bb-403b-a3d2-024ba03486d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_195a2ed7-b9b4-4aff-b628-68f48f9638d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_195a2ed7-b9b4-4aff-b628-68f48f9638d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_1c9179e7-b1fa-4b14-9c44-0fe50e1e309e" xlink:href="bsx-20201231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_1c9179e7-b1fa-4b14-9c44-0fe50e1e309e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_79ea18e8-af66-4d31-9974-4305a93e9901" xlink:href="bsx-20201231.xsd#bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate_79ea18e8-af66-4d31-9974-4305a93e9901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_856feb71-7874-476e-9a05-9f6b90c968f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_856feb71-7874-476e-9a05-9f6b90c968f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_de3cf2b6-4dcb-46f1-bd9e-6952818e26e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_de3cf2b6-4dcb-46f1-bd9e-6952818e26e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1bdd61e8-877d-45a2-9ee8-7ba45db0cfbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_Goodwill_1bdd61e8-877d-45a2-9ee8-7ba45db0cfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_06abf528-9fc6-410c-9839-e9c72de68898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_06abf528-9fc6-410c-9839-e9c72de68898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7c16c481-a838-42d6-8d21-02f9a5142c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7c16c481-a838-42d6-8d21-02f9a5142c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_733eb1c7-fe31-448a-87df-9267bc84fe23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_733eb1c7-fe31-448a-87df-9267bc84fe23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_666b06ab-9d4c-4314-b16e-b145452b3e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_666b06ab-9d4c-4314-b16e-b145452b3e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_20c3b3ca-7b4b-4640-aeeb-af8f8ba8ba66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_20c3b3ca-7b4b-4640-aeeb-af8f8ba8ba66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d3de1c61-106e-4855-aa70-47c99579cca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d3de1c61-106e-4855-aa70-47c99579cca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_780b594e-eac8-461f-be41-9369bfe7668e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_780b594e-eac8-461f-be41-9369bfe7668e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fa8cc7f0-c71d-4249-afd1-942309fda3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fa8cc7f0-c71d-4249-afd1-942309fda3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_54a6550a-4486-480d-9779-a9491acb1513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_54a6550a-4486-480d-9779-a9491acb1513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_24286ae1-2816-4290-bf35-d04f38dc9853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_24286ae1-2816-4290-bf35-d04f38dc9853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bbb5674a-0706-4d16-9f27-b6f2ae66b376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_bbb5674a-0706-4d16-9f27-b6f2ae66b376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_7cbc64fe-5a44-42de-99b8-c1becfcb8b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_7cbc64fe-5a44-42de-99b8-c1becfcb8b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_8f19dfe3-50ae-4d7e-aa51-1e2283df1f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_8f19dfe3-50ae-4d7e-aa51-1e2283df1f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76d625dc-4725-4a56-afec-d15196d64a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76d625dc-4725-4a56-afec-d15196d64a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_530cfb47-0b71-4b36-8b9f-92001b569951" xlink:href="bsx-20201231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_bsx_DiscountRateFairValueInput_530cfb47-0b71-4b36-8b9f-92001b569951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_43150151-e3cb-48e7-b6f5-4b3632fc3474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_43150151-e3cb-48e7-b6f5-4b3632fc3474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_f116c8a6-3fb6-4bcc-87f9-e3f347e01bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_f116c8a6-3fb6-4bcc-87f9-e3f347e01bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6a8ffa66-65f1-46b1-9b3e-47377ef6a822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6a8ffa66-65f1-46b1-9b3e-47377ef6a822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_49634414-0226-4e8d-a7ee-b818936aee40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_af800158-4cd6-4917-b449-79ddbe6fb29a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_af800158-4cd6-4917-b449-79ddbe6fb29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_da868b30-c29b-4688-82e7-6cbf3039f611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_da868b30-c29b-4688-82e7-6cbf3039f611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_53a57300-40c2-402a-9844-bd225d0f347e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_53a57300-40c2-402a-9844-bd225d0f347e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ff92127f-1362-4ae1-bac2-f5df6f3280ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f739a7b6-9e58-4598-997f-a764b29d8fb9" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ff92127f-1362-4ae1-bac2-f5df6f3280ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_137753d3-1170-4c7d-a63f-0bccef5e0bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_137753d3-1170-4c7d-a63f-0bccef5e0bd7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_556917cb-edf4-49a7-bedc-507cd4162294" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_srt_RangeAxis_556917cb-edf4-49a7-bedc-507cd4162294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_556917cb-edf4-49a7-bedc-507cd4162294" xlink:to="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ce3cc25b-8d57-42ad-b309-ba32e9d182b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:to="loc_srt_MinimumMember_ce3cc25b-8d57-42ad-b309-ba32e9d182b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b6872ed3-d8c0-4360-9a46-7bdbfaaa5942" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:to="loc_srt_MaximumMember_b6872ed3-d8c0-4360-9a46-7bdbfaaa5942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_cbda11df-b791-4071-821c-a227005c30fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f97a0532-9c23-4188-89b1-59e26e1ce9d0" xlink:to="loc_srt_WeightedAverageMember_cbda11df-b791-4071-821c-a227005c30fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_f7b49624-546b-4ba5-a151-86ea21937eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_us-gaap_ValuationTechniqueAxis_f7b49624-546b-4ba5-a151-86ea21937eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_f7e7cc70-9b1d-443d-ab49-1c1fbbe6dbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_f7b49624-546b-4ba5-a151-86ea21937eb4" xlink:to="loc_us-gaap_ValuationTechniqueDomain_f7e7cc70-9b1d-443d-ab49-1c1fbbe6dbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_e7d0b04f-8b84-4bad-8e6d-94e87b21c548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_f7e7cc70-9b1d-443d-ab49-1c1fbbe6dbef" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_e7d0b04f-8b84-4bad-8e6d-94e87b21c548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b5234d49-a1e6-42e4-ba23-35bec5ab25a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b5234d49-a1e6-42e4-ba23-35bec5ab25a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e6e1ce9-eb46-4012-afa0-b897024c951a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b5234d49-a1e6-42e4-ba23-35bec5ab25a6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e6e1ce9-eb46-4012-afa0-b897024c951a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_150c8fe4-72e2-4ab4-b040-061de48400bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_150c8fe4-72e2-4ab4-b040-061de48400bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f103fd0e-963a-42a0-ac80-c1e9c35ebf60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_150c8fe4-72e2-4ab4-b040-061de48400bf" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f103fd0e-963a-42a0-ac80-c1e9c35ebf60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_16631bc6-5d36-454d-b65c-7ffbdd53e633" xlink:href="bsx-20201231.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f103fd0e-963a-42a0-ac80-c1e9c35ebf60" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_16631bc6-5d36-454d-b65c-7ffbdd53e633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_447582ba-1cb9-41f4-a91b-34bef38da04d" xlink:href="bsx-20201231.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f103fd0e-963a-42a0-ac80-c1e9c35ebf60" xlink:to="loc_bsx_RevenueBasedPaymentsMember_447582ba-1cb9-41f4-a91b-34bef38da04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_043c781b-0c23-485d-9933-a545bd3ee059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2f274fca-cbb3-4be3-844f-3c34ba4de38d" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_043c781b-0c23-485d-9933-a545bd3ee059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_043c781b-0c23-485d-9933-a545bd3ee059" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_71e77b90-3e92-421f-8f59-7246d26d08f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_71e77b90-3e92-421f-8f59-7246d26d08f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_0fab1507-7811-4b40-9bc1-9000b3f8c9b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_0fab1507-7811-4b40-9bc1-9000b3f8c9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_4100c85e-34e6-4fbc-b6e8-296e0d8b121c" xlink:href="bsx-20201231.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:to="loc_bsx_PaymentOfContingentConsideration_4100c85e-34e6-4fbc-b6e8-296e0d8b121c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_21b37c78-4f6d-4407-9419-dda793604132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_f0beb2ff-3fb2-49d0-b180-08c4b111f0ac" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_21b37c78-4f6d-4407-9419-dda793604132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_a5030d5b-6f8c-457e-9699-1ff3e48bce5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_043c781b-0c23-485d-9933-a545bd3ee059" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_a5030d5b-6f8c-457e-9699-1ff3e48bce5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_efabe932-ab2f-44bc-a9b5-de2c604a33f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_a5030d5b-6f8c-457e-9699-1ff3e48bce5b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_efabe932-ab2f-44bc-a9b5-de2c604a33f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_a5030d5b-6f8c-457e-9699-1ff3e48bce5b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_de83ce33-76ba-45ff-82b4-1c35e4b3fb3e" xlink:href="bsx-20201231.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_de83ce33-76ba-45ff-82b4-1c35e4b3fb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_b6f4e1f2-f6d9-431c-8a32-df27b673a6b8" xlink:href="bsx-20201231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:to="loc_bsx_DiscountRateFairValueInput_b6f4e1f2-f6d9-431c-8a32-df27b673a6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d7c8b799-81b4-445a-9e95-a2c56f3ba78b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_0d08babb-0bf8-4552-bd7a-8d146f377e5c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d7c8b799-81b4-445a-9e95-a2c56f3ba78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StrategicInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_59a73b89-65be-4359-b960-f93d73675f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_1ba1f2cf-6eeb-47dc-9e36-79e402c4f688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59a73b89-65be-4359-b960-f93d73675f0d" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_1ba1f2cf-6eeb-47dc-9e36-79e402c4f688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a97d930e-f79d-42f6-8c79-f9c177fe6416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1ba1f2cf-6eeb-47dc-9e36-79e402c4f688" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a97d930e-f79d-42f6-8c79-f9c177fe6416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_85d5fe2e-d9e0-40ae-9198-dc91d403dc85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a97d930e-f79d-42f6-8c79-f9c177fe6416" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_85d5fe2e-d9e0-40ae-9198-dc91d403dc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_607a33c7-1ed2-4d31-9807-8d44afd6f4ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_85d5fe2e-d9e0-40ae-9198-dc91d403dc85" xlink:to="loc_us-gaap_SubsequentEventMember_607a33c7-1ed2-4d31-9807-8d44afd6f4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_1ba1f2cf-6eeb-47dc-9e36-79e402c4f688" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_ff76942e-8783-4bd7-8880-e3d316680a55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_ff76942e-8783-4bd7-8880-e3d316680a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_16c6bf30-c1bb-4361-a0c2-ede14b41a44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_EquityMethodInvestments_16c6bf30-c1bb-4361-a0c2-ede14b41a44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_5d75f2ff-46ab-4fa3-b82a-c2f9d3bb5070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_5d75f2ff-46ab-4fa3-b82a-c2f9d3bb5070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_4ba275d0-7600-4f2b-bc12-b24fcd418142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_4ba275d0-7600-4f2b-bc12-b24fcd418142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8018b467-fd44-47cd-bf6b-b55380ad633c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8018b467-fd44-47cd-bf6b-b55380ad633c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_16785502-18b5-430e-b5cd-ffd1cec65276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_Investments_16785502-18b5-430e-b5cd-ffd1cec65276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_94379ea5-bdae-4834-97eb-5af569f2555b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_ed82a786-1d36-4b15-8b83-cfdeb87c2e41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_cd4d145d-2384-4cf4-8dc4-822b2e9adf0c" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_ed82a786-1d36-4b15-8b83-cfdeb87c2e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSale"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0cf51b37-52ef-4bfa-9960-d7cee604eabf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_f8efd738-cadb-435a-8c65-e842a24e3161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0cf51b37-52ef-4bfa-9960-d7cee604eabf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_f8efd738-cadb-435a-8c65-e842a24e3161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSaleTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_50d813f6-fbad-46ea-8702-26d6bd39b124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_729d008d-f9be-465f-8e96-8373e9328852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_50d813f6-fbad-46ea-8702-26d6bd39b124" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_729d008d-f9be-465f-8e96-8373e9328852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#AssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_472b4298-3899-4a0b-bc10-f79242a86805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_472b4298-3899-4a0b-bc10-f79242a86805" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_afa44d44-491c-4250-bc76-3a77fa08fa6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_afa44d44-491c-4250-bc76-3a77fa08fa6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f262934-65e9-476e-acc3-5bff6155525f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_afa44d44-491c-4250-bc76-3a77fa08fa6e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f262934-65e9-476e-acc3-5bff6155525f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_5cbead3a-140e-4fe8-b850-7f27d3baaae3" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f262934-65e9-476e-acc3-5bff6155525f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_5cbead3a-140e-4fe8-b850-7f27d3baaae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9e3f4964-3ff7-41bf-ac64-a77e57f4d5d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e2c6c6f9-fcc7-439c-b27b-da4fbb5cf61b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9e3f4964-3ff7-41bf-ac64-a77e57f4d5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a7bb0210-b2c5-4085-bae5-20f56ae721ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9e3f4964-3ff7-41bf-ac64-a77e57f4d5d0" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a7bb0210-b2c5-4085-bae5-20f56ae721ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_38bd23a6-c08b-49cc-bb96-8650ccea0815" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_db2cde82-c728-4141-aac4-e5255cce346b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_db2cde82-c728-4141-aac4-e5255cce346b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_95b1189e-e107-4a39-8ce4-6d7e7f66bb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_95b1189e-e107-4a39-8ce4-6d7e7f66bb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f66a3760-01f8-48b5-89a2-b4d22a202aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f66a3760-01f8-48b5-89a2-b4d22a202aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9dd9264-442f-4e52-b8a3-6128a58a3ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_e9dd9264-442f-4e52-b8a3-6128a58a3ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_565a0c48-fd89-439f-8a31-9d81f87959d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_565a0c48-fd89-439f-8a31-9d81f87959d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_f0e38ea1-492d-478f-86b4-7e3ec57f8de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent_f0e38ea1-492d-478f-86b4-7e3ec57f8de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_4d50e552-b3b7-4041-8d1b-a53c987f3f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent_4d50e552-b3b7-4041-8d1b-a53c987f3f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_2d4f184f-efc3-451e-b818-07bf15e198ae" xlink:href="bsx-20201231.xsd#bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent_2d4f184f-efc3-451e-b818-07bf15e198ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_bf57cb6c-f92f-48e6-bcb7-03d145c5fe5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_bf57cb6c-f92f-48e6-bcb7-03d145c5fe5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_f22694e4-5627-4ecb-9ceb-846f0b1de4f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_f22694e4-5627-4ecb-9ceb-846f0b1de4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_f14b75b7-0cae-4de1-a467-a13c125351b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_f14b75b7-0cae-4de1-a467-a13c125351b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_5315b927-3d40-4943-a049-fb63884b290b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable_5315b927-3d40-4943-a049-fb63884b290b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_69e3af73-1d50-4790-a4a8-512b90675900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_69e3af73-1d50-4790-a4a8-512b90675900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_dc091140-e6de-474e-8946-7713c4e1f596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_19dbf896-9042-4583-8ea0-a1cbace3e93f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_dc091140-e6de-474e-8946-7713c4e1f596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0840564-8266-441c-9ac7-eaa74af0b065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4f68dd2c-1291-4c20-9567-1ce909014d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0840564-8266-441c-9ac7-eaa74af0b065" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4f68dd2c-1291-4c20-9567-1ce909014d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_048db12c-d952-4e30-97f4-609acd0cf0a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_eb201cd2-f2aa-49c0-a79c-c5d0304a51a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_048db12c-d952-4e30-97f4-609acd0cf0a5" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_eb201cd2-f2aa-49c0-a79c-c5d0304a51a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_b67623a5-88f5-4236-bd31-3b5d088091fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_048db12c-d952-4e30-97f4-609acd0cf0a5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_b67623a5-88f5-4236-bd31-3b5d088091fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c9879a05-e9fe-4772-a6bb-e396e7252211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_048db12c-d952-4e30-97f4-609acd0cf0a5" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c9879a05-e9fe-4772-a6bb-e396e7252211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2dcd690c-0f22-4956-aebb-579cbfc19a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2dcd690c-0f22-4956-aebb-579cbfc19a07" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f833fac3-b215-4f83-90f3-2896a2552afa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_srt_RangeAxis_f833fac3-b215-4f83-90f3-2896a2552afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_36b720f4-106c-4976-b78d-20b0ddcc770e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f833fac3-b215-4f83-90f3-2896a2552afa" xlink:to="loc_srt_RangeMember_36b720f4-106c-4976-b78d-20b0ddcc770e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_af0b9e4e-131a-4fee-b4f5-9c55d6ae07cc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_36b720f4-106c-4976-b78d-20b0ddcc770e" xlink:to="loc_srt_MinimumMember_af0b9e4e-131a-4fee-b4f5-9c55d6ae07cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b98b78b-024c-4aad-a264-5335941c6656" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_36b720f4-106c-4976-b78d-20b0ddcc770e" xlink:to="loc_srt_MaximumMember_9b98b78b-024c-4aad-a264-5335941c6656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_714b3b24-efd7-4405-aacc-c27e48ba2833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_714b3b24-efd7-4405-aacc-c27e48ba2833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_714b3b24-efd7-4405-aacc-c27e48ba2833" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_d8dc7dea-d528-4999-95e6-cb52f46e421b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_d8dc7dea-d528-4999-95e6-cb52f46e421b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_8ab4a0e4-95bf-488e-8905-a7f5f004037a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:to="loc_us-gaap_PatentsMember_8ab4a0e4-95bf-488e-8905-a7f5f004037a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_ea6b3a39-a91f-47b2-83f8-8880ad7cecd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46789f6c-f498-4e54-9f5e-76a7423cb95f" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_ea6b3a39-a91f-47b2-83f8-8880ad7cecd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_278e80c2-424b-43f7-b17a-14d6746aaf09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_278e80c2-424b-43f7-b17a-14d6746aaf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_13cfc88d-12f8-4c5d-98f2-f4c0583a8d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_278e80c2-424b-43f7-b17a-14d6746aaf09" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_13cfc88d-12f8-4c5d-98f2-f4c0583a8d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_534e6c1b-5636-45cb-9c36-423331e65183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_13cfc88d-12f8-4c5d-98f2-f4c0583a8d8c" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_534e6c1b-5636-45cb-9c36-423331e65183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ac508c88-35d1-438b-a088-acd8aecca43d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_13cfc88d-12f8-4c5d-98f2-f4c0583a8d8c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ac508c88-35d1-438b-a088-acd8aecca43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3c7bee28-246a-4df4-b5ad-12a7649e3592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3c7bee28-246a-4df4-b5ad-12a7649e3592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3c7bee28-246a-4df4-b5ad-12a7649e3592" xlink:to="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_7a753c0f-a1a1-4afe-93db-e9f21444c54b" xlink:href="bsx-20201231.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:to="loc_bsx_MedsurgMember_7a753c0f-a1a1-4afe-93db-e9f21444c54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_6223f404-a4e9-441c-8ce5-4322b7b3b5c0" xlink:href="bsx-20201231.xsd#bsx_RhythmandNeuroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:to="loc_bsx_RhythmandNeuroMember_6223f404-a4e9-441c-8ce5-4322b7b3b5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_51febb52-d4bd-4ef9-ab80-8f98cc64085d" xlink:href="bsx-20201231.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:to="loc_bsx_CardiovascularMember_51febb52-d4bd-4ef9-ab80-8f98cc64085d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_445e0c61-db03-43e5-97a7-62a6070ef997" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4aa8fcd-8d4c-407c-b7e4-8cbb4e7754bf" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_445e0c61-db03-43e5-97a7-62a6070ef997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ec9fea8a-136c-4ff3-83e3-f4ed05a3c42d" xlink:to="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ad6b1434-19f4-4fbb-a97a-6a59cf24506a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ad6b1434-19f4-4fbb-a97a-6a59cf24506a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_324467ab-9f6d-4530-9a14-2bdad76669e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_324467ab-9f6d-4530-9a14-2bdad76669e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_0f3a145d-7e93-4729-bc0c-ed77140a7f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_GoodwillGross_0f3a145d-7e93-4729-bc0c-ed77140a7f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4bff57b7-efa3-4b80-b41a-62c28e3d62d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4bff57b7-efa3-4b80-b41a-62c28e3d62d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_482a4a09-aea0-4569-a3df-737c80300d03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_482a4a09-aea0-4569-a3df-737c80300d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e15d2961-9979-46ff-952d-21aff6f0c980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_e15d2961-9979-46ff-952d-21aff6f0c980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:href="bsx-20201231.xsd#bsx_GoodwillTextualsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6283592b-bc42-4dd0-9bce-fad6f522c5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_Goodwill_6283592b-bc42-4dd0-9bce-fad6f522c5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_01e3735c-cc83-486b-bd03-69eb61e9d17c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_01e3735c-cc83-486b-bd03-69eb61e9d17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_66c362e6-d61d-4144-8542-ce991d3f558e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_66c362e6-d61d-4144-8542-ce991d3f558e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5f910595-bfd5-4835-8457-3f9de84869f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5f910595-bfd5-4835-8457-3f9de84869f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_894ee226-dff3-4aee-ab6e-2fc1cee558a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_894ee226-dff3-4aee-ab6e-2fc1cee558a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_1562e5ed-d678-4f83-8bdb-475f0de931af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_GoodwillTextualsAbstract_f6626293-0e76-4585-8ff5-ec7cbd99b629" xlink:to="loc_us-gaap_GoodwillTransfers_1562e5ed-d678-4f83-8bdb-475f0de931af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:href="bsx-20201231.xsd#bsx_OtherIntangibleAssetsTextualsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f2db9e9d-90fd-47a7-a3a3-21fdd0a4d3de" xlink:to="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4030a95f-b19e-4772-aa3a-1e7d17a34e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4030a95f-b19e-4772-aa3a-1e7d17a34e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cc2106d6-b936-4692-ac60-87e1093d619e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_cc2106d6-b936-4692-ac60-87e1093d619e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_67792e8a-29d0-4bf8-ad4e-31a433c32955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_67792e8a-29d0-4bf8-ad4e-31a433c32955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b192f943-8898-4c35-9e4f-314a97fbb9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b192f943-8898-4c35-9e4f-314a97fbb9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8c1a010f-5562-4120-a1a6-88bc3ffbaadc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherIntangibleAssetsTextualsAbstract_1626f5c1-707d-47c2-b639-ba44eed2add8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8c1a010f-5562-4120-a1a6-88bc3ffbaadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20201231.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4f7260a8-415b-4ab5-89a9-e0b28e2339c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8aecb053-221f-42fa-bddf-bae3cebd871d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4f7260a8-415b-4ab5-89a9-e0b28e2339c7" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_8aecb053-221f-42fa-bddf-bae3cebd871d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5fde4436-7d24-4070-8a41-1c5593ba7ac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8aecb053-221f-42fa-bddf-bae3cebd871d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5fde4436-7d24-4070-8a41-1c5593ba7ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#FairValueMeasuresandDisclosuresPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a78e48c3-eacf-4e80-9f96-30baef2a2aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_83d67e65-3951-4a5f-9a0f-c3f7c4c0f5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a78e48c3-eacf-4e80-9f96-30baef2a2aae" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_83d67e65-3951-4a5f-9a0f-c3f7c4c0f5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5ce3257b-0e70-4391-a8c0-821b35ec010f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a78e48c3-eacf-4e80-9f96-30baef2a2aae" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5ce3257b-0e70-4391-a8c0-821b35ec010f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6a1fbf9d-4754-47a3-9051-e4c72ca13827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cfa49a57-0247-4c71-bce5-d40f334a39ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6a1fbf9d-4754-47a3-9051-e4c72ca13827" xlink:to="loc_us-gaap_DerivativeTable_cfa49a57-0247-4c71-bce5-d40f334a39ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_117a69d4-9837-43b4-896c-ba96609e8a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cfa49a57-0247-4c71-bce5-d40f334a39ca" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_117a69d4-9837-43b4-896c-ba96609e8a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6c47361c-7505-44fa-b4eb-8e8ad47613c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_117a69d4-9837-43b4-896c-ba96609e8a15" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6c47361c-7505-44fa-b4eb-8e8ad47613c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cfa49a57-0247-4c71-bce5-d40f334a39ca" xlink:to="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_814d9bd1-5445-4915-901a-0bbfc3a0c08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_814d9bd1-5445-4915-901a-0bbfc3a0c08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4f0b2820-d291-4def-ac4e-88237d154cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4f0b2820-d291-4def-ac4e-88237d154cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_9b4c7db1-b83c-4038-90c0-580934ef30ef" xlink:href="bsx-20201231.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_9b4c7db1-b83c-4038-90c0-580934ef30ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ba706171-463d-4812-a06d-089bea708c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ba706171-463d-4812-a06d-089bea708c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_da7f0d19-f48f-405e-8189-20671f09ddcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5cb936d3-2c20-4f4f-9085-65eaf41c203b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_da7f0d19-f48f-405e-8189-20671f09ddcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_68966f17-c936-41d4-8cef-c1471261c02f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6a1fbf9d-4754-47a3-9051-e4c72ca13827" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_68966f17-c936-41d4-8cef-c1471261c02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_68966f17-c936-41d4-8cef-c1471261c02f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_407558b6-562d-4c44-8e78-7a15d9659370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_407558b6-562d-4c44-8e78-7a15d9659370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9580d40b-5ced-494f-a572-db3f2e2d2ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_407558b6-562d-4c44-8e78-7a15d9659370" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9580d40b-5ced-494f-a572-db3f2e2d2ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d92a50fe-d484-4892-b539-6c5a82594152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d92a50fe-d484-4892-b539-6c5a82594152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c251f18b-f3e6-4453-9810-3b7ee00de46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d92a50fe-d484-4892-b539-6c5a82594152" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c251f18b-f3e6-4453-9810-3b7ee00de46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_17e280de-1fa0-4f9b-8738-23afdc3df9a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bb9c1fc9-c7a5-436d-bee6-c1f56afe720a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_17e280de-1fa0-4f9b-8738-23afdc3df9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0d09cd9c-f132-44d6-98a5-da5fcb9549ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_17e280de-1fa0-4f9b-8738-23afdc3df9a9" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0d09cd9c-f132-44d6-98a5-da5fcb9549ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_497dd3d9-d652-4818-90be-8931d5e3d0b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_497dd3d9-d652-4818-90be-8931d5e3d0b8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a440caaf-262e-4f0b-9984-6f14e266f50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a440caaf-262e-4f0b-9984-6f14e266f50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_553201eb-15a8-44b3-b8af-d92c3426c0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a440caaf-262e-4f0b-9984-6f14e266f50f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_553201eb-15a8-44b3-b8af-d92c3426c0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2167c4e7-44a6-47e8-9a31-1f06ce3ecae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_553201eb-15a8-44b3-b8af-d92c3426c0d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_2167c4e7-44a6-47e8-9a31-1f06ce3ecae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_2946e282-794d-4c56-95aa-965f9899f616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_553201eb-15a8-44b3-b8af-d92c3426c0d2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_2946e282-794d-4c56-95aa-965f9899f616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_316cb933-1d7a-4fad-9246-accb3dc82a32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_HedgingDesignationAxis_316cb933-1d7a-4fad-9246-accb3dc82a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8d525f3b-6413-4d16-9345-7e28e5b1c4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_316cb933-1d7a-4fad-9246-accb3dc82a32" xlink:to="loc_us-gaap_HedgingDesignationDomain_8d525f3b-6413-4d16-9345-7e28e5b1c4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c7af3226-9ef5-4ffa-ab34-9b711d36dd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8d525f3b-6413-4d16-9345-7e28e5b1c4bc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c7af3226-9ef5-4ffa-ab34-9b711d36dd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4a870294-e9ee-451f-9cb0-868eb1e47c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8d525f3b-6413-4d16-9345-7e28e5b1c4bc" xlink:to="loc_us-gaap_NondesignatedMember_4a870294-e9ee-451f-9cb0-868eb1e47c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1d03feff-383f-4157-b4ce-0827f864f43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1d03feff-383f-4157-b4ce-0827f864f43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1d03feff-383f-4157-b4ce-0827f864f43f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6f6fbb9b-b520-414d-a703-9fbfe96cc568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6f6fbb9b-b520-414d-a703-9fbfe96cc568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_286667a9-3ad0-484c-92c7-add772a528bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:to="loc_us-gaap_ForeignExchangeContractMember_286667a9-3ad0-484c-92c7-add772a528bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_e14f7b6c-794c-4846-8621-bcf3b60b68e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:to="loc_us-gaap_InterestRateContractMember_e14f7b6c-794c-4846-8621-bcf3b60b68e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeignCurrencyDenominatedInDebtMember_1dfe86b5-39bd-4ffb-84a9-19237c6eb9ec" xlink:href="bsx-20201231.xsd#bsx_ForeignCurrencyDenominatedInDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9857db59-5c09-4c7e-82dd-35d403f6b707" xlink:to="loc_bsx_ForeignCurrencyDenominatedInDebtMember_1dfe86b5-39bd-4ffb-84a9-19237c6eb9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_22ddf011-29b0-45f3-bcda-9e87f7fde922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_22ddf011-29b0-45f3-bcda-9e87f7fde922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5b70181-4c5d-42f9-8b1f-69cb0e8a63d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_22ddf011-29b0-45f3-bcda-9e87f7fde922" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5b70181-4c5d-42f9-8b1f-69cb0e8a63d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_70e973cb-0888-49c3-baad-0fa99b36d405" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5b70181-4c5d-42f9-8b1f-69cb0e8a63d2" xlink:to="loc_bsx_BTGAcquisitionMember_70e973cb-0888-49c3-baad-0fa99b36d405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6bd1760b-408e-43b3-a58b-3c0ad51f215a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6bd1760b-408e-43b3-a58b-3c0ad51f215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_65d71c73-08e3-4313-9eea-bf7857d63866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6bd1760b-408e-43b3-a58b-3c0ad51f215a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_65d71c73-08e3-4313-9eea-bf7857d63866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_78348463-acc1-41c0-bc53-11801bc6970b" xlink:href="bsx-20201231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_65d71c73-08e3-4313-9eea-bf7857d63866" xlink:to="loc_bsx_November2019AggregateOfferingMember_78348463-acc1-41c0-bc53-11801bc6970b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_b2ae0cd7-93f3-46a7-9ad9-4206397832e7" xlink:href="bsx-20201231.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_65d71c73-08e3-4313-9eea-bf7857d63866" xlink:to="loc_bsx_December2027NotesMember_b2ae0cd7-93f3-46a7-9ad9-4206397832e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_61d8f06d-aac9-43dc-b114-dbcb9e6e0956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_61d8f06d-aac9-43dc-b114-dbcb9e6e0956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_61d8f06d-aac9-43dc-b114-dbcb9e6e0956" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember_22d75a5d-b67f-4f3a-ae6b-ada92742b3ad" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_bsx_LicensingArrangementAssetsMember_22d75a5d-b67f-4f3a-ae6b-ada92742b3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8985a071-f79a-4305-a963-05d55e127b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8985a071-f79a-4305-a963-05d55e127b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_f208cd49-9286-4868-a151-336faff664bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_f208cd49-9286-4868-a151-336faff664bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_10033dda-bcaa-4abe-a9b7-e5dab4586238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_10033dda-bcaa-4abe-a9b7-e5dab4586238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bb67108b-a050-428b-8522-371df49bf860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bb67108b-a050-428b-8522-371df49bf860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_acaa1f27-3155-4f33-80b5-1a1bccefdce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9e1863c5-269e-431b-84e2-8fc2ae9dbe86" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_acaa1f27-3155-4f33-80b5-1a1bccefdce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_25176341-dfd6-4cc9-bb45-6d575e5ff020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_25176341-dfd6-4cc9-bb45-6d575e5ff020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25176341-dfd6-4cc9-bb45-6d575e5ff020" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e6377e50-a407-4490-86ae-081dbfc49a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:to="loc_us-gaap_CostOfSalesMember_e6377e50-a407-4490-86ae-081dbfc49a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_4d29bf1d-48eb-46cb-b3bc-969077385295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:to="loc_us-gaap_InterestExpenseMember_4d29bf1d-48eb-46cb-b3bc-969077385295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_65592024-ef8b-4949-80ab-c9b15e2556ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e0c1b02d-170a-45dd-88b8-8407f33d263c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_65592024-ef8b-4949-80ab-c9b15e2556ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83fe39fd-3b6a-48dd-87b8-483b85a5ed09" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5391a967-2ce2-4ecc-a222-9f2211dff603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_LongTermDebt_5391a967-2ce2-4ecc-a222-9f2211dff603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f905b90-6140-4e4d-b98e-967fc3a26d23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6f905b90-6140-4e4d-b98e-967fc3a26d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_e9002ce8-dfb3-4d84-ab05-f4947f79f5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_e9002ce8-dfb3-4d84-ab05-f4947f79f5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge_306219ef-1ea1-4d94-acbf-70398ea2f85e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeCashReceivedOnHedge_306219ef-1ea1-4d94-acbf-70398ea2f85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_8f4bc008-5c1b-4e40-9cdd-c519369ea48c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_8f4bc008-5c1b-4e40-9cdd-c519369ea48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_839dd06a-8644-4bde-96ff-0995a870d78f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_839dd06a-8644-4bde-96ff-0995a870d78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0b6a0503-97cb-44c3-be24-c9405dbcbcae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0b6a0503-97cb-44c3-be24-c9405dbcbcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_4d94916d-aac3-4d25-8432-a367dac1051d" xlink:href="bsx-20201231.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_4d94916d-aac3-4d25-8432-a367dac1051d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_cea078fd-1d8b-4f3c-a8ef-dd8cd306afbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_cea078fd-1d8b-4f3c-a8ef-dd8cd306afbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_e2cf063f-4683-4cc8-9b47-dbe7d0cca67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_e2cf063f-4683-4cc8-9b47-dbe7d0cca67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_94314eed-487a-4d3d-817c-df0b09a3a730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_94314eed-487a-4d3d-817c-df0b09a3a730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2666ba72-acb7-4dd6-bcee-a0af3d1584c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2666ba72-acb7-4dd6-bcee-a0af3d1584c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1a6937fe-0d9a-4ce9-8ebd-65d600ece587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_1a6937fe-0d9a-4ce9-8ebd-65d600ece587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_53a696e5-e82a-40d6-92eb-4e2e1fd71545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_53a696e5-e82a-40d6-92eb-4e2e1fd71545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8bee7d2d-1739-4d72-8434-56408b238e4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8bee7d2d-1739-4d72-8434-56408b238e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8fa5ce9b-82af-4f12-be21-72181c35cffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8fa5ce9b-82af-4f12-be21-72181c35cffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_80179e31-3517-404f-8eee-71950d070e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_80179e31-3517-404f-8eee-71950d070e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_d1b5fb12-5bdb-41f0-9f54-90c3c4ca2831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_d1b5fb12-5bdb-41f0-9f54-90c3c4ca2831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4eca6661-7940-4e5a-85bb-e4c5c6f81a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_InterestExpense_4eca6661-7940-4e5a-85bb-e4c5c6f81a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_8cfa8ce1-c002-4b9e-8176-c314e7e7294b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_8cfa8ce1-c002-4b9e-8176-c314e7e7294b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_ecb84673-07b5-4c26-8f27-3c3f1a69f743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_ecb84673-07b5-4c26-8f27-3c3f1a69f743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_935d2078-95be-4734-9e0a-d4202d5ba4bd" xlink:href="bsx-20201231.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_935d2078-95be-4734-9e0a-d4202d5ba4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_f99aedb0-5908-435f-ace3-ddd85218879e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_f99aedb0-5908-435f-ace3-ddd85218879e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_2236e968-8692-4152-b1ea-a2317ec74bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_2236e968-8692-4152-b1ea-a2317ec74bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_56fe9b02-a610-4f02-96cc-ec45387cd61c" xlink:href="bsx-20201231.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_56fe9b02-a610-4f02-96cc-ec45387cd61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2b6723fe-676b-4393-a878-c7de91d9ab78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_2b6723fe-676b-4393-a878-c7de91d9ab78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3c4f4eb0-69da-4ffd-8411-447bf5063a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3c4f4eb0-69da-4ffd-8411-447bf5063a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetCurrencyExchangeGainLoss_f5c81cda-5116-40ee-960e-a2aef1fe1037" xlink:href="bsx-20201231.xsd#bsx_NetCurrencyExchangeGainLoss"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_bsx_NetCurrencyExchangeGainLoss_f5c81cda-5116-40ee-960e-a2aef1fe1037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_c2a39ace-f839-4e16-a156-4c98963e901b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_c2a39ace-f839-4e16-a156-4c98963e901b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ee4dad91-69a6-482a-847d-8d8c426aa48c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ee4dad91-69a6-482a-847d-8d8c426aa48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_eae076df-a5a8-4d3a-94e3-c245fc0e69d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_eae076df-a5a8-4d3a-94e3-c245fc0e69d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0700fed6-3ffa-4014-a724-64c9d8644361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0700fed6-3ffa-4014-a724-64c9d8644361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_1f5cf36b-d7b0-4bea-8e02-f939977c8a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_1f5cf36b-d7b0-4bea-8e02-f939977c8a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ea0ded2d-eb92-4d44-91f1-b51790dbf91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ea0ded2d-eb92-4d44-91f1-b51790dbf91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9e5a1083-0646-46c1-9495-0f73248542fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7f6920f6-a0b3-451e-b160-35068e37b0c4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9e5a1083-0646-46c1-9495-0f73248542fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_497dd3d9-d652-4818-90be-8931d5e3d0b8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_eb1bae45-da1a-478e-b2ad-fed30cf48f62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_srt_RangeAxis_eb1bae45-da1a-478e-b2ad-fed30cf48f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_eb1bae45-da1a-478e-b2ad-fed30cf48f62" xlink:to="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_caf73b7d-ebf1-4489-98cb-e1d4a723fbae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:to="loc_srt_WeightedAverageMember_caf73b7d-ebf1-4489-98cb-e1d4a723fbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a7a50a84-f169-4176-8b7e-cbe6b329dc48" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:to="loc_srt_MinimumMember_a7a50a84-f169-4176-8b7e-cbe6b329dc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4575dd0d-17b8-44b6-a0c5-02a0c505d74b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fa71ae9b-6cff-4daf-a72e-14666db775e1" xlink:to="loc_srt_MaximumMember_4575dd0d-17b8-44b6-a0c5-02a0c505d74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03e2110d-4573-4f35-b4c4-ef69fd220fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03e2110d-4573-4f35-b4c4-ef69fd220fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0e156233-b364-480d-b47d-b2994bc6095e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03e2110d-4573-4f35-b4c4-ef69fd220fb5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0e156233-b364-480d-b47d-b2994bc6095e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_24341172-f5a7-4122-84db-278041ccfa4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0e156233-b364-480d-b47d-b2994bc6095e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_24341172-f5a7-4122-84db-278041ccfa4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d495175-3462-4712-9892-c32f025baf7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d495175-3462-4712-9892-c32f025baf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4d495175-3462-4712-9892-c32f025baf7a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_df5ca593-2d13-4ac6-9629-290d0cb42aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_df5ca593-2d13-4ac6-9629-290d0cb42aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f44f8f16-e200-4db1-8837-0bf4eda75a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f44f8f16-e200-4db1-8837-0bf4eda75a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_725b8d98-e861-4549-b8b1-6db2931bf00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5aade52-8a3a-406c-bc54-49377c8e3db5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_725b8d98-e861-4549-b8b1-6db2931bf00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4c854471-9e1b-4773-ab4d-ffa5289266a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4c854471-9e1b-4773-ab4d-ffa5289266a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4c854471-9e1b-4773-ab4d-ffa5289266a2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementAssetsMember_3ee26c98-90a4-4b9c-9f94-39523bff40d9" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:to="loc_bsx_LicensingArrangementAssetsMember_3ee26c98-90a4-4b9c-9f94-39523bff40d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementLiabilitiesMember_e09d986e-9f06-44fa-aeb4-b245d38b501c" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:to="loc_bsx_LicensingArrangementLiabilitiesMember_e09d986e-9f06-44fa-aeb4-b245d38b501c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedOutstandingDebtMember_cfd7bc85-576a-407a-bfb1-4e8df1832f3e" xlink:href="bsx-20201231.xsd#bsx_EuroDenominatedOutstandingDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ab1156a-c7d2-40ee-8b4d-b13d97f08073" xlink:to="loc_bsx_EuroDenominatedOutstandingDebtMember_cfd7bc85-576a-407a-bfb1-4e8df1832f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86ad940a-eec7-4af5-b282-d6720f24ac86" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_5c56204a-35a2-4647-b1da-35162ff398b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_5c56204a-35a2-4647-b1da-35162ff398b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_35ebee2e-d231-45a7-b13c-9ae40623e019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_35ebee2e-d231-45a7-b13c-9ae40623e019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_17a87958-6308-4906-9287-953ce7ad566e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_DerivativeAssets_17a87958-6308-4906-9287-953ce7ad566e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset_c841203e-14df-4df4-b074-7b9dd0a1a329" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_bsx_LicensingArrangementsAsset_c841203e-14df-4df4-b074-7b9dd0a1a329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_0828a246-45ee-47ec-a0f3-3bd4ff997123" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_0828a246-45ee-47ec-a0f3-3bd4ff997123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_e0002703-d7af-429e-abc0-8b8b96e23c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_DerivativeLiabilities_e0002703-d7af-429e-abc0-8b8b96e23c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_115b2997-946e-4d8b-a7ea-a12bbbd51e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_115b2997-946e-4d8b-a7ea-a12bbbd51e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_5c2f8187-63ae-4ca9-972b-f18914142b8d" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_bsx_LicensingArrangementsLiability_5c2f8187-63ae-4ca9-972b-f18914142b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_44b6581e-cd8d-4703-83fe-777877ee9271" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_44b6581e-cd8d-4703-83fe-777877ee9271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_683767da-6add-4e36-b086-530c6a8bd9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_683767da-6add-4e36-b086-530c6a8bd9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_77fff7ef-f7f4-452e-9af3-57ad38884053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_Cash_77fff7ef-f7f4-452e-9af3-57ad38884053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_c24c951b-42f8-424f-a0ee-5c4f85485c23" xlink:href="bsx-20201231.xsd#bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements_c24c951b-42f8-424f-a0ee-5c4f85485c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_808c87f1-7249-4704-8f04-495204959614" xlink:href="bsx-20201231.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_bsx_DiscountRateFairValueInput_808c87f1-7249-4704-8f04-495204959614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_557feb16-7204-41ee-ab05-b2f1fbf60eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_557feb16-7204-41ee-ab05-b2f1fbf60eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_0a585cbf-849f-4195-ad42-0170fa8836d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_PaymentsForRoyalties_0a585cbf-849f-4195-ad42-0170fa8836d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_f73b6e7e-e6ca-432e-81f8-6b0831aa1318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_f73b6e7e-e6ca-432e-81f8-6b0831aa1318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_6806ef12-393d-4d87-87f5-a13ba7da7e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4c26da66-2edf-4d83-8fdc-c98b95a9c351" xlink:to="loc_us-gaap_DebtInstrumentFairValue_6806ef12-393d-4d87-87f5-a13ba7da7e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2d7dff03-1ff5-4f6a-8f9e-c8029c7aaf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_58588ad7-fbae-416c-b3b9-de2cdd444ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2d7dff03-1ff5-4f6a-8f9e-c8029c7aaf5d" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_58588ad7-fbae-416c-b3b9-de2cdd444ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d9a36d83-62e0-4033-a08b-516ba8ffbbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d9a36d83-62e0-4033-a08b-516ba8ffbbe7" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_854c92ec-bbe3-4597-8adb-e7c48001dc11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_854c92ec-bbe3-4597-8adb-e7c48001dc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a1dce8cf-ca68-4304-9d16-0a81e685f176" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_854c92ec-bbe3-4597-8adb-e7c48001dc11" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a1dce8cf-ca68-4304-9d16-0a81e685f176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d955eee2-fedb-40a4-8e73-09a156b18a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a1dce8cf-ca68-4304-9d16-0a81e685f176" xlink:to="loc_us-gaap_CommercialPaperMember_d955eee2-fedb-40a4-8e73-09a156b18a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_089303a0-cfb9-4e7f-99a9-7b5551956144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:to="loc_us-gaap_DebtInstrumentAxis_089303a0-cfb9-4e7f-99a9-7b5551956144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4acdc2ba-73dc-4c45-8bd9-2aefc816e7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_089303a0-cfb9-4e7f-99a9-7b5551956144" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4acdc2ba-73dc-4c45-8bd9-2aefc816e7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_e68ee273-9aa6-4fc5-bad6-6bc54592955a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_d6ff5c1f-228c-4ef6-9a7b-1ea4d9ee640d" xlink:to="loc_us-gaap_ShortTermDebtLineItems_e68ee273-9aa6-4fc5-bad6-6bc54592955a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_f623dc79-b13f-47c6-80c3-ec4332dc1404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_e68ee273-9aa6-4fc5-bad6-6bc54592955a" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_f623dc79-b13f-47c6-80c3-ec4332dc1404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_b1347afe-ff4b-455d-b4e4-89d55552dfd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d9a36d83-62e0-4033-a08b-516ba8ffbbe7" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_b1347afe-ff4b-455d-b4e4-89d55552dfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_d3b4d679-5683-4045-9b3b-31e0741d1d12" xlink:href="bsx-20201231.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d9a36d83-62e0-4033-a08b-516ba8ffbbe7" xlink:to="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_d3b4d679-5683-4045-9b3b-31e0741d1d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_e11330b6-ff1c-484e-91c0-0521c8fe22c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d9a36d83-62e0-4033-a08b-516ba8ffbbe7" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_e11330b6-ff1c-484e-91c0-0521c8fe22c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_853ed1da-723b-42c0-8d27-fb648d471a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d9a36d83-62e0-4033-a08b-516ba8ffbbe7" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTextBlock_853ed1da-723b-42c0-8d27-fb648d471a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_59958132-3272-4a79-955b-c6d40f5ded20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_59958132-3272-4a79-955b-c6d40f5ded20" xlink:to="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9b809490-ebd1-4227-abe7-1e1f7e1c4709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d256bf2-6dd0-40fe-b6a7-3b7ab5192be2" xlink:to="loc_us-gaap_ClassOfStockDomain_9b809490-ebd1-4227-abe7-1e1f7e1c4709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_c1a27d32-774a-44ee-b91c-58583f350a45" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9b809490-ebd1-4227-abe7-1e1f7e1c4709" xlink:to="loc_bsx_A550MCPSSeriesAMember_c1a27d32-774a-44ee-b91c-58583f350a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_DebtInstrumentAxis_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_71ea6dc6-b8c7-4df7-8263-f66a8ac2fadd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember_0c8c6ad4-f460-4804-86c7-4ab51f283f75" xlink:href="bsx-20201231.xsd#bsx_April2021TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_April2021TermLoanMember_0c8c6ad4-f460-4804-86c7-4ab51f283f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember_f2d4c510-f759-4417-9c99-107ca5d0f3e8" xlink:href="bsx-20201231.xsd#bsx_A2020TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_A2020TermLoanMember_f2d4c510-f759-4417-9c99-107ca5d0f3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember_be93e4c8-e078-44c7-ace9-5e5583eeea64" xlink:href="bsx-20201231.xsd#bsx_February2021TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_February2021TermLoanMember_be93e4c8-e078-44c7-ace9-5e5583eeea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember_41d5f00f-448e-4d8a-907e-d350c52e4479" xlink:href="bsx-20201231.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_ThreeYearDelayedDrawTermLoanMember_41d5f00f-448e-4d8a-907e-d350c52e4479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember_af17f9ea-f963-4e1e-a398-51f8f4e31fcb" xlink:href="bsx-20201231.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_TwoYearDelayedDrawTermLoanMember_af17f9ea-f963-4e1e-a398-51f8f4e31fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_3cfd4ebf-f856-4c8f-af8f-56c8f7224e83" xlink:href="bsx-20201231.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_3cfd4ebf-f856-4c8f-af8f-56c8f7224e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_0e0e4f5e-951e-44e6-9fe1-e3c4cc8c6c37" xlink:href="bsx-20201231.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_0e0e4f5e-951e-44e6-9fe1-e3c4cc8c6c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_debaa01a-cc27-40f1-bc3d-929cc586cb8e" xlink:href="bsx-20201231.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_debaa01a-cc27-40f1-bc3d-929cc586cb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_a8ea35db-c32c-4e32-b897-d8c2b909f83e" xlink:href="bsx-20201231.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8648f705-e509-47a5-8809-560ede6d1681" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_a8ea35db-c32c-4e32-b897-d8c2b909f83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b2ea308a-16fc-48a2-88b2-97618b19dc29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b2ea308a-16fc-48a2-88b2-97618b19dc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b2ea308a-16fc-48a2-88b2-97618b19dc29" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember_1c0dc55b-514a-41ff-a7c9-faa03468eff8" xlink:href="bsx-20201231.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_February2019AggregateOfferingMember_1c0dc55b-514a-41ff-a7c9-faa03468eff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember_9de9fb27-dff2-4216-9bfa-c74ce2c73001" xlink:href="bsx-20201231.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_May2020SNAggregateOfferingMember_9de9fb27-dff2-4216-9bfa-c74ce2c73001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember_76a89a27-88fc-4922-8741-668302044f71" xlink:href="bsx-20201231.xsd#bsx_January2020NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_January2020NotesMember_76a89a27-88fc-4922-8741-668302044f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember_c3f2725a-bf73-4139-b844-20b63abc17c4" xlink:href="bsx-20201231.xsd#bsx_May2020NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_May2020NotesMember_c3f2725a-bf73-4139-b844-20b63abc17c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_a2d62c7b-de0a-45ad-bfa3-15b7e9f1ebee" xlink:href="bsx-20201231.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_November2019AggregateOfferingMember_a2d62c7b-de0a-45ad-bfa3-15b7e9f1ebee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_3e58b658-7df7-4d96-b9a8-dbc905a92a56" xlink:href="bsx-20201231.xsd#bsx_May2022NotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_May2022NotesMember_3e58b658-7df7-4d96-b9a8-dbc905a92a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_5b0f2378-c9a3-40b5-bd54-235077789e73" xlink:href="bsx-20201231.xsd#bsx_October2023NotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_October2023NotesMember_5b0f2378-c9a3-40b5-bd54-235077789e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7d04f1cf-1e8c-495f-97ec-db661063cfe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7d04f1cf-1e8c-495f-97ec-db661063cfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_81468895-6ffc-4972-98b7-a399f5eba74f" xlink:href="bsx-20201231.xsd#bsx_March2024NotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2024NotesMember_81468895-6ffc-4972-98b7-a399f5eba74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_48425a81-4538-4c44-9721-a2d05c11feeb" xlink:href="bsx-20201231.xsd#bsx_May2025NotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_May2025NotesMember_48425a81-4538-4c44-9721-a2d05c11feeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_8bf076ba-4533-426d-82cd-8abae82f5cbf" xlink:href="bsx-20201231.xsd#bsx_June2025NotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_June2025NotesMember_8bf076ba-4533-426d-82cd-8abae82f5cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_f49a3d1c-e3fc-43eb-843b-b6b46e734be3" xlink:href="bsx-20201231.xsd#bsx_March2026NotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2026NotesMember_f49a3d1c-e3fc-43eb-843b-b6b46e734be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_37c47cf4-4bc1-4c63-be30-d7939fe238fe" xlink:href="bsx-20201231.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_December2027NotesMember_37c47cf4-4bc1-4c63-be30-d7939fe238fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_7a0218b9-499a-4310-acd9-c36310ac0494" xlink:href="bsx-20201231.xsd#bsx_March2028NotesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2028NotesMember_7a0218b9-499a-4310-acd9-c36310ac0494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_30143139-7973-4a6b-b310-0605caaf696f" xlink:href="bsx-20201231.xsd#bsx_March2029NotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2029NotesMember_30143139-7973-4a6b-b310-0605caaf696f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_89a08db0-dd5e-480b-8c9d-89404b45ab87" xlink:href="bsx-20201231.xsd#bsx_June2030NotesMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_June2030NotesMember_89a08db0-dd5e-480b-8c9d-89404b45ab87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_7f2c2729-550d-4c3d-9fa3-7447c419c192" xlink:href="bsx-20201231.xsd#bsx_November2035NotesMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_November2035NotesMember_7f2c2729-550d-4c3d-9fa3-7447c419c192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_fe579722-fc13-4308-80f0-dad784e71b1f" xlink:href="bsx-20201231.xsd#bsx_March2039NotesMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2039NotesMember_fe579722-fc13-4308-80f0-dad784e71b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_e527284c-a79e-4d9e-9da9-452b84f4efe2" xlink:href="bsx-20201231.xsd#bsx_January2040NotesMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_January2040NotesMember_e527284c-a79e-4d9e-9da9-452b84f4efe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_cda4c0ad-c28f-418c-89ea-9a8e45f4f27b" xlink:href="bsx-20201231.xsd#bsx_March2049NotesMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_March2049NotesMember_cda4c0ad-c28f-418c-89ea-9a8e45f4f27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2022TermLoanMember_7fd245b1-0d10-43ad-a430-0200a194f04e" xlink:href="bsx-20201231.xsd#bsx_August2022TermLoanMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_August2022TermLoanMember_7fd245b1-0d10-43ad-a430-0200a194f04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a75f5a45-445f-49ba-8f50-f8491e31f9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_InterestRateSwapMember_a75f5a45-445f-49ba-8f50-f8491e31f9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_ee39cec0-62f1-432c-9367-c6962b76d56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_ee39cec0-62f1-432c-9367-c6962b76d56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_cdd85249-cdbe-4b3d-9ecf-4317c2811dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_SeniorNotesMember_cdd85249-cdbe-4b3d-9ecf-4317c2811dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_3cef9876-18a3-4d0d-a483-f83c29bba2ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_UnsecuredDebtMember_3cef9876-18a3-4d0d-a483-f83c29bba2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3caeb296-8d77-4104-86b2-a84b7128091a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3caeb296-8d77-4104-86b2-a84b7128091a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_6e4e1713-990b-410d-8677-6bcdf7115e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_6e4e1713-990b-410d-8677-6bcdf7115e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_e2dcfc8a-79e6-4565-b66c-04e99d3ac4e2" xlink:href="bsx-20201231.xsd#bsx_August2019TermLoanMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6ff3b85-6af8-4398-91cb-0623b06bf659" xlink:to="loc_bsx_August2019TermLoanMember_e2dcfc8a-79e6-4565-b66c-04e99d3ac4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_ddcf4a87-b8d9-4e79-885d-08aa52c7198c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_ddcf4a87-b8d9-4e79-885d-08aa52c7198c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e73f1907-0c2e-4b1b-9ee6-4f2a9d9e779d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_ddcf4a87-b8d9-4e79-885d-08aa52c7198c" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e73f1907-0c2e-4b1b-9ee6-4f2a9d9e779d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_311ef039-dc0c-456f-9f10-e9048cfc2bfe" xlink:href="bsx-20201231.xsd#bsx_The2018FacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_e73f1907-0c2e-4b1b-9ee6-4f2a9d9e779d" xlink:to="loc_bsx_The2018FacilityDomain_311ef039-dc0c-456f-9f10-e9048cfc2bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a4e76f23-08c3-481d-a0d6-7ae6358a153a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_CreditFacilityAxis_a4e76f23-08c3-481d-a0d6-7ae6358a153a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_448c3a06-d68f-4bba-96ed-548a395cccd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a4e76f23-08c3-481d-a0d6-7ae6358a153a" xlink:to="loc_us-gaap_CreditFacilityDomain_448c3a06-d68f-4bba-96ed-548a395cccd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b4ce11bf-9f38-4a39-abf9-3f772cd49a14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_448c3a06-d68f-4bba-96ed-548a395cccd2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b4ce11bf-9f38-4a39-abf9-3f772cd49a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_f6090964-5731-475b-9e4e-9aa3068c6c46" xlink:href="bsx-20201231.xsd#bsx_CovenantAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_bsx_CovenantAxis_f6090964-5731-475b-9e4e-9aa3068c6c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:href="bsx-20201231.xsd#bsx_CovenantDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantAxis_f6090964-5731-475b-9e4e-9aa3068c6c46" xlink:to="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_fd0471a9-6689-4034-a46d-4e4eeea3a39a" xlink:href="bsx-20201231.xsd#bsx_CurrentRequirementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_CurrentRequirementMember_fd0471a9-6689-4034-a46d-4e4eeea3a39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_bb04e9f8-408a-4c12-addf-0ab4e0050d2d" xlink:href="bsx-20201231.xsd#bsx_ActualCovenantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_ActualCovenantMember_bb04e9f8-408a-4c12-addf-0ab4e0050d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_2d44669e-b0b5-4c00-9438-d820eb6a61c8" xlink:href="bsx-20201231.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_2d44669e-b0b5-4c00-9438-d820eb6a61c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_8813344b-7f4a-4062-96f8-3088482d79f6" xlink:href="bsx-20201231.xsd#bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_8813344b-7f4a-4062-96f8-3088482d79f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_49a74adc-b5fa-48ce-9c46-62e762ca04c4" xlink:href="bsx-20201231.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_49a74adc-b5fa-48ce-9c46-62e762ca04c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_fe04dfa8-f0d2-4f83-876e-db9e37f78c09" xlink:href="bsx-20201231.xsd#bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_fe04dfa8-f0d2-4f83-876e-db9e37f78c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementExtensionThroughTheRemainderOf2020Member_e4f99afb-da9d-49cb-8841-960e6072d0cf" xlink:href="bsx-20201231.xsd#bsx_RequirementExtensionThroughTheRemainderOf2020Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_4a7f7408-b75f-4528-aaea-ffdc7b1992e5" xlink:to="loc_bsx_RequirementExtensionThroughTheRemainderOf2020Member_e4f99afb-da9d-49cb-8841-960e6072d0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ce6355c6-1839-4bb6-8aaf-193f9a55246f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_daf58e5a-a0e6-4ac8-9fa2-0f44e79f4707" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ce6355c6-1839-4bb6-8aaf-193f9a55246f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f7a9fbf8-4dc9-434f-9ff7-f462e085aaba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ce6355c6-1839-4bb6-8aaf-193f9a55246f" xlink:to="loc_us-gaap_CommercialPaperMember_f7a9fbf8-4dc9-434f-9ff7-f462e085aaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_a4c9fc97-fbaf-4d11-9361-bd24ca8a20b8" xlink:href="bsx-20201231.xsd#bsx_August2019TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_ce6355c6-1839-4bb6-8aaf-193f9a55246f" xlink:to="loc_bsx_August2019TermLoanMember_a4c9fc97-fbaf-4d11-9361-bd24ca8a20b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b365343d-31ff-4a9e-916c-f1da8df07f3a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_96d1f77c-dc27-40ac-9ec4-af39d243959a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_96d1f77c-dc27-40ac-9ec4-af39d243959a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_cefd8a18-b6ae-4355-890f-ce8194d20921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtCurrent_cefd8a18-b6ae-4355-890f-ce8194d20921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e09ae71e-76c1-478c-aed9-7eb35cac6435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e09ae71e-76c1-478c-aed9-7eb35cac6435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_33eda191-56a0-404d-9cf9-abebfa9ecaa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_33eda191-56a0-404d-9cf9-abebfa9ecaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a1a31b66-227d-4675-9759-eceb0d35d9dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a1a31b66-227d-4675-9759-eceb0d35d9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_3496f6b2-5243-425a-bd86-fafcb8f259b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_3496f6b2-5243-425a-bd86-fafcb8f259b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_e0f88a79-4653-444d-9719-a06e1ec0a06f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_e0f88a79-4653-444d-9719-a06e1ec0a06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3f2b1982-70f3-47e5-8aaa-bd9eb3bfd025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_ShortTermBorrowings_3f2b1982-70f3-47e5-8aaa-bd9eb3bfd025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_0e8341d2-7aa5-431a-9666-1819c7ce1ac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_RepaymentsOfDebt_0e8341d2-7aa5-431a-9666-1819c7ce1ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_0515cb17-78ee-4dd1-ba20-6a09df839d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LineOfCredit_0515cb17-78ee-4dd1-ba20-6a09df839d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_636e7fb8-a066-45fa-8a8d-03e029e1846b" xlink:href="bsx-20201231.xsd#bsx_MaximumLeverageRatio"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_MaximumLeverageRatio_636e7fb8-a066-45fa-8a8d-03e029e1846b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA_ac150480-e3e3-4804-935f-4ce3921a4e90" xlink:href="bsx-20201231.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_DeemedConsolidatedEBITDA_ac150480-e3e3-4804-935f-4ce3921a4e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_444ed3d2-cc6d-45cf-9daa-f619590c2664" xlink:href="bsx-20201231.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_444ed3d2-cc6d-45cf-9daa-f619590c2664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_22a4053d-8be7-44ed-893a-3d08f302f2cb" xlink:href="bsx-20201231.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_22a4053d-8be7-44ed-893a-3d08f302f2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_80240c98-5e9e-4a7c-beca-ed249afc068a" xlink:href="bsx-20201231.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_80240c98-5e9e-4a7c-beca-ed249afc068a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_ce29a9e9-aa16-43f9-9b4e-d022f7338845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_CommercialPaper_ce29a9e9-aa16-43f9-9b4e-d022f7338845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding_bfc5bdea-9edf-4f49-ab6c-556d96d02417" xlink:href="bsx-20201231.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_MaximumCommercialPaperOutstanding_bfc5bdea-9edf-4f49-ab6c-556d96d02417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9e542f1c-f928-4215-a75c-3f2e2b7e368f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9e542f1c-f928-4215-a75c-3f2e2b7e368f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageMaturityDays_9f92cfd9-b0e6-4a60-99da-572be10bc387" xlink:href="bsx-20201231.xsd#bsx_WeightedAverageMaturityDays"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_WeightedAverageMaturityDays_9f92cfd9-b0e6-4a60-99da-572be10bc387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_a8b32709-f72b-485a-9a49-959f010b06f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_a8b32709-f72b-485a-9a49-959f010b06f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_793f54c3-f0e4-48e8-ba3e-9146fadfcce5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_793f54c3-f0e4-48e8-ba3e-9146fadfcce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_7a093d5f-e299-419a-9901-fe7d2fcada88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_7a093d5f-e299-419a-9901-fe7d2fcada88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_d2413e11-a0c1-4b86-b38f-52ba7bd99f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_d2413e11-a0c1-4b86-b38f-52ba7bd99f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_9e781869-7680-4b62-a1c0-9431e3bafa9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_9e781869-7680-4b62-a1c0-9431e3bafa9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f4bad841-182d-4a53-ab0a-c6a1fe481b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LongTermDebt_f4bad841-182d-4a53-ab0a-c6a1fe481b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_1bef1783-002e-4ff0-b0ad-f9a7a7f04f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_1bef1783-002e-4ff0-b0ad-f9a7a7f04f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2c7add63-afc9-467a-87c3-2bd9897ab064" xlink:href="bsx-20201231.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2c7add63-afc9-467a-87c3-2bd9897ab064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_aa85893f-5abe-4f33-895f-eb0ded477be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_aa85893f-5abe-4f33-895f-eb0ded477be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Seniornotesissued_bc5b5cab-f16b-43f4-993a-e222738827b5" xlink:href="bsx-20201231.xsd#bsx_Seniornotesissued"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_Seniornotesissued_bc5b5cab-f16b-43f4-993a-e222738827b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_814d75a7-78c2-4590-ba1b-8aedeeea1124" xlink:href="bsx-20201231.xsd#bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest_814d75a7-78c2-4590-ba1b-8aedeeea1124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d9bf2af3-7710-492a-a301-d08e11af4674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d9bf2af3-7710-492a-a301-d08e11af4674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_b0e57602-d90d-4cb0-a7df-076d83374805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_b0e57602-d90d-4cb0-a7df-076d83374805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_6bd40962-b80a-4bf6-bfcd-9318214234bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_6bd40962-b80a-4bf6-bfcd-9318214234bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_73d16a30-f052-4a54-aed2-cd77420ceb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_73d16a30-f052-4a54-aed2-cd77420ceb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_c7ab648b-0e5f-4ad7-b9ce-371b4ee569ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_c7ab648b-0e5f-4ad7-b9ce-371b4ee569ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_c80ec8af-f0c3-4dd8-b880-5c27b1a428d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_c80ec8af-f0c3-4dd8-b880-5c27b1a428d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_7de41c3c-57cf-4899-9880-6714d71757e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_PurchaseObligation_7de41c3c-57cf-4899-9880-6714d71757e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_acb6c4bd-dc11-4f2b-818b-58d7bc38404b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_07a373e6-3d99-4cff-b6e3-b5ea6b2603c4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_acb6c4bd-dc11-4f2b-818b-58d7bc38404b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Leases" xlink:type="simple" xlink:href="bsx-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ac54d392-3e43-478d-82d0-9efa8edd3d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_88ed77c6-cc31-4cf9-85f6-cdad0a18a010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ac54d392-3e43-478d-82d0-9efa8edd3d1b" xlink:to="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_88ed77c6-cc31-4cf9-85f6-cdad0a18a010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_01cb0dec-f01a-44cd-82b2-6a38605c09d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_732dc811-2cfe-4cb7-8ac8-7e43c8ad7f09" xlink:href="bsx-20201231.xsd#bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01cb0dec-f01a-44cd-82b2-6a38605c09d2" xlink:to="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock_732dc811-2cfe-4cb7-8ac8-7e43c8ad7f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_86dd1ccf-61d4-479d-9792-854ba657b15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01cb0dec-f01a-44cd-82b2-6a38605c09d2" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_86dd1ccf-61d4-479d-9792-854ba657b15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_fcbc4ba1-463c-4c54-b2e4-7c49469cc639" xlink:href="bsx-20201231.xsd#bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01cb0dec-f01a-44cd-82b2-6a38605c09d2" xlink:to="loc_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_fcbc4ba1-463c-4c54-b2e4-7c49469cc639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_c93604ca-e2e0-4a1f-89f1-5a97715e64d3" xlink:href="bsx-20201231.xsd#bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01cb0dec-f01a-44cd-82b2-6a38605c09d2" xlink:to="loc_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock_c93604ca-e2e0-4a1f-89f1-5a97715e64d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ef702f59-168e-4885-a61d-6a4587999f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef702f59-168e-4885-a61d-6a4587999f34" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6117106d-7124-401a-94aa-8a54ffb702ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:to="loc_srt_RangeAxis_6117106d-7124-401a-94aa-8a54ffb702ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d3ed16cb-0c73-49e3-aa6e-7379f1f6431e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6117106d-7124-401a-94aa-8a54ffb702ff" xlink:to="loc_srt_RangeMember_d3ed16cb-0c73-49e3-aa6e-7379f1f6431e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a6f91068-b925-4d06-9272-e5bde9648486" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d3ed16cb-0c73-49e3-aa6e-7379f1f6431e" xlink:to="loc_srt_MinimumMember_a6f91068-b925-4d06-9272-e5bde9648486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3f14bfc5-d6b6-4605-b580-e7a9e778ffc6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d3ed16cb-0c73-49e3-aa6e-7379f1f6431e" xlink:to="loc_srt_MaximumMember_3f14bfc5-d6b6-4605-b580-e7a9e778ffc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_24a13a01-3f39-471d-a1f3-903e1b636d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c3e7aa21-9f06-45d5-9a24-d1b9bd88e470" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_24a13a01-3f39-471d-a1f3-903e1b636d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_fe77a048-8b06-44be-9daa-b4cb894654d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_24a13a01-3f39-471d-a1f3-903e1b636d25" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_fe77a048-8b06-44be-9daa-b4cb894654d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8c3316d0-e543-4524-b74d-728268d83691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_24a13a01-3f39-471d-a1f3-903e1b636d25" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8c3316d0-e543-4524-b74d-728268d83691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_88840886-0e92-4e0e-a21f-a75da2a8f1c8" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_a91c1abb-b4fd-4bb9-ba94-b23c46d350c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_a91c1abb-b4fd-4bb9-ba94-b23c46d350c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_217b3bfd-0ab4-4a04-ab7b-aa59549e315d" xlink:href="bsx-20201231.xsd#bsx_LesseeOperatingAndFinanceLeasesOptionToExtend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend_217b3bfd-0ab4-4a04-ab7b-aa59549e315d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b6c6710f-0dbc-4261-ba4c-5af7bae31233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b6c6710f-0dbc-4261-ba4c-5af7bae31233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4665efc7-6c75-4fea-906e-743f534fddf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4665efc7-6c75-4fea-906e-743f534fddf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_47c74ae3-3e94-4514-aedd-931de6d49bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_47c74ae3-3e94-4514-aedd-931de6d49bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d34791fb-0e40-40b5-a361-2aff45ba1543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d34791fb-0e40-40b5-a361-2aff45ba1543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b36acc0d-da6e-4a29-a74b-35ec097787e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b36acc0d-da6e-4a29-a74b-35ec097787e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e10c00f6-42f0-4080-9832-6df5fa707c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseCost_e10c00f6-42f0-4080-9832-6df5fa707c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_a0808572-3d14-401e-b7d0-ee1905d6fe1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_a0808572-3d14-401e-b7d0-ee1905d6fe1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_c274948d-7014-44ca-90c8-a8d13db986ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeasePayments_c274948d-7014-44ca-90c8-a8d13db986ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9cdba09b-74b3-42a2-9624-b978b81458f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9cdba09b-74b3-42a2-9624-b978b81458f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_2ec9a695-52d4-41aa-864d-8e5cceb2ed0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_2ec9a695-52d4-41aa-864d-8e5cceb2ed0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_2b138b77-de22-4007-ad54-106be091dc01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_2b138b77-de22-4007-ad54-106be091dc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_5e28c242-1653-4d7e-9647-f533ec8803d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_5e28c242-1653-4d7e-9647-f533ec8803d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_8e1da4c3-05d2-41a6-bc4b-4a8e8c3b2401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_8e1da4c3-05d2-41a6-bc4b-4a8e8c3b2401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_d14fd969-7b1c-4e2f-9c48-24d1b4ccb88b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_d14fd969-7b1c-4e2f-9c48-24d1b4ccb88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_bf00704a-b889-49d0-81d5-99554f5fdd6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_bf00704a-b889-49d0-81d5-99554f5fdd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60ac84ec-2269-4eee-9c0c-6bcd5737cb0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60ac84ec-2269-4eee-9c0c-6bcd5737cb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_27010309-2b78-492c-885d-5ae74eff6a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_27010309-2b78-492c-885d-5ae74eff6a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2ec121e9-d60d-4fad-aea0-44012a858869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_OperatingLeaseLiability_2ec121e9-d60d-4fad-aea0-44012a858869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LesseeLeasesNotYetCommencedAmount_1f226203-6fde-4bd4-8304-b2f2f31d3824" xlink:href="bsx-20201231.xsd#bsx_LesseeLeasesNotYetCommencedAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_bsx_LesseeLeasesNotYetCommencedAmount_1f226203-6fde-4bd4-8304-b2f2f31d3824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f297255f-f13c-4f09-8028-c171db68943f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_da064401-ca05-408d-9899-9652a6d10843" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f297255f-f13c-4f09-8028-c171db68943f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivities" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivities"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bdd277f2-a036-4328-a598-d0aa4be5f99a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2cc6a303-4739-41ac-929a-e65ba1784357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bdd277f2-a036-4328-a598-d0aa4be5f99a" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2cc6a303-4739-41ac-929a-e65ba1784357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_77d12b5c-9cdb-4d1c-ac91-107f18874dcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ae8d9163-4bc9-442e-8bbe-4f2f96a1cb7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_77d12b5c-9cdb-4d1c-ac91-107f18874dcb" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ae8d9163-4bc9-442e-8bbe-4f2f96a1cb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_d2ebcb9a-ffd6-417f-975d-895d3974d86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ae8d9163-4bc9-442e-8bbe-4f2f96a1cb7a" xlink:to="loc_us-gaap_RestructuringPlanAxis_d2ebcb9a-ffd6-417f-975d-895d3974d86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_d2ebcb9a-ffd6-417f-975d-895d3974d86a" xlink:to="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember_d6fbc74f-e4b2-4dbd-aa6f-742fa0c0d544" xlink:href="bsx-20201231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:to="loc_bsx_A2019RestructuringPlanMember_d6fbc74f-e4b2-4dbd-aa6f-742fa0c0d544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_448b8c38-0f43-4319-b611-f03ed810e357" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_448b8c38-0f43-4319-b611-f03ed810e357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_7e78b4ef-d4d3-4b12-bde4-1ca456b33b97" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:to="loc_bsx_RestructuringPlanMember_7e78b4ef-d4d3-4b12-bde4-1ca456b33b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember_c5a6d3d6-68c6-4552-b833-b72daea8d43b" xlink:href="bsx-20201231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_083141fa-5325-4add-8ded-78065178f359" xlink:to="loc_bsx_A2016RestructuringPlanMember_c5a6d3d6-68c6-4552-b833-b72daea8d43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ae8d9163-4bc9-442e-8bbe-4f2f96a1cb7a" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_44b4a09e-93ee-46db-b57b-a7b4a5ca22e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_44b4a09e-93ee-46db-b57b-a7b4a5ca22e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesTableTextBlock_a596deb4-11a8-4288-b715-548ca2b4b209" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringChargesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:to="loc_bsx_CumulativeRestructuringChargesTableTextBlock_a596deb4-11a8-4288-b715-548ca2b4b209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_7fc8211f-bf50-45d0-9f68-b3c20d260de1" xlink:href="bsx-20201231.xsd#bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_cbc59cfb-62ec-4a9d-9c0e-120f25c35f45" xlink:to="loc_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock_7fc8211f-bf50-45d0-9f68-b3c20d260de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#RestructuringRelatedActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c966e216-37e9-41de-af0e-fd3eb2efb5f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c966e216-37e9-41de-af0e-fd3eb2efb5f6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c5be969b-61d0-405e-ab9e-8f4803728634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c5be969b-61d0-405e-ab9e-8f4803728634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5be969b-61d0-405e-ab9e-8f4803728634" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a872e69e-80c5-464e-b340-db4a1ebf0f53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a872e69e-80c5-464e-b340-db4a1ebf0f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2d35ae7e-c406-4286-92b4-81e08b0042fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:to="loc_us-gaap_CostOfSalesMember_2d35ae7e-c406-4286-92b4-81e08b0042fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_722975d2-deb6-4bfd-bdbc-c4d0f62b19b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_afc25cc3-91cd-41ac-9b2b-ae7093a1ff98" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_722975d2-deb6-4bfd-bdbc-c4d0f62b19b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_4dbc96d8-8672-4bf8-899d-ccd377ed9076" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_4dbc96d8-8672-4bf8-899d-ccd377ed9076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_39c99dfb-7ec3-45d6-af59-c5e6be2b7745" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis_4dbc96d8-8672-4bf8-899d-ccd377ed9076" xlink:to="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_39c99dfb-7ec3-45d6-af59-c5e6be2b7745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_2d4559fa-eac2-49f7-9a5c-1d7bbba317c3" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_39c99dfb-7ec3-45d6-af59-c5e6be2b7745" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_2d4559fa-eac2-49f7-9a5c-1d7bbba317c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_bbdea70c-b68b-4fa2-84ee-ce40b11d115d" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain_39c99dfb-7ec3-45d6-af59-c5e6be2b7745" xlink:to="loc_bsx_RestructuringPlanMember_bbdea70c-b68b-4fa2-84ee-ce40b11d115d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionAxis_3bd49044-b61a-4a3f-8977-83e5c767dc19" xlink:href="bsx-20201231.xsd#bsx_StatementOfOperationsCaptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_bsx_StatementOfOperationsCaptionAxis_3bd49044-b61a-4a3f-8977-83e5c767dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementOfOperationsCaptionDomain_b633f03e-6df2-4d5d-ad21-ba21d234cb01" xlink:href="bsx-20201231.xsd#bsx_StatementOfOperationsCaptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementOfOperationsCaptionAxis_3bd49044-b61a-4a3f-8977-83e5c767dc19" xlink:to="loc_bsx_StatementOfOperationsCaptionDomain_b633f03e-6df2-4d5d-ad21-ba21d234cb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_34420234-b165-4218-a8eb-ff945bca57e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain_b633f03e-6df2-4d5d-ad21-ba21d234cb01" xlink:to="loc_us-gaap_CostOfSalesMember_34420234-b165-4218-a8eb-ff945bca57e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_cb339a74-606f-4f28-a7cc-c58c27071b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementOfOperationsCaptionDomain_b633f03e-6df2-4d5d-ad21-ba21d234cb01" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_cb339a74-606f-4f28-a7cc-c58c27071b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_c8100574-231d-4a22-998a-03cc160bace6" xlink:href="bsx-20201231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_c8100574-231d-4a22-998a-03cc160bace6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_1786391c-d0dc-4a73-96a4-ebc7e67b6917" xlink:href="bsx-20201231.xsd#bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis_c8100574-231d-4a22-998a-03cc160bace6" xlink:to="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_1786391c-d0dc-4a73-96a4-ebc7e67b6917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_27331b31-da67-4ddc-8fa7-192b449b1f51" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_1786391c-d0dc-4a73-96a4-ebc7e67b6917" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_27331b31-da67-4ddc-8fa7-192b449b1f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_0e6ccdf5-3d55-44c9-859c-a296c9d90ff3" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain_1786391c-d0dc-4a73-96a4-ebc7e67b6917" xlink:to="loc_bsx_RestructuringPlanMember_0e6ccdf5-3d55-44c9-859c-a296c9d90ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_srt_RangeAxis_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_120c0503-b33c-4d63-a8e7-bccb98f1ef1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9d65d0e6-bafc-4c1f-8c89-2dd5ba226b1a" xlink:to="loc_srt_RangeMember_120c0503-b33c-4d63-a8e7-bccb98f1ef1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_78bdd2b7-fb0a-4180-87cf-6cff5b579397" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_120c0503-b33c-4d63-a8e7-bccb98f1ef1f" xlink:to="loc_srt_MaximumMember_78bdd2b7-fb0a-4180-87cf-6cff5b579397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0d778d4c-eef4-4ffe-8851-944ae248552a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_120c0503-b33c-4d63-a8e7-bccb98f1ef1f" xlink:to="loc_srt_MinimumMember_0d778d4c-eef4-4ffe-8851-944ae248552a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_fd315a86-750a-4831-b95d-f7abd165bdfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_fd315a86-750a-4831-b95d-f7abd165bdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_fd315a86-750a-4831-b95d-f7abd165bdfd" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_5fc12dc0-f487-447f-a495-7b0f20054db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:to="loc_us-gaap_EmployeeSeveranceMember_5fc12dc0-f487-447f-a495-7b0f20054db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_15e22e40-650b-4a76-99f8-3e049cc5e377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:to="loc_us-gaap_OtherRestructuringMember_15e22e40-650b-4a76-99f8-3e049cc5e377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCostsMember_5f41c76f-99f6-40e2-bf6b-3e05943eefa9" xlink:href="bsx-20201231.xsd#bsx_TransferCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:to="loc_bsx_TransferCostsMember_5f41c76f-99f6-40e2-bf6b-3e05943eefa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedToPlanMember_5b4dde23-989e-4566-8f9f-14e81105094a" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedToPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0c304ed1-e05d-4863-8e9f-cc1f1772aa41" xlink:to="loc_bsx_RestructuringRelatedToPlanMember_5b4dde23-989e-4566-8f9f-14e81105094a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_c27784e2-ed19-4592-b36c-324f0af1e3da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_us-gaap_RestructuringPlanAxis_c27784e2-ed19-4592-b36c-324f0af1e3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_c27784e2-ed19-4592-b36c-324f0af1e3da" xlink:to="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringPlanMember_032bd9c1-8800-4351-900d-c2b8f241b1d1" xlink:href="bsx-20201231.xsd#bsx_RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:to="loc_bsx_RestructuringPlanMember_032bd9c1-8800-4351-900d-c2b8f241b1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019RestructuringPlanMember_d7a9d197-81cf-4170-96ac-398d37966f24" xlink:href="bsx-20201231.xsd#bsx_A2019RestructuringPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:to="loc_bsx_A2019RestructuringPlanMember_d7a9d197-81cf-4170-96ac-398d37966f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2016RestructuringPlanMember_68c645f2-9445-41ed-9d40-1bafc530eac4" xlink:href="bsx-20201231.xsd#bsx_A2016RestructuringPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:to="loc_bsx_A2016RestructuringPlanMember_68c645f2-9445-41ed-9d40-1bafc530eac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LotusDiscontinuationMember_a6f6d179-20c9-4702-991c-f13bbe9158a3" xlink:href="bsx-20201231.xsd#bsx_LotusDiscontinuationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_354ff38b-c0f4-4ed4-b7e9-5df812f8000f" xlink:to="loc_bsx_LotusDiscontinuationMember_a6f6d179-20c9-4702-991c-f13bbe9158a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_776710b8-fae7-484c-9ce6-ea4b27280c47" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_bd0328c9-2917-4e46-95a5-efdc0c6c7d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_bd0328c9-2917-4e46-95a5-efdc0c6c7d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringrelatedCostExpectedCost_df8a4052-3bf3-4a0f-8bbe-96e6c5cccd11" xlink:href="bsx-20201231.xsd#bsx_RestructuringrelatedCostExpectedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_RestructuringrelatedCostExpectedCost_df8a4052-3bf3-4a0f-8bbe-96e6c5cccd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost_d89cee9c-ed92-465c-9130-4312ad0dda9d" xlink:href="bsx-20201231.xsd#bsx_RestructuringandRestructuringrelatedCostExpectedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_RestructuringandRestructuringrelatedCostExpectedCost_d89cee9c-ed92-465c-9130-4312ad0dda9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOnFutureCashFlowsAmount_9a415274-db68-4204-9229-c8d379dcd383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOnFutureCashFlowsAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_EffectOnFutureCashFlowsAmount_9a415274-db68-4204-9229-c8d379dcd383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_7975da1a-bc0a-47bc-a18f-49f19116e7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_SeveranceCosts1_7975da1a-bc0a-47bc-a18f-49f19116e7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransferCosts_e38ddb6b-3c65-4352-a0d8-ca44d35a835a" xlink:href="bsx-20201231.xsd#bsx_TransferCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_TransferCosts_e38ddb6b-3c65-4352-a0d8-ca44d35a835a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_162001e7-ce1a-4ffc-847e-9f52e950fcc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_OtherRestructuringCosts_162001e7-ce1a-4ffc-847e-9f52e950fcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_62dbf82a-c1cb-4186-871b-46c36606066a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_RestructuringCharges_62dbf82a-c1cb-4186-871b-46c36606066a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_15324cde-2478-4175-b2c8-8992c0afa48f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_15324cde-2478-4175-b2c8-8992c0afa48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringRelatedExpenses_1d15c72c-19c4-4cc7-b67d-ac4bce9b8f35" xlink:href="bsx-20201231.xsd#bsx_RestructuringRelatedExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_RestructuringRelatedExpenses_1d15c72c-19c4-4cc7-b67d-ac4bce9b8f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_2c3054e6-7382-4954-acb1-f78d56af976d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_InventoryWriteDown_2c3054e6-7382-4954-acb1-f78d56af976d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0ff2d8df-3ac0-4c9d-a425-3cae2b94a679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_0ff2d8df-3ac0-4c9d-a425-3cae2b94a679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringChargesIncurredToDate_c7d19676-4de2-4956-be5a-9a715d74e3a5" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringChargesIncurredToDate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_CumulativeRestructuringChargesIncurredToDate_c7d19676-4de2-4956-be5a-9a715d74e3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_6917677f-fba5-46eb-9bf2-210e7c07e879" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringRelatedCostsIncurredToDate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_CumulativeRestructuringRelatedCostsIncurredToDate_6917677f-fba5-46eb-9bf2-210e7c07e879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_646b1511-cb79-459b-8f3d-c91d7859a11d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_646b1511-cb79-459b-8f3d-c91d7859a11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_e1f6a763-1eea-4f8b-82bb-f6857942573f" xlink:href="bsx-20201231.xsd#bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5b6b3fd1-fb29-4f44-8f08-857d02a58331" xlink:to="loc_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate_e1f6a763-1eea-4f8b-82bb-f6857942573f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_a4dec9d5-79d0-45bc-8850-3dfc5abb9f47" xlink:href="bsx-20201231.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_5a0d607d-d541-4def-9ad3-7ca172309079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a4dec9d5-79d0-45bc-8850-3dfc5abb9f47" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_5a0d607d-d541-4def-9ad3-7ca172309079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:href="bsx-20201231.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e64efb74-b223-4d5c-b897-f1973e0a8455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e64efb74-b223-4d5c-b897-f1973e0a8455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_852ed115-cb06-4443-8ee0-363fe1a75406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_852ed115-cb06-4443-8ee0-363fe1a75406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_79e97b15-ddcb-426d-a60e-afb6428a6a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_79e97b15-ddcb-426d-a60e-afb6428a6a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5ddd0ff4-44c2-4235-be57-3e1b85178e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5ddd0ff4-44c2-4235-be57-3e1b85178e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_25f52127-084b-4c68-8cd5-b8e610cf0b08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_25f52127-084b-4c68-8cd5-b8e610cf0b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b0a9baf3-8c66-4c36-8c6e-d3dd32fd913f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b0a9baf3-8c66-4c36-8c6e-d3dd32fd913f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_8c5479e0-0649-445f-b184-5666ab0ef49a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_8c5479e0-0649-445f-b184-5666ab0ef49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_17e7b2ae-024c-4a6a-a424-23227f698c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_3165dfff-0f10-48a4-8c1b-0414fe97c0ad" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_17e7b2ae-024c-4a6a-a424-23227f698c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:href="bsx-20201231.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract_6e6dd8ba-4aed-4235-8956-ce84839196c8" xlink:href="bsx-20201231.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_bsx_OtherCurrentAssetsAbstract_6e6dd8ba-4aed-4235-8956-ce84839196c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_85654c4b-a2af-45d4-b167-5ae5d954e649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_6e6dd8ba-4aed-4235-8956-ce84839196c8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_85654c4b-a2af-45d4-b167-5ae5d954e649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_0803d010-bedd-4439-ba51-5ea3b3a22e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_6e6dd8ba-4aed-4235-8956-ce84839196c8" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_0803d010-bedd-4439-ba51-5ea3b3a22e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangements_19bbc8f3-0ec3-4faa-80c5-184a93b6ce53" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_6e6dd8ba-4aed-4235-8956-ce84839196c8" xlink:to="loc_bsx_LicensingArrangements_19bbc8f3-0ec3-4faa-80c5-184a93b6ce53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_fad356aa-48b1-4067-aaf2-629532b0964e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_6e6dd8ba-4aed-4235-8956-ce84839196c8" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_fad356aa-48b1-4067-aaf2-629532b0964e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_47033dd9-e206-4fe1-bbbb-8ee50ff684c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_6e6dd8ba-4aed-4235-8956-ce84839196c8" xlink:to="loc_us-gaap_OtherAssetsCurrent_47033dd9-e206-4fe1-bbbb-8ee50ff684c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_de67a93d-18e2-4e59-9264-da093974e561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_de67a93d-18e2-4e59-9264-da093974e561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_af110904-3e6a-4366-aa8e-4d2ad44e3b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_de67a93d-18e2-4e59-9264-da093974e561" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_af110904-3e6a-4366-aa8e-4d2ad44e3b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8e76317d-f62d-475d-86f4-3a897e759074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_de67a93d-18e2-4e59-9264-da093974e561" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8e76317d-f62d-475d-86f4-3a897e759074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_1b393278-1e68-482c-b109-ea273dfe4f53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_de67a93d-18e2-4e59-9264-da093974e561" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_1b393278-1e68-482c-b109-ea273dfe4f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d72c0698-8256-4d68-b9e1-1fd75ac33d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d72c0698-8256-4d68-b9e1-1fd75ac33d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6afedc60-e15e-4ccc-acd0-9bc87c54e299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d72c0698-8256-4d68-b9e1-1fd75ac33d02" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6afedc60-e15e-4ccc-acd0-9bc87c54e299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_094737d2-861e-4d87-98f3-aefb1f811b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d72c0698-8256-4d68-b9e1-1fd75ac33d02" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_094737d2-861e-4d87-98f3-aefb1f811b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9195fd92-3052-4423-8da4-3e265e1aab4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d72c0698-8256-4d68-b9e1-1fd75ac33d02" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9195fd92-3052-4423-8da4-3e265e1aab4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_e2a9a7c7-b0f5-46d9-b5cc-0e24a4ad0640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d72c0698-8256-4d68-b9e1-1fd75ac33d02" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_e2a9a7c7-b0f5-46d9-b5cc-0e24a4ad0640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3698aef0-4c14-490d-9d74-3655aadf0ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d72c0698-8256-4d68-b9e1-1fd75ac33d02" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3698aef0-4c14-490d-9d74-3655aadf0ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_4e795c9f-b6fe-4467-8500-c418790df6d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_InventoryNetAbstract_4e795c9f-b6fe-4467-8500-c418790df6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_672021aa-29f0-440c-b27e-0395a8fef77f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_4e795c9f-b6fe-4467-8500-c418790df6d4" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_672021aa-29f0-440c-b27e-0395a8fef77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c7e7d069-e8fe-4152-9fa2-d630d36017f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_4e795c9f-b6fe-4467-8500-c418790df6d4" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c7e7d069-e8fe-4152-9fa2-d630d36017f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d2069250-df81-45e7-8b00-af415e68ba02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_4e795c9f-b6fe-4467-8500-c418790df6d4" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d2069250-df81-45e7-8b00-af415e68ba02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f319d7a2-d5bb-46c1-a791-e2af23113259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_4e795c9f-b6fe-4467-8500-c418790df6d4" xlink:to="loc_us-gaap_InventoryNet_f319d7a2-d5bb-46c1-a791-e2af23113259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_464428c9-2254-4757-88b4-b22d95af7246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:to="loc_us-gaap_Land_464428c9-2254-4757-88b4-b22d95af7246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_20845fac-ba31-4f22-8ae5-d9b5e951718b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_20845fac-ba31-4f22-8ae5-d9b5e951718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross_bce6c3c8-802c-4af5-a5c5-19c98eda2a6d" xlink:href="bsx-20201231.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:to="loc_bsx_EquipmentFurnitureAndFixturesGross_bce6c3c8-802c-4af5-a5c5-19c98eda2a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_1c1b9585-0af5-4924-a632-6a9ec0159cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:to="loc_us-gaap_ConstructionInProgressGross_1c1b9585-0af5-4924-a632-6a9ec0159cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c8abc943-7385-4d79-987f-757b7b298623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c8abc943-7385-4d79-987f-757b7b298623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f8c6dc5f-025b-491c-ac89-8a3e901a75e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f8c6dc5f-025b-491c-ac89-8a3e901a75e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7501bf9e-44e9-4f6d-a5c2-87c2983d34fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_23685f8b-c85f-4cb9-9f56-d67a13a19063" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7501bf9e-44e9-4f6d-a5c2-87c2983d34fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_0deffafb-5d4c-4a0a-8c5a-2635bf64982a" xlink:href="bsx-20201231.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_0deffafb-5d4c-4a0a-8c5a-2635bf64982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PercentOfFinishedGoodsAtConsignment_2283118d-fd58-46c0-9e42-3b4a80225b43" xlink:href="bsx-20201231.xsd#bsx_PercentOfFinishedGoodsAtConsignment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_0deffafb-5d4c-4a0a-8c5a-2635bf64982a" xlink:to="loc_bsx_PercentOfFinishedGoodsAtConsignment_2283118d-fd58-46c0-9e42-3b4a80225b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_59a8049b-0ff3-4d57-af3b-827f6deb106f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_0deffafb-5d4c-4a0a-8c5a-2635bf64982a" xlink:to="loc_us-gaap_Depreciation_59a8049b-0ff3-4d57-af3b-827f6deb106f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_ae90c5d5-9165-4900-bd62-f0a1469a9f33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_ae90c5d5-9165-4900-bd62-f0a1469a9f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5bad8aa9-234a-4ba5-9207-eeb03491c712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5bad8aa9-234a-4ba5-9207-eeb03491c712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_4e213990-0cea-49f3-b894-d2d034ac771b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:to="loc_us-gaap_DerivativeAssets_4e213990-0cea-49f3-b894-d2d034ac771b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_3fb5d59c-ec4d-4307-b6a9-aba9c0297b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:to="loc_us-gaap_Investments_3fb5d59c-ec4d-4307-b6a9-aba9c0297b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAsset_70c50237-1cd7-4574-b8fc-7b3f6c8db73d" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:to="loc_bsx_LicensingArrangementsAsset_70c50237-1cd7-4574-b8fc-7b3f6c8db73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongTermAssets_4564c5eb-bfe3-416d-84f6-3118f23e9662" xlink:href="bsx-20201231.xsd#bsx_OtherOtherLongTermAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:to="loc_bsx_OtherOtherLongTermAssets_4564c5eb-bfe3-416d-84f6-3118f23e9662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3b02ad0c-dba7-44d0-bbe2-75672cb7e001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b9e7ac81-1566-420e-abae-3adf79f3d721" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3b02ad0c-dba7-44d0-bbe2-75672cb7e001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_116288df-c2a7-46d1-b9e7-8f9daf76b424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_116288df-c2a7-46d1-b9e7-8f9daf76b424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_d3105a4f-3811-4754-9e99-41e246848efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_116288df-c2a7-46d1-b9e7-8f9daf76b424" xlink:to="loc_us-gaap_LitigationReserveCurrent_d3105a4f-3811-4754-9e99-41e246848efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9dd07198-34ae-4307-9c19-411bdfb185f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_116288df-c2a7-46d1-b9e7-8f9daf76b424" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9dd07198-34ae-4307-9c19-411bdfb185f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_9021b18e-039a-44fc-a7e5-c6955190da1e" xlink:href="bsx-20201231.xsd#bsx_AccruedRebatesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_116288df-c2a7-46d1-b9e7-8f9daf76b424" xlink:to="loc_bsx_AccruedRebatesCurrent_9021b18e-039a-44fc-a7e5-c6955190da1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e16583d1-d712-4449-b317-11ef86e86dd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_116288df-c2a7-46d1-b9e7-8f9daf76b424" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_e16583d1-d712-4449-b317-11ef86e86dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2292dce3-0869-433f-9709-629175687f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_116288df-c2a7-46d1-b9e7-8f9daf76b424" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2292dce3-0869-433f-9709-629175687f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0d9d8228-fd28-4fc2-9e04-249b6dc482b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_116288df-c2a7-46d1-b9e7-8f9daf76b424" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_0d9d8228-fd28-4fc2-9e04-249b6dc482b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_4abba790-3189-4b02-9ca0-0df3f5787c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_4abba790-3189-4b02-9ca0-0df3f5787c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_f145ca4f-bce7-4a34-a84a-706b2005d347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_4abba790-3189-4b02-9ca0-0df3f5787c8c" xlink:to="loc_us-gaap_DeferredRevenueCurrent_f145ca4f-bce7-4a34-a84a-706b2005d347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_2a230712-68d6-4555-a83b-fa2165993fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_4abba790-3189-4b02-9ca0-0df3f5787c8c" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_2a230712-68d6-4555-a83b-fa2165993fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_517dcaf3-3d34-4130-9d41-96e5cf4870e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_4abba790-3189-4b02-9ca0-0df3f5787c8c" xlink:to="loc_us-gaap_TaxesPayableCurrent_517dcaf3-3d34-4130-9d41-96e5cf4870e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_d1a68be8-524a-44e9-bf3c-feb4a08c88b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_4abba790-3189-4b02-9ca0-0df3f5787c8c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_d1a68be8-524a-44e9-bf3c-feb4a08c88b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_8ae5efb5-095d-4d6e-8a29-3fabf8a0458a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_4abba790-3189-4b02-9ca0-0df3f5787c8c" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_8ae5efb5-095d-4d6e-8a29-3fabf8a0458a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1b971550-7b31-46b7-812b-0ee5f231d3b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_4abba790-3189-4b02-9ca0-0df3f5787c8c" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1b971550-7b31-46b7-812b-0ee5f231d3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_039bafec-f4c2-4b17-a723-85de8d41dc10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_039bafec-f4c2-4b17-a723-85de8d41dc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_9ea8744d-b828-43eb-b37a-ee0443f69789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_9ea8744d-b828-43eb-b37a-ee0443f69789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9acb33d3-5b6b-4de2-9cde-85069cefe86e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9acb33d3-5b6b-4de2-9cde-85069cefe86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_a2f3a00b-0c2e-4146-8426-579c0814cf63" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:to="loc_bsx_LicensingArrangementsLiability_a2f3a00b-0c2e-4146-8426-579c0814cf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d2ab91a0-e644-4042-8f5e-183e749262f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d2ab91a0-e644-4042-8f5e-183e749262f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_a1f0641b-11c1-4255-9442-a7353e9f30d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:to="loc_us-gaap_DeferredRevenue_a1f0641b-11c1-4255-9442-a7353e9f30d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_3a5ac965-620e-49aa-8d86-9c43275673ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_3a5ac965-620e-49aa-8d86-9c43275673ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2cb40aa6-93ea-4d67-bc9a-026968360189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1a136340-8ee5-493c-acb8-3ef1343b6348" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2cb40aa6-93ea-4d67-bc9a-026968360189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a1b3adf4-3b32-4fa6-a046-61d2252a0a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_8f08fb42-92ab-4acc-afa2-4105c67a9955" xlink:to="loc_us-gaap_StatementTable_a1b3adf4-3b32-4fa6-a046-61d2252a0a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a1b3adf4-3b32-4fa6-a046-61d2252a0a25" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e4b01e13-195d-4c16-9b8c-16cb8c2c2c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_27959a1c-19fb-4d8d-b523-fd3a2b1a2b35" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e4b01e13-195d-4c16-9b8c-16cb8c2c2c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9b1d2cfa-b64d-45f7-936d-0f556110f502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e4b01e13-195d-4c16-9b8c-16cb8c2c2c29" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9b1d2cfa-b64d-45f7-936d-0f556110f502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a1b3adf4-3b32-4fa6-a046-61d2252a0a25" xlink:to="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_828072cf-0895-4471-9255-dd231c93adad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_828072cf-0895-4471-9255-dd231c93adad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a0bfe6dd-8f33-474d-8708-d1ff1cd2bcf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a0bfe6dd-8f33-474d-8708-d1ff1cd2bcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_a6352c54-0d67-4075-8379-2a287544e803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_a6352c54-0d67-4075-8379-2a287544e803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_36293564-5683-4b5a-86a3-fd456114a9bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_36293564-5683-4b5a-86a3-fd456114a9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsLiability_07cb9ea6-281b-406b-9301-c4f9eb8c7eaa" xlink:href="bsx-20201231.xsd#bsx_LicensingArrangementsLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_bsx_LicensingArrangementsLiability_07cb9ea6-281b-406b-9301-c4f9eb8c7eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_6f0ef3b3-0314-4456-9f95-1dae0361bc32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_DeferredRevenue_6f0ef3b3-0314-4456-9f95-1dae0361bc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_dc2302fa-b3ca-47b0-aa71-05afe0345708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_37a14f52-9abf-4f4f-a961-81fa0ab9f329" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_dc2302fa-b3ca-47b0-aa71-05afe0345708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1411351d-d73e-4185-b606-74835e597e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_9ddf062e-d57a-471d-a035-311792f79c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1411351d-d73e-4185-b606-74835e597e19" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_9ddf062e-d57a-471d-a035-311792f79c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_982204b1-f03d-4f15-9924-36b17cf0523b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_83fc5328-401a-4a6e-85d1-b364fc552ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_982204b1-f03d-4f15-9924-36b17cf0523b" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_83fc5328-401a-4a6e-85d1-b364fc552ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_6df90f3a-aed4-4397-8f29-fc2d95c46772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_982204b1-f03d-4f15-9924-36b17cf0523b" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_6df90f3a-aed4-4397-8f29-fc2d95c46772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b38051bc-77ff-4033-ba6a-238f55f0e006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_982204b1-f03d-4f15-9924-36b17cf0523b" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b38051bc-77ff-4033-ba6a-238f55f0e006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_24b3c6b3-e23d-479d-8dcf-41ded751aadc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_982204b1-f03d-4f15-9924-36b17cf0523b" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_24b3c6b3-e23d-479d-8dcf-41ded751aadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f714f979-7213-4666-9b75-f3ede7ff800a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_982204b1-f03d-4f15-9924-36b17cf0523b" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f714f979-7213-4666-9b75-f3ede7ff800a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesDetailsRateTable"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IncomeTaxesAbstract_48f1f209-3f92-4a8d-be1f-94dfe3acde92" xlink:href="bsx-20201231.xsd#bsx_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3af58a55-67f8-4086-9e51-e277bbe7455c" xlink:href="bsx-20201231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IncomeTaxesAbstract_48f1f209-3f92-4a8d-be1f-94dfe3acde92" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3af58a55-67f8-4086-9e51-e277bbe7455c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateAxis_f5478cd1-1e50-4b61-88ab-583f9eca07a0" xlink:href="bsx-20201231.xsd#bsx_TaxRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3af58a55-67f8-4086-9e51-e277bbe7455c" xlink:to="loc_bsx_TaxRateAxis_f5478cd1-1e50-4b61-88ab-583f9eca07a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxRateDomain_3322ec1b-debd-4c56-b02a-efc55787c7b7" xlink:href="bsx-20201231.xsd#bsx_TaxRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_TaxRateAxis_f5478cd1-1e50-4b61-88ab-583f9eca07a0" xlink:to="loc_bsx_TaxRateDomain_3322ec1b-debd-4c56-b02a-efc55787c7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:href="bsx-20201231.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3af58a55-67f8-4086-9e51-e277bbe7455c" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7502af8c-d437-416e-a18a-4697805dead1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7502af8c-d437-416e-a18a-4697805dead1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a5fc5425-27f6-498a-a8e0-802a14d65e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a5fc5425-27f6-498a-a8e0-802a14d65e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_1379e376-9783-481b-b489-5b2a36603340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_1379e376-9783-481b-b489-5b2a36603340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7de3277f-b905-4971-b927-e76fb445aa72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_7de3277f-b905-4971-b927-e76fb445aa72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_9e18b962-f2fe-452f-9313-d4ee95cb4510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_9e18b962-f2fe-452f-9313-d4ee95cb4510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_91ca630c-acfa-4c20-b705-c66268adea38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_91ca630c-acfa-4c20-b705-c66268adea38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_af3d8780-5c84-4889-b522-f7f12dc5e1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_af3d8780-5c84-4889-b522-f7f12dc5e1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_5ac24a5d-b4c6-4dc3-8d0e-ea17a0024e66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_5ac24a5d-b4c6-4dc3-8d0e-ea17a0024e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_cd78809a-df9e-417b-8831-12f21302d041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_cd78809a-df9e-417b-8831-12f21302d041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_c209eb25-eef0-44f3-ae65-b621b2ec3ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_c209eb25-eef0-44f3-ae65-b621b2ec3ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_f02deb56-299c-4ba0-9e36-6871c6832b8e" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions_f02deb56-299c-4ba0-9e36-6871c6832b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact_39151fa6-1b67-4613-88b0-e2a3a13c826e" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact_39151fa6-1b67-4613-88b0-e2a3a13c826e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_8146c09d-f1ce-436d-94a7-5c11271ea8b2" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers_8146c09d-f1ce-436d-94a7-5c11271ea8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_2e02254f-1b18-4c09-aabb-c2a07abbbca7" xlink:href="bsx-20201231.xsd#bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision_2e02254f-1b18-4c09-aabb-c2a07abbbca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_5ba369e7-2265-4773-9a94-e1acdeacfc52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_5ba369e7-2265-4773-9a94-e1acdeacfc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_38c6168f-113f-4dcd-a9bf-48ae7d065f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_38c6168f-113f-4dcd-a9bf-48ae7d065f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0326595c-cf9f-46e4-861f-27e2cb1109bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5803f441-9e9a-46a7-9f1c-8cc3be9b8c5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0326595c-cf9f-46e4-861f-27e2cb1109bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#IncomeTaxesIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IncomeTaxesAbstract_cd9e577d-fb91-4b34-95d4-88139b0e247b" xlink:href="bsx-20201231.xsd#bsx_IncomeTaxesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_a2cdd1cf-d5dd-42bb-b99d-64e27abf03eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IncomeTaxesAbstract_cd9e577d-fb91-4b34-95d4-88139b0e247b" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_a2cdd1cf-d5dd-42bb-b99d-64e27abf03eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d581e340-e278-4299-a663-4bf7fe9c6a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a2cdd1cf-d5dd-42bb-b99d-64e27abf03eb" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d581e340-e278-4299-a663-4bf7fe9c6a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d581e340-e278-4299-a663-4bf7fe9c6a43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_90d0fd25-a4b4-4b43-bcf1-aa031fb5d509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_90d0fd25-a4b4-4b43-bcf1-aa031fb5d509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssetsHeldForSaleDomain_146b41cd-9cd4-47f0-8abf-22c72ced711a" xlink:href="bsx-20201231.xsd#bsx_AssetsHeldForSaleDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_bsx_AssetsHeldForSaleDomain_146b41cd-9cd4-47f0-8abf-22c72ced711a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsDomain_e3965b57-45cc-4b96-85a2-600e3ea3f74f" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetsDomain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_bsx_DeferredTaxAssetsDomain_e3965b57-45cc-4b96-85a2-600e3ea3f74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesDomain_f3d694d4-0416-40f4-8846-097b29cac62b" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxLiabilitiesDomain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_bsx_DeferredTaxLiabilitiesDomain_f3d694d4-0416-40f4-8846-097b29cac62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_4a0160e6-f817-484b-b76a-16e64bd01f87" xlink:href="bsx-20201231.xsd#bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f33e197-2512-46ed-9740-44b4c811822b" xlink:to="loc_bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain_4a0160e6-f817-484b-b76a-16e64bd01f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a2cdd1cf-d5dd-42bb-b99d-64e27abf03eb" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_be98623b-26b5-4c0d-aa81-649c21719cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_be98623b-26b5-4c0d-aa81-649c21719cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d976a76b-0d78-4755-a8dc-cfdb6bafb0a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d976a76b-0d78-4755-a8dc-cfdb6bafb0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9ad6d569-73f1-4c0c-80f4-8393fa12b794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9ad6d569-73f1-4c0c-80f4-8393fa12b794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21745f7a-269d-4592-ad6b-a4feba5f899a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21745f7a-269d-4592-ad6b-a4feba5f899a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_063682bb-d969-4637-aa45-6a760a8a59bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_063682bb-d969-4637-aa45-6a760a8a59bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ffa7b799-3142-448e-89c0-69012917de21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ffa7b799-3142-448e-89c0-69012917de21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_304613af-a1b6-4cd3-a6ba-aded90b7f65c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_304613af-a1b6-4cd3-a6ba-aded90b7f65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_73721260-c2d5-4811-8a93-6a1d5044127e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_73721260-c2d5-4811-8a93-6a1d5044127e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_94c2a084-bc5f-4fa6-a697-0fe52763ab9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_94c2a084-bc5f-4fa6-a697-0fe52763ab9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_27d62e90-9b6a-4add-913c-8b2776dd55a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_27d62e90-9b6a-4add-913c-8b2776dd55a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_097eb197-e6ab-4282-88df-59d8a858b1b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_097eb197-e6ab-4282-88df-59d8a858b1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f097f992-7cb3-484b-b762-559e21c75820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f097f992-7cb3-484b-b762-559e21c75820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_0215d214-a2a1-45e3-92cf-4893a3e8bfb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_0215d214-a2a1-45e3-92cf-4893a3e8bfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_13449dff-6b40-45f4-944d-80429830b535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_13449dff-6b40-45f4-944d-80429830b535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_fa932528-c53c-46ca-84fb-a2ca24fa7b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_fa932528-c53c-46ca-84fb-a2ca24fa7b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_ea12a2cf-166d-4152-92c6-43b6d58a6a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_ea12a2cf-166d-4152-92c6-43b6d58a6a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_6000cc51-a7cc-429e-8e89-a9317844cd72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies_6000cc51-a7cc-429e-8e89-a9317844cd72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_c1675dc3-d29e-41a5-bb22-5030825a9fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_c1675dc3-d29e-41a5-bb22-5030825a9fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_61285838-94da-496d-bc5b-a480f1e626b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_61285838-94da-496d-bc5b-a480f1e626b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FederalBenefitOfUncertainTaxPositions_ddc91458-2fad-4730-be91-767a296821a8" xlink:href="bsx-20201231.xsd#bsx_FederalBenefitOfUncertainTaxPositions"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_FederalBenefitOfUncertainTaxPositions_ddc91458-2fad-4730-be91-767a296821a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fa2bec50-4301-4f5e-a2a1-e4148a35617f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_fa2bec50-4301-4f5e-a2a1-e4148a35617f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_c0dc2b3f-2015-4aa3-a6af-7d3653519f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_c0dc2b3f-2015-4aa3-a6af-7d3653519f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_772b9aa9-fc40-42b6-abfb-4f54621432f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_772b9aa9-fc40-42b6-abfb-4f54621432f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a7eee7ee-0709-4d47-a60b-65f51dbcc019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a7eee7ee-0709-4d47-a60b-65f51dbcc019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4ee4611a-9088-4f99-9b63-ed7c9f7a8274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_4ee4611a-9088-4f99-9b63-ed7c9f7a8274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_263d0d0c-8034-459f-bf5d-69cb942edcae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_263d0d0c-8034-459f-bf5d-69cb942edcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_e8c1e699-2e4d-4071-abef-c4c17993aa5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDerivatives"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_e8c1e699-2e4d-4071-abef-c4c17993aa5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d32e2e1e-e967-457c-b708-49fece0efe1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d32e2e1e-e967-457c-b708-49fece0efe1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_99efb78d-51e8-4b9d-a1c5-d1d5003b4e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_99efb78d-51e8-4b9d-a1c5-d1d5003b4e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_399e7b48-28d8-4b23-90dc-e8da752b80e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_399e7b48-28d8-4b23-90dc-e8da752b80e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5ecbaffe-3cd6-470c-982f-795d2c8250a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5ecbaffe-3cd6-470c-982f-795d2c8250a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_3af2ea5c-3e9c-46fc-9fa3-f8a4db1bd5a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_3af2ea5c-3e9c-46fc-9fa3-f8a4db1bd5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_4610ae2b-c22a-4e70-8805-7712ddeda715" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit_4610ae2b-c22a-4e70-8805-7712ddeda715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_8c85af3a-aadb-4c0c-a6f7-d1cf5ef6481d" xlink:href="bsx-20201231.xsd#bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit_8c85af3a-aadb-4c0c-a6f7-d1cf5ef6481d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_bb2771d6-5d8a-4cf6-8a66-e145bb5cf830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_bb2771d6-5d8a-4cf6-8a66-e145bb5cf830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_776d6cfc-31e0-4896-813a-ab513b6569cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxLiabilities_776d6cfc-31e0-4896-813a-ab513b6569cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_b75cbecc-bd0f-4141-afcb-955fb952a7e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_b75cbecc-bd0f-4141-afcb-955fb952a7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_94164906-e581-4ada-aa1f-20cd6214d58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_94164906-e581-4ada-aa1f-20cd6214d58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_6fc78ea3-6a23-4296-b964-240f9c78d636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory_6fc78ea3-6a23-4296-b964-240f9c78d636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_17cbb0f3-b4b3-4cda-a26d-f01b65d65517" xlink:href="bsx-20201231.xsd#bsx_DeferredTaxAssetValuationAllowanceIntraEntity"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_DeferredTaxAssetValuationAllowanceIntraEntity_17cbb0f3-b4b3-4cda-a26d-f01b65d65517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance_b69dd9a3-b27a-42f2-b4dd-ecfd2621c8d2" xlink:href="bsx-20201231.xsd#bsx_ChangeinDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_ChangeinDeferredTaxAssetsValuationAllowance_b69dd9a3-b27a-42f2-b4dd-ecfd2621c8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_816cb09f-b54b-4146-8d8f-0b2726d3d9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_816cb09f-b54b-4146-8d8f-0b2726d3d9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneRegimeTaxIncentive_96a4193e-1ca1-401f-b851-7b81dd4af723" xlink:href="bsx-20201231.xsd#bsx_FreeTradeZoneRegimeTaxIncentive"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_FreeTradeZoneRegimeTaxIncentive_96a4193e-1ca1-401f-b851-7b81dd4af723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeTradeZoneTaxIncentivePerShare_7bde65b2-ae5c-48c6-911e-0e3dd21eb0dd" xlink:href="bsx-20201231.xsd#bsx_FreeTradeZoneTaxIncentivePerShare"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_FreeTradeZoneTaxIncentivePerShare_7bde65b2-ae5c-48c6-911e-0e3dd21eb0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TaxIncentivesInPuertoRico_c57e3ca9-3ff2-4898-9c78-4cc8cdd4c65c" xlink:href="bsx-20201231.xsd#bsx_TaxIncentivesInPuertoRico"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_TaxIncentivesInPuertoRico_c57e3ca9-3ff2-4898-9c78-4cc8cdd4c65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b8525305-aa8c-4917-a3d6-ed596ac62173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_b8525305-aa8c-4917-a3d6-ed596ac62173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_42f1311d-f6b9-4401-b79c-277cde1e2c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_42f1311d-f6b9-4401-b79c-277cde1e2c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0bda10c2-d20e-4e31-876b-66e533707a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0bda10c2-d20e-4e31-876b-66e533707a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_76d0f6f8-c848-43ba-ab3f-c49f3513a6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_76d0f6f8-c848-43ba-ab3f-c49f3513a6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8fd62991-21b4-49c0-a676-a2b7c734cbf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8fd62991-21b4-49c0-a676-a2b7c734cbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a72cbe0a-fdce-4133-9798-313157262695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_a72cbe0a-fdce-4133-9798-313157262695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5b5dade0-a290-4666-b700-c10933f1c169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5b5dade0-a290-4666-b700-c10933f1c169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_4719ad3e-2b79-4e4e-9b37-7b8e8ca36809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_4719ad3e-2b79-4e4e-9b37-7b8e8ca36809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1bfb0ccc-a2d5-4792-b54e-a3fca4416336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_1bfb0ccc-a2d5-4792-b54e-a3fca4416336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NetSettlementPaymenttoIRS_91728f0a-f78b-4a12-ac3a-a46959bc327e" xlink:href="bsx-20201231.xsd#bsx_NetSettlementPaymenttoIRS"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_NetSettlementPaymenttoIRS_91728f0a-f78b-4a12-ac3a-a46959bc327e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_c2792b07-8464-45ee-baad-7310ec6dcb76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_c2792b07-8464-45ee-baad-7310ec6dcb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_559ac4d3-44a0-47ab-be8f-4e25e8c67b49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_559ac4d3-44a0-47ab-be8f-4e25e8c67b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_b4dd2b96-36c2-4474-9d35-f25e495ea961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_b4dd2b96-36c2-4474-9d35-f25e495ea961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_483b34e8-9bd6-4cbe-b2a5-9a7c332b603f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_483b34e8-9bd6-4cbe-b2a5-9a7c332b603f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_fa24ba3d-cfa1-4e71-8cb5-5508fe955719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability_fa24ba3d-cfa1-4e71-8cb5-5508fe955719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment_21334275-08a4-42bf-9d81-8b956bdf2659" xlink:href="bsx-20201231.xsd#bsx_Onetimetransactiontaxpost1986EPnetpayment"/>
    <link:presentationArc order="61" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_Onetimetransactiontaxpost1986EPnetpayment_21334275-08a4-42bf-9d81-8b956bdf2659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TransitionTaxPaymentRemaining_b35bfe9f-d024-4fcf-9eef-eb2b290a5f73" xlink:href="bsx-20201231.xsd#bsx_TransitionTaxPaymentRemaining"/>
    <link:presentationArc order="62" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_TransitionTaxPaymentRemaining_b35bfe9f-d024-4fcf-9eef-eb2b290a5f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_0f721ece-4b8d-42a0-9729-8bbf707dee6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:presentationArc order="63" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_0f721ece-4b8d-42a0-9729-8bbf707dee6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct_78d5420b-45d8-408b-955a-f9405250ff97" xlink:href="bsx-20201231.xsd#bsx_TheCARESAct"/>
    <link:presentationArc order="64" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0d7117f3-d8e7-4fde-916c-bb45ff4b87cb" xlink:to="loc_bsx_TheCARESAct_78d5420b-45d8-408b-955a-f9405250ff97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20201231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_88015701-8445-4668-90ae-7f7d29f1328e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_abef43d0-1d6e-4f56-83ee-7c7a50a0ce82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_88015701-8445-4668-90ae-7f7d29f1328e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_abef43d0-1d6e-4f56-83ee-7c7a50a0ce82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_efa27a5d-f693-40b4-b4e3-ca434b8e4985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_efa27a5d-f693-40b4-b4e3-ca434b8e4985" xlink:to="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_97ffb99c-c992-44b5-ab03-6947cace3950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_97ffb99c-c992-44b5-ab03-6947cace3950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69a83b4-942b-41e3-a1b5-e34a42b22840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_97ffb99c-c992-44b5-ab03-6947cace3950" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69a83b4-942b-41e3-a1b5-e34a42b22840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UpfrontCashMember_0310deaa-1165-432f-be5d-881c04a2d578" xlink:href="bsx-20201231.xsd#bsx_UpfrontCashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69a83b4-942b-41e3-a1b5-e34a42b22840" xlink:to="loc_bsx_UpfrontCashMember_0310deaa-1165-432f-be5d-881c04a2d578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumContingentPaymentMember_5e9c720b-0d19-4bee-b38e-f664ae969ae8" xlink:href="bsx-20201231.xsd#bsx_MaximumContingentPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69a83b4-942b-41e3-a1b5-e34a42b22840" xlink:to="loc_bsx_MaximumContingentPaymentMember_5e9c720b-0d19-4bee-b38e-f664ae969ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_us-gaap_LitigationStatusAxis_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_0255dc2f-bec6-437f-9bbb-ba2271e95b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_0b653dcd-0cc2-4d9f-bab5-7b73bfde4ff8" xlink:to="loc_us-gaap_LitigationStatusDomain_0255dc2f-bec6-437f-9bbb-ba2271e95b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_77ec5bf4-4211-49d4-8484-91ab0386105f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_0255dc2f-bec6-437f-9bbb-ba2271e95b2a" xlink:to="loc_us-gaap_SettledLitigationMember_77ec5bf4-4211-49d4-8484-91ab0386105f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_151840e2-6fd8-4cfb-89aa-0da443399c80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_srt_LitigationCaseAxis_151840e2-6fd8-4cfb-89aa-0da443399c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_14b8e718-4649-41b5-952c-0bc6d02f6976" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_151840e2-6fd8-4cfb-89aa-0da443399c80" xlink:to="loc_srt_LitigationCaseTypeDomain_14b8e718-4649-41b5-952c-0bc6d02f6976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedToOneJudgeInMAMember_0ff52f36-7229-447b-881b-ae602220316f" xlink:href="bsx-20201231.xsd#bsx_AssignedToOneJudgeInMAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_14b8e718-4649-41b5-952c-0bc6d02f6976" xlink:to="loc_bsx_AssignedToOneJudgeInMAMember_0ff52f36-7229-447b-881b-ae602220316f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b4534f00-ee49-4774-bf27-6df94e27a0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b4534f00-ee49-4774-bf27-6df94e27a0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_88c894d1-0965-4af9-9deb-f1203144f9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b4534f00-ee49-4774-bf27-6df94e27a0ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_88c894d1-0965-4af9-9deb-f1203144f9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4f6f7d50-5367-4df4-b30d-310d20846a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_88c894d1-0965-4af9-9deb-f1203144f9a3" xlink:to="loc_us-gaap_SubsequentEventMember_4f6f7d50-5367-4df4-b30d-310d20846a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df65ea3a-e6d6-4c59-8134-5a87921346c7" xlink:to="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bb268847-1cde-442d-ad15-df8f5ee45971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_bb268847-1cde-442d-ad15-df8f5ee45971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_124f39b6-40f0-42a1-b8c1-bfbca74499bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_124f39b6-40f0-42a1-b8c1-bfbca74499bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_f4c413e0-aad4-4b04-a5e8-2caf76ee8c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LitigationSettlementExpense_f4c413e0-aad4-4b04-a5e8-2caf76ee8c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain_babeb110-e624-40b8-94ae-374bd33fd387" xlink:href="bsx-20201231.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_LitigationSettlementReceivedGain_babeb110-e624-40b8-94ae-374bd33fd387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_0c9e9c85-7223-477f-ba89-4fa5f3382336" xlink:href="bsx-20201231.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_0c9e9c85-7223-477f-ba89-4fa5f3382336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_b1883394-2679-40e6-a21e-20db561ca4ba" xlink:href="bsx-20201231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_b1883394-2679-40e6-a21e-20db561ca4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_3cc7e39c-aaba-41d4-8776-a452dd2bf99e" xlink:href="bsx-20201231.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_3cc7e39c-aaba-41d4-8776-a452dd2bf99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_6a5b15e9-7822-4e6f-8676-50dd81275503" xlink:href="bsx-20201231.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_6a5b15e9-7822-4e6f-8676-50dd81275503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh_0b6d369c-cf2d-4793-b82a-907830518bf2" xlink:href="bsx-20201231.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_CertifiedclassactionsinCanadaMesh_0b6d369c-cf2d-4793-b82a-907830518bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_c10509c2-44dc-4174-a4bf-bda5535467c9" xlink:href="bsx-20201231.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_c10509c2-44dc-4174-a4bf-bda5535467c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_fb38c5cb-b888-4538-95ee-6a04794bbc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_fb38c5cb-b888-4538-95ee-6a04794bbc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllegedBreachofPurchaseAgreementAmount_6959e562-1273-4f0e-92ec-1605d012162d" xlink:href="bsx-20201231.xsd#bsx_AllegedBreachofPurchaseAgreementAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_bsx_AllegedBreachofPurchaseAgreementAmount_6959e562-1273-4f0e-92ec-1605d012162d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_29d0ab1c-56a0-4bf4-b1ad-78d8deb86f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_42d35cf8-558d-4a4c-8b61-487bb854a500" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_29d0ab1c-56a0-4bf4-b1ad-78d8deb86f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_aea57446-d9ea-4f29-97df-e5e4247d3bbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3bf0a305-b3c8-4a45-bb22-3d7f485d3187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_aea57446-d9ea-4f29-97df-e5e4247d3bbe" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3bf0a305-b3c8-4a45-bb22-3d7f485d3187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_5691037d-97af-4932-b54a-c498b0de5154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract_804d8736-9b65-460f-80b4-9cd9cd842cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_5691037d-97af-4932-b54a-c498b0de5154" xlink:to="loc_us-gaap_ClassOfStockDisclosuresAbstract_804d8736-9b65-460f-80b4-9cd9cd842cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract_804d8736-9b65-460f-80b4-9cd9cd842cab" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:to="loc_us-gaap_StatementClassOfStockAxis_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_05cf9583-246e-43ef-9f46-3fb5b90f0c5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_f6b485e3-6c59-4aef-a5c7-1c0b776f8a5e" xlink:to="loc_us-gaap_ClassOfStockDomain_05cf9583-246e-43ef-9f46-3fb5b90f0c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_1b832f39-9118-4ff8-94a9-e99b5f002a80" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_05cf9583-246e-43ef-9f46-3fb5b90f0c5b" xlink:to="loc_bsx_A550MCPSSeriesAMember_1b832f39-9118-4ff8-94a9-e99b5f002a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_351e9d1a-82b5-4a1f-b5a2-c7b4c54b166c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_05cf9583-246e-43ef-9f46-3fb5b90f0c5b" xlink:to="loc_us-gaap_CommonStockMember_351e9d1a-82b5-4a1f-b5a2-c7b4c54b166c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e2b4d31b-c677-4507-9ac2-51924f55a3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e2b4d31b-c677-4507-9ac2-51924f55a3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c9578a15-1c0a-474c-b72f-83270896f5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e2b4d31b-c677-4507-9ac2-51924f55a3f5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c9578a15-1c0a-474c-b72f-83270896f5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2fc930fa-297a-4631-a175-fe16f7340e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c9578a15-1c0a-474c-b72f-83270896f5b5" xlink:to="loc_us-gaap_SubsequentEventMember_2fc930fa-297a-4631-a175-fe16f7340e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2b6ca589-07f4-410a-a043-2587bfd64a73" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:to="loc_srt_RangeAxis_2b6ca589-07f4-410a-a043-2587bfd64a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_973bd215-1555-4243-91e1-94f905cc095f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2b6ca589-07f4-410a-a043-2587bfd64a73" xlink:to="loc_srt_RangeMember_973bd215-1555-4243-91e1-94f905cc095f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ff7aecf-8427-4443-8359-b735f5ba3579" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_973bd215-1555-4243-91e1-94f905cc095f" xlink:to="loc_srt_MinimumMember_0ff7aecf-8427-4443-8359-b735f5ba3579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ce35bdea-5573-43b5-8b8b-a96f2e1c6993" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_973bd215-1555-4243-91e1-94f905cc095f" xlink:to="loc_srt_MaximumMember_ce35bdea-5573-43b5-8b8b-a96f2e1c6993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4ee6f9c9-9c90-4e57-950c-669ad19d5478" xlink:to="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e056f68a-38c4-4960-b936-a8704a66a435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e056f68a-38c4-4960-b936-a8704a66a435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1d5f54a2-c1a5-43b0-a6ce-d7e3f7c14f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1d5f54a2-c1a5-43b0-a6ce-d7e3f7c14f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_c96af96d-dca0-4143-82ee-9d6d6adb24b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_c96af96d-dca0-4143-82ee-9d6d6adb24b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_8fa454f0-08e3-4047-ba3c-32ae6e4a3b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_8fa454f0-08e3-4047-ba3c-32ae6e4a3b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1011c1b0-3788-46c8-9902-4f7efc950223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1011c1b0-3788-46c8-9902-4f7efc950223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_ecaa0df8-18e3-43af-8c46-f1f6043abafe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_ecaa0df8-18e3-43af-8c46-f1f6043abafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_e87e6838-ca5d-44cd-9bdc-8454b9bfb7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_e87e6838-ca5d-44cd-9bdc-8454b9bfb7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_34ea8f3b-ad3c-4dc0-84c9-4d945b7ba020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_34ea8f3b-ad3c-4dc0-84c9-4d945b7ba020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_fa83e084-3307-4110-903e-7e7addeaed8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PaymentsOfDividends_fa83e084-3307-4110-903e-7e7addeaed8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_b70d8e8a-08c8-4564-b860-c223ca37d779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_b70d8e8a-08c8-4564-b860-c223ca37d779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1aa4e992-b020-4300-a007-08d91e55f3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1aa4e992-b020-4300-a007-08d91e55f3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_31305a3b-bf37-4c5a-bdff-22a8191dbcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_31305a3b-bf37-4c5a-bdff-22a8191dbcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a98bf007-5cc4-4d4a-a52d-26032f355de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a98bf007-5cc4-4d4a-a52d-26032f355de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_950404a0-2a57-49d1-86e8-cb3d0f3d9e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_950404a0-2a57-49d1-86e8-cb3d0f3d9e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_69234c39-083b-4005-90c4-835c6534c80c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_69234c39-083b-4005-90c4-835c6534c80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_68dc530b-d8af-42fb-8a61-32604c615660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_68dc530b-d8af-42fb-8a61-32604c615660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_2ea8dbe1-6b91-4135-b0bc-a3db5627f74d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_2ea8dbe1-6b91-4135-b0bc-a3db5627f74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9f6f702f-e7d2-41da-b296-955672bd5b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9f6f702f-e7d2-41da-b296-955672bd5b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_3edff8b4-5437-474f-a2eb-62d7a19513f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_72a1c998-dac2-4f24-8be2-ee1b8634afea" xlink:to="loc_us-gaap_TreasuryStockShares_3edff8b4-5437-474f-a2eb-62d7a19513f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockInventiveandPurchasePlans"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockInventiveandPurchasePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIncentiveAndPurchasePlansAbstract_c68c9fcb-1d65-464e-a8a8-211fdbd8b300" xlink:href="bsx-20201231.xsd#bsx_StockIncentiveAndPurchasePlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c6434a42-aec3-464c-9978-7cd9768d4219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_c68c9fcb-1d65-464e-a8a8-211fdbd8b300" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c6434a42-aec3-464c-9978-7cd9768d4219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockIncentiveandPurchasePlansTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:href="bsx-20201231.xsd#bsx_StockIncentiveAndPurchasePlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_2b0b264a-e21e-402c-842c-8808cff83883" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_2b0b264a-e21e-402c-842c-8808cff83883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_1087c830-1741-4fbf-b1a8-cb9036a4a693" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_2b0b264a-e21e-402c-842c-8808cff83883" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_1087c830-1741-4fbf-b1a8-cb9036a4a693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_644286b4-5de3-481a-b4ba-40d6baf8c22b" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis_1087c830-1741-4fbf-b1a8-cb9036a4a693" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain_644286b4-5de3-481a-b4ba-40d6baf8c22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_17c7940b-a581-401e-b94b-a71bc43c2554" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable_2b0b264a-e21e-402c-842c-8808cff83883" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_17c7940b-a581-401e-b94b-a71bc43c2554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_a45aaaf1-4676-4b09-81e3-fca39e282259" xlink:href="bsx-20201231.xsd#bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems_17c7940b-a581-401e-b94b-a71bc43c2554" xlink:to="loc_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock_a45aaaf1-4676-4b09-81e3-fca39e282259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e5b26781-c204-498f-9102-0cd251b865f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e5b26781-c204-498f-9102-0cd251b865f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_b34c7977-9069-4432-aa0b-bc3e08b71a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_b34c7977-9069-4432-aa0b-bc3e08b71a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_4a47a18d-2ba3-4361-8698-f21182c063e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_4a47a18d-2ba3-4361-8698-f21182c063e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_98bed65f-d42a-4647-afc6-35dc9977e62f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_98bed65f-d42a-4647-afc6-35dc9977e62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_7ee50456-4ea2-4e68-90ea-5a2f02aa6c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_7ee50456-4ea2-4e68-90ea-5a2f02aa6c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_8ea1a5ca-4261-470b-9438-a471779353b9" xlink:href="bsx-20201231.xsd#bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:to="loc_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock_8ea1a5ca-4261-470b-9438-a471779353b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9d3a4708-0989-4135-aa92-90c0826c6947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_fd1676c8-016f-4157-9aa0-9ffe975a25c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9d3a4708-0989-4135-aa92-90c0826c6947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#StockIncentiveandPurchasePlansDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIncentiveAndPurchasePlansAbstract_9808c791-355e-40e2-9d42-fb677a656d43" xlink:href="bsx-20201231.xsd#bsx_StockIncentiveAndPurchasePlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StockIncentiveAndPurchasePlansAbstract_9808c791-355e-40e2-9d42-fb677a656d43" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dd1b4a7c-0faf-41d4-94e3-f76bbaa8e6ff" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b7982914-8a11-4cf6-9b92-e57069ad5053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:to="loc_us-gaap_CostOfSalesMember_b7982914-8a11-4cf6-9b92-e57069ad5053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6cfb1a4f-a94b-467d-b7d3-13f72a5de373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_6cfb1a4f-a94b-467d-b7d3-13f72a5de373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b4f182a-0e72-4357-a8ca-6bb34ab7e703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c501b347-8a95-4020-a782-46a383b6c1e8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5b4f182a-0e72-4357-a8ca-6bb34ab7e703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_bab3a30f-6810-4d0a-9456-ccaf07c5bd82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:to="loc_us-gaap_PlanNameAxis_bab3a30f-6810-4d0a-9456-ccaf07c5bd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_34af8725-f361-45ae-ab3a-4d388e93f535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_bab3a30f-6810-4d0a-9456-ccaf07c5bd82" xlink:to="loc_us-gaap_PlanNameDomain_34af8725-f361-45ae-ab3a-4d388e93f535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2011LtipPlanMember_335905c0-ff43-45ee-bec0-9c7b25af79ce" xlink:href="bsx-20201231.xsd#bsx_A2011LtipPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_34af8725-f361-45ae-ab3a-4d388e93f535" xlink:to="loc_bsx_A2011LtipPlanMember_335905c0-ff43-45ee-bec0-9c7b25af79ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bb97ea93-c054-49ad-aee2-24fe448ae947" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:to="loc_srt_RangeAxis_bb97ea93-c054-49ad-aee2-24fe448ae947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bb97ea93-c054-49ad-aee2-24fe448ae947" xlink:to="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e6fb5dc0-d1ed-4f3b-8d92-bc3d29ef6a10" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:to="loc_srt_MinimumMember_e6fb5dc0-d1ed-4f3b-8d92-bc3d29ef6a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d711989-c50f-4cf6-99f2-1f9c69e3129d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:to="loc_srt_MaximumMember_5d711989-c50f-4cf6-99f2-1f9c69e3129d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_15c2e105-9257-4cf2-8ca0-889b69bca612" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fc621bf7-4ce2-45c6-8117-c73724ed6d4b" xlink:to="loc_srt_MaximumMember_15c2e105-9257-4cf2-8ca0-889b69bca612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c06c215-5c41-4a6a-91c0-f833fe0a1675" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Fairvalueofmarketbasedawards_312eea77-efe3-49ea-9a49-7cbfa02a5169" xlink:href="bsx-20201231.xsd#bsx_Fairvalueofmarketbasedawards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Fairvalueofmarketbasedawards_312eea77-efe3-49ea-9a49-7cbfa02a5169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_5949e396-00cd-4f6c-9678-208de4b53dcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharePrice_5949e396-00cd-4f6c-9678-208de4b53dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostStockOptions_428a7b4c-313f-4566-8337-233e863f4911" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCostStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_UnrecognizedCompensationCostStockOptions_428a7b4c-313f-4566-8337-233e863f4911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_bf10d789-3bbf-4978-9800-868ea622b8c6" xlink:href="bsx-20201231.xsd#bsx_RangeofthetargetnumberofperformancebasedDSUsawarded"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded_bf10d789-3bbf-4978-9800-868ea622b8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4dfe6dd9-092d-4c0f-9f45-22fcf85c5010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4dfe6dd9-092d-4c0f-9f45-22fcf85c5010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_9a8fd432-f60f-46fb-86c0-4371fe1a760f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_9a8fd432-f60f-46fb-86c0-4371fe1a760f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ac85cd56-9fe6-411a-b84a-f5ffb8f40085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ac85cd56-9fe6-411a-b84a-f5ffb8f40085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dab5d866-07a9-4ac1-a193-70352974a7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dab5d866-07a9-4ac1-a193-70352974a7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_67ab3a5a-44f0-4037-b567-4db87c31a9df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_67ab3a5a-44f0-4037-b567-4db87c31a9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Measurementperiodmarketbasedaward_98f9ccc1-cd5a-4944-ac8d-3a64b8bce513" xlink:href="bsx-20201231.xsd#bsx_Measurementperiodmarketbasedaward"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Measurementperiodmarketbasedaward_98f9ccc1-cd5a-4944-ac8d-3a64b8bce513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ccecfac8-6b08-47a8-b57c-4cadc7d9181b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ccecfac8-6b08-47a8-b57c-4cadc7d9181b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e6dd878-e869-4069-90bf-37482be9fad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e6dd878-e869-4069-90bf-37482be9fad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_091e3b3b-4327-431b-a817-aae470fb9361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_091e3b3b-4327-431b-a817-aae470fb9361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d2e3658b-8704-4a5b-8cc5-2fe0b10e7805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d2e3658b-8704-4a5b-8cc5-2fe0b10e7805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f6bc078c-a6ac-407d-8f5e-aaa409e5602d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f6bc078c-a6ac-407d-8f5e-aaa409e5602d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a57125f8-507d-46c8-bd6b-6329fa88b08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a57125f8-507d-46c8-bd6b-6329fa88b08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_edaa75dd-e346-48f9-81ca-8909be3aca79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_edaa75dd-e346-48f9-81ca-8909be3aca79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_bac19bf4-a0eb-4bff-b70b-2c7561eb4056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_bac19bf4-a0eb-4bff-b70b-2c7561eb4056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4ae7528d-6930-4531-82c6-2bb20809ef13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4ae7528d-6930-4531-82c6-2bb20809ef13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2e4060ab-2a35-43ae-8a5e-64bf75852e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2e4060ab-2a35-43ae-8a5e-64bf75852e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_4a880dbb-8c8b-4a7d-bb8e-967bd372a6b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_4a880dbb-8c8b-4a7d-bb8e-967bd372a6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1d825dd8-250a-402f-b2a5-ac1e01148249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1d825dd8-250a-402f-b2a5-ac1e01148249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ffb71c8d-84d5-4a28-848b-99813a127db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensation_ffb71c8d-84d5-4a28-848b-99813a127db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_120b4c5f-420c-42d4-b0c7-79f485850bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_120b4c5f-420c-42d4-b0c7-79f485850bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2724b265-c2a6-42db-b2a6-343eb76c2706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2724b265-c2a6-42db-b2a6-343eb76c2706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b47878d4-f079-4c54-a9d8-c3d61187b296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b47878d4-f079-4c54-a9d8-c3d61187b296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ShareBasedCompensationNetOfTaxBenefit_bc5f11e7-ef5d-49ba-8bb4-313cf60e1a8b" xlink:href="bsx-20201231.xsd#bsx_ShareBasedCompensationNetOfTaxBenefit"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_ShareBasedCompensationNetOfTaxBenefit_bc5f11e7-ef5d-49ba-8bb4-313cf60e1a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareBasic_5ead1df2-50af-4941-949b-49aae26e73a4" xlink:href="bsx-20201231.xsd#bsx_CompensationExpensePerShareBasic"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_CompensationExpensePerShareBasic_5ead1df2-50af-4941-949b-49aae26e73a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CompensationExpensePerShareDiluted_2e9d4c72-cbed-4744-89e4-05ec2eeaa8d7" xlink:href="bsx-20201231.xsd#bsx_CompensationExpensePerShareDiluted"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_CompensationExpensePerShareDiluted_2e9d4c72-cbed-4744-89e4-05ec2eeaa8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b6ddccec-cfd8-4bd5-b857-dd25a8f8bd61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b6ddccec-cfd8-4bd5-b857-dd25a8f8bd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26829a51-2566-4775-bc56-0dc3666333c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26829a51-2566-4775-bc56-0dc3666333c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_666286d4-3dad-43f6-8afb-d125c21e5bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_666286d4-3dad-43f6-8afb-d125c21e5bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2caa86f5-5b74-4db3-91f5-630d61078d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2caa86f5-5b74-4db3-91f5-630d61078d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_92fe5ae8-754d-45c9-b95d-22909827e15b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_92fe5ae8-754d-45c9-b95d-22909827e15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_379a8e4b-cfd4-45a7-8f2b-0b1f67eb4363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_379a8e4b-cfd4-45a7-8f2b-0b1f67eb4363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9485e432-f162-4937-932f-5a408c9e136f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9485e432-f162-4937-932f-5a408c9e136f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d1d6112c-fd3a-4193-827c-b0756d2646ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d1d6112c-fd3a-4193-827c-b0756d2646ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_71dc33ea-4e0c-4564-ac68-fbe0d1b50e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_71dc33ea-4e0c-4564-ac68-fbe0d1b50e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4b7ddd28-ce73-49cc-95b4-b490c25bd4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4b7ddd28-ce73-49cc-95b4-b490c25bd4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_52508581-d19a-4659-a09e-31ee6b90b8a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_52508581-d19a-4659-a09e-31ee6b90b8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e1f3687b-90f2-4e56-a344-7633df3c079e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e1f3687b-90f2-4e56-a344-7633df3c079e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVest_2185bac4-0e78-41f4-aaaf-af6e58bce99f" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVest"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_OptionsExpectedToVest_2185bac4-0e78-41f4-aaaf-af6e58bce99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_b86e1d55-3439-4cdc-9d0d-899c6cdbb1dd" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_OptionsExpectedToVestWeightedAverageExercisePrice_b86e1d55-3439-4cdc-9d0d-899c6cdbb1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_e45fed73-cacf-4855-ade6-8d9ded46a8c8" xlink:href="bsx-20201231.xsd#bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife_e45fed73-cacf-4855-ade6-8d9ded46a8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_72add538-4369-4dba-8b24-ed81631f1a7d" xlink:href="bsx-20201231.xsd#bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_72add538-4369-4dba-8b24-ed81631f1a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b131863c-27bc-41d7-a335-0be0652c5ced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b131863c-27bc-41d7-a335-0be0652c5ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7a4b8dba-57e4-4aeb-b40d-51cb1259db94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7a4b8dba-57e4-4aeb-b40d-51cb1259db94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f49c49cd-621e-4bcd-ac2b-5cf85d459b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f49c49cd-621e-4bcd-ac2b-5cf85d459b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_640032a0-8048-496b-a655-1ef8fc17f7af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_640032a0-8048-496b-a655-1ef8fc17f7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1141a8fd-ab34-44e4-84f6-760f089e6d24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1141a8fd-ab34-44e4-84f6-760f089e6d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_629d0f70-8cbe-4fcc-bd8a-64711865a288" xlink:href="bsx-20201231.xsd#bsx_RangeofthetargetnumberofmarketbasedDSUsawarded"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded_629d0f70-8cbe-4fcc-bd8a-64711865a288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7c3f5339-4b02-447d-8df9-0aa4f3599873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7c3f5339-4b02-447d-8df9-0aa4f3599873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_f24a01ca-5d37-4c4b-a422-b770b5d6553f" xlink:href="bsx-20201231.xsd#bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase_f24a01ca-5d37-4c4b-a422-b770b5d6553f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b4622772-6069-45a8-9f5e-69766de771fc" xlink:href="bsx-20201231.xsd#bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless_b4622772-6069-45a8-9f5e-69766de771fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_63e1524f-9c98-4635-abd3-38cfd3b91acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_63e1524f-9c98-4635-abd3-38cfd3b91acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards_604691b5-9b4a-493f-96a0-b12bd675eba5" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCostNonVestedStockAwards"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_UnrecognizedCompensationCostNonVestedStockAwards_604691b5-9b4a-493f-96a0-b12bd675eba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UnrecognizedCompensationCost_fec94a7c-b202-4083-9c1a-101becbb6f97" xlink:href="bsx-20201231.xsd#bsx_UnrecognizedCompensationCost"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_UnrecognizedCompensationCost_fec94a7c-b202-4083-9c1a-101becbb6f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageRemainingVestingPeriod_431e547e-418a-4ff3-84f0-a574a9fffb08" xlink:href="bsx-20201231.xsd#bsx_WeightedAverageRemainingVestingPeriod"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_WeightedAverageRemainingVestingPeriod_431e547e-418a-4ff3-84f0-a574a9fffb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Annualweightedaverageforfeiturerate_b90f1d5a-1d94-4202-a945-961e02948c33" xlink:href="bsx-20201231.xsd#bsx_Annualweightedaverageforfeiturerate"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Annualweightedaverageforfeiturerate_b90f1d5a-1d94-4202-a945-961e02948c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VotingPowerOfAllClassesOfStock_bb263c11-7b87-40ac-ad9e-1a1cdd1eb293" xlink:href="bsx-20201231.xsd#bsx_VotingPowerOfAllClassesOfStock"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_VotingPowerOfAllClassesOfStock_bb263c11-7b87-40ac-ad9e-1a1cdd1eb293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_36a423ac-6df0-43fb-9314-09d27ed28d98" xlink:href="bsx-20201231.xsd#bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant"/>
    <link:presentationArc order="61" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant_36a423ac-6df0-43fb-9314-09d27ed28d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Nonvestedstockawardsexerciseprice_2d83a0e8-c083-4ccf-8b98-2b4a357eef01" xlink:href="bsx-20201231.xsd#bsx_Nonvestedstockawardsexerciseprice"/>
    <link:presentationArc order="62" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_Nonvestedstockawardsexerciseprice_2d83a0e8-c083-4ccf-8b98-2b4a357eef01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_563ca14b-01e5-47b6-9bb8-33c5b74f2bd4" xlink:href="bsx-20201231.xsd#bsx_FairValueOfFreeCashFlowFcfPerformanceAwards"/>
    <link:presentationArc order="63" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards_563ca14b-01e5-47b6-9bb8-33c5b74f2bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_76e637de-bc15-4edc-8c4c-35d63ae588cf" xlink:href="bsx-20201231.xsd#bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards"/>
    <link:presentationArc order="64" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards_76e637de-bc15-4edc-8c4c-35d63ae588cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_a163f8b5-5576-419a-8bbc-cb60e0740e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:presentationArc order="65" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe8e6f23-c177-4069-8df3-3edb3cc0eed6" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_a163f8b5-5576-419a-8bbc-cb60e0740e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstanding"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3ec2adbd-d4c8-4635-a893-caad92da4503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_15597557-caba-4e91-a0f9-f2b6a7eb0f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3ec2adbd-d4c8-4635-a893-caad92da4503" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_15597557-caba-4e91-a0f9-f2b6a7eb0f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3bd1180d-7292-4726-86d8-d10839361d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6bb49fd6-d835-4471-b6e5-2268b91c1999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3bd1180d-7292-4726-86d8-d10839361d9e" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6bb49fd6-d835-4471-b6e5-2268b91c1999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8ebb1af0-36d4-470e-9397-e2f3e4dffcc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3bd1180d-7292-4726-86d8-d10839361d9e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_8ebb1af0-36d4-470e-9397-e2f3e4dffcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1053c5da-945e-4f0e-bf9e-cf871023dc4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_39b9f50e-e04c-4a1e-882b-275369ef2010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1053c5da-945e-4f0e-bf9e-cf871023dc4d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_39b9f50e-e04c-4a1e-882b-275369ef2010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9297066-4069-44c7-9c74-ed9d9d52de51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_39b9f50e-e04c-4a1e-882b-275369ef2010" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9297066-4069-44c7-9c74-ed9d9d52de51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9297066-4069-44c7-9c74-ed9d9d52de51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4cc6401f-8cfb-4b6a-ba13-ec7626e06519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:to="loc_us-gaap_StockCompensationPlanMember_4cc6401f-8cfb-4b6a-ba13-ec7626e06519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f76f68e3-0dd8-45bd-9fb2-bff3aef6f7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f76f68e3-0dd8-45bd-9fb2-bff3aef6f7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_713946bf-934e-4c87-aae3-9b358990b7f8" xlink:href="bsx-20201231.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89a9a066-7bb1-4d78-997d-2faade8a8c8a" xlink:to="loc_bsx_A550MCPSSeriesAMember_713946bf-934e-4c87-aae3-9b358990b7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_39b9f50e-e04c-4a1e-882b-275369ef2010" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_43d4b3e2-5e18-4511-abf8-2fdd38484a09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_43d4b3e2-5e18-4511-abf8-2fdd38484a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_83ef6015-c63e-4be5-9aa0-05fdd421008c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_83ef6015-c63e-4be5-9aa0-05fdd421008c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7959197a-6a7d-433b-bdd0-71e277ef8404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7959197a-6a7d-433b-bdd0-71e277ef8404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e9cb1d84-402c-4dc3-b6fe-32692e855284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1dbf248e-dac5-4787-91a9-ebd511da4434" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e9cb1d84-402c-4dc3-b6fe-32692e855284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ffccf681-58d3-4d43-a246-d254925f7fa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_2b4b6802-5c0b-4fd2-8607-f4774a75d205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ffccf681-58d3-4d43-a246-d254925f7fa6" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_2b4b6802-5c0b-4fd2-8607-f4774a75d205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bd9ecdc8-f251-446e-b8e6-35e14383fd21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_c4a3c2ae-236f-4297-b902-e6bb009fc5dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bd9ecdc8-f251-446e-b8e6-35e14383fd21" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_c4a3c2ae-236f-4297-b902-e6bb009fc5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_c22490ff-570c-43db-947b-f4a62cb1c196" xlink:href="bsx-20201231.xsd#bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bd9ecdc8-f251-446e-b8e6-35e14383fd21" xlink:to="loc_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock_c22490ff-570c-43db-947b-f4a62cb1c196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6ca62155-f5ce-48c5-b5cb-4916e5f99ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bd9ecdc8-f251-446e-b8e6-35e14383fd21" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6ca62155-f5ce-48c5-b5cb-4916e5f99ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_fdfac80c-a9ad-4614-980a-acd15c08eaaf" xlink:href="bsx-20201231.xsd#bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bd9ecdc8-f251-446e-b8e6-35e14383fd21" xlink:to="loc_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock_fdfac80c-a9ad-4614-980a-acd15c08eaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_e6c19ffc-1cf5-4061-addd-182e7c596938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bd9ecdc8-f251-446e-b8e6-35e14383fd21" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_e6c19ffc-1cf5-4061-addd-182e7c596938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_e04adaba-e825-4ac4-8f1a-096b87779da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bd9ecdc8-f251-446e-b8e6-35e14383fd21" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_e04adaba-e825-4ac4-8f1a-096b87779da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1b6aa2ee-e7d7-45f6-9451-4339aa5b222a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1b6aa2ee-e7d7-45f6-9451-4339aa5b222a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c1c3b04a-d4d1-4e3e-bc59-24ec18f86141" xlink:to="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_9afb2e9c-c912-4237-a87f-8b2ae1dff732" xlink:href="bsx-20201231.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_MedsurgMember_9afb2e9c-c912-4237-a87f-8b2ae1dff732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_fcec7720-94cd-4d51-8a27-6d094ce686c4" xlink:href="bsx-20201231.xsd#bsx_RhythmandNeuroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_RhythmandNeuroMember_fcec7720-94cd-4d51-8a27-6d094ce686c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_066f34da-cadb-4f22-89f4-39ba0fe26523" xlink:href="bsx-20201231.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_CardiovascularMember_066f34da-cadb-4f22-89f4-39ba0fe26523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_e76ea7ad-2deb-4e7b-b078-09d529fbe7e0" xlink:href="bsx-20201231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_BSXReportableSegmentsMember_e76ea7ad-2deb-4e7b-b078-09d529fbe7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_af71eb61-9ab3-4698-8bc3-7b203786b4b1" xlink:href="bsx-20201231.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_af71eb61-9ab3-4698-8bc3-7b203786b4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_2249d43f-05fc-4218-a7ce-52a1312d01d8" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_2249d43f-05fc-4218-a7ce-52a1312d01d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_9195acd8-7aa6-410d-95ac-c39c83e6218b" xlink:href="bsx-20201231.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_9195acd8-7aa6-410d-95ac-c39c83e6218b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_9014d99a-81fe-46aa-ba6e-0926408b628d" xlink:href="bsx-20201231.xsd#bsx_SpecialChargesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_SpecialChargesMember_9014d99a-81fe-46aa-ba6e-0926408b628d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_53639660-db17-4c4b-be11-18fd80778523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_us-gaap_CorporateMember_53639660-db17-4c4b-be11-18fd80778523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConsolidatedBSXDomain_6547d798-aedb-489f-aafd-2c3fcef0a2b2" xlink:href="bsx-20201231.xsd#bsx_ConsolidatedBSXDomain"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4983ed3-98f3-4949-be83-e22ac19a01f8" xlink:to="loc_bsx_ConsolidatedBSXDomain_6547d798-aedb-489f-aafd-2c3fcef0a2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f68b72f9-9604-45d6-9fbb-87e349e063d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_srt_StatementGeographicalAxis_f68b72f9-9604-45d6-9fbb-87e349e063d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f68b72f9-9604-45d6-9fbb-87e349e063d6" xlink:to="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2015abc5-8f53-4f38-9a28-3301f75b2ca7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:to="loc_country_US_2015abc5-8f53-4f38-9a28-3301f75b2ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_7487224f-8fd7-45f5-b2d9-4c49bbef9a11" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_IE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:to="loc_country_IE_7487224f-8fd7-45f5-b2d9-4c49bbef9a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCountriesMember_f65f0860-3aac-4190-94ad-0bc86fafac2a" xlink:href="bsx-20201231.xsd#bsx_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f2f87a06-0196-4f6e-b3dc-aec3dbd651a8" xlink:to="loc_bsx_OtherCountriesMember_f65f0860-3aac-4190-94ad-0bc86fafac2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_84c36751-f8e4-438b-a1ad-ff20361bbdcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_84c36751-f8e4-438b-a1ad-ff20361bbdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_00437b32-7b40-4111-8388-4be06a0dab25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_84c36751-f8e4-438b-a1ad-ff20361bbdcb" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_00437b32-7b40-4111-8388-4be06a0dab25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_3e566813-8d0e-4c37-8bd2-b0d5112f6609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_00437b32-7b40-4111-8388-4be06a0dab25" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_3e566813-8d0e-4c37-8bd2-b0d5112f6609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aab88012-7cd2-4371-a5e3-1d6f5399994e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aab88012-7cd2-4371-a5e3-1d6f5399994e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11d7fc4d-6ae3-459d-8e8a-c3fd25d4b877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aab88012-7cd2-4371-a5e3-1d6f5399994e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11d7fc4d-6ae3-459d-8e8a-c3fd25d4b877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_6f8c07be-a8f7-4441-b0d2-4c05634feddc" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11d7fc4d-6ae3-459d-8e8a-c3fd25d4b877" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_6f8c07be-a8f7-4441-b0d2-4c05634feddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93a5b868-22a6-4918-8a16-da43d2636d81" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_bb98b8eb-6e5d-4225-9147-ff1edc1f6413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_NumberOfReportableSegments_bb98b8eb-6e5d-4225-9147-ff1edc1f6413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6e4be4fd-f04f-4431-998f-3cdd35aec012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6e4be4fd-f04f-4431-998f-3cdd35aec012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_0e2cb0b5-d780-4f84-a54f-4e5cb736bb07" xlink:href="bsx-20201231.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_0e2cb0b5-d780-4f84-a54f-4e5cb736bb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_efc04055-517f-4bdb-977c-845b6f3c6e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_Depreciation_efc04055-517f-4bdb-977c-845b6f3c6e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments_f148207e-6124-4944-8b49-b3560aba35ec" xlink:href="bsx-20201231.xsd#bsx_OperatingIncomeLossAllocatedToReportableSegments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_bsx_OperatingIncomeLossAllocatedToReportableSegments_f148207e-6124-4944-8b49-b3560aba35ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_39a59dce-bfab-45d0-b10a-09731bd9e996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_OperatingIncomeLoss_39a59dce-bfab-45d0-b10a-09731bd9e996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_22e70ce3-aaee-473c-9e93-d748c17679a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_22e70ce3-aaee-473c-9e93-d748c17679a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a5276019-e954-44fb-8c93-9fdbb531c373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a5276019-e954-44fb-8c93-9fdbb531c373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1394b3a1-da1f-42e0-88c1-c9c4a490fea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1394b3a1-da1f-42e0-88c1-c9c4a490fea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_620d6360-e7c9-4b8b-aa4b-ca582d4eed10" xlink:href="bsx-20201231.xsd#bsx_Segmentoperatingincomeaspercentageofnetsales"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_bsx_Segmentoperatingincomeaspercentageofnetsales_620d6360-e7c9-4b8b-aa4b-ca582d4eed10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_c4e660e4-bd20-4738-8641-f9c7060c71cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_OtherAssets_c4e660e4-bd20-4738-8641-f9c7060c71cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_540bb4b6-dba6-426c-b275-c5e3e2f7615b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_Goodwill_540bb4b6-dba6-426c-b275-c5e3e2f7615b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8fb4ae9e-e1bb-4a8d-8394-a63e7dbd3d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8fb4ae9e-e1bb-4a8d-8394-a63e7dbd3d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4de8a764-f12a-4a1e-8a30-8c1d2a3e4ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4de8a764-f12a-4a1e-8a30-8c1d2a3e4ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_0768f098-14be-4901-bd36-d4b098e918b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ed980040-4950-43d8-ae7b-bb899d0c87b0" xlink:to="loc_us-gaap_NoncurrentAssets_0768f098-14be-4901-bd36-d4b098e918b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20201231.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7934595c-a752-4ddf-879f-5005c7184ab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f43b6501-e177-46a3-a06e-e0a283f6a674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7934595c-a752-4ddf-879f-5005c7184ab3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f43b6501-e177-46a3-a06e-e0a283f6a674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1f0eac42-e951-4b24-b7eb-340efd40b005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_7320e62a-fcc5-4a3d-a419-07ca8cfcd79a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1f0eac42-e951-4b24-b7eb-340efd40b005" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_7320e62a-fcc5-4a3d-a419-07ca8cfcd79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6b719b8e-748c-442b-ac63-63cd74850d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_7320e62a-fcc5-4a3d-a419-07ca8cfcd79a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6b719b8e-748c-442b-ac63-63cd74850d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4da43df-3455-415f-b7b4-f7dd99e9b048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4da43df-3455-415f-b7b4-f7dd99e9b048" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_94057187-c5e7-44cf-b627-0bc47e1c960c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0a0dce8d-a5e0-4dbc-b4c0-b4f66c249dc7" xlink:to="loc_us-gaap_SegmentDomain_94057187-c5e7-44cf-b627-0bc47e1c960c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_f9a3d3da-0245-440d-9a68-6b94fff5efa9" xlink:href="bsx-20201231.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_94057187-c5e7-44cf-b627-0bc47e1c960c" xlink:to="loc_bsx_BSXReportableSegmentsMember_f9a3d3da-0245-440d-9a68-6b94fff5efa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_28f86fb6-6ec4-4412-812f-9fe5d42a0970" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:to="loc_srt_ProductOrServiceAxis_28f86fb6-6ec4-4412-812f-9fe5d42a0970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_28f86fb6-6ec4-4412-812f-9fe5d42a0970" xlink:to="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_36f943ef-0501-4acf-933d-a3523917911a" xlink:href="bsx-20201231.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_36f943ef-0501-4acf-933d-a3523917911a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_900bd0c7-ddab-4428-a4ac-dac80daa09e0" xlink:href="bsx-20201231.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_900bd0c7-ddab-4428-a4ac-dac80daa09e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_a4a66745-680e-4171-8974-f477e4e13584" xlink:href="bsx-20201231.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_a4a66745-680e-4171-8974-f477e4e13584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_72845569-6523-437e-94cc-363189293076" xlink:href="bsx-20201231.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_72845569-6523-437e-94cc-363189293076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_55b64934-3ef4-4f21-9d9f-020b76e82ef2" xlink:href="bsx-20201231.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_55b64934-3ef4-4f21-9d9f-020b76e82ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_9ccb1700-b9f2-47a8-a0a7-583251f29c9f" xlink:href="bsx-20201231.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_9ccb1700-b9f2-47a8-a0a7-583251f29c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_2a2e9229-9f66-4b9d-9246-f26ee1bfa7d6" xlink:href="bsx-20201231.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_2a2e9229-9f66-4b9d-9246-f26ee1bfa7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_9a3cecb9-2a85-4ce2-b88d-56fe0cf5f611" xlink:href="bsx-20201231.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a98286-8f73-4870-907b-6fb00dbe8311" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_9a3cecb9-2a85-4ce2-b88d-56fe0cf5f611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_370d68e6-2460-4133-b786-0c5dc54bb2fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:to="loc_srt_StatementGeographicalAxis_370d68e6-2460-4133-b786-0c5dc54bb2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_370d68e6-2460-4133-b786-0c5dc54bb2fa" xlink:to="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_f961631b-d158-4b5e-8e7d-e8b22a2ffa8f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_country_US_f961631b-d158-4b5e-8e7d-e8b22a2ffa8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_777e4157-0a90-4156-b2b7-03d77d644813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_us-gaap_NonUsMember_777e4157-0a90-4156-b2b7-03d77d644813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_070b7e0b-95b4-4871-86d2-b8fa43582458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_us-gaap_EMEAMember_070b7e0b-95b4-4871-86d2-b8fa43582458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_9a7bdf30-5a09-444c-8e5a-4f3dfe8f9df4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_srt_AsiaPacificMember_9a7bdf30-5a09-444c-8e5a-4f3dfe8f9df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_d207d5c9-fca5-4f07-935d-4da9f9ee388c" xlink:href="bsx-20201231.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_bsx_LatinAmericaandCanadaMember_d207d5c9-fca5-4f07-935d-4da9f9ee388c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_fa1d3461-d505-46d0-bcc4-2f0758280dd1" xlink:href="bsx-20201231.xsd#bsx_EmergingMarketsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0792ba3a-7a3d-4920-929b-32dc88601232" xlink:to="loc_bsx_EmergingMarketsMember_fa1d3461-d505-46d0-bcc4-2f0758280dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_cbe32b5d-2f3e-438f-a71b-11aab555d569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_599af112-7a6e-4c09-9f88-78d79f4bf385" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_cbe32b5d-2f3e-438f-a71b-11aab555d569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsTotalNumberOfCountries_8ef66be7-02c2-44aa-a142-aebb71e75363" xlink:href="bsx-20201231.xsd#bsx_EmergingMarketsTotalNumberOfCountries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbe32b5d-2f3e-438f-a71b-11aab555d569" xlink:to="loc_bsx_EmergingMarketsTotalNumberOfCountries_8ef66be7-02c2-44aa-a142-aebb71e75363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6ff3e241-66fa-46f2-b019-82ec330a6f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbe32b5d-2f3e-438f-a71b-11aab555d569" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6ff3e241-66fa-46f2-b019-82ec330a6f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_4fb85ba7-cb1d-4b3a-8857-8c58da2cb0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4da43df-3455-415f-b7b4-f7dd99e9b048" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_4fb85ba7-cb1d-4b3a-8857-8c58da2cb0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e44c28e8-2a24-4928-82a8-bf0bfa9db3b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_4fb85ba7-cb1d-4b3a-8857-8c58da2cb0f6" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e44c28e8-2a24-4928-82a8-bf0bfa9db3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_9ee953f3-702b-45e6-b087-19ccf8e7e37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e4da43df-3455-415f-b7b4-f7dd99e9b048" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_9ee953f3-702b-45e6-b087-19ccf8e7e37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_941e7f2b-3ed8-4425-829b-93f5c31e4e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_9ee953f3-702b-45e6-b087-19ccf8e7e37b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_941e7f2b-3ed8-4425-829b-93f5c31e4e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f1d03fc5-279c-428e-9698-809cbaf76ffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_9ee953f3-702b-45e6-b087-19ccf8e7e37b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f1d03fc5-279c-428e-9698-809cbaf76ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_26451405-4fb1-4930-b84c-17f588f46cc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_73a1f958-6867-4447-a0cf-b0e0a8a125a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_26451405-4fb1-4930-b84c-17f588f46cc3" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_73a1f958-6867-4447-a0cf-b0e0a8a125a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_89d6bdab-0142-4c60-b76e-0cddd4f968ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_60e5c3a4-c0d4-42f4-abe4-26e866e009c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_89d6bdab-0142-4c60-b76e-0cddd4f968ae" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_60e5c3a4-c0d4-42f4-abe4-26e866e009c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_4694ca5c-38b6-4944-a3b2-dc4960ca7b17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_4694ca5c-38b6-4944-a3b2-dc4960ca7b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_2f21ea37-bdb4-46e4-86e3-8c1620ea16ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_2f21ea37-bdb4-46e4-86e3-8c1620ea16ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_dbc59e96-c7db-4acd-a455-8c48bc694ee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_dbc59e96-c7db-4acd-a455-8c48bc694ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_87c63f75-3d1e-44cc-820d-33a6f517387b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_87c63f75-3d1e-44cc-820d-33a6f517387b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b84f2869-ae56-43a3-b9a5-933cf9db6b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b84f2869-ae56-43a3-b9a5-933cf9db6b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_070ba16c-29ac-416c-9a26-93e60eed0173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_070ba16c-29ac-416c-9a26-93e60eed0173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_301b57a9-c433-40ca-93ce-67e58234fb08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_301b57a9-c433-40ca-93ce-67e58234fb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f0d3c3ee-9044-46cf-97cd-6816832a5fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f0d3c3ee-9044-46cf-97cd-6816832a5fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_a07afd62-8eea-42e7-b8eb-32f0b4e98dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_a07afd62-8eea-42e7-b8eb-32f0b4e98dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b4242f17-1ecf-4722-bf4a-27eec050a598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b4242f17-1ecf-4722-bf4a-27eec050a598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_f04e21e8-bb47-4096-9eab-6233594731e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_f04e21e8-bb47-4096-9eab-6233594731e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_822726b4-337e-4c30-b969-2fe9a1c0b62c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_822726b4-337e-4c30-b969-2fe9a1c0b62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_48d6ab1a-c38f-49b9-9ac2-0466ac2aa94b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_48d6ab1a-c38f-49b9-9ac2-0466ac2aa94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5a5b8e41-e0c3-4345-83d2-c2ea23856939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5a5b8e41-e0c3-4345-83d2-c2ea23856939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9e7acbba-fecb-40c6-86eb-3e6b2ee52c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9e7acbba-fecb-40c6-86eb-3e6b2ee52c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aef146df-56ff-4555-b0a7-680972c2c790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_f0728616-7101-4939-8127-04535ce9d602" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aef146df-56ff-4555-b0a7-680972c2c790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20201231.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_23168633-b8ae-4c6e-8c28-6d29e1b04b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_8b2c964e-ee22-4042-a892-df1816ea0ff6" xlink:href="bsx-20201231.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_23168633-b8ae-4c6e-8c28-6d29e1b04b56" xlink:to="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_8b2c964e-ee22-4042-a892-df1816ea0ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#NewAccountingPronouncementsNewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b54c607d-5667-4f37-b926-fb1e60753f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock_173289fa-d71b-47e0-a9b2-71639599f6d3" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b54c607d-5667-4f37-b926-fb1e60753f4d" xlink:to="loc_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock_173289fa-d71b-47e0-a9b2-71639599f6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock_10cab376-a107-4fc2-9777-1b0be6c8fd00" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b54c607d-5667-4f37-b926-fb1e60753f4d" xlink:to="loc_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock_10cab376-a107-4fc2-9777-1b0be6c8fd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock_31b3000e-2fe3-4612-b7ea-82449f7bc827" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b54c607d-5667-4f37-b926-fb1e60753f4d" xlink:to="loc_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock_31b3000e-2fe3-4612-b7ea-82449f7bc827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_e3f73597-b82e-459c-a6f1-b759bf94fa80" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b54c607d-5667-4f37-b926-fb1e60753f4d" xlink:to="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_e3f73597-b82e-459c-a6f1-b759bf94fa80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_1252cdd3-e956-4d65-8d80-9f650557f0e5" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b54c607d-5667-4f37-b926-fb1e60753f4d" xlink:to="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_1252cdd3-e956-4d65-8d80-9f650557f0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_8fbbe68f-2fdb-43c3-8eda-4a36fa8f6bbc" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b54c607d-5667-4f37-b926-fb1e60753f4d" xlink:to="loc_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock_8fbbe68f-2fdb-43c3-8eda-4a36fa8f6bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_81b46b71-aa6c-49e3-a048-9394443736e6" xlink:href="bsx-20201231.xsd#bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b54c607d-5667-4f37-b926-fb1e60753f4d" xlink:to="loc_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_81b46b71-aa6c-49e3-a048-9394443736e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansNotes"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2323b224-8f49-4e27-814b-68d3fb532b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_5b467fbe-de71-499b-8a3f-d143e8a6589a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2323b224-8f49-4e27-814b-68d3fb532b36" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_5b467fbe-de71-499b-8a3f-d143e8a6589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansEmployeeRetirementPlansPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93375251-f263-4547-88a1-1a78af3d6030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e28134aa-cd49-48ef-a8a2-7184d1440b40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93375251-f263-4547-88a1-1a78af3d6030" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e28134aa-cd49-48ef-a8a2-7184d1440b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_2c06e5e9-e745-4fdd-8d5e-5ec014e13940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e28134aa-cd49-48ef-a8a2-7184d1440b40" xlink:to="loc_us-gaap_RetirementPlanNameAxis_2c06e5e9-e745-4fdd-8d5e-5ec014e13940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_671888bd-ebde-4c81-af7f-be087e15c694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_2c06e5e9-e745-4fdd-8d5e-5ec014e13940" xlink:to="loc_us-gaap_RetirementPlanNameDomain_671888bd-ebde-4c81-af7f-be087e15c694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember_63fc74f1-5548-474a-b53d-f76c37c0fddb" xlink:href="bsx-20201231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_671888bd-ebde-4c81-af7f-be087e15c694" xlink:to="loc_bsx_ExecutiveRetirementPlanMember_63fc74f1-5548-474a-b53d-f76c37c0fddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember_0c401c94-a899-4501-b657-4c9797022069" xlink:href="bsx-20201231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_671888bd-ebde-4c81-af7f-be087e15c694" xlink:to="loc_bsx_InternationalRetirementPlansMember_0c401c94-a899-4501-b657-4c9797022069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5a95f173-996b-4332-a334-8e8b7eb02941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e28134aa-cd49-48ef-a8a2-7184d1440b40" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5a95f173-996b-4332-a334-8e8b7eb02941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_01597853-a808-47f4-8f65-2dcf90477dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5a95f173-996b-4332-a334-8e8b7eb02941" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy_01597853-a808-47f4-8f65-2dcf90477dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e756a09a-6c19-48f8-8b74-fe5aa37468b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_bf3b6661-8be6-4448-888b-3f6413f6a076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e756a09a-6c19-48f8-8b74-fe5aa37468b4" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_bf3b6661-8be6-4448-888b-3f6413f6a076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_3d0116f5-398e-460d-8bec-1ef020dc2d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e756a09a-6c19-48f8-8b74-fe5aa37468b4" xlink:to="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_3d0116f5-398e-460d-8bec-1ef020dc2d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_e64d0ee5-d105-4347-95cd-0468e6f3e53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e756a09a-6c19-48f8-8b74-fe5aa37468b4" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_e64d0ee5-d105-4347-95cd-0468e6f3e53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_5159e701-c886-4efb-a3b3-7fe73eb334ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e756a09a-6c19-48f8-8b74-fe5aa37468b4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_5159e701-c886-4efb-a3b3-7fe73eb334ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_d397a9f6-9481-419f-a85a-905351a12df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e756a09a-6c19-48f8-8b74-fe5aa37468b4" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_d397a9f6-9481-419f-a85a-905351a12df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_85e461d2-1af1-4195-81a5-7d6ff0ebffa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e756a09a-6c19-48f8-8b74-fe5aa37468b4" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_85e461d2-1af1-4195-81a5-7d6ff0ebffa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_fb374d2d-1f6e-4782-a8b8-cf9b413fe156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#EmployeeRetirementPlansDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b305866d-40b1-403d-a6cb-3587854e9254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b305866d-40b1-403d-a6cb-3587854e9254" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_fb035862-3efa-453b-803a-c0a2086d0613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_RetirementPlanNameAxis_fb035862-3efa-453b-803a-c0a2086d0613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_fb035862-3efa-453b-803a-c0a2086d0613" xlink:to="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExecutiveRetirementPlanMember_cd3bea82-d643-4975-b7b2-02d71bb96398" xlink:href="bsx-20201231.xsd#bsx_ExecutiveRetirementPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:to="loc_bsx_ExecutiveRetirementPlanMember_cd3bea82-d643-4975-b7b2-02d71bb96398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InternationalRetirementPlansMember_f8f93ea1-9556-4615-803f-d46601536831" xlink:href="bsx-20201231.xsd#bsx_InternationalRetirementPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:to="loc_bsx_InternationalRetirementPlansMember_f8f93ea1-9556-4615-803f-d46601536831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember_1dc694f5-f9a3-43ce-813e-2021e2e81b73" xlink:href="bsx-20201231.xsd#bsx_UKPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_2b7be67a-b250-447e-bd5f-c7c0eda78412" xlink:to="loc_bsx_UKPlanMember_1dc694f5-f9a3-43ce-813e-2021e2e81b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b923b2de-344f-40e1-8865-9f8e288f12b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b923b2de-344f-40e1-8865-9f8e288f12b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6121643-71e4-488a-b531-91b455e29585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b923b2de-344f-40e1-8865-9f8e288f12b8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6121643-71e4-488a-b531-91b455e29585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_3b0b4763-7c2c-4ee1-9e89-5d3e474e0c4d" xlink:href="bsx-20201231.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6121643-71e4-488a-b531-91b455e29585" xlink:to="loc_bsx_BTGAcquisitionMember_3b0b4763-7c2c-4ee1-9e89-5d3e474e0c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2f0f2cda-718c-4a92-a2a1-688890b68c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2f0f2cda-718c-4a92-a2a1-688890b68c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_348e45f4-08bc-40b1-bfef-be62b95e5f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2f0f2cda-718c-4a92-a2a1-688890b68c63" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_348e45f4-08bc-40b1-bfef-be62b95e5f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_c1054706-a8d5-410e-802f-a72345a89bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_348e45f4-08bc-40b1-bfef-be62b95e5f8e" xlink:to="loc_us-gaap_OtherContractMember_c1054706-a8d5-410e-802f-a72345a89bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember_42dbc242-a27d-41ce-8394-bdba3d88302a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_348e45f4-08bc-40b1-bfef-be62b95e5f8e" xlink:to="loc_us-gaap_DefinedBenefitPlanCashMember_42dbc242-a27d-41ce-8394-bdba3d88302a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6cdc2fd-28fc-46cc-84d3-5fdc86b7f1e5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bd78d99b-9082-4388-9597-5a39cbb130f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bd78d99b-9082-4388-9597-5a39cbb130f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f35ccad4-58db-4513-a308-3174d4870796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f35ccad4-58db-4513-a308-3174d4870796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e69ae0bc-f4f4-45cd-bff1-5e3612f40abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f920c6f-7904-44b7-bc42-b2b861c975a2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e69ae0bc-f4f4-45cd-bff1-5e3612f40abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f2c556aa-6216-49de-8ccd-a03875d2ee00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f2c556aa-6216-49de-8ccd-a03875d2ee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f2c556aa-6216-49de-8ccd-a03875d2ee00" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_758a4d9d-69fb-489a-af82-56a75e855390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:to="loc_us-gaap_DomesticPlanMember_758a4d9d-69fb-489a-af82-56a75e855390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UKPlanMember_eed740b1-6ae1-4fe4-a7a1-5ce85fd09e21" xlink:href="bsx-20201231.xsd#bsx_UKPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:to="loc_bsx_UKPlanMember_eed740b1-6ae1-4fe4-a7a1-5ce85fd09e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherInternationalPlansMember_4e31f5b4-3a49-4207-9b17-abe9dd87ac45" xlink:href="bsx-20201231.xsd#bsx_OtherInternationalPlansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_05fef32d-ac8b-4b89-ba9c-ea8ceb6e3557" xlink:to="loc_bsx_OtherInternationalPlansMember_4e31f5b4-3a49-4207-9b17-abe9dd87ac45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7c1935b1-d16b-4f45-86ed-07e39090ef9a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_srt_RangeAxis_7c1935b1-d16b-4f45-86ed-07e39090ef9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_188823df-c422-4a49-992f-719047f7697a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7c1935b1-d16b-4f45-86ed-07e39090ef9a" xlink:to="loc_srt_RangeMember_188823df-c422-4a49-992f-719047f7697a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f677355-739c-461e-bc23-53a20198649f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_188823df-c422-4a49-992f-719047f7697a" xlink:to="loc_srt_MaximumMember_1f677355-739c-461e-bc23-53a20198649f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f0e764ea-6e70-4f9a-a48d-463b77b97ac2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_188823df-c422-4a49-992f-719047f7697a" xlink:to="loc_srt_MinimumMember_f0e764ea-6e70-4f9a-a48d-463b77b97ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_4eb073e3-48a1-4762-83b7-57ad308ef8d3" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_d51bef39-2b8d-4ec0-a315-62d3eaa76837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_d51bef39-2b8d-4ec0-a315-62d3eaa76837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_9641e199-d502-47ca-9e3c-6304eac2f8b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_9641e199-d502-47ca-9e3c-6304eac2f8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3a4f4886-6711-4d95-a2b5-2992674088ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_3a4f4886-6711-4d95-a2b5-2992674088ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_912a9921-bbb2-467e-96f1-26599e367a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_912a9921-bbb2-467e-96f1-26599e367a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3337912b-6810-4ac9-b004-5094df072b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3337912b-6810-4ac9-b004-5094df072b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_beb68675-5a80-4339-82c4-f38262adbe32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_beb68675-5a80-4339-82c4-f38262adbe32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_cd3a590c-7102-4844-b283-cc4395dd6da5" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets_cd3a590c-7102-4844-b283-cc4395dd6da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_8e91f51b-3b6a-4ad3-ae3d-6fa9d8eb3de5" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO_8e91f51b-3b6a-4ad3-ae3d-6fa9d8eb3de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_114579d5-e4ea-4536-a8c9-9c07288ef946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_114579d5-e4ea-4536-a8c9-9c07288ef946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_052dca1b-398c-45d8-b741-d7379f0c5b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_052dca1b-398c-45d8-b741-d7379f0c5b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_062f4345-ec06-46f9-9891-3ba024bccaed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_062f4345-ec06-46f9-9891-3ba024bccaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Pensionbenefitobligationbenefitspaid_6d149c57-8599-48bb-be4a-ec7eed21eb9f" xlink:href="bsx-20201231.xsd#bsx_Pensionbenefitobligationbenefitspaid"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_Pensionbenefitobligationbenefitspaid_6d149c57-8599-48bb-be4a-ec7eed21eb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_9e9b7780-b6a8-46a5-901d-0d0f15afec4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_9e9b7780-b6a8-46a5-901d-0d0f15afec4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fa8c1501-e76a-4603-9bb1-e504d4e58baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fa8c1501-e76a-4603-9bb1-e504d4e58baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_1b6899f1-63aa-47ed-8cde-cc2c0362df9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_1b6899f1-63aa-47ed-8cde-cc2c0362df9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_6e38718d-5019-4a2d-b5b2-da5c9ce7ffc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_6e38718d-5019-4a2d-b5b2-da5c9ce7ffc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_b094b66d-32cd-4c2b-9e63-2bf6f5f546b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_b094b66d-32cd-4c2b-9e63-2bf6f5f546b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_e1e90ae5-7318-4667-8232-4af90463af9e" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss_e1e90ae5-7318-4667-8232-4af90463af9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_f3be79e9-d849-42b0-8a08-de1f4bc5f921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_f3be79e9-d849-42b0-8a08-de1f4bc5f921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_99663a6c-6a21-4c14-a050-503a50546498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_99663a6c-6a21-4c14-a050-503a50546498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_7246cf24-0d8e-45c1-93f5-0797212f9f60" xlink:href="bsx-20201231.xsd#bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn_7246cf24-0d8e-45c1-93f5-0797212f9f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExpenseRelatedToMatchingContributions_a0d1fff5-087b-4a1a-953b-9cadbbde8f97" xlink:href="bsx-20201231.xsd#bsx_ExpenseRelatedToMatchingContributions"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_bsx_ExpenseRelatedToMatchingContributions_a0d1fff5-087b-4a1a-953b-9cadbbde8f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0d2c2b1a-80cc-4ccc-87f4-60a0097ca76c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_0d2c2b1a-80cc-4ccc-87f4-60a0097ca76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3b34fb19-a1ce-49d0-bf11-a78ce6e400f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3b34fb19-a1ce-49d0-bf11-a78ce6e400f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_1691ce24-df12-4453-8acb-704d26809355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_52a6c2e0-9ea9-4652-8ae4-0f146ae85f7f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_1691ce24-df12-4453-8acb-704d26809355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ScheduleII" xlink:type="simple" xlink:href="bsx-20201231.xsd#ScheduleII"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ScheduleII" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_33b5db06-63d2-4980-91cd-b7362759fbb1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_3ff44e08-a84c-428c-90e6-f18d0e266394" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_33b5db06-63d2-4980-91cd-b7362759fbb1" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_3ff44e08-a84c-428c-90e6-f18d0e266394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ScheduleIIDetails" xlink:type="simple" xlink:href="bsx-20201231.xsd#ScheduleIIDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ScheduleIIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_2d5965f3-6018-4563-9aa9-a601aeb78e81" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_bb11bbf6-a731-4089-9c9d-d5e63283fbdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2d5965f3-6018-4563-9aa9-a601aeb78e81" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_bb11bbf6-a731-4089-9c9d-d5e63283fbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_4e6df58f-af1d-4a36-b98c-e489080582ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2d5965f3-6018-4563-9aa9-a601aeb78e81" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_4e6df58f-af1d-4a36-b98c-e489080582ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_a6e11f47-542c-4c19-aa49-bd31609158b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2d5965f3-6018-4563-9aa9-a601aeb78e81" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_a6e11f47-542c-4c19-aa49-bd31609158b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_fae98fe4-1f73-4735-8157-435b69082e21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2d5965f3-6018-4563-9aa9-a601aeb78e81" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_fae98fe4-1f73-4735-8157-435b69082e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_170f7244-b31c-4f32-b6f9-41f8a1903624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2d5965f3-6018-4563-9aa9-a601aeb78e81" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_170f7244-b31c-4f32-b6f9-41f8a1903624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6d41be08-31de-4600-8d4a-8e9d86f7f02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2d5965f3-6018-4563-9aa9-a601aeb78e81" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6d41be08-31de-4600-8d4a-8e9d86f7f02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_bf320e9e-c4da-46c0-baf7-ff929970a401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_2d5965f3-6018-4563-9aa9-a601aeb78e81" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_bf320e9e-c4da-46c0-baf7-ff929970a401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>bsx-20201231_g1.jpg
<TEXT>
begin 644 bsx-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X3 .17AI9@  34T *@    @ "  +  (
M   F   (>@$2  ,    !  $   $Q  (    F   (H $R  (    4   (Q@$[
M  (    1   (VH=I  0    !   ([)R=  $    B   1<.H<  <   @,
M;@  $9(<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                     %=I;F1O
M=W,@4&AO=&\@161I=&]R(#$P+C N,3 P,3$N,38S.#0 5VEN9&]W<R!0:&]T
M;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X-  R,#(Q.C Q.C$Q(#$P.C(X.C S
M $IA8V]B<V]N+"!!;&ES<V$    &D ,  @   !0  !%&D 0  @   !0  !%:
MDI$  @    ,Q-0  DI(  @    ,Q-0  H $  P    $  0  ZAP !P  " P
M  DZ     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                        ,C R
M,3HP,3HQ,2 Q,#HR,CHU.  R,#(Q.C Q.C$Q(#$P.C(R.C4X    2@!A &,
M;P!B ', ;P!N "P ( !! &P :0!S ', 80     & 0,  P    $ !@   1H
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M@=L_/B3#'.<#CD"K7AVR\3Z5J,,&I8O+80>1YPNRV )'8.0W+':RJ3U.W)H
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M;S5K6SE%OEYKIEW+;0+ND/X?PCW; ]ZRK[3=<UK87ODTJWV$&& %Y3G'60,
MIP,?*#CG#4 ;5G86MA&R6L"QAVWN1RSM_>8GECQU/--GU&")FC3=/,O6& ;V
M'!(SV7.TX+$#/>@"/;J-RRL9$LX2#E% >4]"/F/RK_$",-[-4MMIUK:.9(HR
M92NUI9&+R, 20"QR2,D\9XS0!9+JI 9@">@)ZU6?4K-6E03K)+$N]XHOWD@'
MKL7)_2@"-;RYN(6>VL7#!P%%TWE!QCJ,!B/Q H:WO[B!!)>"UDYW_9E#=^,%
MP>@]N?:@!9-*M)V1[E&N&4+_ *YRRDKT;;]W.><@5')HMH^J'457R[AP@D9
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MXD8$D*5&"#QP3T]: &+IUIIM@EO9P+#")HR$7.!\RCC/L ,=@*T: "B@ HH
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M4 %% !10 4A(4$D@ <DF@"&[_P!2O_76/_T,5/0 44 %% !10 44 %% !10
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MWM=RBG[)*0<,5SD+C''7-9*?$;0CJ-U8RFYBFMI/+;=$3N.]TXQG/*?J/0X
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M6FW;L7;Z8XIOV>')/DQY/4[10 ODQXQY:8R#C;W'>@0Q#&(D&#D84<'_ ":
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M,'/TH JIXNTJ186628^:,\0.2O'ICG\*M-X@TU(;2<SDPW9(A<1L<G\N/QH
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M&X@= 3Z#)H ?M'H/RHVK_='Y4 &T>@_*C:/0<>U !M7.<#\J H'0 ?A0 M%
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M3XK^&[NY$NL^"_#>JZ9)O;+&U:VEDMF_W=NZ)?\ KA7@>B^)OVG?@_\ L?\
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MR[MVU6])^!/[4C?&SXS?%_P"/#7]B_\ "OK^.Q_M#[?YWV_=),N[R_+7R_\
M4_WF^]76>(?B=\+?#_QH\/\ AK6M8T&V^)5[92+I4-PJ_;OL[,FZ-)-OR>8R
MC$>X>9Y?RJVQL?*_[%-]9Z-^W5^U?HMW>10ZI?:K;WMK:2MMEFC62Y9V5?XE
M7SX_^^EH ]JT?]KTZK^T-\7/A=_PBHC/@'1/[9_M8:CN^V_N89/+\KR?W?\
MKL;MS?=^[7)_L2_M_6?[8GB+Q/I,O@W_ (0W4=)M(;RWB.K?;3>0M(R2M_J8
M]OEMY7][_6?P_P 7C?P_OK?7/V^/VNKVPN(KVSA\)-:236\@=5FCM[:.2/\
MWE>.167^%E85\J_L_>-IOV6_AC\,/C/:P2/'JD7BKP[>-&-W[P01R6"_\"N%
M_P"^5H ^]?A-_P %'K7XL?M97'P7LO S6UFNH:C91>)/[7W^>MJL[>8MOY'W
M9/)_YZ?+NKU?]D7]J%OVJO!_B?71X:_X1@:+KLVB^1]O^U^=Y<<;^9N\N/;_
M *S[OS?=^]7Y^?LK?#I_A?\ MS?LYV,T+0W>H> 6UB\,N?,::ZM[^9]S?Q-N
M;;_P';_#7T/_ ,$E;RSL_!'Q=\./>0G6['QO=3SV+';/'&T<<:2-']Y59HI%
M_P" -0!Z=X._;A_X2SPU^T/JX\%_9?\ A4D]Y#Y/]K;O[6^S_:.=WD?N=WV?
M_II][_9KU_\ 9S^,9_: ^"WA;X@#2/["&N023_V=]I^T>3MD>/;YFU=WW?[J
MU^>GP'OK?6O@Q^WYK.GSQWVD:A<ZO+:7ULZR1W"-'>LK*R_>7:Z-N_VJ^Q/^
M"<?_ "9/\+/^O&?_ -*IJ .__:2^..G_ +.?P9\2?$'4;3^TH])C3R; 3^2U
MU-)(L<<0;:VW<S#YMK;5W-7*?LB_M5VW[5/PTU7Q-%X>?PUJ^E:A+IVH:#)=
M?:989$567YO+C^\K?W1\RLO\-?*?_!63XV^'M(\:_"+X=>(UNKWPO'J<?B7Q
M)9V 5IYK6.3RXX55F5?F7[1]YO[M<G^QK^U=X,US_@H+XU7PC;ZEI/@SXGP^
M?]CU>**&2/5XU\UF_=R2+MD;[3_%EFF7_@0!W?B+_@JI\1?!^JZ+IVO_ +*_
MBC1=1UJ?[)IEKJ6HW%O)?3;E7RX%;3]TC;I$7:N?O+_>KN])_P""B?BR'6/A
MEI?BWX$:SX'O_''BK_A&XK;6M0FMY((]UHOVI5DLT:1=UTWR_+_J_O?-\N;_
M ,%%_P#DY#]CG_L>E_\ 2W3J/^"B_P#R<A^QS_V/2_\ I;IU 'MW[/?[57_"
M[/BM\4?A]JOA0>$O$/@6_6V:/^TOM8OX6DD7SU_=1[5^56V_-_K5KF?$W[;C
M:7\6_C!X-TCP8=8L/AGX6N?$.HZR=5\A99HK=9A9K'Y+8+;MOF;OEVO\OR_-
MXM^TEXAM/V0?^"@GA#XOWI:V\(>.-#N-+UQHQMW30QJ%W?P_PV7_ 'RU9/[-
M?@N^F_8#_:-^+FOPK_PDWQ-TKQ#K$T@!7_1UMKE8UP?X?,:X9?\ 9=: -CPW
M_P %0/BIXTT.VUKP]^R7XOU[1KL,T&H:7>75S;S;6*MMDCTYE;YE9?PK[6^"
MOCS5_B=\,-!\3Z]X5OO NL:C$SW'A[4B_GV;!V7:V^.-LX4-RJ_>K\V?V0?A
MK^V3KG[.G@^^^&'Q6\'^'O TT=P=.TO4[6-KB%?M,JR;F;3Y/^6GF-_K&^]_
MP&OTY^&MAXGTSX?^&[+QGJ%OJWBNWT^"+5M0LUVP7%TL:B61%VK\K-N_A7_=
M6@#Y4_:<_;V\>?LZ^//$^G1?L^^(O$O@[11;O_PF2W=Q;Z?,LD,;-^\^QR1J
M%DD,?^L^\O\ P&H/@]_P46USQG:WWB'QW\%=>^&?P[M-&?6O^$PO9KBXLID^
M3RXXF:TC61I/,&S:WS?P[J](_P""CG_)D_Q3_P"O&#_TJAKY@_:OT_4[[_@D
M9\,9-.CD>VM=*\/3WVSM#Y"KEO\ 9\QHJ .C'_!5K7KFR/BFR_9S\:W/PJ^T
M$GQ@DDFP6BRF.2;:ML8=ZD,OE_:-NY=OF+]ZOHKQM^U@7_9WTKXK_"KP7J?Q
M=@U*>*.'1])\Q+D*S,LFY8X9F5HV7:R[?^!5UWA7XG_#7_AGG3/%UMK.C0_#
M.WT>,?:3(IM(;98UC\EE[,O^K\O[V[Y=N[Y:^<O^"05O=Q?LLZM<20RV^FW?
MBN^GTN.5MVVU\JW7:O\ VT67_@6Z@#A])_X*K?$?7O$FJ^'],_96\4ZEKVE[
M?M^EVFI7$ES9[ON^=&NG[H_^! 5Z/^TE_P %((?V<=2\"Z=>?#R\U34M:T2W
MUS6K/^T&MY="CE=4V2*86W-N\Q?F\OE5_O5C?LK_ /*2#]J#_KC9?^@QU\7^
M*/VL?A9XS^,O[2FN_$#3M<U9?&5BWAOPU<:+;PW$=I:0MB*=A+-'M;=;VDWR
M[OF\R@#]=_B]\7;7X8_!+Q'\1[*T3Q#::7I+:M#;17'DK=Q[=R[9-K;=RG[V
MTU/\!_BH?C=\'_"?CO\ LL:-_;UBE[_9_P!H\_R-V?E\S:N[_OE:^#/@E\:C
M\6/^"3/Q"TN[N3+K/@_0;O0[@'[WDK'NMF_W?)98_P#MDU?6_P"P3_R9S\)_
M^P)'_P"A-0![[7YR^%_^"IWQ$\?6MW?>$?V6O$_BS3;6Z>T>]T74KB\A650K
M-&S1V#*K;65MN?XEK]&J_#S]FS4/VG/!'[-GC_QU\'?%MAI_@;1=?NY=3T9+
M&WN+]IU@MVFN%$UL_P"[6%HCCS/^63?+_> /T%\&?\%!](\:_LR^._BE:>$K
MNSUWP2QAUCPC>WOER1S[E"KYWE_=;<WS-&K;HV7;7E^A?\%,_B[XFTFTU32?
MV1/&NJZ7>1K-:WUC=7<T$\;#Y61UT[:R_P"T*XGPIX(\)V/_  3-^-'C;P_X
MPNO'&J^-O,U/7-4OK-+*>.Z\Y-UO)"KR;65F9OO-N\W<ORLM2?L_?"S]M[5?
M@=X%N_!7QC\%Z/X1N-(MY-*L;VTB:>WM/+7RXW8Z=)\RKC^)O]Z@#Z2^,'[7
M7Q)^''@SX=:UHG[._BKQE>^)]*^WZEI6GO<^;H4VR)OL\VVRD;=F1E^98_\
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MV&KQK:K+<7,M[>VLT.Y)'\ORUDAV[5^\TBT ><_\.5O@C_T-/C__ ,&%C_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^)_VEOA3\6OBGI_Q5\/\
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MWPMU7Q1^R?XL\!>%M)C;5[CPVVF6&EQWV]#(L85(A/-MW#C;YDFW=_%7M]%
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M;VOK::"&55W2>6RQMN95;Y=W\7RUS'Q%^'?Q&_:0\9!M1\!77PYTNX^'VO\
MAN:]U;4K&ZDBOKY;95^6UFDW0KY;;6^5FVR;EC^7=]@T4 ?)_P /?A[JVBZY
MX<UN[^#_ (U&N^&+*YN?/UOXDS:E;_:OLK0^7IT,U_-'+YGF.FZY6U"JV[[P
MVT[]F?X*^-/@C\1M8U;5O#^G7-K\0TDUC6I](,,:^'-06:21;-1\K36K1S;5
M:/<WG+(S+MFW+]744 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 9U]JEEILEHEW=V]J][-]FMUFD53-)M9O+7/WFVJ[;1_=:M&OSQ_P""B7@?
M4=!^+W@SXK>(_#L7C[X96=G_ &==Z&M^UK>Z>\:W5Q/<6[97:S0J6W(RR;K:
M/YEVK7;_ +2GA7P;I.G> OCMI5C)96UQK6A:CJOC#[3/<:W;6&Z..WM[6*1O
MECF\[RY@LD?RLS-'<-\M 'VO17YP?'R^F;QC\>_'819_&_@_QEX4T[PU?.?W
M^FV[&TW00-]Z..?[1<^8J_+)YC;J/"NH30^/O!OC^"-6\>:U\<=6\/ZCJB\W
M,NE[;F'[$S'YFMXHH866-OE7RU9?FH _1^BH9I#%&S!#(57(5?O&L+0O%!UK
M4+VPETN]T>\MH89VAOFA8E)&D5&4QR2+UC;]* .CHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<MIO_)3->_[
M ^G?^CKVNIKEM-_Y*9KW_8'T[_T=>T =31110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45X!\:
M/VMM&^#WQ&T#P/;^&-?\9>(;Z);R]M=!A666RM6$VV38S;II&:&3;#'N;:CM
M_P \UDU/&_[36D^ -:NHM:\*>+;#PS:75G9W?B^YTZ.VTN"2Z9%B_P!=(LTB
M[I%5FCAD56;YF7:VT ]KHKR75_CY';_%;4/A]HG@WQ)XMU?2[.SO=3NM*:QC
MMK&.Y:18O,:XNH69OW3-B-6^6L[3?VI_"NJ?$I/":6&M1VLFN7/ABW\1RPPK
MIMQJUO#YLUFK>9YWF+MD7<T:QLT;*K-0![77+:;_ ,E,U[_L#Z=_Z.O:ZFN6
MTW_DIFO?]@?3O_1U[0!U-%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO@/X>^&OA?X>M]!\*:!I_AS2(#\EGIMN(H\\?,<?>;_:;YFKJ: //_A7\"_
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M';_L<[;_ -1[1J /5J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+I5FGF7%]J%PL,,*_P!YG;Y5KY>O_P!M'7/BUJ$^C?LZ^ ;SXAS)(T,OB_6
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M[<WW/N[/]JO(_P#AGC]HCXG0I_PL/X^CPI9-_K-)^&^F"U/_  &]E_>?^.T
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M^P/IW_HZ]KJ:Y;3?^2F:]_V!]._]'7M '4T444 %%%% !1110 4444 %%%%
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MOKJUY9WMU_9>G%9+.U:W4+YU[\NUI9.?O<[J .]HHHH **** "BBB@ HHHH
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MUV9F9OGVG:S;F;C=]Z@#G/\ AF#XH?M'2+>?M ^.#8>'78,/AOX'E:VLMO\
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M7X*_96^%?@'QIJWB[3?!UG+XIU.\DO9]9U%GO;H2R-N;RY)F9H_F;^';7K]
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M]'7M=37+:;_R4S7O^P/IW_HZ]H ZFBBB@ HHHH **** "BBB@ HHHH ****
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MN>7[$URT5@JLK2*N55IG7;N5EV[EW* ?2U%?)OQ0_:S\3>"_&_CJ\LK/1?\
MA O 6M:)H>L1W<$[7]Z]]Y?FS0S+(L<*P_:(?E:.3S-LGS+\M,T7]K#Q-J7Q
M TB[N[31H?A[K/CZ_P#A_96\<$XU..:".3R[QIFD\MEDFAD7R?)5E5E^9CN6
M@#ZUKEM-_P"2F:]_V!]._P#1U[7&?M/_ !'\2?"7X+:OXE\(6-MJ7B*&[TZR
MLK.[MWGCD>YO[>UV^6DD;.VV9MJ^8OS;:^"OBU^W]\9?@GXXU[^UI_AC<ZA'
MIXMR;73;YH[R2UFDB:.V7[;N95N)+F-I&VK_ *)/\NY560 _5&BOCCQ-_P %
M8?V<_#ZDV?B;5/$3J,;-+T>X7_T<L:UYQXH_X+#>&+&^@LM#^%_B2YN[D1M;
MQZ_>VNE>8LG^K;.Z3:K?WJ /T.HK\F?B7_P5U^,/AGQ)+X=3X/Z=X1U^-UB;
M3?$/VN>Y1F&5_=_N&^;<NW^]^-<-\3/VYOVL]$^(EMX/\17?_"!ZC(\/VBTL
M- ADDACDQM9?EN&^ZW\/S4 ?L_6?JVL:?H-HUUJ-];:?;KUFNYEC3_OIJ_,G
M]I725^'UUJGA+5OV@?BUXF^)4<=NUM82?;K'0I&D96Q)]CMI&8>66_U;?>^7
M<OS;?"O''P%U/X<?$S_A&?&6B>$=3\3Q^3ON[71_$NNJ_F*K+\TDGER??^;:
MO_CU 'ZJ^*?VPO@AX+5UU7XK>$XY8_O0V^JQ7$H_[9QLS5YU-_P4F^"]]*\/
MA:Y\2^/+I3M\CPWX<O)VW?\  HU6OG7P5X9LOV6?C?!I'C:PMO$]M;P()M-\
M&?!N$0/),O[MAJ"KYC;<_P .[^)?O5[3^UIXZ74/'&C>"+)OCIX:73?]9=_"
M[1,6EVLRQ[=UQ_=B"M]W[NYO[M &_P#\-E?$+Q(/^*,_9C^(^H;ON-XF^SZ&
MI_[^,U \=?M@>+5']F?"_P"'?@,-_P!#-X@FU%D_\!%KPWXF?!?PMX+^(+^%
M]:T3]J/XM,HA\S6K6_DN]-E\P*P"S*T:_+NPWW=OS5[#X=^R_LC>*]1\#_"[
MX!>//$.GZA<6]S>:];W_ )]I<2,BKN62XF;;M7Y6^[]W_@5 '*>+]<^,6D7D
MMG\0OVN/AG\*[M55I=-TG2[1YE5O3[9(LB_]\UYAKWBKX&QKGQ]^VQ\0?$S-
M]ZU\.ZE+#;2?]L[6&3_T*O??C1X6O)/C5?7.G_L@^'_B?]H:V:7QIJ6HZ5 T
MO[M59MLT;2'R]NWYOF^3^[MKI_%5G\4O ?Q$;3?A5\%? <?A13#C7)M1CLI)
M-P_>?N8H]R[?F7^+/WO]F@#C_A_^PK^S=XQ\*Z;XWL_"6H^.+;4+47MK?:]J
M-_)/<1E=R_N9I%^9O]I5KC/#OB.WTB4+\,_V%+Z*8-A;GQ!8Z=H;_P"\TDBR
M-7OWQ&L?VC;[XAL/ VJ_#?2_ H,7E/K-K?3ZDQVKYN]498\;MVW:WW?>E^(?
MPC^,/BWXC2:KH?QR?P=X-5X6B\/Z?X7M9Y_E5?,5KJ5F9MS*S?=_CV[?ERP!
M\Y?'O3?VD?B=H_@N_P!=^'V@?#_PSX2\3V&O3'1+U=8U6UCC$D+RQ0^3)#)Y
M4<[R;?+9OE7:K;:XCQ=\1M*_:A\1:3X)T;XU^*KJ_P!+\865_I6L:K#HJVT-
MO;N^_4-T.GV[0S+-')''"TFZ3S(9-K+)M7W7]L+X%7U[))XOMO'OQ?>ZU74K
M&PAT/PK=75QINE1959KK['9V\DC*L<<DGS;MTC*IQNKAOB-\,?@;:>)/#/CG
MPG\)O%VI>)]#OM.5]/N? 'B%X+S3H8UM/)6.:U\F-XH=LD;+MW26Z;F^9J ,
M;QG\/_V?-)^)">!?BG\??B/\0_&<UU#:R^'[S5[V6$32;=B^7:P[8U^96^]\
MM>G_  X\/>'?@!\9)_#/P@_9BU^WS<QZ;JOC.\G6UMOLC-&TDD%Q<2227$:X
M5MB[=S)_>KZXM]'L;74)[Z*Q@CO;C'FW2Q*))-J[5W-]YL+6E0!X1>>&_P!H
M'6OB]'>GQAX.\-?#:TU!98].T_39KS4M0M58;H9Y)MJPLR[OFB^[D?>IMO\
MLE^'9OC"WQ&USQ)XQ\3ZK#J+:EINGZIKDGV#2W[+;V\85=JC<NUMWRGO7O-%
M '-:%X#\-^$;W4+[1?#^EZ1=ZC,UQ>75A91PRW,K-N:25E4;V9F8EF]:Z6BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M))&K,O\ P*KM% $?E+OW;5W_ -[%2444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+:;_
M ,E,U[_L#Z=_Z.O:ZFN6TW_DIFO?]@?3O_1U[0!U-%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !117!^*_C'X'\!^+M \->(_%FD:-XAUZ3RM-TR]NECFN22VW:O^TR[59OO-
M\J_,VV@#O**X;6/C)X"\/^+K7PGJ?CCPYIOBBYDCCAT6[U>WBO96D(6-5A9_
M,9FR-OR_-Q6A-\1_"EKXU@\(3>)M&B\67$1GAT%K^$7TD>UFW+;[O,*[59L[
M?X6H ZFN6TW_ )*9KW_8'T[_ -'7M=37+:;_ ,E,U[_L#Z=_Z.O: .IHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *Y;3?^2F:]_V!]._]'7M=37+:
M;_R4S7O^P/IW_HZ]H ZFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N6TW_DIF
MO?\ 8'T[_P!'7M=37+:;_P E,U[_ + ^G?\ HZ]H ZFBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^%!?_P#QZ@#J:*Y;_A7.E?\ /UKW_A07_P#\>H_X5SI7_/UKW_A07_\ \>H
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MYTK_ )^M>_\ "@O_ /X]0!U-%<M_PKG2O^?K7O\ PH+_ /\ CU'_  KG2O\
MGZU[_P *"_\ _CU '4T5RW_"N=*_Y^M>_P#"@O\ _P"/4?\ "N=*_P"?K7O_
M  H+_P#^/4 =317+?\*YTK_GZU[_ ,*"_P#_ (]1_P *YTK_ )^M>_\ "@O_
M /X]0!U-%<M_PKG2O^?K7O\ PH+_ /\ CU'_  KG2O\ GZU[_P *"_\ _CU
M'4UGZ-JEOKVCV6IVN6M[RWCN(MPVMM90R_H:QO\ A7.E?\_6O?\ A07_ /\
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MZU[_ ,*"_P#_ (]1_P *YTK_ )^M>_\ "@O_ /X]0!U-%<M_PKG2O^?K7O\
MPH+_ /\ CU'_  KG2O\ GZU[_P *"_\ _CU '4T5RW_"N=*_Y^M>_P#"@O\
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M2QRL;.*..UM/FC+* T-NK;?O+YGS?-0!Y[X1_;&?XA?"'X9>)]'\'K_PE?Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^)'@OXBVVH:9?Z_X_P!32YM=&O;%8#]M:.62:2.2.;=\JK&NY6V_Q;6^N/\
M@IA?:AIO@?X*WNCZ7_;FL6WQ2T6:STO[0MM]LF6*Z:.'S&^6/<VU=S<+NKZ?
M^&W@&Q^%_@'PWX0TR>XN=-T+3X--M9+QE:=XX8UC1G955=VU1]U17/?&3X'Z
M'\<(?"$6NW6H6B^%_$=GXGLAISQIYEW;^9Y:R[D;='^\;<J[6_VJ /CG6OBI
M\0O$'[<GP.U;XG?"MOA9%I6D>(YX(U\0V^LM>1K8,TC?N57R]NU>&^]NJM\
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M^KQZAXT\,_\ "*ZA%#-&(HK7:R[H1Y>Y9/F^\S,O^S7+>)_V)_!GB3P-\/M
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M"21?*\$:)_:+VVS;EIOG78K;OE_O;6KRK_AOH_\ 1N7Q_P#_  A__M]?5=%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7X]>#?'GQ2U_P+X?U0:SK.@VRW&I36>V2V@8RM&T'F!O]:K*=RK]W[K8;Y:
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M6V7;=R75O)?1R0-:F2/[,K*VY%_=LTC#=N/@9XN\G53!H*1W5W\9;7Q7N%Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO-OCIX_U+X<^
M?MVAP6\^N7^J:?HFG"\5F@2XO+R*UCED"LK,JM-N*[EW;=NY=VZ@#TFBO)O#
MNB^,_AGJ$NI>(_B%+XO\&QZ;-/JESXBMK6UN[":+:RR0?8[:.-H67SO,63++
MMCVM]Y:YMOVOO#5IX;U[6M5\->*-$BT[PRWC"TM;ZUM_/U72E^]<6X6=E5EW
M1[HYFCD7S8]RKNH ]]HKP]?VI-$MQ?+JWACQ1X<NK9M.F:VU*TA$C65]<K;0
MWV(YFQ"LA_>*VV:-1\T2U:\3?M*Z1X=U8Z=;>'/$.O7S^)6\)VT6G16W^EWR
MV'VQO*::>-?+55:-F;;^\5OX5W4 >S45\[>&/VAOL,FI6$L'B3QSXEO?%FJZ
M9IN@6=E8VEW#':JKR1[FN5A:&%65?.DD5F:1?EW,M<TO[65[XC^('@#5/"N@
M>)M>\):WX;UZ]E\/6UC:P:A)-9W]M;^<WVB2/R]O[_Y?,7=N7Y=VU: /JZBO
ME?5_VP-3U#QMIMGX3\-'4O#6N^%-,UC1=7O3'$INM0OH[2V\_P#?>8L.^:-6
M41^9N5OX?FJGX'\>?%S2[:U\>ZOJD^M^!+R..[\N]:R\M[.2=(VDCAAM(9K.
M95D6:.*2:^5HUDCDD63;)0!]:45P7Q-T;6=6L[6:R\?7/@#1K!9KK4M0L+6S
M>>2-4^7,UW'+##&OS,V8F9L+\R!6W?.^@_%KXE?$[PW\.]#A\33^#O$&I>#]
M7\576M6FF0^9>K:S06]D6M[J&18XYUN4N)%55;C:K+0!]BT5\N>,OB)XL\1?
MLY:;\9;'X@3>"+63PE::Q::'I^E6MS'<ZE-&KI!,UQ')),LDLD$,<</DON9O
MWC,Z[-CXM?$[XH>&]2^%)M--TG0]%UK6=&LM<NI9VFNS-<2-YUG!"T>U555^
M:9FW?-M5<_,H!]%T5YK\?M:\6>&?A-KNH>"K2[O->C\D+_9]JMU=Q6[3QK<S
MVT#?+-/'"TDD<;9#M&J[6^ZW@]]^T5K'@GX8?%GQ-X6\<CXK)X7TA[H:9XDL
M(=/U[2+Y6966\LTALMMKM7S/FC6;Y)-OF;E50#["HKQ;QG^TA!\.](LM3U[P
M1XKM]*%O83:MJBPV:VFDM=2+&JR,US^^96;YEM/M&WY?[R[J^I?M3:%HOBW6
M=&G\,^)'L-&\06?AO4O$*PVHL+6\NEM_(W;KCSF5FNHEW+&VW^+:NUF /<:*
M^8_BG^TU?)KWA[2_".EZW!I__"?Z;X7OO%'V:T?3KB3[2L=Y9J&D:967]Y&9
M/)5=T;*LF[;N]#MOC]8_\++TCP=?>%_$NC-K5U>V.D:OJ=O##:ZC-:HTDRQQ
M^=]H5=L<C+))"JLJ[E9E968 ]9HKP'PS^UII?BWPEX2UW2? WBZZE\7MN\/Z
M3LT^.\U&)83--,NZ[$<<<:C:S3/'N;:%W[EW;/[*_P 0]9^*7PG;7]=N)KB]
MDUS6;93<6HMI8X8=1N(88VC55VLD<:KTW?+\WS4 >RT5\J_LI?&KQ9\8/'WB
MDW/B :]H=@DT>HQI':K::=??;)%MHK"2%=UQ;R6J^8TDC2?\L]K*WF*O0?M+
M?$R?P3\1/A=H]W\3/^%6^&M:_M7^TM7W:?%N:&&-H5\V^ADC7YF;^'YJ /HJ
MBOF3X8_M%R:?X2UJ:^U2]^*-LWBUO#W@_5M+BLUN_$ZF".9O+9?(M6\EOM<;
M3+Y<>VT;^+[W9+^TUH%YH.BW6FZ%K^J>(=4U2ZT6'PG##;QZE'>VJNUW%)YD
MR0KY2QLS-YWEM\NUFWKN /::*\3TG]J30/$5YX)L="\/>(M<OO%-M>W$=I;P
M6\4FG_8[B&WNX[H331^7)#)-M95W?ZM]N[Y=U;2/C1J'@>ZT7P%X@T[7OB!X
MTTW2].G\2ZQX>M+;R(&N)&A^T-#YD<TD?F1R,WV:&3:J_,J_=H ]UHHKR6^_
M: T_2?B1I/A/4?"OB72K?5]4DT;3O$-];V\5A=W<=N\S1QHTWVC;MCD59/)\
MMF7Y6965F /6J*\\^(GQ7@^'^I:!I$6@:MXH\1Z\TWV'1=$-L)WCA4--.S7$
MT,2QINC5BTGWI8U7.ZOG;X._M6Z@VAZ;XC\8:MK6I69T+4=2O--BT2UA\J%-
M?DLUNY)"T<BF&';YD?E_=1F^:3Y6 /LRBO"_'GQNB@^(OA[PWINHZKI9M?&-
MKH>H7%OIUO=6VH23:7=7OV/+2^9#MC6"1I%7=N:-55E=MO,>*_VJ(/%7P"\:
M^,-"L?%G@[3K?P])K>D>+FTJSOX;F'<5\ZWC^T-'YBX5OL]RT,GS?=^5MH!]
M-T5XYKG[27A[P]XTNM$GTG7+K2-/U6UT+4_%-O#"VEZ=J%R(_(MIF,WG;C]H
MME9UB:-6N(]S+\VW/TO]J;1=4\81Z,/"WB:VTZ3Q1<>$!XBNX;5=/&IP^;^[
MQ]H\YE;R?ED6'9N959E;<% /<Z*\^^(OQ8MOA[J&A:7#HVJ>)?$6N23)I^BZ
M/]G^TRK%'YDTFZXEAA6-%V[F:1?F=57<S5Y#-^T!J7Q.^-/P?TSP;)XAT_P9
MX@TG4-;O+NU@L%:9K>:WC:UN%N=TT*QLTD<RQHLFZ2/RV^61E /I^BOG7]HC
MXB:UX+\<:9'JGB/Q1X!^&\>C7-[=>*?"^@QZGMO%FC7R;MI+6Z6VA6%FDWM&
MJM\W[Q?+VMRWQ@^/FK?#KX!> ?$.L?$'21!?ZJUOK'B[P2;>\EN-/CCN66YL
M(9HY(Y)&\NV:95CD6-6N-ORKYB@'UG17RI\6/B;XU\"?"#X'3^,/&L'PUUG7
MM<L=.\5ZW;M8B. -IMW-*HDN(YK>/,T,?S+N7C"MMKL/V</B)>>,O%'Q TVU
M\;?\+.\'Z/-8KIGB_;:,)II86:YM/,LXH[>3R=L+;E7<OVC:WW: />Z*^:M:
M\>:MXXUKXE:K=_%%O@_X(\%:LOA^/4($T]/M%UY-M))/=37T,T:Q^9<QQQQQ
M^6S8;<S;E5,VQ_:.NM#\4>#-2\2>-?#FI>#SX$US7-;U7PNRW>F74]C=6D?G
M02*K2?*LDZ^6K-\S%?F95H ^IZ*^7_BW^U!>Z?\ "7QQ<:9HVO\ @#QOX>AT
MN_?3==L[>:[-E=721K<1K#)<1R*VRXCV[O,5D;<JG;N] T?]H&VU*S\30R>"
M/%EAXET![/[1X4DM+>?49%N_EMI8VAGDM_+9ED7S&F58_)D\SRU7=0![!17S
M9J'[1UUXM\1_#N#P_%J'AR23Q]<>$_$ND:I%:R3HT>EW-RT#-%)-']Y;>3='
M)_L[OO+7TG0 45\[?!SXQ>)/$WQ.N&UR]CD\(>,X+J^\%PK%&ODPV,WD2KYB
M_P"L^TQ-#=Q[F9MK2?PKM7F?V4?C-XS^)7B'PW:^)-:_M&"]^'UEKLRBVABW
MWDFH7<+R?NT7'[N.-=OW?E^[0!]7T5\Z?%K]I!;'3?B'I>C6OB30I_"5]96.
MH>*+?3K&ZMX)IFM)%CCAFN5:3S([H+G;\OS-_=W;>M?M2Z!H?BI]-'AOQ-?Z
M:/$MIX0?Q#9P6[:>NJ3R0Q^3\TZS!5\Y=TGE^7E656:3"L >X45\O?!?]J+4
MK^TM-+\5:)X@U&_U/Q+K^D:5KL-O91V5Y+:W=XT-DN)D82?9[?:LDD:QLR?-
M)NW4SX:?MA7GB+X;^#K_ %GP#KNI>+]>LK_4QHGAU+/<;2UF6.2:-9KW]Y_K
M$7RU9IF8-^[VT ?4E%<-\2?BCI7PK^'-_P"--7MK^72+,0L\-I;DW+>=)'&F
M(FVMNW2+\OWO;=\M<1XE_:>T_P 'R7$&H^"?%0N]*TI=<\16]K'8S-X>LFDD
M59KMENBK;A#-)Y=NTTFV)FV_=W 'N%%>1V7[0FCZQ\1+GPOHV@:_KT%C<VEE
MJ&O:;%#+96,MQ;K<0^:GG?:/+:.2-O.6%H?GYD^5MM;0_P!ICP_KGBZSTF+2
M-;@T?4-9N/#^F^*YXH1I=_J%OYGFV\3"8S?>@N$61H5C9H656;Y=P![+17B/
MPY_:;TCXB7?A$0>%O$VE:;XIDNH-&U;5([5;:ZFMXGDDCVQW+2*VV&?;NC56
M\EV7Y=K-4;]J[0;[3M+OM&\+^*/$<U[I4WB'[)I<5J98-*CF:-+UO,N%5HYM
MN^-(V::1?^6?RLJ@'O-%?-WQH_:GL]+^'WBF;P#8ZOXEU.W\&-XFCUO1H+:2
MVTJ&XAF:RN9UFD5FWM"TGEQQR-MC9F7;MW>W> =2N-9\#>';^]D\Z\N].M[B
M:3:!ND:-69L#_:- '1T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>mcps202010-k1.jpg
<TEXT>
begin 644 mcps202010-k1.jpg
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M /X65S_\@T?\)E^THO7X8> !]?&5S_\ (-+_ ,)C^TIU_P"%8> ,?]CE<_\
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4A0P,C;N&9@HD<*%#8KU2BBBO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>mcps202010-k21.jpg
<TEXT>
begin 644 mcps202010-k21.jpg
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M"A4G?_9-NK7X6O\ $3P'X^AFA^)JW]SJVM^(;Q97M_$T#1[H[^%V&Q5$0"-
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>mcps202010-k31.jpg
<TEXT>
begin 644 mcps202010-k31.jpg
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6^I+W_DXS0?\ L5-1_P#2RRKTJBO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>mcps202010-k41.jpg
<TEXT>
begin 644 mcps202010-k41.jpg
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H-\(%EM895O-PN0\8(G^SR&:WW\?-Y4I,B9^XQ++@\U]-CI2T45__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>mcps202010-k51.jpg
<TEXT>
begin 644 mcps202010-k51.jpg
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:4R,MWI^FPP2(9,^8595&TMDYQUR<UVE?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>mcps202010-k61.jpg
<TEXT>
begin 644 mcps202010-k61.jpg
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M9M&ET;7;[0IK>>9)6:2VD\MGRG&&/(&3CUKO:****************:RB12K
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*IZ$\^M=W117_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>bsx-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20201231"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bsx-20201231.xsd" xlink:type="simple"/>
    <context id="if99852c5f50d49489e7b7697112a652a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a988978970e4005a89f2558e11bca85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0eb79373de9f42768da8b4de1b4c6eeb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i95364ec24cbb4b618f4ac38a93e0259a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i924ec29d9a304f4882d75905eb802224_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie7e548e9c0454041b4a4f4d799765eaa_I20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia2522ce480044b738970a71b97a2834e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic3a4c1a262e0442388a415c87e27e889_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iec2a00e6f06c444a9952e4b94b0d4e6e_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i416c4bf3762343af99956df0491cda23_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ic86a24afa1544f379e9453f8559daca7_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i75a0e4d8d1464b8e96a0b3b99c3831e6_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia6edad1230384f4ea726dde74e58b266_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i97947ef16fd64573b576ede19f2d29ea_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i486c2b6f6b1147f0b09d948b6ad1b5ce_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibf28bd85296f42f49e4da5f20d423b67_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i82aeda8856fa47ed8b39207375fa1aa8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1d1f315a766c43b1aa5940ff8e160594_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iae1d8357f67849468d20db2d30de5e55_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6bbe2d5f3afb49b99ec4c9803ecee919_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i815f4d787d1e4a26a2e65fce1b26129c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i978ec64dad704d138144a11d4f20a868_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7354567f0bca438fa78f4baeeceed35c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie5f0b56fe933409badece00bf9ab8f17_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id118699e701242f1879566050e0064d6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie7af855385df42d583c24a02df379ca7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i66c17b892a204bb2b1c1aa8cd1051251_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia9eec6cd5c3d47bd8cc9fa8a26bae2d0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idf8a046f49ba4e7bbeb5595372a466f6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic48f447708b74f77a26a4f0286cc2a15_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4b040eb90cef4343a857fe2e7740195e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib22777e33f4f476c95138787b75b0db3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i369a19338d4645fcaff218f3e0180a0a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28940fe126704087ba8a61832f5de550_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e988814a30145f686582891ff75a88e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f4c7888c677425da7039956930978ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i069e7ea9c6764fb5ab7629ac3e1b1f7d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8fb62c7fcc6748a29d33c15fc1a6e4ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i214a62bd8ef9406db278c8d1a09ffa31_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf7408d8c0ac4baa9b95744bb4a1416f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf999a62069f494daaa8b34dd39eb888_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89e7c6f8f9b84193a176a221054afca4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c25b897fb8e4965a95e19981c5c8a85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30f6d299f51d4710906bfb8afd9fa959_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2189acf6800a485eac08cc940a299be8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd122064a7e945ed9ca826ffcb42ab6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8e21581818b44be817499b63aaaddd8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0a695a97d72f47aaae3df04c71e8be50_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i11643c9862df4baea0dccd9d1fe58c3b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab42b8f2e9794e569ed587870fb84d60_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56411282f0574a36b407828ddce5e536_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i64a8d1206e3449f0ae7a7ece1b89fb96_I20210121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-21</instant>
        </period>
    </context>
    <context id="i5a34bf00cea546488f2484aedb64dcf4_D20210121-20210121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceSolutionsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-21</startDate>
            <endDate>2021-01-21</endDate>
        </period>
    </context>
    <context id="ic719d29f043447d9a84bc5924b1baf78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i299c7ae54a0247c3ba17d84adb96d2dc_D20190819-20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-19</startDate>
            <endDate>2019-08-19</endDate>
        </period>
    </context>
    <context id="ibbb0c3a277f94a73ada943c59b4bac0e_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f7af4ce5e334ad6a48a0c025a8c309e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35075d47b59a45d1a6bea3504735e270_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a3d5f3065944d128f235b2e66762039_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if2774a1a2bba4fa7853774c9595dcb11_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibed9848d49334621abbf06402ae43b03_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i68e95752e11f41c8bf7a29dafc64ed6a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27a8ea6e29224419867de6bc25119d5a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58f51b9be0cb448cb46a40c48600ea96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d29dc73a76c4cf595703ac8e73f20c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie90da432f6df49e48679d93f666461e4_D20190821-20190821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:DivestedBusinessDueToBTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-21</startDate>
            <endDate>2019-08-21</endDate>
        </period>
    </context>
    <context id="i7b1cd7f1f0194f3aa27fd23d352988c0_I20190821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:DivestedBusinessDueToBTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-21</instant>
        </period>
    </context>
    <context id="i029e2805f8d2493c952047d8981ed692_D20190611-20190611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-11</startDate>
            <endDate>2019-06-11</endDate>
        </period>
    </context>
    <context id="i28538f28a987480db2349df82889a791_I20190611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-11</instant>
        </period>
    </context>
    <context id="i0659d4a09c104d69a40367c98f578cba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1be67d7dc4894d3d9ac61ec671d1f66c_D20190129-20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-29</startDate>
            <endDate>2019-01-29</endDate>
        </period>
    </context>
    <context id="i506a6ba7c7f04e2fbbbc72dd6a366a00_I20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-29</instant>
        </period>
    </context>
    <context id="i571b355da3e14c4088b68574662a2240_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if2a5ec16eee547859b062e1a0491d616_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if04f535d42894b13baf5c1bf29abbdfa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac2d0307d9d04ae1a423eaf989020c84_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c0fc8eddb08406ea3d86b0a6e07223d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idae083babc2c41c6920c5a332adfac61_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2317bba8b93a4381b47fcbb9f84a225a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d7e6ed023a74081b6372d23bc145ba3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i496c2de855594c64bc941488053cc536_D20181016-20181016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AugmenixInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-16</startDate>
            <endDate>2018-10-16</endDate>
        </period>
    </context>
    <context id="i904147befc444b9bbdc64d9876b10897_I20181016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AugmenixInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-16</instant>
        </period>
    </context>
    <context id="i884efc79fc7e4752a4aa11bebd3bbcf3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:AugmenixInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31712f6779184ad8bf710b35128f9962_D20180802-20180802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:ClaretMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-02</startDate>
            <endDate>2018-08-02</endDate>
        </period>
    </context>
    <context id="i83308e067e9f492fbd4a9d89b3ef8503_I20180802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:ClaretMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-02</instant>
        </period>
    </context>
    <context id="i1e1286aef3b14fbbbc9b05febb4fb2e0_I20180705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:CryterionMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-05</instant>
        </period>
    </context>
    <context id="ia7a425fa4f004c2eaea7363a2060f19e_D20180705-20180705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:CryterionMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-05</startDate>
            <endDate>2018-07-05</endDate>
        </period>
    </context>
    <context id="i3cc07fbb23104ef5b60a1a0aac61b408_D20180430-20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NxTheraIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="iad9c6a324c6441d1b8f2cfc19eb1608e_I20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NxTheraIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="i5478b53eb62b479dae6f8838d73e6197_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NxTheraIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6555d4428a7140748bd802e9a768fd8e_D20180416-20180416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NVisionMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-16</startDate>
            <endDate>2018-04-16</endDate>
        </period>
    </context>
    <context id="i3b9fe0db816347ab9940c21c9b0d768e_I20180416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:NVisionMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-16</instant>
        </period>
    </context>
    <context id="i808cb5579b214ed483e0c55813432263_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:Other2018AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie9d42aa1c99141d9a7c12881fbf9ad48_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:Other2018AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf000a38a8df435292fe43a04c563e76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c966453e2a342b3a3f4d64f2c1428d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie298bcc204ee4eb6b430de4388bf4f81_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i761fd86626924956bb4384aaa7769a24_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0cf378e387584a16a29c91ef5252aa72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01e3c724a40741a28dbc546b88724c67_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia5bf5b7491cc40229dcf4fc38c3ff0db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c571473f99c4f8ead199ef961c9e48e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i172db034d54f4af59ea3ef913e7f74b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2018AcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic81e0a9293d34d779237110332e1ab2f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa490a08b9e140b4b87e705cf3401a77_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i225a40fb505b4a9ea385c6900535fdf6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id3a7f90c9cea4edc82150a9d77fd688d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85248c1e3e8d4e798e32297ec2f4a394_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21f76d998b4a431984b2deeb969e9e85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib29c8720d4e5458c8a5b0b896a9227d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib31907c21c804935b3eabe4556382002_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c0d71a4a1294e5a9aaa4452bcfcc83d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5da8394a7b3140a8b169f5c7d428772b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifab990ff13f04a489cc2ddc900075cbb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50e34e4fce414bad91b9758bf3c925fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6d6a824461a469cb0d94f10e9342c7f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i26e8cfad4e524c8bbce668b54331c93b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53e75f811f294c61b8be35eaba703298_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1de9a90b228e4b489fceda143c56c8cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ad66c6f19564d8281c1fa550e0e9503_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i15ebe498a99547009a19b14541a8843b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d6909276f2047e6aacb514e5552c63a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i41f1841703d848508d023ea0e135c3ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia322e236c1ba4565bcbe28841e306760_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic32470da1e8e4392b88a0f486f43a9c1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9d70084f4dd7415eabb7a85e24d97a2a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i604905e66a504173a840028f3327dd56_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7793c5feec074fb6a77322031639508b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i441d6c224b974fa083f08dc17135353f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i793d999a9b624f70a0df23be83f63129_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4452aaad562b4bb899286f3797d9eb2d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e86856187e44c808f6433015dceb738_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i74c2fb79c41b4be6bf7aa2326d6b1cae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibd58d69b28dd40519b4334498825790f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i36f17ca4d9f544e3b7cb7e5c6f72280c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i593eb42527b540c88a5921faa53b3629_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d99afc9e3b24ff09921674dea102a4b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7768e07d07cb437d89233e0f9387ac2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2019AggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80031cfd406b4f6593c9c5e695b180e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2be247223ce41e9a14396e0b34bf4d2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i363dc865fad3412d89a91d89a180cd1b_D20190819-20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-19</startDate>
            <endDate>2019-08-19</endDate>
        </period>
    </context>
    <context id="ia635740e76374063a92852a9184832c4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2cfe49b594e3475db1d49e7d28359214_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i465006924e984ad48ab06e31300af791_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3071c36afac844cb8c57202c79fd7e82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb470d28f5b6409baadf2c224feb3e23_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05947140c3ba40e2aedcd05c7acf1a22_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib3868068050b406f9f740e75ff11f2de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab5863a52ecf47d2b29b015beb18341d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia52ebd7217064b1ebf72672758698988_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa9b86111b3449e7a2b76a24eeffe984_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i248f8c480024432dac8c9a0ddc15c07d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeignCurrencyDenominatedInDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8545367409b943308f16f9d561a3c06f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i21309996213144d8a28d7561f412fa26_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaad7391e2aa54540b42638571113812c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie88422a1b3d241dc8f3bc3352cdf31a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4564e07d2f464045890d0a82a7f30f1b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4cef46aa868a4404ad3def8d54a0fa7c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8adfba5c23d24bc7b650917ab0f27ebe_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i15892080636d4d31ae5423c34889e21a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2eb9d0a4cfa94defa4a9c54410555954_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i48fa4493001d449ba145886a80478889_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i905b6a41d15a4b2088787d8381188854_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2e7225eec3d5430180f5e3302849762c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0fcbf0b422564ac6ad7c97196af88615_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8f7f17dea41f463eb86f00e0bd3fd2f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i928052d310a84aef81dc5679f247ce6c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4efb48e17cbd415e8d90d23bb91fbf35_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic80933ec2cc54616bb475d09124b5eb5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icd4142356f2c47c3b2a80ca179a5478e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i008481e22f624470b6a792954311af1e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93cb97c15d414cb69088b89bb3fca575_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49e7446a63114d61a987f7353caaa479_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i722eb9acea26411b9150036527416c41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59a8047f3879432c83f1a1b97f95fb61_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idf6e3376ee884eb8984657ddcb97aa63_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc3b62df941c48789aff4200f8e67d59_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06cc0641dd65461ca4819856ac55e362_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3407186c51da4b5bae15fe9b0b42918f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib860e3dce61e49049931073399687742_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i142c7d472a8344ce85925c067fa91fe9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6f306bf2384c441f92d64b73af5de0d2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53b6f52da8df4fa7bf11e1a08d9ccb70_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie413d40c497c4213aed17626e6327e26_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3ee1e91c186b4f699e1d1d29e37ff24f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb70a5191e964f5bbfc7cab5cbae8163_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0eab187810704dcaa8f9fa4fcfefcdc6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ead7f5a424543edbf6a6280a486e80e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5e14f3f587f24448a4c91bf888b8b399_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ice90f802b2894cb798cf1495f7ea9a11_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib421eaab309941719fac63dbb93ed872_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4504c169cc844d2ea5b6d6a2e3e9d654_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c3caf59a26546f0adfd22adbf367b9f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4307d6f3a38471491744ddae330f127_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i542629f9607d42d396e07c03c41fc785_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9521f08f13f849d78d220e43a83413e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iddfccdc34ae347398e8196005b47ad2d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaecb6ba3d8414b658b7074879ac58a42_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingArrangementLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if784bc40961d41ea86115e7819324fc8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EuroDenominatedOutstandingDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id18b0f22f1a54a529beaf27a2d386682_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EuroDenominatedOutstandingDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4f3624e58548487f8fe6f34329a5815d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie94729ec536f4bc8bcc1206a1a2d33b7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iace5b35349bc466aa9490fe1abc44349_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i470cf9477e25450cb165bec6ddf55cc4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93322dab74aa4ef38da4b44eda101b38_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb0ee9631c3d49d395dad185461e903d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib2f5bb8d642f42c1af20b67911d62368_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3baeff6199d34f65b27933b63ede7d47_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3b663172db024a7292246bcb9060972f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75fd0298f42f480aa7c38b110f45a007_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if1ccd83cecce48e7a280b063a5658b6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea6c3f5fe650404b94ed7a33ebfa2cca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c13725730644fb4b3b71a64ec29e691_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28d0cd11a8104fe8a096c54c797dbb77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06838a9c5668409daceef0d66f6e0b09_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9e45057621d4a2194b3b7c5a4d322e1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icf15031c1e264e419f6387d7bb871a3f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82968b403f0e490b9ff37937effad01d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4d9f8e01c368432c8b949ad0e9f7804a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5278deff95bf40dab3597ddea1f112c1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i881baa0d70eb4bed8a4f7c036159289e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie943736485e84ce7beed9099a5c89fc9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e7a0b5494fe433698454f3d4be42317_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i072d21384351482298b1bf90b42befe3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2765cf8e499b472db95894650fbbc9b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i65aa69df316c4459b610a9a758daeb5b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2022TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2317e9eeb3514b0ebfa77fad060f3b78_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2022TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i86e54183bfbf4dcea32db5920645d4c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0490e70b8eb4adaadfc6f7e99f1c154_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0dfa649ec60b4e6fb3977d40dd636c0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i713d6358ca344f6b85182e9f67f64ba9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6f07d9d29b542aba0b5805828ee1cec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe8e5ca3e12946a3acf25b897e7d182b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i15fb9c7f5da74f4a84401aa8f7ee2b2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a3a53a9ff3742c0bb73f4f43804fb5a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i6cbd6ca2b191422bbed4a7a82030eee4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i809d5c20fa804d2fbb986afa7dc387e8_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="i6a055566dd0a42d0b5247b6ea377c972_D20200518-20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-18</startDate>
            <endDate>2020-05-18</endDate>
        </period>
    </context>
    <context id="i5653e63d9d764f71b37cce04c14e9918_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i934e92bb8af546eb9e57ac456dd0619a_I20200227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="i56087e653b324fa994949b7d0c138ef8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1160215621b243f6b393f001c1aac0d7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3916b9b9bec94f6c874dd26e645205c5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icc311bfbe55c4b7bab87b29a5c5ad4af_I20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-05</instant>
        </period>
    </context>
    <context id="if810421b7a7142d88feb52f9a24f6b2f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6bccb221eb7049dfa837d52812ecf319_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3b7bd05ff52a4f2ca45526a4f36f0fa7_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:AggregateSeniorUnsecuredDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="i7b1253b180a24f5184077538b81d86ea_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="if5058ef5b1744c99af286b6f6888dea9_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="i0f029b30f006439581bf8725281e3599_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="i498d29e5a70e4570a7844cf14bd02f63_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="ic35171b8628c4dd5ad036a63a32bfb1f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie03682fd1dea4c5b853350dd17ab556a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48219e6ea65a46868b8d56d6f5e591e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b0451592eb8487e9970e7bc57c226fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementExtensionThroughTheRemainderOf2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0fd8889518a24b01acba9958549fd5e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementthirdquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92925008ccf94edb8a9a6fa812cfe728_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfourthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8273828bead4a54bad459aceb05abe5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ac5b05e233743a0918574aa15d416bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a94b491b12e42c693b11e87706c05ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7219d097f654ed583a1166ed6e2afeb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i047968109f334e72b9394ec59f28e192_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1622c8dc4c6c4bf6984d78e57376b51d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idfb077471a35463b9f660b39ea4f3612_D20201229-20201229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-29</startDate>
            <endDate>2020-12-29</endDate>
        </period>
    </context>
    <context id="id1816c871d3e444bb94fda8950db49fd_I20201229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-29</instant>
        </period>
    </context>
    <context id="i0b04a2ce24234007830997dd2dcf322c_I20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020SNAggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-18</instant>
        </period>
    </context>
    <context id="i50f95eeb41c34ca090d9eb073b22e649_D20200518-20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-18</startDate>
            <endDate>2020-05-18</endDate>
        </period>
    </context>
    <context id="i8c38c44c917644b098c633ab638428cf_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0d6a17efae344d4c9df3b7fb951f8515_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6b96a4fc501142cf8461498cce84408b_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i98969d1f5aa24ac4b7604cd2111634df_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i50adfc63c2df4dea89170b844a26339c_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i98b32703709b4b0aa69f93f2f184b39e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if96cc1043cd04c2c983e15e941b3816f_I20190225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:February2019AggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-25</instant>
        </period>
    </context>
    <context id="if1b49800ef2c4501b27527c8995dbbc4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i455c8d39af974255a980e1e70f644bf2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i925f70236c2e410e80b575f9f56d03c6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8101096131dd4084b7d522af75cf5248_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id186cacae9da4651be0c28bb43b1ded4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2019TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib48697a0624648d89ec42eafa9342b77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8dc7bcdaccd44f068db68bbbd79a3e75_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8bbc6a0e526d42a79ee7960aeca28186_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6870f9bf392f498a941330451198f38c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i929c861096094117809bff5aea456e34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i279145e1ed5d4579b641b7df4d63ddf1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i839275644c56406890c934fd58bed027_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id225a6ef1501499aba377c394f95fe05_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if4576480dfa8445591015c36a302939d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44368aec498f423db8c0bf4520a896a7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id58a89551ad04c37b39770710490ccd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idfcc194efc364801bd80478df09f2935_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iebdf6472601d4e179cdc65a60d86275d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29926e2a05fc47c9a3dcfbe25ce22aff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i33eb88f0ba654a56a83ac224f0a18c85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fd4a9fd1c704a35958d7562d8125b01_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3f274031addf44889a33eb68c3ed4dfc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieceadf1a7f8e4fad892abbcf9491307e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i60558a28aa7c4d63a693910b749950a6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4e9f419b17a442ea339ee0791cb497b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7778b7f1e6944fd934bfedde17079ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb71293750e8491687172e77edc978a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17d165f894a04832a1fa68a0e736d01c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60553db20b814c02b1d910e227adc3fc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringRelatedToPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b0af9974fe547798f675a2412349d03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bsx:RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis">bsx:RestructuringRelatedToPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3f9837c2b254cdcbb2ed38175b6637d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad4e9ac9719e43a1b6053144c13aafaf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia070298726984423957d186ea4cbee58_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib9dc1ef08b814cda860643ddf852fff5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b9961b90ffa46eaa0ecfefd2145c16b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bdc512ea545452b8a307ed56cefa316_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib00c2166428146c59f1dbc9ed80238de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia7f722e04aec431e92c5dab638517e6c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d0fc03416e74cf7b79748dfc5fec108_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i169c8823728f4c56bf82523f72a013d7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea3689dbf1264c80b2fc2369ebb72975_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib138f03d5a5c411aa8254cb667a37e63_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1133c37811e34ad8a94424eab435b18c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i101e2c90421b466f8a45ce41d9f8dd58_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie04e61dc46ef4691b3b50088e8133d64_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8703d1164954705a5b4395347a35ba5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5a1888e3e03a40bf807e229e44b6ff2b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibae917fc49bf4be6a5712c59d3887549_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b8e1fcec7c545189678173243202880_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb31286a42734b9eb48b8f675cd3027c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i437f306d342d401085bd4bc596e6f2a3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia9d0c00ba23a4901a24791aa8b568055_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieef5ec3f5c6e45c3b89e5abaaf847a2a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i149a77f1ef8b4e1aa76950f7516e8136_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieb54673ea5524ce182360792b2c9655d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i98a96b3c0c7d4f2b81bce69840269e54_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i05cd1788c0054ebaa6c7c34fd116c721_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3930ab450cbc485eb4182fa96c8c03c0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id98f6675244c47d784ea3093b78e1e84_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iacfedd935c9342268439fe7cbeae60e7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i18140364ac7a4d3699b0c8e6c02ca49a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i080263b4497f43dd86b878ee1c6339bf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3ff943bdcb694439986636ed65f75c91_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2270b92546484cbf82fd0280322db3ed_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i31cc871da3dc48c7a5f796348d8817ae_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia33eedfc21a14d7984d9f03c953ab5f4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id0c6df5a32d14725adccb334ebaac480_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iaca3955aa3774955b74141f0b7742835_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5426d5162838458f96e5bd31e0cac4eb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9c55f725ad2b4e03bb8b3aa0fdf79f67_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if8819d44961a414f9358a2742a3ca164_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i92351a2745854052bb947f9c73f7b6ce_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i78f6d9f528bf4e5b810d4a2a45a83e7a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6c6c1520344544848558a04190ef9084_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5ea799c3840b4e17bb183186348f29aa_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icf19c236e1224a3e9207882bafa38c2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4fc68305d0ea4e12951bcc4b90225f04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id66a034296ae4bb1a925a5b9c0323174_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i13e5df102a644d64adfa3a33ffdcdfd9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ddab50db36b43dd9f17c341352773f6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie43de06282cc43d6808a84e7f69288d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:LotusDiscontinuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1e8f687653b84e89ba20c0702c69ec9f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id2eef7931a47424aadfa33ed87c13bef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69acc2e1fe284629bd66ab64abb82dfe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72c007a8c0e54e8f8dbfbd4c1b84ae74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87d4deec479e42b4921ca3c0c19c6196_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i425c4f006d69412d874f531954a840d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0de6be7750b84ba2becd8b78d3760d22_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2016RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2af5f8f85cb4333aba96313b76a69ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:A2019RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida81f67779e44ee99c0f4576accd6b66_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bsx:TransferCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bsx:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id9c026cbdf6644bdb88b307eed56919f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifad23126719c4bb4bf9ce037ea077942_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i067d126bfe71406d9637e9e0321f9dba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:AssetsHeldForSaleDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a7f21deae51477e88e1f5da1df0f205_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:AssetsHeldForSaleDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6df411a051af4374b3df655f51893efc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxAssetsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e27faab8a7c4a88b4496e70958eb027_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxAssetsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i38649fda4692447aa9a51f8b4b69b77a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxLiabilitiesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c0c0db4113b41ac8f0a3925494b51f7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:DeferredTaxLiabilitiesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i95932fa13d754cceaf54655a7e81a6dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b3d68a05c444d0dacb5095f51e80130_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bsx:LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i51d17bc802334ee58e6912543c9a9101_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i2ca84bcda655492cb7c95b91c9cc7c27_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i75283a86da274266950b25d74cea7669_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i83276247c7f842c9ae8442b64070ca41_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i798449bc56004b03983ad8201e6fc19d_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i847cba4eb27247b1ad73919d3359fdec_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i73b83671a10a405a8f270b82a83376c5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if91e0eeaf600499ebaebbee149714e4c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7854a894ad99488694325a46151ebc34_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i6d753b38040d479e8b54faae20faaad1_I20190115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-01-15</instant>
        </period>
    </context>
    <context id="i2f7956c04d234376aa4eecea14242910_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="id75fe6d2063c4f75b07316a97a020d9a_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="i409422251b4e4e6fa90403e9dba4dda7_I20210127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bsx:AssignedToOneJudgeInMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-27</instant>
        </period>
    </context>
    <context id="i39fb2d8200504ca99f2588af122ccb46_D20171110-20171110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2017-11-10</startDate>
            <endDate>2017-11-10</endDate>
        </period>
    </context>
    <context id="i7798f7ba3d954caf8a24d240d313af4b_I20180912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:UpfrontCashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-12</instant>
        </period>
    </context>
    <context id="i94b1febde39c4df9b5982d8d880defc2_I20180912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MaximumContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-12</instant>
        </period>
    </context>
    <context id="i1e9be71c38ac4607af95364edaf5c01b_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="i26c1603e14d9490f8e287a7453ef6ad2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if76aa1de0a364b9b88b9a216851425ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i364b4c76e483475fb4929cbd7234002a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7d247529a1c463fa7773c98fb47c5b4_D20200901-20200901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-01</endDate>
        </period>
    </context>
    <context id="i4fa9aed9709041149e54010a083bfe82_D20201201-20201201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-01</endDate>
        </period>
    </context>
    <context id="i80fea81c0f1641e2ac476c397df768a5_D20210201-20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-01</endDate>
        </period>
    </context>
    <context id="ia14713cda1cf4913ba849fbbc13bf46f_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i87014aa1c11a45678ccb64e8fe4dd544_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="ie17653a14c754c2ab47d617c083c0151_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="i497fdd9e22bb40c9b7d641cbb2f5890b_I20130125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2013-01-25</instant>
        </period>
    </context>
    <context id="ic981515a7d5b42c29018a2a5a0ae37fa_I20201214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-14</instant>
        </period>
    </context>
    <context id="i778f0f816cf84a6d802f3c954762bc96_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">bsx:A2011LtipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i48dc48db06f64857b9f8f2175ed065c8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4ce12987f1214f89a3dfa34f916446fb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i61e617b0c52e4f2f9d64b27e15217b69_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0a97c4c9280f468985dbf91165af9ea0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i744cf371d9c64de7bdda73270e33e44a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib583bf860ca3439f8e8edbcc584563e9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic1abb0720ff4407591ec3bb6cfe6e577_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7dd3d62482574f8abab9be37411135a7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8dbc60762f9246c08c22c8690df360f5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7b53681c5973450a9bf67b79aa206f65_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1d62047b22344b799f16b3cb7ff597c8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib22247f67db94421b34a23ad85639077_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5927d31a28d44ea785098e97b5f79f96_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i587d1e2ddfb14a2eac94b281ca12ec47_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i58e16f20577a495e80af1b6afc207f5f_I20200218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-02-18</instant>
        </period>
    </context>
    <context id="id21557fe18514f5291709c9c7a7b4c9c_I20190221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-02-21</instant>
        </period>
    </context>
    <context id="i778b96505b084096ac50ff6a8617ea48_I20180215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2018-02-15</instant>
        </period>
    </context>
    <context id="ia6c97b04efa749baa9a5a7d0f8ea8b37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i072f9c9e6d52435999f54ed61545ec04_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1fda8d4a6d204d5592671e4160ebb649_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc16585c6e1d4e3b933534e09af497dc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia2bfcb1707824651a50fb653ad5409d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i42e266465c9541e5884b034945a9b78f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06a7f1a1b2624255b5691acb8602e67d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0820a199efab4817bdf4131117959b05_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if9db1cbfd5784602a23dc09b4c7da6d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2775314c99b49018b5b755c1d609493_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i74ec03875dad48559735244193b46b9c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c01e96e0cd14429b992b394174f5e9e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if8fe71b06ce344c281e40bdc083e4ba9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3a71de8475b842919cc1f06ff9e779cf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7255855cd0894949a78ea4a0040d8c62_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6e2cbc9edb4549aebf26bdc7e9f10bc4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i438f3d71334f422fadced3dba2c1990a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63903523afd04122bb1a4624c0770c00_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia9ef720185f044b09fc4ef729f49cebb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie07c1550f2534b128a6b7a2e8d0dcacb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i511243d7d4314bcfa6398e281d8d6532_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ae346373047401887060e128b7fa20e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc7b8ce837b245dbb215df8479dd5f96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iad363ee5163542b083904b4076004ef1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:ConsolidatedBSXDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0bd94549f8c44f9d8d06813718b34318_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:ConsolidatedBSXDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie5dd6328991b46b09bcc31f021284ca1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b784e91a1d84b03a340b395d9f1d9b8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6c8ed886eb0f41d797c16440876e2205_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i858f772c802b438680691d7c7cb9c6e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbc1298766fb4dc6afdb793f6e79a93b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7b32c44341dc4909bcb9d9a63624fe3b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ieec0796ecad949ba819d979b8949b690_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id00a014d50414ad386436abb58f55a11_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8a659e306f1b44828d0574858121b0aa_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib4ae8f5f4fc54e469b52b21b2e600588_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63189412661642f5a8f2b9aeb53a83a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3310fa9b62c34616bca02c7c2f6b9784_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18f4de09d08c4833944a68b36c8d10e2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if71c0aab91d34037ad9af6a815712b06_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4e68166b1ff440a4bc5ba6146bce9e0c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie2791d1ca0354ea3b2122b428aa941e8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ied722aad4edc4278a94ca946a6b06e8c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8328c5ebea2e4fd6bc961bba6dfac1ba_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0bd85cb4fae54571b1035e5edca0b5f0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f3a0f25c82248db8fd9752a33e01ca9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6bf1776f98e64055a1740c5f1d4c3626_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i513e81ea5c054bb7ab98f1c6f1a9367c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i87e138a0321a4237aaee54dac3eecbef_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idfdceca128a8467f86bcca14efd7146b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if875c662a7874536afea940416d0a63e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iefd0c81147da4757acf01048244a29a2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id75ab8e1ae0d49cbb8ac4badf8c334e3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i123d2d96cb4f4625a7ca2e22d7052b07_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i96570d8f60ec4c059059878654d4e978_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iede0d66fbb154f07be0f0e39b74e8884_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06f5a94b8a8145529296757ce57b7f5a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i937aa716b0d844a989c27397f8bc1d9d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i44f315c2d53749c4a98caeb0c46bf4b8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1502d18d7bc74acbb3d8ab048488f756_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i62b5fd5fd89d4d2e87a701257a100916_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i71ff3b6b5ecd4ff78aefd5a1081e8c46_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i98775703e0eb4e92aeb652fb7cd61026_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if74c3140243949a6826d8ed9cdee8a17_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3406940f365a46eb906ded17bdbd850c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9539e6fa5dcb48d8b5039083c5f40bd7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i48892e98c56344a79b645469f44e7ffb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i70c1a11844804faea3d997d119344357_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i85f5f28e5853409e93d21092b327e718_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i173fb5f80de24dc6b549cf699860ff93_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if596783ed28540409dc77820cae22014_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1a0cf3f990cf48038aaa263848720334_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i35965682e6934441a09c4499546789a5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac0bbd18a4ac488ab44f83280dffe8d9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic5909476c857442b993ed5506e3cef59_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id91bf069a1224ec7b78acb9fbcea277b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if995755c1c9b49b4a9e75000536e2348_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibdcde2cecf294a648e81bb1b6a520713_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iba33321f14c4426c8f27ec58c8dd157d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8d2be57e89ab4990afaf54dfd21a1651_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6206baa0607e4447a0e903f42c1ed97c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd07f73493ec4ed7a9c7b93a28fa803f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iecec850c0f8c45579de9fd9d3cc81e56_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifbf55f8a4d8043ddb1050e3255fcca0f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i815d46a2e6f141779fd9a976198fcb59_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i08fbe1280d8c444c9dfd654d9d62ffba_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id4183c9b4fb7440c8791c7d281bfec1c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i40c4dadc18e044be9fbc4bee8e5e1ae0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia8a6c9c90a3f416e91e71e65395c477a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i528032fe7c344add96992fc9c9effe78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie8e797bf1ad64edfa7c96ff371ef9a6b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8348c7076ad34dc19caa20d96d3a35a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7734b29eb824bbe92e4b31e6104b9eb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0690fd3bd0414ed3803fa0ec3f99dc1a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f26189e8ec34d198388550160abbe6f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i538b7bb9612a453f9a69c50b4385870a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7aa704e50bc84e7c8687de09cd75e04c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic9c9683dda944147b057902c94179e93_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i32b5cf3a4bec4cd88d7475be9f91daca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9e4ccc5194b647ebae6e86a553e04f39_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i25a2689337c343a29b2517e48e80f21f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3027462747254c22a27e928fc0e7507b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i44683e8679ca4adeab31422336b6d2b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8e3f1f1a5e54483791680e1f47026b93_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i477d03746ef641e79d498573339aa789_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieeb9b19833ec4b32a7043c93f3837778_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9077857b3e78429184a7980d2c9e9bd7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia4029bfd2d2d45b88bbd190a55c10e4f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7416538a3917499a98dd18bd9a43544f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idfaf003122284a1caf5f04531f97da3e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i247718be21934f158bd504dc0a59d0d8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i96d22c0398784970921b6ca16cac29df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4eae2a8bac3a45d0a646a1ba30307bb1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia6304d11e4ac4f2bb33c3f2f876312d5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i03b4b47b48264834a5b805b565fc497a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0e9eb5b00d6e4f2e8af5e92882f84e42_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8a94eb1a155c44089342c4fce8a0a175_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia44651ee68c84efd8c565cd8ede42050_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b029b8db40e4478bd41a37cbbf5ba8a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0eea159e14624a668c6b1853597a984f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6fc3285e99ec41baad3226a8fbb980ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37289b8d4ace48da862e203e9243e7ff_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3fde0d89a66a4c76a36d9b5839bd1351_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0ea851bcbdee439aaad834b99357bd76_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="i4c091552d1914709958aece5ac3ec298_D20190819-20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-19</startDate>
            <endDate>2019-08-19</endDate>
        </period>
    </context>
    <context id="i4abcf037f5374f05ba7fe5982239ea34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:ExecutiveRetirementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i707eebe909d64c8ca658b4340f67d9de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id161c1507c9c4caf9953e4e59e994d83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:InternationalRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9302f589d2a941e4a602a1c2a2ab8233_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:ExecutiveRetirementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic0b571ab922c429c9d165e755ab1c084_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91d6efe660df47d2bdc670d53b98a6ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:InternationalRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i468ac5844c254d30825e2c4ab7683ecc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5a830b33ced43cbb812205e0f5ee769_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20811b5cbd4444aa969fc5a82825adaf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:OtherInternationalPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic11f0737ab4b4295aad087680e91578f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a90b04fd34e4f338907045e7245b889_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7d72be05fbe64ee489d3b9d9a331d3d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">bsx:OtherInternationalPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i476309e0b0a84d4088d447ff4ea0c043_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8150f8dd78cd4380a0b054b41ac3d226_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia98c9174caac457e90096de44db28035_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i806afaf84c134ea09c7780052e42855b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82d5d4f9059648dfbe129e24d2e5e76b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f43fb9793c542b6a313df6b768e9fd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7307f52ceeb4874b34c64b3b408a83d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45ca6f37d044456b8c5479fac92d63ad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6df988ad339147759cbbf0249f88b40d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if469866c31ea46fd8b925ca78ec9465e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80602948166348f69cd4d27b5dabf946_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84d6571646ba45d1a7095a0b4e8e4915_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3134c9b872744c01ab4bf5c21d4aad7a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7dd96fb2f5114cd4a6958cc13c50db13_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c25a08438574b52a9f59623d149abc5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie05f8aa1e800416d9668e75d159576ed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic36697475b27449e8bf5b48595d9608d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4f02b4becdb447a6a98b17845a2f0831_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">bsx:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="gbpPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:GBP</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="units">
        <measure>bsx:units</measure>
    </unit>
    <unit id="claims">
        <measure>bsx:claims</measure>
    </unit>
    <unit id="reportablesegments">
        <measure>bsx:reportablesegments</measure>
    </unit>
    <unit id="countries">
        <measure>bsx:countries</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl8zLTEtMS0xLTA_a683da8b-ec84-428e-b58c-33c5672e2f7d">0000885725</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl80LTEtMS0xLTA_ba296e2d-1937-4a09-9aad-360b4b5b648b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl81LTEtMS0xLTA_181ebe90-72f6-4616-8427-ae0fe3177f03">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl82LTEtMS0xLTA_ff7d67ef-4144-4470-a6b0-868f89e3ec2a">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N180L2ZyYWc6ZTNmNmY0NzNiMTdmNGNlMWJkYTE4NmMyZjlkOWVlOTMvdGFibGU6MDhmZDIxZWE1YmY2NDg0NmIwYmZkODQ1YWU4OWNhMWIvdGFibGVyYW5nZTowOGZkMjFlYTViZjY0ODQ2YjBiZmQ4NDVhZTg5Y2ExYl83LTEtMS0xLTA_07c9d87d-a16e-441d-96d9-f6fc91ff8a1c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjkz_6da80cfe-8f0c-4493-8241-2af2e07418e3">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ODRhMjRlZjQxOWJmNDQ3MjllNDg5ZDc1ZTUwYmFhMWMvdGFibGVyYW5nZTo4NGEyNGVmNDE5YmY0NDcyOWU0ODlkNzVlNTBiYWExY18wLTAtMS0xLTA_cdc039f8-6131-415e-a158-cbb8001df3e7">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18xMTY_01053003-cfca-4d96-bdd2-a7cdf8950393">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6YTIzYjA3MmNjMzA4NDM2ZjkxMjQxZjE0ZTNjMjIxYjEvdGFibGVyYW5nZTphMjNiMDcyY2MzMDg0MzZmOTEyNDFmMTRlM2MyMjFiMV8wLTAtMS0xLTA_82080038-c767-44f5-abb6-d49b43208f71">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk0_2b7700bf-b6a0-4c1b-9ee1-f638ba6670b9">1-11083</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMzAx_08eac104-3611-4c12-aeb3-d187f76cc6c7">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ODEyM2RiNDIwNjExNDY4NDlmYmZmYTM1YTAzODM3YTUvdGFibGVyYW5nZTo4MTIzZGI0MjA2MTE0Njg0OWZiZmZhMzVhMDM4MzdhNV8wLTAtMS0xLTA_78e92b7d-b94c-470b-86b4-dcb96d012f06">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ODEyM2RiNDIwNjExNDY4NDlmYmZmYTM1YTAzODM3YTUvdGFibGVyYW5nZTo4MTIzZGI0MjA2MTE0Njg0OWZiZmZhMzVhMDM4MzdhNV8wLTItMS0xLTA_cb98c41f-1e70-4b79-9e5f-15c6c78151ea">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMzAw_fed60d7a-1da0-4da8-be9c-9fc50896da86">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk1_436bd3a0-5cfa-4728-8f4c-edae59038a70">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMzAy_74552753-20b6-4ee4-8886-adfdecfedfc4">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk2_1d7429c1-cda9-436d-93a5-9af2e02c5384">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMzAz_5025c1af-dc94-4eeb-a5a3-ca15d7ad38a9">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjg5_e626b8cd-a8d8-4b5d-b584-60a1322e33f6">683-4000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i0a988978970e4005a89f2558e11bca85_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18xLTAtMS0xLTA_a2436952-906a-43fe-a049-ef76839c30e1">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0a988978970e4005a89f2558e11bca85_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18xLTItMS0xLTA_fb567bcf-f587-4376-b1c3-8706d1b4fe0a">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0a988978970e4005a89f2558e11bca85_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18xLTQtMS0xLTA_423b4ba2-265c-4145-98b7-df89b506bb4c">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0eb79373de9f42768da8b4de1b4c6eeb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18yLTAtMS0xLTA_1cc4301a-5dcc-4958-9a82-dbf7c560c2dd">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0eb79373de9f42768da8b4de1b4c6eeb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18yLTItMS0xLTA_b41690a5-92ae-4bf3-a7de-3c9085567c77">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0eb79373de9f42768da8b4de1b4c6eeb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18yLTQtMS0xLTA_33ae17c0-7a44-444d-aed4-5f2735b3f295">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i95364ec24cbb4b618f4ac38a93e0259a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18zLTAtMS0xLTEyMg_3a0431a6-0c45-4c56-81ea-907d79a60b16">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i95364ec24cbb4b618f4ac38a93e0259a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18zLTItMS0xLTEyMg_f7c4e284-8fe1-4809-943c-8277754c31eb">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i95364ec24cbb4b618f4ac38a93e0259a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6ZmEzMmIwNDJmZWY1NGZjOWFmOTRjMmMxMjM1NjU5NjMvdGFibGVyYW5nZTpmYTMyYjA0MmZlZjU0ZmM5YWY5NGMyYzEyMzU2NTk2M18zLTQtMS0xLTEyMg_d2bd6e1f-e3c6-4615-84c1-3bba072a4177">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk3_56e4ef3f-9076-41d3-8ae6-fff20c2e9610">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjkw_8e45f92c-3e3b-4d52-805b-84f2bf316e26">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjk4_b385f9f8-1166-4cb9-a6ad-0ade48298474">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjkx_47100d37-413a-4064-a5e8-78338d06196f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6YTE2NmVkOGJmNDcxNDk5M2I4MmVhODFmZjk1ODg4N2MvdGFibGVyYW5nZTphMTY2ZWQ4YmY0NzE0OTkzYjgyZWE4MWZmOTU4ODg3Y18wLTAtMS0xLTA_65bb0936-7ebb-45e5-876b-99cfc3b51625">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6YTE2NmVkOGJmNDcxNDk5M2I4MmVhODFmZjk1ODg4N2MvdGFibGVyYW5nZTphMTY2ZWQ4YmY0NzE0OTkzYjgyZWE4MWZmOTU4ODg3Y18xLTMtMS0xLTA_398205e7-4522-4fe6-85b3-b7a206d84bed">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGFibGU6YTE2NmVkOGJmNDcxNDk5M2I4MmVhODFmZjk1ODg4N2MvdGFibGVyYW5nZTphMTY2ZWQ4YmY0NzE0OTkzYjgyZWE4MWZmOTU4ODg3Y18yLTMtMS0xLTA_847caed1-ff00-40d6-a6f9-7bc024a94b7f">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18yNzQ4Nzc5MDczODQ0_a736520f-98f9-4ff0-8f4b-20a4ff66e10e">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18zMjky_950b6319-680d-4c9f-8d51-e0f13f8afc46">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i924ec29d9a304f4882d75905eb802224_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18yMzM2_4e7daa20-af37-472f-be74-d6a168b22b3e"
      unitRef="usd">50000000000.0</dei:EntityPublicFloat>
    <dei:EntityListingParValuePerShare
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18yOTMw_cbaed650-b985-43b5-aef9-25619d1e6465"
      unitRef="usdPerShare">0.01</dei:EntityListingParValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie7e548e9c0454041b4a4f4d799765eaa_I20210129"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xL2ZyYWc6ZDdhZTMwZDQ1YTlhNGU2NmJlYTUwZWUxNTExMTg4Y2MvdGV4dHJlZ2lvbjpkN2FlMzBkNDVhOWE0ZTY2YmVhNTBlZTE1MTExODhjY18yOTgx_f6c5ef17-722d-4b71-8a2a-7045cdbcd2c0"
      unitRef="shares">1417165707</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMy0xLTEtMS0w_d59d0b44-5971-4f54-8029-477f6a5a762c"
      unitRef="usd">9913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMy0zLTEtMS0w_87a85e99-5ca0-4334-beb6-670e5b3684af"
      unitRef="usd">10735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMy01LTEtMS0w_b396fd5d-358d-4ae6-9d57-a3952a714efb"
      unitRef="usd">9823000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNC0xLTEtMS0w_b8a9f635-3747-451a-9b62-2eaab52be34b"
      unitRef="usd">3465000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNC0zLTEtMS0w_df426cb5-3237-4bea-accb-c99353cf2772"
      unitRef="usd">3116000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNC01LTEtMS0w_b51b71e2-0629-4371-b8a0-8246eb265405"
      unitRef="usd">2813000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNS0xLTEtMS0w_c1d231f4-de59-4140-aa73-736b8b1f22f4"
      unitRef="usd">6448000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNS0zLTEtMS0w_ddec54d0-8392-4627-a608-0a57b77eb247"
      unitRef="usd">7620000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfNS01LTEtMS0w_82c0fb34-5aef-4e72-bc64-7bcc4476265e"
      unitRef="usd">7011000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOC0xLTEtMS0w_7d6ea58a-f006-48de-a341-e5afc310d720"
      unitRef="usd">3787000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOC0zLTEtMS0w_4ea99e5c-a9f6-4b09-92f4-dfd067587519"
      unitRef="usd">3941000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOC01LTEtMS0w_f3d4d1b2-e91c-4dec-ade6-2cbcda2477ef"
      unitRef="usd">3569000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOS0xLTEtMS0w_c9a2be28-4bef-4e61-abb2-a7a4c8e44538"
      unitRef="usd">1143000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOS0zLTEtMS0w_afd203b4-c3fb-4dd8-a042-b08d0da3b0d3"
      unitRef="usd">1174000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfOS01LTEtMS0w_d8e8767c-ca86-4407-82ac-2d4568f0fea0"
      unitRef="usd">1113000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:RoyaltyExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTAtMS0xLTEtMA_39926f97-de91-4259-8b68-216471764f5d"
      unitRef="usd">45000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTAtMy0xLTEtMA_024c93ce-d1eb-4718-830c-2b1fac3052cf"
      unitRef="usd">65000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTAtNS0xLTEtMA_ae504d74-4f58-4813-b73b-58ccb5354f06"
      unitRef="usd">70000000</us-gaap:RoyaltyExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTEtMS0xLTEtMA_147741e0-f354-4ef7-b48d-d42580ded6e7"
      unitRef="usd">789000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTEtMy0xLTEtMA_9910ff45-9ca0-449a-9c8e-700c2f60b819"
      unitRef="usd">699000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTEtNS0xLTEtMA_a1af6ecf-16f5-4da8-8a59-3d7104f839ea"
      unitRef="usd">599000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTItMS0xLTEtMA_957e7ce5-fcc0-4f10-bfe5-f5f042cd7971"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTItMy0xLTEtMA_3769e534-f17b-4553-8d48-349d3006c093"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTItNS0xLTEtMA_ec919cc9-86bb-48f9-a080-dff607743365"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTMtMS0xLTEtMA_5c538a4c-8f90-4a07-9673-349dd2aca177"
      unitRef="usd">460000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTMtMy0xLTEtMA_c4af45c3-6ab9-4f9b-be36-4d46386eaaef"
      unitRef="usd">105000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTMtNS0xLTEtMA_01ec64d0-8883-413a-acaf-50e65b8df617"
      unitRef="usd">35000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTQtMS0xLTEtMA_3cd1823f-d395-4bc0-b650-628050648a1d"
      unitRef="usd">-100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTQtMy0xLTEtMA_b7cd3cea-b3f4-4df4-bd9d-9289a3e0756f"
      unitRef="usd">-35000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTQtNS0xLTEtMA_da548212-e048-4b67-8984-8962888ed9ce"
      unitRef="usd">-21000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:RestructuringCharges
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTUtMS0xLTEtMA_179e6d6f-2e34-4d69-85e3-e1fdfd1c6dea"
      unitRef="usd">52000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTUtMy0xLTEtMA_6aa91924-c318-410d-ab4e-6e8ce400457e"
      unitRef="usd">38000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTUtNS0xLTEtMA_19797d07-feac-4ac0-ab74-2fbe20efa9c6"
      unitRef="usd">36000000</us-gaap:RestructuringCharges>
    <us-gaap:LitigationSettlementExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTYtMS0xLTEtMA_bc1639c8-5f89-4847-a230-960efc8b0cd3"
      unitRef="usd">278000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTYtMy0xLTEtMA_f47f54df-0f13-4b8b-8e9e-66810416f76c"
      unitRef="usd">115000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTYtNS0xLTEtMA_c9f03e7e-2771-430a-8f02-f514c69f44e7"
      unitRef="usd">103000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:OperatingExpenses
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTgtMS0xLTEtMA_7082f71e-94be-4884-82ca-c832c5861b9b"
      unitRef="usd">6528000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTgtMy0xLTEtMA_ea0aa13f-611a-4a54-be50-8e2a93fd9b5d"
      unitRef="usd">6102000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTgtNS0xLTEtMA_1f79f5c3-1aa1-4f39-ad50-38fb34f4103e"
      unitRef="usd">5504000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTktMS0xLTEtMA_82cc1223-f344-4aa6-8add-dbecfb24b246"
      unitRef="usd">-80000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTktMy0xLTEtMA_a1fc9871-937f-4f6e-bcc1-dc2fa0b94557"
      unitRef="usd">1518000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMTktNS0xLTEtMA_c2a6d108-d500-488f-9dcb-f67017e57dfa"
      unitRef="usd">1506000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjItMS0xLTEtMA_59b0eb0b-e257-4bf8-ada9-3ad1241ce52a"
      unitRef="usd">361000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjItMy0xLTEtMA_4601563e-7e2e-4661-a97c-30f7ad65d1c8"
      unitRef="usd">473000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjItNS0xLTEtMA_33ce04e0-6a9a-465b-ab49-e9bfdf750f3b"
      unitRef="usd">241000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjMtMS0xLTEtMA_0749fedf-d759-41bb-9475-68c40f1ce1d0"
      unitRef="usd">362000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjMtMy0xLTEtMA_7cb625bd-4ff5-4615-9151-ad2363775f1b"
      unitRef="usd">-358000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjMtNS0xLTEtMA_ddb8b692-c75e-4b58-8908-f37a5c96ecd5"
      unitRef="usd">156000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjQtMS0xLTEtMA_f0203817-3d89-482a-a0b8-ae9e1bf64e57"
      unitRef="usd">-79000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjQtMy0xLTEtMA_7a3f6f2a-f55f-4101-b1b1-da3b72f21ac1"
      unitRef="usd">687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjQtNS0xLTEtMA_14be8704-fc3f-4600-a27a-bb1e569c19c7"
      unitRef="usd">1422000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjUtMS0xLTEtMA_37ebadfa-4c7a-4502-b5aa-82e7b6a0279f"
      unitRef="usd">2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjUtMy0xLTEtMA_c5829d58-538b-4d3e-a230-f3db9544c8da"
      unitRef="usd">-4013000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjUtNS0xLTEtMA_29222d7d-1faf-453f-b2b2-fef2c98fba6f"
      unitRef="usd">-249000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjYtMS0xLTEtMA_33de8a62-17a5-4851-bb44-b98c80b37eab"
      unitRef="usd">-82000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjYtMy0xLTEtMA_5f815bd1-4a16-43b6-9071-2e4ba8622a84"
      unitRef="usd">4700000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjYtNS0xLTEtMA_2016c394-041f-4b18-b429-df830ad7985d"
      unitRef="usd">1671000000</us-gaap:ProfitLoss>
    <us-gaap:DividendsPreferredStockStock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjctMS0xLTEtMTM0ODQ_38c0b270-ad29-4127-a7bf-cc6de8706fab"
      unitRef="usd">33000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjctMy0xLTEtMTM0OTQ_97df1b9a-700e-4c78-9187-f24a767f3dde"
      unitRef="usd">0</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjctNS0xLTEtMTM1MDc_c65a872e-a812-4e3f-9d82-a3d409aa7e43"
      unitRef="usd">0</us-gaap:DividendsPreferredStockStock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtMS0xLTEtMTM0ODk_ba1fcd05-3d81-43f4-bb40-1ea03777aeba"
      unitRef="usd">-115000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtMy0xLTEtMTU2_8ae41da3-c0af-4acf-a968-72275cc92800"
      unitRef="usd">4700000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtNS0xLTEtMTU5_454991ec-a3c9-4c7b-917a-0cbf32990389"
      unitRef="usd">1671000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtMS0xLTEtMA_c07227e5-be7a-47aa-b151-6a01de132553"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtMy0xLTEtMA_e288098f-df95-4913-bfdc-b04b1af4b8b6"
      unitRef="usdPerShare">3.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjgtNS0xLTEtMA_5efb2f57-d9dd-4125-9fef-d1900911704e"
      unitRef="usdPerShare">1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjktMS0xLTEtMA_b30953f9-66e9-4ed5-ba01-0fc29beec324"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjktMy0xLTEtMA_54edeec6-57f0-426d-bef8-64e330ad2f10"
      unitRef="usdPerShare">3.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMjktNS0xLTEtMA_90612444-f1f9-4d9e-abf0-4c77c06f5b2b"
      unitRef="usdPerShare">1.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzItMS0xLTEtMA_85e99615-b442-4fdb-a174-c7ef33d5a261"
      unitRef="shares">1416700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzItMy0xLTEtMA_4c873d9a-e8a6-44fd-8053-ff7e1c7dc5d8"
      unitRef="shares">1391500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzItNS0xLTEtMA_afe35cdc-7ae6-446d-8367-235bdffd2cf2"
      unitRef="shares">1381000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzMtMS0xLTEtMA_3f866433-bf0d-4b39-af84-f8e43061b3cb"
      unitRef="shares">1416700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzMtMy0xLTEtMA_ea9ab042-f3da-47c1-9983-addf27c8257e"
      unitRef="shares">1410600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183Ni9mcmFnOmU0MDgyMjJkOWVhMTRhZTM5NzljMjQ5MzE2NGNhYTRlL3RhYmxlOjJjMWRlZTUxYjhhZDRjYWJiYTU3ZGNkY2U3OWNjNWVkL3RhYmxlcmFuZ2U6MmMxZGVlNTFiOGFkNGNhYmJhNTdkY2RjZTc5Y2M1ZWRfMzMtNS0xLTEtMA_0336d56f-1e8b-4ecf-a08c-1eaa2ff958a5"
      unitRef="shares">1401400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMi0xLTEtMS0w_33de8a62-17a5-4851-bb44-b98c80b37eab"
      unitRef="usd">-82000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMi0zLTEtMS0w_5f815bd1-4a16-43b6-9071-2e4ba8622a84"
      unitRef="usd">4700000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMi01LTEtMS0w_2016c394-041f-4b18-b429-df830ad7985d"
      unitRef="usd">1671000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNS0xLTEtMS0w_73143eea-9189-4b5a-a676-f83c8785d484"
      unitRef="usd">76000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNS0zLTEtMS0w_6f572db0-a7fc-4932-abed-d3857266a752"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNS01LTEtMS0w_d334adb4-dafc-49ed-a3ad-0500206a2617"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNi0xLTEtMS0w_37f825fe-1c9c-471d-b3dd-71472546ea24"
      unitRef="usd">-137000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNi0zLTEtMS0w_1cc44725-1ed0-4352-81d0-54aa0521f517"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfNi01LTEtMS0w_b64221f5-7c2d-4d8c-b490-9258350faa9d"
      unitRef="usd">110000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOC0xLTEtMS0w_5ca32564-295f-40d6-b2c3-1d8a57558a5b"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOC0zLTEtMS0w_fe429fae-ff8e-4520-ae85-54f55793d428"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOC01LTEtMS0w_02f29ad1-7399-49fe-be2d-2898aa35623a"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOS0xLTEtMS0w_70c23445-5e9d-465f-91a4-51c7362f5a8a"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOS0zLTEtMS0w_be13617d-769a-4030-adc3-5aa1c565449b"
      unitRef="usd">237000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfOS01LTEtMS0w_4549ca5e-b943-49cd-8eb1-36acaa58f4e2"
      unitRef="usd">91000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMTAtMS0xLTEtMA_5c032791-4860-4ee8-8931-7b3244ef8f67"
      unitRef="usd">-145000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMTAtMy0xLTEtMA_fc78832b-eb82-4fe2-8cc5-742e77b5c485"
      unitRef="usd">4937000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N183OS9mcmFnOjAxYjdlNWQ0YWJlOTRjZTE4YWU1OTJjM2Y4NzRkNmZmL3RhYmxlOjY3NTFkM2MxZjJlZjQxYTRiYmU4MGU1MmNhZjNmOTc3L3RhYmxlcmFuZ2U6Njc1MWQzYzFmMmVmNDFhNGJiZTgwZTUyY2FmM2Y5NzdfMTAtNS0xLTEtMA_14c8f9c4-c295-417e-b7e2-d01b24b85102"
      unitRef="usd">1761000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNC0xLTEtMS0w_40cabaa5-3d82-41d5-a50f-2aacc0162656"
      unitRef="usd">1734000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNC0zLTEtMS0w_93ff828b-42c4-4665-8b7d-e784a91c66dd"
      unitRef="usd">217000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNS0xLTEtMS0w_3a5dc780-3a00-44c0-9ad2-b71b1ce2c214"
      unitRef="usd">1531000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNS0zLTEtMS0w_f9182a2d-8556-4414-92ab-8903c0fb1745"
      unitRef="usd">1828000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNi0xLTEtMS0w_c958436e-ab32-4386-918a-3bf73533ab98"
      unitRef="usd">1351000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNi0zLTEtMS0w_8bc94cdd-0f88-4c1e-b1f6-c68a0d7d4bf3"
      unitRef="usd">1579000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNy0xLTEtMS0w_745e1510-09d5-4069-b950-af9bb5f4bf84"
      unitRef="usd">194000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNy0zLTEtMS0w_053c3460-c180-44ce-98b5-71fd51ea1deb"
      unitRef="usd">195000000</us-gaap:PrepaidTaxes>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOC0xLTEtMS0xMzUxNg_2d94f1f3-e605-416d-8edb-69f623462c6e"
      unitRef="usd">1133000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOC0zLTEtMS0xMzUxNg_f23e3dc7-3601-4cbc-99a7-7e9a9aa7abec"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOC0xLTEtMS0w_a588ddcf-dd90-472b-a054-560d369ed9f6"
      unitRef="usd">751000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOC0zLTEtMS0w_7c51e4b4-c870-485b-82af-4018e9f3e19b"
      unitRef="usd">880000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOS0xLTEtMS0w_93374b0d-3445-44a1-a0b6-8d677695a1d7"
      unitRef="usd">6694000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfOS0zLTEtMS0w_f36a58bd-80b0-4e39-8308-13db4ee31844"
      unitRef="usd">4699000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTAtMS0xLTEtMA_c4e5f18f-e27b-4b69-bb29-49ba668ab464"
      unitRef="usd">2084000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTAtMy0xLTEtMA_abf1a96d-bf97-4e03-aad1-e6bc13b03748"
      unitRef="usd">2079000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTEtMS0xLTEtMA_f82bd445-2c9f-425e-be29-bbb5c5e1b01b"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTEtMy0xLTEtMA_b817d6b3-a149-4a2e-b402-808e19d12406"
      unitRef="usd">10176000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTItMS0xLTEtMA_da5540d4-f986-4814-a832-85e5ff9a1ace"
      unitRef="usd">5917000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTItMy0xLTEtMA_36e9fd94-a267-4ed6-82c1-75eb4768f031"
      unitRef="usd">7886000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTMtMS0xLTEtMA_215d374b-db66-4ca8-80b5-0ccb8a68eb36"
      unitRef="usd">4210000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTMtMy0xLTEtMA_dcc3d53a-eee2-430f-a32f-f7c4edfffd84"
      unitRef="usd">4196000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTQtMS0xLTEtMA_274f691e-e507-4716-a53c-7e5ca2de7290"
      unitRef="usd">1921000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTQtMy0xLTEtMA_822a21a4-e23b-4d8c-b592-4a9fa3505d42"
      unitRef="usd">1529000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTUtMS0xLTEtMA_cb9ca439-aab0-4ff6-9e31-cfc4949716af"
      unitRef="usd">30777000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTUtMy0xLTEtMA_fb1d1caa-65ce-41f7-8b4a-07dbecf1b515"
      unitRef="usd">30565000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTktMS0xLTEtMA_c60cc048-6879-4379-bc41-8fffe3e8a332"
      unitRef="usd">13000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMTktMy0xLTEtMA_77bbd495-a6c9-4759-90e4-7bd391c51ffc"
      unitRef="usd">1416000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjAtMS0xLTEtMA_3508b802-59c2-42ba-ae3c-f2126b3066fd"
      unitRef="usd">513000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjAtMy0xLTEtMA_e9b67b04-9946-48c2-bc99-42b7baf35e96"
      unitRef="usd">542000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjEtMS0xLTEtMA_61749cc2-a84a-4a6a-968d-df7b5d3a62e8"
      unitRef="usd">2197000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjEtMy0xLTEtMA_1bda3810-e56c-47cd-b385-3560a5d701f0"
      unitRef="usd">2109000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjItMS0xLTEtMA_546d9322-09e5-437a-a2d3-70fa6b44ab8a"
      unitRef="usd">958000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjItMy0xLTEtMA_85068faf-0497-4917-9b7b-fece12b16b76"
      unitRef="usd">800000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjMtMS0xLTEtMA_121e9d33-9b7a-4449-8d77-20c03970a4b9"
      unitRef="usd">3681000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjMtMy0xLTEtMA_4a3e63d5-e3a9-4639-8ad2-303c6d34351d"
      unitRef="usd">4866000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjQtMS0xLTEtMA_3a5f06c8-6643-471b-a415-e43f2a9651bf"
      unitRef="usd">9130000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjQtMy0xLTEtMA_23a8b886-a73d-4d44-98e0-db441c069f73"
      unitRef="usd">8592000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjUtMS0xLTEtMA_8bbfa60a-d2fe-45cf-b583-df0604ec6548"
      unitRef="usd">330000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjUtMy0xLTEtMA_c82c00c1-3b9d-445f-bb2a-4b41572b7dbb"
      unitRef="usd">595000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjYtMS0xLTEtMA_ea96f366-10ff-49b1-a9e1-87592b1e67f9"
      unitRef="usd">2309000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjYtMy0xLTEtMA_3a94fefb-e677-4e57-bf80-da2ebeccc303"
      unitRef="usd">2635000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjgtMS0xLTEtMA_64531727-972a-4f23-8715-651069a732a9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMjgtMy0xLTEtMA_8767e9db-342b-4f57-b989-b07e5c516ee1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk1OTc_67478fb7-7a94-47b9-9cce-ee16e1f29933"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk1OTc_826db844-4c43-4fcd-b039-6575add45a2f"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk2MTA_b3dfaf66-ca6d-4015-8d6c-30546785de48"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk2MTA_e22029f4-b7d8-4753-933b-02ae71324c17"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmY4ODAwODEyNWIzYzQyYjVhYTg2M2Y4NGU0Y2VmNzYxXzI3NDg3NzkwNjk2MjM_e85bb555-16bd-40c3-a366-2799e05aadfd"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMS0xLTEtMA_ee8be5e5-3db1-4c03-966b-84a0c56f1d1f"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzEtMy0xLTEtMA_c8b7f82c-5ed0-4da2-8b69-4a4b1a70eb78"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MDI_1cbba0b1-133f-4728-a93d-3e7a8081d582"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MDI_fca2681e-8ff6-4439-a1a1-027a12bbd243"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MTg_6a4241f8-7a39-4a52-8aba-8af761b82d59"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MTg_80d3ac50-c4d3-4229-a843-ecbf4e4e9932"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2MjI_4bfdc087-329b-43ba-ba42-9ac3db6be188"
      unitRef="shares">1679911918</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmJjZGViOTRiZWM0ZjQyZWM5NDczYjc1YWExNTc2OWJhXzI3NDg3NzkwNjk2Mzg_52dc6f28-d466-4844-a1c3-61d80cc0134a"
      unitRef="shares">1642488911</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMS0xLTEtMA_e774e0e2-2b04-45c1-8109-05e9cc19f031"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzItMy0xLTEtMA_fb36a408-d7e3-4a69-a89e-329feec4b45b"
      unitRef="usd">16000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjVjYmY5MzYwZjVkOTRiZGY5ZTYxMDBlMTFiMzlhMjgwXzI3NDg3NzkwNjk1NjQ_036cc46e-bbe6-4b78-b1ff-fc9027602a98"
      unitRef="shares">263289848</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjVjYmY5MzYwZjVkOTRiZGY5ZTYxMDBlMTFiMzlhMjgwXzI3NDg3NzkwNjk1NjA_645b9ea2-6776-47a2-8ddc-c83f6b523131"
      unitRef="shares">247566270</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzMtMS0xLTEtMA_0893a379-9740-4114-b4f2-2e3d87238b8c"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzMtMy0xLTEtMA_c68c8595-f106-4fcc-8aef-7d996448e8a8"
      unitRef="usd">1717000000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzQtMS0xLTEtMA_fc61f2c2-e2d3-47bc-8920-34d02d7f0066"
      unitRef="usd">19732000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzQtMy0xLTEtMA_aa9f65a2-f7a9-4623-8af1-d8fcc438b07f"
      unitRef="usd">17561000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzUtMS0xLTEtMA_cc4386ca-7921-4ab8-b29b-32b251111238"
      unitRef="usd">-2378000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzUtMy0xLTEtMA_68ddd045-b7ea-4bd7-9c96-b48c240db383"
      unitRef="usd">-2253000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzctMS0xLTEtMA_e4f3efd7-61a2-42f4-8faa-2752540b51c0"
      unitRef="usd">218000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzctMy0xLTEtMA_2d66d092-58ab-4936-92f1-8a4f9a5987bf"
      unitRef="usd">142000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzgtMS0xLTEtMA_d8cedf9b-3fde-4889-b8d0-c5265e53c048"
      unitRef="usd">36000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfMzgtMy0xLTEtMA_07d81233-9118-4410-8fb2-fdbb285f7537"
      unitRef="usd">173000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDAtMS0xLTEtMA_85698734-21f8-4157-96f9-5cb9d3fa8eb7"
      unitRef="usd">47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDAtMy0xLTEtMA_9e41eecb-9b45-4253-8de9-120c2bc86a01"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDEtMS0xLTEtMA_4935541b-1327-4d18-8372-9fe66fbe93ae"
      unitRef="usd">15326000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDEtMy0xLTEtMA_f0e5e54f-9849-41e3-8361-44d4365cd6f9"
      unitRef="usd">13877000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDItMS0xLTEtMA_e6cb6b61-a148-49d4-b9f8-adeddc34c4fb"
      unitRef="usd">30777000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184Mi9mcmFnOmEyN2ZiOTRiNTYxZDRhNzZhM2Q5NzFjMGQyY2I5MjA0L3RhYmxlOjc0M2NiM2NmYTI4YTRlOTE5MzRjM2YyMjBlMmE0MzhiL3RhYmxlcmFuZ2U6NzQzY2IzY2ZhMjhhNGU5MTkzNGMzZjIyMGUyYTQzOGJfNDItMy0xLTEtMA_82d27da8-a171-404a-803f-d29ff2505bb2"
      unitRef="usd">30565000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="iec2a00e6f06c444a9952e4b94b0d4e6e_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMS0xLTEtMTM1Njk_5811d3f0-8278-4139-93d5-ef948b179465"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec2a00e6f06c444a9952e4b94b0d4e6e_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMy0xLTEtMTM1Njk_20e546a4-e095-4edd-b1c0-2e159ef6074f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i416c4bf3762343af99956df0491cda23_I20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMS0xLTEtMA_395d71a2-b03e-4afa-bfee-9f54ac1d3808"
      unitRef="shares">1621062898</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i416c4bf3762343af99956df0491cda23_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMy0xLTEtMA_3b353616-4433-4842-9bbf-e18fd389ce66"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic86a24afa1544f379e9453f8559daca7_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItNS0xLTEtMA_4e82a2e9-f787-4ba3-8d81-cb6c8c949e7b"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75a0e4d8d1464b8e96a0b3b99c3831e6_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItNy0xLTEtMA_886db32c-71d4-44ad-83bb-08f45fc068a6"
      unitRef="usd">17161000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6edad1230384f4ea726dde74e58b266_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMTAtMS0xLTA_a1f92e72-04bb-435f-9caa-65b1d67e9727"
      unitRef="usd">-8390000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i97947ef16fd64573b576ede19f2d29ea_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTItMTItMS0xLTA_72e1fdb0-09c7-4251-aaeb-5803a97597c2"
      unitRef="usd">-59000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i486c2b6f6b1147f0b09d948b6ad1b5ce_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTMtMTAtMS0xLTA_f906c068-0dc6-4221-82f5-2638d1772fbf"
      unitRef="usd">1671000000</us-gaap:ProfitLoss>
    <bsx:CumulativeEffectOfNewAccountingPrinciples
      contextRef="i486c2b6f6b1147f0b09d948b6ad1b5ce_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTQtMTAtMS0xLTA_45f386cd-a247-431b-b5e6-7d8b56d7c66b"
      unitRef="usd">-233000000</bsx:CumulativeEffectOfNewAccountingPrinciples>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibf28bd85296f42f49e4da5f20d423b67_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTYtMTItMS0xLTA_2d2b13ab-3ee1-4a71-951f-49a883d2fd43"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibf28bd85296f42f49e4da5f20d423b67_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTctMTItMS0xLTA_b3ce1cc1-1c4b-4619-a8ed-69b5cf2fdbd1"
      unitRef="usd">110000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ibf28bd85296f42f49e4da5f20d423b67_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTgtMTItMS0xLTA_7df2602c-2901-4a88-8599-fdf85cb0d76a"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i82aeda8856fa47ed8b39207375fa1aa8_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTktMS0xLTEtMA_87e6be78-608a-41db-9bf5-d062daccaf27"
      unitRef="shares">11085132</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i1d1f315a766c43b1aa5940ff8e160594_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMTktNy0xLTEtMA_79a3c01f-d4ed-45c8-8c4f-fffbacfd26a4"
      unitRef="usd">185000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="iae1d8357f67849468d20db2d30de5e55_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMS0xLTEtMTM1NjU_c55d2755-4d71-4493-a001-35297df1f916"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae1d8357f67849468d20db2d30de5e55_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMy0xLTEtMTM1NjU_b6331b13-73f1-4ac2-95ad-c5616b46d806"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i6bbe2d5f3afb49b99ec4c9803ecee919_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMS0xLTEtMA_75cb40c3-3369-4a5c-bbad-bc8ce2760ded"
      unitRef="shares">1632148030</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bbe2d5f3afb49b99ec4c9803ecee919_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMy0xLTEtMA_c44a227c-9dec-4770-8cdd-c6147d13e86f"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i815f4d787d1e4a26a2e65fce1b26129c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtNS0xLTEtMA_21a18fbc-c911-46fc-a22f-3cea518b2d43"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i978ec64dad704d138144a11d4f20a868_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtNy0xLTEtMA_b8a2fb24-e177-4893-8095-f3b16e4ada95"
      unitRef="usd">17346000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7354567f0bca438fa78f4baeeceed35c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMTAtMS0xLTA_82f3d669-91bd-4daa-9008-31a60d71a027"
      unitRef="usd">-6953000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie5f0b56fe933409badece00bf9ab8f17_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjEtMTItMS0xLTA_babde80a-4fcd-42d4-a350-7dc7d41be405"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id118699e701242f1879566050e0064d6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjItMTAtMS0xLTA_dba6e02c-46ee-46f2-9ea1-97391e15f53b"
      unitRef="usd">4700000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie7af855385df42d583c24a02df379ca7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjUtMTItMS0xLTA_3b6dd0d2-6d6a-4dd8-b463-42ef259b4a67"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ie7af855385df42d583c24a02df379ca7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjYtMTItMS0xLTA_f7ca8132-a8e3-415e-aa11-f072ad651c7f"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ie7af855385df42d583c24a02df379ca7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjgtMTItMS0xLTA_cab6d046-fcb3-4cad-a064-209cf5e8f410"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i66c17b892a204bb2b1c1aa8cd1051251_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjktMS0xLTEtMA_d23de662-a31f-441b-bf18-e3f2fe0d22f6"
      unitRef="shares">10340881</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ia9eec6cd5c3d47bd8cc9fa8a26bae2d0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMjktNy0xLTEtMA_f2ab33c3-57b4-4542-9d3d-239f965ed8d4"
      unitRef="usd">215000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="idf8a046f49ba4e7bbeb5595372a466f6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMS0xLTEtMTM1NjA_d959a7c9-9034-494b-aad7-7837c8cdf995"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf8a046f49ba4e7bbeb5595372a466f6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMy0xLTEtMTM1NjA_5821b9ef-bc84-4ad8-a9c7-9ebf6a0f4aab"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ic48f447708b74f77a26a4f0286cc2a15_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMS0xLTEtMA_17730aff-0d3f-4c3d-b728-1da437d01d49"
      unitRef="shares">1642488911</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic48f447708b74f77a26a4f0286cc2a15_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMy0xLTEtMA_24764a7d-add2-4485-930f-2992be300b72"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b040eb90cef4343a857fe2e7740195e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtNS0xLTEtMA_9ec96f94-c829-4924-9d38-f0b6f4140fc7"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib22777e33f4f476c95138787b75b0db3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtNy0xLTEtMA_0215db04-d6e9-4be2-9cb0-6e1d7ca0eb7c"
      unitRef="usd">17561000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i369a19338d4645fcaff218f3e0180a0a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMTAtMS0xLTA_18bf620e-6164-4edd-8e29-a293d9294583"
      unitRef="usd">-2253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28940fe126704087ba8a61832f5de550_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzAtMTItMS0xLTA_7021b035-4479-4488-aef0-1dad2f1a15c0"
      unitRef="usd">270000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i3e988814a30145f686582891ff75a88e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzEtMTAtMS0xLTcyNzc_63f64f4d-1784-4ce8-9d37-edde5ecc2733"
      unitRef="usd">-82000000</us-gaap:ProfitLoss>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="i3e988814a30145f686582891ff75a88e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzItMTQtMS0xLTE4MjM4_b4f4482e-10d7-40eb-800d-aea059470af8"
      unitRef="usd">-10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4f4c7888c677425da7039956930978ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzMtMTItMS0xLTcyODM_ffa2829e-5ca3-4568-892b-9c5491ff1856"
      unitRef="usd">76000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4f4c7888c677425da7039956930978ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzQtMTItMS0xLTcyODk_daf463ab-30f8-4d29-9588-2b594c18c2be"
      unitRef="usd">-137000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i4f4c7888c677425da7039956930978ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzUtMTItMS0xLTcyOTM_4d6fafb6-3c25-41cf-bc75-f86689110bda"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i069e7ea9c6764fb5ab7629ac3e1b1f7d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzYtMS0xLTEtNzQ1Mg_10ef139c-cf0d-4050-b59b-cb65a6502c17"
      unitRef="shares">10062500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i069e7ea9c6764fb5ab7629ac3e1b1f7d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzYtMy0xLTEtNzQ1Nw_f19f0a45-e21b-462e-8cfb-cbb3c69ba036"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock
      contextRef="i8fb62c7fcc6748a29d33c15fc1a6e4ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzYtMTEtMS0xLTc0NzQ_ac2758aa-a326-492b-9d0f-22bc27c9fe45"
      unitRef="usd">975000000</bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i214a62bd8ef9406db278c8d1a09ffa31_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzctNS0xLTEtNzQ2Mw_5f727683-a640-467f-9810-29cdef484f3e"
      unitRef="shares">29382500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i214a62bd8ef9406db278c8d1a09ffa31_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzctNy0xLTEtNzQ2OA_a5500b02-ff4f-4c19-af9d-2557d880607f"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock
      contextRef="i8fb62c7fcc6748a29d33c15fc1a6e4ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzctMTEtMS0xLTc0NzQ_b3f6fdad-716d-42d0-be2c-416c315e24ac"
      unitRef="usd">975000000</bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i3e988814a30145f686582891ff75a88e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzktMTQtMS0xLTE4MjU3_9fb68e7c-09d0-4b7a-aa3c-e229e25fc5cc"
      unitRef="usd">-33000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ibf7408d8c0ac4baa9b95744bb4a1416f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtOS0xLTEtMTgyODY_c6c917e6-5f70-40ef-ab36-d1dab4eadd30"
      unitRef="usd">-535000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i214a62bd8ef9406db278c8d1a09ffa31_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzktNS0xLTEtNzM2Ng_d34f67de-c567-4a5d-b6cd-fd122a9916a3"
      unitRef="shares">8040507</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i8fb62c7fcc6748a29d33c15fc1a6e4ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfMzktMTEtMS0xLTczNjk_536801ba-cc6b-4777-9f2f-2381d292790e"
      unitRef="usd">221000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="ibf999a62069f494daaa8b34dd39eb888_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMS0xLTEtNzM2Mg_5a6268ca-9781-4be0-8aad-ce0fd878aa44"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf999a62069f494daaa8b34dd39eb888_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMy0xLTEtNzQ0OA_371c6bfb-1d43-460d-bc99-d0ef47062554"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i89e7c6f8f9b84193a176a221054afca4_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtNS0xLTEtNzM4Mg_bc13dc3c-6e8b-4da0-9c65-b535d4e9d25f"
      unitRef="shares">1679911918</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89e7c6f8f9b84193a176a221054afca4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtNy0xLTEtNzM4OA_154e567f-71b9-4b61-8304-4d95d4441798"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c25b897fb8e4965a95e19981c5c8a85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtOS0xLTEtNzM5NA_6f50e17d-21b1-4866-baf6-57780c1e38b4"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i30f6d299f51d4710906bfb8afd9fa959_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMTEtMS0xLTc0MDI_e9baea6c-f26c-4ef6-b08d-ed27a7fa1f7e"
      unitRef="usd">19732000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2189acf6800a485eac08cc940a299be8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMTQtMS0xLTc0MDY_1be07fc6-0d8a-4b47-bad1-63d8a20e9937"
      unitRef="usd">-2378000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd122064a7e945ed9ca826ffcb42ab6f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N184OC9mcmFnOjE5ODdmODYxN2M1YjQ0ODA5MWMzZmZkNGRjZDIyNmJjL3RhYmxlOjZhZTk0YWVkMTQ0MjQzMDg5Y2I4YmUwNmYyYzA0OGI5L3RhYmxlcmFuZ2U6NmFlOTRhZWQxNDQyNDMwODljYjhiZTA2ZjJjMDQ4YjlfNDAtMTYtMS0xLTc0MTA_3eab0e10-56a1-462a-8d6f-4d88ee6cfd14"
      unitRef="usd">207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMy0xLTEtMS0w_0f127d33-94d4-4c1f-99f7-6c51d174ea95"
      unitRef="usd">-82000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMy0zLTEtMS0w_71d6d480-7046-4a61-9560-442a2214c1f9"
      unitRef="usd">4700000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMy01LTEtMS0w_dad1af46-bcdb-4d9d-a755-6645c580d282"
      unitRef="usd">1671000000</us-gaap:ProfitLoss>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNS0xLTEtMS0w_4355a7b8-0c93-4e1d-b33d-8c4db89dd1d8"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNS0zLTEtMS0w_53c609af-a31b-45a8-a07b-d4642dbd1f50"
      unitRef="usd">8000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNS01LTEtMS0w_f6e318ff-c662-440d-ac51-28eef35a3a31"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNy0xLTEtMS0w_aaf13309-74e9-4e3d-acca-707ca93956ad"
      unitRef="usd">1123000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNy0zLTEtMS0w_ad59eae7-a610-40d7-80be-8c34ed59d656"
      unitRef="usd">1011000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNy01LTEtMS0w_4daf10d2-08ba-453d-a0d8-22ce78dade46"
      unitRef="usd">894000000</us-gaap:DepreciationDepletionAndAmortization>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOC0xLTEtMS0w_127ffd73-4155-4269-b0b5-518f63ccbfaa"
      unitRef="usd">-82000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOC0zLTEtMS0w_e262d354-e63a-4ea0-867b-91bc2438f819"
      unitRef="usd">-4301000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOC01LTEtMS0w_cd8ea081-f59d-47a8-aa31-d40ae7021855"
      unitRef="usd">-87000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOS0xLTEtMS0w_1a6dce89-ac9f-436c-8682-b4265031ac25"
      unitRef="usd">170000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOS0zLTEtMS0w_fbfe8e48-9b2d-49a2-8f56-e949798402c8"
      unitRef="usd">157000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfOS01LTEtMS0w_9bc7f6c7-68ac-4787-8bce-3d729e0f7e9b"
      unitRef="usd">140000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTEtMS0xLTEtMA_c341d889-94f7-4d05-87e7-35425a662ee4"
      unitRef="usd">533000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTEtMy0xLTEtMA_db140bf7-c911-423a-89fa-ceb7a9c5a3a4"
      unitRef="usd">105000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTEtNS0xLTEtMA_debbe669-8e9e-463a-92d5-2a14545453c2"
      unitRef="usd">35000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:GainLossOnInvestments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTItMS0xLTEtMA_7175f700-f2f6-4dd4-84ef-1f721d5fbf7e"
      unitRef="usd">398000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTItMy0xLTEtMA_e3d3298b-4155-4d54-9c77-f46596bfbfb5"
      unitRef="usd">-30000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTItNS0xLTEtMA_15148215-42c8-44b7-9ee7-581d3f2d8190"
      unitRef="usd">155000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTMtMS0xLTEtMA_d6d0a5a3-eb93-4ad9-898a-6f88f73b5158"
      unitRef="usd">-100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTMtMy0xLTEtMA_34e874c6-bd71-40a0-a19f-1a45180a0f84"
      unitRef="usd">-35000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTMtNS0xLTEtMA_14dc7f22-6777-4e75-81b4-a649b59bb5b6"
      unitRef="usd">-21000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:InventoryStepUpAmortization
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTYtMS0xLTEtMA_e64674ad-0c80-49ef-a385-a925fcf4c320"
      unitRef="usd">58000000</bsx:InventoryStepUpAmortization>
    <bsx:InventoryStepUpAmortization
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTYtMy0xLTEtMA_b6a899ff-e6ea-49cd-879d-316372d677e0"
      unitRef="usd">46000000</bsx:InventoryStepUpAmortization>
    <bsx:InventoryStepUpAmortization
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTYtNS0xLTEtMA_90ed8c5a-9cb1-4af6-b379-502dd0562f9b"
      unitRef="usd">6000000</bsx:InventoryStepUpAmortization>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTctMS0xLTEtMA_c1856edd-228d-4ae3-902e-75eeee2919ce"
      unitRef="usd">-32000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTctMy0xLTEtMA_e8e62a90-3060-402b-9d42-2f9cc70ae5ee"
      unitRef="usd">-358000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTctNS0xLTEtMA_d5c788e1-eb8d-490d-bd7e-c58b73577100"
      unitRef="usd">11000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:OtherNet
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTgtMS0xLTEtMA_dfbf7d23-c6f0-4d51-80cc-794ada5b8f81"
      unitRef="usd">213000000</bsx:OtherNet>
    <bsx:OtherNet
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTgtMy0xLTEtMA_5d295a28-8c2e-464b-aac3-97d3f6cf1f07"
      unitRef="usd">63000000</bsx:OtherNet>
    <bsx:OtherNet
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMTgtNS0xLTEtMA_a5241113-1dc6-46da-8a8c-089dc1e6b55a"
      unitRef="usd">8000000</bsx:OtherNet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjAtMS0xLTEtMA_557256c6-df65-4ce5-9f54-6b57224421b0"
      unitRef="usd">-335000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjAtMy0xLTEtMA_19a2a9f3-b2aa-401c-85e8-1f22e248e10a"
      unitRef="usd">130000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjAtNS0xLTEtMA_88956284-b4c3-4a17-a6fa-aa72ca054897"
      unitRef="usd">110000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjEtMS0xLTEtMA_2f50f81e-f1d2-4535-bb20-8502e877cc66"
      unitRef="usd">65000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjEtMy0xLTEtMA_eaa619a7-3d69-4d63-83e4-b8875f2414c8"
      unitRef="usd">290000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjEtNS0xLTEtMA_a3bb49dd-530c-405c-8baa-a4ba651c9e93"
      unitRef="usd">83000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjItMS0xLTEtMA_6ebc1f90-7684-4028-bff5-85f6a342aaac"
      unitRef="usd">200000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjItMy0xLTEtMA_76c2673e-c9c4-4182-803f-4a1d470d6f04"
      unitRef="usd">-45000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjItNS0xLTEtMA_9049894f-84e8-4e62-aa56-e1ccffe6c1df"
      unitRef="usd">172000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjMtMS0xLTEtMA_c2e4453e-0696-473e-a2eb-284054ed9517"
      unitRef="usd">88000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjMtMy0xLTEtMA_7e6b4b0a-c8f9-41e2-bf26-deff83b47e0e"
      unitRef="usd">105000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjMtNS0xLTEtMA_fa3f0d7b-9f65-42c0-bd41-2c88db60bcca"
      unitRef="usd">-640000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjQtMS0xLTEtMA_13443da1-8e2e-41d6-85fb-d7ccd7b2d880"
      unitRef="usd">-116000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjQtMy0xLTEtMA_f289cf5a-c1af-430f-9709-bf0c6850ac60"
      unitRef="usd">-18000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjQtNS0xLTEtMA_ddf08f2e-14ba-4302-a88d-9350cd2bfecc"
      unitRef="usd">-1164000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjUtMS0xLTEtMA_a863415a-7ae6-4db6-8327-a6252efc6c30"
      unitRef="usd">1508000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjUtMy0xLTEtMA_731f2221-6be9-4561-866d-de4737e0a482"
      unitRef="usd">1836000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjUtNS0xLTEtMA_7f0edbef-3786-4e10-8d99-89a91eca5b88"
      unitRef="usd">310000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjctMS0xLTEtMA_cef2a711-ccf9-430f-83e9-bd850f487072"
      unitRef="usd">376000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjctMy0xLTEtMA_ca3ecc3c-f000-486f-9d4b-58cb6bbdf08a"
      unitRef="usd">461000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjctNS0xLTEtMA_56f5bfa4-2aca-4fec-9105-6cbf39b5fcd2"
      unitRef="usd">316000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjgtMS0xLTEtMA_dc14f986-c0aa-48bf-8732-ffd852ae8edf"
      unitRef="usd">12000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjgtMy0xLTEtMA_2554b6a5-8797-44b0-8709-95cc46ff7846"
      unitRef="usd">7000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjgtNS0xLTEtMA_f60dcabe-629f-45e4-a4fc-5ce2fc71e2cc"
      unitRef="usd">14000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjktMS0xLTEtMA_81a3d64c-09ba-4297-af67-c20b03f59005"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjktMy0xLTEtMA_b787a543-9278-4ecd-ac74-eec816278dfc"
      unitRef="usd">4382000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMjktNS0xLTEtMA_da6edf89-9170-4ced-b3a6-263bcc38759a"
      unitRef="usd">1448000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzAtMS0xLTEtMA_a2de0226-2d1d-4cda-a23d-822d0f86476c"
      unitRef="usd">15000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzAtMy0xLTEtMA_9b999b63-3ba5-47ee-b52b-f8c1eda3a176"
      unitRef="usd">90000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzAtNS0xLTEtMA_3e9b4331-344e-4b13-af70-40d4c732c624"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzEtMS0xLTEtMA_07f94993-f3eb-408a-a5ae-42a68ef1c4c6"
      unitRef="usd">-87000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzEtMy0xLTEtMA_9d084eae-6147-4cf9-99a3-548e5de6773f"
      unitRef="usd">-52000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzEtNS0xLTEtMA_107b9531-0837-4541-a4a2-25cf7cc947e2"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzItMS0xLTEtMA_ade4357a-ed55-442d-ba9a-136b8b18e180"
      unitRef="usd">0</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzItMy0xLTEtMA_f6173221-2998-423f-821c-024a33dcbc1e"
      unitRef="usd">199000000</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzItNS0xLTEtMA_10cb51ad-4be4-43b8-9b38-b701a0a939ab"
      unitRef="usd">0</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzMtMS0xLTEtMA_5c934295-f8f5-4100-a11c-c3b08f7fa798"
      unitRef="usd">146000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzMtMy0xLTEtMA_ac72c640-ef07-48d7-8a43-8977933167b1"
      unitRef="usd">149000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzMtNS0xLTEtMA_be0f1c56-ec2f-429b-b496-6395c5c3b5b0"
      unitRef="usd">172000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzUtMS0xLTEtMA_e4180483-7f6c-4667-a656-6c08949405b1"
      unitRef="usd">-411000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzUtMy0xLTEtMA_65124af0-fd76-409a-8491-196df1287e9b"
      unitRef="usd">-5041000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzUtNS0xLTEtMA_fcd5580a-f783-402a-a357-ec31a75c2f22"
      unitRef="usd">-1921000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctMS0xLTEtMA_014d7ed8-5eda-4282-abf5-ca814268ecba"
      unitRef="usd">49000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctMy0xLTEtMA_a1acc0e9-ccd8-40de-a8b8-1fa9638499ff"
      unitRef="usd">66000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctNS0xLTEtMA_ac2984c5-32f0-42f4-8a5b-4a3a546d8df2"
      unitRef="usd">19000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <bsx:PaymentsForRoyaltyRights
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctMS0xLTEtMjI5MDM_4e30ee71-df1b-4fda-acab-383b07ffa92b"
      unitRef="usd">97000000</bsx:PaymentsForRoyaltyRights>
    <bsx:PaymentsForRoyaltyRights
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctMy0xLTEtMjI5MDc_9a52040e-fa9b-4fda-afbb-659ffaa9fd59"
      unitRef="usd">69000000</bsx:PaymentsForRoyaltyRights>
    <bsx:PaymentsForRoyaltyRights
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzctNS0xLTEtMjI5MTE_d2a2cd99-326d-4b1e-a9cf-b068484062fd"
      unitRef="usd">0</bsx:PaymentsForRoyaltyRights>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzgtMS0xLTEtMA_03808543-ef7c-4256-b6d2-57c70bcd92d7"
      unitRef="usd">0</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzgtMy0xLTEtMA_79496b1c-0c93-451f-83b8-bc8f0e8dd6f1"
      unitRef="usd">256000000</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzgtNS0xLTEtMA_a510f324-dfa5-44bf-9b69-aa78dfe63438"
      unitRef="usd">0</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktMS0xLTEtMTM2MDY_32c07ea0-c6b5-44b6-8b9d-c608bbd4bfc0"
      unitRef="usd">2950000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktMy0xLTEtMTM2MDY_0063d402-2d4d-4d2d-9211-55e407119aaf"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktNS0xLTEtMTM2MDY_bd3c701b-fd6c-481b-bce8-053fd38724f4"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktMS0xLTEtMA_fab174f3-b559-40b4-bda5-fbbfad33c2e3"
      unitRef="usd">2245000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktMy0xLTEtMA_d3af5edc-70c6-4b1c-8e37-09a658a2639f"
      unitRef="usd">700000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfMzktNS0xLTEtMA_f3e03eb8-6ad6-47af-81e7-ef494c99fe24"
      unitRef="usd">999000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDAtMS0xLTEtMA_57820039-97a1-484a-85bf-2c5590f6d3af"
      unitRef="usd">-714000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDAtMy0xLTEtMA_ec10bc83-4ce8-4a7c-8167-8b3cbe48a820"
      unitRef="usd">-575000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDAtNS0xLTEtMA_32714261-4a15-4ccd-9ca1-1d7a49b341b8"
      unitRef="usd">21000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDItMS0xLTEtMA_d0ea5de3-1845-45b5-8025-9b265358bc89"
      unitRef="usd">1919000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDItMy0xLTEtMA_2517fa63-be69-4db6-8cab-d9e63ce7c39d"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDItNS0xLTEtMA_5d578378-78b1-46cd-8165-e5f72d78a247"
      unitRef="usd">569000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDMtMS0xLTEtMA_85f14dbd-5a27-48fb-9a30-1d203234ec0a"
      unitRef="usd">1916000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDMtMy0xLTEtMA_3c1888ba-ba1c-4e99-993e-5dfc6b42755a"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDMtNS0xLTEtMA_8b41e535-4db1-4588-99fa-d21b88f15caa"
      unitRef="usd">569000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDQtMS0xLTEtMA_557b7c7c-d74f-4bb3-ae3b-af9f8cbd2c45"
      unitRef="usd">1260000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDQtMy0xLTEtMA_45b0adc8-6a25-4d59-887f-54846f36c2c2"
      unitRef="usd">3560000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDQtNS0xLTEtMA_4c800c02-da33-4ca0-bcd2-1504a0c89b88"
      unitRef="usd">602000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDUtMS0xLTEtMA_867e225f-8410-4e1c-988e-cd6834767645"
      unitRef="usd">1683000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDUtMy0xLTEtMA_816dd4a2-e30d-450a-83a5-d4cb62e0eed3"
      unitRef="usd">7229000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDUtNS0xLTEtMA_343b0283-6033-414b-9fe9-c1a032d83d42"
      unitRef="usd">987000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtMS0xLTEtMTg3NjQ_103edd03-5493-4d5c-a500-209db7317a50"
      unitRef="usd">28000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtMy0xLTEtMTg3Njg_15ff0277-f20f-4fde-9154-afc0b683c3dc"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtNS0xLTEtMTg3NzI_0fa82bc2-c358-4bfb-9e45-713287219171"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctMS0xLTEtMTg3NjQ_84e31dff-822c-4816-a0b1-2ec6994a1f40"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctMy0xLTEtMTg3Njg_c4a26e20-eb3f-4361-bf0d-15459cd0c527"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctNS0xLTEtMTg3NzI_b9882e50-6e69-49b8-8196-8ac77a063c85"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtMS0xLTEtMTg3NjQ_df99e7a1-032a-4d20-a45f-bb1560eb1acb"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtMy0xLTEtMTg3Njg_44e521e1-bdb4-488f-9dcc-c210aadc493c"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtNS0xLTEtMTg3NzI_10329588-e2f0-406a-bec5-454c2680c9c2"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtMS0xLTEtMA_4bdfebda-af52-4851-a837-93463e82d770"
      unitRef="usd">535000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtMy0xLTEtMA_0bd8c729-d562-4f7d-b4e1-ad6096a6d072"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDYtNS0xLTEtMA_98119dd7-2431-4195-a9aa-2cb1db29c75b"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctMS0xLTEtMA_03e64a12-ce16-4c96-b75a-1acca262b3ff"
      unitRef="usd">59000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctMy0xLTEtMA_ae1acf33-676e-4df4-b58d-4303dd425468"
      unitRef="usd">65000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDctNS0xLTEtMA_c4fccb18-db4c-4998-a434-ce456a2d99fc"
      unitRef="usd">56000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <us-gaap:ProceedsFromStockPlans
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtMS0xLTEtMA_ce346553-75af-4687-ae2b-f0bc086acb9e"
      unitRef="usd">111000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtMy0xLTEtMA_6e262e90-af01-4f51-8ee8-cdcd316c22e9"
      unitRef="usd">123000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDgtNS0xLTEtMA_61d79e97-ef59-463f-94f8-c1b712851811"
      unitRef="usd">101000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDktMS0xLTEtMA_ceba6afa-ee32-4c04-9cf7-8b4a5155b07b"
      unitRef="usd">293000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDktMy0xLTEtMA_b7a391e8-da73-42cf-84e1-b0de9bac077e"
      unitRef="usd">2973000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNDktNS0xLTEtMA_9f288cb2-fcbd-4f2b-932f-66a0249a4a01"
      unitRef="usd">1432000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTAtMS0xLTEtMA_52b74e74-f38a-456f-ab04-8490a1271493"
      unitRef="usd">-2000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTAtMy0xLTEtMA_4e4dd1ff-8ebe-4ee9-897f-6d75e4b70fe9"
      unitRef="usd">10000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTAtNS0xLTEtMA_17429a39-f933-4a6f-8295-41c044de871c"
      unitRef="usd">-8000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTEtMS0xLTEtMA_80be32d3-dfca-4983-9b68-8703a044d0eb"
      unitRef="usd">1388000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTEtMy0xLTEtMA_53ac8377-9add-430c-aec0-c7a9da6f4c3c"
      unitRef="usd">-222000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTEtNS0xLTEtMA_66f00a26-b6ac-47ef-9230-8c54131257d2"
      unitRef="usd">-188000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTItMS0xLTEtMA_51d321d9-b8ab-4b18-b31c-62021cabeb76"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTItMy0xLTEtMA_d3f30bab-4e25-485c-9063-d025a5de019b"
      unitRef="usd">829000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTItNS0xLTEtMA_1c786e16-e4ea-4cd2-9fa3-ae78fabedd80"
      unitRef="usd">1017000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTMtMS0xLTEtMA_aac796be-ce15-49f9-bff7-b6fbd146f80d"
      unitRef="usd">1995000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTMtMy0xLTEtMA_7e2db1d4-c8c8-4794-80eb-404b83e44afb"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOjA1MjMwYmQzOGIwNjQzYjNhODRjNWEzOTQ0OWViYTRiL3RhYmxlcmFuZ2U6MDUyMzBiZDM4YjA2NDNiM2E4NGM1YTM5NDQ5ZWJhNGJfNTMtNS0xLTEtMA_664ff9e2-ecaf-4dfe-9f9c-6867503475fa"
      unitRef="usd">829000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMy0xLTEtMS0xOTU3OQ_a76fed1d-b1ec-4e52-9331-5e74865bb80f"
      unitRef="usd">207000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMy0zLTEtMS0xOTU3OQ_63949007-ff3c-4463-9c66-6446cf4f8309"
      unitRef="usd">242000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMy01LTEtMS0xOTU3OQ_72510af8-bdb7-40f7-8737-c6ccb7fdc2ad"
      unitRef="usd">1037000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNC0xLTEtMS0xOTU3OQ_f88600c4-26a4-4415-b543-44e6ed0d405c"
      unitRef="usd">359000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNC0zLTEtMS0xOTU3OQ_05fe541d-ce32-4472-99a4-0468173a5b19"
      unitRef="usd">449000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNC01LTEtMS0xOTU3OQ_ef180a0b-f541-40ca-bd25-3b35a4fc5d78"
      unitRef="usd">262000000</us-gaap:InterestPaidNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNS0xLTEtMS0xOTU3OQ_3d6153ad-47e5-410c-bcb8-08054a607aa2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNS0zLTEtMS0xOTU3OQ_e04611cf-912c-4728-8319-a3caceeda214"
      unitRef="usd">127000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNS01LTEtMS0xOTU3OQ_2709775e-e25a-4aa8-a23e-f1b242efccd2"
      unitRef="usd">248000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <bsx:NonCashImpactOfTransferredRoyaltyRights
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNi0xLTEtMS0xOTU3OQ_86c30206-4299-489e-a395-4de09f20f481"
      unitRef="usd">-87000000</bsx:NonCashImpactOfTransferredRoyaltyRights>
    <bsx:NonCashImpactOfTransferredRoyaltyRights
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNi0zLTEtMS0xOTU3OQ_a424c108-2231-4697-a104-898f6b6914ff"
      unitRef="usd">0</bsx:NonCashImpactOfTransferredRoyaltyRights>
    <bsx:NonCashImpactOfTransferredRoyaltyRights
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfNi01LTEtMS0xOTU3OQ_69b32207-75c3-48fd-aff9-b9856cb69f10"
      unitRef="usd">0</bsx:NonCashImpactOfTransferredRoyaltyRights>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfOS0xLTEtMS0xOTU3OQ_3b151575-73d1-4d19-aac7-28bb0f3da5c0"
      unitRef="usd">1734000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfOS0zLTEtMS0xOTU3OQ_f32851b2-047f-41d4-8831-147df037da5c"
      unitRef="usd">217000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfOS01LTEtMS0xOTU3OQ_bee9567c-8022-4a8a-9794-bbf04c0189a3"
      unitRef="usd">146000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTAtMS0xLTEtMTk1Nzk_56810aae-b577-4965-a6cf-8fa74a0cb7d5"
      unitRef="usd">208000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTAtMy0xLTEtMTk1Nzk_886cfada-378f-4af0-a11a-492f6db733dd"
      unitRef="usd">346000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTAtNS0xLTEtMTk1Nzk_81c208df-3c4c-47db-b508-19548d8dc6f2"
      unitRef="usd">655000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTEtMS0xLTEtMTk1Nzk_722d4650-ea73-435b-8f12-c30f2f8793e9"
      unitRef="usd">52000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTEtMy0xLTEtMTk1Nzk_8c5800a9-9f77-436b-b863-4d315da13253"
      unitRef="usd">43000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTEtNS0xLTEtMTk1Nzk_f5720a1c-97a4-4235-b616-a3e56ca2afe7"
      unitRef="usd">27000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTItMS0xLTEtMTk1Nzk_bc985bfa-1c03-497d-8b4e-a98f45a67024"
      unitRef="usd">1995000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTItMy0xLTEtMTk1Nzk_c3653837-2a6a-4f3f-9adc-e271362b337e"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185MS9mcmFnOmQ5Njc2NWM3NzY2MTQ2OTY4NjhjNTA3Y2RjZDRhMmVjL3RhYmxlOmQ0M2IxNDg3MjRkNzQ2ZjZhYTA4NjYyMmJjY2ViYTM4L3RhYmxlcmFuZ2U6ZDQzYjE0ODcyNGQ3NDZmNmFhMDg2NjIyYmNjZWJhMzhfMTItNS0xLTEtMTk1Nzk_96fa9f68-57c7-4e9d-9824-3e2b83efb243"
      unitRef="usd">829000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNjA_1a4aa5e0-dbac-47c6-9d40-5d3aca9153a3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE A &#x2013; SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#x2019;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Restructuring-related Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets are related to deferred compensation plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We write-off amounts determined to be uncollectible against this reserve. Write-offs of uncollectible accounts receivable were immaterial in 2020, 2019 and 2018. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2020, 2019 and 2018; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes toward non-hospital settings, particularly ambulatory surgery centers, driven by considerations surrounding costs, reimbursement policies, advances in minimally invasive treatments and remote patient monitoring. We have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers. Many of these customers are smaller than those we have historically done business with and may have limited liquidity. While certain ambulatory surgery centers are performing an increasing number of procedures in response to the COVID-19 pandemic, others have been negatively impacted by COVID-19 restrictions and mitigation measures. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is adequate as of December&#160;31, 2020 and 2019; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have a contract with a customer that creates enforceable rights and obligations,&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Promised products or services are identified,&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The transaction price, or the amount we expect to receive, is determinable and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have transferred control of the promised items to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management product offerings combine the sale of a device with our LATITUDE&#x2122; Patient Management System, within our Cardiac Rhythm Management (CRM) business, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#x2122; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Post-Implant Services&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide non-contractual services to customers to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;services at the time the devices are sold. We record these costs to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Obligations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During the year ended December 31, 2020, we recorded $149&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation of Business Combinations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#x2019;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In those circumstances where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived Intangibles and IPR&amp;amp;D &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which is foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, and IPR&amp;amp;D intangible assets acquired in a business combination. Our IPR&amp;amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;amp;D intangible asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the income approach to determine the fair values of our IPR&amp;amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#x2019; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information related to indefinite-lived intangibles, including IPR&amp;amp;D.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization and Impairment of Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information related to impairments of intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill Valuation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2020 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the second quarter of&#160;2020, we performed our annual goodwill impairment test utilizing the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $800 million, subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. We acquired our Specialty Pharmaceuticals business in conjunction with the BTG acquisition on August 19, 2019. In connection with the execution of a definitive agreement to sell the disposal group for a specified amount, we performed an impairment assessment of our goodwill and intangible assets, which resulted in a goodwill impairment of $73 million. As of December 31, 2020, we classified the remaining assets and liabilities of the disposal group as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less cost to sell. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our consolidated financial statements for additional details related to our goodwill balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Publicly Traded and Privately Held Entities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any, observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities over which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments - Equity Method and Joint Ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;, Investments - Debt and Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; for additional details on our investment balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#x2019;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is impaired and we recognize an impairment loss equal to the difference between an investment&#x2019;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#x2019;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses and impairments associated with our investment portfolio are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note J &#x2013; Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal and Product Liability Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities litigation and product liability suits. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue our best estimate of the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for discussion of our individual material legal proceedings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Costs Associated with Exit Activities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record employee termination costs in accordance with FASB ASC Topic 712&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Nonretirement and Postemployment Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit or Disposal Cost Obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. We record such costs into expense over the employee&#x2019;s future service period, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Restructuring-related Activities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further information and discussion of our restructuring plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Translation of Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency transaction gains and losses are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on our hedging instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not bill customers for shipping and handling of our products. We treat shipping and handling costs incurred after a customer obtains control of the good as a fulfillment cost and record in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our consolidated statements of operations. Shipping and handling costs were $146 million in 2020, $144 million in 2019 and $124 million in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense research and development (R&amp;amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Indefinite-lived Intangibles and IPR&amp;amp;D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above for our policy regarding R&amp;amp;D projects acquired in connection with our business combinations and asset purchases.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMjI_b99b9813-bdf5-4739-bf7b-0ed3445c78c5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#x2019;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczNjc_c7d15dd1-12fc-4bf0-ae4c-4cb9b1fb7619">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Restructuring-related Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyNjU_de60c874-4d2e-4032-a27a-321f2f437ca2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNDk_2d141865-9564-4451-89e2-f5b16c6f14de">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets &lt;/span&gt;caption within our consolidated balance sheets are related to deferred compensation plans.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNzc_e917632b-79e7-469d-b5ff-65f876005f60">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We write-off amounts determined to be uncollectible against this reserve. Write-offs of uncollectible accounts receivable were immaterial in 2020, 2019 and 2018. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2020, 2019 and 2018; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes toward non-hospital settings, particularly ambulatory surgery centers, driven by considerations surrounding costs, reimbursement policies, advances in minimally invasive treatments and remote patient monitoring. We have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers. Many of these customers are smaller than those we have historically done business with and may have limited liquidity. While certain ambulatory surgery centers are performing an increasing number of procedures in response to the COVID-19 pandemic, others have been negatively impacted by COVID-19 restrictions and mitigation measures. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt; is adequate as of December&#160;31, 2020 and 2019; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase.</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNDA_b3eb3a4c-fec8-4e6f-ac78-4b2989e7c9e0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have a contract with a customer that creates enforceable rights and obligations,&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Promised products or services are identified,&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The transaction price, or the amount we expect to receive, is determinable and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have transferred control of the promised items to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management product offerings combine the sale of a device with our LATITUDE&#x2122; Patient Management System, within our Cardiac Rhythm Management (CRM) business, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#x2122; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Post-Implant Services&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide non-contractual services to customers to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;services at the time the devices are sold. We record these costs to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.&lt;/span&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNjg_6f43422c-f1ec-4af6-ad49-36316ff09862">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Obligations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.&lt;/span&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczMjg_11f7c785-7447-4eb4-a281-f141c644b434">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During the year ended December 31, 2020, we recorded $149&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfMjc0ODc3OTIyNjc5Mw_98f012de-3293-4b62-b340-47ba8a8d9b2a"
      unitRef="usd">149000000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMTM_1cbdf9ae-857a-4554-8bc5-ed5888de4dfd">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczMzM_23eb7a70-e130-4e95-a84e-76c78275e8a7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation of Business Combinations &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#x2019;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In those circumstances where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue &lt;/span&gt;&lt;/div&gt;levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:InProcessResearchAndDevelopmentPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMjg_6d225683-7da5-4f3b-9a99-d51069379a99">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived Intangibles and IPR&amp;amp;D &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which is foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, and IPR&amp;amp;D intangible assets acquired in a business combination. Our IPR&amp;amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;amp;D intangible asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the income approach to determine the fair values of our IPR&amp;amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#x2019; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information related to indefinite-lived intangibles, including IPR&amp;amp;D.&lt;/span&gt;&lt;/div&gt;For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date.</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNDI_f87fc2aa-29d3-41d9-8a77-fde2c616a9b8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization and Impairment of Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information related to impairments of intangible assets.&lt;/span&gt;&lt;/div&gt;For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczMjU_56c3c6c0-d242-40c8-8c60-7488d651139d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill Valuation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2020 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the second quarter of&#160;2020, we performed our annual goodwill impairment test utilizing the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $800 million, subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. We acquired our Specialty Pharmaceuticals business in conjunction with the BTG acquisition on August 19, 2019. In connection with the execution of a definitive agreement to sell the disposal group for a specified amount, we performed an impairment assessment of our goodwill and intangible assets, which resulted in a goodwill impairment of $73 million. As of December 31, 2020, we classified the remaining assets and liabilities of the disposal group as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less cost to sell. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our consolidated financial statements for additional details related to our goodwill balances.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNTQ5NzU1ODI5MDUyMw_957e7ce5-fcc0-4f10-bfe5-f5f042cd7971"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMzQ_04ff5973-39ea-40f5-91aa-f2b9d5241ccb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Publicly Traded and Privately Held Entities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any, observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities over which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Investments - Equity Method and Joint Ventures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;, Investments - Debt and Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; for additional details on our investment balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#x2019;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment &lt;/span&gt;&lt;/div&gt;is impaired and we recognize an impairment loss equal to the difference between an investment&#x2019;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#x2019;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses and impairments associated with our investment portfolio are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;in our consolidated statements of operations.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNjU_1e1cba56-dc9b-48fe-884d-37e85dd7aff2">Income Taxes&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note J &#x2013; Income Taxes&lt;/span&gt; for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyNTk_775b6526-b736-478a-b10e-abe50da07f02">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal and Product Liability Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities litigation and product liability suits. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue our best estimate of the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note K &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for discussion of our individual material legal proceedings.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyNTM_1f28bec7-66f8-4cbc-9d51-8d1265dcf4e1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Costs Associated with Exit Activities &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record employee termination costs in accordance with FASB ASC Topic 712&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Nonretirement and Postemployment Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit or Disposal Cost Obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. We record such costs into expense over the employee&#x2019;s future service period, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs of &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Restructuring-related Activities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further information and discussion of our restructuring plans.&lt;/span&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxODU_65434d9a-ac68-4fbf-91f0-4f3d3571a909">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Translation of Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency transaction gains and losses are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNDg_b7a18a69-33de-4a60-820c-efe0193124dc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information on our hedging instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <bsx:ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcxNTU_fc852768-870b-42bf-a4b6-c630280251c6"
      xsi:nil="true"/>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDcyMDE_a34660eb-6705-4bed-ae5d-e7380936c2f9">Shipping and Handling Costs&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally do not bill customers for shipping and handling of our products. We treat shipping and handling costs incurred after a customer obtains control of the good as a fulfillment cost and record in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;within our consolidated statements of operations. Shipping and handling costs were $146 million in 2020, $144 million in 2019 and $124 million in 2018</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i11643c9862df4baea0dccd9d1fe58c3b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDYzNjE_a23d3b21-37bf-4525-89fb-d603ed4cc371"
      unitRef="usd">146000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iab42b8f2e9794e569ed587870fb84d60_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDYzNzE_29ebd9d3-8b6f-41f6-850a-1874c6308bdd"
      unitRef="usd">144000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i56411282f0574a36b407828ddce5e536_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDYzODQ_7a19225f-d4fe-480f-9bea-8bd1407a548a"
      unitRef="usd">124000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N185Ny9mcmFnOjg0ZTVkMTQ4NGMxNjQ5NzM5MzgyMzJhYjliNzAzNmQ3L3RleHRyZWdpb246ODRlNWQxNDg0YzE2NDk3MzkzODIzMmFiOWI3MDM2ZDdfNDczNjE_edbfc4fe-45cd-4a55-a4e8-d59fcff38ad9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense research and development (R&amp;amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Indefinite-lived Intangibles and IPR&amp;amp;D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above for our policy regarding R&amp;amp;D projects acquired in connection with our business combinations and asset purchases.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjMw_01947733-c3f0-46b0-b302-dc3020a72e6f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE B &#x2013; ACQUISITIONS AND STRATEGIC INVESTMENTS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We did not complete any material acquisitions during 2020. We have not presented supplemental pro forma financial information for prior acquisitions given their results are not material to our consolidated financial statements. Transaction costs for all acquisitions completed during 2020, 2019 and 2018 were immaterial to our consolidated financial statements and were expensed as incurred. In 2020, we recorded immaterial purchase price adjustments during the measurement period for the preliminary purchase price allocations associated with prior acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 21, 2021, we announced our entrance into a definitive agreement to acquire Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. We have been an investor in Preventice since 2015 and currently hold an equity stake of approximately 22 percent. The transaction price to acquire the remaining stake is expected to result in a net cash payment of approximately $720 million upon closing and up to an additional $230 million payment upon achievement of a commercial milestone. The acquisition is expected to close during the first half of 2021, subject to customary &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;closing conditions. Following the closing of the acquisition, the Preventice business will be managed by our Cardiac Rhythm Management division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;BTG plc&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;19, 2019, we announced the closing of our acquisition of BTG plc (BTG), a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we integrated BTG's Interventional Medicine business into our Peripheral Interventions division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the Interventional Medicine product lines, the BTG portfolio also included a specialty pharmaceutical business (Specialty Pharmaceuticals) comprised of acute care antidotes to treat overexposure to certain medications and toxins. On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $800 million , subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The BTG portfolio further included a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. In connection with the acquisition, we acquired rights to future royalties associated with the Zytiga&#x2122; Drug used to treat certain forms of prostate cancer. In the fourth quarter of 2019, we sold our rights to these royalties for $256 million in cash, included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proceeds from royalty rights transfer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of cash flows. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price for the acquisition of BTG consisted of upfront cash in the aggregate amount of &#xa3;3.312 billion (or $4.023 billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received 840 pence (or $10.20 based on the exchange rate at closing) in cash for each BTG share. The transaction price included $404 million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&#160;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,619&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,785&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized goodwill of $1.635 billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. We allocated $1.399 billion to our Peripheral Interventions reporting unit and $236 million to the Specialty Pharmaceuticals reporting unit. In 2020, we recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $73 million related to our Specialty Pharmaceuticals business. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transaction with Varian Medical Systems, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 21, 2019, we completed the sale of our drug-eluting and bland embolic microsphere portfolio to Varian Medical Systems, Inc. (Varian) in connection with our acquisition of BTG. The transaction price consisted of an upfront cash payment of $90 million, a portion of which is allocated to the fair value of the services to be rendered under the Transition Services Agreement and Transition Manufacturing Agreement entered into with Varian as part of this transaction. Additionally, we transferred certain contingent consideration arrangements arising from our initial acquisition of the portfolio to Varian and agreed to indemnify Varian for any payments ultimately arising under the terms of the contingent consideration arrangement. Accordingly, as part of the disposal, we recorded a liability of $16 million to recognize the fair value of this guarantee based on our potential obligation resulting from the indemnifications. The maximum amount payable under this guarantee is $200 million in accordance with FASB ASC Topic 460, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which is consistent with the contingent consideration arrangement executed with our initial acquisition of the portfolio in accordance with FASB ASC Topic 805.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Vertiflex, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 11, 2019, we announced the closing of our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#x2122; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $465 million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of zero to $100 million; however, the payments are uncapped over the three year earn-out period. Through December&#160;31, 2020, we have made incremental payments of $20 million to the prior shareholders of Vertiflex in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Millipede, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2019, we announced the closing of our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $90 million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately 20 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $325 million and up to an additional $125 million payment upon achievement of a commercial milestone. Through December&#160;31, 2020, we have not made any incremental payments to the prior shareholders of Millipede, as the commercial milestone has not yet been achieved. Following the closing of the acquisition, we integrated the Millipede business into our Interventional Cardiology division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final combined purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;461&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2018 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Augmenix, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 16, 2018, we announced the closing of our acquisition of Augmenix, Inc. (Augmenix), a privately-held company that developed and commercialized the SpaceOAR&#x2122; Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer. The transaction price consisted of an upfront cash payment of $500 million and up to $100 million in payments contingent upon achieving certain revenue-based milestones. Through December&#160;31, 2020, we made incremental payments of $24 million to the prior shareholders of Augmenix in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Augmenix business into our Urology and Pelvic Health division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Claret Medical, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 2, 2018, we announced the closing of our acquisition of Claret Medical, Inc. (Claret), a privately-held company that has developed and commercialized the Sentinel&#x2122; Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter aortic valve replacement (TAVR). The transaction price consisted of an upfront cash payment of $220 million and an additional $50 million payment for achieving a reimbursement-based milestone that was achieved in the third quarter of 2018. Following the closing of the acquisition, we integrated the Claret business into our Interventional Cardiology division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Cryterion Medical, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2018, we announced the closing of our acquisition of Cryterion Medical, Inc. (Cryterion), a privately-held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation. We had been an investor in Cryterion since 2016 and held an interest of approximately 35 percent immediately prior to the acquisition date. The transaction price to acquire the remaining stake consisted of an upfront cash payment of $202 million. Following the closing of the acquisition, we integrated the Cryterion business into our Electrophysiology division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;NxThera, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 30, 2018, we announced the closing of our acquisition of NxThera, Inc. (NxThera), a privately-held company that developed the Rez&#x16b;m&#x2122; System, a minimally invasive therapy in a growing category of treatment options for patients with benign prostatic hyperplasia (BPH). We held a minority interest immediately prior to the acquisition date. The transaction price to acquire the remaining stake consisted of an upfront cash payment of approximately $240 million and up to approximately $85 million in future potential payments contingent upon achieving commercial milestones over the four years following the date of acquisition. Through December&#160;31, 2020, we have made incremental payments of $12 million to the prior shareholders of NxThera in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the NxThera business into our Urology and Pelvic Health division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;nVision Medical Corporation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 16, 2018, we announced the closing of our acquisition of nVision Medical Corporation (nVision), a privately-held company focused on women&#x2019;s health. nVision developed the first and only device cleared by the U.S. Food and Drug Administration (FDA) to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer. The transaction price consisted of an upfront cash payment of $150 million and up to an additional $125 million in future potential payments contingent upon achieving certain clinical and commercial milestones over the four years following the date of acquisition. Following the closing of the acquisition, we integrated the nVision business into our Urology and Pelvic Health division. We discontinued the nVision R&amp;amp;D program during 2020 and do not expect to make any incremental payments to the prior shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we completed other individually immaterial acquisitions in 2018 for total consideration of $158 million in cash at closing plus aggregate future potential contingent consideration of up to $62 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded gains of $184 million in 2018 within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our consolidated statements of operations based on the difference between the book values and the fair values of our previously-held investments immediately prior to the acquisition dates. The aggregate fair value of our previously-held investments immediately prior to the acquisition dates was $251 million. We remeasured the fair value of each previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for our 2018 acquisitions as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,948&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final combined purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,948&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies. The goodwill recorded relating to our acquisitions is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;347&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded related to current year acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration arrangements transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $532 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The $100 million benefit recorded in 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or in the case of nVision, for milestones that would not be achieved due to discontinuation of the R&amp;amp;D program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$104 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$93 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected contingent payment amounts related to our R&amp;amp;D, commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;458&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, we recorded a $363 million gain on our investment in Pulmonx Corporation presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt; to remeasure to fair value based on observable market prices. As of December&#160;31, 2020, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $272 million, which represents amortizable intangible assets, IPR&amp;amp;D, goodwill and deferred tax liabilities.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i64a8d1206e3449f0ae7a7ece1b89fb96_I20210121"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxODcxMTQ_305b6388-62ea-429d-ae97-f9190ead8a8b"
      unitRef="number">0.22</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5a34bf00cea546488f2484aedb64dcf4_D20210121-20210121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxODcwODY_2694608a-21e5-4dc4-9c8a-9fa6bf6c6791"
      unitRef="usd">720000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i64a8d1206e3449f0ae7a7ece1b89fb96_I20210121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxODcxMDE_b3003767-52d8-4603-844a-53ebe302247f"
      unitRef="usd">230000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxODk5NjI_ae7fb70f-bb50-4324-97a6-efa611c19699"
      unitRef="usd">800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTAyNzI_bda3f833-47fd-4481-84d9-7462f0a0655c"
      unitRef="usd">256000000</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i299c7ae54a0247c3ba17d84adb96d2dc_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE5OTE_a82ffc27-bf10-4bc6-94e0-39ee29cb4c8b"
      unitRef="gbp">3312000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i299c7ae54a0247c3ba17d84adb96d2dc_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE5OTg_109e0dd4-2e74-41b8-aabe-e359cef29651"
      unitRef="usd">4023000000.000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ibbb0c3a277f94a73ada943c59b4bac0e_I20190819"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIxNDY_f020c04d-8d80-461e-9eb1-a39527b6063c"
      unitRef="gbpPerShare">8.40</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ibbb0c3a277f94a73ada943c59b4bac0e_I20190819"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIxNTM_101679dc-08e9-423a-a867-0a46909aac69"
      unitRef="usdPerShare">10.20</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i299c7ae54a0247c3ba17d84adb96d2dc_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIyNTQ_540156bd-717e-4a43-83a2-52d070372492"
      unitRef="usd">404000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NTE_a269ddc7-162e-4795-bad6-a28cc3e80ab8">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4MDE0NGIwMjZjMDU0NTBiYWFmNDUyNTRkZTdhMWIzNC90YWJsZXJhbmdlOjgwMTQ0YjAyNmMwNTQ1MGJhYWY0NTI1NGRlN2ExYjM0XzEtMS0xLTEtMA_ae95c9fa-e133-45b9-903d-6f04cfbfe938"
      unitRef="usd">3619000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NTQ_f4ca2391-32af-4bf3-9f0f-123528666eb0">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,619&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzEtMS0xLTEtMA_4ec12b6d-4c6e-457a-97bb-a8161864dfa2"
      unitRef="usd">1635000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzMtMS0xLTEtMA_8d161dd1-9edc-4111-b921-4d4abf41f0f8"
      unitRef="usd">108000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzQtMS0xLTEtMA_12078a57-b3d0-48fa-9b0d-2851ae2821ce"
      unitRef="usd">232000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzUtMS0xLTEtMA_f42bee97-aa22-4d7d-a2aa-fe13325bbd0f"
      unitRef="usd">252000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzYtMS0xLTEtMA_7228612b-2129-4a73-9151-4e30474da25f"
      unitRef="usd">1785000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzctMS0xLTEtMA_23439585-5f27-41bc-8585-449e8aa4be15"
      unitRef="usd">538000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzgtMS0xLTEtMA_22c94636-125e-46e8-9fd0-582cc16a8f3d"
      unitRef="usd">308000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzktMS0xLTEtMA_fd8ac99e-bafb-4f50-a927-4438f65607e2"
      unitRef="usd">274000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzEwLTEtMS0xLTA_07ee9a85-a731-4aa8-a007-5224397db5db"
      unitRef="usd">349000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo0ZDQ2NTA0ZDA0Y2Q0NTUwOTE3ZWY2MmI1NjhhODJhMi90YWJsZXJhbmdlOjRkNDY1MDRkMDRjZDQ1NTA5MTdlZjYyYjU2OGE4MmEyXzExLTEtMS0xLTA_7c6dd23c-fa84-4616-85dc-b79234ad025c"
      unitRef="usd">3619000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NTU_b8a59fda-124a-41f5-a3f5-c5a1089c668c">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,785&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4f7af4ce5e334ad6a48a0c025a8c309e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItMS0xLTEtMA_1799aebc-0093-40ba-af83-4c90e7708767"
      unitRef="usd">1709000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i35075d47b59a45d1a6bea3504735e270_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItMy0xLTEtMA_435fe2e1-f3df-4559-83a0-072086f8a3e9">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2a3d5f3065944d128f235b2e66762039_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItNS0xLTEtMA_00ccdce2-714f-41b3-b8ff-d5dda9d03acc">P18Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i35075d47b59a45d1a6bea3504735e270_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItNy0xLTEtMA_9e14c70b-b4e8-4913-8198-be779d0002ce"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i2a3d5f3065944d128f235b2e66762039_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzItOS0xLTEtMA_3113870d-4f09-4909-bc94-fbc0aa06a66c"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if2774a1a2bba4fa7853774c9595dcb11_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzUtMS0xLTEtMA_8596aa7d-de21-4bd2-949c-9085a5121e24"
      unitRef="usd">75000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ibed9848d49334621abbf06402ae43b03_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzUtMy0xLTEtMA_e14278df-e233-4ad7-8cdf-401e45476178">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i68e95752e11f41c8bf7a29dafc64ed6a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzUtNS0xLTEtMA_1fae820e-dc6d-4424-8f91-dfc311e60386">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i27a8ea6e29224419867de6bc25119d5a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzUtNy0xLTEtMA_6d1d876d-c819-46cb-b960-d2a09c3726ad"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTozYjA1YzM4NTY3NTg0MTQzYTBmZDI0YzE1OGFhZDlkZi90YWJsZXJhbmdlOjNiMDVjMzg1Njc1ODQxNDNhMGZkMjRjMTU4YWFkOWRmXzgtMS0xLTEtMA_bf376486-c046-474a-933e-225546cfa412"
      unitRef="usd">1785000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i7fced0a5a0974f3da2a2c1b18b5f7299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkwOTU1NjA_4ec12b6d-4c6e-457a-97bb-a8161864dfa2"
      unitRef="usd">1635000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i58f51b9be0cb448cb46a40c48600ea96_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkwOTU3OTY_c97e5c7e-14e7-43d5-beb7-96d14af0fa52"
      unitRef="usd">1399000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3d29dc73a76c4cf595703ac8e73f20c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkwOTYzNTI_e5aad4b9-4171-4806-b7ed-ae988eaadb03"
      unitRef="usd">236000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTY0OTk_957e7ce5-fcc0-4f10-bfe5-f5f042cd7971"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ie90da432f6df49e48679d93f666461e4_D20190821-20190821"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzY5Nzk_7bc66144-95f0-48b6-9635-96284e479f7f"
      unitRef="usd">90000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GuaranteesFairValueDisclosure
      contextRef="i7b1cd7f1f0194f3aa27fd23d352988c0_I20190821"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzc1Mjk_394627d9-cd94-4782-9e1b-3cfe541d8ac6"
      unitRef="usd">16000000</us-gaap:GuaranteesFairValueDisclosure>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i7b1cd7f1f0194f3aa27fd23d352988c0_I20190821"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzc3MDA_f57807cc-6d1e-45d7-8a79-1f5ddf184c9c"
      unitRef="usd">200000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i029e2805f8d2493c952047d8981ed692_D20190611-20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzgyNzg_35b7981f-18e0-432f-b1a2-24c62a6d2b0e"
      unitRef="usd">465000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
      contextRef="i28538f28a987480db2349df82889a791_I20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzg0ODg_f4230bc1-8a02-4c16-8aa7-9172dad65abd"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i28538f28a987480db2349df82889a791_I20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzg0OTQ_d7406bf7-98a4-40ef-b05e-0eadd950bb4e"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate
      contextRef="i0659d4a09c104d69a40367c98f578cba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTE3OTE_977cb711-d4bd-45fe-98b1-b80907fa7e21"
      unitRef="usd">20000000</bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1be67d7dc4894d3d9ac61ec671d1f66c_D20190129-20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzkyMzQ_585f0629-bb84-4b1b-9937-42db59acbdca"
      unitRef="usd">90000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i506a6ba7c7f04e2fbbbc72dd6a366a00_I20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzk0NDM_a3ba5427-bc13-4b91-9e3a-6fc1de09d586"
      unitRef="number">0.20</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i1be67d7dc4894d3d9ac61ec671d1f66c_D20190129-20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzk3NjY_4d4065ba-46d3-4996-b65b-db4f4d9bc186"
      unitRef="usd">325000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i506a6ba7c7f04e2fbbbc72dd6a366a00_I20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzk3OTM_3611dab6-e6c4-4469-8d9e-4fdaaebab05a"
      unitRef="usd">125000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NTk_c38654e7-c9c3-43d1-bb3d-98f563e0807a">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4N2YyOTFiNDEyMWY0MWM1YmY4OTNjNzYzYjI2NWIyZi90YWJsZXJhbmdlOjg3ZjI5MWI0MTIxZjQxYzViZjg5M2M3NjNiMjY1YjJmXzEtMS0xLTEtMA_0096038a-5684-4379-937d-363b70f6a4d7"
      unitRef="usd">763000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4N2YyOTFiNDEyMWY0MWM1YmY4OTNjNzYzYjI2NWIyZi90YWJsZXJhbmdlOjg3ZjI5MWI0MTIxZjQxYzViZjg5M2M3NjNiMjY1YjJmXzItMS0xLTEtMA_6b6103e1-c5d4-43a8-b807-56661cbefafb"
      unitRef="usd">127000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4N2YyOTFiNDEyMWY0MWM1YmY4OTNjNzYzYjI2NWIyZi90YWJsZXJhbmdlOjg3ZjI5MWI0MTIxZjQxYzViZjg5M2M3NjNiMjY1YjJmXzMtMS0xLTEtMA_de610e67-d87a-4177-b749-a054b5e0877f"
      unitRef="usd">102000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo4N2YyOTFiNDEyMWY0MWM1YmY4OTNjNzYzYjI2NWIyZi90YWJsZXJhbmdlOjg3ZjI5MWI0MTIxZjQxYzViZjg5M2M3NjNiMjY1YjJmXzQtMS0xLTEtMA_ca246030-eb08-4a81-92f3-131a4688c917"
      unitRef="usd">992000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NjE_1238934c-84f1-489f-8091-932973d90cbd">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzEtMS0xLTEtMA_f789011b-20b5-4bc3-85d5-a1026b314ff1"
      unitRef="usd">577000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzItMS0xLTEtMA_6fd2501b-1e4c-4bca-954b-ee4617ccc57d"
      unitRef="usd">220000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzMtMS0xLTEtMA_c5da6fa3-e733-4d3c-9000-25abfad85f3c"
      unitRef="usd">240000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzQtMS0xLTEtMA_b8ac8f12-8360-42d2-bf02-21f2a2d2d7c7"
      unitRef="usd">24000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzUtMS0xLTEtMA_af6b10e5-1027-4950-b1cd-cc7a8f015af8"
      unitRef="usd">12000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzYtMS0xLTEtMA_26f1388a-c9b4-43e1-abff-6b7289789fda"
      unitRef="usd">58000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1Yzg5N2M2Nzc0OTk0M2M3OTM0NTUzMTgzYzlhZDBiMS90YWJsZXJhbmdlOjVjODk3YzY3NzQ5OTQzYzc5MzQ1NTMxODNjOWFkMGIxXzctMS0xLTEtMA_96ea76fc-9c6c-47fc-bdd9-03e7a927338a"
      unitRef="usd">992000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i571b355da3e14c4088b68574662a2240_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjY0NjI_281246f6-1914-46b8-b169-52f6d1c6fbf2">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;461&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if04f535d42894b13baf5c1bf29abbdfa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzItMS0xLTEtMA_596a9bec-ff87-4b8e-9cdb-c3e237266345"
      unitRef="usd">210000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iac2d0307d9d04ae1a423eaf989020c84_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzItMy0xLTEtMA_94c5ec9f-3b7d-456d-89e2-760f4e228371">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="iac2d0307d9d04ae1a423eaf989020c84_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzItNy0xLTEtMA_8c42b17b-503a-4fee-9412-9a3cd9019fc1"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1c0fc8eddb08406ea3d86b0a6e07223d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzQtMS0xLTEtMA_ce291dfa-a484-4f5c-878b-bbe51c06f5af"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="idae083babc2c41c6920c5a332adfac61_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzQtMy0xLTEtMA_a33c2a06-a40a-4f99-8a57-7b3992be01c7">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="idae083babc2c41c6920c5a332adfac61_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzQtNy0xLTEtMA_44796ffd-58ac-487c-8536-d2fe90bc1c6b"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i2317bba8b93a4381b47fcbb9f84a225a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzYtMS0xLTEtMA_32294ab2-c686-48ee-9b28-300247c94f0e"
      unitRef="usd">240000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <bsx:DiscountRateFairValueInput
      contextRef="i8d7e6ed023a74081b6372d23bc145ba3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzYtNy0xLTEtMA_14781e1b-a596-4902-bf3a-4e7096f885f4"
      unitRef="number">0.19</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="if2a5ec16eee547859b062e1a0491d616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo2ZWUzMDFhODAzMWI0MDkwODQ5NzA4Yzg0ZTY5MzVhMC90YWJsZXJhbmdlOjZlZTMwMWE4MDMxYjQwOTA4NDk3MDhjODRlNjkzNWEwXzctMS0xLTEtMA_5dedc0fb-e370-451e-a005-ab13deebba8e"
      unitRef="usd">461000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i496c2de855594c64bc941488053cc536_D20181016-20181016"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzExMTg0_694d6f6e-07a2-44c6-88a6-36936a81b625"
      unitRef="usd">500000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i904147befc444b9bbdc64d9876b10897_I20181016"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzExMTk3_5beb4ae1-6319-4958-920b-6c6d339bbec8"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate
      contextRef="i884efc79fc7e4752a4aa11bebd3bbcf3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTE4MjQ_6aff175e-76fb-48b8-ae65-f5c0fdebbdec"
      unitRef="usd">24000000</bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i31712f6779184ad8bf710b35128f9962_D20180802-20180802"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzExODYx_bb93a638-6226-4cec-a4be-00c49635f988"
      unitRef="usd">220000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i83308e067e9f492fbd4a9d89b3ef8503_I20180802"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzExODgy_af913a63-0080-4994-a736-256fea111dff"
      unitRef="usd">50000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i1e1286aef3b14fbbbc9b05febb4fb2e0_I20180705"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEyNDQw_f76a0f87-de9b-4aa7-b900-d03f04f3fb3d"
      unitRef="number">0.35</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia7a425fa4f004c2eaea7363a2060f19e_D20180705-20180705"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEyNTc5_675c4869-26d7-4e89-a0ce-355db6ee3317"
      unitRef="usd">202000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i3cc07fbb23104ef5b60a1a0aac61b408_D20180430-20180430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEzMTc0_12d79ded-f69c-40a3-981f-c222a7fa7e3d"
      unitRef="usd">240000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="iad9c6a324c6441d1b8f2cfc19eb1608e_I20180430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEzMjAx_1a538ead-22d4-45b9-913d-ded5aabc6dbd"
      unitRef="usd">85000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate
      contextRef="i5478b53eb62b479dae6f8838d73e6197_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTE4Mzk_44baefde-3aad-466e-bbd3-034e5acf4f74"
      unitRef="usd">12000000</bsx:ContingentConsiderationPaymentsMadeToPriorShareholdersToDate>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i6555d4428a7140748bd802e9a768fd8e_D20180416-20180416"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEzOTI1_9bf47792-e07c-4336-afa6-fe0330292f1a"
      unitRef="usd">150000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i3b9fe0db816347ab9940c21c9b0d768e_I20180416"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzEzOTUy_153bd0e9-a926-4619-9ec4-08623680f46d"
      unitRef="usd">125000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i808cb5579b214ed483e0c55813432263_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE0MzYw_e09e31ad-9a31-45fa-a796-16f64da9a4e1"
      unitRef="usd">158000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ie9d42aa1c99141d9a7c12881fbf9ad48_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE0NDQ4_b28034a4-cc4d-43c1-8482-e5685c5431e0"
      unitRef="usd">62000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE0NDc1_4584732e-0fdb-4650-a856-5062540909b6"
      unitRef="usd">184000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE0NzY4_a078e880-a79a-4ef9-a3ba-4943965caac6"
      unitRef="usd">251000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjIw_c14a7dd6-18bf-4e07-ab84-d36eb2ffc5eb">The final purchase prices were comprised of the following components:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,948&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTplZTc3NjM0YmNlNTE0ZTAzYmQxODJjNGY3YTU5NDJlZS90YWJsZXJhbmdlOmVlNzc2MzRiY2U1MTRlMDNiZDE4MmM0ZjdhNTk0MmVlXzEtMS0xLTEtMA_3e21dfdb-4546-44e6-bf7e-b8cb68d71fed"
      unitRef="usd">1449000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icf000a38a8df435292fe43a04c563e76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTplZTc3NjM0YmNlNTE0ZTAzYmQxODJjNGY3YTU5NDJlZS90YWJsZXJhbmdlOmVlNzc2MzRiY2U1MTRlMDNiZDE4MmM0ZjdhNTk0MmVlXzItMS0xLTEtMA_74d484f3-4fd5-4f02-8cf5-6e6d5a0fad7d"
      unitRef="usd">248000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTplZTc3NjM0YmNlNTE0ZTAzYmQxODJjNGY3YTU5NDJlZS90YWJsZXJhbmdlOmVlNzc2MzRiY2U1MTRlMDNiZDE4MmM0ZjdhNTk0MmVlXzMtMS0xLTEtMA_a078e880-a79a-4ef9-a3ba-4943965caac6"
      unitRef="usd">251000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTplZTc3NjM0YmNlNTE0ZTAzYmQxODJjNGY3YTU5NDJlZS90YWJsZXJhbmdlOmVlNzc2MzRiY2U1MTRlMDNiZDE4MmM0ZjdhNTk0MmVlXzQtMS0xLTEtMA_776d7325-6f8b-48a7-ad6d-97accc1e2e58"
      unitRef="usd">1948000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjUz_72dbea65-05ad-4f15-8e81-d61deafd5621">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,948&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="icf000a38a8df435292fe43a04c563e76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzEtMS0xLTEtMA_80132c26-c418-4acf-a917-2356c0e41ff5"
      unitRef="usd">939000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="icf000a38a8df435292fe43a04c563e76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzItMS0xLTEtMA_7644d4c1-48c8-4d70-8d29-fc6f75453b29"
      unitRef="usd">939000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="icf000a38a8df435292fe43a04c563e76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzMtMS0xLTEtMA_9d44ec65-ed37-4ef0-8aad-5cdce0b2f01c"
      unitRef="usd">213000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="icf000a38a8df435292fe43a04c563e76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzQtMS0xLTEtMA_99d895a6-132a-4471-ae4c-113c6a88eb2e"
      unitRef="usd">38000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="icf000a38a8df435292fe43a04c563e76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzUtMS0xLTEtMA_adfb949d-5856-446e-8f71-821cb352ee90"
      unitRef="usd">19000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="icf000a38a8df435292fe43a04c563e76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzYtMS0xLTEtMA_6699817a-00fa-430b-9d27-f4ddb4341d4c"
      unitRef="usd">162000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiNzBlNzFhMDg2ZDg0ZWExYWRlZWM1MGFlZDQyMTIwMC90YWJsZXJhbmdlOmI3MGU3MWEwODZkODRlYTFhZGVlYzUwYWVkNDIxMjAwXzctMS0xLTEtMA_1be5916f-89ae-4225-8a91-3b0165ebacaa"
      unitRef="usd">1948000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i2d4a16a910d843b39c9267e9b852ca12_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjUy_38f6fc13-a126-4b75-aae4-ce0896bf34d9">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4c966453e2a342b3a3f4d64f2c1428d0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItMS0xLTEtMA_194b83a3-2437-4eb5-ac03-d0b62382134d"
      unitRef="usd">908000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie298bcc204ee4eb6b430de4388bf4f81_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItMy0xLTEtMA_dbb6c6aa-3ef0-4a85-8750-daec6b8d8d13">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i761fd86626924956bb4384aaa7769a24_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItNS0xLTEtMA_7b0c0fef-f2dc-41ec-be3e-39031f491aac">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="ie298bcc204ee4eb6b430de4388bf4f81_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItNy0xLTEtMA_a5c98cf0-349c-4dfd-a1e3-9146b7380b71"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i761fd86626924956bb4384aaa7769a24_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzItOS0xLTEtMA_a3c3b3dc-b902-4f0c-995e-a04a1200672e"
      unitRef="number">0.23</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0cf378e387584a16a29c91ef5252aa72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtMS0xLTEtMA_bbd5a089-9222-42ba-ada7-dfb31d23c136"
      unitRef="usd">31000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i01e3c724a40741a28dbc546b88724c67_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtMy0xLTEtMA_32491e25-518e-4442-adf1-0564af5c53f4">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia5bf5b7491cc40229dcf4fc38c3ff0db_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtNS0xLTEtMA_7170223f-614f-4502-bc3b-f95c788e37f0">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i01e3c724a40741a28dbc546b88724c67_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtNy0xLTEtMA_c46f90a7-61ec-477b-9c56-77033950d3d0"
      unitRef="number">0.13</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ia5bf5b7491cc40229dcf4fc38c3ff0db_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzQtOS0xLTEtMA_baccc4e8-4169-49fc-8103-4c20887ec0c2"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i4c571473f99c4f8ead199ef961c9e48e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzYtMS0xLTEtMA_88d8a0f6-c6af-4a89-b21e-899d02240e1f"
      unitRef="usd">213000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <bsx:DiscountRateFairValueInput
      contextRef="i172db034d54f4af59ea3ef913e7f74b6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzYtNy0xLTEtMA_0897ffd4-68b0-40dd-a408-8651afeb5073"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="icf000a38a8df435292fe43a04c563e76_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NWRjYjI4ZjFjYTE0MzkzYjk5NDQ4OTlmYmY3NzFhYy90YWJsZXJhbmdlOjU1ZGNiMjhmMWNhMTQzOTNiOTk0NDg5OWZiZjc3MWFjXzctMS0xLTEtMA_26c8b533-145e-4273-88e0-d40f6f0d4554"
      unitRef="usd">1153000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzIwNjU3_5a312fed-8c8a-4d5b-a428-f95e12fa8f6d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;347&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded related to current year acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration arrangements transferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzEtMS0xLTEtMA_6e06355d-8263-4b60-88c3-d95dd12451c7"
      unitRef="usd">347000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzItMS0xLTEtMA_0c4c502c-ef28-413b-bde3-562b7a8ca6c6"
      unitRef="usd">127000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzQtMS0xLTEtODU1NA_b90893d5-cc09-4ff6-8e6a-88fb1585e5c4"
      unitRef="usd">-16000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzQtMS0xLTEtMA_e7d7d8fe-65d4-48da-8bc3-33a9c6ed62e2"
      unitRef="usd">-35000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:PaymentOfContingentConsideration
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzUtMS0xLTEtMA_b16cd8b6-0dfe-46d5-a501-0f3213746e39"
      unitRef="usd">68000000</bsx:PaymentOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzYtMS0xLTEtMA_1a16af1a-03b9-4f8b-b045-53c600b2de80"
      unitRef="usd">354000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzEwLTEtMS0xLTA_69f16185-a21f-4e6c-8b87-5fcdd9871174"
      unitRef="usd">-100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:PaymentOfContingentConsideration
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzExLTEtMS0xLTA_d1aaf4e3-5fbe-4a04-b03b-50436284de34"
      unitRef="usd">58000000</bsx:PaymentOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTo1NDYxOGI3NTMzYmU0Nzk2YWQyZTMxYmMwMmI5MTJiMy90YWJsZXJhbmdlOjU0NjE4Yjc1MzNiZTQ3OTZhZDJlMzFiYzAyYjkxMmIzXzEyLTEtMS0xLTA_f714630e-e682-464a-aed1-21677b677624"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzE4Mjg4_88c2bbd6-7ce4-4888-9760-6f4261f0e43a"
      unitRef="usd">532000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxNzg4ODE_3cd1823f-d395-4bc0-b650-628050648a1d"
      unitRef="usd">-100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzI3NDg3NzkxMjkyNzM_4a90a924-4bc4-4917-a164-223e908aaf9e">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$104 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$93 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic81e0a9293d34d779237110332e1ab2f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzEtMS0xLTEtMA_67fd80c3-b9f9-47d1-8f4a-39d94b32c96d"
      unitRef="usd">104000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="ifa490a08b9e140b4b87e705cf3401a77_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzEtNC0xLTEtMA_da046651-fa79-48f1-a80d-64de11d93c45"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i225a40fb505b4a9ea385c6900535fdf6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzEtNy0xLTEtMA_f6153892-2ebd-4a92-8d14-10dd172da5eb"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="ic81e0a9293d34d779237110332e1ab2f_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzItNC0xLTEtMA_25f71c91-23df-4955-ae8a-cdc483f69a09"
      unitRef="number">0.90</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="id3a7f90c9cea4edc82150a9d77fd688d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzItNy0xLTEtMA_f5f3f89d-c1db-4121-a767-c1fbfa6cb13c"
      unitRef="number">0.90</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i85248c1e3e8d4e798e32297ec2f4a394_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzQtMS0xLTEtMA_3533138e-242b-450b-8edc-0867f79c9873"
      unitRef="usd">93000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="i21f76d998b4a431984b2deeb969e9e85_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzQtNC0xLTEtMA_b0fab79e-09ff-4d76-a2ae-ff55ad01cb41"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ib29c8720d4e5458c8a5b0b896a9227d5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzQtNi0xLTEtMA_1dac3d12-ac46-4bfa-a985-7513d8d9d148"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ib31907c21c804935b3eabe4556382002_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzQtNy0xLTEtMA_8d815b86-fc7e-430b-97ab-5301ce18f8b9"
      unitRef="number">0.13</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i7c0d71a4a1294e5a9aaa4452bcfcc83d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzUtNC0xLTEtMA_6d7f6c93-9d35-48e5-a877-ec0fa76d649f"
      unitRef="number">0.80</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i5da8394a7b3140a8b169f5c7d428772b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzUtNi0xLTEtMA_35dfcdb0-cad6-4074-ba6f-f55f2ac5db5c"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="ifab990ff13f04a489cc2ddc900075cbb_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZTpiMzFiZGI1NThlNGY0OTQ3ODRlZTFiZDRhMmIzYWJmMS90YWJsZXJhbmdlOmIzMWJkYjU1OGU0ZjQ5NDc4NGVlMWJkNGEyYjNhYmYxXzUtNy0xLTEtMA_a03eb26c-90be-4581-97af-c60e8f5266bf"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzMyOTg1MzQ5MTM4MjA_132b9ddc-7016-4979-8497-6ce645f11688">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;458&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzItMS0xLTEtMA_3caa92be-ed1b-4794-8f6d-710cddcf4de3"
      unitRef="usd">319000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzItMy0xLTEtMA_e0fa71c2-c90d-46aa-9920-cfae5bd5a97c"
      unitRef="usd">264000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzMtMS0xLTEtMA_0c5b88bf-4ceb-4e69-8f1c-f814e0f594a6"
      unitRef="usd">183000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzMtMy0xLTEtMA_f4fff1f9-0587-4dc0-8b5c-24204d1c8ba0"
      unitRef="usd">171000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzQtMS0xLTEtMA_7fa941e5-0d3c-4c61-b59f-c25bd850e2a5"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzQtMy0xLTEtMA_e48194a6-c850-41db-94d0-aceac6294c51"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzUtMS0xLTEtMA_1fd859ca-0b89-4a66-8bb0-c51c30000849"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzUtMy0xLTEtMA_c815f300-cba7-4098-98b5-9c97e48b5e1b"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:Investments
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzYtMS0xLTEtMA_94be00c3-4ecd-4b61-ad48-1f55d67db54e"
      unitRef="usd">918000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90YWJsZToyMmMyYTBhOThlYmM0Y2M3OTVlYjMzZjUyMzg4YTAxNy90YWJsZXJhbmdlOjIyYzJhMGE5OGViYzRjYzc5NWViMzNmNTIzODhhMDE3XzYtMy0xLTEtMA_d56865e9-91f8-4723-b574-5103baff1239"
      unitRef="usd">458000000</us-gaap:Investments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTc5NzM_7e29be69-1c14-4151-8518-75ce3f327ef4"
      unitRef="usd">363000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDMvZnJhZzowNWY3Y2MxMjY4NDg0Y2FiYTU1MWQwMTZhZmY5NWU2ZS90ZXh0cmVnaW9uOjA1ZjdjYzEyNjg0ODRjYWJhNTUxZDAxNmFmZjk1ZTZlXzU0OTc1NTgxOTc0Mjc_d032d0fe-81f1-488d-9987-ed7a6cc2cf9b"
      unitRef="usd">272000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGV4dHJlZ2lvbjphNzFkYTNhNzc4MDI0YjhmYTcwMzEyMzNjM2NiZGRmZV81NDk3NTU4MTYxMzU2_f93efd86-dc26-456a-8d05-e786ad5cc356">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE C &#x2013; ASSETS AND LIABILITIES HELD FOR SALE&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of $800 million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement includes the transfer of five facilities and approximately 280 employees globally. The transaction is expected to close during the first half of 2021, subject to customary closing conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, we have classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less costs to sell. Assets within the disposal group are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and liabilities are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our consolidated balance sheets. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities held for sale included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as of December 31, 2020, we had foreign currency translation adjustments of $107 million contained within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt; attributable to the Specialty Pharmaceuticals business to be released upon the closing of the transaction.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGV4dHJlZ2lvbjphNzFkYTNhNzc4MDI0YjhmYTcwMzEyMzNjM2NiZGRmZV8yNzQ4Nzc5MDg4MDQ0_ae7fb70f-bb50-4324-97a6-efa611c19699"
      unitRef="usd">800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGV4dHJlZ2lvbjphNzFkYTNhNzc4MDI0YjhmYTcwMzEyMzNjM2NiZGRmZV81NDk3NTU4MTYxMzU3_c8af59c7-ad6f-47db-bcd7-7e621f439b7f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities held for sale included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xLTEtMS0xLTEzODU2_89948fac-ffe8-445c-b70d-75287221b80a"
      unitRef="usd">37000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xLTEtMS0xLTgzNzE_d091a40c-e76f-432f-b568-3050b0825bb1"
      unitRef="usd">24000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8yLTEtMS0xLTgzNzE_7fed4567-a1cd-43d9-98aa-3374d7f49c37"
      unitRef="usd">79000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8zLTEtMS0xLTgzNzE_49305cf8-5f23-45bb-8aa0-6c5b1fa65f71"
      unitRef="usd">17000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV80LTEtMS0xLTgzNzE_c92beb0a-b938-4f7f-a819-83ec5584b87e"
      unitRef="usd">175000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV81LTEtMS0xLTgzNzE_acffb073-f1cd-4c2d-bff8-6c10c9936b12"
      unitRef="usd">758000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent>
    <bsx:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV82LTEtMS0xLTgzNzE_6ff0e721-66bc-46bd-98e8-a4247476b1d9"
      unitRef="usd">45000000</bsx:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV83LTEtMS0xLTgzNzE_1d16b292-6675-4bdf-a1fc-0eb91d9d3ca9"
      unitRef="usd">1133000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV85LTEtMS0xLTgzNzk_74eb3d8c-765b-4c3f-b080-5b92fcbdf2ce"
      unitRef="usd">25000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xMC0xLTEtMS04Mzc5_127b0b35-51f1-4581-be9b-b75b31e52bda"
      unitRef="usd">27000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xMS0xLTEtMS04Mzc5_e734bcdb-4bc9-4e03-b25a-d2b5a2c3efcc"
      unitRef="usd">148000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGFibGU6OTY1MWRkMjhmMWUzNDRlYmJjMTg4OGJlODUyMWY1YTUvdGFibGVyYW5nZTo5NjUxZGQyOGYxZTM0NGViYmMxODg4YmU4NTIxZjVhNV8xMi0xLTEtMS04Mzc5_52d02795-9d2d-4e31-9d9c-fcf08f893f32"
      unitRef="usd">200000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTM0L2ZyYWc6YTcxZGEzYTc3ODAyNGI4ZmE3MDMxMjMzYzNjYmRkZmUvdGV4dHJlZ2lvbjphNzFkYTNhNzc4MDI0YjhmYTcwMzEyMzNjM2NiZGRmZV81NDk3NTU4MTYxMzU5_3eaee706-bdfc-42a1-9de5-8d00d53c42b8"
      unitRef="usd">107000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzEzODQ_aa01f9ad-c22f-4d77-b610-df76d9c9c0d6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE D &#x2013; GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization/Goodwill Impairment Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization/Goodwill Impairment Charges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;377&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;782&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2020, following receipt of regulatory approvals, we reclassified certain of our IPR&amp;amp;D intangible assets to amortizable technology-related assets and began amortization to reflect their use over their remaining lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; were $460 million in 2020, $105 million in 2019 and $35 million in 2018. The impairment charges recorded in 2020 were primarily associated with our acquisitions of Apama Medical Inc. and nVision Medical Corporation (nVision) following management&#x2019;s decision to cancel the programs due to cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in 2020 also included charges related to our acquisition of Sadra Medical, Inc. (Sadra Medical) as a result of lower sales forecasts, as well as the cost of quality remediation efforts following the voluntary recall of our LOTUS Edge&#x2122; Aortic Valve System and subsequent discontinuation of the LOTUS platform. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,063&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency fluctuations and other changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,061&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;247&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency fluctuations and other changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill reclassified to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Current assets held for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, we recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $73 million related to our Specialty Pharmaceuticals business. We did not record any &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in 2019 or 2018. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion of our goodwill and intangible asset impairment testing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2020 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.127%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzE0MTY_4abac3d1-d991-4d1b-91da-6f1534f4edf7">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization/Goodwill Impairment Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization/Goodwill Impairment Charges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;377&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;782&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i50e34e4fce414bad91b9758bf3c925fb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzMtMS0xLTEtMA_1045a15c-9f95-4b63-ae8e-a27adb78f81f"
      unitRef="usd">11059000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i50e34e4fce414bad91b9758bf3c925fb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzMtMy0xLTEtMA_b807c09b-55c1-4746-b37c-3f6914973270"
      unitRef="usd">6179000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if6d6a824461a469cb0d94f10e9342c7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzMtNS0xLTEtMA_b01513ed-0c75-4090-b041-93ecfcad4bf8"
      unitRef="usd">12020000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if6d6a824461a469cb0d94f10e9342c7f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzMtNy0xLTEtMA_d1af0435-4d2d-4a72-a4c5-80e65186102a"
      unitRef="usd">5706000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i26e8cfad4e524c8bbce668b54331c93b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzQtMS0xLTEtMA_350566cb-9e51-4579-a330-675b87d78f97"
      unitRef="usd">511000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i26e8cfad4e524c8bbce668b54331c93b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzQtMy0xLTEtMA_6595e391-7129-49c5-9a25-ba6361bbf953"
      unitRef="usd">407000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i53e75f811f294c61b8be35eaba703298_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzQtNS0xLTEtMA_c86b11ab-c662-470e-93b4-73613e16acf0"
      unitRef="usd">525000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i53e75f811f294c61b8be35eaba703298_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzQtNy0xLTEtMA_b06124a3-da40-4b58-85af-a6bccd49cf0b"
      unitRef="usd">408000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1de9a90b228e4b489fceda143c56c8cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzUtMS0xLTEtMA_c27d0518-6e36-4e93-807d-7536347d6bf9"
      unitRef="usd">1775000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1de9a90b228e4b489fceda143c56c8cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzUtMy0xLTEtMA_045c0245-3d9f-447d-91e4-2e67e5c68211"
      unitRef="usd">1220000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4ad66c6f19564d8281c1fa550e0e9503_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzUtNS0xLTEtMA_d11590a1-8ebb-4684-9017-17c0ffd4849e"
      unitRef="usd">1754000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4ad66c6f19564d8281c1fa550e0e9503_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzUtNy0xLTEtMA_47545c49-600d-443d-a08b-77dc799cfcfc"
      unitRef="usd">1081000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzYtMS0xLTEtMA_8b3b6190-9857-4c1e-8ed3-14a2fdfecdf7"
      unitRef="usd">13345000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzYtMy0xLTEtMA_86df6118-2076-49e0-8d77-f7336d3d6cc4"
      unitRef="usd">7806000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzYtNS0xLTEtMA_79db63e0-fe04-481e-add8-a7fd5dfde3b5"
      unitRef="usd">14299000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzYtNy0xLTEtMA_59cd29a8-e847-4432-beda-54aea60001be"
      unitRef="usd">7195000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:GoodwillGross
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzctMS0xLTEtNjMx_d16f0cfc-94df-43f7-aff6-b9a9ce2809f3"
      unitRef="usd">19924000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzctMy0xLTEtNjMx_d0c17ecc-6a9b-4655-b9e7-ac97c85e8706"
      unitRef="usd">9973000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzctNS0xLTEtNjMx_05e06944-9808-4b6e-acb8-a7241b4e4ee2"
      unitRef="usd">20076000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzctNy0xLTEtNjMx_c7778227-b84e-4d9a-84b5-244a9536cf4b"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i15ebe498a99547009a19b14541a8843b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzktMS0xLTEtMA_273955c3-3591-47d9-a276-be524881ef37"
      unitRef="usd">257000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i8d6909276f2047e6aacb514e5552c63a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzktNS0xLTEtMA_cf1eb68d-d165-472f-9ea2-6638a09db7d4"
      unitRef="usd">662000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i41f1841703d848508d023ea0e135c3ca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzEwLTEtMS0xLTA_852ec45c-abac-4e90-81d8-82c0c155d2f4"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia322e236c1ba4565bcbe28841e306760_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzEwLTUtMS0xLTA_03eda13e-7936-4ea3-a21f-34b90d51e411"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzExLTEtMS0xLTA_dbad1cc0-14c4-4df1-baa1-1395c3b286c8"
      unitRef="usd">377000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTo4NzkxMGQ0OThiYTg0YzgyYjFiYzRjNTRlMmFhODc2ZC90YWJsZXJhbmdlOjg3OTEwZDQ5OGJhODRjODJiMWJjNGM1NGUyYWE4NzZkXzExLTUtMS0xLTA_5da9d0cf-1a33-441c-9e9c-4329f848b2bb"
      unitRef="usd">782000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzU1Mw_5c538a4c-8f90-4a07-9673-349dd2aca177"
      unitRef="usd">460000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzU2Mw_c4af45c3-6ab9-4f9b-be36-4d46386eaaef"
      unitRef="usd">105000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzU3Ng_01ec64d0-8883-413a-acaf-50e65b8df617"
      unitRef="usd">35000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzEzODE_93b6bdd2-9432-4842-8613-ddd3bb563716">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,063&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency fluctuations and other changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,061&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;247&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency fluctuations and other changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill reclassified to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Current assets held for sale&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ic32470da1e8e4392b88a0f486f43a9c1_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtMS0xLTEtMA_bd28c3bd-c021-407c-8eb8-53e8dd9fd058"
      unitRef="usd">2063000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9d70084f4dd7415eabb7a85e24d97a2a_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtMy0xLTEtMA_d7ee7ca9-58a7-4f03-81ab-66194e799eca"
      unitRef="usd">1924000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i604905e66a504173a840028f3327dd56_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtNS0xLTEtMA_edde02a9-b82d-4003-bc51-61a592ff4bc1"
      unitRef="usd">3925000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7793c5feec074fb6a77322031639508b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtNy0xLTEtMA_ec31db2e-0e83-4469-b431-0054cae304ac"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEtOS0xLTEtMA_80fd4626-b4d4-4373-b6e5-edb0a8981084"
      unitRef="usd">7911000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtMS0xLTEtMA_71eaaf7b-15a1-48ce-a1a0-7c0ddf0398bc"
      unitRef="usd">-1000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtMy0xLTEtMA_e0f7960d-07e7-4bd4-a722-4b1bc1b67489"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtNS0xLTEtMA_778cb794-5683-4d42-98c7-f648470a062b"
      unitRef="usd">58000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtNy0xLTEtMA_b6ce2f4a-b46e-4cde-bb0f-118d2caa8bcb"
      unitRef="usd">9000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzMtOS0xLTEtMA_af6a2443-c760-4fe8-832e-960323a97ca1"
      unitRef="usd">66000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtMS0xLTEtMA_80e67f85-0116-42fa-9412-ff7f446af285"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtMy0xLTEtMA_fbde0985-fb97-4e7b-a341-fb7e47186cc1"
      unitRef="usd">268000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtNS0xLTEtMA_c423465d-239f-42df-a73f-e0dadd28f375"
      unitRef="usd">1712000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtNy0xLTEtMA_48366408-eef8-4c3e-9044-f6f86d178e75"
      unitRef="usd">238000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzQtOS0xLTEtMA_973c06e6-2b65-466d-8953-9f5cccf1c960"
      unitRef="usd">2218000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtMS0xLTEtMA_d2476021-cace-4d42-afac-224d66b9ffa8"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtMy0xLTEtMA_5ccdcc74-6785-47aa-bf7d-a218b4940bd2"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtNS0xLTEtMA_9ff81f03-a60e-43fb-9912-6ed9e2b3cecc"
      unitRef="usd">19000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtNy0xLTEtMA_6b4d3658-d552-402c-b1c1-cdc008f172e5"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzUtOS0xLTEtMA_603c9930-fba3-44d1-91fc-c5477a7acc3d"
      unitRef="usd">19000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:Goodwill
      contextRef="i4452aaad562b4bb899286f3797d9eb2d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtMS0xLTEtMA_9716d85e-4f8e-4b8f-8c1f-a88f8b5f5814"
      unitRef="usd">2061000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3e86856187e44c808f6433015dceb738_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtMy0xLTEtMA_d90f1441-eff3-4008-b5ae-da9050f927d3"
      unitRef="usd">2192000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i74c2fb79c41b4be6bf7aa2326d6b1cae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtNS0xLTEtMA_e898e000-baf0-4ed6-8a27-ff971ef551be"
      unitRef="usd">5676000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibd58d69b28dd40519b4334498825790f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtNy0xLTEtMA_51e66d50-1061-4803-b452-83410dea29ef"
      unitRef="usd">247000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzYtOS0xLTEtMA_1f0f819a-f7dc-4063-8695-b905cfcc4c05"
      unitRef="usd">10176000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtMS0xLTEtMA_7c1f071c-0037-41b3-b863-a09df7bfbfb5"
      unitRef="usd">-2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtMy0xLTEtMA_cfa94fbb-04f2-46b1-8a07-66b0e1491c1b"
      unitRef="usd">3000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtNS0xLTEtMA_1c7a3d20-5392-41dd-a0d5-58f1ec304176"
      unitRef="usd">22000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtNy0xLTEtMA_d7d758d5-10b5-4e29-980c-ce2cb233d3d1"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzgtOS0xLTEtMA_3b5fa9ea-884d-4dd2-b6e3-0ef71bc03f3e"
      unitRef="usd">22000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTEtMS0xLTUwMzU_14be819b-2930-439b-aa5c-560016af6ada"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTMtMS0xLTUwMzU_2845b794-2686-461f-8b93-f01d7f569479"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTUtMS0xLTUwMzU_a15ee14a-aa40-4eb0-b8e8-da3571d7e98a"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTctMS0xLTUwMzU_cb85a980-be69-4178-83f4-a7edf13e5733"
      unitRef="usd">-73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzEwLTktMS0xLTUwMzU_dea5b7a8-c750-4d73-b759-1c9ead4d6c68"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTransfers
      contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTctMS0xLTUwMzU_d6a24dd3-4908-44e0-be6f-2a4acd458b4e"
      unitRef="usd">-175000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTktMS0xLTUwMzU_9887e531-f26c-4c8c-96b1-ca7685e817ca"
      unitRef="usd">-175000000</us-gaap:GoodwillTransfers>
    <us-gaap:Goodwill
      contextRef="i36f17ca4d9f544e3b7cb7e5c6f72280c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTEtMS0xLTA_4fccd5ae-3cf7-4409-8599-f1df2bc0b9bd"
      unitRef="usd">2059000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i593eb42527b540c88a5921faa53b3629_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTMtMS0xLTA_6443d117-2035-45ae-8e75-c3fb717886c8"
      unitRef="usd">2194000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0d99afc9e3b24ff09921674dea102a4b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTUtMS0xLTA_008c53e2-763d-42a2-a632-c0164c9ad2f7"
      unitRef="usd">5697000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7768e07d07cb437d89233e0f9387ac2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTctMS0xLTA_0ff8b339-2427-4b00-8f8a-0c86540e7d47"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTpkYTQ0ZTg3NzQ0NGY0ZGNhOGZmZDhjN2VmZDBlNzgzZS90YWJsZXJhbmdlOmRhNDRlODc3NDQ0ZjRkY2E4ZmZkOGM3ZWZkMGU3ODNlXzExLTktMS0xLTA_ad04277e-f0f6-4c0a-9c0e-4030bcc1240c"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzY1OTcwNjk3ODY4ODI_957e7ce5-fcc0-4f10-bfe5-f5f042cd7971"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90ZXh0cmVnaW9uOmI3NmI3YTBiNDc3YzQyYzg5YzI3YjQzYTRhMWY0N2ZiXzE0MDY_bfe21adf-c642-4c12-8e8c-be1866a4d34a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2020 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.127%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzItMS0xLTEtMA_ef300c30-4875-464c-8fef-b1f0c1c2754a"
      unitRef="usd">689000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzMtMS0xLTEtMA_3f251035-88ec-4f87-a73e-b92039bd97f5"
      unitRef="usd">664000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzQtMS0xLTEtMA_b1755369-b4c9-465a-beea-70477d426942"
      unitRef="usd">651000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzUtMS0xLTEtMA_0d9244ea-1890-4587-95a1-616ee8e71e52"
      unitRef="usd">613000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDYvZnJhZzpiNzZiN2EwYjQ3N2M0MmM4OWMyN2I0M2E0YTFmNDdmYi90YWJsZTowZDIxNzViYzkxNGQ0YTc5OTM5ZTM3MjA0M2MwOWE2NS90YWJsZXJhbmdlOjBkMjE3NWJjOTE0ZDRhNzk5MzllMzcyMDQzYzA5YTY1XzYtMS0xLTEtMA_f4ae4ff2-fbc4-420f-942a-9d8806879fc7"
      unitRef="usd">560000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwMzM1_2fe8f260-933c-4c94-9c8c-f989880e9bb4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE E &#x2013; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Currency Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Management Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Euro, Japanese yen, Chinese renminbi, Australian dollar and British pound sterling. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast, particularly resulting from the impact of COVID-19 on transaction volumes. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Designations and Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax (OCI)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro, Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. We elected to use the spot method to assess effectiveness for our derivatives that are designated as net investment hedges. Under the spot method, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Foreign currency translation adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have elected to exclude the spot-forward difference from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. Amortization of the spot-forward difference is then reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to current period earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we completed an offering of &#x20ac;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. We dedesignated a portion of the net investment hedge in 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In 2019, we settled all outstanding contracts, for $294 million, which is presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Payments for settlements of hedge contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of cash flows. Upon settlement in 2019, we received &#xa3;3.312 billion of cash to fund our acquisition of BTG, which translated into $4.303 billion based on hedged currency exchange rates. We recognized a $323 million loss in 2019 and a $29 million gain in 2018 in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; due to changes in fair value of the contracts.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Interest Rate Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Management Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Designations and Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as cash flow hedges outstanding as of December&#160;31, 2020 and December&#160;31, 2019. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event that we designate outstanding interest rate derivative instruments as cash flow hedges we record the changes in the fair value of the derivatives within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was a $29 million loss as of December&#160;31, 2020 and a $34 million loss as of December&#160;31, 2019. We recognized immaterial gains and losses in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the amortization of our terminated cash flow hedges in the current and prior periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as fair value hedges outstanding as of December&#160;31, 2020 and December&#160;31, 2019. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated balance sheets into earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which generally offset. The balance of the deferred gains on our terminated fair value hedges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was immaterial as of December&#160;31, 2020 and December&#160;31, 2019. We recognized immaterial gains in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the amortization of the terminated fair value hedges in the current and prior periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The &#x20ac;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining time to maturity as of December&#160;31, 2020 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next two years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note Q &#x2013; Changes in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The &#x20ac;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Inputs to the valuation methodology are unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,605&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,865&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $1.584 billion invested in money market funds and time deposits as of December&#160;31, 2020 and $50 million as of December&#160;31, 2019, we held $150 million in interest-bearing and non-interest-bearing bank accounts as of December&#160;31, 2020 and $165 million as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our recurring fair value measurements using Level 3 inputs related to our contingent consideration liability. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, principally the contractual right to receive future royalty payments related to Zytiga&#x2122; Drug acquired with BTG. Prior to our acquisition of BTG, BTG agreed to pay 50 percent of the Zytiga royalty stream, net of certain offsets, to the inventors associated with the intellectual property. In the fourth quarter of 2019, we sold the remaining 50 percent we acquired through our acquisition with BTG of the future Zytiga royalty stream for an upfront cash payment of $256 million to the Ontario Municipal Employees Retirement System (OMERS). In accordance with FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we are accounting for the transfer of the royalty stream to OMERS as a secured borrowing, continue to recognize the financial asset and associated liability in our consolidated balance sheets and do not expect to receive any future cash benefit from Zytiga royalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected the fair value option to account for our licensing arrangements' financial asset and financial liability in accordance with FASB ASC Topic 825, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we have recorded the fair values using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2020 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$365 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$407 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of December&#160;31, 2020. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains or losses from the licensing arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded related to current year acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded related to current year acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;571&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Non-Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our strategic investments and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Goodwill and Other Intangible Assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a discussion of the fair values of our intangible assets including goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our outstanding debt obligations was $10.774 billion as of December&#160;31, 2020, including $1.118 billion relating to the euro-denominated December 2027 Notes, and $11.020 billion as of December&#160;31, 2019, including $1.004 billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzQ3MzY_ac05efa7-de8c-4aa6-aca2-663c5e930ce8"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzQ3NTQ_5f177565-b444-4ef5-9f6f-c3adfa17c8dc"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i80031cfd406b4f6593c9c5e695b180e8_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzQ3NTk_ad02b3e5-73a4-45a5-81b9-d7a7021fa3f9"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="ic2be247223ce41e9a14396e0b34bf4d2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzU3ODg_50b80874-e549-48b9-a136-04b00ee53a37"
      unitRef="usd">294000000</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:DerivativeCashReceivedOnHedge
      contextRef="i363dc865fad3412d89a91d89a180cd1b_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzYwODU_7c2cde82-576a-44dd-bd3e-d92328e1e81b"
      unitRef="gbp">3312000000</us-gaap:DerivativeCashReceivedOnHedge>
    <us-gaap:DerivativeCashReceivedOnHedge
      contextRef="i363dc865fad3412d89a91d89a180cd1b_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzYxNTA_bd99cbd7-7ede-40bb-8d60-4200e69b1443"
      unitRef="usd">4303000000</us-gaap:DerivativeCashReceivedOnHedge>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="ia635740e76374063a92852a9184832c4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzYyMTA_4d2ac00c-f538-4b81-ae20-14945d86e890"
      unitRef="usd">-323000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i2cfe49b594e3475db1d49e7d28359214_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzYyMzI_51883272-acf4-41a7-9dd3-cbc840389373"
      unitRef="usd">29000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1Xzg3NjY_908b1227-e435-4e6f-bfc8-865eb5a55dc3"
      unitRef="usd">29000000</us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet>
    <us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1Xzg3ODk_4b814c49-fae2-4663-a26a-b6c77843deb2"
      unitRef="usd">34000000</us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDI2_6695df72-6f0c-4813-93b4-ff5872bb104d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.213%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i465006924e984ad48ab06e31300af791_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzItNC0xLTEtMA_168c0b96-ca16-45d4-981e-787a8ca141b7"
      unitRef="usd">4531000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3071c36afac844cb8c57202c79fd7e82_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzItNi0xLTEtMA_80cc1666-486f-4ad6-89a0-0931777ccb68"
      unitRef="usd">3891000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieb470d28f5b6409baadf2c224feb3e23_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzMtNC0xLTEtMA_bb307240-f35c-435c-aaca-5253a10a2973"
      unitRef="usd">1004000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i05947140c3ba40e2aedcd05c7acf1a22_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzMtNi0xLTEtMA_57053f71-7b97-4b1a-8c16-d8a60d649937"
      unitRef="usd">953000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib3868068050b406f9f740e75ff11f2de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzQtNC0xLTEtMA_bc050266-75aa-42dd-b075-c945cf75d560"
      unitRef="usd">868000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iab5863a52ecf47d2b29b015beb18341d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzQtNi0xLTEtMA_998fc9fd-3754-442c-b864-4623a44b6c02"
      unitRef="usd">997000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia52ebd7217064b1ebf72672758698988_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzUtNC0xLTEtMA_2b3878cf-68b9-4622-91e7-eec7918f1d92"
      unitRef="usd">4946000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iaa9b86111b3449e7a2b76a24eeffe984_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzUtNi0xLTEtMA_e248497a-2cea-4034-a902-e028d6ebbf7e"
      unitRef="usd">4377000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzctNC0xLTEtMA_9376235b-41b7-48b4-a629-fafdbcbb0b67"
      unitRef="usd">11349000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTphYjIwMDgzZDQ5OTE0ZTUyYTYyOTkzNmJmYjU0YWI2ZC90YWJsZXJhbmdlOmFiMjAwODNkNDk5MTRlNTJhNjI5OTM2YmZiNTRhYjZkXzctNi0xLTEtMA_8486d497-c2f6-4a4e-997e-380db09b4d48"
      unitRef="usd">10218000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzEwMTM4_ac05efa7-de8c-4aa6-aca2-663c5e930ce8"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzEwMTU2_5f177565-b444-4ef5-9f6f-c3adfa17c8dc"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <bsx:ForwardCurrencyContractsTimetoMaturity
      contextRef="i248f8c480024432dac8c9a0ddc15c07d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzEwMzY0_72072e57-2faf-4995-94a5-e9e5e40dbb84"
      unitRef="units">60</bsx:ForwardCurrencyContractsTimetoMaturity>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwMzU2_87f97e5f-41b1-4f08-b3d7-a731a2ff15f3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note Q &#x2013; Changes in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtMS0xLTEtMA_1742764a-0bd8-496b-9f7a-c0e73abb476b"
      unitRef="usd">-99000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtMi0xLTEtMA_bc25e688-0cae-46d1-a091-52a479ff0423"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtMy0xLTEtMA_79163a7c-b53a-4935-b9cd-bfde6428d9a7"
      unitRef="usd">-77000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtNi0xLTEtMA_b8a9f635-3747-451a-9b62-2eaab52be34b"
      unitRef="usd">3465000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtOC0xLTEtMA_588dfaee-f3fa-4985-bb53-d41a3a8a988a"
      unitRef="usd">-83000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtOS0xLTEtMA_b858e33a-1382-41fa-bc5e-293a4c3c8f71"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9d9f79a854eb46e7a7ce5bc9aca39189_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzUtMTAtMS0xLTA_17aa83f7-c6af-4b09-8e37-e62065d9e689"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtMS0xLTEtMA_5a735f86-2899-47ed-b2b6-0332ab551dca"
      unitRef="usd">-37000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtMi0xLTEtMA_8fb245bb-8ee3-4366-bf01-7a6a246bf56c"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtMy0xLTEtMA_c669a1b5-c690-4b20-b4ae-1d0a9f84a3b1"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtNi0xLTEtMA_3df5f582-a36e-4b76-be63-5f8b4037578c"
      unitRef="usd">361000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtOC0xLTEtMA_6e73e76e-721e-40c7-bc06-370344e6fed6"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtOS0xLTEtMA_fdf34ab1-fa8c-4cab-a334-11cee568c862"
      unitRef="usd">5000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="ife5d288e5b274a1897d48f79fe1898ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzYtMTAtMS0xLTA_3415646e-df54-4365-93e7-131025118d61"
      unitRef="usd">19000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtMS0xLTEtMA_882adacd-b826-4274-a124-10b4614884f9"
      unitRef="usd">-89000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtMi0xLTEtMA_7dce6506-31ca-40b9-996c-6d34335d4773"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtMy0xLTEtMA_0d968885-da70-417b-8ea9-8bcfb80659db"
      unitRef="usd">-68000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtNi0xLTEtMA_2beee99c-34db-4442-8666-42e2b0914202"
      unitRef="usd">-362000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtOC0xLTEtMA_3fa1eb6f-249a-4db3-b9f7-28699a6c9360"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtOS0xLTEtMA_0621d4c6-0ad8-4486-9dd2-9e47c7292ff8"
      unitRef="usd">0</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i6053b2dfb5964bde9116753a5b67ea89_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzgtMTAtMS0xLTA_adef48ec-3aed-4dc3-bbf5-1943d8664daf"
      unitRef="usd">0</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTEtMS0xLTA_be398625-250c-4411-8480-830ce2a33971"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTItMS0xLTA_79dc644b-4aca-4269-806b-51b9f438ea2d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTMtMS0xLTA_95052fe0-8ed6-4ad7-8810-b1c522e17bd8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTYtMS0xLTA_3df5f582-a36e-4b76-be63-5f8b4037578c"
      unitRef="usd">361000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTgtMS0xLTA_95bbc4b4-01c5-4c92-8d99-be85f939c63d"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTktMS0xLTA_cc0c2133-e62a-4919-98aa-9ff312be9bea"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="icd0cce5755e845bc84ad3941856321ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEwLTEwLTEtMS0w_43b69fee-d856-4856-a9db-e79db95fde95"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTEtMS0xLTA_05e4f214-2895-4f5e-b21e-368f68a96d4f"
      unitRef="usd">150000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTItMS0xLTA_d4dfcefe-c71a-4af1-98fd-4fb6754f3c28"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTMtMS0xLTA_487a7375-af60-41c7-902a-47890dbb9f4d"
      unitRef="usd">117000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTYtMS0xLTA_df426cb5-3237-4bea-accb-c99353cf2772"
      unitRef="usd">3116000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTgtMS0xLTA_56d0dcd5-928a-4071-b193-b80b967f4bae"
      unitRef="usd">-73000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTktMS0xLTA_da9776bb-773a-48f9-8aa2-3bd96cc63bca"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i46fc99c55039477cb4562c44e8bd8e55_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzEzLTEwLTEtMS0w_30915b8b-fed8-4c4d-8e16-b4776ba79f8d"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTEtMS0xLTA_3e1500f0-1df5-46ff-83ae-f68c9688f96d"
      unitRef="usd">-68000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTItMS0xLTA_23a87387-6df7-4ef0-b835-59e472b536c4"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTMtMS0xLTA_93cc6c4e-faa1-40db-b46f-805c9ee94ae8"
      unitRef="usd">-53000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTYtMS0xLTA_177cfe74-7add-43df-ab0b-05e513f23beb"
      unitRef="usd">473000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTgtMS0xLTA_43d3c0f3-a5db-46ce-aa77-221f0707ff65"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTktMS0xLTA_b862e17b-59ab-479b-ada5-8090830b3d16"
      unitRef="usd">10000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i5d3ca2a7dedb4353af28679c4d3056f5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE0LTEwLTEtMS0w_eef7b1b9-e95c-4067-b3b3-f3b213272fbd"
      unitRef="usd">-33000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTEtMS0xLTEwODEw_713a5206-e02c-4432-b89e-b98de9554169"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTItMS0xLTEwODEw_adb6f52d-f869-4324-b356-6b388ca7bfd9"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTMtMS0xLTEwODEw_bc73d832-ba21-4bf4-b635-746ce6361344"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTYtMS0xLTEwODI0_9f575652-868b-40ab-a852-5464cb2e7f23"
      unitRef="usd">358000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTgtMS0xLTEwODE5_d9e392ad-d2db-4631-92f6-c6626e388e5e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTktMS0xLTEwODE5_09e1e3b0-c6da-4532-a07e-f542be9bfd4d"
      unitRef="usd">0</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i7baeb063e55243649c5aa26166df1f6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTEwLTEtMS0xMDgxOQ_9a047b68-f847-4739-9657-87684029f472"
      unitRef="usd">0</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTEtMS0xLTA_cc425355-3ea9-4014-bfa3-c7f1e719368e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTItMS0xLTA_32c7739d-4939-468b-9c81-40b441ace379"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTMtMS0xLTA_36af2d83-bd10-4695-947e-e689d28f4a9b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTYtMS0xLTA_177cfe74-7add-43df-ab0b-05e513f23beb"
      unitRef="usd">473000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTgtMS0xLTA_1a26183d-583d-43ba-bca4-58c67a284d9b"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTktMS0xLTA_b090d014-fcef-4fb2-a5be-12dcd9ba3e3b"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i1c43b74c73f741998dcb561c36966feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE2LTEwLTEtMS0w_f3d36b0c-f495-4ea5-bc55-bf5c87b00c15"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTEtMS0xLTA_6ce285f2-1368-4d3d-ab4e-4cc0eb43219d"
      unitRef="usd">167000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTItMS0xLTA_351e8c6e-fbf2-4226-8394-363d4031da68"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTMtMS0xLTA_130ad6dd-582a-4196-9137-124020477e76"
      unitRef="usd">130000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTYtMS0xLTA_b51b71e2-0629-4371-b8a0-8246eb265405"
      unitRef="usd">2813000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTgtMS0xLTA_51db832b-bea2-4ded-9c60-2a2d526d9dcd"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTktMS0xLTA_3732a033-303a-41d3-a8c9-20b116fc71e7"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8545367409b943308f16f9d561a3c06f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzE5LTEwLTEtMS0w_154abda0-e229-4b27-8440-6abc9d301849"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTEtMS0xLTEwNzY5_8809742c-6a4b-4801-b36e-15d05a07fff0"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTItMS0xLTEwNzY5_3d3d03ab-c106-4d1d-813f-3592ea5e5300"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTMtMS0xLTEwNzY5_870f328f-94a2-404f-932c-a085f2c7587f"
      unitRef="usd">-43000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTYtMS0xLTEwNzc2_e8c8b388-362e-494a-bd2d-9a90f15f662d"
      unitRef="usd">241000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTgtMS0xLTEwNzcy_b7bfc0e4-df9d-4327-aa11-a1a4915abd67"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTktMS0xLTEwNzcy_b6c2142e-fd6e-4a55-8ba2-bd5fbda4b77f"
      unitRef="usd">6000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i534caf4714ee47c2a679c7c53cd98bf2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIwLTEwLTEtMS0xMDc3Mg_88e369fc-5134-4573-abe0-141a066964f1"
      unitRef="usd">-21000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTEtMS0xLTA_4eeaf38c-c842-4d07-abe4-53f27e043dc1"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTItMS0xLTA_cef00114-7289-42df-9293-9c38e9ca238f"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTMtMS0xLTA_0f23e764-e0bf-4bfc-8208-b7911fd45da3"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTYtMS0xLTA_e8c8b388-362e-494a-bd2d-9a90f15f662d"
      unitRef="usd">241000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTgtMS0xLTA_80e70cd0-747f-44c3-949e-823faf47f659"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTktMS0xLTA_4be4d33f-7825-48b1-8682-546134fcbed2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i453f1b16aa6547a2a7ce07fbde3a9bd9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo1YTQ2N2Q4YzA2MmI0MzMwOThhNzQwMjY2YWQ5YmMzNy90YWJsZXJhbmdlOjVhNDY3ZDhjMDYyYjQzMzA5OGE3NDAyNjZhZDliYzM3XzIxLTEwLTEtMS0w_e8c6f3de-7c10-4609-a67c-b25d28ba12fe"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDIz_f3d5ebe1-a159-4532-9d40-7457290f1ffc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i21309996213144d8a28d7561f412fa26_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4ZWEwM2Y1YWQ1ZDA0OWM0OTZmZDg0ZDBiYTVkMDYyNy90YWJsZXJhbmdlOjhlYTAzZjVhZDVkMDQ5YzQ5NmZkODRkMGJhNWQwNjI3XzEtNi0xLTEtMA_dd514c5b-4119-49c1-b6a9-6045de3d0daa"
      unitRef="usd">21000000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet
      contextRef="iaad7391e2aa54540b42638571113812c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4ZWEwM2Y1YWQ1ZDA0OWM0OTZmZDg0ZDBiYTVkMDYyNy90YWJsZXJhbmdlOjhlYTAzZjVhZDVkMDQ5YzQ5NmZkODRkMGJhNWQwNjI3XzItNi0xLTEtMA_76d6210d-879c-4000-8b5b-27897f8954c3"
      unitRef="usd">13000000</bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="ie88422a1b3d241dc8f3bc3352cdf31a0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4ZWEwM2Y1YWQ1ZDA0OWM0OTZmZDg0ZDBiYTVkMDYyNy90YWJsZXJhbmdlOjhlYTAzZjVhZDVkMDQ5YzQ5NmZkODRkMGJhNWQwNjI3XzMtNi0xLTEtMA_699e8490-2219-4316-a020-61c6cb817db0"
      unitRef="usd">-5000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwMzM0_83db553a-8bab-4752-a270-e2e325771246">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.035%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i4564e07d2f464045890d0a82a7f30f1b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzItNC0xLTEtMA_2a389ae1-bc81-4fea-bfa1-9443b7e539fe"
      unitRef="usd">73000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i4cef46aa868a4404ad3def8d54a0fa7c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzItNi0xLTEtMA_f5ae51e8-26fe-4608-90c0-1d3c95581152"
      unitRef="usd">-343000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i8adfba5c23d24bc7b650917ab0f27ebe_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzItOC0xLTEtMA_847a155a-f537-4aea-91bb-bf5fea9c23a3"
      unitRef="usd">41000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i4564e07d2f464045890d0a82a7f30f1b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzMtNC0xLTEtMA_971d2ca4-22c8-495d-98d3-0c1ff9a86d39"
      unitRef="usd">-105000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i4cef46aa868a4404ad3def8d54a0fa7c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzMtNi0xLTEtMA_7dafd3d3-f52f-41eb-804f-418a52c1fbc9"
      unitRef="usd">-15000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i8adfba5c23d24bc7b650917ab0f27ebe_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzMtOC0xLTEtMA_a8b79bf4-45b3-4a5f-814d-516dd53be9ce"
      unitRef="usd">-30000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i4564e07d2f464045890d0a82a7f30f1b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzQtNC0xLTEtMA_44748ae0-99f1-4bcb-a70b-a519e0e2d946"
      unitRef="usd">-32000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i4cef46aa868a4404ad3def8d54a0fa7c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzQtNi0xLTEtMA_b3d862d9-f0d1-4e8c-8fa1-685766619042"
      unitRef="usd">-358000000</bsx:NetCurrencyExchangeGainLoss>
    <bsx:NetCurrencyExchangeGainLoss
      contextRef="i8adfba5c23d24bc7b650917ab0f27ebe_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTplNTcyOTc4YjUxZDc0Nzk4OWRhOTJlNTk3MWM1MjFkOS90YWJsZXJhbmdlOmU1NzI5NzhiNTFkNzQ3OTg5ZGE5MmU1OTcxYzUyMWQ5XzQtOC0xLTEtMA_64887ee8-b8dd-4325-b61d-57e3896ce732"
      unitRef="usd">11000000</bsx:NetCurrencyExchangeGainLoss>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDE1_72e70d77-f2fb-40a8-bc69-322bf788797f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means.</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDAz_90218bba-2b69-4764-a95f-76a703e18975">The following are the balances of our derivative and nonderivative assets and liabilities:&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The &#x20ac;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i15892080636d4d31ae5423c34889e21a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzQtNC0xLTEtMA_e96a9d46-295b-42d5-974d-9c954f8d9d48"
      unitRef="usd">53000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i2eb9d0a4cfa94defa4a9c54410555954_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzQtNi0xLTEtMA_29add0dd-d0ce-4162-bd55-9abf13488fd9"
      unitRef="usd">72000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i48fa4493001d449ba145886a80478889_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzUtNC0xLTEtMA_7f18ecc1-7240-4234-9874-872066962b4e"
      unitRef="usd">109000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i905b6a41d15a4b2088787d8381188854_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzUtNi0xLTEtMA_cef5fedf-e30f-4682-80dd-f4458bfc3304"
      unitRef="usd">216000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i2e7225eec3d5430180f5e3302849762c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzYtNC0xLTEtMA_f9f61a18-b71a-47db-8503-2d40e85a0107"
      unitRef="usd">162000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i0fcbf0b422564ac6ad7c97196af88615_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzYtNi0xLTEtMA_fc5d3cb3-c336-4e5f-ad11-d56e94825f1e"
      unitRef="usd">288000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i8f7f17dea41f463eb86f00e0bd3fd2f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzgtNC0xLTEtMA_d2b8f5aa-80c0-46c2-8300-c0260ea7c216"
      unitRef="usd">79000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i928052d310a84aef81dc5679f247ce6c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzgtNi0xLTEtMA_8dced763-c8c9-4de6-b119-408a6e5a695a"
      unitRef="usd">33000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzktNC0xLTEtMA_e1214ea5-14b0-4ce0-8e49-5453e2453697"
      unitRef="usd">242000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzktNi0xLTEtMA_61ad5a7c-099a-4785-a98e-f984a81e7ee9"
      unitRef="usd">321000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i4efb48e17cbd415e8d90d23bb91fbf35_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzEzLTQtMS0xLTA_834e8944-faef-46f9-bff0-fd9c9113f4a7"
      unitRef="usd">44000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ic80933ec2cc54616bb475d09124b5eb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzEzLTYtMS0xLTA_4dd8f481-e9e2-4aab-ba53-1157278a227d"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="icd4142356f2c47c3b2a80ca179a5478e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE0LTQtMS0xLTA_429ba127-1f7c-474b-87e9-25fdedca7300"
      unitRef="usd">54000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i008481e22f624470b6a792954311af1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE0LTYtMS0xLTA_2340e7af-928c-451f-81ec-d797ca7fd642"
      unitRef="usd">8000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i93cb97c15d414cb69088b89bb3fca575_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE1LTQtMS0xLTA_f89bb84e-93af-446f-b23a-e6bc0b0ccc0e"
      unitRef="usd">1094000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i49e7446a63114d61a987f7353caaa479_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE1LTYtMS0xLTA_aca5680b-95ff-496e-a1fc-ec7924050b12"
      unitRef="usd">998000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i2e7225eec3d5430180f5e3302849762c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE3LTQtMS0xLTA_6d60dd64-5d24-45aa-8c14-954d03a71fa5"
      unitRef="usd">1191000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i0fcbf0b422564ac6ad7c97196af88615_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE3LTYtMS0xLTA_ee7cf7e2-1d05-44ca-9782-8ae281175b00"
      unitRef="usd">1009000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i722eb9acea26411b9150036527416c41_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE5LTQtMS0xLTA_ff52172d-a5d4-4849-8da9-2cac09508303"
      unitRef="usd">71000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i59a8047f3879432c83f1a1b97f95fb61_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzE5LTYtMS0xLTA_9223ca24-b507-4578-9e1d-146baaee1e5c"
      unitRef="usd">29000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzIwLTQtMS0xLTA_f2392de6-e9c5-40a3-a094-44421aa4b7d5"
      unitRef="usd">1262000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkZGEzMjQyM2RlMmM0Y2FlYjYzMTkyYjJmMjFhZDg5Mi90YWJsZXJhbmdlOmRkYTMyNDIzZGUyYzRjYWViNjMxOTJiMmYyMWFkODkyXzIwLTYtMS0xLTA_0b4b2be0-1fd9-492e-b4e3-442862538691"
      unitRef="usd">1037000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LongTermDebt
      contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzU0OTc1NTgxNzM3MjA_ac05efa7-de8c-4aa6-aca2-663c5e930ce8"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzU0OTc1NTgxNzM3Mzk_5f177565-b444-4ef5-9f6f-c3adfa17c8dc"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwNDEw_3f20157d-1657-41ba-ac90-451806ccb244">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,605&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,865&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2020 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$365 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$407 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded related to current year acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded related to current year acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;571&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMS0xLTEtMA_230453e8-2079-416a-b74a-26c4828211a0"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMy0xLTEtMA_1b038707-ad88-4b1a-ab77-b41b969a2158"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtNS0xLTEtMA_a267a323-f17d-40f2-8508-650b6c6d6b86"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtNy0xLTEtMA_341fd6f5-e498-453d-a3f6-f67a025e530b"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtOS0xLTEtMA_80a3e131-8012-4fe3-87b6-414d6225b689"
      unitRef="usd">50000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMTEtMS0xLTA_e948a87b-d376-42dc-8ce0-c92216df3c82"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMTMtMS0xLTA_29b408f5-600b-495c-9a2f-dfd8bcc8b7a0"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzQtMTUtMS0xLTA_41b600fa-254c-494d-bc44-fcb020fd241e"
      unitRef="usd">50000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMS0xLTEtMA_b444d906-fbeb-4c68-9945-31b5c7144d80"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMy0xLTEtMA_70cc1527-ac4d-4137-ae0b-5406aaa6185e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtNS0xLTEtMA_a5e53783-201e-4ee1-916c-9a35bd896998"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtNy0xLTEtMA_7c2f1cd7-129d-4c2a-8a0c-1b78b9075cc7"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtOS0xLTEtMA_be353c07-fe21-4ac5-8dc2-5ed49026275a"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMTEtMS0xLTA_124c297a-22b6-411b-af83-9593f3a78376"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMTMtMS0xLTA_da1ae609-5bfd-4d14-8b07-8a29f972ade0"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzUtMTUtMS0xLTA_e48083c7-eb7d-44aa-b7c2-cdcfc4f7c23c"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMS0xLTEtMA_4092d81a-22d0-4b2b-8228-b23eaf334d45"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMy0xLTEtMA_924e7e48-d9e5-467c-9769-ce1f8c0e9483"
      unitRef="usd">242000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtNS0xLTEtMA_2a17637b-2bd1-4319-a5cd-93db2dc3d843"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtNy0xLTEtMA_70aaf307-dce6-49df-a449-b35af91ac727"
      unitRef="usd">242000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtOS0xLTEtMA_452aa28e-a40f-4f5c-9eac-8140d8f4a40a"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMTEtMS0xLTA_7da40e5c-fcb6-4020-9648-5d31e2b6f1d7"
      unitRef="usd">321000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMTMtMS0xLTA_bb812cb6-ad80-4de4-bbf2-1ad61ee2a39d"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzYtMTUtMS0xLTA_85b895df-99a3-4954-a1c5-d3805a82a909"
      unitRef="usd">321000000</us-gaap:DerivativeAssets>
    <bsx:LicensingArrangementsAsset
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMS0xLTEtMA_eb373f58-5e6b-4f3f-bfd4-1e0b5fbf748d"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMy0xLTEtMA_7b6c5ed0-3e4f-43dc-a03c-58d9d800b3c1"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctNS0xLTEtMA_0010bce4-9fd0-458d-9964-99df56f13cfa"
      unitRef="usd">365000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctNy0xLTEtMA_82768f3b-5afc-4efd-81d8-2c67f336b8d6"
      unitRef="usd">365000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctOS0xLTEtMA_186a920f-169d-41c3-897d-b0b9363bf0a3"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMTEtMS0xLTA_89a02310-7ea9-4b4d-a246-41e249ed8523"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMTMtMS0xLTA_0412eb68-603e-4c40-bea6-7547c7b3e4c8"
      unitRef="usd">518000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzctMTUtMS0xLTA_18fac086-e182-4bc0-9a36-aed9df40d6a6"
      unitRef="usd">518000000</bsx:LicensingArrangementsAsset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMS0xLTEtMA_570ef5b9-a66f-4cb3-b124-e83d21e869d9"
      unitRef="usd">1998000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMy0xLTEtMA_7c9113c2-940e-40eb-a8da-15883162fe6b"
      unitRef="usd">242000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtNS0xLTEtMA_5a7ac7c6-2874-4498-8b08-b0321e6bf02a"
      unitRef="usd">365000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtNy0xLTEtMA_47277b45-1734-4f0b-a241-89d28f5fe303"
      unitRef="usd">2605000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtOS0xLTEtMA_07e174c7-5d51-443a-9f56-2b06bd39360b"
      unitRef="usd">51000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMTEtMS0xLTA_25164119-fceb-48ff-a022-487279cadd52"
      unitRef="usd">321000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMTMtMS0xLTA_59024fe7-5733-40d9-9f04-dcfbab969234"
      unitRef="usd">518000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzgtMTUtMS0xLTA_582e3171-5b83-4ba5-a6ee-139dbe14d7c9"
      unitRef="usd">890000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTEtMS0xLTA_8febd73a-0c38-46c6-9103-c1b49a42636f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTMtMS0xLTA_a9720a11-d5ca-413f-878f-87065b35a3f1"
      unitRef="usd">1262000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTUtMS0xLTA_7ddbbe93-60fc-47da-a09f-ce755dea209b"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTctMS0xLTA_d4e14535-a4ad-4571-8b7b-a03b9fa35ab3"
      unitRef="usd">1262000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTktMS0xLTA_0fd590a9-bccf-41fe-9dd3-3169b71d650a"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTExLTEtMS0w_77977a78-e4fb-445c-8135-51ae69822402"
      unitRef="usd">1037000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTEzLTEtMS0w_1ffd092f-67b4-4293-9d75-b6b9b5aa666f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEwLTE1LTEtMS0w_1253c5eb-cdbb-4795-80ac-c80fa9321122"
      unitRef="usd">1037000000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTEtMS0xLTA_e0a3f065-b4cb-4d98-abcb-5c11d8cb7fbf"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTMtMS0xLTA_c24bd9a0-25ad-4603-8f3d-d40f1ca9877c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTUtMS0xLTA_9b7d8b33-0f46-46eb-b0b5-be405a9546d7"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTctMS0xLTA_eeac6db6-ef98-4d36-81bd-1a8066d004e8"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTktMS0xLTA_42cd0124-262a-47cf-b381-813308270822"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTExLTEtMS0w_8074c36e-6e43-43c2-9d9b-b1f052752645"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTEzLTEtMS0w_d4d4892a-ee71-4d28-994c-150dcc989f80"
      unitRef="usd">354000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzExLTE1LTEtMS0w_3d4519f8-3743-45b0-9b1f-d9e08ab833e8"
      unitRef="usd">354000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTEtMS0xLTA_cf85fd50-8788-4191-bad7-d51de3850f78"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTMtMS0xLTA_ec4c8995-c7cb-467e-b29a-855c155f2c18"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTUtMS0xLTA_48e0b731-9a7d-4b83-8bce-c21d0b5d57eb"
      unitRef="usd">407000000</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTctMS0xLTA_69553c2c-25ee-41b5-8047-3a7eb943f531"
      unitRef="usd">407000000</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTktMS0xLTA_b7eeaad5-e1a3-4341-b977-09dc67257d2d"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTExLTEtMS0w_b71625b8-2a9d-4160-b01e-0c0345fb43e9"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTEzLTEtMS0w_22b8c310-ece7-4612-a2fc-0ee0be6501b1"
      unitRef="usd">571000000</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEyLTE1LTEtMS0w_c17be766-204c-4d73-a869-ef05b5ca6fb5"
      unitRef="usd">571000000</bsx:LicensingArrangementsLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTEtMS0xLTA_ebfbd874-b168-4ccb-b9d3-1b371034bc68"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibc3b62df941c48789aff4200f8e67d59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTMtMS0xLTA_ec76cff9-9a7c-4a2b-8c33-a192a4627866"
      unitRef="usd">1262000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i06cc0641dd65461ca4819856ac55e362_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTUtMS0xLTA_b7f2b6f6-b838-49fd-b0a8-3a4f2d75b9d5"
      unitRef="usd">603000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3407186c51da4b5bae15fe9b0b42918f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTctMS0xLTA_fc202305-eafb-440f-896d-092f1fa0535b"
      unitRef="usd">1865000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTktMS0xLTA_bb4a83e2-9a9d-4f54-9930-8d947167bfe0"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i142c7d472a8344ce85925c067fa91fe9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTExLTEtMS0w_c0302620-5070-4946-b04d-3948acdb519e"
      unitRef="usd">1037000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6f306bf2384c441f92d64b73af5de0d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTEzLTEtMS0w_ffc44840-8dc3-4179-806c-2b15c2378069"
      unitRef="usd">925000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib6bf32ab7329448780e7b72b8cec2ac2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTo4MGQyMzk5YjE5OWI0NmY0ODhiOTJmODUzYTEyYzZhYy90YWJsZXJhbmdlOjgwZDIzOTliMTk5YjQ2ZjQ4OGI5MmY4NTNhMTJjNmFjXzEzLTE1LTEtMS0w_97548f8c-0a6f-4854-a257-5e41c2bbff8c"
      unitRef="usd">1963000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="idf6e3376ee884eb8984657ddcb97aa63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE1MTM1_230453e8-2079-416a-b74a-26c4828211a0"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ib860e3dce61e49049931073399687742_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzI3NDg3NzkwOTMwMzQ_80a3e131-8012-4fe3-87b6-414d6225b689"
      unitRef="usd">50000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:Cash
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE1MjAx_0904d41c-7520-49c9-9b97-b156e84faeda"
      unitRef="usd">150000000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE1MzQ1_ee6e115a-c72f-4720-859e-fb4b1e996e3f"
      unitRef="usd">165000000</us-gaap:Cash>
    <bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements
      contextRef="if57e9af02be147bf8ace46debf0cbb43_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzI3NDg3NzkwOTQxMjA_bda3f833-47fd-4481-84d9-7462f0a0655c"
      unitRef="usd">256000000</bsx:ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements>
    <bsx:LicensingArrangementsAsset
      contextRef="i53b6f52da8df4fa7bf11e1a08d9ccb70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzEtMS0xLTEtMA_3561902a-f218-41f8-87a4-98ddb48a42c3"
      unitRef="usd">365000000</bsx:LicensingArrangementsAsset>
    <bsx:DiscountRateFairValueInput
      contextRef="ie413d40c497c4213aed17626e6327e26_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzEtNC0xLTEtMA_9c6d186c-0cc4-4684-9968-ead0ce599625"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i3ee1e91c186b4f699e1d1d29e37ff24f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzEtNy0xLTEtMA_ed404b6b-0020-4ed5-b7e7-f8106143c1e6"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:LicensingArrangementsLiability
      contextRef="i53b6f52da8df4fa7bf11e1a08d9ccb70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzQtMS0xLTEtMA_b1e94cde-bb52-4d5c-b064-afbff0162b2d"
      unitRef="usd">407000000</bsx:LicensingArrangementsLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="idb70a5191e964f5bbfc7cab5cbae8163_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzQtNC0xLTEtMA_b9485e88-95ba-4963-addf-3cf61e5385b3"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i0eab187810704dcaa8f9fa4fcfefcdc6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzQtNi0xLTEtMTM5MTk_2569e5b9-e4b3-4362-b369-a5c92d0714f2"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i2ead7f5a424543edbf6a6280a486e80e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmNjIyMDJkYjFlN2U0ODI4ODE3MGFiZDlkYjM5YTM0Mi90YWJsZXJhbmdlOmY2MjIwMmRiMWU3ZTQ4Mjg4MTcwYWJkOWRiMzlhMzQyXzQtNy0xLTEtMA_849be89e-295f-475a-ab48-5cff194e0b5a"
      unitRef="number">0.13</bsx:DiscountRateFairValueInput>
    <bsx:LicensingArrangementsAsset
      contextRef="i5e14f3f587f24448a4c91bf888b8b399_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzEtMS0xLTEtMTA2OTg_a2a83c7c-3dc8-4249-b96f-bbaef3027fd5"
      unitRef="usd">0</bsx:LicensingArrangementsAsset>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ice90f802b2894cb798cf1495f7ea9a11_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzItMS0xLTEtMTA2OTg_4772049a-d866-483e-96d1-907a6d6593a7"
      unitRef="usd">567000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="ice90f802b2894cb798cf1495f7ea9a11_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzMtMS0xLTEtMTA2OTg_20c5067a-19d1-496d-acb9-e34dc8ff6d3d"
      unitRef="usd">52000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="ice90f802b2894cb798cf1495f7ea9a11_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzQtMS0xLTEtMTA2OTg_49e35797-0008-4ed3-aa70-57ebfcd7407b"
      unitRef="usd">3000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:LicensingArrangementsAsset
      contextRef="ib421eaab309941719fac63dbb93ed872_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzEtMS0xLTEtMA_9db98ea1-2da7-4203-8325-cd12e3873d7b"
      unitRef="usd">518000000</bsx:LicensingArrangementsAsset>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i4504c169cc844d2ea5b6d6a2e3e9d654_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzMtMS0xLTEtMA_cb5eae26-eb0e-40ee-b6cf-250f050b82a2"
      unitRef="usd">175000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i4504c169cc844d2ea5b6d6a2e3e9d654_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzUtMS0xLTEtMA_70d8dff1-8f90-4ce6-b060-b4e7f78f1739"
      unitRef="usd">22000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:LicensingArrangementsAsset
      contextRef="i7c3caf59a26546f0adfd22adbf367b9f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpkYjI2NWM2NDA0Yjc0YWFkYmQ5MTU3MmE2MGZmOTUxZC90YWJsZXJhbmdlOmRiMjY1YzY0MDRiNzRhYWRiZDkxNTcyYTYwZmY5NTFkXzYtMS0xLTEtMA_3cceb703-89fb-42b5-adf1-f3df5de12b63"
      unitRef="usd">365000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsLiability
      contextRef="ic4307d6f3a38471491744ddae330f127_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzEtMS0xLTEtMTA3MjI_c163c30a-4f21-4536-a77e-03073c1a6af0"
      unitRef="usd">0</bsx:LicensingArrangementsLiability>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i542629f9607d42d396e07c03c41fc785_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzItMS0xLTEtMTA3MjI_0bf7c9d9-77c8-4b46-a5fc-ec1d862ebbcc"
      unitRef="usd">315000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i542629f9607d42d396e07c03c41fc785_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzMtMS0xLTEtMTA3MjI_ec4d058b-f2f2-4d05-b9c7-8714f4182a59"
      unitRef="usd">256000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <bsx:LicensingArrangementsLiability
      contextRef="i9521f08f13f849d78d220e43a83413e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzEtMS0xLTEtMA_8bf814d7-dd50-48e2-b1e9-cc2ebdcce7ab"
      unitRef="usd">571000000</bsx:LicensingArrangementsLiability>
    <us-gaap:PaymentsForRoyalties
      contextRef="iddfccdc34ae347398e8196005b47ad2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzMtMS0xLTEtMA_49a06f5b-96f3-4d09-8063-700f557679ae"
      unitRef="usd">186000000</us-gaap:PaymentsForRoyalties>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="iddfccdc34ae347398e8196005b47ad2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzYtMS0xLTEtMTA3MzU_58ba0dcf-523e-4c55-bac6-94a02ed565f9"
      unitRef="usd">22000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:LicensingArrangementsLiability
      contextRef="iaecb6ba3d8414b658b7074879ac58a42_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90YWJsZTpmZGQ4ZjA4ZmM4MWE0ZjA0OTY4MjAwMWEzMjc2NGJiZS90YWJsZXJhbmdlOmZkZDhmMDhmYzgxYTRmMDQ5NjgyMDAxYTMyNzY0YmJlXzYtMS0xLTEtMA_22cc153c-5c22-4be8-9ff7-3e2e23e385df"
      unitRef="usd">407000000</bsx:LicensingArrangementsLiability>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE5OTY1_8098346c-2820-4fcb-9b6d-75329d4f445d"
      unitRef="usd">10774000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if784bc40961d41ea86115e7819324fc8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzE5OTc4_3003b3c2-cf27-4f36-b6e2-fa23b1c9468a"
      unitRef="usd">1118000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzIwMDM0_f1ea39fa-3879-40f7-b632-b8f1871af16c"
      unitRef="usd">11020000000.000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id18b0f22f1a54a529beaf27a2d386682_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMDkvZnJhZzo0ZjRmN2YxMTdlNzA0OWIyYWMzMjVhZmY2YjA4NjYxNS90ZXh0cmVnaW9uOjRmNGY3ZjExN2U3MDQ5YjJhYzMyNWFmZjZiMDg2NjE1XzI3NDg3NzkwOTU3ODQ_834a8c8c-ef1a-4460-afd5-e1b1d88741ca"
      unitRef="usd">1004000000.000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDc4_ed8063e8-bb49-4d6a-b58e-912f1758984b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE F &#x2013; CONTRACTUAL OBLIGATIONS AND COMMITMENTS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Borrowings and Credit Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had total debt outstanding of $9.143 billion as of December&#160;31, 2020 and $10.008 billion as of December&#160;31, 2019, with current maturities of $13 million as of December&#160;31, 2020 and $1.416 billion as of December&#160;31, 2019. The debt maturity schedule for our long-term debt obligations is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2022 Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount and Deferred Financing Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which was a variable-rate instrument based on LIBOR.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain a $2.750 billion revolving credit facility (Revolving Credit Facility) with a global syndicate of commercial banks that matures on December 19, 2023 with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. The credit agreement requires that we comply with certain covenants, including a financial covenant described within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility. In April 2020, we entered into the April 2021 Term Loan, described below, and used the proceeds to repay a portion of the amounts outstanding under the Revolving Credit Facility. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. In May 2020, we completed our senior notes offering described below and used a portion of the proceeds to repay $450 million outstanding under the Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of December&#160;31, 2020 or December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Term Loans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $1.250 billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $500 million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our MCPS and common stock offerings to repay in full the remaining $750 million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 27, 2020, we entered into a $1.000 billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding on the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of 0.85%. The credit agreement is subject to a financial covenant described below under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $750 million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $250 million and terminated the February 2021 Term Loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 5, 2019, we entered into a $700 million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December&#160;31, 2019, we had $700 million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $300 million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 19, 2018, we entered into a $2.000 billion senior unsecured delayed-draw term loan facility consisting of a $1.000 billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $1.000 billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August 19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $1.000 billion under the Two-Year Delayed Draw Term Loan and $1.000 billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, the December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $1.000 billion outstanding under the Three-Year Delayed Draw Term Loan (also referred to as the "August 2022 Term Loan" in the debt maturity schedule above). In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of December&#160;31, 2020, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of and through December&#160;31, 2020, we were in compliance with the financial covenant required by our credit facilities described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;br/&gt;as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;br/&gt;as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.48 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2020, we entered into an agreement with our banking syndicates to amend the financial covenant requirement for all of our outstanding credit arrangements as follows: (i) established a deemed Consolidated EBITDA of $671 million for the second, third and fourth quarters of 2020, reflecting average quarterly Consolidated EBITDA, as defined in the credit agreements, for 2018 and 2019; and (ii) maintain the maximum permitted leverage ratio of 4.75 times through the remainder of 2020, with a step-down for each succeeding fiscal quarter end to 4.50 times, 4.25 times, 4.00 times and ultimately 3.75 times for the fourth quarter of 2021 and through the remaining term of the facility. In addition, pursuant to the April 21, 2020 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving Credit Facility and February 2021 Term Loan amendments, the definition of "Material Adverse Effect" has been amended to exclude the direct and indirect effects of the COVID-19 pandemic from what constitutes a material adverse effect through the remainder of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to $500 million in restructuring and restructuring-related net charges related to our current or future restructuring plans. As of December&#160;31, 2020, we had $101 million of the restructuring net charges exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $2.624 billion in the aggregate. As of December&#160;31, 2020, we had $926 million of the litigation exclusion remaining.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any inability to maintain compliance with this amended covenant could require us to seek to further renegotiate the terms of our Revolving Credit Facility or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable&lt;/span&gt;&lt;span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except maturity and yield)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper outstanding (at par)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum borrowing capacity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowing capacity available&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0 days&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55 days&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had senior notes outstanding of $9.205 billion as of December&#160;31, 2020 and $7.661 billion as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 29, 2020, we redeemed $250 million of our $500 million 3.375% senior notes due 2022 (May 2022 Notes) at a redemption price calculated in accordance with the terms of the May 2022 Notes and its indenture, plus accrued and unpaid interest through, but excluding, the date of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we completed an offering of $1.700 billion in aggregate principal amount of senior notes comprised of $500 million of 1.900% senior notes due June 2025 and $1.200 billion of 2.650% senior notes due June 2030. We used the net proceeds from the offering to refinance $450 million of amounts outstanding under the Revolving Credit Facility, prepay $750 million of amounts outstanding under the $1.000 billion February 2021 Term Loan, prepay $500 million of amounts outstanding under the $1.250 billion April 2021 Term Loan and pay related fees, expenses and premiums.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we completed an offering of &#x20ac;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $206 million of our $450 million 4.125% senior notes due 2023, $566 million of our $1.000 billion 4.000% senior notes due 2028 and $227 million of our $750 million 3.850% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;connection with the transaction. In 2019, we incurred associated debt extinguishment charges of $86 million presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2019, we completed an offering of $4.300 billion in aggregate principal amount of senior notes comprised of $850 million of 3.450% senior notes due March 2024, $850 million of 3.750% senior notes due March 2026, $850 million of 4.000% senior notes due March 2029, $750 million of 4.550% senior notes due March 2039 and $1.000 billion of 4.700% senior notes due March 2049. We used a portion of the net proceeds from the offering to repay the $850 million plus accrued interest and premium of our 6.000% senior notes due in January 2020, the $600 million plus accrued interest and premium of our 2.850% senior notes due in May 2020 and the $1.000 billion plus accrued interest of our August 2019 Term Loan. In 2019, the remaining proceeds were used to finance a portion of our acquisition of BTG.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Other Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our $8.855 billion of senior notes issued in 2009, 2013, 2015, 2018, 2019 and 2020 contain a change-in-control provision, which provides that each holder of the senior notes may require us to repurchase all or a portion of the notes at a price equal to 101 percent of the aggregate repurchased principal, plus accrued and unpaid interest, if a rating event, as defined in the indenture, occurs as a result of a change-in-control, as defined in the indenture. Any other credit rating changes may impact our borrowing cost, but do not require us to repay any borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Renminbi denominated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The Renminbi denominated factoring arrangement was entered into in 2020 and had remaining capacity available as of December 31, 2020. There were no amounts de-recognized for accounts receivable as of December 31, 2020 associated with this arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Contractual Obligations and Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had outstanding letters of credit of $124 million as of December&#160;31, 2020 and $105 million as of December&#160;31, 2019, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of December&#160;31, 2020 and December&#160;31, 2019, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our consolidated balance sheets as of December&#160;31, 2020 and December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum purchase obligations, relating primarily to non-cancellable inventory commitments and capital expenditures entered in the normal course of business, were as of December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecorded Purchase Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;535&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzY4_b9a010ae-3087-4581-a12b-59706d450655"
      unitRef="usd">9143000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg0_19301b47-213a-4161-9db7-64b1941a51b4"
      unitRef="usd">10008000000.000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzYwNDczMTM5OTUxNTg_c60cc048-6879-4379-bc41-8fffe3e8a332"
      unitRef="usd">13000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzYwNDczMTM5OTUxNzc_77bbd495-a6c9-4759-90e4-7bd391c51ffc"
      unitRef="usd">1416000000</us-gaap:DebtCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDc0_b404f99f-ab57-4a93-aa6a-e56fe854be7c">&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2022 Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount and Deferred Financing Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which was a variable-rate instrument based on LIBOR.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i4f3624e58548487f8fe6f34329a5815d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzQtNi0xLTEtMA_b94dc5dc-91a2-45b3-aa5e-baf87f4cf18f"
      unitRef="usd">250000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie94729ec536f4bc8bcc1206a1a2d33b7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzQtOC0xLTEtMA_1c6289d4-e96a-4cac-bf0b-a21ea417d89c"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4f3624e58548487f8fe6f34329a5815d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzQtMTAtMS0xLTA_bf5f9305-2af7-4b78-8580-fc8d0c6082a4"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iace5b35349bc466aa9490fe1abc44349_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtNi0xLTEtMA_2bbb4d09-e100-49c9-aa50-5b3867309cf7"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i470cf9477e25450cb165bec6ddf55cc4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtOC0xLTEtMA_caae28d9-1aec-4811-ad70-426f4ee782ea"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iace5b35349bc466aa9490fe1abc44349_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtMTAtMS0xLTA_0ec3be5a-bc79-42bd-8de9-900810906b92"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i93322dab74aa4ef38da4b44eda101b38_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzctNi0xLTEtMA_f118289a-c137-4811-a6b3-d13d92ac1eab"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibb0ee9631c3d49d395dad185461e903d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzctOC0xLTEtMA_145689c7-ac4e-4077-b959-be6a254c110e"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i93322dab74aa4ef38da4b44eda101b38_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzctMTAtMS0xLTA_dbd71569-5942-4807-b8bc-00f04baaa0d9"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib2f5bb8d642f42c1af20b67911d62368_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzgtNi0xLTEtMA_4784dfb3-298a-467e-8962-cec0d3f62702"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3baeff6199d34f65b27933b63ede7d47_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzgtOC0xLTEtMA_0fd5fb84-fa62-4b2b-b072-69b23d8de8fe"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib2f5bb8d642f42c1af20b67911d62368_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzgtMTAtMS0xLTA_4ceda274-b66b-4b73-ad11-d75d708702d5"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3b663172db024a7292246bcb9060972f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtNi0xLTEtMjA2NQ_ed3ae441-4943-42d5-8945-3170c0fd0c1c"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i75fd0298f42f480aa7c38b110f45a007_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtOC0xLTEtMjA2NQ_70f86a74-08e1-4443-a248-d1087ab1a144"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3b663172db024a7292246bcb9060972f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzYtMTAtMS0xLTIwNjk_8a155073-c4ed-442f-a29c-b67c8037fed1"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if1ccd83cecce48e7a280b063a5658b6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzktNi0xLTEtMA_f18bb80c-ae64-47dd-abdd-17fec6b640a5"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iea6c3f5fe650404b94ed7a33ebfa2cca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzktOC0xLTEtMA_1fdacc0f-86b8-4199-b780-a29c7073667f"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if1ccd83cecce48e7a280b063a5658b6a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzktMTAtMS0xLTA_4788c4a0-1852-4de6-8005-0477f7553909"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i80031cfd406b4f6593c9c5e695b180e8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEwLTYtMS0xLTA_c96cf811-c8b2-4478-bf3e-161f2eadf4bc"
      unitRef="usd">1105000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0c13725730644fb4b3b71a64ec29e691_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEwLTgtMS0xLTA_4e0dbd40-b31a-4f48-9aaa-034c9031c3bf"
      unitRef="usd">1011000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i80031cfd406b4f6593c9c5e695b180e8_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEwLTEwLTEtMS0w_ad02b3e5-73a4-45a5-81b9-d7a7021fa3f9"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i28d0cd11a8104fe8a096c54c797dbb77_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTYtMS0xLTA_6e33019e-17eb-484a-b061-86a96db0bdf0"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i06838a9c5668409daceef0d66f6e0b09_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTgtMS0xLTA_35dcdce4-e3af-43ef-b081-eb9c9b13b4ae"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i28d0cd11a8104fe8a096c54c797dbb77_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTEwLTEtMS0w_20105cf7-3dff-48f3-a885-9a02356b98c1"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEyLTYtMS0xLTA_f06b0e05-1078-499a-b3bd-5ff12733b491"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia9e45057621d4a2194b3b7c5a4d322e1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEyLTgtMS0xLTA_af838b2d-0dd3-4214-84df-d35daa111043"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEyLTEwLTEtMS0w_c69a0d7c-55d1-4896-8405-a534c785bdea"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icf15031c1e264e419f6387d7bb871a3f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTYtMS0xLTIwODI_f216f8ad-1e55-4c28-973f-59fcb83e9a8b"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i82968b403f0e490b9ff37937effad01d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTgtMS0xLTIwODI_f60cca88-51ac-478d-bbff-1b3454ab3511"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icf15031c1e264e419f6387d7bb871a3f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzExLTEwLTEtMS0yMDg2_0a2900ea-430b-4d76-98d4-68811e01e00a"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4d9f8e01c368432c8b949ad0e9f7804a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEzLTYtMS0xLTA_6ffbc48f-41bb-4b98-9a22-3a1eee6095f7"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5278deff95bf40dab3597ddea1f112c1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEzLTgtMS0xLTA_aeb4198c-4305-4679-ab6b-91a719ae0b51"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4d9f8e01c368432c8b949ad0e9f7804a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzEzLTEwLTEtMS0w_6b45b85a-157b-41d0-bc06-004e61dcc0d9"
      unitRef="number">0.07000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE0LTYtMS0xLTA_52c9b30f-0f31-4002-b853-217b7468a11d"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i881baa0d70eb4bed8a4f7c036159289e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE0LTgtMS0xLTA_bc433160-e018-4e90-bedb-ad39fa16774c"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE0LTEwLTEtMS0w_59d0a856-7c6e-4032-83f2-fd261bab74a5"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie943736485e84ce7beed9099a5c89fc9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTYtMS0xLTA_4459c637-675d-4dcb-b2a9-7d09fb09113f"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9e7a0b5494fe433698454f3d4be42317_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTgtMS0xLTA_4e6bb3b3-e25e-47ad-9c30-50c07266f024"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie943736485e84ce7beed9099a5c89fc9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTEwLTEtMS0w_f4c5689d-69c3-4e5b-90ee-0f104c607bd2"
      unitRef="number">0.07375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i072d21384351482298b1bf90b42befe3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE2LTYtMS0xLTA_0987ef84-9341-4d67-8e26-10328c65064f"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2765cf8e499b472db95894650fbbc9b1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE2LTgtMS0xLTA_22fd0b5a-84ee-436a-a9a8-637d002bc5b8"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i072d21384351482298b1bf90b42befe3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE2LTEwLTEtMS0w_a17d1742-f99e-4aca-b44d-ee6de2269461"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i65aa69df316c4459b610a9a758daeb5b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTYtMS0xLTIwNTA_1d9a2cd3-3249-4c19-ba3a-28622e4eca94"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2317e9eeb3514b0ebfa77fad060f3b78_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE1LTgtMS0xLTIwNTA_40470241-c743-4875-b6ca-c9b8c2062854"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i86e54183bfbf4dcea32db5920645d4c1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE3LTYtMS0xLTA_c6e6e6ef-2a2a-4d1a-bfde-74d49a51d475"
      unitRef="usd">88000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ia0490e70b8eb4adaadfc6f7e99f1c154_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE3LTgtMS0xLTA_849c5ab1-4b2c-4557-a15f-eefdc515bb9e"
      unitRef="usd">83000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i0dfa649ec60b4e6fb3977d40dd636c0d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE4LTYtMS0xLTA_1d233a76-188e-4397-8344-e342d865c613"
      unitRef="usd">5000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i713d6358ca344f6b85182e9f67f64ba9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE4LTgtMS0xLTA_14576d39-2756-45be-a2e2-982f9542b43e"
      unitRef="usd">7000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia6f07d9d29b542aba0b5805828ee1cec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE5LTYtMS0xLTA_c2265601-6eaf-498f-8b0d-05026aa051cb"
      unitRef="usd">7000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibe8e5ca3e12946a3acf25b897e7d182b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzE5LTgtMS0xLTA_4d7688e7-9cff-455f-9130-96969a738aea"
      unitRef="usd">6000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzIwLTYtMS0xLTA_c22d9b0e-735b-4698-91c6-e742893e9a67"
      unitRef="usd">9130000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTphYjk0MzI0ZmI5N2I0Mjg1ODA0ZTMyMDA5MDlkOGY1Yi90YWJsZXJhbmdlOmFiOTQzMjRmYjk3YjQyODU4MDRlMzIwMDkwOWQ4ZjViXzIwLTgtMS0xLTA_a77a022f-b79a-4396-9434-d63677e1e3a0"
      unitRef="usd">8592000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i15fb9c7f5da74f4a84401aa8f7ee2b2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODg5OTA_9e5bc550-9649-4a6b-bb73-308f505be041"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i8a3a53a9ff3742c0bb73f4f43804fb5a_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODg5OTc_05f87621-cd11-499b-ba56-c9f9d89c0693"
      unitRef="usd">1360000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODkxMjE_6d83f753-9356-4350-b183-1ebcaf1b803b"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i6cbd6ca2b191422bbed4a7a82030eee4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODkxMTA_8f86b75b-93fa-48bb-a61b-73599b63bdd4"
      unitRef="usd">450000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ShortTermBorrowings
      contextRef="i809d5c20fa804d2fbb986afa7dc387e8_I20200421"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODUxNzk_33c4b499-6d9b-4a69-b30f-2645e6ef1b0d"
      unitRef="usd">1250000000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i6a055566dd0a42d0b5247b6ea377c972_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU0NTM_53cd2afe-a186-42ce-a15c-22cac59712eb"
      unitRef="usd">500000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i5653e63d9d764f71b37cce04c14e9918_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU0OTA_b4635809-8236-4e7d-8169-e9e8f027b41e"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i934e92bb8af546eb9e57ac456dd0619a_I20200227"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU1MTg_12ca4601-370f-4c9d-8334-dccb72a3e728"
      unitRef="usd">1000000000.000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i56087e653b324fa994949b7d0c138ef8_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU2NzM_2a0659ca-f5fe-4272-985e-8d2829376bf3"
      unitRef="number">0.0085</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i1160215621b243f6b393f001c1aac0d7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU2Nzc_5a969957-6a30-4151-8c96-0d70cf048fb6"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i3916b9b9bec94f6c874dd26e645205c5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwODU3MDg_b48a2e0f-382b-4b40-b2dc-fe6d9ce13387"
      unitRef="usd">250000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="icc311bfbe55c4b7bab87b29a5c5ad4af_I20191205"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzIyOTE_aba98705-2768-4165-a3d1-4c5694432baf"
      unitRef="usd">700000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="if810421b7a7142d88feb52f9a24f6b2f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI2OTU_a2914774-f28c-4ce2-8a2d-f3a5e7d0cda2"
      unitRef="usd">700000000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i6bccb221eb7049dfa837d52812ecf319_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI5NzA_ddce2954-a2ad-4df3-86b4-0fb1e4a2a03e"
      unitRef="usd">300000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i3b7bd05ff52a4f2ca45526a4f36f0fa7_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzM2MDk_c1be03ab-6f35-4ec2-a5e8-ff1f05c172eb"
      unitRef="usd">2000000000.000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCredit
      contextRef="i7b1253b180a24f5184077538b81d86ea_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzM2Nzc_acd3ba2a-428d-428c-93c0-3da1c69bdd48"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="if5058ef5b1744c99af286b6f6888dea9_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzM4NDU_9e350f54-211d-44b2-97e0-0ce2d1d19a55"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i0f029b30f006439581bf8725281e3599_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkxMTEyMDA_b6318119-568f-4975-ba45-615332156d34"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i498d29e5a70e4570a7844cf14bd02f63_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkxMTEyMDc_283ce3ac-a92c-4810-b7f2-828f74ea8043"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ic35171b8628c4dd5ad036a63a32bfb1f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzUwNTI_b9d1946e-bd4f-45ad-b3aa-b076a3a1908f"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDYy_6fb70a01-3db2-4062-879b-542e8f41a904">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;br/&gt;as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;br/&gt;as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.48 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;</bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock>
    <bsx:MaximumLeverageRatio
      contextRef="ie03682fd1dea4c5b853350dd17ab556a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTo1OGQ2NjI1OWM4Mzg0MzE0YjEwOTExMzgzZGZhMjQ3My90YWJsZXJhbmdlOjU4ZDY2MjU5YzgzODQzMTRiMTA5MTEzODNkZmEyNDczXzEtMS0xLTEtMA_c9548651-357b-495f-8894-9571c2772c32"
      unitRef="number">4.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i48219e6ea65a46868b8d56d6f5e591e4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTo1OGQ2NjI1OWM4Mzg0MzE0YjEwOTExMzgzZGZhMjQ3My90YWJsZXJhbmdlOjU4ZDY2MjU5YzgzODQzMTRiMTA5MTEzODNkZmEyNDczXzEtMy0xLTEtMA_e19ed0b5-0e5d-4bf9-9a14-730dafd04f2c"
      unitRef="number">3.48</bsx:MaximumLeverageRatio>
    <bsx:DeemedConsolidatedEBITDA
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTE5NjE_5f87126e-a30b-45d8-b126-98d4f117dfbc"
      unitRef="usd">671000000</bsx:DeemedConsolidatedEBITDA>
    <bsx:MaximumLeverageRatio
      contextRef="i7b0451592eb8487e9970e7bc57c226fb_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTIxOTE_d3298a5b-85c8-4e70-81f0-89fdf6d80709"
      unitRef="number">4.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i0fd8889518a24b01acba9958549fd5e7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU4NTA_76a9c03f-7c15-48fd-b0d0-e7ee17fb6fa4"
      unitRef="number">4.50</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i92925008ccf94edb8a9a6fa812cfe728_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU4NTQ_52f4899b-3e66-4703-b375-cf661e1af434"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="if8273828bead4a54bad459aceb05abe5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU4NTg_5307b40f-a2f4-4984-b388-756a17e4ea61"
      unitRef="number">4.00</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i3ac5b05e233743a0918574aa15d416bd_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU4Nzg_34bb17f6-e8e0-4511-86d3-4538dda9b425"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:ExclusionFromEbitdaForRestructuringCharges
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzYyNjc_3cf363c9-ac68-48ef-8b41-87afab58fe91"
      unitRef="usd">500000000</bsx:ExclusionFromEbitdaForRestructuringCharges>
    <bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzY0MDE_13bff39a-5fbb-49cd-b9fe-b9257e19c4dd"
      unitRef="usd">101000000</bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <bsx:LitigationAndDebtExclusionFromEbitda
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzY3MzU_5c7c696a-3e1a-4243-b282-7eaa755cf144"
      unitRef="usd">2624000000</bsx:LitigationAndDebtExclusionFromEbitda>
    <bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzY3NzM_bc641705-36fc-426c-8035-bdb87c84d8a0"
      unitRef="usd">926000000</bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i8a94b491b12e42c693b11e87706c05ae_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDU1_058ad1b5-f922-47d7-a419-2a92caadd0ff">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except maturity and yield)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper outstanding (at par)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum borrowing capacity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowing capacity available&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0 days&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55 days&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i8a3a53a9ff3742c0bb73f4f43804fb5a_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTM4NjY_05f87621-cd11-499b-ba56-c9f9d89c0693"
      unitRef="usd">1360000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="ic7219d097f654ed583a1166ed6e2afeb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzItMS0xLTEtMA_3d62e582-925e-462c-9d84-65c72a79d198"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i047968109f334e72b9394ec59f28e192_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzItMy0xLTEtMA_ce8329eb-6d10-4bf6-b5a6-2bcf84fa508d"
      unitRef="usd">711000000</us-gaap:CommercialPaper>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i15fb9c7f5da74f4a84401aa8f7ee2b2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzMtMS0xLTEtMA_9e5bc550-9649-4a6b-bb73-308f505be041"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bsx:MaximumCommercialPaperOutstanding
      contextRef="i047968109f334e72b9394ec59f28e192_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzMtMy0xLTEtMA_5f7912de-60af-45f0-839d-023391ff123a"
      unitRef="usd">2750000000</bsx:MaximumCommercialPaperOutstanding>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ic7219d097f654ed583a1166ed6e2afeb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzQtMS0xLTEtMA_ef468bcc-0c5d-435b-9ba3-0e7fb4454e80"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i047968109f334e72b9394ec59f28e192_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzQtMy0xLTEtMA_50756451-7e23-4399-8bb0-8210766c2d11"
      unitRef="usd">2039000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <bsx:WeightedAverageMaturityDays
      contextRef="i8a94b491b12e42c693b11e87706c05ae_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzUtMS0xLTEtMA_f4857337-665f-43ce-a96c-780f0840662b">0 days</bsx:WeightedAverageMaturityDays>
    <bsx:WeightedAverageMaturityDays
      contextRef="i1622c8dc4c6c4bf6984d78e57376b51d_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzUtMy0xLTEtMA_51890e0a-d44e-449d-a164-3eca37e8ead2">55 days</bsx:WeightedAverageMaturityDays>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="ic7219d097f654ed583a1166ed6e2afeb_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzYtMS0xLTEtMA_9e23da38-dabe-49d9-b3a8-3603f58497b4"
      unitRef="number">0</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="i047968109f334e72b9394ec59f28e192_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiZjAyOGViNTRhYmM0OThhOGU4M2Y0MmJlODAzZDUyZS90YWJsZXJhbmdlOmJmMDI4ZWI1NGFiYzQ5OGE4ZTgzZjQyYmU4MDNkNTJlXzYtMy0xLTEtMA_5232c001-4bd2-4652-a681-437c91653bed"
      unitRef="number">0.0221</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebt
      contextRef="i86e54183bfbf4dcea32db5920645d4c1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc4Mjk_f104fabc-f06b-4f9d-8964-ee0806b3bad8"
      unitRef="usd">9205000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia0490e70b8eb4adaadfc6f7e99f1c154_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc4NDU_1a11e3f5-efc6-4fdb-804c-cccd2beb7e97"
      unitRef="usd">7661000000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="idfb077471a35463b9f660b39ea4f3612_D20201229-20201229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU0OTc1NTgxODAxMjk_780f8af2-6ecb-4a29-912b-0275237ecac7"
      unitRef="usd">250000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="id1816c871d3e444bb94fda8950db49fd_I20201229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU0OTc1NTgxODAxMTI_abee1a81-08a9-4e26-98b8-f8b18568c860"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4f3624e58548487f8fe6f34329a5815d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzU0OTc1NTgxNzk1NTU_bf5f9305-2af7-4b78-8580-fc8d0c6082a4"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0b04a2ce24234007830997dd2dcf322c_I20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTM5MTY_3ad37971-8cde-49a3-ab0e-9e7a777aec79"
      unitRef="usd">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3b663172db024a7292246bcb9060972f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTM5ODI_f6254bfd-5106-4115-b2d0-9ee5a2634c46"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3b663172db024a7292246bcb9060972f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTM5OTI_8a155073-c4ed-442f-a29c-b67c8037fed1"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icf15031c1e264e419f6387d7bb871a3f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQwMjc_c6ef1cfe-9f5b-4ec7-8c70-56e61c1b72b8"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icf15031c1e264e419f6387d7bb871a3f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQwMzc_0a2900ea-430b-4d76-98d4-68811e01e00a"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i6cbd6ca2b191422bbed4a7a82030eee4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQxMjU_763054dd-2a90-4d11-a015-f932d8e57f35"
      unitRef="usd">450000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfDebt
      contextRef="i50f95eeb41c34ca090d9eb073b22e649_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQxOTk_aac6019c-c575-40d1-808b-0e8a124d6f6c"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i934e92bb8af546eb9e57ac456dd0619a_I20200227"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQyMzk_12ca4601-370f-4c9d-8334-dccb72a3e728"
      unitRef="usd">1000000000.000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i6a055566dd0a42d0b5247b6ea377c972_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQyODE_f8a6ae54-5f78-4d11-9a94-1509f2950692"
      unitRef="usd">500000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i809d5c20fa804d2fbb986afa7dc387e8_I20200421"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQzMjE_33c4b499-6d9b-4a69-b30f-2645e6ef1b0d"
      unitRef="usd">1250000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebt
      contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc5MDU_ac05efa7-de8c-4aa6-aca2-663c5e930ce8"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8898dcb5fdeb49bfb1b8f9c6da4b910a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc5MjM_5f177565-b444-4ef5-9f6f-c3adfa17c8dc"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i80031cfd406b4f6593c9c5e695b180e8_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzc5NjA_ad02b3e5-73a4-45a5-81b9-d7a7021fa3f9"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i8c38c44c917644b098c633ab638428cf_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzgzNTk_b9b693fd-e69b-4d10-b75e-7ab67ebdb691"
      unitRef="usd">206000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i0d6a17efae344d4c9df3b7fb951f8515_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQzOTU_de2ddfbd-ddf3-4024-9360-a097739ee08f"
      unitRef="usd">450000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iace5b35349bc466aa9490fe1abc44349_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzgzNzI_0ec3be5a-bc79-42bd-8de9-900810906b92"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i6b96a4fc501142cf8461498cce84408b_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzgzOTg_76f43d28-00c5-4bac-8434-4d5ce2af1505"
      unitRef="usd">566000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i98969d1f5aa24ac4b7604cd2111634df_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQ0MDM_7569f904-b515-4047-b593-a50849c49533"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i28d0cd11a8104fe8a096c54c797dbb77_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg0MTE_20105cf7-3dff-48f3-a885-9a02356b98c1"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i50adfc63c2df4dea89170b844a26339c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg0NDA_1e138afa-79f8-4143-b76f-cd7ba2f05e86"
      unitRef="usd">227000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i98b32703709b4b0aa69f93f2f184b39e_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkwOTQ0MTE_ee1c8fa8-a55a-408c-9b96-9d0b18be56fa"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib2f5bb8d642f42c1af20b67911d62368_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg0NTM_4ceda274-b66b-4b73-ad11-d75d708702d5"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg2NDI_984397d9-63d8-4844-96dd-869ffad50f46"
      unitRef="usd">86000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:LongTermDebt
      contextRef="if96cc1043cd04c2c983e15e941b3816f_I20190225"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg3Mjc_6f004b08-6be6-43a4-9421-88b4bc0fd51b"
      unitRef="usd">4300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i93322dab74aa4ef38da4b44eda101b38_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg3ODk_f118289a-c137-4811-a6b3-d13d92ac1eab"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i93322dab74aa4ef38da4b44eda101b38_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg3OTU_dbd71569-5942-4807-b8bc-00f04baaa0d9"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="if1ccd83cecce48e7a280b063a5658b6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg4Mjc_f18bb80c-ae64-47dd-abdd-17fec6b640a5"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if1ccd83cecce48e7a280b063a5658b6a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg4MzM_4788c4a0-1852-4de6-8005-0477f7553909"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg4NjU_f06b0e05-1078-499a-b3bd-5ff12733b491"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5d9ec1f48cf043558ae23d7ae0c4db07_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg4NzE_c69a0d7c-55d1-4896-8405-a534c785bdea"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg5MDQ_52c9b30f-0f31-4002-b853-217b7468a11d"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6b8ce28d9f8c4177bab45d7803f6cfb4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg5MTA_59d0a856-7c6e-4032-83f2-fd261bab74a5"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i072d21384351482298b1bf90b42befe3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg5NDU_0987ef84-9341-4d67-8e26-10328c65064f"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i072d21384351482298b1bf90b42befe3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzg5NTE_a17d1742-f99e-4aca-b44d-ee6de2269461"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="if1b49800ef2c4501b27527c8995dbbc4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkwNTI_58c067ec-fff0-4c0a-94fc-99c206755a05"
      unitRef="usd">850000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i455c8d39af974255a980e1e70f644bf2_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkwOTY_37dc427d-e42b-41d9-b06c-5a58a033d55c"
      unitRef="number">0.06000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i925f70236c2e410e80b575f9f56d03c6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkxMzc_f34c522e-3f26-411a-ab42-6c9aa5d127fc"
      unitRef="usd">600000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8101096131dd4084b7d522af75cf5248_I20201231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkxODE_494ba4fc-25f0-4f71-bddc-ccafff77c207"
      unitRef="number">0.02850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="id186cacae9da4651be0c28bb43b1ded4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzkyMjE_89cd0594-f7e5-413c-901b-1c637c5a1140"
      unitRef="usd">1000000000.000</us-gaap:ExtinguishmentOfDebtAmount>
    <bsx:Seniornotesissued
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEwMTEz_977b9054-082f-42ca-bb2b-2f3dad5a03f5"
      unitRef="usd">8855000000</bsx:Seniornotesissued>
    <bsx:ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEwMzQ0_8dc0dc99-323a-45b9-85bf-49b9fa6e1630"
      unitRef="number">1.01</bsx:ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEzMDE2_86531699-2cbb-4994-9813-4d0d13946d00">Amounts de-recognized for accounts and notes receivable, which are excluded from &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): &lt;/span&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Renminbi denominated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The Renminbi denominated factoring arrangement was entered into in 2020 and had remaining capacity available as of December 31, 2020. There were no amounts de-recognized for accounts receivable as of December 31, 2020 associated with this arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="ib48697a0624648d89ec42eafa9342b77_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzItMS0xLTEtMA_d01b52da-a38f-40a8-8629-3b9c2d7d2419"
      unitRef="usd">148000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i8dc7bcdaccd44f068db68bbbd79a3e75_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzItMy0xLTEtMA_4c7730b8-1c92-4aa6-a3b2-8589f2f123cd"
      unitRef="number">0.019</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i8bbc6a0e526d42a79ee7960aeca28186_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzItNS0xLTEtMA_8aac7e58-a01f-49b1-8f80-734f31ff48a2"
      unitRef="usd">171000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i6870f9bf392f498a941330451198f38c_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzItNy0xLTEtMA_7e695f37-0819-4caf-b655-f9f86f9983b4"
      unitRef="number">0.014</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i929c861096094117809bff5aea456e34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzMtMS0xLTEtMA_1e2f6799-b68e-4e7e-b474-37ebbfe74bf9"
      unitRef="usd">240000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i279145e1ed5d4579b641b7df4d63ddf1_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzMtMy0xLTEtMA_fa56c717-90f1-437d-8c73-5026cd8ab9fb"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i839275644c56406890c934fd58bed027_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzMtNS0xLTEtMA_c671e14b-af7c-4996-b8e4-baa39a40d4a6"
      unitRef="usd">226000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="id225a6ef1501499aba377c394f95fe05_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzMtNy0xLTEtMA_5bad52a8-16a9-458b-aca9-392dc4ce3934"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="if4576480dfa8445591015c36a302939d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzQtMS0xLTEtMjYzMg_1df5636c-4601-4e5a-9f52-914c488e75c2"
      unitRef="usd">0</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i44368aec498f423db8c0bf4520a896a7_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZTpiMzc1M2JhNWQ2MmE0MGQ4OGZiYzI5OGM0Y2RkOGFhYy90YWJsZXJhbmdlOmIzNzUzYmE1ZDYyYTQwZDg4ZmJjMjk4YzRjZGQ4YWFjXzQtMy0xLTEtMjYzNg_c8567561-3a8f-4bb4-9431-7e115d5969f3"
      unitRef="number">0.035</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEyMzQx_43cd2ec2-2660-4516-91f5-6a425e68dca2"
      unitRef="usd">124000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzEyMzU3_a44ef61a-ece3-42e4-98f2-0c4bd2fe4dca"
      unitRef="usd">105000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LongTermPurchaseCommitmentTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90ZXh0cmVnaW9uOjc0M2ViYWE2M2VmODRlNDE4Zjk3ZTU5OGZhNWZmNjBkXzI3NDg3NzkxMTEyMTU_2bb06f91-2493-45a4-b02d-b0a764652670">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.009%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecorded Purchase Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;535&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongTermPurchaseCommitmentTextBlock>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzEtMS0xLTEtMA_84fde59b-1750-45eb-a794-8e22314dccd3"
      unitRef="usd">403000000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzItMS0xLTEtMA_de8487e7-9dfb-4e45-bd0e-948149935954"
      unitRef="usd">53000000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzMtMS0xLTEtMA_cb040885-1145-4221-b782-7a930141ceef"
      unitRef="usd">41000000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzQtMS0xLTEtMA_ef82dfb5-b420-4db7-b982-c729f5fb7237"
      unitRef="usd">26000000</us-gaap:PurchaseObligationDueInFourthYear>
    <us-gaap:PurchaseObligationDueInFifthYear
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzUtMS0xLTEtMA_357c7d79-159d-41c2-89f8-315cedc0dd3c"
      unitRef="usd">13000000</us-gaap:PurchaseObligationDueInFifthYear>
    <us-gaap:PurchaseObligationDueAfterFifthYear
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzYtMS0xLTEtMA_6790e6b4-8588-44b9-9481-c2725be97f73"
      unitRef="usd">0</us-gaap:PurchaseObligationDueAfterFifthYear>
    <us-gaap:PurchaseObligation
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTIvZnJhZzo3NDNlYmFhNjNlZjg0ZTQxOGY5N2U1OThmYTVmZjYwZC90YWJsZToxYmUzODRhM2NkMTQ0ZDU0OGM3NzgxM2ZlY2Q3NGU4Zi90YWJsZXJhbmdlOjFiZTM4NGEzY2QxNDRkNTQ4Yzc3ODEzZmVjZDc0ZThmXzctMS0xLTEtMA_588b0d9e-914b-4d89-aa90-553b29e74e95"
      unitRef="usd">535000000</us-gaap:PurchaseObligation>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzMyNjk_35cef36b-5795-4684-b0d9-2621d13baf20">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE G &#x2013; LEASES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have operating and finance leases for real estate including corporate offices, land, warehouse space, and vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet, unless the arrangement includes an option to purchase the underlying asset, or an option to renew the arrangement, that we are reasonably certain to exercise (short-term leases). We recognize lease expense on a straight-line basis over the lease term for short-term leases that we do not record on our balance sheet. If there is a change in our assessment of the lease term and, as a result, the remaining lease term extends more than 12 months from the end of the previously determined lease term, or we subsequently become reasonably certain that we will exercise an option to purchase the underlying asset, the lease no longer meets the definition of a short-term lease and is accounted for as either an operating or finance lease and recognized on the balance sheet. In accordance with FASB ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we account for the lease components and the non-lease components as a single lease component, with the exception of our warehouse leases. Our leases have remaining lease terms of less than 1 year to approximately 56 years, some of which may include options to extend the leases for up to 10 years. If we are reasonably certain we will exercise an option to extend the lease, the time period covered by the extension option is included in the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of the arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, we utilize the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operating lease right-of-use assets are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and corresponding liabilities are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on our consolidated balance sheets. Finance leases are immaterial to our consolidated financial statements. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. The following table presents supplemental balance sheet information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operating lease cost under FASB ASC Topic 842 was $92 million in 2020 and $80&#160;million in 2019. Rent expense under FASB ASC Topic 840 amounted to $92 million in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained in exchange for operating lease obligations were $202 million as of December 31, 2020 and $137 million as of December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;530&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we have additional leases for office space and warehouse space, that have not yet commenced, of approximately $25 million. These leases will commence in 2021 and thereafter with lease terms of up to 15 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="id58a89551ad04c37b39770710490ccd6_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzEyOTA_b72a473d-6b6f-4628-8dbf-fc256f2e3534">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="idfcc194efc364801bd80478df09f2935_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzEzMTA_6e2c0ce5-e3cd-4ef0-adb8-e6a5356d4251">P56Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <bsx:LesseeOperatingAndFinanceLeasesOptionToExtend
      contextRef="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzEzNzk_3631c05c-2885-447c-bb26-9fb8cfae3738">P10Y</bsx:LesseeOperatingAndFinanceLeasesOptionToExtend>
    <bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI3NDg3NzkwNzc2ODI_adfd34ef-562c-4b86-b096-c20ce1ec65a9">The following table presents supplemental balance sheet information related to our operating leases:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzItMS0xLTEtMA_837debbd-304b-4403-8b6d-22157ad3a7cc"
      unitRef="usd">458000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzMtMy0xLTEtOTgwOA_f2cef876-6f8b-4c3c-8a8e-fb03e64d7e27"
      unitRef="usd">336000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iebdf6472601d4e179cdc65a60d86275d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzQtMS0xLTEtMA_e084e218-7778-4cbf-98d5-0f7c2ae40acf"
      unitRef="usd">70000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i29926e2a05fc47c9a3dcfbe25ce22aff_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzUtMy0xLTEtOTgwOA_a5e3bc28-6e83-4a0a-9907-7b84cbedf49e"
      unitRef="usd">67000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzUtMS0xLTEtMA_6e062ce2-4729-4734-8305-7a305b340dac"
      unitRef="usd">401000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo5ZWZmYWM3OTNkOWU0MTdhOTE4NTFmYzUxYjk2MzYxNS90YWJsZXJhbmdlOjllZmZhYzc5M2Q5ZTQxN2E5MTg1MWZjNTFiOTYzNjE1XzYtMy0xLTEtOTgwOA_3ace5145-0b95-44ba-8acd-21d80b2f710e"
      unitRef="usd">276000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI3NDg3NzkwNzc2ODM_fc37fa5e-63ba-4eec-8456-d9011052ebbb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTplNjJhOTc3ZmVkNDk0N2UyYjExODdjNDFkOTJiY2U3Yy90YWJsZXJhbmdlOmU2MmE5NzdmZWQ0OTQ3ZTJiMTE4N2M0MWQ5MmJjZTdjXzEtMS0xLTEtMA_f8f1549b-f863-439a-9bca-b4c2bfb93e58">P10Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTplNjJhOTc3ZmVkNDk0N2UyYjExODdjNDFkOTJiY2U3Yy90YWJsZXJhbmdlOmU2MmE5NzdmZWQ0OTQ3ZTJiMTE4N2M0MWQ5MmJjZTdjXzItMy0xLTEtOTg1Mg_1d77eb08-4504-4843-ac8a-f1348d37f178">P5Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTplNjJhOTc3ZmVkNDk0N2UyYjExODdjNDFkOTJiY2U3Yy90YWJsZXJhbmdlOmU2MmE5NzdmZWQ0OTQ3ZTJiMTE4N2M0MWQ5MmJjZTdjXzItMS0xLTEtMA_a567d070-9012-4035-a747-13390781cd42"
      unitRef="number">0.024</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTplNjJhOTc3ZmVkNDk0N2UyYjExODdjNDFkOTJiY2U3Yy90YWJsZXJhbmdlOmU2MmE5NzdmZWQ0OTQ3ZTJiMTE4N2M0MWQ5MmJjZTdjXzMtMy0xLTEtOTg1Mg_dc55bb9d-f6d8-4fdb-b744-69a1643c3540"
      unitRef="number">0.037</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseCost
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI1Njc_895d8bcf-2b01-44a3-b4a5-b5ebea63b555"
      unitRef="usd">92000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzU0OTc1NTgxNDM5NDA_9e216062-de55-40b6-9f2b-bc135cd0e6fe"
      unitRef="usd">80000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI2MjQ_c0ab9461-0d29-4943-b28c-61a4ffc40f04"
      unitRef="usd">92000000</us-gaap:OperatingLeasesRentExpenseNet>
    <bsx:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI3NDg3NzkwNzc2ODQ_cc3169cf-be61-48a3-a0b1-35e260bbec9f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information related to our operating leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTpmNjNiNDlhMmQwNGU0YTUwOTE2MWFiMmJkNzZkMjVjYy90YWJsZXJhbmdlOmY2M2I0OWEyZDA0ZTRhNTA5MTYxYWIyYmQ3NmQyNWNjXzMtMS0xLTEtMA_b9ddc765-4b78-4e7c-8cd2-7235ee187ca4"
      unitRef="usd">91000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTpmNjNiNDlhMmQwNGU0YTUwOTE2MWFiMmJkNzZkMjVjYy90YWJsZXJhbmdlOmY2M2I0OWEyZDA0ZTRhNTA5MTYxYWIyYmQ3NmQyNWNjXzMtMy0xLTEtOTg1OA_d473c5dc-4e98-406a-8a58-e53c7c06f1bd"
      unitRef="usd">77000000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI4MTM_414bdcb6-2377-4556-b8e2-32bca6a61e3d"
      unitRef="usd">202000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzU0OTc1NTgxNDM5NDk_8eda88b6-6ad1-4961-af5c-eaba2ca3fbc2"
      unitRef="usd">137000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <bsx:MaturitiesOfLeaseLiabilitiesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzI3NDg3NzkwNzc2ODU_55c378f2-69e0-4c8c-ac74-24c74e03be03">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;530&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:MaturitiesOfLeaseLiabilitiesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzEtMS0xLTEtMA_8e613e91-6bc9-46a3-aa0b-d4cd66ec20a2"
      unitRef="usd">86000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzItMS0xLTEtMA_5df8e2b6-028b-46df-b86e-af1e74b6ada9"
      unitRef="usd">75000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzMtMS0xLTEtMA_593bdb44-cc3b-4522-9b1c-989bdad99bc2"
      unitRef="usd">60000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzQtMS0xLTEtMA_b2591ed4-bf48-4927-8c29-c1f3d5d3a7ab"
      unitRef="usd">49000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzUtMS0xLTEtMA_cb4ef14c-99a3-48ed-9c5e-e3549c4ccdda"
      unitRef="usd">43000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzYtMS0xLTEtMA_94e9e753-13db-4f4d-a3de-4d6960bf4819"
      unitRef="usd">218000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzctMS0xLTEtMA_7ef251ea-dc26-4ae8-9642-fd6e9b3c1589"
      unitRef="usd">530000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzgtMS0xLTEtMA_d428a377-361d-460d-8d10-d3039e93f148"
      unitRef="usd">59000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90YWJsZTo0NjE0Yjk0ZDYxOTM0ODI3OGY0NjcyMTNkMGJmMzNmNy90YWJsZXJhbmdlOjQ2MTRiOTRkNjE5MzQ4Mjc4ZjQ2NzIxM2QwYmYzM2Y3XzktMS0xLTEtMA_bb7d1d8e-d071-4118-8ac7-4e357ff5a1ae"
      unitRef="usd">471000000</us-gaap:OperatingLeaseLiability>
    <bsx:LesseeLeasesNotYetCommencedAmount
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzMwNjY_92e08fd4-9f35-4650-a62a-85fa6db2bfc8"
      unitRef="usd">25000000</bsx:LesseeLeasesNotYetCommencedAmount>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTUvZnJhZzoxODUyYjI3ODUzOTc0MTRkOGZiNmI4NDY5NDkzY2MwNi90ZXh0cmVnaW9uOjE4NTJiMjc4NTM5NzQxNGQ4ZmI2Yjg0Njk0OTNjYzA2XzMxMzA_6f9730da-08ea-45fa-87c7-41e41f0b920b">P15Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NjY_29306584-bc7f-47bb-9334-11a8913eaed4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE H &#x2013; RESTRUCTURING-RELATED ACTIVITIES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 Restructuring Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 15, 2018, our Board of Directors approved, and we committed to a global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan is intended to support our effort to improve operating performance and meet anticipated market demands by ensuring that we are appropriately structured and resourced to deliver sustainable value to patients and customers. Key activities under the 2019 Restructuring Plan include supply chain network optimization intended to maximize our global manufacturing and distribution network capacity and building functional capabilities that support business growth. These activities were initiated in 2019, with the majority of activity expected to be complete by the end of 2022, following a one-year extension approved by our Board of Directors on February 22, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 22, 2021, our Board of Directors approved an extension and expansion of the 2019 Restructuring Plan to include additional cost optimization activities, including the centralization of certain functional capabilities within the international regions in which we operate, and a one-year extension of the program to complete these activities along with certain other initiatives that were delayed in 2020 due to restrictions related to the COVID-19 pandemic. We expect the majority of activity associated with our 2019 Restructuring Plan, including the expansion, to be substantially complete by the end of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, including the expansion, by major type of cost, of which approximately $340 million to $440 million are expected to result in cash outlays:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of Cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Estimated Amount Expected to be Incurred&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$475 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2016 Restructuring Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 6, 2016, our Board of Directors approved, and we committed to a restructuring initiative (the 2016 Restructuring Plan). The 2016 Restructuring Plan was intended to&#160;develop global commercialization, technology and manufacturing capabilities in key growth markets, build on our Plant Network Optimization (PNO) strategy which is intended to simplify our manufacturing plant structure by transferring certain production lines among facilities and expand operational efficiencies in support of our operating income margin goals. Key activities under the 2016 Restructuring Plan included strengthening global infrastructure through evolving global real estate assets and workplaces, developing global commercial and technical competencies, enhancing manufacturing and distribution expertise in certain regions and continuing implementation of our PNO strategy. These activities were initiated in the second quarter of 2016 and substantially completed in 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $255 million resulted in cash outlays:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount Incurred&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;LOTUS Discontinuation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#x2122; Aortic Valve System, and our decision to retire the entire LOTUS platform. We estimate the decision will result in total pre-tax restructuring and restructuring-related net charges of approximately $80 million to $90 million, which includes $30 million to $40 million of estimated charges expected to result in future cash outlays. We recorded $55 million of restructuring and restructuring-related net charges associated with the product discontinuation in 2020, which is included in the table above for the year ended December 31, 2020, and expect the remaining activity to be substantially complete during early 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In addition, during 2020 we recorded $119 million of inventory charges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and $8 million of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; associated with the product discontinuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2020, related to our ongoing Restructuring Plans by major type: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2016 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;179&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2016 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;255&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;369&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i3f274031addf44889a33eb68c3ed4dfc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NTY_ee3dc626-6325-4b1d-a3b4-57a0cf76ee85">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, including the expansion, by major type of cost, of which approximately $340 million to $440 million are expected to result in cash outlays:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of Cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Estimated Amount Expected to be Incurred&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$475 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:EffectOnFutureCashFlowsAmount
      contextRef="ieceadf1a7f8e4fad892abbcf9491307e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzYwNDczMTM5ODY0ODA_aa1e3ab6-f88d-48b6-9cb4-977dc33e3fc6"
      unitRef="usd">340000000</us-gaap:EffectOnFutureCashFlowsAmount>
    <us-gaap:EffectOnFutureCashFlowsAmount
      contextRef="i60558a28aa7c4d63a693910b749950a6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzYwNDczMTM5ODY0ODc_492e6c11-caf1-4880-ac9a-202a1814503d"
      unitRef="usd">440000000</us-gaap:EffectOnFutureCashFlowsAmount>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="if4e9f419b17a442ea339ee0791cb497b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzItMS0xLTEtMA_60d4ff42-d583-4e04-bb77-ad53332359a9"
      unitRef="usd">75000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="id7778b7f1e6944fd934bfedde17079ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzItMy0xLTEtMA_8dc0c5a8-2aab-4c4f-b8f1-a07fb76896b3"
      unitRef="usd">100000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ibb71293750e8491687172e77edc978a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzMtMS0xLTEtMA_b62d275d-815b-478d-9b25-a2eac2c018a6"
      unitRef="usd">25000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i17d165f894a04832a1fa68a0e736d01c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzMtMy0xLTEtMA_25f2cf96-9214-45a4-bc81-06d53a773fa0"
      unitRef="usd">50000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <bsx:RestructuringrelatedCostExpectedCost
      contextRef="i60553db20b814c02b1d910e227adc3fc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzUtMS0xLTEtMA_d883935d-e1b6-4c7c-a492-b4a759acb11a"
      unitRef="usd">275000000</bsx:RestructuringrelatedCostExpectedCost>
    <bsx:RestructuringrelatedCostExpectedCost
      contextRef="i4b0af9974fe547798f675a2412349d03_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzUtMy0xLTEtMA_cc40a707-c06b-4757-8803-c2902df1fa03"
      unitRef="usd">325000000</bsx:RestructuringrelatedCostExpectedCost>
    <bsx:RestructuringandRestructuringrelatedCostExpectedCost
      contextRef="ia3f9837c2b254cdcbb2ed38175b6637d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzYtMS0xLTEtMA_0296d687-e76e-48b4-b792-5164560b467b"
      unitRef="usd">375000000</bsx:RestructuringandRestructuringrelatedCostExpectedCost>
    <bsx:RestructuringandRestructuringrelatedCostExpectedCost
      contextRef="iad4e9ac9719e43a1b6053144c13aafaf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplZTUzYmY4MTM0MDQ0NzQ4YmI3NTYxMWUyZDI5YjdhMy90YWJsZXJhbmdlOmVlNTNiZjgxMzQwNDQ3NDhiYjc1NjExZTJkMjliN2EzXzYtMy0xLTEtMA_2c084736-03bb-422a-a503-01dceb5bc34b"
      unitRef="usd">475000000</bsx:RestructuringandRestructuringrelatedCostExpectedCost>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ia070298726984423957d186ea4cbee58_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2OTU_839df2ef-4a46-4f7d-9965-8c6b41937bde">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $255 million resulted in cash outlays:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount Incurred&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.&lt;/span&gt;&lt;/div&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzYwNDczMTM5ODY2NDk_957cab66-975b-4ec6-9e5d-5ce528a2e78b"
      unitRef="usd">255000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i3b9961b90ffa46eaa0ecfefd2145c16b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTpiNzc5YmQ5YzA1MTQ0ZjgxOWEzZmUxMWUxODY3YWU0MC90YWJsZXJhbmdlOmI3NzliZDljMDUxNDRmODE5YTNmZTExZTE4NjdhZTQwXzItMS0xLTEtMA_919e31dc-ad9f-461d-96d0-f278cb916388"
      unitRef="usd">86000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i5bdc512ea545452b8a307ed56cefa316_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTpiNzc5YmQ5YzA1MTQ0ZjgxOWEzZmUxMWUxODY3YWU0MC90YWJsZXJhbmdlOmI3NzliZDljMDUxNDRmODE5YTNmZTExZTE4NjdhZTQwXzMtMS0xLTEtMA_a683f3e4-5501-4753-9968-2ef76e9f10c6"
      unitRef="usd">21000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTpiNzc5YmQ5YzA1MTQ0ZjgxOWEzZmUxMWUxODY3YWU0MC90YWJsZXJhbmdlOmI3NzliZDljMDUxNDRmODE5YTNmZTExZTE4NjdhZTQwXzUtMS0xLTEtMA_5367deb0-2b3b-47ca-affa-a9da12e0045a"
      unitRef="usd">164000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTpiNzc5YmQ5YzA1MTQ0ZjgxOWEzZmUxMWUxODY3YWU0MC90YWJsZXJhbmdlOmI3NzliZDljMDUxNDRmODE5YTNmZTExZTE4NjdhZTQwXzYtMS0xLTEtMA_4ee19b2c-0638-4c8d-a158-6481f48c339a"
      unitRef="usd">271000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NjU_52035752-aa86-4b2f-8c5e-d17370e1fc07">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Termination&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Transfer Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="ib00c2166428146c59f1dbc9ed80238de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzEtMS0xLTEtMA_e6cb4394-a0ec-44d7-9f25-a5273b2673ed"
      unitRef="usd">27000000</us-gaap:SeveranceCosts1>
    <bsx:TransferCosts
      contextRef="ia7f722e04aec431e92c5dab638517e6c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzEtMy0xLTEtMA_09548d92-69ad-447a-80d1-ed96a05a7b12"
      unitRef="usd">0</bsx:TransferCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i2d0fc03416e74cf7b79748dfc5fec108_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzEtNS0xLTEtMA_81d750a4-ed90-4b1f-bb65-a6535afe0e1b"
      unitRef="usd">24000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzEtNy0xLTEtMA_558c9a46-9ab3-4691-9eb1-33b794347d97"
      unitRef="usd">52000000</us-gaap:RestructuringCharges>
    <bsx:RestructuringRelatedExpenses
      contextRef="i169c8823728f4c56bf82523f72a013d7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzMtMS0xLTEtMA_b9552217-2078-45f6-a593-6d55a4e9535a"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="iea3689dbf1264c80b2fc2369ebb72975_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzMtMy0xLTEtMA_02e37b94-efe7-4d96-9429-32b5589b463c"
      unitRef="usd">64000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ib138f03d5a5c411aa8254cb667a37e63_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzMtNS0xLTEtMA_8c68c982-2f01-48e8-926e-71790dd503c0"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i1133c37811e34ad8a94424eab435b18c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzMtNy0xLTEtMA_2f202967-281d-4ce5-a86f-7af09d2da8fa"
      unitRef="usd">64000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i101e2c90421b466f8a45ce41d9f8dd58_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzQtMS0xLTEtMA_9756afa0-855a-4569-aeac-cf2e8eab2e5f"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ie04e61dc46ef4691b3b50088e8133d64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzQtMy0xLTEtMA_8858c142-18dd-4d06-98a6-6fe9784250da"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ib8703d1164954705a5b4395347a35ba5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzQtNS0xLTEtMA_b42a7595-9892-4ace-98e9-c7707ac7e574"
      unitRef="usd">51000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i5a1888e3e03a40bf807e229e44b6ff2b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzQtNy0xLTEtMA_3038780b-be23-4220-9154-aa6ca012b774"
      unitRef="usd">51000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ibae917fc49bf4be6a5712c59d3887549_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtMS0xLTEtMTkwNzA_b8013a3c-0b28-4aa2-b367-9a6338603ba2"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i9b8e1fcec7c545189678173243202880_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtMy0xLTEtMTkwNzQ_5afc924a-ef21-47d2-9c98-6d547d40a382"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="idb31286a42734b9eb48b8f675cd3027c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtNS0xLTEtMTg5OTc_29927c43-6eb8-4e32-b499-590866f8da84"
      unitRef="usd">4000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i437f306d342d401085bd4bc596e6f2a3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtNy0xLTEtMTg5ODk_829a9608-e7d1-48d7-a265-21cdb0a0a1aa"
      unitRef="usd">4000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ib00c2166428146c59f1dbc9ed80238de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtMS0xLTEtMA_d5c9fcad-0df6-46fa-8210-e0995eacf147"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ia7f722e04aec431e92c5dab638517e6c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtMy0xLTEtMA_b2c1473a-12ed-4624-a2bb-b70cdd5dff04"
      unitRef="usd">64000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i2d0fc03416e74cf7b79748dfc5fec108_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtNS0xLTEtMA_c9e2294b-33f0-4673-814a-1685f6e0ab1d"
      unitRef="usd">55000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzUtNy0xLTEtMA_ea6d59b6-3b75-41ae-a714-bf4fa4d273b7"
      unitRef="usd">119000000</bsx:RestructuringRelatedExpenses>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ib00c2166428146c59f1dbc9ed80238de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzYtMS0xLTEtMA_c999518f-33fc-46b8-8aae-18d84c85f339"
      unitRef="usd">27000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ia7f722e04aec431e92c5dab638517e6c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzYtMy0xLTEtMA_7b2dd8ce-9328-40f2-ad2a-a3abb746ef3b"
      unitRef="usd">64000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i2d0fc03416e74cf7b79748dfc5fec108_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzYtNS0xLTEtMA_5884cef0-bf78-4383-b92b-114d2db8b031"
      unitRef="usd">79000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3YmU3YzgyNTBhZWM0YmRhOTc5ODdhNDU5ZjM0ODRkNi90YWJsZXJhbmdlOjdiZTdjODI1MGFlYzRiZGE5Nzk4N2E0NTlmMzQ4NGQ2XzYtNy0xLTEtMA_4d784065-29c6-48e0-b4e1-7a73e0b46db9"
      unitRef="usd">171000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:SeveranceCosts1
      contextRef="ia9d0c00ba23a4901a24791aa8b568055_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzEtMS0xLTEtMA_446661be-05fe-4cf5-bc94-4b733257b66b"
      unitRef="usd">38000000</us-gaap:SeveranceCosts1>
    <bsx:TransferCosts
      contextRef="ieef5ec3f5c6e45c3b89e5abaaf847a2a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzEtMy0xLTEtMA_38780b84-4746-459e-b581-4afb70dc5332"
      unitRef="usd">0</bsx:TransferCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i149a77f1ef8b4e1aa76950f7516e8136_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzEtNS0xLTEtMA_d44a8a69-6082-4185-8907-c7b2dbaa0dc9"
      unitRef="usd">0</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="ieb54673ea5524ce182360792b2c9655d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzEtNy0xLTEtMA_e2704e9f-9fb7-45c8-a013-ca6888aec4a7"
      unitRef="usd">38000000</us-gaap:RestructuringCharges>
    <bsx:RestructuringRelatedExpenses
      contextRef="i98a96b3c0c7d4f2b81bce69840269e54_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzMtMS0xLTEtMA_fc839bbd-1280-49bf-934c-0b020412d15d"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i05cd1788c0054ebaa6c7c34fd116c721_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzMtMy0xLTEtMA_ea24b71f-db71-4f70-93df-4840f253c005"
      unitRef="usd">32000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i3930ab450cbc485eb4182fa96c8c03c0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzMtNS0xLTEtMA_629651f7-7b54-4830-aefe-e005382a6dae"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id98f6675244c47d784ea3093b78e1e84_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzMtNy0xLTEtMA_0f475749-10dd-44ee-80cd-4b0803abddd0"
      unitRef="usd">32000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="iacfedd935c9342268439fe7cbeae60e7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzQtMS0xLTEtMA_7b93bdb6-5105-4e26-85e6-32aa9d7b3b88"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i18140364ac7a4d3699b0c8e6c02ca49a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzQtMy0xLTEtMA_9a5fa1fd-64a3-43f2-8f1f-8a86b22bd8a9"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i080263b4497f43dd86b878ee1c6339bf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzQtNS0xLTEtMA_45832b99-937a-47dc-a0b4-87c1d5014eb1"
      unitRef="usd">13000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i3ff943bdcb694439986636ed65f75c91_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzQtNy0xLTEtMA_50c07e6c-f8f0-480d-8fcb-f2cbeeddb6b3"
      unitRef="usd">13000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ia9d0c00ba23a4901a24791aa8b568055_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzUtMS0xLTEtMA_1df92c86-d8cc-4098-b9b3-a7f86fb3415b"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ieef5ec3f5c6e45c3b89e5abaaf847a2a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzUtMy0xLTEtMA_ab79205e-558b-4c31-bb1c-fa6faebfa137"
      unitRef="usd">32000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i149a77f1ef8b4e1aa76950f7516e8136_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzUtNS0xLTEtMA_436a1691-ab1f-4ec1-b286-58241852b02c"
      unitRef="usd">13000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ieb54673ea5524ce182360792b2c9655d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzUtNy0xLTEtMA_79c2e06c-15c1-4338-bc22-71a0590bfdcc"
      unitRef="usd">44000000</bsx:RestructuringRelatedExpenses>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ia9d0c00ba23a4901a24791aa8b568055_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzYtMS0xLTEtMA_51c4ff24-4fcd-4f6f-a617-e7c0533913fd"
      unitRef="usd">38000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ieef5ec3f5c6e45c3b89e5abaaf847a2a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzYtMy0xLTEtMA_ae42d1c6-cc34-42a4-8a8d-72980d911406"
      unitRef="usd">32000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i149a77f1ef8b4e1aa76950f7516e8136_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzYtNS0xLTEtMA_9983c2f6-fb52-407f-9740-f805cfbe0ef6"
      unitRef="usd">13000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ieb54673ea5524ce182360792b2c9655d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTowYjYwYWU4ODE2YWI0Y2U0YmE1NzNjNWE3OTg2ZDE2Mi90YWJsZXJhbmdlOjBiNjBhZTg4MTZhYjRjZTRiYTU3M2M1YTc5ODZkMTYyXzYtNy0xLTEtMA_57d23cd5-a721-467d-be63-d4f3f635975c"
      unitRef="usd">82000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:SeveranceCosts1
      contextRef="i2270b92546484cbf82fd0280322db3ed_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzEtMS0xLTEtMA_44d2ff40-f65c-43f2-bb75-edacc2810ea0"
      unitRef="usd">32000000</us-gaap:SeveranceCosts1>
    <bsx:TransferCosts
      contextRef="i31cc871da3dc48c7a5f796348d8817ae_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzEtMy0xLTEtMA_2de97115-ad19-45e6-b182-8c1a522619a6"
      unitRef="usd">0</bsx:TransferCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="ia33eedfc21a14d7984d9f03c953ab5f4_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzEtNS0xLTEtMA_fc475b64-5f2d-4514-bfb5-6d830ad23721"
      unitRef="usd">4000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="id0c6df5a32d14725adccb334ebaac480_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzEtNy0xLTEtMA_9a4b7815-b132-49c1-a3b8-1065ccf2467c"
      unitRef="usd">36000000</us-gaap:RestructuringCharges>
    <bsx:RestructuringRelatedExpenses
      contextRef="iaca3955aa3774955b74141f0b7742835_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzMtMS0xLTEtMA_23bccd12-baf3-4906-a300-f4ed8ad0b102"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i5426d5162838458f96e5bd31e0cac4eb_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzMtMy0xLTEtMA_904875df-fec1-4561-b2c9-25cb52663330"
      unitRef="usd">47000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i9c55f725ad2b4e03bb8b3aa0fdf79f67_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzMtNS0xLTEtMA_2cfc8805-3fdf-46da-acae-20c977380e8e"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="if8819d44961a414f9358a2742a3ca164_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzMtNy0xLTEtMA_17fde006-22d3-4942-9d7a-135a9fc22dbb"
      unitRef="usd">47000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i92351a2745854052bb947f9c73f7b6ce_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzQtMS0xLTEtMA_88349915-7962-498c-91cd-4b14dd2495af"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i78f6d9f528bf4e5b810d4a2a45a83e7a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzQtMy0xLTEtMA_c6f7f483-c18b-4add-ae04-9553e88d527e"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i6c6c1520344544848558a04190ef9084_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzQtNS0xLTEtMA_346e3420-f5ea-48b2-9ba5-1a07fb2a7468"
      unitRef="usd">12000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i5ea799c3840b4e17bb183186348f29aa_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzQtNy0xLTEtMA_7186b03d-220a-4f99-b2a9-8e26bed226f2"
      unitRef="usd">12000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i2270b92546484cbf82fd0280322db3ed_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzUtMS0xLTEtMA_c5cd5bd9-6ab9-47cb-bd56-c8c107d60fe1"
      unitRef="usd">0</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="i31cc871da3dc48c7a5f796348d8817ae_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzUtMy0xLTEtMA_7c04d90f-0cfc-4cdd-9a9c-f817bc7abeda"
      unitRef="usd">47000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="ia33eedfc21a14d7984d9f03c953ab5f4_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzUtNS0xLTEtMA_35bc5482-8751-4b13-9c9e-3a69472200ae"
      unitRef="usd">12000000</bsx:RestructuringRelatedExpenses>
    <bsx:RestructuringRelatedExpenses
      contextRef="id0c6df5a32d14725adccb334ebaac480_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzUtNy0xLTEtMA_f833c44a-decc-4230-8d96-ba0a1b91a280"
      unitRef="usd">59000000</bsx:RestructuringRelatedExpenses>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i2270b92546484cbf82fd0280322db3ed_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzYtMS0xLTEtMA_599f4013-5226-4dcf-827d-880150b8e592"
      unitRef="usd">32000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i31cc871da3dc48c7a5f796348d8817ae_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzYtMy0xLTEtMA_de07c9da-852c-498e-8f22-d8dcac7a94ac"
      unitRef="usd">47000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ia33eedfc21a14d7984d9f03c953ab5f4_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzYtNS0xLTEtMA_ea82bd0b-bdab-43b6-9700-49f145d370ee"
      unitRef="usd">16000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="id0c6df5a32d14725adccb334ebaac480_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo0ZDRiYzMwOWU1OTg0OGE4OGY3YmQ2ODRmNzA0YTFjZC90YWJsZXJhbmdlOjRkNGJjMzA5ZTU5ODQ4YTg4ZjdiZDY4NGY3MDRhMWNkXzYtNy0xLTEtMA_4d12a649-665a-4dbd-a8ca-c8dd0534b87e"
      unitRef="usd">96000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <bsx:RestructuringandRestructuringrelatedCostExpectedCost
      contextRef="icf19c236e1224a3e9207882bafa38c2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5NTQ_95b3dbab-9515-41b6-a29f-028f24f0860b"
      unitRef="usd">80000000</bsx:RestructuringandRestructuringrelatedCostExpectedCost>
    <bsx:RestructuringandRestructuringrelatedCostExpectedCost
      contextRef="i4fc68305d0ea4e12951bcc4b90225f04_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5NjI_df505fb7-d74c-4629-bff7-ba66a392781c"
      unitRef="usd">90000000</bsx:RestructuringandRestructuringrelatedCostExpectedCost>
    <us-gaap:EffectOnFutureCashFlowsAmount
      contextRef="id66a034296ae4bb1a925a5b9c0323174_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5Njk_20f9d4bb-5261-4018-85aa-8816c6bde84b"
      unitRef="usd">30000000</us-gaap:EffectOnFutureCashFlowsAmount>
    <us-gaap:EffectOnFutureCashFlowsAmount
      contextRef="i13e5df102a644d64adfa3a33ffdcdfd9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5Nzc_19f262a0-cd85-4d40-869c-6067ad4b9ab4"
      unitRef="usd">40000000</us-gaap:EffectOnFutureCashFlowsAmount>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i2ddab50db36b43dd9f17c341352773f6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzE5ODk_95ea66e7-d0bd-4ffe-bf84-a6339e33ca6a"
      unitRef="usd">55000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:InventoryWriteDown
      contextRef="ie43de06282cc43d6808a84e7f69288d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzIwMzY_e10d1aac-e93f-440e-9d66-3584cf8c3af7"
      unitRef="usd">119000000</us-gaap:InventoryWriteDown>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i2ddab50db36b43dd9f17c341352773f6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzU0OTc1NTgxNzIwOTQ_6ea46cea-43eb-4c73-8e1e-cc05afc6bc0d"
      unitRef="usd">8000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <bsx:CumulativeRestructuringChargesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NTI_e63bb1bc-f6c0-4ca3-af85-c21417b38a6a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2020, related to our ongoing Restructuring Plans by major type: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2016 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;179&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.&lt;/span&gt;&lt;/div&gt;</bsx:CumulativeRestructuringChargesTableTextBlock>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i3b9961b90ffa46eaa0ecfefd2145c16b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzEtMS0xLTEtMA_60af89a9-8471-4d1d-ae25-c84f06793adc"
      unitRef="usd">86000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i1e8f687653b84e89ba20c0702c69ec9f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzEtMy0xLTEtMA_9768bbc6-8c07-4f5d-b4b9-c99ee80cc8b1"
      unitRef="usd">38000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="id2eef7931a47424aadfa33ed87c13bef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzEtNS0xLTEtMA_cfe4e2cc-f5b1-453c-aaee-a4bc8efe93c8"
      unitRef="usd">124000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i5bdc512ea545452b8a307ed56cefa316_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzItMS0xLTEtMA_a5fb3d0f-d25a-49d4-83c5-a00d89b2f4b6"
      unitRef="usd">21000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i69acc2e1fe284629bd66ab64abb82dfe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzItMy0xLTEtMA_8fe049c5-a133-467c-acf4-947584371fa8"
      unitRef="usd">26000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i72c007a8c0e54e8f8dbfbd4c1b84ae74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzItNS0xLTEtMA_23347ebe-6491-4805-9983-f0afac5995f0"
      unitRef="usd">46000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzMtMS0xLTEtMA_ff3a5fae-0a42-4078-af36-27f2e0e5b39d"
      unitRef="usd">106000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i87d4deec479e42b4921ca3c0c19c6196_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzMtMy0xLTEtMA_23f10353-f643-41e1-ab49-45c8cf743317"
      unitRef="usd">64000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringChargesIncurredToDate
      contextRef="i425c4f006d69412d874f531954a840d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzMtNS0xLTEtMA_3860db48-eade-4802-b5a9-bb5a29815617"
      unitRef="usd">171000000</bsx:CumulativeRestructuringChargesIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i0de6be7750b84ba2becd8b78d3760d22_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzQtMS0xLTEtMA_96c45992-bf3d-42f1-805a-4336199b81fd"
      unitRef="usd">126000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="ib2af5f8f85cb4333aba96313b76a69ca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzQtMy0xLTEtMA_ca5a6833-6415-4eb1-b95c-4ea942f038ad"
      unitRef="usd">87000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="ida81f67779e44ee99c0f4576accd6b66_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzQtNS0xLTEtMA_63eca985-6d1b-4ce4-bc4a-208224e79ea3"
      unitRef="usd">213000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i5bdc512ea545452b8a307ed56cefa316_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzUtMS0xLTEtMA_0a4ffb5d-9191-428e-8753-8db47d7a18d3"
      unitRef="usd">39000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i69acc2e1fe284629bd66ab64abb82dfe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzUtMy0xLTEtMA_b34c5a0f-aab8-4f17-8f95-0553c8d23b3c"
      unitRef="usd">28000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i72c007a8c0e54e8f8dbfbd4c1b84ae74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzUtNS0xLTEtMA_fd692c82-d78f-47a3-b984-121805c21db6"
      unitRef="usd">66000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzYtMS0xLTEtMA_6866f5be-0653-4be1-bbd0-0c7ec9f153b1"
      unitRef="usd">164000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i87d4deec479e42b4921ca3c0c19c6196_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzYtMy0xLTEtMA_54413585-9525-4755-b683-f76f3a98ee3b"
      unitRef="usd">115000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <bsx:CumulativeRestructuringRelatedCostsIncurredToDate
      contextRef="i425c4f006d69412d874f531954a840d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzYtNS0xLTEtMA_59cf954c-cb1d-4fb8-80e6-4ffd0541d7e0"
      unitRef="usd">279000000</bsx:CumulativeRestructuringRelatedCostsIncurredToDate>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzctMS0xLTEtMA_5a5d901e-c033-4030-830f-a7e4be703b56"
      unitRef="usd">271000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i87d4deec479e42b4921ca3c0c19c6196_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzctMy0xLTEtMA_d83d2f21-31a2-4a6c-bc53-527fcae4fd53"
      unitRef="usd">179000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i425c4f006d69412d874f531954a840d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTo3MmUzOTI2ODZmOWU0NjM1YjI1ZTRhYWZjMmM3NmI4My90YWJsZXJhbmdlOjcyZTM5MjY4NmY5ZTQ2MzViMjVlNGFhZmMyYzc2YjgzXzctNS0xLTEtMA_73c84a66-b560-40ea-b803-3317a737c07e"
      unitRef="usd">450000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <bsx:AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90ZXh0cmVnaW9uOmI4ODdiOTRmYmRmMzRiN2RiOWEwOTFiMTUzYjdkNTMyXzM2NzE_b8a0c5cd-f3eb-46fb-a9e6-c4aafab6942d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2016 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 Restructuring Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;255&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;369&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i3b9961b90ffa46eaa0ecfefd2145c16b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzItMS0xLTEtMA_b0da7227-19ca-43ea-9a64-1d3e0945404c"
      unitRef="usd">89000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i1e8f687653b84e89ba20c0702c69ec9f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzItMy0xLTEtMA_86eb8def-7183-4f97-87b9-856565182e1c"
      unitRef="usd">12000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="id2eef7931a47424aadfa33ed87c13bef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzItNS0xLTEtMA_0fd5e2c8-653d-4db7-83ff-eafae2bab3c7"
      unitRef="usd">100000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i0de6be7750b84ba2becd8b78d3760d22_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzMtMS0xLTEtMA_baa6c689-316d-408b-ab5b-e33f46b7bf7a"
      unitRef="usd">125000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="ib2af5f8f85cb4333aba96313b76a69ca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzMtMy0xLTEtMA_130cfd2c-cb4f-4cb9-b77d-d04d8be45934"
      unitRef="usd">77000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="ida81f67779e44ee99c0f4576accd6b66_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzMtNS0xLTEtMA_be1deb70-3a61-4900-ab85-e911a44dc014"
      unitRef="usd">202000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i5bdc512ea545452b8a307ed56cefa316_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzQtMS0xLTEtMA_c08198b5-a48e-4da8-a674-b37e9701536f"
      unitRef="usd">41000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i69acc2e1fe284629bd66ab64abb82dfe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzQtMy0xLTEtMA_b3b186d0-d1b8-4bff-8a75-1598e0c89a4f"
      unitRef="usd">25000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i72c007a8c0e54e8f8dbfbd4c1b84ae74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzQtNS0xLTEtMA_7983f07c-9cad-419c-a89d-2658e44fb54f"
      unitRef="usd">67000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="ib9dc1ef08b814cda860643ddf852fff5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzUtMS0xLTEtMA_cf640814-7d79-4134-996b-e5c834953568"
      unitRef="usd">255000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i87d4deec479e42b4921ca3c0c19c6196_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzUtMy0xLTEtMA_30890f46-c6bf-441d-a6be-b0fb1a2d9b79"
      unitRef="usd">114000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate
      contextRef="i425c4f006d69412d874f531954a840d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMTgvZnJhZzpiODg3Yjk0ZmJkZjM0YjdkYjlhMDkxYjE1M2I3ZDUzMi90YWJsZTplNDc3YjQ1Yzc4YmQ0MjdmOTEzODhkNzYyYjdjYTk4Mi90YWJsZXJhbmdlOmU0NzdiNDVjNzhiZDQyN2Y5MTM4OGQ3NjJiN2NhOTgyXzUtNS0xLTEtMA_e97f2e14-5fcf-48dc-8368-d30465721bfc"
      unitRef="usd">369000000</bsx:CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ4Ng_b51552dd-076b-43bc-826f-f0abf16a52b8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE I &#x2013; SUPPLEMENTAL BALANCE SHEET INFORMATION &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in our accompanying consolidated balance sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,531&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,828&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect adjustment for adoption of ASU 2016-13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Note: Effective January 1, 2020, we adopted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. Prior period amounts have not been restated and are presented in accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 310&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. Please refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note R &#x2013; New Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,579&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately 33 percent of our finished goods inventory as of December&#160;31, 2020 and approximately 32 percent as of December 31, 2019 was at customer locations pursuant to consignment arrangements or held by sales representatives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,084&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $333 million in 2020, $311 million in 2019 and $296 million in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,921&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,635&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ3MA_518fb515-a019-4ab0-8a50-90b021cd621d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,531&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,828&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect adjustment for adoption of ASU 2016-13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Note: Effective January 1, 2020, we adopted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. Prior period amounts have not been restated and are presented in accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 310&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. Please refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note R &#x2013; New Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzItMS0xLTEtMA_9241aabd-56c5-47d8-b0d7-4c1a62974905"
      unitRef="usd">1637000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzItMy0xLTEtMA_881a2f61-9584-4ba4-ab4e-a275d3f47087"
      unitRef="usd">1902000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzMtMS0xLTEtMA_476c6c33-2111-440d-8c1e-f094425cc381"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzMtMy0xLTEtMA_6d66cbb8-2aff-4ac3-99ad-1504cf6532d1"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzUtMS0xLTEtMA_95bc21aa-05af-4b1e-88db-970c9bb8ab9e"
      unitRef="usd">1531000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0MzllZjgzN2VjMGM0MDViYTRmZjc4OWViNjhlNDQ5ZC90YWJsZXJhbmdlOjQzOWVmODM3ZWMwYzQwNWJhNGZmNzg5ZWI2OGU0NDlkXzUtMy0xLTEtMA_6a18ccfe-7087-4203-bcda-9a9bbd5c9749"
      unitRef="usd">1828000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzItMS0xLTEtMA_8f6a492e-e858-4275-949b-c47280a17354"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzItMy0xLTEtMA_064cc20f-5eb4-46ed-9070-486ef79ba1ec"
      unitRef="usd">68000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzItNS0xLTEtMA_f323fead-2c22-480c-bda3-d9a53165126a"
      unitRef="usd">68000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzMtMS0xLTEtMzMxMA_2310ac2d-db03-4931-9626-74c35c793a50"
      unitRef="usd">10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzMtMS0xLTEtMA_2c256f9e-b035-4689-b9ce-679b2a8ecf19"
      unitRef="usd">49000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzMtMy0xLTEtMA_2f970d0c-d997-491c-8189-04b42ee8ea0f"
      unitRef="usd">23000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzMtNS0xLTEtMA_e47ba6fe-940b-47ec-ad11-c1f951b0f09e"
      unitRef="usd">19000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzQtMS0xLTEtMA_ae78b64c-65be-4d9d-af13-61189fd17f49"
      unitRef="usd">27000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzQtMy0xLTEtMA_873806e3-6df0-4d39-9dbf-1bcb38620814"
      unitRef="usd">17000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzQtNS0xLTEtMA_2e75757a-1e1b-454f-8fd8-492c571dc4fe"
      unitRef="usd">19000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzUtMS0xLTEtMA_02581f64-88b2-44bb-935e-5f870f08fdc9"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzUtMy0xLTEtMA_db4bcc1e-a6da-44be-bbf8-9f102b8d985b"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5MGMyODc4ODZmYzQ0Zjg0OTdkMzQzYWM5ZTUwODkyZC90YWJsZXJhbmdlOjkwYzI4Nzg4NmZjNDRmODQ5N2QzNDNhYzllNTA4OTJkXzUtNS0xLTEtMA_ea1e9a2e-90a4-4e2f-9587-8ec5888ffbab"
      unitRef="usd">68000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQzNg_0a94a2eb-b1c7-4058-98b0-c5ba42fbe4da">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,579&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzItMS0xLTEtMA_85efb986-ec76-401e-9d85-8f96ea0fb0a4"
      unitRef="usd">893000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzItMy0xLTEtMA_da6f6748-c663-47bd-802a-b9eb1e115247"
      unitRef="usd">971000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzMtMS0xLTEtMA_761b967b-ce98-4ce7-a6d4-ec7924f66206"
      unitRef="usd">109000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzMtMy0xLTEtMA_65cc18cb-1ed4-4f91-b67d-9d7a4f3063d6"
      unitRef="usd">192000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzQtMS0xLTEtMA_bb4bec94-2342-45fe-ae26-73ae232d7e10"
      unitRef="usd">349000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzQtMy0xLTEtMA_4892b5b4-cd9d-4a7f-aab1-472bfaa751d9"
      unitRef="usd">416000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzUtMS0xLTEtMA_55a5ec57-ba0d-4627-afe8-f7e9337a59e3"
      unitRef="usd">1351000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphM2I0MjI4OWY4MDE0YmZlYmFiYzU1ZTY1ZDlhMDU1MC90YWJsZXJhbmdlOmEzYjQyMjg5ZjgwMTRiZmViYWJjNTVlNjVkOWEwNTUwXzUtMy0xLTEtMA_ffc72796-507b-4521-bc57-d0c4fafb3872"
      unitRef="usd">1579000000</us-gaap:InventoryNet>
    <bsx:PercentOfFinishedGoodsAtConsignment
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzU0OTc1NTgxNDUwNzI_2fe2db06-88c6-48dd-9a8e-f19000b57842"
      unitRef="number">0.33</bsx:PercentOfFinishedGoodsAtConsignment>
    <bsx:PercentOfFinishedGoodsAtConsignment
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzU0OTc1NTgxNDUxMzY_dc56327f-51b5-49d5-9d25-d7db991b5b4c"
      unitRef="number">0.32</bsx:PercentOfFinishedGoodsAtConsignment>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzI3NDg3NzkwNzU4Mjg_605c913b-7062-47df-ab4d-92f6804b882c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzItMS0xLTEtMA_cac28a21-e73f-460d-b4f0-d90b4f627e64"
      unitRef="usd">208000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzItMy0xLTEtMA_37d01976-d2b7-440e-9aed-a7052463d189"
      unitRef="usd">346000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzMtMS0xLTEtMA_d3858a60-65b5-40e7-9a74-9ecef35ba75c"
      unitRef="usd">133000000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzMtMy0xLTEtMA_4322207c-171c-43f9-ab77-f74669f067b8"
      unitRef="usd">105000000</us-gaap:DerivativeAssetsCurrent>
    <bsx:LicensingArrangements
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzQtMS0xLTEtMA_9598a952-163b-4521-acf5-3beb30e819be"
      unitRef="usd">148000000</bsx:LicensingArrangements>
    <bsx:LicensingArrangements
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzQtMy0xLTEtMA_5af4f2e4-3a93-4dc9-9061-b1d1da004f3b"
      unitRef="usd">186000000</bsx:LicensingArrangements>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzYtMS0xLTEtMA_f22e293d-9113-4088-888d-1dbdf40a7669"
      unitRef="usd">263000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzYtMy0xLTEtMA_ae1d9565-4712-4908-be55-5673d6738c03"
      unitRef="usd">243000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzctMS0xLTEtMA_b6dd0597-0cb4-4665-b18f-9c4c0c63ccf1"
      unitRef="usd">751000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDc0ZmMxMjI5ZDU0OGM5YjY2M2IwYzEyM2U3ZDA3MS90YWJsZXJhbmdlOmEwNzRmYzEyMjlkNTQ4YzliNjYzYjBjMTIzZTdkMDcxXzctMy0xLTEtMA_274db232-80ce-4145-b46a-dd22c3beee1f"
      unitRef="usd">880000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ3NQ_e4315c02-e90a-446b-9504-cabb2002c4fc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,084&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzItMS0xLTEtMA_7b328a91-7cc0-4609-9c3d-bbea94eecd46"
      unitRef="usd">104000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzItMy0xLTEtMA_1d1fbf10-8b41-4a24-b2d6-9c5f73c317ef"
      unitRef="usd">117000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzMtMS0xLTEtMA_ab442ddc-4c70-4a6f-9871-2abba8ccf326"
      unitRef="usd">1292000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzMtMy0xLTEtMA_8590930b-a77d-4bd0-9621-f5db00e612e9"
      unitRef="usd">1198000000</us-gaap:BuildingsAndImprovementsGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzQtMS0xLTEtMA_c4522796-68e4-4aca-8a6c-3ce96279b3aa"
      unitRef="usd">3465000000</bsx:EquipmentFurnitureAndFixturesGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzQtMy0xLTEtMA_c585de2d-37a1-4065-ab90-ec02733f7f50"
      unitRef="usd">3411000000</bsx:EquipmentFurnitureAndFixturesGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzUtMS0xLTEtMA_1b3a0ca6-e51f-473c-8aa1-e805e5db5fba"
      unitRef="usd">446000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzUtMy0xLTEtMA_f88573d6-6f10-4dd4-b274-068a9d669fdb"
      unitRef="usd">442000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzYtMS0xLTEtMA_ee2471fb-0512-4a8f-beb9-1e0a8bf92781"
      unitRef="usd">5308000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzYtMy0xLTEtMA_47f1f26d-b366-4398-9426-e628284144bb"
      unitRef="usd">5169000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzctMS0xLTEtMA_517bbbb4-c073-4ac6-8e51-a7ea811d83f8"
      unitRef="usd">3224000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzctMy0xLTEtMA_7a534488-6cbc-427b-8489-31a3cd574d12"
      unitRef="usd">3089000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzgtMS0xLTEtMA_3f8c4bd2-9d42-43e9-b3d4-1b2a39b524b7"
      unitRef="usd">2084000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0ZWE1ZDJkM2U4MTE0NDlkYWE1YjBiNWQ3YjM2NDg4ZC90YWJsZXJhbmdlOjRlYTVkMmQzZTgxMTQ0OWRhYTViMGI1ZDdiMzY0ODhkXzgtMy0xLTEtMA_e6a462bf-836e-48f8-992f-764af428a1ff"
      unitRef="usd">2079000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzI5Mg_abcf7229-4bbd-4f9d-b613-27f4d03a7da2"
      unitRef="usd">333000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzMwMg_dcd6434d-716d-47db-808a-a96ce664a846"
      unitRef="usd">311000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzMxNQ_0919107c-5261-4fc9-bd4c-28b522e76068"
      unitRef="usd">296000000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzI3NDg3NzkwNzU4Mjk_bcde5b5a-950b-4528-9c58-1d7fa97fdde3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,921&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzItMS0xLTEtMA_e113717c-5c38-4060-b071-bf5dc28f70be"
      unitRef="usd">52000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzItMy0xLTEtMA_52aa7e33-cb91-4775-bd8d-1ebfa68556cc"
      unitRef="usd">43000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzMtMS0xLTEtMA_9dc71aff-841c-487e-986d-2261f3aa3228"
      unitRef="usd">458000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzMtMy0xLTEtMA_dbaf798b-6976-4f2f-81c7-12381f868095"
      unitRef="usd">336000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssets
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzQtMS0xLTEtMA_3d3fbbdc-5a70-422b-a4ce-ef5482ee11d6"
      unitRef="usd">109000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzQtMy0xLTEtMA_3c6bbf84-4fae-432f-a0c4-cc8de54b848f"
      unitRef="usd">216000000</us-gaap:DerivativeAssets>
    <us-gaap:Investments
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzUtMS0xLTEtMA_e22cd7c6-a276-41a5-bce8-38a3d4cc204c"
      unitRef="usd">918000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzUtMy0xLTEtMA_ce8fb14c-3cbf-428f-9c6a-cf45b7dc3a44"
      unitRef="usd">458000000</us-gaap:Investments>
    <bsx:LicensingArrangementsAsset
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzYtMS0xLTEtMA_6b2112a4-b440-4aee-8b19-28b3d8fe2639"
      unitRef="usd">218000000</bsx:LicensingArrangementsAsset>
    <bsx:LicensingArrangementsAsset
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzYtMy0xLTEtMA_4b231024-5529-4d04-bff4-00ac4022d95d"
      unitRef="usd">332000000</bsx:LicensingArrangementsAsset>
    <bsx:OtherOtherLongTermAssets
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzctMS0xLTEtMA_ffcf2866-7d87-45aa-a306-f5c2f531e5ec"
      unitRef="usd">166000000</bsx:OtherOtherLongTermAssets>
    <bsx:OtherOtherLongTermAssets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzctMy0xLTEtMA_0321adee-c5bc-40a7-8214-a853c7ce4b27"
      unitRef="usd">144000000</bsx:OtherOtherLongTermAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzgtMS0xLTEtMA_ea5ac1c2-a495-4ee9-abb4-8a6e8b818d17"
      unitRef="usd">1921000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo0NmVmNGM0NDU4ZGI0YjIzOGM0ZDM3OTExNWY1N2MzMi90YWJsZXJhbmdlOjQ2ZWY0YzQ0NThkYjRiMjM4YzRkMzc5MTE1ZjU3YzMyXzgtMy0xLTEtMA_7233be75-b72c-4e4e-8898-2a8a91c72d62"
      unitRef="usd">1529000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ0OQ_50f856ca-7113-4fca-a7b3-2d53c2aeddd2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:LitigationReserveCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzItMS0xLTEtMA_407d0beb-308b-47b9-8020-d0c31c27eaa7"
      unitRef="usd">505000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzItMy0xLTEtMA_73667082-ad22-403c-afc7-c14b63086019"
      unitRef="usd">470000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzMtMS0xLTEtMA_9cbd3456-b165-4d03-bf9d-309b428335b6"
      unitRef="usd">681000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzMtMy0xLTEtMA_ac714850-3c0e-4dea-bf79-06bb706cb2e0"
      unitRef="usd">708000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzQtMS0xLTEtODM0MA_be0b41ed-b7ef-403b-bd0e-f091a551dc60"
      unitRef="usd">331000000</bsx:AccruedRebatesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzQtMy0xLTEtODM0MA_e104916c-a95c-44f7-9eaa-da97cdaf763e"
      unitRef="usd">298000000</bsx:AccruedRebatesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzQtMS0xLTEtMA_e2e5d7d1-93c4-4b69-997a-91ffa4b7ff1c"
      unitRef="usd">26000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzQtMy0xLTEtMA_3568f161-c4b1-45d6-ab2f-f563c5bf19ee"
      unitRef="usd">56000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzYtMS0xLTEtMA_fb0e1545-b1da-4a0f-8150-656f7deb4a0d"
      unitRef="usd">656000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzYtMy0xLTEtMA_66677a10-4669-465d-b628-5a3b24b3ac26"
      unitRef="usd">576000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzctMS0xLTEtMA_cc23c2e9-08d7-41e3-9a82-6078679d636d"
      unitRef="usd">2197000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTphMDMyNTM3ZGY0MGM0OWNiODhmNzk0OWZhY2NkZGNkNi90YWJsZXJhbmdlOmEwMzI1MzdkZjQwYzQ5Y2I4OGY3OTQ5ZmFjY2RkY2Q2XzctMy0xLTEtMA_2fb24337-0414-4543-9472-dfec3fd8c8e2"
      unitRef="usd">2109000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzI3NDg3NzkwNzU4MzA_b46309be-647d-4a29-b956-b5697077825a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzItMS0xLTEtMA_8c7ca585-a3e4-4211-bb40-f65ce8ed52a2"
      unitRef="usd">138000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzItMy0xLTEtMA_ff2a7cfb-355a-45dd-81f8-559b0c7447bd"
      unitRef="usd">144000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzMtMS0xLTEtMA_5dd92f6e-0de9-4710-ab91-40c1957dd105"
      unitRef="usd">153000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzMtMy0xLTEtMA_763946dc-aa3e-4a84-a1c3-f0194ecdb4ff"
      unitRef="usd">197000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzQtMS0xLTEtMA_84253954-6920-4e46-b855-3639e1e5cfe3"
      unitRef="usd">158000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzQtMy0xLTEtMA_80910aa2-d552-4e0c-963f-45c3471d9f5e"
      unitRef="usd">265000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzUtMS0xLTEtMTM4Mzc_7b0a0fc1-b85c-4eab-b0d6-e388c4017353"
      unitRef="usd">200000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzUtMy0xLTEtMTM4NDE_75ba376c-ef25-4374-844a-aae896e630f8"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzUtMS0xLTEtMA_67b47743-7d2f-4583-84eb-0f4339acf30c"
      unitRef="usd">307000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzUtMy0xLTEtMA_8e6e0d09-61b6-4d5a-9596-017aa729867c"
      unitRef="usd">195000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzYtMS0xLTEtMA_0846ff7b-63fe-4b5c-abc1-724718e9fb04"
      unitRef="usd">958000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTpjY2RkYTBlNDI3MTM0MWU4YjY5NmNhZTBiYTk3NmMxZC90YWJsZXJhbmdlOmNjZGRhMGU0MjcxMzQxZThiNjk2Y2FlMGJhOTc2YzFkXzYtMy0xLTEtMA_89e7e46f-f15e-4136-8a96-62fdcae75c5d"
      unitRef="usd">800000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90ZXh0cmVnaW9uOjBlMjBkOWFmM2RjYzRhZWFiMGY0YjMzNzdhZTBmMzZlXzQ5OQ_b9a599f4-6c85-48ec-bceb-ce6ed2456ee9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,635&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzItMS0xLTEtMA_8473363d-b882-420c-98db-521fb18e6fb2"
      unitRef="usd">547000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzItMy0xLTEtMA_737458d2-3835-4f0b-a3d5-8996b97e7e9f"
      unitRef="usd">667000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzMtMS0xLTEtMA_a601a44f-3b97-49db-9a39-ba2a2c583aea"
      unitRef="usd">64000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzMtMy0xLTEtMA_799c1e4b-9789-4530-8ecc-e376ce6240a7"
      unitRef="usd">227000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzQtMS0xLTEtMA_fab418e2-2722-492d-b0cb-4467ea986f5d"
      unitRef="usd">171000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzQtMy0xLTEtMA_6f9dd8f1-7cbb-43e5-ab5a-bb398f6a412e"
      unitRef="usd">299000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <bsx:LicensingArrangementsLiability
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzUtMS0xLTEtMA_5908cea6-9872-44b8-868d-e286be6befd0"
      unitRef="usd">253000000</bsx:LicensingArrangementsLiability>
    <bsx:LicensingArrangementsLiability
      contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzUtMy0xLTEtMA_4e835774-bf43-49a0-a222-7771c1b58c94"
      unitRef="usd">374000000</bsx:LicensingArrangementsLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzYtMS0xLTEtMA_d3f05afd-7e07-4237-8529-fa473374be33"
      unitRef="usd">401000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzYtMy0xLTEtMA_302e64e6-44fb-43b5-b1fa-bfaf8d7e7075"
      unitRef="usd">276000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredRevenue
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzctMS0xLTEtODM5Mg_33f05edf-ec7a-4b68-b6bc-f34d03630fd2"
      unitRef="usd">257000000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzctMy0xLTEtODM4OA_e203fd33-98bb-4d23-afed-c087d1ae81e0"
      unitRef="usd">257000000</us-gaap:DeferredRevenue>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i33eb88f0ba654a56a83ac224f0a18c85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzctMS0xLTEtMA_14771849-718e-4f73-ac5c-1b58ec534e32"
      unitRef="usd">615000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i8fd4a9fd1c704a35958d7562d8125b01_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzctMy0xLTEtMA_3599d149-ce2a-4648-bcd4-8c0e763897e9"
      unitRef="usd">535000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzgtMS0xLTEtMA_2c5759c8-e80f-48d6-966d-0caad314472c"
      unitRef="usd">2309000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjEvZnJhZzowZTIwZDlhZjNkY2M0YWVhYjBmNGIzMzc3YWUwZjM2ZS90YWJsZTo5YmY3ZjYyOWZjOGU0YTI4YTgxODE1ZmIzMGJmYzFhYS90YWJsZXJhbmdlOjliZjdmNjI5ZmM4ZTRhMjhhODE4MTVmYjMwYmZjMWFhXzgtMy0xLTEtMA_d172f686-c417-4b15-ab0e-79e30f2be9be"
      unitRef="usd">2635000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI3NDg3NzkwODg0NjA_d6cc408b-7251-41ec-ace4-a38d793fafc0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE J &#x2013; INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,422&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related expense (benefit) for income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(reclassified)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(reclassified)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic taxes on foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;TCJA net impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intra-entity asset transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(584.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Due to the disclosure of additional rate reconciling items in 2020, we have reclassified select items in prior years to align with the new categories disclosed in the current year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory costs and related reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit of net operating loss and credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves and accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and product liability reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment write-down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal benefit of uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains and losses on derivative financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment write-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory costs and related reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Tax Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid on intercompany profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid on intercompany profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $474 million. As of December&#160;31, 2019, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $449 million. In addition, we had foreign tax net operating loss carryforwards and tax credits, the tax effect of which was $83 million as of December&#160;31, 2020, as compared to $105 million as of December&#160;31, 2019. These tax attributes expire periodically beginning in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2019, we completed intra-entity asset transfers of certain intellectual property rights among various wholly owned subsidiaries. These transactions occurred to more closely align the global economic ownership of our intellectual property rights with our current and future business operations. These transactions did not result in a taxable gain in any jurisdiction, however, some of the transactions did create a step-up in the tax-deductible basis in the transferred intellectual property rights in certain jurisdictions. As a result, we recorded deferred tax assets in the amount of $4.102 billion, which represents the book and tax basis differences measured at applicable statutory tax rates, net of a valuation allowance of $542 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After consideration of all positive and negative evidence, we believe that it is more likely than not that a portion of our deferred tax assets will not be realized. As a result, we established a valuation allowance of $887 million as of December&#160;31, 2020 and $915 million as of December&#160;31, 2019, representing a decrease of $28 million. The decrease in the valuation allowance as of December&#160;31, 2020, as compared to December&#160;31, 2019, is primarily due to current year utilization of loss carryforwards and the concurrent release of the related valuation allowance. The income tax impact of the unrealized gain or loss component of other comprehensive income and stockholders' equity was a benefit of $78 million in 2020, a charge of $13 million in 2019 and a charge of $37 million in 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain tax incentives through Free Trade Zone Regime offered in Costa Rica which allows 100.0 percent exemption from income tax in the first eight years of operations and 50.0 percent exemption in the following four years. This tax incentive resulted in income tax savings of $64 million for 2020, $173 million for 2019 and $146 million for 2018. The tax incentive for 100.0 percent exemption from income tax was renewed during 2019 and is expected to expire in 2027. The impact on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss) per common share - assuming dilution&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was $0.04 for 2020, $0.12 for 2019 and $0.10 for 2018. Additionally, we benefit from tax incentives in Puerto Rico resulting in income tax savings of $30 million for 2020, and immaterial amounts for 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, we had $261 million of gross unrecognized tax benefits, of which a net $183 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $455 million of gross unrecognized tax benefits, of which a net $355 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2018, we had $427 million of gross unrecognized tax benefits, of which a net $332 million, if recognized, would affect our effective tax rate. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,238&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitation expirations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to U.S. Federal income tax as well as income tax of multiple state and foreign jurisdictions. We have concluded all U.S. federal income tax matters through 2016 and substantially all material state and local income tax matters through 2010. We have concluded all foreign income tax matters through 2013, with the exception of issues for Italy, which have concluded through 2002.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2018, a decision was entered by the U.S. Tax Court resolving all disputes for Guidant Corporation for its 2001 through 2006 tax years and our 2006 and 2007 tax years as well as the tax issues related to our 2006 transaction with Abbott Laboratories. Additionally, we resolved all issues with the IRS Office of Appeals for our 2008 through 2010 tax years. The final settlement calculation resulted in a final net tax payment of $303 million plus $307 million of estimated interest, which was remitted in the second quarter of 2018. Due to the final settlement of these disputes, we recorded a net tax benefit of $250 million in 2018 to remove a reserve related to these years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2018, we received a Revenue Agent Report (RAR) from the IRS for our 2011 through 2013 tax years. We remitted $93 million to the IRS in the fourth quarter of 2018 reflecting the net balance of tax and interest due for these years after consideration of amounts owed to us by the IRS. Due to the resolution of these tax years, we recorded a net tax benefit of $90 million in 2018 to remove a reserve related to these years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the third quarter of 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years stating that the Joint Committee on Taxation completed its review on July 21, 2020, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91&#160;million in the third quarter of 2020 to release the reserves related to these years. We received a refund of $62&#160;million from the IRS in the fourth quarter of 2020 reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize interest and penalties related to income taxes as a component of income tax expense. We had $41 million accrued for gross interest and penalties as of December&#160;31, 2020 and $19 million as of December&#160;31, 2019. We recognized net tax expense related to interest and penalties of $7 million in 2020, as compared to a net tax benefit of $1 million in 2019 and a net tax benefit of $498 million in 2018. The increase in our net tax expense related to interest and penalties as of December&#160;31, 2020, as compared to December&#160;31, 2019, is related to reaching favorable settlements with the taxing authorities during 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that within the next 12&#160;months we will resolve transactional- related issues with foreign and state taxing authorities, in which case we could record a reduction in our balance of unrecognized tax benefits of up to approximately $27 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2018, we completed our analysis and recording of all tax effects related to the TCJA, as required under SAB 118, and recorded a net benefit of $67 million, exclusive of the one-time transition tax adjustment described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2017, we were required under the TCJA to calculate a one-time transition tax based on our total post-1986 foreign subsidiaries' earnings and profits (E&amp;amp;P) that we previously deferred from U.S. income taxes. As a result of various audit activities, the revised amount of transition tax was approximately $939&#160;million as of December 31, 2020 as compared to $856 million as of December 31, 2018. We anticipate offsetting this liability against existing tax attributes reducing the required payment to approximately $597 million, which will be remitted over an eight-year period. We have begun remitting the required installment payments, with a balance remaining of $477&#160;million as of December&#160;31, 2020. In addition, we have provided for U.S. state income taxes of $20 million on all U.S. dollar-denominated E&amp;amp;P accumulated through December 31, 2017, which constitutes the preponderance of our foreign subsidiaries' accumulated E&amp;amp;P through December 31, 2017. We intend to indefinitely reinvest the unremitted foreign earnings of all other subsidiaries as of December 31, 2017, as well as all subsequent earnings generated by all of our foreign subsidiaries. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings and additional outside basis difference in these entities is not practicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to a territorial tax system under the TCJA, in which we are required to provide for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have established an accounting policy election to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyNDk_0e27c9e2-d65b-4176-b306-9849a4f1f6de">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,422&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzItMS0xLTEtMA_8bff351d-95e4-4e92-975d-fe7c3c6c5c70"
      unitRef="usd">-660000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzItMy0xLTEtMA_677142a0-db76-4dc8-a667-ab39bc8a1f74"
      unitRef="usd">-1145000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzItNS0xLTEtMA_3596c702-7bdb-4a02-a97c-2c081584a4b7"
      unitRef="usd">35000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzMtMS0xLTEtMA_b1e60fdf-32b6-4618-aad2-a8894202046b"
      unitRef="usd">581000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzMtMy0xLTEtMA_ce2a5e80-9bec-402f-8637-1fe014318d17"
      unitRef="usd">1832000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzMtNS0xLTEtMA_acf33ce8-4b0f-432e-8380-f9283543cfab"
      unitRef="usd">1387000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzQtMS0xLTEtMA_e3cc319a-cce5-4121-a217-5cd417b057b4"
      unitRef="usd">-79000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzQtMy0xLTEtMA_b83dc5ee-2cf2-440e-8087-3f50e5d92eec"
      unitRef="usd">687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiNmY0Yjk3ZWZhNDI0YjU1ODFmZmFhYWY5MDRmM2IzMC90YWJsZXJhbmdlOmI2ZjRiOTdlZmE0MjRiNTU4MWZmYWFhZjkwNGYzYjMwXzQtNS0xLTEtMA_a16e4d60-369a-4d9a-bba0-917931715115"
      unitRef="usd">1422000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyMTg_4d79eb62-ae58-4408-9f3f-8e5fd3a12567">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related expense (benefit) for income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzMtMS0xLTEtMA_f480b55f-e481-47a9-a9b4-b25271cef55c"
      unitRef="usd">-29000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzMtMy0xLTEtMA_973d1e13-5976-48dd-b1f1-b0c807aef465"
      unitRef="usd">120000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzMtNS0xLTEtMA_7bdbf382-aa24-42e6-8e3a-eb90b203bb69"
      unitRef="usd">-221000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzQtMS0xLTEtMA_79be3130-403b-483f-9944-c56cf0f89374"
      unitRef="usd">-35000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzQtMy0xLTEtMA_55f8c740-1078-4184-bc03-7574f821c716"
      unitRef="usd">54000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzQtNS0xLTEtMA_5bf133ad-5370-411d-ba32-795270e5e7ed"
      unitRef="usd">-27000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzUtMS0xLTEtMA_ad9fe786-3fa7-44d6-b736-b6a3a51363d9"
      unitRef="usd">151000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzUtMy0xLTEtMA_20f37522-473c-4396-94b1-26920b00c339"
      unitRef="usd">101000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzUtNS0xLTEtMA_15802d84-b190-4a61-a53e-adee367396ab"
      unitRef="usd">160000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzYtMS0xLTEtMA_2a623ea5-46e6-426d-a5fa-4dc813f9cbad"
      unitRef="usd">87000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzYtMy0xLTEtMA_16d5676d-f8ad-4392-a187-aa444775c4dd"
      unitRef="usd">275000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzYtNS0xLTEtMA_51e70ab9-f0bb-4e67-9733-d66d49b591a4"
      unitRef="usd">-87000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzktMS0xLTEtMA_cfe5258e-4a09-4d00-b8d2-00ec2eacda51"
      unitRef="usd">-26000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzktMy0xLTEtMA_bcf8e7e8-49aa-417b-ab5e-e29e6285f2df"
      unitRef="usd">-146000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzktNS0xLTEtMA_8a4bd112-cad7-4476-93a1-24665ba6396f"
      unitRef="usd">-124000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEwLTEtMS0xLTA_400ea2d7-5417-4fe9-aef9-a1e09258b4bc"
      unitRef="usd">-6000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEwLTMtMS0xLTA_daab8e3e-26c8-419a-a44b-ed0038a0a9fd"
      unitRef="usd">-18000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEwLTUtMS0xLTA_b7228b96-2a3e-4de0-9f42-b0b8c0ff88d5"
      unitRef="usd">4000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzExLTEtMS0xLTA_2efdb0d6-576d-460f-9aa0-07254c6748ae"
      unitRef="usd">-53000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzExLTMtMS0xLTA_08e013b2-8cdd-4260-8c52-1082ea4d152f"
      unitRef="usd">-4124000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzExLTUtMS0xLTA_3b891976-1181-4b85-9432-24ddc195f290"
      unitRef="usd">-42000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEyLTEtMS0xLTA_850576b2-4ded-4d98-9c31-13908a508746"
      unitRef="usd">-85000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEyLTMtMS0xLTA_dfce95eb-7d7d-4700-8e2a-a20f40549cdf"
      unitRef="usd">-4288000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEyLTUtMS0xLTA_3e29ffe4-6316-4b82-9efa-905a495f23f9"
      unitRef="usd">-162000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEzLTEtMS0xLTA_52ba1cf8-b64c-4d12-b6a8-3906a28fdc39"
      unitRef="usd">2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEzLTMtMS0xLTA_63b5abc8-3400-4a3f-a101-f82ce96c82f2"
      unitRef="usd">-4013000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToxYzFjNzY2NjM4NWM0ZjhlOTk2MjNlMmM0ZDg5ZTNkYS90YWJsZXJhbmdlOjFjMWM3NjY2Mzg1YzRmOGU5OTYyM2UyYzRkODllM2RhXzEzLTUtMS0xLTA_f2d890d5-0d4b-42f2-9c18-15616a2b7d27"
      unitRef="usd">-249000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyNDQ_8bfafc8b-8213-4759-92a3-a20aaafe2872">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(reclassified)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(reclassified)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic taxes on foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of foreign taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;TCJA net impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intra-entity asset transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(584.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Due to the disclosure of additional rate reconciling items in 2020, we have reclassified select items in prior years to align with the new categories disclosed in the current year.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzMtMS0xLTEtMA_d3d3ffcb-17df-4ae3-970f-da8f73a09ca0"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzMtMy0xLTEtMA_ab566ee1-1eec-4d20-b267-c4b109272305"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzMtNS0xLTEtMA_50612e66-dcc3-44b2-a61e-5df532812d37"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzQtMS0xLTEtMA_91c32c4d-c6f3-4c00-a771-aa8d496b0b8a"
      unitRef="number">0.166</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzQtMy0xLTEtMA_1058964b-a933-4ab0-ad5b-24fccd9ee8f5"
      unitRef="number">0.067</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzQtNS0xLTEtMA_9644f794-6660-4b8e-aba4-759130e03fa8"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzYtMS0xLTEtMA_e6c817ac-f1f3-40a0-9365-beb828b94e2f"
      unitRef="number">1.554</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzYtMy0xLTEtMA_a1b7a865-6083-4b4f-9f40-b04ca979ea1b"
      unitRef="number">0.219</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzYtNS0xLTEtMA_fe2eb4ac-8f99-4384-b10f-7553e3ce7b66"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzctMS0xLTEtMA_4397601a-12ab-474b-9bd2-960f1e6f4212"
      unitRef="number">-0.407</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzctMy0xLTEtMA_42440e0a-4fdd-4409-8235-c448950faa9c"
      unitRef="number">-0.476</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzctNS0xLTEtMA_5fe104d5-9e18-4fdf-adec-d6b7624ba3e4"
      unitRef="number">-0.084</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzgtMS0xLTEtMA_d6433020-6821-4b00-9db1-a54c851f9410"
      unitRef="number">0.167</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzgtMy0xLTEtMA_364475b0-b7a3-4cf6-be78-45bba042aed6"
      unitRef="number">0.122</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzgtNS0xLTEtMA_6ffc282c-3179-4e52-9020-cd06d3cff904"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzktMS0xLTEtMA_eeae65e4-0505-4513-bbb7-8e30dca1efe9"
      unitRef="number">0.430</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzktMy0xLTEtMA_c8afa197-4740-4e3d-9c32-94d3bcca69bb"
      unitRef="number">0.042</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzktNS0xLTEtMA_73a51a0d-55a6-438e-b8c0-6d1dc87b1946"
      unitRef="number">0.026</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEwLTEtMS0xLTA_e78351a9-f128-414a-90d6-181de353cbaf"
      unitRef="number">-0.420</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEwLTMtMS0xLTA_3c70ad8a-6ea8-409b-93bf-788cf223a2b1"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEwLTUtMS0xLTA_c5387394-af40-45ff-af29-143f36c17730"
      unitRef="number">-0.052</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEyLTEtMS0xLTA_321316d7-e074-427b-a1d2-e5ad6be71576"
      unitRef="number">0.037</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEyLTMtMS0xLTA_73472627-029c-4566-8113-b3eec4e477a4"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEyLTUtMS0xLTA_45829a2d-948c-4ed0-b3a9-d319ef230e4c"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEzLTEtMS0xLTA_dc61c9e6-fb03-4eab-9f23-0a6345b47d10"
      unitRef="number">-0.077</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEzLTMtMS0xLTA_d2e4b8a2-37fb-40d4-bb33-ecdeee8cb1e9"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzEzLTUtMS0xLTA_d21d6b38-8946-4b10-aaa1-36dbb5cf7e3c"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE0LTEtMS0xLTA_8dbf0134-8cea-4c79-bd35-3a6922d9d371"
      unitRef="number">0.644</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE0LTMtMS0xLTA_e29b45ef-0d6b-4258-956d-9e3e1011d8c4"
      unitRef="number">0.036</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE0LTUtMS0xLTA_d43765ed-e283-46e2-ab1e-2b0cd75930e4"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE1LTEtMS0xLTA_e51ea434-b4fc-4543-a105-10fb5e9907c3"
      unitRef="number">-0.968</bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions>
    <bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE1LTMtMS0xLTA_5b7102e8-358e-4ab3-b39e-f2e2ba67cfd0"
      unitRef="number">0.014</bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions>
    <bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE1LTUtMS0xLTA_adb9ca75-5076-49d8-9b3e-38e0027d113f"
      unitRef="number">-0.220</bsx:EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions>
    <bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE2LTEtMS0xLTA_81d12f62-5680-49d8-bd94-89d435480d36"
      unitRef="number">0</bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact>
    <bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE2LTMtMS0xLTA_55fa523f-94f2-4158-911e-c9a36edd72cd"
      unitRef="number">0</bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact>
    <bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE2LTUtMS0xLTA_a408fe23-2501-4f7e-9cd8-993b754e4a7a"
      unitRef="number">-0.047</bsx:EffectiveIncomeTaxRateReconciliationTCJAnetimpact>
    <bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE3LTEtMS0xLTA_b6d03510-f830-47ef-8fd2-016b6f2f2588"
      unitRef="number">0.102</bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers>
    <bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE3LTMtMS0xLTA_20e942bd-da42-4634-9173-3f6a75f66a33"
      unitRef="number">-5.970</bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers>
    <bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE3LTUtMS0xLTA_23a73ba7-5eb2-4201-b3b0-2fd4f40f5af9"
      unitRef="number">0</bsx:EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers>
    <bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTEtMS0xLTE4MTkx_d1edd87b-300c-4430-af7c-3a396d4b4130"
      unitRef="number">-0.373</bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision>
    <bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTMtMS0xLTE4MTkx_401f06e5-7bf0-4a59-9729-9a9826116896"
      unitRef="number">-0.002</bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision>
    <bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTUtMS0xLTE4MTkx_c9e7fcd8-3743-4d86-884a-0362cfcfacf9"
      unitRef="number">-0.002</bsx:EffectiveIncomeTaxRateReconciliationReturnToProvision>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzIwLTEtMS0xLTE4MTkx_41f31d34-4173-4f18-b4a7-8d75c479e21a"
      unitRef="number">0.518</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzIwLTMtMS0xLTE4MTkx_e65dec36-b265-46b5-9dcf-095f9ea4f9d4"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzIwLTUtMS0xLTE4MTkx_4df516ad-09ad-477e-a8e9-786ed05235ef"
      unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE4LTEtMS0xLTA_a6908805-1199-4bee-b274-a220c7060c71"
      unitRef="number">0.060</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE4LTMtMS0xLTA_80afca73-0bb2-40d6-aa01-4399cd2ddbd3"
      unitRef="number">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE4LTUtMS0xLTA_93078244-cc1f-433f-8604-52a23a5d977c"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTEtMS0xLTA_c452bf5e-eb0b-4db6-8cb6-93d6b4ab089c"
      unitRef="number">0.029</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTMtMS0xLTA_3fe51678-9fe7-46f1-bad6-decd0fa65a50"
      unitRef="number">-5.840</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTo2MDg5NWY5NTM2ZDE0MjU0YmY4ZTg0MmJhZmVlYTFlMC90YWJsZXJhbmdlOjYwODk1Zjk1MzZkMTQyNTRiZjhlODQyYmFmZWVhMWUwXzE5LTUtMS0xLTA_5ea78c42-489d-4f49-ab14-c08efbf7a050"
      unitRef="number">-0.175</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyNDY_3996899a-38f9-4992-a0da-70964c14ade2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory costs and related reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit of net operating loss and credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves and accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and product liability reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment write-down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal benefit of uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains and losses on derivative financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment write-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory costs and related reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Tax Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid on intercompany profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid on intercompany profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Tax Assets and Prepaid on Intercompany Profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzQtMS0xLTEtMA_57c1457f-fd7b-46c6-a362-fb20d74bf81f"
      unitRef="usd">10000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzQtMy0xLTEtMA_071de60d-7a8c-4605-8bad-dff156fc0c5e"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzUtMS0xLTEtMA_80bf7c0a-3283-4ff9-a82a-036ae38df7fe"
      unitRef="usd">557000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzUtMy0xLTEtMA_18e9889c-069b-486d-a1be-c03905e3e33a"
      unitRef="usd">545000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzYtMS0xLTEtMA_90d97950-81d6-43f1-942f-8768a8636a47"
      unitRef="usd">308000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzYtMy0xLTEtMA_2a37251b-1f77-43ac-8d2f-ad1c21ce6277"
      unitRef="usd">258000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzctMS0xLTEtMA_d180a8dc-9e2a-487b-9b03-647489207a02"
      unitRef="usd">23000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzctMy0xLTEtMA_fd03646a-6f22-408e-8906-4671381a3a54"
      unitRef="usd">20000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzgtMS0xLTEtMA_c4afa166-0e6b-4b77-9db8-d6dd9f1539e8"
      unitRef="usd">82000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzgtMy0xLTEtMA_9a07006e-fcce-452a-8a4f-2f1a9ac4eeac"
      unitRef="usd">168000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEwLTEtMS0xLTA_789d4133-09c1-4f9a-a78e-f7036cd79019"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEwLTMtMS0xLTA_3b20b368-1c5f-4aa4-bc36-a8eb468a9823"
      unitRef="usd">42000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzExLTEtMS0xLTA_87696844-ed22-4313-80d1-f1007c5e777c"
      unitRef="usd">134000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzExLTMtMS0xLTA_42c34e6f-155c-4652-9c3e-27da6ebc8fa4"
      unitRef="usd">121000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <bsx:FederalBenefitOfUncertainTaxPositions
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEyLTEtMS0xLTA_64263660-61e5-4904-92b8-16143f2b86ca"
      unitRef="usd">9000000</bsx:FederalBenefitOfUncertainTaxPositions>
    <bsx:FederalBenefitOfUncertainTaxPositions
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEyLTMtMS0xLTA_65806f75-33ce-4ece-9385-b04fcdf75fe2"
      unitRef="usd">10000000</bsx:FederalBenefitOfUncertainTaxPositions>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEzLTEtMS0xLTA_a1d0a9c7-4008-4764-b6ca-e033f8e65e9d"
      unitRef="usd">3551000000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzEzLTMtMS0xLTA_5124a962-f2a2-4c64-b3e1-bf339ac5e7e8"
      unitRef="usd">3447000000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE0LTEtMS0xLTA_a1ecf0ba-44fe-4244-bbd9-636426bb4b1c"
      unitRef="usd">-6000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE0LTMtMS0xLTA_e90bb5c3-db38-46b4-9be4-2a20ca8627c8"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE1LTEtMS0xLTA_fe21e4a5-16d8-4385-bb9d-2211099cf963"
      unitRef="usd">4668000000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE1LTMtMS0xLTA_80ca23b5-f59e-42b8-a246-104b401fe7f1"
      unitRef="usd">4611000000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE2LTEtMS0xLTA_8b634947-490b-4b71-9e58-5a9c96bd049f"
      unitRef="usd">887000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE2LTMtMS0xLTA_55aa803e-3f57-4efa-91a2-9bac4e82415c"
      unitRef="usd">915000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE3LTEtMS0xLTA_25cfe4eb-81e9-4559-be16-b65c0fad3a0a"
      unitRef="usd">3781000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE3LTMtMS0xLTA_c844a630-150b-4512-a280-dbcaf334662c"
      unitRef="usd">3696000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE5LTEtMS0xLTA_6b2c8e60-2845-471b-9588-f516602cb670"
      unitRef="usd">1000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzE5LTMtMS0xLTA_09a9d45f-61d3-494c-9a64-cab66932fecd"
      unitRef="usd">16000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesDerivatives
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIwLTEtMS0xLTA_f4622e20-22c2-4967-b87c-d2358a1db186"
      unitRef="usd">12000000</us-gaap:DeferredTaxLiabilitiesDerivatives>
    <us-gaap:DeferredTaxLiabilitiesDerivatives
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIwLTMtMS0xLTA_636aa297-d39e-45bd-9982-9d69733656d9"
      unitRef="usd">52000000</us-gaap:DeferredTaxLiabilitiesDerivatives>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIxLTEtMS0xLTA_798e9e41-d553-4edb-859e-fef1ccbe93d4"
      unitRef="usd">34000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIxLTMtMS0xLTA_f433ac92-e5bb-4544-969f-c7f97eddf3b9"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIyLTEtMS0xLTA_b0e56971-f636-4759-a126-0cb6dece0e3b"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIyLTMtMS0xLTA_74eab285-6608-4e88-a983-70f980e30edf"
      unitRef="usd">2000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIzLTEtMS0xLTA_8daf91a6-ed8f-46cf-ba4b-d1ea0fa83633"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzIzLTMtMS0xLTA_16c32b67-2592-41e1-9264-89056df6cc4d"
      unitRef="usd">25000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI0LTEtMS0xLTA_f3b4b59f-37f6-4770-8046-9dad7c5cc300"
      unitRef="usd">47000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI0LTMtMS0xLTA_ce51d5af-33ca-44ce-b350-fef18f0c3d07"
      unitRef="usd">95000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI2LTEtMS0xLTA_61e91fc8-3761-4b8f-b032-979ab7d4cb2a"
      unitRef="usd">3734000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI2LTMtMS0xLTA_ac957d33-389a-4371-a9d4-b02eaa6685db"
      unitRef="usd">3601000000</us-gaap:DeferredTaxAssetsGross>
    <bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI3LTEtMS0xLTA_2d9bd4e6-5089-4582-aae5-07af1146fced"
      unitRef="usd">194000000</bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit>
    <bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI3LTMtMS0xLTA_a1e6fc70-ff10-4eab-8875-328bc3385f7b"
      unitRef="usd">195000000</bsx:DeferredTaxAssetsPrepaidonIntercompanyProfit>
    <bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI4LTEtMS0xLTA_7ba2afe0-7586-4f99-9e30-4f4d16815e3a"
      unitRef="usd">3928000000</bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit>
    <bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZToyNmZkYWRjNzgyOTg0Y2JiYmU0NDk0MDRhMjEyOWUwMS90YWJsZXJhbmdlOjI2ZmRhZGM3ODI5ODRjYmJiZTQ0OTQwNGEyMTI5ZTAxXzI4LTMtMS0xLTA_2b54d739-fbb8-49db-bcc0-e4ffd751d044"
      unitRef="usd">3796000000</bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="id9c026cbdf6644bdb88b307eed56919f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzItMi0xLTEtMA_5841b8b1-8f4a-47af-b0fe-c0f84f9c5615"
      unitRef="usd">194000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ifad23126719c4bb4bf9ce037ea077942_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzItNC0xLTEtMA_2caf5d63-19ab-4030-a005-3798b15a7f60"
      unitRef="usd">195000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i067d126bfe71406d9637e9e0321f9dba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzMtMi0xLTEtMjAwOTk_d8e0a910-820e-449b-aa59-7b3a0f3c6b47"
      unitRef="usd">2000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i2a7f21deae51477e88e1f5da1df0f205_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzMtNC0xLTEtMjAwOTk_d9a2104e-6359-4a2a-9d63-e770508a8720"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i6df411a051af4374b3df655f51893efc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzMtMi0xLTEtMA_63fd5327-68ed-44ff-ada9-45ae22f6f5e0"
      unitRef="usd">4210000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i5e27faab8a7c4a88b4496e70958eb027_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzMtNC0xLTEtMA_55d7817e-94ae-4633-b4c9-498845115f9d"
      unitRef="usd">4196000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzQtMi0xLTEtMA_be71b637-30be-49c4-b40c-9da49bf3356a"
      unitRef="usd">4406000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzQtNC0xLTEtMA_a6620368-73e7-4ddc-b92d-d0c13a002d4f"
      unitRef="usd">4391000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i38649fda4692447aa9a51f8b4b69b77a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzctMi0xLTEtMTgyMDA_496e37bf-411c-4e9f-81cd-21672d0f89c1"
      unitRef="usd">330000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i8c0c0db4113b41ac8f0a3925494b51f7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzctNC0xLTEtMTgyMDA_1177179b-d6c7-4c7a-987a-514d4ee8506c"
      unitRef="usd">595000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i95932fa13d754cceaf54655a7e81a6dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzktMi0xLTEtMTgyMDM_040263b6-a360-4757-b4da-aefc7617e889"
      unitRef="usd">148000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i7b3d68a05c444d0dacb5095f51e80130_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzktNC0xLTEtMTgyMDM_035ca7c5-fb80-4913-9cf8-54d6aefd2343"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzgtMi0xLTEtMA_97b414d7-4958-4e85-8cbc-75f186589774"
      unitRef="usd">478000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzgtNC0xLTEtMA_39191847-e79d-449a-b860-c11663a713c4"
      unitRef="usd">595000000</us-gaap:DeferredTaxLiabilities>
    <bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzEwLTItMS0xLTA_df9566f1-37b2-4d15-ae6c-f1b469bf0bb9"
      unitRef="usd">3928000000</bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit>
    <bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTpiMzljZDQzYjhmNzA0NWI0YjU1ZTNjNmU3ZTI5MTZjYy90YWJsZXJhbmdlOmIzOWNkNDNiOGY3MDQ1YjRiNTVlM2M2ZTdlMjkxNmNjXzEwLTQtMS0xLTA_afe298db-6a7e-49b0-8bb3-710dc9bb5fb2"
      unitRef="usd">3796000000</bsx:NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzkxNg_fe4153f0-b718-443b-836d-3494b29ccec7"
      unitRef="usd">474000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzEwNDI_54efe122-ebe6-42d0-9ec0-f2a92c01dc1a"
      unitRef="usd">449000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzExNTY_65b068cd-03f2-4e0a-ba55-ddb54ffc2140"
      unitRef="usd">83000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzExODQ_75972048-7d65-480e-80bb-5c720546a7f2"
      unitRef="usd">105000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzE4NzM_de0ebd12-c994-4d87-b21a-97f80978c98b"
      unitRef="usd">4102000000</us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory>
    <bsx:DeferredTaxAssetValuationAllowanceIntraEntity
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIwMDU_60edb0e5-3071-4f22-8849-3cfe46ef6c46"
      unitRef="usd">542000000</bsx:DeferredTaxAssetValuationAllowanceIntraEntity>
    <bsx:DeferredTaxAssetValuationAllowanceIntraEntity
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIwMDU_aee7f557-9748-4301-bb20-607c0d186755"
      unitRef="usd">542000000</bsx:DeferredTaxAssetValuationAllowanceIntraEntity>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIyMzE_8b634947-490b-4b71-9e58-5a9c96bd049f"
      unitRef="usd">887000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIyNDc_55aa803e-3f57-4efa-91a2-9bac4e82415c"
      unitRef="usd">915000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <bsx:ChangeinDeferredTaxAssetsValuationAllowance
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzIyODI_f7728fa9-02d0-4650-8c98-000c9dae4522"
      unitRef="usd">-28000000</bsx:ChangeinDeferredTaxAssetsValuationAllowance>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI1NzE_81e19c65-542b-469a-ae80-cc8d3307fa03"
      unitRef="usd">-78000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI1OTM_4e3f6e44-1b8b-4fb8-bcc5-fa9e504ac697"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI2MTk_b0fc9cce-fa9c-4e3b-968c-fbc6c723d0c3"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <bsx:FreeTradeZoneRegimeTaxIncentive
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI5MTA_ed84bb94-a46b-44b5-b65a-caa8f13b7bf6"
      unitRef="usd">64000000</bsx:FreeTradeZoneRegimeTaxIncentive>
    <bsx:FreeTradeZoneRegimeTaxIncentive
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI5MjE_459ad8fe-70fe-468d-823e-332a6ad537d8"
      unitRef="usd">173000000</bsx:FreeTradeZoneRegimeTaxIncentive>
    <bsx:FreeTradeZoneRegimeTaxIncentive
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI5MzU_8a5a459a-f413-4986-9524-2ebf457d0650"
      unitRef="usd">146000000</bsx:FreeTradeZoneRegimeTaxIncentive>
    <bsx:FreeTradeZoneTaxIncentivePerShare
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMxMDQ_af4d290c-22bf-4e2d-85e5-9b67bfb9e3eb"
      unitRef="usdPerShare">0.04</bsx:FreeTradeZoneTaxIncentivePerShare>
    <bsx:FreeTradeZoneTaxIncentivePerShare
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMxMTg_c4f44767-8bbb-4473-8c34-b1e180502542"
      unitRef="usdPerShare">0.12</bsx:FreeTradeZoneTaxIncentivePerShare>
    <bsx:FreeTradeZoneTaxIncentivePerShare
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMxMzI_1206ddf7-57ef-4cb1-85c0-ff8804c7fa84"
      unitRef="usdPerShare">0.10</bsx:FreeTradeZoneTaxIncentivePerShare>
    <bsx:TaxIncentivesInPuertoRico
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU0OTc1NTgxNTc5MjE_73a69042-e7e9-48a5-96f9-8bf34a740289"
      unitRef="usd">30000000</bsx:TaxIncentivesInPuertoRico>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMyOTg_9b094213-7d69-40a9-80bb-4f12d71b5c19"
      unitRef="usd">261000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzMzNTI_04244edc-7571-4b36-9ee1-cb475c0b1126"
      unitRef="usd">183000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzM0MjU_6cf126d6-b30c-4f81-a656-58836a2a0d6b"
      unitRef="usd">455000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzM0Nzk_b59daec3-70f0-4a0d-b4cf-50e7c2475b18"
      unitRef="usd">355000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzM1NTI_0a5e230d-085d-40dd-b408-2881e35820c7"
      unitRef="usd">427000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzM2MDY_e1ce7c00-40f4-488d-aa7b-24c7e12b903a"
      unitRef="usd">332000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzgyNTI_3e029fa2-18bb-46fd-a2f6-a1f4e2938f9a">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,238&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements with taxing authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statute of limitation expirations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzItMS0xLTEtMA_b7fc6b5d-5986-49e6-8ec0-de14396b64cf"
      unitRef="usd">455000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzItMy0xLTEtMA_66d43876-4463-4707-a8b4-4a6fdaa6807e"
      unitRef="usd">427000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzItNS0xLTEtMA_3aafbeb3-4536-42ac-8d3d-9e4f60253566"
      unitRef="usd">1238000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzMtMS0xLTEtMA_547a2b6c-8bd3-4b4e-82cf-7e4febd0b9bf"
      unitRef="usd">28000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzMtMy0xLTEtMA_163137e4-d441-4b2e-8736-3fe25e08d7a1"
      unitRef="usd">30000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzMtNS0xLTEtMA_07490fac-70e0-4117-9c04-dfc7cbf4a8dd"
      unitRef="usd">79000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzQtMS0xLTEtMA_72cedd42-92f2-4e66-9dbd-06d738f763b4"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzQtMy0xLTEtMA_699486b0-cb89-4c94-8eb7-e68fbb3a246a"
      unitRef="usd">45000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzQtNS0xLTEtMA_05a5f1d5-0972-4f6d-8b9e-0bb339ccc7b1"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzUtMS0xLTEtMA_81c8e667-8513-442a-9785-b714fe1984fe"
      unitRef="usd">186000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzUtMy0xLTEtMA_e53d1cc8-f1c5-4996-a073-01f69743e0d4"
      unitRef="usd">34000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzUtNS0xLTEtMA_8ca72654-370e-4076-943d-e39fda5ed0c4"
      unitRef="usd">433000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzYtMS0xLTEtMA_7334b168-226e-4ae1-aaaa-7b9777769db3"
      unitRef="usd">27000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzYtMy0xLTEtMA_977bea10-b60c-4c04-a2e3-6b8d71d5e5db"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzYtNS0xLTEtMA_79811488-d728-4b88-bbd8-3be885505f8c"
      unitRef="usd">459000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzctMS0xLTEtMA_629a29cd-249c-48c8-91a8-69323fc11fe5"
      unitRef="usd">15000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzctMy0xLTEtMA_671b2e46-929a-4459-961d-f63490611978"
      unitRef="usd">9000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzctNS0xLTEtMA_e1222012-7936-424f-9e90-434bc04bde78"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzgtMS0xLTEtMA_9b094213-7d69-40a9-80bb-4f12d71b5c19"
      unitRef="usd">261000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzgtMy0xLTEtMA_6cf126d6-b30c-4f81-a656-58836a2a0d6b"
      unitRef="usd">455000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90YWJsZTowOGEzOWIxNDEwMGE0YjY5ODNlMjllOWFlYTYwNzlmZC90YWJsZXJhbmdlOjA4YTM5YjE0MTAwYTRiNjk4M2UyOWU5YWVhNjA3OWZkXzgtNS0xLTEtMA_0a5e230d-085d-40dd-b408-2881e35820c7"
      unitRef="usd">427000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i51d17bc802334ee58e6912543c9a9101_D20180401-20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzQ2NTI_14cc67ae-0015-49f1-b209-66ab98199200"
      unitRef="usd">303000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i2ca84bcda655492cb7c95b91c9cc7c27_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzQ2NjA_45e53a32-e162-4d8c-a0f8-4571fbcd7d9b"
      unitRef="usd">307000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzQ4MTY_45937f62-6c12-4bb9-a27a-bc7feeb70ee0"
      unitRef="usd">250000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <bsx:NetSettlementPaymenttoIRS
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzUwMDc_7a3b94cb-9a6a-4cce-a1af-82b587afd442"
      unitRef="usd">93000000</bsx:NetSettlementPaymenttoIRS>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i75283a86da274266950b25d74cea7669_D20181001-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzUyNDc_3afb06dc-5bf6-4308-b674-f9d8b5e4fbcd"
      unitRef="usd">90000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i83276247c7f842c9ae8442b64070ca41_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYwNDczMTM5NjkyNDI_7a52f650-1033-4c04-8816-7de36168b383"
      unitRef="usd">91000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i798449bc56004b03983ad8201e6fc19d_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYwNDczMTM5NjkyODk_a8e28555-dbd2-4864-9b1d-21a41d71b97c"
      unitRef="usd">62000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU0MDE_8c31db34-a903-4cdd-aee0-e6a3390c926c"
      unitRef="usd">41000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU0NTg_6f1ae8b0-ffee-4f18-b9ed-d0d9ec253190"
      unitRef="usd">19000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU2ODc_05ab6b87-7f08-4324-938e-4d010a4813ab"
      unitRef="usd">7000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU3MzM_0ebf0e10-fe7d-4beb-a2a9-9e62e3d77f31"
      unitRef="usd">1000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzU3Njc_395aaaa5-e693-40c8-9b21-4081f71023f9"
      unitRef="usd">498000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYxOTY_95f3d0ab-d688-4026-ba7d-185f437ea5a9"
      unitRef="usd">27000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYzNjg_bbb81d63-28da-485f-ada4-36697ae658de"
      unitRef="usd">67000000</us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI3NDg3NzkwODgzODg_541db9ae-64ec-4513-9ddf-ab532add53b7"
      unitRef="usd">939000000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzY4MDc_195e5ddc-6aca-4d48-9a40-aa7f411a6282"
      unitRef="usd">856000000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability>
    <bsx:Onetimetransactiontaxpost1986EPnetpayment
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzcwNDU_844176b6-328a-409b-ba8b-bb7e75088de2"
      unitRef="usd">597000000</bsx:Onetimetransactiontaxpost1986EPnetpayment>
    <bsx:TransitionTaxPaymentRemaining
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzI3NDg3NzkwODg0MDI_773a9e58-9106-441c-9da7-b79fdfe70aad"
      unitRef="usd">477000000</bsx:TransitionTaxPaymentRemaining>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzcyNjA_54436d44-04c7-4bdf-a082-9b598b367714"
      unitRef="usd">20000000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
    <bsx:TheCARESAct
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjQvZnJhZzphM2I4N2Y3Y2E1NzI0MDZiYjljYmNkZmIzZTI5YzdkYy90ZXh0cmVnaW9uOmEzYjg3ZjdjYTU3MjQwNmJiOWNiY2RmYjNlMjljN2RjXzYwNDczMTM5NjkzMDk_ad58c0ee-1e79-4ce7-b0ec-50747c95f547"
      unitRef="usd">2200000000000</bsx:TheCARESAct>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzM1MzQz_ff4f6e4c-cfee-4c6c-8250-bbe8fdafa63c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE K &#x2013; COMMITMENTS AND CONTINGENCIES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accrual for legal matters that are probable and estimable was $569 million as of December&#160;31, 2020 and $697 million as of December&#160;31, 2019 and includes certain estimated costs of settlement, damages and defense. The decrease in our legal accrual was mainly due to settlement payments related to litigation with Channel Medsystems, Inc. (Channel), partially offset by charges associated with product liability cases or claims related to transvaginal surgical mesh products. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $208 million as of December&#160;31, 2020 and $346 million as of December&#160;31, 2019. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded litigation-related net charges of $278 million in 2020, primarily related to transvaginal mesh products, inclusive of a reserve related to claims made by a coalition of state attorneys general. Those claims settled in principle in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded litigation-related net charges of $115 million in 2019, which included a net charge of $223 million in the fourth quarter of 2019, primarily related to litigation with Channel, net charges of $25 million in the third quarter of 2019 and $15 million in the second quarter of 2019, primarily related to transvaginal surgical mesh product liability litigation, and a gain of $148 million recorded in the first quarter of 2019, which represents a portion of the total $180 million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;in our&#160;consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As such, a portion of the related gain from this settlement was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded litigation-related net charges of $103 million in 2018, primarily related to transvaginal surgical mesh product liability litigation. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In management's opinion, we are not currently involved in any legal proceedings other than those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2015, BSC filed suit against Cook Group Limited and Cook Medical LLC (collectively, &#x201c;Cook&#x201d;) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#x2019;s Instinct Endoscopic Hemoclip. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (&#x201c;IPR&#x201d;) requests with the U.S. Patent and Trademark Office against the four asserted patents. All IPRs have concluded, and Cook and Boston Scientific both appealed the Patent Office&#x2019;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Boston Scientific patents remain valid, remanding two of the patents for further review by the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;USPTO's Patent Trial and Appeal Board. In November, the Patent Office issued remand rulings invalidating several additional claims. The district court had stayed the case pending the appeals court decision on the IPRs, which is now complete. In the first or second quarter of 2021, the case will proceed before the United States District Court for the Southern District of Indiana, with BSC asserting two patents against Cook. Trial is anticipated in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#x2019;s Senza&#x2122; Spinal Cord Stimulation System. On June 22, 2020, this action was consolidated with case 18-cv-664, described below. The court set trial for October 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2017, The Board of Regents, University of Texas System (UT) and TissueGen. Inc., served a lawsuit against us in the Western District of Texas. The complaint against us alleges patent infringement of two U.S. patents owned by UT, relating to &#x201c;Drug Releasing Biodegradable Fiber Implant&#x201d; and &#x201c;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#x201d; and affects the manufacture, use and sale of our Synergy&#x2122; Stent System. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the University&#x2019;s Petition for Certiorari. UT is proceeding with its case against BSC in Delaware.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#x2019;s Senza&#x2122; I and Senza&#x2122; II Spinal Cord Stimulation Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our Spinal Cord Stimulation systems infringe five Nevro patents. On June 22, 2020, this action was consolidated with case 16-cv-1163. The theft of trade secrets, patent counterclaims, and patent infringement claims from case 16-cv-1163 were set for trial in October 2021. The patent infringement claims from case 18-cv-664 were stayed pending IPRs. On January 6, 2021, the court stayed one of the patent infringement claims from case 16-cv-1163, such that it will proceed with the stayed patent infringement claims from case 18-cv-664.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2020, Koninklijke Philips N.V. and IP2IPO Innovations, Ltd. (&#x201c;Philips&#x201d;) served a complaint against the Company in the United States District Court for the District of Delaware. The complaint alleges that certain BSC cardiovascular diagnostic devices infringe six Philips patents.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Liability Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 27, 2021, approximately 54,000 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of January 27, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately&#160;52,000&#160;cases and claims, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 52,000 cases and claims, approximately 48,000 have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over 3,100 of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general offices regarding our transvaginal surgical mesh products. We have responded to those requests. On December 12, 2019 the Mississippi Attorney General filed suit against BSC in State Court alleging violations of the Mississippi Consumer Protection Act which the Company plans to vigorously defend. There are fewer than 60 claims in the United Kingdom and fewer than 125 cases in Australia. There are also fewer than 10 cases in Canada, inclusive of one certified class action, which has settled and received Court approval. On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#x2019;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. While we believe that our accrual associated with this matter is adequate, changes to this accrual may be required in the future as additional information becomes available. We have also established an accrual related to the claims made by the coalition of state attorneys general. While we continue to engage in discussions with plaintiffs&#x2019; counsel regarding potential resolution of pending cases and claims and intend to vigorously contest the cases and claims asserted against us that do not settle, the final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Initial trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently named a defendant in 118 filed product liability cases involving our Greenfield Vena Cava Filter, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 597 claims, none of which have been filed. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Governmental Investigations and Qui Tam Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena seeks information relating to the launch of the Cognis&#x2122; and Teligen&#x2122; line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of the Physician Guided Learning Program. We are cooperating with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. government and the State of California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to the Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for Boston Scientific and three of its employees, as well as numerous other defendants charged in criminal proceedings.&#160;The charges arise from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials.&#160;A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Boston Scientific employee but acquitted two others and levied a fine of &#x20ac;245 thousand against us and imposed joint and several civil damages of &#x20ac;620 thousand on all defendants. We continue to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against Boston Scientific and its employee and acquitted them of all charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#x201c;technical note,&#x201d; announced that it was launching a formal administrative proceeding against Boston Scientific&#x2019;s Brazilian subsidiary, Boston Scientific do Brasil Ltda., as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. We deny the allegations and intend to defend ourselves vigorously.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments are due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 18, 2019, Blue Cross &amp;amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp;amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia. The complaint alleges that the defendants violated the Sherman Act and the antitrust and consumer protections laws of several states by pursuing patent litigation relating to ZYTIGA&#x2122; in order to delay generic entry. On June 21, 2019, the case was transferred to the United States District Court for the District of New Jersey and has been consolidated with similar complaints.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2017, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp;amp; Development, LLC, and Johnson &amp;amp; Johnson (collectively, Janssen) were served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;complaint filed on behalf of the United States, 28 states, and the District of Columbia. The complaint, which was filed in the United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA to the government in connection with direct government sales and government-funded drug reimbursement programs. The case has been transferred to United States District Court for the District of New Jersey. On June 20, 2019, the complaint was amended to include BTG International Limited as a defendant. In May 2020, a class action complaint was filed in New Jersey federal court against Johnson &amp;amp; Johnson and BTG by two direct purchasers of Zytiga on behalf of similarly situated entities. The complaint alleges that BTG and J&amp;amp;J violated antitrust laws by attempting to enforce certain patents against potential generic competitors. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against Boston Scientific Corporation, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#x2122; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all other similarly situated, filed a second, materially similar class action complaint against Boston Scientific Corporation, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. The Company expects these cases to be superseded by a single amended and consolidated class action complaint in the first or second quarter of 2021. On December 15, 2020, the Securities and Exchange Commission&#x2019;s Boston Regional Office (Boston SEC) notified the Company that it is conducting an investigation related to Boston Scientific&#x2019;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company is cooperating fully with the investigation. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#x2019;s Board of Directors conduct an investigation into actions by the Company&#x2019;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 16, 2020 Mariano Errichiello, individually and on behalf of all others similarly situated, filed a class action complaint against Boston Scientific Corporation, Michael F. Mahoney, Joseph M. Fitzgerald and Daniel J. Brennan stemming from the recall and retirement of the LOTUS Edge&#x2122; Aortic Valve System in United States District Court for the District of Massachusetts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note J &#x2013; Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for information regarding our tax litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Matters Concluded Since December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 30, 2019, Tissue Anchor Innovations filed a complaint for patent infringement in the United States District Court Central District of California against Fountain Valley Regional Hospital and Medical Center, Los Alamitos Medical Center and us. The complaint alleged that the Solyx&#x2122; Sling System infringes US Patent 6,506,190. We reached a confidential settlement in this matter in July 2020, pursuant to which the action was dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2017, Imran Niazi filed a patent infringement action against us in the United States District Court for the Western District of Wisconsin alleging that a U.S. patent owned by him is infringed by our Acuity&#x2122; Lead Delivery System. On June 30, 2017, we filed a motion to dismiss for improper venue and on November 7, 2017 the Wisconsin Court granted the motion to dismiss. On November 13, 2017 Niazi refiled the same action in the U.S. District of Minnesota. We reached a confidential settlement on this matter on February 3, 2020 pursuant to which the action was dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2017, we entered into a definitive agreement with Channel pursuant to which we could have been obligated to pay $145 million in cash up-front and a maximum of $130 million in contingent payments to acquire Channel. The agreement contained a provision allowing Channel to sell the remaining equity interests of Channel to us upon achievement of a regulatory milestone and an option allowing us to acquire the remaining equity interests. We sent a notice of termination of that agreement to Channel in the second quarter of 2018. On September 12, 2018, Channel filed a complaint in Delaware Chancery Court against us for alleged breach of the agreement. Channel alleged that we breached the agreement by terminating it. We answered the complaint, denied the claims by Channel and counterclaimed to recover part of our investment in Channel, alleging fraud in the inducement. On April 2, 2019, Channel announced its receipt of FDA approval of the Cerene&#x2122; Cryotherapy Device. Trial testimony was taken in April 2019, and the post-trial briefing and hearing were completed. During the third quarter of 2019, Channel notified us that they were exercising their option to sell the remaining equity interests in Channel to us. We responded to the notification that we did not intend to purchase Channel since the previous agreement had been terminated. On December 18, 2019, the Chancery Court ruled that Boston Scientific was in breach of the agreement and granted Channel's request for specific performance to require the Company to complete the purchase. On January 10, 2020, we filed a Notice of Appeal of the Chancery Court&#x2019;s decision to the Delaware Supreme Court. On February 4, 2020, the Company settled the dispute with Channel resulting in termination of the agreement, payment by the Company of an undisclosed sum and surrender of the Company's equity interest in Channel.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 29, 2016 Nevro Corp. (Nevro) filed a patent infringement action against us and one of our subsidiaries, Boston Scientific Neuromodulation Corporation, in the U.S. District Court for the Northern District of California alleging that six U.S. patents (Alataris) owned by Nevro are infringed by our spinal cord stimulation systems. On June 29, 2017, Nevro amended the complaint to add an additional patent (Fang). On July 24, 2018, summary judgment was entered in favor of the Company and on July 31, 2018, we received final judgment and dismissal of the action. On July 31, 2018, Nevro filed an appeal. On April 9, 2020, the Court of Appeals for the Federal Circuit vacated the finding of indefiniteness as to certain patents, provided claim constructions for those patents, and remanded the case. On December 16, 2020, the district court dismissed all remaining claims with prejudice, ending the case with Nevro receiving none of its requested relief.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzM1MzI4_02ec0e3f-209c-40a9-8af5-eed8a1fb6fdc">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.&lt;/span&gt;</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzM4NTI_4b0de3cf-903f-486c-b775-e618b480fd21"
      unitRef="usd">569000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzM4Njg_24f241c7-e819-49f6-9d2f-99c7afb13642"
      unitRef="usd">697000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzQzMjU_c0f55534-e15f-439d-a22c-d43da7300074"
      unitRef="usd">208000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzQzNDE_6959a7c9-59f4-4372-8515-a4361fced530"
      unitRef="usd">346000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LitigationSettlementExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQyNzk_bc1639c8-5f89-4847-a230-960efc8b0cd3"
      unitRef="usd">278000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ0NzY_f47f54df-0f13-4b8b-8e9e-66810416f76c"
      unitRef="usd">115000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i847cba4eb27247b1ad73919d3359fdec_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ0ODI_59b0f9e8-0448-4898-bc01-50be29d3d287"
      unitRef="usd">223000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i73b83671a10a405a8f270b82a83376c5_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ1MjY_749a152c-f05e-4b0a-a85b-4ac6ae910617"
      unitRef="usd">25000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="if91e0eeaf600499ebaebbee149714e4c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ1NDE_1692b232-2dbf-4044-9a74-a7649cc4c98d"
      unitRef="usd">15000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i7854a894ad99488694325a46151ebc34_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ1NTc_8418644b-2d43-4220-994c-85713e7115db"
      unitRef="usd">-148000000</us-gaap:LitigationSettlementExpense>
    <bsx:LitigationSettlementReceivedGain
      contextRef="i6d753b38040d479e8b54faae20faaad1_I20190115"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzYwNDczMTM5OTQ1NzM_9c11a5ec-6a52-4c9c-a496-183e7c45cf9b"
      unitRef="usd">180000000</bsx:LitigationSettlementReceivedGain>
    <us-gaap:LitigationSettlementExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzQ0NDU_c9f03e7e-2771-430a-8f02-f514c69f44e7"
      unitRef="usd">103000000</us-gaap:LitigationSettlementExpense>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i2f7956c04d234376aa4eecea14242910_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzk3NTM_628cb731-8e32-427a-9707-c7ccaf37ab63"
      unitRef="claims">54000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="id75fe6d2063c4f75b07316a97a020d9a_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEwMTMw_89386a43-c486-44db-b0b7-8d6db56db16f"
      unitRef="claims">52000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="id75fe6d2063c4f75b07316a97a020d9a_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEwNDAz_89386a43-c486-44db-b0b7-8d6db56db16f"
      unitRef="claims">52000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct
      contextRef="id75fe6d2063c4f75b07316a97a020d9a_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEwNDM4_f1e25fb9-247e-4569-b25b-293d62b4b782"
      unitRef="claims">48000</bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i409422251b4e4e6fa90403e9dba4dda7_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzExNTEy_3697d487-15b9-411a-a1cb-f38c4d19cd66"
      unitRef="claims">3100</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom
      contextRef="i2f7956c04d234376aa4eecea14242910_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzI3NDg3NzkxMDcyNDg_87ef03bd-3989-413e-999a-7053c16027d6"
      unitRef="claims">60</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom>
    <bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia
      contextRef="i2f7956c04d234376aa4eecea14242910_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzU0OTc1NTgyNzc2ODY_ec4ebe43-22e3-48de-88f0-53abd51bed50"
      unitRef="usd">125</bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada
      contextRef="i2f7956c04d234376aa4eecea14242910_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEyMzE2_d962b336-924a-477e-ac25-41031f023011"
      unitRef="claims">10</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada>
    <bsx:CertifiedclassactionsinCanadaMesh
      contextRef="i2f7956c04d234376aa4eecea14242910_I20210127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzEyMzQ5_40bb83c8-96a5-43de-9f51-11a4a9eb866b"
      unitRef="claims">1</bsx:CertifiedclassactionsinCanadaMesh>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i39fb2d8200504ca99f2588af122ccb46_D20171110-20171110"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzE1ODEy_345dd371-af59-40e0-a632-99e2c8bfa8e7"
      unitRef="eur">245000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i39fb2d8200504ca99f2588af122ccb46_D20171110-20171110"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzE1ODcz_83a0b2b8-c1ea-41f5-90cb-80002fee4488"
      unitRef="eur">620000</us-gaap:LossContingencyDamagesPaidValue>
    <bsx:AllegedBreachofPurchaseAgreementAmount
      contextRef="i7798f7ba3d954caf8a24d240d313af4b_I20180912"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzMzNTcy_205a1506-d250-4db1-b59f-7d0e5ec1d9fe"
      unitRef="usd">145000000</bsx:AllegedBreachofPurchaseAgreementAmount>
    <bsx:AllegedBreachofPurchaseAgreementAmount
      contextRef="i94b1febde39c4df9b5982d8d880defc2_I20180912"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMjcvZnJhZzo1YTUxNWJhMmI0MjY0NDgxYmRiODcyODdlNzQ2M2U5YS90ZXh0cmVnaW9uOjVhNTE1YmEyYjQyNjQ0ODFiZGI4NzI4N2U3NDYzZTlhXzMzNjA5_1c500334-d5ba-4b47-8b21-6005ac6d905d"
      unitRef="usd">130000000</bsx:AllegedBreachofPurchaseAgreementAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzE2NzY_1dcc209e-ad60-4b79-8cc8-9eed88b9ddf3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE L &#x2013; STOCKHOLDERS' EQUITY &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. As of December 31, 2019, we had no shares of preferred stock issued or outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. As of December&#160;31, 2020, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $100 per share plus accumulated and unpaid dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between 2.3834 and 2.9197 shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 1, 2020, we paid to holders of our MCPS as of August 15, 2020 a cash dividend of $1.4361 per MCPS share (or $14 million in aggregate cash dividends), representing a dividend period beginning on the May 27, 2020 issuance date through August 31, 2020. On December 1, 2020, we paid to holders of our MCPS as of November 15, 2020 a cash dividend of $1.3750 per MCPS share (or $14 million in aggregate cash dividends), representing a dividend period beginning on September 1, 2020 through November 30, 2020. On February 1, 2021, the Audit Committee of our Board of Directors, pursuant to authority delegated to such committee by our Board of Directors, declared a cash dividend of $1.375 per MCPS share (or $14 million in aggregate cash dividends) to be paid on March 1, 2021 to holders of our MCPS as of February 15, 2021, representing a dividend period beginning December 1, 2020 through February 28, 2021. We have presented cumulative, unpaid dividends covering this period from December 1, 2020 through December 31, 2020 totaling $5 million within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheets as of December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 2.000 billion shares of common stock, $0.01 par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 29,382,500 shares of common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The remaining proceeds are being used for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 25, 2013, our Board of Directors approved and on January 29, 2013, we announced a program authorizing the repurchase of up to $1.000 billion of our common stock (2013 share repurchase program). In the fourth quarter of 2020, we repurchased approximately 15.7 million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $535 million in cash, which represented the full amount remaining under that authorization. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock (2020 share repurchase program). As of December&#160;31, 2020, we had the full amount remaining available under the 2020 share repurchase program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not repurchase any shares of our common stock during 2019 or 2018. There were approximately 263 million shares in treasury as of December&#160;31, 2020 and 248 million shares in treasury as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0_864f09b3-8e43-4298-8e2e-040f2d26f007"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1e9be71c38ac4607af95364edaf5c01b_I20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2NjM_61edbf3f-00ef-4f09-9c51-fa36e1c30ad2"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2Njc_6d83f753-9356-4350-b183-1ebcaf1b803b"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i1e9be71c38ac4607af95364edaf5c01b_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2NzU_3edd686f-5043-4dda-ba23-d8724bffea00"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3NTc_72c887eb-6249-4d71-8367-db4030381bf2"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="i26c1603e14d9490f8e287a7453ef6ad2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3Njg_595be710-1ead-4be7-8a56-0a59ebbfe009"
      unitRef="usd">1006000000.000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i572be4adf4074d23930134cf3d73c21c_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2NzE_6d83f753-9356-4350-b183-1ebcaf1b803b"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i26c1603e14d9490f8e287a7453ef6ad2_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2Nzk_00edeac7-c4a3-485d-a139-3cdb93258845"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i26c1603e14d9490f8e287a7453ef6ad2_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ2ODM_00edeac7-c4a3-485d-a139-3cdb93258845"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="if76aa1de0a364b9b88b9a216851425ba_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3Nzc_00b2f053-df5a-448a-8a2d-a9a80047a28c">2.3834</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="i364b4c76e483475fb4929cbd7234002a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3ODI_85d70463-72aa-41ea-9edb-839c5da2f66d">2.9197</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="ie7d247529a1c463fa7773c98fb47c5b4_D20200901-20200901"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwODMyNjk_3d0ef3e0-76ff-4860-b12e-b3bcf5b432cb"
      unitRef="usdPerShare">1.4361</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="ie7d247529a1c463fa7773c98fb47c5b4_D20200901-20200901"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwODMyODM_604fd913-267b-4318-b9e8-83792b3d8e72"
      unitRef="usd">14000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="i4fa9aed9709041149e54010a083bfe82_D20201201-20201201"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3ODY_fa77dc1f-645e-4de2-b33b-d023ff856a52"
      unitRef="usdPerShare">1.3750</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="i4fa9aed9709041149e54010a083bfe82_D20201201-20201201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ3OTA_a257d563-d778-42da-a348-2a7d11fcdced"
      unitRef="usd">14000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="i80fea81c0f1641e2ac476c397df768a5_D20210201-20210201"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ4MDA_0bb0ddb5-9626-4f7a-9de4-6f8ee7d942a1"
      unitRef="usdPerShare">1.375</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="i80fea81c0f1641e2ac476c397df768a5_D20210201-20210201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ4MDU_1006ea8a-75f3-4630-bf67-ca30521f5ff5"
      unitRef="usd">14000000</us-gaap:PaymentsOfDividends>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ia14713cda1cf4913ba849fbbc13bf46f_I20210201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzQ4MTY_9c5d9291-4765-4c36-b336-7c14385510c8"
      unitRef="usd">5000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0MQ_92a1f2f5-375f-421b-b0c1-23e0cf90db4a"
      unitRef="shares">2000000000.000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU2OA_cdd8c004-f4b3-4b53-a234-0a57243f481a"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i87014aa1c11a45678ccb64e8fe4dd544_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzUwNDk_590a28b5-8aba-43c4-8021-f8ebaff68d35"
      unitRef="shares">29382500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="ie17653a14c754c2ab47d617c083c0151_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzUxMTA_c3a379f5-886e-4720-9e1c-ee13ab001e56"
      unitRef="usdPerShare">34.25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i87014aa1c11a45678ccb64e8fe4dd544_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzI3NDg3NzkwNzUxOTI_ed536d62-3d85-4dcb-b3ce-8d7561463026"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i497fdd9e22bb40c9b7d641cbb2f5890b_I20130125"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTIxNDk_db6691b3-d899-4b8e-90e4-510d46a566bc"
      unitRef="usd">1000000000.000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTIxNTc_afac6079-2e7f-4eea-b426-bcaaabfb8e0d"
      unitRef="shares">15700000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTIxNjU_ef413264-c54c-4f7f-a8fd-b60016ab2e16"
      unitRef="usd">535000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ic981515a7d5b42c29018a2a5a0ae37fa_I20201214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTA0NzM_88757f11-6b88-4d02-9c6a-eec486fc503c"
      unitRef="usd">1000000000.000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockShares
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTA1MDk_5ef701a8-4c54-4125-b2e8-df76831f36ca"
      unitRef="shares">263000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzAvZnJhZzplNTUxZmY1OGFmNzA0ZWMxOWEwYmNhMDlmNjU0MzZiMi90ZXh0cmVnaW9uOmU1NTFmZjU4YWY3MDRlYzE5YTBiY2EwOWY2NTQzNmIyXzU0OTc1NTgxNTA1MjU_81cc3f91-727c-4d83-845f-217c4bfbdb74"
      unitRef="shares">248000000</us-gaap:TreasuryStockShares>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1OTI_1b6a6dd4-bf8d-478e-84c5-14848bc67057">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE M &#x2013; STOCK INCENTIVE AND PURCHASE PLANS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee and Director Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, our Board of Directors and stockholders approved amendments to our 2011 Long-Term Incentive Plan effective October 1, 2020 (Amended and Restated 2011 LTIP), authorizing for issuance up to 171 million shares of our common stock. The Amended and Restated 2011 LTIP covers officers, directors, employees and consultants and provides for the grant of restricted or unrestricted common stock, restricted stock units (RSUs), options to acquire our common stock, stock appreciation rights, performance awards (market-based and performance-based RSUs) and other stock and non-stock awards. Shares reserved under our current and former stock incentive plans totaled approximately 187 million as of December&#160;31, 2020. The Executive Compensation and Human Resources Committee (the Committee) of the Board of Directors, consisting of independent, non-employee directors may authorize the issuance of common stock and cash awards under the Amended and Restated 2011 LTIP in recognition of the achievement of long-term performance objectives established by the Committee. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-qualified options issued to employees are generally granted with an exercise price equal to the market price of our stock on the grant date, vest over a four-year service period and have a ten-year contractual life. In the case of qualified options, if the recipient owns more than ten percent of the voting power of all classes of stock, the option granted will be at an exercise price of 110 percent&#160;of the fair market value of our common stock on the date of grant and will expire over a period not to exceed five years. Non-vested stock awards, including restricted stock awards (RSAs), RSUs and deferred stock units (DSUs) issued to employees are generally granted with an exercise price of zero and typically vest in four or five equal annual installments. These awards represent our commitment to issue shares to recipients after the vesting period. Upon each vesting date, such awards are no longer subject to risk of forfeiture and we issue shares of our common stock to the recipient.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the impact of stock-based compensation on our consolidated statements of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact per common share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact per common share - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Black-Scholes Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years, weighted)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.72%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Expected Volatility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use our historical volatility and implied volatility as a basis to estimate expected volatility in our valuation of stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Expected Term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the expected term of options using historical exercise and forfeiture data. We believe that this historical data provides the best estimate of the expected term of new option grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use yield rates on U.S. Treasury securities for a period approximating the expected term of the award to estimate the risk-free interest rate in our grant-date fair value assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Expected Dividend Yield&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not historically paid cash dividends on our common stock and currently we do not intend to pay cash dividends on our common stock. Therefore, we have assumed an expected dividend yield of zero in our grant-date fair value assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to stock options under stock incentive plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual Life&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total vested and expected to vest as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,787&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised was $84 million in 2020, $140 million in 2019 and $90 million in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-Vested Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value RSAs, RSUs and DSUs based on the closing trading value of our shares on the date of grant. Information related to non-vested stock awards is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Vested&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Award Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant-Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(748)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vesting date fair value of shares that vested was approximately $172 million in 2020, $193 million in 2019 and $170 million in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Market-based DSU Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, 2019 and 2018, we granted market-based DSU awards to certain members of our senior management team. The number of shares ultimately issued to the recipient is based on the total stockholder return (TSR) of our common stock as compared to the TSR of the common stock of the other companies in the S&amp;amp;P 500 Healthcare Index over a three-year performance period. The number of DSUs ultimately granted under this program range from 0 percent to 200 percent of the target number of performance-based DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout the three-year performance period to attain the full amount of the market-based DSUs that satisfied the market performance criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the fair value of the market-based DSU awards to be approximately $8 million for 2020, $10 million for 2019 and $7 million for 2018. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price on date of grant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the expense on these awards in our consolidated statements of operations on a straight-line basis over the three-year measurement period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Free Cash Flow Performance-based DSU Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, 2019 and 2018, we granted free cash flow performance-based DSU awards to certain members of our senior management team. The attainment of these performance-based DSUs is based on our adjusted free cash flow (AFCF) measured against our internal annual financial plan performance for AFCF. AFCF is measured over a one-year performance period beginning January 1st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of each year and ending December 31st. The number of DSUs ultimately granted under this program range from 0 percent to 150 percent of the target number of performance-based DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout a three-year service period (inclusive of the one-year performance period) to attain the full amount of the performance-based DSUs that satisfied the performance criteria. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 AFCF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 AFCF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018 AFCF&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, net of forfeitures to date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Achievement of target payout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year-end stock price used in determining fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the expense on these awards in our consolidated statements of operations over the vesting period which is three years after the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Expense Attribution&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize compensation expense for our stock incentive plan using a straight-line method over the substantive vesting period. Most of our stock awards provide for immediate vesting upon death or disability of the participant. In addition, our stock grants to employees provide for accelerated vesting of our stock-based awards, other than performance-based and market-based awards, upon retirement, if the stock award has been held for at least one year by the recipient. In accordance with the terms of our stock grants, for employees who will become retirement eligible prior to the vest date we expense stock-based awards, other than performance-based and market-based awards, over the greater of one year or the period between grant date and retirement-eligibility. The performance-based and market-based awards discussed above do not contain provisions that would accelerate the full vesting of the awards upon retirement-eligibility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize stock-based compensation expense for the value of the portion of awards that are ultimately expected to vest. FASB ASC Topic 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation &#x2013; Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; allows forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term &#x201c;forfeitures&#x201d; is distinct from &#x201c;cancellations&#x201d; or &#x201c;expirations&#x201d; and represents only the unvested portion of the surrendered stock-based award. We have applied, based on an analysis of our historical forfeitures, a weighted-average annual forfeiture rate of approximately five percent to all unvested stock-based awards as of December&#160;31, 2020, which represents the portion that we expect will be forfeited each year over the vesting period. We re-evaluate this analysis annually or more frequently if there are significant changes in circumstances and adjust the forfeiture rate as necessary. Ultimately, we will only recognize expense for those shares that vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrecognized Compensation Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Compensation Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vesting Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;204&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts presented represent compensation cost, net of estimated forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our global employee stock purchase plan provides for the granting of options to purchase up to 50 million shares of our common stock to all eligible employees. Under the global employee stock purchase plan, we grant each eligible employee, at the beginning of each six-month offering period, an option to purchase shares of our common stock equal to not more than ten percent of the employee&#x2019;s eligible compensation or the statutory limit under the U.S. Internal Revenue Code. Such options may be exercised only to the extent of accumulated payroll deductions at the end of the offering period, at a purchase price equal to 85 percent of the fair market value of our common stock at the beginning or end of each offering period, whichever is less. As of December&#160;31, 2020, there were approximately 6 million shares available for future issuance under the employee stock purchase plan. We temporarily suspended our global employee stock purchase plan for the offering period for the second half of 2020 due to cost-savings initiatives in response to the COVID-19 pandemic and have resumed for the offering period for the first half of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued or to be issued&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Range of purchase prices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$27.91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense recognized&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the Black-Scholes option-pricing model to calculate the grant-date fair value of shares issued under the employee stock purchase plan. We recognize expense related to shares purchased through the employee stock purchase plan ratably over the offering period.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i778f0f816cf84a6d802f3c954762bc96_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzE5Ng_78d4aa0b-fec0-45a2-b25f-3a8afbbe04cc"
      unitRef="shares">171000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzY0Ng_8d36afe1-179e-4ada-aa5e-c7b94159c70b"
      unitRef="shares">187000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <bsx:VotingPowerOfAllClassesOfStock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzEyNzI_701d3d32-2922-4d96-a940-45965cd4fcac"
      unitRef="number">0.10</bsx:VotingPowerOfAllClassesOfStock>
    <bsx:Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzEzNzE_503acce6-1176-4ec6-b8e1-24aa3d16147d"
      unitRef="number">1.10</bsx:Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant>
    <bsx:Nonvestedstockawardsexerciseprice
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzE2MzE_f49fcd6c-6bea-45e0-a9d4-62991418dd6b"
      unitRef="usdPerShare">0</bsx:Nonvestedstockawardsexerciseprice>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1NTI_48c8b21c-3e00-4a2d-aa45-d855729705b5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the impact of stock-based compensation on our consolidated statements of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact per common share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net impact per common share - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i48dc48db06f64857b9f8f2175ed065c8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzItMS0xLTEtMA_530f92d4-dd73-4d3c-9023-aad67063f00c"
      unitRef="usd">9000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4ce12987f1214f89a3dfa34f916446fb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzItMy0xLTEtMA_6439fa27-7c50-4f10-8c1b-9debb22577c2"
      unitRef="usd">8000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i61e617b0c52e4f2f9d64b27e15217b69_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzItNS0xLTEtMA_54c7a3fd-5de4-4699-b0b1-203a59bf61a2"
      unitRef="usd">7000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0a97c4c9280f468985dbf91165af9ea0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzMtMS0xLTEtMA_c797b25f-764a-4955-9ff4-dedef46b144f"
      unitRef="usd">130000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i744cf371d9c64de7bdda73270e33e44a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzMtMy0xLTEtMA_13908a67-36bf-4824-9b58-c24e7edc57d6"
      unitRef="usd">120000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib583bf860ca3439f8e8edbcc584563e9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzMtNS0xLTEtMA_ad045c42-b4d5-4172-b470-5f81e3bf5a46"
      unitRef="usd">109000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic1abb0720ff4407591ec3bb6cfe6e577_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzQtMS0xLTEtMA_748be6f9-890b-4bd5-b319-cf11035f2590"
      unitRef="usd">30000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7dd3d62482574f8abab9be37411135a7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzQtMy0xLTEtMA_a916c2ac-a0e4-4ace-906f-d5481df2f6df"
      unitRef="usd">28000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8dbc60762f9246c08c22c8690df360f5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzQtNS0xLTEtMA_70208b88-f060-4dbb-8c24-c2cc04477168"
      unitRef="usd">24000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzUtMS0xLTEtMA_f68572ab-34cf-4202-986e-3319f06f2d55"
      unitRef="usd">170000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzUtMy0xLTEtMA_311bdac4-467b-4b85-b94c-9cd5c277cb97"
      unitRef="usd">157000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzUtNS0xLTEtMA_ea62305f-b479-4ee4-91e4-445d1cc8ca25"
      unitRef="usd">140000000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzYtMS0xLTEtMA_d76b0a2c-c2ed-4999-8b77-e01b013db318"
      unitRef="usd">28000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzYtMy0xLTEtMA_3311ac41-394f-429d-9ccf-44eedfa2a25c"
      unitRef="usd">24000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzYtNS0xLTEtMA_b185dc65-1da9-4c3b-bb19-682467401c98"
      unitRef="usd">21000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <bsx:ShareBasedCompensationNetOfTaxBenefit
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzctMS0xLTEtMA_4f09f825-7374-4515-a8dd-c6b3347dc786"
      unitRef="usd">142000000</bsx:ShareBasedCompensationNetOfTaxBenefit>
    <bsx:ShareBasedCompensationNetOfTaxBenefit
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzctMy0xLTEtMA_ec838662-f281-493e-9a1c-b3def3b0f13b"
      unitRef="usd">133000000</bsx:ShareBasedCompensationNetOfTaxBenefit>
    <bsx:ShareBasedCompensationNetOfTaxBenefit
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzctNS0xLTEtMA_eb3cbd34-b61a-4b50-b9b6-229ead572d3c"
      unitRef="usd">119000000</bsx:ShareBasedCompensationNetOfTaxBenefit>
    <bsx:CompensationExpensePerShareBasic
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzgtMS0xLTEtMA_670be8bd-ed6f-485a-90ef-29b7d15b6afe"
      unitRef="usdPerShare">0.10</bsx:CompensationExpensePerShareBasic>
    <bsx:CompensationExpensePerShareBasic
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzgtMy0xLTEtMA_368ffbe9-7cb9-4dd5-a826-14379fbcd729"
      unitRef="usdPerShare">0.10</bsx:CompensationExpensePerShareBasic>
    <bsx:CompensationExpensePerShareBasic
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzgtNS0xLTEtMA_d779cd78-8528-4849-a340-096fdedc2e13"
      unitRef="usdPerShare">0.09</bsx:CompensationExpensePerShareBasic>
    <bsx:CompensationExpensePerShareDiluted
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzktMS0xLTEtMA_1fdff9b1-ad6e-4b8d-810f-68373e82c012"
      unitRef="usdPerShare">0.10</bsx:CompensationExpensePerShareDiluted>
    <bsx:CompensationExpensePerShareDiluted
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzktMy0xLTEtMA_677ddc1d-5281-4dc6-9f5e-bda2c3979ab5"
      unitRef="usdPerShare">0.09</bsx:CompensationExpensePerShareDiluted>
    <bsx:CompensationExpensePerShareDiluted
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo1NmJmMWY5ZTg1OWI0ZDM0OGExY2JkZWVjMzU5MWRiOC90YWJsZXJhbmdlOjU2YmYxZjllODU5YjRkMzQ4YTFjYmRlZWMzNTkxZGI4XzktNS0xLTEtMA_8e0a0e10-06fc-4ced-970f-b840eca93b85"
      unitRef="usdPerShare">0.08</bsx:CompensationExpensePerShareDiluted>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1MzQ_07c22178-5ceb-4ad5-8bd7-a1c3d3331cfe">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant-date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Black-Scholes Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years, weighted)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.72%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.01%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzItMS0xLTEtMA_0edda775-d104-4f75-bc3a-4dce93713a13"
      unitRef="shares">3819000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzItNS0xLTEtMA_2b8d1bbd-d3d1-482b-8e49-b4be338ec44e"
      unitRef="shares">2992000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzItOS0xLTEtMA_6765cada-4342-4556-904c-573379a9023e"
      unitRef="shares">3491000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzMtMS0xLTEtMA_0e028fc3-8793-40ae-9e19-7bc8bd607532"
      unitRef="usdPerShare">41.79</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzMtNS0xLTEtMA_4f40dde9-24f7-45b8-986a-71b7834f9e86"
      unitRef="usdPerShare">40.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzMtOS0xLTEtMA_b4a0e9f2-45e3-44e4-bd84-a8704253cf0b"
      unitRef="usdPerShare">27.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzQtMS0xLTEtMA_355b6e46-cdbd-4b12-a6f9-87e1f30085f0"
      unitRef="usdPerShare">10.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzQtNS0xLTEtMA_2cf74a56-55f5-4ac8-a0ac-be30a90aca4c"
      unitRef="usdPerShare">11.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzQtOS0xLTEtMA_e4f7b40d-d3fc-4f60-87bf-a7eabaa7a9de"
      unitRef="usdPerShare">8.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzYtMS0xLTEtMA_3ecf206c-eb79-49e3-a2ee-ea92f7180d83"
      unitRef="number">0.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzYtNS0xLTEtMA_9ca90b5b-a146-459a-9460-9c908084eb89"
      unitRef="number">0.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzYtOS0xLTEtMA_9f36eaff-aa82-408b-baff-01ce264d0f54"
      unitRef="number">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzctMS0xLTEtMA_4dab56a7-7924-4a20-9662-a35297a4ac05">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzctNS0xLTEtMA_e64054f3-bd82-4cd0-8160-358c81144dc9">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzctOS0xLTEtMA_08908531-ffa0-4929-8718-06e14dea7c8e">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i7b53681c5973450a9bf67b79aa206f65_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtMS0xLTEtMA_3fbbf11b-fc76-4883-8fbc-937656b3b8cc"
      unitRef="number">0.0027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtMy0xLTEtMA_15dc0d6f-f1b8-436e-9689-d0e5edd24387"
      unitRef="number">0.0172</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1d62047b22344b799f16b3cb7ff597c8_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtNS0xLTEtMA_c9b17394-d8b0-4f65-9894-c3f63a10db4e"
      unitRef="number">0.0138</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib22247f67db94421b34a23ad85639077_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtNy0xLTEtMA_298452de-e27f-4242-be83-42f03d5f5383"
      unitRef="number">0.0261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5927d31a28d44ea785098e97b5f79f96_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtOS0xLTEtMA_13a9ef8a-5bcd-4567-8318-402605e21b50"
      unitRef="number">0.0261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i587d1e2ddfb14a2eac94b281ca12ec47_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowOTQwNTk5NzRjZmY0MzMwOTQ0MDMxZTM1ZjY3OTM2ZS90YWJsZXJhbmdlOjA5NDA1OTk3NGNmZjQzMzA5NDQwMzFlMzVmNjc5MzZlXzgtMTEtMS0xLTA_072773ea-05eb-477e-8bd1-f0b7fd8fad55"
      unitRef="number">0.0301</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1NDY_e3b4a16c-b9df-4db6-8dab-2580ccfed1b3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to stock options under stock incentive plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual Life&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(666)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total vested and expected to vest as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,787&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzUtMS0xLTEtMA_160a0e28-a26e-4e1e-b1c8-572fcb4b8e04"
      unitRef="shares">26716000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzUtMy0xLTEtMA_ecba538d-20ca-4937-adb9-718b655f4a89"
      unitRef="usdPerShare">13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzYtMS0xLTEtMA_742b95d2-4a3d-41f5-ae7c-5bca7df33eda"
      unitRef="shares">3491000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzYtMy0xLTEtMA_658eb4e9-fc58-44f2-bc6d-d9573470d7a6"
      unitRef="usdPerShare">27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzctMS0xLTEtMA_66f517eb-942d-4c4c-91ba-cb669444d0b3"
      unitRef="shares">4385000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzctMy0xLTEtMA_7606cb32-bf6a-48a8-8a0b-6eb4bcd05b1d"
      unitRef="usdPerShare">11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzgtMS0xLTEtMA_38d1e005-ac87-47e1-b8a2-4153163b6d98"
      unitRef="shares">519000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzgtMy0xLTEtMA_1c8798d8-5884-4161-8a93-73cf71acc1c0"
      unitRef="usdPerShare">22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzktMS0xLTEtMA_58443595-dd8a-4b3b-80ea-6a459e1b0704"
      unitRef="shares">25304000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzktMy0xLTEtMA_1651519b-f0dd-48bc-82d7-5516af101f3b"
      unitRef="usdPerShare">16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEwLTEtMS0xLTA_b1cd2510-769a-4b03-b4bc-1daa24b067ee"
      unitRef="shares">2992000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEwLTMtMS0xLTA_60b81c49-c210-4d42-9112-164acd91b6b1"
      unitRef="usdPerShare">40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzExLTEtMS0xLTA_a233d1fb-06f9-46b5-9d61-73a27ad884f5"
      unitRef="shares">4872000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzExLTMtMS0xLTA_8319d9e5-af3c-4443-8326-ff40da3fbf86"
      unitRef="usdPerShare">12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEyLTEtMS0xLTA_77bf109d-4991-4d14-8a13-40cb2bf4e062"
      unitRef="shares">359000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEyLTMtMS0xLTA_21620cc0-9f8a-4a71-84e2-0559258a8e0b"
      unitRef="usdPerShare">24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEzLTEtMS0xLTA_c5ef195e-942b-4aac-916d-0283c5eeff27"
      unitRef="shares">23065000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzEzLTMtMS0xLTA_c006c9b7-e3cb-413d-912f-c12ffb71abc3"
      unitRef="usdPerShare">19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTEtMS0xLTMyMzM_eac7b8c3-d527-44d1-9e65-f8479cb0c406"
      unitRef="shares">3819000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTMtMS0xLTMyMzc_84edd5ab-5251-41d9-ab1d-208ef87ba27a"
      unitRef="usdPerShare">42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTEtMS0xLTMyMzM_090dfc8f-13f3-435b-83e2-e93503168897"
      unitRef="shares">3096000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTMtMS0xLTMyMzc_85dbc499-96ba-4268-83f7-43d6cff56cc4"
      unitRef="usdPerShare">13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTEtMS0xLTMyMzM_85043b04-4c43-4ea5-a111-b2085ec60102"
      unitRef="shares">666000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTMtMS0xLTMyMzc_4a5d06dd-5ec7-463f-a389-a6a4669c53ac"
      unitRef="usdPerShare">27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE3LTEtMS0xLTMyMzM_e101af2c-de1f-4965-b454-68411136c30d"
      unitRef="shares">23122000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE3LTMtMS0xLTMyMzc_f982996c-5358-4ab0-b5eb-814b3f9d4e01"
      unitRef="usdPerShare">24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE3LTUtMS0xLTMyNDI_5bea03e6-74d8-44e8-a455-d2f42d1445ac">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE3LTctMS0xLTMyNDY_d5342c79-8d37-4def-a769-3728f78280cb"
      unitRef="usd">312000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTEtMS0xLTA_8bd14d43-4dbf-4a88-9245-c5bdd1bc8716"
      unitRef="shares">15105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTMtMS0xLTA_a7f5e867-368a-429b-9683-1200ebd312a4"
      unitRef="usdPerShare">17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTUtMS0xLTA_8e217a63-9017-45d7-b095-e3660b2a26e4">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE0LTctMS0xLTA_517db22d-d627-4bb6-91f5-e1824e668098"
      unitRef="usd">290000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <bsx:OptionsExpectedToVest
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTEtMS0xLTA_125b0d48-bc55-409a-aaba-3e5174f49170"
      unitRef="shares">7683000</bsx:OptionsExpectedToVest>
    <bsx:OptionsExpectedToVestWeightedAverageExercisePrice
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTMtMS0xLTA_0ca4394f-ed91-47c8-88ac-56d248e5d706"
      unitRef="usdPerShare">37</bsx:OptionsExpectedToVestWeightedAverageExercisePrice>
    <bsx:OptionsExpectedToVestWeightedAverageRemainingContractualLife
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTUtMS0xLTA_65ee23c3-4f3d-4454-8c53-ea6eab07d058">P8Y2M12D</bsx:OptionsExpectedToVestWeightedAverageRemainingContractualLife>
    <bsx:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE1LTctMS0xLTA_da4c6b1c-5ade-4590-a15c-0c3c22d408b6"
      unitRef="usd">22000000</bsx:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTEtMS0xLTA_9a84ae90-1906-4219-9d8b-96939a51d0a6"
      unitRef="shares">22787000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTMtMS0xLTA_9abfefb1-003c-4c06-b90f-a6a33135cb66"
      unitRef="usdPerShare">24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTUtMS0xLTA_22bd4a4a-89b6-41ef-a0d7-fa6b3d637879">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo2YjBjZWMyOTg1NWQ0NjY3OTdmZGE2MDliY2I2NTg3MS90YWJsZXJhbmdlOjZiMGNlYzI5ODU1ZDQ2Njc5N2ZkYTYwOWJjYjY1ODcxXzE2LTctMS0xLTA_8d906901-6520-4df9-ad05-cb14f44676d8"
      unitRef="usd">312000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzMyNTI_069eaaa7-9cb6-47a7-b19f-ff6328b568cb"
      unitRef="usd">84000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzMyNjI_90453fdc-a5be-420c-b320-1ba85056a9ae"
      unitRef="usd">140000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzMyNzU_fb0f9576-dabf-4c53-a2ce-99c36b4b4806"
      unitRef="usd">90000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1MzA_05f74572-0ce2-44df-ae0b-93761f69bcd3">Information related to non-vested stock awards is as follows:&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Vested&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Award Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant-Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(748)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzUtMS0xLTEtMA_c4063085-f966-45b6-84fb-3e5e3513cb51"
      unitRef="shares">15250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzUtMy0xLTEtMA_88ae322d-63c7-402a-9428-0b881135a55d"
      unitRef="usdPerShare">18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzYtMS0xLTEtMA_fb1bc4a5-d2c1-49d8-9144-4c0d720a4158"
      unitRef="shares">4375000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzYtMy0xLTEtMA_083666af-ae3f-4fb7-8b36-a10b46606caa"
      unitRef="usdPerShare">28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzctMS0xLTEtMA_39b133f1-f274-4d92-8270-8735a50ac7d1"
      unitRef="shares">6194000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzctMy0xLTEtMA_88883874-a5d9-4193-9fc7-5f08b10c27b7"
      unitRef="usdPerShare">16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzgtMS0xLTEtMA_12dc4370-7aea-4c9f-b86c-1569a6b6441f"
      unitRef="shares">748000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzgtMy0xLTEtMA_c607cf41-88c4-476c-9292-8972e8d51536"
      unitRef="usdPerShare">22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzktMS0xLTEtMA_96b44b70-2539-45b9-8052-2525af7da3e8"
      unitRef="shares">12683000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzktMy0xLTEtMA_40005a10-0787-4395-a221-2441dfc7fea6"
      unitRef="usdPerShare">22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEwLTEtMS0xLTA_2424666f-0a48-4283-9d6b-1c30041e945a"
      unitRef="shares">3656000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEwLTMtMS0xLTA_04e5b40f-a822-4d9e-ac80-15b0181f7886"
      unitRef="usdPerShare">39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzExLTEtMS0xLTA_e98b9ec6-d5ad-4f49-bb67-599a0c5ff834"
      unitRef="shares">4811000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzExLTMtMS0xLTA_77fec515-7703-4604-b503-07e032aec6b7"
      unitRef="usdPerShare">20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEyLTEtMS0xLTA_d97816e8-1483-483b-98ba-d6dc06b7032c"
      unitRef="shares">449000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEyLTMtMS0xLTA_83bbd6b6-cb3b-431d-9688-8bd485526452"
      unitRef="usdPerShare">27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEzLTEtMS0xLTA_309fb92c-c2f1-4bcc-9202-164b7baf951c"
      unitRef="shares">11079000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzEzLTMtMS0xLTA_49851c2b-ac4c-479b-b4bc-233ae559edfd"
      unitRef="usdPerShare">29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE0LTEtMS0xLTMyNjc_88c53091-6bc2-42cb-9a87-cdc6abd18f3a"
      unitRef="shares">3609000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE0LTMtMS0xLTMyNzE_6781b47f-c3dc-432a-b446-84ba1b5fd876"
      unitRef="usdPerShare">41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE1LTEtMS0xLTMyNjc_333956dd-6643-4de6-af19-e3cd6fe4bb31"
      unitRef="shares">4147000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE1LTMtMS0xLTMyNzE_5d18b0a6-bee8-4c78-a75c-000aaec2480c"
      unitRef="usdPerShare">25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE2LTEtMS0xLTMyNjc_6a40cbdb-790c-4bab-860c-54359b01d165"
      unitRef="shares">554000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE2LTMtMS0xLTMyNzE_e2445cc0-5659-46f1-a3b6-8523af6fa0ab"
      unitRef="usdPerShare">34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE3LTEtMS0xLTMyNjc_ddc2677e-ab10-4344-b4d2-c9861dab772c"
      unitRef="shares">9987000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphYmRmZTZiMzg5NWM0YzA3OTk1Mzg0ZjE0OWVjNTY2OC90YWJsZXJhbmdlOmFiZGZlNmIzODk1YzRjMDc5OTUzODRmMTQ5ZWM1NjY4XzE3LTMtMS0xLTMyNzE_f9017840-bda7-45a1-b0bd-eb63824e4512"
      unitRef="usdPerShare">34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzM3MTE_a717568b-d91c-4837-a495-a9c0284fff83"
      unitRef="usd">172000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzM3MjE_1dbc6e2a-734a-44df-bb0a-9ee87ad5ab45"
      unitRef="usd">193000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzM3MzQ_5224e8f1-92e3-464d-8341-392acefac29b"
      unitRef="usd">170000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <bsx:RangeofthetargetnumberofmarketbasedDSUsawarded
      contextRef="i7b53681c5973450a9bf67b79aa206f65_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQyMDQ_ded1ef82-4a24-44e9-b7ed-a8e949f0479b"
      unitRef="number">0</bsx:RangeofthetargetnumberofmarketbasedDSUsawarded>
    <bsx:RangeofthetargetnumberofmarketbasedDSUsawarded
      contextRef="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQyMTA_8471610c-b010-4031-8330-128fee93c458"
      unitRef="number">2</bsx:RangeofthetargetnumberofmarketbasedDSUsawarded>
    <bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1Njc_c39a19a2-6bc9-4ec1-902e-c5f00a585789">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the fair value of the market-based DSU awards to be approximately $8 million for 2020, $10 million for 2019 and $7 million for 2018. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price on date of grant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock>
    <bsx:Fairvalueofmarketbasedawards
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQ2NDI_0deb148b-c01c-490d-ae52-d689c55e6516"
      unitRef="usd">8000000</bsx:Fairvalueofmarketbasedawards>
    <bsx:Fairvalueofmarketbasedawards
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQ2NTM_9890483c-9636-4a13-8a62-fdb22e5d9491"
      unitRef="usd">10000000</bsx:Fairvalueofmarketbasedawards>
    <bsx:Fairvalueofmarketbasedawards
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzQ2Njc_96219876-6eaf-4a59-9f5c-c850e31531ad"
      unitRef="usd">7000000</bsx:Fairvalueofmarketbasedawards>
    <us-gaap:SharePrice
      contextRef="i58e16f20577a495e80af1b6afc207f5f_I20200218"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzItMS0xLTEtMA_1890fa34-2477-46fa-9bad-2cb86c944c4f"
      unitRef="usdPerShare">42.16</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="id21557fe18514f5291709c9c7a7b4c9c_I20190221"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzItMy0xLTEtMA_529758e2-bf02-4529-bc66-4a5d07f0752e"
      unitRef="usdPerShare">40.12</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i778b96505b084096ac50ff6a8617ea48_I20180215"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzItNS0xLTEtMA_90ed1217-0e8f-412e-870c-bf011d7b02f2"
      unitRef="usdPerShare">27.09</us-gaap:SharePrice>
    <bsx:Measurementperiodmarketbasedaward
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzMtMS0xLTEtMA_d1dd24dc-aabf-45a6-8aa5-b1f5c3964a7b">P2Y10M24D</bsx:Measurementperiodmarketbasedaward>
    <bsx:Measurementperiodmarketbasedaward
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzMtMy0xLTEtMA_399cfd5b-7bde-403b-9cbb-10bf474a38af">P2Y10M24D</bsx:Measurementperiodmarketbasedaward>
    <bsx:Measurementperiodmarketbasedaward
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzMtNS0xLTEtMA_344ea0d0-ce65-4d6a-af5b-8c4db0188dca">P2Y10M24D</bsx:Measurementperiodmarketbasedaward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzQtMS0xLTEtMA_d9cdc1ac-20da-45aa-bdb8-a73443ac92a5"
      unitRef="number">0.0137</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzQtMy0xLTEtMA_8bea7640-9522-4ac2-9e96-d203d405edf1"
      unitRef="number">0.0248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTplNTMzYWJhOTYyMzU0YTkzYjc3YWFkOWYyMjJiMjg2Yi90YWJsZXJhbmdlOmU1MzNhYmE5NjIzNTRhOTNiNzdhYWQ5ZjIyMmIyODZiXzQtNS0xLTEtMA_69c680bb-b079-427e-aa50-3a07b313d4ba"
      unitRef="number">0.0236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <bsx:RangeofthetargetnumberofperformancebasedDSUsawarded
      contextRef="i7b53681c5973450a9bf67b79aa206f65_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzU0NDU_61efa783-3efa-42cc-b096-83f2275783ee"
      unitRef="number">0</bsx:RangeofthetargetnumberofperformancebasedDSUsawarded>
    <bsx:RangeofthetargetnumberofperformancebasedDSUsawarded
      contextRef="i67a84154cae143c9ac8a2f46978f87e0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzU0NTE_253203e6-1cfa-4817-9bcc-323e9566f94e"
      unitRef="number">1.50</bsx:RangeofthetargetnumberofperformancebasedDSUsawarded>
    <bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1Mzg_e629f22b-799d-4c3c-9c7b-4bbcd3fea17d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.413%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020 AFCF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019 AFCF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018 AFCF&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, net of forfeitures to date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Achievement of target payout&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year-end stock price used in determining fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock>
    <bsx:FairValueOfFreeCashFlowFcfPerformanceAwards
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzEtMS0xLTEtMA_d1db602e-390f-4175-bb7f-86e069cc3593"
      unitRef="usd">6000000</bsx:FairValueOfFreeCashFlowFcfPerformanceAwards>
    <bsx:FairValueOfFreeCashFlowFcfPerformanceAwards
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzEtMy0xLTEtMA_f807379a-5c9c-494b-b8ed-bec5d9078652"
      unitRef="usd">8000000</bsx:FairValueOfFreeCashFlowFcfPerformanceAwards>
    <bsx:FairValueOfFreeCashFlowFcfPerformanceAwards
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzEtNS0xLTEtMA_a770eadf-3641-40d1-93cf-ffada226172c"
      unitRef="usd">11000000</bsx:FairValueOfFreeCashFlowFcfPerformanceAwards>
    <bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzItMS0xLTEtMA_c70ef77a-74e0-46fe-8507-561df26f8ec3"
      unitRef="number">0.89</bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards>
    <bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzItMy0xLTEtMA_d1caa7bb-aded-4995-bbc8-dc235c62de8c"
      unitRef="number">0.90</bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards>
    <bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzItNS0xLTEtMA_fa7aa0cf-682f-4d15-8363-2cb3bd87cb03"
      unitRef="number">1.18</bsx:TargetPayoutOfFreeCashFlowsFcfPerformanceAwards>
    <us-gaap:SharePrice
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzMtMS0xLTEtMA_2a7f35a3-b8ca-4789-aca8-b8094ce87ef3"
      unitRef="usdPerShare">35.95</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzMtMy0xLTEtMA_5c72abc4-5d7d-44d4-afb6-2e9cc8283b74"
      unitRef="usdPerShare">45.22</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTo5ZDYwNWFmYWRlNTg0NTBhYTlhNGM5NmQ3OTM4MzUxZi90YWJsZXJhbmdlOjlkNjA1YWZhZGU1ODQ1MGFhOWE0Yzk2ZDc5MzgzNTFmXzMtNS0xLTEtMA_9cc519d5-bf1f-4088-a219-750f3cf61c76"
      unitRef="usdPerShare">35.34</us-gaap:SharePrice>
    <bsx:Annualweightedaverageforfeiturerate
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzc2MzA_47db5698-aa9c-46ed-b948-ff9ae2430130"
      unitRef="number">0.05</bsx:Annualweightedaverageforfeiturerate>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1NTA_71dd80ba-e129-46e3-85a4-9b1914cef354">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Compensation Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vesting Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;204&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts presented represent compensation cost, net of estimated forfeitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <bsx:UnrecognizedCompensationCostStockOptions
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphOTg4NDM0MjQ2NzM0OTgxOWQ4N2M1YzBmNzhhMWI4Yy90YWJsZXJhbmdlOmE5ODg0MzQyNDY3MzQ5ODE5ZDg3YzVjMGY3OGExYjhjXzEtMS0xLTEtMA_4f98d008-2513-4389-a4d3-9c5f8ee55627"
      unitRef="usd">35000000</bsx:UnrecognizedCompensationCostStockOptions>
    <bsx:UnrecognizedCompensationCostNonVestedStockAwards
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphOTg4NDM0MjQ2NzM0OTgxOWQ4N2M1YzBmNzhhMWI4Yy90YWJsZXJhbmdlOmE5ODg0MzQyNDY3MzQ5ODE5ZDg3YzVjMGY3OGExYjhjXzItMS0xLTEtMA_dee0232d-3ce5-4cc7-a979-2043c4633ae3"
      unitRef="usd">169000000</bsx:UnrecognizedCompensationCostNonVestedStockAwards>
    <bsx:UnrecognizedCompensationCost
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphOTg4NDM0MjQ2NzM0OTgxOWQ4N2M1YzBmNzhhMWI4Yy90YWJsZXJhbmdlOmE5ODg0MzQyNDY3MzQ5ODE5ZDg3YzVjMGY3OGExYjhjXzMtMS0xLTEtMA_4e9d3b8d-1620-4eb3-9511-30e67213ec9b"
      unitRef="usd">204000000</bsx:UnrecognizedCompensationCost>
    <bsx:WeightedAverageRemainingVestingPeriod
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTphOTg4NDM0MjQ2NzM0OTgxOWQ4N2M1YzBmNzhhMWI4Yy90YWJsZXJhbmdlOmE5ODg0MzQyNDY3MzQ5ODE5ZDg3YzVjMGY3OGExYjhjXzMtMy0xLTEtMA_c3e524c9-cad7-4379-8d97-75cef99cd710">P1Y8M12D</bsx:WeightedAverageRemainingVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0XzgzMjM_bd8cc8e7-6f18-44c3-bff9-2575110eb28d"
      unitRef="shares">50000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <bsx:AmountOfEmployeesTotalCompensationEligibleForGesopPurchase
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzg1ODQ_5bf9e5b2-48a4-4532-9ad8-8b61241faa96"
      unitRef="number">0.10</bsx:AmountOfEmployeesTotalCompensationEligibleForGesopPurchase>
    <bsx:GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzg4MzU_2e4efc36-335c-4445-a0c5-fc067d7a20cd"
      unitRef="number">0.85</bsx:GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzg5ODY_19dcbba1-c97a-44fa-9dc0-26c2c80e056a"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90ZXh0cmVnaW9uOjdhZDFjN2M4YTE2ODQwZTE4NTFkMGVjNDg1M2E2NmM0Xzk1NzU_6f3cd8c8-7285-4522-84b5-fa90e1c189a2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued or to be issued&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Range of purchase prices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$27.91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expense recognized&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzItMS0xLTEtMA_a135df44-2d2b-440c-b3ac-4fb7805d0e13"
      unitRef="shares">1387000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzItNS0xLTEtMA_4aab7f4a-24fc-4c66-911f-77b7bf942a42"
      unitRef="shares">2196000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzItOS0xLTEtMA_d247fb79-10a7-4c8e-917e-f3de2ed3fd23"
      unitRef="shares">2452000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtMS0xLTEtMA_ae4fc590-4737-4d7e-bf97-abce6605e34d"
      unitRef="usdPerShare">29.84</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i1d62047b22344b799f16b3cb7ff597c8_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtNS0xLTEtMA_ba20ca7b-df1d-42fe-9ab6-a2547e7f0675"
      unitRef="usdPerShare">29.29</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="ib22247f67db94421b34a23ad85639077_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtNy0xLTEtMA_ad4e3bb7-98ab-47ed-afe2-88d91f07edcf"
      unitRef="usdPerShare">36.47</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i5927d31a28d44ea785098e97b5f79f96_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtOS0xLTEtMA_a526a905-646e-4d6b-994f-6bc2f7bb0b1d"
      unitRef="usdPerShare">21.49</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i587d1e2ddfb14a2eac94b281ca12ec47_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzMtMTEtMS0xLTA_dd8fd785-6308-4118-8fd3-ec970bacb7ac"
      unitRef="usdPerShare">27.91</us-gaap:EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzQtMS0xLTEtMA_d91387ec-54eb-4986-b025-2064f0db41d2"
      unitRef="usd">10000000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzQtNS0xLTEtMA_b19bcc49-9faa-4626-8b7b-8023cf901df5"
      unitRef="usd">19000000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzYvZnJhZzo3YWQxYzdjOGExNjg0MGUxODUxZDBlYzQ4NTNhNjZjNC90YWJsZTowODM2YzAxMWU2ZjQ0NDIwYWIyOGM5MTg0MTBkMGVlOC90YWJsZXJhbmdlOjA4MzZjMDExZTZmNDQ0MjBhYjI4YzkxODQxMGQwZWU4XzQtOS0xLTEtMA_d5de06a5-7fbe-4778-bcbf-26ec24571a54"
      unitRef="usd">17000000</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90ZXh0cmVnaW9uOmY3MDlkM2M5Y2YwODQ2MWY5ZTdlM2M3YWYwYzczYmFhXzI3NDg3NzkwNjk2NTU_cc832a1c-0ab9-4da2-a82b-fa53e4895983">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE N &#x2013; WEIGHTED AVERAGE SHARES OUTSTANDING&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,416.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,391.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,381.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,416.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,401.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; position in this period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss)&#160;per common share - assuming dilution&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the later of the May 27, 2020 issuance date or the beginning of the reporting period to the extent that the effect is dilutive. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was reduced by cumulative &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Preferred stock dividends&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as presented in our consolidated statements of operations, for purposes of calculating &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss available to common stockholders&lt;/span&gt;.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90ZXh0cmVnaW9uOmY3MDlkM2M5Y2YwODQ2MWY5ZTdlM2M3YWYwYzczYmFhXzI3NDg3NzkwNzIyNDc_0e35baf0-bc4b-45b4-9b24-1119f5acb217">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,416.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,391.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,381.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,416.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,401.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzItMS0xLTEtMA_85e99615-b442-4fdb-a174-c7ef33d5a261"
      unitRef="shares">1416700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzItMy0xLTEtMA_4c873d9a-e8a6-44fd-8053-ff7e1c7dc5d8"
      unitRef="shares">1391500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzItNS0xLTEtMA_afe35cdc-7ae6-446d-8367-235bdffd2cf2"
      unitRef="shares">1381000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzMtMS0xLTEtMA_b96e9529-c118-4eb7-bfe6-beb7ac9b5241"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzMtMy0xLTEtMA_4da2b25f-224b-4dd5-8e00-40051ddb2cfa"
      unitRef="shares">19000000.0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzMtNS0xLTEtMA_6bd2d6f8-2e17-46cd-a463-3b58d357b263"
      unitRef="shares">20400000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzQtMS0xLTEtMA_cc19eef7-e0ab-4a21-b2f2-46e7bff87483"
      unitRef="shares">1416700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzQtMy0xLTEtMA_6f9f7ef9-58f2-4e3c-bfeb-b8242c2b5cd9"
      unitRef="shares">1410600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTo1MTlkZDllYmY1Yzk0NTAxODZlZDAxZDZkMzg4ZjhjYi90YWJsZXJhbmdlOjUxOWRkOWViZjVjOTQ1MDE4NmVkMDFkNmQzODhmOGNiXzQtNS0xLTEtMA_95de2ec9-1b6d-44d4-b352-8cb2839fcb57"
      unitRef="shares">1401400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90ZXh0cmVnaW9uOmY3MDlkM2M5Y2YwODQ2MWY5ZTdlM2M3YWYwYzczYmFhXzI3NDg3NzkwNzIyNDQ_105f7dd3-52de-43b0-9ee4-4f82d21ce08e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; position in this period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia6c97b04efa749baa9a5a7d0f8ea8b37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzItMS0xLTEtMzAzNQ_6a0467aa-3ecd-417c-bd59-f276c16c634c"
      unitRef="shares">14000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i072f9c9e6d52435999f54ed61545ec04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzMtMS0xLTEtMzAzNQ_bb98e398-1f38-4b37-a429-5da0f4794c3e"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1fda8d4a6d204d5592671e4160ebb649_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzMtMy0xLTEtMzAzNQ_04382ab3-b9db-4356-8971-f605d5ae0f52"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icc16585c6e1d4e3b933534e09af497dc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzMtNS0xLTEtMzAzNQ_9a3927f0-7f69-4cb3-8d6f-0294f4d97e8b"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia2bfcb1707824651a50fb653ad5409d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xMzkvZnJhZzpmNzA5ZDNjOWNmMDg0NjFmOWU3ZTNjN2FmMGM3M2JhYS90YWJsZTplMzc3M2Y5YzM1YmM0Y2Q2Yjc2MDdiYjljM2JjOTJhYS90YWJsZXJhbmdlOmUzNzczZjljMzViYzRjZDZiNzYwN2JiOWMzYmM5MmFhXzQtMS0xLTEtMzAzNQ_b354ba35-9031-46cc-93ca-b2950861fa9e"
      unitRef="shares">14000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1Mjg_13190513-d3fb-4ea8-a2db-fe2f469051f0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE O &#x2013; SEGMENT REPORTING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our seven core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), certain investment portfolio net losses (gains) and EU Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our consolidated statements of operations and are included in the reconciliation below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following our acquisition of BTG, we have included BTG&#x2019;s Interventional Medicine business within our Peripheral Interventions operating segment, within the Cardiovascular reportable segment. We present BTG&#x2019;s Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation expense of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;296&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,422&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income of reportable segments as a percentage of net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other corporate assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the announcement of our plan to sell our Specialty Pharmaceuticals business, as of December 31, 2020, we have classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less costs to sell. Accordingly, the total assets of the Specialty Pharmaceuticals business as of December 31, 2020 reflected above include goodwill and intangible assets attributable to the disposal group that were not previously allocated to our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,409&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,477&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,064&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzI3NDg3NzkwNzExNzY_2d376cf4-3616-4ded-ab85-912ce3e071ed"
      unitRef="reportablesegments">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1NzY_48405f6c-a6c0-4bc0-8a86-ae8ffba038d1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzItMS0xLTEtMA_c8d4b45f-e2b5-4c9e-9b14-b5d6f2227818"
      unitRef="usd">3066000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzItMy0xLTEtMA_7b68a007-8183-4580-ab7d-4fd80fa8d096"
      unitRef="usd">3307000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzItNS0xLTEtMA_6d8121ae-5481-4a2b-922f-e99e292ae080"
      unitRef="usd">3007000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzMtMS0xLTEtMA_dde7f472-eafd-42b3-a003-46125e002a56"
      unitRef="usd">2752000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzMtMy0xLTEtMA_07a13da5-148b-4ada-b9ce-336de02c1836"
      unitRef="usd">3140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzMtNS0xLTEtMA_a2a885fd-3180-4831-a52c-7eaa28828f03"
      unitRef="usd">3041000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzQtMS0xLTEtMA_aafe796f-fe03-4cee-988d-062c8be586eb"
      unitRef="usd">3876000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzQtMy0xLTEtMA_01486a42-8a8b-4c0f-8378-87c3c8051ba7"
      unitRef="usd">4208000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzQtNS0xLTEtMA_9908c037-b3df-4d17-9aac-11f719e84fa9"
      unitRef="usd">3777000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42e266465c9541e5884b034945a9b78f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzUtMS0xLTEtMA_e97cc2c0-d0e2-416a-966b-f59f3855d572"
      unitRef="usd">9694000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06a7f1a1b2624255b5691acb8602e67d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzUtMy0xLTEtMA_b7e0bc3b-d201-4de6-a748-8ba03840554b"
      unitRef="usd">10654000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0820a199efab4817bdf4131117959b05_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzUtNS0xLTEtMA_ea2a92dd-0526-4ed6-8f4a-b200d69d69f8"
      unitRef="usd">9823000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9db1cbfd5784602a23dc09b4c7da6d8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzYtMS0xLTEtMA_ac74513c-8db3-4b94-b93c-0399a35ef664"
      unitRef="usd">219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2775314c99b49018b5b755c1d609493_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzYtMy0xLTEtMjk5OA_f2f54435-7930-4162-b039-7c06ec101a7c"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzctMS0xLTEtMA_57acf547-8f29-4565-8c11-728d6e8c6ecb"
      unitRef="usd">9913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzctMy0xLTEtMA_30926c08-b004-4aa2-844e-c4bcd228fc27"
      unitRef="usd">10735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0820a199efab4817bdf4131117959b05_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzZlY2ViZWVlMjY0M2EwYTBiZjgxYjhlNGFkMTY1MS90YWJsZXJhbmdlOmM3NmVjZWJlZWUyNjQzYTBhMGJmODFiOGU0YWQxNjUxXzctNS0xLTEtMA_947cbb1c-99b5-4680-9a95-a713bed3aabe"
      unitRef="usd">9823000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1MzA_e963ea59-4ff3-4cf3-bfed-7dd5886eefe6">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation expense of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;333&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;296&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock>
    <us-gaap:Depreciation
      contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzItMS0xLTEtMA_4d3d085c-24a8-4236-8e37-93d92755e25b"
      unitRef="usd">80000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzItMy0xLTEtMA_ce6ad229-c207-4ad6-87a9-23f827a5adf7"
      unitRef="usd">75000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzItNS0xLTEtMA_02339a62-e6ca-4e5f-a493-20d3a9caff2a"
      unitRef="usd">72000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzMtMS0xLTEtMA_81d678b5-7d4e-42a3-b74e-c2c70e0ed7c1"
      unitRef="usd">96000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzMtMy0xLTEtMA_fe2b45cf-b2e5-4f53-a15b-1c81434e7e0d"
      unitRef="usd">92000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzMtNS0xLTEtMA_de6fb14c-4b22-4d37-bc24-081eff8b0090"
      unitRef="usd">91000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzQtMS0xLTEtMA_2778628a-7e82-4d1f-a76b-11b7013cfcee"
      unitRef="usd">154000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzQtMy0xLTEtMA_3d660ab1-c99f-496b-874a-47bc95249ada"
      unitRef="usd">138000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzQtNS0xLTEtMA_9fe3369a-ad58-4732-a6eb-0987557ca5dc"
      unitRef="usd">133000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i42e266465c9541e5884b034945a9b78f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzUtMS0xLTEtMA_2392872b-4c3f-468d-bb31-0d2490148f65"
      unitRef="usd">330000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i06a7f1a1b2624255b5691acb8602e67d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzUtMy0xLTEtMA_6ff61822-ac25-4a9c-ad28-fdca6aa15b7a"
      unitRef="usd">306000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0820a199efab4817bdf4131117959b05_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzUtNS0xLTEtMA_e0af7619-917d-46da-8a62-709f59981dfe"
      unitRef="usd">296000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzYtMS0xLTEtMA_8664fbcf-7c8b-43c0-b8e1-8c7726990e88"
      unitRef="usd">3000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzYtMy0xLTEtMA_2a878447-15c4-4ce7-a93e-245457b50caa"
      unitRef="usd">6000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzctMS0xLTEtMA_4e5c397c-555d-40af-822e-075efd51150b"
      unitRef="usd">333000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzctMy0xLTEtMA_9aec95c1-0b41-431e-b798-33a8ec589b42"
      unitRef="usd">311000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyZTAzN2RiYTYzMzI0ZjIwYjVjOWVjMjFhOTQ0NzQxZi90YWJsZXJhbmdlOjJlMDM3ZGJhNjMzMjRmMjBiNWM5ZWMyMWE5NDQ3NDFmXzctNS0xLTEtMA_2837a109-81c9-450e-aad2-1bc168a7cb26"
      unitRef="usd">296000000</us-gaap:Depreciation>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1NjA_247ca490-eac2-46cb-9de4-925be95dd431">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(372)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;687&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,422&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzItMS0xLTEtMA_39405314-4bc4-4cd5-a60e-fa7fbf93cec7"
      unitRef="usd">1079000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzItMy0xLTEtMA_bb919527-0fb4-415f-9b6c-2b192ff9eedb"
      unitRef="usd">1204000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzItNS0xLTEtMA_cd83650e-fb57-4403-a8f6-16d250fd06c5"
      unitRef="usd">1102000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzMtMS0xLTEtMA_aa4c816e-7c3b-44b0-bdee-a4bddf83adf2"
      unitRef="usd">439000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzMtMy0xLTEtMA_601d636d-6685-41e5-a6af-787bddf704bf"
      unitRef="usd">666000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzMtNS0xLTEtMA_8483adc7-8d82-45b7-8d7c-cecb2a785c8f"
      unitRef="usd">655000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzQtMS0xLTEtMA_7fc36121-bf65-4a28-8769-6f411018ef8d"
      unitRef="usd">661000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzQtMy0xLTEtMA_ddb1e596-cdd3-498c-98c8-754773ec0876"
      unitRef="usd">1137000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <bsx:OperatingIncomeLossAllocatedToReportableSegments
      contextRef="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzQtNS0xLTEtMA_56372444-421e-47c1-a6c9-713ba3c8f841"
      unitRef="usd">1117000000</bsx:OperatingIncomeLossAllocatedToReportableSegments>
    <us-gaap:OperatingIncomeLoss
      contextRef="i74ec03875dad48559735244193b46b9c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzUtMS0xLTEtMA_91a5ec89-24d0-4663-9dd0-0647676f78c0"
      unitRef="usd">2179000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7c01e96e0cd14429b992b394174f5e9e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzUtMy0xLTEtMA_41d5f89b-2efc-4c26-adf9-b6584a2736d2"
      unitRef="usd">3007000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8fe71b06ce344c281e40bdc083e4ba9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzUtNS0xLTEtMA_eb068ee4-c8b5-4ddd-add6-9836066a25fa"
      unitRef="usd">2875000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2f9b4c30b0c643ff881acaded8dcb23b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzYtMS0xLTEtMA_6c0ba3ff-3169-4eb9-bdff-00b984c2ff59"
      unitRef="usd">143000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i793d999a9b624f70a0df23be83f63129_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzYtMy0xLTEtMzAwMg_c1310150-b7e4-4aea-b975-5b113f7553d0"
      unitRef="usd">56000000</us-gaap:OperatingIncomeLoss>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i3a71de8475b842919cc1f06ff9e779cf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzgtMS0xLTEtMA_8741d12f-4060-4928-90a4-99cae43841bc"
      unitRef="usd">-405000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i7255855cd0894949a78ea4a0040d8c62_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzgtMy0xLTEtMA_5d2d8809-e81f-4ff6-9852-3da3b9c825ac"
      unitRef="usd">-264000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i6e2cbc9edb4549aebf26bdc7e9f10bc4_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzgtNS0xLTEtMA_13f0ab65-1562-44d6-80b0-856ba9283ac9"
      unitRef="usd">-372000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i438f3d71334f422fadced3dba2c1990a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzktMS0xLTEtMA_e875dcb8-0d9f-4882-a28c-cb08833e83da"
      unitRef="usd">-1208000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i63903523afd04122bb1a4624c0770c00_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzktMy0xLTEtMA_3ec615f8-7770-47af-9b1b-e2d1975ef78d"
      unitRef="usd">-582000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ia9ef720185f044b09fc4ef729f49cebb_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzktNS0xLTEtMA_9fa06587-06c6-4895-8a00-b34e2eb5d1f2"
      unitRef="usd">-398000000</bsx:OperatingIncomeUnallocatedToSegment>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEwLTEtMS0xLTA_70408aa3-b101-403b-971e-e13abc600ee6"
      unitRef="usd">789000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEwLTMtMS0xLTA_0dcb4724-2b65-4e3f-88d6-d51cb8a7c92f"
      unitRef="usd">699000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEwLTUtMS0xLTA_c8e3ec53-eab6-4663-bb04-800a910116cf"
      unitRef="usd">599000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzExLTEtMS0xLTA_ba8dec01-a833-4d31-abe1-74e0f14c8a78"
      unitRef="usd">-80000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzExLTMtMS0xLTA_b6d3dabc-4cc7-4fdb-8342-5a8c6ffa06e2"
      unitRef="usd">1518000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzExLTUtMS0xLTA_c405e9d3-9a11-44eb-a655-af8196895517"
      unitRef="usd">1506000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEyLTEtMS0xLTA_6e8d2110-a23c-4676-af39-695de26ba7d9"
      unitRef="usd">1000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEyLTMtMS0xLTA_93f9678b-9ed9-47e2-950f-5c9d9d06f115"
      unitRef="usd">-831000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEyLTUtMS0xLTA_5eb66858-03c3-4f76-95e0-26e39a46fab2"
      unitRef="usd">-85000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEzLTEtMS0xLTA_f314bf20-0f8d-4699-bfbd-ee21de58e46a"
      unitRef="usd">-79000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEzLTMtMS0xLTA_64124ad2-74b3-4b29-b51c-d4e5fc73d5eb"
      unitRef="usd">687000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZTpjNzg4NTBiMjIxNDE0NGZiODYxMThiYTc2YTc5NzBiZS90YWJsZXJhbmdlOmM3ODg1MGIyMjE0MTQ0ZmI4NjExOGJhNzZhNzk3MGJlXzEzLTUtMS0xLTA_6dd68a33-9954-48c5-852d-959d503b84d9"
      unitRef="usd">1422000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <bsx:SegmentoperatingincomeaspercentageofnetsalesTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1NzU_1f782114-08c8-4911-a180-6c04ce70c1f7">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income of reportable segments as a percentage of net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:SegmentoperatingincomeaspercentageofnetsalesTableTextBlock>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ib717274d03a64d25966befc8d8c1cba3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzItMS0xLTEtMA_d2a870f9-5834-4ca9-98c7-de26667ddad4"
      unitRef="number">0.352</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i5b80beac6c5746fbb17a84960bfceacf_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzItMy0xLTEtMA_bfe6e0d0-e41a-40df-976c-edccbc98f958"
      unitRef="number">0.364</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i70cf550c1a4a40a7b4dcb728637b7c86_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzItNS0xLTEtMA_dcec25b3-28cd-4e96-baab-ced8b4dec961"
      unitRef="number">0.367</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i896b539ff58e4f54965afff9e0a03671_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzMtMS0xLTEtMA_8ff01aa3-825f-44c1-907e-5447197f3622"
      unitRef="number">0.159</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="ib225f7e509eb4e4cb10f406928e15cc3_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzMtMy0xLTEtMA_4f33f610-8330-4932-b409-cb7bce9eefff"
      unitRef="number">0.212</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i64dcab411ae84c85a2e7261aa1531f18_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzMtNS0xLTEtMA_4792ac4e-abf1-4305-a1ef-ff06d169c87a"
      unitRef="number">0.215</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i62b583517e214d8f9f5d845b0e44fea5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzQtMS0xLTEtMA_2a24f2dd-ec21-4da7-846e-df640f7148e3"
      unitRef="number">0.171</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i441d6c224b974fa083f08dc17135353f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzQtMy0xLTEtMA_0b3ebfa6-7ae8-40b2-a9ae-fdcb5eb5fd02"
      unitRef="number">0.270</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <bsx:Segmentoperatingincomeaspercentageofnetsales
      contextRef="i0fb96c85284747969bcc60af5f16e923_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyMjQ5MGU4NGEyODg0OTEwYjk2ZTRlYjJjYmIzYzVkZi90YWJsZXJhbmdlOjIyNDkwZTg0YTI4ODQ5MTBiOTZlNGViMmNiYjNjNWRmXzQtNS0xLTEtMA_1d8b45aa-dd53-4684-afc9-73549e4d9a8a"
      unitRef="number">0.296</bsx:Segmentoperatingincomeaspercentageofnetsales>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1MzU_a677a06f-3e8e-411b-b533-f0bb1e81bdf3">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other corporate assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:OtherAssets
      contextRef="i36f17ca4d9f544e3b7cb7e5c6f72280c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzItMS0xLTEtMA_d00069d3-ed9b-4d36-8b02-b4f22487923e"
      unitRef="usd">1638000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i4452aaad562b4bb899286f3797d9eb2d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzItMy0xLTEtMA_925361b7-769f-4af2-aed9-b614b367f2ff"
      unitRef="usd">1803000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i593eb42527b540c88a5921faa53b3629_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzMtMS0xLTEtMA_86b4aaf2-c71e-4ded-85fa-3a325856077f"
      unitRef="usd">1827000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i3e86856187e44c808f6433015dceb738_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzMtMy0xLTEtMA_223a1f3b-5ec6-4e8c-a313-e81d4575d6d8"
      unitRef="usd">1873000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i0d99afc9e3b24ff09921674dea102a4b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzQtMS0xLTEtMA_bab336e6-4f6a-4f28-a08d-e13a4fbd8d88"
      unitRef="usd">2461000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i74c2fb79c41b4be6bf7aa2326d6b1cae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzQtMy0xLTEtMA_f95707cf-478a-4af8-84a5-fd28b1d4606b"
      unitRef="usd">2535000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="ie07c1550f2534b128a6b7a2e8d0dcacb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzUtMS0xLTEtMA_48468a51-8f47-493f-9bee-216ffb7ab460"
      unitRef="usd">5926000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i511243d7d4314bcfa6398e281d8d6532_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzUtMy0xLTEtMA_26a7962f-50ff-4723-9e8e-4e69949a09e2"
      unitRef="usd">6211000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="ic719d29f043447d9a84bc5924b1baf78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzYtMS0xLTEtMA_50f01fff-7b3d-48ab-a3c9-7e39f9aa3290"
      unitRef="usd">1133000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="ibd58d69b28dd40519b4334498825790f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzYtMy0xLTEtMA_aa85b5c5-8e27-4e74-96c0-dd8852017e51"
      unitRef="usd">211000000</us-gaap:OtherAssets>
    <us-gaap:Goodwill
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzctMS0xLTEtMA_f82bd445-2c9f-425e-be29-bbb5c5e1b01b"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzctMy0xLTEtMA_b817d6b3-a149-4a2e-b402-808e19d12406"
      unitRef="usd">10176000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzgtMS0xLTEtMA_da5540d4-f986-4814-a832-85e5ff9a1ace"
      unitRef="usd">5917000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzgtMy0xLTEtMA_36e9fd94-a267-4ed6-82c1-75eb4768f031"
      unitRef="usd">7886000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets
      contextRef="i1ae346373047401887060e128b7fa20e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzktMS0xLTEtMA_2aa76f13-04a4-468f-b6a6-056de242bcc1"
      unitRef="usd">7850000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="ifc7b8ce837b245dbb215df8479dd5f96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzktMy0xLTEtMA_8dc040ad-6ba4-4b50-a75a-ea8bbdd97dba"
      unitRef="usd">6082000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="iad363ee5163542b083904b4076004ef1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzEwLTEtMS0xLTA_f85b34aa-19ae-437c-b3c6-b036e01f700c"
      unitRef="usd">30777000000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="i0bd94549f8c44f9d8d06813718b34318_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToxZWNkMzM2Mzc3YzY0ZjAzODcwYjhiMWVjNzI2YzcxYi90YWJsZXJhbmdlOjFlY2QzMzYzNzdjNjRmMDM4NzBiOGIxZWM3MjZjNzFiXzEwLTMtMS0xLTA_243cb821-0097-4bef-a7ba-a34ea22fc29f"
      unitRef="usd">30565000000</us-gaap:OtherAssets>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90ZXh0cmVnaW9uOjg5MDUwM2Q0N2IxMTQ2NGE5ZjRhYTBhYTNkMGUwODE2XzE1NTM_f15e4734-a2bc-4527-b11b-596280d95223">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,409&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,477&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,064&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="ie5dd6328991b46b09bcc31f021284ca1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzItMS0xLTEtMA_b8bc2835-777a-46c3-80a9-c921caa604c3"
      unitRef="usd">1151000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0b784e91a1d84b03a340b395d9f1d9b8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzItMy0xLTEtMA_4a69657a-74c6-48ae-a16d-09c97869a16b"
      unitRef="usd">1148000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6c8ed886eb0f41d797c16440876e2205_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzItNS0xLTEtMA_d402ff78-dfc1-46cc-add5-cca8e512718b"
      unitRef="usd">1061000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i858f772c802b438680691d7c7cb9c6e4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzMtMS0xLTEtMA_9daea2e9-3831-4d72-ab8f-47a7a9c4b8bb"
      unitRef="usd">382000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="icbc1298766fb4dc6afdb793f6e79a93b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzMtMy0xLTEtMA_50b09069-0c26-4af4-bb50-254b8b674387"
      unitRef="usd">327000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i7b32c44341dc4909bcb9d9a63624fe3b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzMtNS0xLTEtMA_7cb78506-1d66-4c86-81b5-b23b44502015"
      unitRef="usd">242000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ieec0796ecad949ba819d979b8949b690_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzQtMS0xLTEtMA_721670b4-cb91-412e-b723-64932d438293"
      unitRef="usd">551000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id00a014d50414ad386436abb58f55a11_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzQtMy0xLTEtMA_e33ae956-4ce1-4f19-9324-c193217643c1"
      unitRef="usd">604000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i8a659e306f1b44828d0574858121b0aa_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzQtNS0xLTEtMA_ba307e9b-87c8-4c42-8e05-a1cf5a224ed2"
      unitRef="usd">478000000</us-gaap:NoncurrentAssets>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzUtMS0xLTEtMA_c4e5f18f-e27b-4b69-bb29-49ba668ab464"
      unitRef="usd">2084000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzUtMy0xLTEtMA_abf1a96d-bf97-4e03-aad1-e6bc13b03748"
      unitRef="usd">2079000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzUtNS0xLTEtMA_acd69d70-fee9-4de3-9e47-56e81d5fef51"
      unitRef="usd">1782000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzYtMS0xLTEtMA_20ff9acb-8d42-497d-a9b7-8de058a96760"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzYtMy0xLTEtMA_3f49d3c5-e012-4755-aaba-55aaf01ef4d2"
      unitRef="usd">10176000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzYtNS0xLTEtMA_77f78962-0c8a-4f34-ac3d-70a8a23692e8"
      unitRef="usd">7911000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzctMS0xLTEtMA_aace6022-0da6-43be-8a06-2390504a7284"
      unitRef="usd">5917000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzctMy0xLTEtMA_97715665-18b4-4f26-933a-0f6b92077f5c"
      unitRef="usd">7886000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzctNS0xLTEtMA_84a70640-2f7f-483b-8ab6-3d90cd2d0104"
      unitRef="usd">6372000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzgtMS0xLTEtMA_837debbd-304b-4403-8b6d-22157ad3a7cc"
      unitRef="usd">458000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzgtMy0xLTEtMA_464538bc-0087-4d24-98a8-ee7926006743"
      unitRef="usd">336000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzgtNS0xLTEtMA_07b404d4-ccc8-491e-8ff4-2c4e3bb3c1f2"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:NoncurrentAssets
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzktMS0xLTEtMA_590b16b2-8157-4592-bea8-0e4eb6ada47b"
      unitRef="usd">18409000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzktMy0xLTEtMA_80d74dc4-730b-49a9-85ed-99cbfabbfd38"
      unitRef="usd">20477000000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDIvZnJhZzo4OTA1MDNkNDdiMTE0NjRhOWY0YWEwYWEzZDBlMDgxNi90YWJsZToyNDYwYzAzNGE5YWU0NTc2YjhiOGVkODk0MmRjYjM3Yi90YWJsZXJhbmdlOjI0NjBjMDM0YTlhZTQ1NzZiOGI4ZWQ4OTQyZGNiMzdiXzktNS0xLTEtMA_782110fc-59fb-4782-8c8f-7475625f8876"
      unitRef="usd">16064000000</us-gaap:NoncurrentAssets>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzI3NDg3NzkwNzQ4OTU_c20ecc6c-4a59-4d2c-b3d4-6ef136e3b50d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE P &#x2013; REVENUE &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our consolidated statements of operations. The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,701&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,212&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA (Europe, Middle East and Africa)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC (Asia-Pacific)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LACA (Latin America and Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,694&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,654&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying consolidated balance sheets. Our deferred revenue balance was $395 million as of December&#160;31, 2020 and $400 million as of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2019. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#x2122; Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. We recognized revenue of $135 million in 2020 that was included in the above December&#160;31, 2019 contract liability balance. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize sales force commissions related to contracts with customers when the associated revenue is expected to be earned over a period that exceeds one year. Deferred commissions are primarily related to the sale of devices enabled with our LATITUDE&#x2122; Patient Management System. We have elected to expense commission costs when incurred for contracts with an expected duration of one year or less. Capitalized commission fees are amortized over the period the associated products or services are transferred. Similarly, we capitalize certain recoverable costs related to the delivery of the LATITUDE&#x2122; Remote Monitoring Service. These fulfillment costs are amortized over the average service period. Our total capitalized contract costs are immaterial to our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We received FDA approval in mid-2020 and began the U.S. launch of our next generation WATCHMAN FLX&#x2122; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#x2122; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In 2020, we recorded $179 million in revenue reserves primarily related to our conversion to a consignment commercial model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#x2122; Device in the U.S. In connection with the conversion, we repurchased customer-owned inventory and will recognize revenue for consigned units as they are consumed by customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information on our accounting policies relating to revenue recognition.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzE0MjI_98e206f8-ba7b-4d5b-b2e7-3830e753936a">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): &lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,701&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,212&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA (Europe, Middle East and Africa)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC (Asia-Pacific)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LACA (Latin America and Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,694&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,654&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;81&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,735&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,823&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4ae8f5f4fc54e469b52b21b2e600588_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMS0xLTEtMA_14149293-5567-473b-9ae8-081fcdeac0ab"
      unitRef="usd">1000000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63189412661642f5a8f2b9aeb53a83a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMy0xLTEtMA_3d36fb04-d34d-4570-83a9-6546feb8e857"
      unitRef="usd">780000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3310fa9b62c34616bca02c7c2f6b9784_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtNS0xLTEtMA_c4b44d31-57db-4bc2-aa4e-5c8f46510ea9"
      unitRef="usd">1780000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18f4de09d08c4833944a68b36c8d10e2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtNy0xLTEtMA_1e73b4be-1872-4908-9da9-2ad2450ee88b"
      unitRef="usd">1080000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if71c0aab91d34037ad9af6a815712b06_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtOS0xLTEtMA_8125d0e5-6b74-431d-afa2-5bf5d6179729"
      unitRef="usd">814000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e68166b1ff440a4bc5ba6146bce9e0c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMTEtMS0xLTA_79ccd1a1-533f-4b7e-b14f-f33afd5475d3"
      unitRef="usd">1894000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2791d1ca0354ea3b2122b428aa941e8_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMTMtMS0xLTA_d166b10a-13aa-4029-9c78-352ba6908cc3"
      unitRef="usd">980000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied722aad4edc4278a94ca946a6b06e8c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMTUtMS0xLTA_bbc1693a-d888-44a3-9b2a-f07f663066a7"
      unitRef="usd">781000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8328c5ebea2e4fd6bc961bba6dfac1ba_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzMtMTctMS0xLTA_786fa77c-55ba-4825-b771-01a7374f830c"
      unitRef="usd">1762000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bd85cb4fae54571b1035e5edca0b5f0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMS0xLTEtMA_c09096d0-c20b-4fdb-9384-ac46e4e68aca"
      unitRef="usd">918000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f3a0f25c82248db8fd9752a33e01ca9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMy0xLTEtMA_04a79046-e727-4c53-b4f8-19ef83c59af7"
      unitRef="usd">368000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bf1776f98e64055a1740c5f1d4c3626_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtNS0xLTEtMA_704eacf7-1ea5-49da-99be-546e33cef032"
      unitRef="usd">1286000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i513e81ea5c054bb7ab98f1c6f1a9367c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtNy0xLTEtMA_9f88d22d-cf19-4d65-8ff7-e0c79edf65b3"
      unitRef="usd">1005000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87e138a0321a4237aaee54dac3eecbef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtOS0xLTEtMA_b8fe0738-6173-46ab-abbc-edeb64de1b8d"
      unitRef="usd">408000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfdceca128a8467f86bcca14efd7146b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMTEtMS0xLTA_fa4615fc-2195-4e60-a0d1-bd7e41a990a4"
      unitRef="usd">1413000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if875c662a7874536afea940416d0a63e_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMTMtMS0xLTA_8cc83d7c-82f9-4b75-86e7-ea49cdea6ad2"
      unitRef="usd">864000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefd0c81147da4757acf01048244a29a2_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMTUtMS0xLTA_1d7d8427-60e4-4714-ac4a-ea6a064090ee"
      unitRef="usd">381000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id75ab8e1ae0d49cbb8ac4badf8c334e3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzQtMTctMS0xLTA_ab4eb4ee-7d41-4282-ae6e-d029b945ae2f"
      unitRef="usd">1245000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i123d2d96cb4f4625a7ca2e22d7052b07_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMS0xLTEtMA_99d523a9-ddab-49bd-938c-e64fb03dfa1c"
      unitRef="usd">992000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96570d8f60ec4c059059878654d4e978_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMy0xLTEtMA_f873eed0-6412-44c1-8c89-a488453d20bf"
      unitRef="usd">712000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iede0d66fbb154f07be0f0e39b74e8884_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtNS0xLTEtMA_191e735e-214e-4ab4-ac97-f4f79a199e9b"
      unitRef="usd">1704000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06f5a94b8a8145529296757ce57b7f5a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtNy0xLTEtMA_cce74860-7ecc-495d-b6bc-0ebb8cdf7f3b"
      unitRef="usd">1135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i937aa716b0d844a989c27397f8bc1d9d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtOS0xLTEtMA_39dea69e-a42f-4e53-a698-a409af76b41f"
      unitRef="usd">804000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44f315c2d53749c4a98caeb0c46bf4b8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMTEtMS0xLTA_070ecf94-8446-434f-bb91-8c438b621105"
      unitRef="usd">1939000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1502d18d7bc74acbb3d8ab048488f756_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMTMtMS0xLTA_6bd583d1-b6a6-4402-a7c3-df3b98fb3428"
      unitRef="usd">1159000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62b5fd5fd89d4d2e87a701257a100916_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMTUtMS0xLTA_a672483d-f463-4f77-954a-ef24a2970890"
      unitRef="usd">792000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71ff3b6b5ecd4ff78aefd5a1081e8c46_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzUtMTctMS0xLTA_6957c692-6f94-4802-97e2-19fdd88fdc81"
      unitRef="usd">1951000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98775703e0eb4e92aeb652fb7cd61026_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMS0xLTEtMA_fdc32074-e084-4534-adbd-3bf833d93643"
      unitRef="usd">118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if74c3140243949a6826d8ed9cdee8a17_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMy0xLTEtMA_c2758ff8-4c73-4ca3-87fe-dba6f5c6a91d"
      unitRef="usd">169000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3406940f365a46eb906ded17bdbd850c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtNS0xLTEtMA_e8678057-bd31-452e-a851-2a137b0b952a"
      unitRef="usd">287000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9539e6fa5dcb48d8b5039083c5f40bd7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtNy0xLTEtMA_51999902-88eb-4cbf-907b-679027d88a2f"
      unitRef="usd">148000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48892e98c56344a79b645469f44e7ffb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtOS0xLTEtMA_ba9f3a61-415a-40bc-9e9c-ad89062dda5c"
      unitRef="usd">180000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70c1a11844804faea3d997d119344357_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMTEtMS0xLTA_ded5d6f1-6ed7-42a7-83ce-3724920a97c4"
      unitRef="usd">329000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85f5f28e5853409e93d21092b327e718_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMTMtMS0xLTA_f4e4e66d-aa22-456e-afe8-2fea2f4d0fcf"
      unitRef="usd">150000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i173fb5f80de24dc6b549cf699860ff93_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMTUtMS0xLTA_b26ed261-0920-45d6-b81b-92346a97d782"
      unitRef="usd">161000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if596783ed28540409dc77820cae22014_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzYtMTctMS0xLTA_07cff5cf-c63d-4d01-9f09-df0c41be318d"
      unitRef="usd">311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a0cf3f990cf48038aaa263848720334_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMS0xLTEtMA_6d26aa94-ce89-4a03-a349-cedc7d419934"
      unitRef="usd">610000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35965682e6934441a09c4499546789a5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMy0xLTEtMA_f08e31b6-941d-435c-aeb9-868154b8cb90"
      unitRef="usd">151000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac0bbd18a4ac488ab44f83280dffe8d9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctNS0xLTEtMA_82381b62-1a15-481d-949a-cb8770096c5d"
      unitRef="usd">761000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5909476c857442b993ed5506e3cef59_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctNy0xLTEtMA_8487d5ce-37f5-4084-9e76-4f6effb52f4d"
      unitRef="usd">695000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id91bf069a1224ec7b78acb9fbcea277b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctOS0xLTEtMA_9f7ce9fa-d091-41e9-be9c-7854fe359723"
      unitRef="usd">178000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if995755c1c9b49b4a9e75000536e2348_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMTEtMS0xLTA_591e803e-49e3-43cc-ac22-c3f7cf5eae6a"
      unitRef="usd">873000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibdcde2cecf294a648e81bb1b6a520713_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMTMtMS0xLTA_4c0ae3ea-2637-4224-af25-e8b9f2132fa4"
      unitRef="usd">624000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba33321f14c4426c8f27ec58c8dd157d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMTUtMS0xLTA_3aeba8dd-8c68-48b7-a9df-dc671a88baed"
      unitRef="usd">155000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d2be57e89ab4990afaf54dfd21a1651_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzctMTctMS0xLTA_2a1f7ecb-c09e-486a-b218-44a6dbaf2d12"
      unitRef="usd">779000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6206baa0607e4447a0e903f42c1ed97c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMS0xLTEtMA_4e164c3e-5c47-4b0d-b2d8-11c8eb57b81b"
      unitRef="usd">981000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd07f73493ec4ed7a9c7b93a28fa803f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMy0xLTEtMA_c2549896-afb4-4c41-9416-5ae510b069e2"
      unitRef="usd">1317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecec850c0f8c45579de9fd9d3cc81e56_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtNS0xLTEtMA_9dd619d2-a33b-4b17-a272-b313c2ecd979"
      unitRef="usd">2299000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbf55f8a4d8043ddb1050e3255fcca0f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtNy0xLTEtMA_1f1c1764-3f7d-408d-9565-378202c28509"
      unitRef="usd">1293000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i815d46a2e6f141779fd9a976198fcb59_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtOS0xLTEtMA_a0421bda-6c6f-4088-95cf-2232347b8fda"
      unitRef="usd">1522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08fbe1280d8c444c9dfd654d9d62ffba_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMTEtMS0xLTA_c0f14418-5eb8-4548-94f8-250d85c38080"
      unitRef="usd">2816000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4183c9b4fb7440c8791c7d281bfec1c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMTMtMS0xLTA_cb6feb8e-878c-4747-84ed-7e96776b156c"
      unitRef="usd">1154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40c4dadc18e044be9fbc4bee8e5e1ae0_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMTUtMS0xLTA_92be78da-65b1-4d30-bad0-3be188129366"
      unitRef="usd">1436000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8a6c9c90a3f416e91e71e65395c477a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzgtMTctMS0xLTA_ad827a6d-d3cd-4bd4-afea-7f7263df2c33"
      unitRef="usd">2590000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i528032fe7c344add96992fc9c9effe78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMS0xLTEtMA_6df2f1a1-6a6a-4578-aa3c-055c4475afed"
      unitRef="usd">888000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8e797bf1ad64edfa7c96ff371ef9a6b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMy0xLTEtMA_5d4a43cf-d6a0-46d0-ada3-3c8f8a5d0dee"
      unitRef="usd">689000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8348c7076ad34dc19caa20d96d3a35a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktNS0xLTEtMA_7791ee2f-b217-4a16-97ee-b9945075e96b"
      unitRef="usd">1577000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7734b29eb824bbe92e4b31e6104b9eb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktNy0xLTEtMA_0b862709-be52-4942-bd5d-2e034c55b0c1"
      unitRef="usd">741000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0690fd3bd0414ed3803fa0ec3f99dc1a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktOS0xLTEtMA_0f8155cc-db4e-40da-a8da-7f54d0d05fa7"
      unitRef="usd">651000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f26189e8ec34d198388550160abbe6f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMTEtMS0xLTA_2c6e7318-7c52-49ad-80fe-b0f589fac0ca"
      unitRef="usd">1392000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i538b7bb9612a453f9a69c50b4385870a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMTMtMS0xLTA_52391b14-525d-4557-8192-ff925bb36562"
      unitRef="usd">608000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7aa704e50bc84e7c8687de09cd75e04c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMTUtMS0xLTA_dd0444fb-3859-4c81-94ff-a43eabf38551"
      unitRef="usd">579000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9c9683dda944147b057902c94179e93_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzktMTctMS0xLTA_b138abe0-c197-4cc1-8e56-52c508fca0f2"
      unitRef="usd">1187000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32b5cf3a4bec4cd88d7475be9f91daca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTEtMS0xLTA_a6b41306-dc2e-47b9-b5ca-fb03d51a2662"
      unitRef="usd">193000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e4ccc5194b647ebae6e86a553e04f39_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTMtMS0xLTA_d9829390-60ca-4f01-9fd3-bd2161ee5e1c"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9db1cbfd5784602a23dc09b4c7da6d8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTUtMS0xLTA_ac74513c-8db3-4b94-b93c-0399a35ef664"
      unitRef="usd">219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25a2689337c343a29b2517e48e80f21f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTctMS0xLTcxNA_85745cfd-b7db-4aa3-b0eb-c2da22fb2cce"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3027462747254c22a27e928fc0e7507b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTktMS0xLTcyNg_93e0a764-037a-42da-820f-82c5d2b68fb8"
      unitRef="usd">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2775314c99b49018b5b755c1d609493_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzEwLTExLTEtMS03MzA_f2f54435-7930-4162-b039-7c06ec101a7c"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44683e8679ca4adeab31422336b6d2b6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTEtMS0xLTA_70f50cef-efd8-4596-b6ac-18bd93303a08"
      unitRef="usd">5701000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e3f1f1a5e54483791680e1f47026b93_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTMtMS0xLTA_80c22cf1-6a88-4905-a477-ef9bbe618d03"
      unitRef="usd">4212000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTUtMS0xLTA_8e2033c9-e6e2-4ffb-b87a-3292f8ca8754"
      unitRef="usd">9913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i477d03746ef641e79d498573339aa789_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTctMS0xLTA_4a96bec7-b962-4773-bf96-da5aa48bb226"
      unitRef="usd">6167000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieeb9b19833ec4b32a7043c93f3837778_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTktMS0xLTA_614c859c-0d95-49d0-9edc-df59b2f30a01"
      unitRef="usd">4569000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTExLTEtMS0w_30926c08-b004-4aa2-844e-c4bcd228fc27"
      unitRef="usd">10735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9077857b3e78429184a7980d2c9e9bd7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTEzLTEtMS0w_9c4d4052-e5b9-43f0-947b-23ca175988f1"
      unitRef="usd">5538000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4029bfd2d2d45b88bbd190a55c10e4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTE1LTEtMS0w_49195d47-8243-4469-994d-4f7a96f08542"
      unitRef="usd">4286000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTpiMGQwMGM1ZjA2NGM0ZmFhODdmNGFkMTE4ZTYzY2E2ZS90YWJsZXJhbmdlOmIwZDAwYzVmMDY0YzRmYWE4N2Y0YWQxMThlNjNjYTZlXzExLTE3LTEtMS0w_31188610-0539-40ab-8524-0a98431acf03"
      unitRef="usd">9823000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7416538a3917499a98dd18bd9a43544f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzItMS0xLTEtMA_12f880cb-d1a2-41b9-a1c7-0236760bcb96"
      unitRef="usd">5508000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfaf003122284a1caf5f04531f97da3e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzItMy0xLTEtMA_b76f6cdf-4540-4e4d-a371-31c960a8b187"
      unitRef="usd">6097000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i247718be21934f158bd504dc0a59d0d8_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzItNS0xLTEtMA_9e5f99f8-7db3-42fa-967c-4ef430c6ea0b"
      unitRef="usd">5538000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96d22c0398784970921b6ca16cac29df_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzMtMS0xLTEtMA_91c5ccde-fb6d-4aa0-bd98-ab37ad4bcacc"
      unitRef="usd">2097000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4eae2a8bac3a45d0a646a1ba30307bb1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzMtMy0xLTEtMA_00870a8c-930f-4d5b-ac4d-7c80b52ac820"
      unitRef="usd">2264000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6304d11e4ac4f2bb33c3f2f876312d5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzMtNS0xLTEtMA_66ab0e56-8343-4c74-b222-9e14adecde78"
      unitRef="usd">2176000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03b4b47b48264834a5b805b565fc497a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzQtMS0xLTEtMA_49a12d7c-f5c9-426a-b0b4-68c78be76187"
      unitRef="usd">1781000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e9eb5b00d6e4f2e8af5e92882f84e42_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzQtMy0xLTEtMA_426682f1-e347-4443-ada9-d7bd0dfb4513"
      unitRef="usd">1898000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a94eb1a155c44089342c4fce8a0a175_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzQtNS0xLTEtMA_d7aef7b7-1deb-4c3e-b9c3-0b03c8f02cf1"
      unitRef="usd">1727000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia44651ee68c84efd8c565cd8ede42050_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzUtMS0xLTEtMA_2f15440c-9f73-4796-abd5-23ca646a99db"
      unitRef="usd">307000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b029b8db40e4478bd41a37cbbf5ba8a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzUtMy0xLTEtMA_ac131266-d317-4771-83c5-c6ce30f13cfa"
      unitRef="usd">395000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0eea159e14624a668c6b1853597a984f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzUtNS0xLTEtMA_ab2f95d1-7bc8-472b-8178-2e31d1ec2ed5"
      unitRef="usd">383000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42e266465c9541e5884b034945a9b78f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzYtMS0xLTEtMA_69a0a105-7ec7-4821-ba6c-679357241b54"
      unitRef="usd">9694000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06a7f1a1b2624255b5691acb8602e67d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzYtMy0xLTEtMA_91a45a60-61b6-4ad8-a195-6f107bf820f7"
      unitRef="usd">10654000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0820a199efab4817bdf4131117959b05_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzYtNS0xLTEtMA_947cbb1c-99b5-4680-9a95-a713bed3aabe"
      unitRef="usd">9823000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32b5cf3a4bec4cd88d7475be9f91daca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzctMS0xLTEtMA_a6b41306-dc2e-47b9-b5ca-fb03d51a2662"
      unitRef="usd">193000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25a2689337c343a29b2517e48e80f21f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzctMy0xLTEtNzQ5_85745cfd-b7db-4aa3-b0eb-c2da22fb2cce"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e4ccc5194b647ebae6e86a553e04f39_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzgtMS0xLTEtMA_d9829390-60ca-4f01-9fd3-bd2161ee5e1c"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3027462747254c22a27e928fc0e7507b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzgtMy0xLTEtNzUy_93e0a764-037a-42da-820f-82c5d2b68fb8"
      unitRef="usd">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9db1cbfd5784602a23dc09b4c7da6d8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzktMS0xLTEtMA_ac74513c-8db3-4b94-b93c-0399a35ef664"
      unitRef="usd">219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2775314c99b49018b5b755c1d609493_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzktMy0xLTEtNzU1_f2f54435-7930-4162-b039-7c06ec101a7c"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEwLTEtMS0xLTA_42011400-cdac-453c-b9f0-9e0a008124e5"
      unitRef="usd">9913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEwLTMtMS0xLTA_7c4b3119-625d-4b2c-8716-fa187174b8fd"
      unitRef="usd">10735000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEwLTUtMS0xLTA_31188610-0539-40ab-8524-0a98431acf03"
      unitRef="usd">9823000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fc3285e99ec41baad3226a8fbb980ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEyLTEtMS0xLTA_05786017-8190-4ed5-8fd7-714d6decf209"
      unitRef="usd">1093000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37289b8d4ace48da862e203e9243e7ff_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEyLTMtMS0xLTA_63476991-2b78-477a-8f6e-f9980eb9b8ff"
      unitRef="usd">1252000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fde0d89a66a4c76a36d9b5839bd1351_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90YWJsZTozYWZhYWIyZThhZDA0ZGQ5YjQwY2MxNzE5MWY4N2Q0Mi90YWJsZXJhbmdlOjNhZmFhYjJlOGFkMDRkZDliNDBjYzE3MTkxZjg3ZDQyXzEyLTUtMS0xLTA_d9d4d320-2c55-405c-a512-1491e90d0739"
      unitRef="usd">1097000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:EmergingMarketsTotalNumberOfCountries
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzI3NDg3NzkwNzQ4OTc_2bb470fd-7685-4400-bdfe-ede9566cca26"
      unitRef="countries">20</bsx:EmergingMarketsTotalNumberOfCountries>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzY3OQ_9919dadc-f36d-4d21-bcbe-52a3e91e89bf"
      unitRef="usd">395000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzY5NQ_cf3bc634-56d4-419c-8bc5-fe0a15671860"
      unitRef="usd">400000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzk1Nw_a8c722eb-0f09-4c54-ba7a-b6ce5d3c7aaa"
      unitRef="usd">135000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDUvZnJhZzowZTJhOWFmNzA1ZTA0YzExOTEyZWU2MDNjOWE1ZGNiYS90ZXh0cmVnaW9uOjBlMmE5YWY3MDVlMDRjMTE5MTJlZTYwM2M5YTVkY2JhXzI3NDg3NzkwNzQwNjE_a26573f3-6e7a-4779-80d5-0390b1be456e"
      unitRef="usd">179000000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90ZXh0cmVnaW9uOmE4YTIwNjY5N2M3MjQ1NDBhMWNjNmQzYWExOGZiZDQ3XzI3NDg3NzkwNzExMjU_da576c3e-3d37-454d-901f-e6153c264386">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE Q &#x2013; CHANGES IN OTHER COMPREHENSIVE INCOME &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further detail on our net investment hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our cash flow hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt; were reduced by immaterial income tax impacts in 2020 and in 2019.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90ZXh0cmVnaW9uOmE4YTIwNjY5N2M3MjQ1NDBhMWNjNmQzYWExOGZiZDQ3XzExMzM_8ed9ae17-e223-443f-8864-1728928d6606">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzEtMS0xLTEtMA_3d76a716-f547-4245-8a00-f5466f67ea24"
      unitRef="usd">142000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzEtMy0xLTEtMA_b62e79bf-4fac-4669-aaa9-8d097300988e"
      unitRef="usd">173000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzEtNy0xLTEtMA_97ff826c-1203-4340-98ab-983f3eb10f51"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzEtOS0xLTEtMA_7c88d6d3-7369-4c8b-b086-274ee92f4b87"
      unitRef="usd">270000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzItMS0xLTEtMA_e1668fd2-f938-4f5a-9581-2d75baf72806"
      unitRef="usd">95000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzItMy0xLTEtMA_9ea8b722-5e0c-4f21-9178-26598b2f0258"
      unitRef="usd">-77000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzItNy0xLTEtMA_f98241fd-d042-4982-9c4a-ac0b364bea3e"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzItOS0xLTEtMA_ecbe7d75-1401-4289-87f4-bc721c6e495e"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzMtMS0xLTEtMA_75e2b8af-5b81-4252-92f8-86e7604b0a05"
      unitRef="usd">-19000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzMtMy0xLTEtMA_fa958f08-46ff-49ad-a67d-7c35cbab0848"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzMtNy0xLTEtMA_8b8c6223-4b4c-4ccc-8433-5db1ad37cf03"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzMtOS0xLTEtMA_93d299cc-4a0b-49d2-aeff-56595bbb8de4"
      unitRef="usd">-76000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzQtMS0xLTEtMA_73143eea-9189-4b5a-a676-f83c8785d484"
      unitRef="usd">76000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzQtMy0xLTEtMA_37f825fe-1c9c-471d-b3dd-71472546ea24"
      unitRef="usd">-137000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzQtNy0xLTEtMA_5ca32564-295f-40d6-b2c3-1d8a57558a5b"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzQtOS0xLTEtMA_6469dfbc-97b3-4788-861f-37ac6c7e3422"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzUtMS0xLTEtMA_4be61140-ab49-4263-8b40-f47d0b0a7e8b"
      unitRef="usd">218000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzUtMy0xLTEtMA_22669e3f-0530-48a3-8598-f87981c156ca"
      unitRef="usd">36000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzUtNy0xLTEtMA_2b8cc5c3-c53f-461f-9bbd-a14fa99a67d4"
      unitRef="usd">47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiNjAwNTAzNWFhZDY0NGM0ODZkNzkzYTQ5MDMxYWQ1MC90YWJsZXJhbmdlOmI2MDA1MDM1YWFkNjQ0YzQ4NmQ3OTNhNDkwMzFhZDUwXzUtOS0xLTEtMA_7a51d0e5-e0f4-4378-bdc9-c4b15ea3cb47"
      unitRef="usd">207000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzEtMS0xLTEtMA_c12802ac-c5f0-4efc-94b6-dc4e766a1c6e"
      unitRef="usd">-53000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzEtMy0xLTEtMA_efc2e8c0-7bc8-4c76-83ae-1eb19ce7f0e9"
      unitRef="usd">111000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzEtNy0xLTEtMA_33ebf835-036b-427f-b8a3-feff529c605a"
      unitRef="usd">25000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzEtOS0xLTEtMA_1b933157-301a-4f28-82e2-0b20b26d066c"
      unitRef="usd">33000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzItMS0xLTEtMA_bae4e84f-4d03-4b31-9f0d-78c76b4060b0"
      unitRef="usd">228000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzItMy0xLTEtMA_5d588fc2-2958-4451-8443-6a0ad30e36e0"
      unitRef="usd">116000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzItNy0xLTEtMA_8d305038-5281-4c21-bf86-4247e60b3677"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzItOS0xLTEtMA_c7791975-f8a5-4f61-a063-c8bc487dcac0"
      unitRef="usd">322000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzMtMS0xLTEtMA_cb7412a0-5f93-4348-ab93-0987cdece41e"
      unitRef="usd">-33000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzMtMy0xLTEtMA_09861514-ed42-4578-be74-645a86e2068e"
      unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzMtNy0xLTEtMA_cb75b559-ce39-4233-af17-8bad0db4a378"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzMtOS0xLTEtMA_c247a5a2-f315-4ecc-a45a-84758b560135"
      unitRef="usd">-86000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzQtMS0xLTEtMA_6f572db0-a7fc-4932-abed-d3857266a752"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzQtMy0xLTEtMA_1cc44725-1ed0-4352-81d0-54aa0521f517"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzQtNy0xLTEtMA_fe429fae-ff8e-4520-ae85-54f55793d428"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzQtOS0xLTEtMA_9b5d487a-84a9-45fa-8542-92589aa45042"
      unitRef="usd">237000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzUtMS0xLTEtMA_6966e522-50ef-45fc-bce8-6c8171efcd92"
      unitRef="usd">142000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzUtMy0xLTEtMA_eca75e9d-286f-46a0-a48a-dd44496e814b"
      unitRef="usd">173000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzUtNy0xLTEtMA_996d1ab7-5956-4ec4-9e34-37d8c0093b9a"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNDgvZnJhZzphOGEyMDY2OTdjNzI0NTQwYTFjYzZkM2FhMThmYmQ0Ny90YWJsZTpiYTQ1OGU2NTI3ZTk0OWU0OGFjN2U3YzUxNmQ5NzI3Yy90YWJsZXJhbmdlOmJhNDU4ZTY1MjdlOTQ5ZTQ4YWM3ZTdjNTE2ZDk3MjdjXzUtOS0xLTEtMA_ae3caa2b-cc7c-4da9-8907-25c72cbeda3d"
      unitRef="usd">270000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <bsx:NewAccountingPronouncementsPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzMxNjI_0d98b92f-5969-4398-b5c3-404629366375">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE R &#x2013; NEW ACCOUNTING PRONOUNCEMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting Standards Implemented Since December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2016-13&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASC Update No. 2016-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Instruments - Credit Losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and recorded a corresponding increase in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a contra &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;account. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-15&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASC Update No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-18&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, the FASB issued ASC Update No. 2018-18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Standards to be Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-10&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2020, the FASB issued ASC Update No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;after December 15, 2020, for public business entities. We plan to adopt Update No. 2020-10 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-06&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASC Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 470-20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 815-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We plan to early adopt Update No. 2020-06 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2019-12 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASC Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The purpose of Update No. 2019-12 is to continue the FASB&#x2019;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods. We plan to adopt Update No. 2019-12 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No other new accounting pronouncements, issued or effective, during the period had, or is expected to have, a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</bsx:NewAccountingPronouncementsPolicyTextBlock>
    <bsx:ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODk_90ee9a96-e47d-4528-84c3-9aa76a9ff78c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2016-13&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASC Update No. 2016-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Instruments - Credit Losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and recorded a corresponding increase in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a contra &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;account. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock>
    <bsx:ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODc_a1cdb237-1bf3-443d-a71f-6f85d723e67e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-15&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASC Update No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock>
    <bsx:ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODg_7f94e7ba-a60f-41c4-8a59-e5e9d676f2c0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-15&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASC Update No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock>
    <bsx:ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODY_c1b88f49-2818-4626-87a4-66326241b90e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-18&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, the FASB issued ASC Update No. 2018-18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock>
    <bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODU_405c9862-551c-478e-9fb1-158859d4be01">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-10&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2020, the FASB issued ASC Update No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning &lt;/span&gt;&lt;/div&gt;after December 15, 2020, for public business entities. We plan to adopt Update No. 2020-10 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.</bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock>
    <bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODQ_fa2f21af-2b2f-432a-9d55-9dfec8ec241c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-06&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASC Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 470-20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 815-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We plan to early adopt Update No. 2020-06 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock>
    <bsx:ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTEvZnJhZzpjYThkN2JiNzgxYmQ0ZmYxOTdiYzRmMDVlZGE3MTAzMC90ZXh0cmVnaW9uOmNhOGQ3YmI3ODFiZDRmZjE5N2JjNGYwNWVkYTcxMDMwXzI3NDg3NzkxMDI4ODM_b2a20c4b-b3b9-4fce-9f31-2d056babe190">ASC Update No. 2019-12 &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASC Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;. The purpose of Update No. 2019-12 is to continue the FASB&#x2019;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods. We plan to adopt Update No. 2019-12 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.</bsx:ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzOTA_8645fae6-59fc-495c-b456-026fb292d974">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE S &#x2013; EMPLOYEE RETIREMENT PLANS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following our 2006 acquisition of Guidant, we assumed the Guidant Supplemental Retirement Plan, a frozen, non-qualified defined benefit plan for certain former officers and employees of Guidant. The Guidant Supplemental Retirement Plan was partially funded through a Rabbi Trust that contains segregated company assets within restricted cash used to pay the benefit obligations related to the plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also maintain an Executive Retirement Plan, a defined benefit plan covering executive officers and division presidents. Participants may retire with benefits once retirement conditions have been satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.K. Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of our acquisition of BTG, we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom (U.K.) employees (U.K. Plan). The U.K. Plan was closed to new entrants as of June 1, 2004. Prior to the acquisition close date of August&#160;19, 2019, the Trustees of the U.K. Plan executed buy-in arrangements (Buy-in Contracts), which effectively, as structured under the Buy-in Contracts, are intended to provide payments designed to equal all future designated contractual benefit payments to covered participants. The benefit obligation of the pension plan is not transferred to the insurers, and we remain responsible for paying pension benefits. We do not anticipate any additional material contributions or payments to the U.K. Plan or the insurer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the final purchase price allocation of BTG, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rate of Compensation Increase&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the measurement date of August&#160;19, 2019, the funded status was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information on our acquisition of BTG.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information about the U.K. Plan presented below are as of the December 31, 2020 and 2019 measurement dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we maintain retirement plans covering certain international employees. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As of December 31, 2020 and 2019, the funded status of our plans were unfunded or underfunded in aggregate. The outstanding obligation is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation (ABO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected&lt;br/&gt;Benefit&lt;br/&gt;Obligation (PBO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded/Underfunded&lt;br/&gt;PBO Recognized&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation (ABO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected&lt;br/&gt;Benefit&lt;br/&gt;Obligation (PBO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded/Underfunded PBO Recognized&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;466&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the PBO for our retirement plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments and assumption changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical assumptions associated with our employee retirement plans for 2020 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Expected Return on Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Rate of Compensation Increase&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical assumptions associated with our employee retirement plans for 2019 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Expected Return on Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Rate of Compensation Increase&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.94%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.65%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our defined benefit plans excluding our U.K. Plan, we base our discount rate on the rates of return available on high-quality bonds with maturities approximating the expected period over which benefits will be paid. The rate of compensation increase is based on historical and expected rate increases. We base our rate of expected return on plan assets on historical experience, our &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investment guidelines and expectations for long-term rates of return. Our assets are invested in a variety of securities, primarily equity securities and government bonds. These securities are considered Level 1 and Level 2 investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our U.K. Plan, we utilize the insurance buy-in methodology and base our discount rate on a yield curve reflective of the market pricing obtained in the most recent buy-in transaction, which occurred prior to the acquisition of BTG, and movements in market-observed buy-in pricing as of December&#160;31, 2020. We believe this is a reasonable proxy for an effective settlement rate of the buy-in assets. The discount rate is calculated as the single equivalent assumption that gives the same value of the liabilities as if the figures were calculated using the full yield curve. We assume that all pension increases will continue to be linked to the Retail Price Inflation (RPI), both before and after retirement, for all members, with the exception of post-88 Guaranteed Minimum Pensions (GMP), which will be based on Consumer Price Inflation (CPI). We base our rate of expected return on plan assets as equal to the discount rate used to value the buy-in assets. The U.K. Plan assets' investment policy is to invest in fully matching assets. This has been achieved through the purchase of two buy-in policies (Buy-in contracts), which provide payments designed to equal all future benefit payments due from the fund. As of December&#160;31, 2020, the Buy-in contracts represented 100% of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. As of December 31, 2019, the Buy-in contracts represented 99 percent of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buy-in contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buy-in contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the U.K. Plan Level 3 assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Buy-in Contracts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out for benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $102 million in 2020, $98 million in 2019 and $87 million in 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzMyOTg1MzQ5MDQwNzg_9a93eed5-1501-4553-99da-0a4ea81e92d2">The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rate of Compensation Increase&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the measurement date of August&#160;19, 2019, the funded status was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical assumptions associated with our employee retirement plans for 2020 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Expected Return on Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Rate of Compensation Increase&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical assumptions associated with our employee retirement plans for 2019 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Expected Return on Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Rate of Compensation Increase&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.94%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.65%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo3OWZkNjdiN2NjZmU0YjkyOTZhNjkzZTBiNTQ5MTRlMi90YWJsZXJhbmdlOjc5ZmQ2N2I3Y2NmZTRiOTI5NmE2OTNlMGI1NDkxNGUyXzEtMS0xLTEtMA_c60dd44c-68a1-4ac2-9ad6-604957e3375d"
      unitRef="number">0.004</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i4c091552d1914709958aece5ac3ec298_D20190819-20190819"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo3OWZkNjdiN2NjZmU0YjkyOTZhNjkzZTBiNTQ5MTRlMi90YWJsZXJhbmdlOjc5ZmQ2N2I3Y2NmZTRiOTI5NmE2OTNlMGI1NDkxNGUyXzEtMy0xLTEtMA_d6a18ae0-233c-4574-9ef6-07d60a09955e"
      unitRef="number">0.004</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo3OWZkNjdiN2NjZmU0YjkyOTZhNjkzZTBiNTQ5MTRlMi90YWJsZXJhbmdlOjc5ZmQ2N2I3Y2NmZTRiOTI5NmE2OTNlMGI1NDkxNGUyXzEtNS0xLTEtMA_a6e2ec02-504b-497b-932b-e3f9eb3bb6f2"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTowZTVhNDljOGIxMGU0MTBjYjc5MTFkMWY3ZWM2ZDFhYy90YWJsZXJhbmdlOjBlNWE0OWM4YjEwZTQxMGNiNzkxMWQxZjdlYzZkMWFjXzEtMS0xLTEtMA_06dc348c-fa13-4ebb-9e99-c74cca027ec1"
      unitRef="usd">213000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTowZTVhNDljOGIxMGU0MTBjYjc5MTFkMWY3ZWM2ZDFhYy90YWJsZXJhbmdlOjBlNWE0OWM4YjEwZTQxMGNiNzkxMWQxZjdlYzZkMWFjXzItMS0xLTEtMA_8d4220af-c8a5-425d-88a2-18ec3bd4ac11"
      unitRef="usd">216000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i0ea851bcbdee439aaad834b99357bd76_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTowZTVhNDljOGIxMGU0MTBjYjc5MTFkMWY3ZWM2ZDFhYy90YWJsZXJhbmdlOjBlNWE0OWM4YjEwZTQxMGNiNzkxMWQxZjdlYzZkMWFjXzMtMS0xLTEtMA_d9d66612-1891-4322-8bcd-95a935482c74"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzY0MTM_35947042-c976-4efd-96a9-a171027985c5">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;.</us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzY0MTQ_559df2db-f42a-4bab-a531-453a5e0f54a8">The outstanding obligation is as follows:&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation (ABO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected&lt;br/&gt;Benefit&lt;br/&gt;Obligation (PBO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded/Underfunded&lt;br/&gt;PBO Recognized&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;506&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation (ABO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Projected&lt;br/&gt;Benefit&lt;br/&gt;Obligation (PBO)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded/Underfunded PBO Recognized&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K. Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other International Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;466&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i4abcf037f5374f05ba7fe5982239ea34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzItMS0xLTEtMA_f7a3ca4a-4870-4e94-ab81-1ce6a3f495f0"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4abcf037f5374f05ba7fe5982239ea34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzItMy0xLTEtMA_e5c6f43d-89f9-433b-a336-b8b8f9637a32"
      unitRef="usd">58000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4abcf037f5374f05ba7fe5982239ea34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzItNS0xLTEtMA_8916e389-7df3-4411-84f4-c4c8131d4ed7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i4abcf037f5374f05ba7fe5982239ea34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzItNy0xLTEtMA_764e7eb3-135e-42a3-ac1a-9f04c73a134d"
      unitRef="usd">58000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzQtMS0xLTEtMA_c2bb4011-6231-464f-9d7d-f095e6c42b98"
      unitRef="usd">226000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzQtMy0xLTEtMA_efa96aad-4c4c-46fa-84b7-212741e7f4ca"
      unitRef="usd">226000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzQtNS0xLTEtMA_018b70d8-2313-4692-b614-eb6d1f958918"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzQtNy0xLTEtMA_36036184-a370-41d7-a643-57c63d347d2c"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="id161c1507c9c4caf9953e4e59e994d83_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzUtMS0xLTEtMA_8bac2404-b071-4b59-8055-d3b6334e6db9"
      unitRef="usd">225000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id161c1507c9c4caf9953e4e59e994d83_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzUtMy0xLTEtMA_5eb432f6-f337-40b3-841a-8189f5913a9a"
      unitRef="usd">247000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id161c1507c9c4caf9953e4e59e994d83_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzUtNS0xLTEtMA_a9769493-c23b-4ff4-ad2d-d6daa4b35ea7"
      unitRef="usd">132000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="id161c1507c9c4caf9953e4e59e994d83_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzUtNy0xLTEtMA_08732aec-edac-4095-b3cd-2cc806806791"
      unitRef="usd">115000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzYtMS0xLTEtMA_18a18c5b-0bae-41fb-bd5a-8b4f2bcf19ee"
      unitRef="usd">506000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzYtMy0xLTEtMA_317b95ee-8bcb-4722-a55a-0bd6f45d190a"
      unitRef="usd">532000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzYtNS0xLTEtMA_7ed1f0a2-204c-439c-8d9a-153d0fa4277b"
      unitRef="usd">355000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTplMDZiZDVjMmMxYTM0ZWY0OGM1MjQ5YmVkNGEzMjgyYi90YWJsZXJhbmdlOmUwNmJkNWMyYzFhMzRlZjQ4YzUyNDliZWQ0YTMyODJiXzYtNy0xLTEtMA_a545c634-cdab-4352-8c67-d6e52eea92a4"
      unitRef="usd">177000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i9302f589d2a941e4a602a1c2a2ab8233_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzItMS0xLTEtMA_503f6cf3-be83-416f-b2ef-4df29ac82587"
      unitRef="usd">50000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i9302f589d2a941e4a602a1c2a2ab8233_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzItMy0xLTEtMA_7203dcf3-83cd-492b-9c8e-2810937d5e0e"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9302f589d2a941e4a602a1c2a2ab8233_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzItNS0xLTEtMA_ba2f2577-0f3d-4094-a6bc-67dd57862c11"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i9302f589d2a941e4a602a1c2a2ab8233_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzItNy0xLTEtMA_a3517034-84cc-4874-bc18-529202a21a2d"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtMS0xLTEtMzE0Nw_2978837b-fb89-4111-a8a4-3911d6092db1"
      unitRef="usd">212000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtMy0xLTEtMzE1MQ_12441159-acb4-43a9-adcf-1a71acf32335"
      unitRef="usd">212000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtNS0xLTEtMzE1NQ_59fa0588-f912-4eda-927b-c797f0ad8f0c"
      unitRef="usd">209000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtNy0xLTEtMzE1OQ_3e2ee3b0-ae15-405f-a218-7fb6e7230aec"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i91d6efe660df47d2bdc670d53b98a6ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtMS0xLTEtMA_5119c36a-ff5e-4041-934d-a279094c9d43"
      unitRef="usd">204000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i91d6efe660df47d2bdc670d53b98a6ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtMy0xLTEtMA_8d2296f1-74b1-4830-8887-a003967ca3f7"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i91d6efe660df47d2bdc670d53b98a6ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtNS0xLTEtMA_ba4ef40d-d2f5-4c9b-abbd-3ef6d095b317"
      unitRef="usd">123000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i91d6efe660df47d2bdc670d53b98a6ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzMtNy0xLTEtMA_0d5a6a23-f722-4f12-a16a-b12cf7a81b8e"
      unitRef="usd">100000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzQtMS0xLTEtMA_741e54eb-23db-459d-a4f2-4b9c5ddce7f6"
      unitRef="usd">466000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzQtMy0xLTEtMA_78af4cea-d385-4c53-8ea3-a098da0de91c"
      unitRef="usd">488000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzQtNS0xLTEtMA_4f85a799-70b6-480a-b259-63cd4b8f2e9c"
      unitRef="usd">332000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTozODVkMTQxNmZjZjg0ODI1YWEwYjI3MDU0ZDg4N2YwOC90YWJsZXJhbmdlOjM4NWQxNDE2ZmNmODQ4MjVhYTBiMjcwNTRkODg3ZjA4XzQtNy0xLTEtMA_6e47d6fe-1e70-441d-b5ba-a577674c7079"
      unitRef="usd">156000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzY0MDc_c316e889-531c-4184-8685-64b08d3b3dc3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the PBO for our retirement plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan amendments and assumption changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzItMS0xLTEtMA_37c37948-e0e8-40d6-af97-9ea7335debb6"
      unitRef="usd">488000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzItMy0xLTEtMA_5525be7d-fb62-4585-8a9f-1bf92a194e1b"
      unitRef="usd">232000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzMtMS0xLTEtMA_b1c87c92-b705-4109-8c11-908ec536e751"
      unitRef="usd">0</bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO>
    <bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzMtMy0xLTEtMA_afe21780-f918-4268-b76e-04480b5c5ca1"
      unitRef="usd">216000000</bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzQtMS0xLTEtMA_47993b14-03a6-4512-8c9d-de4f0e5c5028"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzQtMy0xLTEtMA_a632d374-2a66-4a43-8ce5-b8d3e6a73d4b"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzUtMS0xLTEtMA_2a5749d9-19f1-4924-9a58-8d7876cd0284"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzUtMy0xLTEtMA_aa10b5d5-3462-4f77-ae4a-29e4d8744510"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzYtMS0xLTEtMA_3b2465dc-5f84-45d4-8f10-1e03cd311142"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzYtMy0xLTEtMA_fea2891d-bbc8-4a5c-aae4-c58815003652"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzctMS0xLTEtMA_edfba701-a6c6-4738-9dac-9c76e0b1e4e7"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzctMy0xLTEtMA_e212f991-342d-45c3-929d-07211634822c"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <bsx:Pensionbenefitobligationbenefitspaid
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzgtMS0xLTEtMA_9d9c78ba-bd4e-4dcb-a692-fb605b35b583"
      unitRef="usd">23000000</bsx:Pensionbenefitobligationbenefitspaid>
    <bsx:Pensionbenefitobligationbenefitspaid
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzgtMy0xLTEtMA_4fdcd001-2f39-4cbf-bea1-43d3f5335c27"
      unitRef="usd">10000000</bsx:Pensionbenefitobligationbenefitspaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzktMS0xLTEtMA_db38bf8e-c8e8-4833-81a8-671cd5de2b4f"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzktMy0xLTEtMA_a1160375-4873-4278-a1af-762336479a3e"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzEwLTEtMS0xLTA_a8eef396-1223-4508-9869-539a0fd9cfbe"
      unitRef="usd">532000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo2MzNhZDQzNmI1YWU0YzJmYmY2NjIwMjlkNGQyZGQyMi90YWJsZXJhbmdlOjYzM2FkNDM2YjVhZTRjMmZiZjY2MjAyOWQ0ZDJkZDIyXzEwLTMtMS0xLTA_6277525e-a14b-4d8f-a263-d24a74cca8a9"
      unitRef="usd">488000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i468ac5844c254d30825e2c4ab7683ecc_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzItMS0xLTEtMA_4cacb271-5355-4869-a74e-dfee6cdf74e4"
      unitRef="number">0.0190</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i468ac5844c254d30825e2c4ab7683ecc_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzItOS0xLTEtMA_4fac934d-6b25-4600-8671-b53c7997674d"
      unitRef="number">0.0150</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ib5a830b33ced43cbb812205e0f5ee769_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzMtMS0xLTEtMA_23bfefb4-babb-4001-997f-414ca47cfc12"
      unitRef="number">0.0010</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn
      contextRef="ib5a830b33ced43cbb812205e0f5ee769_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzMtNS0xLTEtMA_11c176a4-5a92-4fa8-a1df-7c468b7097a4"
      unitRef="number">0.0010</bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i20811b5cbd4444aa969fc5a82825adaf_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzQtMS0xLTEtMA_ef45e1b6-70be-4de1-85eb-50898f04d924"
      unitRef="number">0.0067</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn
      contextRef="i20811b5cbd4444aa969fc5a82825adaf_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzQtNS0xLTEtMA_0c0249af-a1a3-4ab5-9eed-ae6671ecb983"
      unitRef="number">0.0198</bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i20811b5cbd4444aa969fc5a82825adaf_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo0ZWNiY2UwZmFjNWI0MjQ1YjAyNjc4MDQ5NTNiN2M2YS90YWJsZXJhbmdlOjRlY2JjZTBmYWM1YjQyNDViMDI2NzgwNDk1M2I3YzZhXzQtOS0xLTEtMA_31d4f542-263a-4139-a4e8-21e7a877e653"
      unitRef="number">0.0240</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ic11f0737ab4b4295aad087680e91578f_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzEtMS0xLTEtMA_8a71818b-73ce-434c-ba29-2e3315522cd6"
      unitRef="number">0.0294</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="ic11f0737ab4b4295aad087680e91578f_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzEtOS0xLTEtMA_52c899b9-7e86-4709-aef6-1c89d0edd5ec"
      unitRef="number">0.0150</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i1a90b04fd34e4f338907045e7245b889_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItMS0xLTEtMzE5Ng_65825c3e-1e2d-4d22-94b5-bc7da0992aa5"
      unitRef="number">0.0060</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn
      contextRef="i1a90b04fd34e4f338907045e7245b889_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItMy0xLTEtMzIwMA_9ed2927e-56f2-4184-a632-1691c157d6fc"
      unitRef="number">0.0060</bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i1a90b04fd34e4f338907045e7245b889_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItNS0xLTEtMzIwNA_4282d8ca-c590-4d00-b756-1c0bacf6d604"
      unitRef="number">0.0300</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i7d72be05fbe64ee489d3b9d9a331d3d6_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItMS0xLTEtMA_4d1e9853-7936-4b45-aa7c-895acf3684aa"
      unitRef="number">0.0075</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn
      contextRef="i7d72be05fbe64ee489d3b9d9a331d3d6_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItNS0xLTEtMA_cc21d60f-f2e2-45da-9ab5-03d85a88a52c"
      unitRef="number">0.0205</bsx:DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i7d72be05fbe64ee489d3b9d9a331d3d6_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpkYzk0OTc5MTE2Y2M0MDE5YTFhOTlhY2NkZTE4ODZjMi90YWJsZXJhbmdlOmRjOTQ5NzkxMTZjYzQwMTlhMWE5OWFjY2RlMTg4NmMyXzItOS0xLTEtMA_d90de9b3-a86b-4bf8-a4c0-07a8f5187702"
      unitRef="number">0.0265</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzY0MTE_a3a47ffa-a989-44e7-b514-e62248508f8a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of the U.K. Plan Level 3 assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Buy-in Contracts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out for benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzItMS0xLTEtMA_0118841b-cd8f-42cd-9605-8dfcfa212100"
      unitRef="usd">332000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzItMy0xLTEtMA_c5da4948-8d0d-421d-8411-5729a4674b13"
      unitRef="usd">107000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzMtMS0xLTEtMA_ee2de3f3-41e5-467d-8689-9072bae4b490"
      unitRef="usd">0</bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets>
    <bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzMtMy0xLTEtMA_210f0fd0-3fcd-4463-88c7-ae31ef8f5e21"
      unitRef="usd">213000000</bsx:DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzQtMS0xLTEtMA_14b624fd-64b0-43fb-9a8f-c3bc17800e57"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzQtMy0xLTEtMA_93623504-c8a7-42a5-b0f9-125e1e89b322"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzUtMS0xLTEtMA_ab7fad45-f5f4-4151-8488-43a5f9c83f3c"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzUtMy0xLTEtMA_118d4420-247a-464f-9dfc-7fd7feea62d8"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzYtMS0xLTEtMA_4fd57131-9bd1-4629-bc1d-1e68b5e5f751"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzYtMy0xLTEtMA_230d91cf-b45c-4538-abc1-d4739357de29"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzctMS0xLTEtMA_03817858-10ca-4115-851f-76baab73c9c8"
      unitRef="usd">14000000</bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss>
    <bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzctMy0xLTEtMA_87f16dc0-e983-4af6-bb7b-3869b200bb6f"
      unitRef="usd">-20000000</bsx:DefinedBenefitPlanPlanAssetsActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzgtMS0xLTEtMA_e4c4837a-d329-4bc2-bf84-be371862db6c"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzgtMy0xLTEtMA_5d617172-dd51-4ea5-93f3-75a55efeb241"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzktMS0xLTEtMA_93620d4e-a960-4e4b-898d-7aa344330c16"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzktMy0xLTEtMA_e7c57e8d-34c3-4f3b-b11b-88aed60ec3f2"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzEwLTEtMS0xLTA_d9ba9f33-8eea-434d-a83d-5b520f76d9a7"
      unitRef="usd">355000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphNjMxODc2YWY0Nzc0NjZmYTI2ZWJkNDY5MTllODI2ZC90YWJsZXJhbmdlOmE2MzE4NzZhZjQ3NzQ2NmZhMjZlYmQ0NjkxOWU4MjZkXzEwLTMtMS0xLTA_bdd24a1f-738a-4f33-bea4-9e4b8b5c8b35"
      unitRef="usd">332000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzMyOTg1MzQ5MDQwNzE_62f620cb-9a70-4a94-8b89-dc32a701cf62">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buy-in contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buy-in contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i476309e0b0a84d4088d447ff4ea0c043_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzMtMS0xLTEtMA_6ee52868-e92f-4192-86b6-f72c68b276ce"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8150f8dd78cd4380a0b054b41ac3d226_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzMtMy0xLTEtMA_f41bff23-240c-4b7b-b685-10b32d76aea4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia98c9174caac457e90096de44db28035_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzMtNS0xLTEtMA_fb1a5b8c-db98-4552-81ab-ec9098b4373e"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i806afaf84c134ea09c7780052e42855b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzMtNy0xLTEtMA_6b1fb143-ea13-48d7-a10f-97f6d3821393"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i82d5d4f9059648dfbe129e24d2e5e76b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzUtMS0xLTEtMA_813d98f5-c1cf-43c3-93b7-5303f6f8dd77"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3f43fb9793c542b6a313df6b768e9fd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzUtMy0xLTEtMA_09b8d284-95b8-4bf7-aadb-1c8ecd8f0eca"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie7307f52ceeb4874b34c64b3b408a83d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzUtNS0xLTEtMA_a566c786-df11-4345-9899-d852f5fb9423"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTpjMDAwNzEwMDVhZDc0ZWQxOTA2MDRlOGExZTIwOTJjZC90YWJsZXJhbmdlOmMwMDA3MTAwNWFkNzRlZDE5MDYwNGU4YTFlMjA5MmNkXzUtNy0xLTEtMA_f2a76635-25e2-49de-937b-dd1a5fd258f4"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i45ca6f37d044456b8c5479fac92d63ad_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzMtMS0xLTEtODc1MQ_b2231c9c-d2d0-4edb-bcd4-7093d7dab79e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6df988ad339147759cbbf0249f88b40d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzMtMy0xLTEtODc1MQ_205647f5-11e0-42ae-b99f-59571bc4643e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if469866c31ea46fd8b925ca78ec9465e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzMtNS0xLTEtODc1MQ_cdaefbb1-22e6-4c88-9410-a87628016896"
      unitRef="usd">207000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i80602948166348f69cd4d27b5dabf946_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzMtNy0xLTEtODc1MQ_7cef9348-682e-44ef-bded-c79953addcb4"
      unitRef="usd">207000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84d6571646ba45d1a7095a0b4e8e4915_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzQtMS0xLTEtODc1MQ_db2ab550-814a-459d-9882-e007bb2f89c1"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3134c9b872744c01ab4bf5c21d4aad7a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzQtMy0xLTEtODc1MQ_a28a8f73-1613-4289-8904-be7be4d1bc60"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7dd96fb2f5114cd4a6958cc13c50db13_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzQtNS0xLTEtODc1MQ_83f3ff6a-7a8e-4791-86ea-ad4197051da1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4c25a08438574b52a9f59623d149abc5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzQtNy0xLTEtODc1MQ_ac3dc40a-e753-48f4-be3a-ca5f94a78d8f"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie05f8aa1e800416d9668e75d159576ed_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzUtMS0xLTEtODc1MQ_fc5118e5-d9f2-4d8c-adea-d4968d445444"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic36697475b27449e8bf5b48595d9608d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzUtMy0xLTEtODc1MQ_96bcfcf4-b06b-4ed9-8e66-6668e3fbeeeb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4f02b4becdb447a6a98b17845a2f0831_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzUtNS0xLTEtODc1MQ_744d316c-96a9-4a79-a7a1-235a40b2e0e4"
      unitRef="usd">207000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTphYWUyOTMyYWZmZTc0ZWZhOWU5NWVjYzlkY2Q4ODYwZS90YWJsZXJhbmdlOmFhZTI5MzJhZmZlNzRlZmE5ZTk1ZWNjOWRjZDg4NjBlXzUtNy0xLTEtODc1MQ_aa741f7b-8324-4506-9ec0-a56566dbd73e"
      unitRef="usd">209000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic0b571ab922c429c9d165e755ab1c084_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzgtMS0xLTEtMA_3aee6df9-280a-4a3d-a6c6-1e01de149e33"
      unitRef="usd">209000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzktMS0xLTEtMA_4dc332fe-f022-461d-84ae-2671f1fc5849"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzMtMS0xLTEtMjM3NjM_fc18adb7-9763-4619-a7d3-1305f7317851"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzExLTEtMS0xLTA_dc87b74b-a2dc-423c-a76f-0d2cc12dcfc5"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="iae80f466b54e4815ba216462c93cb5b2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzEyLTEtMS0xLTA_1fbc2991-9807-48b6-92d2-c9f65f789319"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i707eebe909d64c8ca658b4340f67d9de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90YWJsZTo5MGI1YzYxMGVhMWI0N2I4YjhiZTkwMTc4YjI2ZjU5ZC90YWJsZXJhbmdlOjkwYjVjNjEwZWExYjQ3YjhiOGJlOTAxNzhiMjZmNTlkXzEzLTEtMS0xLTA_426f5f54-774a-4b30-a7cc-1222f03986b5"
      unitRef="usd">223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzODM_bfaa60f2-ab73-4367-ad5f-423c3bdaa087">We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $102 million in 2020, $98 million in 2019 and $87 million in 2018.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <bsx:ExpenseRelatedToMatchingContributions
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzNDk_4236c7d0-920a-4607-aee3-829d99c82bf8"
      unitRef="usd">102000000</bsx:ExpenseRelatedToMatchingContributions>
    <bsx:ExpenseRelatedToMatchingContributions
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzNTk_73f1555b-6362-482b-8eac-1a72ad95e9bc"
      unitRef="usd">98000000</bsx:ExpenseRelatedToMatchingContributions>
    <bsx:ExpenseRelatedToMatchingContributions
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xNTcvZnJhZzo1M2Y0YTQyZjBlODI0ODliYTRjYzY1MmI2YmE5ZDM2MS90ZXh0cmVnaW9uOjUzZjRhNDJmMGU4MjQ4OWJhNGNjNjUyYjZiYTlkMzYxXzYzNzI_02d97b98-40fa-4291-8c22-e40491dfb830"
      unitRef="usd">87000000</bsx:ExpenseRelatedToMatchingContributions>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90ZXh0cmVnaW9uOjdjNmUwM2EyN2VmNTQwYTc5OGQ2MDI4Y2Y4MzVmNDU4XzY2NQ_c156be67-a394-4ac2-b45b-d665cc91e1b3">&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt; Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cumulative effect adjustment for adoption of ASU 2016-13 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Credit loss exposure (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Write-offs (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Charges to&lt;br/&gt;(Deductions from)&lt;br/&gt;Other Accounts (d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses (b)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Allowances for uncollectible accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Allowances for uncollectible accounts (e)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:20pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&#160;Following the adoption of FASB ASC Topic 326 as of January 1, 2020, we record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and recorded a corresponding increase in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a contra &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; account. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Amounts shown within credit loss exposure above were established through selling, general and administrative expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&#160;Beginning in 2020, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for uncollectible accounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; are referred to as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&#160;Represents actual write-offs of uncollectible accounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&#160;Represents net change in allowances for sales returns, recorded as contra-revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(e)&#160;Following the adoption of FASB ASC Topic 606 as of January 1, 2018, the allowance for sales returns has been reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within the consolidated balance sheets and is not included in the ending balance for 2018 above. Prior period balances remain unchanged.&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItMi0xLTEtMA_a1599508-5286-46bc-9f01-abe885454433"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItNC0xLTEtODMyMQ_2310ac2d-db03-4931-9626-74c35c793a50"
      unitRef="usd">10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItNC0xLTEtMA_2c256f9e-b035-4689-b9ce-679b2a8ecf19"
      unitRef="usd">49000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItNi0xLTEtMA_ae78b64c-65be-4d9d-af13-61189fd17f49"
      unitRef="usd">27000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="if99852c5f50d49489e7b7697112a652a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItOC0xLTEtMA_fafbb40d-c8ce-4c23-8bca-2f518806c441"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ia2522ce480044b738970a71b97a2834e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzItMTAtMS0xLTA_4f85ed9b-0554-4a93-8920-817897b11a1f"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtMi0xLTEtMA_d6a5c5a5-cf1d-4321-8757-790bf55bad9c"
      unitRef="usd">68000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtNC0xLTEtMA_1a12938a-4b5b-4b75-bb27-982c308e4d14"
      unitRef="usd">23000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtNi0xLTEtMA_2a0022ed-85c3-4d5d-8550-43ca656c9072"
      unitRef="usd">17000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtOC0xLTEtMA_68bc68c4-9335-41eb-8496-85a65169b243"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic3a4c1a262e0442388a415c87e27e889_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzQtMTAtMS0xLTA_8bce5654-4cef-4742-ad3a-b92965c01591"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0a695a97d72f47aaae3df04c71e8be50_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtMi0xLTEtMA_121d58a0-b884-4d13-9315-e073007f1a6e"
      unitRef="usd">98000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtNC0xLTEtMA_f53142a7-f55f-40f1-8d6d-13cb1602bb89"
      unitRef="usd">19000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtNi0xLTEtMA_da8e3284-0521-42cf-a5f4-2c0b5c460d67"
      unitRef="usd">19000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtOC0xLTEtMA_a81ac5f1-4610-443f-b0c1-d2bf7397418c"
      unitRef="usd">-30000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="if8e21581818b44be817499b63aaaddd8_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjVjM2U4ZDY5ZmNjMTQ2MGJhZGRkZTYyY2ZhMDIyNDg3L3NlYzo1YzNlOGQ2OWZjYzE0NjBiYWRkZGU2MmNmYTAyMjQ4N18xOTkvZnJhZzo3YzZlMDNhMjdlZjU0MGE3OThkNjAyOGNmODM1ZjQ1OC90YWJsZToyYTNlMGU3NDQwYTA0OTNmODAzNTM3ZmNkZDMzZTM2Ny90YWJsZXJhbmdlOjJhM2UwZTc0NDBhMDQ5M2Y4MDM1MzdmY2RkMzNlMzY3XzYtMTAtMS0xLTA_495df725-b24b-4c57-a87c-c3062ee9c754"
      unitRef="usd">68000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544240936120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 29, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Listing, Par Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,417,165,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544322165960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 9,913<span></span>
</td>
<td class="nump">$ 10,735<span></span>
</td>
<td class="nump">$ 9,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">3,465<span></span>
</td>
<td class="nump">3,116<span></span>
</td>
<td class="nump">2,813<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">6,448<span></span>
</td>
<td class="nump">7,620<span></span>
</td>
<td class="nump">7,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">3,787<span></span>
</td>
<td class="nump">3,941<span></span>
</td>
<td class="nump">3,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expenses</a></td>
<td class="nump">1,143<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
<td class="nump">1,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">789<span></span>
</td>
<td class="nump">699<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring net charges (credits)</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation-related net charges (credits)</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">6,528<span></span>
</td>
<td class="nump">6,102<span></span>
</td>
<td class="nump">5,504<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(80)<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
<td class="nump">1,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(361)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(241)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">362<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(79)<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">1,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(4,013)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(82)<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="nump">1,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Preferred stock dividends</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) available to common stockholders</a></td>
<td class="num">$ (115)<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="nump">$ 1,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per common share &#8212; basic</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ 3.38<span></span>
</td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per common share &#8212; assuming dilution</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="nump">$ 1.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">1,416,700<span></span>
</td>
<td class="nump">1,391,500<span></span>
</td>
<td class="nump">1,381,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Assuming dilution</a></td>
<td class="nump">1,416,700<span></span>
</td>
<td class="nump">1,410,600<span></span>
</td>
<td class="nump">1,401,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544235402504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (82)<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="nump">$ 1,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="num">(137)<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Defined benefit pensions and other items</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(63)<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="num">$ (145)<span></span>
</td>
<td class="nump">$ 4,937<span></span>
</td>
<td class="nump">$ 1,761<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544240899608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,734<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,531<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,351<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">751<span></span>
</td>
<td class="nump">880<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,694<span></span>
</td>
<td class="nump">4,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,084<span></span>
</td>
<td class="nump">2,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,951<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">5,917<span></span>
</td>
<td class="nump">7,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">4,210<span></span>
</td>
<td class="nump">4,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">30,777<span></span>
</td>
<td class="nump">30,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">1,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,197<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">958<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,681<span></span>
</td>
<td class="nump">4,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">9,130<span></span>
</td>
<td class="nump">8,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,309<span></span>
</td>
<td class="nump">2,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of December 31, 2020 and none as of December 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - authorized 2,000,000,000 shares; issued 1,679,911,918 shares as of December 31, 2020 and 1,642,488,911 shares as of December 31, 2019</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 263,289,848 shares as of December 31, 2020 and 247,566,270 shares as of December 31, 2019</a></td>
<td class="num">(2,251)<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">19,732<span></span>
</td>
<td class="nump">17,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,378)<span></span>
</td>
<td class="num">(2,253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Unrealized gain (loss) on derivative financial instruments</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Unrealized costs associated with defined benefit pensions and other items</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">15,326<span></span>
</td>
<td class="nump">13,877<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 30,777<span></span>
</td>
<td class="nump">$ 30,565<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544237653320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Paranthetical - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ConsolidatedBalanceSheetParentheticalAbstract', window );"><strong>Consolidated Balance Sheet (Parenthetical) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,679,911,918<span></span>
</td>
<td class="nump">1,642,488,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">263,289,848<span></span>
</td>
<td class="nump">247,566,270<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ConsolidatedBalanceSheetParentheticalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consolidated Balance Sheet (Parenthetical)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ConsolidatedBalanceSheetParentheticalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544237723288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (1,717)<span></span>
</td>
<td class="nump">$ 17,161<span></span>
</td>
<td class="num">$ (8,390)<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,621,062,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeEffectOfNewAccountingPrinciples', window );">Cumulative Effect Of New Accounting Principles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Defined benefit pensions and other items</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,085,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,346<span></span>
</td>
<td class="num">(6,953)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,632,148,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Defined benefit pensions and other items</a></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,340,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2019</a></td>
<td class="nump">13,877<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,561<span></span>
</td>
<td class="num">(2,253)<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,642,488,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASC 2016-13</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="num">(137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Defined benefit pensions and other items</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock Issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock', window );">Preferred stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock', window );">Common stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issuance (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">29,382,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,040,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 15,326<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">$ (2,251)<span></span>
</td>
<td class="nump">$ 19,732<span></span>
</td>
<td class="num">$ (2,378)<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,679,911,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeEffectOfNewAccountingPrinciples">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Effect Of New Accounting Principles</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeEffectOfNewAccountingPrinciples</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues (Common stock)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues (Preferred stock)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121321822&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121323062&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544242042920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (82,000,000)<span></span>
</td>
<td class="nump">$ 4,700,000,000<span></span>
</td>
<td class="nump">$ 1,671,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale of businesses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,123,000,000<span></span>
</td>
<td class="nump">1,011,000,000<span></span>
</td>
<td class="nump">894,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit', window );">Deferred and prepaid income taxes</a></td>
<td class="num">(82,000,000)<span></span>
</td>
<td class="num">(4,301,000,000)<span></span>
</td>
<td class="num">(87,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">170,000,000<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
<td class="nump">140,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Goodwill and other intangible asset impairment charges</a></td>
<td class="nump">533,000,000<span></span>
</td>
<td class="nump">105,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net loss (gain) on investments and notes receivable</a></td>
<td class="num">(398,000,000)<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="num">(155,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">(100,000,000)<span></span>
</td>
<td class="num">(35,000,000)<span></span>
</td>
<td class="num">(21,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_InventoryStepUpAmortization', window );">Inventory step-up amortization</a></td>
<td class="nump">58,000,000<span></span>
</td>
<td class="nump">46,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetCurrencyExchangeGainLoss', window );">Foreign exchange (gain) loss</a></td>
<td class="nump">32,000,000<span></span>
</td>
<td class="nump">358,000,000<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherNet', window );">Other, net</a></td>
<td class="nump">213,000,000<span></span>
</td>
<td class="nump">63,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="nump">335,000,000<span></span>
</td>
<td class="num">(130,000,000)<span></span>
</td>
<td class="num">(110,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(65,000,000)<span></span>
</td>
<td class="num">(290,000,000)<span></span>
</td>
<td class="num">(83,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(200,000,000)<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="num">(172,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">88,000,000<span></span>
</td>
<td class="nump">105,000,000<span></span>
</td>
<td class="num">(640,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(116,000,000)<span></span>
</td>
<td class="num">(18,000,000)<span></span>
</td>
<td class="num">(1,164,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash provided by (used for) operating activities</a></td>
<td class="nump">1,508,000,000<span></span>
</td>
<td class="nump">1,836,000,000<span></span>
</td>
<td class="nump">310,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(376,000,000)<span></span>
</td>
<td class="num">(461,000,000)<span></span>
</td>
<td class="num">(316,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds on disposals of property, plant and equipment</a></td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(4,382,000,000)<span></span>
</td>
<td class="num">(1,448,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of certain businesses</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">87,000,000<span></span>
</td>
<td class="nump">52,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Payments for settlements of hedge contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(199,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Payments for investments and acquisitions of certain technologies</a></td>
<td class="num">(146,000,000)<span></span>
</td>
<td class="num">(149,000,000)<span></span>
</td>
<td class="num">(172,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash provided by (used for) investing activities</a></td>
<td class="num">(411,000,000)<span></span>
</td>
<td class="num">(5,041,000,000)<span></span>
</td>
<td class="num">(1,921,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration previously established in purchase accounting</a></td>
<td class="num">(49,000,000)<span></span>
</td>
<td class="num">(66,000,000)<span></span>
</td>
<td class="num">(19,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentsForRoyaltyRights', window );">Payments for royalty rights</a></td>
<td class="num">(97,000,000)<span></span>
</td>
<td class="num">(69,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">256,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Payments on short-term borrowings</a></td>
<td class="num">(2,950,000,000)<span></span>
</td>
<td class="num">(1,000,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings, net of debt issuance costs</a></td>
<td class="nump">2,245,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
<td class="nump">999,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Net increase (decrease) in commercial paper</a></td>
<td class="num">(714,000,000)<span></span>
</td>
<td class="num">(575,000,000)<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Payments on borrowings from credit facilities</a></td>
<td class="num">(1,919,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(569,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from borrowings on credit facilities</a></td>
<td class="nump">1,916,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">569,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments on long-term borrowings and debt extinguishment costs</a></td>
<td class="num">(1,260,000,000)<span></span>
</td>
<td class="num">(3,560,000,000)<span></span>
</td>
<td class="num">(602,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from long-term borrowings, net of debt issuance costs</a></td>
<td class="nump">1,683,000,000<span></span>
</td>
<td class="nump">7,229,000,000<span></span>
</td>
<td class="nump">987,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid on preferred stock</a></td>
<td class="num">(28,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="nump">975,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock in connection with public offering</a></td>
<td class="nump">975,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="num">(535,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Paymenttonetsharesettleemployeeequityawards', window );">Cash used to net share settle employee equity awards</a></td>
<td class="num">(59,000,000)<span></span>
</td>
<td class="num">(65,000,000)<span></span>
</td>
<td class="num">(56,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans</a></td>
<td class="nump">111,000,000<span></span>
</td>
<td class="nump">123,000,000<span></span>
</td>
<td class="nump">101,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash provided by (used for) financing activities</a></td>
<td class="nump">293,000,000<span></span>
</td>
<td class="nump">2,973,000,000<span></span>
</td>
<td class="nump">1,432,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash</a></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">1,388,000,000<span></span>
</td>
<td class="num">(222,000,000)<span></span>
</td>
<td class="num">(188,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</a></td>
<td class="nump">607,000,000<span></span>
</td>
<td class="nump">829,000,000<span></span>
</td>
<td class="nump">1,017,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</a></td>
<td class="nump">1,995,000,000<span></span>
</td>
<td class="nump">607,000,000<span></span>
</td>
<td class="nump">829,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash (received) paid for income taxes, net</a></td>
<td class="nump">207,000,000<span></span>
</td>
<td class="nump">242,000,000<span></span>
</td>
<td class="nump">1,037,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">359,000,000<span></span>
</td>
<td class="nump">449,000,000<span></span>
</td>
<td class="nump">262,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair value of contingent consideration recorded in purchase accounting</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="nump">248,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NonCashImpactOfTransferredRoyaltyRights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">$ (87,000,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash flow impact of deferred income tax expense (benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_InventoryStepUpAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory Step Up Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_InventoryStepUpAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NetCurrencyExchangeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NetCurrencyExchangeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NonCashImpactOfTransferredRoyaltyRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NonCashImpactOfTransferredRoyaltyRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentsForRoyaltyRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentsForRoyaltyRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Paymenttonetsharesettleemployeeequityawards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment to net share settle employee equity awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Paymenttonetsharesettleemployeeequityawards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from secured borrowings relating to royalty arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544235353832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,734,000,000<span></span>
</td>
<td class="nump">$ 217,000,000<span></span>
</td>
<td class="nump">$ 146,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets</a></td>
<td class="nump">208,000,000<span></span>
</td>
<td class="nump">346,000,000<span></span>
</td>
<td class="nump">655,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">52,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="nump">27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">$ 1,995,000,000<span></span>
</td>
<td class="nump">$ 607,000,000<span></span>
</td>
<td class="nump">$ 829,000,000<span></span>
</td>
<td class="nump">$ 1,017,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233547480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; SIGNIFICANT ACCOUNTING POLICIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#8217;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2020, 2019 or 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report for further discussion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash Equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets are related to deferred compensation plans. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We write-off amounts determined to be uncollectible against this reserve. Write-offs of uncollectible accounts receivable were immaterial in 2020, 2019 and 2018. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2020, 2019 and 2018; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes toward non-hospital settings, particularly ambulatory surgery centers, driven by considerations surrounding costs, reimbursement policies, advances in minimally invasive treatments and remote patient monitoring. We have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers. Many of these customers are smaller than those we have historically done business with and may have limited liquidity. While certain ambulatory surgery centers are performing an increasing number of procedures in response to the COVID-19 pandemic, others have been negatively impacted by COVID-19 restrictions and mitigation measures. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is adequate as of December&#160;31, 2020 and 2019; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a contract with a customer that creates enforceable rights and obligations,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Promised products or services are identified,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The transaction price, or the amount we expect to receive, is determinable and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have transferred control of the promised items to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management product offerings combine the sale of a device with our LATITUDE&#8482; Patient Management System, within our Cardiac Rhythm Management (CRM) business, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Implant Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide non-contractual services to customers to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services at the time the devices are sold. We record these costs to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During the year ended December 31, 2020, we recorded $149&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2019 or 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Business Combinations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In those circumstances where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration net expense (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived Intangibles and IPR&amp;D </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which is foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, and IPR&amp;D intangible assets acquired in a business combination. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;D intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the income approach to determine the fair values of our IPR&amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#8217; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to indefinite-lived intangibles, including IPR&amp;D.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization and Impairment of Intangible Assets </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to impairments of intangible assets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Valuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2020 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the second quarter of&#160;2020, we performed our annual goodwill impairment test utilizing the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $800 million, subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. We acquired our Specialty Pharmaceuticals business in conjunction with the BTG acquisition on August 19, 2019. In connection with the execution of a definitive agreement to sell the disposal group for a specified amount, we performed an impairment assessment of our goodwill and intangible assets, which resulted in a goodwill impairment of $73 million. As of December 31, 2020, we classified the remaining assets and liabilities of the disposal group as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less cost to sell. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements for additional details related to our goodwill balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Publicly Traded and Privately Held Entities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any, observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities over which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investments - Equity Method and Joint Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">, Investments - Debt and Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for additional details on our investment balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#8217;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is impaired and we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses and impairments associated with our investment portfolio are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Product Liability Costs </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities litigation and product liability suits. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue our best estimate of the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of our individual material legal proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record employee termination costs in accordance with FASB ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. We record such costs into expense over the employee&#8217;s future service period, if any. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information and discussion of our restructuring plans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currency</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency transaction gains and losses are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on our hedging instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not bill customers for shipping and handling of our products. We treat shipping and handling costs incurred after a customer obtains control of the good as a fulfillment cost and record in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated statements of operations. Shipping and handling costs were $146 million in 2020, $144 million in 2019 and $124 million in 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development (R&amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Indefinite-lived Intangibles and IPR&amp;D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for our policy regarding R&amp;D projects acquired in connection with our business combinations and asset purchases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234765528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND STRATEGIC INVESTMENTS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS AND STRATEGIC INVESTMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We did not complete any material acquisitions during 2020. We have not presented supplemental pro forma financial information for prior acquisitions given their results are not material to our consolidated financial statements. Transaction costs for all acquisitions completed during 2020, 2019 and 2018 were immaterial to our consolidated financial statements and were expensed as incurred. In 2020, we recorded immaterial purchase price adjustments during the measurement period for the preliminary purchase price allocations associated with prior acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 21, 2021, we announced our entrance into a definitive agreement to acquire Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. We have been an investor in Preventice since 2015 and currently hold an equity stake of approximately 22 percent. The transaction price to acquire the remaining stake is expected to result in a net cash payment of approximately $720 million upon closing and up to an additional $230 million payment upon achievement of a commercial milestone. The acquisition is expected to close during the first half of 2021, subject to customary </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">closing conditions. Following the closing of the acquisition, the Preventice business will be managed by our Cardiac Rhythm Management division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">BTG plc</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;19, 2019, we announced the closing of our acquisition of BTG plc (BTG), a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we integrated BTG's Interventional Medicine business into our Peripheral Interventions division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Interventional Medicine product lines, the BTG portfolio also included a specialty pharmaceutical business (Specialty Pharmaceuticals) comprised of acute care antidotes to treat overexposure to certain medications and toxins. On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $800 million , subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The BTG portfolio further included a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. In connection with the acquisition, we acquired rights to future royalties associated with the Zytiga&#8482; Drug used to treat certain forms of prostate cancer. In the fourth quarter of 2019, we sold our rights to these royalties for $256 million in cash, included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights transfer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of cash flows. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price for the acquisition of BTG consisted of upfront cash in the aggregate amount of &#163;3.312 billion (or $4.023 billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received 840 pence (or $10.20 based on the exchange rate at closing) in cash for each BTG share. The transaction price included $404 million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,&#160;Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,785</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized goodwill of $1.635 billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. We allocated $1.399 billion to our Peripheral Interventions reporting unit and $236 million to the Specialty Pharmaceuticals reporting unit. In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $73 million related to our Specialty Pharmaceuticals business. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction with Varian Medical Systems, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2019, we completed the sale of our drug-eluting and bland embolic microsphere portfolio to Varian Medical Systems, Inc. (Varian) in connection with our acquisition of BTG. The transaction price consisted of an upfront cash payment of $90 million, a portion of which is allocated to the fair value of the services to be rendered under the Transition Services Agreement and Transition Manufacturing Agreement entered into with Varian as part of this transaction. Additionally, we transferred certain contingent consideration arrangements arising from our initial acquisition of the portfolio to Varian and agreed to indemnify Varian for any payments ultimately arising under the terms of the contingent consideration arrangement. Accordingly, as part of the disposal, we recorded a liability of $16 million to recognize the fair value of this guarantee based on our potential obligation resulting from the indemnifications. The maximum amount payable under this guarantee is $200 million in accordance with FASB ASC Topic 460, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is consistent with the contingent consideration arrangement executed with our initial acquisition of the portfolio in accordance with FASB ASC Topic 805.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vertiflex, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 11, 2019, we announced the closing of our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#8482; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $465 million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of zero to $100 million; however, the payments are uncapped over the three year earn-out period. Through December&#160;31, 2020, we have made incremental payments of $20 million to the prior shareholders of Vertiflex in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Millipede, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we announced the closing of our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $90 million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately 20 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $325 million and up to an additional $125 million payment upon achievement of a commercial milestone. Through December&#160;31, 2020, we have not made any incremental payments to the prior shareholders of Millipede, as the commercial milestone has not yet been achieved. Following the closing of the acquisition, we integrated the Millipede business into our Interventional Cardiology division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Augmenix, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 16, 2018, we announced the closing of our acquisition of Augmenix, Inc. (Augmenix), a privately-held company that developed and commercialized the SpaceOAR&#8482; Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer. The transaction price consisted of an upfront cash payment of $500 million and up to $100 million in payments contingent upon achieving certain revenue-based milestones. Through December&#160;31, 2020, we made incremental payments of $24 million to the prior shareholders of Augmenix in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the Augmenix business into our Urology and Pelvic Health division.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Claret Medical, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2018, we announced the closing of our acquisition of Claret Medical, Inc. (Claret), a privately-held company that has developed and commercialized the Sentinel&#8482; Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter aortic valve replacement (TAVR). The transaction price consisted of an upfront cash payment of $220 million and an additional $50 million payment for achieving a reimbursement-based milestone that was achieved in the third quarter of 2018. Following the closing of the acquisition, we integrated the Claret business into our Interventional Cardiology division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Cryterion Medical, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2018, we announced the closing of our acquisition of Cryterion Medical, Inc. (Cryterion), a privately-held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation. We had been an investor in Cryterion since 2016 and held an interest of approximately 35 percent immediately prior to the acquisition date. The transaction price to acquire the remaining stake consisted of an upfront cash payment of $202 million. Following the closing of the acquisition, we integrated the Cryterion business into our Electrophysiology division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NxThera, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2018, we announced the closing of our acquisition of NxThera, Inc. (NxThera), a privately-held company that developed the Rez&#363;m&#8482; System, a minimally invasive therapy in a growing category of treatment options for patients with benign prostatic hyperplasia (BPH). We held a minority interest immediately prior to the acquisition date. The transaction price to acquire the remaining stake consisted of an upfront cash payment of approximately $240 million and up to approximately $85 million in future potential payments contingent upon achieving commercial milestones over the four years following the date of acquisition. Through December&#160;31, 2020, we have made incremental payments of $12 million to the prior shareholders of NxThera in accordance with the terms of the agreement. Following the closing of the acquisition, we integrated the NxThera business into our Urology and Pelvic Health division.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">nVision Medical Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2018, we announced the closing of our acquisition of nVision Medical Corporation (nVision), a privately-held company focused on women&#8217;s health. nVision developed the first and only device cleared by the U.S. Food and Drug Administration (FDA) to collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer. The transaction price consisted of an upfront cash payment of $150 million and up to an additional $125 million in future potential payments contingent upon achieving certain clinical and commercial milestones over the four years following the date of acquisition. Following the closing of the acquisition, we integrated the nVision business into our Urology and Pelvic Health division. We discontinued the nVision R&amp;D program during 2020 and do not expect to make any incremental payments to the prior shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we completed other individually immaterial acquisitions in 2018 for total consideration of $158 million in cash at closing plus aggregate future potential contingent consideration of up to $62 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded gains of $184 million in 2018 within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated statements of operations based on the difference between the book values and the fair values of our previously-held investments immediately prior to the acquisition dates. The aggregate fair value of our previously-held investments immediately prior to the acquisition dates was $251 million. We remeasured the fair value of each previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for our 2018 acquisitions as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,948</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,948</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies. The goodwill recorded relating to our acquisitions is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $532 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $100 million benefit recorded in 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or in the case of nVision, for milestones that would not be achieved due to discontinuation of the R&amp;D program.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$104 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$93 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to our R&amp;D, commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">458</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we recorded a $363 million gain on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span> to remeasure to fair value based on observable market prices. As of December&#160;31, 2020, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $272 million, which represents amortizable intangible assets, IPR&amp;D, goodwill and deferred tax liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544240904024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets and Liabilities Held for Sale<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">ASSETS AND LIABILITIES HELD FOR SALE</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; ASSETS AND LIABILITIES HELD FOR SALE</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of $800 million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement includes the transfer of five facilities and approximately 280 employees globally. The transaction is expected to close during the first half of 2021, subject to customary closing conditions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we have classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less costs to sell. Assets within the disposal group are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated balance sheets. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other current liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of December 31, 2020, we had foreign currency translation adjustments of $107 million contained within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span> attributable to the Specialty Pharmaceuticals business to be released upon the closing of the transaction.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234941464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows: </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Goodwill Impairment Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Goodwill Impairment Charges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,195)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,973)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">377</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">782</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2020, following receipt of regulatory approvals, we reclassified certain of our IPR&amp;D intangible assets to amortizable technology-related assets and began amortization to reflect their use over their remaining lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $460 million in 2020, $105 million in 2019 and $35 million in 2018. The impairment charges recorded in 2020 were primarily associated with our acquisitions of Apama Medical Inc. and nVision Medical Corporation (nVision) following management&#8217;s decision to cancel the programs due to cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2020 also included charges related to our acquisition of Sadra Medical, Inc. (Sadra Medical) as a result of lower sales forecasts, as well as the cost of quality remediation efforts following the voluntary recall of our LOTUS Edge&#8482; Aortic Valve System and subsequent discontinuation of the LOTUS platform. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,063</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,911</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill divested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill reclassified to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current assets held for sale</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,059</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $73 million related to our Specialty Pharmaceuticals business. We did not record any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2019 or 2018. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of our goodwill and intangible asset impairment testing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2020 is as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:83.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.127%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544338286264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Euro, Japanese yen, Chinese renminbi, Australian dollar and British pound sterling. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast, particularly resulting from the impact of COVID-19 on transaction volumes. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro, Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. We elected to use the spot method to assess effectiveness for our derivatives that are designated as net investment hedges. Under the spot method, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have elected to exclude the spot-forward difference from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. Amortization of the spot-forward difference is then reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to current period earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. We dedesignated a portion of the net investment hedge in 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In 2019, we settled all outstanding contracts, for $294 million, which is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for settlements of hedge contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of cash flows. Upon settlement in 2019, we received &#163;3.312 billion of cash to fund our acquisition of BTG, which translated into $4.303 billion based on hedged currency exchange rates. We recognized a $323 million loss in 2019 and a $29 million gain in 2018 in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to changes in fair value of the contracts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of December&#160;31, 2020 and December&#160;31, 2019. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we designate outstanding interest rate derivative instruments as cash flow hedges we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $29 million loss as of December&#160;31, 2020 and a $34 million loss as of December&#160;31, 2019. We recognized immaterial gains and losses in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of our terminated cash flow hedges in the current and prior periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as fair value hedges outstanding as of December&#160;31, 2020 and December&#160;31, 2019. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets into earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which generally offset. The balance of the deferred gains on our terminated fair value hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was immaterial as of December&#160;31, 2020 and December&#160;31, 2019. We recognized immaterial gains in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of the terminated fair value hedges in the current and prior periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8364;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of December&#160;31, 2020 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next two years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note Q &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:30.564%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.727%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:41.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.129%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.035%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.559%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The &#8364;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:31.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,998</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $1.584 billion invested in money market funds and time deposits as of December&#160;31, 2020 and $50 million as of December&#160;31, 2019, we held $150 million in interest-bearing and non-interest-bearing bank accounts as of December&#160;31, 2020 and $165 million as of December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, principally the contractual right to receive future royalty payments related to Zytiga&#8482; Drug acquired with BTG. Prior to our acquisition of BTG, BTG agreed to pay 50 percent of the Zytiga royalty stream, net of certain offsets, to the inventors associated with the intellectual property. In the fourth quarter of 2019, we sold the remaining 50 percent we acquired through our acquisition with BTG of the future Zytiga royalty stream for an upfront cash payment of $256 million to the Ontario Municipal Employees Retirement System (OMERS). In accordance with FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we are accounting for the transfer of the royalty stream to OMERS as a secured borrowing, continue to recognize the financial asset and associated liability in our consolidated balance sheets and do not expect to receive any future cash benefit from Zytiga royalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected the fair value option to account for our licensing arrangements' financial asset and financial liability in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have recorded the fair values using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2020 include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$365 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$407 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of December&#160;31, 2020. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains or losses from the licensing arrangement.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">571</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $10.774 billion as of December&#160;31, 2020, including $1.118 billion relating to the euro-denominated December 2027 Notes, and $11.020 billion as of December&#160;31, 2019, including $1.004 billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233588632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $9.143 billion as of December&#160;31, 2020 and $10.008 billion as of December&#160;31, 2019, with current maturities of $13 million as of December&#160;31, 2020 and $1.416 billion as of December&#160;31, 2019. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022 Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,592</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which was a variable-rate instrument based on LIBOR.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a $2.750 billion revolving credit facility (Revolving Credit Facility) with a global syndicate of commercial banks that matures on December 19, 2023 with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. The credit agreement requires that we comply with certain covenants, including a financial covenant described within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility. In April 2020, we entered into the April 2021 Term Loan, described below, and used the proceeds to repay a portion of the amounts outstanding under the Revolving Credit Facility. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. In May 2020, we completed our senior notes offering described below and used a portion of the proceeds to repay $450 million outstanding under the Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of December&#160;31, 2020 or December&#160;31, 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $1.250 billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $500 million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our MCPS and common stock offerings to repay in full the remaining $750 million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, we entered into a $1.000 billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding on the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of 0.85%. The credit agreement is subject to a financial covenant described below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $750 million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $250 million and terminated the February 2021 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, we entered into a $700 million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December&#160;31, 2019, we had $700 million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $300 million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2018, we entered into a $2.000 billion senior unsecured delayed-draw term loan facility consisting of a $1.000 billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $1.000 billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August 19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $1.000 billion under the Two-Year Delayed Draw Term Loan and $1.000 billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, the December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $1.000 billion outstanding under the Three-Year Delayed Draw Term Loan (also referred to as the "August 2022 Term Loan" in the debt maturity schedule above). In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of December&#160;31, 2020, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through December&#160;31, 2020, we were in compliance with the financial covenant required by our credit facilities described above. </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.047%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement<br/>as of December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual<br/>as of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.48 times</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into an agreement with our banking syndicates to amend the financial covenant requirement for all of our outstanding credit arrangements as follows: (i) established a deemed Consolidated EBITDA of $671 million for the second, third and fourth quarters of 2020, reflecting average quarterly Consolidated EBITDA, as defined in the credit agreements, for 2018 and 2019; and (ii) maintain the maximum permitted leverage ratio of 4.75 times through the remainder of 2020, with a step-down for each succeeding fiscal quarter end to 4.50 times, 4.25 times, 4.00 times and ultimately 3.75 times for the fourth quarter of 2021 and through the remaining term of the facility. In addition, pursuant to the April 21, 2020 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Credit Facility and February 2021 Term Loan amendments, the definition of "Material Adverse Effect" has been amended to exclude the direct and indirect effects of the COVID-19 pandemic from what constitutes a material adverse effect through the remainder of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to $500 million in restructuring and restructuring-related net charges related to our current or future restructuring plans. As of December&#160;31, 2020, we had $101 million of the restructuring net charges exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $2.624 billion in the aggregate. As of December&#160;31, 2020, we had $926 million of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this amended covenant could require us to seek to further renegotiate the terms of our Revolving Credit Facility or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 days</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 days</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $9.205 billion as of December&#160;31, 2020 and $7.661 billion as of December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2020, we redeemed $250 million of our $500 million 3.375% senior notes due 2022 (May 2022 Notes) at a redemption price calculated in accordance with the terms of the May 2022 Notes and its indenture, plus accrued and unpaid interest through, but excluding, the date of redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of $1.700 billion in aggregate principal amount of senior notes comprised of $500 million of 1.900% senior notes due June 2025 and $1.200 billion of 2.650% senior notes due June 2030. We used the net proceeds from the offering to refinance $450 million of amounts outstanding under the Revolving Credit Facility, prepay $750 million of amounts outstanding under the $1.000 billion February 2021 Term Loan, prepay $500 million of amounts outstanding under the $1.250 billion April 2021 Term Loan and pay related fees, expenses and premiums.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $206 million of our $450 million 4.125% senior notes due 2023, $566 million of our $1.000 billion 4.000% senior notes due 2028 and $227 million of our $750 million 3.850% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">connection with the transaction. In 2019, we incurred associated debt extinguishment charges of $86 million presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we completed an offering of $4.300 billion in aggregate principal amount of senior notes comprised of $850 million of 3.450% senior notes due March 2024, $850 million of 3.750% senior notes due March 2026, $850 million of 4.000% senior notes due March 2029, $750 million of 4.550% senior notes due March 2039 and $1.000 billion of 4.700% senior notes due March 2049. We used a portion of the net proceeds from the offering to repay the $850 million plus accrued interest and premium of our 6.000% senior notes due in January 2020, the $600 million plus accrued interest and premium of our 2.850% senior notes due in May 2020 and the $1.000 billion plus accrued interest of our August 2019 Term Loan. In 2019, the remaining proceeds were used to finance a portion of our acquisition of BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our $8.855 billion of senior notes issued in 2009, 2013, 2015, 2018, 2019 and 2020 contain a change-in-control provision, which provides that each holder of the senior notes may require us to repurchase all or a portion of the notes at a price equal to 101 percent of the aggregate repurchased principal, plus accrued and unpaid interest, if a rating event, as defined in the indenture, occurs as a result of a change-in-control, as defined in the indenture. Any other credit rating changes may impact our borrowing cost, but do not require us to repay any borrowings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renminbi denominated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Renminbi denominated factoring arrangement was entered into in 2020 and had remaining capacity available as of December 31, 2020. There were no amounts de-recognized for accounts receivable as of December 31, 2020 associated with this arrangement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $124 million as of December&#160;31, 2020 and $105 million as of December&#160;31, 2019, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of December&#160;31, 2020 and December&#160;31, 2019, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our consolidated balance sheets as of December&#160;31, 2020 and December&#160;31, 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum purchase obligations, relating primarily to non-cancellable inventory commitments and capital expenditures entered in the normal course of business, were as of December&#160;31, 2020 (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecorded Purchase Obligations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">535</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234894264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">Leases of Lessee Disclosure [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; LEASES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance leases for real estate including corporate offices, land, warehouse space, and vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet, unless the arrangement includes an option to purchase the underlying asset, or an option to renew the arrangement, that we are reasonably certain to exercise (short-term leases). We recognize lease expense on a straight-line basis over the lease term for short-term leases that we do not record on our balance sheet. If there is a change in our assessment of the lease term and, as a result, the remaining lease term extends more than 12 months from the end of the previously determined lease term, or we subsequently become reasonably certain that we will exercise an option to purchase the underlying asset, the lease no longer meets the definition of a short-term lease and is accounted for as either an operating or finance lease and recognized on the balance sheet. In accordance with FASB ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we account for the lease components and the non-lease components as a single lease component, with the exception of our warehouse leases. Our leases have remaining lease terms of less than 1 year to approximately 56 years, some of which may include options to extend the leases for up to 10 years. If we are reasonably certain we will exercise an option to extend the lease, the time period covered by the extension option is included in the lease term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of the arrangement. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, we utilize the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease right-of-use assets are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and corresponding liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated balance sheets. Finance leases are immaterial to our consolidated financial statements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. The following table presents supplemental balance sheet information related to our operating leases:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating lease cost under FASB ASC Topic 842 was $92 million in 2020 and $80&#160;million in 2019. Rent expense under FASB ASC Topic 840 amounted to $92 million in 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for operating lease obligations were $202 million as of December 31, 2020 and $137 million as of December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">530</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we have additional leases for office space and warehouse space, that have not yet commenced, of approximately $25 million. These leases will commence in 2021 and thereafter with lease terms of up to 15 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234883464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Related Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE H &#8211; RESTRUCTURING-RELATED ACTIVITIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Restructuring Plan </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2018, our Board of Directors approved, and we committed to a global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan is intended to support our effort to improve operating performance and meet anticipated market demands by ensuring that we are appropriately structured and resourced to deliver sustainable value to patients and customers. Key activities under the 2019 Restructuring Plan include supply chain network optimization intended to maximize our global manufacturing and distribution network capacity and building functional capabilities that support business growth. These activities were initiated in 2019, with the majority of activity expected to be complete by the end of 2022, following a one-year extension approved by our Board of Directors on February 22, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, our Board of Directors approved an extension and expansion of the 2019 Restructuring Plan to include additional cost optimization activities, including the centralization of certain functional capabilities within the international regions in which we operate, and a one-year extension of the program to complete these activities along with certain other initiatives that were delayed in 2020 due to restrictions related to the COVID-19 pandemic. We expect the majority of activity associated with our 2019 Restructuring Plan, including the expansion, to be substantially complete by the end of 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, including the expansion, by major type of cost, of which approximately $340 million to $440 million are expected to result in cash outlays:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Estimated Amount Expected to be Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$75</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$375</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$475 </span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Restructuring Plan </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2016, our Board of Directors approved, and we committed to a restructuring initiative (the 2016 Restructuring Plan). The 2016 Restructuring Plan was intended to&#160;develop global commercialization, technology and manufacturing capabilities in key growth markets, build on our Plant Network Optimization (PNO) strategy which is intended to simplify our manufacturing plant structure by transferring certain production lines among facilities and expand operational efficiencies in support of our operating income margin goals. Key activities under the 2016 Restructuring Plan included strengthening global infrastructure through evolving global real estate assets and workplaces, developing global commercial and technical competencies, enhancing manufacturing and distribution expertise in certain regions and continuing implementation of our PNO strategy. These activities were initiated in the second quarter of 2016 and substantially completed in 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $255 million resulted in cash outlays:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LOTUS Discontinuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System, and our decision to retire the entire LOTUS platform. We estimate the decision will result in total pre-tax restructuring and restructuring-related net charges of approximately $80 million to $90 million, which includes $30 million to $40 million of estimated charges expected to result in future cash outlays. We recorded $55 million of restructuring and restructuring-related net charges associated with the product discontinuation in 2020, which is included in the table above for the year ended December 31, 2020, and expect the remaining activity to be substantially complete during early 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, during 2020 we recorded $119 million of inventory charges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and $8 million of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> associated with the product discontinuation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2020, related to our ongoing Restructuring Plans by major type: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">369</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233606888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">SUPPLEMENTAL BALANCE SHEET INFORMATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in our accompanying consolidated balance sheets are as follows:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,828</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 310</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note R &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,579</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 33 percent of our finished goods inventory as of December&#160;31, 2020 and approximately 32 percent as of December 31, 2019 was at customer locations pursuant to consignment arrangements or held by sales representatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">880</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,084</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $333 million in 2020, $311 million in 2019 and $296 million in 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234802088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,422</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related expense (benefit) for income taxes consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,288)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,013)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(249)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic taxes on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TCJA net impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intra-entity asset transfers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(584.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Due to the disclosure of additional rate reconciling items in 2020, we have reclassified select items in prior years to align with the new categories disclosed in the current year.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit of net operating loss and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves and accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and product liability reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal benefit of uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,696&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains and losses on derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,796</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Component</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,796</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $474 million. As of December&#160;31, 2019, we had U.S. federal and state tax net operating loss carryforwards and tax credits, the tax effect of which was $449 million. In addition, we had foreign tax net operating loss carryforwards and tax credits, the tax effect of which was $83 million as of December&#160;31, 2020, as compared to $105 million as of December&#160;31, 2019. These tax attributes expire periodically beginning in 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, we completed intra-entity asset transfers of certain intellectual property rights among various wholly owned subsidiaries. These transactions occurred to more closely align the global economic ownership of our intellectual property rights with our current and future business operations. These transactions did not result in a taxable gain in any jurisdiction, however, some of the transactions did create a step-up in the tax-deductible basis in the transferred intellectual property rights in certain jurisdictions. As a result, we recorded deferred tax assets in the amount of $4.102 billion, which represents the book and tax basis differences measured at applicable statutory tax rates, net of a valuation allowance of $542 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After consideration of all positive and negative evidence, we believe that it is more likely than not that a portion of our deferred tax assets will not be realized. As a result, we established a valuation allowance of $887 million as of December&#160;31, 2020 and $915 million as of December&#160;31, 2019, representing a decrease of $28 million. The decrease in the valuation allowance as of December&#160;31, 2020, as compared to December&#160;31, 2019, is primarily due to current year utilization of loss carryforwards and the concurrent release of the related valuation allowance. The income tax impact of the unrealized gain or loss component of other comprehensive income and stockholders' equity was a benefit of $78 million in 2020, a charge of $13 million in 2019 and a charge of $37 million in 2018. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain tax incentives through Free Trade Zone Regime offered in Costa Rica which allows 100.0 percent exemption from income tax in the first eight years of operations and 50.0 percent exemption in the following four years. This tax incentive resulted in income tax savings of $64 million for 2020, $173 million for 2019 and $146 million for 2018. The tax incentive for 100.0 percent exemption from income tax was renewed during 2019 and is expected to expire in 2027. The impact on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss) per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $0.04 for 2020, $0.12 for 2019 and $0.10 for 2018. Additionally, we benefit from tax incentives in Puerto Rico resulting in income tax savings of $30 million for 2020, and immaterial amounts for 2019 and 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, we had $261 million of gross unrecognized tax benefits, of which a net $183 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $455 million of gross unrecognized tax benefits, of which a net $355 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2018, we had $427 million of gross unrecognized tax benefits, of which a net $332 million, if recognized, would affect our effective tax rate. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,238</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation expirations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. Federal income tax as well as income tax of multiple state and foreign jurisdictions. We have concluded all U.S. federal income tax matters through 2016 and substantially all material state and local income tax matters through 2010. We have concluded all foreign income tax matters through 2013, with the exception of issues for Italy, which have concluded through 2002.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2018, a decision was entered by the U.S. Tax Court resolving all disputes for Guidant Corporation for its 2001 through 2006 tax years and our 2006 and 2007 tax years as well as the tax issues related to our 2006 transaction with Abbott Laboratories. Additionally, we resolved all issues with the IRS Office of Appeals for our 2008 through 2010 tax years. The final settlement calculation resulted in a final net tax payment of $303 million plus $307 million of estimated interest, which was remitted in the second quarter of 2018. Due to the final settlement of these disputes, we recorded a net tax benefit of $250 million in 2018 to remove a reserve related to these years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2018, we received a Revenue Agent Report (RAR) from the IRS for our 2011 through 2013 tax years. We remitted $93 million to the IRS in the fourth quarter of 2018 reflecting the net balance of tax and interest due for these years after consideration of amounts owed to us by the IRS. Due to the resolution of these tax years, we recorded a net tax benefit of $90 million in 2018 to remove a reserve related to these years. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter of 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years stating that the Joint Committee on Taxation completed its review on July 21, 2020, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91&#160;million in the third quarter of 2020 to release the reserves related to these years. We received a refund of $62&#160;million from the IRS in the fourth quarter of 2020 reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to income taxes as a component of income tax expense. We had $41 million accrued for gross interest and penalties as of December&#160;31, 2020 and $19 million as of December&#160;31, 2019. We recognized net tax expense related to interest and penalties of $7 million in 2020, as compared to a net tax benefit of $1 million in 2019 and a net tax benefit of $498 million in 2018. The increase in our net tax expense related to interest and penalties as of December&#160;31, 2020, as compared to December&#160;31, 2019, is related to reaching favorable settlements with the taxing authorities during 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12&#160;months we will resolve transactional- related issues with foreign and state taxing authorities, in which case we could record a reduction in our balance of unrecognized tax benefits of up to approximately $27 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2018, we completed our analysis and recording of all tax effects related to the TCJA, as required under SAB 118, and recorded a net benefit of $67 million, exclusive of the one-time transition tax adjustment described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2017, we were required under the TCJA to calculate a one-time transition tax based on our total post-1986 foreign subsidiaries' earnings and profits (E&amp;P) that we previously deferred from U.S. income taxes. As a result of various audit activities, the revised amount of transition tax was approximately $939&#160;million as of December 31, 2020 as compared to $856 million as of December 31, 2018. We anticipate offsetting this liability against existing tax attributes reducing the required payment to approximately $597 million, which will be remitted over an eight-year period. We have begun remitting the required installment payments, with a balance remaining of $477&#160;million as of December&#160;31, 2020. In addition, we have provided for U.S. state income taxes of $20 million on all U.S. dollar-denominated E&amp;P accumulated through December 31, 2017, which constitutes the preponderance of our foreign subsidiaries' accumulated E&amp;P through December 31, 2017. We intend to indefinitely reinvest the unremitted foreign earnings of all other subsidiaries as of December 31, 2017, as well as all subsequent earnings generated by all of our foreign subsidiaries. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings and additional outside basis difference in these entities is not practicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a territorial tax system under the TCJA, in which we are required to provide for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have established an accounting policy election to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234835224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $569 million as of December&#160;31, 2020 and $697 million as of December&#160;31, 2019 and includes certain estimated costs of settlement, damages and defense. The decrease in our legal accrual was mainly due to settlement payments related to litigation with Channel Medsystems, Inc. (Channel), partially offset by charges associated with product liability cases or claims related to transvaginal surgical mesh products. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $208 million as of December&#160;31, 2020 and $346 million as of December&#160;31, 2019. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $278 million in 2020, primarily related to transvaginal mesh products, inclusive of a reserve related to claims made by a coalition of state attorneys general. Those claims settled in principle in the fourth quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $115 million in 2019, which included a net charge of $223 million in the fourth quarter of 2019, primarily related to litigation with Channel, net charges of $25 million in the third quarter of 2019 and $15 million in the second quarter of 2019, primarily related to transvaginal surgical mesh product liability litigation, and a gain of $148 million recorded in the first quarter of 2019, which represents a portion of the total $180 million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our&#160;consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As such, a portion of the related gain from this settlement was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $103 million in 2018, primarily related to transvaginal surgical mesh product liability litigation. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, BSC filed suit against Cook Group Limited and Cook Medical LLC (collectively, &#8220;Cook&#8221;) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct Endoscopic Hemoclip. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (&#8220;IPR&#8221;) requests with the U.S. Patent and Trademark Office against the four asserted patents. All IPRs have concluded, and Cook and Boston Scientific both appealed the Patent Office&#8217;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Boston Scientific patents remain valid, remanding two of the patents for further review by the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USPTO's Patent Trial and Appeal Board. In November, the Patent Office issued remand rulings invalidating several additional claims. The district court had stayed the case pending the appeals court decision on the IPRs, which is now complete. In the first or second quarter of 2021, the case will proceed before the United States District Court for the Southern District of Indiana, with BSC asserting two patents against Cook. Trial is anticipated in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2016, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement action against Nevro in United States District Court for the District of Delaware (16-cv-1163) alleging that ten U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#8217;s Senza&#8482; Spinal Cord Stimulation System. On June 22, 2020, this action was consolidated with case 18-cv-664, described below. The court set trial for October 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2017, The Board of Regents, University of Texas System (UT) and TissueGen. Inc., served a lawsuit against us in the Western District of Texas. The complaint against us alleges patent infringement of two U.S. patents owned by UT, relating to &#8220;Drug Releasing Biodegradable Fiber Implant&#8221; and &#8220;Drug Releasing Biodegradable Fiber for Delivery of Therapeutics,&#8221; and affects the manufacture, use and sale of our Synergy&#8482; Stent System. On March 12, 2018, the District Court for the Western District of Texas dismissed the action and transferred it to the United States District Court for the District of Delaware. On September 5, 2019, the Court of Appeals for the Federal Circuit affirmed the dismissal of the District Court for the Western District of Texas. In April 2020, the United States Supreme Court denied the University&#8217;s Petition for Certiorari. UT is proceeding with its case against BSC in Delaware.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2018, the Company and Boston Scientific Neuromodulation Corporation filed a patent infringement, theft of trade secrets and tortious interference with a contract action against Nevro in United States District Court for the District of Delaware (18-cv-664), and amended the complaint on July 18, 2018, alleging that nine U.S. patents owned by Boston Scientific Neuromodulation Corporation are infringed by Nevro&#8217;s Senza&#8482; I and Senza&#8482; II Spinal Cord Stimulation Systems. On December 9, 2019, Nevro filed an answer and counterclaims, in which it alleged that our Spinal Cord Stimulation systems infringe five Nevro patents. On June 22, 2020, this action was consolidated with case 16-cv-1163. The theft of trade secrets, patent counterclaims, and patent infringement claims from case 16-cv-1163 were set for trial in October 2021. The patent infringement claims from case 18-cv-664 were stayed pending IPRs. On January 6, 2021, the court stayed one of the patent infringement claims from case 16-cv-1163, such that it will proceed with the stayed patent infringement claims from case 18-cv-664.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2020, Koninklijke Philips N.V. and IP2IPO Innovations, Ltd. (&#8220;Philips&#8221;) served a complaint against the Company in the United States District Court for the District of Delaware. The complaint alleges that certain BSC cardiovascular diagnostic devices infringe six Philips patents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2021, approximately 54,000 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of January 27, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately&#160;52,000&#160;cases and claims, adjusted to reflect the Company's analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 52,000 cases and claims, approximately 48,000 have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over 3,100 of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general offices regarding our transvaginal surgical mesh products. We have responded to those requests. On December 12, 2019 the Mississippi Attorney General filed suit against BSC in State Court alleging violations of the Mississippi Consumer Protection Act which the Company plans to vigorously defend. There are fewer than 60 claims in the United Kingdom and fewer than 125 cases in Australia. There are also fewer than 10 cases in Canada, inclusive of one certified class action, which has settled and received Court approval. On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. While we believe that our accrual associated with this matter is adequate, changes to this accrual may be required in the future as additional information becomes available. We have also established an accrual related to the claims made by the coalition of state attorneys general. While we continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims and intend to vigorously contest the cases and claims asserted against us that do not settle, the final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Initial trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named a defendant in 118 filed product liability cases involving our Greenfield Vena Cava Filter, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 597 claims, none of which have been filed. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena seeks information relating to the launch of the Cognis&#8482; and Teligen&#8482; line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of the Physician Guided Learning Program. We are cooperating with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. government and the State of California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to the Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for Boston Scientific and three of its employees, as well as numerous other defendants charged in criminal proceedings.&#160;The charges arise from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials.&#160;A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Boston Scientific employee but acquitted two others and levied a fine of &#8364;245 thousand against us and imposed joint and several civil damages of &#8364;620 thousand on all defendants. We continue to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against Boston Scientific and its employee and acquitted them of all charges.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2015, the Brazilian governmental entity known as CADE (the Administrative Council of Economic Defense), served a search warrant on the offices of our Brazilian subsidiary, as well as on the Brazilian offices of several other major medical device makers who do business in Brazil, in furtherance of an investigation into alleged anti-competitive activity with respect to certain tender offers for government contracts. On June 20, 2017, CADE, through the publication of a &#8220;technical note,&#8221; announced that it was launching a formal administrative proceeding against Boston Scientific&#8217;s Brazilian subsidiary, Boston Scientific do Brasil Ltda., as well as against the Brazilian operations of Medtronic, Biotronik and St. Jude Medical, two </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brazilian associations, ABIMED and AMBIMO and 29 individuals for alleged anti-competitive behavior. We deny the allegations and intend to defend ourselves vigorously.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2018, Arthur Rosenthal et al., filed a plenary summons against Boston Scientific Corporation and Boston Scientific Limited with the High Court of Ireland alleging that payments are due pursuant a transaction agreement regarding Labcoat Limited, a company Boston Scientific purchased in 2008 that provided coating technology for drug-eluting stents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019, Blue Cross &amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia. The complaint alleges that the defendants violated the Sherman Act and the antitrust and consumer protections laws of several states by pursuing patent litigation relating to ZYTIGA&#8482; in order to delay generic entry. On June 21, 2019, the case was transferred to the United States District Court for the District of New Jersey and has been consolidated with similar complaints.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2017, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint filed on behalf of the United States, 28 states, and the District of Columbia. The complaint, which was filed in the United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA to the government in connection with direct government sales and government-funded drug reimbursement programs. The case has been transferred to United States District Court for the District of New Jersey. On June 20, 2019, the complaint was amended to include BTG International Limited as a defendant. In May 2020, a class action complaint was filed in New Jersey federal court against Johnson &amp; Johnson and BTG by two direct purchasers of Zytiga on behalf of similarly situated entities. The complaint alleges that BTG and J&amp;J violated antitrust laws by attempting to enforce certain patents against potential generic competitors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against Boston Scientific Corporation, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all other similarly situated, filed a second, materially similar class action complaint against Boston Scientific Corporation, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. The Company expects these cases to be superseded by a single amended and consolidated class action complaint in the first or second quarter of 2021. On December 15, 2020, the Securities and Exchange Commission&#8217;s Boston Regional Office (Boston SEC) notified the Company that it is conducting an investigation related to Boston Scientific&#8217;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company is cooperating fully with the investigation. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#8217;s Board of Directors conduct an investigation into actions by the Company&#8217;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020 Mariano Errichiello, individually and on behalf of all others similarly situated, filed a class action complaint against Boston Scientific Corporation, Michael F. Mahoney, Joseph M. Fitzgerald and Daniel J. Brennan stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System in United States District Court for the District of Massachusetts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information regarding our tax litigation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters Concluded Since December 31, 2019</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2019, Tissue Anchor Innovations filed a complaint for patent infringement in the United States District Court Central District of California against Fountain Valley Regional Hospital and Medical Center, Los Alamitos Medical Center and us. The complaint alleged that the Solyx&#8482; Sling System infringes US Patent 6,506,190. We reached a confidential settlement in this matter in July 2020, pursuant to which the action was dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, Imran Niazi filed a patent infringement action against us in the United States District Court for the Western District of Wisconsin alleging that a U.S. patent owned by him is infringed by our Acuity&#8482; Lead Delivery System. On June 30, 2017, we filed a motion to dismiss for improper venue and on November 7, 2017 the Wisconsin Court granted the motion to dismiss. On November 13, 2017 Niazi refiled the same action in the U.S. District of Minnesota. We reached a confidential settlement on this matter on February 3, 2020 pursuant to which the action was dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2017, we entered into a definitive agreement with Channel pursuant to which we could have been obligated to pay $145 million in cash up-front and a maximum of $130 million in contingent payments to acquire Channel. The agreement contained a provision allowing Channel to sell the remaining equity interests of Channel to us upon achievement of a regulatory milestone and an option allowing us to acquire the remaining equity interests. We sent a notice of termination of that agreement to Channel in the second quarter of 2018. On September 12, 2018, Channel filed a complaint in Delaware Chancery Court against us for alleged breach of the agreement. Channel alleged that we breached the agreement by terminating it. We answered the complaint, denied the claims by Channel and counterclaimed to recover part of our investment in Channel, alleging fraud in the inducement. On April 2, 2019, Channel announced its receipt of FDA approval of the Cerene&#8482; Cryotherapy Device. Trial testimony was taken in April 2019, and the post-trial briefing and hearing were completed. During the third quarter of 2019, Channel notified us that they were exercising their option to sell the remaining equity interests in Channel to us. We responded to the notification that we did not intend to purchase Channel since the previous agreement had been terminated. On December 18, 2019, the Chancery Court ruled that Boston Scientific was in breach of the agreement and granted Channel's request for specific performance to require the Company to complete the purchase. On January 10, 2020, we filed a Notice of Appeal of the Chancery Court&#8217;s decision to the Delaware Supreme Court. On February 4, 2020, the Company settled the dispute with Channel resulting in termination of the agreement, payment by the Company of an undisclosed sum and surrender of the Company's equity interest in Channel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2016 Nevro Corp. (Nevro) filed a patent infringement action against us and one of our subsidiaries, Boston Scientific Neuromodulation Corporation, in the U.S. District Court for the Northern District of California alleging that six U.S. patents (Alataris) owned by Nevro are infringed by our spinal cord stimulation systems. On June 29, 2017, Nevro amended the complaint to add an additional patent (Fang). On July 24, 2018, summary judgment was entered in favor of the Company and on July 31, 2018, we received final judgment and dismissal of the action. On July 31, 2018, Nevro filed an appeal. On April 9, 2020, the Court of Appeals for the Federal Circuit vacated the finding of indefiniteness as to certain patents, provided claim constructions for those patents, and remanded the case. On December 16, 2020, the district court dismissed all remaining claims with prejudice, ending the case with Nevro receiving none of its requested relief.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234690664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDER'S EQUITY</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; STOCKHOLDERS' EQUITY </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. As of December 31, 2019, we had no shares of preferred stock issued or outstanding.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. As of December&#160;31, 2020, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $100 per share plus accumulated and unpaid dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between 2.3834 and 2.9197 shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2020, we paid to holders of our MCPS as of August 15, 2020 a cash dividend of $1.4361 per MCPS share (or $14 million in aggregate cash dividends), representing a dividend period beginning on the May 27, 2020 issuance date through August 31, 2020. On December 1, 2020, we paid to holders of our MCPS as of November 15, 2020 a cash dividend of $1.3750 per MCPS share (or $14 million in aggregate cash dividends), representing a dividend period beginning on September 1, 2020 through November 30, 2020. On February 1, 2021, the Audit Committee of our Board of Directors, pursuant to authority delegated to such committee by our Board of Directors, declared a cash dividend of $1.375 per MCPS share (or $14 million in aggregate cash dividends) to be paid on March 1, 2021 to holders of our MCPS as of February 15, 2021, representing a dividend period beginning December 1, 2020 through February 28, 2021. We have presented cumulative, unpaid dividends covering this period from December 1, 2020 through December 31, 2020 totaling $5 million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets as of December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 2.000 billion shares of common stock, $0.01 par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 29,382,500 shares of common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The remaining proceeds are being used for general corporate purposes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2013, our Board of Directors approved and on January 29, 2013, we announced a program authorizing the repurchase of up to $1.000 billion of our common stock (2013 share repurchase program). In the fourth quarter of 2020, we repurchased approximately 15.7 million shares of our common stock pursuant to the 2013 share repurchase program for a total of approximately $535 million in cash, which represented the full amount remaining under that authorization. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock (2020 share repurchase program). As of December&#160;31, 2020, we had the full amount remaining available under the 2020 share repurchase program. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock during 2019 or 2018. There were approximately 263 million shares in treasury as of December&#160;31, 2020 and 248 million shares in treasury as of December&#160;31, 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233611304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Inventive and Purchase Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIncentiveAndPurchasePlansAbstract', window );"><strong>Stock Incentive and Purchase Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; STOCK INCENTIVE AND PURCHASE PLANS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee and Director Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Board of Directors and stockholders approved amendments to our 2011 Long-Term Incentive Plan effective October 1, 2020 (Amended and Restated 2011 LTIP), authorizing for issuance up to 171 million shares of our common stock. The Amended and Restated 2011 LTIP covers officers, directors, employees and consultants and provides for the grant of restricted or unrestricted common stock, restricted stock units (RSUs), options to acquire our common stock, stock appreciation rights, performance awards (market-based and performance-based RSUs) and other stock and non-stock awards. Shares reserved under our current and former stock incentive plans totaled approximately 187 million as of December&#160;31, 2020. The Executive Compensation and Human Resources Committee (the Committee) of the Board of Directors, consisting of independent, non-employee directors may authorize the issuance of common stock and cash awards under the Amended and Restated 2011 LTIP in recognition of the achievement of long-term performance objectives established by the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-qualified options issued to employees are generally granted with an exercise price equal to the market price of our stock on the grant date, vest over a four-year service period and have a ten-year contractual life. In the case of qualified options, if the recipient owns more than ten percent of the voting power of all classes of stock, the option granted will be at an exercise price of 110 percent&#160;of the fair market value of our common stock on the date of grant and will expire over a period not to exceed five years. Non-vested stock awards, including restricted stock awards (RSAs), RSUs and deferred stock units (DSUs) issued to employees are generally granted with an exercise price of zero and typically vest in four or five equal annual installments. These awards represent our commitment to issue shares to recipients after the vesting period. Upon each vesting date, such awards are no longer subject to risk of forfeiture and we issue shares of our common stock to the recipient.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the impact of stock-based compensation on our consolidated statements of operations:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Black-Scholes Assumptions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years, weighted)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Volatility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our historical volatility and implied volatility as a basis to estimate expected volatility in our valuation of stock options.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Term</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the expected term of options using historical exercise and forfeiture data. We believe that this historical data provides the best estimate of the expected term of new option grants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk-Free Interest Rate</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use yield rates on U.S. Treasury securities for a period approximating the expected term of the award to estimate the risk-free interest rate in our grant-date fair value assessment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Expected Dividend Yield</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not historically paid cash dividends on our common stock and currently we do not intend to pay cash dividends on our common stock. Therefore, we have assumed an expected dividend yield of zero in our grant-date fair value assessment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to stock options under stock incentive plans are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:49.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.815%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,716</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,096)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,105&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total vested and expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,787</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was $84 million in 2020, $140 million in 2019 and $90 million in 2018.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Vested Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value RSAs, RSUs and DSUs based on the closing trading value of our shares on the date of grant. Information related to non-vested stock awards is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Award Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date <br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(748)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,683</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,811)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vesting date fair value of shares that vested was approximately $172 million in 2020, $193 million in 2019 and $170 million in 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market-based DSU Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, we granted market-based DSU awards to certain members of our senior management team. The number of shares ultimately issued to the recipient is based on the total stockholder return (TSR) of our common stock as compared to the TSR of the common stock of the other companies in the S&amp;P 500 Healthcare Index over a three-year performance period. The number of DSUs ultimately granted under this program range from 0 percent to 200 percent of the target number of performance-based DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout the three-year performance period to attain the full amount of the market-based DSUs that satisfied the market performance criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the market-based DSU awards to be approximately $8 million for 2020, $10 million for 2019 and $7 million for 2018. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price on date of grant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.09&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> (in years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the expense on these awards in our consolidated statements of operations on a straight-line basis over the three-year measurement period.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Free Cash Flow Performance-based DSU Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, we granted free cash flow performance-based DSU awards to certain members of our senior management team. The attainment of these performance-based DSUs is based on our adjusted free cash flow (AFCF) measured against our internal annual financial plan performance for AFCF. AFCF is measured over a one-year performance period beginning January 1st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of each year and ending December 31st. The number of DSUs ultimately granted under this program range from 0 percent to 150 percent of the target number of performance-based DSUs awarded to the participant as determined by achievement of the performance criteria of the program. In addition, in general, award recipients must remain employed by us throughout a three-year service period (inclusive of the one-year performance period) to attain the full amount of the performance-based DSUs that satisfied the performance criteria. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018 AFCF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, net of forfeitures to date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achievement of target payout</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end stock price used in determining fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the expense on these awards in our consolidated statements of operations over the vesting period which is three years after the date of grant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expense Attribution</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize compensation expense for our stock incentive plan using a straight-line method over the substantive vesting period. Most of our stock awards provide for immediate vesting upon death or disability of the participant. In addition, our stock grants to employees provide for accelerated vesting of our stock-based awards, other than performance-based and market-based awards, upon retirement, if the stock award has been held for at least one year by the recipient. In accordance with the terms of our stock grants, for employees who will become retirement eligible prior to the vest date we expense stock-based awards, other than performance-based and market-based awards, over the greater of one year or the period between grant date and retirement-eligibility. The performance-based and market-based awards discussed above do not contain provisions that would accelerate the full vesting of the awards upon retirement-eligibility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation expense for the value of the portion of awards that are ultimately expected to vest. FASB ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allows forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term &#8220;forfeitures&#8221; is distinct from &#8220;cancellations&#8221; or &#8220;expirations&#8221; and represents only the unvested portion of the surrendered stock-based award. We have applied, based on an analysis of our historical forfeitures, a weighted-average annual forfeiture rate of approximately five percent to all unvested stock-based awards as of December&#160;31, 2020, which represents the portion that we expect will be forfeited each year over the vesting period. We re-evaluate this analysis annually or more frequently if there are significant changes in circumstances and adjust the forfeiture rate as necessary. Ultimately, we will only recognize expense for those shares that vest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Compensation Cost</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Cost</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts presented represent compensation cost, net of estimated forfeitures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global employee stock purchase plan provides for the granting of options to purchase up to 50 million shares of our common stock to all eligible employees. Under the global employee stock purchase plan, we grant each eligible employee, at the beginning of each six-month offering period, an option to purchase shares of our common stock equal to not more than ten percent of the employee&#8217;s eligible compensation or the statutory limit under the U.S. Internal Revenue Code. Such options may be exercised only to the extent of accumulated payroll deductions at the end of the offering period, at a purchase price equal to 85 percent of the fair market value of our common stock at the beginning or end of each offering period, whichever is less. As of December&#160;31, 2020, there were approximately 6 million shares available for future issuance under the employee stock purchase plan. We temporarily suspended our global employee stock purchase plan for the offering period for the second half of 2020 due to cost-savings initiatives in response to the COVID-19 pandemic and have resumed for the offering period for the first half of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:51.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued or to be issued&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Range of purchase prices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.29</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36.47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.49</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27.91</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recognized&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of shares issued under the employee stock purchase plan. We recognize expense related to shares purchased through the employee stock purchase plan ratably over the offering period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIncentiveAndPurchasePlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Incentive and Purchase Plans [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIncentiveAndPurchasePlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234735816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,381.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,416.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,401.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in this period.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the later of the May 27, 2020 issuance date or the beginning of the reporting period to the extent that the effect is dilutive. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as presented in our consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net loss available to common stockholders</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544235003368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE O &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our seven core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits), certain investment portfolio net losses (gains) and EU Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations and are included in the reconciliation below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our acquisition of BTG, we have included BTG&#8217;s Interventional Medicine business within our Peripheral Interventions operating segment, within the Cardiovascular reportable segment. We present BTG&#8217;s Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,694&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated depreciation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,422</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,211&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the announcement of our plan to sell our Specialty Pharmaceuticals business, as of December 31, 2020, we have classified the assets and liabilities of our Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less costs to sell. Accordingly, the total assets of the Specialty Pharmaceuticals business as of December 31, 2020 reflected above include goodwill and intangible assets attributable to the disposal group that were not previously allocated to our reportable segments.</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,782&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,477</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233611304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE P &#8211; REVENUE </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our consolidated statements of operations. The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,701</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,212</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,538</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,286</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,694</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,654</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying consolidated balance sheets. Our deferred revenue balance was $395 million as of December&#160;31, 2020 and $400 million as of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2019. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. We recognized revenue of $135 million in 2020 that was included in the above December&#160;31, 2019 contract liability balance. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize sales force commissions related to contracts with customers when the associated revenue is expected to be earned over a period that exceeds one year. Deferred commissions are primarily related to the sale of devices enabled with our LATITUDE&#8482; Patient Management System. We have elected to expense commission costs when incurred for contracts with an expected duration of one year or less. Capitalized commission fees are amortized over the period the associated products or services are transferred. Similarly, we capitalize certain recoverable costs related to the delivery of the LATITUDE&#8482; Remote Monitoring Service. These fulfillment costs are amortized over the average service period. Our total capitalized contract costs are immaterial to our consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received FDA approval in mid-2020 and began the U.S. launch of our next generation WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#8482; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In 2020, we recorded $179 million in revenue reserves primarily related to our conversion to a consignment commercial model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device in the U.S. In connection with the conversion, we repurchased customer-owned inventory and will recognize revenue for consigned units as they are consumed by customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our accounting policies relating to revenue recognition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233343384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Income (Loss) Note [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE Q &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span> were reduced by immaterial income tax impacts in 2020 and in 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544231195960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NewAccountingPronouncementsPolicyTextBlock', window );">New Accounting Pronouncements, Policy</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE R &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Standards Implemented Since December 31, 2019</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2016-13</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASC Update No. 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">account. The adoption had an immaterial impact on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-15</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-18</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASC Update No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">after December 15, 2020, for public business entities. We plan to adopt Update No. 2020-10 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We plan to early adopt Update No. 2020-06 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods. We plan to adopt Update No. 2019-12 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements, issued or effective, during the period had, or is expected to have, a material impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NewAccountingPronouncementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New Accounting Pronouncements, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NewAccountingPronouncementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233620056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Compensation and Employee Benefit Plans [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE S &#8211; EMPLOYEE RETIREMENT PLANS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Domestic Retirement Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our 2006 acquisition of Guidant, we assumed the Guidant Supplemental Retirement Plan, a frozen, non-qualified defined benefit plan for certain former officers and employees of Guidant. The Guidant Supplemental Retirement Plan was partially funded through a Rabbi Trust that contains segregated company assets within restricted cash used to pay the benefit obligations related to the plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain an Executive Retirement Plan, a defined benefit plan covering executive officers and division presidents. Participants may retire with benefits once retirement conditions have been satisfied. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.K. Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our acquisition of BTG, we assumed a benefit obligation related to a defined benefit pension plan sponsored by BTG for eligible United Kingdom (U.K.) employees (U.K. Plan). The U.K. Plan was closed to new entrants as of June 1, 2004. Prior to the acquisition close date of August&#160;19, 2019, the Trustees of the U.K. Plan executed buy-in arrangements (Buy-in Contracts), which effectively, as structured under the Buy-in Contracts, are intended to provide payments designed to equal all future designated contractual benefit payments to covered participants. The benefit obligation of the pension plan is not transferred to the insurers, and we remain responsible for paying pension benefits. We do not anticipate any additional material contributions or payments to the U.K. Plan or the insurer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the final purchase price allocation of BTG, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rate of Compensation Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the measurement date of August&#160;19, 2019, the funded status was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:84.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our acquisition of BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the U.K. Plan presented below are as of the December 31, 2020 and 2019 measurement dates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other International Retirement Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we maintain retirement plans covering certain international employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of December 31, 2020 and 2019, the funded status of our plans were unfunded or underfunded in aggregate. The outstanding obligation is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:44.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded<br/>PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:44.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">466</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the PBO for our retirement plans is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments and assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending obligation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2020 are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:45.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.083%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2019 are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.94%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.65%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="padding-left:36pt;text-indent:-13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our defined benefit plans excluding our U.K. Plan, we base our discount rate on the rates of return available on high-quality bonds with maturities approximating the expected period over which benefits will be paid. The rate of compensation increase is based on historical and expected rate increases. We base our rate of expected return on plan assets on historical experience, our </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment guidelines and expectations for long-term rates of return. Our assets are invested in a variety of securities, primarily equity securities and government bonds. These securities are considered Level 1 and Level 2 investments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our U.K. Plan, we utilize the insurance buy-in methodology and base our discount rate on a yield curve reflective of the market pricing obtained in the most recent buy-in transaction, which occurred prior to the acquisition of BTG, and movements in market-observed buy-in pricing as of December&#160;31, 2020. We believe this is a reasonable proxy for an effective settlement rate of the buy-in assets. The discount rate is calculated as the single equivalent assumption that gives the same value of the liabilities as if the figures were calculated using the full yield curve. We assume that all pension increases will continue to be linked to the Retail Price Inflation (RPI), both before and after retirement, for all members, with the exception of post-88 Guaranteed Minimum Pensions (GMP), which will be based on Consumer Price Inflation (CPI). We base our rate of expected return on plan assets as equal to the discount rate used to value the buy-in assets. The U.K. Plan assets' investment policy is to invest in fully matching assets. This has been achieved through the purchase of two buy-in policies (Buy-in contracts), which provide payments designed to equal all future benefit payments due from the fund. As of December&#160;31, 2020, the Buy-in contracts represented 100% of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. As of December 31, 2019, the Buy-in contracts represented 99 percent of the total plan assets, as compared to the target percentage of 100 percent, and are considered Level 3 investments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2020: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2019:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the U.K. Plan Level 3 assets were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Buy-in Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out for benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $102 million in 2020, $98 million in 2019 and $87 million in 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234917432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.748%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at<br/> Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13 (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Credit loss exposure (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Write-offs (c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Charges to<br/>(Deductions from)<br/>Other Accounts (d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at<br/>End of Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for credit losses (b)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for uncollectible accounts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Year Ended December 31, 2018:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Allowances for uncollectible accounts (e)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:20pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Following the adoption of FASB ASC Topic 326 as of January 1, 2020, we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> account. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Amounts shown within credit loss exposure above were established through selling, general and administrative expense. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Beginning in 2020, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for uncollectible accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are referred to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated balance sheets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Represents actual write-offs of uncollectible accounts.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Represents net change in allowances for sales returns, recorded as contra-revenue.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;Following the adoption of FASB ASC Topic 606 as of January 1, 2018, the allowance for sales returns has been reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the consolidated balance sheets and is not included in the ending balance for 2018 above. Prior period balances remain unchanged.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544241721576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SignificantAccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include the accounts of Boston Scientific Corporation and our wholly-owned subsidiaries, after the elimination of intercompany transactions. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. We assess the terms of our investment interests to determine if any of our investees meet the definition of a variable interest entity (VIE)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For any VIEs, we perform an analysis to determine whether our variable interests give us a controlling financial interest. The analysis identifies the primary beneficiary of a VIE as the enterprise that has both 1) the power to direct activities of a VIE that most significantly impact the entity&#8217;s economic performance and 2) the obligation to absorb losses of the entity or the right to receive benefits from the entity. Based on our assessments under the applicable guidance, we did not have controlling financial interests in any VIEs and, therefore, did not consolidate any VIEs during 2020, 2019 or 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-K and Regulation&#160;S-X.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this report are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in millions may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying consolidated balance sheets for potential recognition or disclosure in our consolidated financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare our consolidated financial statements in accordance with U.S. GAAP, management makes estimates and assumptions that may affect the reported amounts of our assets and liabilities, the disclosure of contingent liabilities as of the date of our consolidated financial statements and the reported amounts of our revenues and expenses during the reporting period. Our actual results may differ from these estimates. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Annual Report for further discussion.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated balance sheets at cost, which approximates fair value. Our policy is to invest excess cash in short-term marketable securities earning a market rate of interest without assuming undue risk of loss of principal amounts invested and we limit our direct exposure to securities in any one industry or issuer. We consider to be cash equivalents all short-term marketable securities with remaining days to maturity of 90 days or less from the purchase date that can be readily converted to cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash represent cash on hand required to be set aside by a contractual agreement related to receivable factoring arrangements and deferred compensation plans and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. Generally, the restrictions related to the factoring arrangements lapse at the time we remit the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customer payments collected by us for servicing previously sold customer receivables to the purchaser. Restrictions for deferred compensation lapse when amounts are paid to the employee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash Equivalents</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash equivalents primarily represent amounts paid into various qualified settlement funds related to our ongoing transvaginal surgical mesh litigation and current amounts related to our non-qualified pension plan and are included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caption within our consolidated balance sheets. The restrictions related to the various qualified settlement funds will lapse as we approve amounts payable to claimants, at which time we no longer have rights to a return of the amounts paid into the various qualified settlement funds. Restricted cash equivalents included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets </span>caption within our consolidated balance sheets are related to deferred compensation plans.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration Risk Disclosure [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, derivative financial instruments and accounts and notes receivable. Our investment policy limits exposure to concentrations of credit risk and changes in market conditions. Counterparties to financial instruments expose us to credit-related losses in the event of nonperformance. We transact our financial instruments with a diversified group of major financial institutions with investment grade credit ratings and actively monitor their credit ratings and our outstanding positions to limit our credit exposure. In the normal course, our payment terms with customers, including hospitals, healthcare agencies, clinics, doctors' offices and other private and governmental institutions, are typically 30 days in the U.S. but may be longer in international markets and generally do not require collateral. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We write-off amounts determined to be uncollectible against this reserve. Write-offs of uncollectible accounts receivable were immaterial in 2020, 2019 and 2018. We are not dependent on any single institution, and no single customer accounted for more than ten percent of our net sales in 2020, 2019 and 2018; however, large group purchasing organizations, hospital networks, international distributors and dealers and other buying groups have become increasingly important to our business and represent a substantial portion of our net sales. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions, in both the U.S. and international economies. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, the COVID-19 pandemic has accelerated an ongoing site-of-service trend of shifting procedure volumes toward non-hospital settings, particularly ambulatory surgery centers, driven by considerations surrounding costs, reimbursement policies, advances in minimally invasive treatments and remote patient monitoring. We have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers. Many of these customers are smaller than those we have historically done business with and may have limited liquidity. While certain ambulatory surgery centers are performing an increasing number of procedures in response to the COVID-19 pandemic, others have been negatively impacted by COVID-19 restrictions and mitigation measures. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions, as appropriate. We believe our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span> is adequate as of December&#160;31, 2020 and 2019; however, if significant changes were to occur in the payment practices of government customers, or if there is an increase in bankruptcies among our ambulatory surgery center customers, we may not be able to collect on receivables due to us from these customers, and our write-offs of uncollectible accounts may increase.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products primarily through a direct sales force. In certain international markets, we sell our products through independent distributors or dealers. We consider revenue to be earned when all of the following criteria are met in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a contract with a customer that creates enforceable rights and obligations,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Promised products or services are identified,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The transaction price, or the amount we expect to receive, is determinable and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have transferred control of the promised items to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to provide additional services. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs as a selling expense when incurred. We recognize revenue from consignment arrangements based on product usage, or implant, which indicates that the sale is complete. We recognize a receivable at the point in time we have an unconditional right to payment. Payment terms are typically 30 days in the U.S. but may be longer in international markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record a contract liability, or deferred revenue, when we have an obligation to provide a product or service to the customer and payment is received or due in advance of our performance. When we sell a device with a future service obligation, we defer revenue on the unfulfilled performance obligation and recognize this revenue over the related service period. Many of our Cardiac Rhythm Management product offerings combine the sale of a device with our LATITUDE&#8482; Patient Management System, within our Cardiac Rhythm Management (CRM) business, which represents a future service obligation. Generally, we do not have observable evidence of the standalone selling price related to our future service obligations; therefore, we estimate the selling price using an expected cost plus a margin approach. We allocate the transaction price using the relative standalone selling price method. The use of alternative estimates could result in a different amount of revenue deferral.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> on our accompanying consolidated balance sheets. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Implant Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide non-contractual services to customers to ensure the safe and effective use of certain implanted devices. Because the revenue related to the immaterial services is recognized before they are delivered, we forward accrue the costs to provide these </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services at the time the devices are sold. We record these costs to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. We estimate the amount of time spent by our representatives performing these services and their compensation throughout the device life to determine the service cost.&#160;Changes to our business practice or the use of alternative estimates could result in a different amount of accrued cost.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state inventories at the lower of first-in, first-out cost or net realizable value. We utilize a standard costing system, capitalizing variances between estimated and actual production costs during periods of normal production, and amortize to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over inventory turns. We expense manufacturing variances during periods of abnormal production, or less than 75 percent of manufacturing capacity. During the year ended December 31, 2020, we recorded $149&#160;million of abnormal manufacturing variances attributable to lower production levels resulting from the COVID-19 pandemic and lower than forecasted demand for our products. We did not record any abnormal production variances during the years ended December 31, 2019 or 2018.</span></div>We base our provisions for excess, expired and obsolete inventory primarily on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional provisions for excess, expired and obsolete inventory in the future. Further, the industry in which we participate is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to excess, expired and obsolete inventory.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state property, plant, equipment and leasehold improvements at historical cost. We charge expenditures for maintenance and repairs to expense and capitalize additions and improvements that extend the life of the underlying asset. We provide for depreciation using the straight-line method at rates that approximate the estimated useful lives of the assets. We depreciate buildings over a maximum life of 40&#160;years; building improvements over the remaining useful life of the building structure; equipment, furniture and fixtures over a three to seven year life; and leasehold improvements over the shorter of the useful life of the improvement or the term of the related lease.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Business Combinations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the amounts we pay for each acquisition to the assets we acquire and liabilities we assume based on their fair values at the date of acquisition, including identifiable intangible assets and in-process research and development (IPR&amp;D), which either arise from a contractual or legal right or are separable from goodwill. We base the fair value of identifiable intangible assets acquired in a business combination, including IPR&amp;D, on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimates of inputs and assumptions that a market participant would use. We allocate to goodwill any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Transaction costs associated with these acquisitions are expensed as incurred through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In those circumstances where an acquisition involves a contingent consideration arrangement, we recognize a liability equal to the fair value of the contingent payments we expect to make as of the acquisition date. We re-measure this liability each reporting period and record changes in the fair value through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration net expense (benefit)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on our consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue or timing or likelihood of achieving regulatory, revenue or commercialization-based milestones. Payment of additional consideration is generally contingent on the acquired company reaching certain performance milestones after the acquisition date, including attaining specified revenue </span></div>levels, achieving product development targets and/or obtaining regulatory approvals for products in development at the date of the acquisition.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">In Process Research and Development, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived Intangibles and IPR&amp;D </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indefinite-lived intangible assets, which are not subject to amortization, include acquired balloon and other technology, which is foundational to our ongoing operations within our Cardiovascular and MedSurg businesses, and IPR&amp;D intangible assets acquired in a business combination. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. We classify IPR&amp;D as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of the associated research and development efforts, we will determine the useful life of the technology and begin amortizing the assets to reflect their use over their remaining lives. Upon permanent abandonment, we write-off the remaining carrying amount of the associated IPR&amp;D intangible asset. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the income approach to determine the fair values of our IPR&amp;D. We base our revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected levels of market share. In arriving at the value of the in-process projects, we consider, among other factors, the in-process projects&#8217; stage of completion, the complexity of the work completed as of the acquisition date, the costs already incurred, the projected costs to complete, the contribution of other acquired assets, the expected regulatory path and introduction dates by region and the estimated useful life of the technology. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to indefinite-lived intangibles, including IPR&amp;D.</span></div>For asset purchases outside of business combinations, we expense any purchased research and development assets as of the acquisition date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization and Impairment of Intangible Assets </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record definite-lived intangible assets at historical cost and amortize them over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows: patents and licenses, two to 20&#160;years; amortizable technology-related and customer relationships, five to 25&#160;years; other intangible assets, various.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall or an adverse action or assessment by a regulator. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate fair value of our intangible assets as the present value of estimated future cash flows we expect to generate from the asset. In determining our estimated future cash flows associated with our intangible assets, we use estimates and assumptions about future revenue contributions, cost structures and remaining useful lives of the asset or asset group. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information related to impairments of intangible assets.</span></div>For patents developed internally, we capitalize costs incurred to obtain patents, including attorney fees, registration fees, consulting fees and other expenditures directly related to securing the patent.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Valuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate any excess purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination to goodwill. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. For our 2020 annual impairment assessment, we identified the following reporting units: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the second quarter of&#160;2020, we performed our annual goodwill impairment test utilizing the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, we announced the execution of a definitive agreement pursuant to which we agreed to sell our Specialty Pharmaceuticals business (disposal group) for a purchase price of $800 million, subject to certain adjustments including cash on hand as of the closing date of the transaction. The sale is expected to close in the first half of 2021, subject to customary closing conditions. We acquired our Specialty Pharmaceuticals business in conjunction with the BTG acquisition on August 19, 2019. In connection with the execution of a definitive agreement to sell the disposal group for a specified amount, we performed an impairment assessment of our goodwill and intangible assets, which resulted in a goodwill impairment of $73 million. As of December 31, 2020, we classified the remaining assets and liabilities of the disposal group as held for sale within our consolidated balance sheets at their respective carrying values, which approximates fair value, less cost to sell. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements for additional details related to our goodwill balances.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text">Income Taxes<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the asset and liability method of accounting for income taxes. Under this method, we determine deferred tax assets and liabilities based on differences between the financial reporting and tax bases of our assets and liabilities. We measure deferred tax assets and liabilities using the enacted tax rates and laws that will be in effect when we expect the differences to reverse. We reduce our deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that we will not realize some portion or all of the deferred tax assets. We consider relevant evidence, both positive and negative, to determine the need for a valuation allowance. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as estimates of the impact of future taxable income and available prudent and feasible tax-planning strategies. We recognize interest and penalties related to income taxes as a component of income tax expense. As part of the Tax Cuts and Jobs Act (TCJA), we are subject to a territorial tax system in which we are required to establish an accounting policy in providing for tax on Global Intangible Low Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to treat the impact of GILTI as a period cost and report it as part of continuing operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Income Taxes</span> for further information and discussion of our income tax provision and balances including a discussion of the impacts of the TCJA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal and Product Liability Costs </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are involved in various legal and regulatory proceedings, including intellectual property, breach of contract, securities litigation and product liability suits. In some cases, the claimants seek damages, as well as other relief, which, if granted, could require significant expenditures or impact our ability to sell our products. We are also the subject of certain governmental investigations, which could result in substantial fines, penalties and administrative remedies. We maintain an insurance policy providing limited coverage against securities claims, and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. We accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue our best estimate of the minimum amount of the range. We analyze litigation settlements to identify each element of the arrangement. We allocate arrangement consideration to patent licenses received based on estimates of fair value and capitalize these amounts as assets if the license will provide an ongoing future benefit. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations; all other legal and product liability charges, credits and costs are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of our individual material legal proceedings.</span></div><span></span>
</td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy', window );">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs Associated with Exit Activities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record employee termination costs in accordance with FASB ASC Topic 712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Nonretirement and Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if we pay the benefits as part of an ongoing benefit arrangement, which includes benefits provided as part of our established severance policies or that we provide in accordance with international statutory requirements. We accrue employee termination costs associated with an ongoing benefit arrangement if the obligation is attributable to prior services rendered, the rights to the benefits have vested, the payment is probable and we can reasonably estimate the liability. We account for involuntary employee termination benefits that represent a one-time benefit in accordance with FASB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 420</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. We record such costs into expense over the employee&#8217;s future service period, if any. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other costs associated with exit activities may include contract termination costs and consulting fees, which are expensed in accordance with FASB ASC Topic 420 and are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. Additionally, costs directly related to our active restructuring initiatives, including program management costs, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities are included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our consolidated statements of operations. Impairment of right of use lease assets and lease termination costs directly related to our active restructuring initiatives are expensed in accordance with FASB ASC Topic 842 and included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our consolidated statements of operations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information and discussion of our restructuring plans.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translations Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Translation of Foreign Currency</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate all assets and liabilities of foreign subsidiaries from the functional currency, which is generally the local currency, into U.S. dollars using the year-end exchange rate. We show the net effect of these translation adjustments in our consolidated financial statements as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We translate revenues and expenses at the average exchange rates in effect during the year. For any significant foreign subsidiaries located in highly inflationary economies, we would re-measure their financial statements as if the functional currency were the U.S. dollar. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency transaction gains and losses are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span>in our consolidated statements of operations, net of losses and gains from any related derivative financial instruments.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock', window );">ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development (R&amp;D) costs, including new product development programs, regulatory compliance and clinical research as incurred. Refer to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Indefinite-lived Intangibles and IPR&amp;D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for our policy regarding R&amp;D projects acquired in connection with our business combinations and asset purchases.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Publicly Traded and Privately Held Entities </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For publicly-held equity securities for which we do not have the ability to exercise significant influence, we measure at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within our accompanying consolidated statements of operations. For privately-held equity securities for which we do not have the ability to exercise significant influence, we apply the measurement alternative approach and measure these investments at cost minus impairment, if any, adjusted to fair value for any, observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We account for investments in entities over which we have the ability to exercise significant influence under the equity method if we hold 50&#160;percent or less of the voting stock and the entity is not a VIE in which we are the primary beneficiary in accordance with FASB ASC Topic 323, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investments - Equity Method and Joint Ventures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. We record these investments initially at cost and adjust the carrying amount to reflect our share of the earnings or losses of the investee, including all adjustments similar to those made in preparing consolidated financial statements. Lastly, we have notes receivable from certain companies that we account for in accordance with FASB ASC Topic 320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">, Investments - Debt and Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for additional details on our investment balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we evaluate our investments to determine if there are any events or circumstances that are likely to have a significant adverse effect on the fair value of the investment. Examples of such impairment indicators include, but are not limited to, a significant deterioration in earnings performance, recent financing rounds at reduced valuations, a significant adverse change in the regulatory, economic or technological environment of an investee or a significant doubt about an investee&#8217;s ability to continue as a going concern. If we identify an impairment indicator, we will estimate the fair value of the investment and compare it to its carrying value. Our estimation of fair value considers financial information related to the investee available to us, including valuations based on recent third-party equity investments in the investee. For our investments for which we apply the measurement alternative, if the fair value of the investment is less than its carrying value, the investment </span></div>is impaired and we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. For our equity method investments, if we determine an impairment is other-than-temporary, we recognize an impairment loss equal to the difference between an investment&#8217;s carrying value and its fair value. We deem an impairment to be other-than-temporary unless available evidence indicates that the valuation is more likely than not to recover up to the carrying value of the investment in a reasonable period of time, and we have both the ability and intent to hold the investment for at least the period of time needed to recover the value. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses and impairments associated with our investment portfolio are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span>in our consolidated statements of operations.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Standard Product Warranty, Policy</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer warranties on certain of our product offerings. The majority of our warranty liability relates to implantable devices offered by our CRM business, which include implantable defibrillator and pacemaker systems. These products come with a standard limited warranty covering the replacement of these devices. We offer a full warranty for a portion of the period post-implant and a partial warranty for a period of time thereafter. We estimate the costs that we may incur under our warranty programs based on the number of units sold, historical and anticipated rates of warranty claims and cost per claim and record a liability equal to these estimated costs as cost of products sold at the time the product sale occurs. We assess the adequacy of our recorded warranty liabilities on a quarterly basis and adjust these amounts as necessary.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling, General and Administrative Expenses, Policy</a></td>
<td class="text">Shipping and Handling Costs<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not bill customers for shipping and handling of our products. We treat shipping and handling costs incurred after a customer obtains control of the good as a fulfillment cost and record in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span>within our consolidated statements of operations. Shipping and handling costs were $146 million in 2020, $144 million in 2019 and $124 million in 2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544231919784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize all derivative financial instruments in our consolidated financial statements at fair value in accordance with FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we present assets and liabilities associated with our derivative financial instruments on a gross basis in our financial statements. In accordance with FASB ASC Topic 815, for those derivative instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. The accounting for changes in the fair value of a derivative instrument depends on whether it qualifies for, and has been designated as part of a hedging relationship, as well as on the type of hedging relationship. Our derivative instruments do not subject our earnings to material risk, as gains and losses on these derivatives generally offset gains and losses on the item being hedged, and we do not enter into derivative transactions for speculative purposes. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information on our hedging instruments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span>, and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544245437192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock', window );">ASC Update No. 2016-13 Financial Instruments - Credit Losses (FASB ASC Topic 326, Financial Instruments - Credit Losses)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2016-13</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASC Update No. 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">account. The adoption had an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock', window );">ASC Update No. 2018-15 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-15</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock', window );">ASC Update No. 2018-18 Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-18</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASC Update No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock', window );">ASC Update No. 2020-10 Codification Improvements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning </span></div>after December 15, 2020, for public business entities. We plan to adopt Update No. 2020-10 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock', window );">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We plan to early adopt Update No. 2020-06 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock', window );">ASC Update No. 2019-12, Income Taxes (Topic 740)</a></td>
<td class="text">ASC Update No. 2019-12 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Simplifying the Accounting for Income Taxes</span>. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods. We plan to adopt Update No. 2019-12 in the first quarter of 2021 and expect it will have an immaterial impact on our financial position and results of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock', window );">ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-15</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2016-13 Financial Instruments - Credit Losses (FASB ASC Topic 326, Financial Instruments - Credit Losses)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2018-15 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2018-18 Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2019-12, Income Taxes (Topic 740)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-10 Codification Improvements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234692584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans Employee Retirement Plans (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy', window );">Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a December&#160;31 measurement date for these plans and record the net unfunded and underfunded portion as a liability within non-current liabilities, with the current portion within accrued expenses, on the consolidated balance sheets, recognizing changes primarily through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension plans. This accounting policy may address (1) the types of plans sponsored by the entity (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544334916504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration arrangements transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$104 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$93 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Investment [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">458</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,785</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text">The final purchase prices were comprised of the following components:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,948</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,948</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234904488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets and Liabilities Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the major classes of assets and liabilities of the disposal group as of December 31, 2020 are presented below:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities held for sale included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Other current liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233596472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Goodwill Impairment Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization/Goodwill Impairment Charges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,195)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,973)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">377</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">782</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,063</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,911</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill divested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency fluctuations and other changes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill reclassified to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Current assets held for sale</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,059</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Expected Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December&#160;31, 2020 is as follows (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:83.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.127%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544245604872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions (Table Text Block)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.213%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note Q &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock', window );">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:30.564%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.727%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments (Table Text Block)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:41.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.129%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.035%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Table Text Block)</a></td>
<td class="text">The following are the balances of our derivative and nonderivative assets and liabilities:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.850%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.559%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.497%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The &#8364;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:31.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,998</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our consolidated balance sheets as of December&#160;31, 2020 include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$365 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$407 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#bfe4ff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded related to current year acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">571</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233652456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.744%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022 Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount and Deferred Financing Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,592</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which was a variable-rate instrument based on LIBOR.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock', window );">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.046%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.047%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement<br/>as of December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual<br/>as of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.48 times</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</a></td>
<td class="text">Amounts de-recognized for accounts and notes receivable, which are excluded from <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying consolidated balance sheets, are aggregated by contract denominated currency below (in millions): </span><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renminbi denominated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Renminbi denominated factoring arrangement was entered into in 2020 and had remaining capacity available as of December 31, 2020. There were no amounts de-recognized for accounts receivable as of December 31, 2020 associated with this arrangement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentTextBlock', window );">Long-term Purchase Commitment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecorded Purchase Obligations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">535</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 days</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 days</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of term loan and revolving credit facility agreement compliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544234960824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock', window );">Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text">The following table presents supplemental balance sheet information related to our operating leases:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to our operating leases:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information related to our operating leases:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:52.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock', window );">Maturities of Lease Liabilities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturities of our operating lease liabilities as of December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">530</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maturities of Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Cash Flow Information Related to Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Cash Flow Information Related to Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544245428008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Related Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring and Related Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Impact of restructuring costs on the accompanying financial statements</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring and restructuring-related net charges (credits) by major type and line item within our accompanying consolidated statements of operations (in millions): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Termination<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Transfer Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesTableTextBlock', window );">Cumulative Restructuring Charges [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cumulative restructuring and restructuring-related net charges incurred as of December&#160;31, 2020, related to our ongoing Restructuring Plans by major type: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring charges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to our Restructuring Plans, including program management, accelerated depreciation, and fixed asset write-offs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock', window );">Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative cash payments associated with our ongoing Restructuring Plans were made using cash generated from operations and are comprised of the following: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 Restructuring Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">369</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember', window );">2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring and Related Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Impact of restructuring costs on the accompanying financial statements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our estimates of total pre-tax charges associated with the 2019 Restructuring Plan, including the expansion, by major type of cost, of which approximately $340 million to $440 million are expected to result in cash outlays:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Estimated Amount Expected to be Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$75</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$375</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$475 </span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contractual cancellations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the restructuring program, including program management, accelerated depreciation, fixed asset write-offs, and costs to transfer product lines among facilities.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember', window );">2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring and Related Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Impact of restructuring costs on the accompanying financial statements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of total pre-tax charges associated with the 2016 Restructuring Plan by major type of cost, of which approximately $255 million resulted in cash outlays:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount Incurred</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring charges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring-related expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">271</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Consists primarily of consulting fees and costs associated with contract cancellations.</span></div>(2)&#160;&#160;&#160;&#160;Comprised of other costs directly related to the 2016 Restructuring Plan, including program management, accelerated depreciation, fixed asset write-offs and costs to transfer product lines among facilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid in the period to fully or partially settle a specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeRestructuringChargesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeRestructuringChargesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544245566200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Trade accounts receivable, net [Table Text Block]</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,828</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 310</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note R &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,579</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">880</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment, net [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,084</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other long-term liabilities [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544242040680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Tax rate</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income taxes at the federal statutory rate to the actual expense (benefit) for income taxes is as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(reclassified)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic taxes on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TCJA net impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intra-entity asset transfers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(584.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Due to the disclosure of additional rate reconciling items in 2020, we have reclassified select items in prior years to align with the new categories disclosed in the current year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Summary of Income Tax Contingencies [Table Text Block]</a></td>
<td class="text">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,238</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements with taxing authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statute of limitation expirations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,145)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,422</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit of net operating loss and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves and accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and product liability reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal benefit of uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,696&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains and losses on derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment write-up</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs and related reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,796</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets, deferred tax liabilities and prepaid on intercompany profit, are included in the following locations within our accompanying consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Balance Sheets</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Component</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid on intercompany profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Tax Assets and Prepaid on Intercompany Profit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,796</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related expense (benefit) for income taxes consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.969%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.970%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,288)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,013)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(249)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544353275144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive and Purchase Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems', window );"><strong>Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock', window );">Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our assumptions used in determining the fair value of our AFCF awards currently expected to vest as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019 AFCF</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018 AFCF</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, net of forfeitures to date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achievement of target payout</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-end stock price used in determining fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the impact of stock-based compensation on our consolidated statements of operations:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact per common share - assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Black-Scholes option-pricing model to calculate the grant-date fair value of stock options granted to employees under our stock incentive plans. We calculated the fair value for options granted using the following estimated weighted-average assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.201%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant-date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Black-Scholes Assumptions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years, weighted)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.01%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]</a></td>
<td class="text">Information related to non-vested stock awards is as follows:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Award Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date <br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(748)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,683</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,811)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of shares vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock', window );">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:51.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued or to be issued&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Range of purchase prices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.29</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36.47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.49</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27.91</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense recognized&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="7" style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to recognize the following future expense for awards outstanding as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Cost</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts presented represent compensation cost, net of estimated forfeitures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock', window );">Market-based awards, valuation assumptions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the market-based DSU awards to be approximately $8 million for 2020, $10 million for 2019 and $7 million for 2018. We determined these fair values based on Monte Carlo simulations as of the date of grant, utilizing the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price on date of grant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.09&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> (in years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to stock options under stock incentive plans are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:49.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.815%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,716</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,096)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,105&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total vested and expected to vest as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,787</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Market-based awards, valuation assumptions [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of employee stock purchase plan activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544465335416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,416.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,381.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,416.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,401.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in this period.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544242772888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows (in millions, except percentages):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,694&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock', window );">Reconciliation of depreciation by reportable segment to total [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated depreciation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">333</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(372)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">687</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,422</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock', window );">Segment operating income as percentage of net sales [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,211&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,782&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,477</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of depreciation by reportable segment to total [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment operating income as percentage of net sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233569192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions): <div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,701</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,212</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,538</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,286</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,694</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,654</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,735</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544235030856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544242151496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension and Other Postretirement Plans, Policy [Policy Text Block]</a></td>
<td class="text">We also sponsor a voluntary 401(k) Retirement Savings Plan for eligible employees. We match 200&#160;percent of employee elective deferrals for the first two percent of employee eligible compensation and 50 percent of employee elective deferrals greater than two percent, but not exceeding six percent, of employee eligible compensation. Total expense for our matching contributions to the plan was $102 million in 2020, $98 million in 2019 and $87 million in 2018.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]</a></td>
<td class="text">The outstanding obligation is as follows:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:44.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded<br/>PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:44.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation (ABO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Projected<br/>Benefit<br/>Obligation (PBO)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded/Underfunded PBO Recognized</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">466</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the PBO for our retirement plans is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendments and assumption changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending obligation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</a></td>
<td class="text">The following assumptions were used to measure the fair value of the benefit obligation and associated plan assets as of the August 19, 2019 measurement date:<div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.292%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rate of Compensation Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the measurement date of August&#160;19, 2019, the funded status was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:84.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2020 are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:45.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.083%"/><td style="width:0.1%"/></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical assumptions associated with our employee retirement plans for 2019 are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Expected Return on Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Rate of Compensation Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.94%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K. Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International Retirement Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.65%</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Rates of compensation increase were not weighted by the relative fair value of the instruments. As such, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December&#160;31, 2020: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value hierarchy of the U.K. Plan assets measured at fair value as of December 31, 2019:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-in contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the changes in the fair value of plan assets for our funded retirement plans is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the U.K. Plan Level 3 assets were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Buy-in Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out for benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544233373544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies Significant Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">$ 3,787<span></span>
</td>
<td class="nump">$ 3,941<span></span>
</td>
<td class="nump">$ 3,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductionRelatedImpairmentsOrCharges', window );">Production Related Impairments or Charges</a></td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionRelatedImpairmentsOrCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionRelatedImpairmentsOrCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544223052184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments (Details)<br> &#163; / shares in Units, $ / shares in Units, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 21, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 21, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>GBP (&#163;) </div>
<div>&#163; / shares</div>
</th>
<th class="th">
<div>Jun. 11, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 16, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 02, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 16, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of certain businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,951<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
<td class="nump">7,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4,382<span></span>
</td>
<td class="nump">1,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(196)<span></span>
</td>
<td class="num">(354)<span></span>
</td>
<td class="num">(347)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 8.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,023<span></span>
</td>
<td class="nump">&#163; 3,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash Acquired from Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(308)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Global Peripheral Interventions (PI) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_DivestedBusinessDueToBTGAcquisitionMember', window );">Divested Business due to BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of certain businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesFairValueDisclosure', window );">Guarantees, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor Obligations, Maximum Exposure, Undiscounted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember', window );">Vertiflex, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate', window );">Contingent consideration payments made to prior shareholders to date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_MillipedeMember', window );">Millipede [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | In Process Research and Development [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | Technology-Based Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) | Other Intangible Assets [Member] | Weighted Average (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_AugmenixInc.Member', window );">Augmenix, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate', window );">Contingent consideration payments made to prior shareholders to date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_ClaretMedicalIncMember', window );">Claret Medical, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_CryterionMedicalIncMember', window );">Cryterion Medical, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_NxTheraIncMember', window );">NxThera, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate', window );">Contingent consideration payments made to prior shareholders to date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_NVisionMedicalCorporationMember', window );">nVision Medical Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_Other2018AcquisitionsMember', window );">Other 2018 Acquisitions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member] | In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member] | Technology-Based Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member] | Technology-Based Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member] | Other Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember', window );">2018 Acquisitions [Member] | Other Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Asset, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember', window );">Preventice Solutions, Inc. [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">$ 720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration payments made to prior shareholders to date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from secured borrowings relating to royalty arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of guarantee, including, but not limited to, financial standby letter of credit, fair value guarantee, guarantee of collection of scheduled contractual cash flows from financial assets, and contracts that contingently require the guarantor to make payments or perform services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12201-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_DivestedBusinessDueToBTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_DivestedBusinessDueToBTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_MillipedeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_MillipedeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_AugmenixInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_AugmenixInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_ClaretMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_ClaretMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_CryterionMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_CryterionMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_NxTheraIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_NxTheraIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_NVisionMedicalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_NVisionMedicalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_Other2018AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_Other2018AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2018AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544238253896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="nump">$ 347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average (Member) | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average (Member) | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration liability, probability of payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationLiabilityProbabilityOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of contingent consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544242205992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</a></td>
<td class="nump">$ 272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Measurement alternative investments (1)</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">414<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Notes receivable</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">$ 458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized Gain (Loss) on Investments</a></td>
<td class="nump">$ 363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544240158152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Assets and Liabilities Held for Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">$ 1,133<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Disposal Group, Including Discontinued Operation, Inventory, Current</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets', window );">Disposal Group, Including Discontinued Operation, Other Assets, Current</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent', window );">Disposal Group, Including Discontinued Operation, Goodwill, Current</a></td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent', window );">Disposal Group, Including Discontinued Operation, Intangible Assets, Current</a></td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent', window );">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent', window );">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable', window );">Disposal Group, Including Discontinued Operation, Non-current deferred tax liability, Current</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as income tax obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544323515384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 13,345<span></span>
</td>
<td class="nump">$ 14,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(7,806)<span></span>
</td>
<td class="num">(7,195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, Gross</a></td>
<td class="nump">19,924<span></span>
</td>
<td class="nump">20,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="num">(9,973)<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">377<span></span>
</td>
<td class="nump">782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,951<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
<td class="nump">7,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(73)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherIntangibleAssetsTextualsAbstract', window );"><strong>Other Intangible Assets (Textuals) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Future Amortization Expense, Year One</a></td>
<td class="nump">689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Future Amortization Expense, Year Two</a></td>
<td class="nump">664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Future Amortization Expense, Year Three</a></td>
<td class="nump">651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Future Amortization Expense, Year Four</a></td>
<td class="nump">613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Future Amortization Expense, Year Five</a></td>
<td class="nump">560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
<td class="nump">2,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember', window );">Rhythm and Neuro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">2,192<span></span>
</td>
<td class="nump">1,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,697<span></span>
</td>
<td class="nump">5,676<span></span>
</td>
<td class="nump">3,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GoodwillTextualsAbstract', window );"><strong>Goodwill (Roll Forward)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">11,059<span></span>
</td>
<td class="nump">12,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(6,179)<span></span>
</td>
<td class="num">(5,706)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(408)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Other Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">1,775<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (1,220)<span></span>
</td>
<td class="num">$ (1,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_GoodwillTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill (Textuals) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_GoodwillTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherIntangibleAssetsTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Intangible Assets (Textuals) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherIntangibleAssetsTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544244438664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Payments for Hedge, Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet', window );">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,349<span></span>
</td>
<td class="nump">10,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,465<span></span>
</td>
<td class="nump">3,116<span></span>
</td>
<td class="nump">2,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Derivative financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other Operating Income (Expense), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(362)<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetCurrencyExchangeGainLoss', window );">Foreign exchange (gain) loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Fair Value, Gross Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liability, Fair Value, Gross Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,774<span></span>
</td>
<td class="nump">11,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember', window );">November 2019 Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,105<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementAssetsMember', window );">Licensing arrangement assets (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_EuroDenominatedOutstandingDebtMember', window );">Euro-denominated outstanding debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,118<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements', window );">Proceeds from royalty rights transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,605<span></span>
</td>
<td class="nump">890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
<td class="nump">1,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">603<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Licensing arrangement assets (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair Value of Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Licensing arrangement liabilities (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair Value of Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,094<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ForwardCurrencyContractsTimetoMaturity', window );">Forward Currency Contracts, Time to Maturity | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="num">(343)<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetCurrencyExchangeGainLoss', window );">Foreign exchange (gain) loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Net gain (loss) from foreign currency transaction exposures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Payments for Hedge, Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | BTG Acquisition [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(323)<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,946<span></span>
</td>
<td class="nump">4,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCashReceivedOnHedge', window );">Derivative, Cash Received on Hedge</a></td>
<td class="nump">$ 4,303<span></span>
</td>
<td class="nump">&#163; 3,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average (Member) | Licensing arrangement assets (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average (Member) | Licensing arrangement liabilities (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing arrangement liabilities (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing arrangement liabilities (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Foreign Exchange Contract (Member) | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,531<span></span>
</td>
<td class="nump">3,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Derivative financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Derivative financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Foreign Exchange Contract (Member) | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet', window );">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract (Member) | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign currency denominated in debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">868<span></span>
</td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign currency denominated in debt [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ForwardCurrencyContractsTimetoMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forward Currency Contracts, Time to Maturity in Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ForwardCurrencyContractsTimetoMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NetCurrencyExchangeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NetCurrencyExchangeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from secured borrowings relating to royalty arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCashReceivedOnHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period on settlement of a hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCashReceivedOnHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) recognized in earnings during the reporting period representing the amount of the cash flow hedges' ineffectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_EuroDenominatedOutstandingDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_EuroDenominatedOutstandingDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingArrangementLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeignCurrencyDenominatedInDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeignCurrencyDenominatedInDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544221423672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 18, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 19, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Capital Lease Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DeemedConsolidatedEBITDA', window );">Deemed Consolidated EBITDA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ExclusionFromEbitdaForRestructuringCharges', window );">Exclusion from EBITDA for Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LitigationAndDebtExclusionFromEbitda', window );">Litigation and Debt Exclusion from EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Legal payments remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Seniornotesissued', window );">Senior notes issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest', window );">Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Purchase Obligations, Future Minimum Payments Due, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Purchase Obligations, Future Minimum Payments, Due in Two Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Purchase Obligations, Future Minimum Payments, Due in Three Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">Purchase Obligations, Future Minimum Payments, Due in Four Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFifthYear', window );">Purchase Obligations, Future Minimum Payments, Due in Five Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueAfterFifthYear', window );">Purchase Obligations, Future Minimum Payments, Due Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase Obligations, Future Minimum Payments Due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumCommercialPaperOutstanding', window );">Maximum Commercial Paper Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_WeightedAverageMaturityDays', window );">Weighted Average Maturity, Days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 days<span></span>
</td>
<td class="text">55 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Short-term Debt, Weighted Average Interest Rate, at Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_CurrentRequirementMember', window );">Current Requirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_ActualCovenantMember', window );">Actual, Covenant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember', window );">Requirement, third quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember', window );">Requirement, fourth quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember', window );">Requirement, fifth quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember', window );">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementExtensionThroughTheRemainderOf2020Member', window );">Requirement, extension through the remainder of 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain', window );">the 2018 Facility [Domain] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember', window );">February 2019 Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember', window );">May 2020 SN Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember', window );">January 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember', window );">May 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.85%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember', window );">November 2019 Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember', window );">May 2022 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.375%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember', window );">October 2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.125%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember', window );">March 2024 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.45%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember', window );">May 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.85%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember', window );">June 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember', window );">March 2026 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.75%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.625%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember', window );">March 2028 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember', window );">March 2029 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember', window );">June 2030 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.65%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember', window );">November 2035 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember', window );">March 2039 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.55%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember', window );">January 2040 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.375%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember', window );">March 2049 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_August2022TermLoanMember', window );">August 2022 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember', window );">Unamortized Gain on Fair Value Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember', window );">Finance Lease Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_August2019TermLoanMember', window );">August 2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember', window );">April 2021 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember', window );">2020 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember', window );">February 2021 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.85%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember', window );">Three-Year Delayed Draw Term Loan [Member] | Debt Instrument, Redemption, Period Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember', window );">Two-Year Delayed Draw Term Loan [Member] | Debt Instrument, Redemption, Period Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember', window );">Aggregate Senior Unsecured Delayed Draw Term Loan [Member] | Unsecured Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember', window );">Euro Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember', window );">Yen Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember', window );">Renminbi Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DeemedConsolidatedEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed Consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DeemedConsolidatedEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ExclusionFromEbitdaForRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion from EBITDA for Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ExclusionFromEbitdaForRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal payments remaining to be excluded from calculation of consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationAndDebtExclusionFromEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationAndDebtExclusionFromEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumCommercialPaperOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Commercial Paper Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumCommercialPaperOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio permitted by revolving credit facility agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Seniornotesissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Senior notes issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Seniornotesissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_WeightedAverageMaturityDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Maturity, Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_WeightedAverageMaturityDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:durationStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_CurrentRequirementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_CurrentRequirementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_ActualCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_ActualCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementExtensionThroughTheRemainderOf2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementExtensionThroughTheRemainderOf2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_August2022TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_August2022TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_August2019TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_August2019TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544241190136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 458<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">10 years 6 months<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent Expense, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths', window );">Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo', window );">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree', window );">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour', window );">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five</a></td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, to be Paid</a></td>
<td class="nump">530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LesseeLeasesNotYetCommencedAmount', window );">Lessee, Leases Not Yet Commenced, Amount</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 401<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">56 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend', window );">Lessee, Operating and Finance Leases, Option to Extend</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LesseeLeasesNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Leases Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LesseeLeasesNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LesseeOperatingAndFinanceLeasesOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Leases, Option to Extend</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LesseeOperatingAndFinanceLeasesOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544237253032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Related Activities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember', window );">2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember', window );">2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bsx_LotusDiscontinuationMember', window );">Lotus Discontinuation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance Costs</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member] | 2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other Restructuring Costs</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Restructuring [Member] | 2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringChargesIncurredToDate', window );">Cumulative Restructuring Charges Incurred to Date</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember', window );">Transfer costs [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TransferCosts', window );">Transfer Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Restructuring and Related Cost, Incurred Cost</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember', window );">Transfer costs [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember', window );">Transfer costs [Member] | 2016 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate', window );">Cumulative Restructuring-related Costs Incurred to Date</a></td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate', window );">Cumulative Restructuring and Restructuring-Related Payments Made To Date</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost', window );">Restructuring and Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureCashFlowsAmount', window );">Effect on Future Cash Flows, Amount</a></td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Lotus Discontinuation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost', window );">Restructuring and Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureCashFlowsAmount', window );">Effect on Future Cash Flows, Amount</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost', window );">Restructuring and Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureCashFlowsAmount', window );">Effect on Future Cash Flows, Amount</a></td>
<td class="nump">340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Lotus Discontinuation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost', window );">Restructuring and Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOnFutureCashFlowsAmount', window );">Effect on Future Cash Flows, Amount</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringRelatedToPlanMember', window );">Restructuring Related To Plan [Member] | Maximum [Member] | Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringrelatedCostExpectedCost', window );">Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringRelatedToPlanMember', window );">Restructuring Related To Plan [Member] | Minimum [Member] | Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringrelatedCostExpectedCost', window );">Restructuring-related Cost, Expected Cost</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member] | Maximum [Member] | Employee Severance [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member] | Maximum [Member] | Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member] | Minimum [Member] | Employee Severance [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember', window );">Restructuring Plan [Member] | Minimum [Member] | Other Restructuring [Member] | 2019 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member] | Employee Severance [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member] | Other Restructuring [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member] | Transfer costs [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Lotus Discontinuation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Employee Severance [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Other Restructuring [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member] | Transfer costs [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Employee Severance [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Other Restructuring [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member] | Transfer costs [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringRelatedExpenses', window );">Restructuring Related Expenses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Restructuring and Restructuring-Related Payments Made To Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeRestructuringChargesIncurredToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Restructuring Charges Incurred to Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeRestructuringChargesIncurredToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CumulativeRestructuringRelatedCostsIncurredToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Restructuring-related Costs Incurred to Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CumulativeRestructuringRelatedCostsIncurredToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring related expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringandRestructuringrelatedCostExpectedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Restructuring-related Cost, Expected Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringandRestructuringrelatedCostExpectedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringrelatedCostExpectedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring-related Cost, Expected Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringrelatedCostExpectedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TransferCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transfer Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TransferCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOnFutureCashFlowsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The quantified amount of the future effect on cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOnFutureCashFlowsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_A2019RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_A2016RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bsx_LotusDiscontinuationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bsx_LotusDiscontinuationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bsx_TransferCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringRelatedToPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringRelatedToPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis=bsx_RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544236212296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherCurrentAssetsAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
<td class="nump">$ 655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangements', window );">Licensing arrangements</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other Assets, Miscellaneous, Current</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">751<span></span>
</td>
<td class="nump">880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Trade accounts receivable, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Trade accounts receivable</a></td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">1,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,531<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Allowance for doubtful accounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss (beginning balance)</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASC 2016-13</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Net (credits) charges to expenses</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Utilization of allowances</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss (ending balance)</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">893<span></span>
</td>
<td class="nump">971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,351<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EquipmentFurnitureAndFixturesGross', window );">Equipment, furniture and fixtures</a></td>
<td class="nump">3,465<span></span>
</td>
<td class="nump">3,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Capital in progress</a></td>
<td class="nump">446<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">5,308<span></span>
</td>
<td class="nump">5,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="nump">3,224<span></span>
</td>
<td class="nump">3,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 2,084<span></span>
</td>
<td class="nump">$ 2,079<span></span>
</td>
<td class="nump">1,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract', window );"><strong>Supplemental Balance Sheet Information (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PercentOfFinishedGoodsAtConsignment', window );">Percent of finished goods at consignment</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 333<span></span>
</td>
<td class="nump">$ 311<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted Cash Equivalents included in Other long-term assets</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">458<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAsset', window );">Licensing arrangements, asset</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherOtherLongTermAssets', window );">Other, Other Long-term Assets</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets (total)</a></td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal reserves</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related liabilities</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AccruedRebatesCurrent', window );">Accrued Rebates, Current</a></td>
<td class="nump">331<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">656<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities, current</a></td>
<td class="nump">2,197<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued Royalties, Current</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes Payable, Current</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other Sundry Liabilities, Current</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">958<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,309<span></span>
</td>
<td class="nump">2,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued Income Taxes, Noncurrent</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Estimated Litigation Liability, Noncurrent</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued Income Taxes, Noncurrent</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Estimated Litigation Liability, Noncurrent</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsLiability', window );">Licensing arrangements, liability</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">$ 615<span></span>
</td>
<td class="nump">$ 535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AccruedRebatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Rebates, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AccruedRebatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EquipmentFurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equipment, furniture and fixtures Gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EquipmentFurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherOtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, Other Long-term Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherOtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PercentOfFinishedGoodsAtConsignment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of finished goods at consignment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PercentOfFinishedGoodsAtConsignment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information (Textuals)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544240206888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details - Rate Table)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems', window );"><strong>Schedule of Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate</a></td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">Effective Income Tax Rate Reconciliation, State and Local Income Taxes</a></td>
<td class="nump">16.60%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</a></td>
<td class="nump">155.40%<span></span>
</td>
<td class="nump">21.90%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential</a></td>
<td class="num">(40.70%)<span></span>
</td>
<td class="num">(47.60%)<span></span>
</td>
<td class="num">(8.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense</a></td>
<td class="num">(16.70%)<span></span>
</td>
<td class="num">(12.20%)<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Effective Income Tax Rate Reconciliation, Tax Credits, Research</a></td>
<td class="num">(43.00%)<span></span>
</td>
<td class="num">(4.20%)<span></span>
</td>
<td class="num">(2.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance</a></td>
<td class="num">(42.00%)<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="num">(5.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">effective income tax reconciliation, compensation-related</a></td>
<td class="num">(7.70%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</a></td>
<td class="nump">64.40%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions', window );">Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</a></td>
<td class="num">(96.80%)<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="num">(22.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact', window );">Effective Income Tax Rate Reconciliation, TCJA net impact</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(4.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers', window );">Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</a></td>
<td class="nump">10.20%<span></span>
</td>
<td class="num">(597.00%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision', window );">Effective Income Tax Rate Reconciliation, Return to provision</a></td>
<td class="num">(37.30%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</a></td>
<td class="nump">51.80%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Effective Income Tax Rate Reconciliation, Other Adjustments</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="num">(2.40%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported tax rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="num">(584.00%)<span></span>
</td>
<td class="num">(17.50%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Return to provision</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, TCJA net impact</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544241355800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income Taxes (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (Loss) from Continuing Operations before Income Taxes, Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (660)<span></span>
</td>
<td class="num">$ (1,145)<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income (Loss) from Continuing Operations before Income Taxes, Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">581<span></span>
</td>
<td class="nump">1,832<span></span>
</td>
<td class="nump">1,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">1,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current Federal Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="num">(221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current State and Local Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current Foreign Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred Federal Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred State and Local Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred Foreign Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(4,124)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(4,288)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4,013)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Deferred Tax Assets, Inventory</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Deferred Tax Assets, Operating Loss Carryforwards</a></td>
<td class="nump">557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557<span></span>
</td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</a></td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FederalBenefitOfUncertainTaxPositions', window );">Federal benefit of uncertain tax positions</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Deferred Tax Assets, Goodwill and Intangible Assets</a></td>
<td class="nump">3,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,551<span></span>
</td>
<td class="nump">3,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Deferred Tax Assets, Other</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Deferred Tax Assets, Tax Deferred Expense</a></td>
<td class="nump">4,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="nump">4,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="num">(887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(887)<span></span>
</td>
<td class="num">(915)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred Tax Assets, Net of Valuation Allowance</a></td>
<td class="nump">3,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,781<span></span>
</td>
<td class="nump">3,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Deferred Tax Liabilities, Property, Plant and Equipment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDerivatives', window );">Deferred Tax Liabilities, Derivatives</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Deferred Tax Liabilities, Goodwill and Intangible Assets, Intangible Assets</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts', window );">Deferred Tax Liabilities, Inventory</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Deferred Tax Liabilities, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred Tax Liabilities, Gross</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Assets, Gross</a></td>
<td class="nump">3,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,734<span></span>
</td>
<td class="nump">3,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit', window );">Deferred Tax Assets, Prepaid on Intercompany Profit</a></td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit', window );">Net Deferred Tax Liabilities and Prepaid on Intercompany Profit</a></td>
<td class="nump">3,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,928<span></span>
</td>
<td class="nump">3,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets</a></td>
<td class="nump">4,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,406<span></span>
</td>
<td class="nump">4,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="nump">478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</a></td>
<td class="nump">474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="nump">449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</a></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory', window );">Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DeferredTaxAssetValuationAllowanceIntraEntity', window );">Deferred Tax Asset, Valuation Allowance, Intra-entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ChangeinDeferredTaxAssetsValuationAllowance', window );">Change in Deferred Tax Assets, Valuation Allowance</a></td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other Comprehensive Income (Loss), Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FreeTradeZoneRegimeTaxIncentive', window );">Free Trade Zone Regime Tax Incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FreeTradeZoneTaxIncentivePerShare', window );">Free Trade Zone Regime Tax Incentive Per Share</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TaxIncentivesInPuertoRico', window );">Tax Incentives in Puerto Rico</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="nump">$ 1,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Unrecognized Tax Benefits, Decreases Resulting from Prior Period Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">$ (303)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">Tax Adjustments, Settlements, and Unusual Provisions</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NetSettlementPaymenttoIRS', window );">Net Settlement Payment to IRS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Income Tax Examination, Penalties and Interest Accrued</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income Tax Examination, Penalties and Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(498)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in Unrecognized Tax Benefits is Reasonably Possible</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit', window );">Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability', window );">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability</a></td>
<td class="nump">939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Onetimetransactiontaxpost1986EPnetpayment', window );">One-time transaction tax post-1986 E&amp;P - net payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TransitionTaxPaymentRemaining', window );">transition tax payment remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense', window );">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TheCARESAct', window );">The CARES Act</a></td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets</a></td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bsx_AssetsHeldForSaleDomain', window );">Assets held for sale [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxAssetsDomain', window );">Deferred tax assets [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets</a></td>
<td class="nump">4,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,210<span></span>
</td>
<td class="nump">4,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxLiabilitiesDomain', window );">Deferred tax liabilities [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="nump">330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain', window );">Liabilities held for sale in Other current liabilities [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ChangeinDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Deferred Tax Assets, Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ChangeinDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DeferredTaxAssetValuationAllowanceIntraEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Valuation Allowance, Intra-entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DeferredTaxAssetValuationAllowanceIntraEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Prepaid on Intercompany Profit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FederalBenefitOfUncertainTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal benefit of uncertain tax positions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FederalBenefitOfUncertainTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FreeTradeZoneRegimeTaxIncentive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Free Trade Zone Regime Tax Incentive</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FreeTradeZoneRegimeTaxIncentive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FreeTradeZoneTaxIncentivePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Free Trade Zone Tax Incentive, Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FreeTradeZoneTaxIncentivePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Deferred Tax Assets and Prepaid on Intercompany Profit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NetSettlementPaymenttoIRS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Settlement Payment to IRS</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NetSettlementPaymenttoIRS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Onetimetransactiontaxpost1986EPnetpayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>One-time transaction tax post-1986 E&amp;P - net payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Onetimetransactiontaxpost1986EPnetpayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TaxIncentivesInPuertoRico">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Incentives in Puerto Rico</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TaxIncentivesInPuertoRico</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TheCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TheCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TransitionTaxPaymentRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transition Tax Payment Remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TransitionTaxPaymentRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from contingent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28511-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28446-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2A<br> -Subparagraph (SAB Topic 5.EE.Q2(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=SL116722634-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bsx_AssetsHeldForSaleDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bsx_AssetsHeldForSaleDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxAssetsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxAssetsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxLiabilitiesDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bsx_DeferredTaxLiabilitiesDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544322252408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 10, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 27, 2021 </div>
<div>claims </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 15, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 12, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for legal matters that are probable and estimable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 697,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 569,000,000<span></span>
</td>
<td class="nump">$ 697,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,000,000<span></span>
</td>
<td class="nump">346,000,000<span></span>
</td>
<td class="nump">$ 655,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,000,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="num">$ (148,000,000)<span></span>
</td>
<td class="nump">$ 278,000,000<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
<td class="nump">$ 103,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LitigationSettlementReceivedGain', window );">Litigation Settlement Received, Gain | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Loss Contingency, Damages Paid, Value | &#8364;</a></td>
<td class="nump">&#8364; 620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss Contingency, Damages Awarded, Value | &#8364;</a></td>
<td class="nump">&#8364; 245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product | claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom', window );">Product liability cases or claims related to mesh product - United Kingdom | claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia', window );">Product liability cases or claims related to mesh product - Australia | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada', window );">Product liability cases or claims in Canada, Mesh | claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CertifiedclassactionsinCanadaMesh', window );">Certified class actions in Canada, Mesh | claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bsx_AssignedToOneJudgeInMAMember', window );">Assigned to one judge in MA [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product | claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product | claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct', window );">Total Product liability cases and claims settled related to Mesh product | claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_UpfrontCashMember', window );">Upfront Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AllegedBreachofPurchaseAgreementAmount', window );">Alleged Breach of Purchase Agreement, Amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_MaximumContingentPaymentMember', window );">Maximum Contingent Payment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AllegedBreachofPurchaseAgreementAmount', window );">Alleged Breach of Purchase Agreement, Amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AllegedBreachofPurchaseAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Alleged Breach of Purchase Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AllegedBreachofPurchaseAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CertifiedclassactionsinCanadaMesh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Certified class actions in Canada, Mesh</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CertifiedclassactionsinCanadaMesh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationSettlementReceivedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement Received, Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationSettlementReceivedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - Australia</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims asserted related to mesh products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Productliabilitycasesorclaimsrelatedtomeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - Canada</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - United Kingdom</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Product liability cases and claims settled related to Mesh product</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bsx_AssignedToOneJudgeInMAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bsx_AssignedToOneJudgeInMAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_UpfrontCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_UpfrontCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_MaximumContingentPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_MaximumContingentPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544322380312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Dec. 01, 2020</div></th>
<th class="th"><div>Sep. 01, 2020</div></th>
<th class="th"><div>May 27, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 14, 2020</div></th>
<th class="th"><div>Jan. 25, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 535<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,289,848<span></span>
</td>
<td class="nump">247,566,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred Stock, Liquidation Preference, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareCashPaid', window );">Preferred Stock, Dividends, Per Share, Cash Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3750<span></span>
</td>
<td class="nump">$ 1.4361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible Preferred Stock, Terms of Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2.3834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible Preferred Stock, Terms of Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2.9197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareCashPaid', window );">Preferred Stock, Dividends, Per Share, Cash Paid</a></td>
<td class="nump">$ 1.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends Payable</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,382,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockTermsOfConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific terms relevant to convertibility. Includes class of preferred stock and number of shares convertible into, exercise (or conversion) price or rates, dates relevant to conversion timing and events relevant to conversion. Describe also any beneficial conversion features. where convertible preferred stock with a nondetachable conversion feature is in-the-money at commitment date. For contingently convertible preferred stock, discuss the circumstances of the contingency, including the events or changes in circumstance that would cause the contingency to be met and any of the significant features necessary to understand the conversion rights and the timing of those rights. Include also an events or changes in circumstance, if any, that could adjust or change the contingency, conversion price, or number of shares, including significant terms of those changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockTermsOfConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544242511880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive and Purchase Plans (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
<th class="th"><div>Feb. 18, 2020</div></th>
<th class="th"><div>Feb. 21, 2019</div></th>
<th class="th"><div>Feb. 15, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Fairvalueofmarketbasedawards', window );">Fair value of market based awards</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 35.95<span></span>
</td>
<td class="nump">$ 45.22<span></span>
</td>
<td class="nump">$ 35.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.16<span></span>
</td>
<td class="nump">$ 40.12<span></span>
</td>
<td class="nump">$ 27.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_UnrecognizedCompensationCostStockOptions', window );">Unrecognized Compensation Cost - Stock Options</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock Issued During Period, Shares, Employee Stock Purchase Plans</a></td>
<td class="nump">1,387,000<span></span>
</td>
<td class="nump">2,196,000<span></span>
</td>
<td class="nump">2,452,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased', window );">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</a></td>
<td class="nump">$ 29.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">9,987,000<span></span>
</td>
<td class="nump">11,079,000<span></span>
</td>
<td class="nump">12,683,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">3,609,000<span></span>
</td>
<td class="nump">3,656,000<span></span>
</td>
<td class="nump">4,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Measurementperiodmarketbasedaward', window );">Measurement period - market based awards</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">1.37%<span></span>
</td>
<td class="nump">2.48%<span></span>
</td>
<td class="nump">2.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</a></td>
<td class="num">(4,147,000)<span></span>
</td>
<td class="num">(4,811,000)<span></span>
</td>
<td class="num">(6,194,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="num">(554,000)<span></span>
</td>
<td class="num">(449,000)<span></span>
</td>
<td class="num">(748,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">23,122,000<span></span>
</td>
<td class="nump">23,065,000<span></span>
</td>
<td class="nump">25,304,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,716,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">3,819,000<span></span>
</td>
<td class="nump">2,992,000<span></span>
</td>
<td class="nump">3,491,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(3,096,000)<span></span>
</td>
<td class="num">(4,872,000)<span></span>
</td>
<td class="num">(4,385,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</a></td>
<td class="num">(666,000)<span></span>
</td>
<td class="num">(359,000)<span></span>
</td>
<td class="num">(519,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 170<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Employee Service Share-based Compensation, Tax Benefit from Compensation Expense</a></td>
<td class="num">$ (28)<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ShareBasedCompensationNetOfTaxBenefit', window );">Share-based compensation, net of tax benefit</a></td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CompensationExpensePerShareBasic', window );">compensation expense, per share - basic</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CompensationExpensePerShareDiluted', window );">compensation expense, per share - diluted</a></td>
<td class="nump">0.10<span></span>
</td>
<td class="nump">0.09<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="nump">41.79<span></span>
</td>
<td class="nump">40.20<span></span>
</td>
<td class="nump">27.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 10.44<span></span>
</td>
<td class="nump">$ 11.76<span></span>
</td>
<td class="nump">$ 8.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</a></td>
<td class="nump">15,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</a></td>
<td class="nump">$ 290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OptionsExpectedToVest', window );">Options expected to vest</a></td>
<td class="nump">7,683,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OptionsExpectedToVestWeightedAverageExercisePrice', window );">Options expected to vest, weighted average exercise price</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife', window );">Options expected to vest, weighted average remaining contractual life</a></td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</a></td>
<td class="nump">22,787,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value</a></td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase', window );">Amount of employees total compensation eligible for GESOP purchase</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless', window );">Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_UnrecognizedCompensationCostNonVestedStockAwards', window );">Unrecognized Compensation Cost - Non-vested stock awards</a></td>
<td class="nump">$ 169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_UnrecognizedCompensationCost', window );">Unrecognized Compensation Cost</a></td>
<td class="nump">$ 204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_WeightedAverageRemainingVestingPeriod', window );">weighted average remaining vesting period</a></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Annualweightedaverageforfeiturerate', window );">annualweightedaverageforfeiturerate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_VotingPowerOfAllClassesOfStock', window );">Voting power of all classes of stock</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant', window );">Exercise price of the fair market value of our common stock on the date of grant</a></td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Nonvestedstockawardsexerciseprice', window );">Qualified options exercise price</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards', window );">Fair value of the Free Cash Flow (FCF) performance awards</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards', window );">Target payout of Free Cash Flows (FCF) performance awards</a></td>
<td class="nump">89.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="nump">118.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense', window );">Employee Stock Ownership Plan (ESOP), Compensation Expense</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded', window );">Range of the target number of performance-based DSUs awarded</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased', window );">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.29<span></span>
</td>
<td class="nump">$ 21.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">0.27%<span></span>
</td>
<td class="nump">1.38%<span></span>
</td>
<td class="nump">2.61%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded', window );">Range of the target number of market-based DSUs awarded</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">High end of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded', window );">Range of the target number of performance-based DSUs awarded</a></td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased', window );">Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.47<span></span>
</td>
<td class="nump">$ 27.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">1.72%<span></span>
</td>
<td class="nump">2.61%<span></span>
</td>
<td class="nump">3.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded', window );">Range of the target number of market-based DSUs awarded</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=bsx_A2011LtipPlanMember', window );">2011 LTIP Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of employees total compensation eligible for GESOP purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Annualweightedaverageforfeiturerate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Weighted Average Forfeiture Rate The weighted average of estimated forfeitures for grants based on historical trends</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Annualweightedaverageforfeiturerate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CompensationExpensePerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>compensation expense, per share - basic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CompensationExpensePerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CompensationExpensePerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>compensation expense, per share - diluted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CompensationExpensePerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price of the fair market value of our common stock on the date of grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_FairValueOfFreeCashFlowFcfPerformanceAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the Free Cash Flow (FCF) performance awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_FairValueOfFreeCashFlowFcfPerformanceAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Fairvalueofmarketbasedawards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of market based awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Fairvalueofmarketbasedawards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Measurementperiodmarketbasedaward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measurement period - market based awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Measurementperiodmarketbasedaward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Nonvestedstockawardsexerciseprice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-vested stock awards exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Nonvestedstockawardsexerciseprice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OptionsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options expected to vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OptionsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OptionsExpectedToVestWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options expected to vest, weighted average exercise price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OptionsExpectedToVestWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options expected to vest, weighted average remaining contractual life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RangeofthetargetnumberofmarketbasedDSUsawarded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Range of the target number of market-based DSUs awarded</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RangeofthetargetnumberofmarketbasedDSUsawarded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RangeofthetargetnumberofperformancebasedDSUsawarded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Range of the target number of performance-based DSUs awarded</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RangeofthetargetnumberofperformancebasedDSUsawarded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ShareBasedCompensationNetOfTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation, net of tax benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ShareBasedCompensationNetOfTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Target payout of Free Cash Flows (FCF) performance awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_UnrecognizedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Compensation Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_UnrecognizedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_UnrecognizedCompensationCostNonVestedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Compensation Cost - Non-vested stock awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_UnrecognizedCompensationCostNonVestedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_UnrecognizedCompensationCostStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Compensation Cost - Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_UnrecognizedCompensationCostStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_VotingPowerOfAllClassesOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voting power of all classes of stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_VotingPowerOfAllClassesOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_WeightedAverageRemainingVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>weighted average remaining vesting period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_WeightedAverageRemainingVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of plan compensation cost recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average purchase price of capital shares purchased through an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=bsx_A2011LtipPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=bsx_A2011LtipPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544241889992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">1,416,700<span></span>
</td>
<td class="nump">1,391,500<span></span>
</td>
<td class="nump">1,381,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="nump">20,400<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">1,416,700<span></span>
</td>
<td class="nump">1,410,600<span></span>
</td>
<td class="nump">1,401,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Payment Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544322167256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>reportablesegments</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | reportablesegments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 9,913<span></span>
</td>
<td class="nump">$ 10,735<span></span>
</td>
<td class="nump">$ 9,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="num">(333)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income allocated to reportable segments</a></td>
<td class="num">(80)<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
<td class="nump">1,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="num">(789)<span></span>
</td>
<td class="num">(699)<span></span>
</td>
<td class="num">(599)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(831)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(79)<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">1,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,951<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
<td class="nump">7,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">5,917<span></span>
</td>
<td class="nump">7,886<span></span>
</td>
<td class="nump">6,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">458<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">18,409<span></span>
</td>
<td class="nump">20,477<span></span>
</td>
<td class="nump">16,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">5,701<span></span>
</td>
<td class="nump">6,167<span></span>
</td>
<td class="nump">5,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">IRELAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bsx_OtherCountriesMember', window );">Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-Lived Assets</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,066<span></span>
</td>
<td class="nump">3,307<span></span>
</td>
<td class="nump">3,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeLossAllocatedToReportableSegments', window );">Operating Income (Loss) Allocated to Reportable Segments</a></td>
<td class="nump">$ 1,079<span></span>
</td>
<td class="nump">$ 1,204<span></span>
</td>
<td class="nump">$ 1,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">35.20%<span></span>
</td>
<td class="nump">36.40%<span></span>
</td>
<td class="nump">36.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">$ 1,638<span></span>
</td>
<td class="nump">$ 1,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
<td class="nump">$ 2,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember', window );">Rhythm and Neuro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">3,140<span></span>
</td>
<td class="nump">3,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeLossAllocatedToReportableSegments', window );">Operating Income (Loss) Allocated to Reportable Segments</a></td>
<td class="nump">$ 439<span></span>
</td>
<td class="nump">$ 666<span></span>
</td>
<td class="nump">$ 655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">15.90%<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
<td class="nump">21.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">$ 1,827<span></span>
</td>
<td class="nump">$ 1,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">2,192<span></span>
</td>
<td class="nump">$ 1,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,876<span></span>
</td>
<td class="nump">4,208<span></span>
</td>
<td class="nump">3,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="num">(154)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeLossAllocatedToReportableSegments', window );">Operating Income (Loss) Allocated to Reportable Segments</a></td>
<td class="nump">$ 661<span></span>
</td>
<td class="nump">$ 1,137<span></span>
</td>
<td class="nump">$ 1,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Segmentoperatingincomeaspercentageofnetsales', window );">Segment operating income as percentage of net sales</a></td>
<td class="nump">17.10%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">29.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">$ 2,461<span></span>
</td>
<td class="nump">$ 2,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,697<span></span>
</td>
<td class="nump">5,676<span></span>
</td>
<td class="nump">$ 3,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">9,694<span></span>
</td>
<td class="nump">10,654<span></span>
</td>
<td class="nump">9,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="num">(330)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">5,508<span></span>
</td>
<td class="nump">6,097<span></span>
</td>
<td class="nump">5,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember', window );">Total allocated to reportable segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income allocated to reportable segments</a></td>
<td class="nump">2,179<span></span>
</td>
<td class="nump">3,007<span></span>
</td>
<td class="nump">2,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">5,926<span></span>
</td>
<td class="nump">6,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income allocated to reportable segments</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember', window );">Corporate Expenses including hedging activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">(405)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
<td class="num">(372)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember', window );">Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">(1,208)<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="num">$ (398)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">7,850<span></span>
</td>
<td class="nump">6,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_ConsolidatedBSXDomain', window );">Consolidated BSX [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets (segment reporting)</a></td>
<td class="nump">$ 30,777<span></span>
</td>
<td class="nump">$ 30,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeLossAllocatedToReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Allocated to Reportable Segments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeLossAllocatedToReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeUnallocatedToSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Unallocated to Segment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeUnallocatedToSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Segmentoperatingincomeaspercentageofnetsales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment operating income as percentage of net sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Segmentoperatingincomeaspercentageofnetsales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_ConsolidatedBSXDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_ConsolidatedBSXDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544239494280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>countries</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EmergingMarketsTotalNumberOfCountries', window );">Emerging Markets total number of countries | countries</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 9,913<span></span>
</td>
<td class="nump">$ 10,735<span></span>
</td>
<td class="nump">$ 9,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">5,701<span></span>
</td>
<td class="nump">6,167<span></span>
</td>
<td class="nump">5,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,212<span></span>
</td>
<td class="nump">4,569<span></span>
</td>
<td class="nump">4,286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember', window );">Emerging Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">1,252<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,780<span></span>
</td>
<td class="nump">1,894<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">780<span></span>
</td>
<td class="nump">814<span></span>
</td>
<td class="nump">781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology and Pelvic Health Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,286<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
<td class="nump">1,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology and Pelvic Health Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology and Pelvic Health Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,704<span></span>
</td>
<td class="nump">1,939<span></span>
</td>
<td class="nump">1,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">1,135<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">804<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">761<span></span>
</td>
<td class="nump">873<span></span>
</td>
<td class="nump">779<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">610<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,299<span></span>
</td>
<td class="nump">2,816<span></span>
</td>
<td class="nump">2,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">981<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,522<span></span>
</td>
<td class="nump">1,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,577<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
<td class="nump">1,187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">741<span></span>
</td>
<td class="nump">608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">689<span></span>
</td>
<td class="nump">651<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">9,694<span></span>
</td>
<td class="nump">10,654<span></span>
</td>
<td class="nump">9,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">5,508<span></span>
</td>
<td class="nump">6,097<span></span>
</td>
<td class="nump">5,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,097<span></span>
</td>
<td class="nump">2,264<span></span>
</td>
<td class="nump">2,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | APAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,781<span></span>
</td>
<td class="nump">1,898<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments | Latin America and Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 307<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
<td class="nump">$ 383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EmergingMarketsTotalNumberOfCountries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Markets total number of countries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EmergingMarketsTotalNumberOfCountries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_EmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544242133672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="nump">$ 218<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(77)<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="num">(137)<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">$ (63)<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544230868616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 19, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 506<span></span>
</td>
<td class="nump">$ 466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="num">(488)<span></span>
</td>
<td class="num">$ (232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets', window );">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO', window );">Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Defined Benefit Plan, Service Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Defined Benefit Plan, Interest Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Pensionbenefitobligationbenefitspaid', window );">pension benefit obligation, benefits paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined Benefit Plan, Plan Assets, Contributions by Employer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss', window );">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ExpenseRelatedToMatchingContributions', window );">Expense related to matching contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Executive Retirement Plan Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">2.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Executive Retirement Plan Rate of Compensation Increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=bsx_UKPlanMember', window );">U.K. Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn', window );">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Executive Retirement Plan Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Executive Retirement Plan Rate of Compensation Increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=bsx_OtherInternationalPlansMember', window );">Other International Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn', window );">Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.98%<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Executive Retirement Plan Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.67%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Executive Retirement Plan Rate of Compensation Increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember', window );">Other Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember', window );">Other Contract | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember', window );">Other Contract | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember', window );">Other Contract | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Defined Benefit Plan, Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Defined Benefit Plan, Cash | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Defined Benefit Plan, Cash | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember', window );">Defined Benefit Plan, Cash | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_ExecutiveRetirementPlanMember', window );">Executive retirement plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_InternationalRetirementPlansMember', window );">International retirement plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="num">(223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember', window );">U.K. Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Assets for Plan Benefits, Defined Benefit Plan</a></td>
<td class="nump">$ 213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="num">(216)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Executive Retirement Plan Discount Rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Executive Retirement Plan Rate of Compensation Increase</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember', window );">U.K. Plan | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember', window );">U.K. Plan | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember', window );">U.K. Plan | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Acquired and Established Plan Changes, PBO</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plan, plan assets, actuarial gain loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ExpenseRelatedToMatchingContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expense related to matching contributions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ExpenseRelatedToMatchingContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Pensionbenefitobligationbenefitspaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>pension benefit obligation, benefits paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Pensionbenefitobligationbenefitspaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=bsx_UKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=bsx_UKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=bsx_OtherInternationalPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=bsx_OtherInternationalPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=bsx_ExecutiveRetirementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=bsx_ExecutiveRetirementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=bsx_InternationalRetirementPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=bsx_InternationalRetirementPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=bsx_UKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140544241891848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss (beginning balance)</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASC 2016-13</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Net (credits) charges to expenses</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Utilization of allowances</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss (ending balance)</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>91
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MP:'Z&0#\OI12'R_, [H7/[?_ 5!+ P04    " "W@E=2#T:<ECP#  #Q"0
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M7]EBS0$71E11VW.<T*XPJ:TL-6LSGJ6LD934,.-(-%6%^<LM4+:96*[UNO!
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M!'!MH.XO&9.O$]VM^H^3[#]02P,$%     @ MX)74F$>=X/H!@  M2$  !@
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M@J]_(["^$6S1O'&^9D*PLKF<4R);"B4@_S]C3#S<J)?8FU]J'/X+4$L#!!0
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MK0DSDU\>1G.8V>;?_?CEG+N/S&:3"09=^=!D.DL&T!ZG[,0IL]>F 4Z?RO]
MY+:!I 6DAT(T155ST@S)FJ\+$V=[*5XJB ^R?B.W!P4O(*>](Y#?)--5\]PF
MB$I77$6<GI]N,(\Z_4=(B 2RCF)P4Q#JZX,"A%)#XZWW6UNS,T<-O>XC1G/4
MYS%3/2;3$Y-IE,F*0[HO*M8FT:8D;">DKOYK/\#(3+T[2!*:HK&$0"?),$!:
M7CYTOLABH30[\9M=X+?A4D(X&&Y =<^J\AA"FGW#!VR&# <^71!DEDYPCIC5
M68SC_,1Q'N7XI$7QZ\A4KY( ,2CIJAU/_LV\YAC%N3\VQWD^H(@@\^%MMP01
M9#:TV2.X.!%<Q*>;$.5K5==V$(7><@E#J%GS7*UA_C&8=Y 6=C"TTN0,4FR9
M?,9'=N'=8I[BP>LCDTF.TO:1Z1#88YU,7&V=7,SM)LV1VV=(..],QJF:%WY,
MC<8;C=!<F0S)JQ<&WD +[,2/O'2!)I@E@DWQ](]93?(X\S-5D429@ZPP6=N.
M)B@,R.RR#6E3 ;JP)K=KWO!-I7%5D2"WAU>R)8;UQK!CC4!IM.@EU)&F4=)?
M86P;+>0;49KO1X?]Q63<&>S%<V!<?60VQ1GZR"&PS\\IE20N54!H@XPV:0EF
M* SN,:Q-B*/L4C\6\32,(7%'K!#HR"M*?8).MB19E. _3&JZ,S&*TLF\7Z8)
MGGP0Z!1%KA#DD'>?C),X21X585^; A:"9IJ5O'WUCAC5XQ25R;MM%JHKMJYJ
MJZ[NS/#6A](@]@<)(PTF6%&(@YW1'R+J*W&B)8FKEG]*5IZL7DQ_OKA(\=F]
M1*"C))3_,&PRQ/8).M62Q&7+,15X<K6CA&B):8 2 J6+ "5,H@SCKL_(:90D
M+E+LW.AB!J7DJX<1#>5K'YL%TC5B-9D-DTB?DE,E25R6?#K&WYZ],:M$C'XN
M"GD (=85*9RK+QGF@;1]O0Q!H*-I7']1IT1H7(FTHW<VS3%:%%,$"5IEEB@6
MS]@!L]'E 75*@UY0&K]K]=@1]T5!DD_P$<6P\Q0OQ0@VC6<8ZL0&I1?2NQ&2
MAMNG:U;&U%5Y&J_RCUW2MST@<"SX4+_=D7W-0,R9&<)_.U1[HV!15R+E.9T%
M8@C!9E-\\87:]6*S3]G5?1JO^X]2%)R7R@CTLE)[H5C]?]+WRWF"2QX$B:_*
M,)/QN>,D HVW01[96[L2@=D"4P2(J<I(5=7OB5A%9#ZRG1J+D\-.7D<?:83@
M"@E#9BF^2E]AX"3+HD*).C%"XV+D-/H;*78P_G9>Z8.TG:$"AM\TB^(=(HJT
M2O!RCB #Q1Q!AJ@Z64+CLJ1/58HW5NLW(DUO'.?E"PJOY='Q\I%Y8#!]9(B7
M$R<T+DYZ@0P*1=>NC;WE)2Q58!6J)50!G*:O,CQ^F!!9+'"&,7-]ADZKT+A6
MZ3$<-A&&4_<8M)H7VT;4XCE4]Q#)D>#+RB6.#3@ P\956^JD3!J7,K&"7YV*
M8KS@IX@DR?#6YA+#YI,,+U,8.%G$&PRITSII$JWY7ZJ&-<75-3]U8B*-=RZZ
MZ+*Q$^K<["5_J<1!U6\$? QZN5(PM<R2$EDFHD[W&Q,C/("6&'2*:RP,F@RM
M]MURMC5S00J=3[K+V3)%-,H"3Y<8=(I/)@0:(N8$3WJEX$'J ($\V:@-ERA%
M7XQXU) V21X8NYBU/C6G:=(K-8W9WMD*J4>:RQU9"PFF(#+QD4,$!EWD:&%>
M8N!39]*C>/6.3^H$2_H]@@4E>9)L)5]K4BEU@,1AJJ *A*XO-BC%U^1+!!O<
M8D34CE<T^UYP6B:-:YENXQ3K<15BM^.RJ%@-2_M]()*17LG,$]8=8P2;S_!E
M/(*]D/Z=RDFO5#D0VFZHVR@ ]F6ER885D05^BHH8+UMVI"^*HA5F+_?26)^M
M4SSI!<73B_(SOL#^.K9([V41:&<@6(\LLO<4YYHY39/%-<WYR-:B>1Y.9ZOR
M[%3FWTQY!;6W;;?*0A,ZPX0(G>(9#0.G.0Y>8>#I)"KN,J=PLG@WIS_HF"N^
M-[-E2+]FZC5%.S_XV!FE>%E&L(OX=G#FY%@6EV-6XL)"%,174YKV9%625H%U
MF^'*[!BC;!$U1/%&%@+U.,8@?6Y.4V67S[OL>Z-\&D/;<.E1;)-YTW2'Q%XK
M#=+_ -*S #   THS\R73 D_72P3J>>%J 9:='9")"["X%TS],O+E][C EU9!
M%US4=*LHI.\")]2R[V@^27Y:1 SXH^00!98'MH00K,?N:HV6.8V6Q36:G<)V
M8:J%S5AJRR3O>A.$[_:U>./<-A-!>;-7)DL\?2&[5#E>L#$HOJFT0JU&FZF9
MTV79]_28CF%M^Q+6!\J+<!AZ ]+&52?/M%_UCL/8(T#',#$-6=QCO@!+ DM[
M#(J?A5IA4.^<4-]C3M=E<5T7ZVAL3DO^>$<C\Z48702J' :=!6AC9X*\3?P^
M;Z?PLKC"^P'R5V%K^69XLD R<RS&*#WP#<H7:3'AC78$Z>W!=&01F]$><^X$
M7G[Y)!"R6/G+GT"/_K5J:=ZU_763$EY8;5+C'>1%I655F,.Y;?,=IL#PL[,+
MT-.+OEY+TL!V)8(=48KW<3%LXMGM^\OIP/SRKMX?X _"-%GSYZIIS PR^@(*
MID"W+G)?STTG>/,&@<X#*A&!0MJ(RL3<R<3\LDS\@YS$S<&\J'M\*9@L%GC)
M1; !5ZX0J._*OGN<TLS3:+?TZ;#?M_L K"9?F_89">\@5M^X$W!Y7,#9G'W;
M'ESAY;M6H[>]>7<V-7B4*$=Z9*%@0Z!98$8B.X63-!YL9R>FXW*M+5*.)2S+
M(*10<KZ<2@.2!8%F@3T%!$JGT4*4.[&6Q\7:%U9) K/AP*,=<'..79;?U?/.
M8YMXG0^0O4,:F"U(ERZ^"YH[V99?:*>)9F0S@SF(VU;E8R/8+,<N=[\[^_V'
M% (Q[4,]JC%(2W%\]M3+CLMG^_20(G8XVJ=)3I^>GE#Z9)_+&7S^.?FP:I\S
M<F;:QYY^8A**AR(UWX#)R?L9W(]LGR1JWVBQM\_6K(768F=?;CF#B#$ ^'XC
MA#Z^,3]P>I[KX7]02P,$%     @ MX)74O#2YONW @  EP@  !@   !X;"]W
M;W)K<VAE971S+W-H965T."YX;6R55EUOFS 4_2L6VD,K=87PD8^*1%J35MO#
MM*I1MV<7;H)58U/;)-V_GVT(HL%-LSS$7^=<WW-\P:1[+EYD :#06TF9G'N%
M4M6-[\NL@!++:UX!TRL;+DJL]%!L?5D)P+DEE=0/@V#LEY@P;Y':N0>Q2'FM
M*&'P()"LRQ*+O[= ^7[NC;S#Q"/9%LI,^(NTPEM8@WJJ'H0>^5V4G)3 ).$,
M"=C,O6^CF[O$X"W@-X&][/614?+,^8L9_,CG7F 2 @J9,A&P;G:P!$I-()W&
M:QO3Z[8TQ'[_$/W>:M=:GK&$):=_2*Z*N3?U4 X;7%/UR/??H=5C$\PXE?8?
M[5MLX*&LEHJ7+5EG4!+6M/BM]:%'T''<A+ EA,>$^ -"U!*B<PEQ2XC/32EI
M"5:ZWVBWQJVPPHM4\#T2!JVCF8YUW[*U7X29.EDKH5>)YJG%DC/)*<FQ@ARM
ME6YT$2B)^ 8ML2S0O2XDB=RH(]#%NJXJ:E<P12LB,\IE+> 2?45/ZQ6Z^'*9
M^DKG;';VLS:_VR:_\(/\5I!=HVATA<(@#!STY=GTT<Q!7YU/GSKH=^?3)^_I
MOCZG[K#"[K!"&R_^Z+",V9CE*#,=>*W)#E-S7"Y?FU")#67>%KO%:!+%@?VE
M_J[OX1 :CB8NY,H1-!X?(=])BSIIT4EICR"5()FIK^R@4AS-]00CPC):YWJ%
M,/1+%2#TPR*$*4HL);@=:3*8]&4&4Z<A0V0TD-D8,D2.D^24(7%G2/Q?AIP6
M3SG;?E4@RA/RXT&J2>A4/P3&D5/\$!@>E\T[[4FG/?FTSJ\&LJ\&!?%)D;A,
M2(8%/)L='UACPQ Z#MQ/Q1 Y#6<NY)UC^V#PJ#6>^;V7NKFR?V*Q)4PB"AM-
M#JXG.HIHKL%FH'AEW_//7.E;PW8+_>4 P@#T^H9S=1B8JZ/[%EG\ U!+ P04
M    " "W@E=24]>+Y#DJ   ,A0  &    'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;-5=^V_<QK7^5PC=HK6!E6S+3O.P8T"6G41M' N6'!<H^@.7G-UES"4W
M?&B]^>OO^<YC9LCE2DIN6^ ";6Q+Y#S.G,=W7L,7V[KYU*Z<ZY+/Z[)JOSU:
M==WFFT>/VFSEUFE[4F]<1;]9U,TZ[>B?S?)1NVE<FO-+Z_+1Z>/'?WVT3HOJ
MZ.4+_MEE\_)%W7=E4;G+)FG[]3IM=J]<66^_/7IR9#]X7RQ7'7[PZ.6+3;IT
M5Z[[L+ELZ%^/_"AYL7956]15TKC%MT=G3[YY]0S/\P,_%V[;1G]/L)-Y77_"
M/R[R;X\>8T&N=%F'$5+ZX\:=N[+$0+2,7W7,(S\E7HS_;J-_QWNGO<S3UIW7
MY<<B[U;?'GUUE.1ND?9E][[>_N!T/U]@O*PN6_YOLI5GGWUQE&1]V]5K?9E6
ML"XJ^3/]K'2(7OCJ\8$73O6%4UZW3,2K?)UVZ<L73;U-&CQ-H^$OO%5^FQ97
M5#B4JZZAWQ;T7O?RJEA6Q:+(TJI+SK*L[JNNJ);)95T66>':%X\ZF@2//LIT
MP%<RX.F! 9^<)F_KJENUR9LJ=_EP@$>T.K_$4UOBJ]-;1WSMLI/DZ9-9<OKX
M]/$MXSWU6W[*XST],-[$-I-_GLW;KB$6^=<M$SSS$SSC"9[],9HF_[QVG[OD
M55EGG_XU1>#;1__IW?6;Y"SY\_]\=?KDR?/DZN+[GRZ^NS@_^^DZ.3L_?_?A
MI^N+G[Y/+M_]>'%^\>8JN6R**BLV)<U;+Y+SNFII&7G*(O&N;Y+,_\3ER:*H
M4GHZ+9.VHQ^0\'5M0N^7?>Z2;N5(B'@[/-:KFKBS2JYH3[1!VB^-WFSJ1L9.
MJSRI:?SMJB[+W7&]K6C\MI^W15ZD#9%AEJ2+SC4\K"L+XFUYD48N*OI%5J\W
M:;5+Z%BJ-F49;D^2CRM7)7U+8Q45O5JTI!EHSF[&X]!KZS8YVKK947+4M_@O
MK>&(%W.$!\YE4!(AEU;WV$%!6\V+FP(ZJ.6?Q%N@Y1!)VM:U;30];0 ;+ZH;
MUW8@H>R'_D%/U:0R\!@=:E(L$FQP\+RC<UI#&6,\TBY%51A5TN2&9DWGI?,#
M)EAWMTL>_'SQYF%RDI"BXB'IGT3?K4LVKH'BIA_2_])RUQ:C-6Q7CF9J> 5[
MP[?)DE0FD9OF)C[I&CI*<')@$WOR)+D&=]@412X$=4*735- XR=S5]&.Z,5F
M)QNB=1+]A 4P$CW8@M'2+EG1S^=UMTJ>/)0QZBV8A=9>-*3119T3;82O92A^
M<4V'FK1!!,M=4M"A9YU-0P1CX?GR>9LXVE:]IH-70M&V'!_SJ<Q:S\MB*>Q
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MBC&\_6P-KHN^)4@&#Z9C BA )6X5J:'E1TM2-%8#_]-4=!B,'0N:WS7L4("
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MYW%]W3:4&<CP@S$E,D;LZZ-YK)4V)5=<DL@LP7T:L9*@ UGFS ;;,RHZH&<
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MX>+Y:N*A_ Y5/2^VW4!2YSLMN=[XGA[$LH>IZ<%^I7@;I2=QF9,&)U%5&ZC
MI0C[27>#=R $>0P:B!YG"2WV;#&S?X.[(L>:Z\0?.4Y#:N!=!*8^JLPG6_FM
MNAO&EA8-V#?FUZQ'?JFMT):#S39#4#G"L%+>+"S.RLRX1O6-'<L01UN82*#\
M\/5%,2?_A6/JZB1D#LT"C6)T66'K@M;AC*W&+%J-R_HLCU]Y!G >U=V7J=9
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M-3^-%FA4/C^T?["#&<H'>@W-0X.0]PP<76CIFU:4V3_V5[-/KN%BPI;12JR
M4<IEP@XM?BT6=&:>S<S@EOI3(4OQB\5V-1O2Q-BV^.3*8E5+H(#H7+@;J0Y?
M:L'A+'Z1NSH:U+$IKCH6W4T.C<,M40#55A>#\0*\'6ZTB&^AB<AA%[V8MK/K
MK1JP 'M?"BWCW%Z8/+JX9,QBL7HDETHMO+9H1-01;VH6D6(*"W< 8Z+.'M56
M4S6D6\"VPR1 40U1]=# C98.WM+[K=QQR14W%UY#B3;UNEZ["4>/[RDT?ZV
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M'QR7GE;(T$LB:J3KAB9]?"-D$]<*W9(+%W?',-"4T@27?/G4F(0_.C-UCY3
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M!.J$JE'ON-7-J ;-53=%$TJSN,Q+I,AT:;27N@?3<6PS>M 7FD<J4<I(N=R
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MFPY@?ZZ!B'I"#+;_&KGX!U!+ P04    " "W@E=2F:1]Q64<   -:0  &0
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MV-3K,D/B/>0'.8VTW\@"T -C83 7!-D8[0J$!4I(/ #.@6=30),K#QP\P^7
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M1YEXXF:CZ >8'=Y9*D\L2@2$H.B)%CXM^24X 06KWH&?B@1Z:@!G:ZT7N$3
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M&%C-S\?E@'#=9$/1'/PUUEY'LQ?B#9'AVYW%.PVDTL:*^/A<&J=K'K-3+>H
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M]_"!?63_^B_30;__$WOAYNQ*:3B6S)>.WEJDLF SK7F^%$1W]IM@*YZR0A7
M("EB#"3;%# <IC&U8,>7W?YHR.8RRTC*#'X)I!+KN="!7+3^<;_7[?6F^\?V
M+SL@ L4*F%]K  &8O2BU+*2@T<?](8C!2_;JCOJ30UMUV<-*V&.Y;9X9ZKVT
MS 0#C0>'U2Q3^?*L$'KMSA])B32,B) 7(F5SU'"OV8TQ)<\3P4 >!;OUR]*G
MV2X8UZK< (!?\?%)_Y2=R-P?T'28^)Z(3<$D; #[%$S#,'-JCXD'@/6?\=.
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M)J]N4/9M^ 2V"'#+-H SGL.F&1X)D>.Y >&17AXLZA;T91-0 ))!)@E3#7)
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M]T5[\WQ?J.1;A]T+C5'%C)W<7G^Y/XVV G:7&/ 8'.C7G@/W!VL#L@@"-Q?
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MW"V^H^];2K,B+O7A,RKF:86DZCX1;'SCK8N#ALG<N<M1)$N=V&O?+: VKA/
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M_0,I7' 5%NKQLX9KS:EYVXDP6X(GR8$F3L6B9L%*+AP'48:_R (P_AN%!Q#
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M"7!"VA+(88)]KEXX( WZ8>8"5A;'HQ'=L=9YOHW+CZ!B:WII1&[@(BL*N"^
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MT%:$5G;KT]BA8P%Y;GY!3R,QF]+_6%Q04$<3,;FD_ZF8C$EY]"09DDR,AG-
ME;"5U9[N%M"?Z*(^",RV]D_' [Z2N*(FJ/8<B]@:O9Q>OA*?]ENM<W:#16?#
M4US!K1$W^*W*TFJ[PTU#N%?@T!W<-? ICB50'_:LJ&\H8$:B< ZE<]?.6> %
MO!.=S0%N3ARA8=\LC;PPW+2F&U?R"6;O !)/!I'&>L?NA?JM&[5"V27?&SK!
MG!8NUYJOS=7D;;B1VTX/]YJ_2+NDACU7&98.>K-I)U2US8LW%=_/+8SWIN#'
M%9I396D"QC.#ZA]?:(/FPO;FOU!+ P04    " "W@E=2$PN#,W@*   N(
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MUA4L0/5U"!2TMSI=!7?FY 4NN$J5S</0L.?QPTAF. 7G,)I>FK():#&T\!7
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M,!V?V6L=]7],ON7?7%'S,4_YSXV2"% T .]7>6[J_] &_D=XK_\74$L#!!0
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MF9F3VJJ;K*6'-IG'*S7.-"W:G)@B\VV53?UR91O7>'PU+8Q;XIMF81KYNJT
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MW&(M&U&IA #\"E'8SWX%78C(0*J!220N9+V\(@4_W>",)%',@ 0@<ZI7:Q!
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MBEW\!(5%G+^;RC]?C\3Y9H[PP5"_JMHYG;0@#P)?O'0^MW,R))QM?.. G@N
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M&[%HJT7?[V:S4>#)P8$D6[!M!%(7>+ -!>L5)Q"%M\05*@>&\3JZO'^T;N!
M758\S>!@PGT4W&B"\624^H1BG^45[M])?>U['V@D^1>FHVOZ3F8,DP)@#SK3
MP$$(E/VG)XGY6K@O7\E[7S@*$^OLP_XO4H:_^'1X\>DC:<[2WQ@MB;YOR/$/
MX9R^$4.ZZ")L6_I4F_W5\'G+FU 70B(FC9BA8J>(D0GVFIMGR8J8>4E:@$1?
M^PT[0:C=MXB * FAO^1]S-HEN8<S3@_&=//SP X4A53^&^<L2%$].QX='!S\
MRPMS\!+=O S/6P/FJY#)0><< '*EI!19?[-LV8+.3#O.#;>;%&956PF3N;5W
M9U_5;8=<ZYL6$LP1!W=+P?JF65TSKZPF87M%(-3#JJX6) =MC*9<>5%N'"[5
M],0N&2:XF\WJO[/ZJ&T!!-#!D9YCA1DR9US9ZI/BD$FAO8TQDXI$YI>V5MQ7
M=E9P;TO'KW_'TZ;8U$Z@^X:6*22*??FDZ_<.OE3>K@K.CZ61+/?OW8$<Z1.S
M&M@L>D41:=.&%$S:6'_KEU,Y$9& @EP:-C>E)O9C.I#PC);,$;+%0+!F+:5W
MQ$P7SG+/2RCX(T?CJM"&9;A$DQZX61#J%[[(H1IG(0B_%\Y[CQV?\F/,4DO;
MA*97;<0(RG2 %!R,64>R/KLQRZJ\QZ7$*MB23/K:L </14(*TZE;#H;SZ!V&
MWY7#[62D<WD!S:?:X=1*)S.2P5&FZ:%U17C-/2%1+8^:CZZCEK,S%?M8,_5Y
M.1K@DBK;D7Y#U-O0'RR6IA,!U7NT155K7?E+B\;D0?ZUK6.8<:^2__5@%]8+
MJG 8U"Z:B9R&UC3C"FWA(R5-+#8AM43&C+:FWVEC='C.*M/FH^S&^2*V6\6C
MEW6KG?^-3ALAU-3>,>F\8\^#.)!X,X@73RP<C<;$/\HG@FLQXLC"2W6A[A0F
M],J7-N>&Q!3Q^/62'B2P6["3&/PW=E*Q^F/MAQ@,F[QK<\>I]D\&'1P$["5:
MW9]$@Y68BL>7K][O(9--<:2K%P0$??#D\.CPI$?IAV2+$.EDOSBT!3JS%<2Q
M5E7FDI/=07E!%Z$E C5C;N=.<>WNM^)<)16/V*1]:_G\B,U$K.6N*]=P<[BK
MN1]TTV6 Q5]1'7]+;P&Z7]AD=ZGO>W/TKS:T>]>D_/*0\4:9)L#0=\<UT'[!
MA[N$"J#_5BN7G2E802IW%1HTN&._1DD9@Y0^XP]7/P\B\*D3@3.BMSCZJ0N%
M! ;3[,;-?46Z!"U(J$_G++^5%+%F=AV*4B<'P='H>U__=%!72^D2[AX?'S[K
M&O3/T/YI2,VE:\MH1?+&0??".=G+W S:3"!TH+&4P63R0V**D)7%E%'H&9&F
M'V4=12),Q@W4?8R6QR=I;H&%Z(WW\C;G<LZ2BC$$\<VKL[T,I=\JA$M$FC0]
M4XE&VNUT=:6O()L]]JOLRKA*1DQV^5H4?ZZXZS<TD'9F7>3(5>E>.YQDMT2W
M)MM,=-;:)4]1:4'=9G2Z&*$BUPL, L]<ATSJ\=Q%+0ZPM/H0*2XH9'V\</,%
MSQ3MA0<T&$^'U5(^G%INB)P7?@+Y,T5HHALZ+/=":(K,G2CL1#E5IF:'>YUV
M)$H[?]=WR/M)___0,=DY,F!@3(A-3+W5-=\ETC3\"'J&,"6)>-)TF):I>PN6
M(:_1;RV1ZCK<BH$)O[^F6V (;6U#L;]+"02$#)?FV%ZZ-;F,D)-"E,+S E5=
MK7%Q_"\+:)$_NH;]@0IPRLY.-WI'!ES,#3D*TO$:B,FZI$?1,FZ7QD4+.^Q+
M$RS>IS,M8B;MM+#E7,82V"JUM53UI)4R>D J4C'@Z Q0-\# $4CD]H'3EW 7
M]Z;22_E =P,HJV'RO7B2Z9I[[E,0G3E*8JD^.#L7)8JV9;"YFE_:T6@06C&D
M+6!GF_=H5]_!SMYOQ[AB5Z)..NSOR=W;LL5%VVYT2P;WNM_AXBUCJ;,51T!Q
MUI,/("@\'%H\8*Z:4%R+O6W2> 021]*GDVTP)G<$]@]Q6#ALBPTHI5FRHA,;
M;P3,\?A4_8_;T@M]'+^EJ*@DZTMD_L66ALSTC<G>.,)FE>110W#"T82SO4E>
MHODL9$B5L=!00[O=D+E?D3I[XJ2X0I#:%7W)VH'LT\23E\/^OU9!N@&*L-%^
M=NGKV%TN!^O")@2>TJW:RSX&S47NM\LQH&._P5W@8&/@RG=>H+H5Q =.1IA,
MF6JM9R^>QZBFU&1>\%!"MH3!H^ L'>>XZ(]SX(3_V;KLVBP)%&F'YU+.1DLB
MQ^P@:PZ3,V>:9Z_;R<H#K]&R2WQ@@810&?O)FJ*1[NB?6O)@LBM:0TRV%N 5
MDQ<EFROBR+==FZ[M-JFM_5KW5'5:5L,*A2%5L0CKG?LYN50AT\VU0A(F4K3A
M(\PQ)T.]4HX^T)*&L-#2E % GW@C?%YZ]CEVIG]?1%,9U4V XM-B4R, *[.W
MI& (=^\M19W<=EUADG3929'OFL@ZDZ>._WX@R4DHCYLXMQ,*G<S#G95$!AR6
MP!2=]7MP+O/2E24IZ89\ZC--^6#:6B9LB2L*G";XJ)$#TN$I18R$&;3B.7KM
MR>I1.(A&"7J?-%R%-HC":=S+-1T26,V\T<KAB#YZU,*:)\,<ZYI]<V92>A;)
M#ZW$:,'J9#]MQGJ>]AI$2_J4^8J[*R1/7,8J3[>1&+;*KU:A3@G%I"(U9,S[
M,4&HA2V])*U\J"?*^EL@^"02U),D+AMWHE@NJ;?5CC4C*@63SR5<:><41&6'
M+T)AOJN%SI$:T;-NK3:*Z2@R0%^0<K!A0K KL(Y[JP8DAU-?22O+F1[S/!SS
M'JBY[55L'T@]UEZ#B*%!_10]J+)XBE8D!R)RF(^.>H7/X2%T":@J&>>&(FZD
M4$9?7W-;_8XC7F\#9!-XPB&D*VM\VL_W'!Z%ED*CZ:(@R;&*?>ESJ-#'%Z3_
M-UUD:9(VC>VZHV"*C#%/W9-[8@E>O[$<;76Q1HE4 "RQF,EH^FMM3V;ELVL*
M4&4WS A5R&RR9DU%*2J69%WVJMU2IG_)4RK#LSYF9Q9L=:8ZT86DM<[3"Y#Q
M)$%-_^3KE6ND<*_(0HMII5WSF"V=<MRSE,[=DOV8MC0ML7WE?N=4 87PT^@X
M]G 4&\L[Q<@I1IDCTJJG*@OU4N$,Q3[GWLJ8=A*Z32RB3I_RPG&BYF(=;7RP
M+<_:]F:TXTVK4KZ\D?$E^!/;+!'P)K=63,D"-:P3T+4'Q&H6%%UZ6'JF%I8L
M[M')\7>'Q\]@2-N:8_5^G$GD] C1OW@7AA'"[1\\2AI&W[K53@X/NM7@R1=%
MPB1;W>I$TXTF%1+^$@</Y@RYU[2O,NW+@^$=I[(7,?LB;9,<-(V N"]Q04J)
MI 0W0N?1A]>\?TS&[92^5.@DP=&A'*P87'D1H4%N,"@%[/BR,K^3PTW,TAOL
MQ5[DA&OBH<[.SUZ]SA[CA;/^" -<U:ECZ7A-2/5+ O"5) /VDI8K<C;0_Z-Y
M]-#1&#*BFMSO8,$0, 5=!B/+B;#H:]USR0+#NRZ^X **X75'7\&(ZX5'$!7'
MGD$,7I%[$K2A-+AW?"E"XA5+"2;T*Z!G\4FXA ;HX-O%@+EAGB6H'X3.G&">
M 12HUT3R0WM*VL,0!10D&&5A.I']DG92)'DQ$YK ^/X=/C@%"#;IZ2I!K&#4
MG/A$XAIS0H]O+N)FUAZ)DV:@6YDR9NUVTW";B8D ]&A-G/.^R<U^C\QIR3VA
M=3<& %5L\Z;R=,H1FMSX1^F,OB*C^:XE,Z M\2/60=TR(7TD,G[V\N+R]2MI
M#;ZDGS_RCX<ODGY_G7Z\C>(32S&5\Y7$YJI*>H:JGS,1193Q?2(%AEFZ)(I.
M4,/UBV,9ZMQKGIB<BS-B3Y*5SQ[1_ *BBA3P_JAKF"HLU\]QOQYO?ZLBZ;4+
M[6S0"G,&L77C)^17HS:[@(6"\NFU,,6Y8;Y^IP6?5G7+DV.2/(C-5UKD3!)2
M[\UDZDT3-AYI*P;R&3M:QEO2*9R^U0!-]Q>S#H=8?>WN\C*0,J_:^1-;2-*Z
M[GJ&.G\T)N7OQ-FNK^G')<"6CE/@Y@VJ?36NR7$UWQWV_OWY2/+15W+'QP;U
M9]KU<S]'$UPUO4ZL_S#+0/F+V*$P_ '8]B,?(&XR%=_[T.6&!GUO)#KGP+S1
MJ>V'!(,??+5=U4MB.*C)/.>6#OB*1OOS4LE 4UN  +:*OBIUB@1WV1"Z%FXE
MSMF: G_^C38)"9[0(<=4_P/VGFJR-^A/$^-%\9%/R5B0J:R$U0-F=SAJ]SK+
MH&4LHX"$BS^T8R=N;8FN#3*UA+P%J#,PT^/(A7'=KJU.(X7;VNO2ALRCX(EL
MK;.CS4E/WE6T<LTVVC+D\.IA&H]->>4D(XB$5\Q)=!UXW=X!=.XIO6U_Y1[2
MW82739"!\&5-;HT-@H"^X,2Y2V+5@QV;\P#GW2#<R4E/[Y;YI[O$/7ILMQ[W
MZ:Z3I67"T\@+!2G4<[YU[S_,<O6=?'"UX*0HL=U[W])*II22^D]DT.(G*N.1
M]DD!<P=D[XBU2!FQ=;68]*.71_'3C^64%>K@X\]6'3V![55W66.'B)?7;V7$
M*ERQ$ZW,0[3/:[/=*!VZ">YLKQM$C%+/5O?[BO09$I$H68=L  Q^4X&?1,BV
M>CQJ:?)(7-!:(">-P)9/;EOD7L=D&#7-!/WW?UU?O#T+V<<TO,PMKL3D&A""
M+'(/-XEO.$Z+QW<-QCTXN_?!KK-WB$LV>J^.7I^YW3A;AXO+ KH'T88"^7RT
MDZ/V_RI+B9%]YQ<$5ZG/A-\&@Y"ZXMZNA'7(F'9,(V+"93\R3+.0#NAADDYV
MJM0>18;IF4-?M,O)%D?&"7Q"J^SS+S2\HSZ_!SSV&#VTUKPA]Y;4B=1Y M=+
M!9*8FJ"T97(%'*FBJ<YXQDP[@!+V#;R6Q#-R&U&IC2",ZIRL,.V3/-35W+L/
MG^A=+'#52%+<<@)W6:Y8D+QHR!&9.KG<=<#Y?X'KMP*P(&2]?')L\?=A_O@.
M[=:WFSS/P2:2+=2MZKC'(HE4]INCHM+>*0=!ZZ+<O/:!!,%[%E_ROS?03'U^
M5]'&Q7NN:9EY."_@[/8\5,IRV(NEDL%XU[%>ITM99>):EH9<[E70@Q:,-;5=
MM^Q@8K"K60:-F%P VU<[QWHWSFORKGXC"_G.WG# UYM7U_Q0=V(3+J&H=QQ^
M=%_3^0=1PR6)OK$D?/O$  M?JHY]A2OLBNS=/@6KMBQ-N:M!AB@'&*6YJ'%5
M-V9&7[[_>/WS5?8ZG]M@2L[@C4RS7PR:B\. G#PFO^W=>^AEE\$%/_Z7K[X.
M'-?C-/45KN3E:*_K#I_I+<TLP'_62FVW.G9 G 0@+BE:,*7/7E?PLPG%A;\W
M&]S)!3)B.TIO@*B[6SS_I0Q"QHOB_=4BN]S/WKCF]SED7V?"M_CFSY?T^NB\
M3MJDI&>\UC1I;+B<H J[XORES>6:);T8N0M0\K[3< MJW+WFEP<T?I8RVE7_
MQLS7WZ3_)^.;WKDQIDM2"?X_V[FH:"TW/PYT>7V^Q[7U62BX!#2$Q)FK0Z9?
M.N$&.<*D8^+V3%E,(W/3/F0Y$6*13B%PS,??D#=1\M7-6ON5=(:?MMT]]EM5
M\. $FFZ@O%\DDO1UF /J4-#MJ[38O7W2=G K)'U>8N1U%6VYVC5FF'J8[$-Z
MF@(:5HO-$"8K+)>W65EBPU\*DY- 5ME;I'KKKQO<YN"GW%IS#3,$NYM$7!A=
MCM<-A%A!]TEX1X>17[$9]55DA=MRQ=.8(-BU7AZ7X?Z^;\3%VJ(#GJS2=N'D
M1B N=)D)ZJI85&Y1P;W\2+>(S,4+8V^Z]O[9%HOMUII_26G^[]K.W:KQ%LWX
M;S&H?V9L=*!J^_?RO8OW\E$DA%OOK\TWO82O+]Z]/G+SK7<E4VC8.0\WB&17
M#C6-[?LF/_:O]H"K*[/SV5DY7="FR?S<CLP1WT^Z8Y3O/E;H'!$ML>@M*<3
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MS)Q\+N4%'K@0E/$)8D:!NM8H;/."P?9L\6N/)-DS$H!*PX" :*/!G$8.%HL
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MG$7-O ?%!G5W%V@41T)MP1.8V T5/:AS -6\.;-(=2VIZ4BV<-%*QW]%.MZ
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MS%-^NY8AU$8#\/TJSTOW@0C4O^1[_S]02P,$%     @ MX)74NJH799K!0
M" T  !D   !X;"]W;W)K<VAE971S+W-H965T,C(N>&ULG5=A3^,X$/TKHYYT
M!Q*D3>FR["X@%>CM(AUL1=E%I]-]<),IL7#BKNU0^N_OV4Y"65%T6B&:Q/$\
MOYEY,W:.5]H\V(+9T5.I*GO2*YQ;?NSW;59P*6RBEUSAS4*;4C@\FON^71H6
M>3 J57\X&!SV2R&KWNEQ&)N:TV-=.R4KGAJR=5D*LSYCI5<GO;37#MS(^\+Y
M@?[I\5+<\XS=M^74X*G?H>2RY,I*79'AQ4EOG'X\&_GY8<)WR2N[<4_>D[G6
M#_[A,C_I#3PA5IPYCR!P>>1S5LH#@<:/!K/7+>D--^];]#^#[_!E+BR?:W4G
M<U><](YZE/-"U,K=Z-47;OQYY_$RK6SXI56<>W#8HZRV3I>-,1B4LHI7\=3$
M8</@:+#%8-@8# /ON%!@>2&<.#TV>D7&SP::OPFN!FN0DY5/RLP9O)6P<Z=W
M@3;G-'YD@RS0K!"&+7VMG76BRF5U?]QW6,A/[V<-Z%D$'6X!38=TI2M76)I4
M.><O ?I@V-$<MC3/AF\B7G"6T$&Z1\/!</ &WD'G]D' .]B"-Q&F@FN6IFRB
MR_3/>&Z=@4K^?0-_U.&/ OYH&_[XYOKR^O.,II,;FGT9WTQ>B^+;&-=?;R=T
M3;__=C1,TT]T-[G\_.5V<D'C[Y.;\>=)A)W1UV^WL]OQ]066H[]9F!AS0L2X
MG,,['[4=64$\2J$.[&Z((7[2#_[GB#H)B$8"-DI /TN ]KWT94;IWB@]3-[C
M>O A3=[YZU&:#.@:[8,7"Y0:Z05ENBQ1<1!O]D#\HY:/0G'E;/1E^(G2#XEG
MD(S^Y^+"HFGXVURJ.E3S,Y%1.D@._760 N^V8%IHA5[CIUO.:B.=!."*D6-^
MRE3MH[,PNB2'N9E06:U$P 3SU2_2F7,F:LL>4IHV$@BZ7V+)1NK<$IJF110
M/O>]$.VJ5CD56 D#C 95.1D!'_GCKZ7R?%O@=])=2D=4]47XGX4)>NFYOW1N
M9[A+AS3 W]7Y=$8[!R_L/,P--X[8[7E>UL;6\(><!CH"4BZ57C/'J?N^C>;>
M&EN+C;%?*E'9/5H5,BO(EZ./QGX;#A_*X&I><XOI):>TQ6+:RH 1XBUM$_ D
M^++!UFYU^A?IHE6[ IIBDTGD?FED!JFX0KBHMGOLD@YIPTA40BNJA8!(L <^
MP 6$##Y!>G[A%P'%CANL#$.?(-#H* E)V98%"6F*N6*JESHNFND*R]I&X#ZK
M":P7GI>F:^V8_NIZ3-!%H54.@S]H@HRZ=> A\CS$6"A$.1X%\)2@?,.>&)(A
M*S!AVO%)V?5L.V:AO[Y6-AW)MN[VVQ!5=5#\1C.)A8B,;9?=9DYS%#XN+*"G
M-6HIH2E\A:C@PE8 SS-GY PT$?':>@C/SR&5MC;KQJ9D5WB%W74MY:6Z]II'
ML1(FCZ1#.;W:=N0B##5-(W:%^4\%D(3&UI7#<ZL-L-!\"_B"M5SLQ^S[X9;S
M[>LO8G9:_<(:6?VY?3[;0#IM9_RIW4=C4D'Y.KIV)=8T?!\W[ZC0*H,WF$*-
MQN=\+RN_([<FAI?:N%"<0?9^Q1"E)Y_$CF37:BT]A^HR-HN]S0F [>3W>E5
MO]N]6@G[,B%[(:E PB%2_Y^=A=L3AR^,6!$[D^EL-Z%QEFGC-:O6>\]=S:]H
M.*\SOU^L<10L QB2/S6^>O&NX9;+1YES!9V!U.8V@WX8FTIEM9)Y$ ?JPW$9
MJP4]!V1$HUA?YFB$Z*:-_RU_1*QC)1Z%5*&_(%:;$6J:QFM'I_[&Z;1D<Q_.
MX+YMU96+!]5NM#OFC^/I]GEZ_$:X$@8ZL:1X =-!\OY=CTP\=\<'IY?AK#O7
M#B?G<%O@4X6-GX#W"XTFT#SX!;J/G]/_ %!+ P04    " "W@E=2W(<O0;\(
M   5&   &0   'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6S=66MOX[@5_2N$
M.RT<0+'UEIQ) B23['2 YH$DTT51] ,MT38[DNBEJ#SVU_=<2E:<V)ZX*/9+
M@8DH4Y>7AX?W1<[QD](_ZH40ACV7156?#!;&+(_&XSI;B)+7([44%;[,E"ZY
MP4\]']=++7AN!Y7%V'?=>%QR60U.CVW?K3X]5HTI9"5N-:N;LN3ZY5P4ZNED
MX U6'7=ROC#4,3X]7O*YN!?F^_)6X]>XUY++4E2U5!738G8R./..SD.2MP)_
ME^*I7GMGM)*I4C_HQ[?\9. 2(%&(S) &CN91?!%%08H X[=.YZ"?D@:NOZ^T
M_V+7CK5,>2V^J.)7F9O%R2 =L%S,>%.8._7T5]&M)R)]F2IJ^V1/K:P_&;"L
MJ8TJN\% 4,JJ;?ESQ\/:@-3=,<#O!O@6=SN117G!#3\]UNJ):9*&-GJQ2[6C
M 4Y6M"GW1N.KQ#AS>B_FH-BP.[%4VLAJ?CPV4$L?QUFGXKQ5X>]0X?GL2E5F
M4;/+*A?Y6P5CX.E!^2M0Y_Y/-5Z(;,0"SV&^Z[L_T1?TBPRLOF#?1;)_GDUK
MHV$2__J)^K!7'UKUX2[UEU^O+J\?V-WE[<W=P[?KK]LX_*D*<KVC>LDS<3*
M;]5"/XK!Z?7-PR6[87_Y4^I[WF>V,0V[:>!>XE%4+%-:L&E30VU=BYIQ_(2G
M\DK^+G(F*Z.866@AX$=$ 9\6 B,M*_41NQ+Y?:/G#KM;O)A%R7B5LVO1:.78
MUR]<YU(]\CIK"JX=]K20V8(T$5+0RN%<\[D6<VX=3<V8 C#$#<TMV:N) ($;
M-A<5?2 H0-X [$RK$M^ B ,6AI<BEQDOX%V/,A/UB/TJT,?K!JLB0.*1%PVI
MH'FVK,CZ:<Z I4)8(ZTUJ=TBZ:S!E%6F2K%34#QG19.W@D;H[@-;:C63])V
M[:F,<?QCD,WP"Z&/Q#Y".F(W?YQR)FL*9;">G(;ONXQ</DIX/)N^[ $?>]A2
M*-H-WW>23*!'6A/'1^SZH18%&IC!,U*3M790OQ*#5U<UMR$?6#3C^;\11=?L
MCVPF6T@Q6T.0BTS:-%/R'T*SX9>;BZL#S(C<DV.K&=QG*EBEJL-NC*IXX2"3
MP0^([E(UI'\%#.+H0J3YO?6(#JC#YDKE3[(H6F.!R6LR)E[-)2V9PW4-D^62
M2VUM*UMP/1=D6]EO#0"2LC%(%[61!L[0,T'L=\)LF&FXCZD/'.!!D&LRB-(B
M:<XW/1\-7U%:8.+6M_<=(2O"V/H'>)BI0BH[IE V/ WGD*H/+*3+[Q1_K+]?
M6']'F)XCT%CFAE<7=P=$22%(6]N9J9H,ZJPP"]7,%^SIU;) :2WZ_?AO[,RA
ML2\V<$*.E%'<["3Q_JT=/*05', :9JJ5I$[#G[$H2%O;@M5@O;GEJ09DT1J?
MZ@V.+)-6_GXN"H%:8'PF"]DN=4I5TXC]H@JTM ::8<T:2.OYPU>'.%CPQS5]
MZ+6)(_E< [NAC%*U=MO2#5_O$P9J#K/HX-\*+9<P3,BM#ZLWX[FS&D:XW^:(
M+03; +#*&.O@[I=P/EZ8%W8+@RJ1 QM#UE"_PK,1#516.2\4<&] 8=0_)V?=
ME1)@+N^Y!76$W"A#D_4;C8WM=F(S%MDT"OM:+@M I$^4R)G$'O?[SS/8Q))7
M+X1O/V.0=HDSN\EP#B@J$23HDTT[8FG6XGE]<,3^(<"QK;;@,YDHIP@D5"]=
M]U&8*B<\O D]TE6&9Y]8X+AQ;-O 3=K?:-\G?N8[2>3CHQ>Z)!)Z[W<X<-(D
M9J'CNRG>DR1A#T3DQZEFXL23D'FN$T<A?J1^ $\NNF@XW&D-!\S'8E*/56/.
MOJS3^CKC)^B;> %:J$^"R';0!+OXNJ :)I-OHO1NZE(7CX2T)OXF8Y.837PV
MV2#*PS*](,5?T%&4;YMU!UM! /[=F/E0OQ]-M/QXDZ6MDV+[ Y(// ]/FF,7
M4Q^'OYVT>8Z;3&SKNZ%M/7<+?V$P83%,,XZB]Q3&L4>C@H2>WLK2]BT@?,?#
M_*V=^[#::$\BO3!@4<OD=X3-0F66R"ZY'('>KB#I"Q&G"[^$:2'RN<VZ=.Q$
MK*:L%[K1 1OZ<8AGD/@'[.O_=3WPOZ1W-B1S24%4E/I$UP3O9UN**C9,T@D$
MX@D](WIN%,J=U0Y3%[OJ1+!./.%4-Y;QOCJC17B0"CR2Q59];/2?,#UFA,>E
MB37MT/?_T$)]EW_N\+X@&OGLSRR(1V';)&@V7,^+1A/T^YX51A.A>1_&DI%'
M'Y.12\UD%*,YLSC? &E]TYKN>DQ8#P<QHB&UJ1MLP8* 37Z>)L%["+X3(A#X
M3H3(_F::'5Q%SL1'/'%P>M[7Y1V*TB3?>R8R2N11/O&2E<&\=]&Z-1U,A]B4
M.&FZ'JK[8\L*+ 0B%ZC<U*?(Z]K<:5^B.%JK]&RA454(-IEUCM6Y>EG@O(U"
MI!8T!SH^+J <>ZB;;5K,:]V8%8 G9Y).+XL>*VT+RJ6I+-H(UD'8HV0;YK)>
M*I@RFVO5+ \(P4(4;7EES_EK->>;*FG*L4"$"7NG!0B& $DJZNJEL'=X+.-:
MV_**[@$H'K8W$BC+M'J6)=2@FD+0;+\[K"!$;5CIB$,YB#)-4Z0N7IS7.G#-
MHJAOO]IT&[-T84DWCY0PINJU,'][!-RP)"S7:#EM6DONRLVW5+:GV">AZ4!*
M]P^(JJJI"YQ=^AR%@;OKX$W ?T/Q?%B V7S3<6TX^3ZZ'[69._+:-FQ=V(5#
M?J,D@,4$,.@ ONN'?N<H&65*388385R,[!\F*;O5E+D-:"=3-NV-#O+9LCU4
MD"OY\(Z0GDC<GI- \79_3.!RWOY>&3O(NFOAN1 <"433Q>VAFATV=;\-,,Q6
M*YTK#G$,*E=?P@CU;A"WMW+^9V(A=4*7"ASX4VA]V8-WQR';=K4X7KNJ+07R
M)5U(URU3[:UMW]O?>9^U5[VOXNV%^172+4[16,4,0]U1$@W:M:Q^&+6T%[]3
M98PJ[>M"\%QH$L#WF5)F]8,FZ/\GX/0_4$L#!!0    ( +>"5U)70UQ #0H
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M]&\RR?-BMYM_]!,,=D:2$O7:#UZ&$(G&]732GK:SW;0>:=[%Z\'PANNU\[#
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M<*47\'QJ;:@O:('FH_GY?P!02P,$%     @ MX)74JGH=LH^#0  L"<  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C<N>&ULU5IK<]LV%OTK&&^R:\\XLBC)
MKS3)C.TXJ;=-XG&<[70Z_0"1D(0-2:@ :5G]]7ON!4"1LN1Z']U.IXTLD<#%
M?9S[)%\MC/WJ9DI5XK[(2_=Z9U95\Y<'!RZ=J4*ZGIFK$G<FQA:RPD\[/7!S
MJV3&FXK\8-#O'QT44I<[;U[QM6O[YI6IJUR7ZMH*5Q>%M,MSE9O%ZYUD)UZX
MT=-911<.WKR:RZGZK*HO\VN+7P<-E4P7JG3:E,*JR>N=L^3E^8C6\X)_:+5P
MK>^")!D;\Y5^7&6O=_K$D,I56A$%B3]WZD+E.1$"&[\$FCO-D;2Q_3U2?\>R
M0Y:Q=.K"Y#_HK)J]WCG9$9F:R#JO;LSB6Q7D.21ZJ<D=?XJ%7WLXW!%I[2I3
MA,W@H-"E_ROO@QY:&T[Z6S8,PH8!\^T/8B[?RDJ^>67-0EA:#6KTA47EW6!.
MEV24SY7%78U]U9O+8IZ;I5+B1E7:*JB[$M>Y+)W8_6@JY?9>'50XAA8?I('D
MN2<YV$(R&8@/IJQF3ER6F<JZ! [ 7\/D(#)Y/GB4XEN5]L0PV1>#_J#_"+UA
M(_20Z0VWT&O)>JY*-=&5$S^=C5UE 9*?'SE@U!PPX@-&6PZX, 6\QDD/O#(3
MC9K#>4''/]VJ>_"0F_3KSYL4_?@I'S_=7HK/XJ]_.1DDR3?B\L/U]Y]^O+P4
M-Y>W5S>7'RX_WHKK[\\^?A9O<62ILM7AP:D\$V]-H5RETX<0>&=R.*TNI\+4
M5I"?PXM^J;73+)B9B/>USF19[8N%$M+!LW%*-5/QNOA<S^<YDY3Y.OU](<7$
MFE\5OI6F?/%++7,]T:"0!7['@=\Y5@L$()$J6R'0T/="63 PT;CD6,4JJ-BU
M^.J)VR<R(Q;2B;FTE99YOA23FJ +4:RIIS,P>B/'8RUN+3P25V4E4D <K#CA
MU-2JJ:RP/(799;DD32A :J&KF:;0!6#IE!=(-Q.U(\H&IRU95U%*,\[UE"'C
ML"=GBEA&2T@!/?$#=)P[(RC6LAK ]N6]2FL*;)NTNU&/J;E3EFRJFJT=/6;Z
M3C,Z$.2=SD#/]<0U:2;5D YR%6#<\FDL8B0/Q9>I"G>8#^@HTUZ@F;PC254I
MR"L<F;DGOO2^ZWGMG^%L4A1B*9F/X+:&M//;]QV4R0UZ:ZMM@_0!]:P%-P=7
MQM+M)=%F>"D0TN-<B2^E)C+?04V9*<0N,;K70MANP_F>A]A*$L)1FIM@XQ)I
M"9JPK#?)T/Q[72K!L:P_PAZK<7 P<UMDIB$RB$.;SNHI(2\YI7WT2<L9C0'P
M58<);UH2KEZ^(*!8<#!EHX#Y<W_QPI0<\-P>%#O3Z4RHR41QELR7^\0M<%NG
M54U:(G^P?,KZ;JP$$(!(Y5T&P+;F#L A@/L3,P!I6OJ;BMP<.,[A8T0ZW S^
MXVG2BL9JD0CV,G2Q;MY"H]?_!BP$I72LKATB#1P8VG 39>W*P^#)8,:2-/"!
M!<&8W(PP24AA5!!$P [Y3J0:H<_.F1FF#JZ8.5B.@T'F?0 RH8B Z^$+"ZK'
MM?<-3[:1LFM*8]O\]<05>7!9AJ*&_8_N ^J@.Z]M.D.- A/ H4G+)I7K'F15
M:FP6 G4(58P\4@=)GVLYUCF85F[E;A3VE+:L$ \2,9'X?2?S6D5LKX.8X.L-
M-&E2"5.<>\D7,&<3#PLE248O3D,ZDMU@8>(5U$RJ&3ULX2A/P\Z:Y\13.#X1
M>R_%6^U24^/G#9GL\I[$ SG$T]I"<66,4$SX)CAD)\-?E2D*8M<V6[\W>NX_
MAO1QUO"S?OY6[PXIR%6RJAV'%?SOU>A>BEU@L]!Y3FK<$^\ZZFHKXID8),,F
M\;>4MSM(CK"Q<\@SL3O<@^ 3Q2&)"D!QWM079RO#^DR!6@0"3%$Y7)5W2'(>
MP>0E+<SKTG<.#,)R2V0G6*^6R3&ZAS4WH&0$\AS.H0&..2LCHT!4Q1A<QR*1
M^=MH;[CJ)VRQ.!'.6,K YH/:!WX6I6"O:9)N*[_->6634&-UHCN4FZS!,0)@
M1VIJ\?L0$!/O\DX%^B2*]UF6M42G5I<!'72/0W/X/3?6JY#R:?3C9:Q$J,I*
M:X0]'-5R\OU5&(EW(YVP4::IK4%>W1/H:0?N\7K*HKG.V ''$OPB[' W@C7$
M]+34O[)N9I2 ' 4F-'\Z7S:UU:>+*]$+#K+=CIM\(A0*7DL^E$2]0(5MM9 (
MTU"F^7@$A($*RA,J;E=>H;M>MHVK7=%QO[,TK8O:EQ[1U3ZU7.WL_-,>,KWY
MIX\L76]M1Y<O@?^#+RWFM]?GS\3AB#Y.\,%>.OC&_USYS6!P%/X-Q?!IR!\,
M#L5@="R2X4 DR2%11.&/3_Q^)H:'="4Y/MZL''C<_U4YU^>?((''V6_IJA\5
MUM+5J*TK=*[\KW_Z9%WU1ZS:A/[UZ8#1$>EJ=$(V&;+&DL,C<28L, 7/7DBX
M<8A:T2>T]R42A7R?,/T@R*P!\T<EK6^ONP;HI@7&*MOD'&&Z++M@=PV? _!Y
M%BL ?UY4$;*$^*SL'943J7$P Z@!%*P7J#I</,1_9U2X<7FS.T48W!.H8 E-
M#2U6LH10F<\4(7^':J!1Q^[A'G"WZLSG4F=(5\A,NTE_3URAQTJY2X"R%$K'
M$+12=&TYE:M!.( >K%X^</$(9!*=(D%J$013JDE;A4FKK.#82#:)@?RA<<AJ
M/EKYK-28Z0<>"H'(&5*$G*JU6N/![6W%QX.%CY<AN\G>(YZ0]$[[ST5Y(/'M
M$-_:14O2?QX^Z?Z37*#?.SI^3D1/GHM!;X2M=#PQR/$A;7.H(X<<K:E87D3)
MQKX9Y@ZN6UQ&=T$)C'ZD\ TI@H^KTYE/"[)@G5H5J@07*JU,RW*U>UX'S(4N
M0*X.EUZMO?\M( "_/P4@!KW3T39 '#$@Z'/8Z^/SB9 X/B0P]/GSZ/!/#8FG
MA.[)UOH[!O20KGZ_N-YBH4D\_>/M87WHXW5.+ 5DM?D>B.,XM+1K[2HR)':W
M)D)K]Y% 6[F 4H'8I52 J#Y"'$<(_V]#>](.[5W!N3HA\=\%Q6^:@3D4LFE>
M9W&RV0">*WT:\ONMT3<M.Y<WM8TH#GJ3=U+GDL8#6# #>/P<$T7WV)29'P)2
MXU_;T%#/Y];<:VIU<#I15-''YV@C#" &Y(6!3#-96\#V^,4*\U'*!H??[$R
M%8F1>:9<9:R/:&6V.HXIQ!V^.VE$C]17BS>BI$N=%EL-<ZE])J*;KE!,:YTI
MFE^[%@_!FN0BN2FG+Q!3BG7]HENCCC%T]3QH(J*AIH?=<2!TC?5.I4''^ZTN
M0P'^N+^ZR>=/2<<E<\968I5"]/8RZ[L;\$WN\[VZ4[E(>+?_/FC)!P(1;UTL
MP25R%*:K$0XW2&$J5ZAJ9C*3F^F2Z6X'GA1+K?*,W.&. N(D#R.8.%20]BO:
M0IKZ^&J'^E"O([Z-&HVZ,9;7G\TC,)F&]I;!9E+VMHS(;)Y)QB$2,5M A;Z,
M(TGX_!=F[% JKL:.D1^YN8WRD ,LH$^<I7TT%(1'Y!5R*7*5I9\HE*OI),Q4
M57Z0WP"51T1AV,E@\5[2U23( Z=I:$:DSPD.'.(H @JB"-%LU:0\ZI_BS+ 6
MU6LW W5G94)/PC1NBI8^-*6M(VL7G7Y2PZ%;1O73?1ZV^4-I0AJGC(V3^CA
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M#Y!8PK[#.S/\PT7OC$F4@7#*H6BVI,ML5\5L!>VVJ3\I:BSR A9(V3O!P(U
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M8&9 *9N-9R)ZK]F]0?O,8!#!-S$':G6E(-"""#\Y !QD72UKEI-P0=WF2Y)
M1'M]LV0)MW:T#(CO9? 7>>3PEF$R(+37,/U&G?# NG\MTKV_ ]/N 9HM&8F&
M>BTPCKGWK8L O6.B TLH<SH0ED&$IL+L#5&KFK@JX7(CRCC[2QB_8.D2=ZI,
M#]H_P/NM].PHJHR#%RL2=JH /J(1?.TU@J^/:P1U!2M7G8GO(%$>X-1]P-CB
MV"7*(P; T_P8.8%@?@@78$;N34-0>S_] Y*J9_#/]H:<R9 L"UDHD;P,E(87
M#ND"$V(&#?V!P%#BD@JK870W9W)P @6>(UI Y$15A8 %;9N(U^-+YP6NP#Y9
M^JHF,#,=DO#E"JMP#=D8+#MIQ/$U\YS.X,53>)-.?8**56R+8B%$\)%GD>6[
M^;.9:L<G$@\7',]DTPF6+YNZWV#$=?Y'/?RNZ/K.^YQBF"V;G.2F02.'-FZ@
MQ]G0,:YK,N+%=TGZU\B;S ?[CDP.]@G1,9@93$ (6H]^:<=R1F8Q0Z+"UDL"
M=]^T;L*OJEQ2;SDOV60.88X0*&9:U>VFZ/*2'JY<7G:K&?ACKJ;PA+@,*3<S
M(%L-.4G&;[U8%#.U=6HF[ VCH;ATE\2MF@I3#\ V8<;;[39@ZP239ZH9F>L0
MUN.T%UN0%!)E7T4E:J2$+2 /&+-D]N"(G-?L&E.EAF4Q+8A^.XNT:H4>JYNJ
MUC-\+\NRWC(GAX2-WH**!YFZ92N,Z*4@"GS/I^VI*E*$BL7@8VP8UB S2<!%
M6"Z8WU_:1,<B+BMX"W\EGU^PF.O%^,JAR1&W(-T%<A+S-(4SSWH^_Z.'#4!2
MI'+0Y_,&NA 4MP74%"_K HD2R8G/*6\)TMB01&(V,.I$TZMIMSF\W>R'+*&I
M[FS$P.VC5?&*BTKB[S "L4?"A[+XTW&X9 2,T "6(OARB+0XD*+*' "@6B@.
M-N]&!R(5:0V B-3"T9JC-1 "?/_J[J//Q4QHW)*6>MK2P7&X2C3$EJE-^8S9
M]2&@(*Z 0,$C"YI@Y+R9LR' 3HK!E!QU /Y[ZR2*L-@RH%6X6SQ@ILQ*IW@X
M=C%==^SD\WM@T>^5SK:'8=@2ME4?FW[3S>A3DBG+;D7*/^$ID;]G(+/=K%1J
M)^)EPT[WQH>Y)4O'G1)/\*J$/RVS+?I*EUG(\>9@"^:RY[.DD6P8ALS@BY&S
MW3IH<6M02",,.HZ@<&R)0R@('3:.\77N2!6<\U&)>0AT+UW,I"8J).TG#S!=
M OQ#=%KKNF&3C=#=,4K,/ *0]DERK\U+$5,C:WI!+'=+HJLAD.<- 5J$CBK]
M.+HZ"FV#+2N'QLB<[S(9L,1Y 4V,>">P0\PNFK^).?2T9R3GJ;R#ENB#-6%0
M/'MF$<(#K0MN83-3\ 2@JYB,7NUGES!>!.S9M271TP0 8FC#_QN)P)A&8MLG
M=:G;\2-YAM2+=A^S@]^0HYEL5_LX8V!J^% BG%[(<,0Y :!^AQ5#'9+3(P@$
M6::1=9ATP@_=/.8BK-0@IM( B!69>#W 7F6O^Z;>.!%]I@F"%"N#NX_8 'KB
M*8C5 %+#V45AQ,B*4"',3TY6F BO_0W0$C!%.%8,WZM??[M^=4K8MZ$1'4"#
MB"_"=B6<>.Q9\098*R1X*E8K="@'!%J0@5,L- A8S]P<"N$M8E4,I2UQ-#:Y
M/)["5H!F,X!+OIXBZE0W.[;N'/UWQO%H*!>D01 I30/K4S63WK1 &7NU6C#1
M@D8B12<HK)+H,+^%$!?]DY26-6L&I*<1=M_R;O+(XT^F/#S\&YJ'W=2"GAR/
M(ZQE"FD1PHB.RN2;[-W07147I1-@7F_"\/".V2&[4R.L#8Q&=(862V=M(:\4
MW;>ZIB!;6>LAD>BG%GV6M@:JX)=9<83:7)!:-.=P^.^K GQ-!>'A!8K_( B[
M (80(A2?G6)$J[ZG#9V:CTWNH=]$L#:.$55NF:N:+!D$XD'QGR86-6\O. /6
MM![,'<Y,]!XWOZ<.M1"E/#Z!B0ICF2SF)* <:"5$E32HJ&NN+(B7\VQ'U,@C
MANXWWM#]YJ@Q^DY"#&1V^Y#@0YW>#YX .R3F78I!T=3 [-@/U*V(-I=B1+$[
M5C@G;7\FMHGAV:@*S]K._O V:%$%@9U(./:"L8!+/;D:A%&E UYI0@/QB6$.
M\7<L:IP2<Q-H''22C.EKUXV%M(*-'P5:;L"=B>FUV<L:O._1CY<W+Q^/OW%5
MSUE]8V@^NKRY>IR]K\D"RKY\^B5"![)B%EY7:@XH(5]YCO M!R$OOGP1D-S;
M#F;$>D5%',E@=?#,5WP4K#"I"XA5 I]N0V=@8[^E-1001_X@O/]2+1F?;C0/
M7\'E%:6. 3>0/*-I.IH%L34K*,K8F2#F8)JB-S:&&^6AO<.3$W#L(#>V7HEC
M*\,Q.)S!3.-/+1J(3VE*=XMM$,O*^@W62PH\E%T,6G2ZBB0N,1B85%-6W[>B
M5\9>=#CJX$#/Y\(Q6!(*_-0E0:<"6;K9"$>=LR>^]*+-^"VD,N<G1.=:3T%(
M[1 *R[J>,U_*%GVY*,I25'8D9XF08_M(.1S/P2^#ZC"MABJ%2HB_PR:<>Y.9
MH_^>K!A)F=B6K!*E[G*?9Z/H0\8DP94Q@;AZ29JBQ:.(KD$03GUEG'"30PUO
MV:==.F6M805Y8AUVFJA6<,J?]W@*851L.E3^ 'RBF"I09]G;Q"_R?^F2.,M>
MF7/>"#OX'B*2M8#T;I+%#GV%\\2['&Q':7:<QS(/Z4"G>\@*'##5L3#[2?18
M!.# \41I,F4F=:/I0IA'$X]W/(=RG$7?00^TF<,B)76.(]6&.II^U5>*I.R5
M#YF T08-:>7@U4340<Q_8LY F]HBZF^B-,\KXKY%/LO>K7;=:AU%OP/4$&=G
M_QMAW=1\"XR)G.D8[Q8C_G+Y_OK]AU>OB44]__J"^*4JCM'0-SO2/-:3.%YP
M>!V/KMZ]>>R5-R,.;V*UQT"<Q+< [3KD*=93O,^D8KS.F 6;%7D)I=$8 //K
M8?SDX+SMBSBK<1MR$V3X9$QQ)A'Z>@<8<Z5-R7FN1#)+8)\Z><1.)\D\L\'V
MA(H.Z!$ *OW!#9$X7P$EWH?\N+Q4DKV-4BI@/95S3<!@<M $C!!=XMPZ14&A
M53@5KX;$7*B0G)4D4<29K&B0AI:2]PG9AY&1^'=+6KUG5MJ999I'7L5T<4%S
MX[Q&YMB+/0XT#%L9YA]&^3//\(3)6-Y8<'FJ3RDE61,(D?10JA.^);,QU[UE
MX^7H_LJV]DGT=V[IPW^?OOIDI'Q-(E ]G$:O;]1;\>CZBJBT5<+F.6+J?O<F
MHF!H_4;%GP.-(1#\QAD<+$^#G>/4Y0JZYW1M2;0[0#M&6@R GJ/&K09'Q]BP
MNKTY-9LD* =D(S)6U">K3Y@V,H>(!'>D<EN> VO_I@A-O#3#:H,:F7GOW=V2
MH1T'+V=5"VG!'M9C/\M^LR3[J]B= .A%R<NP!"2LXG5M5E Y/HJQ.'PS(9U@
M3;"?2UIW$:R:&1T8G3M!AE5 KS@'\V_<I2^I 6PJR62M**.1WYQ=+^U AS..
ME$O"\EPRJ&7- I%M++$ET[H0%YVL;?]8V(/&@!@#0I2U8$D)@WU69'*>"DP5
MWP;B5<HE1 .-BTP2-2'*GUT,M083R1SQRQNRMYML9$*A'H8CA(Z!.@ESJ\."
MWQ<K4?9I=B*'TL8WI(X9*.^!C01KXT-E2-$5["]!5/( :"2DSQ$WJ05A91"(
M96^4.6FQJZS5[%<@F?V$ $Q9"F;PUY8;[/5N#JZH-@6]3=(J4W=(Q Y3/!27
M!V3B+(?@]!F*\C-SFB,)BBS%B4?RZ?NAIS[Q$VQ*7/F(70RC,;&5=.33 ?I'
M&,.K%P&\T_3]1EQ2[#_TBC>&4*[!<WILL0G9&6T'OX7*(XH/6$[;(_[)HBDB
MV"C&1?P]+TK+TMB $6A>:W <>FZJNI9.3/2Y,-.RKVP('Y';I0J7'T2_GDB*
MDMH;8;?JY$(=9;'NU_JZQ2W$_(7.,X_$"Z?NS8.CT'+ U#MQ/&8AV7A[CIU:
M_<'%AB/?(?0,HZYRR[HK&"M99K7'S%!!O&A1P:TC+&/M(M$?N(OW^6A:*ICZ
MM$;\Z2TIIZ?78JEF-^;V^-UY>PL>[ECW\*X18'+,.LF@[ANS)A:"E&ZAPL2T
M4>\8DQG=7(4^[?JE$](337=4?8GB7GX9J:XQ91T=+^\8F>:N1)H#7#=;EC_L
MM2?-LNF=4HH6SME^!<3! 10EPDG17' ,(:$MCK/'[@8:\494\XF)7HU/PT7/
M'(XU<LN9/I1K%25CP\3S*<@I_::LGA?;;D"ITYWF:6]\)17<OVDT-]FO9'PC
M6R-.M%/G)))9 Q0X>K\?IS;U#H @BT&38X:!M0T0BLVL)B[G^6?,%3E6,;B.
M95V?/PU5TT^/^H91?5$A3/!0E_,]QRV$UOB0.;/&'BK:E5R62%M;% W1:4&Z
MB_P+!\%V92UQ1V*5D'Y@G)KE'.<;J,'8"&@XY*6:_2QG3E3\B8<L5SF2-'7=
M%C$*.X&YI?7T0:=BOL*XKOG^HLZWDIC$>3GA30DPTU$1'_R3<>:*5[\(;)+3
M0]E6,$"0+(/T%517CQWIQST2 F3*L.+]->33D558.C)'F+[Z(HYAIR,38/(9
M&U^O0C4#:_J.R\U>N9GC6)"5H4="B'[^C_/GWUCE6[*80^O/.W'TF^R3DX]
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M0DD,(;0 [V?&^.J&!-0_LSC_-U!+ P04    " "W@E=2@V/N3:\"  #^!0
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MWZP ];R#-!B^IH'O@09T.B(M>!]6>!\>B/<2XJB% ['+,SCH5'SDT3(3WW*
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MQ_->X.'4\7.9R,7FN&QI$8]C;PJ 0X(Y(90ZJ@DD>0^LR'@(I?T89U)ZY#8
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M"_P3<EQBFBA8XM;P388EVG2OVF[@]-J_)!?:X;O4=RO\(P"&!'!]J;7;#<C
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M;&'180PP=P-] .XP":4KL$GR9$P2 D6A&&NEO1C/#RE/.UWI3% TRW (N<4
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M! =.(U+%+*T*AH6 8)O)[2FE<#1!F4CCQ8J7S[0?=V(PX[G;?^ZX06Z&!;Z
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ME=U ZX649C^Q!W3]\?(?4$L#!!0    ( +>"5U)]![" B@8  )D6   9
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MHY!J((^%42U0MCR$B([05HM^5\%A>9OBOG]\ES6KE4+*!0YNU$KF"YKSR('
M!(&S7CQP0= VE7[@W,@3D:N)PK3ZJ\UT5RR8$\$2#<$2_0^"Y;$X8PAN=6'&
MKT;+I$'/EUPOA%#OV R4A@=( GAVHS;WB U4667?8Y,3.1UL'+ZI@3=KH40C
MNL5C^# *(L 3-VW'F%3?D!#@:\D^>YQ.#/XD>M^82:XG%[(3Y;;A H(.(C+
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M:JZ= ,;OE+*;AC,P/'6=_1=02P,$%     @ MX)74C]I"YB8!   5 D  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULE5;9;N,V%/V5"R,/">#&(K4'
MB0$GXW8&F$R-+"V*8AYHB;:$2*)*TG'\]SVD;"<M)BGZ8'&]YR[GD/3E5NDG
M4TEIZ:5M.G,UJJSM+R834U2R%>9<];+#RDKI5E@,]7IB>BU%Z8W:9L*#()FT
MHNY&TTL_M]#32[6Q3=W)A2:S:5NA=]>R4=NK$1L=)N[J=67=Q&1ZV8NUO)?V
ML5]HC"9'E+)N96=JU9&6JZO1C%U<1VZ_W_!;+;?F39]<)DNEGMS@2WDU"EQ
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M&L$'L^$*%A*EO\#X I_&(GR&G]SY@3^A1;$,O_Q\"/9FG9\YL%A+T%N9:JF
MP:.,L]1@K,' \]M?.M5%OF>/(EUK:PA@< ./Q5K@B@-WE-!=0)%(_'"#N'M?
M?^6/O&^V7(4T7:[*<9"'V".G:.!*H1%6(+H-*Z&T ;.3<'BB4QG*!+.,9J;
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M6@.SOQ9"[R;60?-_$/\$4$L#!!0    ( +>"5U)@%0MYQP\  'YZ   9
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MIGIQWN@UT)3.2);H6W'_GA8.68"Q2)3]B^X+V:"!XDQID1;*@"!E//]/'HI
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MN+&9"?!\)>!ZD7?,AX+B2]+T+U!+ P04    " "W@E=246IG\:@'   G*P
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MTO?#-)/9^:G@:R Z:55;]Z/OS+ZT,K^HNW&_DT+]6ZAR\OQ'SF?KHBQ!5L_
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M 9X9AW?M(X]+*"%&"_ .ERQ$C!1@H:38D:%X4UPG%$A\A52.$O,B'5\C(KD
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M9[RH!<3O-WE>;3Z<B/*_Y<4?S3O>_A]02P,$%     @ MX)74K3^?$"M$
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MG#F=)R+ZJ@;:!?!U]>!KN(5U15P-%5T!5'7UJ/HY>TJ+'XRA._;,RCA?LGW
MT?\,X=8%N'5MP*W+55KT< M.=N E'6013$G0V_%(;(2MJ<R&**(%F.Q.*=X8
M3&=71&+1.TE^+'@GL5%Y!X#N3@'T,?M35T3N?DUGV&2A-3GT!=#?-43_*<3N
MBC"/B8(W78!YUS"I/P$QN6*NCQW58 )KN/ID7P]21^R\7" 2-[)1I 6*H(;Y
M^93Y0T7"<!6,08$QJ&'5Y033ATJ*,0I8H4 R5%^+&9P]IML*"KQ#K93XN1J_
M8?EDTNP1,3Y4["HH8#S58_Q99X^(XZ%BHTP!R*D>R/]5KUG9Z^O1&1(%L*8V
MRO<4H);JH5;FKC)7HF+EA/0JO]<2FS[_2DP4)$<!K^F9$W\J)OY!O_(ML<%N
MWSF)C>H)&+"#=^I*OB<IP/<>;5U+; 1W9#8*A/: 4CP+A7Q/Y ZJ&FC@#L]:
M'=\3Z_B^JG] +)YA_>@$<.J).Q@_4'08F,G3,], G!Z1RWG< V3/ J9Z0"&>
MA;V )RGYJ*8/L(MGMA4PF=YBYD\4N:8';.295?E/,KTEY*6H['A .YZ>=H:G
MMVFRZ0,Y^(Z%Z>T#>OL6T-L7T9LH2K ^H+=O#;U]$;U=16[I WK[;X?>ON2Y
MK&I  ;U]/7K_WFR?JH=FAB^[@3LZ#_8!LWT;F.US9W+TF+WW5)G\^B(@]VM/
MPR8+K<EAWP'5?3VJ'YW[^MHGMCO?1!NW?XA%8D,5&80/G.!/.6(T)O?U1:07
MW9$<)1+<D>Q35.X 8_AZQC@E1HE;#<(E\(?'QX!.@K=[4AR(NPGB*+83 1!2
MH"<D-4H=D5X&P#J!C8<: ;!(8,8B!C,H$$DC5,SP $@C>+NS/(%8HPI4'0:N
M"?0U*NW\,<W? J">P,8AGX [(&IM$Q!(RO^J74H B!^\W2X@D!S^46T# @#U
M0 _J-_'W)-MD)X*>$+ ZM)'ZAX"TH1YIA\)1'N0=+4<O:TW>$4I*.($B&"'@
M<3A0_W]X:&Z+BAQ]V33]8N@ZKM;H2UJ\5._0QZS8Y/+.B!D_I8K<+ 2P#O5@
M+9D9QL<N0H#@D-J8%X"@X?2C.<?,"[&P'ZDB 3 ;ZC-\TVDA)NS*60$0'.HA
M^";)3XD7W&E]&\=Q0L#%<'I5_IAY(2:\K@HO(@#12)_P&DZ,2/*P534S(D#8
M2(^PDIEAC!<10&9D(X6- !6CZ:?1CY@7D22-544",#32I[&FTT)R4D;5%\#7
MR.2D3)/F'$!$,U<D='.^"GP$V!O92'$CP-=H0D5D\FR253I4* /0&YF4,60A
M%!'@C"'D=%(V#L1@AU<O37CH.36(KXT?GGQ3G?)W. V2,R4%'K'^SG:8"3N<
M/,FQ ?#8X?1&SG&"HQ$1E!US5RF-'$YJY$PY5/FF"(H=3F_DV*B(8X<3'SE3
MA*I&(1239Z56S.%42LZ4@O<( #WC&N043(Z-Y!L[G"3).>Y0S(@ 2D[%J$"4
M%Z9.4J:^*0/B _TIMA%!7E8ZH"L]/H(R.:DR@AR\#^A)[UC:_/3X#OV#Y<V*
M2KN^?5QE3>B:'F^+=Z_/:(Y_;HAY)2FV4?O O!)T0 HZ_0G5:XL'P-A7C<N,
MA/-94B/%$Q7,"T^Q'OM-XWL.?0GF!:S8QOE)S M3!Y2I)M$?/"-Y/<)FH;?I
M.<2QQH"2U33T9SDYBSF)*R8VJN&8DZCB 8VJ0>R)6/,65[[$2%SY,B/5RN<4
ML9CH*<<T_*<^*X(Y52TF-L[;8TXLBP?4LB:1%RM#PJH?MEGH;7H.<20VH*[M
M!JUX0'=Q>A+&YH2SF%AYRP$G?,4#RE>3Z(TX(R,S$DZ5R(Q4QTHPI[3%9."I
MJ2J QO5CS.EN,;%2'N(TM7A05/O,\KHH?Z _RZ1F[U?%2RY_88G^I3:]#G#@
M/R"E50[X67(@3F2+K:ALL<N_7&9*L6?4>I+H904T'+99Z&UZ#G'P/B"\5<;V
M/$D.IYG%KI4R$*=LQ0/25I/@#I^5'&&ST-OT'.+0?T@0JPKNR5,83O**72O5
M(4[ABMTIU:%Q<17+02()[HP\+0E*C)0DR*EH\8",MAVNN%RNN[%;-/";%D_=
M:Q9V;IT@IIQR%E,K]2).^HH'M*\&,:62<R^J0'",0 <9870@SL*7E'_WF)6*
M$2>*Q0.J6),PC7YI >;$KGA [3HE3.>A/DX:BZUH8S$GCL4#ZEB3.(T6MV).
MW8J'Y:VCXW1R%N-TJMBS4H+AI*1X0$MJ$*)=BYYF*<VY5RYGK'SL7EU=-2.Z
MR>OM>XOWO^[?C_VQ>RET[_=/[7NSNU<Y0S/;EV[?Q.5CDE<H90]-D\Z']I!R
MN7V-]?9+73QU+W:^+^JZR+J/:Q:O6-D:-']_*(KZ]4M[@_W;Q*_^#U!+ P04
M    " "W@E=2U$2#76(*  "V,P  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M."YX;6RUFV]OVS@2A[\*$>P!+>#4$DE)=I$&2.SN7H%T+TBVMR\6]X*6:4>W
MLNC5GZ2Y3W^D))LR.:25'NY-:SM#ZL<A.<]P)%V]B/+/ZHGS&GW?Y47UZ>*I
MKO<?I],J?>([5GT0>U[(OVQ$N6.U_%INI]6^Y&S=-MKE4QP$\73'LN+B^JK]
M[;Z\OA)-G6<%OR]1U>QVK'R]Y;EX^7017AQ^>,BV3[7Z87I]M6=;_LCK;_O[
M4GZ;'GM99SM>5)DH4,DWGRYNPH_+A*H&K<4_,_Y2#3XC-925$'^J+U_6GRX"
MI8CG/*U5%TS^]\P7/,]53U+'7WVG%\=KJH;#SX?>?VX'+P>S8A5?B/SW;%T_
M?;J87: UW[ FKQ_$R]]Y/Z!(]9>*O&K_12^];7"!TJ:JQ:YO+!7LLJ+[GWWO
M'3%H$,:.!KAO@,T&U-& ] W(V :T;]"Z>MH-I?7#DM7L^JH4+ZA4UK(W]:%U
M9MM:#C\KU+P_UJ7\:R;;U=>/S7Z?<SF1-<O1+<M9D7+TV*ZX+T6WK-3TO%OR
MFF5Y]1Y=HF^/2_3NI_?H)Y05Z&N6Y]*@NIK64HWJ<YKV5[[MKHP=5PXQ^BJ*
M^JE"GXLU7Y]V,)7#.(X%'\9RB[T]+GGZ 9%P@G"  T#08G3S< XT7XYO/O.,
MAAQGAK3]$4=__ZB?>(D635G*R4$W5<7K"OUQLZKJ4FZ6?WFN0(]7H.T5J.,*
M#USVE:4U7Z.454^(%6NYE4]_XW\UV3/+I81*3G>:-W*JU+QWZM)>'6O506N@
M4Q"U"E0,>K[&@?3.\W!:;!M"XU.;I6T31]'1YF3XT7'XD7?X2U[*H:FPTWEW
M<G V-(ZNJV1P_9 08QR 3>#0&!\UQEZ-=UFJ8FRQ1:PL6;%M=RKHZ-B^.#4=
M#=C,8EA@<A28> 5VZZ!;G1,9#:I4AG!6<-%47G\FEA0<F_X$;"B!Y<Z.<F=O
MD.O1-[.NG42AH<^VF<T"6-_\J&_NW?2_E6S-)0Q3T:@=5_*4RS6ZROD$%;SV
M[/DPT $_\+K >0DPA ?VDHE)8C@"LIH'&'9%.$!3Z%5ZD\NLI 62!!%*2[[.
M:I0+.7DP;D)+Q>5P _9: :N$.J1B+17_F%.!>>O58MMG$3&7&&0UPS.'7(V6
MT,^64\^N1;.J-TU^U.];9QHNH9\N-P=G/ R<<7KA13>E=W)*T;L5WV9%H4+=
MJDM#WH-NH_;&I*;3;)O8"(5+O\WID#500C]1%LVNR3NB\,U&9K:(K?\M<S@5
MM-L!L[78M_F4V*";QX5*%>++D( #A6CB$*AI$OIQ\JM,Z]YU&TFF<ND3*[>\
M0K5 _+L\2+CVE8T-.C==;MM@8KH<P,_<,2*-G]#/GV]UEF?_80>GLL/Z@D=B
M$^426\$,, H3<RR0D6LP&DZAGTYOW3*\6)_=+S:D@)@(T(Z:([9MG!M&TR[T
MX^Y+\2RWABA?)T@MS5'9+=:DPW[2#7K_.2LR>4A:HU^$6%?=U>1RD1DP+Y_A
MQ8)MJ,WF9HH"&,V3$'8+UN##?O -A/\N3\TJW[XOA5S4(Y7;B L#<\="1G,'
MLK'F(/9S<*#\@;V@KZR623;+1^JV84>L2 ,8T="1Q&(-1$Q&Z<X<R@B0_EOY
M(&05)8ZH@#5(,?5N$CGU>U[6TJ5[N<_K]IBFCF5[A95S>2'6\,)^>-W)?L&Q
M0R RD0L9#8+FJ22-*^S'U6V3Y2K"5>V8L]V^%,_N$Q &^(('2[I7"EB%<T<D
MPYI#V,^ASWI"-DU99'53\E;U)ONN/L.*;8K(DZ\9G4&KT!5D-&RP'S8+ML]4
MT4<&%^G7K90(:[3C/C5/YPO0R!5,-!WPW*O0N_!!K7-+1D2L<@-D%<:.;4HT
M;8B?-G?2@1]5"MTE@9(U:[Z7!X&L34X@N<2&!\'8W%J053!SR=6,(7[&O#6J
M]))#J)YC28:L$B.2+PE H&3F6#5$(XA@;[@<6]'\C<N-*='TWE>K&Q3K_ "Y
MYV6JLGR)N,TAU]BJ7 .Q&J6BJ+)MX5JV9[HFY$,0_ VJ9YYKB.V&I\/3#"+^
MP]SRW%(&:GA6?0PR"D-S5=@',SQW\)UHN)%H1#'U4/?Y512'RN6HE)-H8A$_
ML08EU84JGW[VED]S46PO98:T\Q10B<VKR&0:8$/-TQ=@@QV )IIZY$SU3X80
MN2;D&>2.LTH>5MK[1I=B<_FMZJNJX)ALHM'(#-. $2%F6;@W&BXIQR&9:# 2
M/QC-NC X NA89::J@!%VI:I$4Y'XJ:A2U:ZD *\7FV[ST/*M;32<@-.["9J
M] P!P6+UI%O<X,T!&VW8T@H8$>*@!-7XHW[\M1MPTN_#N^,^O''?R !H%9MY
M$&1$'<5%JHE&_8<J.%B@=[60B -/_10H&\ZQ>5Z!K"+LR"RH1B$]4UQ,T[*1
M80ZN*9UV.KA5Y0?0'=]*G)>>TR.UP1%9E0[ B":.B$$U7:C_Z'3/7DN1Y_T-
MM"[YRS.VRO*L=IPHJ7U@BF?6!-E&2>#:III1U,^HP_P\\)54ZK\-0FUJ$*M(
M#1AAUXF*:K90/UL6HE!D49!N\Z=UBQHX_:#0[213I6T3.8(QU:R@(^XG@8J
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M@IN1VIWG[RZ,7)<GW/?2&%F4'U? ,E!V #Y?2&F>+JR#^E>5B_\ 4$L#!!0
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MHA %$W25)L4B1V?)E$[; QPSO;;*D8URGXAVQ#&=&,C"AXB8Q 0$&@UFQP'
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MR@DM^/Y!P32_JS0']0L ]R==_0 BR^KJ!Q!AQ:Z6)6"@I8>!4$ XY"W(ZJ@
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MY_81G@N*I!\;EWD:^</1NBMPC:O' &&2, 2QD;X6?K8]V)$IM@=Z1NU;5JZ
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M3BWT^J=NF0D127?2(2+5D7Z_\=:GGH!.<QJR=%Y.[)C>TSA=E3:L9W70I(I
M[ >O8U(#$;^#GGW=9TQJ +Q72'JM$_#.H.Z*A6BZC>CCQFLMEY0E7/Y.U)R)
MNDZ*ZB60VV^W[UT]+=\VVOG^$WX_KMZ>*H:I7N9ZQ?)XE/!-E!D;TC0X-,VJ
M]Z-6OQ3IJGQYYEU:%.FR_+B@X91FG(#]?9:FQ>87_H#M6VI/_@]02P,$%
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M9P'.XF^&>W74!DOE7H@OMO,VF7B!S0@SC+5U0<WK 1>89=:3R>/?RJE7Q[3
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MX_?>Z,FFSJ;@]N=7ZW]O@]?!/":5FA39O]-9O?AP$IZ@F7I*UEE]5[S\HOJ
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M\= .S 51ZL3E@H*!H(R,8[^.WQ3Y?'2C,^I9WVU@"*Y.XY %SO1Q821@TIE
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M;S2/^K?^[A;?ZL42)?E,+YK797$(D5,C<50>@<B-&%&_&/F)W-W3(I+;N0V
MHI@%=F< J( -9)?4Z![U[Y#M)7)@5RMRI @"$3L "#3@/S-"ROQ"^I9$WE>U
M/=X9M:<. !*V-L<0B _L!3(CNLPONF_$XGMJP?P\@EE\3T&"!^@_WE^0>UF<
M&5UG?EW_/A9G@-J&]K)B J+D  TRH\G,KUT^%F?NYA?!$;,= U'VO.M1.^Y'
M9& #BFT=B?GU<I*4L[1X3JKI.DO*0SB<&8%C_ B'>T:0F%^0O!S.W/,C&MK[
MS!, Q4A@[Q! MJ0<2,:9D3SF7]7MXW &G#1A[HPF"&6G-#&,&IH,1D:97T;?
ME,9#@*'M]2L PIC:JR<0A8<ZS(@N\XON6Q&YOQ8LS_$ D?L+$GD>#!#YGH+1
MN? 2.3>ZSOVZ_GU$SEV])<SI<PC%Z8 L<R/+_/\_S.+NZI6+R%88$.6<9?6H
M;?=I1(;<-Y+)_9)Y??^?_3-KU[;1.'Z$_49N-(GON:?AO1#A[@Y&PM%4 (4#
M89-E#!D;O!/!MRYT[#G5V</DW%VWC2BU]U5 5. ,)P U>#&"&S'E?C$=&$[H
M3_3=1R/<*" _PJ*/&[7B/[#HX^Y"C7,[%9@ *!'8Q!"#MH:.1KC1'^[GZ7\6
M=9+MO;-R2!<)0^@B^.N[2!A2%GY2?I,;.L+E98*=G3T M;/%VG4E9"N4 ^PM
M#'N+MUSP".CB ;&360 ER-"E"6'$0.S9A/R14V=A1$"P(PPT0]GBQRA;0&1L
M-SB &2!BL77!SD_$;S,#W!4+9H[[+H@/N6\H7;SA:?Y$N,N2X1%K>%[X>=Z7
MV0F7FFT=!B"$.;S@L[/KM^%WX>?W25'JQM)=C3YV5]^J9@ST-Y,6:C9O_K=W
MR]/ZP"--:8A>'H'HI2%Z>2C1]RO'AWQGH/?N@!<P@:,E%E@'4!,(182=$$*H
MP6M8TM"[]-/[ZPAL=\N+]B0Z-7?/DF:.H'2Y2M*R;?.I)M:YJLYTY_Z^3JNT
M:?+Q+'U659W6ZU*-2I6U#=.L*WLP.IV6:I;6U;LS/<FJNEQ/-;0=(;K.G2?[
MBF>ZPGG;SWYD:_GC [K57[4 H%@]IU.E1\Q\G77#Y/0VOGO71):I)K#NX;2H
MO.L2::1('F%=(HTD2?^ZY$?&J+O0&&%G9VD"P;A]BR*6[GG4B$8#Z:0T$BC]
M$FCH!@QDUZK1+WF$JQ%RZT;W6]X>DZ[>R) [M[>A2Q+A$"D869)^69H4>55D
MZ:P=/LUZZTM<-"\S>1O"B(<\PDV(T,A%^)8;/:&[A4,#:=^ZG( P+NQL>[SU
MAM!2:8YJWK2JNKL^W?LWFZ>;M[FNVG>8K.?7^'W<O9-ES'2OB-UJZDOS"F7J
M29L,SINI5'9O775?ZF+5OH?T6-1UL6P_+E0R4V4#T+\_%47]^J6I8//NV^7_
M %!+ P04    " "W@E=2^:RVR58)  !T/0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970V-BYX;6RUFV]OHSH6QK\*BNZ+CC1W@@W^=]56:I/NWDK3*FJG=U<:
M[0N:N D[!+) VMO5?O@+A.10VWA(6-Y,F_3XV/@9_VP_V.=O2?HC6TF9.W^N
MHSB[&*WR?//;>)S-5W(=9%^2C8R+O[PDZ3K(BX_I<IQM4ADLJD+K:(Q=EX[7
M01B/+L^K[V;IY7FRS:,PEK/4R;;K=9"^7\LH>;L8H='^BX=PN<K++\:7YYM@
M*1]E_K29I<6G\2'+(ES+. N3V$GER\7H"OTV12XM2U0A?X3R+6O\[I3/\IPD
M/\H/MXN+D5LV249RGI<Y@N+'JYS(*"I3%0WY3YUU=*BT+-C\?9_];]73%T_S
M'&1RDD3_"!?YZF+$1\Y"O@3;*'](WGZ7]1.1,M\\B;+J7^>MCG5'SGR;Y<FZ
M+ERT8!W&NY_!GW5/- IX;05P70 K!3!J*>#5!;RN!?RZ@%_US.Y1JGZ8!GEP
M>9XF;TY:1A?9RE^JSJQ*%X\?QJ7PCWE:_#4LRN67#_)5QEOIG$UE'H11]LGY
MQ0ECYRZ,HD*6['R<%Y64H>-YG?!ZEQ"W)$38N4OB?)4Y-_%"+CXF&!>M.S01
M[YMXC:T9IW+^Q?'09P>[V'UZG#IGOWR:)]LX3T-I:N"D<SHDZG2&+-/N6;@Q
MRX=G]0YR>%5:KRUMF 7+92J7034JDA=G+]#WKT6H<YO+=?8O2T7^H2*_JLAO
MJ>AF+=-E&"^=NR#](?/,R9,\B)QXNWZ6:5GOH8>=_SFVWK[>U<.J>DK,O%YB
M]WS\:F@;.;2-6-MV7_ N"R)S=;NBI%&=$,@[5+C['Z '(9=YY&/4U)"*8\_<
M=GIH.[4*."G^[Z<%S(IAG*^<236 9?K9^1H&SV$4YN_.]ZOGK JQR<@.U3%K
M5_VT.E,7,DTQ3RA],]%C?+=%5GYH*[=WS2J(E[*DR_^ID\2A8M&ODSX77ZZW
M45!.0<XDR.>K7[<;YVKQ[R*TF.3R8G#LQV$1>GB,FRP/BYE'EL/E6QK$6;";
MRV9I.)>FCA=:IR(FS)V*7 "XV_?I]@QYD/-D&8?_5;%<<]W5F]<8,Q^;UYA?
MD+5Y3_>WWVZFSN.WJV\WCQ8Q$8:,>%A&(J Q\DXG45VVV5^$N4@92(8HBBA3
M4&3*13S>TOD >62G_'T2__KTZ'R_DR76K7T"<$9DX.X'EB+:H_NICBB,L-K]
MABA"A=K]IER<MG0_P!G9Z:Q-LEV$ )PB.T_["P$ 17:"VH4P8,T5ZI1LBL($
MJT(8<S&S$!@8B>V,_'N4/!>KFV)%FF3S9//NG)6_?BHZ;).D>:G04QSF7>3!
M #Z,AI4' Q$Q/EV>NNS'68>[BCRF*"Y\11YC+HI;Y ',8CMFCY2G6)%VG54P
MH!+[ \L%!,4]UK=UV8\CP-7D,D6IHDX-48*WK.(P4!G;J7R\6MVG(0QLQ6Q@
MO0"TF/?0BVM];!A=>A!'VN R94(M:@&ZL1W=M5I/:1(ERW<GB!?.3$:OX=SY
M7091L6(\GH$><-=SAQ7) ]QZ]G6F5:2Z[,?)IS&_[U0R1?GJWG)JS.6WK),]
M8+AG9_BI.AT!0Z_A0@QL0WC 7>\G2U2K;KJY(!!79=.#"F*JFWU#%*=^BVJ
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M3PS<$@/[! +8)7KX!,)P>H&J9^HFABCD4J*^-#(E:[VM(("(PD[$%AV.X(T
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M4/S])4GR_8>R@L-%Z\N_ %!+ P04    " "W@E=27O)W"]4$  !L%   &0
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M GA0(^#F FY5H%<CX.4"WJ4"O5R@EWHFHY+ZP2>*3">"[Y'0:-"F+U)GIM)
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M1*P@W5%,EZ#2N1N"02([VLIN%-^DASUO7"F>I)=K2J!L- #>+SE7AQN]0''
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MM:J9?S:7YT[*A,TW9_ 74$L#!!0    ( +>"5U*7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ MX)74L2:7O%D!0
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MWG7XVI=Z[?E>XT]!/TGU<+ZW7!]_67Z?1)P7%YS3;45]^@M02P,$%     @
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MO !02P$"% ,4    " "W@E=2!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +>"5U+0)>B![@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( +>"5U*97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ MX)74B]$Q<?A!@  [1X  !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( +>"5U*)YW.U*P8   0:   8              " @20/  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "W@E=2#T:<ECP#  #Q"0
M&               @(&%%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ MX)74L%5#8CQ!@  PAL  !@              ("!]Q@  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( +>"5U*TIPZ]N (
M *@(   8              " @1X@  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    " "W@E=281YW@^@&  "U(0  &               @($,
M(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ MX)74AS^
MD]#N"@  VS4  !@              ("!*BH  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( +>"5U+PTN;[MP(  )<(   8
M  " @4XU  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "W
M@E=24]>+Y#DJ   ,A0  &               @($[.   >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ MX)74CR\@BC&&0  6U<  !D
M         ("!JF(  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    " "W@E=2I7M1ESD%  #I"P  &0              @(&G?   >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( +>"5U*@]6:H90<  "81
M   9              " @1>"  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ MX)74IFD?<5E'   #6D  !D              ("!LXD
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "W@E=2++I^
MQE\6  "R20  &0              @(%/I@  >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( +>"5U*J"5UD,0@  +P5   9
M  " @>6\  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
MMX)74A,+@S-X"@  +B   !D              ("!3<4  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    " "W@E=288'6#0<'  !)$   &0
M            @('\SP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( +>"5U)!WMSL-!,  ) W   9              " @3K7  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ MX)74NXUG(9X)@
M]W4  !D              ("!I>H  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    " "W@E=2^;5]'/L*   .'P  &0              @(%4
M$0$ >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( +>"5U+=
M[S]"&A,  -4W   9              " @88< 0!X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ MX)74NJH799K!0  " T  !D
M     ("!UR\! 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +>"5U*IZ';*/@T  + G   9              "
M@;A7 0!X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ MX)7
M4@O@IN?:!   WPL  !D              ("!+64! 'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    " "W@E=2XHQ+E.<O   0H@  &0
M        @($^:@$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( +>"5U*3PJGB<@0  "\+   9              " @5R: 0!X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ MX)74G741THM"0  <B$
M !D              ("!!9\! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    " "W@E=2@V/N3:\"  #^!0  &0              @(%IJ $
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( +>"5U)J'8(P
MY @  ,8@   9              " @4^K 0!X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ MX)74ALRSI,: P  V 8  !D
M ("!:K0! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "W
M@E=2;Z\](OH$  !F#   &0              @(&[MP$ >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( +>"5U(NA-D*C0P  (4K   9
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M970T,"YX;6Q02P$"% ,4    " "W@E=2[V<BS8H(  #R%@  &0
M    @(%0Y $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M +>"5U)=5QKE90D  -(:   9              " @1'M 0!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ MX)74NYTCT 7!   V D  !D
M             ("!K?8! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    " "W@E=2:<WM+=L&  #V$@  &0              @('[^@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( +>"5U(_:0N8F 0
M %0)   9              " @0T" @!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ MX)74A0.=/># P  *PD  !D              ("!
MW 8" 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "W@E=2
MIW)6#I$'  !N&0  &0              @(&6"@( >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( +>"5U)OG$J_S (  "L(   9
M      " @5X2 @!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ MX)74F 5"WG'#P  ?GH  !D              ("!814" 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " "W@E=2%*1R#F<%  #B&P
M&0              @(%?)0( >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+
M 0(4 Q0    ( +>"5U(H<E(S%@,  ,8(   9              " @?TJ @!X
M;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ MX)74J??P/%L
M!   51(  !D              ("!2BX" 'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6Q02P$"% ,4    " "W@E=246IG\:@'   G*P  &0
M@('M,@( >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( +>"
M5U(#WEH(M!,  #*7   9              " @<PZ @!X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL4$L! A0#%     @ MX)74K3^?$"M$   6&P  !D
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M=#4Y+GAM;%!+ 0(4 Q0    ( +>"5U(*A?O## T  %](   9
M  " @5F  @!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @
MMX)74EU7B1UX!0  :Q@  !D              ("!G(T" 'AL+W=O<FMS:&5E
M=',O<VAE970V,2YX;6Q02P$"% ,4    " "W@E=2,/D(A0 &  #&'   &0
M            @(%+DP( >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4
M Q0    ( +>"5U+>UN'IT@T  +%6   9              " @8*9 @!X;"]W
M;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ MX)74B-2$ZIJ P
M< T  !D              ("!BZ<" 'AL+W=O<FMS:&5E=',O<VAE970V-"YX
M;6Q02P$"% ,4    " "W@E=2K0].!^8)   '-P  &0              @($L
MJP( >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( +>"5U+Y
MK+;)5@D  '0]   9              " @4FU @!X;"]W;W)K<VAE971S+W-H
M965T-C8N>&UL4$L! A0#%     @ MX)74E[R=PO5!   ;!0  !D
M     ("!UKX" 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4
M" "W@E=2XUJIE\8)  #I1   &0              @('BPP( >&PO=V]R:W-H
M965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( +>"5U+:YIZ*A@,  #T+   9
M              " @=_- @!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L!
M A0#%     @ MX)74@@+AEZ  @  @ X   T              ( !G-$" 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " "W@E=2EXJ[',     3 @  "P
M        @ %'U ( 7W)E;',O+G)E;'-02P$"% ,4    " "W@E=2Q)I>\60%
M  ";+0  #P              @ $PU0( >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ MX)74I=W<N0L @  ]B@  !H              ( !P=H" 'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ MX)74M9((R[W 0
M*R@  !,              ( !)=T" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     $T 30 2%0  3=\"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>606</ContextCount>
  <ElementCount>763</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>162</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Balance Sheet Paranthetical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical</Role>
      <ShortName>Consolidated Balance Sheet Paranthetical</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure</Role>
      <ShortName>Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105102 - Disclosure - Acquisitions and Strategic Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments</Role>
      <ShortName>Acquisitions and Strategic Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Assets and Liabilities Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale</Role>
      <ShortName>Assets and Liabilities Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Hedging Activities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</Role>
      <ShortName>Hedging Activities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Contractual Obligations and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</Role>
      <ShortName>Contractual Obligations and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2126108 - Disclosure - Restructuring Related Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RestructuringRelatedActivities</Role>
      <ShortName>Restructuring Related Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</Role>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2132110 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2136111 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2138112 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2140113 - Disclosure - Stock Inventive and Purchase Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockInventiveandPurchasePlans</Role>
      <ShortName>Stock Inventive and Purchase Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2143114 - Disclosure - Weighted Average Shares Outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</Role>
      <ShortName>Weighted Average Shares Outstanding</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2146115 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2149116 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2152117 - Disclosure - Changes in Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</Role>
      <ShortName>Changes in Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2155118 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2157119 - Disclosure - Employee Retirement Plans (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes</Role>
      <ShortName>Employee Retirement Plans (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2161120 - Disclosure - Schedule II</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ScheduleII</Role>
      <ShortName>Schedule II</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2217202 - Disclosure - Fair Value Measures and Disclosures (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies</Role>
      <ShortName>Fair Value Measures and Disclosures (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2256203 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2258204 - Disclosure - Employee Retirement Plans Employee Retirement Plans (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies</Role>
      <ShortName>Employee Retirement Plans Employee Retirement Plans (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2306302 - Disclosure - Acquisitions and Strategic Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables</Role>
      <ShortName>Acquisitions and Strategic Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2311303 - Disclosure - Assets and Liabilities Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables</Role>
      <ShortName>Assets and Liabilities Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2314304 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2318305 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2321306 - Disclosure - Contractual Obligations and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</Role>
      <ShortName>Contractual Obligations and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2324307 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/Leases</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2327308 - Disclosure - Restructuring Related Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables</Role>
      <ShortName>Restructuring Related Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RestructuringRelatedActivities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2330309 - Disclosure - Supplemental Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</Role>
      <ShortName>Supplemental Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2333310 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2341311 - Disclosure - Stock Incentive and Purchase Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables</Role>
      <ShortName>Stock Incentive and Purchase Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2344312 - Disclosure - Weighted Average Shares Outstanding (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</Role>
      <ShortName>Weighted Average Shares Outstanding (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2347313 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReporting</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2350314 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/Revenue</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2353315 - Disclosure - Changes in Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</Role>
      <ShortName>Changes in Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2359316 - Disclosure - Employee Retirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/EmployeeRetirementPlansTables</Role>
      <ShortName>Employee Retirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Acquisitions and Strategic Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails</Role>
      <ShortName>Acquisitions and Strategic Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContingentConsiderationDetails</Role>
      <ShortName>Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Strategic Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StrategicInvestmentsDetails</Role>
      <ShortName>Strategic Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Goodwill and Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2419407 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2422408 - Disclosure - Contractual Obligations and Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails</Role>
      <ShortName>Contractual Obligations and Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2425409 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/LeasesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2428410 - Disclosure - Restructuring Related Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails</Role>
      <ShortName>Restructuring Related Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2431411 - Disclosure - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2434412 - Disclosure - Income Taxes (Details - Rate Table)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable</Role>
      <ShortName>Income Taxes (Details - Rate Table)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2435413 - Disclosure - Income Taxes Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails</Role>
      <ShortName>Income Taxes Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2437414 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/CommitmentsandContingencies</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2439415 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/StockholdersEquity</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2442416 - Disclosure - Stock Incentive and Purchase Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails</Role>
      <ShortName>Stock Incentive and Purchase Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2445417 - Disclosure - Weighted Average Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails</Role>
      <ShortName>Weighted Average Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2448418 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReportingTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2451419 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RevenueTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2454420 - Disclosure - Changes in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Changes in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2460421 - Disclosure - Employee Retirement Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails</Role>
      <ShortName>Employee Retirement Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="bsx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2462422 - Disclosure - Schedule II (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ScheduleIIDetails</Role>
      <ShortName>Schedule II (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ScheduleII</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="bsx-20201231.htm">bsx-20201231.htm</File>
    <File>bsx-20201231.xsd</File>
    <File>bsx-20201231_cal.xml</File>
    <File>bsx-20201231_def.xml</File>
    <File>bsx-20201231_lab.xml</File>
    <File>bsx-20201231_pre.xml</File>
    <File>exhibit21-listofsubsidiari.htm</File>
    <File>exhibit23-2020eyconsent.htm</File>
    <File>exhibit311-ceo302202010xk.htm</File>
    <File>exhibit312-cfo302202010xk.htm</File>
    <File>exhibit321-ceo906202010xk.htm</File>
    <File>exhibit322-cfo906202010xk.htm</File>
    <File>exhibit42-descriptionofthe.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>bsx-20201231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>97
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20201231.htm": {
   "axisCustom": 2,
   "axisStandard": 36,
   "contextCount": 606,
   "dts": {
    "calculationLink": {
     "local": [
      "bsx-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 1068,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 5
   },
   "keyCustom": 122,
   "keyStandard": 641,
   "memberCustom": 96,
   "memberStandard": 58,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.bostonscientific.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105102 - Disclosure - Acquisitions and Strategic Investments",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments",
     "shortName": "Acquisitions and Strategic Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Assets and Liabilities Held for Sale",
     "role": "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale",
     "shortName": "Assets and Liabilities Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Hedging Activities and Fair Value Measurements",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
     "shortName": "Hedging Activities and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Contractual Obligations and Commitments",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitments",
     "shortName": "Contractual Obligations and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - Leases",
     "role": "http://www.bostonscientific.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126108 - Disclosure - Restructuring Related Activities",
     "role": "http://www.bostonscientific.com/role/RestructuringRelatedActivities",
     "shortName": "Restructuring Related Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - Supplemental Balance Sheet Information",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation",
     "shortName": "Supplemental Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132110 - Disclosure - Income Taxes",
     "role": "http://www.bostonscientific.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136111 - Disclosure - Commitments and Contingencies",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Statements of Operations",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138112 - Disclosure - Stockholders' Equity",
     "role": "http://www.bostonscientific.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140113 - Disclosure - Stock Inventive and Purchase Plans",
     "role": "http://www.bostonscientific.com/role/StockInventiveandPurchasePlans",
     "shortName": "Stock Inventive and Purchase Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143114 - Disclosure - Weighted Average Shares Outstanding",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding",
     "shortName": "Weighted Average Shares Outstanding",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146115 - Disclosure - Segment Reporting",
     "role": "http://www.bostonscientific.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149116 - Disclosure - Revenue",
     "role": "http://www.bostonscientific.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152117 - Disclosure - Changes in Other Comprehensive Income",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome",
     "shortName": "Changes in Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155118 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157119 - Disclosure - Employee Retirement Plans (Notes)",
     "role": "http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes",
     "shortName": "Employee Retirement Plans (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2161120 - Disclosure - Schedule II",
     "role": "http://www.bostonscientific.com/role/ScheduleII",
     "shortName": "Schedule II",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Policies)",
     "role": "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2217202 - Disclosure - Fair Value Measures and Disclosures (Policies)",
     "role": "http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies",
     "shortName": "Fair Value Measures and Disclosures (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2256203 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements (Policies)",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2258204 - Disclosure - Employee Retirement Plans Employee Retirement Plans (Policies)",
     "role": "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies",
     "shortName": "Employee Retirement Plans Employee Retirement Plans (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementPlansPensionsPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306302 - Disclosure - Acquisitions and Strategic Investments (Tables)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
     "shortName": "Acquisitions and Strategic Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311303 - Disclosure - Assets and Liabilities Held for Sale (Tables)",
     "role": "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables",
     "shortName": "Assets and Liabilities Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314304 - Disclosure - Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318305 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables",
     "shortName": "Hedging Activities and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321306 - Disclosure - Contractual Obligations and Commitments (Tables)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables",
     "shortName": "Contractual Obligations and Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324307 - Disclosure - Leases (Tables)",
     "role": "http://www.bostonscientific.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327308 - Disclosure - Restructuring Related Activities (Tables)",
     "role": "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables",
     "shortName": "Restructuring Related Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Balance Sheets",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330309 - Disclosure - Supplemental Balance Sheet Information (Tables)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables",
     "shortName": "Supplemental Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333310 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341311 - Disclosure - Stock Incentive and Purchase Plans (Tables)",
     "role": "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables",
     "shortName": "Stock Incentive and Purchase Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344312 - Disclosure - Weighted Average Shares Outstanding (Tables)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables",
     "shortName": "Weighted Average Shares Outstanding (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347313 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350314 - Disclosure - Revenue (Tables)",
     "role": "http://www.bostonscientific.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353315 - Disclosure - Changes in Other Comprehensive Income (Tables)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables",
     "shortName": "Changes in Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementPlansPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2359316 - Disclosure - Employee Retirement Plans (Tables)",
     "role": "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables",
     "shortName": "Employee Retirement Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementPlansPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Details)",
     "role": "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProductionRelatedImpairmentsOrCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Acquisitions and Strategic Investments (Details)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
     "shortName": "Acquisitions and Strategic Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ifebff9fa165845099c6ce6e1372b7c51_D20180101-20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Balance Sheet Paranthetical",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
     "shortName": "Consolidated Balance Sheet Paranthetical",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Contingent Consideration (Details)",
     "role": "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
     "shortName": "Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "i5652084f5c3f41dea13147f2b3d78acb_D20190101-20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Strategic Investments (Details)",
     "role": "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
     "shortName": "Strategic Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Assets and Liabilities Held for Sale (Details)",
     "role": "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ic719d29f043447d9a84bc5924b1baf78_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Goodwill and Other Intangible Assets (Details)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsForHedgeInvestingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419407 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422408 - Disclosure - Contractual Obligations and Commitments (Details)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
     "shortName": "Contractual Obligations and Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425409 - Disclosure - Leases (Details)",
     "role": "http://www.bostonscientific.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428410 - Disclosure - Restructuring Related Activities (Details)",
     "role": "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
     "shortName": "Restructuring Related Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "i64748ffebbb64a0481b1cdc590c675a0_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431411 - Disclosure - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails",
     "shortName": "Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434412 - Disclosure - Income Taxes (Details - Rate Table)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable",
     "shortName": "Income Taxes (Details - Rate Table)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "iec2a00e6f06c444a9952e4b94b0d4e6e_I20171231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "iec2a00e6f06c444a9952e4b94b0d4e6e_I20171231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435413 - Disclosure - Income Taxes Income Taxes (Details)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails",
     "shortName": "Income Taxes Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ic3a4c1a262e0442388a415c87e27e889_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437414 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439415 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.bostonscientific.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ic981515a7d5b42c29018a2a5a0ae37fa_I20201214",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bsx:Fairvalueofmarketbasedawards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442416 - Disclosure - Stock Incentive and Purchase Plans (Details)",
     "role": "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
     "shortName": "Stock Incentive and Purchase Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "bsx:MarketBasedAwardsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bsx:Fairvalueofmarketbasedawards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445417 - Disclosure - Weighted Average Shares Outstanding (Details)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails",
     "shortName": "Weighted Average Shares Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448418 - Disclosure - Segment Reporting (Details)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingDetails",
     "shortName": "Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bsx:EmergingMarketsTotalNumberOfCountries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "countries",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451419 - Disclosure - Revenue (Details)",
     "role": "http://www.bostonscientific.com/role/RevenueDetails",
     "shortName": "Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bsx:EmergingMarketsTotalNumberOfCountries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "countries",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454420 - Disclosure - Changes in Other Comprehensive Income (Details)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
     "shortName": "Changes in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460421 - Disclosure - Employee Retirement Plans (Details)",
     "role": "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
     "shortName": "Employee Retirement Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ic3a4c1a262e0442388a415c87e27e889_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462422 - Disclosure - Schedule II (Details)",
     "role": "http://www.bostonscientific.com/role/ScheduleIIDetails",
     "shortName": "Schedule II (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "ia2522ce480044b738970a71b97a2834e_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
     "shortName": "Consolidated Statements of Cash Flows Consolidated Statement of Cash Flows (Supplemental Disclosure)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if8e21581818b44be817499b63aaaddd8_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://www.bostonscientific.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20201231.htm",
      "contextRef": "if99852c5f50d49489e7b7697112a652a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 162,
   "tag": {
    "bsx_A2011LtipPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2011 LTIP Plan [Member]",
        "label": "2011 LTIP Plan [Member]",
        "terseLabel": "2011 LTIP Plan [Member]"
       }
      }
     },
     "localname": "A2011LtipPlanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2016RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Restructuring Plan [Member]",
        "label": "2016 Restructuring Plan [Member]",
        "terseLabel": "2016 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "A2016RestructuringPlanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2018AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Acquisitions [Member]",
        "label": "2018 Acquisitions [Member]",
        "terseLabel": "2018 Acquisitions [Member]"
       }
      }
     },
     "localname": "A2018AcquisitionsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2019AcquisitionsVertiflexAndMillipedeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Acquisitions (Vertiflex and Millipede)",
        "label": "2019 Acquisitions (Vertiflex and Millipede) [Member]",
        "terseLabel": "2019 Acquisitions (Vertiflex and Millipede)"
       }
      }
     },
     "localname": "A2019AcquisitionsVertiflexAndMillipedeMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2019RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Restructuring Plan [Member]",
        "label": "2019 Restructuring Plan [Member]",
        "terseLabel": "2019 Restructuring Plan [Member]",
        "verboseLabel": "2019 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "A2019RestructuringPlanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2020TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Term Loan",
        "label": "2020 Term Loan [Member]",
        "terseLabel": "2020 Term Loan [Member]"
       }
      }
     },
     "localname": "A2020TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A [Member]"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/Cover",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]",
        "label": "ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]",
        "terseLabel": "ASC Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities [Policy Text Block]"
       }
      }
     },
     "localname": "ASCUpdateNo.201712DerivativesandHedgingTopic815TargetedImprovementstoAccountingforHedgingActivitiesPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]",
        "label": "ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]",
        "terseLabel": "ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]"
       }
      }
     },
     "localname": "ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2016-13 Financial Instruments - Credit Losses (FASB ASC Topic 326, Financial Instruments - Credit Losses)",
        "label": "ASC Update No. 2016-13 Financial Instruments - Credit Losses (FASB ASC Topic 326, Financial Instruments - Credit Losses) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2016-13 Financial Instruments - Credit Losses (FASB ASC Topic 326, Financial Instruments - Credit Losses)"
       }
      }
     },
     "localname": "ASCUpdateNo201613FinancialInstrumentsCreditLossesFASBASCTopic326FinancialInstrumentsCreditLossesPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2018-15 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)",
        "label": "ASC Update No. 2018-15 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2018-15 Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)"
       }
      }
     },
     "localname": "ASCUpdateNo201815IntangiblesGoodwillAndOtherInternalUseSoftwareSubtopic35040PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2018-18 Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606",
        "label": "ASC Update No. 2018-18 Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606 [Policy Text Block]",
        "terseLabel": "ASC Update No. 2018-18 Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606"
       }
      }
     },
     "localname": "ASCUpdateNo201818CollaborativeArrangementsTopic808ClarifyingTheInteractionBetweenTopic808AndTopic606PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2019-12, Income Taxes (Topic 740)",
        "label": "ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2019-12, Income Taxes (Topic 740)"
       }
      }
     },
     "localname": "ASCUpdateNo201912IncomeTaxesTopic740PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)",
        "label": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)"
       }
      }
     },
     "localname": "ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2020-10 Codification Improvements",
        "label": "ASC Update No. 2020-10 Codification Improvements [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-10 Codification Improvements"
       }
      }
     },
     "localname": "ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_AccruedRebatesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Rebates, Current",
        "label": "Accrued Rebates, Current",
        "terseLabel": "Accrued Rebates, Current"
       }
      }
     },
     "localname": "AccruedRebatesCurrent",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ActualCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actual Covenant.",
        "label": "Actual, Covenant [Member]",
        "terseLabel": "Actual, Covenant [Member]"
       }
      }
     },
     "localname": "ActualCovenantMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]",
        "label": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]",
        "terseLabel": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "AggregateSeniorUnsecuredDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AllegedBreachofPurchaseAgreementAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alleged Breach of Purchase Agreement, Amount",
        "label": "Alleged Breach of Purchase Agreement, Amount",
        "terseLabel": "Alleged Breach of Purchase Agreement, Amount"
       }
      }
     },
     "localname": "AllegedBreachofPurchaseAgreementAmount",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid in the period to fully or partially settle a specified type of restructuring cost.",
        "label": "Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Table Text Block]",
        "terseLabel": "Amount Of Cash Paid In Period To Fully Or Partially Settle Specified Type Of Restructuring Cost [Text Block]"
       }
      }
     },
     "localname": "AmountOfCashPaidInPeriodToFullyOrPartiallySettleSpecifiedTypeOfRestructuringCostTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_AmountOfEmployeesTotalCompensationEligibleForGesopPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of employees total compensation eligible for GESOP purchase",
        "label": "Amount of employees total compensation eligible for GESOP purchase",
        "terseLabel": "Amount of employees total compensation eligible for GESOP purchase"
       }
      }
     },
     "localname": "AmountOfEmployeesTotalCompensationEligibleForGesopPurchase",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_Annualweightedaverageforfeiturerate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Weighted Average Forfeiture Rate The weighted average of estimated forfeitures for grants based on historical trends",
        "label": "annualweightedaverageforfeiturerate",
        "terseLabel": "annualweightedaverageforfeiturerate"
       }
      }
     },
     "localname": "Annualweightedaverageforfeiturerate",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_April2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 2021 Term Loan",
        "label": "April 2021 Term Loan [Member]",
        "terseLabel": "April 2021 Term Loan [Member]"
       }
      }
     },
     "localname": "April2021TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AssetsHeldForSaleDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held for sale",
        "label": "Assets held for sale [Domain]",
        "terseLabel": "Assets held for sale [Domain]"
       }
      }
     },
     "localname": "AssetsHeldForSaleDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AssignedToOneJudgeInMAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assigned to one judge in MA",
        "label": "Assigned to one judge in MA [Member]",
        "terseLabel": "Assigned to one judge in MA [Member]"
       }
      }
     },
     "localname": "AssignedToOneJudgeInMAMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AugmenixInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Augmenix, Inc. [Member]",
        "label": "Augmenix, Inc. [Member]",
        "terseLabel": "Augmenix, Inc. [Member]"
       }
      }
     },
     "localname": "AugmenixInc.Member",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_August2019TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August 2019 Term Loan [Member]",
        "label": "August 2019 Term Loan [Member]",
        "terseLabel": "August 2019 Term Loan [Member]"
       }
      }
     },
     "localname": "August2019TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_August2022TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August 2022 Term Loan",
        "label": "August 2022 Term Loan [Member]",
        "terseLabel": "August 2022 Term Loan [Member]"
       }
      }
     },
     "localname": "August2022TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BSXReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BSX Reportable Segments",
        "label": "BSX Reportable Segments [Member]",
        "terseLabel": "BSX Reportable Segments"
       }
      }
     },
     "localname": "BSXReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BTGAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BTG Acquisition",
        "label": "BTG Acquisition [Member]",
        "terseLabel": "BTG Acquisition [Member]"
       }
      }
     },
     "localname": "BTGAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CardiovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiovascular [Member]",
        "label": "Cardiovascular [Member]",
        "terseLabel": "Cardiovascular [Member]"
       }
      }
     },
     "localname": "CardiovascularMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash flow impact of deferred income tax expense (benefit)",
        "label": "Cash flow impact of deferred income tax expense (benefit)",
        "terseLabel": "Deferred and prepaid income taxes"
       }
      }
     },
     "localname": "CashFlowImpactOfDeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CertifiedclassactionsinCanadaMesh": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certified class actions in Canada, Mesh",
        "label": "Certified class actions in Canada, Mesh",
        "terseLabel": "Certified class actions in Canada, Mesh"
       }
      }
     },
     "localname": "CertifiedclassactionsinCanadaMesh",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest",
        "label": "Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest",
        "terseLabel": "Change-in-control provision, repurchase price of aggregate principal, plus accrued and unpaid interest"
       }
      }
     },
     "localname": "ChangeInControlProvisionRepurchasePriceOfAggregatePrincipalPlusAccruedAndUnpaidInterest",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_ChangeinDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Deferred Tax Assets, Valuation Allowance",
        "label": "Change in Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Change in Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "ChangeinDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ClaretMedicalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Claret [Member]",
        "label": "Claret Medical, Inc. [Member]",
        "terseLabel": "Claret Medical, Inc. [Member]"
       }
      }
     },
     "localname": "ClaretMedicalIncMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CompensationExpensePerShareBasic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "compensation expense, per share - basic",
        "label": "compensation expense, per share - basic",
        "terseLabel": "compensation expense, per share - basic"
       }
      }
     },
     "localname": "CompensationExpensePerShareBasic",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_CompensationExpensePerShareDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "compensation expense, per share - diluted",
        "label": "compensation expense, per share - diluted",
        "terseLabel": "compensation expense, per share - diluted"
       }
      }
     },
     "localname": "CompensationExpensePerShareDiluted",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_ConsolidatedBSXDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated BSX",
        "label": "Consolidated BSX [Domain]",
        "terseLabel": "Consolidated BSX [Domain]"
       }
      }
     },
     "localname": "ConsolidatedBSXDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ConsolidatedBalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Balance Sheet (Parenthetical)",
        "label": "Consolidated Balance Sheet (Parenthetical) [Abstract]"
       }
      }
     },
     "localname": "ConsolidatedBalanceSheetParentheticalAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "xbrltype": "stringItemType"
    },
    "bsx_ConsolidatedCashFlowSupplementalDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Cash Flow Supplemental Disclosure [Abstract]",
        "label": "Consolidated Cash Flow Supplemental Disclosure [Abstract]",
        "terseLabel": "Consolidated Cash Flow Supplemental Disclosure [Abstract]"
       }
      }
     },
     "localname": "ConsolidatedCashFlowSupplementalDisclosureAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "xbrltype": "stringItemType"
    },
    "bsx_ContingentConsiderationLiabilityProbabilityOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration liability, probability of payment",
        "label": "contingent consideration liability, probability of payment",
        "terseLabel": "contingent consideration liability, probability of payment"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityProbabilityOfPayment",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ContingentConsiderationPaymentsMadeToPriorShareholdersToDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration payments made to prior shareholders to date",
        "label": "Contingent consideration payments made to prior shareholders to date",
        "terseLabel": "Contingent consideration payments made to prior shareholders to date"
       }
      }
     },
     "localname": "ContingentConsiderationPaymentsMadeToPriorShareholdersToDate",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CorporateExpensesincludinghedgingactivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Expenses including hedging activities [Member]",
        "label": "Corporate Expenses including hedging activities [Member]",
        "terseLabel": "Corporate Expenses including hedging activities [Member]"
       }
      }
     },
     "localname": "CorporateExpensesincludinghedgingactivitiesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CovenantAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Axis]",
        "terseLabel": "Covenant [Axis]"
       }
      }
     },
     "localname": "CovenantAxis",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CovenantDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Domain]",
        "terseLabel": "Covenant [Domain]"
       }
      }
     },
     "localname": "CovenantDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CryterionMedicalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cryterion [Member]",
        "label": "Cryterion Medical, Inc. [Member]",
        "terseLabel": "Cryterion Medical, Inc. [Member]"
       }
      }
     },
     "localname": "CryterionMedicalIncMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CumulativeEffectOfNewAccountingPrinciples": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect Of New Accounting Principles",
        "label": "Cumulative Effect Of New Accounting Principles",
        "terseLabel": "Cumulative Effect Of New Accounting Principles"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPrinciples",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Restructuring and Restructuring-Related Payments Made To Date",
        "label": "Cumulative Restructuring and Restructuring-Related Payments Made To Date",
        "terseLabel": "Cumulative Restructuring and Restructuring-Related Payments Made To Date"
       }
      }
     },
     "localname": "CumulativeRestructuringAndRestructuringRelatedPaymentsMadeToDate",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CumulativeRestructuringChargesIncurredToDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Restructuring Charges Incurred to Date",
        "label": "Cumulative Restructuring Charges Incurred to Date",
        "terseLabel": "Cumulative Restructuring Charges Incurred to Date"
       }
      }
     },
     "localname": "CumulativeRestructuringChargesIncurredToDate",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CumulativeRestructuringChargesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative restructuring charges.",
        "label": "Cumulative Restructuring Charges [Table Text Block]",
        "terseLabel": "Cumulative Restructuring Charges [Text Block]"
       }
      }
     },
     "localname": "CumulativeRestructuringChargesTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_CumulativeRestructuringRelatedCostsIncurredToDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Restructuring-related Costs Incurred to Date",
        "label": "Cumulative Restructuring-related Costs Incurred to Date",
        "terseLabel": "Cumulative Restructuring-related Costs Incurred to Date"
       }
      }
     },
     "localname": "CumulativeRestructuringRelatedCostsIncurredToDate",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CurrentRequirementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Requirement.",
        "label": "Current Requirement [Member]",
        "terseLabel": "Current Requirement [Member]"
       }
      }
     },
     "localname": "CurrentRequirementMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_December2027NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2027 Notes",
        "label": "December 2027 Notes [Member]",
        "terseLabel": "December 2027 Notes [Member]"
       }
      }
     },
     "localname": "December2027NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DeemedConsolidatedEBITDA": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deemed Consolidated EBITDA",
        "label": "Deemed Consolidated EBITDA",
        "terseLabel": "Deemed Consolidated EBITDA [Member]"
       }
      }
     },
     "localname": "DeemedConsolidatedEBITDA",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DeferredTaxAssetValuationAllowanceIntraEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Valuation Allowance, Intra-entity",
        "label": "Deferred Tax Asset, Valuation Allowance, Intra-entity",
        "terseLabel": "Deferred Tax Asset, Valuation Allowance, Intra-entity"
       }
      }
     },
     "localname": "DeferredTaxAssetValuationAllowanceIntraEntity",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DeferredTaxAssetsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets",
        "label": "Deferred tax assets [Domain]",
        "terseLabel": "Deferred tax assets [Domain]"
       }
      }
     },
     "localname": "DeferredTaxAssetsDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DeferredTaxAssetsPrepaidonIntercompanyProfit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Prepaid on Intercompany Profit",
        "label": "Deferred Tax Assets, Prepaid on Intercompany Profit",
        "terseLabel": "Deferred Tax Assets, Prepaid on Intercompany Profit"
       }
      }
     },
     "localname": "DeferredTaxAssetsPrepaidonIntercompanyProfit",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DeferredTaxLiabilitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities",
        "label": "Deferred tax liabilities [Domain]",
        "terseLabel": "Deferred tax liabilities [Domain]"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Acquired and Established Plan Changes, PBO",
        "label": "Defined Benefit Plan, Acquired and Established Plan Changes, PBO",
        "terseLabel": "Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAcquiredandEstablishedPlanChangesPBO",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets",
        "label": "Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets",
        "terseLabel": "Defined Benefit Plan, Acquired and Established Plan Changes, Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAcquiredandEstablishedPlanChangesPlanAssets",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DefinedBenefitPlanPlanAssetsActuarialGainLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan, plan assets, actuarial gain loss",
        "label": "Defined benefit plan, plan assets, actuarial gain loss",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsActuarialGainLoss",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return",
        "label": "Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Assumptions used to Determine Expected Return"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsAssumptionsusedtoDetermineExpectedReturn",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "label": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "label": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DiscountRateFairValueInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount Rate, Fair Value Input",
        "label": "Discount Rate, Fair Value Input",
        "terseLabel": "Discount Rate, Fair Value Input"
       }
      }
     },
     "localname": "DiscountRateFairValueInput",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Noncurrent Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssetsCurrent",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DivestedBusinessDueToBTGAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divested Business due to BTG Acquisition",
        "label": "Divested Business due to BTG Acquisition [Member]",
        "terseLabel": "Divested Business due to BTG Acquisition [Member]"
       }
      }
     },
     "localname": "DivestedBusinessDueToBTGAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers",
        "label": "Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Intra-entity intangible asset transfers"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntraEntityIntangibleAssetTransfers",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_EffectiveIncomeTaxRateReconciliationReturnToProvision": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Return to provision",
        "label": "Effective Income Tax Rate Reconciliation, Return to provision",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Return to provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvision",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_EffectiveIncomeTaxRateReconciliationTCJAnetimpact": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, TCJA net impact",
        "label": "Effective Income Tax Rate Reconciliation, TCJA net impact",
        "terseLabel": "Effective Income Tax Rate Reconciliation, TCJA net impact"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTCJAnetimpact",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions",
        "label": "Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Uncertain Domestic Tax Positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUncertainDomesticTaxPositions",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_EmergingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets [Member]",
        "label": "Emerging Markets [Member]",
        "terseLabel": "Emerging Markets [Member]"
       }
      }
     },
     "localname": "EmergingMarketsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EmergingMarketsTotalNumberOfCountries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets total number of countries",
        "label": "Emerging Markets total number of countries",
        "terseLabel": "Emerging Markets total number of countries"
       }
      }
     },
     "localname": "EmergingMarketsTotalNumberOfCountries",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_EquipmentFurnitureAndFixturesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment, furniture and fixtures Gross.",
        "label": "Equipment, furniture and fixtures Gross",
        "terseLabel": "Equipment, furniture and fixtures"
       }
      }
     },
     "localname": "EquipmentFurnitureAndFixturesGross",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_EuroDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Factoring Arrangements [Member]",
        "label": "Euro Denominated Factoring Arrangements [Member]",
        "terseLabel": "Euro Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "EuroDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EuroDenominatedOutstandingDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro-denominated outstanding debt",
        "label": "Euro-denominated outstanding debt [Member]",
        "terseLabel": "Euro-denominated outstanding debt [Member]"
       }
      }
     },
     "localname": "EuroDenominatedOutstandingDebtMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ExclusionFromEbitdaForRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion from EBITDA for Restructuring Charges",
        "label": "Exclusion from EBITDA for Restructuring Charges",
        "verboseLabel": "Exclusion from EBITDA for Restructuring Charges"
       }
      }
     },
     "localname": "ExclusionFromEbitdaForRestructuringCharges",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ExecutiveRetirementPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive retirement plan [Member]",
        "label": "Executive retirement plan [Member]",
        "terseLabel": "Executive retirement plan [Member]"
       }
      }
     },
     "localname": "ExecutiveRetirementPlanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price of the fair market value of our common stock on the date of grant",
        "label": "Exercise price of the fair market value of our common stock on the date of grant",
        "terseLabel": "Exercise price of the fair market value of our common stock on the date of grant"
       }
      }
     },
     "localname": "Exercisepriceofthefairmarketvalueofourcommonstockonthedateofgrant",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ExpenseRelatedToMatchingContributions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense related to matching contributions",
        "label": "Expense related to matching contributions",
        "terseLabel": "Expense related to matching contributions"
       }
      }
     },
     "localname": "ExpenseRelatedToMatchingContributions",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_FairValueOfFreeCashFlowFcfPerformanceAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the Free Cash Flow (FCF) performance awards",
        "label": "Fair value of the Free Cash Flow (FCF) performance awards",
        "terseLabel": "Fair value of the Free Cash Flow (FCF) performance awards"
       }
      }
     },
     "localname": "FairValueOfFreeCashFlowFcfPerformanceAwards",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Fairvalueofmarketbasedawards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of market based awards",
        "label": "Fair value of market based awards",
        "terseLabel": "Fair value of market based awards"
       }
      }
     },
     "localname": "Fairvalueofmarketbasedawards",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_February2019AggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2019 Aggregate Offering",
        "label": "February 2019 Aggregate Offering [Member]",
        "terseLabel": "February 2019 Aggregate Offering [Member]"
       }
      }
     },
     "localname": "February2019AggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_February2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2021 Term Loan",
        "label": "February 2021 Term Loan [Member]",
        "terseLabel": "February 2021 Term Loan [Member]"
       }
      }
     },
     "localname": "February2021TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_FederalBenefitOfUncertainTaxPositions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal benefit of uncertain tax positions",
        "label": "Federal benefit of uncertain tax positions",
        "terseLabel": "Federal benefit of uncertain tax positions"
       }
      }
     },
     "localname": "FederalBenefitOfUncertainTaxPositions",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ForeignCurrencyDenominatedInDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign currency denominated in debt",
        "label": "Foreign currency denominated in debt [Member]",
        "terseLabel": "Foreign currency denominated in debt [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedInDebtMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ForwardCurrencyContractsTimetoMaturity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Contracts, Time to Maturity in Months",
        "label": "Forward Currency Contracts, Time to Maturity",
        "terseLabel": "Forward Currency Contracts, Time to Maturity"
       }
      }
     },
     "localname": "ForwardCurrencyContractsTimetoMaturity",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionAxis",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Axis]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Domain]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumption [Domain]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Line Items]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsLineItems",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTable",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table]",
        "label": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]",
        "terseLabel": "Free Cash Flow Performance-based DSU Awards, Fair Value Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "FreeCashFlowPerformancebasedDSUAwardsFairValueAssumptionsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_FreeTradeZoneRegimeTaxIncentive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Free Trade Zone Regime Tax Incentive",
        "label": "Free Trade Zone Regime Tax Incentive",
        "terseLabel": "Free Trade Zone Regime Tax Incentive"
       }
      }
     },
     "localname": "FreeTradeZoneRegimeTaxIncentive",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_FreeTradeZoneTaxIncentivePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Free Trade Zone Tax Incentive, Per Share",
        "label": "Free Trade Zone Tax Incentive, Per Share",
        "terseLabel": "Free Trade Zone Regime Tax Incentive Per Share"
       }
      }
     },
     "localname": "FreeTradeZoneTaxIncentivePerShare",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_GlobalCrmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global CRM Reporting Unit [Member]",
        "label": "Global CRM Reporting Unit [Member]",
        "terseLabel": "Global CRM Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalCrmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalElectrophysiologyEpReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Electrophysiology (EP) Reporting Unit [Member]",
        "label": "Global Electrophysiology (EP) Reporting Unit [Member]",
        "terseLabel": "Global Electrophysiology (EP) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalElectrophysiologyEpReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)",
        "label": "Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)",
        "terseLabel": "Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less)"
       }
      }
     },
     "localname": "GlobalEmployeeStockPurchasePlanExerciseAmountequivalentto85ofFairMarketValueofCommonStockatbeginningorendofeachofferingperiodwhicheverisless",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_GlobalEndoscopyEndoReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "label": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "terseLabel": "Global Endoscopy (Endo) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalEndoscopyEndoReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalInterventionalCardiologyIcReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Interventional Cardiology (IC) Reporting Unit [Member]",
        "label": "Global Interventional Cardiology (IC) Reporting Unit [Member]",
        "terseLabel": "Global Interventional Cardiology (IC) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalInterventionalCardiologyIcReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalNeuromodulationNmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "label": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "terseLabel": "Global Neuromodulation (NM) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalNeuromodulationNmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalPeripheralInterventionsPiReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "label": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "terseLabel": "Global Peripheral Interventions (PI) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalPeripheralInterventionsPiReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalUrologyandPelvicHealthReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "label": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "terseLabel": "Global Urology and Pelvic Health Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalUrologyandPelvicHealthReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GoodwillTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill (Textuals) [Abstract]",
        "label": "Goodwill (Textuals) [Abstract]",
        "terseLabel": "Goodwill (Roll Forward)"
       }
      }
     },
     "localname": "GoodwillTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_IncomeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Abstract]",
        "label": "Income Taxes [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxesAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "xbrltype": "stringItemType"
    },
    "bsx_InternationalRetirementPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International retirement plans [Member]",
        "label": "International retirement plans [Member]",
        "terseLabel": "International retirement plans [Member]"
       }
      }
     },
     "localname": "InternationalRetirementPlansMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_InventoryStepUpAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Step Up Amortization",
        "label": "InventoryStepUpAmortization",
        "terseLabel": "Inventory step-up amortization"
       }
      }
     },
     "localname": "InventoryStepUpAmortization",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_January2020NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2020 Notes [Member]",
        "label": "January 2020 Notes [Member]",
        "terseLabel": "January 2020 Notes [Member]"
       }
      }
     },
     "localname": "January2020NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_January2040NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2040 Notes [Member]",
        "label": "January 2040 Notes [Member]",
        "terseLabel": "January 2040 Notes [Member]"
       }
      }
     },
     "localname": "January2040NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2025 Notes",
        "label": "June 2025 Notes [Member]",
        "terseLabel": "June 2025 Notes [Member]"
       }
      }
     },
     "localname": "June2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2030NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2030 Notes",
        "label": "June 2030 Notes [Member]",
        "terseLabel": "June 2030 Notes [Member]"
       }
      }
     },
     "localname": "June2030NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LatinAmericaandCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America and Canada [Member]",
        "label": "Latin America and Canada [Member]",
        "terseLabel": "Latin America and Canada [Member]"
       }
      }
     },
     "localname": "LatinAmericaandCanadaMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "label": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Legal payments remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LesseeLeasesNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Leases Not Yet Commenced, Amount",
        "label": "Lessee, Leases Not Yet Commenced, Amount",
        "terseLabel": "Lessee, Leases Not Yet Commenced, Amount"
       }
      }
     },
     "localname": "LesseeLeasesNotYetCommencedAmount",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LesseeOperatingAndFinanceLeasesOptionToExtend": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Leases, Option to Extend",
        "label": "Lessee, Operating and Finance Leases, Option to Extend",
        "terseLabel": "Lessee, Operating and Finance Leases, Option to Extend"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesOptionToExtend",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities held for sale in Other current liabilities",
        "label": "Liabilities held for sale in Other current liabilities [Domain]",
        "terseLabel": "Liabilities held for sale in Other current liabilities [Domain]"
       }
      }
     },
     "localname": "LiabilitiesHeldForSaleInOtherCurrentLiabilitiesDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingArrangementAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement assets",
        "label": "Licensing arrangement assets [Member]",
        "terseLabel": "Licensing arrangement assets (Member)"
       }
      }
     },
     "localname": "LicensingArrangementAssetsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingArrangementLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement liabilities",
        "label": "Licensing arrangement liabilities [Member]",
        "terseLabel": "Licensing arrangement liabilities (Member)"
       }
      }
     },
     "localname": "LicensingArrangementLiabilitiesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements",
        "label": "Licensing arrangements",
        "terseLabel": "Licensing arrangements"
       }
      }
     },
     "localname": "LicensingArrangements",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LicensingArrangementsAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, asset",
        "label": "Licensing arrangements, asset",
        "terseLabel": "Licensing arrangements, asset"
       }
      }
     },
     "localname": "LicensingArrangementsAsset",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LicensingArrangementsLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, liability",
        "label": "Licensing arrangements, liability",
        "terseLabel": "Licensing arrangements, liability"
       }
      }
     },
     "localname": "LicensingArrangementsLiability",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationAndDebtExclusionFromEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion of litigation payments and any debt Issued to fund tax deficiency payments",
        "label": "Litigation and Debt Exclusion from EBITDA",
        "terseLabel": "Litigation and Debt Exclusion from EBITDA"
       }
      }
     },
     "localname": "LitigationAndDebtExclusionFromEbitda",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationSettlementReceivedGain": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement Received, Gain",
        "label": "Litigation Settlement Received, Gain",
        "terseLabel": "Litigation Settlement Received, Gain"
       }
      }
     },
     "localname": "LitigationSettlementReceivedGain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LotusDiscontinuationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lotus Discontinuation",
        "label": "Lotus Discontinuation [Member]",
        "terseLabel": "Lotus Discontinuation [Member]"
       }
      }
     },
     "localname": "LotusDiscontinuationMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2024NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2024 Notes",
        "label": "March 2024 Notes [Member]",
        "terseLabel": "March 2024 Notes [Member]"
       }
      }
     },
     "localname": "March2024NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2026NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2026 Notes",
        "label": "March 2026 Notes [Member]",
        "terseLabel": "March 2026 Notes [Member]"
       }
      }
     },
     "localname": "March2026NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2028NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2028 Notes [Member]",
        "label": "March 2028 Notes [Member]",
        "terseLabel": "March 2028 Notes [Member]"
       }
      }
     },
     "localname": "March2028NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2029NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2029 Notes",
        "label": "March 2029 Notes [Member]",
        "terseLabel": "March 2029 Notes [Member]"
       }
      }
     },
     "localname": "March2029NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2039NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2039 Notes",
        "label": "March 2039 Notes [Member]",
        "terseLabel": "March 2039 Notes [Member]"
       }
      }
     },
     "localname": "March2039NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2049NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2049 Notes",
        "label": "March 2049 Notes [Member]",
        "terseLabel": "March 2049 Notes [Member]"
       }
      }
     },
     "localname": "March2049NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MarketBasedAwardsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market-based awards, valuation assumptions [Table Text Block]",
        "label": "Market-based awards, valuation assumptions [Table Text Block]",
        "terseLabel": "Market-based awards, valuation assumptions [Table Text Block]"
       }
      }
     },
     "localname": "MarketBasedAwardsValuationAssumptionsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_MaturitiesOfLeaseLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturities of Lease Liabilities",
        "label": "Maturities of Lease Liabilities [Table Text Block]",
        "terseLabel": "Maturities of Lease Liabilities"
       }
      }
     },
     "localname": "MaturitiesOfLeaseLiabilitiesTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_MaximumCommercialPaperOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Commercial Paper Outstanding",
        "label": "Maximum Commercial Paper Outstanding",
        "terseLabel": "Maximum Commercial Paper Outstanding"
       }
      }
     },
     "localname": "MaximumCommercialPaperOutstanding",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_MaximumContingentPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Contingent Payment",
        "label": "Maximum Contingent Payment [Member]",
        "terseLabel": "Maximum Contingent Payment [Member]"
       }
      }
     },
     "localname": "MaximumContingentPaymentMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum leverage ratio permitted by revolving credit facility agreement.",
        "label": "Maximum Leverage Ratio",
        "terseLabel": "Maximum Leverage Ratio"
       }
      }
     },
     "localname": "MaximumLeverageRatio",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_May2020NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2020 Notes [Member]",
        "label": "May 2020 Notes [Member]",
        "terseLabel": "May 2020 Notes [Member]"
       }
      }
     },
     "localname": "May2020NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2020SNAggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2020 SN Aggregate Offering",
        "label": "May 2020 SN Aggregate Offering [Member]",
        "terseLabel": "May 2020 SN Aggregate Offering [Member]"
       }
      }
     },
     "localname": "May2020SNAggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2022NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2022 Notes [Member]",
        "label": "May 2022 Notes [Member]",
        "verboseLabel": "May 2022 Notes [Member]"
       }
      }
     },
     "localname": "May2022NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2025 Notes [Member]",
        "label": "May 2025 Notes [Member]",
        "terseLabel": "May 2025 Notes [Member]"
       }
      }
     },
     "localname": "May2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Measurementperiodmarketbasedaward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement period - market based awards",
        "label": "Measurement period - market based award",
        "terseLabel": "Measurement period - market based awards"
       }
      }
     },
     "localname": "Measurementperiodmarketbasedaward",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_MedsurgMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedSurg [Member]",
        "label": "MedSurg [Member]",
        "terseLabel": "MedSurg [Member]"
       }
      }
     },
     "localname": "MedsurgMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MillipedeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Millipede [Member]",
        "label": "Millipede [Member]",
        "terseLabel": "Millipede [Member]"
       }
      }
     },
     "localname": "MillipedeMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_NVisionMedicalCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "nVision [Member]",
        "label": "nVision Medical Corporation [Member]",
        "terseLabel": "nVision Medical Corporation [Member]"
       }
      }
     },
     "localname": "NVisionMedicalCorporationMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_NetCurrencyExchangeGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net currency exchange gain (loss)",
        "label": "Net currency exchange gain (loss)",
        "negatedTerseLabel": "Foreign exchange (gain) loss",
        "terseLabel": "Foreign exchange (gain) loss"
       }
      }
     },
     "localname": "NetCurrencyExchangeGainLoss",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Deferred Tax Assets and Prepaid on Intercompany Profit",
        "label": "Net Deferred Tax Assets and Prepaid on Intercompany Profit",
        "terseLabel": "Net Deferred Tax Liabilities and Prepaid on Intercompany Profit"
       }
      }
     },
     "localname": "NetDeferredTaxAssetsAndPrepaidOnIntercompanyProfit",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NetSettlementPaymenttoIRS": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Settlement Payment to IRS",
        "label": "Net Settlement Payment to IRS",
        "terseLabel": "Net Settlement Payment to IRS"
       }
      }
     },
     "localname": "NetSettlementPaymenttoIRS",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NewAccountingPronouncementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Accounting Pronouncements, Policy",
        "label": "New Accounting Pronouncements, Policy [Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_NonCashImpactOfTransferredRoyaltyRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash impact of transferred royalty rights",
        "label": "Non-cash impact of transferred royalty rights",
        "terseLabel": "Non-cash impact of transferred royalty rights"
       }
      }
     },
     "localname": "NonCashImpactOfTransferredRoyaltyRights",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Nonvestedstockawardsexerciseprice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-vested stock awards exercise price",
        "label": "Non-vested stock awards exercise price",
        "terseLabel": "Qualified options exercise price"
       }
      }
     },
     "localname": "Nonvestedstockawardsexerciseprice",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_November2019AggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2019 Aggregate Offering",
        "label": "November 2019 Aggregate Offering [Member]",
        "terseLabel": "November 2019 Aggregate Offering [Member]"
       }
      }
     },
     "localname": "November2019AggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_November2035NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2035 Notes [Member]",
        "label": "November 2035 Notes [Member]",
        "terseLabel": "November 2035 Notes [Member]"
       }
      }
     },
     "localname": "November2035NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_NxTheraIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NxThera [Member]",
        "label": "NxThera, Inc. [Member]",
        "terseLabel": "NxThera, Inc. [Member]"
       }
      }
     },
     "localname": "NxTheraIncMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_October2023NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 Notes [Member]",
        "label": "October 2023 Notes [Member]",
        "terseLabel": "October 2023 Notes [Member]"
       }
      }
     },
     "localname": "October2023NotesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Onetimetransactiontaxpost1986EPnetpayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-time transaction tax post-1986 E&amp;P - net payment",
        "label": "One-time transaction tax post-1986 E&amp;P - net payment",
        "terseLabel": "One-time transaction tax post-1986 E&amp;P - net payment"
       }
      }
     },
     "localname": "Onetimetransactiontaxpost1986EPnetpayment",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingIncomeLossAllocatedToReportableSegments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Allocated to Reportable Segments",
        "label": "Operating Income (Loss) Allocated to Reportable Segments",
        "terseLabel": "Operating Income (Loss) Allocated to Reportable Segments"
       }
      }
     },
     "localname": "OperatingIncomeLossAllocatedToReportableSegments",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingIncomeUnallocatedToSegment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Unallocated to Segment",
        "label": "Operating Income Unallocated to Segment",
        "terseLabel": "Operating Income Unallocated to Segment"
       }
      }
     },
     "localname": "OperatingIncomeUnallocatedToSegment",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OptionsExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options expected to vest",
        "label": "Options expected to vest",
        "terseLabel": "Options expected to vest"
       }
      }
     },
     "localname": "OptionsExpectedToVest",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "bsx_OptionsExpectedToVestWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options expected to vest, weighted average exercise price",
        "label": "Options expected to vest, weighted average exercise price",
        "terseLabel": "Options expected to vest, weighted average exercise price"
       }
      }
     },
     "localname": "OptionsExpectedToVestWeightedAverageExercisePrice",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "bsx_OptionsExpectedToVestWeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options expected to vest, weighted average remaining contractual life",
        "label": "Options expected to vest, weighted average remaining contractual life",
        "terseLabel": "Options expected to vest, weighted average remaining contractual life"
       }
      }
     },
     "localname": "OptionsExpectedToVestWeightedAverageRemainingContractualLife",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_Other2018AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other 2018 Acquisitions - immaterial in the aggregate [Member]",
        "label": "Other 2018 Acquisitions [Member]",
        "terseLabel": "Other 2018 Acquisitions [Member]"
       }
      }
     },
     "localname": "Other2018AcquisitionsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other countries [Member]",
        "label": "Other countries [Member]",
        "terseLabel": "Other countries [Member]"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets",
        "label": "Other Current Assets [Abstract]",
        "terseLabel": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentAssetsAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OtherIntangibleAssetsTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Intangible Assets (Textuals) [Abstract]",
        "label": "Other Intangible Assets (Textuals) [Abstract]",
        "terseLabel": "Other Intangible Assets (Textuals) [Abstract]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OtherInternationalPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other International Plans",
        "label": "Other International Plans [Member]",
        "terseLabel": "Other International Plans"
       }
      }
     },
     "localname": "OtherInternationalPlansMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, net",
        "label": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNet",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherOtherLongTermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, Other Long-term Assets",
        "label": "Other, Other Long-term Assets",
        "terseLabel": "Other, Other Long-term Assets"
       }
      }
     },
     "localname": "OtherOtherLongTermAssets",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of contingent consideration",
        "label": "Payment of contingent consideration",
        "terseLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentsForRoyaltyRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for royalty rights",
        "label": "Payments for royalty rights",
        "negatedTerseLabel": "Payments for royalty rights"
       }
      }
     },
     "localname": "PaymentsForRoyaltyRights",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Paymenttonetsharesettleemployeeequityawards": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment to net share settle employee equity awards",
        "label": "Payment to net share settle employee equity awards",
        "negatedTerseLabel": "Cash used to net share settle employee equity awards"
       }
      }
     },
     "localname": "Paymenttonetsharesettleemployeeequityawards",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Pensionbenefitobligationbenefitspaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "pension benefit obligation, benefits paid",
        "label": "pension benefit obligation, benefits paid",
        "negatedTerseLabel": "pension benefit obligation, benefits paid"
       }
      }
     },
     "localname": "Pensionbenefitobligationbenefitspaid",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PercentOfFinishedGoodsAtConsignment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of finished goods at consignment",
        "label": "Percent of finished goods at consignment",
        "terseLabel": "Percent of finished goods at consignment"
       }
      }
     },
     "localname": "PercentOfFinishedGoodsAtConsignment",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_PreventiceSolutionsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preventice Solutions, Inc.",
        "label": "Preventice Solutions, Inc. [Member]",
        "terseLabel": "Preventice Solutions, Inc. [Member]"
       }
      }
     },
     "localname": "PreventiceSolutionsIncMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from secured borrowings relating to royalty arrangements",
        "label": "Proceeds from secured borrowings relating to royalty arrangements",
        "terseLabel": "Proceeds from royalty rights transfer"
       }
      }
     },
     "localname": "ProceedsFromSecuredBorrowingsRelatingToRoyaltyArrangements",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - Australia",
        "label": "Product liability cases or claims related to mesh product - Australia",
        "terseLabel": "Product liability cases or claims related to mesh product - Australia"
       }
      }
     },
     "localname": "ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_Productliabilitycasesorclaimsrelatedtomeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims asserted related to mesh products",
        "label": "Product liability cases or claims related to mesh product",
        "terseLabel": "Product liability cases or claims related to mesh product"
       }
      }
     },
     "localname": "Productliabilitycasesorclaimsrelatedtomeshproduct",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - Canada",
        "label": "Product liability cases or claims related to mesh product - Canada",
        "terseLabel": "Product liability cases or claims in Canada, Mesh"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductCanada",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - United Kingdom",
        "label": "Product liability cases or claims related to mesh product - United Kingdom",
        "terseLabel": "Product liability cases or claims related to mesh product - United Kingdom"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_RDRegulatoryandCommercializationbasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "label": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "terseLabel": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]"
       }
      }
     },
     "localname": "RDRegulatoryandCommercializationbasedMilestoneMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RangeofthetargetnumberofmarketbasedDSUsawarded": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range of the target number of market-based DSUs awarded",
        "label": "Range of the target number of market-based DSUs awarded",
        "terseLabel": "Range of the target number of market-based DSUs awarded"
       }
      }
     },
     "localname": "RangeofthetargetnumberofmarketbasedDSUsawarded",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_RangeofthetargetnumberofperformancebasedDSUsawarded": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range of the target number of performance-based DSUs awarded",
        "label": "Range of the target number of performance-based DSUs awarded",
        "terseLabel": "Range of the target number of performance-based DSUs awarded"
       }
      }
     },
     "localname": "RangeofthetargetnumberofperformancebasedDSUsawarded",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of depreciation by reportable segment to total [Table Text Block]",
        "label": "Reconciliation of depreciation by reportable segment to total [Table Text Block]",
        "terseLabel": "Reconciliation of depreciation by reportable segment to total [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfDepreciationByReportableSegmentToTotalTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_RenminbiDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renminbi Denominated Factoring Arrangements",
        "label": "Renminbi Denominated Factoring Arrangements [Member]",
        "terseLabel": "Renminbi Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "RenminbiDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementExtensionThroughTheRemainderOf2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, extension through the remainder of 2020",
        "label": "Requirement, extension through the remainder of 2020 [Member]",
        "terseLabel": "Requirement, extension through the remainder of 2020 [Member]"
       }
      }
     },
     "localname": "RequirementExtensionThroughTheRemainderOf2020Member",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, fifth quarter following qualified acquisition [Member]",
        "label": "Requirement, fifth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, fifth quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementfifthquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, fourth quarter following qualified acquisition [Member]",
        "label": "Requirement, fourth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, fourth quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementfourthquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, sixth quarter and thereafter following qualified acquisition [Member]",
        "label": "Requirement, sixth quarter and thereafter following qualified acquisition [Member]",
        "terseLabel": "Requirement, sixth quarter and thereafter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, third quarter following qualified acquisition [Member]",
        "label": "Requirement, third quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, third quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementthirdquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, by Type of Restructuring Three [Domain]",
        "label": "Restructuring and Related Cost, by Type of Restructuring Charge [Domain]",
        "terseLabel": "Restructuring and Related Cost, by Type of Restructuring Charge [Domain]"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostByTypeOfRestructuringChargeDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, by Type of Restructuring Three [Axis]",
        "label": "Restructuring and Related Cost, by Type of Restructuring Charge Expected [Axis]",
        "terseLabel": "Restructuring and Related Cost, by Type of Restructuring Charge Expected [Axis]"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostByTypeOfRestructuringChargeExpectedAxis",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.",
        "label": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA",
        "verboseLabel": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan [Member]",
        "label": "Restructuring Plan [Member]",
        "terseLabel": "Restructuring Plan [Member]"
       }
      }
     },
     "localname": "RestructuringPlanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringRelatedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring related expenses.",
        "label": "Restructuring Related Expenses",
        "terseLabel": "Restructuring Related Expenses"
       }
      }
     },
     "localname": "RestructuringRelatedExpenses",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RestructuringRelatedToPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Related To Plan [Member]",
        "label": "Restructuring Related To Plan [Member]",
        "terseLabel": "Restructuring Related To Plan [Member]"
       }
      }
     },
     "localname": "RestructuringRelatedToPlanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]",
        "label": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]",
        "terseLabel": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]"
       }
      }
     },
     "localname": "RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredAxis",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Axis]",
        "label": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Domain]",
        "terseLabel": "Restructuring and Related Cost, by Type of Restructuring Charge Incurred [Domain]"
       }
      }
     },
     "localname": "RestructuringandRelatedCostbyTypeofRestructuringChargeIncurredDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringandRestructuringrelatedCostExpectedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Restructuring-related Cost, Expected Cost",
        "label": "Restructuring and Restructuring-related Cost, Expected Cost",
        "terseLabel": "Restructuring and Restructuring-related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringandRestructuringrelatedCostExpectedCost",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RestructuringrelatedCostExpectedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring-related Cost, Expected Cost",
        "label": "Restructuring-related Cost, Expected Cost",
        "terseLabel": "Restructuring-related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringrelatedCostExpectedCost",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RevenueBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "revenue-based payments [Member]",
        "label": "revenue-based payments [Member]",
        "terseLabel": "revenue-based payments [Member]"
       }
      }
     },
     "localname": "RevenueBasedPaymentsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RhythmandNeuroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rhythm and Neuro [Member]",
        "label": "Rhythm and Neuro [Member]",
        "terseLabel": "Rhythm and Neuro [Member]"
       }
      }
     },
     "localname": "RhythmandNeuroMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Line Items]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Line Items]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationLineItems",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Table]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Table]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationTable",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_Segmentoperatingincomeaspercentageofnetsales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment operating income as percentage of net sales",
        "label": "Segment operating income as percentage of net sales",
        "terseLabel": "Segment operating income as percentage of net sales"
       }
      }
     },
     "localname": "Segmentoperatingincomeaspercentageofnetsales",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_SegmentoperatingincomeaspercentageofnetsalesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment operating income as percentage of net sales",
        "label": "Segment operating income as percentage of net sales [Table Text Block]",
        "terseLabel": "Segment operating income as percentage of net sales [Table Text Block]"
       }
      }
     },
     "localname": "SegmentoperatingincomeaspercentageofnetsalesTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Seniornotesissued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes issued",
        "label": "Senior notes issued",
        "terseLabel": "Senior notes issued"
       }
      }
     },
     "localname": "Seniornotesissued",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ShareBasedCompensationNetOfTaxBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation, net of tax benefit",
        "label": "Share-based compensation, net of tax benefit",
        "terseLabel": "Share-based compensation, net of tax benefit"
       }
      }
     },
     "localname": "ShareBasedCompensationNetOfTaxBenefit",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_SignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Abstract]",
        "label": "Significant Accounting Policies [Abstract]",
        "terseLabel": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "xbrltype": "stringItemType"
    },
    "bsx_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Line Items]",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SpecialChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special Charges [Member]",
        "label": "Special Charges [Member]",
        "terseLabel": "Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), litigation-related net charges (credits) and EU Medical Device Regulation (MDR) implementation costs"
       }
      }
     },
     "localname": "SpecialChargesMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialtyPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Pharmaceuticals",
        "label": "Specialty Pharmaceuticals [Member]",
        "terseLabel": "Specialty Pharmaceuticals [Member]"
       }
      }
     },
     "localname": "SpecialtyPharmaceuticalsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "statement [Axis]",
        "label": "statement [Axis]",
        "terseLabel": "statement [Axis]"
       }
      }
     },
     "localname": "StatementAxis",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_StatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for statement [Axis]",
        "label": "statement [Domain]",
        "terseLabel": "statement [Domain]"
       }
      }
     },
     "localname": "StatementDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StatementOfOperationsCaptionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement of Operations Caption [Axis]",
        "label": "Statement of Operations Caption [Axis]",
        "terseLabel": "Statement of Operations Caption [Axis]"
       }
      }
     },
     "localname": "StatementOfOperationsCaptionAxis",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_StatementOfOperationsCaptionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement of Operations Caption [Domain]",
        "label": "Statement of Operations Caption [Domain]",
        "terseLabel": "Statement of Operations Caption [Domain]"
       }
      }
     },
     "localname": "StatementOfOperationsCaptionDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StockIncentiveAndPurchasePlansAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Incentive and Purchase Plans [Abstract]",
        "label": "Stock Incentive and Purchase Plans [Abstract]",
        "terseLabel": "Stock Incentive and Ownership Plans [Abstract]"
       }
      }
     },
     "localname": "StockIncentiveAndPurchasePlansAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "xbrltype": "stringItemType"
    },
    "bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues (Common stock)",
        "label": "Stock Issued During Period, Value, New Issues (Common stock)",
        "terseLabel": "Common stock issuance (Value in excess of par)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesCommonStock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues (Preferred stock)",
        "label": "Stock Issued During Period, Value, New Issues (Preferred stock)",
        "terseLabel": "Preferred stock issuance (Value in excess of par)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesPreferredStock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of term loan and revolving credit facility agreement compliance with debt covenants.",
        "label": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]",
        "verboseLabel": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SupplementalBalanceSheetInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information [Abstract]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "xbrltype": "stringItemType"
    },
    "bsx_SupplementalBalanceSheetInformationTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information (Textuals)",
        "label": "Supplemental Balance Sheet Information (Textuals) [Abstract]",
        "verboseLabel": "Supplemental Balance Sheet Information (Textuals)"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow Information Related to Leases",
        "label": "Supplemental Cash Flow Information Related to Leases [Policy Text Block]",
        "terseLabel": "Supplemental Cash Flow Information Related to Leases"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow Information Related to Leases",
        "label": "Supplemental Cash Flow Information Related to Leases [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information Related to Leases"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_TargetPayoutOfFreeCashFlowsFcfPerformanceAwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Target payout of Free Cash Flows (FCF) performance awards",
        "label": "Target payout of Free Cash Flows (FCF) performance awards",
        "terseLabel": "Target payout of Free Cash Flows (FCF) performance awards"
       }
      }
     },
     "localname": "TargetPayoutOfFreeCashFlowsFcfPerformanceAwards",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_TaxIncentivesInPuertoRico": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Incentives in Puerto Rico",
        "label": "Tax Incentives in Puerto Rico",
        "terseLabel": "Tax Incentives in Puerto Rico"
       }
      }
     },
     "localname": "TaxIncentivesInPuertoRico",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_TaxRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Rate [Axis]",
        "label": "Tax Rate [Axis]",
        "terseLabel": "Tax Rate [Axis]"
       }
      }
     },
     "localname": "TaxRateAxis",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_TaxRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Rate [Domain]",
        "label": "Tax Rate [Domain]",
        "terseLabel": "Tax Rate [Domain]"
       }
      }
     },
     "localname": "TaxRateDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_The2018FacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the 2018 Facility",
        "label": "the 2018 Facility [Domain]",
        "terseLabel": "the 2018 Facility [Domain]"
       }
      }
     },
     "localname": "The2018FacilityDomain",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TheCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The CARES Act",
        "label": "The CARES Act",
        "terseLabel": "The CARES Act"
       }
      }
     },
     "localname": "TheCARESAct",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ThreeYearDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three-Year Delayed Draw Term Loan",
        "label": "Three-Year Delayed Draw Term Loan [Member]",
        "terseLabel": "Three-Year Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "ThreeYearDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalAllocatedToReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total allocated to reportable segments [Member]",
        "label": "Total allocated to reportable segments [Member]",
        "terseLabel": "Total allocated to reportable segments [Member]"
       }
      }
     },
     "localname": "TotalAllocatedToReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Product liability cases and claims settled related to Mesh product",
        "label": "Total Product liability cases and claims settled related to Mesh product",
        "terseLabel": "Total Product liability cases and claims settled related to Mesh product"
       }
      }
     },
     "localname": "TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_TransferCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer Costs",
        "label": "Transfer Costs",
        "terseLabel": "Transfer Costs"
       }
      }
     },
     "localname": "TransferCosts",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_TransferCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer costs [Member].",
        "label": "Transfer costs [Member]",
        "terseLabel": "Transfer costs [Member]"
       }
      }
     },
     "localname": "TransferCostsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TransitionTaxPaymentRemaining": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Tax Payment Remaining",
        "label": "Transition Tax Payment Remaining",
        "terseLabel": "transition tax payment remaining"
       }
      }
     },
     "localname": "TransitionTaxPaymentRemaining",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_TwoYearDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-Year Delayed Draw Term Loan [Member]",
        "label": "Two-Year Delayed Draw Term Loan [Member]",
        "terseLabel": "Two-Year Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "TwoYearDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_UKPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Plan",
        "label": "U.K. Plan [Member]",
        "terseLabel": "U.K. Plan"
       }
      }
     },
     "localname": "UKPlanMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_UnrecognizedCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Compensation Cost",
        "label": "Unrecognized Compensation Cost",
        "terseLabel": "Unrecognized Compensation Cost"
       }
      }
     },
     "localname": "UnrecognizedCompensationCost",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_UnrecognizedCompensationCostNonVestedStockAwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Compensation Cost - Non-vested stock awards",
        "label": "Unrecognized Compensation Cost - Non-vested stock awards",
        "terseLabel": "Unrecognized Compensation Cost - Non-vested stock awards"
       }
      }
     },
     "localname": "UnrecognizedCompensationCostNonVestedStockAwards",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_UnrecognizedCompensationCostStockOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Compensation Cost - Stock Options",
        "label": "Unrecognized Compensation Cost - Stock Options",
        "terseLabel": "Unrecognized Compensation Cost - Stock Options"
       }
      }
     },
     "localname": "UnrecognizedCompensationCostStockOptions",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_UpfrontCashMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront Cash",
        "label": "Upfront Cash [Member]",
        "terseLabel": "Upfront Cash [Member]"
       }
      }
     },
     "localname": "UpfrontCashMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_VertiflexIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertiflex, Inc.",
        "label": "Vertiflex, Inc. [Member]",
        "terseLabel": "Vertiflex, Inc. [Member]"
       }
      }
     },
     "localname": "VertiflexIncMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_VotingPowerOfAllClassesOfStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voting power of all classes of stock",
        "label": "Voting power of all classes of stock",
        "verboseLabel": "Voting power of all classes of stock"
       }
      }
     },
     "localname": "VotingPowerOfAllClassesOfStock",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_WeightedAverageMaturityDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Maturity, Days",
        "label": "Weighted Average Maturity, Days",
        "terseLabel": "Weighted Average Maturity, Days"
       }
      }
     },
     "localname": "WeightedAverageMaturityDays",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "durationStringItemType"
    },
    "bsx_WeightedAverageRemainingVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "weighted average remaining vesting period",
        "label": "weighted average remaining vesting period",
        "terseLabel": "weighted average remaining vesting period"
       }
      }
     },
     "localname": "WeightedAverageRemainingVestingPeriod",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_YenDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yen denominated factoring arrangements.",
        "label": "Yen Denominated Factoring Arrangements [Member]",
        "terseLabel": "Yen Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "YenDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20201231",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "IRELAND"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States [Member]",
        "verboseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r879",
      "r880",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share",
        "terseLabel": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r879",
      "r880",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r514",
      "r524",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r790",
      "r844",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "High end of range [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r514",
      "r524",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r790",
      "r844",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r255",
      "r413",
      "r417",
      "r791",
      "r843",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r255",
      "r413",
      "r417",
      "r791",
      "r843",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r456",
      "r514",
      "r524",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r790",
      "r844",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r456",
      "r514",
      "r524",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r790",
      "r844",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]",
        "verboseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r177",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleII"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r256",
      "r257",
      "r413",
      "r418",
      "r846",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r256",
      "r257",
      "r413",
      "r418",
      "r846",
      "r863",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r885",
      "r886"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Entity-Wide Disclosure on Geographic Areas, Revenue from External Customers Attributed to Individual Foreign Countries [Axis]",
        "verboseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r363",
      "r519",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Statement, Scenario [Axis]",
        "verboseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r763",
      "r765",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance.",
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average (Member)"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r19",
      "r47",
      "r84",
      "r261",
      "r262",
      "r823"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Trade accounts receivable, net",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.",
        "label": "Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)",
        "terseLabel": "Cumulative effect adjustment for adoption of ASC 2016-13"
       }
      }
     },
     "localname": "AccountsReceivableChangeInMethodCreditLossExpenseReversal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/ScheduleIIDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r261",
      "r262"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r41",
      "r804",
      "r827"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued Income Taxes, Noncurrent"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued liabilities, current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued Royalties, Current"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r66",
      "r337"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [
      "r97",
      "r101",
      "r103"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax",
        "terseLabel": "Unrealized gain (loss) on derivative financial instruments"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r99",
      "r104",
      "r476"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Unrealized costs associated with defined benefit pensions and other items"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r94",
      "r101",
      "r103",
      "r104",
      "r714"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r101",
      "r103",
      "r104",
      "r830",
      "r855",
      "r859"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r100",
      "r104",
      "r107",
      "r179",
      "r180",
      "r181",
      "r657",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Asset, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r606",
      "r607",
      "r608",
      "r609",
      "r793",
      "r794",
      "r795",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r263",
      "r280",
      "r283",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Accounts Receivable, Allowance for Credit Loss (ending balance)",
        "periodStartLabel": "Accounts Receivable, Allowance for Credit Loss (beginning balance)"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r52",
      "r263",
      "r280"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedLabel": "Utilization of allowances",
        "negatedTerseLabel": "Utilization of allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r151",
      "r317",
      "r326"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization expense",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r167",
      "r237",
      "r244",
      "r251",
      "r273",
      "r653",
      "r658",
      "r716",
      "r801",
      "r825"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r21",
      "r23",
      "r88",
      "r167",
      "r273",
      "r653",
      "r658",
      "r716"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r702"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r11",
      "r14",
      "r334",
      "r341"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r264",
      "r266",
      "r291",
      "r809"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Notes receivable"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r672",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r26",
      "r336"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r506",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r506",
      "r520",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]",
        "verboseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r639",
      "r640",
      "r643"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1": {
     "auth_ref": [
      "r627",
      "r643"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination",
        "verboseLabel": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r150",
      "r648"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration net expense (benefit)",
        "verboseLabel": "Contingent consideration net expense (benefit)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r646"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": {
     "auth_ref": [
      "r646"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r638",
      "r641",
      "r645"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "negatedLabel": "Fair value of contingent consideration",
        "terseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r638",
      "r642"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r638",
      "r642"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "ACQUISITIONS AND STRATEGIC INVESTMENTS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r635"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "terseLabel": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "verboseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r632",
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r632",
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r162",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations Policy [Policy Text Block]"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalLeaseObligationsMember": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing recorded for a lease meeting the criteria for capitalization. A lease is defined as an agreement conveying the right to use property, plant, or equipment (land or depreciable assets) usually for a stated period of time.",
        "label": "Capital Lease Obligations [Member]",
        "terseLabel": "Finance Lease Obligation"
       }
      }
     },
     "localname": "CapitalLeaseObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r62",
      "r860",
      "r861"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash Acquired from Acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r17",
      "r62",
      "r153"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r32",
      "r155",
      "r162",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r143",
      "r153",
      "r160"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period",
        "periodStartLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period",
        "terseLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r143",
      "r723"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease)\u00a0in cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]",
        "terseLabel": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r165",
      "r167",
      "r197",
      "r198",
      "r199",
      "r201",
      "r203",
      "r213",
      "r214",
      "r215",
      "r273",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/Cover",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r36",
      "r802",
      "r829"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r79",
      "r362",
      "r811",
      "r834"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common Stock, Capital Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/Cover",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized",
        "verboseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.01 par value - authorized 2,000,000,000 shares; issued 1,679,911,918 shares as of December 31, 2020 and 1,642,488,911 shares as of December 31, 2019"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r427",
      "r430",
      "r525",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Compensation and Employee Benefit Plans [Text Block]"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r110",
      "r112",
      "r118",
      "r652",
      "r662",
      "r814",
      "r838"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r117",
      "r129",
      "r813",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Income (Loss) Note [Text Block]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentration Risk Disclosure [Text Block]"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r336"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Capital in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r401",
      "r402",
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.",
        "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price",
        "terseLabel": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockTermsOfConversion": {
     "auth_ref": [
      "r44",
      "r45",
      "r391",
      "r394",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific terms relevant to convertibility. Includes class of preferred stock and number of shares convertible into, exercise (or conversion) price or rates, dates relevant to conversion timing and events relevant to conversion. Describe also any beneficial conversion features. where convertible preferred stock with a nondetachable conversion feature is in-the-money at commitment date. For contingently convertible preferred stock, discuss the circumstances of the contingency, including the events or changes in circumstance that would cause the contingency to be met and any of the significant features necessary to understand the conversion rights and the timing of those rights. Include also an events or changes in circumstance, if any, that could adjust or change the contingency, conversion price, or number of shares, including significant terms of those changes.",
        "label": "Convertible Preferred Stock, Terms of Conversion",
        "terseLabel": "Convertible Preferred Stock, Terms of Conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockTermsOfConversion",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate Segment"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r123",
      "r791"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy": {
     "auth_ref": [
      "r162",
      "r351",
      "r352",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.",
        "label": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]",
        "terseLabel": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r168",
      "r603",
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current Federal Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r172",
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Current Foreign Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r168",
      "r603",
      "r612",
      "r614"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r168",
      "r603",
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current State and Local Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r810",
      "r836"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current",
        "verboseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "CONTRACTUAL OBLIGATIONS AND COMMITMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r803",
      "r807",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "negatedTerseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r77",
      "r169",
      "r391",
      "r394",
      "r395",
      "r396",
      "r735",
      "r736",
      "r738",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r382",
      "r737"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in Unrecognized Tax Benefits is Reasonably Possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]",
        "terseLabel": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r168",
      "r604",
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Federal Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r168",
      "r604",
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Foreign Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r577",
      "r578"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r151",
      "r168",
      "r604",
      "r612",
      "r613",
      "r614"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r42",
      "r43",
      "r594",
      "r805",
      "r821"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "terseLabel": "Deferred Tax Liabilities, Gross"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r577",
      "r578"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r168",
      "r604",
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Deferred State and Local Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory": {
     "auth_ref": [
      "r601"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from intra-entity transfer of asset within consolidated group. Excludes intra-entity transfer of inventory.",
        "label": "Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory",
        "terseLabel": "Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Deferred Tax Assets, Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "terseLabel": "Deferred Tax Assets, Gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Deferred Tax Assets, Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Deferred Tax Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Deferred Tax Assets, Net of Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Deferred Tax Assets, Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpense": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.",
        "label": "Deferred Tax Assets, Tax Deferred Expense",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from contingent liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from restructuring reserve.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges",
        "terseLabel": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r596"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r578",
      "r597"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Deferred Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "terseLabel": "Deferred Tax Liabilities, Inventory"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDerivatives": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from derivatives.",
        "label": "Deferred Tax Liabilities, Derivatives",
        "terseLabel": "Deferred Tax Liabilities, Derivatives"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "terseLabel": "Deferred Tax Liabilities, Goodwill and Intangible Assets, Intangible Assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Deferred Tax Liabilities, Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Deferred Tax Liabilities, Property, Plant and Equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Accumulated Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r446",
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r431",
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "terseLabel": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r35",
      "r431",
      "r432",
      "r454",
      "r499",
      "r800",
      "r824"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Assets for Plan Benefits, Defined Benefit Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Executive Retirement Plan Discount Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Executive Retirement Plan Rate of Compensation Increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r479",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r441",
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r481",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashMember": {
     "auth_ref": [
      "r457",
      "r458",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash [Member]",
        "terseLabel": "Defined Benefit Plan, Cash"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r448",
      "r457",
      "r458",
      "r497",
      "r499",
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r445",
      "r457",
      "r458",
      "r459",
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "verboseLabel": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r431",
      "r454",
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "terseLabel": "Defined Benefit Plan, Funded (Unfunded) Status of Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r433",
      "r437",
      "r469",
      "r491",
      "r499",
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Defined Benefit Plan, Interest Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r435",
      "r468",
      "r490",
      "r499",
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Defined Benefit Plan, Service Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r483",
      "r484",
      "r487",
      "r488",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r151",
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "negatedTerseLabel": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r151",
      "r232"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r90",
      "r91",
      "r715"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCashReceivedOnHedge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received during the period on settlement of a hedge.",
        "label": "Derivative, Cash Received on Hedge",
        "terseLabel": "Derivative, Cash Received on Hedge"
       }
      }
     },
     "localname": "DerivativeCashReceivedOnHedge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]",
        "verboseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r89",
      "r92",
      "r675",
      "r771"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Asset, Fair Value, Gross Asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r89",
      "r92",
      "r675",
      "r771"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative Liability, Fair Value, Gross Liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r673",
      "r676",
      "r685",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r670",
      "r673",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r670",
      "r673",
      "r685",
      "r693",
      "r694",
      "r698",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Assets, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Assets, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Liabilities, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Liabilities, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r90",
      "r91",
      "r715"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r665",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r664",
      "r666",
      "r667",
      "r670",
      "r671",
      "r679",
      "r685",
      "r695",
      "r697",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r162",
      "r173",
      "r664",
      "r666",
      "r670",
      "r671",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r413",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockInventiveandPurchasePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r11",
      "r332",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r334",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r334",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as income tax obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Non-current deferred tax liability, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r334",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Goodwill, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r334",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r334",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r334",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r334",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r151",
      "r333",
      "r339"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedTerseLabel": "Gain on sale of businesses"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "ASSETS AND LIABILITIES HELD FOR SALE"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r506",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r39",
      "r41",
      "r806",
      "r826"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends Payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r397",
      "r818"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "terseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r397",
      "r818"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "terseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r505",
      "r509",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r119",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r194",
      "r197",
      "r201",
      "r202",
      "r203",
      "r208",
      "r209",
      "r815",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Net income (loss) per common share \u2014 basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r119",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r197",
      "r201",
      "r202",
      "r203",
      "r208",
      "r209",
      "r815",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Net income (loss) per common share \u2014 assuming dilution"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r204",
      "r206",
      "r207",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r723"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectOnFutureCashFlowsAmount": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The quantified amount of the future effect on cash flows.",
        "label": "Effect on Future Cash Flows, Amount",
        "terseLabel": "Effect on Future Cash Flows, Amount"
       }
      }
     },
     "localname": "EffectOnFutureCashFlowsAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "negatedLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "negatedTerseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Other Adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r567",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "effective income tax reconciliation, compensation-related"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r580",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Effective Income Tax Rate Reconciliation, Tax Credits, Research"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetailsRateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "negatedTerseLabel": "Employee Service Share-based Compensation, Tax Benefit from Compensation Expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": {
     "auth_ref": [
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of plan compensation cost recognized during the period.",
        "label": "Employee Stock Ownership Plan (ESOP), Compensation Expense",
        "terseLabel": "Employee Stock Ownership Plan (ESOP), Compensation Expense"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average purchase price of capital shares purchased through an employee stock ownership plan.",
        "label": "Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased",
        "terseLabel": "Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r183",
      "r191",
      "r193",
      "r212",
      "r277",
      "r390",
      "r397",
      "r559",
      "r560",
      "r561",
      "r608",
      "r609",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r731",
      "r850",
      "r851",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r63",
      "r238",
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r713"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Measurement alternative investments (1)"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r702",
      "r703",
      "r704",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r499",
      "r703",
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r702",
      "r703",
      "r706",
      "r707",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r457",
      "r458",
      "r463",
      "r499",
      "r703",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r457",
      "r458",
      "r463",
      "r499",
      "r703",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r499",
      "r703",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r708",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasuresandDisclosuresPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r709"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Fair value of contingent consideration recorded in purchase accounting",
        "verboseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r499",
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r710",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r157",
      "r158",
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair Value of Assets Acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r267",
      "r268",
      "r282",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Future Amortization Expense, Year One"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Future Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Future Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Future Amortization Expense, Year Three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Future Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r318",
      "r321",
      "r325",
      "r329",
      "r792",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r325",
      "r796"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r318",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r717",
      "r719",
      "r721",
      "r722"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Net gain (loss) from foreign currency transaction exposures",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r162",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions and Translations Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r457",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract (Member)"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet": {
     "auth_ref": [
      "r683"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) recognized in earnings during the reporting period representing the amount of the cash flow hedges' ineffectiveness.",
        "label": "Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net",
        "terseLabel": "Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net"
       }
      }
     },
     "localname": "GainLossOnCashFlowHedgeIneffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r673",
      "r684"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "terseLabel": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r126",
      "r151",
      "r265"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Net loss (gain) on investments and notes receivable"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r151",
      "r384",
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r303",
      "r305",
      "r799"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r162",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r162",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r306",
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, Gross"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r306",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impaired, Accumulated Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r151",
      "r304",
      "r309",
      "r314"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r310",
      "r311",
      "r626"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Translation and Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Goodwill, Written off Related to Sale of Business Unit"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r121",
      "r167",
      "r237",
      "r243",
      "r247",
      "r250",
      "r253",
      "r273",
      "r716"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Guarantor Obligations, Maximum Exposure, Undiscounted"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesFairValueDisclosure": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of guarantee, including, but not limited to, financial standby letter of credit, fair value guarantee, guarantee of collection of scheduled contractual cash flows from financial assets, and contracts that contingently require the guarantor to make payments or perform services.",
        "label": "Guarantees, Fair Value Disclosure",
        "terseLabel": "Guarantees, Fair Value Disclosure"
       }
      }
     },
     "localname": "GuaranteesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r670",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r151",
      "r330"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r151",
      "r330"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Goodwill and other intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentPolicy": {
     "auth_ref": [
      "r67",
      "r162",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.",
        "label": "In Process Research and Development, Policy [Policy Text Block]",
        "terseLabel": "In Process Research and Development, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r171",
      "r615"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r116",
      "r237",
      "r243",
      "r247",
      "r250",
      "r253",
      "r797",
      "r812",
      "r817",
      "r841"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r171",
      "r615"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r506",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r12",
      "r13",
      "r14",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]",
        "verboseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r581",
      "r592",
      "r599",
      "r610",
      "r617",
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Income Tax Examination, Penalties and Interest Accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "negatedTerseLabel": "Income Tax Examination, Penalties and Interest Expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r168",
      "r192",
      "r193",
      "r235",
      "r579",
      "r611",
      "r620",
      "r842"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax (benefit) expense",
        "verboseLabel": "Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r162",
      "r575",
      "r576",
      "r592",
      "r593",
      "r598",
      "r605",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Tax, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r146",
      "r156"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash (received) paid for income taxes, net"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).",
        "label": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option",
        "terseLabel": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in operating assets and liabilities, excluding purchase accounting:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r320",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r320",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite Lived Intangible Assets Major Class Name [Domain]",
        "verboseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r316",
      "r323"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r115",
      "r231",
      "r734",
      "r737",
      "r816"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r141",
      "r145",
      "r156"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r457",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Unamortized Gain on Fair Value Hedges"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r54",
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r18",
      "r85"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r31",
      "r86",
      "r162",
      "r211",
      "r296",
      "r298",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r56",
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r55",
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory Write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "terseLabel": "Investment [Table Text Block]"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r271",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r835"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r25",
      "r65"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.",
        "label": "Leases of Lessee Disclosure [Text Block]",
        "terseLabel": "Leases of Lessee Disclosure [Text Block]"
       }
      }
     },
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r161",
      "r162",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, to be Paid"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r51",
      "r167",
      "r273",
      "r716",
      "r808",
      "r832"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r75",
      "r167",
      "r273",
      "r654",
      "r658",
      "r659",
      "r716"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r702"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r11",
      "r14",
      "r334",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Current"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r40",
      "r807",
      "r822"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term Line of Credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r71",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r79",
      "r362",
      "r371"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal reserves"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r79",
      "r362"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Estimated Litigation Liability, Noncurrent"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 9.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation-related net charges (credits)",
        "verboseLabel": "Litigation Settlement, Expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r40",
      "r383",
      "r807",
      "r829"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term Debt and Capital Lease Obligations",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long-term Purchase Commitment [Table Text Block]",
        "terseLabel": "Long-term Purchase Commitment"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r77",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r368",
      "r370",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "verboseLabel": "Accrual for legal matters that are probable and estimable"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r362",
      "r365",
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Loss Contingency, Damages Awarded, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r362",
      "r365",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Loss Contingency, Damages Paid, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money Market Funds, at Carrying Value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash provided by (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash provided by (used for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r143",
      "r148",
      "r152"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r194",
      "r195",
      "r200",
      "r203",
      "r237",
      "r243",
      "r247",
      "r250",
      "r253"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income (loss) available to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "verboseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r237",
      "r243",
      "r247",
      "r250",
      "r253"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)",
        "verboseLabel": "Operating income allocated to reportable segments"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r747",
      "r754"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r743"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r743"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r743"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r744",
      "r748"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r742"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r751",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r750",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r739"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rent Expense, Net"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r16",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r74"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r35",
      "r800",
      "r824"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "verboseLabel": "Assets (segment reporting)"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "totalLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other Assets, Miscellaneous, Current"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other long-term assets (total)",
        "verboseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r95",
      "r101",
      "r718",
      "r720",
      "r724"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r104",
      "r114",
      "r725",
      "r727",
      "r731"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r97",
      "r101"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net change in derivative financial instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r97",
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r97",
      "r101",
      "r674",
      "r680",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r101",
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Derivative financial instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r101",
      "r105",
      "r682"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r98",
      "r101",
      "r681",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax": {
     "auth_ref": [
      "r98",
      "r101",
      "r681",
      "r699"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r687"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r688"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r109",
      "r112",
      "r114",
      "r117",
      "r390",
      "r725",
      "r730",
      "r731",
      "r813",
      "r837"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income (loss)",
        "verboseLabel": "Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r99",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r99",
      "r101"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax",
        "verboseLabel": "Defined benefit pensions and other items"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r101",
      "r105",
      "r106",
      "r475"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r102",
      "r117",
      "r579",
      "r619",
      "r621",
      "r725",
      "r728",
      "r731",
      "r813",
      "r837"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherContractMember": {
     "auth_ref": [
      "r457",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is classified as other.",
        "label": "Other Contract [Member]",
        "terseLabel": "Other Contract"
       }
      }
     },
     "localname": "OtherContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r74"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "totalLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/LeasesDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Other long-term liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other Operating Income (Expense), Net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r151",
      "r346",
      "r352",
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other Restructuring Costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Restructuring [Member]"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r74",
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other Sundry Liabilities, Current"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedLabel": "Payment of contingent consideration previously established in purchase accounting"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeInvestingActivities": {
     "auth_ref": [
      "r135",
      "r149"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Payments for Hedge, Investing Activities",
        "negatedTerseLabel": "Payments for settlements of hedge contracts",
        "terseLabel": "Payments for Hedge, Investing Activities"
       }
      }
     },
     "localname": "PaymentsForHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r132",
      "r135",
      "r174"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Payments for repurchase of common stock",
        "terseLabel": "Payments for repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "negatedTerseLabel": "Payments for Royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends paid on preferred stock",
        "terseLabel": "Payments of Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r133",
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payments for acquisitions of businesses, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Payments for investments and acquisitions of certain technologies"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy": {
     "auth_ref": [
      "r162",
      "r483",
      "r501",
      "r504",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension plans. This accounting policy may address (1) the types of plans sponsored by the entity (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]",
        "terseLabel": "Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPensionsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r162",
      "r483",
      "r501",
      "r502",
      "r504",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension and Other Postretirement Plans, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r481",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r528",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareCashPaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Preferred Stock, Dividends, Per Share, Cash Paid"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r45",
      "r165",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred Stock, Liquidation Preference Per Share"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Preferred Stock, Liquidation Preference, Value"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of December 31, 2020 and none as of December 31, 2019"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r21",
      "r60",
      "r61"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r20",
      "r22",
      "r301",
      "r302"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestiture of certain businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Net proceeds from issuance of preferred stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "terseLabel": "Proceeds from long-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from borrowings on credit facilities"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r137",
      "r139",
      "r154"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Net increase (decrease) in commercial paper"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "terseLabel": "Proceeds from Royalties Received"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds on disposals of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductionRelatedImpairmentsOrCharges": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.",
        "label": "Production Related Impairments or Charges",
        "terseLabel": "Production Related Impairments or Charges"
       }
      }
     },
     "localname": "ProductionRelatedImpairmentsOrCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r14",
      "r108",
      "r111",
      "r142",
      "r167",
      "r182",
      "r192",
      "r193",
      "r237",
      "r243",
      "r247",
      "r250",
      "r253",
      "r273",
      "r652",
      "r655",
      "r656",
      "r661",
      "r662",
      "r716",
      "r817"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r66",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r65",
      "r336"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r33",
      "r34",
      "r338",
      "r833"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r64",
      "r162",
      "r338",
      "r866",
      "r867"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r33",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property, plant and equipment, net [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r33",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r120",
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Net (credits) charges to expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "totalLabel": "Purchase Obligations, Future Minimum Payments Due"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueAfterFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, after Year Five",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due Thereafter"
       }
      }
     },
     "localname": "PurchaseObligationDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Five",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due in Five Years"
       }
      }
     },
     "localname": "PurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due in Four Years"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase Obligations, Future Minimum Payments Due, Current"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due in Two Years"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "Purchase Obligations, Future Minimum Payments, Due in Three Years"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.",
        "label": "Receivable with Imputed Interest, Effective Yield (Interest Rate)",
        "verboseLabel": "Average interest rate of de-recognized receivables"
       }
      }
     },
     "localname": "ReceivableWithImputedInterestEffectiveYieldInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r104",
      "r107",
      "r114",
      "r725",
      "r729",
      "r731"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r244",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r243",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r242",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Repayments of Commercial Paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r139",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "terseLabel": "Repayments of Lines of Credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedLabel": "Payments on borrowings from credit facilities"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedLabel": "Payments on long-term borrowings and debt extinguishment costs"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Payments on short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expense [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r162",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expense, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r17",
      "r32",
      "r153",
      "r160"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash and restricted cash equivalents included in Other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r24",
      "r35",
      "r160",
      "r864"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash equivalents included in Other long-term assets",
        "verboseLabel": "Restricted Cash Equivalents included in Other long-term assets"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r347",
      "r348",
      "r354",
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and Related Cost, Cost Incurred to Date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r347",
      "r348",
      "r354",
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and Related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r347",
      "r348",
      "r354",
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Restructuring and Related Cost, Incurred Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r151",
      "r346",
      "r352",
      "r355"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring Charges",
        "verboseLabel": "Restructuring net charges (credits)"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "verboseLabel": "Restructuring and Related Cost [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r49",
      "r397",
      "r562",
      "r831",
      "r854",
      "r859"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r183",
      "r191",
      "r193",
      "r277",
      "r559",
      "r560",
      "r561",
      "r608",
      "r609",
      "r850",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails",
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansEmployeeRetirementPlansPolicies"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r428",
      "r429",
      "r431",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r520",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r428",
      "r429",
      "r431",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r520",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r228",
      "r229",
      "r242",
      "r248",
      "r249",
      "r255",
      "r256",
      "r259",
      "r412",
      "r413",
      "r791"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r416",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r749",
      "r754"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "verboseLabel": "Trade accounts receivable, net [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r485",
      "r486",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r104",
      "r730",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r77",
      "r169",
      "r391",
      "r394",
      "r395",
      "r396",
      "r735",
      "r736",
      "r738",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable": {
     "auth_ref": [
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting pension and other postretirement benefit arrangements with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]",
        "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r483",
      "r484",
      "r487",
      "r488",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r673",
      "r685",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Table Text Block)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r12",
      "r13",
      "r14",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AssetsandLiabilitiesHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "verboseLabel": "Tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r527",
      "r551",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "terseLabel": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r313",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r313",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r31",
      "r57",
      "r58",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions (Table Text Block)"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r684",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments (Table Text Block)"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r349",
      "r350",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r349",
      "r350",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "verboseLabel": "Impact of restructuring costs on the accompanying financial statements"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r237",
      "r240",
      "r246",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule Of Segment Reporting Information By Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r528",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of employee stock purchase plan activity.",
        "label": "Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r530",
      "r541",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Compensation, Stock Options, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r80",
      "r165",
      "r213",
      "r214",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "verboseLabel": "Schedule of Weighted Average Number of Shares [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Expected Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r224",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r259",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r224",
      "r226",
      "r227",
      "r237",
      "r241",
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258",
      "r259",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "SEGMENT REPORTING"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r162",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Selling, General and Administrative Expenses, Policy"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r151",
      "r346",
      "r352",
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance Costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r532",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r544"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share Price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r547",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance (Shares Issued)",
        "periodStartLabel": "Beginning Balance (Shares Issued)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r37",
      "r803",
      "r828"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term Debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.",
        "label": "Short-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Short-term Debt, Weighted Average Interest Rate, at Point in Time"
       }
      }
     },
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r162",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Standard Product Warranty, Policy"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r224",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r259",
      "r313",
      "r342",
      "r348",
      "r356",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r165",
      "r167",
      "r197",
      "r198",
      "r199",
      "r201",
      "r203",
      "r213",
      "r214",
      "r215",
      "r273",
      "r390",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/Cover",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r83",
      "r179",
      "r180",
      "r181",
      "r183",
      "r191",
      "r193",
      "r212",
      "r277",
      "r390",
      "r397",
      "r559",
      "r560",
      "r561",
      "r608",
      "r609",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r731",
      "r850",
      "r851",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r212",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Payment Arrangement [Member]"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "auth_ref": [
      "r526",
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r45",
      "r46",
      "r390",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Stock Issued During Period, Shares, Employee Stock Purchase Plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r45",
      "r46",
      "r390",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock issuance (Shares)",
        "verboseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the number of shares issued.",
        "label": "Stock Issued During Period, Shares, Period Increase (Decrease)",
        "terseLabel": "Stock-based compensation (Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r45",
      "r46",
      "r390",
      "r397",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockIncentiveandPurchasePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r167",
      "r179",
      "r180",
      "r181",
      "r183",
      "r191",
      "r273",
      "r277",
      "r397",
      "r559",
      "r560",
      "r561",
      "r608",
      "r609",
      "r650",
      "r651",
      "r660",
      "r716",
      "r725",
      "r726",
      "r731",
      "r851",
      "r852"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r166",
      "r397",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDER'S EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r390",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Stock Issuance (Par value)"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r732",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r732",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r732",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r583",
      "r591",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Summary of Income Tax Contingencies [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL BALANCE SHEET INFORMATION"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r572",
      "r573"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "terseLabel": "Tax Adjustments, Settlements, and Unusual Provisions"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r618"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)",
        "terseLabel": "Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense",
        "terseLabel": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability": {
     "auth_ref": [
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability",
        "terseLabel": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes Payable, Current"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r770"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r267",
      "r268",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": {
     "auth_ref": [
      "r96",
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.",
        "label": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax",
        "negatedTerseLabel": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax",
        "terseLabel": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r82",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r82",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetParanthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r82",
      "r398",
      "r399"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost - 263,289,848 shares as of December 31, 2020 and 247,566,270 shares as of December 31, 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r390",
      "r397",
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r606",
      "r607",
      "r608",
      "r609",
      "r793",
      "r794",
      "r795",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RestructuringRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized Gain (Loss) on Investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r574",
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Decreases Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r588"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r587"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "terseLabel": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt [Member]"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r175",
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ScheduleIIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow [Member]"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r203"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r196",
      "r203"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Assuming dilution"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r194",
      "r203"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperations",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3098-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27405-111563"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2599-110228"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3,4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12201-110248"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121321822&loc=d3e3913-113898"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121323062&loc=d3e15009-113911"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28511-109314"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28446-109314"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.EE.Q2(f))",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=SL116722634-122817"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r877": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r878": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r879": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r880": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r881": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r882": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r883": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r884": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r885": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r886": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r887": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>98
<FILENAME>0000885725-21-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-21-000008-xbrl.zip
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MNUH_75TTVKL-IW?=B8HW+OV0T%6XJVN%? J8I3"CJ^"'4&R&ZTNG=\#R]_K
M[<Q:.*HEQLP%/&I#"NIJC.0#!H 49M 8^EHXG:_-C6_P^JSOS=O;K72'?FN+
M4D,0,0-C;R+#G&>U'(U\+YW%\+V]4QCFC..-' \!#<4G8>\:82B!*\.8T"@4
MH8J'&:TOO7=UY1;M;#<+*=4R:R>!A%K'L4$,NF(0R[9C"IKWH<#TUFQLFSW^
M*J>$)NI! D()$CJVA)9H>1.6S4T?EED7YLV1,@I,I59PJ(J6#!9+P)O9,E'I
MV&FFA5%3Z.;SD;!R]\$H)V\)<DJ0&)!C&KW,"44DY\0"<ZA\GC+1_G"3GP.%
MK[_QM/:020/E2.<R&4P>>^T1HJ4S&?8T<.^V9G2.X=IY#34#RI@B]&*BKM2(
MJ1#E,;.>9^#K)AJN]YJ+N_=P$DN/)2/[6M'!:#!D^K(&JJ%WU^9P-N+TZ'4(
MS;=0,UIC]IA#9ZZ6$*DTSZR=DZ^C!](,^N9/M1QZ*AR[F<85&5IQ 5O$CM(C
MJP1CC0^:>\:29N3O#OR9NH^JY-4) X=FC,N9(63O70ACTW^!&9P7_C<Y/CM?
M.3Q/9A?_/'OKM,!_?_[\L+8S&X1V5S9/OCY>_6M;?+I[?@;<8_L"]FACW^YB
M3?/+%Z\.,1S,^O'>C_IXG%V^6K^09;N[.CG1]6@IN/B?\^O+2,;O+XYU<[I:
MSF474!=D)XX*JT=7L%#6[**EI^B\Y#GD%P=*S=B3C5V+Z'J)+A:4$30IUL3.
MQ1![ZW,(F[>WR^O \!DRO 7)G5WEJH+:*H&/%KLM:O>6B";<Q^! [ D3^V;V
M!$= JEZ#4D/-3!H .&L%RVD"XW2Y.F<FC6.YS_1\+><'>3&^\%R27O ]I\9,
M%KLQ>"8LT%0+)U96BO.,WEN>G3Y0<K*QN0!7RN#,V46,5$EB<84X66X-N<V!
MOQ\7R_Z0.>_O"37%?*[+H\"<''*():@4Q1A3(./M'&HL#R+SX(<7N;J6O:!X
M8'/%PB*"&*'47BM-N=?;03[LEZ*-32B,<^7-M:(3*CYQCS6/=JTY0YDN$S\N
MODQ*"-S0S'QA=KW[T)UE5\2U0FN5C30YUC)A)AY"^I[Z1J<!%7M5]%BDL2^<
M(Y4>*D/L$V;DO,Y2OQEWDEH2 L1D.BMQ+:XQ=N^4 T+-_>),A@-X6]Q+Q]N;
M9TM*M<N8I@"L5$K5E*A$#,%7#OMJ>3]8.C$C]Q@TQT[>=QC-!GVAHB%:0B[9
M!6#:4PN[!9"V:$F^*0N[ D"*Q5251;,F'D.-J9J-[:DES?G(>Y264DW=<TS8
M",A7WR6:&K'@==4,;?_LZM8AVZ:512V*3,(<,3O'XKEXC.B%QF;PZ5O9CFH@
MIV)SU!([AISZ.&I2DT@MT9O\B!%J"C)]FYLC@%NT0/3=$WI3'HV0HJ/1Z%O%
MJ0^QAKK/G>+W(U^3 * 04O5%,*98:E$PY^DUN)23VV,+W(^<K0:PT&?:4DUI
M!H9")*XCI8Y!N/KIMZ:YQJ'J][5MSM:/;Q22[;6DX69:A+!C:QG]2,U*%HH*
MV#@+R%Y \N.3%Z=/3F39'NC9>C439))#=E%3DN@L:@4A= ZHAP"YM9CV IF[
MLFZ+U3/9U+-C6<\$F9S9<N.N6EW&7I+D;)')!9^")5]4]@*9AT]UE&Z>OOCA
MB:Q/I.K9Z6AP-Y=66[&0*RHUU7&J:R_%FUM#3J[T:K_N5X<F7[2UF[1HV&7,
M^?>#DZ_7SHZW6(\&L6>-CK6@8BW>%(-+#*0^UAKV"\B;CE2[QW,T/DX5  N;
M\Q1'H5LF5GVV+,S^[)EAWG1\VSV>%@L;,PN7!-BS$]<ZA**&:PH>>+_PO+VH
MN'MD1[69B)C4A(*E$)O/33UDSLU\,;3II]L3R=:VET 'I40Q><J*6,E13QB"
M\[%5+3G,8#UM C'P1I#)6*&7S!6]&8NFTK,(!$@M%5]%]P*96\S6MH=,:7%,
MW1>@UM!%S\5,!I&)(&9V,ZCRF%1<NAF,LL^0L;D@"1M$3FF<;$>-JJ_S.GAS
M*MG:;JK6B5.)@7N/I-BC)=Q1>N^LI@M#RG-HI3JA2+5[/$WZ10K19P6/C3KW
MV AC<:8_NLJ<=H--(+[M'D_H%OYJ<,554XZ]$WFITK19"EXL;=LO/'>3K>T&
MV9"ZSU6PF8DB:BBYEJRQIIX!R-7IKVY/(UO;9O4C!RT($7*)Z"J11 ;?16(H
M(0'O!22WEZUMLX5L8Y9>V<P$L'?'ADLR_:GB'0C.H!AK M'L1I#)XT@HEYLS
M]X4A-V((05WG0%DJS*#5Y*3BTK8P.ELN+@ R(W\Y\"<JYHWUB\5FA>#SYU_]
M]<>KEU\]=?7S>/V[$P;B(3UB;^8JN?0R#D7DFII9(7LW@ZJZ[U;+QZ>Z/KFG
MY?3-?4T/5L_.7S6^P9W'C]?ZV)CQ?>\VTLNYS#B2<\'7WM"E@CU92*M<HR:.
MQ9-3FKX]_CH^][1>X@/YP>I4)VQ_;Y9105% DW5A;#M3'K7ZG-25@*5C@QDM
MN?QFW](O'WWSVN^WM2GQ/[0]-ON[IYO%XZ6\^L2KYQ^LENWR.6W[N*X34FB5
M4NS2 GJP$"OLQ]]FT+7Y<DD?LH^\>G"@S\N/O&<#_<QH\TR_-0M>GXT[_G&Q
M^<>;)/IZM5:CT%?/ZY.QZW=LA%U+?5^E]%PY3$>>K\?A-R[]D%;Z*<2,3G,*
M]D\*PD 1C,>$%*#BP07^=AER79WH2Z'ZW:J^@T/GFVV,2*NGY]NVEX\O7O75
M\Z?V=EO;KCXQ)M^^-X;:U81O9-2 .;;B&[+F!A3&; 'NR_FK!R;?(I-W<O L
MINA&81XJ$XZ39J6XI,$'YZ1G]M-/%=X'X;V7^-W97%[[2@3<I,#8?".+Y7>K
MS>;+%Y>?^Z,>G]_@YLGBZ9LW>=7$X_+".>B>J216P65?0Y(NE1!KH6H,<U S
M]Y:58/J3$0<&SY#!6YRNT3(V6 'U6!(Z+B*MPZBV[5J"0CCXX)U3Y=;,Z(&>
M?KM\IIO3\<+KV=)4'+$S.9P]NAJ*6)8'HJTV%VN6VKW P1$?:#P';UP")7+V
M7W0%7>K<S^<L8N^C(TZ;P6+6#&@\DLM+"M\]6Z]U65_<T^7J9'%^6]\NQ[S_
MQ\KE;6Z^+Y%2D A:.^8&!;@X'XL63P']#'8#'+@\:RYOT2\/%I>6P6>7L'@M
M/4/*D(WA3$PS6-2<1&3?\8S7S;@YX4+)>U_&'@'- B4G 53M?<QK3=_-':BQ
M/:_QLNQE/-C\6^'+<-?GS_SNLA= ZE21G /$ $TJ51;76O6QNCSA[NXSBJ;[
M,2G)S=(&%HJH!9-YI%PU%F-+E<">>$8EVY/@S+66C.ZN-J??]X=R_-ZBH%O3
M6Q_'K.CN"^F[Q@9$9F.04<S <C-GG;FK/:8B!WN[ 7O[U@!86RZQY37926BA
M>21:NS>\Y&(HT'J);%E94_8^Y1@DEI15#H%N?PSO,,TQ/>NKS543ECE&'1L\
MZRCA"(R>8@K@50_6-V_KFXW4O!J3'VWD]EEG8NJ5N<;HS,SRV.X4$U1$I=),
M?<89E;#.Q^ .>=T$\KK=%-K&%JJ Y*:M8#!=V8'2:-C3@HNI'^QMY@'ND-=-
MU/!R$2TN!8MI@"&AQ3P12#ZEUGU/]6!X^V)XA[QN>M;G*X:2L>;0,WJ^V&V=
M1IDSI]2U'*QOWM8W&ZEY^WG=;@R.(L:0\JB^YM&<D[I/G9O9G(3J4I_1AJ[Y
M&-PAKYM"7K>3;6<Q8)4^RL55,5>0D=3E&D-M3*7#P=[F'> .>=U$#<_"7/?%
M)Y$4<9P5E*NZW$O3(%P:'PQOWH8WFV"W V6Y$X,#'QPS)_O7(S82H)9-5W;T
MT 72](L&#UINREKNA@JJ6P[L%40L,4)7$%(P8GGO@\6$&?0EG9I?/@BBVV.O
M$B& ^!(:H&^5>B@UA BU]>#%'=B[MV[W=E3%S1P/'Q..)JK0,:'#2.R:$S*%
MWH/K?DY=O@\-?B94L5+5""5"B02-5])"TTXMHKANV=^,EA(.M)K0A+FT7B16
M&#&VU%Q2=.RS%-<A:]$9S2,<:#6=;-E;V -'+H74L)E8TX@0:D B5O R?>DV
MB5FI+^58EE4?/E']%3[_L-:GLFB7_-W<6;9SAE]4 )Q>ZX#Z2>1#4U%OH(5-
MKF'MPF@!5E"X1D3O8HP<9[ %^4#<^1!WBVT5D(RKR,$RBV;_%O&6>E 2<IC)
MO.[!XVZ)N%<*HGY43-WFGFH72Q+TS4?!8BJ!,N5&@;PWHAY<[(&I4_&IH!D@
MJM9@:788>5"/&H(#0LYI#M/G-\G4J?@3UVOI8VD#8D*I25JNG#TGZ18 ??RX
M_<E4;(EZ[CXW-<??,04ME+ISZDH+O4&?P63^QZ-IYS+/<3/R!,A%:,$[(13M
MY%N-*7,'S%53G;X[.1!UND3=9L:GO2"IS[4T]%&IL6L02F'?2P]Q^AYU3CKZ
MTC:^6TA9'"].%S=;'S,));W-4]/(<0A:H=:(R:=2QG$KSMPHEJCE(]=H!ZY.
MR:]6\Z8((:8.U4)^*"#DJOC,$C'3H7'T[JER<Y,DU[>9J;A6(Q"25X"> #&[
MDB0S<,3@O72O!]=ZH.N$O"N'6CA7'X>7K26Q$:H0EQ)ZE9@/JG7>3-EF(1UK
M1DR2S)%A2UZ8<L\AABHBF/G@V&;-E"WZE QCV5ZJ"B3TWA+@Z%Q($3+Z5'$&
MA]_MM;"?WRS-%KU8Y/,E^!XH,P:H%+H7HVCN''M)?OI>[,#-27%SBWZS]:0A
MY*1CIX6:"B-,,;<V%)I8W)V^W_Q:%NN_R?&9?OGB_D7[__$&7Z_UGV>C <Y;
M#+FZ^+5+-S_J"'M;W.#PVBV]?/@?]B5E79^\^$Z?Z?&OW-6WRZ=GIYOS*_Q,
MG%NIH21HG=%7I$PLO2,XUTE3;G$&14?;0 MN@#HWS.:I$,BE6IUIMM;2F!>N
M@N298I(:HX8$'P>!PH% ?_C48'394ZK1-\$2BZB/7;F,>A#VU&=%H(\$LT+)
M:6A5DU=DA\S!NQP"<Z*<<08'C!YDQTYUJT>HN6$&H8!8E2)#M#B2N[ WZY\5
M@0ZRX_8)E'IPJ70(A!71=X:6L.0@/39U;5X>Z" [=G"XL+$G@!AE@'%D/DYS
MR5"H:@6I\R+01X)9M%RU1VA"K6.77+KWZL51XUI+GD$%ZFT8_51$HJ(/#5U%
MSA7!!]'F<X*D*4!62#-JH_#U8BG+NI#C5].7KUHV?[>HX_KEXSOK]9BW/'_V
M.@68?P"HW7<Q"*I>V5=+V0KVQ*R^^0:L(?<.V#]Z5-_[\9OUZ><_CK>\^+#Q
MXT^Z>/QD+"(^,U?P^'V;V&?)FV;^6:)%5.6$/9;2:ZY28K6$GWP*,^#-.X"[
MOU@N3LY.MB;#?B\C;W2E=_>D<2K%FS;S+CML580Z=\%>N_;:ZEZ'D"TNP[V+
MN/+\&L2=)6E I>4>!0$C!FVE)TE 3I"2FLR? 6D^.$1,@9:S)$]4CSWT2-G$
MC.6%@I5]Z31*W$K@BXFI23?1V9&J.4QK?$"*3-LK?5=VG1P4($;+B9EJ]\BQ
M9Q46[V?49.Q Y)D0>?<]T J"5Y$R&CRCS]Y$8DVAE<(6_RG/83+O0/9YD/UF
M-H)&A]4GKI40FPG86%)+ AJ41UW%#"3K@<@S(_+NM7:NH4J/+#!*A[J3UAN
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M\DS6+\#AK,06:Q97(C)VQ1 2$T;LH9F]H.$P[VGX6X1DF_.,&1KX8%HK>B0
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M)"QE$[#>)^2(V9F2M;#/,:!)V%CDD']-?B7NP/#W+/>*)W/405T0=*63RPK
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M)GGZ?-@R,._]W+$C\!6][LI&WUB66SQ>:GNT^GZI_WG6'NNWR_MW9D*%P+W
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M@3)X-KPU :[A2&(U9LT#9JQ+,.2Q69P5Q6D3&OE< (L!#FQ\P0.0<DC\B$B
MIZ@MP?X-6MSHXP1<Q4J)R*>2A0%R4J%#HEC 0QZ3MGBQ&XNS0C\9BUP29D%K
M-&?@+?.(QWA6MC9Q: EK2W!V8W$>@C)A>"7B@3%2," PL2)A+ C5@ODQ[B??
M*%/+!1Q0%>HDD$QA$77#N8E9'&(T7OA&:MD2)W:E%F<PMCJ5V61V="Z+H=1V
M.L''KV700UBFM0Y]P53$8JNDC2R/9!@&8%N2H/T[[OZF,%MD25:C.#24-.(B
M"#!^'T@J% W]V.+^"Y)0ORV^RR,$FM6X0@&A,8O@?Q >TY1*&EM!>:();L1:
M@UU\ZP\TJZK7#H05;%(LM&326*D"GU$:!)&*#%5MR7E=:<'M%2VHV"#Q$U^&
M-F2,!['P(TZLG["8T$A5SD:[);?V5I[%L2$! +=-(N;;6!@F8'"#(!!2QGP-
M,DG7]704:Y50&%+&C2<JH!A$"K0(D@!F8ARW9</SPYA\*SK@AH"<PE@%-N:,
M"I]C45!.#-7"BJ:<[,,/UCS"HR8D(^ 0)8;"ORQ4G&-5&T$D%B @EB7ME]S:
M1TICYD=AP&4@_)@)(07N">?*",D"H#-KL''O-OS;1@WFCWDQ+=.1+<M!U<MR
MX1^]&/Q515^ERFSS]3IR)I/(A)# IY0"8OM:)F%"6!CXB8B-K(_7;K7E77_-
M68W!IT"W 6,LQ5K-B1\"W(2$&0V&0QAB-O5]VZ YJSG9)C*4:A+@@;E,Q$10
M7T5:^O"_IL*L@;5JI-[;[W7_:4CM86O0BCQ]*RV57$D=2!8:(B,625_)@ 0D
M5LIOO]5Z/!JT&NLEHP",E>];+-Z94*6"0 <)37@< 1DR8?NMUR/2H)58,1(H
MIEBL&*<1XP&3X#J34(51F&BP:FN0O(!?=\M4'DD-#]#KK40K.D3<"JM"18B)
M+,"0Y>!_X4HC!R1BEM'V&[)'I40KRLR6@EGE2S\,-6.$@S]&P:AIT"8B_7@-
M;-GC4J(518%9%/K61APS=Q.#)WN%&L^,!!@B85LVE'U#B5"<>W*2CKI#&!8M
MY<CLR)$T<KW5:46I>@H7%;A1C%C&8JX,\V40:Z624$G>EJU'&W5Z&":.6 OF
M35B?193)"$ J4CX/@Q"(MN#KL$;U6-5I-=52$QU0#DQ;6,U\):4)*(TD3Y02
M''1M/8Q=#S3I+!V=[<OBHUU/,Q/$E*.985);QHWD$;64!.!"L0#/(5T/,W.O
M@EQ1QFUB+#%< +9+IN-(!I$1*N2!4,8/6E.8^D$)\KZ@=3I**RE6"V:I+>>B
M&5I93@OK7G[^;=-,\V7S.[9S@_67//255L9:ALE\TO" X;D\8:Q,'+WONUG.
M??'0=*(QOL=VDA9.,8XR.3J0PZ5<[-/_X&>WKPOI""0.UU93&B0LYF]4?_-W
M5EXT$7X84@-@RF(B1,BEU3:4.K":BB93#T31V<CD^T"[+)5O ^V%2__)TIE4
M.B%!G(1!S!("SEB<V%!P2@-A9<!P+CU,QO,C<NM]L7HZ23_9BQ?=Y>2ZS&;^
MP>2*26RMLH(($S'-M8Q"KEC 2!+%1AC;;MG</<[=HBB,'_G:#TFLA69:XHE,
M@64P4<!G8&!]VBT*M]%X)*M"?A<OO -2<B<"$@&A2<B%H5(P7,:-")6^II)*
MQ6D05)R@K0): 8Y=)O/_0#::J##VI1*4:D:%%C";0AN'H52^)IRU6S;WPM=N
M;9KX)K*)C2)B$A8;JHR.8F+"0 DN(R7;+8I5X=@M"HA%7.J0,Z9IR$Q . TM
MS!JI8MQ)J'7;#,W);&PO)J#LYD-;3E+=(NNO0LD#@CE!UK! *\5]2DEH21):
M&T>BO4)I'1&CX$+Z*@3?G\$_4HI()!K$0V&B2".3=HOB<')NBPLHUB8.IGT_
M(7$02\R$HB*4TA >X[Y9X8<Q3]IF7%:'7;=H4'PIB"(L,0&S+ D"+DA,&- O
MZC9WB?8*I77D*S8Q59:$B;(1LY:!MP*\RP@9!+X)3-1N4:P NVZ3=\510(2%
MJ2(Y,PS&#@Q,G"3,2J():X&#OVN3=&3-"SN"'YQ\7LSPSVY9VLF.G-BS'*/M
M%P'-"6T'!J*0^A\7J&L:?2G3XK7,IO;%;/[C[_!NLM#GLSW[R5Y*29Y?U!^-
MIY/27>&WQ.9Q/R0)-R;F&J@A)Q(T* 3SYTL=&$JCC=[<K][0ENB-%%SC[EPM
MI69A; 4A(C*6,:/P;(GPX>O-;4@KN"W5N7,E?BAZPTF$AS1SIOT ;9/0<<P)
M":EEE(>A>OAZ\WA$14UH6")(*"+&C3N(3EC*#+5 OZ,6B.H^#/G?Y)XM7DL*
M$A8D2L0BT"&C*I*!'Y@DP@@?GHC;@B77^S#4CT\O;!R0. FIME8Q'C,5,!W!
MGPJ\$<D#\SCTXM8HP=KH!0NUC)(@-H0Q%D:* VS$(I%:4!,%TCS\L,%ZN1AW
MZIK>8D@C,HG@7)H@P-RL.!2XVX)0)A+. 5,V>O/ +-Y#T9N$18)'D0Y\*UF4
M&*X$!0B*N=6"1:%]^'KSH.S0P_9W;E%OP#4E5##N1U' >!();<#7B55HI$I
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M5E\%V1;BYJ^7F_W%C4,U%C"F*(3_]R1X,A]VJ3^>%?ET9#KU+$W</[^.P>P
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M@G77F,*69?W7'CS4;R50_R,/\_/[Q)J(F%AV?(/1"R-Y1UFA.U@CE7"!"2I
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MK."NGCS_\179N\H2%=LT$G\K2Y1M!R*X]311LAT&T:TOO])@&W"I)9T-XNV
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MD:41$)/\QM3;1XKI:X)HG\^MJU=P"=:>^O5>CW,@90AHQI-9-D>U9;A3MKX
M&KX&X2X@VQ)]:YP21#O\&HOZ>0:^'9VY2\>%U=:E OJT:L_5]BV]I] HN)Q>
M.=7G7GF>8XDGKSJ&!&Z4D\NO\EF65^'9W5R_S3-/CHSWE"Z]L0+G%:Y1'^!]
M\!YW.=R(W:G;PJ*?I>N(ZZTL)YX@50M&SLI[H*8[TZ* 3E3U1C&,-)&3Z2/$
M,/9>!1PP+.$=WX^ F6HE.C*2ID.DL8Q3P5G,-LSTX3/3]<12!!3 DF$ZF0 "
MV0PPI<A'& K,9I[]9(N9U\>0@]1NK]VNG,BJ0N@EE%VTL4PJK[C)Q_9LFLD%
M# \Z)]Y3_#'^E09T>^Y,IZY WA@+Y/U=W#4_@[M5]^=0:LMG]X"12P.+XUI#
MYN/#R"_O6>P38H(8'/= =AB)6$>&EG=B'@3<D,@74;+!R U&K@8C76PP@S>Q
MGM0:,+*0""^($Q@8'%W[*7C>H\ZU7Y1# %=X2M%P(X"6(8S!# _4P.: ON&H
MG7EG1?YY<MY\O0T,U;J^N4"DJ^?N-D7CYCT*KWE##]W7_J_-9=^]X.;^-1<B
M)7UR0R^?7 R/^E1U:,.PEVGU]D/89A>3^&]MLXNW_>A.RIQ&P8_5(WTHO:5W
MO"/N0=6_O_.B-M41F6Y2ZNI [MEUI6U</*@^L7O62KK0G.70@VM>?SQ\A:=;
MZ2\'NQ_#?=IG^T 5#G=?#M]]^.@?[IZQ WIEF?)\'RC%NS=_,G>Z%?3Q\.3C
MU[<?SF;OWO38_AL\U^&4P;W!Y1.NHE I(H*H$UNE.BRT88?'D>H(H1,=J-"/
M:/CDM[WKH?2!G>WP@Y;<)S]XNL,%,M.JXQVN?Z/N5?E]]]UNZ\2950N2_7I+
MN8 /2J('UW&J]9N%;)UFX> F.KE6<EO=(4\5)W"C_&):0L?*=H99[Y43 !?8
M7Z1@"TY):&.@ Y1V6&*C#@]5T%&QI"0RG"EK?NQ\IQ^$V9](V?MGV7T/"@AZ
MUSN,C\,HKQH?FL%_Y<9^9^ZK;W#BFS@Q6\8)SF(MK?$[24)(AQ$3=624B$ZL
M-*%,"J;BY"=PXD?R&5<;)4N^$8W"PE _F(:":PQN90$8&^:C3')O6E:1+'C3
MZO#5R?R(PB9LC^%\?%8VPX=_3N'1\%AO!*^6(YOXE):. 8[D2.-,!5Z(IX7@
MQ>4$-QH4IO2P0FQJKD_#]/S@J7QV;6QJ$U.]CW6G>NF^9H98.P8#BW(RL5C=
M%R4$PL*SDJ!K\LPM:L_KE,FR!**#'S4"M$EBW5K*J*X5B7>FN,0R MD@X!9Y
MYN5@$I:49D%*7975N6HPPI:J@@UDH20TVSG\DMF92PIXZH?>Z?9@>V?;BVF$
M)<2>X8LOWK)._E49H/V2:B9I,:Q6I,;P;(D7@3:[)%/C>BRG)IW4_;HK/?R^
MS;J;NH\_;+/Z.BFZ.!!YT5VHP\M,GK729/WMU;'9P5=X[E<=[N_JKX>[?Y+W
M,@Y@>$G2$1PL#P-+A+7*%0RRA%^BR/K$?O^$]F]#2AOPPZW)E.<VRQJ#Y#V]
M*47[PAH$3-YG#R"!<=5\<(!#UV8:^(]6G&?O14A4%/BB$W%B.DR+I,--Z'<L
M2?P@X3+1+/HNEWNL"[YAZ\C)"<Q\>78& (((@\!B)_7.TOPR7YUS#%V5 2O=
M/B68+RZ+T"WK)IAN)[&D!B:2R#'0S"\I3#^;S;S_JJ?V2Y?: ?=/1VDUL:>E
M>7)I2QO%#6W""!D0EC#.J8E#04*K.*&4LO=]-].C@#P!:-/PB*S\?T\ZT87I
M_GPT'9I\4G]_=:H?.1+R,LOE!#QJ\(;A6_&XYOQL_^L^?<]L;*2D!.2'J28Q
M33K*QJQC(NE'7%&J HO%EK?GI7P;&?[FJ33+4)A*HM>!U!1T)L/$RHJJP8<E
MC"RPNE0[G?JO(-SV_1_5KKK!&_;&X==_3$>U.0O(%E9Q@3_G?5!UX,\S<O:-
M1PYSUU_<1 :*ZIPKZWIN02O1ET+M\/YOZDXFW?:>OG0)I*GKZWA:D;"M:[V[
M+U@C&-VX\ZNS"W-SW:9MQ\HOOO857W$^FB[1=03F''DZ]#;_/*K2>.V\\'ON
M"K\7Y9;S&TP*;P:$L;S:ZJ]58I?KI3OC&KH#G4)?5&$V!;@6+@L,1@$P:C(%
MB,"L#M,<B>WX.E(,UPSXIR5\B P$+FJ@X.I3MW^H3/+*^!9"8E7C&;O>"&@Z
M<<XSNBKPZ766YL9@W#WU>[DXXPH-\=:W@?[(%@,<TB>W0.T6R$^OHOL>:!M(
MZT@6KW'"+9Y;(SUY9$A_",]XKY6T)@I)1\%P=UB@PHZTX"_1,/*%\6W$HA!+
M9!'_*M(O:D[,JTUL/<1Y@ @)4_0/.0*\GE6F@0IG&OQ5$E1D1#?.C IF+DT*
M&]N0<2LT82$CS%<,?%EF8B'B*+12.A8$4X**Y;E ?HH$5:CA0,/-C_)P@72/
M>*Z<?7F?1#JTB1]W8DH-'IGJ=[BDLA.#-+11VE!-GOSF;S$_WO*C<"LF\95)
M\]UDOH?E#WSKB*7=7$^K[3.+XZ@KXG&,96KL2-MVO>R3WXXPQ%GGBM[ #)N,
MTD_(8/,O,\^=K^;"J\N[J# *GXX\:!:9IFMP%^@DDHB:F_H5-ZWB]9=V52%+
MFU-:G) UO8(6 0]&=>C5W8F14)ST7G<$\)9Y^]9.:D[BYO!YGH'$2CR28NGT
MVDI.12,GC/[F'EC&2=6Y?K\_WUT U';H^:3SGYM5MQY#1K?C$,9YG%?K$\\+
MBSL8/ME?FSQ(%\]9NK'.7"6+6Z0J\PQHY95;;CX&:/E/;-L!4Z@#RTTD$JU]
M%A$EC3$VHCJ1X"XR'K^/GS3WG!>+]>$SVU&%E1_!\0%B_UQFGT%X3WZYJ+N@
MN,T;X^O^;$_OLU[%E?CU]04K3KHO]GK>X4MOYQ 0\^!D\-,5-KYS/M.53.6K
ME77N*'<9Y+)-*MG\;/(RWQ;D]I.,>7 GS?YXJ[>;X78W)RO\< [8\@&$MY?Y
ML7FI>WBI6@\O&1&?5ML85I 6=.'2N\@#G1N':T8_2>YL]+]Y3J9\,'WQS@MT
M<O[U?=OM!T#5NL<G7O_?O\C+-O8AIW^M& 'F6GB--2_P^3>_[T8]?TX]@QLT
M\XY@Y=+]';SX>>3H^$:FMR+3Z,EO_9/>ON=OWSWF;.S$[0GMQ>F@?] ;#.Y%
M:AM<O6MQ;G!US60J&ESM;H"U55([[@_^X[WL[IP<'F_ =3U$2C?HNEY"I;1!
MUQ<;=&V5U$X/CGN#P[W7O5UO<-)]B9'Y_?TJ,K^!VC60;Q!OH':]A!K64$LW
M2-LJH1T='Q[UCD_ZO0VTKH= -]"Z;D+E-;0&&VAME=#V>J^Z>QX [$ZOM]L_
M>+5!V/60ZP9AUTRH@5\C+-L@;*N$MM\_Z'F#[LO>R5MOMS_8V3L<G!YOF.R:
M2/=><7;]$EU:\4:;I+.V3$C6))UMLLXV!N-AZF? -\1\O80:U\0\W!#S5@EM
MOWO\G]Z)]_+PV#ONO>H/3HZ[!R?U)K*!6\P[//!Z?Y[V3]YNP15[W1.WTG>X
M\Y_?#_=V>\?>?O?DI'<\\+H'NUY_,#B%CXY.CW=^[PYZ ]RI4]WK#7H[I\?]
M3?1Z;11G ^%K)E1&:@B/-A#>*J$->GN]'83EE_V#[L%.O[OG[79/NAN<70OI
M,K+!V?42:E#C;+S!V58);;][T'W5P^2V.3_&4/;I8- 'CHS\%R[8>SOH.]Z[
M ..=PX-=8+[U-<>]P>G>B;L$\SFZ^,6&$Z^'AC!_@]5K)=2H"6O$FUT?J^[+
MSTGMS]/NP4G_!.#U=<_A+GRPU_R^M +I=5\<GIYX=1@$]XILL'@M%"#:Q"?6
M2ZAQPYOY!HI;);0%$QX _CH"786+!Z='1WON]^[QVTW,8GTD'F]X\'H)U8\:
M\!4;\&V7U'9^[QZ\ I[;K\(/0'V[KXY[-0J_Z9_\[G5W=@Y/ 8/Q PQ25+_V
M#UZY&Y:"RG/6O('I]= -?Y,@O79B;>K_B$W$8M5]^4FQ84W3X\.]BAN[S2B[
MFQSI]1'O!FS73ZQ-42"Q*5NQZK[\I-@.3W[O'0,I?GEXO._6X#8PNQZ"O5^8
M7;_\]U:\T68S2ENF9$SGNU$VVU$V1N.!:JB_R69>.[$V=8Y\LN'F[1+;;O^X
MY\IU;GF]OWH[IRYGX_#ER_Y.L]%DY_#XZ/"X>]+S7AV^[AUCA'H3E%X3Z6^P
M>/W$VA1&\C=5Z5?=EY\4VP* =P[WCWH'@TVP9(VDN\':M1,K;THD^9L"GZON
MRT^*K=XC_=8[?', 3/?W_I$[ZK!W?-+M'W@O>@<]H,"8B5%][YCP8E-*O;OD
MQAW:&\Q>#RW98/;ZB94UF+VI'+KJOORDV!IT=L"+6_D M0<7H!@K:@RZ.^[+
MK3H'KXIO>/V#W1YPZMW>)GRQ-@JQ@>?U$VNS"]#?E!U==5]^4FQ'Q_V#G?X1
M<.9%EK/WLM>K-Z#TCE_W=S8I=NLB[?O%WO5;;&[%&VUR/]HR)05I<C]>;U(_
M-C;C82JH'X@-7U\SL3:;%?U--=)5]^4GQ=;[Z_?^BWZ]/_R:C>/>8.?WWN[I
MWH:SKXO$'P;^LNT-_-Z:5.-H08UDFU^B,B*;>JBK[LO/R@TW]7@^Z?S'&YSN
M[W>/WVZ,Q9I(U@]_JK1(M)F5#T-V(+I!_]5!]V2SHWE]).J']-N3L7FQYNG4
M<:QE.8L?"N_=3CN_3*3*;-//^=S^[=^J^.722WSORTL=8D >?QWG9>K&L[ 9
M#.PG^^OGU$S.ZU#1\ETJGTSRX7.RN$6J,L^FDYMO^7$MOJN %\4NT4NR7OH3
M.YN:__?D!W0G>-+<=%XLQ'9F.ZJP\F-')A-;/)?99SDKG_QR81B&Z:CI$*,N
M9')EQ&Z6VQ7I+0VJMB-XZ)V/:GSMJ%8QTAN5[*9NWJ2;/RB%Z,FWG_5A6D[2
M9+:B,:FH][;WXG30/^@-!C\R.A=[_)VI^V#>]'!:>#OY$)X\6X>7O!XX7N3E
M)!]Y YV"!J=)JN&5BW%M@;RT]*1WEN5*9IZQGVR6CVVQY<%3IXG4DVEA"T^.
M#'Q0?+0P ;P\\8;6H-G'ZU,-'9V<RXDG"^M-2VN\= 0MJB*7QBODZ,SB'2G.
MG4_X_'P$-S8-E&.K4YE-4EMN>RB,85J6=:\FN3>!^\LD+X9>!IB.SRGRZ=DY
MM#;*/SF<7[2$& YWUIU)A^,BAZ\GY]8[M_"$<^S%&.Z!/L ;0SOP3OCMY[S(
MS+;7Q6%H&IM8?3X"Z9S-O,Q*L- >=,(;Y@4V" )DQ)M9691;WF=H7L)SI/DD
M1]I638X+&#@8&'QD9LNRDXX^R7+>6Q"0IV;0K6P,QM(;G\]*^!#>U(US#BT4
M\Y[ 6R36#8G,2L^D\FR4E]9=. ' AE'W (3M8J!-6EI9VJJMIA6=CTQ:C0Y^
MW Q.,QQU277O_Z:@KI.9ZW::N$[BA2G:= _&T!8C-^A.-N6T.+/%[/H^PTB
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M#F5E.0Z/^X->HW2O;+9U07^47?ADY50-IQJ@(L-,RHK;Y-ELC-DFB!I#3$D
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MBS%(7C6\%"%'G6LB7%7D/;'UCQ+GFKV0V/@Q-9B$6SL%31P,ID,=5#V?P9P
MO[9,I??TQ='OS[::+^W<C%OTTIU_,2N3Z4A7:;7P#)?LZ?(PE[J:9'F.66QE
M7F"6["9*OQ;(CS&4P@('=,LP>!]BKE.K2^E=+J=U605!WR<N9]/%[. K77O<
MJ(^RK%)QSZ:IL9]3Y]^4YS ASMVWH!?SO0ON6:"I8/[KV;/ACW<M]CU@7_GK
MZ=PI6?9OZ_@)!O53-.^G3LZ5[]A0 5-%=1'OP _!748N1[M8K/DL1_9LXY#
M)4W^UJ<+P4&G"&BG$5U'\I-+!40TVFC"'6O"$5H%F+;HCM:&[V;BYW+TP=1@
M?!0XG\0PU=S276=.G&!Q@:Y>#@8O(:N#7TMW.C/77+5L?S9 <-?B!VI01R^1
M+W];\J\*:T=[V*CWU]%\"6C/(7<3W=_/_YHUW[Q,%=(,5(%C^_5__A5$P:_#
M.>+4-XRGA3YW.QI=K*%*TT3R</#E!/NUY?5'>MM[6O_Z;#G_OPFPEA9Y%.[5
M+.K=N)3X?.,ZWD\<7FI[V#UNY/K[S!3YF<V^+^#N%//]TB^-A)O?KQ5QDN-N
MH:LBQFT:F!90[] L<>-OM2^BSHR%)MU.&]S+5%1;1EVR&]RA;9757$B3YM4D
MF"U Z0I=_AO:]/=49P>44!7I3?+ROR<O/URYRD 7+JD,W0Z#N<VI/(J7SJ/X
M9ICA CMMG R4?NT;H7>/^W:OL1V+';[+I+6*=LRWR@_R;/;E$@D";:Q"5 .W
M7%CI<;L=_V^"2[T-:W*>%I<PE!*W$ZO.-J^W-KDEB4R"@3^O9W)56^_R1K$&
M&+PEFMF P]92FH?&V$RU\%;OC\--W@;Q8K']W*T".ZC'5G'-Q=T*ZH'I!B[3
M&7SD^=K*SLDSK]32;1 #Z4FWD@Q$=.1X#K+4D0M7U<O.WM/]X_ZS3>+Q+2@3
MVR0>?R>J=CG1OM7 \I,11;>=0.IFL\%B3UVK!^&[$<4;7QN0ZGC_V8_$%:4+
M)-JJ$DGM>[G@^X5Z,_5VNZ;$2S&I-P!7"W;6I6@!UDZ6:(ZN^R;5"$MC-!OV
M-\&]->#FRWJBJYT\UEEWW/<.##,#,X0[.Y_V=W:?-2LJ%^^0SES.P-@7>;-9
MU6NX\N5F=HY/.MA0Z?:NX=_S:D+_6]Z<]+?E=MW90E>U;.0GF6;5CJ"ITM.)
M'%D,H%_7M<L=&'3P3391@[M6+"1A0_G1;1__::U9NMEIS-&SC:=^+S'?[DG_
MY'1WGA-P;(<YN+='=;6C):MT,543@_6?RT6YKZ2P_S=UI1#FF[OK7.P)8HN+
M^"^G2AJKZU)%:K;(PKR8;]<8KF5-JL*$%XHV%:[+5;D#MT/\S%:<'VW6/U*@
MEK$*\-G^F([LPD>3X--.7<*U\\]"GSS]^,RM81>R*9.%8+QW^E=G=^[Q]D?P
M_&JT&XZR7TL"; (PDR9/4>(>SBTORV$8L9[5<@)D4Q.G$EU3<*Q.8L1<28L[
MH3U9%([^I+ASO'1;S?%BY_,M+8,V:4<2F(K,O#F^NURW[DO "EW,QEA' +Q&
M]/_SC]4R)<)-/K9UK:$SD(D;B85I:7#(.:UIN:CE<[/[ZVJ4H/8T2Z/>'YA!
M4,SP6__2P,/[NA $EF6H*LND+L8@SPIKF\WVLDH&\X[J/ OM8A!-G (#83C8
MXR+]Y'9S@]2SJE0!;OZN2B<A&T-"F$S!QBZ2?M##S5VZ:+V'?%'AK"IAYF;[
MTIS%0A"..J)N7,PZG9/"A<RVE[M\4Q]P=YBK(U+DX.$,U=09YMF\O?KII>?*
MZ_F_+M=N.,]KNKI0LO,<"^Q=O0MK!=0M5IN!YE<XWER-0G,%#".,/HAFJZXF
M@Z)H0D'V2UKMQ =MG_/<;8#&Q+ITI3O&\9_<RWB $GPQ'X;N<B4<?//!O+Y(
M?U$1:'6FZ,EO3K6:^8.+@:-Y><(U#J@=NOHZ52&>I8 85J*\P%>KC-_CWN#P
MH'LR-\M5EZJKJ]7PN=M5E<C*Q^@((@C]CB[>'F:5S -LSNE["00:O$;OZ>\O
MGWF[%U/5!T.X FA7<\?)8M.=F_K[6$H"E K3UG5=H\+Q^LHGQ+F#M2LQ%0NF
M'A+S"R^U! :9*^ET5B\>]49F6LB]-)D' U_(B=LJM.C!Y4 MEL4:(9E 2(#!
MF&#:]-XSF*R[6^X"U[&Z5&==$ L^W>\?]+VGY1 +W]3)U%C^"SSLB;MW4;OI
M>R'!A6'"7$:))>Q<R1)7X\H5=;KAW6'01BYCTM6\JFM&72FQ6B7?NCQ,-_;Y
MC8J#I>FNQ+&ON;2)!BRY8)728/KEQ29WWQYT7_4.EE/U^@>'2Y_4;55ROQAR
MN.&ERR6$A7<"NN>J'DU1F^")W9W3_LG;IOF_F/?G5)HB'>>9!';ZVM4JA)<\
M[NWUNP<[UTP(D%UUT5S4_8-7O==+C1Y5.HL77068=J'($O-H-CC]P*QSG,09
MLFK6[;_8Z^W/=S,<]SWG(E]B^%4P'M=_ET@YAN&7ZK]6:V)SEG">NT(CLBK,
M5*<1&X/U2!;< 6<?*G8^1>X#Q*Y)LJQB4[FK7"=-\VE=9@0#7I725;VON]RH
MMINX^";7STU0C,;1^8:'T_@/0_D!W9JFIMOZVJ0WS7X/IQ9X^/!>=_>:*39W
MSN=9&I>A;&G KJL9C9ND/H%$ZJIWS9-P9M8-UP];VN.YY?6F!>Y,0>G](7%X
M7%6]VNZ9:NL5MMKLMYE7#)T76UQV.MP)$E7Q-%04MQ*T#98-=RBD'^VWD+NR
M*TLABL:*78";99PI+^C<]YWK;XQGNSG1SU8CJ38,.\AQUK_5+__]6AR77_='
MHO[75$I?+L6.*3N+LM/?W*Q:-"4"*X=ND<?;9&,X2%YF&$W%CPL>YO)&QZH"
MVYQ<SK,_Z]VZ2^L56&ZMJH6YW-NK(P(HOEEY6(M8XW$=-I@S#UF5^!C,XTF-
MNG04Y@9M>4%G=Q$FJ*]VM</FR:#>(K=T:<^(R_ZY4+#&!2 O:O\%;5P*:FSR
M2^\^P3"37VTQ]S:7\*.KZK!>LU/;I9]O1'+G(KD&UZ_%\84MN"C$W2\=C#KO
MSD;0:^V=I.-E)_)UBANEYO5^YGL"-F*]8['VP>D&.@M0ZQV"OS^ZDSY&^+P?
MZ.255*=)/G[>"=S=EX[(0P-0'3UWLK_28&5CI!:5(QIW8QZ=:>S:)8-6E59V
M3G2UR\%@RB+6I;V\+0),VV7*M5G[O(\-KKB#LZ87T\6V^Z4M2Z8I5%1O4UJJ
MKX_5W4O@R]]<96R]E_*--<7K\SZ]W?YQ;^=DT#M8;#1?#N:Z:O(NP/39UNG6
MT-9.#R9/\;%:ZG'-52Y!'0* G^KD?9A4>58O.\\7K5RN=KT"K6?>T^.7SSP,
M:[J:<;4 ZXIPB\RFFF<L5699Y)C4Q3"^35BWO>Y\$2-S8>H;]QU0<OEMA^YM
MER,8>&__X*2WM]<]Z+[&T^1?[/6.#N&CYO%7N5%5IJ8.%"\-_'( ORIK/IJ
M^XC/T?9F+O4(4U/#36KJ=T9H422D+M8^69K-$A=A%I;0:?J-VGUTN-<]GJ<9
M[!2S?#X+&Q>P6J.O9KT<7;-._^V%^?7%8;=\"-#G,N#K06OLU(4EIJ6M60Z<
M7<'N!EV=1*")B]3]<&Q'G7Y1H$N-7G?-&0_DIYNN<.M"\ZN\_?1E>OVE5SM;
M-D4^IJ,4\-H[R7%#*+@+W@Z\WI*3L.O\^>IX-XS[+M8OEI[\U]%U?<&/ 7Y2
ML%'0[OS)51BIOG;)0:EOV;JNF>M:O_2*.Y=\(PM7Z2)_F:+MP=5)O.D9V(51
MB1-A@<S-Z0*-&*&S8%.R>9A\Z;F+9^ "RW*HPR5B+=8LFYH4UZTBWL!3+]LQ
M%X9K9N B^-Z$]ZLS(QSY:9:@KC'Y@SR9?,:^5K9>RW&=LHRU ]R!3M!4ENOZ
MC!.#RZS;%TS8O(7Y0M2PJKV!!8J6<@:<L:Y*';D4D,5@XIU?TJ&CW///RTF]
M@+6UQ.6JCM2MZ'.)YU+"/$77=]T7@-S<NL+#L'296XYPB(X [K9H.0"_A-QU
M-;SS?+*HH.V]MM!"'^9@==$R ;QVZY\[6')I@Q]\!$]!&7P3\WWNDK'FY+0R
M'VZ-LU'@FIQ69V=4!J5.S"KR+&MB@=C^R^/#=[V#3O=E<Q;'65,^IDX*LU_L
M<%SEG/5W>\^6%ZM:K2(_N4;C-J@,<S.MA-OJ5_^NS;WTLO^HVLO(+M5[&8(A
MKC)AYXLN=4NNF);+D=8P/]+19O5C+:(-1T6=\ER;R*W%)]X CU0LY#7?[.?N
M;-UKOCD J[@<8JW;\-Z ?7Y3I),%OQN,7?FU'5 S;S!)AU4"IO=TL#-X5FW3
MK(C I<);3>RJ+JAEG#(V9QJY?-:+)RI?R ,IIXZNN9S/967>1'SO?._]=.S,
MYB*=VU25EW=MM7.Z*I6V6'1S!=;<<97S1>7:X#GZN'3J7Y4)A![=<B6/>I>]
MTX[EA O'.[/I4$E@794*8E$@MQ3]=&\P>'9S%8!+5. UQH:3S#95 ;Y5X4&T
M7\,>Y%;])0U[Q185)%WR8%XT4:9R.JP*)R\G/1Y?#,_-PUA/CU]VG]6)YIA[
MM4B'<8J'=?\OUE^^E&[FDM)K;%'@]M3'2L$/KKT?U:Z=O(1'XZ%7J-L75>PZ
MSAEMHO/W@6.O,?!3+BS?Q=^]HYUJ8;'Z%#3QTR).NVOMV'N!)P',[9W3M]T7
M #JUK9M'I2[D!!R!\Y."GS[ZW[(I>KN%5PSSNF9-M690I;R."\#-^@#["HM<
MM?<9%B]+9;4_YEN,;\G3_%KI.P!PGDU'+H][."TU[EC(JR>ZTW'7DFL[N#MT
M56-N9# [@V91+2VO*XE=;PN;![C4K'+I=KONL!C4@7K+:#:;$QL\)P#+7)6I
MK!).*DE.50<LJ+;CY0V*U2EW5QC;-3V[L+-UT4.\L.ZE ZZ -E'YBOC#[\8V
MAUJ,W8FZ)4P#?=U!Z9_MA;.WZU,\%QE@KIXDGH[I"O.:ZJK+^P02*RM_I=E<
MM=^<.0R,P8ZM R=OITXGW\FK,EWS'.NLJC3L!;OS&;G4^%%U\NO019GJ0$Z3
M6#P_[A6#.U@>V&7SST-9KCA^@_M5V?T";JCJ6">88H;'(5>$,QW5.X>KPK-8
M^F4QW=TYU7BL;8(EI\IJG^+82=!FLRJP>&$QZW+,H#87"W7TNMGX7/X(K9[K
MQ#?"U:[KJ*'S0/DWRAIA@&-QZ ENA8-73^=I<TNV$RYOC.(%L,+!JM]H4DQ'
MSEK^DF-^S5 MIW5,1VDFJQJ.6'QT_DLUVI?VZ"55G3]G?9N2T^5L9(#VV_5$
MJWEDX)(] MNR! 1S(%H^M*:6FOG@V+.;S'5Y*9S4($V7L.SHM-O\!F/82*R<
M#<>@XF6UH<^X0\7=E'%GX,)SYH9KOO&E-E]5].!Z,[GH\KS(S@[J7+ETC?,=
MJC 8)C;?@+^74N^W,*)XCO/6Z5Z5%+IHJ)P? .7J+R/N="Y\OS2+YQXIVNOF
M,)9Q@\-;%P!D7BKZ0L6OY9V,6PB6;FL?5J \AA=J"M.U+S'FKO<A?G,&H,#G
M^RN62L<C1K@-H!V5F]FW]E(MG7[L@K@5^E8Y!AB3KG<FH+*].NTODNC_.KEZ
M:I13Y8O%0VM;JZ9IYM:]EQ70;5]Q)R1/4K@!][C4*?D+(^/J*]?<;DD=JR.(
M< IF;E/HI171:W?-5/:^LUN5/<6#A4:C*A=A+)>.TUZLV*2X\CGZT#C9\\G9
MS.+%Q,4:_"X'H+SD*P&#*=VK?JVF7PYLQDT-O'=.>=W ?[O.U[4I&HOB7Q+M
M1XH_U?("%4;8:8"KMF5+N\P64#2:EM>A9Z,*=[#P\@@3'*)-@L./U)^:'V?=
M:M+RDRLYN,!<U"<[N,.Q<"#6?]?-C:_](ZL[%_;95'9E?DS.?(--58>PJ-9"
M':;.3X&K+0H>;CE%6EWM>ES4NJCXFLO&WEHN2GEU_<>Y?=GR27<2EY'.TW'#
M.L^R7#FWXL+[ZL7[5IC=;J+^D^42\+BL3@\3;S&IMY'1\L&DY1HO^*-N&1P!
M6X_ 7$NK,S:O:IG;T#O")8"\F. )JS:;^YFH=;6.W3RG:EZPT,X+\8S/]:9[
MVQP-BGJ;3R<Z']JK)6'PRWJGY\6. P_""&_J(#RK@C\NLQ.3URJNAQW J8(Q
MGV85PDV2(O\\.:^B!7A:$:Z%-*D@^% 78V@F<54EN#J[+9/EI"&(5?40=ZID
MD4_/JGR;$H^<F3@ZB1DOLJCS$)I!KD&F&<T+<JG$46^WK3#ADJ@V"\$M#6P/
MWA[TCE_-JQ/T/N$A].!AE'-8.D(V.IH.O1W0IF&*/UP'5%MU#*\R/54&>Z=2
M6-6< _8TQUJXSSR5YLA8"U4OSV2S(0:@<V>KVK]D]M!E?@1RG)9>;Z^_J.ER
MC>"==#?2N"=I'!WW]ON]XV_(8U$"H;$RFY6_>P-(;[_WJGMR?#BO/?/B H8=
MU1CFYLRCHK#N:#W[Q3O:Z;>Q^W^#7J^")E^EPE58#1./ZY)&7_#W13':.4%;
M=KB 98*<GLU)6E-!H3E5:UZKI$FVN2[+ 9.7\;"E#/],R[H:X$BG8^?/7:;$
M-5G-5>5GNHR>9C7@Q%5(:7I3'[JUO.6MR"=-WJM[K-4N$%HV\<9J)WU]>E?U
MR]+==J@ 0]V!UY/ZA,9YQ3)7(:OQDPO;J6HC-NF2UZ['URM9K@1PKNO"+_/W
M_(3T/BMO+CK11%,OB,D53&KXT6+,ECC]TZ.3G>[R,<PMSP'_R0D*^NJ] L&B
M0];J]_[N'%]^TVL<*KE$ -Q::A,D7!2JJ%850,N6]H\V*QQ+T^*Z$F@76URZ
M_VG_]>G@V;R9)K>A7GE/ZFP03,/#]7)T+7&5^^G+E\?/%K7>7/'31:9+?1[Y
M18A(ZPOK&-2Y'+J%\J4Z<1HKP583*!V?NW7@9M+AZB-,YW)RM=#,-5AT837R
MPK!O$IM;3M<.QY-T!Z%]GG$*ZNL66)<GP<:KN6LY[!SN]^9[A0$,,%NI++'D
MYZOFO,TJAVTCB;LN++ G52.(TP6N-U-B.>?B".M< F0NDJ264_#KJ.CWZGBI
M+-<?X8YE/E1M;*N0?;[%9'Z:5E64$W@>>E+S#8*N<'-#3*]8L3K'M\;UI0I=
MRS:GR4LKZZ0 UVPFS]RR!"8(Y]FW%G;7L"H[Y@VB0GQ#$\[!TBIK1Y@:H.OU
M_T4 /0.GM\HJ=/LMZ@ARE66 D?E1.<&BMIB%5=IY 'I>8P'/N-.NS/ARSF!9
M&?AY>'WI0/;&(WE4/O5@L2)7E4L^:<Z_;/4H_.@[5SBQ./,35WWRT2*+ ]PB
MK-N*:R7.@6M2,%WNX>4*A/,U'U?SKZBJW[@D7:S)X7;5+C#GYH4C=T3HE<.1
MFB7:I@9Q4^_XRI+JC_+*VW?M-F;T=LSHF^[)SN_[W0-O#[[QNM79#]TQIB9C
M'M5.ECMV\W2OV]UY=F&/<;41Y.+1@_/67N[]M=@H\/_9>]OE-HYD6_15$'/.
M/2-%@!Q1LF<\=MP;05.TS6W+TI;D<9SSYT0#:)!M-;JQNP%2\-/?6BLSJ[(:
M "7-MFR1QA];)('^J,K*SY4K-37AC>ZT;GL1$CR1S9PHXGVW>IR:MCFZ+NIK
MQG&[1E3L(D:N^NE5N8C3*@[N\<>6IM.SGUZ>OC[_Q*8W-&7[QRT6]RLVD'ZR
M"_3X4UBATQ;P@M&_PCDO$_A2AR%UY4@:2- 2"=]J?A3<KK"H8BRG5Q62H>ON
M0&3Y.U2/BGF(J!ZGKI3RZ-55L0R;X\)@CQJ?%U. <(FHOV)'BG@.UM]*I]Q"
MK0&6RD(?!8KLY$Q>7<&>)"H6YI\C'TDA<G5-N;*!"M*_@G'4Z>8I&_V.*/Y/
M"'+]QZ<*<CT<ZM_H4)__^/KBQ_,?(GE8V943^/KG6F]ZD>I-M\Z8WT4T$]RV
M$*SD_;\/Y+>1Y&4/^<R?))'!%DUSH&T/X':K!YUW!2E[P,HXNPIZR,NKHEL4
M4VE0'!48XM4(M!4?Q%X&S5<=3=OB<@TEJ+"]F!OI5T&=6H=)4*$S=OS-=%0X
MXD_QTYO8HP3$'Q1PFNF6U0'Y_ )?1#N@=D+(*PPY!7Z#3@C$(Z/;XQ$AX\C6
MM9'?N5$8U9"1,SY7UDLXUZ;\R*;I[Y?OG6M1>RW9(\QFD>NS =*^J5^XT1FN
M[/SBE5SHOV=JJ[_)O<RHQ"[FUYEYS]S&E\Z</WA]^J^7#[<')84 L9R9S)A+
M'@16+Q'=S%N<3!V\L^R*HZ)IM%[)A,D[NWV\.+/SO&5F,6^(=4_U>)=?G%IX
MQMI_1;>X"6L<WG]% $4,N)4-L%FC]H@[Q+YD1SRR7BHC:SSL?@"H/E8;/!#6
M]#^Y0(:R@3W\X]@\_O+_R0[9!@R&6-YJ8[=L*V35X"K*_H(-8&Z#6#G.WPQ2
M !G/&'9%.=LN:B]^V<A$T&E'?3FU^PJ61/OY^-55!@G/V!6TVS/I\3U-U!F%
M<3%*? M!C1:)>_&'YZ]_>C4ZGT7J)2?HZRCHA<XYFE6])M=CZWFZR%)ZX:T/
M7Z%#'*F^$^">X.'&/6U4/7JW51 +-04VT'$$=I40V>B66 Q#Z'Z$UF]?,!7Z
M^YJ4 \'D-K3#@!8Y6U;,6M(A$+M_4]4URPY U,_;Z5KH1M'B2<("/EO8C[!@
MO5$I=^6B@(O;V6E-BL^RQ&4S#=\/3GJD;^C7I)D$X6/20)GV$:%.+8/WU[1D
MQ]5W&0R\V6=A<ZH0[98YD<U^MT8(1=F)8#/7+EY>O!K:,1@2PT>]=+6KG;"M
M'O.QRE%PAW".N_)RW5U6&M8^>/;RH;!IQ$>5&Q;^%LC81_IUE#:K A07_IF.
M^%-?+E<,Q >R+0E^<53ZX/+-BFY&B@)AQX";5)", D%V476>RHK?0;,LI\3,
M2($PL[?A8ZY[>04^^"SZP(6>[E7)%\C2RM8A#18 >:(CL"<;V=98)M_A I.J
M*5+CKQ1RL[:SK0RTKO>SE_)4Z8$&#Z"%&./+H&=&)K?8]ZS7_6N?=4!;[UJ/
M+,G8U'A8.$T4Q"[_$#)U57EM%UZ".Q$SIF3DP7^MI?=:^WON]FG]P%[+%PE!
MY4M>][B\2*37GK=^GT[+B(R%<^!G.2E"-EU:P&P:_-DH3!'9/K-RNRXYUNO1
M:$'(C:X3;I)@V6 ^N]N\9U6E=OAGNVC&OG[];?"^IJ,'X1\/:4>12[SLJ%O"
M[\*1&]1"F9$ &N/!Q;,L4FBTXW/OZ@9Q4'H,24,X_"%<G:$RX=-:23=?/R.]
M\L_5-HSB-]:6!H4%HRT3A-(S[: E]QN@RVY[9QLV>F"]%CO R80=B\>0L,D/
M=^T[FON"]IG(1\)"!.>"E>?ENE:8!-S+#>'4Z;)R;[FBPTWN60%92?"8[Z![
M%;$)#^*6)'-I(S":\RL* 6HOP!W>X^/Q+XDZCPB;;M,:<4QD88[H;'X]A^S,
M0(1&4EG[]<-[&H,G[/X.W3 0>@KD 53ZJ29\SU]<G%GD]2_#2+]"SN,\YCSR
M7LABA-Q%V&'MC_6N3Q\6'C!F <C!R>%QNKFJ:N.7%TH:C92@/1TS2S&=AL!D
M&H?(Q"S.H6K_\>>7@0$A4J[=+@ A= AAP72]&HA"(@&2J!+)(U#EU*,YF!U-
M2VQ&#UY]<RH7ZBY+^V6J %Q>/53:,P3P-D:@#VJ_N5Q);S?1^<C!!?5=P<N?
M'J ='U]9U&M/:]:M+T?6P9ET1RXKC>?6\%*B^0J1.V-%T*19CA/2D!/1DZ@7
MI%C:OC V["F*RF^#NE&M$5,W)'IR- 15+W/',8:ZYF#U%@KG(#<?6VZ&$+%G
MV,<T@>;%Z]/1U^J#IO%_Q>C1\:,GG_\ENJ<2@0OK=I<WN=DTEK$P>B*1Q6Q"
M(6D<#$_"]!&J#_4_P<0-[D_.FV,6XC E\^.W3K3!IXZ9WEU[KID3/?,QWR&<
M"VC#"E[$'-Z$247:YS1[)N,RW*+/=SZKZT5TL(^#&'QLE$'8)#^":L_A/_GB
M+]0-P_@TW]]E4.E'ZHHF6?"]=6V3(DJ[EM]Z&()E,!76WK$5U90'0H+?9W Y
MSFCG_8NCLU;R-K)M0X?"=C-S*4RZXE^36^%X7()1N#F:M?W B;C/$?N[*W;[
M(0[XXCNW1S,[N.Y,( C;@P59EJKZF(U?%!RCMO; %O9,-1L_'&5(\SEI6<[>
MP>4DJ9CPZZD\FTG!S@)*GMX?'OS43GO+:2G+Q_]X_-EOLFV[,]H'>L[?0/:_
M^%21BY^,=D ^;Y"3WI7*.W2+WPU;>@H'YS_*59P-[;+T,3PWWHZRF45B5H\C
M8=46\S3@&[7  +8@^L:P*7.6,H*#Z[)J#O[S[[:W!R[U#]K1_U,"[UJ.GO[+
MVO</"_B!+=9.A\3AZ+$@-\,X(*@ J_J1^S.L-M'=S/4>S:IBP6^ME\M2D;-$
M1&$\1DY_ E62SW4('U:\XT'%?.RI4!=G%Z-_G?_X_*=7HU>OSW^,A!<*1TI5
M6'$9=G!@[>D,(,'^^8\7KR\4.>7K][=U 1PV_:/G][]__FH'G\8IZ8?"+KYV
MQ7RC2QK0J<7)Q%*![_?UAV"7@=1PFV]=?NP+GF79_-U(D$-*YG?0 T47(N.R
MB56?%YCWWDX+5/TNFE]*'7OT35LLMN98#B?J^(J@ZHT0581@OT2=N(S 6_2
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M;IQ+AL:3MG$W N3O*'QUH=4C$_)-G-=QR^7I^/9E^48C.N'8=\L2#_NHO^(
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M;6+OV.IO+)T>RO NH1'.#25$2DLW5:Y]$Q.F"K?E*\C&K+3IN_OV+\LW.NJ
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M" #!(4)C(>SG,K;(+^6#6Z]E]X@G*N:9N1+CY-OL.)7QVX-Y!L'7"TZ!1I,
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M] TFRUD8C5F8J(4BQ\W>-2PN"J!(JEVP3AHVXZ6.20NO]^31HQV!\<_%9CQ
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M]'QT$3XP.CD>1;L@$R$'FWD\.DVI/>%=;]H5P5WAZF%AWC0@MF!A0&;QA;L
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MRM6P5Z>HCXRDSIIN,;QOC8B@.#D7 I4YIC7+HVW?51[2>6AMHT,A=B4./9.
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M7OZO8K'\ZNEH62V93S5L-/4*[C@/)['-L$HQ[:$M90ILX&H+O.*J8%PWTT4
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M=HMC<\!>=M8"D4"$N],!*_>D 9S V3R/AC3Z(-2H3"A[!9%EKHV<,FLU>J;
M=8*(2N!A85-;J&]J5 O:GF5,+ C1J!B&,YP1 I5KU,C.S.=L1[I7?FGZ3RJ,
M=WD4:W2'^(I6W)#F6SPP!9TOL05'H7">@5'VQ_!9Q I;P6:1T1MG%,5P$;CN
MG5QLLP:00G*NBR'<)2BNUTE:%>.+>N*YQ0!VW\@##H%',^Q-U>W5AB<:Y-"^
MH%MQS'[,' @L/=A ])71!6?#L]A+T,*SS[AOQ\.V: P&6 ".KHNW&]S+%Z7.
MDO_4/)%K>>-K0SZYA7L,Z8NA$44AQ(E"CW!VSO *P&^FO!OX>%)'$_Z]-+_:
M-DOYUWS)HU-YY91CM19;.9,7*#"@!WPX?CM*6Z<26Y+?GNID@TFD))=QZC[H
M\8)+N"!;WEZ*97A,(NC\\/GXBMC^X$)H_\, RSIZX=*L1V/:TA!R-J,I'$/I
M=RJB+',N8TU:)!I:_/@Z>Q0FF2TI4S.#?5&BU$]8^-5#;)T:UQ]1KRAO1YTJ
M7GA]-6V-NR6;A7[V3'5(TI@C')_@R(\<G)V>ZIOXX]"I7,'3I@B.!0C$"Q/.
M39U >KN)%@Y VCK.J&4&+;5))5B&0V)9N)_G0# ':?CDKQSL)!5'J36NF64/
M%_Z DLES9ER@G94D]+5-Q^WD\6D3^<B-A?)*;G5$@$L\F^J&YP#9<+11!2&-
MM#(F4[,?EE%Z3%6*:5'!E*;&DE"Q!0R_X>*OYQ3;Y$X)\OE)24UGE<M?FO!E
M7 .#82C[*Q9LA>>J4-$SH>&2L:BKT:7;#%]V0FBZ:?"1<=@_:(R$8./DXX?R
M%=B VEKR4&KYN_ )M\>0BQ38C?!0,"1+PL'_FILGWU&)FNFR<IMV]7 2#,7+
M0%F.?_C51?.2XH9T<BN/;%("R=*H9?H\;]DN$T:+7]^0/92Y!F-<^LB=@;-L
M9+OVA<_Q/]\[SE\W6_TV2VB?I"[U_=AZINT(C_\;M]KE#9<UG Q2V-'K >DE
MENP-2-(@I*!U<PIF9N:)C716>(9!:_CH7\IT75HAX#JMOF43+D[N=^2^-W(O
MC"V05LI&/!_ %)A)[)]=*S3:P0WMR/2 9-)CY[&T=EZC+KZAF6X!9+!+8V9T
MXO21"*=COS<U@!*G=$)@,PT1R3*GC!I9YV0/7<W3LQ.8#TE0+\3C)%=,NJ,U
MT=)=LL>CB38X&[%9UE,V1-N1Y,'EGD!3Z!FYJ6*@$"?:VJPQ,(@DK9^#7W1$
M>T"B";C* KA$*2) S#4<^ G7*K5=X4Z0/U.7-!6UF3G"4!UW^7T7$=<,HA\[
MPYW.C/EHB#1NE_44R\9U[ 4,\9J'=W-45$5%9K(Z'%?B8+V3Q*2R' R7PU^J
M*UOF$4I$A4(F>G U3\.C24:4/NY&J-Q#)=W^JE;2K4>*@PHJ_E(R_$D&39VI
M3/D@7_,%"?D,"_#^T@D#,P2-L[X6DT3C&5)05J-9<$&MWPU"73E.:3 !G+B/
ML-DW75> #] 8>G5FXO1NAFH=&Q7^\+N?XJL,WC(RJ7NI. P7CAO3]2++)FY2
M!)K[X>:#@\D4RPA4[$&)^,41DNE&+'Y,!HNB.E,5]@)RC8XAFZ!P47,;I[%2
M:>HK+N9CRMPKYZ?+KB\+"$T$3#/)3.58]J.GAIZIE$H!Z*0,I+:(>LNN8M?2
M.#>W98HKOYW) +;6J,;6W@H6G=WBFGCXK'I$MX,Y;/47!?)$+.ML1<MZ3[+@
M/=",0O>#K?X^K0_3T#6-NHT::[-+"3:05Q ! &%IG(]\3*/LE9?]DEIUYPY*
MR2ARBXL1V&AXFRJ%K3)5@M-Q*CL(6(^S1 Q-T,8%%S PO2B)9(>I8(^=;F^+
M=5\2Y;$8Q(8!)V&%)7H?9/B:#D$]:<9!JJ/:TG]B>QJ/*4;.)SH&2PY#EPYY
M=5%8 XM(V$U*VU,S4!%.S[%72Z5;.:LB.:OIZ_J97C3WK$[26/ +1G(I\0,:
M T[2B$(C4[*@\WLZ=VCV>ZE(:"0":D68\_V#T%9O3*,_,7Q\Q75M/,[9FT9X
M9@OMD(8DG)#GQXA ,< *EC1ER(4(^Z\WJ3>8"J"I-X:KE>P<YE]SQ(I @ I"
M+<VY+?Z-.BL($ R?",_M<R)L(8W\@8E.#T4NHP WJ^B;*7S K>$ROFE$SA^'
M>SO!5/ RX $_;CL_.R@1$RJ>@0M6.T^U5\ (O[.KY@L&6UO>"P8[]N>Y4QQB
M/9)H3*N7(^K>),T=NU,7(T0;Q(X+DAS4)VI;<721$A,.G#X2L4QYFQD7^>.(
M*LTZ!O"1*V:N$I7&B]2NK:4BOHY&IOZ()AR;PCX&E-3A <NTMA4L])% HHJ>
MQI4Q)M  QU[F!.IO*60?K NL9!ZYVWCFU+FWEMD*'NJB:ML%O9'OP*7."3_L
M=K:3PZV:/P6RDWFIE )(WH'3(C5?]8M,(55($[@]P!'*F<L])_7FUTDSO6QQ
M^L(E4_K8[^F-54ENJ+$/=#&+;75WJ^96LYCDEB;UAV91& HB]@&1S^M9KL_&
MVBYM,[#$%-!_-WU;MO20B=]:4[RX[+=1--JLOC-UHR'AC1@6$\^8>FJ8"Y,+
MI;MOU";[T)JKK4MAF-CT+L#]NDA(*YMBQY6D^G7PP,9D:ZO?= G82CFEFW7X
MMBVT:-D]2E$"V&'U<YP#I\(M(T8<93EB53B3K,R,$5WL::KAS5O\(C/6K=_+
MI.W<Z23,EECT-^=57JLK@A>@,KGN8@/\^U;5+HX):\Q(KLS"[\#AZZQ$&W.$
MUE2:J^"6)J$;%G+K5BY&1#VMJ('*[^DR<UJ\B0 1B=U-X\A)MBMLFUUX[?B6
MN:9D A'5K78&RDDL?3-,KU%)331<UI2'V5?SBBR_)/ LEST+XS$0V+)27]WK
MZ=>U,J2'U(3;("F28HSUWGJ$S6)ZX/LF[K[,1,-VJ"F]#BZB1C"PA;<I=EAE
MSB.6T\R]RD-9@W$.EPQNYV9S9EVY!DN0C="H-#,09$_2 B E9GR7DXGF^$;3
MC9X=X@5=B4ZZ?MT/.K175NHY4X$PE2Y3I21@'NKREBNM<2,,'M&M)I\X:8YY
MG*MBO8[Y&(?.!B)TZ:Q3ZN?PG_ZKIKTT!RX?<VDRS0[Z%V>7]9,Y\K#X"1Y3
M.]V"]\#1AW8"R9P&*KP[?<TF"\&HLZ (#M:>>\*+T!6X<U.[QW:\0J.K8KXT
M?_VLC$.37<!&8MT_8 XW+Q@7J)3A#R(Q\",&4,(G!XW5, J[7&!6.GBTX'RA
MQ&?OD93!+7!IE[A%3HLD181TJ,N%NYKE6'VK%61>5]@2P3I9M^0L')@@ C9F
MF$9N*W-;M)S&G!*>KEJB,$8Y4.::(U78S#PWEC'BB22-R]E*G 9M\*"7HLI]
MWRFO),/?%C$7B]\U+HZN='9C;C1:R:6=V\'HCG?R,'LH[T9@,&545ER;+EIG
MQO7FYRH",H^*Q&0;N"4CJN +<"5 G<X!C>F?[2@OM]-\23/OPI$*;11?QSS&
MA^88&@P,3#(#B&2L5)XP[DRV1KCTEF'HH9YQ!#J^+EE#.E@N% 3G"6M1J5L7
M&WPRIIMKVLNTNT"8*QF^M]#!4 &,C$"17M)X,"/%.#2I UR1VY3&$4_[? 'B
M(A.ZRD=ZX(K;7VD@?V"IJ0[MAFY#'$T@D7@H:-%H*E#"+9"6.#)%HL%+.,\S
M+:VOX!OF)ZSTB;WYW'@W#EY5HR.XK8T!-C?ZBH5U.2?6HY21R2B<F#ERDB2P
M]LQ<@:JUA?&X-++IW (;WJ9=*X^F5]\BM$_#)AI>&P$=';.8<K)?IU6NR\P[
MF?F#5<W,KZS 3*FUZ4I;,!PEX0";#F$+RL#<18D)-S2!K<&R=-<2)PO;8R=.
M?K.-D].<FXS<26"A]2?G[GFA1M',(&G#IZ?:'B_4K*YD)GS[\,$[Z\255(FW
MM'5>^Z!WC%Y IHZD;;2M:"8^SD#NH\5!T()-*>S'9*2" (T=D/A_1:Y!93Y$
M.2=0HYN,O /B-$95\Y(MES^41=9K9D*_ER86ZL@_\%YPY(+6\9CA!:\A5&19
MH#12HFL$5Y%SXBP/2/URQRE&ZL$Z-38RW?0*S-S0 8Z#OX#YDV0&L<-8S@M<
M+M+!9H@SVUR77ONT%@]F-)Y;/$>RB4#<R?S1C$<S(6O*/NCMYX6[>[=@/Q<H
M^_F@I@Z?-[3]F]>'WM A#X<>1&,2FUNR\/@I\"3 >PG/%?>' I0.9@O:'-^D
MYL\ DK#]>Z5_EJW_K<$WTA!$4R6= JJ\F+/$?+'Q'>P9LIWG8B[R0;N13#DF
M9:PY/'?-><G8XM.3_>Q;9;;"BP"TL9&6@'^7$?P11-':%[UZ$!0N;S63,@UM
M8'@94]T,$ !ZO4JH*A ',7QCJ"'Q8W35C6:MC-/Q^IGHM6'%#1< R4 LQH/I
M!9]S*3,D!+Q+I>."K4]IC&S0?VDPZ^6Y8H0^#:K+]3*AAX3K7PD2+^X1> @Z
M%C_<2D.O6E[%'-F&W9<58S5982*I.A0(&&4#6PY,.OCWMR16[?Z1@YMCYHC.
M'W;8>D:A\X/U4(/F_L!]JL[S^&9RTTZ=6 ZS?0-X[=N;;6MT"=N-N;<&VN:3
M92F$N--1@[7>^BTMV]]M:2JB_XRN-*:L>Y^<^M5"D<Q(U20ITT@+LIO.,UT:
M+UTRO]2!.W\6C-FN'3[.3\.3PE(B3)*-4T'T(4ACBP'>6F"LBW3=8C-=.R3\
M[Q#!&\2 R2J#-\IZ7)L@"[(&=A:Y[FFG/'M)%8)>*1)!'NMU6]RGYM3P8,.R
M']L?5H2_"FD@$(&=TMNB*R[*P'-B7"R$YRG8Y)G#BT/Q'<T8VLV&,YVJ8?:.
MVP:EF]D-? W*L)EU9;/MRD&?-D,(X]Q!"?G#UCH[^4--!7IH5)?ZF-B_YTE*
MA%5N;30JH#M'+'%;@B*K186*4<<*A[0+G  !\469SNS)L'M='-RL!?O)10*7
M EW)F/J#R/1>>(I266XFV45$94B+\XU2%J.<I&I+2HGK@]F,84THU>RA3*9P
M+1UU@4V.L*],X1HCO@6QFK*94#GEQKD+21^:ZN-0,&V=O$*)5>,\.\Y4ISC6
MLB!^\1B;BB;(4.4WYBMX2BRR',VKS3F'>PF++&<%MD1$<3YCF]=6(UX#@.Q@
M0)C$,J6Z"668,AV%J<9XQL(2RXH^"DM^](>?'V(I44P<=817Z1 4T,;AT>$K
M^BMK//X+_GP,!\4FF/X>VZ.?4 9CH%[^R#-[!UO]+2[*5AD583 .5QI=>NC-
M\.]W5#B%G[=! [QFE%T70930,'8?7G21Y-*U6,"B29H[)6CHN?/$(]_7TV*1
M+4M][9R$F8]-KS\N4*$AJW3@?L*]IP]K>72)"M]1.:46.BH.;1T49Y 01)+J
MGZFAQ'$M"&N;2F0K&L-APJ4>EE]24I1B!-J.[X85DV% Z!OX2--J$2Y&C?;@
M 1>H,60J3,L3#0]CFN-12>T>/;B"HYE5'$ME Z=T\$ZQ!33)Z[+Q53/?N7'B
MP)*-"1-.MZBG$$79:912K.?&*N]8A$_I%N:8JOH$DYLDYDD-1-,S-+-@=<ZC
M/3O.=25T%P7!H5/B;0I2E)8X5H6,M:.H#?7L;OTBR5F69_2[_B^-"0CO"%$-
MES)1S1#5& X"-' <RJVPZY*Y4+J%S"H^<RP"FHI'P3ZQ"0YIE%-G6+2> #W+
M$Q3>>)QV(C>E'3'(8:8D$3P],A\"/Q+>F$6]E,_0/>%0FLJ,6. .+3U5^AD+
MXC_F4?3/G5-RF,TK9YT+[^G*+ QI2A>&.Y;[C,:0"]PSEM'JEC<[KZ.4QIWT
MJA?\;NB=7?G6+3@1JC$TFN,-DK9N1@C1"')F>[-5UHC9\"T3P$#S81=0WS.E
MR)21P9M23JQ*;MO@]C$=X##9!G=L -O4-P @OTL!2M?5?&/&'VZM:NYTA>,-
M?W"A*CBE?TJ1EK2:2<N"]-$VT#<=:>&.> +YH&**4)XGIB_0K9FD<&DSQ!K)
MF$C2W)(0P:<Y@J?1\.RBASI5V%)6V5;]USI#C[HV8%$J^4O2#-I@2*]LG]T:
M]UY\\,*^#G:]!;3W!C';!B>_ULA+JRSG%Q  >8%&C>40W9^'220:%2 ]Q/0[
MB0R_R7-@@M=%S16%1SEX_CB7CUR%-Z^/\!^O0GR2&.0T4E(FMR-)-2"+,V8J
MXQY)4B)N.G_B-%>QLL+]G>4Q54-],8PKKPWGD&>G0%09IL6[(H.$FY$+C]\C
M;.A6/,E1,HYDS;1^_@QC&&227VEWT^L%8OI)W9=V;*2>Y_A+Z%93N[..782;
M2NSI=[*CUWR;/UE:;;Q[_0E7=?PE@'^]<D+=[^ *82=IL$$4CW4.57Z_]4H7
M.K 'C-V%*F8/0^:B-U_+':O<+?FN<<8.;'/$J;/@Z)C\-D9<5F:$ESS;/BS8
M(-B_6!^H7O@K.E5W;@]&#G+JQP0S57]N&[?/O\'G-]X*!GU2&%QI-&D"BHP$
MXZ0HJY ]2AT'+)3 C'OIO(;7P?5].C])YPIF+?L^\')P6[^BV4O@1!13,.W!
MFG&(#"08;>\<V'\\ ASX6@_72R,+:0_'@!$S/?+0P"BB<":1BF\P$L-C:LN]
M!HP8+T%>W.IZHH7GM_K +YH%PWX)-E;MQ09P6\ XYVJRR1#K,'97$;=)PG'N
M9?!C<AW6V4,>O\YE:]@:S/.(X>,F)6P"M:/&0P).2U.7L9@0#\%$W"G";EH>
M5<EV6X0 %-BY5#IQEQGV)^J2P[JX4*" "8JZ(]\C7"9'F[L>37?V#WKVVI.C
M[*5?1P+'1J8:F5%>3]$=HBR/?^!+<0=79IU>X10.[95AO&R\-SQ$=K=;BR&I
MXB?B*'<F67(V_:5W$OT$1J>A5\@\,VM&QCF%>LE16!BC() 4XA=J=)DS1N==
M/"ZMH.]37V]!&"U5>M4Z.8S""^0 H$O!]C/[:5'C95>V=$S01MUB1/+HI"J+
M)TPM:=US8NBZ^,IL1[?9')TG6>3W<1@\1KUV/:53UH<. *@D[A?CJ5-.NTO!
MV\3\*(5,-1F<1BZS$6MN1)7I&;(]^N2F@@? L7ETIPMQ66B@!N^ZT'.Y9<XG
M.+*<4!UC" E;3] UI7&$&MD 'JG+9$?&<1,(/9F6)C@+N@?99NNR*\T\)O6/
M_8WP:W15O*(U2D1G<53$^,04GF&C&O(,*?:S^Q:8 %'G1.5\5/-,J5P/BR-_
M/>%>XC_(AURR)X>)--.RYQ]R'(&JBI4!GM('+@%P$^-R<=6,@ZSGUGK!.N*6
MN=G@2S/D.BZA(R8L#B1 8?FAZ1#>S-^;G^%N>L"1;(;+W0G%:.SJ^TPN9UQ$
MEYE4<[-00^V!Z#,VN.59654=-XJZGV\^Z8,%8%LT>J[D*6Q<<*-;CAE\#OZA
MBY#J3!)2&!V8RVYR)@9Y@QQ!SLGH2NP4Z,XEJ38XT0K\T038\$QF$G.N@>T\
M0@KZQQH*SHX%=-I_3@6AP<H]8K0XB:T26J3H<&5-+4-?,%7^" %16Y0B!\:Q
M,7.U(>[E,00!P=+3W!)'8MFB![-"EACJVWERQB5@6"H4C/&P)<!.TL](%?I(
MSBDUU>ZIQ%$5!<[(4BJR8>;!/^FR VQURC,G,>PS&-UVK$&@#"Z/EXU#_V#<
M.![K2C>N@ %\FE3JB"F+^$8)Y^4\[=?<44D'>FL-MK5@8O,I"0VAO) W Y,U
M]-C?,+XN4I+GL4XW3VM,U5V_Y,1GB1M:CJ9V9:S&:@_7:Q@"#?-J%27'#9DU
MVQ#9X:0**HW#] ZLGE$.*,HH_"=!V+:T![YWQ/.!<2SD5Z5FY(L72LL)+%30
MY;47&E4!2_ $'P%(-LTE.VZ>Q^8*90]0<4:V)Z@A)1 56^/88*H*H;1K+"N*
MI*QAFI1G!=_]N:^R5H>E1DD1>HU#9$S01%G3.66,7SH]-MXXCCPR%Y43WS1N
M$]%B<$^.4#*0#Q,$I:0FY):A?0Q14X%"0*[/N:R?YZ$V0E&Z)9**>0S:0"K(
MG.;T.*XH!6=8TX<W2&9"7AG[$V@ *_@A'X\WB3P_D(-HGT0%16F)4><_\\3
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M:FT49BI,IIL6%7/$.O3I'@2/0](?;3L6,42YU@$-56U_7W%E%BE0IZ_*F^+
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MAH'^NI_1"1$Y!5+NXH4S?&8*+>"B^TZG3-1!%27?UW9GZL$!>B<:#HKH+I4
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MW\,YGT_0,YT&8A!NNO!?1X-*K?CQA;J,GON+48A18E./\J3_Y6(J4:_<14U
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MLG<>EQ)5P24\'"1R15^:J PN?HH7-TH*^)]H!-8CK7\492!H47[SDU$\@V@
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M V2]X0&M""3\S644S^Y&Q <.HH*G!3X6^$V.W8!HEXM'\#C@OGSI26?! Z@
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M=Z9/LLZ2JD<X?&B#X-= U#@7.\@9@4Q_094:32\I4#''-2'V@1Q%](T07O)
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M$R>Q6+^][97/?^4C#HMN^5ON 3W#?X/P]N__$_Y'W2&)]Q1U^9O^A2+?, Z
M=-^<]BZ)J9A<1NG?_JY)I_H@B^K_++(\'"]>/NS2)V 0,1:IDR?.,ZL[>N)&
M@^UI6>_OA5_DX:UPOA:SF9<NGGM]:U<S3E)G7*3Y%+8*B,8OLBQ,8B<9.TF1
M.K$ &8=1'()7\8#29G,O#3-S!<ZJIS_BZ'5S?6=[\M@7LOH0T[>ZSIUP)B(6
MJ9>+P-HIV)A7O6X''")G%$81[*;K>)G<.K@2"/+550>L,/5G)Z0G7G:<;],P
M@Y_\5'B9H ==]?K.3#T%C@J$MC,7*:H3%Z^,B@ >F<QQ%=SX#7KM+I_BS;U>
MIZ<NIB."0X9U3CPBOA"6X^=TW677&7D9O'J>A'&>.>,TF3E &/#5L>,7:2IB
M?^&,H\+/"WI-UG$^6:\TWZY7Y,WG:7(?SF!OHH7S:G!QJ3Y#?NT5[$F6^"%M
MWET(*\;5>?Z_BS +Z1VXM'_=?\-6-=?Y$/L=YT3^^!J?@9=GPD_@N_Y=>"EH
M5[P!]]%U;B+8Z=R1]5OJ;OZMOCF?AFG-O=?%9";B\%[=I7[6]XT39)?E&W]'
MW3Z.Q/W:U0'=X%'\].V7=>N JX3G3WEC8&,SN HHW0-6C2)G(3RZ<)Z&0!)P
M$&$2.*F(RH3X@BQXY/=)\7#6Y[Z.><(4_(:.!'CM[5T8Y%-I=MDW2CNS:V[Q
M1F!2%OGJ6ZI.RXZ$X-EE>3?L_YVFQJ:8B-,12+/OI]X8J/N-%]UYB^PO?RM]
MTBR,3RM;6/WZU<>P4SVQ4O,O6=RT:;^D"7#RYS09A_E*8@*+8 (;0AY&M^Q$
M[%;O?0)M/Z$OF-,7.'>@U5Z==\[.+LN:3!H$KRXZY_#/LI*[ZCC78$PHM03T
M@8),RRR7;(K26P+!ZI 4Y_FPT]4J3;YL2;M>]*H7X6N_D>B.HN0.K%PGQ$6D
M\".HN3L/Y*\T9TJOYJ-0MD\@,C\-Y[DTCU!T!REP=YJI'WV0T?!!I#ZE5(;E
M\+_>/'3@4A:<DYE-1GJEJ 3..?+FF7BC_O%6&?EA3*=%-U5=3* CR4U78'0,
M!\A0TFV0CY>\UB%>J\1C^&\7YYV+J][*/W<[J_^V[K%]^&/W:J/'/N#M;.'Z
M[Y>/;DL,YR,1RI-DDA\;QFA<H/?_H"GT/D:3\YWPQ6P$)M2@YY))]B/!I .*
M\US\>!_'F@K&BR;ULM9'G#]Z<3$&7Z=(4?+[29:#L1R ,[,6]N*X2E2ZG<OG
MZ_79 QJA4A5TJ'RD$53XL_#^*:+1^W'\3S%Y:+^%Q(<8@7"2= $O%O/38NYX
MLP26]Y_UTP8.#A\)**&**75DH@ KUTQP;&T8['@$1/>'8;/V6SQ<1Y&38)!<
M15U13= OE*<G[N<BSL1128HJ6O\Q%+:N\3BNGL7C:"Q9K'0WGG':\1Z(BI=W
M-QI+(:MTR?E1&QC'[FOT?MS"W&\)<3V*DW3F11AGEH+!N?72T(O7H4P<G@'1
MZPR/V]7XX_K;S3\^7O_+^?G7__T__K_+L\O^6R=/X8'AHYW._10)W1^GA/T6
M";]^^O;;5^=],!&*#K 8!VX+X^+8(A"]3O^XQ<(SQ*+V52P<>53RN6-1>RD@
MNIW^48N'YXU%[:>DZ#V7I&@()6P;B^IWGR#2<!1M$%A25$,Y2W7R>U.DW!NB
MC' R6$0XAEV.<P?#44GJH#V9AJ,B1X&1)US"),NKL%!J10$4ZAU9UE4NM*(R
M7JP"FRV%O&09]-F5+ONMEOMZT@F.%DZ4W-FN<"1N190YJ<B*B);*!541?DDV
M+?(@N9-%6117L^N?LX[S 5X%])=3Q?2=@&M\)-8 5M,SJX'5A=K*\J?PG5CC
M7E.1/(F2$980WR91$>=8K0\/]% "CQW\3Q$76)MF'B8+R98-^FLTX7SG=R_"
MTO\%F'8\M+1BZ*MB,GX ?'4.VS_K.*;\3IX*;KRJW%=5W;"9;"[0DOC0@D+@
M8>&BX#U8KX9O@=]@.7^,9#+C0CGU!;,D$!$=.GW(]?4-G( 7^],0R$1O3.05
M\"O3* "$+ZOA\?%UGBW#:%9."!]5Q&/O-DFIYDW2 8;$U,J93,<BQ9DE5/:<
MP*$70!].D2%]3('P01K)?9%/R%P*L1&%(W]DND(:?@V7 L_APW7-/N]/FL1X
MQD%:3$Y%Q)P")P7[8QXK[GVLR,:S2[!<5^2BAICDXH&VX7S0<O.]#-\>B!G>
MB=OK@QCT0MU*H=Z ;'8G@+:\C(OB+>-?48=YW]@+4^?6BPI!WH(#WH(F>7@V
M''$LF*_HZ/!%5I4]/@]KT;5H8,[V2G+!)CLJI,R,W,"EIG!L'BR1F#D9CS.P
M6D>+&JE@!<*Y=C+&Z^2WTZ8"]:;)K9C)'9^DW@R["K@:7EHWUO88NGF@7>%P
MVU&PKI4I>B'E?/:#@IYZ,ZJ"_I+/N::%)).M"!3-?G)FLPY;-<8$2D/ @S(_
M]>9+@AL8 )Z"FH6$%"U#\58<K&?@BGQ:P4+\AE*_"FD;+T!JP 88_$M:T@RD
MQFJ8 C;&,#$7*BN_/XPE:V.],HL!/)$I&&V3:?D(@6N LV'I\%\LJQ9 E#,O
M+ZT WAK3=<Q)]*FZE\F2&FJ?:7FHR,_.5^KQG,2!7' F>YA0-SVK2'B$#-AK
M$;!MC^%OSL=W7YP/LWE$&\>ZXX8,L[W>AP=%X?LB!6L0WOU;C)]<AO!VOHA)
M$?%FG/ >O9:M  (L+9^)3*I8<1]F))+T(RMXX,X[8'"?).')QW?O7L-#Z.G,
MZ]Y,W"7I=V[W,G0OVP5F\E&!?!1(6KA=B@P0""A]@7.(P^1AC@2(Z)B:%V I
MW@*MNYYS,D_A$4F1P=7RE]W7),ACH:UJ7!E\C+21:44C??D975U=T-TT!(T[
M!6D"NP,R"/R[F_?.#?6XP86YMLR8V7*S&9ES$F99 =\Q$LB1>JVO]YL%UY+>
M'X*-Z0 [CM%F"Q+=*2+/#_9KA)MI.V:R8X0LKM74@R8^;:6K34:2T<39D?2W
M,H1IA<<:ZD%2L0D(C]FB%J8)D9:T(QQ7G.3Z6Y@88=F@&4)2UCZ(YDQPA ET
M)%GA-3K2^AA00O"6C!I_LL*?NK;=R]J#OP!?#JJ9&TB5L@15AI_Y7^2=@3I0
M'"I=/OA$^ =Z2)@\I=VB.U&!F$LR@3V<>?9?0.9>1FMF/P(5)]X3H2(E1XYX
MP?M.(35]/U@U8:99I^T#M/H K\J[<9Q]@&NWB.FV0JD=!R0&2'2/C?&PK*C%
M&*[+B;'0BCYEFSPFTPS%;6!;83+8RQ&78:_<9]WOTIOP&I\L37H"_ ,%AWUG
MI6&[-^SJ!V'#>K]K?B8+4G5"<S-R9?UL7KI2B=S!?2A#M(%I? *4%;#.9@$T
MW$BK5TM%8,5@EQ@->^Z^;MDE^TF+W?>2/O>O5[;<;)JKR-8MZ%2T-C,)_ %$
M5HD!&9VCF+,!C:.7G?[9\#&-HX-AY[)[]N2-HU>=WOE%@YZZ_F_#LW8']F@'
M+@8OTI'</ZL.29!\O._YM!4YR6URL\U,P6X#9Z@_ZGS[41C-/^)-T\N;?/%*
M!CG0G=NL2:3=N9J=N]QC&;*Y"\+U+& 12G<K>_U4!+,?![T$W7O8G_M7@CE;
M-2SA,9;%06Y32Q4M5;14L9HJC@@(:$53G0!M&4]<"<D9,6A7, MCF?BZ%3JD
M\FPC+YL&CE^_58\%Q]\C[/N5P]\OMQW^OHNIIT<XD'9PV>DW[V1VL1//@H'?
M2KACD7!79]N.MVPEW,L<S7FG@;JGE7"MA-LS"3<\?V &<ROA=B;A!LT[F=U+
MN,/J1*S_XB\B$U[J3[FC"<OSDSF5ZJWRN3=BE)J-V!->Z+F]LVV984VK^G-)
MHCW>X%YGN)/]W;T\>:0865V*<)@$XO8NSEH.?,8-[G:V-<1:#CPR#NRU.O!Y
M=>!N]G?W''A82+,K;.IDX47YXD$TEPU<S3TD[K-MS;LUH#[/[,COX>YVM[:>
MGV9[=R\YGBC>>.#T<=YRW[-RWWG+?2WWK=RSBV[+?<_)?8],Q.T]]ZV? +[7
MO83U?7BZ*NP7JRKLNEP5=O+UE__AS>9OKU\_W'"X#UOT\/!JG)F)S8;-:KM5
MQ["4,MC%/EEC1U_UAF>E&=QG9@)W'2 >DAAA)6$/=6FN-N.4X4TK!Z R_(^-
MU=0>TNI#0I@AQ%DK@4PA9:L&>OB1,0++@!7P:Q0!,W@7HZEIB%W\Z>;3[Q_>
MG<))PB<%8A;Z3A)+T"=$),PL^ G"%OM#F/YWH(-,W)*H*:,;P5&&>4@2)[-Q
M6PV.&HX#3[U;$;G.3 CL 6:X"1\$1C(#NA$(XP0W3\-4#8Y@U%>:'4!]O_2-
M\836Y$594EJ8Y^1B-D]20@J#[SD-O(6#*"- KN*[1+Z(%PY<%"4+ 4MB\$/8
M5AML4?V9*!]HP%- 6>J3S%M*4"<% QK09'0O@B4;*#!Q+^#/*(R3,5R.&#EJ
M7KWO98@F@CW2B%OEA8$ZXY\2.;>7D6<2A!CY&7%ODOATZ8'FHUQ>1 +<]6>1
MAED02O2INRD!G*W9(@MTDF]!8+JZW6#^#PG( 9;FRO=I\!$_B27,B9?35QIL
M'TF#I:'PYCB]. :[Q!>\-R(.U/4>PL/@.</;Q=(:EW9C[O&9*OQ(^[FP)!!/
MB#5FX ;A[P62=.DP%$+D\D' EA51P)@/0+RP&M?Z1(;_Q#50AGCF!2#Q&!%,
MH4K !?+;\;D$8W'@.AE!V%J=O%[<&V"Z5X.+7DDG][KKE/*E4<IGC]/)H8$?
M;)7R^E-:MY4,#*BUM<1(M5 43Q5NI()1-1=7@0>K2*:,CY.+2>I9R*9N+0YA
MYMV2?F6LJ'B2:#A"A.V:*;!52V<KW%-#@RT-K#',D-5(8]7MON>\Z@\UG! 2
MQP0A4&S86E($80H'HO3 :D(H:2O/B>#,)GQ^\+Z<S1\)A!;<@:K*G%_#L<C\
M4."\)><F25'C2U! ON(UFQ)*/0:H\@B2>N*E@5)4<U!N&O)(*DKUAOI%9& G
M-(ML?M7KU)R'YZ&X[P2('8QFTX.\$VH:B2BY.U00I/IO+M73O;/JZ4Z^$)^_
M.X9@Q1]H/\X\@A><S<)<@5,'MUY,:,,*M#(7_C2&14W0IV ]<"L8O!,;Z86'
M=N>XB- <K2]3G*?)GX(0$'T"U47E,D)T<8'H;1(HMYEQ$TD0S1#\5MAD4+;0
M!FNC)JZQT,X?8Z&5,.XDG#[9%C/ONY#D0!"0]0=,H-@I@7?B+?!>I#IX7S@7
M^)7\MCL#"4=NTATZ;E$(9,08=P9$'1_#\)+LEY/M,TF3NWRZYW)L[=2)9GHR
MM+2&< FMQ79DSLM<<K[6C7%7^S$\9Z"&29CV/ 8YQOB5FGVQEB'VV]W>5H+*
M0IOWE4*;??ST?8W^KRAVVK42ZW?+2JRW0>P?_M#;E#N-9\RA133!LW(\F['(
MYZ%Q:Q5F9"KWS)ND@AR,/6?;?8V2-91VAR72O=@@0/8HRFUZRJI)IQ,J(JY5
M[K7L3T8EC@[PHDI87[%_2C=5HR)*2"B3=8W=>82XY<-N>3>:@UN^,:;Q X)[
ME]C(6W+H)PJR'3?N,VW!,OJSPE OS4;@03IR,@*/=2A28$%.J J<&,1/J1V2
M@')FS)YNLP3UM1RZ!(+N0TRKM<<=[T1>X]YZ5A@X\]-P7C7#?@BS>QER[+E0
MO*\ZO7[_,2C>P_-._^+I$9Q[_<YY[_PYX*8'3P\,O7>+[:_^\U/"6/>&FR"N
M-A!+[_!@JC>7ML<.,?LB^-4'NG,O@%]]J#NW%7[UX2-V7MMC;5?T.#[99K2H
M3HUN4[BXW =,IQ:>K"7DA_HFKUI";@GY  AYV%A"/@8XM5^2)*"2$NQ,"5.*
M\\F:O",#4KMH"(),"_.S>@+69;_7?]L>4WM,3RNW]Q"RYT.<>_$DQ.@]COW-
MGTI^[V^S_=EY0[ ,6K2)U4!^#0%[:8]H);3R#D_H&.SM&ZH8GY"83N(L#&1W
M-U4YR=BD<S(2L1B'^>ILR6%:#B?PGZ5O;@V[QAS/8-B>3G-/I]_;R>D<@[7]
M161Y6O@Y8P>L[5L\$CMA^,@A6JTE]V*6W&5[0@T_H=U@,VXBM57%7YS$8OVA
M[O.5Q^!P;-MW?R364O]B6_'8&K0O'2WJ[6;N2GM$6P3T=I@T:U58NPGM)I0W
MX9@@=TMEG6U'?4,.HAG-K[HU^:K<5M];#PXCX7>:V?S=Y&WN=2LHB>N;P+F3
M6]W/T*&>/\5[PD3BC@1I>"MB0G&+2Y"(!&/J1=AA2#AL<ELP%1Y6LN*9 OY+
M!:[%1O$K8>/^].V7_08TV)*4=-77!U,U<%.I&MC';=A,@MX)@P#8+!;?H!IO
M)YP.;/;J8J"!%%4@06.&$.JO@D4,Q)C@+&^%P0O!2S,!'X9B]>M<^"$!"GR&
M;YMYOBC(RL\T+!#!; 5AX,1)+L_*0<#H]K0VD\N,$0-RF(7MEV:V8?\KR85S
M[5"]6.^M\S4T&-[7O@]>([4Z?T[@:>&.MU0B@6/*'LN,B?J!RA$=T(M@-? +
MQKA"$ T$K29LT0_P6P?V_V=]Y5=S)>*@?"WF$C4=F_7?>;G'\)YAYEPS$/87
M@9"CW!YNNM9#T[5.SVG6N=ZD(?&S?8KO0?+/$#ZD 5WVX#WY199)@?5=$-!K
M,9LSWDF1\>'A>4]J.#R7>(^,:HXP_Q(OGZ'Z? (DGWHH_9Q83'CTA\+]9^L%
M)1I"]X_"*,P7"IE!O>RH+!&KCO&:ZAB/TB)IGK.Q17WI3CB97(179^>6>[<Q
M@#>!EUS/O9GG?)2XKA]BOT,<'?\>DF!0?RAA-LL_OK:05PP\"JFQB[<9 E3Q
M,Q!3";V42((X)Y/4FVF7A$# Z;\X.2,7K@,24B*)IM\%.$XD(T#X@+2($YP.
M<AMJD9&Z.(/#1WV)M\B5,245<2!2T$DTH4/A1?NPB?1% C%BT'>*P2?*,E0\
MO(H9.&R@H]2H$@UUN^BTM+F]_=7ORKDH:@"'RKA9QG,56!Z.ZJL7I)HL7:;+
MD](O7U<A-ADXC;']<#B'[V4XO 6NND.+V\OX_ ES?HPHYT1!.,0C"&4P00ZQ
ML0"%X([;)"K8,,%GHNW.>NK73]]^^^J\#R8"2/[LLO_6N48/W'=^]R)0=5\7
M&9H]R$Q9,<K$OPL\%]2Y5/I8E%#,^5ESV!$T: X4L5;B;#?2!C\<6ZT:^WD1
MFVTIX'14QIM5S'Q3*F;^%VS_>U7,_%.UF'D?=^9!,+97O:ZV11Q9OUT:-$$J
MP1+^7FEDEY31*XK#(ZWXD2L,X&*85 P;_#/CN%&0B^=H2>MC9-&NYT\139R8
M W\T!E.*C%'@(*;@;PE.(IL4L.0$M !\',Y8BF'?BCF.GJ+WJ.%*(?F^[*'B
M%*8DU5^%<5O$\50V"LW_,@]CA'-B00SWC(1:7:!,I17*0R%M2\M*!^^)S1GH
MT@[U8=F+/)BL&L("Y0S[CBL>@\QP$-A.*!Y_^%2:'6'Y24=8KFU2H?@#CJ84
M$]#='PQ.=QMH,8$6,X^E9+2M) DO39&0G@DB^1CA4WM-A4]ML%XNEZNC,KY1
MY7XWU7*_@U/&H 3^6<0"%<"YNVILH#='L%344SSGH#+WA:8)FATTT[F<$]06
M^&BGO,F?(R]^K3!4$=Y:WF.&3&7HQ@?E:8/P&.4G@1TIQU>I@$"@ OF<+5WQ
M4ND(RO<D0"(X+NHT]^ZUQXG9F[X98T>OI VX)S,?7OFJ/S1CLG *#HY?3(H\
M B8Z9*<,:$4)>YK6^2^@"0)H9.OA,<3CD@MQ)R>:5@A)6BJ:BJ[JJ$@?=]U?
M7<O$>V!YF#<7]["KF3S5G\4H+5#_@2G:<]%BXTDV3/0RH+".BBI$,[@P1 ,/
M>'5F_5Q#8X.S;OERZV>VZ#*AW\8PQ'6K*]/FM<T\U6&B:O@>/FPD< M3P0-)
MF%TR;?[PQ)S2&+[#I?IO=+YERN2A$-9O:JO%YT6:%1ZG<_F\=%23 [(]D%&6
M'.'H]JO+?OF7TD1_=56Y&'.5)99,+);L7;@F?V_&R'J2T]S:>!7^IXAEF  ]
M_B1=;!7'8A['R^VP;BKR,!5R-"[]LQK(PC%1,HQ"E^F[*9VTBM<><R;+?'E9
MYC.[!(H%AXQ)9L"3%98L<:3Z !.[K.=(&5$I,^8?EN?URM(N\-S'?&4UI"]]
M6G2@E]Q#37CX:#6L:ZI&O-$[P>V^15<8O@/\S7K]JT8%"R^-6&9VG*^-FZM(
M+MX_M(OWI78GK_E[]R:+KH/F+^';F9GKMJ8&75NC ]8*^J:01$W+3ZT/<,"&
MG2U]HO4=4&P=7RZK+9-/M(-%X-]GM]XD1 J"!4_UV!-93YCQ]'/V(41Z*^R[
M_<@+05?2('(:3^LGF(V1<I$8P/' 54]CL<B<B8@Q 7C ELB6Q]3K#:N&1$6E
M!61]J[OX;/L#^Z95@]_Q4;4G;@W8)<T#;!3'(L)T7$8F0J;2=/(OX 8NT=>P
MN@003VG5&91646_IXEK7<=5Z2Q2:%>F$TCLVJ5KA9/-QK"T]'I!,FWUV:17\
MK1N8K-?#1Y$*.:\X*P],IL\F<^=5SS)1$IPH@9EO:WRQ"BICV6Z(K@R-S]Y\
MJ#*N\Y]>+)T=]* UI>GH>20FL!3\Z.5MD6?G.K([DB[##"H=9R#&F-EP3:1=
M!0&E/8$6)^H=BH&/4YD")4_?JG'SLG+O5&.51^/F-/.^<=Z/__V@20&>(GH$
M-%WED2>/7J1F!!0%8=S$ VS4?';8]@R$D#]UEV6!(B^2.,3@]EQS>Z*ZEY4D
M4+O?:VM/EDQLR[!&UW<NDQ6''.+X0R53.8&(N?DL,Z+?J'1B;[;*,-$(;E\Z
MPS',2(K>#"LBT+ ;8_6YRYE*:R"6G,F<L5,/@G_NA4&U/ >I7[T"WU95N2B2
M!-;MN+9S$B4T+7KF+3@AZJ<%1?0"?H?2P^1Y*T7$90SHL:?LR7K!K4@SC FH
M6H;"'OW%:T19AY[[.$KN,I7VI<HD*1)5C=K">-Y&PF)11.R1JOYW$:8\,XPH
MD.2G/3&TT4G2_]8>] T%<XU[J8L<VB+TBO]<*LW!E2G2DQH6M*LO!!8AKA$U
MC9P>N#191=4="HP2/-AL>@!3 QM9D<R[WX361_*5L!P,G,Q1DJ:\H9A-:.A$
MON$YC6)[Q$2^L_/^<\R-&PZ?9\C=LXP/W+/%7F[T6(F:4"DNZ9T1@$D%=P (
MG/]M<$P:!H*TN3398BC=,0P=K)[_L.[\R_+H,,:DM:/YVM%\+[YS1SN:KWY'
M5AEU[1"HXQH"=3(XWP*]N)UDUA)Q$XGX[&+0$G%+Q/M-Q/VS!DKB_1J0OM;D
M^8-^$*OB1QO@\.XA4.B@LQ[K^@=I9!>?]-<-?* M8&'W\%#/.NLQE-M#W<-#
M/7A.78^3VLATU)XD1"AI7*O4L/Q=0D6:XNQE^$V[HDVV_N(S19$FIX% #)28
M"QI$C)W/<9)3?=U8R"ZM4O^.KD?SO31=2)2,4.T9KHI:CU6%G?7$.TSDI[(:
M/!64<*?4MTQH9J9:1;W< @Z](V#+(L7O"L0(CP?SQT6836V$$JJQNS0-$+)F
MKHD5+HTBM&T*7):Z!O P%_I".AU$')Q43A9?4"(E<\YM;Z[5F]MO:F]N8Q/P
M#2V!^37\=Q$&6.Q#%2_>'._$7A+@!'_W%6U4BT)U+!<=YZ.NO_JOS'EG:E!P
MY=>Q%RVRD+C;U+O<*%P*NN8+5SWA)9^TI&C6<3PW=:Q].>Q1PW:#"K3>ZP*M
M?XA@@C+;-#71N?Z,P!V_$W#'1S UBE1JA'8OE_;R9ZO8+<Y3S\^QRNO3*)*%
MB:KP31?"'7W9FPVXFHJ)ES*T'K6%@A&1F*T[B$JW3UB42FTLC?R:+6K</-FF
MBZY&$BO+KUE,N;S;N]BWMG#M(&O!]FJQ6Q6N-3H9<+519*H^TO8DY6? 1,VO
M/6OT$3YS;>&!5CBU575M55U;5;?;A(<.V(8QV+UM4=V1EG)L.YNSK4AJR;B)
M9-QMZ;BEXP.@XX:2\=;F4OT,YT83'>)?88\]+,2AW'SL+QAXX@0[[5=[:8<Y
MM_MDT-^\QK.=JO[BIS.\;(^GL<?3ZS5VYOV#ML>^R&H4S1G+9I&]=@@*;6E
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M7>RTZXP+S'H\H(,P6^+CWB.$B:1#!BIC0:!WG^$]G+&'R QD&U!29B3 EL"
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MO![*4CG>+5 =@51$2K^Z:(N#I8_+BD#; I4%"F/+6$GX"3$F5%(4WBD'557
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MA-^^)(_:A-_^G5F;\&L3?FW"KSEB\F>T(TYK38<VPW><F9$KM]=ODWPM*1\
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M==P$I].<_&>X?EV6\Z %!]DI1-9ZST8Z#ZZ!QNQJ;L-193[.1)6%+:JG$XC
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MD8?(V@S=L!H:]0MPSDR<":NUU1I[@5^5A@PNDZJJ7B!5"J&J(CBY&NY"1R3
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M_"74H!"H0 G:9$91=2ZJFT<>.RYF@CVZUQKQAR$]Z$A6?)0UM(^UI"Y5E:U
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M4*NL0S"_H#V2(@/!1&,M.5"@KO1?$P1K ,[7!+MM72!!+(45*H7#-:WJ1X8
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M1_R,^,AV!*?E%PVZ@QAMJ$$0YXW4+A<A.??3EMK+\<3L=Z_XVT>^Y6F+5PG
M&#1P8Z7IA/C2^IKIB;6CS,X#?7^\X]UIC8_\B#?V&R674^,_'JC#5.Z,U8J#
M";P.B/YW1/3#BEC%TW'X;FP/.6A_7RD7_+A1^<%!X.[F6Y7CSI/QE>%53ZXN
MAW*2O>O&GAS(8A-KW:PI"E&C*X*T">;*\>%%>+S?QKTIT5=)]/&Z)?IFI-X7
M8X^Z6TXPSU(3Q0K!^=Q-%/5_I5^7I:_#5/ZVS2/,WJSM81U>_FY='5,%MA.;
MK)+M>*[9/[-EM<0\O0RW=!Q$NPE^]>:P0*903;]+7+=9^)+V+$2YT=./I[@O
M0L[UC\U&OV*>_]4(Q9&EA'PECQXK:(**81FP#L[".>ZU#TI&VL[%:7(CH)Z9
MU3$Q-/R1,'IWF%V?X94T^MK'Q(&GNMWJ5U2+ K#^"'YS]%,@?2'_:+P(#()V
MF&#MC71]NF$LPX>BHD+VYV\]H7@=_'-&,TJ9[OJ-(S64<BG*:W[5BC)9(W&S
M^F+4LS#XY3H8#V@(__O#ZH-*=C$>743-M&5.9'&^'TL6!Z56=HR#[T]FNPY
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M;6M"K*@*2?7!J'YKZ.=-E0E6!GIR)H8S%A,JU=;:D#=HS?"[)L+C46G9Y '
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M[ @T5D(,2>Z0PB;G4JN @E"4* A%0L%ZH^#/$0KR7')JA0!4RPP0C E05C'
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MC!$NH0ENRG24,652*7FYBM:_A @C6?]J6?\X2/%.J,':2J#\Y/O0Q/^AC#!
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MQ(A2O+&=;67WH1VL'W5X@J!5@J %$.B>"224@.=!4T$[GRWB/!/< >,$!41
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M)JB$)M_89IOL_B<9"[31KDJ:XOE:^F,44R9+7]S2*P63F/D 01G ,Q5T2;
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MHN 204J(!UUA!:'8<4J%D5KFMZ-MW[^F_^GYLDFO"B(?53CG+4<260%<SG-
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MA[-R:S29-M70ZF%Y@\-R]_7F=&_6:V[_X!3&^-%+;XB*$HFD<*YYEI!U3*)
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M^,+7211\1A-'3)VXVTV<O@FQ7#\;]BE?>=L:.#?9%X_>M?[\!KF<C'?C%/3
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MUO*:;8['%OY:&&OK,/^X/=P\ROW5]M(57_FU;UU_T)^>DDIQ-Z*XG665(<B
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MKJ =)U$PD;5[T!6$UH#:9%&@Q&F=B/#67JXK5,_"PWL6!K#]SZ<>E/[B)>T
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MGAM6'1O5L7'?JD8%]&T!?5ZY(' JFYQ1'6G"B&-ID8L^5T/DGDJ-O<DY3ET
M]$MV<\SSJP$TO7$\/AG[P]S7X9QF\;*\%YT(=WH[&K^?KT>EII5$/VU^Y"[
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M=;3Y44;0VJ/!R"98!5@J@G2,&OG@ R/24_@08$IK8;3G"]-[+:%487KW6"*
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M5^6C<[I]\YF2KR@S5WZ,7Y$K/_O6;>4K+-FM[OKMSYCF+WZLZEIW_<[9_-W
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M78?Y);/5^6K]\2F<#3<\(DL7E[S8RV+1DYZ ;U+(?GO<E0,C+__W3\J,E]8
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MCF\D;-$HPU05IDS![#)SL9HR*!" I?*%[(9Y^W6-G8M'-#7R_;(&,G.@]B;
M-[<"GUV<1QI!*!%]?M-5&PR5N8?99*M?G9G;Z.M:<#I6T?[4P9_BR !]T7<I
M8/<J&/KI3YTT<P-&.SUQ+0%HO^V! ,VL<=? T(E6>;15*[+[!C#2+- XX9>V
MK,T@,.'G-STY,Q437PG#L19  >>O&YUXHP?57(N7^5N9TY@BWDE7*BP&,Q9$
MG>FBL>ZYN0!V$H2?V\K6[AOZ%)>NNLH36^L!/GS<,+G]^[(Q#+MO?^_MOGWA
M9B?$2;!NLQ/:EA[I_=&$ZU7/ ,8]>] JY?UBV49C'D&K:N7!7T.<C>!>=G,U
M/A\MQE9_XACV>]L(:[?.-)&M'N7<3O>Y7J-:CW7QHFKTEU8":3SJYIGJP<C.
M#,)5VTHX&QET?SXMQ^? 2RZL6'_J8*8PFMG5__45KHK7E)S;!YSQTLYW@3/O
M?[$Q-PL"TZ6@.O_HK;D=)[],K'#'3W@S@M9)X9U57W6)-HS36A3QQBS::5E>
M%Z[/$/^"PW5KI&MU1:C>W\ DN-QX;Y^UVO'=8Y\:%%8+H>%N[+\\LL70?G"N
M3:)Z9\![/7/0-K4U.^%N,F6[(-.LK3*5G<9*]7W>RVI[EIEQSWIOM5XS07F(
M(T7W>N8TP]^62,J6T]S;-;OVH*F">CQT.VO<JCN]0DQ62_/3C[Z@_-K@SW-$
MB[/&AL]QVYF_6"0'1+[,I[:2I2G6:X/5K?:8G8VU.H6WH>7"GJMV1ZKA)LM,
M\[\_UM@E7+=_4N19(2/.2<143&BH&,EYEI%"Z4BF8<J96!B9F,LLU"H0+$H$
MU4G!$IDKGH<%IY&4N=S0V.5N*^IF8UR-*0_<L2"4?V[GVJ7@;^)8S]49SW50
MGNEA.RZRO"C7MH%6M@5T2:$OIEH[05$W&87["XRC)_1T:I T35S&FO5@5F#4
MKNDB,=:#GP'O<O'5:E^OM-;:;&AG'ABCYASKPF86:=,DL@V&)N:V#:BNLW,=
M>'R[*KE3AVS "]HTY^S@Y2XP]RAXU:_X3K4'#K1MZG+ L#H?HSJ.N@7*_@FF
M0:VVBXC7W\:)][,>;!X7WO:L/T& 9C=#/DHZ=[1VW9)X-G:QC&<_.0"F"^ L
M'M**^'T+'Z'C!/4+VZJG@#4,#I4?(6YC+29TVNKIZ@9:SE!AR[JFC/O"N3H
MTXI"S-UH957Z,X0_]FLP][3P&(MW= F)'1-D]^D+CP\R'>\@$[<:T^I7K-=@
MBR=]T&G< E:2 U^^C^/RS#NYMJ>.;X6Q;.N \[E^*O.ZH_J9KG#/65-5-73@
M4KSQ/'Q,J74T=XDG-?6LR,/MX%KKR>,5T3D;C-(6,F-1"*&D0'F,..@V9V#Q
MA,' 0U3Z6GIUKS$W-'>V<)YVC'@C#19)V$XJL6Y;4T3;08UOVOVK:=-:V*FF
ME+PZZQ4HJ=R<\\474F-ML<A=4UWW2ZVIIXT;N70]YNR6A%Y62?/:JK8[T@[_
MS$:^[ @]W&8U391@W*E7\K!?)DZ  5&LI(-;^ J7&ZZA24Y<&T=J!:C\T'E;
M,=<FJ:J%%_^3A_^!W3%/.9T/W:W0H<X<L'G&YNK&'G$IO=;9=VH=:U*MC]_E
M6/9'G5Q?NS]SV4WGRX>7+M>0Q:P-*[U01,T%8FO4 ,,V2-:.P<!-C#E6=Q=Y
M)/4%X3_?%35'H]L@R@\(HC2@#K9P?HX@KHF9;,OVYLKVPK4JV_N&&,EB].C:
M\KWY4B/-HRA.TS32"0VIY!$%SSY)=)2&5 FQ6>5^U\4>3.C,.T@NU&4=5ZS=
M\./.6GVL-IK==&B,7;&%O\E<7>VX'.G+7J'1X\*8M&V0@.79/QE?T2%]:"=Q
MK073:;FUP^('EVT14&G9I*3MPW_"Z)O_Z+%&W;X>?'IWDJ0REJD,B(IH1&@@
M<Y++-" 9S7.5)F$8LTWMUJ\U<=U#^5,;H76+V@]M2UM=6==NE;,#-WR13-U
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M.LY^OPF@D:$%SP$_@!BP\]K.K'9D80WM5D-Y'?\PD88:,$M7%KO;<S-WXU3
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M4];=8:@;&''4H%JJ-:\#[?AQIAQT<V-5SWJ[=;,?!G_MB2[#R;8]_RXGT=X
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M"=*:'A=8C8&5:A[<1GWR0:WU\AIZ^R.E"ZS#UF1@\)8:V%,;S]I_[;;K8?L
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MMWA]P! F,N:)O_-8^&5=R?*H?O7JP+[1RXO)HR?.^&!O]Z1(LCS(I"2I"C&
MBA6>/&,D+!*EBC"GDLDGS\%Q74V=(+:Y$6A\!#:.T0>O=M_^WMM]^Z)W/)Z
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MEOI+?SRKO&9K:8,Z<F,2K\ G??C5%%5,3%>!O8_1&?6X)+SMW,C1N920KRG
M99OUNUH!;:BG9HAJ55#2Z\L6CTWYY^\3K/R1RF(;K%S-.O'AIP\G5($/G@A.
M:*J =1A+B8#?B1*TH(H!0R'KQ-$UP<K9Q$CK4;M^\U8M*W>2M-O@S<,0SM'Q
MP4F<AJ'B(B4ZE6!9T)217#%-:*$XUX*+(.$(97H%X7CY84P(+L_Z8)][@<);
MR1_\ AKD(WWS.,UH/+6Q&G0HEL9KKG3+VU9UY<WFA>48)P6?=*E!L&M=OX7Z
M-O^\<3H6_?-V-Q"LY04'N6]&/C6>^D;[I+<LY;A^Q. F;L*UH\EMY3Z0BU?<
M+8J:BRNA>&X(BC<M"TC27A)6.^:Z&]6%=(L3S<,-)((WUFWN=M"@(N#G"(O0
MXR:7!,82V"+838G)V,9X,K/1%QG$F%W.<"E,GK5K"E76;S?97^M!%,YA\0R(
M'P&WCJ:W';E^ ZH8\O(4'!M7CI(N@Y^Z&C\MR4(1)XGB,4+<TR#/19HG&4W3
MB$<173Y\H*O9WLHSK6:#5BEVRW^H?K]L_;:=R.XGLG\^D7&>)MBI*9F,L5TS
M!"\Y5@1#\&FL@SS(^(^:R)XG\5TFLN?T64YO-HKZ5A/9HV<L2>]SPO6:@/'<
M7+E<,>?YEB-_']%XV^6[Z'TP&W!L2::=WD@;8\]XDUY[W!;P]\;[M&Z04-\Z
MS_+6[[\N<%#?C!9^)YUY%6SX%6&"0ST]*EX @7K$IXWW_!RB$SV,/EP>';_J
M'^Z]O#QX_R$X>'\0?AA^H$?'AY\.OW[X^N'3?G3X?O]R$='I-/[X:3\Y>+\?
M'!SO7WS\]/?%AZ__]#]^.DT.HH/X$!&?/GT(/WSZ]_ _7U^V$9V"@"&,*"=)
MBN'H.&.$Q9DB<1J++"A23E7VY'F6+G;FW@T,_#8R]$YX2O<T8'BM)=*K3GAS
M55GZG68;_(03QI;--N")EF&JM4YHEB=,!&FD0QY0%JHTO *.Y:X!+(](=[F5
M5;>259W9NJE(PP 4#)&)0EG%<ZSYR$!TI6DHA2YX(3# E:W'S+'['+.R0>+(
MAN_J_,9VPLH/LYGNGKJL^T0W/S__8^7305L^*0WR2:<947G&$58H(R*CC/ @
MH2+109YAKWD8+ X3>[C!*FL'&;RQSN./PA/>/._RF\&&?X2D7%6QM#^2@QGN
MZ2K9^:<>*%.V>SQNW6XK2&\G2/]N"U+)(PI>:4"T"')">1X2%A4Q">.0TS3/
M)0O!*65L49#^A"##/\9COA9A=K,R<DUJRJ;4M)HOUVG5\ISS:INLPF35(KRZ
M5C< 5S]&TMGFL5P>Z]/+$]CEG,54DIP6""W)"I('6 (71RR+%0ND4-L\UC:/
MM<UC?9O&]<";VP35-D'U@T*^/PV4LC/OX5FGR6%T$!U^E8C4&J!I?G1\$("N
M^WIP? H&_N#LX][O_8.W\^;]/Y^.]C['X " [OL[.<+I(U]E<O#U[_#P^.#B
M:._PT]'[5Y\/_MB_F,LY%5G.@C 48)&(A% A8Y(G*B$\#*)4Q"$MBO#)\R3[
MYCCN-N=T?[RV.\3>IZ_&2+F?,=K;5-.WI9JVPY!^N!CKIJ,*%24!B+%0@ZD/
M8HP3EE!!M*9IF$DIDTP]>1XM:7+9IJ.^)W?NCY0NS'Q:,L !M?<DKAY%3FH]
MQ94_SZ7SAK<B[%8BK).QDHGB:<%CHC,<**YB21C0(HD2+@JN\J2($6Z2?K,(
M6Z.,U2:(L*/IF2[GB_BW1M8F22USA(?CD9R5)7QQ*ZON(*LZ22&1<YD7843R
M. VP73XBH@@B$H5P_/";RF2&LFIK;?U0-OUKL:OHD9E73S=<4K7^LI5/MY)/
M[]KRB1>I" .=D#"(,D)9$A#$5"=29CPO@C#A18[5B0OR:2'^O[6B[H<Q#_44
MF,B-M)CRBW8'Y",SIC9=1NVY8SSF%UMQ=5=Q]:$MKJ*T".,\YT0R@<74.B3@
M\Q4D%5F4LRQGA>)/GB?Y-XBK-;*D;ERFV$T9;,L4?\ &K8ODW)8I;D7H=2)4
MMD4H2S7/TD(2)E-): 8_":48"6*=<19E<9SSC2]3O'=^_XYEBC<=B%(7UFWG
MH2R=AY*M_SR4:^>;S,U#48(R*5G&6)Y26@0LID#6@99*!(%.B_92'@(^IIXF
MN  RNJJ U:$E(6P+S@E;R'+U\'ZGX](&9EP]ZQ4EK.M0BOJJ2?. &W!-XJ=V
M&*K7O)PV4"LM];:M3.U4INZ?1'D8T;1(2<A"L/I3D1,1IHPD.+ TE&DABNA'
M5:9F07:7RM0D>18%WZ<R-;M99>KM/DOB^($7N\1A\H<%O*SO=.4Z;$#^8!MP
MP]KD>:_S'LN8;V#8_&A/:==.I03A#$MI90&NZ)7XWNN]EZIL:XK<LC;[,9RV
MJ0<TILIK,[-C0T_<C%WZT<=M]V&M(AUO^M5GLJNP?PFL39P8;/C9V.5O$/'/
MSF>#';L>XO&1M2=<S2)+2V9_O4'7Q[=MT0T(]-9QTX=8Y#?;*H_SQ>\IPV=B
M-9GUW->#V99+\F,MST8&=I>8T,PM8.MNFM9;NW>^-;C 6L;=O[W\*Z!%$B<8
M_&%4A+'@12)#\&09%T(55PSNVM;8WR+$'GU\_^[KP=ZKLZ.]W:^FJW_O\_G1
MWM_)X===^N'K:0!K3 Z^_G-V\&(^Q/YQ\/'XX/S@_4L*:[CX\.GO\Z/C77CN
MY_A@[^S3T=Z;P>&GSU\/W[\\GZNQ3UC*F="2%$6>$2IR39A4@LA81W$6I6E,
MDR?/HW"=:NSO"4GEGJHR'M30O)*UEP81N8Q4$ >98BJ@7(><1K'F!<L9L+#,
MZ=(@XOPL434KT:B?YV_/L*]6QQ3?FW4"3\-^\5/]KM+%;/!7O]!;UKT9ZUXV
MV3$J$RU906*1X9B^5)&<Z8AD:5!0'45YG(7M>J@FEW,'N_BQ\](-QR?=B;LZ
M<Y2:>9;>0437L,8/VQ]-9M/-'W_TH]GFL&&;7-)(A)D@21!S0@L-&H^&$6$\
MEHH%(2LDLLWB$(__N8WS_3U\JO6[\I[JKS?%!;)=(]MNMYO/O9)!(7.ME AR
M&J2:QRI/1<!3'611%*NMX[!)8K0+(:8C%H+O1SA%7&MP"$F>Y8((H1,X]K1(
MN,%B7*/&M@>(5&VDK;/4;U!<!SEX_D)&DH8R96#/)#R.(PY$(--PZS>L-^<V
M!A <FHQXD +G!F@ ,49RGF0D$S%CD=!!B'U>=_(;-BZ2O)'\>4-?Y$X<N_5%
MOCLKMGP12C.6%H4B2<XEH7D&2C2)4Z*B0K- 2#@U<0-?9"U,^[7N7UJ>/[P>
MR.)N2<3O$"SY0??X,0)\$]_MD;FZ^R,R*<<XW1PG%X+-)L_,C$.EO^C!>(*C
M@[9N[RJW%S1I)@3/!8LYC?-08.N"$*S(*8^BY('R98\"Y.4':?%.IU\<18QR
M$1&9YBEH<8PHBB@G<1!$-).,%H%>-Y"7K:U]76_S_^Y^2P'1X]NPVSDGN<IT
MJE40Q3RC 8C(-,XB%<5@\])$\'CKG#R,6&LY)R'-\E"'@O"$@5AC >+!8,I$
M9P%X+7F>%!2<$_9MB9+M )3M )2'[RQ>1TB&>1/-9)^.S_CH9X-(_D'"K=-:
MG"BM9% (HN,L(#0)->%!D! NPEAIC=8[V&PT#3>YM7AM)J#\S(&!G_G=;C:Y
M9DD7RJUFM*S)4!M+TR#=QQ;\X5?8>%WB5>"\!6'>:\WYJV[_,FNT"3?OX;EF
M6W9GIT,]ZE_L]/9'\ME&[\F5#>1'H]Z1G([!C>F%Z4X/J6&G=ZY[?#0"]I2(
M?H6-Y(-QA?.,QD5O/.O,?<<_=?>J]]3__LL.MJ27_2_@O0PNX;D#928B\=$E
MW)5/?<@-6]='YB/@/]F';?GJGOMVPJ4^VGWSK__*:1[]UOOS4I7C4SWHO;VL
MIGJ(C>QPUTD/#(V9-/WN0UB2C>89FX/C1-T>PI[TP._4<EK9)\/Z>D-^V=,7
M$]@W/<*I3HA$ '>2NO\%OU1RU1^C8<(GEZ9COM3PQ4DYKN"N\"P.7RJ?]7!<
MU!3!5)PI9COLS31ETPP%^P.G.IL4Y1BG+//JK#>Q \KQH_^^A25'62HCI?,D
M21B5*162T9#F>9#$4B9QBHYEF(-?F1+_P[Q)U\I:_PK.JQI/W>>WF*'^!^S
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M8_"?IED2<<IY&,)>J%@(6<2K7<]K*16#8RM(THNN WB-X['!K7I[QDM]-A[
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MX+TR>@7O)D>2UHJ7>Q(Y'^*=1P$6F9QZ8)5X?7FKN^O*)[RSZTES]^![\^R
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M# O%55^A7$KA<Q=4:9('=)7801P6HH2WL)A2KM478AA?F;GLJ6B<-EN#X][
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M,\"FQ>_1CTI+!4;.9CQI@<7*.4(+MK+*'!Z/^H-19O8#\UP!U\GXXS)G-X@
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M]B]$[25U0C-!()HE/.ADD@B:"Y 9SE.THE;[)53[F9T7XI5E@6($V UJ3T(
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M6\+7"%6WNNV#EN>^K-8=UR=?WE:ZL >Z<"-7VET/*=RU''>>!CI+,KG7IQ,
M#<C#M?%:LH3G]5/P"MJ8W9O\Y^Y9S8O.X@]<Q&N<PR8\?_<DMK_%!@SF\/F'
MVU7"LW>RO[G]O7GV3VOO[.OWYKOW\!TO=G8;8G^WP1I'&W!=XV3G\Q9M7DYX
M'OW^M7&TQ9J?_SS:V=W"^YL?#IMG7T7CK-UNG/G3QB8XF&<;8F]WC_SG;'NV
MITM,#&.?F?BT$HA+[I%.,2%'$O;$4R7 QUR7^FK)[?-L,?;,3-^-Z$SOTXKJ
M&1ZJ6WI0RG[([DFOQJ*YL*@QBT4L44%R9:G6T2.>M$)6L8B<H9@9%XQ* K!(
M7BTN?;KSZR_KX-:-<,-J.N(EA)O#?HPUX,P%..]G <<1)023!CGN#3@_PB(7
MHT4*<Z4"I])P"H!SS5;OTS$?OA+_AM?^S?(!SMO>J%_CS5QX\VD6;W PE',
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M!GOQ)(+:79T2^'ML_9*/$)S1K"!G/XK]WOKEZ/6[7S>ZE%FI:X_<)'6]MC^
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M,DDFY)D-R1+E83=V]L@N7K3?;KC?OU:QT"]?>O%+5@?. >LYT'-:RYNZ\03
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M_X>4%!>E?SW&^ J 6@+LS07JNUF@VN# CJ,!)2T- IQRL .$1-(QK;U5+@4
M:E/=XD\3K,T7JR74OA'L'LQBUWG%@LZBU5*"N$N 7<D$4MGY+9DDC.<,F16T
MFFUB..O)A=HKP+UH=>+-AO[3Y+M-!MFK13\ZCSU@L\Z7(<.- NY@.Q2.6IJC
M/M8XZAW^;))0>=.0EMHACJU#5L-?!9?<.QIA[QCH%Z*I";<E\-X,D^*A8\1*
M-/XQP/^EKJ"(S\%$9J@-*- J),\(,C1)Y*6D,H*!$45LXO3O M[' V\)V3<
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M8]S;Q!7A,7+EJ<USQ)07S >C7:+KT>#*_(]'X-MWE_7Y'X<_/HK/6F.C./5
MLMPA#ON*'),1$1&PL'D89\([>T(VJ!79TT?K4I/_'@[7,@6DN7!]-PM7%E@
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M8'O)Y!B&[4X (_LE(KI2DE>*./,SP-$*<.37(9]=__FNT[*GIZUSN&XW]%L
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MZ3>Y%5KH"M?L*3=(+,M9:I5*=E03(DZKJD8H^15W5*O!Q([.6!\ME9P09XC
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M'$0-SP$UG)N[4 ?BUE/KBV6V,>[Y8\(]G#A@G601%=P#]_" '(@/E+S#%*=
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M%/X]W-[XT-G:>,N_'GQC7W<^B>T_ONYO?<ZK?YU;]_UL;0 NC2%G<T2-G.,
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MRAIKQA8^9:XT45GL!#<\1; SI-%<\,0"F'X<6+&937\W7#G=A50ZQQQ#D0I
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MRXFR_&MHX>'7ZJF*\&-\K?HK*$ON5T277UOJ*9OKI!&MQO -XZM;H;+S][]
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MFG-,K-5)Q4@=O2*B>7, #<O=3M5AC,^B97^T#T>'KWO]?N\8S@I0-;PS/)G
M:/-(8?37?^]C?_A/UWXVH^T#CUOT'[C'6PK_'FX#%-[:> L0^!O[NO-);/_Q
M=7_K<U[]ZV\ B5E>Z]9/@,D;>V(;8+&)PGDA<N0D%S];Z9!SBB&&=1)8.#!Y
M2!XU/FL*1^% Z.2S[T_8H18B:<P.+R[EE-] 9 WW@9+V.CT'6FUPT@T )K-L
M34 ^AR L?!M>=[;[;5")42"%4;^2A1-M2<S+K/E8=;4>$.U)UI:E]!WDM?6.
M2MOI93$8N8/HAUF>>0"NF8R!2D,YIGN092Z(M,FZLX9H W@I,MC,J\]Z.PO@
MJ94=61"V^9-[?7M8J>/>: @"MQO*K3C_R=#NP_U+N1Q&/E][3)D C"K2!"X"
M5%Y*Y4LWKE(/]4;;O7XL-1E<]#^C=MZ=<JN.,P@[/(*;E?MR^L#?8]>"WGM9
M [M\?5NDJNRQQ!;5!S)P\_VV _F?+P!?O64;:$X!_&ZRXC?UBN_)1JO@LXN@
M1%>+S0HSI'8?].E_1K8/*CR3<Q9O+_.9]&.UU;"M\PA0;9D5S)J4F.+4X\RA
M"20ITY@G)^SN1KX#)IB@\A?V"Y+T0SRR)R4V GDZ(>&_,P4W@G,B./TN%DDK
M20GR@1"4F\LA9X5$WB03M/%8&K:R1E:9O$)PGA5UE9@8#3)3@E@!HS: 2.KW
M#J\3"$!WZT?]=N>4T,K<L0JU5LAO\CZ9MA%.N;RDX$J(C;))D+\S60-<HY_)
M D3%438"JY67\+@V!:<%WXUDV':W:,$%J7YYR:*SO0-D&$KA5M_M@M"#SV7
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M!Y_$%_C<]L;[GZV=#^W6SKIH[;R%O[>^?3U\"\_E?P+0K!N4P[_KN]X(KJ4
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M QX =##?L3+K!9Q@I(PISBPV1 O%K24B<")=:(YU@6/]N;?+N',@4"6*.F*
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M0C'[2+5-%,GH02A:V' 0. YAJ@#MJ>BM!Y:@LYIY3W69R7TIYCI^HHGT6I'
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MA&>)$^!(A!&N$G4L*&V]6RC&]L"-\W?;[/3_U>V#P>YW=F>:7W$F6M_Y=&3
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M>Z6%"]$N<6EV9=]FV8 ([2/5P21 &Z*4LXZ+H#1F2?KD>&7?*YMVL;?S^4B
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M.9/:1L^-3IRRX+3'#HR?8JN-M*HZOEE7F[Z8V'3]^,AK(<&!)HC9'"'H7*Z
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M-FID)*<H!1F-8YX(#7 DV/43ER<N#G3K?EG=43WU"&?;>U]KML^&@R+T%TA
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M$:$J&O$&;!@+'XC2VF,L>'2YB)GRC*=<+M(K2NY-W2MK7;6U3JN74>X422C
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M!,-9^H]892B2P7/A0F)8+ JQ+I58=Z?=:,.CI1Y%\"17H6G/0%''P2#DD\]
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M/GW1'/]1,[7*L.##4S 1$*VEL0UN4#,^RV-D>:+AEI/QW:'82MX>V_K\I98
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M0*'N^5#W+;4FYPAU)&A RDM@.%#01A$02"HAM1=4) N+O,%:KG)EZMR1N^3
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MN<C=W*=T'#WU-$9G 4L?@9E 04L4P1L5)35(.X.2%9-\MJ6+02P#'?][H;+
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M4L$545GF1W$F/1GI-9M5])C-='X,6(>VD]!CG>43]*KAQ,;"9CV,SP;#HK)
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M42($H!\+2IC0E !&\"1/XR"1Z3HF0SV2$V*MX<!7^NO>PCKY<<>Z_9#>B,4
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M:,(QP3#31'I92C,FH]B/'C,W8&W\MU])'.BE62_-YJ19QA5(JB!.?":I$%0
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MG5PV06:O47% 7\[SR$P<Z2#).!<I3R3E:2H 6<<Z\5B4:N$%R;>H".Z9^'&
MU<YI%*DD]1--&.5@%,5A2 25P,0L36GD^Q&8L,C$_L-G6O<5/O>?%WWONIX?
M?W?N-4;Z%I;N"^ZB]10=6'J1_0"1_6<7=PD-1Q6'"0D] 2*;20HBVY/808\R
MD85A%',4V=1[K(&C:Q,J?41'UPMF_Z?HX=*S_X/8OX/8>!P'7ABG) EU0JA2
MD@@6**(\Z8?<\P)%,V3_D#U6+Y?O%5N\2RKU_0VV_A[/#3_?T2-9UZ1<OYR
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M2/I^'(<@=D-)'],W^&U9NH]?KT/\.OY1D=R=ILOUO=W[#L#?;&?6(X?T17<
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MHJ3L!J(\& ]0N^"G#0W"1H,L'?>"L/.>K^R>O&2:^WQT\N$TCH07IU(1+\S
M(M<>)X)'$5%*1#3+9.!3;V,[#5>2W(#?J)KA6P.R389D\0-+J9Y@]C\?[_UY
MFD0L"3R:DD3%$0%NUB3UA""1A(\C&F/KLXUMWUL,J=R"8GRV-3@YUY65.'PR
M*7,QG0",U)\O\E(/X'3R0B$H'EX/A#[+QV,48_D8J<W?FDO5A.<C0>7C*;=V
MQB,@8H=*:;"51(!<+XK*R-I?2CV$AUSJ7^L!+\8:[OS0V0I>^Q,NP"R MUOY
MDWF+X(FPM^^'<QO;^>]Y$XZZX&>:B%+S3X1G8%O_PH=7_+K:^-?LV*-\3.;V
M</[U5Y^#_>_<L5HV#&GLA4' (Y$QJD+%DB0)5!;*)).^IM3*%OB-5CLH&:0.
MM/9C+IFB5#.99H'P5)S&2,.QC%>>Q-/:07O3$@G>SJN:EI/SP7^FO(3=1HYJ
M@"=*W*&>F-E6DY(3#6\^N;9]P@;PP;@"L6>84(*-R7,["6(X!/T^!9AZ42)"
M@!\8J@-(,"K@F9<<>&]:@?8OD/N*JS'<OYJ**E<Y?*6KAG7Q 9;GX1G2I%0;
MX3\"$3J0@#DT_-[LIGF1LV$AX*D:#J@8Y=+<N:S.\PM<(([>NG%Q.*++7%6G
M;B. R::3*3Q+3"O808 X#O' @I8N4H%Q/BXF@U)7T^$$Q0E' 62F<9W9[1E@
MW.LC['X%XL>BJ_/B2H.-O@G6_4CC6@U2FK\OX"@$_!PH15^0Z44];@SN3Y16
M4[@4'R-XE5?-=^Z(2GN"JU\>KJ]/L+NVRA@GW+V/(8D2MK?$:6=+AJG5CX5S
MGHX-PEMS-7V 5+UOB/K$;97YW.3PGYSS\<'X$DBA**\;=<U>GKJF1U\.3Y7V
MM%!^0"1CE%"5)D0$/B<LR5*/):EDJ0";8LOW%CO2#H15V)L.\9?Z B@*-K8R
MY"**XE-C+ECZ53D8"<"%$B3>2/-JBH3&@2<O+H:@M>UT.SZ9XM&8GP%7:K Q
MC%62 <5>\J&3ZARG\9E!7NM#C^A7GJ?%O^H5[]0+[E#G"T:+!U>'>^]/8T\K
MX>F(A%[B$YJ!<9NFE)%09IK&.HLEC=<I:M"?[EU.EVN=9%&4@#0!@X"&GD^$
M"#P2>XGTE)_&211M;$=T4;2L]F#<W1?]P_BP$16;T:&Y<G#$"+TAZ'5C$UQJ
M(T['^LR8$@-]"1<"R1D%+O0P![@!DA?D:0[_5UD\-<P_(9R"C\<&PYCO.=RQ
MK!]0+!^A"L@)GHP_$0@/8(>^:+4(''2%08:\.D=)_ACR^2G\0(ML_))Y]_KP
MR_YI*F)T=F.VLR<('(1/F(Y2$G$F62R41UFVL9VFR?T\/X:2UT1M]V1Q.[(X
MVI.G4<1YZH6:A!G(=:HS@(IP*H0)+JE. SR3C6WFW].]L]F"2+1C.1XER)[J
M.TJ1"C0!_'5+0+ +<O5,Y^.>=FZFG>.]@],L28(TXXQX&+J@<>01M"\(J%7)
M%-<4CFQC>TEJ5QN^ ..\)0EGEB[3.7=R.J\B15"A%R4<> FZ?J"F&J^MO0C7
MFI>#Z20'K=AHZE71DG/TN(SK7Y9Z6!,T?F,<@[".)6]A7[<=,3G(8<TVQ(*_
MG(YKK6R=$$7I5E#/P#7*W9:MPT>E/M< +2Z;.]IH8R$_G1=# !S5?P_T?Z;H
M!\+(#0>M/]99?F=S/V,LC0(999&G0'^D3"<BB5GB^P&/HX"?[N$9>#Y@P8=S
M8"VYC6&_VWW) _..Z*4'CGS)G ?W!F7N:Y_)."* M4&9QPSKNU./2)FJ$$RO
MC'OAQO:2RJ5&:%L7.O+.0)[S\NS. CF"P_=2FD4RS"C./O%#GR99($*5I%P*
MI N?.;IXH"+OR6$U.1R?')Y2'6:QII3@I$NPND5*A,1"8@X0SZ-< K]N;/LW
M!/4,.?C,R)#[4D2F19:QC/MQE-+(8T"@4L?:#Y- )#+R#46D-46D/45\&XH(
M#D\^G0HODYC5@B2 C<Q"05B<2I().)0D")4G04"$-X!]2Q'IUN#Y&NA_ XD+
MXTPWRGB,K7. DM#;61;3L_/!JU+KP4G)E1[\ QIX\%:?Y<;UCTY/=-4/=@LP
MEP=O<\F=S]0H^VK@>]Z6A^%+O.= ?]:C"\,^65F,9A" A3Q97E9P&:[-(!&#
M=MH@AF'+:/D=ZSL4^&#$V!@GLC=!O &89^;EG*EO5]]92,4OX<?5$Z"#6\%R
M/ ES$'@.]AB S0_JMWK)_!X=GNR<:I52(1@EG,:@ :B(B(@C3B18=YD?BD1D
M\<9VO#J]S71JLHA@W5! ?_Y?.?^/^Z<T8EREF28)SK:F<:I(&J!5'P(?<A6%
MB4H! 20W0 !+  X#K)O>[VG@*S3PY?UIRB..=$" $T.<M!(3%@64!' ^-$J4
M!P8Z=GY:3,B?IX'46JJSB@._NZU:0XL3C&-]A0%HF\+0D%9NLGNTG%ACW67Z
M6'LD<2:RLXO7J&=<4-?.NK?\"4WSGW$KT!@?P5(K ,UZ0-#;/AWA&ZM\.,7=
M>:)R![/BKV=MOM'E.USYH_C;@I7\VN74]I&.8[T7Q[&'GP_W_CSE&54!\R0)
M NPYK .0VI&."!,Q*&S!=*C%QC:PW!*]?4M]O>)X[^=][X_W]L=[<G8J:49I
M$B=8&86@+ E)*D-*A*]!'T9>$-$ C]=?DHIQ>VV\XH2S5 =^E(*^Q=%I0J=^
M0AD05L@Y5TJEYH07E'%_PK<_X2\'IR!D8Z6RA$2)!@:6P@<&Q@S^+$T]*I.,
MI]2<\&+#\(ZNW7$)_)CEZF*_UE5KU.J<;0J*\LU4EZ YP>HLG#GGDF)_''NN
M2TW5P=B^$;[0"T9Q[[WC$^D?G9Q]/CJ1!M4G(8^91P.B$\T(!8!'6)PQD"=9
M2'E"O0![>2[I1K_$JC/0:P0G T "2Y-,[E\U*V<,.3Y??\^MB@K7++7A_1@S
M.<_&&!8"IOG-2H8?OTG4 R3O]3'H5B8\1@.P<Q(5 VMXG-FR!)KY@8(CB*0/
MK!'$B\.*&MX 6C@K,< V[>RQ36YTN[S95C]QD[/X8Q#'R3F?_%U,A^K V%'[
MII +!"U<\A;X_R73SI>CDX-3D*B4:H6=_C!)481@*&OM$REH MI;@+*+P5"^
MH0AJ<Y!G@W;O07C@=@^X*YF;EJYZ#NWF.NWUE@6D:Y9#T\N?!1KR#C^^/XTE
M")I8Q42$8+_1+/4) *281&D:QCS@GHHQSSJZ(6_F&\N?IR..7OZLIIVC+Y].
M1839,3)$9ZU'*- *#D?.2.3I1 8@@X2? JR[@78>7?ZD]Y(_][,Q>_GS,!KR
MC0[CD0Y"H!POC13@'X4TY*4D2%-?AU$:>*:A07!#A/<;RY^G(XY>_JRDG>!P
M[\.I]B4(&@]$CY=1,"M313A/! FH3+0?".:%'*><+7%+/4C^_,],PYI'<#S,
M4L.[*9BWY?5Q9E-!X+1W30GHF1[+7%<G\*S?AH7\].)._>P:)4:HO8!E/"#
MCY@SEL&I!UE,N)]1'; PS1B?KYK-_# +P8S!UBG4DQ$+/8_'*HR2.&0J"3<&
M&GCI HW\<JK!PC9$ =L]S)LL2E,ZUI1NHYM!CY7YLRD_7"F ,%C$*Y?<4/VR
MT/)HE<L!Z  >6/=KBDUSNZ5EQ%]]P>W_F;@R-E?5;?H\25@0OZCT+_4?O]:C
ML?*Q\3N8'\UW=)H4%Z[XF;&M*/:Q_MEUFW6W=Z716Z8T>JXYE?TN2K>"@*[\
MVMOR5WYWTVU]?XO%[%ZWO?F[*.P7"X;_K6[[E4$:Z]EE^%[S(OSH-F_UI!-O
ME_<[_(!IXOMC+*RN<?0 (/3,B_Y8QWC'L6D_Y>,:!%0_WV;ZR1T:XZWYV2/N
M>*PWODWK\N>T<S[K=^Z>.Y?>1;BL['=_WSU9NUZ\OS50\C<^Q*J:NXZ\>K&]
MB>_\_GWKX1?BC+*-A(NKX]_WOQS_??#Y:&__ZO#W?>_#QP_1\9XQ)8?'?[\:
M?CCY<'7T93CZ9W>ND?#''?KAY##Z\''?.SS9N?IP\C8_^OB)PKM>'__]/OKP
M]U_G1Q]W0GB'3__WI6X/;R:VB"23L8@4B3!?D3(=DQ1[("KMTY#%(J8R6^Y'
M_X&Z"-]#!C_E',U>@O82]-&<N;T$_282]+J1H'&L:)@F(#QI'!*:> GA<$B$
M\CA3G,>IE^CED8!>@O82M)>@WTF">CQF$6>)2H*,)B V=:@RS!'U=2IT9$<R
M)WVL= V$ZU$+3T&_94(+D*M1B"VZN22I"A5AFF:Q%T1A%&.JT";8%+UX?6FC
MHI=O?9W-76&/1&V&Z=4M@*NF.\BDL&U$.MU''C)<^7G/6WV$I/1;"<J#L6U$
M4[VMD^I?E<5HUY[1&].*&JY^4Q]F+U?O)%</NV9_!"HP$#%(4Z% N JJ21K(
MC"0@5[50GF B6]HZZ'[S>]9HMEK/UH]8.]ZS]3JP=6N+^G'HA\##1%&*F=4!
ML'4"P"G,=!!I+U4)]Y<6K/1L_6S8^A': ?1LO09LW;&"O(0R+P/;)_&T1ZCO
M)X1)#[@\DXD4&>6I4AO;R>*<HJ=CZ_O&29^CI7$!O.!: MW+R%BR-<]0;#VI
MD?$&CZ@76@\46G]V38PDD%HI&A 6F$E7<4R8$HIXL4K"-$OB4-"-[<5F*/=S
MG:R1\[GGZ?6P,'J>?B2>[L2Z&$CF6'A$BI01*ADEJ18)T7&:"1'R@,8X,7$Q
M6:!GZF?#U$]K7_1,_3A,W;4N(AYEOHJ(QQ)0U%FL2"J8)AYP=,BDE(GP@:G7
MB*=?0ACCK9U5AJ8$]@C!JIS6N"BR!QL5/ZXOY*<UM"KV="^LOI6P>M^U*E)?
MIF!*)"2-L,DB#7"T6AKA7'&::9\!VM38.V+1KEBHENB]FS\B1W\OFZ+GZ&_*
MT:U-H:-0^5*F)/-E1"AC,>%>$A+/ST!0TU"#Y-[8#A?Q1\_0SX*AOY<]T3/T
MMV3HCCV12IX$<41)F'B:4"^)":.A(CIDF>*15IX$AJ;A8GNG)^'HEQ"I>*<G
MDZ$>F5&R9H SF!.F!<!T<EZ40/+ZI44F?APCHG-V?\/1G9B3VVD/KA=5=Q)5
M'V9B%&%(A1^G) AB$%5<^X3#_R.)P'GV<,9*A!O;2U+W;R^I>E?F&G/VTQH3
M/6<_-F>W5@7PKX#C](B(L3\@9DOP0(<D%JE*?!7I2(EE3LV>L9\%8S^M4=$S
M]B,S=L>Z2%CJ^S1-B4J"E% !?PFA4A(*G:91Y$59*C$$N9@,]22L_1)"%>\F
M?#*=F'F%PWR43VQ_+S-8QLY/ZP,43VY;M.&D&4GU&ING'6<[%Q=#V#TQU.XL
MC[/7S4GVXNINXDIV+8PX8#Q@4I& XB#(5*8XWSLE,0N#,).^G^EH8WO)>._>
MN_DL^/M[61@]?W]/_NYD1"6^"#2-"0-&)Q1P!V&QKT@6AY1YL>^S)-W8?@@8
MZ=E[C=G[>]D9/7M_1_;N6!O:#P)$721AIOZ<9H1IYA$:4B$]*I1&]NXC&=^M
MX\.^[5W\L-YSKB]Q"/NLBBFV%ZX7WC<&>;0-6A<A_^#.(?<?)-2W!WE\\7S6
MM:[N/X7JAVT.\@BL^6,T9^J%="^D^Q:C/ZR0[IC(]Q[5U0OI7DBOB2CJA73?
MQ?39">EN$=B]YYGU0OJ>GII_F2%%VV9#NY.15L]3,@OR9B7ETXYT_EL/>*D'
MU51\Q,ECDV+P?NO=UN"5AOWCP^Y =%X-KO1PB/_;^;3(!B-T9UZ8$4]\HLV
MJJPHX2'CP<=IF5<JMX[/K<'?."'Q4J-,D<,ISH#A<$/SP&SQ@2,^F>BR&DS.
M@0;.SG'*8FSN#HN%1\%^X[QW<XMF*G>[A&$AOWH[;]62ZO7?_/-PT^7BGNN!
M_BSU13VQ*Z^JJ;9E?P<3;F;2FQF <T]J;^4%SWAJ^,'8[%"%@\W4X#]37L)&
MXC;9L9G<:(H*M^X*:,N,$('-$=?F5X8X0$4,=HMI.1F4&GCYTF0^PS'AS+#I
MQ.WT[]-< 5' A>5%8?,6S.<X!0T#\-WMCLV1FMI+0RPX<,]\;(>X>TGW^Y;N
M<4'XA3O?3H>8Y@:3$G;**5)#'#L")<?@-1>XJ*+,-3!"W7@&"=@,#K7OY:C/
MW;ZAK8.W[P;'699+DZ&Q<W&A0:V:=W./36>(NET[[!S\/,O'R!E-2M, &$-.
MAW:'2A.-@ ?G8S@)>RD.JC3EJOS:7 \/O<O<RLA7?B)DZ@5A2+6.4AV#W1;1
M4#+.?*\.J5 74O'BT'OLCKTO-*OK_A,._PQPPJ%/I8P3K@FP"U9R93X1@<=(
M''/!4I\QH#7L/K=ZKO?@8CBM[D0M@>0I%5*!11E1%DB12!8)YDLF92*#Q$+*
M;T$D!T;25)/C<3/O4E<[4I93K5XV*7S<.:61CD(>!D3[<4"H2B7A7I82&B5^
M!L>5*":0%&X>CPN[FX^X%2]VLVM5B**^U*-\XF3/:@VQ-=B;ZKK?[X(LL_,Q
M*]WH B=.)2) Y:;N=B9BWE68/4)\^-9T"@2XHU!7&Q'5D58[8_5^/*VF?/BF
M+"Z-KGS1PHH>GGP "F5AD@%QQM('"A6"$1XDG B99%J+Q-,:A%40+?;*;"@4
MZ X/#8D+:+$ <,91(>KR4L\UF@8"<QKUV>.T#('6^2).LVRE<X-2!F_UI1X#
M7^Z<(1>^U0"Y)H.?WNZ\_7F0@:IM<$N+4GQ_!CMW4<K?NI4%:S(A6U2??SG2
MDY8)WU@P-"G@K5XP[[V_.MR3IPD/!:-2$,9C3@ U:,)]GI$T$%&:\$Q1&FQL
MLQMP@I/G2"+Y370'A)$-<1 V0'Z\"L6YL+D#1O:C83INU<M 3;5MM]+R[(!G
M>$.@G"I'([.VTNSXY&I07%DV!^#BC Y8U8S6,>A\VIG'7.F6?!]9X211D(8\
MC14(,QK$,8L\$40JH5+S!/YI%8[O/8;"Z='S(S$%K%6>ACP37JPDB406$QIZ
M*1%Q0DG&5"HB31$V 5-\4WVTZ(IZ! WEM 0-MI((-$G=Q>@7LR30!VXFM_,F
M=W[H''1>^Q,N#">M_LF\&^Z)=*'OT[F-[?SWO*R7<\'/-!' +)^($3*_\.$5
MOZXV_C7K_,O'9&X/YU]_]3G8_RZ=O2YUH &><\E WFHFTRP0GHK3V(MH',MX
MY<X^&<[PHQ9G3,[S<@[L!]XLS!@7L,Q<.E].%U:4^HR7JE8*^C.L<]P(=H<W
MZ*SGL/7HH)/0_I1/S.__*'+C.!H9#**Q#S"(-WL_L POAMI8*1,T62YSV 7X
M_(_I\'H0^)MNV:B$ZL5UEV/M'.O<>3*=DH9!$@<T 62<TD RKE-0T"*F7N))
M3GU7HY*X&A6//<#8[HV8V^F,#U>@,[X<GAQ&1Q\_P;H/ %1%019''O&],+05
MKVGJQR11.HS].!5A&H+^6$R%LD&4CA)9R5Y6LPQ1N==$B,IE?JQ.JUW^G@']
M@,6FZ"V](Z)A0&U,R"CV/"J\D &^42GPI(XSZ3-EJ<\AFN5Y>#WU?5/J.][[
M=,K!EDJC*")**#"GTY@2)GQ% A\$A#+9DG)C.PZ^0GTS4OH&9 ^T>#.ROQ&=
MKX+TMS$'GK,);]G5(OIV$W!'+O28#Q&F=UF]#6]I$^?@1ML58^=8ZT2_]&>X
M0:5=O.QN5OK]TV]OS?:- W>_5;UOZC<&UJ]=O;UW]SW<=_\TE:&O1$@)9QZJ
M&J4(U]HC.N9AR#S)@AAKL!=536.J<+N3AKG.RJ*J5I$;-\U.P:34(Z%+*RQ"
M!YO,I7<AI?LG"?:D] U(Z>CD[#3.?("3PB-9IC7F;8/5R[0BRE-,RR *?>:!
M/;580->2TDH*\5F-0)R3H@'"3A[-"K.E]'=7?__#R[D?G=3V[<N^9%(+CO<D
M]KD6L4@3DF1>2F@8 $0)4R Z!>?!:>J'7&QLWQ"1,OX58ZU51M/QTI+.@PVL
M1R@2[JGF\:DF//QR>.IID7G:!P&E$T6HT(+P@#/"-&@1.)\D@\/8OD'56:\<
M,W+EAXHG]I1R>THY^BA/0Q9A\[@(8! #5.1AJP<1^/!7ZF>)[P5AQ@ 5L<6A
MFO,>7)MXD[L!"/@I^J3NKKQN D\+4FRY!MT<Y#.8'U8DS]'FROAE46("8R><
MWDDZ6FPP"<94B1\9O?Q\;:B#B=TQ7A5CV)YK[-I?Y;A/QE^(&^3LVC$L>> '
MS@"&&Y]CJAA<,1S6/K]N/A@?DN8@NBE>=;*A26TT^8N+>[^)-&0S)R12U!7F
M$4Z'RCD)C6_&%9C7U-:QI:>=.$]7>!GJFEX8%7AQ41:?3;(&O/*:F7=U0.I@
MO"J5IWK;G-<;=UPO6)Q]^'Q\\N&415FH/"Z(BE. 2UX0$\%!!?IIE-$PT3SB
M;&EOS%J:/6,FWVM$F<UL:+W\R#H<>/6ZRFUNJ.4PO!J]4L#:1H2#M2,G"^/(
M3W;_V#%RN=3_F>8HEZ=CI<O!NYW?!KY)=FUNV/CU?P @ 9RV.S4^U#\*4>W(
MR7$&]TP.@>>FI<V., VX6]=K!WH87><8]27SY)>CCV>G0HC45W%(@E1Q0H$3
M"5><DC &&Y-K.$NE-[;CU3RYB9GFPVF57VH7-QH40-R3?.1TC8FS6D=H<QIP
M[I4L<X%IU7I87#UCQGYEG;W&U3O08V2S&A<-'"1*#,=? =Z:9].:A9&=ZR1I
MC,&OVN%F:B@*C4DQX4,$"Q/BLS1NU#I6*^0JYYCY_=\#6-889(D5+:!RC1;^
M:?^_^.CBUS<_.XBAX1M]F1?3"G2QTIDN<8W&M6[RX;M^VZW!3F73!*9#(T0N
MX4GP2T /"J0*DL^E@Q VXG.9XZ*M>]V0T.P[8<!RK<' "F%TTKP&7 !4L"/E
M=&0.4+VR)['OMOYUSD4^S"?7+U@:'82XUJ,OGZZ.]\Z^P/\_C:BO!..:Q%1+
M0G$X#U,*Q).(PH K%84BP92N53.*EWOS!JVK=]9869,TOYZH'E/%4<P-]!GV
M9E:2Q%R"BE,4K&A./<)YDE'?YW&0!AO;:;0XX&F%1[B6VZEQ!F/=E\PON&E7
MFJ'I:@.(@-:&]1D,^!G/QV!-Z\]Y9;]'?3B9@ XT]4+&6*H#CXT2J.M='F0.
M?0\',B:G'@-V!)74L2_A'5'[H/+9?P/?NM=YP00IKX[VWI^FE/I)+&(2!BD0
MI,<$V$$I_$<D.HF\%" 7$&3$;@)=KF@!+7O1258N+C5:"P.#0(C!'!<&";>%
MA4*?3<?N%PL4AT0*)H6A.G=<E2LJY(T!#[\%:G8&R#J2XHR4='G2;^M%OV#R
MFU&R\(R#TR0).=,1MI#U8@)T*4')\H2(A&4JTX"5N-K8ILDB*=ZD9&?]@EN#
M [C %1@:J&OH\ +37I2+V!H4:7U-,SD :TA@CZ:AYTW2%TR8\AI+O")*PUA1
M2CPJ$T(%@CTO#0@3$4M%&">)3S>V@QORE9$2ZP)N50R'O"1*CPL3:P!*<U8-
MY@K49]*D9"XSRJQ[LP"9F$^,FD99"9;018'66>W,1%MKN6W5?4[][)7/,Q(:
MW>YCYX '.PL$EM'W<//Q)7KC<0'H/'7BOGYL8\0YCU !UY4SBUD!89+-;CDQ
M_A1_!-H %4!SUS,]QIPF6P1M[K_ZK;?@&1-=CJR"P/6VEMV,V[<Q(Q$*M4BI
MX\#BX^N.K@&+&+"3!4Q+WMP$PYHJ9EC>!#.QT"(&(*;R#!ZF\<"LJ[S26-=M
MHPCP_;@ =6>HR?0\?<;NB,7V"GP QU7F6 G.K2^QNJXF>C3G@N@X_*_L/1K0
M #=QPKP9+ R,^/NP ,  LG_"QV<F7/&ZN,(T9OB%%7V#GWX_>'UR\+,Y1$M<
M4I<3..\5E%5#&. $.*:\.D>_@4G]00I#(KDHAKF\'FB3QV>K>F:6=JY7!;S,
M4NH$00.<VN)ZU$E30ZLF)\TBJC8%[5E2B\F,WP?A!])3#K!L=HJ5U$-]EE>N
M5/\<=D-H#4PX!M:Q9;,C9%IS'$;JY*:@'^1EU>29[Q[_=;!'? ;X$@@,;F[P
M0=U:P3J%=G?>[K\;@$XUWI\*-L)6[!:#(3?)[H>\!$(,DD[:5H,G$/XV9;YK
MXBLRJ/1<F_>"UVI4O1^\.%T_D^G[Y1 S?5642D]KXNN$$2HUX$]/2Q)Y"<7B
M^RRB">C]K<54WP%061/G7B"LAKWA?W.=;;I,W+K9";"V_<)\?H:FT]@8/L,"
M6&:SECW:=>0P*M7] &5)JS]  IGHBZ%1-:TF3EJ=YT/=P%U4,1R[:M<YB@O/
MJZ^<\$\: ?,E!]%YUGC5.R'23)>.V^I.-S-];3;=2]8*V,"ABSK+'!5X<>5\
M$&#CF1XRA57'W0X;IHYE=#$LKO'SHJQ3FFL1#9>6A8T^Z;8+C?F53<DWV-^:
M B?H#3'/1==V9<6RJR.3O#KO( SC5"XN7 ZUN12O,[U& '(H+6!U(/S/W/?M
MV8Q!:!.$'NC7 X!DC->MVY2C&0Z,9*A3%;-,2I_&GD!/GHX#F7$O"&B:G/I!
MLM$1UJLEN272H^D(A*Y\! -EUN[8;5\.;(]=\S*P?1)H;B^OY+# $-@)//&W
M82$_/;EXD4Z\P.].WG\^^ON/\\,1B):/'SRXY^</H[?Y\9Z\/MY3PZ,O\.S@
M??3AW9QX^?C7^=')OO]AM'_]X>.?8"K\Z1WOO<K_^1W$U1<46>_!KOT XFEX
M_G]?#OW#+W]^.<TRFL6:2B)-%JB,)4F#R"-"Z#13/.-Q**WX!U+0:@>%M_)C
M/ >N<8@CNG>E8@&E'@] $5 .<EZ#V+Y !5U.]9,7LRTTSS, [^CX9'_POX/_
M^O_2P/=_!:%X>'AP<KA_= +Z]&@/_GUT<G#T^_[1[@%HV&>)7,PV8+K32"OL
MEP8RPXB/$2\_Z<D,C+W@9>.\17\M+\_0W)IH>3Z&A9Y=#U297^KQ3$QKTUAI
M0X284PRPE2BMT'+!QX/PM3<%LZ_$7!VX-:8QF7*\DBO35*34YKHA!VO*H!M3
M5 AB%P2JL5#@GI@\@RO7P^+"B&2\0VW'3'(CO;8&QY>Z#2_:B%JI6V &%I43
ME ,T)7,C86M?M"U@,;)S1F6@F,7(B)Z@40!?R2'/1TU]HOD:T3"J"6,#CE!!
MN!4;Y60,LGR<X1^ZV8+B"E$<_ 0@.@+GNJ76" '@L@WMKA[O=VY>?7CMDB-L
M9<UT#)H$-9\QW&9=3>XMT"[ ,\&^7*6U;>$F&6KGME7<%%4K DS8\I(WRS::
M+P.KHH SE*:NH'Y5)#K<\II8:J1PIHNSDE^<U_^&FS:>T[SZ9#[3Z!D'.0W'
M-+G"DS*>!;M(\Q(5VD>8685 Q"QIV#T48X#5+U5WJP$U@8N36N,Y;N)6FR9:
MR$+6EU8#HO:J:M.>B-GISGYDFD]@?=:C #0Z/H,/@1 J\XGE*-O."UO=7(.*
MRN7,]AK&Z3;&00!4C''CS;I :.0*C]N]))CU@!"JPGS=73,8688L#<8O)KIN
MLU>_BR6"^E_F;L"NP\FYP2.C8JPGO+QVV._C=(SQ9UT#.:"KR?4%2@FX8X6_
M /;&#)(&]V$2)'I_#'*"3;=(!2_'%U+.UV$B]I-\: ["-M2KVDI:A*GF_+!C
M7&?OS0. \=&%/RJ N7,;O>>FHQJ\A729/MB4S6163"=H.%>V&&IV"\WJ4$"@
M[#&6/89C-@>./?"8_S/%8%5F-P,O+S+83W@)W&,\H^E%,5YXD$57]AF8RF?^
MV2'R9VH =].RL.04MJ<MA:ZF$NB_RJ:&$/19X62K@U^X;377#HOQ&<'VD(:*
MP7[FPZ9W(YZ#P?Q-36N;!%M.ATZ.-K>R6^]^_.O@'. T?%%+_1K,&#$FS!DV
MCUVNL5H!BQT X595Y^3AN8O8N<6U?4.&:/T;,GP=T<XBX#"24:##, EY1F,A
M4AG[(HK\2">4Z6@-&SB8LP 9C^)M5)2UM5SIAL=L6K+A,M[V9>6.W&W>9)TR
M53NAC=$)MFUCZUJ5[ZQ->ZVS48&Y;"]=$ S8# X,,9MUY3"(Q8Q6D+96+=SG
M7T;O_F>: UJY?L8>9^?<&Z.+S.K RIR2  T)  J!< .HW/XCY &(:=TK1D>"
MS:M+L[,&C%IE!V $SF<&T6X-W@%4!>A=7S<"C"V67MH4@T\1Z'1=P=A);&*#
M I_&@%KQ,]@&X&0+Q"=U'*@RR1FP6<8UC8$*0RT<T3:H 0/YG$?:>B>-!L Y
M:J@J"@<TZR5UWKE^27CUJ\9AWVDQ#,29$?,,N)&)SJ.7U3GT%[:S>SNKL6[\
M_7)=4<-YV[#5W- 6E8# UBX2UC5E3+L'@A#UNK,;S4O7I2B5X:4&U[7 &"OL
MQVUNC:I? M&AX]VZ32\LY,V*=[Z)DCKF1>M$LOJYB]%FR&33-7H9:@N$X9N\
MK'7F9B]KGE[6M-;?,/^D:_"*B7[CCJTTYQIP;EO;^G@N/@;O!M:JM1G.ZB[%
M8+G:\C4^W%SH\=UQ[7+GF:N?:URQ+;7-!$H:KX0].Q JKTSO"I/G:]%\O3QC
M[KDEPF'#P0XF?#2P7O%JSI]MNHYC]+CQF5K8#Q^ZUM7NQ0K< .LEJ0TNN\Q:
M5-<QTM;RN^N3ZQHADQOL]L2P) B'VO$LP:P96F8MT>\PRX^;75&(7(#&8Z=
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M[(C_8&R@$TC'W]OA![I]2*7UIVH&-G2+V_ .0PYJZ[R^WVYQ!H9+799A*O9
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M/+>H9EQ,=*?=SQ@/J[8X<FNH6W^-B>5:D3R<[Y[?Z1.SDMN:@.WR,USD3C@
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M[!R>^G8V[:!V$"*,@F]G+S:H9?R7-8GJGN.XMJV&P#'\PDOTZ5ZWZ0YSO=X
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MU(#\*<#HF6/%-:C6H/I87FL-JH\&JF.'U%M)).<8!"P1H(IXH#2R(*Z6#\3
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M5T^2TVP/=&$M5?;U<B^EN$BCONCTFND[K[J^%;_\S?_^O>GZ9T-+OG)A:;G
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MNT![-:ULVK__^=<"VNIB!B&U%\QLCOL</--4&PY*,B=I]DH*%R50&UFUU1>
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MJJM3%8E>G")1(W6J1ZD;\\%#MQ1,C2*\C]:]\49MY[F;A?_S>/<_W]4.MYX
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M(M/$.A<(8UDSBZYE=K;LX5K/ZMACCDXVYMK!V"Z5,-\O5G[(*<?#3K 7FM*
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MW$IK5P*<"P*\.*[UWC(KN28T>R1 )C.Q7@7"/;.\*'ZFZ L!<CHKU9I*@)4
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M*F</CQQ5ZJC4<1MU*'2]G ?&7#(0C'0\::YP2V-2L,Q,=<7FA3JF7#'0EKL
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M46_8^M)/_W1ZQX/N:<OAT@G-'.*%95YO*-);N0R!@IJRWW2.CMV(A^X"BIO
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MB$9& HF>QB  Q/IB:OCC.)@@=)VVQTQ8G@^V$T,>2N=Y_-+U%_MC7L>A<;O
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M.^S<=,$"SR9BMM]AH!?W^[/9JBP^=R?%1O;9H\%P?%8<S6;QS!H<#P=AD@<
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MS\F HRU^L+\-?'X@=ND.@WN3W>=_'NZ\V_VT>_3JV\$[D"4OWG??/W_%SLJ
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M@VV0/U6)WNF^>3-;W^VCXUXU)S!3;[HY-N_RJ+Q;S=7/$R&;;YZ]/<YKO3N
M-R5ALPZJ"PU4GX',[8[_KC2I# JX:'\ 6YM1^:./_^IR:)OEL>Y^^PR_;_.]
MYY\_&!RCL4:BR%7(4?8::0XRR5BKI#4I*>W;(F.NJY^^>=:I=U-G=[">][]$
MA#U6NEC;V.YW_CT!;LT/^F0N,AHYL'PVGK3+I%C>,;F#.C6(.S6*?[8=]-TA
M_E9-:I[-BG0ZP#KMFL.?O:3?7\!VS<65MM-#SM?OZYUWC0(&&,V8G2EV=6#]
MORV8AL/33B7 P7R<Y+X&U0>/0.&K7 /#.!X.1L>-+G84QX>#L-YYF[4%^&!W
MU/RI4M#L\7&OVWQ35D!]/1%5G<BCN<N\\W$"*E=6(4!KFVM=%J9K//L@#'&<
MBTL.Q_# ^1Q[-,Y:6[YU13.+VERV>K,']F._^FS^C)^%WS7Z7[Z@V^]FC1!T
MU#S2T^FS+DZ*770V-]IH9W <^Y46W&0EP*V&V=F>/2S1#O-[E6X\FO3@ ;)/
M?AB/\\BSYEVIY=F%\[';K^Y2.=@N3'U6R8^'<51K6&##9^U]6$_327=\V+G(
M#%.=N?Z*627.0PL/G35P%V,?1E)ILZ&:)%OY%/+0EG]'+WZT_K3S8G/SY51_
MKS<U?/;\]Q/\I&5XS,9)]TL^,'M8/_8C-C+?'C<8G%M2:<G.?'(&^GE7#[_$
M4;/]FI.2DT/8G1?0GS^2=ZSK=4>'>9.FQ5LU]XA?,Q]EQ^"7BH5B?77E 5!_
MC"JC(1\]3^"^O6X"XW+_$,8PO47E6@.L?>D.)B,@@WR[_F@ZI&X&C@>C(9N8
M+N\F^(;,1?7#G PFO>Q7S5ZX?%0%9+@)H\H/">BO?)!7F)Z3A8FPE?.R<O55
MEP#I3 GG LMD"CS/'-7I1::]FJQFLU<QV" M7XI!V\ZI]H<VQ*G+HG)/-UA^
M\ ._A86"%S"#@(%\NI]W0%43-[-CGOEV3>AFKS<XJ:@]"Z0S('K(*7U236/&
M9\OFZ](-^* &03.>BL'FK')HLSP_<R90'01,_5IS6IT>6#8[N=90@!2 86K'
MSWD7UUT=N]Z+&V>]:IPHMN'FP[[MO1W%-X,T/@$947PQ9WTQ_H,E/CC*%"(N
M,<0Y"\@JDI!,6@1%690J7O#%W)<SKEY$V__8S=K;B\$@G'1[O6DH])+U?3-Q
MX\HM)S#'9;'/+O;'#RH9#NMAD94X(4X\1]H*@V).GI%*)NKQHW&\:43$XU6Y
MM_N=S<E'&$+UJ%=QO>7Y:)MMMH#NV4G=%.:5;*H[:$[?FB(> >0[4\QW?INB
MO@.P1QS__I"2^6F[)KCS#+;( 'AZ9@4M'.-D#7!V@%/'(3P;C$ 3V&Z,F,H9
MT'G6&TQ")T=03ZK+-H?#'#A6&1+[V0;:SI;.&[ @NJ!6/FNLK(>UM;->=#P9
M@IY3^64N(@%PDDVC"LH5>,XX-BK=V!Y7T_RM4NK/3I.OIJE[9IH.X6^5(V=A
M>BH3L9NG9]1,S]0(K3TKM_WBZGSS2^P-CJM36I?M0GBW0<D$'GXT0TF&TY(Q
MCII!]GUODC7=RZZ'_9;-X=_7+YG,^<EL?@;;[V<S^S(WU^R0,%-2/B1\T@R@
M-J"R]GHTNSC/5&5+Y<4\>^/USI8=9L?=5 6&@1SGX]XQF+Z+]YQ_(.N\I^>^
MXXQ#=-GCU5LD=8? M_\+9G9^!MA668-Y.!U\I73R2IO3SP:]GG75X?*7N, C
MH\H)HK%^UK. ^.R#A5FMZ+[.%?@SCD]B[$\_EBLMYI<2RZ+EG=7R#CYXXK1.
MW" *,XZXI!)I93F2DE%).7$&7U3I9_%;#R^SEJHN^E&K<KN#+S4?7D.9TVU3
MYLZ >U%+&'5^JYV<@-S?GW;F&*\>= 'EG0;FG=G'*W*L?P.LKY_-VGFH:-WO
M*1:Z42Q\_9#5$W87GM U3WC._3M]U'-_AF=NVRJ_!GVC/XEU</!4V:N%]$S9
M?-ATC/.GY3")O^=#O"53'KJA.A,['@Z^=$,\%TS<'![6'OOA\K/*2F$[L_$7
M=:LGU:)6KO^S:G>CS"QBY*0Z?!W#WG V'SM4F@'\8WN#CZ>5^[^RA19NU.OF
M?56%S54JUYG0ODHL=F(O5OMNB=:F;Z^U-7C\GO*D6ZH\/1X!\KV8O7F@'NP?
M%Q?#]58J+ _>QL^JV(,ZQ0&>8YA%9HGSOJ@ OOW L?!&2XJ$(!YQI2,RR1&P
M9+06)G 7,3D?\RUTI#P&X6)6$2UUDB5''6',2T7<"L;C$;%,EZ08$7QA[Z\,
MWJN' H5QSX\'M;Y(\17TQ>JI6Z1)5(^Q".C.(J(?2'NH!K6^9.(Z0$K]D+TX
M)UE)^ *:71R?9G%3:1*CJ8@[\T#=K#.$.J^Y6S]<'8($LJD[&E?)K$U8P)GK
M9@I#CIIJ_I8%?QRD)YV3PVXO=GK1?LE2^47L@[3+@4N;WL=*_BYX]UX.NR K
MC[-K==*O<SW#TJ>[NAIP8W_$+YEB25J58KDTX^R'F3[M),#E#_-#$;:Q5(W-
M!)IW_?'$ > Z+D<[QA%@ NX_KM);0+\][MDJ!*=259>"Z'(MEU28KJ.3<AQ1
M=;A1A>/=H:Y[A:2^5NMW6#Z/;IS_?0>6)-B57\",7*A[M5=9"*/I40]7< V\
M]WR6N3Z"WYH2#3.K=+N_E1?Q=+1WTM_ZWPF\FEZOB2@'Q.<UQU<?DJ6)$IL0
M=30ASJA%)@@!/T ^Z.@!5X])$\3R47L59P?$5]41V^=MRH3009WJ/[6+:<8,
M"^?##3D\K-=I=@H-W 2,]WO+9C+/U@);5K,W+6F#%AQY(,AJTIR=& -Y=FKV
M;,D$Z]P&$__^M&4S?.YDO=ZIXQS<<"83)$_\F>FV+9WQQCF7;9]9N/]%QNB,
M\A'UU-6=':B]^!5&GH.O!Z"_9*ND0NXLN>+M^IOU.IF@<I["'.53ZZ6%9^HK
MP7C)DP5/ 83J*]VGU[6NVYM788K5;*UW=G)!C)R74AE45<[S^.Q#I(&?C*8Y
M(^?<N/,%ZYY;L(4*.2,/BA>H<]GBRC347'IF/>/9]1S >DY'N&0&+QA@J9O+
MT75.HQW^T M+R97/SA=O^X.3<S<9=_J#'&#>ZU;!]+9_O5'A&XYJ0=>.\P$N
MG;4'UK@?D7?YFD1W;Q$#AM"Z5N.^_1KK& %5U/;S:OO.!T<MQ9X[Y)@SB">?
M';X,9CA@(9UUD1A\WN'+$_$X!D^#CYPHHP/8SY%3'(C%%HOS:O[%,VB#".U<
M] +=AT*]O![4#Y_H[ QH%H*,E!B/+6=$.BE]$DQJZ046N=[O0WEW9V1:AT;]
M.!P@+T6+5/?F.:IZ1!5T']*C.PT^4.U2&:NQO6ETIVDLQ/G@S"53^. %K+[C
M@?LQHGX0F5E12A- T6!UMOMGVE0S:;.3@RI]M]*=X+*Z-M:B'MH]<RX^*TW3
MG%W_0,6M1W1&Q3UWDC\ONP6SZTYA $>#RCL_56QGFN+H?$Y>E2E6Q7;VLG8\
M'%A_V-P3M,DF?S?7\P)%=E _[9/S(:/U,S=)SCD, #35V:\A%U:MXD3A)HLJ
M\\) :KVTR==>J W:Q(7FT$_;&PWRN*I*G*.)&W5#-Y^!+(0WU)</JE"%.H:U
MYZM,ZSHA;CY#M7Y\+ORR7HKMG&0=NM-LQ]E$CJLLS?DT/EFV1-48ZZ";J4W0
MK%K^M0F=J!+61[-LS,L7LAG1\LUYFYB):^C%YR-=O^^%;D;W.+W0;?2O[4X#
M<KY;4^O)5&8/%FI7/>F$R7!*^0W,#RU877D7CN9YS+#2>8%R;N0ERW/=2E47
MA<=UJOVIAZSV-ZWLGO,08G\T;;B^!1@?G,:XV!.Y/::!;TR# =FA!_A@_]7I
M^T]_]O:>;^.]Y[WNP?YKN,<!V3G:I@='6^+]\QVZ\^:<:?#I[;?WGUX?[C[_
M]]'.B[<\WWOOW;\/=U_L?MK]]/;TX--[N$_O\\ZW@Z__^7;P;6]_\X.6N9]I
ME$C :B)NA$>."XDPE<E10X-1_+PR3$E2DD8:DA)<$&F\LCSJR+$W<!=SKP'#
M/R[L]V:6$[2U\_+OO8.MK<[KK?WMUU4]O\[+OS=WW[2B),U*\MZE2NSR!6GZ
MU70:"'::CC6="HN/<R(N.:P _2%[*#NO9PUZ'L$D_* ^>ZXGD&59%D?Y&!=D
M(6B4C:X ^L&+RL4ZKBL!@2P\:DKQ-'_OO)D<3S.<>N<G+DN^-!Q\B_ *1 H"
MC:97UQ\Z7\FXTHS.N),'PZ-*]P$[(0X;)W$C*T8+XZH-DJL,I@K0/0:5JJX5
ME'*897Z4X6#R\1 &^MHZU^WL#_.16Z4Z9X*MBC"/XL=A_%C)Z&R7Y/RCIJY)
MH_#E:CP@*ZL/Y!KRDU$M_8]M;7),GW+@8,GM4ELB3\!C+C'SKC%#CF!&JP7.
MIR9?HY]4BOB2?;-TA_A<&B;OUCB[],P.@2?O5MR5:RYU0Z5!=5[F-?==>.A<
MA\IF$R]_6WTVT=P^GRCXV)EWYLJK7]LR3>FEJNQ25EM&>0.O^%)=DQC?KO_/
M>K4P*_W0WS_\.UOM)[/A.2+\<__%&1*T2V"]B.HE6[@1K-56SO5F1H-A7:L7
M[EVQ7X0;5>=7;_O=?)O_@;T>!D>=W_(*_+Y @+_-EN3WF@%GOU<TYWN#AH*R
M=1.S.Z(Z":O+P^6"CU69(<S/%N@]\\C5/695V>I8A-JLSC[-N6>S8LR&E,=G
M1E*#-#_AY!1ER)])*?JS_N/L*/7W*CS2'\[MK'SZ!T/.)WE^7!6/FS0%ZF+G
M_-5/ZNK'8*O4M#Z8Y80 "=??&( 2/O9G7I/LM $3NJE;7+_9</R\SM1LZ:8W
MJ3Q;0$+PN>,%7JD78<F&:";ES-*#C9B35JI6*%,'S]2CE#-4AHUCIBHGE0FS
M4Y<G&E5;HXIULZ=U%;KZKE,2JYP,3:%F&%4UN'&L$F:GGAEXIIDM6CUHUTUJ
MEJMO.WO*LTLY&"Z.K_3T^"D!I[3] :<_-C//FJ71)^\(=H8(PXG4F@O+O79,
MRZ1,D.T+4)T&7\%S].O<JWFJ?_;0]++WVQ_F F''PUP18.[<7902L_)BLSIV
MHYI=ATW1QC,1$%.1,F[*I&>\3WV4N3]5+I$>I_Q]GJCK0NL_V6WSQA_&,.G%
MO72NO6FVCYYW1UE: #7\PKZ;G=.]_8]DY]LKL?/\U<GNMX\?C#4LQB 0$3"S
M7 B&C D688",U20:&NB%)C=&2VEL,I%$3I+00IF4F,,T 7HN)GYGL9-F1ERU
MD9K#BJH>XM02:7(?ZUT\VU'3W;1$;E5U1><10)7<FF[CV2YL A2G^L"9#,N\
M*Y]^_W1Y>1.5'T[ V0ECE&EKL0E4:6XHU<IXPKW#"O@%1W.688[L\"-08R,E
MY-F6I'/.J?KSS45*U1.PRA(]'L6GTQ=_3!MA=_L5@U07G>_^-QX<-\QKS+K"
M*I-O;@$X;U;8\/)ZQ<OG&ADV[^EU*OBE;^-U<OFEW[DM%>O4T!O=]OOO"<;*
M8(V\TFVK?I#-AEC2U?>RYKW?^>B27KNYNT<<MJJG;!89^<BE\QIXXGP;SU]I
M(K:FIT6O(Q@B50^32N/>K,CV5YZ9UXWIN7ABE$,JJNJL9R;F!R#Z43O8*W5[
M;4GOZN7=<"\Z:&[0*/RFL_&@6V?Y?%S:L;H_R8?YYYI68]#&!''>A1@Y,];:
MH!EWQC"A7%"R;EJ--3&+3:O9>17YHF*\.5?'WH(B]FP>5-%\:&^F<$WY,&_Z
M63=K1%=4BZ[;60\8?,?GW4^ANTMW/[T_>HL//GT&+?G]X>ZGS]_>[__9W=T'
M;7G_=6^G>ZZ=]2</S_.*[M)M=D!WC][OO^[N[6^+W:,MNK>_V]MYL4UVGW_^
MNOOB[>E_OFV-=^;MK+W$(7#ND=06E&[K*3(V2"0Q-T)%QI0(:QMXG5]H9_W_
MW08\UV#A L#S .0>&R($#<00KK Q0MOHH[">14^-SO9I#4!TYTC<C>-IC[7F
M\[F&XE0J_SWH?]R/PZ-:.._U:ZE< 'IM@)[. !JD);"\&%'&/%C%BB,3DT18
M!8EM7GP1"T#;!= V2,@L&??2HC(XU04+'*\+Q]VYO+0RTN@Q10)SA[A1#AE&
M'8HLF>B8<S+1M0WV0SA6.OB_*A_((ST?;)Q>YYU<WS\=:\(,<D3?I*X19D>-
MPV[T]-+'?E@WE9#D)FXJS=<UOGMG"J'KQJB[=*:TQ**[^B%\Q=B_=?L=^*)>
MYLK?;^H7^.4MY;_..+\7W-KG9_3.9@1W5F%>_NOG/?\?YP]86_7@ERI"DU&X
M$RT(R2NI0; %_QH,\R_-WT>[@[I,>'\\4W#D:NLW)^_W_SG<?=[[M/=B^^O.
MB[=X9__/3P>@N^SL__5YY]T!>_]NA[Y__M?AP>EY_>;/WNZ[+;SW;H<??-J"
M^[R"ZW>[51+ENU=?WW\*\"SOX1Y_?3KG#\ R>,:UA]U#&.+1@7X3C4%><>\M
MIBIZLK9!<Y/7<_K-V6*U=XZ+_.XU\7$S"D_5_U:*I?^\<"!YJ<"CUWORI6S<
M/E;ZK16T=,$&*T1T+2+:7B0B'3BEV";DM16(4Q&0UI8BHJ-G+G#K245$\@(1
M7=#VK@GU^Z&9<WZ65:"9OQ:-LQL2?6.C,9CF,)AD>VPZ[I75$)<?Q]U40[R+
M"6H+62^?F?LAZQR?"J]^S-KUKGY3;>J]E/]2:/M:M+VS2-O!!"DER3QM2"ZI
M1Y%V/B C+*P9UQ04R;6-B]KCU4G[SN%R*\H_Z\);GG#Z6)QZKW-^?0Z/:TU5
MB28U>1P[?\XR)#?GL9YUELN;\=".X\>N[VS/T_T?-%VR2J2?1YAW^SE]JXF)
M[5^23+'^>)-)MA>>W[K!9'PNFG[>$=[%WN"D+M(P<S#/2@ZP61=Y6/2E 9;G
M\\-7;!*OB8NZ6&331+#9:K].JN9">8TJPGR62;>0M);]F:-YEMPTF;)[9LIF
M643WE<3V<R/3FW3E::'AEX/1>#XCU9YH/M%TFEA1%>@6105 3=KYP(3A"G.*
MO%$2\9A A9'6($L4P53!,O@+%;; 6O68NL@I$=Q8;0*66B3"F182"WJAJ, #
M99;F1H=VQINUWXZ1BR=U=>>>7(VF!LJ\#WQ%O/TX!M6].;'+[U7I9LWOQX-A
MS><Y47":O'$ZS0#.V<V-LW8QL^/)/'=D^N[T/LV%UOMAKB^2BX;T1_F*IK3E
MF=(@SO:J,I>CPQASKMNT1% %\JHUP"AGHQS9(<SO+*>Y75K-WK/MQ1I8BUD!
M#[%MEF<?_'#';RRKDE,?#E\NMY<=!3=)IO5&K',UIEL/=NGBSLN[Y&.3@7Z/
M>3Z;WD^.)E4ZZP4_8*[,_M7'$=B7^4#MGWR>5IN:]4G&?K8A?MU4H,RXKSX(
M84*BP:'$J47<68>L8#D1B%D1<1+<ZHOI/RXYR13A/'(6J$Y&.Y5"H-X++?6R
M]!_0+ZNJ:%45AWD&3_=<J,$-,G%^,);OARS\O/@$7I>PNVY\ N?KC-\L3>2[
M\0EDW6C]4S)31!GL2@W67/[VZH:I?->#OOR,='XX1U8T]^02B7Z=K).;+N,]
M%.:Z[,RQ+?IB-9REX4ZU4_(ZH;O-D=A*ANY>LC?GBMFL9M=<->O\MOGGWE7B
MPZXT(S>*EGY\4_YR./A4Y0-4WH]FTJO7BQ/_\HH3?ZL)*RNR)([O>AF390'N
M8 '>-M;JO][.3=4*$8""SNMI">-P'8GY^*-/?UQAL$2?ENC3Y9$#W#J?,%-)
M,,43%LZJ%(71E#(3+>,Y<F#JT[EF].EW/#V/)'3@N+?S_'WW_7,8X]'.UX/]
M'?S^W0'>>[%#X/[BX.B?S[LOMK[M?/IX>G ^M>;H[<GNT;\_[[[;.3WX]M?A
MSK?7O?<PIH-O;^%9>MWW[U[!6'9.]Y[_NWLNXBLIR[SE%G&M,.+1<&2=)HCX
M*"U+W(B$US;$Q<R:ED:>WE'&7>&VPFWWQFV%T&Y-://4W2B\3)P%I$TRB#/F
MD&5,(J>=3D8RX#L*A*8+H15"*X1V,T*K(X?@%E_'3[_%X2#8T>$58CZ7G<(5
MJKLFU2VD16M#9&3:(!420YP3@C1/''GN-6$D\!A4=G]K2N@?A>\*WQ6^^TG&
MZ5$NBS2:>Y2V^W_6T3!O<C!,X;CK<MQ<G5.21Q4=0X2)B#BU#%E/+#()<Z^8
M)8R'55+G?N!>G,89P)/$[S-B^>393_X**:<_+J'W.#--KT'R"JL87338! EJ
MD+=2:,<9QTFJ8$(L'L@6,/RK,\7PJ',<@^XJ:0X\DSPA$U1 "1L1I>?4&;VV
M0>G%G--K4OP=)I[>D&,N/98KL/UIL"U8O356%YQKR1II;4 <;$S :K)@<3J%
MP,!4G$25N+<%JP6K-\1J\1#=!5X7/$28:*=PT @6@P%>#45.$HZBDX$D([0A
ME6R]=6&9@M=?$:_%[W''R)U+6B8QDT1S9%D^ER=!(2LY0T)YR0+C*E"_+*7_
MX7#[*Q1CN59V[W6(:,E</#XB"D023P16WH#Z:),Q@D4>1:YUQH-FQ39O 0N]
M/5,/"G8JY9@CAQ78YDX8I+$0*# G&>-1!F>R_B#NR/W:H@.D MN?#]N"U5MC
M=:XQB A*'4T2)<84XM@QL,T)&.A$FR0,8=9DVYRK@M6"U6*;/PQ>%XO:&R4-
M-PQYRASB*8&N'VA 009KN6,B6M5T7"UX+7@MMOD#(W<N:;%6C-KH40S6@Z0U
M CGF Z+>:RSA'V4(()>T22O^%8['OS^[I13J7<]#6UAX^01<@X4M%93ZR#7&
MG#O%M%'8*N*,LE2#F5L<$RV@X(-%QP31EF@O',+.1L1)<L@% <:.XXDZGXB)
M<6U#X(L'D0]4@_(^">J!3UZNF&!<F/@>)JA0='%"_7Q>7CBV(LH9$6.N/PU&
MK:(460&\C%V0B8M #+; RTN,VO;R\L^':2'L5M%2(>Q6$W;Q1-X%:2]X(E4,
M)&%+$<4YJH\9CW0P%A'! DZ64Z7<V@83%_T9A;0+:;>$F@IIMYJTBSOZCNE[
MKG-;P867C",?+.C<3%"DO50HR"AHC-90R]<VB+IX\%OH^TX:T,RJ8?Z@\4 I
M/[PJ17++8$OYX5)^^ ;EAXDIY8=+^>&'WYMW5'ZX%&$M=8D?WXJ4NL0MK$O<
M*36)2TWB4O;I[D,L#<,T"6T"M8:3R*W$U!)/+;5.4\;J;L8EN&=Y.^-O>\__
M^0QC^KI[]/[3^T\?X9IM<O!NZ^3@TS;;>?X6OW_^D>_2@Y.]9^?;&>_PW7=P
MW?,M"L]UM/?\%=_Y],_AP?Z?W9U/_F1W__7G/7BF]Y\V^;F:Q *S)'UBR$7-
M$"<R(4=C0CPD:JS75&B5@WM6I>93*6E7N&W5N*T0VJT);:&('<4L9$+3.4R<
M&^J0\3HBJ@DV3 41<2Q%U@NA%4*[.:&5FL0/1W4+L23.TD2%4@@G%G)N#$=6
M.H^D"D$H+:DGI-0D+GQ7^.YG&Z>_1,#%/7+<0L %$T1AQI'FWN?&.1PY3S02
MU%!8/DHL#:NDSOT*N8&E=.X/N<AC)Q2QSE#J.37>!")%5$)81SS6O#C*6D!$
M.W-'67Z>DP_4**V9<B@Y;1 GA""K+4?,$!(D-C0X4+A VVI1J;!2XF]EH%OP
M>FN\GL[P2G9>?2 T-VH1!EGO..+,PJO@$R(6%M G!DJ?*'@M>+TA7HM#XRXP
MNSN7L63WU0=ADL5":Y1@31"/P2)#0>1Z953"-NB$/6 6FX+9@MEBJC\X>A<D
M[MZK#RS2&)G#R$8B$,<B(;#1-5+)R:@HPS:64KJEE.[#3\EU_(9@V\44I<0A
MY5K0+GBI<!#,&6VEL\56;P43+0:U$&(\DQ:EE!N984Z083P %2F##0=QPEG6
M(>[*:]BB<X\"VY\/VX+5.[/3-S_H0*F1B2#%'4%<,XRTU@I9C)F1REN6U)VT
MS2A8_16Q6FST.[71<] !CXGC@ )-H.%[XY!U+B 6DPS8",=(+J5;\%KP6NSS
M%B!WH91N$%9:RE#*I<)X(A19 DJR(]0G935Q.@)R\5W%>I?C\M6HSM"V"*=2
M<^:GU9SQS')/+)4T8LXIT]IR(KQ6D:JHM2FNC!:0]IF.O;G5I^#1(<J"0UR8
M@"Q/0-_.>!&"CRK)M0TN5ZGX;GL+SI1Z886[?SWN+H1]:\)>R#_2-G$?+0I,
M9_M8,*2C9<ABHX/%(1KB@;"U+H1="+L0=B'LXM1\(-)><&KRI(55QB"%G41<
M8XL<%09)Y@-W.M%H<MA"*:5>2+N0=B'MXMEN WW/=6X9N0HR141B;N#.24!.
M.(NL4$HJ[A569FV#B.(D^4E5>?.T9AAU^Q/;S.N%ORP4YUWXOD^3T;B;3M>N
M5-2WF3Y.UY6 *3X>C+KYWD^'L0=?\B4V-7D;T"]<V,P6GE]B'4S,9'SY)>?G
MY/X/!V@>$F'L7+7)A9^'PWEUSX\1N6&TGY%-XSA\:GLG]G2T]J^S19&[?71N
M#L\__N7K4/\\MZPU546?O"/8&2(,)U)K+H!%M6-:)F6"K#D6KHEA,Y<-"-1;
M0DW@FF).J+08BWQL*(2A(44V8^S=R1%,FS]+T<D8+:@72># #=<F*J>D4810
M*P6U'Y[GPNG_/WMGW]6VCBW\K^+5._<^[2R<6K)L2YU[NQ8%VD.G0 _0TVG_
MZ9)MF;@D<8Z=%.BG?[;\DC<22$(@3M@S:SHA\:ND_=/6UGZQB$7,80;U<3J?
M!4T5]EN@/^\U9>="98>=0>K$6]:0[%P/]7.X_[M6$EQN*)Z__Z=I!>V_.O*K
MZ)_\_/+[^\_3YO'^Q_;1AR],7_ODZ\?F\8?CG\<_O]Q\^_D=KM.Z//K][?H_
MO[]91_O!C\ FKIX 3<<F@<D(9R9WN6.ZS+=X:/MV&( NIV 2ZVKI2?MJICR-
MR_Q32]2ND2:M5I2D5S(-=5+&7E,903$,C+B3_ZGS \(11M)/C73H*-O5CK)&
MG!DR@Y];K>0J>S-_!O)_36V"1TI*SAU[F:3DGM6PF5A]-FK:X-9RE[TO=39]
ME(<EF#I[_*7$AF;._J9D:ASD23]'TV<_1>;L>N2M?CDU<?4=R_#M2?VJ9_]5
MO?$\V72WJ>462RZ_35EQI[?(.P63>0>>UDB&BN&SR8C[4(/3QB8=JK$]:6MW
M;>G1[^/F]_T_?Q^WM>7HB_7M]\?VM_8W>OSS\.KH9^OR^ -<#_YW-%G7":YZ
M1-]?'L/UOOW\J_D=[G/4_A[#$].CG[LW)U__M+[O?[S\#N\VD0;7]@+;@[6D
MJ2S%36:%+JRCA6<*)3W;=D+E^^[&[]IB"C>DZ6;3-.**$H<3^*_/F*\X\9@0
MOFM+">\;\IRF'&FZ%IH.[?&.0QU?>:$9^2XUF<,=DTL1F<2/!)5$,$5\4#(W
M>SL5,\:MKNEW@[_[<0IK].[2H>C/(B_&4J;O^7/W^MGU5-?NHG-D)SS(M.4Q
MSIHJU+^4QO//[TZ0E@O1<BQ:W2>P' @$-7W/<DQ&+&'R@!!36%P%CNTJSUE=
M&E_,>E-?Z79 A"W.(B>P(T9")8E-F!=1WPX]+@-?2S<1I73?M6A$.7XZ.1Y)
M51N!<NIQ2V>N@C4D=3E(M*M,6/=SRW<")Y!Y=LC;7@B8_>8Q)?!,I;_B0,'[
M97>477OV,;TKT"WN6V25/;$''8&@60@T8S%AS!/"]@DS+5NZL+PBN@BY",U0
ML<A2 !J+\A=OR8,SY&$$?GVE=66Z DKKHTCKB%K@VC2T/68"1D%:);-!6I5C
M^CRTE2L].V2^=DZLD;0^!Y-#G@U/9;T'J 7/8E'R!&I!U15(FH5)\V54+Z#2
M\9@(A4E$1'3I,V8*Z7"3PY3@N4$(:@%[\?;!H$$30GVE]0G4 I36ATCKB%X@
MB>4[H6/:3&^21)YG2L6D285B(?<8Z/56O:3U.1@+=H->7Z:Q;!DO+V3<>66T
MD@R-!NO4#@8]\@'ZXQ/T!D)G(>A\&_-S\2ESG3 PG8@SDSDA,WE$+),HRPY"
MFQ#"J,ZV6:/%")H.ZJ<C+%< %"7YP9(\5!\B)2D7.M+1#[C)I!.8$O0',W X
M)XYEV=#+JR[^B;:%^811#W8#A*$3ZK"AS)"=T)!9UF]W<]DL@XV>F<WAY=.J
M%1F\,'RZGTI%;';55XBDA9 4C"H7*HQ\Z4&?2#=P3>;9W!2A#$P1>*ZR?**8
M\J:M:&Z%I:#IH2Y"6R_3 XKJPT1UJ#THT H LL2T&0UA'1#8IJ B-"V/$N+:
MC%,:O'A+"%H?GE3<RK&>&5T9A\_,ZO#$^L'04^JSZF1P/[]H^V%X5_E%IOL"
M6;,0:RY&U0(1@@+ ?6GZ(5,F"P,?% 1!M7.XY?BVXSM<5^.Y73!@?KT S0TU
M%M:5NC6BL#Z&L-Z,9,(+@]#271'9PF2!'YD^])C)[-".'-MV JK+>]RN$; 6
M87T.QH3#=A>:6"<JB9(4?N@803]-52>X,:)67YO4IL8BX\+D"?<HAEDXWQ=]
MM%=VT7D*[]C*>PB-GDO1Z7)4E0A]F_L15V; =9@NMVV3$\E-UR-!Z(2*^BP"
M5:).'M9H9]A0.P.*\R.)\X@+! &IM#T')-FS348];DHB(]-SJ6V[S!/25JMP
M9$8KQ$(!V0>=<#S1R9(QL9AY]PD:J"Y<?W!LOZ0.I8%BW+(8\SV;"\^2'O&%
M)RFWF=*Q_<MI9QC;_S!F'USEO,[5,( VAR%L"]<DE *T'8N;@KLZ+Z205A2*
M(/(!VLXV!?=O0*[TU>1206(CL3&WU780^VA ;)=ZGD,=!<HU\TT6\LB$3K/-
MD#+IL2"07(HM2VY5O_3HPVS6RZ="GYI\VP;!D](2(2R?F*"4>R(@+/ MSQ.A
MI41-TS"?ZZS+:9RWXXASE,ZMG"5!K M)&E=QKYGG8%;M;BNY4>IV,F:=I5GK
MA89,U6A:9F/^O,R/EX39<<DR29B9TP!ZKCZOL=NP^'QYC:=K'=7[PU!62QVY
M4&)GA@WP* U@+Y+9NCJ@%%TJ"G&Y,T_R7:ER4Y#-23/F&+$W/7/NU_P/8-<N
M/)6\4,9^G 6Z\(MQ"DB;(QOQDJVXX:UT<-W-BR\8IZK73SL&3&Y:#YRCO1XL
MDT_2!W<N@*9/ST6WU:6#].C5>Y![2;NK.EFA?QQV@E3)3#V*FN@VG#D>=4H1
M&*W:F79^]F2+P[/J"[QX^Y*\&E<0[H ><1X(O<4/?;)!_8SR>D]?9>PG<#%X
M&@V>2K/\?&<2PD=LG;62>L&-N4Y?UU*8L @PE\O X8P%U&&A;7%8==* 2=]S
MN:V"8+H-UYXC=&BX0/B2J7!/M@)=;![:\9:IH)IP-;$&9@.3;K;=P/K^]3C^
M1K]<?6^__WG\]=""ZY)OL.X__AFPH_T_G>/SX_B8PI7/)NT&IZUO].//[^?O
MVM^^'L$Y?\([_!7#N]#CWQ=7Q_N7\#R']K??WYL3.;%9( .?>L1T;$=OT;G"
ME!Y39A@IY09A!)_9B[>D(6X[ _WW0Z1GD9(+ST ".Z\EMN8SYIGFV$DTJG=5
M:A?2;5&ZG8R6_)6!L%EHNCX%NKF697(78.<[=N )H>M&AIINSGUT>PX^B%\:
M_V[,NR!;YH4W'A2^([EM^;8=J)#9@>]S0JGE*"MRE/)<@8I/O=$PEI"9VGZD
M(I^9OO1]DVEO: !"9#("*A'S@B@@],5;JS'%"WHYQ6=>WS\4LH<(V?2LR$-?
MOQ%1ZX.H]9)]!>W5AN,KZU1AG$+96E2VCH>R14A /%<RTY%"9SV2VN4OC$PO
M %W+]RSA28:R]1CKANWR7)S^SB>]IDJ-/$-9)Y\396NEAIW-&@&+T95:G!#?
M"?R0P7^D%*Z( B NA46/#&4TG:X,59B:8'8L1;2*F*.([YJ>Y>N82T5,[BC?
M="PN>&2Q4- <LZZW%&8?PS[]J!8,%-R9@HMJT;KD=40ML@*+,B$C'?]@FTSZ
MCBF4"DVI7-<C*O"%CI$F#7';1VOMME:4+30 ;HK(C1@ ;1*RR&'4I*XM86UO
M"U,RQ4U*E">YYRG7T6D)&FPN ^"XP]_(CGXI':;6E=_8;B4?<2<$V7ACDGRC
M>M6R(.9RP7M)7A5.EK?_U6,NT_O]P>A^?UR..^-*I<KH)#WCJO(3\&\,T+V-
M:A/>B&2<&K]DJY][#>B?XD[62_MYYIZ&L9L963]H[N2_R';N().J;JJR/&&:
M_K:MPAB:9'!VMU]F4HNS_-9R>'-9."DT9OK\+>1EN?7>DD34SUL2X-RP"D O
M["[I-@BEC^(L9SE+7?8^S[ZY?1"W^&'Y(FZ(*_2^J9N6LD8WPNUHF>5=!U?3
M1NC:MT&N?>CHAHYNJU@7!H1$EF=[TF<^H\*1,K2XYW)+">)X/)H>^H;&TOM6
M@MW+;[\OK9/SP#DZ/Z#?Z)%UM'_@?#M_WSPY;S6_T6-XQ@-VLO_]YZT N?;I
MSY-S6"G^OKP^.M?/^>?5$9QS]/7 .?GZ_N<W>MHZ.K]@Q^TC'2 W:BSETLLK
MRIN>'2B3V2PP?4F%295M$T='I8>N7@D*5C_CRQ9)(#JZ;1K/T,Y55[J-V+D<
M&G A?&%ZBNNLW)8PI8I<D\#7H:7"T%$!.KJAH]M\H"!26+[%HM!FBD6VS87E
M6<Q1'F6./S/F'QW=ZH*&$0__WP?.\<4/U^'4"6QE$J4S@8>4FH+YCND'7B@M
M(:B43KY3C XYFR1HN*N[-OFJ\MO]/KS2V:]52 7UE.FX$349X<S4%8%-X@H2
M@&X5NE& \K5Q\H4:;\W$;N!, 6)WO/N#44Y#'D@S<(0%TYIEF;[G:*W7@N$>
MN:%KL1=O[8:U<JT7W2:?E8>(%WK45Y83^<IE2C%85-F^"(6T;1+:H8N6P+J3
M8S3D-21*<,<V/6'#6MEGCBFE%YA<.  -V^5,2CU9>[>+6*W=$HA"ABZ.M9.M
M$1?'(* $9MW(C*BBNO2L-(7V<[3LD#N2<^GHDE.T8:%L;9)LH2)<,Y$;,?V&
MP@J5\&U3<M>'Z2SBIF2!95J>Y)%#N.=9NMISP[U/Y-#%L9XNCJ\G,D(NW2TS
MLDT.DU:NH*3*."_.@J8*^RTM]D4YW,/.>VC0OW1[GD3#N?E<#[ISN/.[5A)<
M;B@#OO^G:07MOSKRJ^B?_/SR^_O/T^;Q_L?VT8<O3%_[Y.O'YO&'XY_'/[_<
M?/OY':[3NCSZ_>WZ/[^_6<"+']*6S(LB:4K!A<F8\DS?(<Q4+J6,.Q:/N"RP
M#B-!A;NZ-#<-%"BMH>N!F#,JI%"4>Z'CD-#R.'>@0Q2@M:L]D]*^*GR5UN/<
MNFND2:L5)>F53,-*&LHBR2 5^9_CPM;-"RSGXR/W:=5>KQ%,VR HMWQ>XVS4
MTW5^1]=_377^?:1,H;#F6,;UU;,:-GN$3*&TP:WE+GN?-^DC^.G"PY+YG%3G
M]";=!)/-].S(@Y<2&^K=^4W)U#C(!7E?!4JKJX9-=A:QR-6L%_,KOHE[<+=@
MCGY]";R#&[6TUGRKI-ZT)<LF>JQ,[WNM*:SJC>=9[&U3R^D:22LP6F^@M^OT
M%GFG8#+OZ"I&0\5AR53RS[WD!5:T6$5%BZEKFRVI:M%MPA-=G^P']-O7;];Q
M[P#N]1VN?TB_?_UX>0S/?'3>TM>BW_<F;1L'].CW 3O^_;WY_>>?]O'O/^EQ
M&][EY_?6M_:?<)W+ZY.O>HWT_7+"5&\1PCDCOAGH>A:,!J$I7,LQ>1@%D:2$
M0N>_>&MO4QFB;:DRA$1]/D2-N*+$X;E_/6.^XL1C0OBN+26\;\ASHG(DZMJ(
M.JS&&3BAU,8\0*@5 E%): )@B>EX5$CF>LPG.@>%=3ME#!+U658FWPW^[L<I
M+-6[=SJ(//N*Q2LH0!XE:5MJJ^YU[\UOE2:AS)IW[VY7G2,[X4&F#9!QUE2A
M_J6TMR,TEX3F6*Y0I6BH[,@V&5$ZC; 'T'2Y,(7E45\JYC-A:4AQT$C_5:,Z
MQJOV)GWV0KZRLN0HSD\NSD,="%:-D16%EFE'L*!DS+5-S@//E,HF*N*1 ]KL
MB[>4V#42Y>?@H;H;]/JRI3?WRA0/(SN 2RD>4]I@^YBT L7C7B>?O&,*][B3
M#D)H20B-)>\DS'<IBT+39;YE,COR32%Y9 :V'Q"/6Y9R/(#00Q$T'0/KM!^A
MY*Y<FT#)?7S)':H/PG:I[5C,#+CT3$:E8_I6)$Q"'444%[Y-Z8NWMPTHZY/<
MYV"G."CRX:6YB*6QW\]]4M%>L4:U86^T)][=5#V$[%F(/5]&M0;I>Y$,F6-&
M3L1,1AQB<L8YZ _2B43 [<C6>1X>K#:@$:*^DOL$:@-*[HHD]V:D)@H/&:.6
M29DG3>:RR!1A%)A>%'J14M*E(0?)19O#T\K=9ZF?)88[]U:@.3R+9<L3: [#
MA<H$B?(?AUV&0%H(2-_&PF"CT/%@ZC"%'Q( $A6F'Y#0),KEOJ.<R',(&B"V
M6I*?0)- 27XL21[9S["M4) @,GWF!"9S;&Y*$&4S9)XM;,<+%17UDN3G8)#(
M36]I+%O&A8P[QLM6DMWA[/_L5S4KTRKNS0-0]<L'Z)9/T"F(GH70$XPYZ-J<
M>-SA)K$"75^%."9W2&1ZKB^E[]F!"/2JYG9.7;1'U%MR7SZM&I'!"\,GE.$G
MD^&A^L"]B+AA8)E*<%V6+')-W_=\T^:N\ &YON]&.OSHE@S?FLW0*+$:X2O'
M?&9T91P^,T/$(N!Y DO$K2PF5=]\AJY!ZBQ$G8LQGTH6,&Y[T@QM*DSF!]3T
M(\Y,7]D>X2X-?5=G"KIM#YV?.FAZJ+'L/H'M 65WI;([U!B<T"4>\:@9A@XQ
MF9*.*;1[M.=(QU&1\BDC.HBD'K+['(P-A^TN-+'.FA(E*?S0,8)^FJI.<&-$
MK;[6EM$=8MVJQ/NB9_;*CCFX+K+?Z!15I7OW+6 AI!:"U.6H@J'=M* OE2F%
M:P&DF&]RP4/3D])FS+:M@+@ *1=-$]LKU4^@9*!4/X%4#U4/Y06.IT",;1;8
M)HMLW_0) ='F4H6NI:"C*4BUJ)%4;Y?%8GJP^$$G7$D>EC(SFPU-'29]G86M
M>G9,*["R!JH+WA^<=T!27;=/,6Y9C/F>S85G28_XPI.4VTSIO -+ZFJ8=^#!
MW#ZXRIF=:V0Z3:TO163;)E=*ZOJ+H2FY'9J.#U-TY+FAD-Z+M[9S.TOMQB8>
M6(&L;D:N%Z0V4AOS;VT/M8\&U/;#D#*I-_1M+K6Z;9N^DLP4L)SF/G2:;SM;
MEH!KC=2>DH']]5B"[EFUYH>IBV?E^9[GO*=."?V^3.H<%H)L^(4DERF=U770
MZN>K"GW,H&;GCG&E#%T(OCBU+(ICI'E]^R*-=%HE?2\CR>4O&;?RE,YP0!,>
MP/R[#^_?NS'\I!-FQE7<:QIM"<?&O1C.E-UNFEP#=W09@_R*JJP08G3A39/0
M2* ;C:MF'#2KA]97:;7@KWS/MF&<E\\Q._=\G.6O$18/E?625(^+/#/\X';Y
M%:HSLH;Q=>35JZL/#YX6-S]Q=7UP&JM.H';RBRR0:;[L.D8;G@/=VTVR6!_S
MIDJ57^:Y+J>#D1-+@;*&IT@?9*??FWW*I-BL:8 2FTTTT,B_S728C/A"F3[T
MT:4IHYY*W\C6E;S)7KP>SST>=\R)-IQ\_=GB.TC6/]H]Y71& TFH"!FG%B/4
ME9;E2->7CB-H&"E[9LNN5_CCSB^5]?(4[A?].%3ZB&QD]!<;%GGB]U;2N3!U
MK9Y)R6X8)S"&RX$N4RTJ^J(@"S&,?^.7A*$.4@['9RHHI7O'Z*8@VBF\D:'^
M[FL*#'_,[W^AI;N3/UG.AUR80>A&#X-[04]D\-PZ-=8G]4NU#)*?77RFQO#]
MX *+LWC3&#[.YWXO;L%%JGH9_50"<0R_?V/JS->JUTQ">+Z+F[S%9L-<&C>Q
M:H5Z+^N7KLD1M6!@Z*H<9?D Z,9+U=,=&N3SA-^3^412EA-H)YFNQA'D/5G<
MNP=/DA4:RDX)\"3(M\I"?1EXF5Y2U/+0J7@*7.F[O3O_L),_;!L&1]ZI^B;%
M_<W$A\;[I2>PXB;5\\A\J%8IS@NEQ"8[AC9*%"R'40_#!6X8%R4,# WZI)//
M57H.NLG'/_0JZ"?EJ\-8[[6*T@?5#*"?M[QU(0O%]#/>G'#YH"S.HRN-%+5)
M,GA,N)66@U^@(\.Q<E#/!PZ0()MPS_)84+['*Z&T8NE#/Q<2 2]0?!O%%_T4
MOLEKJXS<LI]5LVG4AYERI&?SMLAOK(J;2OA=SYBC\V4YP5;E+W0_^?H1.I=P
M[;+33A4,@);Q&=I?&8>=J%5@\N7IY\-7.R#,/3U=ZPW2O"MS5H^4DM@I&AMN
MTLX[#%"1:P:% A"H;C488![KF9P;'_H2AE-/P0,<Q9VXW6\;GXNGSHR7'XX^
MOZJ&6*4:#.;[/5V$##2ZVX^Z!X^ZU#P/':"T6E.UQ7COZXIG^I>B_V8,F($,
ME]_^OQ&(P4NWXN!&#R.X3/&]%@'=ES=:>0J:Q9"O+@<'-N&9?*7@<O"CT@+2
M:X+B?5$T:;>?!LW\)6'<7"4#X='WT2/JY;OBBSPJ#T0V&S0G2,8O("]H6C>%
M*(9*^X\6;U@T@N[%J _MI(9:Y>!H:($H3=KE6.R$>1F?F9):U/:9?)AAE1^X
MK9[!*Z'H)3VX_TC/[.BNT2J@3(<CM2?3"TTNE6HZ@?Z@3X?+5-\4L)DZS=CC
M4\OXHQO%4Q,QQU,+4=UM7<^^FFGQJ4H8[;9:29"+*98N&I0N.KHY.;\@1[__
M=([V_[PZ_GWPPZ612ZU IS/R+)-)P4SN<V&&@4WA&Q+ S]/*$M5.M=%(+"H*
MY1-7.2F/5/8:*5<$?$LE\.RF$J5)EL*<(D$/TE-O;_3$NW2$-[,%Y,Y"1D7Q
MBMK5,6+PH^MB'2-\V$>K$#7W TW9'*G$ .82A4<N<N2<M9IFNRF1R7H])=<V
MO61/KIO-4>VH?EVZ*4>N?NAM0ZFHB=7 7!6WGJ0?:K+'FU\1R[7-,9)*RR96
M;%N^\2@VWO*-9V/C+=-XY]J0@XK'^B:\;2J^."-&><*T^&P*+TYOCF=0)NS!
MT1C,<VU+*,NW)&<AL[C.B.A%$5/2"BQFSW;7O:LRSC-U!_MYM+^K[:U71_M_
M-;_O!];WKW]>GYSOTJ/]4WB&@^OOYX=7)^<??]YV!SN"<W;MHW,X_^O[R^/?
MIZWO^P?.T?ZWJ^,/7]BW\_>MHY^[#CSO9!T<5RF'<I>;2M#(9$10D[N^:T8>
M#5SN4\\-U,KJX&!91.3=9O..$\>*>!AZ/ B9S2T)Y'.8SX@,[)!2%WE72]X-
M@\TB1OPHHK9)F1683"?%\5WNF,3R;1IZKE22(>^0=\B[(AQ+\$ 0CP52!LSQ
ME+ LX8:*L="GW+(=#,=:+]F.AYI<Y!/I^#PP0U]PDSD.:')$^J8*A"6XSVS/
M!DV.3DF_@U1#JCTKJG'+E9&,. N(K5>J(O!T>2Z'*D:YX_A(M353;:BON3X!
ML#';U(D>3,9#SY3$BDSA16YH@Y9F"WL+J%8_:^BF''F/U;9^#XQ'/L\CMRMG
MV1V;5#/*N][WGG?&:L[F<JU5M(>&G*^R:>JBO3TXV)S3T E9)"Q'N* 01+XB
M5"C*0JH<Y;EW:&]H@UN73C=6\8X3.Q0\<LQ 5[A@=F";PO8]T[$M.W)S\ZHW
MVP:W05'H*Q3?->>?0W@CO%<";SO2=;&%)^S 8=1WI0TPB%S?<[D24<@0WK6$
M]W!!;@F?AY0S4S@^-YD?P8)<AKY) JZ"D$>6"B3"&^&-\-X^>"O/MKS(H8%2
M/N,>\VT6N/"OSRRN,[^AW72]F![9#9*.ZP8>=\TP(D3GYG-,P84P0^[0R($9
MF-$9=E-$-"(:$5VK-ED T9[E 9R5L$3HLH 'TG7TWB^S(M<+18CY4]>-Z!%7
M)"H]U[4=DSJ*F@PZQQ2VYYMA2*03A=3A$4-$XXY;W8Z<DM)PF])?K2%'Q"#%
MRQO,#K&%.0SP83$[Q%8=B=DA,#O$U@R];0@.GI$Q#G-$8(X(S!&QGL;#'!&8
M(V(M[G>H?M3)B1-S1&"TS3./MF%.(-W(]D*+,>:X/@\<YHE(!H*&KBW#V<6!
MT.7G=LF@;U^_W)R<']U\^_J]_?U<;U1\;YY\_>(<?_T+SFM=?J-_LI/];U??
MSR8W*MXWOY\?.D>_X=[M[ZU\HT)?__R2?/]Z_//DZ^G/[_L7#)Z]-9HCXF0_
M($=__O I]$\@ C.DH2Z]&_JF'X3,]"QAAUXH?4]@G@AD'C*O8)X;1H)S&=JV
M(,SS'!'X?F11)B+.?68A\^K)O)LQYE'+<9D7.28A"IA'I3)](2+3$8Y'_("Y
MS$;F(?.0>65E!N8*[KJ!391D;A1R7U!0_3RN L%<1V$1R/72[7A<HPM"J2+?
M)R:ERC59P+DI&+%,R3V7<HNX7+@OWE++0[(AV9XWV;CE6E0P3ES79CQR!:Q\
M0NKY#JQ[(F ;DFW-9!O7V[Q 10(ZRG0Y529C*C+]4,$X]H1P;!BA@<^V@&SU
MLXYNRI';%8H_'6][L&Z<N15 %WO7J3/99A.=A2XLXESF^I(Y(9&>)1QI^4QQ
MQ01QD.CK)/J?D];'T*?2=QS+Y(1)DSDB- 7GU%26Y?D^C;@(R(NWY*$\GR[F
MZXP+08D=! X3FP7"YQ[U& LL(GWF1TY 2<BD##V)%K5:RO&X9B8IESSR;).X
M.IL7Y<+DPF*FKSQ?L9#X@6NMS**&TEQ?:?;"4+@1D-LAA,%J2KK"X4% [,"Q
M0I_8*,UUE.8)"Q*W(SN*7&EZDL,ZRQ/$Y*Z2I@P9$9[ED% 2E.9G(,TLH* \
M<V9SQV.^0Z6('.%2.R1,2#] ;7K=<CLQ"P=V&#!+FLIS=$[-2$_ MC0#Z42"
M28^'/-H$;;I^AH5-.7)9-[9Z&D!6F(MPW*(W/5S5NBMBM>Z;  \-NE]] ]5E
M%GQX=A3+B;B41''+8L0%!=?E0-B0:'\!5]WA\X&SX.//@E\F;4I1 &L/KAPS
M%!$U6<@#4%Q!>PV9<'45*X<Q-FT6W*#@^Y4+ZV9LS2*V$=OS8SNP75=XS'-\
M;5D4BON1XS,.T :"6QQ=]>H)\_$EC7#]( KT0L9R?>V>+$RN7-=T]1QL1[Y2
MRM^*K(2(=$0Z(OT^>U1D49_Y*@A]QCSI2L%]XG'F2!I9W":HB:\7WA-V9)AV
M0YNX@2F@ITPF/6%*3Q*3VHYDED^5I6;XZR"X$=PUP1.">Q6ZN.4['I&^H#1@
M5 0B)*ZC/,>1/@DLSA#<:P;WQ$:"]!B)/-_D-F4F<RS7%"JP3.FXCNN&?EB4
M'+0$@ALW06IWY)0\AN4P/>ZW86@%R^<UA,MHKL6=OLR1E\.%!LJ10>AZW/,
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M*9/1Z;C,V_J-@4!9-U 6"8!$H#P'H(@<*.X(4&SF6"-$&2R6V,1BJ5HKL?F
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M3A^:9:B"00_^>Y#P]4;)U(#GN95 R7Y8]GF<3AY_.D&+$J)Z&JJI*[QJH[S
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MQUR:ISX2(*8Z\Q&Q0C(_^ZPJ4]$8^VXKMF.&D;EHN  ):PA"AAF<Z@M"3'"
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M)8&<I^K ?GD&H%.?4O W:<7!C7$>@U+KW'8),/Z <Y*KCDIW##6L-R,[A2$
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M:($ "@(H"*! A6 4& 4"* B@(("N@+@& JCZ&$D!M)-G&37:&\8^%5?6JTP
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MK@F(Z888:-#*N",HFH!8(Q"#';>J*(F@>C8UN0"CP"@P"E1/4#V;[;BJSL!
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M&10UF'%BIU19@-;;U,:B,\ 8Y1%6L0P4*0L;K6HJ\-\Q&Y?#&Z=R)E(;IR!
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MPPAUS%+II(R9[:#HR_9VTNI/$KP^6(X5TX]O'WI=WNW]_LK6R"O$'J@E2CO
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MO7.B.P+PYR.!*Y6P'E$!N]BY!?.7VT*_+[R@@312YEK<#ZRGN8X+S8*A64^
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M.W",/@@9>)T-)]SJ>M9#[]*Z#=L?24Z]\-,@S?/&PKR9B>AS5"(YP:*E$>O
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M)!;"38.1P=1H(6H6D=/\0G$"_3LNB]VF2.%6]%UY\N'VDO>R_:0/P_5XFK
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M?T^<39H8O,&<T8&L<*ZU48&Y4CO&8D56LJ59+$F=#"IEFE1R.90$[G'K#Z:
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MCKS:7+EW.$56B-[?+.,&ZIO1=#:YFG_2_T#1EJ9F;T;7@8>S_'HX\J-B4WV
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M)"5Q+#,2%#..II!=;1_B88 G3K0>M=- H\X%'+O$2!PHSZ@5A&J))J2.#.T
MIPC-1G!IE>1U\MWWCF/U= 1<O^7G<F_X"(L;R.GY\.OSGXL;\NO1J6^7,WV?
M-[9N*I/2%FW*K<@@7$Y$!(VGG4UHBYN ]I45P2JO(-'*MF[M)1Y^$.IA#X[C
M\^(QCUU]6#SS?M=>2AJ]SX1K#N66*1#G+!I\F4G@6F=5)]]U/[C'']7ZN+C7
M^1/9F0,5^K<VP%JV2&\#K.;8A(W('L]DV+[5.ZZIFX.21RG!*8- V#QD(O'
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M@]TW#W7Z2].E9]E7N)2]-7IO*:5%]7@:2!FTL@Q(3#;A@8O;:+F8)L88:PR
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M:!Y**A-Q,3N"#PS9XV98J=:H';S38%(%550HJ;V[\C>C&4Q@.F^9/Y_?GC[
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M!XYXS]""$=D1%R00]"9Y-D)8*ZNX[B<9X>LBW#Y'XMVR5]<@W:IR'80<54B
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M:AFE"M'C/I%P>>6<.&<]H2)&IFGP:&+MZEWLA>2<3= #ZVG@C/7]T-]$673
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MO,L UI#O_<:+,?[#XEB-_61D$@AN3";!4843RY2R#-P0,#H'B5Z -U6<V2'
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M8]2%>#B2M4&\,&KUUE(+H?:^:N@LD54RFO!96:\4T2;C/D^M1KDHAOZ(,2&
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MY&9?A0Z9;]%O# _*_D2FC2K%?A)O*J9XA1+DZ-I002U7WN5X&*-P+_@_J3F
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M\O5O/KM&L\GC2$<B1@/"1=S]@B>2X19H3:EU(A4OJ1W9N2Y9HOLC."?JU%9
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MT,H13QT@M0%T<#38S0";T_ ;]ACK9<Z;$^93RQP:YMY[F#'?MPW9"%@6VII
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M0:(EIE@,C"N7@JMW$':T8?^<3J?+LI9)-LP%8X\#D)V'O_VD,$L7\?^):,Z
MR(!?^<@#4:5'=9+*!5.OY.A)B. R)]])B'XG]K5,Q*/?A3XMBFVFL):4"NXI
ML52B/>QT(%ZC1\@@VXQ*S<:?9$3 WB.^S&EV\MQJF57U,X0'ZM721&7?Z2#&
M)"N-ZHD/ G=UB5N[E5F3TIV>6@<Z\=.R'7L-]^=\.CU6M4RFO:]2RP'-NS*T
M64:X2S__",MIXR/.\IU^KB_>_[EH>KI"&FGN$LT&YWT,N)OF&$E(UA,M#4.G
M4GENNYP&[_;6B^%A984\Y(XZ7AKMZC#B36Y^>K<$G(DB*U$N20+E.!M*0Y^4
M':'>RRR4<]:<5C+(MI%<#&U/@PLM[.YU]?KL:G8]7;[)-^6Y%LVJ?:]ZRF3\
M<1PF\.ML_ALL9I_?7L_C)QS;*'/I:>D4HI) (4:)UI'DG 1C:% )#271Y4)^
M?P070[T#*JJ%7[UN97^;S(*?W!9_*V4*;W"]G?CIS7'2:G2 !L87/T&A+6=6
MS7(Q'GYO=H3&A)CE.\4._3+ Q_&T>,.S.4S3+(./GV8Y0^G(L&K7_M>G<?P$
MZ#N/%Q,H;4"DYMP83G01NU3>$E>ZJ&EGM$Y@#,NQ V-/:4P7-0=.2? [D:EE
M5ATO;75C'_KBQQ._7C9* 9.1%L 4EYFXZ-#KU4*AR9Y0.S;F)()C/I[6B<H3
M [J8*7)2S&BA_-[7SF7N_SF=0YQ]G!:+Z>ZPGL\6RS]FTY7KV4SF9BB+D:92
M.Q84<4'ZDO*'L+6G)# >DC8*@E<=%OM=WWLQ;*NNE!8&]2K?^AA8E$!TTI?<
M.%YL<&H%DIQYPB@+$$/0V76IPOC8.WXR8Q]AM["@5XW6;5<JA:NWK;Q&4C!0
MT@"1S")/,X[8RDR)5T9ZEW,.M,L)4*>7710OAA=_"T%ZE6Q]-IU>^\E?:YQ^
MA3/?-A:9EQ)6P=',DD+&)B=+%7].O).XJFD&E#MIHQ!=7-^G7W51Y!A:]"W4
MV/M.IN#[SUG#T=E?Q4AZ-ID\G_C% A9H,)4M;A0"UR(R1DRP9=@^$I\<$.99
M3(E!X*X+*QY_RT418D"!MW"AUY7"C;/YN03"-"?9&1W,U?GUEY6#.4/?M/$Q
M%P7M;(J_DY#"L_RQL::%]I(+Q*P3+FU2Y$"<8))0E[B!Q&UR7?:8WD NBE&'
M5=M#TNE>F5%H4W]I;.H&6G,[LH"[(QKQ9(6G8$DL5I6,,1,;T%GC:&\+90 R
M91U(]>2++HHTPXJ]A12]CO!OKUC?Y%_G ,_]XM.OD]E?O\:,UA3NGE>EZ\O:
M_U*X7GHF Z%H8!%I@D9/+%@B1"Q%"3-Z85T:$.SPRHLB2BU5M%"FUZG\A^;2
M%<<^NU[>A[IHQ6HT:&$2D! 98H44B8TR$J&2%AZ4M9M'@JVTV?&U%T6=FBII
MH4_OX^=[I_!O_IK"?/%I_+DYAG__YFU;ZQ[/M,@V***4T:4:4=.9)9(8- 5J
M) 6^8>\,W+"I*]*+X=UA=-G"OOX)2!&-LNL)K,^J'Q/=UBX('\K9]LA%JB/'
M*:2B9$1Z[8ECD9)LA<A <:"F3@OFH48P(%O]9'*R'#V.QEO:BN./4'YI^>]Q
M,L/G__/OR_DU?/\0_07XNGPY:9#\\^\+^%B^Z,OW5U-T27!^HA]2'O>Z_(,R
MZ*_CQ0@]W="<IM)<^ANQ)(F3($@V.@3OB\BKW-<]@FE 3GY""<WC=0""GZ*R
M\2F/</0X))G5458;^>KPZ$6S374"-T)M^NO)\H",6J$;<E>^81+9&,Q#1@VF
MRVX<Z:&(@[,E*LJ"D(98[U1IETV)-Y83J;VP(NC(H(H]=P26K!Y]8B391?X5
MR%%N\G"=]1-8_ ZKE%OC+'=,(B"&:V;,Q:-UG( RN-7[I*BJU'9Z \GA#?@!
M-?6@OV\?,3_4>_]8:)C@CS[^!N@F^,FS:7J6KE"^B^4<A_P%UA["#5@=<V!>
MYG))$W# )I%@DB!,9,.]2B JQ3GO@O*<^%)//176D-*D&A_X"6&^@"\PF7TN
MTEAC7$-4069FN2^%J5 $0AGB;?0$ET\A?3!@:!4&=<!V3KP96A4M70#[LJ4<
M2/SAKZ#95X,/P@N:B;:,$IDH&NA2:1*CS]1$%9*M4A7W+HC+=G/V5D=%:JPG
M0A<T-1V9^W".X[GLKYXM>NXAVPI;QP8J7'^R-5R1+#0KT=A0\@P]XA/6@BL)
M-E6.\0ZAZ2>\CUJ*WD6D RJX"03BE+'7R]49]'KS$4(YJLK:E*5 .  D '[K
MH@E<^6Q<W*A7VQYS]?#1A]_&^TAZ-IR8!O0.%O/E*JESQ<+@#'@G2*1*ED;K
MB7@ 3KC,(*7UX*3I,!OQH7=F(GZW.0OOO?4R=^/]!=]2K[JW]F]<U XP=MA_
MN_-@^ G]](;;0P.;.NPAO@%7X$TX.6K.0BZI@PA"JJB)9<R0:(3A$I).LDM+
MQ]/0XI;-='@E[B*U@97W.TKJZOIJ#01T#BKA,I(8)"*S"*52*B<ABL0=9.T9
M'4I]]]Y\N'VUE^QG0PANX*WT=__U#A"5#&/..H(.?EZ?^+G,"<LN:@>"<=>E
M"F8W#=Y]\P^HP;T%-_0<O >$J<B!444<5V5,B,'&4EC(NJ!=B%ZS+J<5^VKP
M__QC0X&O\=OF!\WG14'O(/^M_/WGNU>W+__KK[_^+<P6R]ET$<=HJHSS./Y;
MG%W]H]'H1BK'*FGP3E6E^X)=C*\^3YXRT)]\Y#^^@[X_F/5S[W%Q2/CP=0G3
M4J7E;^/TS[^/I0GH:1D:LO-2)1MX*6]C6/D\<P&;>2Z/CJ2.^!N3<E%!">L'
M'U 5;4/94 A#+]<GPZT*3$H1K(_2"FHRF$Q!ZB<5\G!4==3R I9^/*FAEYLG
M'U QK8/9U QUSN98=!%D2,&B'^J4-DQX9I5@3VKFYB7]SHN>X=C2>')=+D'>
M0[R>HUA@\?)KG%PCUE]Q(RH^V_6R<=G>Y)=^7M+2%F]AW@!Z?1O$Q!+.<&G1
M-?2QQ.U:@TZ:=P1"4HPEC^RK4AUMJ 'T/7C;4-?]G/$[:D,?=QQ'4N!&+7 +
M5\ L[N.,$1^R)3RG)*RTTE-70UH[H3S\ =!1V+AYWE=/DQ6NG5O!OB@BA/0
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M4AAB0^(DT-(6@6>MV[0].Q!O__N%E9G?Y5>-:&N@@K:H$OZ99.?/_"C"[Z<
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M*\[X_F(33L.M5$H[4D2V2NH'%/6T2(06S#KN!#6Z^R#?Z9[/@_<&]JTLA[7
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M:)!=RLKZ>9O7T?>F2_!8?+1_SA^+V,'MB;'HHBT*@B+5H, 1*$G>,J=$;%)
M%$3*2GZW:^.^F^$\6-),_VYQ1X7E:'H:G.'=1;6J]^N JZ46PC9@#R.+4(.\
M>_WA",OWZ1D:O=W:D B$5%+,+",^FTP"4&N J:A=DT"M7X^X1S"A3X?8Q^"5
M*Z_>_PGQ<C;\L;;J6BECBAS+SCQ12I;P3GH2E$@D&QUQ;4[Q\;NT,MYYD_[#
M[3H\C%L8L7*AY3RY>^07!0!KZ^I5'D*4E$4G<9YS...56M"@5>G=ZHPSE'.Z
MKE^XD>+[[_0,>*YLSJVO<I,CQBW;*P>?:NV^7OLMJ@XG6(%SKG*6FF)09[()
M.46'\VH"F6C@?MM.5*USJRV7/_RTZIX+MC=ZEY.I('*.41L;)<A@@^>"9R^E
MBRYEJ\PVJU<2;(4,DPFD<N"%4_VB@\YD4L["RIV*+N*'41K^&*9+?[9Q93"]
ML4[E7D<.E#CP^#9KQ8GU( G-3&H/5N&HT6AGH-I#U-]C*3*2L^D_QI/RQ>I^
MG\:C>(F81[-!4BQ %H[P8!.1&!GAZIXIHGD2X+W15K21T]\7Z8/L]#V,=]Z_
MBU*3U5ZV^M[$>'E>ZEVO/_T<SH:+HIF!TY(!PRDX*5JJ&:-'*XE(M* 2?.39
MAB;YJOO!?'7 %GRVD*N]@_8N1.%EEM9J@N$E(S(Y13P/BG#GN#:26@M=:M8J
MN-RKG[5CKD6?UCL0_^&'D__V9Y?P.?\<F@>.<8^(<$41 KX#N@@X:%Q7<JV<
MF_<,8&UDD;OA>W6RJ@RV:.EZ%^9E"=Q+N=GE=(%T((0PB#,0;1DMNE".!$HE
M4=3)E*GA@?=TMGT7W*N+U>.N11NYNW/Z><F,FGZ%.#X9#?\/TH?1S<Y1@P!!
M6VT44=[2<A!8!.BC)%E8KKE/1>N\IS!M-])7SVO$:F4ID4UAY?]>HEV2'Z7W
MTZ)R.YR>0BK?66;(WAB?8Q)>.1J)827*M%*2P*T@,4KA5$HZ^;49=N-FZ%$@
M7J"G]4M<98F20X"__3RPX%C&)34107L<JI,@'D0B.GN7+ 21H)6KO?W\ZF.M
MJ*JHD+)]_%T*P[Q#,PT8D\JXI C@.IA()33Q%N=]%W&ZQX5+=E+W,X/>0/4"
M_:L^6W==R=9WI?F1%DQG<W14\11]<71G(Z)+E@0C&4D&P\I,HPJVITVSF[!>
MG:D&7W>]R=7WID5P"*,TKW\84,US*2$C$*DN/:;0T:U#^H.G7(88?3DTZL.?
M;@-[]:@ZG&W8:#TJ76&97!P6X,;7&W3+#Z87?I@&.C'IHC+$JG+";D,@ :1'
MO 8@<0:ADRIDEWN]0#]I0L,&/VFP(W_K$ N&)Z-W\Y.K>/4-[3==Z*+^BB1\
M'$^G P<N&(.K4PSI+-K&*^(H2X0FM([R&:)L=;)[!.P7Z) /P/<&=VVPQ_\F
MSB[G6427D]'G&P\SR!@1LI(X!*8L-S05Q(6 7RHJDP1E@^_)-;=!?'7#VCQN
M<+D&N_USJ).A/[M^+5C0UKG,B!8>,1I(Q,8$)$8>J= \9=?3F>4=;*].5HVY
M#=[58*]_WGIV&"[G2L)OKY997I.!!F$-*XJRI;^L]#R1H (GR:OH(IB<8T_E
M55L0OGI:918W^-O!F_I=YO\US/-O^LEL&(<7?C0;!.IDT#H1P6,B,O* IM*"
M\)!U5EE)'=JT:#\8\JM'MN9Y@XM6/@7X"?ONX T,'/6@B!&L1*,:EU%<<'RM
M2M4LCNC9W9<*O/=-7Z!/M25F@PLUV.N_DZVT,LV7L@K/(H#!M0U)MM0K\D#1
M*M22!"S+$%5V?25K[,3Y GVO#T8W>&"#(X*UU?7[/^/\:.RKG\'RD&Q#NJ;3
M^++H2+3G#(=B)HFGBF+P(+RB.!)+U]-)P@'H7[VU1_8W^/#!!Q/WCO?3Z>7Y
MQ3QZN)Q"FHW_#C.8G.//O__S N(,TF(9/S!<ZI@YVBQ9(%)%1IS(BE#C#&<\
MNZR[-!RL@>4%.N.#T+@AK_>HLXP"932%KS!/:/\V_LW/XNEP='(KAAUXFECI
MI$VH-0&C#.:)4P+CUNA3"*EH!9L.CM;I9B_4D^H3L<%5&AQGW/#R[^CE[_Q9
MG#=W&YW<&7"+C$7)R"N#\H FCBL?Q&]IC#CXXE^VZ/)HZBEU)GJC8S]3[X%/
M\ +]]&&]8(,_MSCOV/HDGV!6^I&-TS N?[YD-ZS&\H_CT<DW**U-%SOLR]UU
M$83,@3GB6<2QW14MY\P8\<9&T" IS7T5>%5]L%?O?QP^L^&E:'$BT_WU+J_U
MYWR3I ^C. $_A0'3#A\(XYR4&2=2*H%&CX$8*A/7ECJA>BH,JO(\KZ_ @WK(
M!L\_^K3H]W@*Z?(,X54P]4*J2T*@1D#IA.AQD6DTFED$0Y3Q25 +V:8F[8;J
M/TJ/$GZ/P\L?V!L>N9Y?#E0HBP\@(,]SA ,&<<*32#VG5B>JV_31>EQZ?@_M
M(]W$_?;AJD\)MRZX7KRXWU[D==5R.\3RO<H^!A- &T\"5Q0C 0,D))5)-)%"
MPDA8LB85ET]!W*^)0^QC\%[%_6(2 ;SE)&F)8Z(SBB!43BA/AH7@M%@_HWG2
MXGY[\=!9W&\?(_8O[I=M=@)PLG-*E61^IHI#9Y*DUI0IH:WHTB+L28G['<IS
M97-6?I6__]<-IV.I*!1F1;+SZ'0B K%,0"&. 0?+@A$=:+UYS6= X,$F:B#I
M\O9RBBNEZ71>7SI=6++,,,%Q$7@"(J3,1%)@Q%JM2@MWX-;BXKR-+-46/*_!
M?36V>G*B1;WRZE7I K!EF'\OPH>)]ZOPV<%'CB>C0>1_/]"H&6<E7#$,2NMA
M.Q<DQEF-!:D4<*=LD^WB!_*6>]8"#^,L^W!0.91X^^W7&[B6\Z4(-."@B7@B
MCT0"/JT#ZXA* J210*-,'4**3=?N/[2H;/YQ1=OUHHRY2(V>'WJ]\S,X&4^&
M,%W(UV>:>4R^-+1 J-YQXCG.E]I:ZVC0-NHF>XM[8'R-29JRVD!6;@.L52C?
M 5C+^&0KLH>)2YIQNM[&JRHA#6*4[0"%M"!5EH3:@ !I8"1D*-+\F@>G0.'L
M^PP\Y9Z8Y.$=91\>&CC(LF?Q:#;Q<;;::F-424.+8DY21#**2WK*,_&&"ZF\
M=2$T41/9@*7_D*824^.Z9NXEFGGGIZ=+;)*G$+DL'FX28BN[.L))$E+P(EDK
M*.^I7/DGJ.?B"]4,WV XN%;3?7MU_=]_#F&"-SF]^@@_X&RQ9-,Q19X3X3;C
MX^N2]"B3("JG:'4PF:UKZM5QCV[P7@/;5EPVD+*]AO8;^-(?<"Z.=!?O:NNG
M ]B6<>Y>:!\F]FU!^S;/:L99RZ&M$VB:':=19V(<E41*?.="Q&$Y\& UB\XH
MW^3T_A$XV#TA\Z/SKWVH:NE7'T87E[/IW )L.9N'9&QR+A!'+2=26$N<<CA\
M>^%B"$S0W':>O(NI_RBJ(9O;_.9(*AI$VYN@\=5IMU Q^B2)LBD0J9@@'B=W
M)-7()*VAQC51EMV!Z:5YR2%4]#26B"4TT,X#Q=5&EKCND"HF7'*49I<@-.-9
M4A^:E)OMP/32O.00*AH<5]].Z/B&O[5(JN-1*>T]T9SI4G2#2\>(T#P5UJC$
M 6@/[<E7<%X78;6XJMBX83NJ55)M!US]I3/_!/88TID/(^]>?SC"\LW3F6_@
MHRI#%AP!18LS8[".!.\B 6\C! U"J2:])OOUB+W2F=LZQ#X&;]&(;WP.T]DP
MWDCU,\IZF5PBVF5$9)TG/F,PC8]N%%BEA&NC+W@'RD,G41Y*T_I.\'$VKISF
M?"NM$R"9^;:V]H!S7@9)O,'93\52<9:H@W6]JT>?^7HD:4>9J')FT?PXZ58>
M]<WL:0F"914D$7ZN;$4-<8$9@M=P*5GCH^S2\6;G39X!F?6,6#'&GTYF@Z\E
M1)U/+"8R)Q2Z6&(:'RU+1:R&1*@!' <<A6ZJP7C1&Z,M?K4^TMZZZPN/W ]G
MH&*_JVL0JVFA XP]XO+N#E'_;;\__#Z"@74.CS!?Q2%['0ZSUG*1,HF2%\E+
M'&"<XYD8YJ@TV6AGZK[6+5G<$C+7)W$?JU4F[S?_Y_#\\GP%)&MC<%8A1KAR
MM,& A,@%4<+C%.JLENN-40ZG[]:=^YMTC[+]N(;A*@:W<R!HJI] ,@6C2V,P
M#8:B.Y8H6]J$D'!V, $?)G8YW>O&X,T[/T$&#S;<UG?PWW]9>_J/^.7\&_//
MR]-]A?R7\N_WKQ^N+?'''W_\+>!D/QY-XQ"G^F$>QK_%\?DO<W.LHH</'V[?
M?SH\OSB[3^/YQB__\A/(;8#+*]PBYS!(\.<,2D?AO_YEF/[CKT/A18I:,FF$
MD#&J0&/VP>'* N-9(\5@,[ICS?1WF/GAV?0H:ZVNT<1H&P&NV\XP$7,.&OU.
MQ@R6>9QFG)?&FD !!ANQ+AVP_!7\%/[SW_X?4$L#!!0    ( +>"5U+(RZO(
M"/T  "5H 0 3    8G-X+3(P,C Q,C,Q7V<Q+FIP9^R\!U137;<VNNG21(KT
MHH"@TGN19J&)B(TN(M)+B/2>(*@H54!!0(H"%B @-?0(*$B7+@0($(H"@00P
M!-/^O._7SOG.=_]SSCUWW#O&_9DA*W/OO?9ZYEQKKKF>E1$V]3MU 3AVV<3<
M!*"CHP/":2^ NJA\U#C<VP, +"V!LP  '*&]V %ZFB9#.XBDXP$8:#H=[070
MJ?S]?!&=ZI\Z'TWOICOWI\Y-TV<2O '&/^L#1S9?Y?_Q"4C2+MU?%P58:.<X
M:,?^M.,,T?4_L0[E4 [E4 [E4 [E_U"Q]?9W X<%G;CF!0X&GS!V\PX&!YY0
M45945E115E9145315--6_R_64E565=%55M%54:%=TU75UE56 RZ[N(+O!8']
MY4^<]_,."G*A03(_8_@;?^$V><;X=]TA(_U/G4%% P R,OZA%]']@P?]@\NP
MZOYA_R&7.91#.91#.91#^3];_HE_J.IJ:/_+<P!P&7 !7 $P< \(HI7^@#QP
M C@/^ '>M.,@X ^2 C#3,?R5=3#3"F& Z4\=X%Z@$_F[_H/N]%_KT+@*/=W?
MOGWAQM+3_TT7Y_^K<7?_<OR73^IW*A*X"!QA9F9A9CK"PL+"RGJ$C8./DX.=
MG4.(AY>+3TQ80EQ,6%3TA+2B[ E)>2E1T=-:9^255=35U25D=?2U5?44U=15
M_VB$CI65E8.=0Y"34U#UI.A)U?^V4#\!W$> *1K'HCL)T'/3,7#343\#$C0K
MF>C^E+]U+QT] R,3,\L15C9V6H7Z8S2/&1CH&1F8F!AISM+%T*X#C-Q,/"=5
MSC/S7G=AD0S@4WV0_OJ(U(7JCN,W1K#2:O<"XUC9^ 4$A81/R<B>/G-674-3
M2UM']^(E8Q-3,_/+-V]9V]C:V3NXNKE[>'IY^P0%AX2&A4=$QC]\]#CAR=/$
MC,SG+[*R7^;DOBDN*7W[[OV'LIK:NOH&>&-3<V?7YR_=/5][^T;'QB<FI[Y/
MSRPNH9=75M=^_%S'[>SN_<+O$PY^_^'7'W[^3?ZE7]PTO^@9&1D86?[PBXX^
M[(\*W(Q,)U68><Y?9W$)X)54?7"$[T+ZZ^H.5BFU&]CC]P)'V/BEU1=/X?YP
M[4_/_FN.Q?W?\NSOCOW#KQF @X$6A-P,W( AL/_[-/ FENTT0TK32 B\\);<
MZM?1WG:=QQ_D799VK[<^B[VG5FT?QG5[;56[/[M+7#'S6G6NV%7?*&/6-61,
M_6RLHO0S173OR<MG##\SZ_ !CH2;7_"R%EDHQPQ75HNDQG>-@6+=WUQO9SZS
M'1@R$W+79KSEN^A\_.(+T-55*XWSYT($KD9_.'\]_[/FZLW&^T9W^"K-F/+
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MQR+.=^LF,TOAZ!_#$8T/&+/C)J^&D7,NAJ&9.G[H-^&+F#(OU^6G;UVO%+I
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MKE<F]F0+%;B!^#5I2.;X"UWZSRRRUG>\FF0[JKCW<WI2[F6NC)OVW2/=IFU
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MBRH[7*SX'>UV1T9L3>]94#'C^2;%JO^ZY41T^)NN797#JK+&-?A>W@;MX[U
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MJSBM6!3ZC9N6F\B-;6^7^PK9#*\U2,6N&MEXA1N>Z3F60B0[XH>P8]@+KGN
MRK="D;(03!F)(5W%>L'0.T7:PR_'#10#CZ^[PR[ 0^ZM\*2V&9L%97F>9'.S
M^AJ7&2FL9QLTX=LA><2(F"#(_/A(-9=GOMQ;PTO+[LXZ@/;14O^5^^YW[[/-
M"85ZXZQ^6IR?0W:%HLL7+!)V<9SYUDF80#YM/X*<\V:>;^@_&OH=J3[!_9P
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M,W8;M!0M*NB&';)4TP6*VV\ A$ZMN*N"J!A3Y$LW-Y\Z]OL!;3EW>6A/G\)
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M29)HZ>,QVD8AHGH+)GB*E^487]F5_992F)0#F[5J07\KOY%!J>[A63')#&K
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M%?,LZGM8^BL#?Q<5>**Z3X9G*Q.?W8:>5.U4]>#KC]U3@QI"7XL7VROMU:#
MM-]&R423.8+J\*AE";CM@[)5,V>^L8E.65](DKH.GQH8ID[Z:*0^R=+N0Z'7
M[1BSI(/7X L5/!N\D+Q:N7?#4M=C->AK 6#/RH9C:GD=Q%VKWZI"6B29C.B$
M-34HUF^O!IOM%G ;@#-3^.0&NM<]&O@9YIHU%2:W;'.(0\D*?*/Q;TCUSVZ?
M7#R@^$[LU2&M=3XACKLC:+UF*O^6%?,6A>N?0?*FUQYPT,A 3H+(_YV8\44F
MIK2>GJZB\/M3N+O$*G)XW\?(TT')"&3TOND09*VK8>V"3\A)QWM!6?]2=M[B
MF@)A&A8T, /OQ'C\S-)6+HHL[(TR>#(V.7ZA4KY7L7FL" +=0@/K*^-G=W+4
MH,]D?VGSMQL+)*6W8Z!@P.JBN+@.85JXX^D-9)1%96G.Q)\2F7=)2(@:=)O5
MK\&TKSF NY8B81)XWZUJ45S",.1V2;XN(.R:N/_OUS;:\(81W*-#6%=A(F?>
MNNMDK->NB0!.PW2(0PDJCRZ3^"(D==)X,52D\WQV'95IRZD\/]065\QU2/I)
M,(RP%B&YOZ13IU6K"7\?I,YZ")TJ4H.VQQA'GQM3;)B"Z@2X1U9N6K@G>+>P
M8+Z85W#%[6AHCEMH8.4R,MO/[Y[5Y-4YZ%?XL"MT8Z!-#>JD%!Y+=K3"6Z1*
MO3/O33%M=/(R& 4S;GV'CY,[AJR[F[TLH?E[C1)8]'_CULG_SP5[2:GHE/P2
MAO4&6E]Z%Z>/\=%DHXF1:J NZU?5@.064XK\U<\0,S9XW4?9LY )+4"[-[NP
MJ=[YYUD"5]%!(5A;-0C=0=N(F(H.XT^&>:MZ1QP]7YW#-DW+]P34^VRKJ#Q4
MY>T?%DC-(T1-3SP!>UR$'U5<4%8H/*<81L#<4D^_BX9"M=_XCZ4]G=\UV>H
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M.=Q)\4R1(+W@<*;QOD5?RD.ISS^2,WSVX4\4U-HK&!"]IY ._#9_8$QWBZ<
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M7#(4'.AFWG?SJ^YIE2RRO&%:SK/D)ES0Z@;KX*]!4YL);1J_A]^+I*$K 80
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M^K=P%;,6>S"W7670W)BY! 6K05$-STD-9\E+,NM.:@^<BZPNPX=GC;-^5K[
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M9^4$Q:,7K2GK/V<<:8^/MG'=;UX4'#0PQNM <1*%QS0^>0LV< B+?((YZO5
MI4,9(GMH5^X,]'@>Y,<-<-4V<S5-MW[[Z--C)A6*GIX\YB7_6=7Q*QQ G1NB
M::-(B)L:JZ(O4D0+KMXL:T4=^6N/*3-.["YO\/Z!2?8N]"H"2&3-E"4HH,T
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M/:R%X:%UQ_;>K<C'CGM=RY"]3&X:,OK6]^L^,^]^;_*M40I"N1N Q@V MXF
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M>;#X@&R$:!>/#;[2#X>;(PK[M; +,Z91P06!?U56Y)KLH_P&6"#LDI6V&?R
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MHC-S.D/.29[I9BZ3<"KX:U:RXX_.C1,L^!G95G ?77_&X;3TBAE)71]VJW3
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M")"XI(F72A"WK?&59M8PZ&O28+I.]?-A1WI0\!IV0*R+ALR;SZSGB]U+0NG
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MX@\# V+M /?Z'(]HT)*E<^U:_JG.(Q%K]S[#>WAY-ZP[5S*;/BFNC;/=VHI
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MA8/$43@P^-:70E#AZFKQ]WTH4G#!WS9S*Y_4!O_R5I>:B#+S) 0A>P.0 4J
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M&#MD-8X'P*YQY1;<&NOI?A\2K<XL#;_HWF3-DS=,9.KA*=&)MDZ;)::IO-5
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MQ[L+L%&EJ5>^K4R[%[!6!_S1*&10*VR0P8Z3^Q1F&)F]9V\!_>2"L2TQ48+
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M0GDB#)N7&\LP-^X[D!:=9J#1XN)E[4U<]>* 3&L1FAM,;Q]Y9#.,S+2C6&!
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M3I)) !'W7)@$"$/J)7(&98BQ1*L%X\F1YC8)*D'5)N;+Z,)AT?Z'X=5SRJV
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M>R7;P1^CG%>?P,%NK,[^H2:.SSFJ[VY,SO'+AU'$NI1-K\3 IK[-OZ>\4'O
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M(NL?1.O@??I<WS**([/OY #JG^);!G*B$_Q&:K!S_O5^+3BXE9*#NP<..MU
MJYPZ[N=EE3[6W24WJI;U>N:^P&K2:RIFY1EX2$LY6:54CE9)IK'51]< ]B.Q
M #I/F2P.P$"E?@R R6U#,P15?-@7^4[6#7L^*,.H B]MQH03A0$/*1349RJ*
MBT$2.PSZ7D2%%S N<3#+##PRVMR8O8UH7$L+.G$'5G0]#C4*/<ZI&ZF.PQ%$
M*/9@[,8N%,AQ.(TPPXXPJ_QM#>QIJGYO:N[5U3?YD?)\:F'>FD+RE5R*Y_=9
M^A_RLK8JRUM5,T+5:WG*"VDVU<!L#)/I+9^LF6'D>?B,UWU ZJ4&)G93+H\-
M.'&JI8;NNRF6.C<-FP(^\4H%FGTN\J\IX^S-\^^EBAMNR]MF]YM6PYLV!0Z*
MDC!QH*_J@2/?\R$.J ^],,0!\Z(XB@S;%)@+,3\&6PO;:\MMQC<#3*%'0N/"
M.S(S2>&;UEV=^"HTY">E 4BSG\$^V$=I>C <1)M4-D"*2?EM.$K;I'?&DP86
MWN9+^=?[WW@F7>NEVE-ACVF6JF>KXAQ733^2!?=%$+$D@<(G*O:52*>-(P\B
MXH>(Q4'L$Z-Z&7K#SLT];J6^ />-W/4>*'XA^< .+IIFT&,^^^".'2#1X?I;
M#]>70H-6:HO5IHU0LEI$6F_D:6M#&Z&Q4_+9[.YA5/4^+WAZGUU]IP_RY>&J
MF94BP#:+F$<^\3P>0[<.,$U$!..8)3"1_IH7!0%&D5%T_M'1YD9,K;"@DQ9T
MXH*?&H%_-J.CXU#KL9 U $<FG\/8V:]QJH6)3:HY/N"D#*.E^S:QZ-TTC$\^
M<%QRM6^RW3O$$Z'O^#X,DMB%R/55VU/7A8GCB!!)>G$"HWKP!\:9&X?48E[4
M&TEF9'$(1SV:L(#.R 31 V;4]A<GD+!)"X>&FI003NB[306G+A]PU+NZ?^19
M^OTZH[^T4UN 1!($KH!^H'*X??D3%CB$(G9%&(5.[&#MEL>[CY_;)]])6,=_
M_#*@GLL>!#7.:L_"9>2/?0Q(#$Y?SX)FJL-60XC,#D(/(G#LW'/WINF..0\*
M_.)4\_!5PYR7F^J!%W6:4[_,"F,\2GPD($^P7 0%(8$)E?Z+P)'+61)0QXG-
M-JGWCC._?>A:3+!4J6!U27!<2VSFQ^R'5/4#(DPN*0GC7'J#L0>)*F+OD] E
M&/D)(^&BRBN\G C0S5A3PPE^JL<V7$ONAU7/.3P;K)%GBP:G1L!Q*@ =1<"F
M2[A_H$D=PJ.Z;KN#QR\V=P8_2O=R5=1'C4_UD?HC+O[.J_HL'G_#!5N$@?0.
M0QS!)&94M07V((YH#)'GNC2)?$_^3=<W/#G:W%S%GL"@D1A T C=!D?58AM4
MH#D-^&E7TBJ,(W.%)H(V =1W/*T".9$?>O8K:>28:B-TQ$\]_8S)W%9M=?I>
MK/Y- VM(2/M^DA:O:Q4XR \X=HF<JU1T& L#M0WG0(R)2Y@3<->L,F/_X7-C
M5R4;4,(-J_S0ATW/L1H*QL@<J8V#>>V&/0I;+=+0?_ZTU1CV:+93=F'?->8^
MTM4C+^[3[/YC_=F7=VHUT)27N1%O56Y&D?)R(9*8.[%@T.-,+D(])X2Q4 VX
MJ> ^(FX41$S73](:<6Y?<R<T:*4&];()9$TQIEP VDFN/]GK07_:8[(.Z,B,
M\'I8ZCM/UC&=R(&R@*V1"V6$TQ$W2N\YD[E21FKUW2FS&P>6D:A7R(N <)=X
MTIGR<( A<@,$8X]SF'@B)O)O"+G"9!>K>>S<MJWN;NXN/X#++U^N[KX85GEH
M8-)SGLR5'_O0XOANIWF9A1<*6JV?T#QYVL((+[39J7CP\J\#4XH>GW!:*,J^
M$=>2MYLR9,VCKS/&19JE%5^J(F57W]L<U]_RG'U+E\M%$#/F8,&AYR=412Y1
MB/U80-_W?"Y"AAVS6E3G"#,W5ZJ3JXX(S.O=UG2M4K,M75?M;?0%] $7]Z:Q
MEV<93X\QIC+)R#RS44-Y!QM%UCO@&UU@K0SX::T.Z/0Y?'Q@GE-C 5:K*3?G
MR#-M1HX%Y'82=FP\TWQ1^IEGI723"<_D"%5.ENE][3>WOY#O<LH6*$2AY\81
MI!BY$!$1PH0Z'/I>@ES"0L8BU-7'NM-;FNJ,J_7MOJR+=3<!JSXUHH-65+ 1
M_J+[70F4_/IK*BTKG%Z>6@-U&D)\+2#UUZ:V 9UH:7H^L$8K4Q.4CBQ,M1XS
MV;K41*G^LM3HOF'^\MN\>,I5*G\;(26"V/4"+Y%\C"*('$QA''(',OEK$E)$
M.=?J;WG@^7/S:M?B@2_\WKP,_C9Z>C[H&9B,S*([<(P0>7] >YO>W_80DSIT
M!_3;]M$.738P>5"5*WBC3O_ZQ0HNBT+%ZC=5G3>7?,;/ZE>7ZIQ0E7VNGJ^S
MLBKJV:2LHSGN'G!V\Z0>H4(ZOO)2ND/-?MC"H9[O.YA!-W9BB"(A(.&A"T,2
M^=*W\\*8<J/\PZDDGQOU'*HP 7JZJUSC_G6M_J &X (T$( >!J")@ZHD"J"%
MH8Z&:H"X:-M0&&9$3O9NZ='G+-^8D8EYCB^+>9[GU(:SFBHZF?#39IM.;9.=
MA-7)!1@VP[Y9E6G&RU)*2=*L%G)3^^>:20%2D>+U-LLEE>(5G%UF_:*(\F]2
M5K;9@ZF[96QOT2PH19[ON1$,797C'Q,$8^H1&#!74(]RRI%C%CP^H?0FK#E-
M2'JG/.AI?]&OW-0'H-U!!1T$]7YW#P30HO!BB[5I>K*S#6LVST[YANG-M#-]
M:T:>:^?WNAC/M*]@.)MS[93B3SK;OH)=MN?;UQ#!_"BAG<)5N0JJMN+SO\B9
M?*N=VM5W7M"TY)^+5"XY'=>/>!A0Z*- SIDB8C!.'%4.F- (^8)$KG:^J/'H
M<UM;M@K4)7"4!J#*@?*%+G9KKO)6#_"D%-'?'3>WT.DSAU%Q'WG6F"7D^J<3
MHT(_T5&%?1,8'5T,AO#(.8;Y,R<[U!BL;O^$8_A#+'0Z^917>\O;_X;33+7-
MN<FZRQ=A1 ,W("'T0L(@PFX(X] +H7 Y]I#'(S\*#$ZMSQ1GIH?92E!5F5M*
M6-?R)JVK81H&--1(>HN:,3%_G98A4HF#S4)JF_RD5/E9F::[=:26(.9PCM;S
MPT"4UVOJ88[7T:X= QYG[IJ_XT7ZM2XFIRIBIMDG7EW7&VUJAO]WSNYY-UR5
M$R[7%DM<EG)-P=F[59%F]Y_X]\KU/DHA'TIY[\)-L$.\F$(:1D*U(B8P\9$#
MJ>]C(3CR4:S5BG@$V>;FUF_4 VT!6J#*TVY4!+6.+SYZZ0,1#OJJ@D97H)0%
MK@<:=2_4H_1]4=MOP>G%P2O:=FP^_\]K5OT%R"N:=Z+ER>N9V6@9,Y(ACBQR
M;(\XV1)H)*CZ"Z2QAA@89K(B)?_'2@Y]]57^9]W-/D3,(Y[K0\Q\#!$3/HPI
M"6# <2BHPQ/F:\WA)\:9VWR\$1/4<@(EZ*#$\4/ :D9$G _7V/$+0Y R#S X
MCH/5<( #0TU[>']<WYVC]A.7#\QKE*L-EBY7BJ.^<"I91YT0-'D%G+V70JN#
M_54SN]Z(*UQDDI?*S[QHSO6?]S^@?OVY]/^)2Y%<#,C_(!P2&"<T@2C&B+L1
M]WV/F/#*B++.C9OZDH*-J(/8:4P3ZS'<3 PW,DL.M)EY5NGX:%I-51U1W&GS
M7\?'?2>I=H(AAV8>E-6-^(*7O&RCYQWD\H!P'Q+'0:I?N M)0&(8(TZI4,>X
MB9$7N3/"W#BZ+F2="U"+:%CA]C",>HQZ%C@C\Z A+@-2$ [H;C<)87N0B=,0
M#NBXFXAPZ,*!:\0JIW^_Y4_R97C ZM0NOR_P8U=-HV:5\G)5/>2%BCBYR]_P
MS<5L@6@0!_)SE^M'U?0S\A0'8 \RY$;($QBAQ*R]T3G2S(TO:F7 1D#0JM.%
M:M??3*T2V.BTWD-:JV6X-#W+GIH+V*FL-/8R=V0#F:^(;0!K==U\ED#3KJYM
M8+>S!K?RT#,JE6\'Z;5.0T2(&]'(@0EQ/,F[.(0X]C ,(U=0QTO"('9->/?(
M6'-CU28+9B<:=Z _=@QD/3*T!-W(5#<8M6&%MX_C8;W\]H'AIB_"?5SOO:6X
M3]QB?N+_-L_*?)DR%4?T!LNW@/(O#YQ7G[&J]/W JY3BI69/6./GS>B5[\L-
M6L%!+3GXZ87L/^MT@#T39OV3U='@GNC<5!]V.P>@@_ Z<KQI]KS)#B\'J=D_
MFASV@(&'#+2N@%E^RBOI'V7L0XZS\I93GGY5N0JJ66_3=V#]?3@1C@GC% 8)
M$A A1&#BN0)RP?V ,(_XICETQC*8?$O39,+=%9AQ@%M%0+$6_@)DNF$BPTVB
MN=4_)LQC;^!WR*HLL$UK\-L>SEA4JE')<IE_JXE,Y 5X6W"65D"=XE^ 5KM1
MFH@/QM;J=KZQ$--NT@_%:&?K??"#S%VT6Z[2H&E5QWR\;6HOWO)'G*K=?+6*
M?+'CCY=TM6QW_/LL?D72BN$%Y[$K@0M@Y(:!:K3D0$68T/.$BH'W/!(D>M1I
M6[3Y,>H+[;JJEY)86_W:O1W>J@C4ZP;H1LFFMG//O[EZ<WWW[E+?:;1J^-.N
M^VL9<V3>_D]E1?V5P6M9<Z*%PSA6_<7.*F,,[(\L0JP.-]D:90R0^DN849YO
M/GM+MSPK!2_445RW5X@9B@4G'J28!JK'F0JI%![D%(<$!:%P1**;%K'G^7/;
MA.U$E%]<:;SW>@C#T_/9F<B,/"V- HK^]' F.!.Q_ &0+-'T$0R.L.V^NR8C
MS2,B][GOV&7#-FFZ)]Z(=NF+EUT1B7HE)&DT+R[+.M3@\E']YATOUK4G%D+2
M6^)(BL,.)A %GF0\/V0P<7F,'0<E/D$F1U#GB3-;@I1>R5J?3?695J-Z.P&7
M3>3,!6C4 GV]S#9YSC2IWH[/=(::BJ_'LI'QAH\=:&WN_IPIT:1;07;0V]X7
MLO3481Q]RZNTZ1NI.M&M\TS<T(L3%OK030*UY:,:$C%I/Z(:GV 4"$2-0B_W
M#S,W3MU(">I^AX/3=PZ@JD=_YV,U^NZ(.4S&3'4<!9L,=&"D29GEN+;;C''B
MZHE+1K_':?$7O%SQN@K8RP(N?\G5 GF95L^W<F6\P!Z-B/ 1=#V/021B#Q(B
M+4)#QGTGY(F7&#54FD#FN7&4A<J_2GE0:P]ZZE^ #@"P00 H""8J#VWP'ND1
MZ<S>CI%9>4XOQG2EH,U--8LBT 9B_QCEG\WM8*WP\X"A!Q8+4\4M.7O3=%M1
M4Z_TT%>/:@]X_=N;=5.6A0B2,(DC)%\>KKH'$NE#!UCZT+[K$H$#.?L9^=!F
MP\]MWFJE!ZV@M>=X 7H:K/^RT<&P3)B9>?3FD/% 'WDZL(JW>16P0;!9+?YE
M)L&T-;\&H;-3ZFO84X9QWP=5MX^W%<2R^P]<LG!7 /CY]XRI,F/U7L75=RHO
M;?8I%KY'L1LD'/*Z"&\4))"$Q(%Q@@(J<,3\<$B9Q$'":'V;TQ=);'2Y &MM
M0*W.Q;IH^/,%Z*L$&IW:;4(SAAQF1#VB',\FT_#E2'8P9LZS<+1)H,,$F91'
MS\)JFT[/>Y@MC[*F\7KW]VVNVLR35>W/OGFN_XB+*J7I$Y9?I4-)0(F30)^*
M!"(6J JT.%0[*[Z(B!>@R#G/N]05Y<?P-.N=RJX;\@N%U**X_FM/IW,]3VTS
M#O5"QS#.JWBDENQBP4,UA71<;U5;FE?V7$U1.^W%&C_QC/UN<GJ_@6SO-[0U
MRO]2]Y*ZS-C+8N4WJZJL<*9::&_5+5\'DM5J85JM\%)ZF(_N@K@L=DC@PC *
M!$04QS#!B0-#WR<^P\CU$O,>BK-0;6YS@X5-TG5GO :E.K7CJM=AX"]UAX$>
M5A>@0PNT<($U7J '&%"(#=AKGX6A3;;D9R'PC";&'_>E'+;//RO[6S\.F(=V
MTY\:S$/O8X<+\Y)P8)4T5<_W1M1E0U1M_V5>KE2)D"ZGTL,<8>QCN0YD#D2(
M$)BX4035[XCOX) DPJAFVO'QYC:_U^+6577JRCL]B8U3\'41UYOX+.(X\FQT
M'H3FM=?T@+%:B>W$D-/69=/3?Z=*F^9M0VLQ/CZF=4EQE:CZMFX@<L\SFO)R
M,]CZ"T#8H9@)!'%,U/(E"F 24 I9$GE.*#SJ1$8UVHQ&GQT#;82OO; 7XO>^
MIN%\9&0;378:"_&QN<HBV .J1@X S6Y%21,!)JXV.0";W4J40QXRC/$^MS75
M-@>F[U;\.GN?BNKA;QP7BR2)$ M< 7WB48API$XQHQ!R09W C5P/!UKY=[H#
MSHW7.GE[X0)RN?E^5:G/ZZ-T=1]7C]VJ5/Y!*J,:FKQ7E:N5.H8MWTZ:0X_7
M;((\,I7MP?>BS4C^C%.YQ%?RUGC:8S!=>&R2ULDQ)^4I702VJ4G[OF%LM YI
MN\Z>Y!+S __*EVZ;KQEPAXB84"@"SX.(N(X**R/RGPEV&$*AXS(3(CHRUMPX
M:!.?JMJG*VDO0"TO< =69SP&M![%6()O9'8Y"SEC7M' Q":E'!MN4C;1T'N;
M2'1N&9A]B[^_7=6>T_^5D_*25C?"<]RHSC9+%6/)"U1BV29F3/Z+I_=95_/_
M.J/Y(Y=7J3VOK.0+CEP41EQ(.P22>5P_@H0G#,:!%SJ,>JZOUU)]- GGQE=2
M,J TK-<F2D<@E;P &P6!ND*E?_;C,ELE0:>E^F*5GO7%K::&6;O67P4];GQ5
M X_,J*]@6_-LW['PMYH ;%W(:7."Q\)X)TUXM(&&S2_R<86*D7O'F_^_SE0C
MPDR^D7)]OJ!^1 *&$IB$7)U#Q '$7#JM/.!)C*F+.'$'1/X>'72F$;X]"<UH
M^SC">A1\/F#3T&DG)_BID_1GM7^@@YTQ+6IA8I/BC@\X*5UIZ;Y-/7HWF=>Y
M^E+);U!M&-V(=6_R\BVNCUS?Y>H =1'Y4<RQRV'B.CY$@2,@3JB "?<1P=Q+
M* ETRUZ='FYN#N1:8G4>MY$9M$*#/QJQ#2I :4!^G%CL SEV=,UK8*A?5,LN
MEA/5V#H;4Z.:6_H0'2G!I?&0R2IRZ2O4+]!E<-? HNJ,U8XD7JH=Y^M,/CNM
M\++=#J.$DX0X##(O">7J/W)A+)#\#TX\!T7$X]QHW_'H:',CXHVP]6X\E*Y)
M*^_ C<?C6.OY=M80')F!SP'/O*2Y#BA6RY<?'7#:4N4ZNN^4)=>ZZ8P.4TTL
M_X))+R[D6+7O]!%$3AV4)@)( L=!'N6Q*XA9 X;>TTW>]FD*@;=5WGXJ^7T]
M41;\*2_4 ?;AKB0G(=2CA8&PC$P"37^H1BS+O:!>ZFJ]]U/[^.E[/;W4:V]O
MIZU+!O1R>E 1L/*K5V&J^?)SD7]-2\D&_99T*>4WXO+^OJCW3.2_,Y6 L_R\
M7*D2=<6J#HS]/7NJZ4/.QKRL%KX;\L2-0A@DKO060HEM[,4^Y,)CC'N"D 3K
MKMM&DG%N/D:CIIP=(6T4!4^=IA>*/KH @2>EK'*\<:>N^E6C[P5XDAJKCBY*
MY7IO>E4K#=)6:X/^4R.]&J?7ES,P^,AL^%_%U@9=R5[?YE/U+WM=VYOU/AO7
M*L>ZI(TT\G3]U,:%[D7GM9&'&ES<@!<%9W?X>^.F_);G[%NZ7,J!MGM2JC[?
M(@H$@I2H<@8H\2"A-((B21Q?1)Z+B5$,N<G@<W,$.MGK0^$N-;Z3O_[6=]JL
M&M<KT+>,WJ)C++Q'GH=M0CVD!($Q9I:+#NB//W69 6-D]A06,'^&U>#Q+URJ
MR^IP91\EKH>9#WW".428,9C$!,' YX*A&''N&X5.G1QQ;IPV+'S\[EMN,7J\
M9P\]4K.*\LA,IA<_+@$=/7Q\%YX)XL=[@\XA@'P7 \T(\CTWGE'>I+PN2^G9
M+6@4!=3EJF44DMZ5AWQ(7"PD!_DQC4//\Z-@\<2+-&=?*EQ4>B34'\+D2]@>
M:+R/X@V_3[.ZI$'7)_JG1FC02&VX%_L"4\P3/^$1ACP.D*IM2"6F@D./Q&Z,
M&?$#5[287F5L"D2[8<;#\ZI.=1\!3#T^'@K/V!$&M5@7+0R6BV5LJ6N]7$7W
M_.D+1FQIMK=DP_8U [F0/G"V6LH%<+UIWK79K5V_.]5[]XY_K]Y( ?^^P"Y&
M'DT$1(ZC8MQ#!K'#,4P"AP<JPIT)(T=-?^BY>6R=Y'6(1WUXTW6B;H^V_JCE
M!TH!4&M@> 1N8!5->A@%Z[')PR+,Y@QCC)A5_M$??5IV,D9EA[O,GS",V:[^
ML4JKYX^\>LB9BLDLFW3I18"B*!$!@QZ.?;G>= 6,8S>"L<-B3IV(X?^/O7=K
MCAO'U@7_"AYF8JHCA-XD 9) S)-\J]:$R_;8KN[84P\9N$IY=BJI3J9<UO[U
M!R"9F90RDPF0(,7:,6>?+LL6R;76!_(#L+ NF5=%N3-RYL99M9J@UA.T%/5C
MIG.HNM%0 *Q&YAQ_F+R9Y0(((6GDG*A).>."O2\)XM+EO5,RZ@R/$X5 1"HC
M'/&XKL^"11I#DF4)C#7*2$KB! NOPE =LN;&"JT4JP#U5[I =B.(0-"-3!*]
M4>N3CW$)C\#9&&?%39V+<<GN$YD8%V_IVPCR1['Z80O6;91<;C\P414^;P)2
MLS3%3.09S&*>0ZQ3 JE@#$9IA+ 6D?D?]^L'V2%M;ORQ5Q;4VH*=NCUC?[NA
M=N.08 ".S"(#L.O1,M(!D["=([L$3MQ TL'VXSZ2+C<-];GLSMVJC<\BR5G,
MDSB%*A?8NJ(%9 PCF&(:Y21".4V= @,OR)D;A[2W^?OSY7IKW]MM\AQ87Q])
M;[@F=(@X(S7 \W$2AW'<',]%O9)/XZ2]YQT8IR_O&Q&T6?Y@V^4/=;,VBY8J
MV*[\5&S?J7)YN[;YV-?E/Y2\-8S4NF#?A.5ZNZ^6LB!<<I30',J,1A"S1$,B
M$@:S*-=<FC>+4L_F>J%4FQOS'"P#+<V!L0T<C+/]YQOSVE<]ZW[$MJT&H;X!
M1\$&WHWF7F<X1V;&B4>R1SQ3:-##1CL%TV[B6*C0J!Y'2@67,,1_];$HRP\&
MAKK@YZ.1>DAW?:-TL5'[7; JW_\TFU\C8[EFFZ>;K;HWBJ^;N.I5I7 3B9XQ
M)46:"JAD9"8,D4C((XIAA*1.8LF5IOEB6VS9RL?_-8JN7C/(7N/1/4&_K(RQ
M?P.\,@LLZW_<6L/Z.-#&&65*"!(\ES!7N8(8$0XY%0D4,1<Q31 2>>SOY7S]
M49[.2_K+QVJ4+0^!@[WM)/_F!3CX!U75(KQE-:C,O@+/#0<W7FDI4[PN/O[:
M5W\)IO'W]AQ_WZ'NZ20>=1#".YG'4?<5G-2CXG[:R3VNR+Y!E<5F:]NXO%-\
M^W&Y5I6H!<]8)+!Y"6@4<XBERB'-DA0RS@C*9"XU\]J,GA8SMPFCTA(:2??
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MBL.$)SG$(N:0QBJ%-"$)RGC,4I;Y,%QO3>9&>;4A5Z"U#;*VM HD78&=/5?
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M4S!G-),ITQ%*TG[EJ8Z%S8[-&EWM"?*+#ZVI^.,;<-B%M"-'!<)O;%X: -V
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M+$M(1J!D600Q5Q%DF="0F5F%9$JE.'?JS>8@:VX32=L#OU-V<'AH%]9N:\]
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M3]^5>-R4P^4_BMW=^G'W33%9+)_>*;M"5*QL0WN]X^M[:\>"4*@DSE* :8(
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MKQ N2Y7O!Q,IF=_OUZMH:TV/2IVD]#]M=L'CO=WIEM89$\1Y*M.= =^-00(
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M603>(7V5 A6N'I_=,PU;\N%O2MX:JGJGML5M58W[W?J>%68T9AA+#3F0.!8
MVA,_)&82B"2#(J9$QS3QX8MS#<V-+VH[HY:AT>^5J9XL<19:-Y8( =C(+-$+
M*V]NN 1$2&XXV]:DW'#)X^?<</'ZB16.:R'(]W^HC2BV-H+__%A)N'&9"*E3
M@+.< *AT!GB:)$#DF7G95)K*Q.N\<7 +Y\9& ;1G]^JR+6>OHLK=B:2(S[X/
M;DSXJKT\,H6^5@=/IR!\J1-F(15\UL@_AR;P)8R#B?]>;*AWX;&WCV51\O]G
MS;?78O=%IW&";XP]V\*V:"[XL-ZTM';,;\H,=HT*3W,^ZVF14IKK%&&@L88
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M5+#2LL+'!T [TMH70>F#MI\Y @(V,&?T2!D&*/L:,8$ &ZDRS.XE,^*"/Q^
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M-$"(Z0\8D5Q"BHL48IQ2$1&11,JJ-?;1IT_M,VX%;,QP]V.00_3.GQ5=A,G
MWVYP..R/@BZ"9:3SGRX\8<YZ3FK=<\!S>,]HISHGQ>T>Y9R^R+?(QKJ-5OFV
M+2/4E@R<R9Q+EC,*"T$T8R&]UR&4(5BD6,@TQYE(K<C*8JRI4==.5+AL>S28
MGC"\:2,%7O&Z6,+J=#%@9["IH IE,8*8Z/\@+O5/4A&]N\0)3SA2/"%NV\E
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M*')3Y3!/B#:7D@QBCN)<R9BDTFK#YBO U(A'ZP :)?3B^#=@U- ,;)HM-9I
MK0K8Z.+?S-![OLX;9T//PL"T-?4)<*C!./!$C&0L#C<A;L4;+T"SKZBCSV/'
M*_9X@=+/BD!>\AR_X]@;^NM:_/-QM:Z=<+N,V-7U0ORY>%P]TGE=RFUEFF7,
M,B6E7FTPQ,($]24,09H0 96218HP3Q/J=&[H-/K4UB M/.A(?]7)\-:_F'Z
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MITA2&.59!E&NX249SJ'$D40$$ZE(-%O(6].!:C2 20-P=]A_8XCM[-EP[^7
MB]4SO"IU6) _G&UKATE("_?,B*/:N7;:[UN[EG?Y<?4[I21O.L283/H;^LL$
M.IEZ$0M>SLMZT$_50DCQJ"_3H[:^H+K>MC:+\SA+HA32R+3SRY&".,\)C&6.
MI91YSIF31_@B::;&]%ME0%LZPG@[ZY#$YPK5_;EW*FT<HE>@UNK*G USZ;H7
MOVQ>[0ANM-D:F/_&FBAGM@P"<$@RO4R@4;DV"';[5!SFH7Y,W<;]Z#'E:I;B
M-$=9KN=(9EP3;RH@I3*!11Z;[IY"*,%=B+?[\*GQZ"9$K6P^SK61T8T,GT%G
MQVV^@ Q,51LL;GI!<"::8]J&Y(UGSQ^5!HYIMO]5'[W&L_>QWN#,Z]I:!PF^
MDN(\$QSF')L"0IQ!1@6&,4VR#!<DQL2IS]K)D:;V^=:";NJ-M6F\WOG5YW&V
M^[R#H#?PMWXI<.Y-><^!$K0E[\G!QFW(>T[G@W:\9V^XJ+AT4XVO7-SN*M_O
MWNV4*9(*B2$2:0$1SA/((DJAP*F*:$HT -*MWJ3%J"Y?Q#AU)[^]^_V/=Y]N
MP-=W7SY_O?GPZ7>O:M2]2-NQ2&#TAO9)M#6\M^)VNRM\'X11'  :H,YU[[ O
M4?W:!H<3-;&M;KV@]<@WO7.ER[*JRW86'+,\1Q%,BECS3)HAB#GCD%"B319!
M1"JMRF.?'&%J-LI6R"NP$=._?\4S*%F6Q%E,(YA*4V^-<@Q)%E&H$BJHE#+3
MP'KT O$%<R2"#HMA/QD'P65HZK4$Q*_OQS&E@_7\>/;P\?M]'-/M:*^/HQ>Z
MQX&\J18K;=>9HC;B];?_T[:LB+A2(HLS*&EJ.ICG N)(YJ:->9HF:9()N\W;
MR1&F1HA=(8&6TK'QQVDD^[_E(/@,_"T/!HU](,?%$(T4O[$/59BPC5[M>Z(U
MCM\W6I!&K]C=V(S^"]VKPGZ3_'%9KI_BA-V4Z[F<H8PF1980J IFS#N<0%IH
M^B\RAI#,4TFD%9L=>_C4B*P6RCBUX^05^PULQ+6O\'J 7C^#78K)P.3E"H=3
MM=93>E]0F_7@D:-58CVE3+?NZLEK/"/3R]5#M:+SWY?5X\.;MJ!(IYL")A(I
MGA0PBTR .HX(I#@6$,4\IIG"*$F<G#YGQIO:I[P1%]3R@N<">[6N. >XW2E0
M0!@'_OHO0M ]CMT.EZ#A[&>&'#>JW4[_@^!VR]L\CYG;=C*?U37GRT<I.L5P
M]K(W(XPB8GH:%9G09H*V&2")4@I%FA)*4Z4-!Z<X3?NAI\8\W1X\K>S/B@CY
MYMIZ3(KEP?0@4 ]^2!(,9?>#:F? @IY7VX\^[K&U,RH'I]?N3W _L_DH5RLI
M/S_()34GY-<+\;Y<F#3:CY*NY.ISG3%[4YGVT LQR],HSNM.VE*:TO3,5*4O
M.)0LE5&6)DK8]1)S'GEJK-8(?P6VXM<%H5H%0*.!^6MM'*PKT&AA?\KA-BWG
M#X8& WM@7IL6SO:G3(/A/=+I4V#<G<ZHO+#K.;MR>]YH9UI>:G;/NOP>X&?Z
M?M+Z-)6-VC2.+$YB*E $D6!Z%RU0!AFA"G*<)X3$-*>)4Q?@_0$F1_C5XA9^
M+']HN^I,7H<=?G:VZ"6H#,W,UH X&Y2GM YI-AZ,,:IQ>$K#?1/PY'6>&UC3
MVNBUJ8_2;7AZO5SJB:T=@:^?=I=\H4_FG^HR*@V7K'[7%ZY7'Q9-']1_R/+V
M;BW%]0_-0+>R_N-;NI;;DBNSG-$X(HK!2$52FXL*09HGVGHL),MR',<)<6HA
M,;+\4^.@4QUK00<!TY6V>UV+0E,.:;-BZZ6[@0*4B[:I[178P %:/)I+@$&D
M4T3)<7,^\@MGN<.?[FLT]#'!E-\@]X.'EYG'H*<7(ZLP[A'(R\S/P3G*"XGA
M6V))E0LIVGJA7_3GVRS][ZNE^:7]]]7.,ICQ*"(XDAARFFA3'-,(4H($S!/#
M!YA163B9XLX23&V=;$MTFU*!1F"PD?@*M*IM_J7^LVN=)M?IL72$#0GZP*M*
M(+P]BCUY8A:V"I2K$".7A_+$Z+!NE.^#?!LW_9!-AZB_5W/3AG6U.P_?_6W?
MQ:/B0K%$Q) )3B!*,(<DX0FDB"*1*IS'W,GOYB7%U/AP)^C%WC:_6;&CP,&Q
M'I@&.S!O%# A\3O'7$>)01UR%P$9MB.2CR C-T"Z *O#?D>7/,RC\%YYNZ@#
M'+3!RKFIXJ?'K%/K2KGZJ.GZPUK>KV8,HSB/(SU#.-6DF&&DMW92:'M1B9QD
M**<DMR[ 9S7DU!BP(S78B0TV<H/O1G)0B^Y27,X._O/>N?"@#GV.\))X.A3M
M"X[K6,7[0N#K5L_/":J^NGYV#QJOOI^38L_J_+G=Z4[?__FXD$F41J9 \Z8B
MI=*;=:18#A4QN<I1IB#)B(1"T:+@DBD:*UNN/O+\J1&S$1$8&>LBXCX5/H^!
M>)YQ+X1F8'H=!A5[WKP0G9%(<@^E,#S8HWH/Z1V[:S2&ZQ&Y2V=]EWGV/*L6
M=5'Y?Y3KNS>/JW5U+Y>;&+6G;0>$B,2(D$(8ZS,QU1<(Q%E!(8N+ A6%("R+
MG3J?V8PZ-9[;" U^:JG!1NRK;8SFDTW_A LFP6X''AS:@7DR"*KNG=%<4 K:
M'\UJX'&[I+E@<= KS>EFSQJ=]P_SZDG*NBW&YY\+_:W?E0_FQ/+=M\]?N@ZA
MMMS<C*A(&UPYA5E>((A2F4"<Y 1F"#&)$H8D<@I:<)9@:MRU40#4&H"M"LUA
M_RNCQ6]7S]W)[WP*![M/E1VK#3H! S/< -B[5]+TQ2]H]4QG(<:MF.F+T4&5
M3.\'^;I9FA;MFT\J2CC+&$&0""PA0MIN8WF2F@/#2*HLTV8O<ZN OC>"U<<U
M:LGSC8!^Y<[W :0)2R(6YU#0(H*(Q@A23CG,11JAF.K]>^&4:.H#WZB^I18\
M+\K?!\_64>0-R> N($LT/'PZ1W4.ZZUY/L3(?IBC^AUZ6(Y?YAMK\[ TO3P,
MG>J?Y[(.#%J(;M7XF<(*<:4T8A'2C$A%##'+"IBD:9+EE!51:M6^R&70J7WE
M79GK3!#:$=8U@,8"<SL>"(WDP.30%=>$QK0"UWA>V^#I$2!C#U#8F!B+<4<.
M@[%'XC#RQ>%>=R] &V5H&(UK8^>F^B_-;WM1AE^EJ6-3+FXW6^9'.O]8*CG+
MXCR+,U7 *,EBJ+>F":0T2Z @G,A"*HF95>S?I8),C;!:76J3SBAC<M2,__T*
M_-P$*=,V2'FY40GPG4Y@KI6R/VZ_: [/>RO&FIF!"?#?:5+LG25C3<Y(7I5A
M)\G)%Q,"V1ZGS46/'\V[$P*$KALHR/.\NW HN5Q*41]N?"S_>C2%VK0TS1^D
MQF*&\SAFBJ<P9C*'"+,<$D:)R3!5),JR(BJL_-\.8TYM[=J*W!SZ&7?&5FJP
M$]NDW32).LX-/<[.@IW]'1C;@5>?<+#ZM BQ!2IPYY"SPX[=4,06AR-]1JQO
MO;2ZDSEEK18F4M.$;;;-BMH3AS;.?2_ .55"RD(0F.8HA2C3_$73F,((\3B-
M,B'BF/B5>W*696ILU@V WBG3A$-O&X:U"H%7K4J_!2P+Y3Z;=NPWTAP-S(K#
M3\\%]:2\@1VFP)2[."]4<<H;M],EJ/P?Z=Y8X<NR,CW@/B^_R>6/DLNZGB1)
M,$\RE<,T%:9L)\&0*%+ .,M%&D>8$1;9]E4X-L#4>+.5L3X=;,5T;@EP%,A^
M=@L!S^"&G#,R3KT!^M2_M#7 T6>/UAF@3[-N8X#>Z]Q/.+_J'>92/^]QJ;>4
M7^7<^'1;ZEC-."HR)CB"$<TI1%QE$*=20F'*9$:D*")DY5XY-]#4ON]GLH)6
MV,U*:UE=Z"RXYX\60T$V\#<_"EKV9WZA4!OI3.\Y>LL6O3;<8?6W,*=U-ICT
MG,;UWC[::9N-$MW3-*OK U0TUR;7_%&T+:PJDXGR*$5;^JU:O*&KN^N%,/_W
M3F^,?]"Y,=1F,1:2\BB"A=F0HBS/(<LXA@5A&8T5HU'L%,EXL413X^#G-;VO
MP%8GT%4*;+6Z D:AVO"H?^BH=D'Q=*^YM?20CSEC0[O/1YBLR^JT7P+P8)7<
MO81ZN5KOEV#86PW^H@?[,7C=N7R_A%^;C,42B:-,:3LWDZ90!8\@BZ("*I40
M7$0FS\^I4$7/6%-CW5I4L).UK1_IF.5F [(=20:";FCGN2]JSIQF@4=(MNH;
M;E0>LM![GV%L;KF .YY9E^T[G>>2,"(HS/-8[Y=)Q"!+A8*)43G%*A84.Q/'
MD8&FR1K/=S(7,,8Q:!WHXD+ 1N$*1ZS\>*('B. D<6RL\1FB1^.C]-!WO1\W
MF#*#M=5R(_G=HOSKL3G8S96@BJ8""IDRB! R/6=B!F/.3>$ P1/IY(0\/LS4
M>&$K);A^>%A6E#<F_U9FK^96)Q"V(XC+<1N8'BZ%S)DI^A$)R1,G1AJ5)?JU
MW>>(,U=[E^O_<V,$8U10J6($42Z,P2 8I 7FD$N<B4AD:4R=$I(ZSYX:%VC1
M]/][F@5=S.P^=$\D!OZZ;4'P*<N_KV[@BOQ_OHC=?T2O(W7X#R[QB/0WYD"=
MP;2HOW@Z-WF=V_(L3.2QPMJ29W$$$><8,A)+B!*62<:BB%%K1UCO2%/[:AMK
M]9FT=7JS@UNG']GS7K!@>(UBV!^!RJ-$T)FWT3[^/11V8P6X.[]N;D'K-G#T
M1:7WWC]>V+F-&L_BRJUN\#-GODHNRQ\FO,B4"OEP__"XEF*;"JJ4Y.ORA_R_
MI9QO__4K7<M9%'&"D##!Y$03J2 Y9 5AD#/,<$906JAH]D,N665K_'A*XO(9
M=.49[BO8M&@H-QG+2].EH5) 2+B4O+I=E/^2 BRW^CIZN'RGS,[R&F$:!F;R
MG09-\:)6![ 1]PILU0"U'N#5-KG<J/);.+ON0C!#VH"^HHQJ+UZ(U[YM>>GC
M/.LB_?58KI_^D.N[2NQ*$[\M51M,_UJN?TJY>$.7RR?37.[>U+^\7H@_%WJ,
MN?FGY@DSQE1.<Q3#/,X*D["C(([B J8)$307.4.94\).*,&F9N4V4H%&L4XI
M\"NPTPVTRH&-=J!1KSZ>V2D(FF<Y5E<*->%V#/T2TS@P98\X@^XUF@+#';1T
M4RC9QJWH%!C1@T)/H9\_0 W/K_*'7#S*KUM[<)8FE%#3\;E((\WV><8AI44.
M22SUSXIS%CD50W$;?FJ<?K;^Y!5H=0 [)0*6]SR<'SMR'@[U@2DX+.!A*W^>
MQ&VT$J"'$DRG%NA)=)R*@IY^BJ>?1*Z;9*:/U6IU_8.6\SJ'J7I3W=]7BSK5
M]*Z:Z^>M7M-5R6=QG"@B10233&40"8H@RZBV>&-5J"373&AJ055K.K?TI;B-
M[\1_6RD&=#7(-2B;-,%7<ZW!;X!N=#!E(WBM!5AUU'!TR3A.CZ7;9CC0AW;M
M:+S;M,Q7'VN\K[MX-PJ K@97H-8AH!/(#[R@CB)'$<9U)OGA<^!P\GS,!<%F
M)L-S*>_D8E7^D+O!34CL^WGU\^]2W,K?:;DP__A:JFII:'A.5ZNZ1T9;$^N&
M_IJE*<:$9GK>,I)"A#(!&=-,*3-.(Q)G+"ZR30G1&\= M5!"6GW4SZN0WHSF
M"GNFY/,/O@UJ-[J"6MDK8-3=_I75.H-]I9OX#OK+(U NV&MA1\[CS_*8GKL7
MF%F_L+[0,Q \%C"8@.,'$(;&]FC48?!!/,(=^+IB<JEG,>VVH<$Y)WG.M0T=
MQ3%$IFXAH[B 1<$SG$B"B<JLXQR.#C&U8X)62F#$].[H<P)-B]B&BS$:FAH'
MA,<AC.%BF,:*7_" RRV"H1>)OM"%XS>.%[/0*_BS8(7^*]VYKFT;;[HA?ZV>
MZ'S]]-54U%O-TA@ISE,&,8LST\\M@TPE!%**TBQ%G,H\=S"&^\::J$V[$;?N
M#[YL! ;+6F+[S_LDON?Y[R*X1JIH,BA$]AP8 JJ16- ',B<6/(=%#P^>O'4T
M)CPG?)<+SU[K=Z;PGI9+$]LNFZ0X;4UN3G%+P[=T];B4XO-"6YV/2Y,9HR_X
M5"V6FU_-L4;3*'E6B)03'J<P3S&&2*8<,D$HS(H<*Y4H5+B5,0@FV=3L3*,8
MJ#4#K1KUQ!J?2"M[O5OL*M,6<G,,E0\WMW:' B\R8P-S_FZR+IH?Y^U]<"Q#
M;NW#"3?JMCXXIOM;^O #N)NX;^1R7:I2BOJ8@/*ZC'2Y>$,75- _Y.INEF>*
M)TC;NFG!"H@*+B$IM,$;)TP1(H5,[4+!K$:;&OEN!0:UQ* 5&90F%L@(?06,
MV/;VW'F\S]N^05$<VK<_/H#VEG%0($<RD2\%U,E<M@:HQVX^_XS1#&AK=;J6
MM/U-%]90U%;"L]_;BFYOJJ8Q%F]_GHD(1XFI$('3*(5(\ C20AO2"DN<)BF*
M$+<J,N,KP-0X^GE%!&-K/?L7N*F,9V2_ AM-ZE\]2PS:SM1Y*A\:_X'9?;K0
M>U9]'& *7J0:9)BI\*\4Z8BC;05)V\>^3&5)1Z5/5IQT?8YOC]@?^JVLED]?
MZ<\_]/.7)9VO/LGU9Z4'E\L?<C7#41$1C!2DB3#)RRR'.",)+ 1+E>(4(9FZ
M=3T]-^34UI:MQ'H[3W^"K=!7P$1M50IL!'?MD'H6>[LSE+"(#KQ:7 ZF1X-5
M6WS"]EP].^K(;5AM43CLS&I]I[OU^_N\8G3^23YJ@2OQ.*]7R$_W7^6#:<&X
MN/US4:XWA15S3K392V&L,@Y17A#(XB2'"D5,Q()D&;.V>>V'G1H;-9*#/='!
MJT]__ :VX@,COX>OW6$VSMNUPV \,#]-!5Y[VW48F$>R6$/"[62INJ/68Y\Z
M/&PTJ]1=P:XMZG&W;Z-NMOZP,(:N>=OJ6FPH5OJ]20F,8YY#E"8FL"*-(&.$
M(B$R0953WO'A$%/C=",AV(GH5=CN")!VYN-E\ Q,QX[(>/31/J5\V*[9!Z.,
MW"/[E):'';%/7GEI[[W7CZMR(5>K:_[78[DJZR/4UT^=WW9MV@J>JB3F,4R*
M'$'-!P4DA9(PSPI)TR+%/'>*"_ 18FH<T6WGMM$"=-6X NRI^P\!&^TY3)T=
MYPP](0.STJ!S<4%7/7<PAVFGYR#'"_71<T?J= ,]CV?Y<>GU8EV*<OYHJL9\
M,Q$ =9# )_VBOJU,6^<9HR2),I3 +#<MEN.H@)BB'.9)G*9"HEP*I]8#YP:<
M&D=VY04[@:^ $1E\;X1V9,&SH-LQ7D@H!V:W"U%TYB];:$)RU=DQ1^4E6P3V
M.<CZ/H^P]Z91X'R3G\_I2K]B2SZGY?VJ=4:8#/[5W4-S9>,+GPG*A"PTYZB"
M)8:"N-Z\Q1)&*!(Q%RI),+4]I/.486JLM.EJN=4#U(KHJ0"-*OZ!,+ZS=/[P
M;@3L!Z:Q\[!OW*'K"AA%0*L)@.UL##\/#@'\P\_'6/']P\V+6QK 98CV90EX
M/GF\)(++5'^68W#AH]Q7IO=+*6^65,C_5RWD5WE;U@VK/VBE%V8=G*59G%(9
M$RA4KE<@;?A"5F0(%AS3A$=$<F353MIBK*FM-$9<4,L+C,"@D;AN]+Z5V9[4
MS@%]?A$)"-_ B\6XR-G3?D $1Z+WBY!T(G!+;'J(^MP31B-D2U6ZQ&M[BW>+
M6GI[NS2YI/IM,9[^NCS7QW(A/ZSE_6J&J2RD4A@*G&<0R9Q EJ01I D14<1B
MCK/8L0-M[X!3H]KG\C:!*TUYNN]&9E +[>K".0>ZI4,G()1#NW<N0]&GJ:L5
M-(%[MO:/.79+5BL$CG1<M;O/OUAIN;C5W/7&1-:+MGGKZZ<;_;S:F<G3"/."
M<I@)BDT<HH+,'' *)A5GC$<\=O(*GQUQ:HRS$Q@\D]BX&HS,7E[C\[C;<4Y0
M- <FG4N!]"HN:@5.Z'JB_8..7D+4"H-C54/M;O1D'I/1\UG5A?=V*VV198PD
M208Y5CE$F?X/C54,<T9IDM"":=2=V.;8*)-CF#J93"_"M9@7&#+',;5DDDN1
M&IH]/$!R9XP^$(*RQ-&!QF6&/ET/V*#W8C\&N%G6:=9/]4.;7&SCNUTV&19-
M'?=9HDR^'<(F[T'O=PB-(<:YWN_PG!%%<ZIW/RZ$8#/HU/CAJWS0C[JCJSKP
MH5L#V(T>K "W8XO0, Y,'AMQ&_*XVE2)V,A\5:=BM7THPK&)"T@AR<5JW%&Y
MQ@6)?>IQNM?]6'O;#Z@IZ7A#?YE>0*8>^H*7\[(V>K[*]>-R<5-]658_RI4Y
M.\R12+,T49"H5.^*A. 0FSZPA+-<$(8B2:QHR5N"J7'4KK=66X/5'#P:/<!S
M14QI%J.*<3(];)2Q/^'UFZWS)^:#S\' !#=I^.V/W0>?AI$.XX>9#J=3^HN@
M[#F[]WON:"?Z%ZG=/>>_[$&^21G+\@<U@W:*$<TBH;3)FQ*8(L0@BO,<,D0S
M*$1<%!+S"&5.[<:/CC*U]>1]M93E[0*\>5R:YDU/8-/%9/6L-TVG0-O;<L7G
ME:G;Y)K <0QTRR/_2Z$<^IQ_*]\.M)!)'#W:A\WC.#;0R*D</;H>9G/T7>P9
MA"S^^=AT-%O=5!L:DL^Z6MQ4IAAY349"BM=/?ZY,V\O/#_71W>+VVM!9+<HU
M6]7?TBQ/,"KR-(4$J02B+(DA(9& 0N92)*(@HA!.@<L#"#DU9NKH:);MY49+
ML#CHW6,Z]M FD*K6UIQTOWK4"IL:J[^!:J-T74BJT=HQ2'J(E\*.^EYZJ@=F
MSKU9WBH(#CL&F3Y!9I:_=&?9Z*K?AM_ 5EVPTQ=\WV@<,IQ[P D)&@(^A)SC
MAHT/B/1!J/F08WFN1)R;SIFK79OEWY>F$49MJ:UGB+"8%TI CAB"R/1V(S'A
M4$19CG'$&(F=&EKV#S>UU:&)P**MS)UN[X[$WH^Q)44'0VYHLMW M9-TVY[G
M>CZO?E+3"-C4)7^SE*)< _/:7[5[@P EM-P "TJ&_2..2VM6VA\0E-U=;E2S
M6JYG'S5G-5$OFMZ:F @I5"X92B!%&DV$XU3OA!F'2JF<%VF:4VD5BW+\\5.C
MDIV$QKYPBS,Y 6 _;UP.R\ \X8B(]???KWC/]ZYO['SK^K?][_S$DT?YKONU
MVGS'9ZYR=ZA\*V\7=<NKQ;KE!FV$?*GF)>]N,E2D$DD8A1'.3"'50D"&(Q/M
MP3(A(Z)(;ITM8#7BU+[NCM!@)S78B&VS1?"$_KPW)#B@ _/"RV%I[]H(CNE(
MKHP V#KY+9QPZO%3V#UG-+^$DUI=/X3;C7X[NC:H^+V6^%BS\.W;GK T0GD:
M09Z:%"^2,D@0I]H2BQ(J(E:0S(JT'<>=&G5O8N7-#&_]$N"GEAQL1'>F'->I
ML-L!#@#PP%0>"%OGK9\C4B'W@+9#C[H9=,1C?U?H>KN[F?E6JG(AQ6NYT#^L
MO^B7:!,61!?BW6JM=Z+EZDX*\Y<W=_H5DZLOKS_/J&(1CR2'-(\81+E$D'+.
M89HC_7\RPRRQ"C#V%V%J;-9J 5HU@)%V%QI75S/OZ%+_&;3:7#6_-2UT[$TK
MSZD[;[<./R&#^VLOF8O7GP>? WM[=_BY&,D 'FQ.G,SBR^#LL9,]'SR:X7R9
MXEU+^L(GN2]1-S^K_ROI\JV<TR<IWB[ISQNYO/]8T45;;!C)HI 2$9@S44!$
M<P%)$INRJR3C).(%BJR2>6T&F]JRH^6%1F#02@R,R,#(#(S0'E6>S\)]?@$)
M">+ 2\4+X&=/_B%Q'(GF+\;3B<YM >HA[K./&(VB;97IDK'U/;Z1E$HN-;/?
MT%^-=;IMIC CE.0)%@RJ%!.(4I) EL2%W@$DB8KS'$=)YA9.>6JHJ5'N1M(Z
M&KF1]0ILI76-FCP)L-W11!C8AK?'?1#SB*0\!T;8<,J3HXT<4WE.Z\/ RK-W
M^/'%II;LF^J>E8LVN)M7MXOR7U)\$*:VBRJ-<[MM%]L:CL_;QNJ_Z97*](GE
MC?>[N7@6*13G:9) %=$,HDPRR(B(89*)*.8Y2T3J%&4YI+!3XZQMF>>.LG5[
MYU9=T-6W_42?;\XZ.H-6Z2NP4]OI]&*4U\6./Z?R$@S,P"\^_\Y</L;$A%P-
M!I5WU/5D#.3W5Z11QG1;TX0L9^_TN.NG#PM5+>]KH3YNRT%(FK*(9QP2*A.(
M$J)7HX@0R'A!<(I4;AF?V3_,U-:11E+0$=6CSL899/N).QQ> U.N+U363&F'
MQ([C5AN26TG^M]OJQW_H!S3\IG_8I[4S#Q^%D.P4W%")Y=67]H$QIG(;2;Y[
M93%""4TI@9'*$A.LS2%-J()9)M*"89G1./?K^')LN*F10K>?2$?>"RKPG(';
MSK0+!^+ 3'$1?A?T6^F#99C.*D='?*$>*GW:G^Z6TGN7NV_CJUS<EPM6OI6+
MZMX8/E*\IUQ/H,DX62Z-]Z0>JSTZYHP@3)%F%\(BB+3] 5FN+0]2\-S4,XT4
ML3IT<Q]Z:IRSD1YTQ =;^4%7 8\S?,=I.>\1&0[L@;EI4CC;>TZ&PWLD/XH#
M[F%<*7Z(]7:]=WK@B/WN?11]WNG>ZPGNJ\/UMS=_/@C]_$^5!C>/T_=ZM 4O
MZ7S7Y'#5Y'*95"ZY>G_][;6^Z:9Z*'F:Y.<NK^-?GW;=[Z3 42Q1!G$F,XAP
MQB VW0NC*,)13DBD5QC;Y65DV:>V/FE-0*,_^%3]#1@(8)R"K5:=KJ KTQED
MEY G5^"5P0*81]1H  W'E=VMO]ES[]@OU_E%<L*OS,"K[$N]+>![@XE[E\V7
M>(/LE_\)OTDCV0^3XQ\G8^2%YJ_'FAE;HM',H1>"NFM/O90(GD>!CVPE_WK4
M@[PS3O-V:Y*@C+&48ZB22)M.J5"0QA3!6"FNF)#,T3E]=)2I&3D[(4$MI>,.
ML!]1RT.^2W$:^FS/&2+W [T^"(*>XQT=:-SCNSY=#T[M>B]VWXZ]63[IKTHO
MVW]H;N&&;GC[KI*B2.)([Y12Q!%$5 E("YG .!.%()C(@EK5%NP=96I?_U90
MT$IJ8KKXWSR.@4X#>W[3$ 2N@4E@#*3LC>,@B(UDQNZ0"QLX?!:#'E/P]+VC
M&6UGQ>^:5^<O'J;<]\V;_[Q>R'5Y_V R;0LB,IY'.60"2XBPQ) PP2#-*-/J
M,Q$55O$27J-/C3KM"QL;-9J2B+4B86M,/Y^A\UP[*.Y#AV-,$?*P);V]H9]<
M.6_;*0A>ROLHA!>6\7[^S$F5\#ZJKFOY[N,/\=M<?Y1KP[^?5;-___RX7JWI
M0AC'RKTIVC%+(RDD3C.84JD@,BGH3.D%)<IEP2474B+JLL\^-^#45HY67A,J
MTAZ\=42^ HW0;MOOLYC;[<1#(CGP6G 9B,X;=%MD0N[5SXXYZK;=%H']';SU
M?;YL8]J]?U8?Y6HEY:[R_<[ED#,2QSS)89ZF)N!&4&V_1AE,>"H0*U!"[#;V
MUB-.CV^,P.9+:43N] < WYV]1O; VW).0#@')YT+D?3@'4MTPA+/N4%'9AY+
M# ZIQ_9&WV)AQE?!UX\F:L342GA;W=-R,=,<D[.49Q ED8!(Y0BR@C$H,L58
MFL1YEDJWXF!'QYD:SSP3LZG^\;V1U+GRUW%<[0@E %H#TX@/4!YEO'IA"%NV
MZ_A0(Y?IZM7WL"Q7_^5^C/!E67$IQ<I4^_JP6CV::MW:\JD6/^1R7;*Y_+)L
M\W;K'GZSI$@2E<4*DLRX'(M,VR;:)(&81"J.L<ABC%V8PG'\J3&(Z2CQT*K0
MU+TK6R7,FONPD;WI^ G*!=#OQL)L;JM%4QCOX9'-2ZXOUA?J>76C'=?)LZ.C
M :=D8)KZ\FPF/G1FHB,]V(K?=!0-1V">P(4D-E<11B4\3WSVB=#W,1?55VT3
M0\V'NQ\AAG*6898G,"V0WJXIF4$B<@[C-#$5[@4EPHD2SXXX-1+<U/WL2'P%
MVA@_[U@_>_QMC:R J YN;C6 NH#G6S7U/" #U$OM&?0E*J6>Q^!$C52+&ST"
M\%>K\G8AQ4WU>2'_\U'<R@^+/ZY;CWN4$$Q3E4$>\02BB":0<1E#E D5\3SB
MG!/K:/F>@:;&,1M93<>N:B'!/XVXQJ#ZX]HCHJ$7XO,NR5# #4PC(V+F$"4=
M"+NQ0II/8Q@HZM@"C[X0X;[;QXOGM5#B6?"MS?5^]MJ[^X=Y]21E;?M]_KG0
MW'17/IC]\KMOG[_\0Y:W=VLIKK6M2&_E%_V:W-&5MAA+8T-^NZ/ZW=G\HY@Q
M*B,680ZQB'*(<KW9U<9<#A-<)%G!"$_LR'8 V:;&SQO5FCT5V"K7'!:],OK]
M=@4V*H)61[#1!]1:FIU:H^?V#\+-6@PY^W9VY0O-Z<!+Q_C3Z6R_#@!\2$LW
MI'BCVL0#X+IO/0\QA+N=O>N<]4VNU_,Z?;;IA"?%[^;T7F4H*EB:0A$1O;&G
ML8(TR1#$*A9I(O0*4%B%?=@,-C4^[[1KVPD,-A)? 2.SO>UX%NKS-G=( (=V
MNHZ+G;WM'1+#D>SOB[!T,L1MP>DQQL\^8C2#W%:9KE%N?8_O0>H#?:K3Y#2)
MRT59+=]*MI[1%.>2QA$4DA"("A%#IK(,9C)'!8MRGD?I;"%O3<$#V_/38P-9
MO=ND>;>[PPWHK6BEU/M*,*\6MW!M"I:S:KFL?I:+VU5= 5-HT8'\91J'/9:K
MN_KMY]7*M>CI"?!MCTZ] 1WKO/1ABZ4V.6L1@9$QY&EI'P9ACTB/CC3RN6B?
MMH>'H;U7^]'%M@=Z'1.S*;CYM*NS.4OB.%,**RA8IB 2,84DBQ&4><Y9D69%
MD:B9MB%99;L_/SNFRSO?'7FX5W\K,JAEOMJ6S'WJ%LIU(XOST--"R(PS!541
M)1IZE4.,>*Q_C;$VC)-,H^]R,!(4^#',XY>!W8ZN@X(Y,'-?B*,SC5MC$Y+1
MSP\Z*KE;8[#/\_8W^E'^^W)1KO5SM;WY06\L%K?EKO;R?;5<E_^JK=-WOQ[D
M8B5-"Y+W^D6<<4Y)S'+-_LR0D>$A+*AFI%322!8)$=B)C/S$F!I#O7]<FR#?
MKL2@%?D*U,URC-1N#.4Y07:T-3SL W-9HP"L-0 [%9HB]5<U^+P^+.UH8S,5
MSB1W&9(AF<]3DE'I\#*T]CGRPJ==6BBZJ47]CU)T@L<_+WZ7U>V2/MR5_'JI
MJ?NCWFS6$F[ZL'Q8B/)'*1[I_'VUE.7MXHW)<UF6<O7ZJ?FQ$VY#,Y)Q;6%#
M2@J]85<D@32*<IASP8M$(!S9U>M[">&G1M+=(LR=S Q-U3NM0:VVMHS,$4%#
M+FVKC'(!=LJ#5GNP51^PI_:7)_#]INZQX1V%->H;9K=>3/6]&7B5F>(K<T$Y
M\/'F;ICBXB/(_T*ERL>;F=.%ST>4X>5[C^WL!=/H)4*HB%(8"VYBBHWK48H,
MJD*FS$0 "N*4<3Z0G%-;3P?J.'7"LG_!QF/==\5NN9S &S#PRCB5R7_1KF-'
MIF:J#<>ZHO[;]AH[@O>0;<:.#>?I7UG?R:46Z6$I[_16=%MMQ50O_6+^H5IH
M">JKOE2K]5*NM5#&R=/IP;ZZ%O]\;!J3?)+KS^J&_IHI1 @36:Y?GE1O#XE
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ME@%^/G#;D_& L(_$TN'A=^)P3P![R-WUB:.QOJ>JW>7 ]Q'NZ\0?]5GV:],
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M?UWK%2S"44PHP9!RA6$50$.),E@%S5@49#PBR#)5]=@PT^.&IHN2$A/4<LY
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M.)X]K;G@T6[,KK-FJJ&OR4;<K];JB8W[+LQ%@FF*(4%,M^CA"%(N<LAPIH-
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M?E+B?B<ZOD[]1*W#FV==&6USM>3:K_"DWZTYC44>D3"&<1!0B/(40TRY@'G
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M98399:>>'LSFW1\G";6657\ ZYVTH&S$M>.,'HS-.,,/;@-SQAZPO9C@^SG
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M#8K7E)$CPXR;*W):SX,DD9Y+W5CAKZL5_UDL%C>/3Z18ZYG\K#;.\QSQA**
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M3F.(HR2%41BD,18HX=*JW\WQ8:;&32_Z(K3M+"M)W3I)O +5C'4NAVI@CG%
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M_QX>!E96TYI 4:D#6GV:+7834;91.H&=4I>=KEK,H]L)[#"S,_HIK<^)N?A
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M8DS-D#A9'%Y7RMR 2A-0JP)VNE07:FV\%.@_-W%F+#3\= Q,4P/-A*]*_89
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MF>=!1G@H!8PQ11 %>0!Q)@2D69@E&4]I**WZ05I+,#7CHE&@C<H&6H49:)0
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M^IN$<N,G"4Y"[5.>R\D)Z&JOK-:;.[%^?+]:KU<_=6>].<U3SDFJ>$'&RG)
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M>L+RAAQ]M.B^$2#L!@F.,9S;#J3JK?!UO=*G97&2H#Q2;VJ2ZIX'G$M(0Q'
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MU8P34N@0CNJ\\4/QH^!BR74?]J]"O1/JA;D7\XS%5&UK%6,F.%6&',&0(!;
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M&0XXZO\K:!  ;->]?V]1Z/Z@!L*/ED=XE]S8?%IOR,"3P/1>#N^99#Q[Q9R
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MU<S>W2*7%Q!#X3PPT4\'8O>5R%!0C[1 B0FYU]HE!+>>)8W7XT9;Z80HV5T
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M%Y!.6(_TGRA[^IWT56_4A*=AS\)ZWG+'HOL1^(-7+.X6\@\XQYJ25T0)K 9
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M/@+0[#E-5MP;EUR D H'52>=1(8!7+(68Y)1R2;UL ?V16U_L=/C/G68E$>
MDQO)/$$3X8&30U8/6I4J#J)"#U9DSH(2LE%2W1/3I$Z9?/ D93Z<)O44R8X
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M$*/2DY1'< JW[6Y^'>7F9'-A H(/$H@1BANDH)?!*)4UUTXV<5)NDS&23>=
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M?#EPXR?2YJU)'*L?2\%T+11?F[.'+$$F@K)R64.-Y:#*Q!5IO6--SHE/PMW
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MWZ%>&]6,$G3W&P].8G$V(Q<@;*P9L5I!X#X![:0D.^EI!VWB67<A;N JC>9
M.U(=PV]:#[-VZ:=-<35QS"*76H+=U(DZ&ZK0ZLOLO=1:,MOF-.LQJ@8NEVB.
MK4,5,&90;7;_ZYOZS6G<),@0LT^9MO[:FSXA!Y>Y!$%A8&(L.Y>:M";H1M[
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M(?# A1$LQ]QD1FHGZD:RFQP(@3VW-_WJ8P0@NW?_] WVG#:^!)G N]I.39H
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M-U3XINQ*G,+L^@;L^E+AQC(,2!QF7T\D%:B0&'@=%(A<'$,F62Q-,G_Z9F3
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M,)>%Y\59G>_$VWLS(4]/^4!-[=NB_1F 8 0V??\)V8]?SG&^PLMPD,(]84J
MF*N_Q9T!EPUQ*(LR5JHB59/4P ZT=4/N,[V1Z5LW(X!;O=%<K??=*GF?O>(E
M0B@IU8PUVE6$)Q^?B>*%"U+*)BF"#U+4#5K/]"ZF'SV, %#OUV3&PS*_72XR
MN==_#TMR7]9?+^^5F%"I)C_R8FR])^?@H\C@N1'(E):Y37K^HU1U2V9^IE<O
M_>EC#.#"&?WJX\\XQV6HYZ8O\MET/EUM4LH^X\X2WW,!B#=K=42P%,B!4KS6
M9K$$0LJ<,+'$>9M4^H/([0;'9WKY<@(-_GFKZS8]=4Y;6[=[Y$@JZ_8)X*JN
M[OOA%/,*UV$Z.ZUF+I\Y$M7L%<'):AZ+PIB2-I!SG:R@8H1H,@/)5'(N"8;.
M?$,3S6L>O_F ;<NL9",*EBEB<(D"B(!U;ANGR+6XDE 8'Z4XEI6!NT7VK]-;
MS>7ZE?$(W)X7^3\NML%!G:7[&_YQ@Z_E8D[?INW9R*8IG])1)!'(D].FCG'.
MM=2(A&>#8%$'BZ7-J*\G43E2\!T C\6I=#4"('Z@][TI+_+BO&KJ5SR+N)QX
MQ;"$6#.>"Z\50N0)6B$@\N@S1E:D;G(+NX^8@3M0M-/]HF=%C !,/X19G4;_
M_A/B^I?Z[JJE*AB>A C%)+"Y5@!E%FCY>0:"6ZYD1N%4DY.GAP@::;'S\;:J
M%PV,%$F[SK*Q9$*]U8!">% LT^K()=5[@((8;&#F9%@:LG=OORKO@*,#Y#\@
MDE;+]>1=G8>YD85(FGGI2 (YVFUK<I>#AN)DD22CS&,7T-"'W@ ,O;H+EEM/
M'6DQ_.%6YG"9C@$(NSU528<*K0-=I[K79"8@"2A0AJL0@G=<=TG9[@Z%(?V8
M(S1V5^<'B&]@K?\ZG4_/+LXN"8^%^"3FA=?5EXH*(C*"/GE1]'=,%-/ER+B3
MWF\]>6#-'Z*W11]"'%K[X<L-PH-E''748&/19.Y$O<YE$KRG#<P*DXSM4K+=
M3?LWGSR,J]F;]@\6X@B<R)\(NFO\9?H9[V7C__#UU_ ?B^7+65AM0S>.*BG+
M$\57CIRER#DX6>_.LA Z&IY,:A+R/H'&D38T.3YH::6G40Q ?82Y:]9^"V>X
M<Z\M%FN]JK=P0=;2WP2!65JN-D07:9-.KDESXR?2.6S,TPPQW9%YM/)&8"#?
MAG4]N]I9=V&$]"G6CLR"OF BPVYB .0FI^*0"]&D!>\M*D:+J^/U?;<9P,'"
M'P-R'NID\,/7>I"Y&R4D)$95R-/P!92SBJ*-$J 8[;TL3 ;?9():!]I&VI+I
M^*VT;[V,&6J5H=TZ3#K0*F3$C="U7"D4B(8<72,XDTH04^*T4+NF;5B#UCL>
MNN+M0.4,'#/N4NK>+-_C\O,T[>0CN)&8-+C !,DG*/(=+(,L1:FS$[2T74I<
M.X6.^P@8:5.OXXX1CY;T.)!2JWEV'*PN?0+:K6/-#P]2TTZ^\3Q+(B:,LA0?
M2QV1]0R7^U0,=^9TO&+OH^1(*8]@$WO_:7I^7HM:YOG?PSS3VS[N'#_4DM9)
M3J!K]B-9QP">.S+!A@7EB]8AMQDS^!!%@T/G6&W?S4_M1?1##R%]S!+_<C73
M1XB,4FL!WFNRP9[3IJX3AR+JQ$V>=+H;PCT]T^R7)XVE/'U%V^'[4B-!C\'\
M=,K1G@1O4N$.:Z_]ZJY95S--$C"D=<9=<MDT.0'H1MY($\P.!,5!6?1/TM (
M<+>SZ+4W,,["MNPS3)>;C*DWRY>?:C%HO98,,@I1@+E8>^&0G?=( 8@HT=FH
M#>.FR9%G)^I&FBK4#^KZU\_82S5>)(I05YOVP;4Z^7U=7_AQFJZK]0[)^>_R
MJ;UF]3^9C9XFN.UK,'F5WBVR0U%JTJ.J S1BX5#'=$%0!%#/DG>RR3I^C*@&
MK4WWM3CGT1&#%B'E>A!<!X:%4!,ULV:<.62<-\G0[D;>P EJ?6&F0[?38W73
MXY7A< ;LX**R[I]]:F/V:)E80Y/F+$;-:-=+O@YY4<*!%P34D'3D5IB8PLG:
M%_<VF#)]PGPQPS?E\BDW%?##UQNOMK&41Y9=<)Y<"EMON9PAI[,6K>?B2Q'*
M:]=DN,93"1VQF7L*CNZ%!BWU-8(@80]7FT-#QSR7Q6OPO+)1V_#[8!(HYV7B
M5E<^6JZ]._0,BZZV('A@8SU&(Z-(OMG'2/UVB9>74S+P9'DBYT KBIXL<@C(
M)*U3YA)C.A?3I('S-RD;AS$["@$=4'6X,@8^D/WAP\\W^-@=*.>HO;(B@\Z!
M@^+)@RL,@:G DO08T';I3K;OL\<'AR-4M^A1C@/CX%5M<[;&?"FA5Q?X8;&7
MJ>+1R"@*Q*+JQ&I-BXBE!)9[X:(NQ@G9 1R='SC,P55[Q+21^, P^ALN*2B:
MX9?7\W1Y.Y5]<.@")",U*),*T$L&TJLD8TFI2-<!+_<_>9BRI/; .%*& R/@
MU^EL-CW'?)FQS[,S5J"'8&OCVA(4.$7^FXV>N\RD"Z7+5=Z=CQTFA[R][H^1
MWM!=5$EC_J8S?X7C%_-\ER]K*6KTV@"+Q)+*WM:=T8.7.BM)_[-WRUCV]S]]
MPC.'R95L#YEF<A\:3Q<?SW ^K5;PKSOJC6>ZB.1J&$AF$.O](2H%)?/@F)%<
MVBZVY/XG#Y.:=@)L'"?#@1'P<D;B6_^*>9K"['HS=,)R*6(!*VJ*N<4$T<0Z
MC(E,HY"&5!T[H&#_IP^3#-(>"3W(<F@T++_2!VV\XCM,R**+R])!Q#HU1)!_
M')6JP[I$XC)E@[Z+67CP <.,<CP!)GJ1Z,"P^.W+AT^X#->TIQ2M9 3D) P!
MF>P9>)$LD" TA4[,:\\ZH.'NYPXS;K$]"(Z2W]"Z_QO)X@J^+Q?+\\5V@O?E
M7J=4#L@I4K:%D4PT!Q<VPZD*.I^8\G>'H>R'PN./&6@^X@F@T:-X!T;*FS6!
MG-3J;CK*.S:8S2D%GT#*0CYQ/:^+@<03K"@^H+.^=#GM?.01 PTM;(^0OL0Z
M=*CQ  NQQ,P\5C=9U&X#G,2BD0'M?BFJDNITJ8Y1ZL&H>(8GFWV(<P3WN=LI
M=>]))9O6>+_<[$DEE$TRJ@!%%1*-K&DXB %2EIQEX02J)JD$C] T[#GY2>]U
M^]+,*.YV'V!FMP:U5\$8DI#EEJQH\ I\4.2.:\$ID-?6L2:I[(]2->PE7F_:
M[X:J Q0Q<$W?FS_F]#F?IN<;D?B0&4<3@:50_?D4(!@F@$LO>$P\\]QEH%JG
M.KY;3Q[V?N8D!NDX:8\%)CN$8YT.%"O5PEE0V5#@1VX::&N,LP63=EU,S=.
M,G29YQ':VX>! T0Y D_GRN9M^H*\*>_7B_2/C4"8$5()$D.6P8/2VD)PEH$T
M(7.I4R";VB1E\B&*AKWX.ZF7TX]61@"OF_3O%DAA3"DM/=A2Z[^P<E"RH062
MA$H:I=1-JH7ODS)P.F0_.KX[;O8X@8\ ,GN6UR]7E6(6E?*2:1!HJY/'JW45
MM>]']I%YGIEJTB7E,:*&O5T>.JOV,-V, &=/$=SUW,YD3$FU'SYZ4=M'>G!>
M*$@E)<EBL:)-,<4AQ(XNW_) J!Q12W"0WD:%S7>8%A_GT__"_#IOJXXP;[NY
M[4[L\HMY_F4:XG2V&31+O[LXP[Q9ZM?L1VE%MDZ"UF3XE;2U382NS=159%H'
M"IN;U/;US,?H\D'[1O3IM3T"L-_H6$C<O9YG+ _W,+R2P^IM6*ZO;<"-DJ4[
MTJ@=!K)0'$H.M/2S5!"P.."1G"J*S'@(3>8LMF5K=!FP_2R%$6%A#"LC3)=_
M"[,+O+'D?\50:X/SFSD9BXOE<CK_^$-835>_SQ=QA<O/E>'7\_.+=;4E\T1_
M%6YOA=IDK4MRD(Q \O^4AZ#KY5PT.6B5BBU-]H(6S(PN%[BG53"TWL>$_=U:
MO[7O[1$&O>&WQ7QY2S;U[W=22)_FT_^\V+56NA:*2103,YV!"TNA-L77X&I?
M$&T\-UF$I&S;Q="2N]&E/?>\.D:#C!$LE^M& _^^F&5B<W7M5=YM0G##4\3(
ME)0%+/,:5-$(W@L+!854+ 3E.XV4.."*\0!J1Y>IW0^<VVON3]#0Z/!9QD_X
M\%-W!&DQG;A;QQIC9!).072L5@-(3@$B=X!%%*=TD8;]^5N"L-J(,XL(0;@$
M*AH'D>4"R##QI+()K/&9R+-O"?(4'!W=$N0I^AK!AOQ0^X'B3.+!!S!!RWK/
MG,$I2WY%3#H5'XWW;68__BE:@CP)!!U;@CQ%(R,%UNWD34SH4W(<"I,,E,L)
M?)UV*8MURLB8N&\R".J9-@1YDOZ?W!#D*<H88T,0X\G#-+9 0H.[ZT*7//@0
MDO8B.F&ZU-0\QX8@3U+=MQJ"/$6.SZ<AB'#:UC(A$92MF0H*?/(24@KTD1ZE
M3UW \:=I"'(H8MI(?'P-07@4Y!I:A(SD-5+\FB 4'H )DX*7*LCRK7CN>38$
M.1081\IP9 U!2O#".I8I0+!UG+>-X$RM0D]2)(:E^$[]8)Y90Y!#=7^,]$90
M5=6Y,466E@ND_=#86$"ERI?2$9*.(1!?BLG_;@U!#H5,,[D/C:?[S2Q42DG6
M&> NDNNNC$[@,C<@$8DG9J)5I@MJGEU#D(.Q<9P,AVX!L;^)A<;DLXL*7,D1
M%",V?!(.2B II&1M-%U0\#P;@AR*A!YD.30:'FQ?$;RWEM>;F!RQWL0XB+Y8
M\H^U9])EJ6TG0#S7AB '8Z(7B0[=%.)N0PMO'..!,V ZD8'3OA"DD8(GRQ++
M.1<G_HP-00X%P5'R&UKWW^A8H52*O) DBK'UPM23X^RL!')UK& ^)G;W4/1/
MV1#D8&CT*-X1-P1)C$4A'0.G34T0+!IB#@BF),<*\R;&/WM#D$,1TI=8APXU
M'F ARZADRAD8)P.H9.V-9$,$892)Q>ML[T[X^E,U!#DF(CU6G ,CXNT2/]?T
MCH3O%[.+#1/7.Z1@T16K"D2==,VUE^"0^+#"ERB"2LIVZ3/UV#.Z8>,9'F[V
M)M@1W,K^]'":^@]??PW_L5AN*C.W$P@2^=,QDQ]MZ8MBM1E.T1(B=TDSE3SY
MUXTK$KY%XS/K*'-,6D KS8T;E->,_1;.+A?RYM O)D\AOZ)0+V<!L10'0FDC
MO71&-"^5Z4+GL/?&S?#2'9='*V\$V-PD7B]FBX]??PBK/2SNSJ2*9*+X>BB-
MM6EUHB5>HU";D>1:F/&J"2([43=:'!Z/CT5K98T @9N Y0%6N,S<!PI8E.#U
M9#R:VO\N059<>VZ\Q+MW4OW@[A&:AMV23XFVOA0S HR]GK]=+A(Y,.](743)
MIQ?S_(J\WMGBO*: 7W9'-#X&46=0D;=2J],UA)0*T K*WMK(<VR2C]V)NF%3
M*TZ)N_Z5-0H$/EI#>\]E84ICM,) PLC)97$.@M$94);BLU/1I48E04^B\YEU
MF#LF0&FIP?$#=.\JI\7,=%():C\U6H-20XS" Y,8,WINBVC20^H 6H=NF-D0
M.T_#Z=&*'$G+UBY[A,M%68KT@%SB6-L=:W#.*L@F8\#(>$Q=&F\.N*$/A<CC
M47+0IOX4A0W<N_,=R0LWBS60JR&4JRTKE0'E5('@E(48C LJAB!]E^"X4]?.
MJZ<^LRZ,AVR\ATMY#-"X3-M@4DM-;FIB/A/C/$*TEKZ3=7A<=-+Q+C%%=W ,
M:5R.T-A=G1\@OH&U_BM9T[.+L\LL8:-T]A24,,>)W$* ]\HZD-FD()0R@G?Q
MWSOI_=:3!];\(7I;]"'$0=V2#>GARPW2 VUC3G $B;[6Y!+]P98"6ELFC+;%
ME-[6_:TG#W,^U9O^#Q;BP*O_[SC]^&F-^07!*5R)(>90A+<21*R)6RXD\!@\
M2*M8RO5^W7?ID]H)!7LI&"8^[PL-QPMU!('U58/A2U?I/7[<])W8;)*H&/.^
MUKJ&2!#/7$'09.(P!)4PYWAOT'O/[;WW4?7,6ND><ZK3GW;& +4M[9?Y(-$6
M1H1#5IK7>9(>G*3HC7&M*,SRUG:*2YX.K9M4C*2Y]_':O8N;@T4]<!K5S[-%
M#+.WN)R>UR3C&47^N-SD_]#B>CM]A^>+Y7HZ__C[?'H9E9=0[\VSIC#<2U",
MOHM&&O+K6;",0G/ENB3S/_W) X/G<!4O3B;O@='T_AS3-,S67]]^"LNSD/!B
M71.3+Z\)R7V+HB@.CAL+BK,$D;9[B(6'@!Q#5EVR-1]_RL!)4KV@I$<YCF$?
MNH@K_,\+$LN/%>D?Z,^V!I<YGV)$,+$@2:<$B"*0#V<]6DR^1-=F1]I/S[ E
MAJ=U<WK0R#B!M5MXM,IB%%+")EY4.E*HZ)B&%)6KT]9ELDV:[3Q(T<![5Q_Z
M_C:&#A#^^%"TL['6AJA4MA!436G1T8!+VH-G)3,6D+%.4]J.1= H/)]^-/TX
M?@X0^PBP\VJZ.E^LPNSGY>+B?'-!5OM-7H\_+)B%9((#^6JN=K&RQ$E,8(5P
MJI02O&HR+?(;= U;0WW2K:Y/#8T;<)=#@IV3/@@%1OGJ'-+"],0D.!]C%CQA
MMZ/F/B$WABVP5QQTQ]@!2AD;ROX=9[DLEO02?UNLZ5=I0>'J_ +SFW/<EIM>
M!B8E:^V\5"#KH:[*H1INM"!E0"T\HU"EB=MU(+VC1>0AJ'D,DXU4. *DWID1
M_$.8A7G"]Y\0UR_F^47.FVTDS"K/LT5M0D\;S"W9U.JVV45M\;U?+AOKH%'%
M+&L2BG3UHL(4"-YRH(!;%Y\"JC83[D[#WK#M,TZ<MCDZO(Q@%3V)P1LI8-(%
M%$'4A@*Q=KT+$:*2#+@Q6)R51N@F:<D'TCMTCMWXH/?8IM$(!^,^HH[.&>L5
M0M:>1(@VT9:;,V@71):1,75WE&2K(^K3^!VME-S],/LI$A^!J7QTXDBQY*_9
M:,"C=K4SCP/O+2U :U04/KMRMU%)LQ[?5T0-VQ9IZ%[RA^EF!#B[M4H?7Z0O
M29+3O'LQJ2TC92H%'%<"E%$<@G82A"LA%UX,BTU<U4,)'EV_\0,A\]A6^O_8
M>[/EMI(=7?A53OSW.)WS$'%N/)1W^P^7[;!=IZ.O&#D@;?:626^2<I7[Z0^2
MFF5*6B17:J5<'55A2Z:T%H8/2 "9";327P<XW2' C^3G\?UJGG FLRDJ9 4A
MBGIDK^Y49N+(!+1UH#KGKDE3C7NIZJY?^3B(&T\3'<#J??AQ-F!K>=[6YH([
M7)-%K=<SX=#YDA*4[90;$P(XXSE$73(7OAALTX/@(<*ZZWD^#KA&U4<'^'H1
MUE\N)M6^(C%>$]BL1.FYM YR9AZ4T@:"\@*RBT8'Y.*GIH3C0.L>FKKKICX.
MJL;20@> VMYGP[RN;)P-CIAO*(6_BGMQ/7/<F22CAN"" <7K<2 G'=2+#=Y$
MI;-NLJ<\@+;N>J^/Y+9&UDH'0/O':5B%Q09Q?3ER]:IB-,,BE=.4FG,9:[MH
M28F4S *84#$P^LSD)AO.]U+57?/V<< UGB9Z@M6[>#+_?+XE=';]YK>_OIVQ
MQ+T. K.%Z&L%*%"2$@U%D\85Y8HWM>]T4W#=35MW7>%'AMA(6IF\:>>5._Y8
M1S]C?KY<K99_U@&['_ DU*//GY8?EC]JO?#9:E5O#6WCSAE/GM=3:1!Y"?72
M4!VQI!2P@IHA1\G\D+/#AU/078_YXQ#VB.J8>BS!MN#RF<B^46BYR&A^#QD_
M+2E)7JZVZ?*7Y0G]""4Z+\,&9\1CX)3:0"BFCO>IPU2]K>5OIH.7Z#WC V!W
M# W=];4_'GB/II(.%M8=LWKO8/_-/,3YR7SS8^:T*1@M!UO;72AK$'Q@&BB-
MCIXE3ZZ]Z:S0/6CMK[?^N-6T5FKK$YD?-_CMFBA_HZ\V/[9WE"AU>GW98OHR
MWN6SC#(5$<U99TEE"H>8/8+Q6E!FA<)@T\G)QQ#?7]?_9MAMJ]@.P/R/Y3+_
M.3\YF?&8L^&T/+CMG7**C4F$]*V-@5+YR%*)V"1).2>@OZ$!(Z4BAPBX V#L
M,(8/F):?%_/_QOPZUZN791XN6UU=E".?+?*%8Y_CFCX[_8KYQ>FJZN#L)^DI
M./]>?W,]8R;$0G9!KCZ9LQMYWDD/Z),5&8USWCV2%QR=N?XF'33SDM,"XQ<S
MEM>+>J]GN?HQLXF;I!R'4.NJ2F0#+@L.M2]UT%R)9)L<$VS"S3!S>'I[,=.K
M_A?#_PV?,+-28JRW2@K*[57P0.MG+N"%L3$Y55 \5DHW#D?#[.#I;1GU 8%?
MS!:N&HJN9\:86)=%\%FE.KI20>24*D>NM-(B2C1-3FXTXF>8'3R]W:T>U/_+
M6<&]779G@B4990J42JF:<BL& 3%"**ZX&.C_VW.3>[2,>WD<9BU/;Z.N5YAT
MT9Y[3.%LQY"\72[2C:4URXP\&0Z<D2M13FL(P3)0-GFOK4\I/%85<ES.AMG+
MT]EV[!,2O]@Z\Y,LK&-1USLV&%(]G,D+1%0<O#0^%K3&N"8UT99,#;.,I[,O
MVAT0?C&C.,_%KGTP*\&E9 N#9&M#::$\K:&9I*&$9+[D($/W\=;/; V[WO!+
M[,A.!8;]3<.?F<8"/X<-YD]=6LB5M[@N%ZV"T9J%6K"H??M9AMJW$()7GH<4
MN>;=%ZYV<C;,3GZ)W=\)(?&+K2+7Q2"4<"8@!^$XB4%X!K%(#9FI(EU.WNGN
M+6-O>WAZ&]<]J/_77#!>GG/R*?QU73 Q1FVL"L LJ\='2#J^" O1%!'0F"AM
M]V'5;M:&F<C?>RM\!%!T;2TWSOY]6H7%^HS RSO>=YVMJDVXMF=:/RVO/8[/
M;(K)J(*@@U)UBQ1)<=%!XA%32=&1B![OL.>HO VSEU]BKWQ26/1:Y1UXZO ]
MKE(%QF><N<)]+BB!PLLZ*=@BA* Y<!3"R=K_@#_6VK$W\</0_DOLB+=5["^6
M,]S>P-G6JS]]"8O+(Y769"-T3J"LJ*,TZUWG@@DR95*>/E/!->G9^JA<#C./
M_]DH'P\J$U^\VC:[.5UL/E!,=GFP_/7BV^EFIF4])JPLL'I=0D5IP$5?C\(P
MQBE0]%X/N59U]QN&@>WI[#./*,\^O>M=\1.?*<DU(W0#RGH1P>$V:=!;+J4H
M22K[6'N[=Q(Y#&Z_Q#;M.(KJ%H2[;GA=O_FZ'63XKKP[W=1NGNNM#;Y9_CDK
MG)M4&TC(4N_,Q)3 V>+KC';B&UF]-3'ME;T!7 R#\2^QI_I(JNX YY<-=NX^
M4G1KLN8?:RRG)V_F!6<FN%*",6!TH87%1 X^2@K@K;06"WTLFAS6/(;H82VX
MGMX&Z*,IL@/0CFNQRANI%%? A""+15<G!R-"=-QY:0*B8D_,.4\ITG\GD-4A
M=!1;5A"G3#+UG%9[I3Q87T=EFD)H?JR<]0@VAOF*7V+3Z[&4W8'WN*=;X5O<
MO"O7^\[-<G#&1<D@B=J VC@'3E#L:E(LDDE?#.<M@+P/D<-@^O0VGIHIJ@,0
M'M)!0LN@K60,%$N"_A !O%,*8A9"9[:-+Z=UJOLU_I"_RM[.>&H[=G-SXKV:
M#[12A-IWK-KM/^I<@%*\X(*DRZ4AYNN)B!A(#$7G8HH4CN%C!0*'\C ,RW^G
MG9OCU#R:]_T___:31D@R_]Q^M/VD_M8'+/^K_OW'A]<WGA^7ZPW9:YJ?E>#3
M_Z:@YNPU=QCT2]R$^<GZ)A?K^==O)P^UEGO@@?]V1?!M5LZ?^Q.>QB$>_]K@
M(E/\,+J[6#^+Z\TJI,V,4P*I99; >;U>D2PE5T868#$E+!I9S$T&#MQ'U-$S
M88>/K;A#'6?3+$015I44(,4H04640.M" 9FDBD%EE*Y)57 D^ON8S7 TZGX:
M/3N!=B<,2->KS6R;V9W-A]*&TK<4 7-1E,H%2N4P)]#,IJRX$<(/V4ZAAUZ#
M(WUW&XHWWCKQ .,I]+T\5O@](.9B**2W@6DIP"<A:XML5V=0<M"^M@'C"7T>
M4C\;CIDIYV0=H;';.C] ?!-K_??YHC87/B<\H4Q)Z @N:PM*A R4?WL*_*0@
MHKD3@V8)#=+[C3=/K/E#]+8<0XA3:_^LM?3%9#;CK$!:8K-+K$X29."#,F!C
MCB6$H/V@$2O#M'_]S=,,Z!E-^P<+<6+MW]H\NH!OS('S7"!:ST$QR\$)GB (
M81G32;(R)(0=A(*=%$PS46<L-!POU Y*F74CX"P.PO1E,?_7Z=G:6&Q4W@@%
M6IE(\5#0$.KY#V<P".ZEQ=CD9,YN<J8=ZS5EC#FBFKH$V_D TF+1ID39'ME=
M!J4DI7S$&?#$2XQH<L0F%R7N(FC:I&8,93^(GP,DWR>"SH].8JX[2J].EG^>
M.V*TF45&]N6B4U5<&1SQ UZALY%<LE9-&K<.)[$WE!T"B8=Q-H9^.D#>#M^_
MM<JHA52YMA3@6.^*HJ+PG^((J2,F':+0;3M-W*)GVB&%/2R58RBJ4[R=[^"<
MVRFQL8U.@?P^,<2X@% "@^B\94(EKWG3W;D[*>NCMGR4_@=@ZG!E=("N.ZSO
M^8]/]("MN+AFR142$N6X=5,PDKB8(CP8GE$YQ5AL$I(]2-FT S-[\'#C*J]?
M-%9V+F(2SF3)#,$;&6JEC4%(CD'BZ)/4&(MI<LSS0<JF]74C(V$8S@Y4R\17
MUCZ\_("?3T_J3_P(B_QB^?4KKM(\G,S_>\M5#&O,O\]/L&[.7Q1SN#&2QV1
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MY-G7>LUG_:Z\.]VL-Q344A!PQ>C[Y7I>?VY]:\ZUXRK[F#EHI<A$/-?$-@_
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M&FJ=#G7D2<4F6V!W$=3%XGB4LA_$SP&2[P!!]QXD/W?2R88BZ[@8CT63G$J
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MZF*YURPSRU#XQ[:$(WD:9A)/>2^P%T#\PK9QN5AF'G6)Y"%TS!0(\L+ %ZW
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M6D1CA2P(QII("Y.7$!P%7LEF]#S[$&V3-LSCD#\,X4]YTV\"-7< [ELKTC8
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M8=JFS72FC3];J; G5.YBZ'S<(D.NC9 2HC2*4D5B+M:-VRB\5S$9YMO,E1E
M6R=9T5AXN MO(RFG4[RM+\WVW+,+)17G5D#1@6R4B]HT*4<0UC'%4RI!M3EO
M.8"X3A W%B(&(.XH]?0$N><_+K_\]SEE$:OTY<<;_(XG6T-567G-K0:IC* D
ME0M*);R )$5A0D?*-$+CM?<>\J:=UM;=\CN6(GN"YW63^YF_B]''.H2,FBPN
MR'I2P"2(29.9>UFW3U'FQA'B$"H[\9$CPF2(FQQ%9ST!\O7BV^EFO948/W?]
MN>@4M)<@,J=H)B0#W@@/PK/,4E0BA"9W>>ZAJ1.PC8^$NS!WI%HZ19BXJ TH
M55SA!I#>#!16<'!.6F"Q*,S!ZF":]+B^AZ9.4M])$':(6CI%F#QGQ9)S=]D[
M0&<XI67*0W3$C\D4(4L>"V-M [V?:>HDNIL$88>HI0>$S1=AD>;AY&KK_2RL
M2$XKBB; 8YU\:2GI#U%E*"5H0?&%,6'(YO#^Z-I-S[3C=SO)&T9050>(VYXD
MHC=?C<0@$;TK.[A;?Z)'KG=_=&[%)D3.M0GU>JXXN_[F*N^1R^QM88[9)CV[
MQF1BXLAO#%3M:@,SA8HGO@3[9IYJ2R=R *M5W2?:"G/K,LX7!XDH3/+UC%*H
MHUQ] E^\ NFUD+$4Q6[?L]EY$_:A]TR+J.FTOVRDB@YA=6,!VC*$S%/889#8
M8 8HS@T0,"I:7Y3.TD7-!G56&?2R:5.);@%VG%(F1MEOIZOE2UPLO\ZW=R'>
M46"["8M,'+[$N+DXJ%*RC;0R@+:F1LTV0"P4W2ITN7 G19$X &1#WC5M,M$%
MQD9720?AWQBQ])O+$^ZU66<.QH# 7(]@. FNY 3DV*/7P2>IFUP9')6+04AO
M=I>@D^1F,EAT8!._+Q?XX_>P^B=N7ITN\OK9YD58K7X07V?7S7321C 50.I
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M89<+.E;N![N@[[@B>^O$"6WO*[1R1></?W2'M(NIMFXI^U"3#@E&( /%I(3
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M,0814@N\[*!E&&*>0N5S+(%W@)F;]]X^8,:OWZI*WN-JOLR?_EQ>LA4P"F_
M96LIHM\VFHH"@E/1<N&8YX_0O/A.^H9AZRE45ELJIG^\U=XUYXP95,@ME^ ]
MBY6Q3(P1BR:F7"SG&E63Z3V#*1R&N:=0RFVKG$X2?.YOI:8H<BK)!; >#2AM
M-$1C$E!&ZGV6(:E!1;Z[GC\,'D^ET#N*%#OP/V_F"WQ7;@W]J9=V,[&A@K,0
M7=[.>_3@G,[ 7 A:),N]:Q(HW4503UW)1K@./X;8.X7/FSH58W5A7U86[ID%
MED1-&7B$.N@15!'!9X_6^C8#:1X@;.)[T*.H?P"F#M;%U&WNOB#Y5G?!QCD#
MDG,L3'K(B:7J6POXPAF@9\J1UQ5QT$&TG0_O#Q"'ZVXYIB [\#([#"60;9@B
M)%E&HK32<4HK639@ QJI7>"ZS?"8 Q>F1^J$>/S"=*2HNP/+Q:!I@K4,S$ V
M=0,NQ@#>8 :M7)!>IY1RDWM/NXB9>.K#D0J^%R\'2+L#Q-Q_72NJA)S'ZB'K
MS0UB $(L'F2Q5J2L?.!-)C(??V7ND3!TB-+WNC"WCP8FCELNAJ)N[:H8YIDW
M"K25')35=<VN0R9#D,S4YHQJR+WKZ\_LJ6/JX8O-49+J1,,7J ^V6,4<1%NW
M9+5P$$)M$UQRLI%[+W#(U(:;3YW&NH_3R@[5'B"BJ95[NEIM*WW_.IVOMMT-
M+X[P95:'=?K:$L;7.:$*@C*9,C15^\A+\DEAB)KO>/[T"C]$5\N1!3=U870[
M _1"(!=K3ZR%NUH:K WL5.("0LX%6(@*&=,LBSQ \;N>/4V;K1&5?K3 )N\I
M>XG6S9?Y*O_K-*SHR65Y<K+\DX(1^OYD7N:80Z(?7,^K:LZY%%DI8VBMB[4?
MA$J,@5<4G&0G&$83#$]#&O8=3L$T;;E&!,\C";\?B)7EZ6KS90\VG>-2*A7!
MEMJYD!E! 349EF3.*2>R]65(^'@$"=/4W-N K*GX.T+9O.S%)25/5H6<(.I"
M7+I$X1V%=74>NC4B!:8&-8\[G()IRF>-,-90^/U ;#W_ZY++L,B;+[C"4 :R
M7)"I7(*#0H$ J.(D.&L0<O0H20$NW1[ ^Q#>CB%GFG2Z#?@>32W](/&WOS:X
M6!,7G[ZLEJ>?OWSZ@A^PRI/T]JY4T%QLRJOB?2@1<O"4>_@4@9PX)X?.T# K
M,DM#[J\=\.II.J2U05@3<7=0__WX9;G:?+K=M3R'HAWJ ('5?;:07+VS*8 5
M5?=EB[*LR1V'G=3T-.%FA GS1PN\1]2<&UJJFR8ZU0.OTM<ZN $70@'N9?%!
M:Z':W&NX@YZ)Y\P?K^F'L'. V#M SXOEUZ^X2O-P\CY\P]7%,FR#+[$63W(B
M)J2J>Q[%UFFV IG3(<0VN]J[J.D,.8?H^?9FY=%"G[I$>=>IPZ"2+\D3T9%D
MH3+G]1X/AYB%2L$%P>*@P<%'G=U\"E 838H=^)";R_*;^0)?;_#K>L9LD%:2
M9Y79DUP2K<_1H*0L$X.)PC!Y.Z=O<5+\DIZ>QJL='[N,(?1.L/-LD>^X'3CS
M)O-B;8)\-ADNI'K32T$HTI,Q2*]O[W>-!Z&[R>IIB/V!FM^!II'4T FHSG<"
MR3F7[ *G?-,$I%55:W">%4CHN%=9,"]X*P2=T]#3S/OQX'*(@#O!QI4X_EB$
MK[2HS_\;\\OY.BU/%YOW*_PZ/_U*UK#]T?7Z-"P2OEBN-^NWN)DA\P$M1["F
M-E"T+D' [,%BE#J%9$@"[1>UO>GN:8K?>!A\+$5V@-MZ;^@B]KS'4TN).7#/
M09O R%.K##Z5>E -8Z$ (X70Y';>,/)ZNCPS#@H;J*4#L-V4U(TN()LZ?_4]
M9:]5<Y]Q%GB0/!H#0M@,RE@-WFH/F#"R+'7VN<G%FN$D]G0POH7K&TT]^P//
MGP%OL9U5E#^->!+Z6_BQW4QZ5VX52V92>5/J36K*JVL;\SHW*SL#)90471':
MQR9C3N^AJ:?3L.,@;"P%=.#+WE^\]^-FF?[Y<OY]GG&1J[%<,Q-DQ;E@24R4
MD8-2U3];3OZ9&>28&/W=I%@^A+B>]ES&0=?H*ND 9I?%P>?+U6J[S4VK?A&1
M>R? LD(L6-2U,%C-Q5.0&4MFHDFNL(.6GHI?XX#H6(%W@)GK7K:*:,;02<4S
MT1^"KNV,ZMT54PO+W">;D(<D6Z]ME9!IYQ^U7M#V%G4'4'ES[6+NC&FN4^06
MK,/:Q#5SB($42[F%S\75FESSR^P33TIJDLL=*N/)&^7^-?]Z^O4-?L<5K9P?
MJA9F1AJT);JZ7M;^'R60*W09F$0F/'*GS+!&N3\_>^)126.J?A3Q33XN![]B
M?K%<K)<G\UP3L=^>O_[T\MDL)*Z9<@Q08KU/RQ1X60]=)91>\*#0LP$0N.OY
M$P]-&AL&HXAQ8BC\]E<Z.:TGXUZ1N'Z+\TT.KY:K#UBEE#:G=9+PBR]A]1G7
M,PJH,4M:_U*JUZ!T*K41>(!BN->>)6',D /7P]\X\7REL>'22-0' VBL\;V[
M.#@[74G??UH^QRWC&7/E^T4X2:<G6R76.L$UT]D*9"9$4$S+#"ZBA2H&<%X&
MDC5S13)11!JR"(U)T\13GL:&X63JFARH;^:;\_+Z^0[/#HN<.2842]Z!QCKN
M(-@$$5, S$+Y4!(S;LA]V2'OFGB U-C &EV\'211MRN9"84/'CV$P"G(D\6#
MCPHA,R&*E=(YU:0^<TCYN-WXJ1:IU#&2[B.;NL7!N]/->A,6F;SJ+):D8ZYC
M,S!3&%A4W<<S";0VV1MB2?$A@\@>?-'$,ZD:Y5DC";8#=_)F1[.TR[7WLBKY
M(GRCSS8_9AZU^G_DO=F26T>2)OPJ;7WO7;$O9GU#D50->R211E)3UO\-+!8/
M$E.9  M 4N(\_>\!(#?D=@"<P#E0=[5$*A>$+U]$^!;NHO $Q0L'2G -P>H$
ML@@4T:(TKDF.83\R!YZ#U3JNT[.>!CZK_H'3+U_)?GNU"5W\&JH=N/KQ)OQ8
M3CR1GTKV$#>/&PP#3VX':"LB<A:3[#0N\9DE!AZ8U??YU)<P1W RW:M4W^'K
M;KG )+@HA64>"C$"RNDZ"XJ.7?)+"R.^F"EM,U0O$#CP3*ZF>:L^=3,"S+W]
M<T6GZ-5T^;7*:I-E>759"_$FULNB59)0&"KB!!W$(&NQNS(EY)+2;G.J?E#V
M-$D#3_EJ@:N>Y#\")'U>A-FRU+>\/T]G859-Q5?+):Z6K]*ZL!/SS_/%J^6G
M<('+#8=O:->D^9=9+?^L0ZZ]S+H ^1PD1.Y#[8;/H:#-HJ20@VM2 GD<V0,/
M#VN!R!/J<02H_8@)I]_KNYY_3%=?WUU^NR(&KP_TMZ5@6DV_XW]/\2+?.^8S
M>342.8? :AUR= :B= 6TB,%&DGJQ31K<'TCOP)/)VM0&M-?<H.'2&T<(5Q7O
MU[[0'==[>U%XM(X[X\$:QX@C(R#PM&YKQ5'&4$N5F[BH+Q V\%"S)DYIG[H8
MP?%WMQ!^4E0,N7;:X$YD<I>TA!!9@&0"+Z@<C[S)-+R[1 P\UJSU8X.]9#P"
M?-PMP*K2N$'^A$<LW#H)C-61 J4P\K)#AN*##;8P5423N-B3% T\M*QU^=OA
MTA\XVO4+?JE!XPT?AR<YDPTY&]HMI;99,#: L^0;";JQG;>TASH5/O1"S,"C
MRGK/&9Y<02,XV/Y.7"Y_F9-CLWP_>\P)GX3@M",7''2HXTJ+E.!\]6LB(Y$H
M:R,V<4A?I&S@46@M#KI^M3'P@;>9?#NKDV^GR^45^<0QZ:A3B%"XB36/JL@G
MEH%<9"&L=$[8V*7-^X,/[H:$LPGE'R>XH9N_?PVS&@JFHW%%'_MA,?\^K747
M=(=?+=+7L,0/BVG"]^75ER^+]<L[^N]9FGZCL_?BJ@97%L3QJUG^??8M3&]<
MUHGC*EL=:D5S$J"TIYL^\ @N8*X]T#D772Z^1N1U>Z!^%I'^L2AQ!)?CARVS
MMV^AWUR15'[#/U>?_\"+[_@KR>?K<I)]+"(4"=9R<G:]"! DW6B9.>0\%+("
MFK0*ZDA?-W">5;J@A6;&"[A/F.:S_-\8%I/(4%O#!&3/R&].D4&P=3" -=E)
M:95C39)1+U+6#61GE0'H5QOCA=?G.CE@S8^)63%O!$3' JA8#,22,GC)G>!*
M2!6;1/-?(JP;N,XJ;-^K+L:+K9_7 P/6#%F9N:'3%PK3HH;\5&U9(R!E:Y5@
M":-B)P37+67=T'56\?E^M3%B>-59 6M^D@W1*!>!CN3:C3!;B#XA2,NC0M3&
MAR;)GY<(ZP:NLPKD]ZJ+L6+K56WZ?X<EQS"Y4&B[U.F>.3LZEQT#G<CWYD$)
MEYM$P3K0U@UA9Q7P[ULCHP39Q&94/,D$VB;:)H[$Y"L'QE8WF5MMVQ26/22E
M&X3.(I+?D[P/1\R\=E!K5:"_?87PL.P[I&B2BAERXKS.,X_@.)W VF5;ZWL5
M4[$%EO8ALAO*SBI@WTQ'O9U8__FW!](FHO^Y_M;Z._6W/F+YM_KG[Q_?W?O\
M.%^NYK-EFM*O3LLT_4>:7VZ66?<(7-ZG=CF]_':Q8V0]",)N?_%OMP3LDK;]
M_0>ZWX\8K&-6,N9_/[;HJ'[TJTBP"6E%*M0J2R] 8NT>9ET&)S(#CR4XS)F,
MZC;;[!X9QU=2U4][7W[!Y1*Q=AR]F"^O%OB9A/83_> _)XZ8L3892*D.K:W-
M'ITF#S3ED%G@+C#>Q%=[D;)AFU<?@8:'%51]ZN \CHMUW_C##XWMKS<X.AXC
MK,T!PGBJF=I$5BL/H%2JD(D"R!5WANG$_.U\]_$=(.OLY-4W4EB]0L/%Z[#\
M^O/%_(]WLS)?7*[5\!$OUMTTYYL5/\POING'+:BM%#DYNOY$*E@CIA9<G5QC
M:0>1-9]MZ32Y[B@B1G6&[ .(>TGBDZEA!,[3FHG:^WJ]4>\<D29GGLB8-SPK
M.H!][;)(Y['3*@:CR0_4308L/$'/L*WR>P!6G_(>NOIDK_VQPV=)D0SU0+>N
M(7=1T34/4: "FY17QJ=D9/^GU %8:I;Q&.20.D()@W==6+^VG6X,.N+EEVF(
MU1F</N J>6F8JEU&!#)0@1=POG#0P5O+-1JR*#M J_N*PW:M[PE(C01\'F;S
M&UR%Z<7A=O/U[S<PG!\EK8WEC,4R4;0';AR9+,YI"'0-$724=M9[7V23(IM^
M7>]/Z2OFJPM\7]Y_PT6H%9[K!?+F;>%FLI9S3C'G##"DRU4A0PB"<!RLSD$$
M5WAJDFSH0MRHC.=],/'@)7O?FACP#EHN5I./M61O/1C4<&XY,QDL%V2EU9/6
MJU!;@&I52JPBZ_(DA3[T#G3HOW9A<V_5@>=<]J[,^;&2'0,<MA,9L\3,38K
MDI6@/$H(P2!8:>EF+*:^R>L5$$../CU"8[LZ/T!\ VO]U^FLYAZN)W&:XHEY
M!]$+#2HS UY8 5C[5'FCG')='C)VTON]E0?6_"%ZF_<AQ*&UO\D\;0F7A:O:
MDPRRB8:<**8AZMH(V :/UKI24G_:O[OR,&&0WK1_L!!'$"C[*5S4,7&?OB*N
M?JD_785>S\$DB6*Z[< 75CN"9PT^T(F8>?0Q.X?*-DGH/$70P+.06YD+O>IA
MI'C:SHT6Y%K+4#5>ZMQH2V8W^=H2/)/(HY$FMQD/\S1)PYJ@_:B\ XX.D/\(
MD/1^]147O\UG:3-X]4[\YGJ /!VG@2D'+E8QJ8B;/N-1I>B\,EKE)O[]2X2-
M#U6' &#>4!MC0=?KIYAQ24IN,MW:NN;I-6V^:!7Y!,()X[*3QC>9HOPL5</>
M@"UQU8L>Q@"JQVR#7V[JQG)@1I%'"2F054BF0@:_KBDT6@23.7.JR;BKY\D:
M-F_4W+#J42<C0-BF^.<^3[5%SKJSQ+;&R//$0XQT\I8,*D8/,?B:"I-)F2PU
MZ^3%'1#V?HFT82_&/H'P(/O=JU8&[SMSCYM7L[SI9XC;"K1O56.?YV_729N)
MX'8]:A!8B H4F0 0HHWD.FNOJQ/-]<YPMB?ZR^RQZ+ W80,@M17[",ZM^S+[
M6+L OR^_+W$MO$DTR5C."K <$RAAZO YE4"'8F,@7H0\P<6X0]6P]V+#TZH_
M78P.6-<6Y(^M13E1QF@LR8))EN14ZK %5F-Z2A8MZ2C.I4D4ZWFRAJVP.!FT
MCM+&>+%UZP5/E$U6T:8 B727*\W7;V+73ZXSFJQ\+$V&L[](62>$-7M#>GJ$
M':B34;2IO<_23HO\F[9R-T8EGV2IK.>EOI95C.07-01)Y[0(I2@= ]>G\"-?
M)K03")L],ST9"'O6V.@.OAW^ZLN3VK'WSOSZ290FI,0RY)HP4T%X\LU5!*DQ
M,6^ML]@F%+LGH9T0V>S5ZE"(/%9CHT-D+32?(&>)L6+(1BUU3SE&XI("3"ZZ
M!,ML,B>X>RLIG5#5[)7JR5"UM]1'AYOE1Y+GVS^_X6R)OY&O$XA\IZT F?FZ
MU@<AVAIM1NZ9SJ8@;S)8_EFJ.J&I66O*DZ'I&%V,#EC738 G25CE%4G%LLI%
MK2KW+#D(+G.9HW<&FS25>9R<;@'79DTF3X:E@\0_ A#MQ%[>QQ59CG46Q]L_
MT[JAYL_SQ1,.S\2G' /SD9SG*.DT#H($5_-CWKKHN-*N363C")J[P?$<$P"G
M4N0(,/M8KN.&F>N-^.8*:V?-C_.+B]H1_6Z#38')!^,U:%%?!/):6FM4!H<Z
M)8P",VO2,?!(NKMA]YQR#D,H](SP^VZV9;;VCOK\QWPB(I<N6@L9A2 9,PLA
M:P6<F8C,\YQ8DYJ00PGNAMAS3&"<1(5G"U7"'DXT"I>$$L"-KKW.+))DE86B
MI<3D').Y43N60TGN!M=S3(J<2(WG"MC:8G3BR+L+=60GN7JB7B(&ZEMN4,&A
M2S(*-:+#M5+<#:[GF&$YC1+/%JW3[SC)7)7LZZRZR!,H% 5\4@Z$RCRJE*)S
MC9IZ'4AQ-[2>8RKF-$H\([2NFY[N\AH+V3I,A=KPU(/RF8'C]5F!UUH577(V
MC09='DYT-\R>8[+F9*H\(]A.# O)*4P@!.U)A4BF3F()3$Q96VE39(-"M!L<
MSS'+TT1%8X?>[[.\S8IB?OMGHA_=SJ$5EG$FF0<1K:L#8!(XIS/H@%9A*2;X
MT\>GGJ*V&RC/,5G47GG[(]1O$#I;SZ_*GUO7F=7(&A<</613A\64D"%@8%!E
M*NI8/W>*#/=^X7MQ_MFDPQ0PBJ+]36;UM_GJOW'U>GY))W<B26WV!B]T; LF
MP92,H&)6X"2K+Q"**))GZ3K-PWMQH6XP.:<L3__R'>OM6/^UP]W]=RQ\4H2W
M0NL"A=<F>X4.6\>$@\0MS]$XKV23\=4'TML-C7^9O$W/"AQ[N[N/6+OSI]KJ
M;_9EVQSR55I-OZ\?D=[GHE/_NQ<^L->&>/L0WU.'O'M+OIKE!ZO>-$J+.0MK
MBX# I $E"2!!>P>9A: BZN)]DT:YG2D\NO;BI84>Z[ N4JHCL&KK]OK2F8<$
M7O@ :&H1KZ7=JNT@4AE=X_LV2'M0=]%:B>=] ![</K_3QY[P,&S8;K\[4*W-
M7$1-:$DY@LH\04B> V>V<.>LRJE)U/]D1^+M6_PGEJP5P-LG^0%=]MS0)HJ)
M-I$2""ZN!\R+XDW@*=HF]\,>-)[+ ;@/KI[N2=JORD;@H-QCZ,-%V/1&R@)C
MBG1:EY+IMN"V@+<Z@_,Z2T^R<J:]77)-S5A:F/:L^^<NV8,4,48T;7O7,">Y
MXB6 EK598\C$ 5TJ8!TSFHR!(G63&-L3](SHS#I,TR]AYP"Q#QQ9>T5VD7_
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MG]'JC'F,Q!.<--X)P53D4)C,=$UQ#;Z.*)8F<IL*TT(V&1G1\*3YE+YBOKK
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MT+_/Y_F/Z<4%[96=GJK571414QW[+>GX4D7C)M:'BBL7I#8DUI.<C,\0V0V
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ML)<.QH6DEUX3WC8UMCI%3"2FS HHKCB$DB)XK4OT6@2+IWEJ_#*MW3#X5\A
M--'>>0'TNG^Q5]PHS^CTUH[75B35=JCC1QGYT(*K^M)J8'SNTX):_A6R#BUT
M-T)TDOVZ"&]GJ^GJQ^=%F"WIN^NOKP.%G[^&V6V3 '+ K<-0VX0)69].&8C>
M*!"*%4_?RN;V;FR)TNXD=T/K7R&]T%*7(XNM/"P N\/WA).\(B-Y1E4[I*2Z
M'87)4!@G6R8;K7F7,3M[+=JM ?3991+:"G]@5+VF[? %I[,N]871^)P];1;R
MN<C7$D40@SD#II(%G?')9=$!4WLLV0U19Y= :"GX$=RMF^E3\TM:_RO.EC>3
MYZL4B<V)(_E$5JNWM(K5D"5/*[L"C-BC;2*)U2:1E!?HZ@:VL\TN]*F5H=\,
M+A#I9L_X_\UG^!&_3-?9-V*'Q$Q\3;P)BGN)P%-MX\3(#(U.<[#1\9Q5*%;(
M#@?5"\MTP\M9)A/Z%/"8L'*7B0^X6+^@G=B8T>@H(*!.H%PR)"2.P%#F+#A&
MEKND"UY<J!M>SC([T*^0!T;,7?J7[V8?KG"QFG^<IODD:8LR!0^RT!6LG'=0
MG02R\))+A/OTH'?\HTAY<H%N"#F[6'Y_0AV!<?/[;(%I_F56Z]2(J>O'^.16
MKOXQO[K(M1]%6KTM!5/EE7[D8UB1">>TT)+I.D6.\.^YA2"S <R:#M-$1IQM
M$GH]C-QN0#S;#, )=#A>I$[(?^"2<W)'3?2@Z/:&:'T"86W*R%$DUJ0I]Q/T
M=,/:V4;Z^]#">,%$9_H"PQ)KU[2KBRK&]?2VS;P/NORG\WROM02+.7"6!&3!
M$!1*#JX.+#0&M926V=!F+%\_Y'>#ZME&_0?0\;DA^P-QNWB$9VLR*Z8X2$ZY
MVA6PYHUE?2_DB]1<!H--!E?U07PW5)]M=N#D^ATOIM_@/CR[DHWPGH/@49&Y
MDQ@$8PT$$6VR4J583GE6[T5\M]F 9Y>*&$R_XVD7L!?KGW"UNL#Z>'CYC^GJ
M*_T\?>/5U>KK?+$I^@E6I(@L0,FI-@N4$KPE#U22;::M,,+X)@TA>^6B&]C/
M+DLRO,9'C_J/F*_2>C??$\(OX=L2WY=7W[Y=3%.(%UA'4%VMZ$N_3"^G&V@L
M)SKJ'#+2KA>>@3+&U(>A#!)G7LK"$S=-FKDTX*7;#CC;U,W0VA_]/KB>]/W^
M=LH5+M<=8C%/E.4^9(E0YWR3/Z)(\E':FJQ EX(TCIT2Y\_1V@W'9Y=2.I7V
M1F!YUS1^_K]7R]7Z"KIS&[V:Y=]G5\NK</%A,?\^7:XW(8\ELI02;<(Z@-)Z
M4;.O"$&6%)3B1K8I)=N+RFZ@/+N\57N-#?]RZI:;#^%'_6,U?_?QT\1S*URI
M-I!U$53@ D*JI>Z*C!\?DWPPFO:I!U*/+] -,6>9Q^I'J",XJ.Z,5@N7T]E:
M.Q]P%BZJE;SI*[(^E*_/X20(ZY%9<,K4YDN($$/(8"5GF$Q.T38YJO:DLQOT
MSC9SU5)K9P3*ZQ:;6ON05):@5" CUH8($5TA,T%HL@Z,C:J):;<GG=U >;8I
MKI9:&X_K<1UO>#=[RHPE-RPLYS-RN7Y\($G7'DR36J<IHC<@31+$L%7@L]10
MB%7E-09OFB0&#J*V&T[/-K_57H,C.$*)G==7:^/UO^:1O*C5^T)FF_V5&+M:
M;*R6=2CXUN9]:LBJ<C)*A8[\K=K!)$6Z.T30X(--4HIHF&SR*+4W#KK!^6P3
M6\-H>KP07[_U6><VZ =^GB_(!KJZO+JHM\#VD=K;L)B1/F[>D/^HXP54##)#
M*K60%2T'EZ(&K9DKZ+6V;1I:]\=")Y";L\UT#:3K@5WW]S-<32]Q5;D,ZQ#O
M*OSY;;Y<<>_,VP_TW6\;UW,BN)1*6 W,!56;S!>ZG1QQ%KTV,1=A] Z 'W7E
M.R_8#6YGEVMJ)_2ABYGO;I1MO.(C7H9IW1R3*'4DZ!?(3! C)1$CB 4PBB@\
M"[KL5J4^7M#\W"+=$'-VN9E^A?M7N%5WK8L)*U9PK%G6Z#)M$W+VO!6>MDDL
MEMF,:/(H+]==3KI!^&S3,L-J?N@#\BN^?O7Q[2=B>V)=UDJP"$K7?J#,K9MK
M!"A>,2TT*\5W>31]YR.[(>?L<B?'"*XW??_GWQX(E;CZY_I;Z^_4W_J(Y=_J
MG[]_?'?O\R/=Z_/9,DWKDY0R3?]!"-XL\WI^>3G=)(/"+-^?*WR/A>7T\MO%
M2WF2YS[M;[>D[C*Q_= '8.B!;/QSA;.,^=^/NR[NK/=J9[TWTV6ZF%<G]%5<
MDCE% '&.<6WIJ'9*Z5IM0+XF"PBVV"Q\X5*X)NWE]Z+RV!NTTV*?2?X_T6_]
M<U('"BB9&?!LL$Z%,N DDDR2#9H%EM UZ06]'YG=QJ^V.L#:H6SW$FRHO(-/
MO.^XH T_[)GW!E=A>M'ST7?]H:<Z 1]E8I"#$$L0A)#Z[,=+NBFC@JA00@I*
MTEV+RKLF!:<G/0C7UL;=)3[7,K1)+D9CD '(^JMA1NUKAST%.CCKR:=6)C5I
M)OTX.>=TL.V#FMV#K0=EC, [_>EJ21;KDKR3?UU--U[)JS^GRXFWI43O$R3O
M:W8F:@B123!>V1022J^;]!)Y@IYA0=6'JN?]RWVD\*E_72"^F=> S81V5G"2
M-I97HK8_H=T5.'&%4@7ZBA!.G0Q(]R@;%E*]Z+\#I@Y7QL#Q@]^_D=!FJ]=A
M^?57O(RXF##)6<80@'-#5J@4!2+2V>T<3TS5ND';95;]@P\>'Q".4-J\+PD.
MK/Y?PY_3RZO+FU/WNB9PRXE&GVP-C+#,/:A8ZZ^D0[K'C0KH26+8!0O/K])M
M>M3Y :-'V8[@"OJ%1/-EK97U>XSE^AAET6B94P:6:G%)KNVW HG&1BMCR:A*
M:=*+X3%BAH51 ]OE:(F/$#7;+<6$UCFMS\5$8I&V@(\Q$BM"6(Y>1]&D4_+C
MY QL]1ZMYA=P<X#,1X"<39EZOF5F>VQ:BTG'4O/6G(/R68%3C@YG7@TX9SC3
M3<JZGJ!G7-@Y1-7S_N4^('R6B]4=J9!1ANO]Q#6G6QH%F%(S/*E$<)XL-):#
M4E*2)^"ZN$?TZ7<00_^UBY;'E^_6P/H,KJ8>I#LJ;'RFW]CN&5X#4983^4:1
M.58-/*]% A:3R4R0$=CI@<@!"+DE8IC#I ^E/HF/ R4\L%OT:KF<?IEA_CQ_
M/\/_NLI?\-WLUU?7[ETI6A1IP I16U_96#V[" $-$T*0]V=V;J!'G:+GUA@+
M$ [5WKR!*,=@DUS%)?[KBD3XMG;@K])9;Y6HM%2%,4"LLK%602S"@LG%*Q0V
M,&QCDSQ.3[>.2&=PW?0I]W'"9[NYG$O.J\R!^1HQ"L6#SQBA\+H'E"H^-&FO
M^21%PYJUO>C[90P=(/SQH6A[DJIBBLV:@9;&DL-(AGJ4+$,-10KFE FF27+R
M46I&AYY#-/T\?@X0^PBP\^!L_N6FCDZ)+.N\0="ZUCP&E<!%0YZ>LS$ZK8)F
M31)(3Y/4[?W3&5UC/4E_=#CZL7ZN'2Y>K=8UFO3%.@0$ZW!+XYRRP%-&LNY$
MAI"YAEQ<T72$:V^;/![M1-W(4MT'0N%9A/6AEQZ+OPZ'VT=<KA;3M,)<LVRU
MX(3^>/NOJ^GW<+$N0=EAD M5I(^T/UEAM7Z;0W2)_E5B"E8I[V-J ;P]Z1Q9
MQJ(?"+;4U1A.OMN(ZTT?E>MG T4EQ67M21:R A69@J#1@4BA6(/HDFU3(/8T
M32.+//9TRO6D@T'/MAH;>8R1CYAP^AWSWZO!&NGG(^?D\)CZ!HM%!UX%!&E5
MS%*6+%V7%QTOK3.R@,%Q*.E=L /'(C\LYK5/XL7U0^!4FX;.%^DB3"^7"UP_
M:%K5(;M?OVU^<L*21Y^<KE$U6=WDFCQTY#"7H(N43CQHR_8H:O9>>&0&^_$P
M:BOZ<\/5[[,I?>E_DWSS_'(2N7-2>@7"U,:&#&OG98X$HQRUX2FH&%J [!X5
MW=ZG_941=[A2Q@&_F_X&-=VP?+]XO>;TXX;3S_-?B=/M3[ZZJM7D))F)3,FB
M](GN^!A \9J*MK7SM]*B-KLIWG?I_W<X!9U@UZP?5CO8M5;&."#7?7.]#K.0
MP\0$';E&#]8) 0I- 5<[S6N6L^/":LVZM!DX</E.8&O6U&H,9]P!:AAZ+#$N
MZNLNS,34<MN-8SF=;1BIVZ@6>&5I:@%Z$;DV8I7D]HH GEDGF>8NED[#B%]:
MJ!-ZFO60:H">?D4[].O]^6K=GO?A?@BSO-D0RTT]ULV^^/6.M9DXT\ROV[KE
M1&>O)6=713(Y<]!::F5LZM(]YS@JN@52FW5P:@"Q$VIE#!&M^S'C-^$R?,'E
MAS#-FP!=B=(EG2)M(N= :4FN<FW$:@*CO:5B3+I)Y]P7Z.H&NS,/X!^EC*%K
MJ"XN\ OFGQ88TM=Y^7"U2%]K;=F7!:[C,:\NYU>SU:1VET9M!- -3AYS80A>
M8 )NF,YT3G$CNHPO[K9:-]"<2\B]D91'>R:]JJU?<+L3A,\L1)Y F]J%MU8F
M1UY;0[OL,D9GBFSS].1%TKJ![.R"[OVJ9.QM=#ZMYNF?7^<7I*QES5ZM?MRG
MO%,+B4<^I->6$2\1V5.+B(?+_#9?W;[N#QBT5<I ]ACH;!$>O,T%4*,2RF89
M8Y/F.,^3=729U:.?_E@O%1D+"W6N<I3)U5U%?XODH<ILBW(Z2[Z;I&G)_^AZ
MX/2(G@<U64UT='Y'T^%-;I[^K,8'5<N6-B\@3AO/F;29<!8**"_7,W!"'8;J
M(LNHN6XR&+3M>?6ZAD/>E_4BMSM@>=M<BJGLK#3@8ZU]-*R JXU8?,KT_TZ)
M%&(+KE^@:]1GTSY(>="0JT=]C, B_Y2^8KZZP"U'/_U8\[>IB52(IOA$!W>J
ML_A06W)*60)C?,C<9ZUV.T;TM*&>IFG@[DA]ZG[WSNM)$6/ %&ED[:3>E=>Z
MT+^82+<R2C"UP%8%+!!TJ@6++%IKB@NZD4GY!$4#'U-]Z?R!_=2' D: I'L;
M;OL&FAQ=KYT$H6J'0TD<^$)FIBQ11\\*2[K]?3>&MS3]Z/BYVVU_@0\=FM2:
M_?KZPZ=/N*@CGK9O.7AT4A1).XG79XZEK&O"/*#W41?&1-A](_YX)/*Q#Q_1
M?72 MN9]BFX,Q\7\\K*V3"!Q;!F0FJ///( 3L;X,XH4LO2 @V:B25I$;TZ1B
M_ $EP]:$]P24?N0\ J \]1 11519\@C)6 M*,[IT0Q*@N1>J:!UD:=(&]9@'
MO\U T\PZZ4'XX\30=FLEKZT+7-<;-X"R*D&T@GP!*2QSWA0=3X6B45@J?>B[
M\ZO??80_/A1MCU-1DI>L!!#>$A-&<@C<:BC(3;&R%H">XMWX&&R<GC3=Z=7O
M/F(?N-_-QS#[LME&(IH4M// ;.WBQ$D6@2FZU[6SL62CPNZPI,,;W-RL.NS[
MH[YOIL,%.@84;,'KK8Q9U.V@-9E@@BCV'#D9[,63L9>8[]1 K3L.AFYI<Z#&
M=G5^@/@&UOJOTUEM0'K;:\<&3'3N*4'7J"+"G23'/UJIZ0@,4MLNLR([Z?W>
MR@-K_A"]S?L0XM#:W[2?W1*>4.J8,8#6M0!(DO?EHHL0Z/X3R)/QOK?3_][*
MP_@FO6G_8"&.P&:\Z\W_<E,$9$7@R7L'N1K1J@A%3*  1!Z=D2H4;-)[]5%J
MAGUYVLIS/5[P(T#/A^MUUVQ\^AIJ!NMJ]76^J&/')\BT*<8%D"[17>H-@^BE
M@> L4\&8H&03Y_5YLL839SU0[_-F2A@II-XMEU?$"<]T?ZH:">2A]LR/#())
M"-FB+#9Q<O2;9/R>)FD\D=AV4#I ^*.#T9OI]VG&6?X85O@!%ZEJZ0N2UV]"
M\29#3K48E5=+32""SR:;D*-0L4E10A?BAO6*6T.K!X6,#F2_3/]U-<UK%6V^
M@;.$$U>"TJH0#!S6N5;* KD ":0(:% %&3OU##X28X_2-JQAU1IBQZMC% B;
M)\2\_)G$5P_B0#R\+Z_GL^_UB2/9H/=YGG#&>>)T-DM;W_Z8Y,![5@5IL20R
M3H5H$NS=D\YANX"T0%X[-8T"A2]NK,WK#DPAL%P<\/7NDJ$ &9T&"B^&T7]&
M$N) AUWW9S?->H$,<N+MKY@1 .[)G?,9%Y?+ZYVU)$8GZ"P:)QVD.CQ2J93!
MQYS T3$??2S1YB8V7'<2A^T$TC_H&BEG!+![W$9=DH&Z=H5JE\+ZS'8B%097
M9(20R710.3'B*/DZ@T?I:&,@R)S.;WA W[#=0$[E.ARGEC&@;3/JC61UP]*D
M!">1.052,DL.$&?@F42P:$/.&#"[W 19#VD9MBM( Q0=*>X1(.86^N%'#4"_
MOEI46;Z:Y=_FL[3YCTFT+#MT@3R<^HQ-&P4D&P:);,H4I,VV4PYO;PAU(6[@
M/B#]@ZIWC8P 97<J,A\$DWD("NLXW%A!H"1C$!AM'>:RYZAUD:4)N)ZA:> F
M'RWLJW[D/RXH?0B+]XOU0X--)X#KVWLBN60ZT*T=B[2U6WZ F$L!(8+CGN>8
M2I.010?:!FX%TA1:O>AC!!!;,[/)4;RY6DQG7XB1Z3QO=LYO^,?Z6\M)\"Z6
MNE-TJEFPK ($+3((P^JK!*TS-C'9NY$W<#N0_H'60"NCF#)P-R7V83%-M]O&
M:Z:8"@Q$T+;.ON3@#)+G&V5F16:/LLE;LB<IZH:I,PKO]R/[$1Q93T6+;\[F
MB?%"JB0]W>MT$"O&-/DEM$.<U,EH^I9C39X:O4A9-U#]!2+WA^EB!.!:$_T1
MOVV;?!%_7Q;A\M:$W#3[XA/C<M*21<BN]BT0=71G,(0(.GM5,EP;T^Y"?)F^
M;D [HU!]"[V,%FZ_7=5:2)+?CO_R>?X3WOYPG@@,+D?D8*+GH+C4Y-C$!$'6
M7N3"%JN:A+N.HKH;-,\HH'\Z'8X L-=AP)_GBULN[I_XO@[L8Z( VBQJNW+R
M@(0WX+4V5L2LXV[O^'Z#L$^3U@UZYQ3:[U<;(\#7YP6&Y=7BQYWXS40B.= N
M*M"JNM16%0@"(QB1;>!>\T9/@1^AI1N"SBBL?ZR\SZ*3V[M9?5DX_8YAEO__
M]MZLR8UD1Q=\GU]Q;=[1Q_?%[-J8I;9JV525-)*J>]YHOL!3[),BU2135>I?
M?^$D<]^"9 3#,^N<)95KA /X  ?<L5RT;_UX%F9[MW-[^(']]W3KN/@#&[O5
MQA/;UZ7-ZTYNO>ZRM5(R+OF2(O"\;JVD$((+#@3G)<?LHKP]QO3>)A[=WG;X
MG<]%;ZBU6:P3S-8"V4[<>$V\7ZYA_ZKNQA?V]*JK83**%$@)")AD)3:!]]:!
M3=E;<C:5X -=!QVT[G&2] <"T=U;H^/)])G8MW2_B5C7V1Q@Y1Y_[!"V;@="
MCF?Q2N;&UBQ#Q@T%E;P6*H7 P)>"WNH@=-*C6[SZAG<+7.=SO#N;__D1%V6^
M^%9/9&+5@S>?_UBWDEZ^"]/%^L[B9+D\__9]/=UC4Y E*/(01@7 .M%*,5%3
MC>H'QUPBET ZUV4*SV&K:-YT[8*&ZWV=CBB<D9M_[4OINH*<,V>3DPRX5100
MESK6@X=Z&NV9-$$%<[N,ME<0CM>*\-@8Z0&:.POLF0)SV^;$*"6<J8%1KFG
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MI-HJ9-]4EF.^0^%)_J_SY:HF4DV<))>$<0W)R-HZ$S7X$ ANFNA4@C/FTM'
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M6IJHF!G./AW*_2:\]9-OE3O_L^UD]I[D,SN=DDIL^C--A$#+$LHZE@Y!69F
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MXF</SH\]5?LO3.?U?/0F,=OQ\T:69%7AH#6%]<JJ .169RC6)&D3(W;%)[S
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MC-X^\AG^O&[[@_HAAB7^/__7_P%02P,$%     @ MX)74@@J#,@W"0  ?F,
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MN/VK(!6TQ*86;SV?.ZE6BW<C@C-]+-3JMLB.%W<[VL=_\S?$^&]02P,$%
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MV?@)D(62&.X4!P"*: "/%)$Q-\1(5V^I0L("IC558ZP2TVL&?&=H:G@6@C#
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MZOA.(OFFJ^-V,W<X@?_RU M&IWP6CJ<.,<+J!JFEI14-$(IF(3=2Z=L\CGT
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M.ZL==RYNR)8^/#H=*SM(_K0)[8%.,W-WDPV^83AW==]4M5]W/?D_4$L#!!0
M   ( +>"5U+TDHK+F04  # I   =    97AH:6)I=#,R,2UC96\Y,#8R,#(P
M,3!X:RYH=&WM6EMOVD@4?M]?<>JH:2H%WS"$6Y$(. K:-E3@;-NGU6"/PVR-
MQSL>0MA?OV=LDX8DI&D+W:0+BBS,F3F7[UP]<>M%;]#U/KUW82*G$;P_/W[;
M[X)6,HP/Y:YA]+P>G'KOWH*CFQ9X@L0IDXS')#(,]TP#;2)ETC",^7RNS\LZ
M%Q>&-S04*\>(.$^I'LA :[?4+WBE)&C_UGI1*D&/^[,IC27X@A)) YBE++Z
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MFM0%,#WX5*B+I 3X(KL"P!7!>S6AAP*.R<+?VZM??YI<1MD%;&92X<]XAF$
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MB#(B,+>,LC?:HEP+SL6*1=B4]R8/>"$-A5ZNC%XD=4J*K2"2[GRM+%Y\WQ!
MVIX DAL8G,D8W18^ .-[=F9RI,\!8[&M]+__.'][)_J.&TAOISCK+M73A*=[
ME;J7GZ.'W=&RG&08SC!M9><0G5/#[LMN#?'.%<1E@7/,5T'FQX<8VCX$^EC?
M8L]NG>G\9FIA[>Y"@$$>47$S>;A!#PF,W'.G62Y+]M,NL+&:1#4PC:@'D"8Y
MS?TRKDTSU'S"?C,]5>L7;DG^*BF+FGMEO:9!F'=P(&X7^'UG+F;WCDU*0%Y6
M\YR7@5H*XQ(.WO:RZ+Q6%9AKX>Y?:P0]!\::EE;$6:7)\HY4/,ZBTAF'F'NG
M>"H%7(8=\HWA)6O&W6Q)1&G5E(QIP9T"41?K5QBM>NM,L=W8N,6&S@Z?E0PK
M7TP+CEA[.LG*2D5QV+;@*:+0544#:GR)W5),:*<5&[.Z(E><H)N9[&1.G]LS
MV5T=6L>^J1\7!8J-:9JH8/"^IW@)WJ,!S_OMY_1><I3/6%KC0ES;ER(X!"@[
MBO<:-9",3!NMF3M9IE$+&:RE(=!G+4R/G'0 <GV)7G7>A<DJ8[AP@IH7S%I@
M7VC3BZ=U-I(%_--9N/1!]S>UJAZ](*JI=&I:A/'L/S-_T)TR)/$29W#QGW5\
MH7U@75.BW2:C.0\5 .R(4N8J"_B+]/>+RFXNL*'MX$9UW338I,=FL;W2#.(W
MV4TI4X&6P)":F'.\"IC2E,8]4D:O-F+# (6ZA@,W<Z9\=@-KN!04T)*[H*9*
MCX1FPYM6I)^52?K[*FNS,A4K 1))XL$;:2AU5-H^/CUE*S9Y"'X% F?]F F&
M_-:+'D;L 6@=QV"!6#8Y>)@-[ZUX?&-$B^C?S,'8)U"QQBG=%BM>#CY'0,/3
M;#E!UB9"A<P.<%95BG4(T@J9\9$3I_QNZIASK3LJ!N>3G1+M#:IW>[<)2U\#
M <V<G@4D+),9V?A-==)R%F!%.X6,DTZZYYFKID(>KPXUN=M1K:R._3YZ/PHX
M5!*EW)[U0EB^/2>E"^I-N_2NMY(RRJ_=9V2R,P;DP5@19)1AQYX@8G+?*./%
MIH9S#F[G'MS42HB31.T-M9.)UZQCXZBKY")SQ]C)5/A*NW=$@W(4+UV+6Q/>
MRM ]ZI0IKEN  \T.E@H_8DY_PDF6L7@QKZFP3]1*]@*KDOFXAR(+KG,+@J-/
MO/+>+1F>Z;4BYOF6O*".C3&3E6?O$EOZ-:^03YO,3K+?]$PS<I.!(<8:*R<1
M=C7_[F(_7#1O[9,N =^5I.+J"-WI+FXA^D*5 2.,*.?U@A6>Z#!WXWX#ZZKK
MB+>+%?.Z,#EN0(K[0(I'1T>C9T_/3O7D)#$?"R4<6Z9*?TIF7)QZ<FJ<O+JF
MC^WMV_>1A:ZLB.(_Z[+2]A5.A<UPTEJ2Z<F"-.2X$/5':@(B4.@/XD0ZM#F/
MT,Z)'Y-/RNNF_4X*\3$MGP=1<1,)>*>[G7-\\"O]X'/S8-&:V7\:YREFCC)$
M'2_JCVD. LSUH0Y]BG8C$M)M/YCB6%M7VBTL609*_6Z1QS5/]<2&NRN+\H5"
MG-&N]5[J?GRSWQ6@><O3YGL,>E'@N#)/NPQ;.K^>I4H+FL'7Y.6@!>'RW=1J
M+ 7T=1R$E.0.<",960$-+XT*+B67')]/I)Q:!Q?YNQ:[(4?!>3/2J6_$/%Y1
MLZUC5+HCD05D''&X?G+R%35[P&3RFO7%58;I+?;@W;'CK0LQ'25<G^,2B'[>
M ;L6#)G&5.QE^O%Y[V^\&%.4&;W=.M%%GK',>'B-BT>XK;$<Y!UF35,<SL=-
M$#0Q=#:#XIG4G+%O$U><1BZ;N=TVX_5;, %Z<><VW-Q\KMHILCN8??F>TVJX
MH/MFW8+M0J$CLG1+]$*W44^KWRP71G<59>ITH$;[+EM_W]%;SFT0'LKXELV?
M@+^XS9C-8D,I(DYI#!^V >5/H1G<$N.D#2$<-]BIQV:S+XQJ^('=&,=F79H%
MMOMUND6=D5.XSM71!#-+P)]9ZYED7.UO<F07]U2+O%QEDQ8QU(K>FT[F.DN<
M(AY!69)_U!9G\#G<HWGI568W.9_C/.J)IYAD Y^M5?D%)X"0#M(*U6)97R/B
M.935W-N1:P%0L@"8S<W .,D;0?[/AF='8\[V<;=D4$]\-8K!LK1!,D&$L<K4
M-''25I(,#0/4]>9IE#4]G+#<-&>>RA;(Q/8QY8;4!5:EU$6C!YJ31V'V3\6T
MTRER;0J7D1YAG0:LE\+5&!9F'P=\ D5Y@CWRL@Q^QGY*A3*CT'C!>1N$/=13
M4I U5MQECD6Q\QTYZ@%ZERKMM";9DL#H%V]62-*>)UYPI4P''IV?K&)+O:WO
MX&"K<K\KR:C3!#;:Q$K 9%;O^LG%[=Q[R\ 7[I\OK,;E&Y2AJ;&F2.PX$>^!
MMJPIQ%'?Z&FG)OQ(F$7V.&"!EP09FQYD"8;!<S(C0?LL:] 2Z)D#;CR(FM":
MR,%M+;GA1F><R1GM6_Y=7XG,4IL25@XQ3[+#)<V#/6Q#JZ_OF0-6W&O RF8L
M%(W!IAZS0(.(#%$4$YTJ!/4I<+2(]AW>SWM&!);1C-Z.EB=-D;S QIJ5<D=A
MF"FF$T6IO=[+(PZDRCB=J)2,:L=V(PT62^_3&U>1;:6??MZDF*\Z8# 0X6=%
MC4EW=&?R.BIH U5UIGBYK$9H!57?Y<H2%3 <H+"\@13)TFC#;H)>H7/D:WKL
M6)%?WO1_<IX2[YJW8WY9X&'P5*ENY19C C,5\7QN-'4*:FTE!HW3?Q-O5(OJ
MZCTWTI[?."2:8/=@&Q3 SYA+B<809ZEADJOD&Z%Q,\%J<[X7U_%[1OUPWE?4
MP1A>?CX#Z$PB:;I5XA; ;E'QHI[F^U)W@&\UEUW@$.C0&BF%9]!@<E5U<\!)
MY!C94%EI@A1.DT0V"I7BP ]-!.8_Z0'1&+=$(6!Q:AK](2CG:0+OE]"=2;DH
M%$6M_8L*1<Y8+\M)=Q^B&<9,8;N$I7]@&"UVRULW&HZ:[#>R6?N]M3EGKO74
M#5';?+_8T&,W\!;?3RQWQX28<3+E2>6,7\1F.E]44I)FU/V<8 HTH+M42YDP
M-^%NN*<#DLML^?:_:Y\< C3;ML.;C=V>H\WZ.5J?M3/3Q>0;HT_:' ?YI=&-
M;_S2QNLR]0IA]-VZFZT-,78T(O>B)J4-Q;6#)"9*4[9.5 (&]C'()NTS-JNZ
MY01#[;.0""05KDA)5-L=_[FO-.',GGV:(!+\DT\BMG9S[ \<X:HDF;!1D+3)
M(AJ/60!ZBJ$[4F,4_-A((I]$Z80"K[(\NV+>A.@6[2[3$A!G/1H'Q\LR,"PD
M^X>?<$Z!*>DN\V4GUKA!HW([G8*:&QO+@-R-)J%(7)PKAJB<,M;-T8(ZG+H,
M<?%K%F$1[\S;2F. 3U)H)ME@-+<R5:ICGA1.#MD?<L:'5B7KM2I!AM"B@[7:
MOW,GV!S5V+K1#%:W2_+ZTB(J)UF;R9%_T7"ZKAF<69X=."DH+D7Z!2F4#XY:
M3M<  R?/W^FGKKF8-VRH.5'"?<RU<@6DHU81WUBPU%W22QL='YT<>TZ8J&RZ
M0MB4Y)&CBK@ST#Z'_35U&Z/6[C4&O3F#4(H<CJ^ZX=P-[>_>-^J0^<J-<'7.
MIN\*L+(!A75J""+\5S@TMTSMG_WG9MI)'=HF1= V9M\H$>;9-<F<1L\X52KF
M?+8+#;N3IMX9=_16+?:VIKKZ!4SH.Z)FTL%/ND,3,"K$1(XDVIZJCG?)>'96
M1YDVRNJP+9CU\ +L[$!S$BO%:93.6W(T[+PL)3N'2-Q.);MJ0VF[BOFJ.$Y'
ML'L7L*Y[+LA6+7SI(&M;LB\VZU6>@B3$H#SY\NW'5>=4NST*UF)1"Z:O]@]A
M$92T\OMS1X::HH+N%^I"BNU2$^=I73ZDCD@"69I8= +0>%H</^J^*5E;;M?Y
M9E8X=+/J#,D\S.$WVF?;64T]T]'89T=U0ER\O0I?D8I+=E#5AEM%9:FJ/M7)
M2XV3/OQN%%K/%407=3FU_5&H.L$J<FG"/08IF_=:$F=,4Q=029M:F?4%-.=2
MTY5CA>HQ-X&S?6F\Q28EMT?U!U%Z@9V]?B646DB%/!SL5EBZY;!V"%K3YMH[
MXIJ;'CZ-'*KU>X,K?([/9N^87]\=0B8]0SO;G**B96QG[S91>#_0"<2>B\@4
M=#M>]W#S;D?:@=5T*2+W]-Y+XI8E)/%ARI&C 6@4?S$S:1VT](D.^RJ9$D'K
MS7)\@=V'(4$?P:?598#I(5GI,69:4Q@%YT3(3@) AV6_ #LU:MP^<G[&2=(!
M29B&\V4H92.-DIG.J9$#X0H)2M^BH]DNY7E)B;Y*B,NR^Q<[AJ044<U\<T*W
MRL;BA0JK4!EA\4L/*>$2FT*:RY-!.^E(<\*[5J1<'KB'-\Q4<<&R#DV8/-78
MPEDOA2W]%Z<"G#H_NMFP=ZQN@S?OTDGCD)V7ES20O#D !RN6.4Q+9_U*E<E%
M)A-#M,-MU=':VE8V78-I6H>D,TC_#PIIU\)4QLJ)MZ%'I,@K$FK]_&(M.D;S
M"F,AV((_H7Y-/A)C(A.7#<ICYU'!K5VU/VN[3KG;&/YW3E&G=Y37MU7K7>Z%
MV9P]FYK,*]Z^GF)F&0\'P5IC;ZS#&Z4EX3XW1))2KO&--[^(^!J[1(6$VNZ9
M[<*2Y7D,Z+KR33P_]KGZ42S+9= L!($+A*7KNY)/"-89*N-QLY!MS^DONZA)
M.FF#GS^ZV9_&;#5.O*4UB;D]=%T7_NFNO.WMR!SW7_-,E"3MR*"-65^ZF\$D
M'G==-=GVQ4N)NRXUP*G7,D]WII0N8G M+O+=4P(%(OV"ZZ+2UC((Q?C#X<<V
M^8JGH5WG7='T1FQV#3DB!&T*HZBC$B@6%W QUWB2J&^HV?Y,0UL"*MRQY6UJ
M#0QL!?G#EE_,N'OO&.# 5@ (-N*E)Q!PL\0JQX;Z"%.$O"TNGQ&JFA28#J2Q
M'J(F.%[I:Q@YAR#U$*1>+TC=0E-C^?9AFJ,O4N-K[I=QE>0II[PHTSU-!1?8
M!CTC 2!RFA-;X$6F[:!5_=T\>^%="OO^Y;J*]J8$MN[W#73J;,QHPU*R:O%.
M%>_S1N7]9>MWRKJ,LD393HK8VN?/G"Q_6"GF9<\5)6=;FC1I\%N&688E3>L"
M@?KP[01[>!J%5XDQ9ZR,:0M'L7[!JB!PREY$W"7MK1DWB@*K5[0<'@ 3M.BK
MX-@VNMI$R=/S15<4K4@_2"78N(836+IDX!!'V)XX@J>/C#&A.)4H($]:6<+(
M][:3=0V*PC8J"M(=V-6@N;'($C49G3=F, ;[CJC86U+/GQT&,0ZD$\9&T>NY
M;28B_"ALZ2FKZ"AL\9!-:*+>%R#(J<\KFYGZ.EI25.FA06;!=J=+]KG/7?27
MK(A,%&F[;G;#[\"^-5@GC+D Z.W"C6==Q@I) R\F5]IF01N[SMTL0]*!"!">
MCV:7Y.TYIU]JL&%:H@Z$;!@D*OPT"V:PO<?=ENF>2EE1#W3?;-U<Q*]L/8>Z
M!S)%HLC1+L7(_#4[!K#5YDUHDD]+V'2-#A?4EXMZ9IP&9.HVJBM:.]W4G>!$
MDWO4E3(WN^G90R!)N+2&+E0HE%.TH+=GOG'*3\R!5XMH?*<(I,1T7N&+?=T'
MI"%_]P&XE7T+FWFAV)B;>Z7PLHBRC_A0'4@UI<XK8D?)]7$F(S8SO1>;\5<)
M<U%LWPL1N;D2%(<R$2,*ILZ-G9DF'YONZBX/C[5M;!44T(^LFRBU,-U,.!WQ
M#W%*1ACM+R(<RQ@ZY&,2;25B#(<ERYB#7K!FLIAO#?00E5WY52[5D=/HBDO7
MB:%&5<5I8CHZY^8?VW"/G,72R+9?_++.5HBH%^Z%=K!+-/EFRCH)"H:5:G?6
M*B:P1^OG35#'2\?_+[5ZF]7H>5U.&4OL>]>NT6O[X(-W& V^<5WQGY'<G<S@
M80DWE:8."3KAEE/,"Z;-B>T+&!+.)UC+JV*3-&$ZOGD\PFL=S<3@-"IB[=8T
M%/&< TT=T&Z?)MVU-3,#S\_*?V%B<AZQB$>8>;02H<'/A""(#LKLHD]6HO36
MLW=YCH"9;QM5[H@:G8&T:;Q%*O*\2 B@.]>@<Q1DEU@$=A+NA:DX0 LUHSDO
MHOVP;XWS-PJ#X>2[Y5QT'V\*KG[U%;D>P7,KVNOJ#JJ6QKRW-.2TS]R4\I_,
MD!R?=FR@.1H#W+K&LKG>.I>KR>S&6*.IT2=-D)OXGG<[,["0]GT53:)L<F.J
M! SM1/V'[*;H>,VD$HF1NBI)OSG*>9SNRO8U_DP3\B():EP76"B4.?4'"Y5@
M)[,*QY/1CDSL/FE!EGF9!D.)&:(L[CJ&./:^DAMJ:+3/:9)1UN\X-NUQG05Z
MZVC!(>JS=;YV8AGBC8,;\<[CC3Q@+_5I=,>#D$,497NB*+<3$%[)_TLZ<:-@
M*\_$E3:GY"Z149+;)?8V(0\L2Y6Z%J)'W:76/_2X7=)JN[K=KU'-P/*\D0)D
M1T#X=90X7;*8<>TX2_6BJ=MTA6+!3CBH+I,B+M>3[W?AQM7I8[HHVAED$GNH
M1?MC8SI;(3\K#"YP6JGO'+8.84D[AU]1)Y1>5F1D+ F3D O8B5@,O<_OKZGI
M3)J>1ZF>QNXWJG/S8\$F9[^JL;:).$@E#SG;7@SG/I.<S9H.'[!;TC5T+[W?
MXP_E\#E*HH X_03_!A:(*VE1@8%%E%B//HMHV#$')X4%:#>84\>$'Y*K)%47
MW!?1Y:/KF4-L>>3M82\#'MT!'J& K&<S<L^9QM=2">?HRZWV@52><Z5K5C:Q
M>DF?Z2LA@B?5I2X@$O4=Q1\(*VFZYK:\);%#G?S\Q6RJ9)B0#LWUF'$RNI3/
MF)%0[6Y_3D2R>U?-.E&V,YP96K3\NKA*KD0(VZZ3>OMXJ>TPJDNM3)M1[J=G
MHS". :,S#!8]GV0!QM3@2T**>53H9N5<6YJTH+SZD8NEU *W#B_89W;N(-1Y
M$ 1PML=")Z=A&5O"]?M\"1<4TE!C&1-\#8J,"LUY( @*KDPBI*.(F1YTUA77
MD#(7M<%:UH*D&]_P?(6&GMUL&J?!Y_HB>EL\'8/W9YN]/VT'<.2BG?0.JX L
MD#/ZKD<>"3C.=4MT!4AL/.\!V6;!N$Y350&M))@ZA1[*L.]7L@[9-31X,7<#
MC[<@I7W;0+(UI#W8]/<ZJ*2_C3I5]EO3' LCZRS!NLFXI3F9?*S!)-^2TW-.
M#G7LYK&M81IO.J%C.- U#Y3T:?21<2YW3*>&T2;==[-YVIUGS"@0:@.QPX7F
MM:)IS'<)MT-77]STRF_H089LCP?I3CU'G#UHTC0D)+=*;&"3[*I="L,X[48(
M2%X[!1XR3CEP7CAECIHJUS6[$W/=$I ]?[[A)F#<I^)J56*GI:2\-'2&_J@,
MH&#)I"'9NA.-X5S_9/(1@WC55BGDBD&? D\K<3,D;,*ZG3YS+T@SA(X?G'+>
M2"\#= )*VV%TN4NB.7O=PQ[':7OJ2MCK&FRDWXB]?&L\%$/1NK\'*H[DV,3,
MBZ5=&?SF1"MVRZ5(0U+J5N6<SYO!*M(;,?&7YSAMM$\F8SR$)N@DEZ\91 U%
M8)!0(!<@"VAWXN_*X=M=$@E_='8@WCC7V*M5(Z>C.'[B7/$PEX>+*)DFT&[0
M+'2J81H!-,Q87E/ST&G:TSQ-\^N$!_52E_[!?+X_?3T/)K5T$XUFX^2BIHA)
M/@-]0DJ!X$_T]I,"CY?G1<'!'!<;_""J]$ZSE::+XJ=&C]$,<P-<(N^I:=H_
ME2H;#M+#.S"GB;R<?G.][O42)2Y8\!!LO6<$G0'V-1"L&17DS+"2T]:PK@01
MBU4]2O)9%Y42YK]M[%F<,[)"ML M8/LNB<PWF6GNU-?!_S/DYYW+* RZ%AAI
MP0[%R3Y5,.;%S#DX$\64>DO22><ZE+@A.\/:,'@/X!O'>:C"ZY7_Z!6]7UB6
M*DP8%(4TP;JBXJ:[PG7=7IF1>S,KB]]]^_CL!7IZ) , ZP4H R"5$6C)A! ?
M"Z3*2Z4J,RQO"FH+JI(^[8BTZ:+Y990FEP![Q:VQQ2X%T>_ED4>')WO3?7TV
MQL+_%P_&A,USUC1>^G-TO5UTU]U&LWERY6[--'E-<\Z:N:-K<@7)=@%TOTKR
MN@3MV21_2"&_7P$GO_85D)+ X7&53KL]AS!1<AX=OT!<Q"R-5WA%(JH"5V92
MRDFT6@VI:6@M7%*O@++W&WU MPLCES=*)7@T]D3?:6=24C9"  L 19YE1  J
M3O='D7/1Z/KC.Y:C@.GDWDC.[EP>*Y0F_8DZQA=U3P%SZ(\OXWZ.MGUC5(JE
M-)A']Z=])HP\YW8NZB\TMRCX-_57WI A].!+<$')Q:;QKP*: =Q!U0A74*#9
M+YVDJ4S/D RYG3]1\AFPLT>/CT;/GHC[J(N):(PZ'IT\/7F\"(>](3CK#L#Y
M!38]JV<N";W3]+X_Q%BW!8=[<)%$*"$BIDJZ,FD14G+K87TUW-E":=V\6'!X
M*9*:A^G!3-N5<L+<&Y7*!^XMN=8!AT&1UZ2?RYEF"GE A:/8#M!&@\7$&!G"
M4EYB +U.CR'>,O"M[>1;FW";X]&SHV=G=R<2HT_](G&7E/D_%+<W,JZU;EEO
M$E)[-@Z@35-VUF*,@Y5_@L:/-!RI<3FK3UQ;VGT!A;&<3C-1_&==5NRA=I5K
MT,I<3>T\JY*#5XFTOSHW-_$+Q=:R%LPB"2@>%SMAF#T.)"?0:M!B3!I*+ *<
MZ>)64E6AI^0='X].#_]&7YKW8_IN&^N==7O?K[O0GA/D\02)S"(A:5T&CTX>
MCXY/&T;=O!X#(0<TVI.B/87T]VB3L00-\HPZBL#A_28W[1*-O)FB?U*Z28$<
MU8;>>HVJS-3[QI ()64@66O V'_5F9)1#R>V]'<>-0;S-LLQ; ./R'@K_9()
M-5'TSG?J O"E@'_I\E=4$!FUVF%T6$2OS%!@QKXWTX!C3*8>PUT\KMV,YK!=
MN7B0$\4#I!.<K/96.X2%"^4$\Q5,J\DY8*"A: :.9NY0@[4</X-Y?Z_9BG;
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MAOL"&RF(<^(2=G=)<4O[,QP(M@B7)I54?6R0=J,1UC#XY?9-P(+%5:<6W;V
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M^)NIQ3+4K%0*V+$^0]!.#(EDM9%I??(1A%E /4TMD9P<=_$B?4D,] 7&I..
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M@!/+6.#:\=TZ[- )G=3114Z<,G?<21B7^ 2G6);<6\3VL5J"69EWXIW'.\0
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MW =*2\\@S3.<W74+I[!#PN3#$NG!_E&C10[%7_>64V\RCUW7C&_[M BS&3#
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MA=<&'E;"I!'::Z7R'R>E69SYHPDP368)^_M"8^/__^U]:7,;1Y+V7T'L[,X
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M/-)@0]#NZUI/CC!/FUS/"K&3F(I$B"UHGT\B#H!A\NG3V !D"XFTBWMC+-4
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MP="H@HJ"L4 B6^7)9) :- *H8;IY3J'LM/F3XF[-;0-O?0Z)FT7AP$^@+P-
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M<W@M,C R,#$R,S$N:'1M4$L! A0#%     @ MX)74FO@$:'%(   K&X! !
M             ( !/DD& &)S>"TR,#(P,3(S,2YX<V102P$"% ,4    " "W
M@E=2ME]=.$4H  !_J@$ %               @ $Q:@8 8G-X+3(P,C Q,C,Q
M7V-A;"YX;6Q02P$"% ,4    " "W@E=2M&JG2U0' 0#;+@L %
M    @ &HD@8 8G-X+3(P,C Q,C,Q7V1E9BYX;6Q02P$"% ,4    " "W@E=2
MR,NKR C]   E: $ $P              @ $NF@< 8G-X+3(P,C Q,C,Q7V<Q
M+FIP9U!+ 0(4 Q0    ( +>"5U*"<@)AK/H! #S>%0 4              "
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M,C!E>6-O;G-E;G0N:'1M4$L! A0#%     @ MX)74I@+<4P\"0  'E8  !T
M             ( !*]$+ &5X:&EB:70S,3$M8V5O,S R,C R,#$P>&LN:'1M
M4$L! A0#%     @ MX)74E5I%+]+"0  .%8  !T              ( !HMH+
M &5X:&EB:70S,3(M8V9O,S R,C R,#$P>&LN:'1M4$L! A0#%     @ MX)7
M4O22BLN9!0  ,"D  !T              ( !*.0+ &5X:&EB:70S,C$M8V5O
M.3 V,C R,#$P>&LN:'1M4$L! A0#%     @ MX)74NH[8[RC!0  OB@  !T
M             ( !_.D+ &5X:&EB:70S,C(M8V9O.3 V,C R,#$P>&LN:'1M
M4$L! A0#%     @ MX)74K?P%),0K@  5@\% !X              ( !VN\+
M &5X:&EB:70T,BUD97-C<FEP=&EO;F]F=&AE+FAT;5!+!08     #@ . -(#
(   FG@P    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
